PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Bhatt, DL; Pollack, CV; Weitz, JI; Jennings, LK; Xu, S; Arnold, SE; Umstead, BR; Mays, MC; Lee, JS				Bhatt, Deepak L.; Pollack, Charles V.; Weitz, Jeffrey I.; Jennings, Lisa K.; Xu, Sherry; Arnold, Susan E.; Umstead, Bret R.; Mays, Michael C.; Lee, John S.			Antibody-Based Ticagrelor Reversal Agent in Healthy Volunteers	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE CORONARY SYNDROMES; ELEVATION MYOCARDIAL-INFARCTION; ASSOCIATION TASK-FORCE; PLATELET TRANSFUSION; ACCF/AHA GUIDELINE; CLOPIDOGREL; PRASUGREL; ASPIRIN; INHIBITION; THERAPY	BACKGROUND Ticagrelor is an oral P2Y 12 inhibitor that is used with aspirin to reduce the risk of ischemic events among patients with acute coronary syndromes or previous myocardial infarction. Spontaneous major bleeding and bleeding associated with urgent invasive procedures are concerns with ticagrelor, as with other antiplatelet drugs. The antiplatelet effects of ticagrelor cannot be reversed with platelet transfusion. A rapid-acting reversal agent would be useful. METHODS In this randomized, double-blind, placebo-controlled, phase 1 trial, we evaluated intravenous PB2452, a monoclonal antibody fragment that binds ticagrelor with high affinity, as a ticagrelor reversal agent. We assessed platelet function in healthy volunteers before and after 48 hours of ticagrelor pretreatment and again after the administration of PB2452 or placebo. Platelet function was assessed with the use of light transmission aggregometry, a point-of-care P2Y 12 platelet-reactivity test, and a vasodilator-stimulated phosphoprotein assay. RESULTS Of the 64 volunteers who underwent randomization, 48 were assigned to receive PB2452 and 16 to receive placebo. After 48 hours of ticagrelor pretreatment, platelet aggregation was suppressed by approximately 80%. PB2452 administered as an initial intravenous bolus followed by a prolonged infusion (8, 12, or 16 hours) was associated with a significantly greater increase in platelet function than placebo, as measured by multiple assays. Ticagrelor reversal occurred within 5 minutes after the initiation of PB2452 and was sustained for more than 20 hours (P< 0.001 after Bonferroni adjustment across all time points for all assays). There was no evidence of a rebound in platelet activity after drug cessation. Adverse events related to the trial drug were limited mainly to issues involving the infusion site. CONCLUSIONS In healthy volunteers, the administration of PB2452, a specific reversal agent for ticagrelor, provided immediate and sustained reversal of the antiplatelet effects of ticagrelor, as measured by multiple assays.	[Bhatt, Deepak L.] Brigham & Womens Hosp, Heart & Vasc Ctr, 75 Francis St, Boston, MA 02115 USA; [Bhatt, Deepak L.] Harvard Med Sch, Boston, MA 02115 USA; [Pollack, Charles V.] Thomas Jefferson Univ, Dept Emergency Med, Philadelphia, PA 19107 USA; [Weitz, Jeffrey I.] McMaster Univ, Hamilton, ON, Canada; [Weitz, Jeffrey I.] Thrombosis & Atherosclerosis Res Inst, Hamilton, ON, Canada; [Jennings, Lisa K.] CirQuest Labs, Memphis, TN USA; [Jennings, Lisa K.] Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA; [Xu, Sherry; Arnold, Susan E.; Umstead, Bret R.; Mays, Michael C.; Lee, John S.] PhaseBio Pharmaceut, Malvern, PA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Jefferson University; McMaster University; McMaster University; University of Tennessee System; University of Tennessee Health Science Center	Bhatt, DL (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Heart & Vasc Ctr, 75 Francis St, Boston, MA 02115 USA.	dlbhattmd@post.harvard.edu	Weitz, Jeffrey/AAD-1929-2019; Bhatt, Deepak L./Y-3070-2019	Weitz, Jeffrey/0000-0002-1092-7550; Bhatt, Deepak L./0000-0002-1278-6245	PhaseBio Pharmaceuticals	PhaseBio Pharmaceuticals	Funded by PhaseBio Pharmaceuticals; ClinicalTrials.gov number, NCT03492385.	[Anonymous], 2016, BRIL TIC; [Anonymous], 2018, EFF PRAS; [Anonymous], 2014, J AM COLL CARDIOL, DOI [DOI 10.1161/CIR.0000000000000134, DOI 10.1016/j.jacc.2014.09.016]; [Anonymous], 2017, PLAV CLOP BIS; Bhatt DL, 2007, NEW ENGL J MED, V357, P2078, DOI 10.1056/NEJMe0706859; Bhatt DL, 2007, J AM COLL CARDIOL, V49, P1982, DOI 10.1016/j.jacc.2007.03.025; Bhatt DL, 2014, CIRC RES, V114, P1929, DOI 10.1161/CIRCRESAHA.114.302737; Bhatt DL, 2010, JAMA-J AM MED ASSOC, V304, P1350, DOI 10.1001/jama.2010.1322; Bhatt DL, 2009, NEW ENGL J MED, V361, P940, DOI 10.1056/NEJMp0806848; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Buchanan A, 2015, BLOOD, V125, P3484, DOI 10.1182/blood-2015-01-622928; Cannon CP, 2010, LANCET, V375, P283, DOI 10.1016/S0140-6736(09)62191-7; Chen ZM, 2005, LANCET, V366, P1607, DOI 10.1016/s0140-6736(05)67660-x; Godier A, 2015, NEW ENGL J MED, V372, P196, DOI 10.1056/NEJMc1409373; Gurbel PA, 2009, CIRCULATION, V120, P2577, DOI 10.1161/CIRCULATIONAHA.109.912550; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Hillis LD, 2011, J AM COLL CARDIOL, V58, pE123, DOI 10.1016/j.jacc.2011.08.009; James SK, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3527; Jin LJ, 2017, HEART LUNG CIRC, V26, P49, DOI 10.1016/j.hlc.2016.05.113; Koski Renee, 2018, P T, V43, P352; Mangiacapra F, 2015, CIRC-CARDIOVASC INTE, V8, DOI 10.1161/CIRCINTERVENTIONS.114.002106; Mehta SR, 2001, LANCET, V358, P527, DOI 10.1016/S0140-6736(01)05701-4; O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI [10.1016/j.jacc.2012.11.019, 10.1161/CIR.0b013e3182742cf6]; Pollack Jr CV, 2015, NEW ENGL J MED, V373, P511, DOI 10.1056/NEJMoa1502000; Reed GW, 2015, CLIN CARDIOL, V38, P92, DOI 10.1002/clc.22357; Roe MT, 2012, NEW ENGL J MED, V367, P1297, DOI 10.1056/NEJMoa1205512; Siegal DM, 2015, NEW ENGL J MED, V373, P2413, DOI 10.1056/NEJMoa1510991; Smith SC, 2011, CIRCULATION, V124, P2458, DOI 10.1161/CIR.0b013e318235eb4d; Tantry US, 2013, J AM COLL CARDIOL, V62, P2261, DOI 10.1016/j.jacc.2013.07.101; Teng R, 2016, J THROMB HAEMOST, V14, P2342, DOI 10.1111/jth.13511; Valgimigli M, 2018, EUR HEART J, V39, P213, DOI 10.1093/eurheartj/ehx419; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wijns W, 2010, EUR HEART J, V31, P2501, DOI 10.1093/eurheartj/ehq277; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Wiviott SD, 2013, LANCET, V382, P605, DOI 10.1016/S0140-6736(13)61451-8; Yusuf S, 2001, NEW ENGL J MED, V345, P494; 2013, CIRCULATION, V127, P730, DOI DOI 10.1161/CIRCULATIONAHA.112.141572; 2015, EUR HEART J, V36, P1762, DOI DOI 10.1093/EURHEARTJ/EHV104	38	63	65	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 9	2019	380	19					1825	1833		10.1056/NEJMoa1901778	http://dx.doi.org/10.1056/NEJMoa1901778			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HX9ZZ	30883047	Green Published, Bronze			2022-12-28	WOS:000467769800008
J	Takahashi, J; Cher, A; Sheeder, J; Teal, S; Guiahi, M				Takahashi, Joelle; Cher, Abigail; Sheeder, Jeanelle; Teal, Stephanie; Guiahi, Maryam			Disclosure of Religious Identity and Health Care Practices on Catholic Hospital Websites	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							REPRODUCTIVE HEALTH		[Takahashi, Joelle; Cher, Abigail] Univ Colorado, Sch Med, Aurora, CO USA; [Sheeder, Jeanelle; Teal, Stephanie; Guiahi, Maryam] Univ Colorado, Sch Med, Dept Obstet & Gynecol, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Guiahi, M (corresponding author), Univ Colorado, Sch Med, Dept Obstet & Gynecol, Anschutz Med Ctr, 12631 E 17th Ave,Mailstop B192-2, Aurora, CO 80045 USA.	maryam.guiahi@ucdenver.edu	Sheeder, Jeanelle/D-4960-2013	Sheeder, Jeanelle/0000-0002-4463-3569				Catholic Health Association of the United States, CATH HLTH CAR DIR; Guiahi M, 2018, OBSTET GYNECOL, V131, P534, DOI 10.1097/AOG.0000000000002477; Guiahi M, 2014, CONTRACEPTION, V90, P429, DOI 10.1016/j.contraception.2014.06.035; Hesse BW, 2005, ARCH INTERN MED, V165, P2618, DOI 10.1001/archinte.165.22.2618; Thorne NB, 2019, OBSTET GYNECOL, V133, P105, DOI 10.1097/AOG.0000000000003029; Washington State Legislature, WAC 246 320 141 PAT	6	20	20	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 19	2019	321	11					1102	1103		10.1001/jama.2019.0133	http://dx.doi.org/10.1001/jama.2019.0133			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP4YY	30874747	Green Published, Bronze			2022-12-28	WOS:000461683500020
J	Drew, L				Drew, Liam			THE MOUSE IN THE VIDEO GAME	NATURE			English	News Item							RESPONSES											Aghajan ZM, 2015, NAT NEUROSCI, V18, P121, DOI 10.1038/nn.3884; Campbell MG, 2018, NAT NEUROSCI, V21, P1096, DOI 10.1038/s41593-018-0189-y; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Holscher C, 2005, J EXP BIOL, V208, P561, DOI 10.1242/jeb.01371; Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033; Pakan JMP, 2018, CELL REP, V24, P2521, DOI 10.1016/j.celrep.2018.08.010; Radvansky BA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03262-4; Rueckemann JW, 2017, CURR OPIN BEHAV SCI, V17, P155, DOI 10.1016/j.cobeha.2017.08.008; Saleem AB, 2018, NATURE, V562, P124, DOI 10.1038/s41586-018-0516-1; Sofroniew NJ, 2014, J NEUROSCI, V34, P9537, DOI 10.1523/JNEUROSCI.0712-14.2014; Zmarz P, 2016, NEURON, V92, P766, DOI 10.1016/j.neuron.2016.09.057	11	3	3	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 14	2019	567	7747					158	160						3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7LD	30862929	Bronze			2022-12-28	WOS:000461126600017
J	Havlicek, V; Corcoles, AD; Temme, K; Harrow, AW; Kandala, A; Chow, JM; Gambetta, JM				Havlicek, Vojtech; Corcoles, Antonio D.; Temme, Kristan; Harrow, Aram W.; Kandala, Abhinav; Chow, Jerry M.; Gambetta, Jay M.			Supervised learning with quantum-enhanced feature spaces	NATURE			English	Article								Machine learning and quantum computing are two technologies that each have the potential to alter how computation is performed to address previously untenable problems. Kernel methods for machine learning are ubiquitous in pattern recognition, with support vector machines (SVMs) being the best known method for classification problems. However, there are limitations to the successful solution to such classification problems when the feature space becomes large, and the kernel functions become computationally expensive to estimate. A core element in the computational speed-ups enabled by quantum algorithms is the exploitation of an exponentially large quantum state space through controllable entanglement and interference. Here we propose and experimentally implement two quantum algorithms on a superconducting processor. A key component in both methods is the use of the quantum state space as feature space. The use of a quantum-enhanced feature space that is only efficiently accessible on a quantum computer provides a possible path to quantum advantage. The algorithms solve a problem of supervised learning: the construction of a classifier. One method, the quantum variational classifier, uses a variational quantum circuit( 1,2) to classify the data in away similar to the method of conventional SVMs. The other method, a quantum kernel estimator, estimates the kernel function on the quantum computer and optimizes a classical SVM. The two methods provide tools for exploring the applications of noisy intermediate-scale quantum computers(3) to machine learning.	[Havlicek, Vojtech; Corcoles, Antonio D.; Temme, Kristan; Kandala, Abhinav; Chow, Jerry M.; Gambetta, Jay M.] IBM TJ Watson Res Ctr, Yorktown Hts, NY 10598 USA; [Havlicek, Vojtech] Univ Oxford, Dept Comp Sci, Wolfson Bldg,Parks Rd, Oxford, England; [Harrow, Aram W.] MIT, Ctr Theoret Phys, Cambridge, MA 02139 USA	International Business Machines (IBM); University of Oxford; Massachusetts Institute of Technology (MIT)	Corcoles, AD; Temme, K (corresponding author), IBM TJ Watson Res Ctr, Yorktown Hts, NY 10598 USA.	adcorcol@us.ibm.com; kptemme@ibm.com		Harrow, Aram/0000-0003-3220-7682	MIT-IBM Watson AI Lab; IBM Research Frontiers Institute; IARPA [W911NF-10-1-0324]; EPSRC [EP/M013243/1] Funding Source: UKRI	MIT-IBM Watson AI Lab(International Business Machines (IBM)); IBM Research Frontiers Institute(International Business Machines (IBM)); IARPA; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank S. Bravyi for discussions. A.W.H. acknowledges funding from the MIT-IBM Watson AI Lab under the project 'Machine Learning in Hilbert Space'. The research was supported by the IBM Research Frontiers Institute. We acknowledge support from IARPA under contract W911NF-10-1-0324 for device fabrication.	Arunachalam S, 2017, SIGACT NEWS, V48, P41, DOI [10.1145/3106700.3106710, DOI 10.1145/3106700.3106710]; Biamonte J, 2017, NATURE, V549, P195, DOI 10.1038/nature23474; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; Bremner MJ, 2017, QUANTUM-AUSTRIA, V1, DOI 10.22331/q-2017-04-25-8; Buhrman H, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.167902; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Cincio L., 2018, PREPRINT; Demarie TF, 2018, PHYS REV A, V97, DOI 10.1103/PhysRevA.97.042319; Dunjko V, 2018, REP PROG PHYS, V81, DOI 10.1088/1361-6633/aab406; Farhi E., 2018, PREPRINT; Farhi E, 2017, PREPRINT; Goldberg LA, 2017, COMPUT COMPLEX, V26, P765, DOI 10.1007/s00037-017-0162-2; Kandala A, 2018, PREPRINT; Kandala A, 2017, NATURE, V549, P242, DOI 10.1038/nature23879; Li Y, 2017, PHYS REV X, V7, DOI 10.1103/PhysRevX.7.021050; Mitarai K., 2018, PREPRINT; Preskill J, 2018, PREPRINT; Rebentrost P, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.130503; Romero J, 2017, QUANTUM SCI TECHNOL, V2, DOI 10.1088/2058-9565/aa8072; Schuld M., 2018, PREPRINT; Smolin JA, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.070502; Spall JC, 1997, AUTOMATICA, V33, P109, DOI 10.1016/S0005-1098(96)00149-5; Spall JC, 2000, IEEE T AUTOMAT CONTR, V45, P1839, DOI 10.1109/TAC.2000.880982; Temme K, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.180509; Terhal BM, 2004, QUANTUM INFORM COMPU, V4, P134; Vapnik V., 2013, NATURE STAT LEARNING; Wan K. H., 2016, PREPRINT	28	463	465	12	152	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 14	2019	567	7747					209	212		10.1038/s41586-019-0980-2	http://dx.doi.org/10.1038/s41586-019-0980-2			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HS4RB	30867609	Green Submitted			2022-12-28	WOS:000463851300001
J	Picard, A				Picard, Andre			Helen Clark: blazing trails from domestic to international politics	LANCET			English	Biographical-Item																		CLARK L, PUBLICATION LIST	1	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 9	2019	393	10175					977	977		10.1016/S0140-6736(19)30440-4	http://dx.doi.org/10.1016/S0140-6736(19)30440-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HO0OW	30860041				2022-12-28	WOS:000460604200015
J	Hoxhaj, G; Ben-Sahra, I; Lockwood, SE; Timson, RC; Byles, V; Henning, GT; Gao, P; Selfors, LM; Asara, JM; Manning, BD				Hoxhaj, Gerta; Ben-Sahra, Issam; Lockwood, Sophie E.; Timson, Rebecca C.; Byles, Vanessa; Henning, Graham T.; Gao, Peng; Selfors, Laura M.; Asara, John M.; Manning, Brendan D.			Direct stimulation of NADP(+) synthesis through Akt-mediated phosphorylation of NAD kinase	SCIENCE			English	Article							BIOSYNTHESIS; MTOR	Nicotinamide adenine dinucleotide phosphate (NADP(+)) is essential for producing NADPH, the primary cofactor for reductive metabolism. We find that growth factor signaling through the phosphoinositide 3-kinase (PI3K)-Akt pathway induces acute synthesis of NADP(+) and NADPH. Akt phosphorylates NAD kinase (NADK), the sole cytosolic enzyme that catalyzes the synthesis of NADP(+) from NAD(+) (the oxidized form of NADH), on three serine residues (Ser44, Ser46, and Ser48) within an amino-terminal domain. This phosphorylation stimulates NADK activity both in cells and directly in vitro, thereby increasing NADP(+) production. A rare isoform of NADK (isoform 3) lacking this regulatory region exhibits constitutively increased activity. These data indicate that Akt-mediated phosphorylation of NADK stimulates its activity to increase NADP(+) production through relief of an autoinhibitory function inherent to its amino terminus.	[Hoxhaj, Gerta; Lockwood, Sophie E.; Timson, Rebecca C.; Byles, Vanessa; Henning, Graham T.; Manning, Brendan D.] Harvard TH Chan Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA; [Ben-Sahra, Issam] Northwestern Univ, Dept Biochem & Mol Genet, Feinberg Sch Med, Chicago, IL 60611 USA; [Gao, Peng] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Metabol Core Facil, Chicago, IL 60611 USA; [Selfors, Laura M.] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA; [Asara, John M.] Beth Israel Deaconess Med Ctr, Mass Spectrometry Core, Boston, MA 02215 USA	Harvard University; Harvard T.H. Chan School of Public Health; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Manning, BD (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA.	bmanning@hsph.harvard.edu	Manning, Brendan/ABD-6528-2021	Manning, Brendan/0000-0003-3895-5956; Gao, Peng/0000-0002-9991-6064; SELFORS, LAURA/0000-0002-1317-7353; Hoxhaj, Gerta/0000-0001-6179-3583; Ben-Sahra, Issam/0000-0001-9333-4162; Asara, John/0000-0001-7450-2589	NIH [R00-CA194192, P01-CA120964, R35-CA197459]; NATIONAL CANCER INSTITUTE [R00CA194192, P01CA120964, R35CA197459] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by NIH grants R00-CA194192 (I.B.-S.), P01-CA120964 (B.D.M. and J.M.A.), and R35-CA197459 (B.D.M.).	Agledal L, 2010, REDOX REP, V15, P2, DOI 10.1179/174329210X12650506623122; Ben-Sahra I, 2017, CURR OPIN CELL BIOL, V45, P72, DOI 10.1016/j.ceb.2017.02.012; Ben-Sahra I, 2016, SCIENCE, V351, P728, DOI 10.1126/science.aad0489; Ben-Sahra I, 2013, SCIENCE, V339, P1323, DOI 10.1126/science.1228792; Byles V, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3834; DeBerardinis RJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600200; Hirai H, 2010, MOL CANCER THER, V9, P1956, DOI 10.1158/1535-7163.MCT-09-1012; Lewis CA, 2014, MOL CELL, V55, P253, DOI 10.1016/j.molcel.2014.05.008; Lien EC, 2016, NAT CELL BIOL, V18, P572, DOI 10.1038/ncb3341; Liu L, 2018, CELL METAB, V27, P1067, DOI 10.1016/j.cmet.2018.03.018; Love NR, 2015, P NATL ACAD SCI USA, V112, P1386, DOI 10.1073/pnas.1417290112; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; Pollak N, 2007, J BIOL CHEM, V282, P33562, DOI 10.1074/jbc.M704442200; Robitaille AM, 2013, SCIENCE, V339, P1320, DOI 10.1126/science.1228771; Stanton RC, 2012, IUBMB LIFE, V64, P362, DOI 10.1002/iub.1017; Yuan M, 2012, NAT PROTOC, V7, P872, DOI 10.1038/nprot.2012.024	16	61	63	5	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 8	2019	363	6431					1088	+		10.1126/science.aau3903	http://dx.doi.org/10.1126/science.aau3903			42	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO2MV	30846598	Green Accepted			2022-12-28	WOS:000460750100048
J	Mack, I; Ritz, N				Mack, Ines; Ritz, Nicole			African Tick-Bite Fever	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Mack, Ines; Ritz, Nicole] Univ Childrens Hosp, Basel, Switzerland		Mack, I (corresponding author), Univ Childrens Hosp, Basel, Switzerland.	ines.mack@ukbb.ch	Ritz, Nicole/G-2924-2015	Ritz, Nicole/0000-0002-1498-1685					0	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 7	2019	380	10					960	960		10.1056/NEJMicm1810093	http://dx.doi.org/10.1056/NEJMicm1810093			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HN8QX	30855745				2022-12-28	WOS:000460461500009
J	Kirby, T				Kirby, Tony			Australia reports on audit of silicosis for stonecutters	LANCET			English	Editorial Material																			0	31	32	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 2	2019	393	10174					861	861		10.1016/S0140-6736(19)30478-7	http://dx.doi.org/10.1016/S0140-6736(19)30478-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HN4AP	30837133				2022-12-28	WOS:000460126900011
J	Nakkazi, E				Nakkazi, Esther			Death of Ugandan man tests country's preparedness	LANCET			English	Editorial Material																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 2	2019	393	10174					863	863		10.1016/S0140-6736(19)30480-5	http://dx.doi.org/10.1016/S0140-6736(19)30480-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HN4AP	30837135				2022-12-28	WOS:000460126900013
J	Atkins, JL; Long, RA; Pansu, J; Daskin, JH; Potter, AB; Stalmans, ME; Tarnita, CE; Pringle, RM				Atkins, Justine L.; Long, Ryan A.; Pansu, Johan; Daskin, Joshua H.; Potter, Arjun B.; Stalmans, Marc E.; Tarnita, Corina E.; Pringle, Robert M.			Cascading impacts of large-carnivore extirpation in an African ecosystem	SCIENCE			English	Article							TROPHIC CASCADES; EXTRACELLULAR DNA; DEFENDING PLANTS; PREY PREFERENCES; SAVANNA; ECOLOGY; WOLVES; ELK; COMMUNITIES; REDUCTION	Populations of the world's largest carnivores are declining and now occupy mere fractions of their historical ranges. Theory predicts that when apex predators disappear, large herbivores become less fearful, occupy new habitats, and modify those habitats by eating new food plants. Yet experimental support for this prediction has been difficult to obtain in large-mammal systems. After the extirpation of leopards and African wild dogs from Mozambique's Gorongosa National Park, forest-dwelling antelopes [bushbuck (Tragelaphus sylvaticus)] expanded into treeless floodplains, where they consumed novel diets and suppressed a common food plant [waterwort (Bergia mossambicensis)]. By experimentally simulating predation risk, we demonstrate that this behavior was reversible. Thus, whereas anthropogenic predator extinction disrupted a trophic cascade by enabling rapid differentiation of prey behavior, carnivore restoration may just as rapidly reestablish that cascade.	[Atkins, Justine L.; Pansu, Johan; Daskin, Joshua H.; Potter, Arjun B.; Tarnita, Corina E.; Pringle, Robert M.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Long, Ryan A.] Univ Idaho, Dept Fish & Wildlife Sci, Moscow, ID 83843 USA; [Pansu, Johan] Sorbonne Univ, Stn Biol Roscoff, UMR 7144, CNRS, F-29688 Roscoff, France; [Pansu, Johan] CSIRO Ocean & Atmosphere, Lucas Heights, NSW 2234, Australia; [Stalmans, Marc E.] Dept Sci Serv, Parque Nacl Gorongosa, Sofala, Mozambique; [Daskin, Joshua H.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA	Princeton University; Idaho; University of Idaho; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Yale University	Atkins, JL; Pringle, RM (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	jlatkins@princeton.edu; rpringle@princeton.edu		Daskin, Joshua/0000-0002-1134-7072; Potter, Arjun/0000-0002-7789-6349; Becker, Justine A./0000-0003-4168-8350; Stalmans, Marc/0000-0001-9779-6292	U.S. National Science Foundation [IOS-1656527, IOS-1656642]; Cameron Schrier Foundation; Princeton University; Greg Carr Foundation; Parque Nacional da Gorongosa	U.S. National Science Foundation(National Science Foundation (NSF)); Cameron Schrier Foundation; Princeton University(Princeton University); Greg Carr Foundation; Parque Nacional da Gorongosa	We acknowledge support from the U.S. National Science Foundation (IOS-1656527 and IOS-1656642), Cameron Schrier Foundation, Greg Carr Foundation, Parque Nacional da Gorongosa, and Princeton University.	Allen BL, 2013, BIOL CONSERV, V159, P158, DOI 10.1016/j.biocon.2012.12.004; ALLSOPP R, 1978, E AFR WILDL J, V16, P153; Atkins J. L., 2019, DRYAD, DOI [10.5061/dryad.h4r1003, DOI 10.5061/DRYAD.H4R1003]; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beilfuss R., 2008, LANDSCAPES GORONGOSA; Berger J, 2001, SCIENCE, V291, P1036, DOI 10.1126/science.1056466; Binladen J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000197; Bivand R.S., 2013, APPL SPATIAL DATA AN, DOI 10.1007/978-1-4614-7618-4; Bjorneraas K, 2010, J WILDLIFE MANAGE, V74, P1361, DOI 10.2193/2009-405; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Bouley P, 2018, BIOL CONSERV, V227, P233, DOI 10.1016/j.biocon.2018.08.024; Boyer F, 2016, MOL ECOL RESOUR, V16, P176, DOI 10.1111/1755-0998.12428; Brown JS, 1999, J MAMMAL, V80, P385, DOI 10.2307/1383287; Burns Z., 2010, THESIS; Cook RC, 2010, J WILDLIFE MANAGE, V74, P880, DOI 10.2193/2009-031; Craine JM, 2015, SCI REP-UK, V5, DOI 10.1038/srep16738; Csardi G., 2006, INTERJOURNALCOMPLEX, V1695, P1, DOI DOI 10.3724/SP.J.1087.2009.02191; Daskin JH, 2016, J ECOL, V104, P79, DOI 10.1111/1365-2745.12483; Deagle BE, 2019, MOL ECOL, V28, P391, DOI 10.1111/mec.14734; Dial KP, 2008, TRENDS ECOL EVOL, V23, P394, DOI 10.1016/j.tree.2008.03.005; ESTES JA, 1974, SCIENCE, V185, P1058, DOI 10.1126/science.185.4156.1058; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Estes R. D., 1999, SAFARI COMPANION GUI; ESTES RD, 1991, BEHAV GUIDE AFRICAN; Ferrero DM, 2011, P NATL ACAD SCI USA, V108, P11235, DOI 10.1073/pnas.1103317108; Ficetola GF, 2015, MOL ECOL RESOUR, V15, P543, DOI 10.1111/1755-0998.12338; Ficetola GF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-434; Ford AT, 2015, TRENDS ECOL EVOL, V30, P725, DOI 10.1016/j.tree.2015.09.012; Ford AT, 2015, J MAMMAL, V96, P918, DOI 10.1093/jmammal/gyv090; Ford AT, 2014, SCIENCE, V346, P346, DOI 10.1126/science.1252753; Fortin D, 2005, ECOLOGY, V86, P1320, DOI 10.1890/04-0953; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Grinnell J, 2001, ANIM BEHAV, V62, P93, DOI 10.1006/anbe.2001.1735; Hayward MW, 2008, S AFR J WILDL RES, V38, P93, DOI 10.3957/0379-4369-38.2.93; Hayward MW, 2005, J ZOOL, V267, P309, DOI 10.1017/S0952836905007508; Hettena AM, 2014, ETHOLOGY, V120, P427, DOI 10.1111/eth.12219; Hijmans RJ, 2012, RASTER GEOGRAPHIC AN; JARMAN PJ, 1974, BEHAVIOUR, V48, P215, DOI 10.1163/156853974X00345; Kardous CA, 2014, J ACOUST SOC AM, V135, pEL186, DOI 10.1121/1.4865269; Kartzinel TR, 2015, P NATL ACAD SCI USA, V112, P8019, DOI 10.1073/pnas.1503283112; Kauffman MJ, 2010, ECOLOGY, V91, P2742, DOI 10.1890/09-1949.1; Kingdon J., 2015, KINGDON FIELD GUIDE, V2; Kranstauber B., 2016, MOVE VISUALIZING ANA; Laundre J.W., 2010, OPEN ECOL J, V3, P1, DOI [DOI 10.2174/1874213001003030001, 10.2174/1874213001003030001]; Le Roux E, 2018, CURR BIOL, V28, P2493, DOI 10.1016/j.cub.2018.05.088; Long RA, 2014, ECOL MONOGR, V84, P513, DOI 10.1890/13-1273.1; MCCOMB K, 1994, ANIM BEHAV, V47, P379, DOI 10.1006/anbe.1994.1052; Owen-Smith N, 2015, OIKOS, V124, P1417, DOI 10.1111/oik.02218; Pansu J, 2019, J ECOL, V107, P1355, DOI 10.1111/1365-2745.13113; Pansu J, 2015, MOL ECOL, V24, P1485, DOI 10.1111/mec.13136; Pebesma E. J., 2005, R NEWS, V5, P9; Peckarsky BL, 2008, ECOLOGY, V89, P2416, DOI 10.1890/07-1131.1; Pinheiro J., 2017, NLME LINEAR NONLINEA; Pringle RM, 2017, NATURE, V546, P91, DOI 10.1038/nature22902; R Development Core Team, 2009, R LANG ENV STAT COMP; Radloff FGT, 2004, J ANIM ECOL, V73, P410, DOI 10.1111/j.0021-8790.2004.00817.x; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Ripple WJ, 2001, BIOL CONSERV, V102, P227, DOI 10.1016/S0006-3207(01)00107-0; ROBBINS CT, 1987, ECOLOGY, V68, P1606, DOI 10.2307/1939852; ROBBINS CT, 1987, ECOLOGY, V68, P98, DOI 10.2307/1938809; Schmitz OJ, 2004, ECOL LETT, V7, P153, DOI 10.1111/j.1461-0248.2003.00560.x; Schmitz OJ, 2008, SCIENCE, V319, P952, DOI 10.1126/science.1152355; Stalmans M., 2016, AERIAL WILDLIFE COUN; Stalmans ME, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212864; Steinbruch F, 2014, PHYS CHEM EARTH, V72-75, P13, DOI 10.1016/j.pce.2014.09.007; Stigand C. H., 1909, GAME BRIT E AFRICA; Suraci JP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10698; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; Taberlet P, 2012, MOL ECOL, V21, P1816, DOI 10.1111/j.1365-294X.2011.05317.x; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; Terborgh J., 2010, TROPHIC CASCADES PRE; Tinley K. L., 1977, THESIS; Trussell GC, 2006, ECOLOGY, V87, P2979, DOI 10.1890/0012-9658(2006)87[2979:TFOBER]2.0.CO;2; Vasse G., 1909, 3 YEARS SPORT MOZAMB; WASER P, 1975, East African Wildlife Journal, V13, P49; Willerslev E, 2014, NATURE, V506, P47, DOI 10.1038/nature12921; Winnie J., 2017, FOOD WEBS, V12, P88, DOI DOI 10.1016/J.FOOWEB.2016.09.002; Wronski T, 2006, BEHAV PROCESS, V73, P333, DOI 10.1016/j.beproc.2006.08.003; Wronski T, 2009, ACTA ETHOL, V12, P71, DOI 10.1007/s10211-009-0058-5; Yoccoz NG, 2012, MOL ECOL, V21, P3647, DOI 10.1111/j.1365-294X.2012.05545.x; Zinger L, 2016, SOIL BIOL BIOCHEM, V96, P16, DOI 10.1016/j.soilbio.2016.01.008; Zuur Alain F., 2009, P1	84	68	69	10	113	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 12	2019	364	6436					173	+		10.1126/science.aau3561	http://dx.doi.org/10.1126/science.aau3561			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HT5RC	30846612				2022-12-28	WOS:000464620000041
J	Norton, EC; Dowd, BE; Maciejewski, ML				Norton, Edward C.; Dowd, Bryan E.; Maciejewski, Matthew L.			Marginal Effects-Quantifying the Effect of Changes in Risk Factors in Logistic Regression Models	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Norton, Edward C.] Univ Michigan, Dept Econ, Dept Hlth Management & Policy, Ann Arbor, MI 48109 USA; [Norton, Edward C.] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Dowd, Bryan E.] Univ Minnesota, Sch Publ Hlth, Div Hlth Policy & Management, Minneapolis, MN USA; [Maciejewski, Matthew L.] Durham Vet Affairs Hlth Care Syst, Durham Ctr Innovat Accelerate Discovery & Practic, 508 Fulton St,Ste 600, Durham, NC 27705 USA; [Maciejewski, Matthew L.] Duke Univ, Sch Med, Dept Populat Hlth Sci, Durham, NC USA; [Maciejewski, Matthew L.] Duke Univ, Sch Med, Dept Med, Div Gen Internal Med, Durham, NC 27706 USA	University of Michigan System; University of Michigan; National Bureau of Economic Research; University of Minnesota System; University of Minnesota Twin Cities; Duke University; Duke University	Maciejewski, ML (corresponding author), Durham Vet Affairs Hlth Care Syst, Durham Ctr Innovat Accelerate Discovery & Practic, 508 Fulton St,Ste 600, Durham, NC 27705 USA.	matthew.maciejewski@va.gov	, Edward/AAQ-1719-2021	, Edward/0000-0003-4555-0631	HSRD VA [IK6 HX003157] Funding Source: Medline	HSRD VA		Cummings JR, 2013, JAMA PSYCHIAT, V70, P1084, DOI 10.1001/jamapsychiatry.2013.377; Irony TZ, 2018, JAMA-J AM MED ASSOC, V320, P1027, DOI 10.1001/jama.2018.12115; Karaca-Mandic P, 2012, HEALTH SERV RES, V47, P255, DOI 10.1111/j.1475-6773.2011.01314.x; Meurer WJ, 2017, JAMA-J AM MED ASSOC, V317, P1068, DOI 10.1001/jama.2016.20441; Norton EC, 2018, HEALTH SERV RES, V53, P859, DOI 10.1111/1475-6773.12712; Sackett DL, 1996, EVIDENCE BASED MED, V1, P164, DOI DOI 10.1136/EBM.1996.1.164; Tolles J, 2016, JAMA-J AM MED ASSOC, V316, P533, DOI 10.1001/jama.2016.7653	8	148	149	2	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 2	2019	321	13					1304	1305		10.1001/jama.2019.1954	http://dx.doi.org/10.1001/jama.2019.1954			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HR3XR	30848814				2022-12-28	WOS:000463076800017
J	Henderson, CM; Fink, SL; Bassyouni, H; Argiropoulos, B; Brown, L; Laha, TJ; Jackson, KJ; Lewkonia, R; Ferreira, P; Hoofnagle, AN; Marcadier, JL				Henderson, Clark M.; Fink, Susan L.; Bassyouni, Hanan; Argiropoulos, Bob; Brown, Lindsay; Laha, Thomas J.; Jackson, Konner J.; Lewkonia, Raymond; Ferreira, Patrick; Hoofnagle, Andrew N.; Marcadier, Julien L.			Vitamin D-Binding Protein Deficiency and Homozygous Deletion of the GC Gene	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							D METABOLITES; SERUM; AFFINITY	A 58-year-old woman with debilitating ankylosing spondylitis who was born to consanguineous parents was found to have an apparent severe vitamin D deficiency that did not respond to supplementation. Liquid chromatography-tandem mass spectrometry showed the absence of circulating vitamin D-binding protein, and chromosomal microarray confirmed a homozygous deletion of the group-specific component (GC) gene that encodes the protein. Congenital absence of vitamin D-binding protein resulted in normocalcemia and a relatively mild disruption of bone metabolism, in this case complicated by severe autoimmune disease.	[Henderson, Clark M.; Fink, Susan L.; Laha, Thomas J.; Jackson, Konner J.; Hoofnagle, Andrew N.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Hoofnagle, Andrew N.] Univ Washington, Dept Med, Seattle, WA USA; [Hoofnagle, Andrew N.] Univ Washington, Kidney Res Inst, Seattle, WA 98195 USA; [Bassyouni, Hanan] Univ Calgary, Dept Endocrinol & Metab, Calgary, AB, Canada; [Argiropoulos, Bob] Univ Calgary, Alberta Childrens Hosp Res Inst, Calgary, AB, Canada; [Lewkonia, Raymond; Ferreira, Patrick; Marcadier, Julien L.] Alberta Childrens Prov Gen Hosp, Div Med Genet, 28 Oki Dr, Calgary, AB T3B 6A8, Canada; [Brown, Lindsay] Childrens & Womens Hlth Ctr British Columbia, Dept Pathol, Vancouver, BC, Canada	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Calgary; University of Calgary; Alberta Childrens Hospital; University of Calgary; BC Women's Hospital & Health Centre	Marcadier, JL (corresponding author), Alberta Childrens Prov Gen Hosp, Div Med Genet, 28 Oki Dr, Calgary, AB T3B 6A8, Canada.; Hoofnagle, AN (corresponding author), Univ Washington, Med Ctr, 1959 NE Pacific St,Rm NW120, Seattle, WA 98195 USA.	ahoof@u.w.edu; julien.marcadier@ahs.ca		Brown, Lindsay/0000-0002-2790-5112; Fink, Susan/0000-0003-1705-0103	National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [P30DK035816]; NIH National Institute of Allergy and Infectious Diseases [K08AI119142]; University of Washington Department of Laboratory Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI119142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK035816] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Washington Department of Laboratory Medicine(University of Washington); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by grants from the National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (P30DK035816, to Dr. Hoofnagle), and from the NIH National Institute of Allergy and Infectious Diseases (K08AI119142, to Dr. Fink), and the University of Washington Department of Laboratory Medicine.	Aranow C, 2011, J INVEST MED, V59, P881, DOI 10.2310/JIM.0b013e31821b8755; ARNAUD J, 1993, HUM GENET, V92, P183; Bikle D, 2017, J STEROID BIOCHEM, V173, P105, DOI 10.1016/j.jsbmb.2017.01.007; BIKLE DD, 1984, J CLIN INVEST, V74, P1966, DOI 10.1172/JCI111617; BOUILLON R, 1980, J STEROID BIOCHEM, V13, P1029, DOI 10.1016/0022-4731(80)90133-8; Bouillon R., 2018, VITAMIN D BINDING PR, V1, P97; Cai GQ, 2015, CLIN CHIM ACTA, V438, P316, DOI 10.1016/j.cca.2014.08.040; Chun RF, 2014, J STEROID BIOCHEM, V144, P132, DOI 10.1016/j.jsbmb.2013.09.012; Chun RF, 2012, CELL BIOCHEM FUNCT, V30, P445, DOI 10.1002/cbf.2835; COOKE NE, 1989, ENDOCR REV, V10, P294, DOI 10.1210/edrv-10-3-294; DAIGER SP, 1975, P NATL ACAD SCI USA, V72, P2076, DOI 10.1073/pnas.72.6.2076; Henderson CM, 2016, CLIN CHEM, V62, P179, DOI 10.1373/clinchem.2015.244541; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hollis BW, 2013, J CLIN ENDOCR METAB, V98, P4619, DOI 10.1210/jc.2013-2653; Jeffery LE, 2016, NAT REV RHEUMATOL, V12, P201, DOI 10.1038/nrrheum.2015.140; KAWAKAMI M, 1979, BIOCHEM J, V179, P413, DOI 10.1042/bj1790413; Laha TJ, 2012, CLIN CHEM, V58, P1711, DOI 10.1373/clinchem.2012.185827; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lin YT, 2017, EXP NEUROL, V291, P62, DOI 10.1016/j.expneurol.2017.02.003; Pike JW, 2008, ENDOCRINOLOGY, V149, P3656, DOI 10.1210/en.2008-0042; Prietl B, 2013, NUTRIENTS, V5, P2502, DOI 10.3390/nu5072502; Robinson-Cohen C, 2017, J CLIN ENDOCR METAB, V102, P3075, DOI 10.1210/jc.2017-00296; Robinson-Cohen C, 2013, JAMA-J AM MED ASSOC, V310, P179, DOI 10.1001/jama.2013.7228; Safadi FF, 1999, J CLIN INVEST, V103, P239, DOI 10.1172/JCI5244; Trujillo G, 2013, J IMMUNOL, V191, P848, DOI 10.4049/jimmunol.1202941	25	28	29	1	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 21	2019	380	12					1150	1157		10.1056/NEJMoa1807841	http://dx.doi.org/10.1056/NEJMoa1807841			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP7VK	30893535	Green Accepted, Bronze			2022-12-28	WOS:000461898400010
J	Pizzo, PA				Pizzo, Philip A.			Management of Patients With Fever and Neutropenia Through the Arc of Time A Narrative Review	ANNALS OF INTERNAL MEDICINE			English	Review							INFECTIOUS-DISEASES SOCIETY; EMPIRICAL ANTIBIOTIC-THERAPY; MALIGNANCY AMERICAN SOCIETY; CLINICAL-PRACTICE GUIDELINE; INVASIVE FUNGAL-INFECTIONS; FEBRILE NEUTROPENIA; ANTIMICROBIAL AGENTS; ANTIFUNGAL THERAPY; CANCER-PATIENTS; HEMATOLOGICAL MALIGNANCIES	The association between fever and neutropenia and the risk for life-threatening infections in patients receiving cytotoxic chemotherapy has been known for 50 years. Indeed, infectious complications have been a leading cause of morbidity and mortality in patients with cancer. This review chronicles the progress in defining and developing approaches to the management of fever and neutropenia through observational and controlled clinical trials done by single institutions, as well as by national and international collaborative groups. The resultant data have led to recommendations and guidelines from professional societies and frame the current principles of management. Recommendations include those guiding new treatment options (from monotherapy to oral antibiotic therapy) and use of prophylactic antimicrobial regimens in high-risk patients. Of note, risk factors have changed with the advent of hematopoietic cytokines (especially granulocyte colony-stimulating factor) in shortening the duration of neutropenia, as well as with the discovery of more targeted cancer treatments that do not result in cytotoxicity, although these are still the exception. Most guiding principles that were developed decades ago-about when to begin empirical treatment after a neutropenic patient becomes febrile, whether and how to modify the initial treatment regimen (especially in patients with protracted neutropenia), and how long to continue antimicrobial therapy-are still used today. This review describes how the treatment principles related to the management of fever and neutropenia have responded to changes in the patients at risk, the microbes responsible, and the tools for their treatment, while still being sustained over the arc of time.	[Pizzo, Philip A.] Stanford Univ, Sch Med, Lorry Lokey Res Bldg,265 Campus Dr G1078, Stanford, CA 94305 USA; [Pizzo, Philip A.] Stanford Univ, Stanford Distinguished Careers Inst, Stanford, CA 94305 USA	Stanford University; Stanford University	Pizzo, PA (corresponding author), Stanford Univ, Sch Med, Lorry Lokey Res Bldg,265 Campus Dr G1078, Stanford, CA 94305 USA.	ppizzo@stanford.edu						Aguilar-Guisado M, 2017, LANCET HAEMATOL, V4, pE573, DOI 10.1016/S2352-3026(17)30211-9; Aquino VM, 1997, MED PEDIATR ONCOL, V28, P191, DOI 10.1002/(SICI)1096-911X(199703)28:3<191::AID-MPO7>3.0.CO;2-E; Arif S, 2017, CLIN CHEST MED, V38, P555, DOI 10.1016/j.ccm.2017.04.014; Ascioglu S, 2002, CLIN INFECT DIS, V34, P7, DOI 10.1086/323335; Averbuch D, 2017, CLIN INFECT DIS, V65, P1819, DOI 10.1093/cid/cix646; Baker TM, 2016, LEUKEMIA LYMPHOMA, V57, P2245, DOI 10.1080/10428194.2016.1193859; Batzlaff CM, 2017, CLIN CHEST MED, V38, P385, DOI 10.1016/j.ccm.2017.04.002; BODEY GP, 1966, ANN INTERN MED, V64, P328, DOI 10.7326/0003-4819-64-2-328; BUCHANAN GR, 1993, HEMATOL ONCOL CLIN N, V7, P919, DOI 10.1016/S0889-8588(18)30212-0; Chen SC, 2014, INTERN MED J, V44, P1315, DOI 10.1111/imj.12597; Cooper KL, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-404; Cornely OA, 2014, CLIN MICROBIOL INFEC, V20, P5, DOI 10.1111/1469-0691.12371; DeVita VT, 2008, CANCER RES, V68, P8643, DOI 10.1158/0008-5472.CAN-07-6611; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Farmakiotis D, 2016, INFECT DIS CLIN N AM, V30, P143, DOI 10.1016/j.idc.2015.10.011; Feld R, 2002, CLIN INFECT DIS, V35, P1463, DOI 10.1086/344650; Flowers CR, 2013, J CLIN ONCOL, V31, P794, DOI 10.1200/JCO.2012.45.8661; Freifeld A G, 1996, Oncology (Williston Park), V10, P599; Freifeld AG, 2006, NEW ENGL J MED, V354, P90; FREIFELD AG, 1995, J CLIN ONCOL, V13, P165, DOI 10.1200/JCO.1995.13.1.165; Freifeld AG, 1996, ONCOLOGY, V10, P611; Freifeld AG, 1996, ONCOLOGY, V10, P615; Freifeld AG, 2011, CLIN INFECT DIS, V52, pE56, DOI 10.1093/cid/cir073; Girmenia C, 2017, CLIN INFECT DIS, V65, P1884, DOI 10.1093/cid/cix690; Gopalakrishnan V, 2018, CANCER CELL, V33, P570, DOI 10.1016/j.ccell.2018.03.015; Greene RE, 2007, CLIN INFECT DIS, V44, P373, DOI 10.1086/509917; Hakim H, 2018, CLIN INFECT DIS, V67, P541, DOI 10.1093/cid/ciy153; HUGHES WT, 1990, J INFECT DIS, V161, P381, DOI 10.1093/infdis/161.3.381; Hughes WT, 2002, CLIN INFECT DIS, V34, P730, DOI 10.1086/339215; Hunger SP, 2015, NEW ENGL J MED, V373, P1541, DOI 10.1056/NEJMra1400972; June CH, 2018, NEW ENGL J MED, V379, P64, DOI 10.1056/NEJMra1706169; Khanal S, 2018, BIOMEDICINES, V6, DOI 10.3390/biomedicines6010030; Kimura S, 2014, J INFECTION, V69, P13, DOI 10.1016/j.jinf.2014.02.013; KLASTERSKY J, 1982, REV INFECT DIS, V4, P294; Koh AY, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006342; Le Clech L, 2018, INFECT DIS-NOR, V50, P539, DOI 10.1080/23744235.2018.1438649; Liles WC, 1997, TRANSFUSION, V37, P182, DOI 10.1046/j.1537-2995.1997.37297203521.x; Longo DL, 2017, NEW ENGL J MED, V376, P982, DOI 10.1056/NEJMe1700833; LOVE LJ, 1980, AM J MED, V68, P643, DOI 10.1016/0002-9343(80)90243-0; Luplertlop N, 2018, J MYCOL MED, V28, P249, DOI 10.1016/j.mycmed.2018.02.015; Mellinghoff SC, 2018, ANN HEMATOL, V97, P197, DOI 10.1007/s00277-017-3196-2; MEUNIER F, 1989, AM J MED, V86, P668; Micol JB, 2014, CLIN MICROBIOL INFEC, V20, pO453, DOI 10.1111/1469-0691.12445; Orasch C, 2015, CLIN MICROBIOL INFEC, V21, pE25, DOI 10.1016/j.cmi.2014.10.014; Orlowski HLP, 2017, RADIOGRAPHICS, V37, P1119, DOI 10.1148/rg.2017160110; Pappas PG, 2009, CLIN INFECT DIS, V48, P503, DOI 10.1086/596757; Patterson TF, 2016, CLIN INFECT DIS, V63, pE1, DOI 10.1093/cid/ciw326; Peters C, 1999, BRIT J HAEMATOL, V106, P689, DOI 10.1046/j.1365-2141.1999.01619.x; PIZZO PA, 1990, J INFECT DIS, V161, P397, DOI 10.1093/infdis/161.3.397; PIZZO PA, 1984, AM J MED, V76, P436, DOI 10.1016/0002-9343(84)90663-6; PIZZO PA, 1979, AM J MED, V67, P194, DOI 10.1016/0002-9343(79)90390-5; Pizzo PA, 1999, NEW ENGL J MED, V341, P893, DOI 10.1056/NEJM199909163411207; PIZZO PA, 1993, NEW ENGL J MED, V328, P1323; PIZZO PA, 1986, NEW ENGL J MED, V315, P552, DOI 10.1056/NEJM198608283150905; PIZZO PA, 1983, J PEDIATR-US, V102, P125, DOI 10.1016/S0022-3476(83)80310-2; PIZZO PA, 1982, AM J MED, V72, P101, DOI 10.1016/0002-9343(82)90594-0; Polvi EJ, 2015, CELL MOL LIFE SCI, V72, P2261, DOI 10.1007/s00018-015-1860-z; Price TH, 2006, TRANSFUSION, V46, P1, DOI 10.1111/j.1537-2995.2006.00693.x; Price TH, 2000, BLOOD, V95, P3302, DOI 10.1182/blood.V95.11.3302.010k35_3302_3309; Price TH, 2015, BLOOD, V126, P2153, DOI 10.1182/blood-2015-05-645986; Shojania KG, 2007, ANN INTERN MED, V147, P224, DOI 10.7326/0003-4819-147-4-200708210-00179; Steinbach WJ, 2015, PEDIATR INFECT DIS J, V34, P1020, DOI 10.1097/INF.0000000000000797; Sung L, 2007, ANN INTERN MED, V147, P400, DOI 10.7326/0003-4819-147-6-200709180-00010; Taplitz RA, 2018, J CLIN ONCOL, V36, P1443, DOI 10.1200/JCO.2017.77.6211; Tebruegge M, 2012, PEDIATR INFECT DIS J, V31, P626, DOI 10.1097/INF.0b013e318250b066; Truong J, 2016, ANN ONCOL, V27, P608, DOI 10.1093/annonc/mdv619; van Duin D, 2018, CLIN INFECT DIS, V66, P163, DOI 10.1093/cid/cix783; VANDERWAAIJ D, 1992, EPIDEMIOL INFECT, V109, P315, DOI 10.1017/S0950268800050317; Walsh T J, 1999, Transpl Infect Dis, V1, P247, DOI 10.1034/j.1399-3062.1999.010404.x; WALSH TJ, 1991, NEW ENGL J MED, V324, P1026, DOI 10.1056/NEJM199104113241504; WALSH TJ, 1995, AM J MED, V99, P164, DOI 10.1016/S0002-9343(99)80136-3; Wingard JR, 2004, CLIN INFECT DIS, V39, pS38, DOI 10.1086/383052	72	16	16	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 19	2019	170	6					389	+		10.7326/M18-3192	http://dx.doi.org/10.7326/M18-3192			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP1ZR	30856657				2022-12-28	WOS:000461468300016
J	Liao, WQ; Zhao, DW; Tang, YY; Zhang, Y; Li, PF; Shi, PP; Chen, XG; You, YM; Xiong, RG				Liao, Wei-Qiang; Zhao, Dewei; Tang, Yuan-Yuan; Zhang, Yi; Li, Peng-Fei; Shi, Ping-Ping; Chen, Xiao-Gang; You, Yu-Meng; Xiong, Ren-Gen			A molecular perovskite solid solution with piezoelectricity stronger than lead zirconate titanate	SCIENCE			English	Article							TEMPERATURE FERROELECTRICITY; ELECTROMECHANICAL RESPONSE; PHYSICAL-PROPERTIES; SINGLE-CRYSTAL; CERAMICS; CALCIUM; NIOBATE; BARIUM; ORIGIN	Piezoelectric materials produce electricity when strained, making them ideal for different types of sensing applications. The most effective piezoelectric materials are ceramic solid solutions in which the piezoelectric effect is optimized at what are termed morphotropic phase boundaries (MPBs). Ceramics are not ideal for a variety of applications owing to some of their mechanical properties. We synthesized piezoelectric materials from a molecular perovskite (TMFM)(x)(TMCM)(1-x)CdCl3 solid solution (TMFM, trimethylfluoromethyl ammonium; TMCM, trimethylchloromethyl ammonium, 0 <= x =<= 1), in which the MPB exists between monoclinic and hexagonal phases. We found a composition for which the piezoelectric coefficient d(33) is similar to 1540 picocoulombs per newton, comparable to high-performance piezoelectric ceramics. The material has potential applications for wearable piezoelectric devices.	[Liao, Wei-Qiang; Zhao, Dewei; Tang, Yuan-Yuan; Li, Peng-Fei; Xiong, Ren-Gen] Nanchang Univ, Ordered Matter Sci Res Ctr, Nanchang 330031, Jiangxi, Peoples R China; [Zhang, Yi; Shi, Ping-Ping; Chen, Xiao-Gang; You, Yu-Meng; Xiong, Ren-Gen] Southeast Univ, Jiangsu Key Lab Sci & Applicat Mol Ferroelect, Nanjing 211189, Jiangsu, Peoples R China	Nanchang University; Southeast University - China	Xiong, RG (corresponding author), Nanchang Univ, Ordered Matter Sci Res Ctr, Nanchang 330031, Jiangxi, Peoples R China.; Xiong, RG (corresponding author), Southeast Univ, Jiangsu Key Lab Sci & Applicat Mol Ferroelect, Nanjing 211189, Jiangsu, Peoples R China.	xiongrg@seu.edu.cn	Zhao, Dewei/F-5928-2010; Li, Peng-Fei/A-9047-2015; Liao, Wei-Qiang/AAY-9358-2020	Zhao, Dewei/0000-0001-7914-6288; Li, Peng-Fei/0000-0001-5228-6192; Xiong, Ren-Gen/0000-0002-0596-9561; Tang, Yuan-Yuan/0000-0002-8369-572X; Chen, Xiao-Gang/0000-0001-8547-0885; Zhang, Yi/0000-0002-6375-1712	National Natural Science Foundation of China [21831004, 21427801, 91422301, 91856114, 91622113]; Natural Science Foundation of Jiangsu Province [BK20150596, BK20160029]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by the National Natural Science Foundation of China (21831004, 21427801, 91422301, 91856114, and 91622113) and the Natural Science Foundation of Jiangsu Province (BK20150596 and BK20160029).	AGUIRREZAMALLOA G, 1993, ACTA CRYSTALLOGR B, V49, P691, DOI 10.1107/S010876819300182X; Ahart M, 2008, NATURE, V451, P545, DOI 10.1038/nature06459; AIZU K, 1969, J PHYS SOC JPN, V27, P387, DOI 10.1143/JPSJ.27.387; ALCOCK NW, 1978, ACTA CRYSTALLOGR B, V34, P1970, DOI 10.1107/S0567740878007098; Berlincourt D., 1964, PHYS ACOUSTICS PRINC, V1; Body M, 2004, INORG CHEM, V43, P2474, DOI 10.1021/ic049956r; BRAUD MN, 1990, J PHYS-CONDENS MAT, V2, P8209, DOI 10.1088/0953-8984/2/42/001; Cai HL, 2012, J AM CHEM SOC, V134, P18487, DOI 10.1021/ja3073319; Cross E, 2004, NATURE, V432, P24, DOI 10.1038/nature03142; CROSS LE, 1987, FERROELECTRICS, V76, P241, DOI 10.2109/jcersj.99.829; Damjanovic D, 1998, REP PROG PHYS, V61, P1267, DOI 10.1088/0034-4885/61/9/002; Fu DW, 2013, SCIENCE, V339, P425, DOI [10.1126/science.1230473, 10.1126/science.1229675]; Fu DW, 2011, J AM CHEM SOC, V133, P12780, DOI 10.1021/ja204540g; Fu HX, 2000, NATURE, V403, P281, DOI 10.1038/35002022; Garcia V, 2009, NATURE, V460, P81, DOI 10.1038/nature08128; Guo R, 2000, PHYS REV LETT, V84, P5423, DOI 10.1103/PhysRevLett.84.5423; Haertling GH, 1999, J AM CERAM SOC, V82, P797, DOI 10.1111/j.1151-2916.1999.tb01840.x; Horiuchi S, 2008, NAT MATER, V7, P357, DOI 10.1038/nmat2137; Hua XN, 2018, J AM CHEM SOC, V140, P12296, DOI 10.1021/jacs.8b08286; JAFFE B, 1954, J APPL PHYS, V25, P809, DOI 10.1063/1.1721741; Kiczenski TJ, 2002, J NON-CRYST SOLIDS, V306, P160, DOI 10.1016/S0022-3093(02)01157-2; Kitaigorodsky A. I., 2012, PHYS CHEM SERIES MON, V29; Kitaigorodsky A. I., 2012, SPRINGER SERIES SOLI, V33; Kutnjak Z, 2006, NATURE, V441, P956, DOI 10.1038/nature04854; LANDER JJ, 1951, ACTA CRYSTALLOGR, V4, P148, DOI 10.1107/S0365110X51000441; Lee D, 2015, SCIENCE, V349, P1314, DOI 10.1126/science.aaa6442; Li F, 2018, NAT MATER, V17, P349, DOI 10.1038/s41563-018-0034-4; Li W, 2017, NAT REV MATER, V2, DOI 10.1038/natrevmats.2016.99; Liao WQ, 2018, J AM CHEM SOC, V140, P3975, DOI 10.1021/jacs.7b12524; Liao WQ, 2017, J AM CHEM SOC, V139, P18071, DOI 10.1021/jacs.7b10449; Liao WQ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8338; Liu H, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.017601; Liu YM, 2013, J APPL PHYS, V113, DOI 10.1063/1.4801975; Lu H, 2012, SCIENCE, V336, P59, DOI 10.1126/science.1218693; Miller JM, 1996, PROG NUCL MAG RES SP, V28, P255, DOI 10.1016/0079-6565(95)01024-6; Moulson A.J., 2003, ELECTROCERAMICS MAT; Nakatani N, 2011, FERROELECTRICS, V413, P238, DOI 10.1080/00150193.2011.554269; Ogawa T, 2002, JPN J APPL PHYS 2, V41, pL55, DOI 10.1143/JJAP.41.L55; Park SE, 1997, IEEE T ULTRASON FERR, V44, P1140, DOI 10.1109/58.655639; Park SE, 1997, J APPL PHYS, V82, P1804, DOI 10.1063/1.365983; Pasciak M, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.024114; Paton LA, 2010, ANGEW CHEM INT EDIT, V49, P7684, DOI 10.1002/anie.201003541; Saito Y, 2004, NATURE, V432, P84, DOI 10.1038/nature03028; Scott JF, 2007, SCIENCE, V315, P954, DOI 10.1126/science.1129564; Setter N., 2002, PIEZOELECTRIC MAT DE; SHIRANE G, 1952, J PHYS SOC JPN, V7, P12, DOI 10.1143/JPSJ.7.12; Sun ZH, 2016, ANGEW CHEM INT EDIT, V55, P11854, DOI 10.1002/anie.201606079; Tang YY, 2018, J AM CHEM SOC, V140, P8051, DOI 10.1021/jacs.8b04600; Tressler JF, 1998, J ELECTROCERAM, V2, P257, DOI 10.1023/A:1009926623551; Valasek J, 1921, PHYS REV, V17, P475, DOI 10.1103/PhysRev.17.475; WARNER AW, 1967, J ACOUST SOC AM, V42, P1223, DOI 10.1121/1.1910709; WEIS RS, 1985, APPL PHYS A-MATER, V37, P191, DOI 10.1007/BF00614817; Wu JG, 2015, CHEM REV, V115, P2559, DOI 10.1021/cr5006809; Xu GS, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.020102; Xu WJ, 2017, J AM CHEM SOC, V139, P6369, DOI 10.1021/jacs.7b01334; Xu WJ, 2016, ADV MATER, V28, pCP4, DOI 10.1002/adma.201600895; Yasuda N, 2000, JPN J APPL PHYS 1, V39, P5586, DOI 10.1143/JJAP.39.5586; Ye HY, 2018, SCIENCE, V361, P151, DOI 10.1126/science.aas9330; Ye HY, 2016, J AM CHEM SOC, V138, P13175, DOI 10.1021/jacs.6b08817; Ye HY, 2016, ADV MATER, V28, P2579, DOI 10.1002/adma.201505224; Ye HY, 2015, J AM CHEM SOC, V137, P13148, DOI 10.1021/jacs.5b08290; Ye HY, 2014, ANGEW CHEM INT EDIT, V53, P11242, DOI 10.1002/anie.201406810; Ye ZG, 2008, WOODHEAD PUBL MATER, P1, DOI 10.1201/9781439832882; You YM, 2017, SCIENCE, V357, P306, DOI 10.1126/science.aai8535; Zhang WY, 2017, J AM CHEM SOC, V139, P10897, DOI 10.1021/jacs.7b06013; Zhang Y, 2015, ADV MATER, V27, P3942, DOI 10.1002/adma.201501026; Zhang Y, 2015, J AM CHEM SOC, V137, P4928, DOI 10.1021/jacs.5b01680; Zhang Y, 2014, ANGEW CHEM INT EDIT, V53, P5064, DOI 10.1002/anie.201400348; Zuo RZ, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2710768	69	292	297	79	939	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 15	2019	363	6432			SI		1206	+		10.1126/science.aav3057	http://dx.doi.org/10.1126/science.aav3057			70	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP0BC	30872522				2022-12-28	WOS:000461329000046
J	Tanne, JH				Tanne, Janice Hopkins			Parents of US boy who survived tetanus after nearly $1m of care refuse vaccine	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Guzman-Cottrill JA, 2019, MMWR-MORBID MORTAL W, V68, P231, DOI 10.15585/mmwr.mm6809a3; Oregon Health Authority, 2018, OR KIND VACC EX RAT; Tiwari T., 2011, Morbidity and Mortality Weekly Report, V60, P365	3	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 13	2019	364								l1172	10.1136/bmj.l1172	http://dx.doi.org/10.1136/bmj.l1172			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP5VW	30867159				2022-12-28	WOS:000461751600018
J	Kowaleski, JM				Kowaleski, Jeffrey Michael			Wearing Two Hats	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Kowaleski, Jeffrey Michael] Penn State Milton S Hershey Med Ctr, Div Gen Internal Med, Sect Palliat Care, Dept Med, 500 Univ Dr,POB 850,Mail Code H106, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Kowaleski, JM (corresponding author), Penn State Milton S Hershey Med Ctr, Div Gen Internal Med, Sect Palliat Care, Dept Med, 500 Univ Dr,POB 850,Mail Code H106, Hershey, PA 17033 USA.	jkowaleski@pennstatehealth.psu.edu		Kowaleski, Jeffrey/0000-0002-7139-6335					0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 12	2019	321	10					941	942		10.1001/jama.2019.1323	http://dx.doi.org/10.1001/jama.2019.1323			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HO5JE	30860563				2022-12-28	WOS:000460961000010
J	Ablasser, A; Chen, ZJJ				Ablasser, Andrea; Chen, Zhijian J.			cGAS in action: Expanding roles in immunity and inflammation	SCIENCE			English	Review							CYCLIC GMP-AMP; AICARDI-GOUTIERES-SYNDROME; ENDOPLASMIC-RETICULUM STRESS; CGAS/STING-DEPENDENT INNATE; DNA SENSOR; ENDOGENOUS 2ND-MESSENGER; EXONUCLEASE TREX1; I INTERFERONS; ACTIVATION; CELLS	DNA is highly immunogenic. It represents a key pathogen-associated molecular pattern (PAMP) during infection. Host DNA can, however, also act as a danger-associated molecular pattern (DAMP) and elicit strong inflammatory responses. The cGAS-STING pathway has emerged as a major pathway that detects intracellular DNA. Here, we highlight recent advances on how cGAS and STING mediate inflammatory responses and how these are regulated, allowing cells to readily respond to infections and noxious agents while avoiding the inappropriate sensing of self-DNA. A particular focus is placed on the role of cGAS in the context of sterile inflammatory conditions. Manipulating cGAS or STING may open the door for new therapeutic strategies for the treatment of acute and chronic inflammation relevant to many human diseases.	[Ablasser, Andrea] Ecole Polytech Fed Lausanne, Global Hlth Inst, CH-1015 Lausanne, Switzerland; [Chen, Zhijian J.] Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dept Mol Biol, Ctr Inflammat Res, Dallas, TX 75390 USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Ablasser, A (corresponding author), Ecole Polytech Fed Lausanne, Global Hlth Inst, CH-1015 Lausanne, Switzerland.; Chen, ZJJ (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dept Mol Biol, Ctr Inflammat Res, Dallas, TX 75390 USA.	andrea.ablasser@epfl.ch; zhijian.chen@utsouthwestern.edu	Chen, Zhijian/C-6039-2012	Chen, Zhijian/0000-0002-8475-8251	NIH [P50AR070594, U01CA218422]; Cancer Prevention and Research Institute of Texas [RP120718, RP150498]; Lupus Research Alliance Distinguished Innovator Award; Welch Foundation [I-1389]; ImmuneSensor LLC; SNSF [BSSGI0-155984, 31003A_159836]; Gebert Ruf Foundation [GRS-059_14]; European Research Council (ERC-StG) [804933 ImAgine]; Fondation Acteria; NATIONAL CANCER INSTITUTE [U01CA218422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR070594] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas; Lupus Research Alliance Distinguished Innovator Award; Welch Foundation(The Welch Foundation); ImmuneSensor LLC; SNSF(Swiss National Science Foundation (SNSF)); Gebert Ruf Foundation; European Research Council (ERC-StG)(European Research Council (ERC)); Fondation Acteria; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Research in the Chen laboratory has been supported by grants from the NIH (P50AR070594 and U01CA218422), the Cancer Prevention and Research Institute of Texas (RP120718 and RP150498), Lupus Research Alliance Distinguished Innovator Award, the Welch Foundation (I-1389), and ImmuneSensor LLC. Research in the Ablasser laboratory is supported by grants from the SNSF (BSSGI0-155984, 31003A_159836), the Gebert Ruf Foundation (GRS-059_14), the European Research Council (ERC-StG; 804933 ImAgine), and the Fondation Acteria.	Ablasser A, 2013, NATURE, V503, P530, DOI 10.1038/nature12640; Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Aguirre S, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.37; Ahn J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6166; Ahn J, 2012, P NATL ACAD SCI USA, V109, P19386, DOI 10.1073/pnas.1215006109; An J, 2017, ARTHRITIS RHEUMATOL, V69, P800, DOI 10.1002/art.40002; Andreeva L, 2017, NATURE, V549, P394, DOI 10.1038/nature23890; Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932; Bakhoum SF, 2018, NATURE, V553, P467, DOI 10.1038/nature25432; Bridgeman A, 2015, SCIENCE, V349, P1228, DOI 10.1126/science.aab3632; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Cao DJ, 2018, CIRCULATION, V137, P2613, DOI 10.1161/CIRCULATIONAHA.117.031046; Carroll EC, 2016, IMMUNITY, V44, P597, DOI 10.1016/j.immuni.2016.02.004; Cerboni S, 2017, J EXP MED, V214, P1769, DOI 10.1084/jem.20161674; Chen Q, 2016, NATURE, V533, P493, DOI 10.1038/nature18268; Childs BG, 2015, NAT MED, V21, P1424, DOI 10.1038/nm.4000; Civril F, 2013, NATURE, V498, P332, DOI 10.1038/nature12305; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Coquel F, 2018, NATURE, V557, P57, DOI 10.1038/s41586-018-0050-1; Corrales L, 2016, J CLIN INVEST, V126, P2404, DOI 10.1172/JCI86892; Corrales L, 2015, CELL REP, V11, P1018, DOI 10.1016/j.celrep.2015.04.031; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Crow YJ, 2015, NAT REV IMMUNOL, V15, P429, DOI 10.1038/nri3850; Crowl JT, 2017, ANNU REV IMMUNOL, V35, P313, DOI 10.1146/annurev-immunol-051116-052331; Dang EV, 2017, CELL, V171, P1057, DOI 10.1016/j.cell.2017.09.029; Denais CM, 2016, SCIENCE, V352, P353, DOI 10.1126/science.aad7297; Diner EJ, 2013, CELL REP, V3, P1355, DOI 10.1016/j.celrep.2013.05.009; Dobbs N, 2015, CELL HOST MICROBE, V18, P157, DOI 10.1016/j.chom.2015.07.001; Dou ZX, 2017, NATURE, V550, P402, DOI 10.1038/nature24050; Du MJ, 2018, SCIENCE, V361, P704, DOI 10.1126/science.aat1022; Franz KM, 2018, P NATL ACAD SCI USA, V115, pE2058, DOI 10.1073/pnas.1716937115; Gaidt MM, 2017, CELL, V171, P1110, DOI 10.1016/j.cell.2017.09.039; Gall A, 2012, IMMUNITY, V36, P120, DOI 10.1016/j.immuni.2011.11.018; Gao DX, 2015, P NATL ACAD SCI USA, V112, pE5699, DOI 10.1073/pnas.1516465112; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; Gentili M, 2015, SCIENCE, V349, P1232, DOI 10.1126/science.aab3628; Gluck S, 2017, NAT CELL BIOL, V19, P1061, DOI 10.1038/ncb3586; Gonugunta VK, 2017, CELL REP, V21, P3234, DOI 10.1016/j.celrep.2017.11.061; Gray EE, 2015, J IMMUNOL, V195, P1939, DOI 10.4049/jimmunol.1500969; Gunther C, 2015, J CLIN INVEST, V125, P413, DOI 10.1172/JCI78001; Gulen MF, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00573-w; Haag SM, 2018, NATURE, V559, P269, DOI 10.1038/s41586-018-0287-8; Hall J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184843; Harding SM, 2017, NATURE, V548, P466, DOI 10.1038/nature23470; Iracheta-Vellve A, 2016, J BIOL CHEM, V291, P26794, DOI 10.1074/jbc.M116.736991; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Ivanov A, 2013, J CELL BIOL, V202, P129, DOI 10.1083/jcb.201212110; Jeremiah N, 2014, J CLIN INVEST, V124, P5516, DOI 10.1172/JCI79100; Johnson JS, 2018, CELL HOST MICROBE, V23, P366, DOI 10.1016/j.chom.2018.01.012; Kato K, 2017, ANNU REV BIOCHEM, V86, P541, DOI 10.1146/annurev-biochem-061516-044813; Kawane K, 2006, NATURE, V443, P998, DOI 10.1038/nature05245; Kerur N, 2018, NAT MED, V24, P50, DOI 10.1038/nm.4450; King KR, 2017, NAT MED, V23, P1481, DOI 10.1038/nm.4428; Kranzusch PJ, 2013, CELL REP, V3, P1362, DOI 10.1016/j.celrep.2013.05.008; Kretschmer S, 2015, ANN RHEUM DIS, V74, DOI 10.1136/annrheumdis-2013-204845; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; Lan YY, 2014, CELL REP, V9, P180, DOI 10.1016/j.celrep.2014.08.074; Lee-Kirsch MA, 2007, NAT GENET, V39, P1065, DOI 10.1038/ng2091; Li LY, 2014, NAT CHEM BIOL, V10, P1043, DOI [10.1038/NChemBio.1661, 10.1038/nchembio.1661]; Li XD, 2013, SCIENCE, V341, P1390, DOI 10.1126/science.1244040; Li X, 2013, IMMUNITY, V39, P1019, DOI 10.1016/j.immuni.2013.10.019; Liang QM, 2014, CELL HOST MICROBE, V15, P228, DOI 10.1016/j.chom.2014.01.009; Liu HP, 2018, NATURE, V563, P131, DOI 10.1038/s41586-018-0629-6; Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630; Liu Y, 2014, NEW ENGL J MED, V371, P507, DOI 10.1056/NEJMoa1312625; Lugrin J, 2018, IMMUNOL REV, V281, P99, DOI 10.1111/imr.12618; Mackenzie KJ, 2017, NATURE, V548, P461, DOI 10.1038/nature23449; Mackenzie KJ, 2016, EMBO J, V35, P831, DOI 10.15252/embj.201593339; Maelfait J, 2016, CELL REP, V16, P1492, DOI 10.1016/j.celrep.2016.07.002; Mann DL, 2015, CIRC RES, V116, P1254, DOI 10.1161/CIRCRESAHA.116.302317; Margolis SR, 2017, TRENDS IMMUNOL, V38, P733, DOI 10.1016/j.it.2017.03.004; Marichal T, 2011, NAT MED, V17, P996, DOI 10.1038/nm.2403; Martin M, 2018, CELL REP, V23, P3537, DOI 10.1016/j.celrep.2018.05.029; McFarland AP, 2017, IMMUNITY, V46, P433, DOI 10.1016/j.immuni.2017.02.014; McWhirter SM, 2009, J EXP MED, V206, P1899, DOI 10.1084/jem.20082874; Moretti J, 2017, CELL, V171, P809, DOI 10.1016/j.cell.2017.09.034; Mukai K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11932; Namjou B, 2011, GENES IMMUN, V12, P270, DOI 10.1038/gene.2010.73; Paludan SR, 2013, IMMUNITY, V38, P870, DOI 10.1016/j.immuni.2013.05.004; Pelka K, 2016, IMMUNOL REV, V269, P60, DOI 10.1111/imr.12375; Petrasek J, 2013, P NATL ACAD SCI USA, V110, P16544, DOI 10.1073/pnas.1308331110; Pokatayev V, 2016, J EXP MED, V213, P329, DOI 10.1084/jem.20151464; Raab M, 2016, SCIENCE, V352, P359, DOI 10.1126/science.aad7611; Rice GI, 2013, LANCET NEUROL, V12, P1159, DOI 10.1016/S1474-4422(13)70258-8; Rodero MP, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01932-3; Rongvaux A, 2014, CELL, V159, P1563, DOI 10.1016/j.cell.2014.11.037; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862; Seo GJ, 2015, CELL REP, V13, P440, DOI 10.1016/j.celrep.2015.09.007; Shi HP, 2015, P NATL ACAD SCI USA, V112, P8947, DOI 10.1073/pnas.1507317112; Sliter DA, 2018, NATURE, V561, P258, DOI 10.1038/s41586-018-0448-9; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Tang CHA, 2016, CANCER RES, V76, P2137, DOI 10.1158/0008-5472.CAN-15-1885; Vincent J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00833-9; Wang H, 2017, P NATL ACAD SCI USA, V114, P1637, DOI 10.1073/pnas.1621363114; Warner JD, 2017, J EXP MED, V214, P3279, DOI 10.1084/jem.20171351; Watson RO, 2012, CELL, V150, P803, DOI 10.1016/j.cell.2012.06.040; West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156; White MJ, 2014, CELL, V159, P1549, DOI 10.1016/j.cell.2014.11.036; Wiens KE, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005809; Woo SR, 2014, IMMUNITY, V41, P830, DOI 10.1016/j.immuni.2014.10.017; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Xia TL, 2016, CELL REP, V14, P282, DOI 10.1016/j.celrep.2015.12.029; Yang H, 2017, P NATL ACAD SCI USA, V114, pE4612, DOI 10.1073/pnas.1705499114; Yang YG, 2007, CELL, V131, P873, DOI 10.1016/j.cell.2007.10.017; Yu YS, 2019, J CLIN INVEST, V129, P546, DOI 10.1172/JCI121842; Zeng L, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan5689; Zhang X, 2014, CELL REP, V6, P421, DOI 10.1016/j.celrep.2014.01.003; Zhang X, 2013, MOL CELL, V51, P226, DOI 10.1016/j.molcel.2013.05.022; Zhao QL, 2018, GASTROENTEROLOGY, V154, P1822, DOI 10.1053/j.gastro.2018.01.065; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003; Zhou W, 2018, CELL, V174, P300, DOI 10.1016/j.cell.2018.06.026	114	327	337	21	166	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 8	2019	363	6431					1055	+	eaat8657	10.1126/science.aat8657	http://dx.doi.org/10.1126/science.aat8657			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO2MV	30846571				2022-12-28	WOS:000460750100034
J	Raman, R				Raman, Ritu			Modeling muscle	SCIENCE			English	Editorial Material							FABRICATION; DESIGN		[Raman, Ritu] MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Raman, R (corresponding author), MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	ritur@mit.edu						Bian WN, 2009, NAT PROTOC, V4, P1522, DOI 10.1038/nprot.2009.155; Cvetkovic C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03723-8; Cvetkovic C, 2017, MICROSYST NANOENG, V3, DOI 10.1038/micronano.2017.15; Cvetkovic C, 2014, P NATL ACAD SCI USA, V111, P10125, DOI 10.1073/pnas.1401577111; Duffy RM, 2014, WIRES NANOMED NANOBI, V6, P178, DOI 10.1002/wnan.1254; Grant L, 2019, TISSUE ENG PT A, V25, P1023, DOI [10.1089/ten.tea.2018.0202, 10.1089/ten.TEA.2018.0202]; Neiman JAS, 2015, BIOTECHNOL BIOENG, V112, P777, DOI 10.1002/bit.25494; Pagan-Diaz GJ, 2018, ADV FUNCT MATER, V28, DOI 10.1002/adfm.201801145; Raman R, 2015, STEREOLITHOGRAPHIC 3; Raman R, 2017, ADV HEALTHC MATER, V6, DOI 10.1002/adhm.201700496; Raman R, 2017, ADV HEALTHC MATER, V6, DOI 10.1002/adhm.201700030; Raman R, 2017, NAT PROTOC, V12, P519, DOI 10.1038/nprot.2016.185; Raman R, 2016, J BIOL ENG, V10, DOI 10.1186/s13036-016-0032-5; Raman R, 2016, BIOMED MICRODEVICES, V18, DOI 10.1007/s10544-016-0068-9; Raman R, 2016, P NATL ACAD SCI USA, V113, P3497, DOI 10.1073/pnas.1516139113; Raman R, 2016, ADV HEALTHC MATER, V5, P610, DOI 10.1002/adhm.201500721; Ricotti L, 2017, SCI ROBOT, V2, DOI 10.1126/scirobotics.aaq0495; Sambasivan Ramkumar, 2015, Results Probl Cell Differ, V56, P191, DOI 10.1007/978-3-662-44608-9_9	18	6	6	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 8	2019	363	6431					1051	1051		10.1126/science.aaw3611	http://dx.doi.org/10.1126/science.aaw3611			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HO2MV	30846593				2022-12-28	WOS:000460750100032
J	Dyer, O				Dyer, Owen			MSF suspends Congo Ebola effort after deadly clinic attacks	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 4	2019	364								l1010	10.1136/bmj.l1010	http://dx.doi.org/10.1136/bmj.l1010			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HO6SQ	30833274				2022-12-28	WOS:000461061900012
J	Huberman, S; Duncan, RA; Chen, K; Song, B; Chiloyan, V; Ding, Z; Maznev, AA; Chen, G; Nelson, KA				Huberman, S.; Duncan, R. A.; Chen, K.; Song, B.; Chiloyan, V.; Ding, Z.; Maznev, A. A.; Chen, G.; Nelson, K. A.			Observation of second sound in graphite at temperatures above 100 K	SCIENCE			English	Article							THERMAL-CONDUCTIVITY; TRANSPORT	Wavelike thermal transport in solids, referred to as second sound, is an exotic phenomenon previously limited to a handful of materials at low temperatures. The rare occurrence of this effect restricted its scientific and practical importance. We directly observed second sound in graphite at temperatures above 100 kelvins by using time-resolved optical measurements of thermal transport on the micrometer-length scale. Our experimental results are in qualitative agreement with ab initio calculations that predict wavelike phonon hydrodynamics. We believe that these results potentially indicate an important role of second sound in microscale transient heat transport in two-dimensional and layered materials in a wide temperature range.	[Huberman, S.; Chen, K.; Song, B.; Chiloyan, V.; Ding, Z.; Chen, G.] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [Duncan, R. A.; Maznev, A. A.; Nelson, K. A.] MIT, Dept Chem, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Chen, G (corresponding author), MIT, Dept Mech Engn, Cambridge, MA 02139 USA.; Nelson, KA (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.	gchen2@mit.edu; kanelson@mit.edu	Chen, Gang/J-1325-2014; Song, Bai/GYQ-7055-2022	Chen, Gang/0000-0002-3968-8530; Song, Bai/0000-0003-3013-9831; /0000-0002-2612-7750	Office of Naval Research under MURI grant [N00014-16-1-2436]; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-SC0001299]; NSF EFRI 2-DARE grant [EFMA-1542864]	Office of Naval Research under MURI grant; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NSF EFRI 2-DARE grant(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)NSF - Emerging Frontiers in Research & Innovation (EFRI))	This work is supported in part by the Office of Naval Research under MURI grant N00014-16-1-2436 (G.C. for high thermal conductivity materials, including phonon hydrodynamics); in part by the Solid State Solar-Thermal Energy Conversion Center (S<SUP>3</SUP>TEC), an Energy Frontier Research Center funded by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under award DE-SC0001299 (G.C. for thermoelectric materials); and in part by the NSF EFRI 2-DARE grant EFMA-1542864 (K.A.N. for thermal transport in 2D materials).	ACKERMAN CC, 1966, PHYS REV LETT, V16, P789, DOI 10.1103/PhysRevLett.16.789; [Anonymous], 1986, LASER INDUCED DYNAMI; Bandurin DA, 2016, SCIENCE, V351, P1055, DOI 10.1126/science.aad0201; BECK H, 1974, PHYS STATUS SOLIDI A, V24, P11, DOI 10.1002/pssa.2210240102; Bosak A, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.153408; Cahill DG, 2014, APPL PHYS REV, V1, DOI 10.1063/1.4832615; Cepellotti A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7400; Chiloyan V., 2017, ARXIV171107151CONDMA; Crossno J, 2016, SCIENCE, V351, P1058, DOI 10.1126/science.aad0343; Ding ZW, 2018, NANO LETT, V18, P638, DOI 10.1021/acs.nanolett.7b04932; Donnelly RJ, 2009, PHYS TODAY, V62, P34, DOI 10.1063/1.3248499; Fugallo G, 2014, NANO LETT, V14, P6109, DOI 10.1021/nl502059f; Fugallo G, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.045430; GRIMSDITCH M, 1983, J PHYS C SOLID STATE, V16, pL143, DOI 10.1088/0022-3719/16/5/002; GUYER RA, 1966, PHYS REV, V148, P766, DOI 10.1103/PhysRev.148.766; GUYER RA, 1966, PHYS REV, V148, P778, DOI 10.1103/PhysRev.148.778; HEHLEN B, 1995, PHYS REV LETT, V75, P2416, DOI 10.1103/PhysRevLett.75.2416; JACKSON HE, 1970, PHYS REV LETT, V25, P26, DOI 10.1103/PhysRevLett.25.26; Johnson JA, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.025901; Johnson JA, 2012, J APPL PHYS, V111, DOI 10.1063/1.3675467; Koreeda A, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.265502; Lee S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7290; Lindsay L, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.115427; Maznev AA, 1998, OPT LETT, V23, P1319, DOI 10.1364/OL.23.001319; Minnich AJ, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.095901; Moll PJW, 2016, SCIENCE, V351, P1061, DOI 10.1126/science.aac8385; NARAYANA.V, 1972, PHYS REV LETT, V28, P1461, DOI 10.1103/PhysRevLett.28.1461; NULL MR, 1973, CARBON, V11, P81, DOI 10.1016/0008-6223(73)90058-4; POHL DW, 1976, PHYS REV LETT, V36, P480, DOI 10.1103/PhysRevLett.36.480; Pop E, 2010, NANO RES, V3, P147, DOI 10.1007/s12274-010-1019-z; Rogers JA, 2000, ANNU REV MATER SCI, V30, P117, DOI 10.1146/annurev.matsci.30.1.117; Scott JF, 2000, J PHYS CHEM SOLIDS, V61, P185, DOI 10.1016/S0022-3697(99)00280-2; Siemens ME, 2010, NAT MATER, V9, P26, DOI [10.1038/NMAT2568, 10.1038/nmat2568]; Wilson RB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6075; Yamaguchi M, 2002, PHYS REV D, V65, DOI 10.1103/PhysRevD.65.063518; Yamaguchi M, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.172102; 2010, PHYS REV B, V82	37	100	101	11	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 26	2019	364	6438					375	+		10.1126/science.aav3548	http://dx.doi.org/10.1126/science.aav3548			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HU9VW	30872535	Green Submitted, Green Published			2022-12-28	WOS:000465643400044
J	Chui, AJ; Okondo, MC; Rao, SD; Gai, K; Griswold, AR; Johnson, DC; Ball, DP; Taabazuing, CY; Orth, EL; Vittimberga, BA; Bachovchin, DA				Chui, Ashley J.; Okondo, Marian C.; Rao, Sahana D.; Gai, Kuo; Griswold, Andrew R.; Johnson, Darren C.; Ball, Daniel P.; Taabazuing, Cornelius Y.; Orth, Elizabeth L.; Vittimberga, Brooke A.; Bachovchin, Daniel A.			N-terminal degradation activates the NLRP1B inflammasome	SCIENCE			English	Article							ANTHRAX LETHAL TOXIN; END RULE PATHWAY; INHIBITION; CYTOTOXICITY	Intracellular pathogens and danger signals trigger the formation of inflammasomes, which activate inflammatory caspases and induce pyroptosis. The anthrax lethal factor metalloprotease and small-molecule DPP8/9 inhibitors both activate the NLRP1B inflammasome, but the molecular mechanism of NLRP1B activation is unknown. In this study, we used genome-wide CRISPR-Cas9 knockout screens to identify genes required for NLRP1B-mediated pyroptosis. We discovered that lethal factor induces cell death via the N-end rule proteasomal degradation pathway. Lethal factor directly cleaves NLRP1B, inducing the N-end rule-mediated degradation of the NLRP1B N terminus and freeing the NLRP1B C terminus to activate caspase-1. DPP8/9 inhibitors also induce proteasomal degradation of the NLRP1B N terminus but not via the N-end rule pathway. Thus, N-terminal degradation is the common activation mechanism of this innate immune sensor.	[Chui, Ashley J.; Rao, Sahana D.; Johnson, Darren C.; Orth, Elizabeth L.; Bachovchin, Daniel A.] Mem Sloan Kettering Canc Ctr, Triinst PhD Program Chem Biol, New York, NY 10065 USA; [Okondo, Marian C.; Gai, Kuo; Ball, Daniel P.; Taabazuing, Cornelius Y.; Vittimberga, Brooke A.; Bachovchin, Daniel A.] Mem Sloan Kettering Canc Ctr, Chem Biol Program, New York, NY 10065 USA; [Griswold, Andrew R.; Bachovchin, Daniel A.] Mem Sloan Kettering Canc Ctr, Weill Cornell Grad Sch Med Sci, Pharmacol Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Bachovchin, DA (corresponding author), Mem Sloan Kettering Canc Ctr, Triinst PhD Program Chem Biol, New York, NY 10065 USA.; Bachovchin, DA (corresponding author), Mem Sloan Kettering Canc Ctr, Chem Biol Program, New York, NY 10065 USA.; Bachovchin, DA (corresponding author), Mem Sloan Kettering Canc Ctr, Weill Cornell Grad Sch Med Sci, Pharmacol Program, New York, NY 10065 USA.	bachovcd@mskcc.org		Vittimberga, Brooke/0000-0002-4224-3276; Griswold, Andrew/0000-0003-2957-2355; Chui, Ashley/0000-0003-0037-5761; Orth-He, Elizabeth/0000-0002-8180-1330; Ball, Daniel/0000-0003-0693-7614; Okondo, Marian/0000-0003-0065-8155; Taabazuing, Cornelius/0000-0003-2361-5457; Johnson, Darren/0000-0002-0858-6152; Rao, Sahana/0000-0003-4592-8921	Josie Robertson Foundation; Stand Up to Cancer-Innovative Research Grant [SU2C-AACR-IRG11-17]; Stand Up to Cancer is a program of the Entertainment Industry Foundation; Pew Charitable Trusts; NIH [R01 AI137168, T32 GM007739, T32 GM115327, P30 CA008748]; Alfred P. Sloan Foundation Research Fellowship; American Cancer Society [PF-17-224-01 - CCG]; Gabrielle's Angel Foundation; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI137168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739, T32GM115327] Funding Source: NIH RePORTER	Josie Robertson Foundation; Stand Up to Cancer-Innovative Research Grant; Stand Up to Cancer is a program of the Entertainment Industry Foundation; Pew Charitable Trusts; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alfred P. Sloan Foundation Research Fellowship(Alfred P. Sloan Foundation); American Cancer Society(American Cancer Society); Gabrielle's Angel Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Josie Robertson Foundation (D.A.B.); a Stand Up to Cancer-Innovative Research Grant (SU2C-AACR-IRG11-17 to D.A.B.; Stand Up to Cancer is a program of the Entertainment Industry Foundation; research grants are administered by the American Association for Cancer Research, the scientific partner of SU2C); the Pew Charitable Trusts (D.A.B. is a Pew-Stewart Scholar in Cancer Research); the NIH (R01 AI137168 to D.A.B., T32 GM007739-Andersen to A.R.G., T32 GM115327-Tan to E.L.O. and D.C.J., and the MSKCC Core Grant P30 CA008748); an Alfred P. Sloan Foundation Research Fellowship (D.A.B.); the American Cancer Society (Postdoctoral Fellowship PF-17-224-01 - CCG to C.Y.T.); and Gabrielle's Angel Foundation (D.A.B.).	Adams S, 2004, CANCER RES, V64, P5471, DOI 10.1158/0008-5472.CAN-04-0447; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; BAKER RT, 1991, P NATL ACAD SCI USA, V88, P1090, DOI 10.1073/pnas.88.4.1090; Broz P, 2016, NAT REV IMMUNOL, V16, P407, DOI 10.1038/nri.2016.58; Chavarria-Smith J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003452; Coutts SJ, 1996, J MED CHEM, V39, P2087, DOI 10.1021/jm950732f; D'Osualdo A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027396; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Finger JN, 2012, J BIOL CHEM, V287, P25030, DOI 10.1074/jbc.M112.378323; Fink SL, 2008, P NATL ACAD SCI USA, V105, P4312, DOI 10.1073/pnas.0707370105; Frew BC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002659; Hellmich KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049741; Hong JH, 2015, MOL CELL PROTEOMICS, V14, P674, DOI 10.1074/mcp.M114.042168; Johnson DC, 2018, NAT MED, V24, P1151, DOI 10.1038/s41591-018-0082-y; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; KLIMPEL KR, 1992, P NATL ACAD SCI USA, V89, P10277, DOI 10.1073/pnas.89.21.10277; Lee PCW, 2011, MOL CELL, V43, P392, DOI 10.1016/j.molcel.2011.05.034; Levinsohn JL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002638; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Menard A, 1996, FEBS LETT, V386, P161, DOI 10.1016/0014-5793(96)00422-X; Okondo MC, 2018, CELL CHEM BIOL, V25, P262, DOI 10.1016/j.chembiol.2017.12.013; Okondo MC, 2017, NAT CHEM BIOL, V13, P46, DOI [10.1038/NCHEMBIO.2229, 10.1038/nchembio.2229]; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sandstrom A, 2019, SCIENCE, V364, P42, DOI 10.1126/science.aau1330; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sastalla I, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-188; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Squires RC, 2007, J BIOL CHEM, V282, P34260, DOI 10.1074/jbc.M705687200; Sriram SM, 2011, NAT REV MOL CELL BIO, V12, P735, DOI 10.1038/nrm3217; Tang GQ, 1999, INFECT IMMUN, V67, P3055, DOI 10.1128/IAI.67.6.3055-3060.1999; Van Goethem S, 2008, BIOORG MED CHEM LETT, V18, P4159, DOI 10.1016/j.bmcl.2008.05.079; Varshavsky A, 2011, PROTEIN SCI, V20, P1298, DOI 10.1002/pro.666; Wickliffe KE, 2008, CELL MICROBIOL, V10, P1352, DOI 10.1111/j.1462-5822.2008.01131.x	35	135	142	5	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 5	2019	364	6435					82	+		10.1126/science.aau1208	http://dx.doi.org/10.1126/science.aau1208			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HS0XY	30872531	Green Accepted, Green Submitted			2022-12-28	WOS:000463585700038
J	Balk, EM; Rofeberg, VN; Adam, GP; Kimmel, HJ; Trikalinos, TA; Jeppson, PC				Balk, Ethan M.; Rofeberg, Valerie N.; Adam, Gaelen P.; Kimmel, Hannah J.; Trikalinos, Thomas A.; Jeppson, Peter C.			Pharmacologic and Nonpharmacologic Treatments for Urinary Incontinence in Women A Systematic Review and Network Meta-analysis of Clinical Outcomes	ANNALS OF INTERNAL MEDICINE			English	Review							RANDOMIZED CONTROLLED-TRIAL; GENUINE STRESS-INCONTINENCE; PELVIC FLOOR EXERCISES; QUALITY-OF-LIFE; TRANSVAGINAL ELECTRICAL-STIMULATION; OVERACTIVE BLADDER SYMPTOMS; DOUBLE-BLIND; SINGLE-BLIND; OLDER WOMEN; MAGNETIC STIMULATION	Background: Urinary incontinence (UI), a common malady in women, most often is classified as stress, urgency, or mixed. Purpose: To compare the effectiveness of pharmacologic and nonpharmacologic interventions to improve or cure stress, urgency, or mixed UI in nonpregnant women. Data Sources: MEDLINE, Cochrane Central Register of Controlled Trials (Wiley), Cochrane Database of Systematic Reviews (Wiley), EMBASE (Elsevier), CINAHL (EBSCO), and PsycINFO (American Psychological Association) from inception through 10 August 2018. Study Selection: 84 randomized trials that evaluated 14 categories of interventions and reported categorical cure or improvement outcomes. Data Extraction: 1 researcher extracted study characteristics, results, and study-level risk of bias, with verification by another independent researcher. The research team collaborated to assess strength of evidence (SoE) across studies. Data Synthesis: 84 studies reported cure or improvement outcomes (32 in stress UI, 16 in urgency UI, 4 in mixed UI, and 32 in any or unspecified UI type). The most commonly evaluated active intervention types included behavioral therapies, anticholinergics, and neuromodulation. Network meta-analysis showed that all interventions, except hormones and periurethral bulking agents (variable SoE), were more effective than no treatment in achieving at least 1 favorable UI outcome. Among treatments used specifically for stress UI, behavioral therapy was more effective than either alpha-agonists or hormones in achieving cure or improvement (moderate SoE); alpha-agonists were more effective than hormones in achieving improvement (moderate SoE); and neuromodulation was more effective than no treatment for cure, improvement, and satisfaction (high SoE). Among treatments used specifically for urgency UI, behavioral therapy was statistically significantly more effective than anticholinergics in achieving cure or improvement (high SoE), both neuromodulation and onabotulinum toxin A (BTX) were more effective than no treatment (high SoE), and BTX may have been more effective than neuromodulation in achieving cure (low SoE). Limitation: Scarce direct (head-to-head trial) evidence and population heterogeneity based on UI type, UI severity, and history of prior treatment. Conclusion: Most nonpharmacologic and pharmacologic interventions are more likely than no treatment to improve UI outcomes. Behavioral therapy, alone or in combination with other interventions, is generally more effective than pharmacologic therapies alone in treating both stress and urgency UI. Primary Funding Source: Patient-Centered Outcomes Research Institute. (PROSPERO: CRD42017069903)	[Balk, Ethan M.; Rofeberg, Valerie N.; Adam, Gaelen P.; Kimmel, Hannah J.; Trikalinos, Thomas A.] Brown Univ, Sch Publ Hlth, Box G-S121-8, Providence, RI 02912 USA; [Jeppson, Peter C.] Univ New Mexico, Sch Med, Dept Obstet & Gynecol, Div Urogynecol, 2425 Camino Salud, Albuquerque, NM 87106 USA	Brown University; University of New Mexico	Balk, EM (corresponding author), Brown Univ, Sch Publ Hlth, Box G-S121-8, Providence, RI 02912 USA.	ethan_balk@brown.edu	Balk, Ethan/AAJ-2547-2020	Kimmel Supron, Hannah/0000-0002-2673-9650	AHRQ, U.S. Department of Health and Human Services, Rockville, Maryland [290-20-1500002-I]	AHRQ, U.S. Department of Health and Human Services, Rockville, Maryland	Under contract 290-20-1500002-I from AHRQ, U.S. Department of Health and Human Services, Rockville, Maryland.	Abdulaziz K, 2012, INTERNET J GYNECOLOG, V16, P34; AHLSTROM K, 1990, GYNECOL OBSTET INVES, V30, P37, DOI 10.1159/000293211; AHRQ Methods for Effective Health Care, 2011, METH GUID EFF COMP E; Aksac B, 2003, GYNECOL OBSTET INVES, V56, P23, DOI 10.1159/000072327; Alhasso A, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001842.pub2; Amaro JL, 2006, ACTA OBSTET GYN SCAN, V85, P619, DOI 10.1080/00016340500495058; Amundsen CL, 2016, JAMA-J AM MED ASSOC, V316, P1366, DOI 10.1001/jama.2016.14617; [Anonymous], UR INC WOM MAN; Balk E, 2018, COMP EFFECTIVENESS R, V212, DOI [10.23970/AHRQEPCCER212, DOI 10.23970/AHRQEPCCER212]; Balk E, 2018, AHRQ PUBLICATION, V212, DOI [10.23970/AHRQEPCCER212, DOI 10.23970/AHRQEPCCER212]; Balk E, 2018, PCORI PUBLICATION, DOI [10.23970/AHRQEPCCER212, DOI 10.23970/AHRQEPCCER212]; Bent AE, 2008, NEUROUROL URODYNAM, V27, P212, DOI 10.1002/nau.20471; Bo K, 1999, BMJ-BRIT MED J, V318, P487, DOI 10.1136/bmj.318.7182.487; Brubaker L, 1997, AM J OBSTET GYNECOL, V177, P536, DOI 10.1016/S0002-9378(97)70142-X; Brubaker L, 2008, J UROLOGY, V180, P217, DOI 10.1016/j.juro.2008.03.028; Burgio KL, 2008, ANN INTERN MED, V149, P161, DOI 10.7326/0003-4819-149-3-200808050-00005; Burgio KL, 2010, J UROLOGY, V184, P598, DOI 10.1016/j.juro.2010.03.141; Burgio KL, 1998, JAMA-J AM MED ASSOC, V280, P1995, DOI 10.1001/jama.280.23.1995; BURNS PA, 1993, J GERONTOL, V48, pM167; But I, 2005, J UROLOGY, V173, P1644, DOI 10.1097/01.ju.0000157336.87781.32; But I, 2003, UROLOGY, V61, P558, DOI 10.1016/S0090-4295(02)02249-5; Capobianco G, 2012, ARCH GYNECOL OBSTET, V285, P397, DOI 10.1007/s00404-011-1955-1; Cardozo L, 2004, OBSTET GYNECOL, V104, P511, DOI 10.1097/01.AOG.0000134525.86480.0f; Cardozo L, 2010, CURR MED RES OPIN, V26, P253, DOI 10.1185/03007990903438295; Castro RA, 2008, CLINICS, V63, P465, DOI 10.1590/S1807-59322008000400009; Diokno AC, 2004, J UROLOGY, V171, P1165, DOI 10.1097/01.ju.0000111503.73803.c2; FANTL JA, 1991, JAMA-J AM MED ASSOC, V265, P609, DOI 10.1001/jama.265.5.609; Fujishiro T, 2000, J UROLOGY, V164, P1277, DOI 10.1016/S0022-5347(05)67155-8; Ghoniem G, 2009, J UROLOGY, V181, P204, DOI 10.1016/j.juro.2008.09.032; Gittelman M, 2014, J UROLOGY, V191, P1014, DOI 10.1016/j.juro.2013.11.019; Goode PS, 2003, JAMA-J AM MED ASSOC, V290, P345, DOI 10.1001/jama.290.3.345; Gormley EA, 2012, J UROLOGY, V188, P2455, DOI 10.1016/j.juro.2012.09.079; HAHN I, 1991, NEUROUROL URODYNAM, V10, P545, DOI 10.1002/nau.1930100604; Haylen BT, 2010, NEUROUROL URODYNAM, V29, P4, DOI 10.1002/nau.20798; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Holtedahl K, 1998, ACTA OBSTET GYN SCAN, V77, P671, DOI 10.1034/j.1600-0412.1998.770616.x; Hung HC, 2010, MANUAL THER, V15, P273, DOI 10.1016/j.math.2010.01.008; Ishiko O, 2001, J REPROD MED, V46, P213; Jabs C, 2013, J OBSTET GYNAECOL CA, V35, P53, DOI 10.1016/S1701-2163(15)31049-5; Jackson S, 1999, BRIT J OBSTET GYNAEC, V106, P711, DOI 10.1111/j.1471-0528.1999.tb08372.x; Kafri R, 2013, INT UROGYNECOL J, V24, P1181, DOI 10.1007/s00192-012-1992-8; Khullar V, 2004, UROLOGY, V64, P269, DOI 10.1016/j.urology.2004.02.029; Kim H, 2007, J AM GERIATR SOC, V55, P1932, DOI 10.1111/j.1532-5415.2007.01447.x; Kim JI, 2001, PUBLIC HEALTH NURS, V18, P64, DOI 10.1046/j.1525-1446.2001.00064.x; Kinchen KS, 2005, INT UROGYNECOL J, V16, P337, DOI 10.1007/s00192-004-1270-5; LAGROJANSSEN ALM, 1992, FAM PRACT, V9, P284, DOI 10.1093/fampra/9.3.284; LAGROJANSSEN TLM, 1991, BRIT J GEN PRACT, V41, P445; da Costa AALF, 2018, SAO PAULO MED J, V136, P73, DOI 10.1590/1516-3180.2017.039420122017; Lee PE, 2001, J UROLOGY, V165, P153, DOI 10.1097/00005392-200101000-00037; Lian Aixia, 2015, Zhongguo Zhen Jiu, V35, P327; Lim R, 2017, J UROLOGY, V197, P1302, DOI 10.1016/j.juro.2016.11.091; Lin Alex Tong-Long, 2008, BMC Urol, V8, P2, DOI 10.1186/1471-2490-8-2; Liu ZS, 2017, JAMA-J AM MED ASSOC, V317, P2493, DOI 10.1001/jama.2017.7220; Lohr KN, 2008, METHODS GUIDE EFFECT; Lopes P, 2014, GYNECOL OBSTET FERTI, V42, P779, DOI 10.1016/j.gyobfe.2014.09.009; Lose G, 2000, BRIT J OBSTET GYNAEC, V107, P1029, DOI 10.1111/j.1471-0528.2000.tb10408.x; Lovatsis D, 2017, INT UROGYNECOL J, V28, P147, DOI 10.1007/s00192-016-3090-9; Luber KM, 1997, NEUROUROL URODYNAM, V16, P543, DOI 10.1002/(SICI)1520-6777(1997)16:6<543::AID-NAU4>3.0.CO;2-E; McFall SL, 2000, J AGING HEALTH, V12, P250, DOI 10.1177/089826430001200206; Millard RJ, 2004, BJU INT, V93, P311, DOI 10.1111/j.1464-410X.2004.04607.x; MOORE KH, 1990, BRIT J UROL, V66, P479, DOI 10.1111/j.1464-410X.1990.tb14992.x; Norton PA, 2002, AM J OBSTET GYNECOL, V187, P40, DOI 10.1067/mob.2002.124840; Oldham J, 2013, NEUROUROL URODYNAM, V32, P460, DOI 10.1002/nau.22326; Oreskovic S, 2012, COLLEGIUM ANTROPOL, V36, P243; Peters KM, 2009, J UROLOGY, V182, P1055, DOI 10.1016/j.juro.2009.05.045; Rogers R, 2008, INT UROGYNECOL J, V19, P1551, DOI 10.1007/s00192-008-0688-6; Rovner E, 2011, NEUROUROL URODYNAM, V30, P556, DOI 10.1002/nau.21021; Rovner ES, 2013, J UROLOGY, V190, P2243, DOI 10.1016/j.juro.2013.06.042; Rutledge TL, 2014, GYNECOL ONCOL, V132, P154, DOI 10.1016/j.ygyno.2013.10.024; Sand PK, 2009, INT UROGYNECOL J, V20, P827, DOI 10.1007/s00192-009-0857-2; SAND PK, 1995, AM J OBSTET GYNECOL, V173, P72, DOI 10.1016/0002-9378(95)90172-8; Schreiner L, 2010, INT UROGYNECOL J, V21, P1065, DOI 10.1007/s00192-010-1165-6; Shamliyan T, 2012, COMP EFFECTIVENESS R, V36; Shamliyan T., 2012, AGENCY HEALTHCARE RE, V11, P95; Smith JJ, 1996, J UROLOGY, V155, P127, DOI 10.1016/S0022-5347(01)66567-4; Spruijt J, 2003, ACTA OBSTET GYN SCAN, V82, P1043, DOI 10.1034/j.1600-0412.2003.00130.x; Steers WD, 2007, BJU INT, V100, P337, DOI 10.1111/j.1464-410X.2007.06980.x; Subak LL, 2005, J UROLOGY, V174, P190, DOI 10.1097/01.ju.0000162056.30326.83; Subak LL, 2002, OBSTET GYNECOL, V100, P72, DOI 10.1016/S0029-7844(02)01993-2; Syan R, 2016, BJU INT, V117, P20, DOI 10.1111/bju.13187; SZONYI G, 1995, AGE AGEING, V24, P287, DOI 10.1093/ageing/24.4.287; Talley KMC, 2017, J AM GERIATR SOC, V65, P1321, DOI 10.1111/jgs.14798; Tannenbaum C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-004135; Terlikowski R, 2013, INT UROGYNECOL J, V24, P1631, DOI 10.1007/s00192-013-2071-5; THUROFF JW, 1991, J UROLOGY, V145, P813, DOI 10.1016/S0022-5347(17)38459-8; Tu YK, 2016, VALUE HEALTH, V19, P957, DOI 10.1016/j.jval.2016.07.005; van Kerrebroeck P, 2004, BJOG-INT J OBSTET GY, V111, P249, DOI 10.1111/j.1471-0528.2004.00067.x; van Leeuwen JHS, 2008, MATURITAS, V60, P138, DOI 10.1016/j.maturitas.2008.04.012; Visco AG, 2012, NEW ENGL J MED, V367, P1803, DOI 10.1056/NEJMoa1208872; Waetjen LE, 2005, OBSTET GYNECOL, V106, P946, DOI 10.1097/01.AOG.0000182576.48290.6d; Wang AC, 2004, UROLOGY, V63, P61, DOI 10.1016/j.urology.2003.08.047; Wang SY, 2016, UROLOGY, V91, P64, DOI 10.1016/j.urology.2016.02.027; WELLS TJ, 1991, J AM GERIATR SOC, V39, P785, DOI 10.1111/j.1532-5415.1991.tb02701.x; Wiegersma M, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7378; Williams KS, 2006, BJU INT, V98, P1043, DOI 10.1111/j.1464-410X.2006.06484.x; Wu JM, 2014, OBSTET GYNECOL, V123, P141, DOI 10.1097/AOG.0000000000000057; Yalcin I, 2006, UROLOGY, V67, P1304, DOI 10.1016/j.urology.2005.12.006	97	22	23	1	23	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 2	2019	170	7					465	+		10.7326/M18-3227	http://dx.doi.org/10.7326/M18-3227			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HR3WA	30884526				2022-12-28	WOS:000463070700005
J	Huang, HL; Weng, HY; Zhou, KR; Wu, T; Zhao, BS; Sun, ML; Chen, ZH; Deng, XL; Xiao, G; Auer, F; Klemm, L; Wu, HZ; Zuo, ZX; Qin, X; Dong, YZ; Zhou, YL; Qin, HJ; Tao, S; Du, J; Liu, J; Lu, ZK; Yin, H; Mesquita, A; Yuan, CL; Hu, YC; Sun, WJ; Su, R; Dong, L; Shen, C; Li, CY; Qing, Y; Jiang, X; Wu, XW; Sun, M; Guan, JL; Qu, LH; Wei, MJ; Muschen, M; Huang, G; He, C; Yang, J; Chen, J				Huang, Huilin; Weng, Hengyou; Zhou, Keren; Wu, Tong; Zhao, Boxuan Simen; Sun, Mingli; Chen, Zhenhua; Deng, Xiaolan; Xiao, Gang; Auer, Franziska; Klemm, Lars; Wu, Huizhe; Zuo, Zhixiang; Qin, Xi; Dong, Yunzhu; Zhou, Yile; Qin, Hanjun; Tao, Shu; Du, Juan; Liu, Jun; Lu, Zhike; Yin, Hang; Mesquita, Ana; Yuan, Celvie L.; Hu, Yueh-Chiang; Sun, Wenju; Su, Rui; Dong, Lei; Shen, Chao; Li, Chenying; Qing, Ying; Jiang, Xi; Wu, Xiwei; Sun, Miao; Guan, Jun-Lin; Qu, Lianghu; Wei, Minjie; Muschen, Markus; Huang, Gang; He, Chuan; Yang, Jianhua; Chen, Jianjun			Histone H3 trimethylation at lysine 36 guides m(6)A RNA modification co-transcriptionally	NATURE			English	Article							METHYLATION; DEACETYLATION; ENRICHMENT; STABILITY; REVEALS; DOMAIN	DNA and histone modifications have notable effects on gene expression(1). Being the most prevalent internal modification in mRNA, the N-6-methyladenosine (m(6)A) mRNA modification is as an important post-transcriptional mechanism of gene regulation(2-4) and has crucial roles in various normal and pathological processes(5-12). However, it is unclear how m(6)A is specifically and dynamically deposited in the transcriptome. Here we report that histone H3 trimethylation at Lys36 (H3K36me3), a marker for transcription elongation, guides m(6)A deposition globally. We show that m(6)A modifications are enriched in the vicinity of H3K36me3 peaks, and are reduced globally when cellular H3K36me3 is depleted. Mechanistically, H3K36me3 is recognized and bound directly by METTL14, a crucial component of the m(6)A methyltransferase complex (MTC), which in turn facilitates the binding of the m(6)A MTC to adjacent RNA polymerase II, thereby delivering the m(6)A MTC to actively transcribed nascent RNAs to deposit m(6)A co-transcriptionally. In mouse embryonic stem cells, phenocopying METTL14 knockdown, H3K36me3 depletion also markedly reduces m(6)A abundance transcriptome-wide and in pluripotency transcripts, resulting in increased cell stemness. Collectively, our studies reveal the important roles of H3K36me3 and METTL14 in determining specific and dynamic deposition of m(6)A in mRNA, and uncover another layer of gene expression regulation that involves crosstalk between histone modification and RNA methylation.	[Huang, Huilin; Weng, Hengyou; Sun, Mingli; Chen, Zhenhua; Deng, Xiaolan; Xiao, Gang; Auer, Franziska; Klemm, Lars; Wu, Huizhe; Qin, Xi; Su, Rui; Dong, Lei; Shen, Chao; Li, Chenying; Qing, Ying; Jiang, Xi; Muschen, Markus; Chen, Jianjun] Beckman Res Inst City Hope, Dept Syst Biol, Monrovia, CA 91016 USA; [Huang, Huilin; Weng, Hengyou; Deng, Xiaolan; Wu, Huizhe; Zuo, Zhixiang; Qin, Xi; Mesquita, Ana; Su, Rui; Dong, Lei; Shen, Chao; Li, Chenying; Qing, Ying; Jiang, Xi; Guan, Jun-Lin; Chen, Jianjun] Univ Cincinnati, Coll Med, Dept Canc Biol, Cincinnati, OH 45221 USA; [Zhou, Keren; Sun, Wenju; Qu, Lianghu; Yang, Jianhua] Sun Yat Sen Univ, Key Lab Gene Engn, Minist Educ, Guangzhou, Guangdong, Peoples R China; [Zhou, Keren; Sun, Wenju; Qu, Lianghu; Yang, Jianhua] Sun Yat Sen Univ, State Key Lab Biocontrol, Guangzhou, Guangdong, Peoples R China; [Wu, Tong; Zhao, Boxuan Simen; Liu, Jun; Lu, Zhike; Yin, Hang; He, Chuan] Univ Chicago, Dept Chem, 5735 S Ellis Ave, Chicago, IL 60637 USA; [Wu, Tong; Zhao, Boxuan Simen; Liu, Jun; Lu, Zhike; Yin, Hang; He, Chuan] Univ Chicago, Dept Biochem & Mol Biol, 920 E 58Th St, Chicago, IL 60637 USA; [Wu, Tong; Zhao, Boxuan Simen; Liu, Jun; Lu, Zhike; Yin, Hang; He, Chuan] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA; [Wu, Tong; Zhao, Boxuan Simen; Liu, Jun; Lu, Zhike; Yin, Hang; He, Chuan] Univ Chicago, Howard Hughes Med Inst, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Sun, Mingli; Deng, Xiaolan; Wu, Huizhe; Wei, Minjie] China Med Univ, Sch Pharm, Dept Pharmacol, Shenyang, Liaoning, Peoples R China; [Zuo, Zhixiang] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Canc Ctr, Guangzhou, Guangdong, Peoples R China; [Dong, Yunzhu; Zhou, Yile; Huang, Gang] Cincinnati Childrens Hosp Med Ctr, Div Pathol, Cincinnati, OH 45229 USA; [Dong, Yunzhu; Zhou, Yile; Huang, Gang] Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA; [Qin, Hanjun; Tao, Shu; Du, Juan; Wu, Xiwei] Beckman Res Inst City Hope, Intergrat Genom Core, Monrovia, CA USA; [Yuan, Celvie L.; Hu, Yueh-Chiang] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA; [Jiang, Xi] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Pharmacol, Hangzhou, Zhejiang, Peoples R China; [Jiang, Xi] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Bone Marrow Transplantat Ctr, Hangzhou, Zhejiang, Peoples R China; [Jiang, Xi] Zhejiang Univ, Inst Hematol, Hangzhou, Zhejiang, Peoples R China; [Jiang, Xi] Zhejiang Engn Lab Stem Cell & Immunotherapy, Hangzhou, Zhejiang, Peoples R China; [Sun, Miao] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Sun, Miao] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA	City of Hope; Beckman Research Institute of City of Hope; University System of Ohio; University of Cincinnati; Sun Yat Sen University; Sun Yat Sen University; University of Chicago; University of Chicago; University of Chicago; Howard Hughes Medical Institute; University of Chicago; China Medical University; State Key Lab Oncology South China; Sun Yat Sen University; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; City of Hope; Beckman Research Institute of City of Hope; Cincinnati Children's Hospital Medical Center; Zhejiang University; Zhejiang University; Zhejiang University; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center	Chen, J (corresponding author), Beckman Res Inst City Hope, Dept Syst Biol, Monrovia, CA 91016 USA.; Chen, J (corresponding author), Univ Cincinnati, Coll Med, Dept Canc Biol, Cincinnati, OH 45221 USA.; Yang, J (corresponding author), Sun Yat Sen Univ, Key Lab Gene Engn, Minist Educ, Guangzhou, Guangdong, Peoples R China.; Yang, J (corresponding author), Sun Yat Sen Univ, State Key Lab Biocontrol, Guangzhou, Guangdong, Peoples R China.; He, C (corresponding author), Univ Chicago, Dept Chem, 5735 S Ellis Ave, Chicago, IL 60637 USA.; He, C (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, 920 E 58Th St, Chicago, IL 60637 USA.; He, C (corresponding author), Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA.; He, C (corresponding author), Univ Chicago, Howard Hughes Med Inst, 5841 S Maryland Ave, Chicago, IL 60637 USA.; Huang, G (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Pathol, Cincinnati, OH 45229 USA.; Huang, G (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA.	gang.huang@cchmc.org; chuanhe@uchicago.edu; yangjh7@mail.sysu.edu.cn; jianchen@coh.org	Zuo, Zhixiang/M-4441-2016; Hu, Yueh-Chiang/AAX-2370-2020; Huang, Huilin/AAA-8376-2019; Tao, Shu/I-1530-2018; Zhao, Boxuan/Q-2159-2019; Dong, Lei/AAA-9495-2020	Zuo, Zhixiang/0000-0002-2492-2689; Tao, Shu/0000-0001-5177-6771; Zhao, Boxuan/0000-0002-3729-4511; Dong, Lei/0000-0001-9574-0148; Weng, Hengyou/0000-0001-6474-2861; CHEN, ZHENHUA/0000-0002-1381-0235; Qin, Xi/0000-0002-1154-5634; Qing, Ying/0000-0001-6763-6204; Shen, Chao/0000-0002-9406-7075; Xiao, Gang/0000-0002-9476-3847; Sun, WenJu/0000-0001-6976-4664; Su, Rui/0000-0002-4807-6229; Yang, Jian-Hua/0000-0003-3863-2786; Hu, Yueh-Chiang/0000-0002-7992-0525; Auer, Franziska/0000-0002-1193-6002; Zhou, Keren/0000-0001-7905-3399; Wu, Huizhe/0000-0001-7964-1342	National Institutes of Health (NIH) from National Nature Science Foundation of China [R01 CA214965, R01 CA211614, R01 CA178454, R01 CA182528, R01 CA236399, RM1 HG008935, R21 CA187276, R01 CA163493, R35 CA197628, U10 CA180827, R01 CA137060, R01 CA157644, R01 CA172558, R01 CA213138, 2017YFA0504400, 91440110, 31671349]; Cancer Center Support Grant from City of Hope National Medical Center [P30CA33572]; Deutsche Forschungsgemeinschaft (DFG) fellowship [AU 525/1-1]; NATIONAL CANCER INSTITUTE [P30CA033572, R01CA211614, R01CA163493, R01CA157644, R01CA182528, R01CA211066, U10CA180827, R35CA197628, R01CA214965, R01CA236399, R01CA178454, R01CA213138] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RM1HG008935] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK120282] Funding Source: NIH RePORTER	National Institutes of Health (NIH) from National Nature Science Foundation of China; Cancer Center Support Grant from City of Hope National Medical Center; Deutsche Forschungsgemeinschaft (DFG) fellowship(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by the National Institutes of Health (NIH) grants R01 CA214965 (J.C.), R01 CA211614 (J.C.), R01 CA178454 (J.C.), R01 CA182528 (J.C.), R01 CA236399 (J.C.), RM1 HG008935 (C.H.), R21 CA187276 (G.H.), R01 CA163493 (J.G.), R35 CA197628 (M.M.), U10 CA180827 (M.M.), R01 CA137060 (M.M.), R01 CA157644 (M.M.), R01 CA172558 (M.M.) and R01 CA213138 (M.M.), and grants 2017YFA0504400 (J.Y.), 91440110 (J.Y.) and 31671349 (L.Q.) from National Nature Science Foundation of China, and Cancer Center Support Grant (P30CA33572) from City of Hope National Medical Center. J.C. is a Leukemia & Lymphoma Society (LLS) Scholar. C.H. is an investigator of the Howard Hughes Medical Institute (HHMI). M.M. is an HHMI Faculty Scholar. B.S.Z. is an HHMI International Student Research Fellow. F.A. was supported by a Deutsche Forschungsgemeinschaft (DFG) fellowship (AU 525/1-1).	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Batista PJ, 2014, CELL STEM CELL, V15, P707, DOI 10.1016/j.stem.2014.09.019; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Deng XL, 2018, CURR OPIN GENET DEV, V48, P1, DOI 10.1016/j.gde.2017.10.005; Dominguez AA, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.2; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Geula S, 2015, SCIENCE, V347, P1002, DOI 10.1126/science.1261417; Hacker KE, 2016, J BIOL CHEM, V291, P21283, DOI 10.1074/jbc.M116.739375; Huang HL, 2018, NAT CELL BIOL, V20, P285, DOI 10.1038/s41556-018-0045-z; Joshi AA, 2005, MOL CELL, V20, P971, DOI 10.1016/j.molcel.2005.11.021; Kizer KO, 2005, MOL CELL BIOL, V25, P3305, DOI 10.1128/MCB.25.8.3305-3316.2005; Li ZJ, 2017, CANCER CELL, V31, P127, DOI 10.1016/j.ccell.2016.11.017; Linder B, 2015, NAT METHODS, V12, P767, DOI [10.1038/nmeth.3453, 10.1038/NMETH.3453]; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Olmos Y, 2015, NATURE, V522, P236, DOI 10.1038/nature14503; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Su R, 2018, CELL, V172, P90, DOI 10.1016/j.cell.2017.11.031; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun XJ, 2005, J BIOL CHEM, V280, P35261, DOI 10.1074/jbc.M504012200; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Wang Y, 2014, NAT CELL BIOL, V16, P191, DOI 10.1038/ncb2902; Weng HY, 2018, CELL STEM CELL, V22, P191, DOI 10.1016/j.stem.2017.11.016; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Xiang Y, 2017, NATURE, V543, P573, DOI 10.1038/nature21671; Yang JH, 2013, NUCLEIC ACIDS RES, V41, pD177, DOI 10.1093/nar/gks1060; Zhou K. R, 2013, NUCLEIC ACIDS RES, V45, pD43	31	268	274	12	165	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 21	2019	567	7748					414	+		10.1038/s41586-019-1016-7	http://dx.doi.org/10.1038/s41586-019-1016-7			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP9JT	30867593	Green Accepted			2022-12-28	WOS:000462010000060
J	Muraglia, KA; Chorghade, RS; Kim, BR; Tang, XX; Shah, VS; Grillo, AS; Daniels, PN; Cioffi, AG; Karp, PH; Zhu, LY; Welsh, MJ; Burke, MD				Muraglia, Katrina A.; Chorghade, Rajeev S.; Kim, Bo Ram; Tang, Xiao Xiao; Shah, Viral S.; Grillo, Anthony S.; Daniels, Page N.; Cioffi, Alexander G.; Karp, Philip H.; Zhu, Lingyang; Welsh, Michael J.; Burke, Martin D.			Small-molecule ion channels increase host defences in cystic fibrosis airway epithelia	NATURE			English	Article							LIPOSOMAL AMPHOTERICIN-B; INVASIVE FUNGAL-INFECTIONS; ASPERGILLUS INFECTION; LUNG TRANSPLANTATION; CFTR POTENTIATOR; BASE SECRETION; SURFACE LIQUID; LIPID COMPLEX; CL-SECRETION; IN-VITRO	Loss-of-function mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) compromise epithelial HCO3- and Cl- secretion, reduce airway surface liquid pH, and impair respiratory host defences in people with cystic fibrosis(1-3). Here we report that apical addition of amphotericin B, a small molecule that forms unselective ion channels, restored HCO3- secretion and increased airway surface liquid pH in cultured airway epithelia from people with cystic fibrosis. These effects required the basolateral Na+, K+-ATPase, indicating that apical amphotericin B channels functionally interfaced with this driver of anion secretion. Amphotericin B also restored airway surface liquid pH, viscosity, and antibacterial activity in primary cultures of airway epithelia from people with cystic fibrosis caused by different mutations, including ones that do not yield CFTR, and increased airway surface liquid pH in CFTR-null pigs in vivo. Thus, unselective small-molecule ion channels can restore host defences in cystic fibrosis airway epithelia via a mechanism that is independent of CFTR and is therefore independent of genotype.	[Muraglia, Katrina A.; Daniels, Page N.; Cioffi, Alexander G.; Burke, Martin D.] Univ Illinois, Dept Biochem, Urbana, IL 61820 USA; [Chorghade, Rajeev S.; Grillo, Anthony S.; Zhu, Lingyang; Burke, Martin D.] Univ Illinois, Dept Chem, Urbana, IL 61820 USA; [Kim, Bo Ram; Tang, Xiao Xiao; Shah, Viral S.; Karp, Philip H.; Welsh, Michael J.] Univ Iowa, Dept Internal Med, Pappajohn Biomed Inst, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Kim, Bo Ram; Tang, Xiao Xiao; Shah, Viral S.; Karp, Philip H.; Welsh, Michael J.] Univ Iowa, HHMI, Pappajohn Biomed Inst, Roy J & Lucille A Carver Coll Med, Iowa City, IA USA; [Welsh, Michael J.] Univ Iowa, Dept Mol Physiol & Biophys, Roy J & Lucille A Carver Coll Med, Iowa City, IA USA; [Burke, Martin D.] Univ Illinois, Carle Illinois Coll Med, Champaign, IL 61820 USA; [Burke, Martin D.] Univ Illinois, Carl R Woese Inst Genom Biol, Champaign, IL 61820 USA; [Burke, Martin D.] Univ Illinois, Beckman Inst Adv Sci & Technol, Champaign, IL 61820 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Iowa; Howard Hughes Medical Institute; University of Iowa; University of Iowa; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Burke, MD (corresponding author), Univ Illinois, Dept Biochem, Urbana, IL 61820 USA.; Burke, MD (corresponding author), Univ Illinois, Dept Chem, Urbana, IL 61820 USA.; Burke, MD (corresponding author), Univ Illinois, Carle Illinois Coll Med, Champaign, IL 61820 USA.; Burke, MD (corresponding author), Univ Illinois, Carl R Woese Inst Genom Biol, Champaign, IL 61820 USA.; Burke, MD (corresponding author), Univ Illinois, Beckman Inst Adv Sci & Technol, Champaign, IL 61820 USA.	mdburke@illinois.edu		Chorghade, Rajeev/0000-0001-7162-1419; Daniels, Page/0000-0003-4883-025X; Welsh, Michael/0000-0002-1646-6206	NIH [5R35GM118185, HL091842]; Emily's Entourage; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL091842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118185, T32GM007337] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emily's Entourage; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge M. Sivaguru at the Carl R. Woese Institute for Genomic Biology for assistance with confocal microscopy, S.E. Denmark and C. Delaney for assistance with rapid injection NMR and D. J. Blair for helpful discussions. Support was provided by NIH (5R35GM118185 to M.D.B. and HL091842 to M.J.W.), and by Emily's Entourage. M.J.W. is an HHMI Investigator. K.A.M. is a Medical Scholars Fellow.	Alaiwa MHA, 2016, JCI INSIGHT, V1; Anderson TM, 2014, NAT CHEM BIOL, V10, P400, DOI 10.1038/nchembio.1496; Andrews NJ, 2011, CHEM SCI, V2, P256, DOI 10.1039/c0sc00503g; Busschaert N, 2014, CHEM SCI, V5, P1118, DOI 10.1039/c3sc52006d; Busschaert N, 2010, CHEM COMMUN, V46, P6252, DOI 10.1039/c0cc01684e; Castagnola E., 2013, J CHEMOTHER, V19, P339; Chang EH, 2015, INT FORUM ALLERGY RH, V5, P178, DOI 10.1002/alr.21440; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; Cho DY, 2011, INT FORUM ALLERGY RH, V1, P123, DOI 10.1002/alr.20028; Cho DY, 2009, AM J RHINOL ALLERGY, V23, pE10, DOI 10.2500/ajra.2009.23.3389; Cioffi AG, 2015, J AM CHEM SOC, V137, P10096, DOI 10.1021/jacs.5b05765; Davis JT, 2009, NAT CHEM, V1, P138, DOI [10.1038/NCHEM.178, 10.1038/nchem.178]; Davis SA, 2015, J AM CHEM SOC, V137, P15102, DOI 10.1021/jacs.5b05766; Denmark SE, 2010, J ORG CHEM, V75, P5558, DOI 10.1021/jo100837a; Derichs N, 2011, FASEB J, V25, P2325, DOI 10.1096/fj.10-179549; Devor DC, 1999, J GEN PHYSIOL, V113, P743, DOI 10.1085/jgp.113.5.743; Drew RH, 2004, TRANSPLANTATION, V77, P232, DOI 10.1097/01.TP.0000101516.08327.A9; ElEtri M, 1996, AM J PHYSIOL-LUNG C, V270, pL386, DOI 10.1152/ajplung.1996.270.3.L386; ERMISHKIN LN, 1977, BIOCHIM BIOPHYS ACTA, V470, P357, DOI 10.1016/0005-2736(77)90127-4; Farha MA, 2018, ACS INFECT DIS, V4, P382, DOI 10.1021/acsinfecdis.7b00194; Fischer Horst, 2012, Wiley Interdiscip Rev Membr Transp Signal, V1, P247; Fischer H, 2006, J MEMBRANE BIOL, V211, P139, DOI 10.1007/s00232-006-0861-0; Garland AL, 2013, P NATL ACAD SCI USA, V110, P15973, DOI 10.1073/pnas.1311999110; Garnett JP, 2016, SCI REP-UK, V6, DOI 10.1038/srep37955; Gray KC, 2012, P NATL ACAD SCI USA, V109, P2234, DOI 10.1073/pnas.1117280109; Grillo AS, 2017, SCIENCE, V356, P608, DOI 10.1126/science.aah3862; Hullard-Pulstinger A, 2011, ONKOLOGIE, V34, P254, DOI 10.1159/000327802; Jiang CW, 2001, AM J PHYSIOL-LUNG C, V281, pL1164, DOI 10.1152/ajplung.2001.281.5.L1164; Karp Philip H, 2002, Methods Mol Biol, V188, P115; Koulov AV, 2003, ANGEW CHEM INT EDIT, V42, P4931, DOI 10.1002/anie.200351957; Lowry CM, 2007, TRANSPL INFECT DIS, V9, P121, DOI 10.1111/j.1399-3062.2007.00209.x; Monforte V, 2013, J HEART LUNG TRANSPL, V32, P313, DOI 10.1016/j.healun.2012.11.013; Monforte V, 2010, J HEART LUNG TRANSPL, V29, P523, DOI 10.1016/j.healun.2009.11.603; Monforte V, 2009, J HEART LUNG TRANSPL, V28, P170, DOI 10.1016/j.healun.2008.11.004; Myerburg MM, 2010, AM J RESP CELL MOL, V42, P676, DOI 10.1165/2009-0147OC; Oliver KE, 2017, CURR OPIN PHARMACOL, V34, P76, DOI 10.1016/j.coph.2017.09.018; Palmer SM, 2001, TRANSPLANTATION, V72, P545, DOI 10.1097/00007890-200108150-00036; Peckham D, 1997, BIOCHEM BIOPH RES CO, V232, P464, DOI 10.1006/bbrc.1997.6200; Perfect JR, 2004, CLIN INFECT DIS, V39, pS207, DOI 10.1086/421958; Pezzulo AA, 2012, NATURE, V487, P109, DOI 10.1038/nature11130; POULSEN JH, 1994, P NATL ACAD SCI USA, V91, P5340, DOI 10.1073/pnas.91.12.5340; Quinton PM, 2001, NAT MED, V7, P292, DOI 10.1038/85429; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; Ratjen F, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.10; Rijnders BJ, 2008, CLIN INFECT DIS, V46, P1401, DOI 10.1086/586739; RINGDEN O, 1991, J ANTIMICROB CHEMOTH, V28, P73, DOI 10.1093/jac/28.suppl_B.73; Saint-Criq V, 2017, CELL MOL LIFE SCI, V74, P93, DOI 10.1007/s00018-016-2391-y; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shah VS, 2016, SCIENCE, V351, P503, DOI 10.1126/science.aad5589; Shen B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034694; Slobbe L, 2008, PULM PHARMACOL THER, V21, P855, DOI 10.1016/j.pupt.2008.09.001; Stone NRH, 2016, DRUGS, V76, P485, DOI 10.1007/s40265-016-0538-7; Tang XX, 2016, J CLIN INVEST, V126, P879, DOI 10.1172/JCI83922; Thomas AA, 2016, SCIENCE, V352, P329, DOI 10.1126/science.aad6981; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Wainwright CE, 2015, NEW ENGL J MED, V373, P220, DOI 10.1056/NEJMoa1409547; Wallace DP, 2000, BBA-BIOMEMBRANES, V1464, P69, DOI 10.1016/S0005-2736(99)00248-5; WIDDICOMBE JH, 1985, P NATL ACAD SCI USA, V82, P6167, DOI 10.1073/pnas.82.18.6167; Worthington EN, 2011, METHODS MOL BIOL, V742, P77, DOI 10.1007/978-1-61779-120-8_5; Zabner J, 2003, AM J PHYSIOL-LUNG C, V284, pL844, DOI 10.1152/ajplung.00355.2002	60	56	56	6	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 21	2019	567	7748					405	+		10.1038/s41586-019-1018-5	http://dx.doi.org/10.1038/s41586-019-1018-5			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP9JT	30867598	Green Accepted			2022-12-28	WOS:000462010000058
J	Iacobucci, G				Iacobucci, Gareth			NEWS ANALYSIS Digital health: GPs aren't "Luddites" but want safe, equitable care	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Care Quality Commission, STAT CAR IND ONL PRI; IACOBUCCI G, 2019, BMJ-BRIT MED J, V364, P9816, DOI DOI 10.1136/BMJ.L531; IACOBUCCI G, 2019, BMJ-BRIT MED J, V364, DOI DOI 10.1136/BMJ.L748; Razzaki S, 2018, COMP STUDY ARTIFICIA; RIMMER A, 2019, BMJ-BRIT MED J, V364, DOI DOI 10.1136/BMJ.L661	5	3	3	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 19	2019	364								l1258	10.1136/bmj.l1258	http://dx.doi.org/10.1136/bmj.l1258			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HQ7ZZ	30890525				2022-12-28	WOS:000462644400008
J	Birn, AE				Birn, Anne-Emanuelle			Child health and child rights: Uruguay's progeny	LANCET			English	Editorial Material									[Birn, Anne-Emanuelle] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5T 3M7, Canada	University of Toronto	Birn, AE (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5T 3M7, Canada.	ae.birn@utoronto.ca							0	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 16	2019	393	10176					1092	1093		10.1016/S0140-6736(19)30508-2	http://dx.doi.org/10.1016/S0140-6736(19)30508-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HP1HF	30894261				2022-12-28	WOS:000461416600015
J	Arie, S				Arie, Sophie			WHO calls for more action to protect children from online junk food advertising	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Advertising Association, 2019, HFSS ADV EXP UK CHIL; WHO Europe, 2019, MON RESTR DIG MARK U	2	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 15	2019	364								l1221	10.1136/bmj.l1221	http://dx.doi.org/10.1136/bmj.l1221			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP5WF	30877110				2022-12-28	WOS:000461752800008
J	Dyer, O				Dyer, Owen			California jury awards $29m to woman who said Johnson & Johnson talc caused mesothelioma	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		DYER O, 2018, BMJ-BRIT MED J, V363, P93486, DOI DOI 10.1136/BMJ.K5430; DYER O, 2018, BMJ-BRIT MED J, V362, P12582, DOI DOI 10.1136/BMJ.K3135; DYER O, 2019, BMJ-BRIT MED J, V364, DOI DOI 10.1136/BMJ.L402; Dyer O, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3045	4	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 15	2019	364								l1215	10.1136/bmj.l1215	http://dx.doi.org/10.1136/bmj.l1215			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP5WF	30877111				2022-12-28	WOS:000461752800005
J	Han, F; Wang, F				Han, Fei; Wang, Fei			A white ring around a naevus	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HALO; VITILIGO		[Han, Fei] Suqian First Hosp, Dept Dermatol, Suqian City, Jiangsu, Peoples R China; [Wang, Fei] Southeast Univ, Zhongda Hosp, Dept Dermatol, Nanjing, Jiangsu, Peoples R China	Southeast University - China	Han, F (corresponding author), Suqian First Hosp, Dept Dermatol, Suqian City, Jiangsu, Peoples R China.	srhanfei@163.com						Aouthmany M, 2012, J AM ACAD DERMATOL, V67, P582, DOI 10.1016/j.jaad.2011.11.937; Bolognia JL, 2018, DERMATOLOGY, V4th; Cohen BE, 2016, PEDIATR DERMATOL, V33, P44, DOI 10.1111/pde.12717; Hofmann UB, 2009, ACTA DERM-VENEREOL, V89, P402, DOI 10.2340/00015555-0654; Mundinger GS, 2014, NEW ENGL J MED, V370, P262, DOI 10.1056/NEJMicm1306230; Weyant GW, 2015, INT J DERMATOL, V54, pE433, DOI 10.1111/ijd.12843	6	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 14	2019	364								l997	10.1136/bmj.l997	http://dx.doi.org/10.1136/bmj.l997			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP5WD	30872280				2022-12-28	WOS:000461752500004
J	Li, L; Mao, YX; Zhao, LN; Li, LJ; Wu, JJ; Zhao, MJ; Du, WJ; Yu, L; Jiang, P				Li, Le; Mao, Youxiang; Zhao, Lina; Li, Lijia; Wu, Jinjun; Zhao, Mengjia; Du, Wenjing; Yu, Li; Jiang, Peng			p53 regulation of ammonia metabolism through urea cycle controls polyamine biosynthesis	NATURE			English	Article							CANCER; DEGRADATION; MUTATIONS	Cancer cells exhibit altered and usually increased metabolic processes to meet their high biogenetic demands(1,2). Under these conditions, ammonia is concomitantly produced by the increased metabolic processing. However, it is unclear how tumour cells dispose of excess ammonia and what outcomes might be caused by the accumulation of ammonia. Here we report that the tumour suppressor p53, the most frequently mutated gene in human tumours, regulates ammonia metabolism by repressing the urea cycle. Through transcriptional downregulation of CPS1, OTC and ARG1, p53 suppresses ureagenesis and elimination of ammonia in vitro and in vivo, leading to the inhibition of tumour growth. Conversely, downregulation of these genes reciprocally activates p53 by MDM2-mediated mechanism(s). Furthermore, the accumulation of ammonia causes a significant decline in mRNA translation of the polyamine biosynthetic rate-limiting enzyme ODC, thereby inhibiting the biosynthesis of polyamine and cell proliferation. Together, these findings link p53 to ureagenesis and ammonia metabolism, and further reveal a role for ammonia in controlling polyamine biosynthesis and cell proliferation.	[Li, Le; Mao, Youxiang; Zhao, Lina; Li, Lijia; Wu, Jinjun; Zhao, Mengjia; Yu, Li; Jiang, Peng] Tsinghua Univ, Sch Life Sci, Beijing, Peoples R China; [Du, Wenjing] Chinese Acad Med Sci, Peking Union Med Coll, Inst Basic Med Sci, State Key Lab Med Mol Biol, Beijing, Peoples R China; [Du, Wenjing] Chinese Acad Med Sci, Peking Union Med Coll, Sch Basic Med, Beijing, Peoples R China	Tsinghua University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Jiang, P (corresponding author), Tsinghua Univ, Sch Life Sci, Beijing, Peoples R China.	pengjiang@tsinghua.edu.cn		Jiang, Peng/0000-0002-4218-0092	1000 Talents Program for Young Scholars; Tsinghua University Initiative Scientific Research Program; National Natural Science Foundation of China [31571470, 81722035]; Tsinghua-Peking Center for Life Sciences	1000 Talents Program for Young Scholars; Tsinghua University Initiative Scientific Research Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tsinghua-Peking Center for Life Sciences	We thank H. Wu, Y. Liu, W. He, Y. Wang, J. Na, S. Fu and W. Wu for materials. We thank G. Alderton for discussion. We thank J. Zhang, J. Cheng, L. Li, X. Xiao, F. Sun, N. Li, H. Li and all of the Jiang laboratory members for technical assistance and/or discussion. We thank Y. Ding, W. Wang, Y. Tian and Z. Hu for help with the LC-MS/MS experiments. This research was supported by the 1000 Talents Program for Young Scholars, the Tsinghua University Initiative Scientific Research Program, Tsinghua-Peking Center for Life Sciences, and National Natural Science Foundation of China (31571470; 81722035) to P. J.	Bourgeois S, 2010, J CLIN INVEST, V120, P1895, DOI 10.1172/JCI36581; Cheong H, 2012, NAT BIOTECHNOL, V30, P671, DOI 10.1038/nbt.2285; Cheong H, 2011, P NATL ACAD SCI USA, V108, P11121, DOI 10.1073/pnas.1107969108; Contractor T, 2012, CANCER RES, V72, P560, DOI 10.1158/0008-5472.CAN-11-1215; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454; GLASS JR, 1986, BIOCHEM J, V236, P351, DOI 10.1042/bj2360351; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Jiang P, 2013, NATURE, V493, P689, DOI 10.1038/nature11776; Kahana C, 2005, CELL CYCLE, V4, P1461, DOI 10.4161/cc.4.11.2115; Kim J, 2017, NATURE, V546, P168, DOI 10.1038/nature22359; Kosenko E, 2007, J NEUROSCI RES, V85, P2491, DOI 10.1002/jnr.21385; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lanpher B, 2006, NAT REV GENET, V7, P449, DOI 10.1038/nrg1880; MEYSKENS FL, 1994, J NATL CANCER I, V86, P1122, DOI 10.1093/jnci/86.15.1122; MICHALOVITZ D, 1990, CELL, V62, P671, DOI 10.1016/0092-8674(90)90113-S; Newsholme EA., 2009, FUNCTIONAL BIOCH HLT; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; Panickar KS, 2009, NEUROCHEM INT, V55, P98, DOI 10.1016/j.neuint.2008.12.022; Rabinovich S, 2015, NATURE, V527, P379, DOI 10.1038/nature15529; Sankpal NV, 2009, CANCER RES, V69, P753, DOI 10.1158/0008-5472.CAN-08-2708; Spinelli JB, 2017, SCIENCE, V358, P941, DOI 10.1126/science.aam9305; Thrane VR, 2013, NAT MED, V19, P1643, DOI 10.1038/nm.3400; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675	26	65	72	8	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 14	2019	567	7747					253	+		10.1038/s41586-019-0996-7	http://dx.doi.org/10.1038/s41586-019-0996-7			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7LD	30842655				2022-12-28	WOS:000461126600045
J	Vaughan, J				Vaughan, Jenny			Jenny Vaughan: Overturning injustice	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item									[Vaughan, Jenny] Doctors Assoc UK DAUK, London, England; [Vaughan, Jenny] BMA, London, England		Vaughan, J (corresponding author), Doctors Assoc UK DAUK, London, England.; Vaughan, J (corresponding author), BMA, London, England.								0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 14	2019	364								l024	10.1136/bmj.l1024	http://dx.doi.org/10.1136/bmj.l1024			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP5WD	30872373				2022-12-28	WOS:000461752500005
J	Witze, A				Witze, Alexandra			AI could help to predict eruptions	NATURE			English	News Item																		Albino F, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08564-9; Anantrasirichai N, 2018, J GEOPHYS RES-SOL EA, V123, P6592, DOI 10.1029/2018JB015911; Furtney MA, 2018, J VOLCANOL GEOTH RES, V365, P38, DOI 10.1016/j.jvolgeores.2018.10.002; Gaddes ME, 2018, J GEOPHYS RES-SOL EA, V123, P10226, DOI 10.1029/2018JB016210	4	1	1	2	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 14	2019	567	7747					156	157		10.1038/d41586-019-00752-3	http://dx.doi.org/10.1038/d41586-019-00752-3			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7LD	30862920	Bronze			2022-12-28	WOS:000461126600016
J	Brustad, N; Eliasen, AU; Stokholm, J; Bonnelykke, K; Bisgaard, H; Chawes, BL				Brustad, Nicklas; Eliasen, Anders U.; Stokholm, Jakob; Bonnelykke, Klaus; Bisgaard, Hans; Chawes, Bo L.			High-Dose Vitamin D Supplementation During Pregnancy and Asthma in Offspring at the Age of 6 Years	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							WHEEZE		[Brustad, Nicklas; Eliasen, Anders U.; Stokholm, Jakob; Bonnelykke, Klaus; Bisgaard, Hans; Chawes, Bo L.] Herlev & Gentofte Univ Hosp, Copenhagen Prospect Studies Asthma Childhood, Copenhagen, Denmark		Bisgaard, H (corresponding author), Univ Copenhagen, Copenhagen Prospect Studies Asthma Childhood, Herlev & Gentofte Hosp, Ledreborg Alle 34, DK-2820 Gentofte, Denmark.	bisgaard@copsac.com	Brustad, Nicklas/AAQ-3383-2020; Bisgaard, Hans/N-4761-2016	Bonnelykke, Klaus/0000-0003-2003-1018; Stokholm, Jakob/0000-0003-4989-9769; Bisgaard, Hans/0000-0003-4131-7592; Brustad, Nicklas/0000-0001-6383-8845	Lundbeck Foundation; Danish State Budget; Danish Council for Independent Research; Capital Region Research Foundation; Danish Council for Strategic Research	Lundbeck Foundation(Lundbeckfonden); Danish State Budget; Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Capital Region Research Foundation; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	Copenhagen Prospective Studies on Asthma in Childhood (COPSAC) is funded by private and public research funds listed on http://www.copsac.com/. The Lundbeck Foundation, Danish State Budget, Danish Council for Strategic Research, Danish Council for Independent Research, and The Capital Region Research Foundation have provided core support for COPSAC.	Bisgaard H, 2016, NEW ENGL J MED, V375, P2530, DOI 10.1056/NEJMoa1503734; Bisgaard H, 2011, J ALLERGY CLIN IMMUN, V127, P1155, DOI 10.1016/j.jaci.2011.02.007; Chawes BL, 2016, JAMA-J AM MED ASSOC, V315, P353, DOI 10.1001/jama.2015.18318; Feng HX, 2017, J ALLERGY CLIN IMMUN, V139, P1508, DOI 10.1016/j.jaci.2016.06.065	4	27	28	2	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 12	2019	321	10					1003	1005		10.1001/jama.2019.0052	http://dx.doi.org/10.1001/jama.2019.0052			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HO5JE	30860552	Green Published			2022-12-28	WOS:000460961000019
J	Bhutta, ZA; Mitra, A; Horton, R				Bhutta, Zulfiqar A.; Mitra, Arun; Horton, Richard			India and Pakistan: a plea for sanity	LANCET			English	Editorial Material									[Bhutta, Zulfiqar A.] Aga Khan Univ, Ctr Excellence Women & Child Hlth, Karachi 75500, Pakistan; [Bhutta, Zulfiqar A.] Hosp Sick Children, Ctr Global Child Hlth, Toronto, ON, Canada; [Bhutta, Zulfiqar A.] Univ Toronto, Toronto, ON, Canada; [Mitra, Arun] Indian Doctors Peace & Dev, Ludhiana, Punjab, India; [Horton, Richard] Lancet, London, England	Aga Khan University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Bhutta, ZA (corresponding author), Aga Khan Univ, Ctr Excellence Women & Child Hlth, Karachi 75500, Pakistan.; Bhutta, ZA (corresponding author), Hosp Sick Children, Ctr Global Child Hlth, Toronto, ON, Canada.; Bhutta, ZA (corresponding author), Univ Toronto, Toronto, ON, Canada.	zulfiqar.bhutta@aku.edu	Mitra, Arun/AHA-9307-2022; Bhutta, Zulfiqar/L-7822-2015	Mitra, Arun/0000-0001-6742-4033; Bhutta, Zulfiqar/0000-0003-0637-599X				Akseer N, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1608; Asian Development Bank, 2017, HUM CAP DEV S AS ACH; Bhutta ZA, 1998, BRIT MED J, V317, P363; Gaibulloev K, 2009, ECON POLIT-OXFORD, V21, P359, DOI 10.1111/j.1468-0343.2009.00347.x; Helfand Ira, 2013, NUCL FAMINE 2 BILLIO; Ministry of Finance-Government of Pakistan, 2017, PAK EC SURV 2016 201; Stockholm international peace research institute, 2019, SIPRI MIL EXP DAT; Torlesse H, 2018, MATERN CHILD NUTR, V14, DOI 10.1111/mcn.12739; Truschke A., 2018, WIRE; United Nations Development Programme, 2018, HUM DEV REP 2018 STA; Wilson N, 2009, MED GLOBAL SURVIVAL, V122, P89	11	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 9	2019	393	10175					970	971		10.1016/S0140-6736(19)30534-3	http://dx.doi.org/10.1016/S0140-6736(19)30534-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HO0OW	30860037				2022-12-28	WOS:000460604200011
J	Apte, RS; Chen, DS; Ferrara, N				Apte, Rajendra S.; Chen, Daniel S.; Ferrara, Napoleone			VEGF in Signaling and Disease: Beyond Discovery and Development	CELL			English	Review							ENDOTHELIAL GROWTH-FACTOR; DIABETIC MACULAR EDEMA; VASCULAR-PERMEABILITY FACTOR; OXYGEN-INDUCED RETINOPATHY; FACTOR MONOCLONAL-ANTIBODY; RENAL-CELL CARCINOMA; PHASE-II TRIAL; TYROSINE KINASE; TUMOR VASCULATURE; IN-VITRO	The discovery of vascular endothelial-derived growth factor (VEGF) has revolutionized our understanding of vasculogenesis and angiogenesis during development and physiological homeostasis. Over a short span of two decades, our understanding of the molecular mechanisms by which VEGF coordinates neurovascular homeostasis has become more sophisticated. The central role of VEGF in the pathogenesis of diverse cancers and blinding eye diseases has also become evident. Elucidation of the molecular regulation of VEGF and the transformative development of multiple therapeutic pathways targeting VEGF directly or indirectly is a powerful case study of how fundamental research can guide innovation and translation. It is also an elegant example of how agnostic discovery and can transform our understanding of human disease. This review will highlight critical nodal points in VEGF biology, including recent developments in immunotherapy for cancer and multitarget approaches in neovascular eye disease.	[Apte, Rajendra S.] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; [Apte, Rajendra S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Apte, Rajendra S.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [Chen, Daniel S.] IGM Biosci, Mountain View, CA USA; [Ferrara, Napoleone] Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA; [Ferrara, Napoleone] Univ Calif San Diego, Dept Ophthalmol, San Diego, CA 92103 USA; [Ferrara, Napoleone] Univ Calif San Diego, Moores Canc Ctr, San Diego, CA 92103 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Apte, RS (corresponding author), Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA.; Apte, RS (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; Apte, RS (corresponding author), Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA.	apte@wustl.edu	Chen, Daniel Shin-Yu/AGD-8923-2022	Chen, Daniel Shin-Yu/0000-0001-5085-3579	NIH [R01-EY019287-06A1, R21-EY026707-02, R21-EY028701-01, P30-EY02687]; Champalimaud Award; Glenn Foundation for Medical Research Award; Starr Foundation; Jeffrey Fort Innovation Fund; Edward N. and Della L. Thome Foundation Award; Research to Prevent Blindness, New York, NY; NATIONAL EYE INSTITUTE [R21EY026707, R01EY019287, P30EY002687, R21EY028701] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Champalimaud Award; Glenn Foundation for Medical Research Award; Starr Foundation; Jeffrey Fort Innovation Fund; Edward N. and Della L. Thome Foundation Award; Research to Prevent Blindness, New York, NY(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by NIH grants R01-EY019287-06A1 (R.S.A.), R21-EY026707-02 (R.S.A.), R21-EY028701-01 (N.F.), and P30-EY02687; Champalimaud Award (N.F.); Glenn Foundation for Medical Research Award (R.S.A.); Starr Foundation (R.S.A.); Jeffrey Fort Innovation Fund (R.S.A.); Edward N. and Della L. Thome Foundation Award (R.S.A.); and an unrestricted grant from Research to Prevent Blindness, New York, NY to the Department of Ophthalmology, Washington University School of Medicine, St. Louis, MO. The authors would like to thank Mr. Danyel Cavazos for assistance with the illustrations.	Adamis AP, 2005, RETINA-J RET VIT DIS, V25, P111, DOI 10.1097/00006982-200502000-00001; ALGIRE GH, 1945, J NATL CANCER I, V6, P73, DOI 10.1093/jnci/6.1.73; Alitalo K, 2005, NATURE, V438, P946, DOI 10.1038/nature04480; Allen E, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aak9679; Apte RS, 2006, PLOS MED, V3, P1371, DOI 10.1371/journal.pmed.0030310; Apte RS, 2018, CELL, V173, P5, DOI 10.1016/j.cell.2018.03.021; Apte RS, 2016, JAMA OPHTHALMOL, V134, P285, DOI 10.1001/jamaophthalmol.2015.5469; Arjaans M, 2013, CANCER RES, V73, P7147, DOI 10.1158/0008-5472.CAN-13-2532; ASHTON N, 1966, AM J OPHTHALMOL, V62, P412, DOI 10.1016/0002-9394(66)91322-5; ASHTON N, 1952, BRIT J OPHTHALMOL, V36, P465, DOI 10.1136/bjo.36.9.465; Atkins MB, 2017, ANN ONCOL, V28, P1484, DOI 10.1093/annonc/mdx151; Atkins MB, 2018, LANCET ONCOL, V19, P405, DOI 10.1016/S1470-2045(18)30081-0; Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Bais C, 2010, CELL, V141, P166, DOI 10.1016/j.cell.2010.01.033; Bakall B, 2013, AM J OPHTHALMOL, V156, P15, DOI 10.1016/j.ajo.2013.02.017; Ban N, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.120824; Barleon B, 1996, BLOOD, V87, P3336, DOI 10.1182/blood.V87.8.3336.bloodjournal8783336; Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; Batchelor TT, 2013, J CLIN ONCOL, V31, P3212, DOI 10.1200/JCO.2012.47.2464; Batchelor TT, 2010, J CLIN ONCOL, V28, P2817, DOI 10.1200/JCO.2009.26.3988; Bates DO, 2002, CANCER RES, V62, P4123; Bennouna J, 2013, LANCET ONCOL, V14, P29, DOI 10.1016/S1470-2045(12)70477-1; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Berlin J, 2013, CLIN CANCER RES, V19, P258, DOI 10.1158/1078-0432.CCR-12-1800; Bhutto IA, 2006, EXP EYE RES, V82, P99, DOI 10.1016/j.exer.2005.05.007; Birkenhauer E, 2015, INT J MOL SCI, V16, P7159, DOI 10.3390/ijms16047159; Borgstrom P, 1996, CANCER RES, V56, P4032; Bressler SB, 2016, JAMA OPHTHALMOL, V134, P278, DOI 10.1001/jamaophthalmol.2015.5346; Brown DM, 2013, OPHTHALMOLOGY, V120, P2013, DOI 10.1016/j.ophtha.2013.02.034; Buehler A, 2013, FEBS LETT, V587, P1650, DOI 10.1016/j.febslet.2013.04.008; Calippe B, 2017, IMMUNITY, V46, P261, DOI 10.1016/j.immuni.2017.01.006; Calvo P, 2015, BRIT J OPHTHALMOL, V99, P723, DOI 10.1136/bjophthalmol-2014-305684; Campochiaro PA, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-016-0816-5; Campochiaro PA, 2016, OPHTHALMOLOGY, V123, P1722, DOI 10.1016/j.ophtha.2016.04.025; Caprara C, 2012, PROG RETIN EYE RES, V31, P89, DOI 10.1016/j.preteyeres.2011.11.003; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Carrel A, 1913, J EXP MED, V17, P14, DOI 10.1084/jem.17.1.14; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; Chaudhary V, 2016, CAN J OPHTHALMOL, V51, P302, DOI 10.1016/j.jcjo.2016.04.020; Chauhan VP, 2012, NAT NANOTECHNOL, V7, P383, DOI [10.1038/NNANO.2012.45, 10.1038/nnano.2012.45]; Chen DS, 2018, CANCER J, V24, P193, DOI 10.1097/PPO.0000000000000327; Chen DS, 2017, NATURE, V541, P321, DOI 10.1038/nature21349; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Chung AS, 2013, NAT MED, V19, P1114, DOI 10.1038/nm.3291; Chung AS, 2011, ANNU REV CELL DEV BI, V27, P563, DOI 10.1146/annurev-cellbio-092910-154002; Chung AS, 2010, NAT REV CANCER, V10, P505, DOI 10.1038/nrc2868; Combadiere C, 2007, J CLIN INVEST, V117, P2920, DOI 10.1172/JCI31692; Dalton HJ, 2017, CLIN CANCER RES, V23, P7034, DOI 10.1158/1078-0432.CCR-17-0647; De Bock K, 2013, CELL METAB, V18, P634, DOI 10.1016/j.cmet.2013.08.001; de Palma M, 2017, NAT REV CANCER, V17, P457, DOI 10.1038/nrc.2017.51; DEVRIES C, 1992, SCIENCE, V255, P989, DOI 10.1126/science.1312256; Dong A, 2014, ANGIOGENESIS, V17, P553, DOI 10.1007/s10456-013-9402-5; Dugel PU, 2017, OPHTHALMOLOGY, V124, P1296, DOI 10.1016/j.ophtha.2017.03.057; Duh E, 1999, DIABETES, V48, P1899, DOI 10.2337/diabetes.48.10.1899; Duh EJ, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93751; Dunn EN, 2017, OSLI RETINA, V48, P100, DOI 10.3928/23258160-20170130-02; Eilken HM, 2010, CURR OPIN CELL BIOL, V22, P617, DOI 10.1016/j.ceb.2010.08.010; Elman MJ, 2012, OPHTHALMOLOGY, V119, P2312, DOI 10.1016/j.ophtha.2012.08.022; Elman MJ, 2011, OPHTHALMOLOGY, V118, P609, DOI 10.1016/j.ophtha.2010.12.033; Eswarappa SM, 2014, CELL, V157, P1605, DOI 10.1016/j.cell.2014.04.033; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; FERRARA N, 1989, BIOCHEM BIOPH RES CO, V161, P851, DOI 10.1016/0006-291X(89)92678-8; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Ferrara N, 2016, TRANSL VIS SCI TECHN, V5, DOI 10.1167/tvst.5.2.10; Ferrara N, 2016, NAT REV DRUG DISCOV, V15, P385, DOI 10.1038/nrd.2015.17; Ferrara N, 2010, NAT MED, V16, P1107, DOI 10.1038/nm1010-1107; Ferrara N, 2010, MOL BIOL CELL, V21, P687, DOI 10.1091/mbc.E09-07-0590; Fischer C, 2007, CELL, V131, P463, DOI 10.1016/j.cell.2007.08.038; FOLKMAN J, 1987, SCIENCE, V235, P442, DOI 10.1126/science.2432664; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Fortune B, 1999, INVEST OPHTH VIS SCI, V40, P2638; Fukurnura D, 2018, NAT REV CLIN ONCOL, V15, P325, DOI 10.1038/nrclinonc.2018.29; Gabrilovich D, 1998, BLOOD, V92, P4150, DOI 10.1182/blood.V92.11.4150.423k45_4150_4166; Garcia-Carbonero R, 2017, ONCOLOGIST, V22, P1281, DOI 10.1634/theoncologist.2016-0133erratum; Gasperini JL, 2012, BRIT J OPHTHALMOL, V96, P14, DOI 10.1136/bjo.2011.204685; Geloneck MM, 2014, JAMA OPHTHALMOL, V132, P1327, DOI 10.1001/jamaophthalmol.2014.2772; Gerber HP, 2005, CANCER RES, V65, P671; Gerber HP, 1999, DEVELOPMENT, V126, P1149; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Gerhardt H., 2008, ORGANOGENESIS, V4, P241, DOI [DOI 10.4161/0RG.4.4.7414, DOI 10.4161/org.4.4.7414]; Gross JG, 2015, JAMA-J AM MED ASSOC, V314, P2137, DOI 10.1001/jama.2015.15217; Hainsworth JD, 2007, CLIN GENITOURIN CANC, V5, P427, DOI 10.3816/CGC.2007.n.030; Harrison WW, 2011, INVEST OPHTH VIS SCI, V52, P772, DOI 10.1167/iovs.10-5931; Hegde PS, 2018, SEMIN CANCER BIOL, V52, P117, DOI 10.1016/j.semcancer.2017.12.002; Heier JS, 2017, LANCET, V390, P50, DOI 10.1016/S0140-6736(17)30979-0; Hellstrom M, 2007, CELL ADHES MIGR, V1, P133, DOI 10.4161/cam.1.3.4978; Ho AC, 2014, OPHTHALMOLOGY, V121, P2181, DOI 10.1016/j.ophtha.2014.05.009; Holash J, 2002, P NATL ACAD SCI USA, V99, P11393, DOI 10.1073/pnas.172398299; Holz FG, 2018, JAMA OPHTHALMOL, V136, P666, DOI 10.1001/jamaophthalmol.2018.1544; Holz FG, 2015, BRIT J OPHTHALMOL, V99, P220, DOI 10.1136/bjophthalmol-2014-305327; HOUCK KA, 1992, J BIOL CHEM, V267, P26031; Huang YH, 2013, CANCER RES, V73, P7144, DOI 10.1158/0008-5472.CAN-13-1989; Huang YH, 2012, P NATL ACAD SCI USA, V109, P17561, DOI 10.1073/pnas.1215397109; IDE A. GORDON, 1939, AMER JOUR ROENTGENOL AND RADIUM THERAP, V42, P891; Incio J, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aag0945; Itatani Y, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041232; Jaffe GJ, 2017, OPHTHALMOLOGY, V124, P224, DOI 10.1016/j.ophtha.2016.10.010; Jager RD, 2008, NEW ENGL J MED, V358, P2606, DOI 10.1056/NEJMra0801537; Jain RK, 2014, CANCER CELL, V26, P605, DOI 10.1016/j.ccell.2014.10.006; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Jayson GC, 2016, LANCET, V388, P518, DOI 10.1016/S0140-6736(15)01088-0; Joyal JS, 2012, ACTA PAEDIATR, V101, P819, DOI 10.1111/j.1651-2227.2012.02692.x; Jung K, 2017, J CLIN INVEST, V127, P3039, DOI 10.1172/JCI93182; Junttila MR, 2013, NATURE, V501, P346, DOI 10.1038/nature12626; Kamoun WS, 2009, J CLIN ONCOL, V27, P2542, DOI 10.1200/JCO.2008.19.9356; KECK PJ, 1989, SCIENCE, V246, P1309, DOI 10.1126/science.2479987; Kelly J, 2007, J CLIN INVEST, V117, P3421, DOI 10.1172/JCI32430; Kelly PN, 2018, SCIENCE, V359, P1345; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Khan KA, 2018, NAT REV CLIN ONCOL, V15, P310, DOI 10.1038/nrclinonc.2018.9; Kim IK, 2006, INVEST OPHTH VIS SCI, V47, P357, DOI 10.1167/iovs.04-0087; Kim KJ, 1992, GROWTH FACTORS, V7, P53, DOI 10.3109/08977199209023937; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; Klement G, 2000, J CLIN INVEST, V105, pR15, DOI 10.1172/JCI8829; Kloepper J, 2016, P NATL ACAD SCI USA, V113, P4476, DOI 10.1073/pnas.1525360113; Kopetz S, 2010, J CLIN ONCOL, V28, P453, DOI 10.1200/JCO.2009.24.8252; Lassen U, 2015, NEURO-ONCOLOGY, V17, P1007, DOI 10.1093/neuonc/nov019; LeCouter J, 2003, SCIENCE, V299, P890, DOI 10.1126/science.1079562; Lee CG, 2000, CANCER RES, V60, P5565; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Li XJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11017; Long D, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.120231; Ma WX, 2016, ADV EXP MED BIOL, V854, P73, DOI 10.1007/978-3-319-17121-0_11; MacLachlan TK, 2011, MOL THER, V19, P326, DOI 10.1038/mt.2010.258; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Maguire MG, 2016, OPHTHALMOLOGY, V123, P1751, DOI 10.1016/j.ophtha.2016.03.045; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; McDermott DF, 2018, NAT MED, V24, P749, DOI 10.1038/s41591-018-0053-3; Michelson IC., 1948, T OPHTHALMOL SOC UK, V68, P137; Miller JW, 2013, OPHTHALMOLOGY, V120, P106, DOI 10.1016/j.ophtha.2012.07.038; Miller JW, 1997, AM J PATHOL, V151, P13; Mintz-Hittner HA, 2011, NEW ENGL J MED, V364, P603, DOI 10.1056/NEJMoa1007374; Mitamura T, 2018, ONCOGENE, V37, P722, DOI 10.1038/onc.2017.348; Mitsuhashi A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9792; Motz GT, 2013, IMMUNITY, V39, P61, DOI 10.1016/j.immuni.2013.07.005; Nagy JA, 2009, BRIT J CANCER, V100, P865, DOI 10.1038/sj.bjc.6604929; Nakamura R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8847; Negri L, 2018, PHYSIOL REV, V98, P1055, DOI 10.1152/physrev.00012.2017; Ohm JE, 2001, IMMUNOL RES, V23, P263, DOI 10.1385/IR:23:2-3:263; Okabe K, 2014, CELL, V159, P584, DOI 10.1016/j.cell.2014.09.025; Oladipupo SS, 2014, P NATL ACAD SCI USA, V111, P13379, DOI 10.1073/pnas.1324235111; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Ott PA, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00202; PAJUSOLA K, 1992, CANCER RES, V52, P5738; PARK JE, 1994, J BIOL CHEM, V269, P25646; Pastuskovas CV, 2012, MOL CANCER THER, V11, P752, DOI 10.1158/1535-7163.MCT-11-0742-T; PENN JS, 1994, INVEST OPHTH VIS SCI, V35, P3429; Poltorak Z, 1997, J BIOL CHEM, V272, P7151, DOI 10.1074/jbc.272.11.7151; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Presta LG, 1997, CANCER RES, V57, P4593; Nguyen QD, 2018, ACTA OPHTHALMOL, V96, pE1, DOI 10.1111/aos.13325; Rajagopal R, 2016, DIABETES, V65, P1072, DOI 10.2337/db15-1255; Rakoczy EP, 2015, LANCET, V386, P2395, DOI 10.1016/S0140-6736(15)00345-1; Regula JT, 2016, EMBO MOL MED, V8, P1265, DOI 10.15252/emmm.201505889; Ruhrberg C, 2002, GENE DEV, V16, P2684, DOI 10.1101/gad.242002; Saharinen P, 2017, NAT REV DRUG DISCOV, V16, P635, DOI 10.1038/nrd.2016.278; Saint-Geniez M, 2009, P NATL ACAD SCI USA, V106, P18751, DOI 10.1073/pnas.0905010106; Sakurai Y, 2005, P NATL ACAD SCI USA, V102, P1076, DOI 10.1073/pnas.0404984102; Schmittnaegel M, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aak9670; Scott IU, 2017, JAMA-J AM MED ASSOC, V317, P2072, DOI 10.1001/jama.2017.4568; Segarra M, 2012, BLOOD, V120, P4104, DOI 10.1182/blood-2012-02-410076; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; Semenza GL, 2000, CANCER METAST REV, V19, P59, DOI 10.1023/A:1026544214667; Sene A, 2015, TRENDS MOL MED, V21, P43, DOI 10.1016/j.molmed.2014.10.005; Sene A, 2014, TRENDS ENDOCRIN MET, V25, P107, DOI 10.1016/j.tem.2013.10.007; Sene A, 2013, CELL METAB, V17, P549, DOI 10.1016/j.cmet.2013.03.009; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; SENGER DR, 1990, CANCER RES, V50, P1774; Sepah YJ, 2016, OPHTHALMOLOGY, V123, P2581, DOI 10.1016/j.ophtha.2016.08.040; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Shojaei F, 2007, NAT BIOTECHNOL, V25, P911, DOI 10.1038/nbt1323; Shojaei F, 2009, P NATL ACAD SCI USA, V106, P6742, DOI 10.1073/pnas.0902280106; Shrimali RK, 2010, CANCER RES, V70, P6171, DOI 10.1158/0008-5472.CAN-10-0153; Silva RLE, 2007, FASEB J, V21, P3219, DOI 10.1096/fj.06-7359com; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Smith Lois E H, 2003, Semin Neonatol, V8, P469, DOI 10.1016/S1084-2756(03)00119-2; Snuderl M, 2013, CELL, V152, P1065, DOI 10.1016/j.cell.2013.01.036; Socinski MA, 2018, NEW ENGL J MED, V378, P2288, DOI 10.1056/NEJMoa1716948; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Sonmez K, 2008, OPHTHALMOLOGY, V115, P1065, DOI 10.1016/j.ophtha.2007.08.050; Spooner K, 2018, ACTA OPHTHALMOL; Stepien KE, 2009, RETINA-J RET VIT DIS, V29, P1067, DOI 10.1097/IAE.0b013e3181b1bb06; Sweeney CJ, 2001, CANCER RES, V61, P3369; TERMAN BI, 1992, BIOCHEM BIOPH RES CO, V187, P1579, DOI 10.1016/0006-291X(92)90483-2; Tong RT, 2004, CANCER RES, V64, P3731, DOI 10.1158/0008-5472.CAN-04-0074; Van der Veldt AAM, 2012, CANCER CELL, V21, P82, DOI 10.1016/j.ccr.2011.11.023; Wacker A, 2011, CURR OPIN CELL BIOL, V23, P676, DOI 10.1016/j.ceb.2011.10.002; Wagle N, 2011, J CLIN ONCOL, V29, P3085, DOI 10.1200/JCO.2010.33.2312; Wakelee H, 2017, CLIN LUNG CANCER, V18, P50, DOI 10.1016/j.cllc.2016.09.013; Wallin JJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12624; WARREN RS, 1995, J CLIN INVEST, V95, P1789, DOI 10.1172/JCI117857; WechslerReya RJ, 1997, CURR BIOL, V7, pR433, DOI 10.1016/S0960-9822(06)00211-9; Weekes CD, 2018, CANCER CHEMOTH PHARM, V82, P339, DOI 10.1007/s00280-018-3622-8; Weekes CD, 2014, INVEST NEW DRUG, V32, P653, DOI 10.1007/s10637-014-0071-z; Wells JA, 2015, NEW ENGL J MED, V372, P1193, DOI 10.1056/NEJMoa1414264; Willett CG, 2004, NAT MED, V10, P145, DOI 10.1038/nm988; Winkler F, 2004, CANCER CELL, V6, P553, DOI 10.1016/j.ccr.2004.10.011; WISE G N, 1956, Trans Am Ophthalmol Soc, V54, P729; Xin H, 2016, CELL, V167, P275, DOI 10.1016/j.cell.2016.08.054; Yang SY, 2002, ARTERIOSCL THROM VAS, V22, P1797, DOI 10.1161/01.ATV.0000038995.31179.24; Yao J, 2011, P NATL ACAD SCI USA, V108, P11590, DOI 10.1073/pnas.1109029108; Yaspan BL, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaf1443; Yonekawa Y, 2013, AM J OPHTHALMOL, V156, P29, DOI 10.1016/j.ajo.2013.03.030; Zirlik K, 2018, ONCOL RES TREAT, V41, P166, DOI 10.1159/000488087; Zissen MH, 2011, NUCL MED COMMUN, V32, P343, DOI 10.1097/MNM.0b013e328344894b	206	759	794	52	275	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 7	2019	176	6					1248	1264		10.1016/j.cell.2019.01.021	http://dx.doi.org/10.1016/j.cell.2019.01.021			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	HN9HD	30849371	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000460509600004
J	Zhang, M; Buscaino, B; Wang, C; Shams-Ansari, A; Reimer, C; Zhu, RR; Kahn, JM; Loncar, M				Zhang, Mian; Buscaino, Brandon; Wang, Cheng; Shams-Ansari, Amirhassan; Reimer, Christian; Zhu, Rongrong; Kahn, Joseph M.; Loncar, Marko			Broadband electro-optic frequency comb generation in a lithium niobate microring resonator	NATURE			English	Article							MODULATION; NOISE	Optical frequency combs consist of equally spaced discrete optical frequency components and are essential tools for optical communication, precision metrology, timing and spectroscopy(1-9). At present, combs with wide spectra are usually generated by mode-locked lasers(10) or dispersion-engineered resonators with third-order Kerr nonlinearity(11). An alternative method of comb production uses electro-optic (EO) phase modulation in a resonator with strong second-order nonlinearity, resulting in combs with excellent stability and controllability(12-14). Previous EO combs, however, have been limited to narrow widths by a weak EO interaction strength and a lack of dispersion engineering in free-space systems. Here we overcome these limitations by realizing an integrated EO comb generator in a thin-film lithium niobate photonic platform that features a large EO response, ultralow optical loss and highly colocalized microwave and optical fields(15), while enabling dispersion engineering. Our measured EO comb spans more frequencies than the entire telecommunications L-band (over 900 comb lines spaced about 10 gigahertz apart), and we show that future dispersion engineering can enable octave-spanning combs. Furthermore, we demonstrate the high tolerance of our comb generator to modulation frequency detuning, with frequency spacing finely controllable over seven orders of magnitude (10 hertz to 100 megahertz), and we use this feature to generate dual-frequency combs in a single resonator. Our results show that integrated EO comb generators are capable of generating wide and stable comb spectra. Their excellent reconfigurability is a powerful complement to integrated Kerr combs, enabling applications ranging from spectroscopy(16) to optical communications8.	[Zhang, Mian; Wang, Cheng; Shams-Ansari, Amirhassan; Reimer, Christian; Zhu, Rongrong; Loncar, Marko] Harvard Univ, John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Zhang, Mian; Reimer, Christian] HyperLight Corp, Cambridge, MA USA; [Buscaino, Brandon; Kahn, Joseph M.] Stanford Univ, Dept Elect Engn, Edward L Ginzton Lab, Stanford, CA 94305 USA; [Wang, Cheng] City Univ Hong Kong, Dept Elect Engn, Hong Kong, Peoples R China; [Wang, Cheng] City Univ Hong Kong, State Key Lab Terahertz & Millimeter Waves, Hong Kong, Peoples R China; [Shams-Ansari, Amirhassan] Howard Univ, Dept Elect Engn & Comp Sci, Washington, DC 20059 USA; [Zhu, Rongrong] Zhejiang Univ, Coll Informat Sci & Elect Engn, Electromagnet Acad, Hangzhou, Zhejiang, Peoples R China	Harvard University; Stanford University; City University of Hong Kong; City University of Hong Kong; Howard University; Zhejiang University	Loncar, M (corresponding author), Harvard Univ, John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA.; Kahn, JM (corresponding author), Stanford Univ, Dept Elect Engn, Edward L Ginzton Lab, Stanford, CA 94305 USA.	jmk@ee.stanford.edu; loncar@seas.harvard.edu	Buscaino, Brandon/AAY-4442-2020; Wang, Cheng/AAE-9492-2020; Zhang, Mian/L-5634-2017	Wang, Cheng/0000-0002-1939-1422; Shams-Ansari, Amirhassan/0000-0002-2165-7832	National Science Foundation [ECCS-1541959, ECCS-1609549, ECCS-1740291 E2CDA, ECCS-1740296 E2CDA, DMR-1231319]; Harvard University Office of Technology Development (Physical Sciences and Engineering Accelerator Award); Facebook, Inc.	National Science Foundation(National Science Foundation (NSF)); Harvard University Office of Technology Development (Physical Sciences and Engineering Accelerator Award); Facebook, Inc.(Facebook Inc)	This work is supported by the National Science Foundation (award numbers ECCS-1609549, ECCS-1740291 E2CDA, ECCS-1740296 E2CDA and DMR-1231319); the Harvard University Office of Technology Development (Physical Sciences and Engineering Accelerator Award); and Facebook, Inc. Device fabrication is performed at the Harvard University Center for Nanoscale Systems, a member of the National Nanotechnology Coordinated Infrastructure Network, which is supported by the National Science Foundation (award number ECCS-1541959).	Beha K, 2017, OPTICA, V4, P406, DOI 10.1364/OPTICA.4.000406; Bernhardt B, 2010, NAT PHOTONICS, V4, P55, DOI 10.1038/NPHOTON.2009.217; Coddington I, 2016, OPTICA, V3, P414, DOI [10.1364/OPTICA.3.000414, 10.1364/optica.3.000414]; Cundiff ST, 2001, REV SCI INSTRUM, V72, P3749, DOI 10.1063/1.1400144; Del'Haye P, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.063901; Demirtzioglou I, 2018, OPT EXPRESS, V26, P790, DOI 10.1364/OE.26.000790; Dupuis N, 2012, J LIGHTWAVE TECHNOL, V30, P466, DOI 10.1109/JLT.2011.2173463; Dutt A, 2018, SCI ADV, V4, DOI 10.1126/sciadv.1701858; GRAUPNER P, 1992, J APPL PHYS, V71, P4136, DOI 10.1063/1.350844; Griffith AG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7299; Herr T, 2012, NAT PHOTONICS, V6, P480, DOI [10.1038/nphoton.2012.127, 10.1038/NPHOTON.2012.127]; HO KP, 1993, IEEE PHOTONIC TECH L, V5, P721, DOI 10.1109/68.219723; Kim J, 2017, OPT LETT, V42, P1536, DOI 10.1364/OL.42.001536; Kim J, 2016, IEEE PHOTON CONF, P503, DOI 10.1109/IPCon.2016.7831201; Kippenberg TJ, 2018, SCIENCE, V361, DOI 10.1126/science.aan8083; KOBAYASHI T, 1972, APPL PHYS LETT, V21, P341, DOI 10.1063/1.1654403; Kourogi M, 1996, IEEE PHOTONIC TECH L, V8, P1698, DOI 10.1109/68.544723; KOUROGI M, 1995, IEEE J QUANTUM ELECT, V31, P2120, DOI 10.1109/3.477736; KOUROGI M, 1993, IEEE J QUANTUM ELECT, V29, P2693, DOI 10.1109/3.250392; Liang W, 2011, OPT LETT, V36, P2290, DOI 10.1364/OL.36.002290; Metcalf AJ, 2013, IEEE J SEL TOP QUANT, V19, DOI 10.1109/JSTQE.2013.2268384; Millot G, 2016, NAT PHOTONICS, V10, P27, DOI [10.1038/NPHOTON.2015.250, 10.1038/nphoton.2015.250]; Okawachi Y, 2011, OPT LETT, V36, P3398, DOI 10.1364/OL.36.003398; Ozharar S, 2008, IEEE PHOTONIC TECH L, V20, P36, DOI 10.1109/LPT.2007.910755; Papp SB, 2014, OPTICA, V1, P10, DOI 10.1364/OPTICA.1.000010; Pfeifle J, 2014, NAT PHOTONICS, V8, P375, DOI 10.1038/nphoton.2014.57; Saitoh T, 1998, J LIGHTWAVE TECHNOL, V16, P824, DOI 10.1109/50.669011; Sakamoto T, 2007, OPT LETT, V32, P1515, DOI 10.1364/OL.32.001515; Savchenkov AA, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.093902; Suh MG, 2018, SCIENCE, V359, P884, DOI 10.1126/science.aao1968; Suh MG, 2016, SCIENCE, V354, P600, DOI 10.1126/science.aah6516; Trocha P, 2018, SCIENCE, V359, P887, DOI 10.1126/science.aao3924; Wang C, 2018, NATURE, V562, P101, DOI 10.1038/s41586-018-0551-y; Wang C, 2018, OPT EXPRESS, V26, P1547, DOI 10.1364/OE.26.001547; Xiao SJ, 2008, OPT EXPRESS, V16, P8498, DOI 10.1364/OE.16.008498; Ye J, 2003, IEEE J SEL TOP QUANT, V9, P1041, DOI 10.1109/JSTQE.2003.819109; Yi X, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14869; Zhang M, 2017, OPTICA, V4, P1536, DOI 10.1364/OPTICA.4.001536	38	312	320	57	417	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 18	2019	568	7752					373	+		10.1038/s41586-019-1008-7	http://dx.doi.org/10.1038/s41586-019-1008-7			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HU0GZ	30858615	Green Submitted			2022-12-28	WOS:000464950700052
J	Huang, SS; Septimus, E; Kleinman, K; Moody, J; Hickok, J; Heim, L; Gombosev, A; Avery, TR; Haffenreffer, K; Shimelman, L; Hayden, MK; Weinstein, RA; Spencer-Smith, C; Kaganov, RE; Murphy, MV; Forehand, T; Lankiewicz, J; Coady, MH; Portillo, L; Sarup-Patel, J; Jernigan, JA; Perlin, JB; Platt, R				Huang, Susan S.; Septimus, Edward; Kleinman, Ken; Moody, Julia; Hickok, Jason; Heim, Lauren; Gombosev, Adrijana; Avery, Taliser R.; Haffenreffer, Katherine; Shimelman, Lauren; Hayden, Mary K.; Weinstein, Robert A.; Spencer-Smith, Caren; Kaganov, Rebecca E.; Murphy, Michael V.; Forehand, Tyler; Lankiewicz, Julie; Coady, Micaela H.; Portillo, Lena; Sarup-Patel, Jalpa; Jernigan, John A.; Perlin, Jonathan B.; Platt, Richard		ABATE Infect Trial Team	Chlorhexidine versus routine bathing to prevent multidrug-resistant organisms and all-cause bloodstream infections in general medical and surgical units (ABATE Infection trial): a cluster-randomised trial	LANCET			English	Article							INTENSIVE-CARE UNITS; STAPHYLOCOCCUS-AUREUS; UNIVERSAL DECOLONIZATION; POVIDONE-IODINE; GLUCONATE; REDUCE; ENTEROCOCCUS; MULTICENTER; ICU; INTERVENTIONS	Background Universal skin and nasal decolonisation reduces multidrug-resistant pathogens and bloodstream infections in intensive care units. The effect of universal decolonisation on pathogens and infections in non-criticalcare units is unknown. The aim of the ABATE Infection trial was to evaluate the use of chlorhexidine bathing in non-critical-care units, with an intervention similar to one that was found to reduce multidrug-resistant organisms and bacteraemia in intensive care units. Methods The ABATE Infection (active bathing to eliminate infection) trial was a cluster-randomised trial of 53 hospitals comparing routine bathing to decolonisation with universal chlorhexidine and targeted nasal mupirocin in non-critical-care units. The trial was done in hospitals affiliated with HCA Healthcare and consisted of a 12-month baseline period from March 1, 2013, to Feb 28, 2014, a 2-month phase-in period from April 1, 2014, to May 31, 2014, and a 21-month intervention period from June 1, 2014, to Feb 29, 2016. Hospitals were randomised and their participating non-critical-care units assigned to either routine care or daily chlorhexidine bathing for all patients plus mupirocin for known methicillin-resistant Staphylococcus aureus (MRSA) carriers. The primary outcome was MRSA or vancomycin-resistant enterococcus clinical cultures attributed to participating units, measured in the unadjusted, intention-to-treat population as the HR for the intervention period versus the baseline period in the decolonisation group versus the HR in the routine care group. Proportional hazards models assessed differences in outcome reductions across groups, accounting for clustering within hospitals. This trial is registered with ClinicalTrials. gov, number NCT02063867. Findings There were 189 081 patients in the baseline period and 339 902 patients (156 889 patients in the routine care group and 183 013 patients in the decolonisation group) in the intervention period across 194 non-critical-care units in 53 hospitals. For the primary outcome of unit-attributable MRSA-positive or VRE-positive clinical cultures (figure 2), the HR for the intervention period versus the baseline period was 0.79 (0.73-0.87) in the decolonisation group versus 0.87 (95% CI 0.79-0.95) in the routine care group. No difference was seen in the relative HRs (p= 0.17). There were 25 (< 1%) adverse events, all involving chlorhexidine, among 183 013 patients in units assigned to chlorhexidine, and none were reported for mupirocin. Interpretation Decolonisation with universal chlorhexidine bathing and targeted mupirocin for MRSA carriers did not significantly reduce multidrug-resistant organisms in non-critical-care patients. Copyright (c) 2019 Elsevier Ltd. All rights reserved.	[Huang, Susan S.; Heim, Lauren; Gombosev, Adrijana] Univ Calif Irvine, Div Infect Dis, Sch Med, Irvine, CA 92697 USA; [Septimus, Edward] HCA Healthcare, Clin Serv Grp, Houston, TX USA; [Moody, Julia; Hickok, Jason; Spencer-Smith, Caren; Forehand, Tyler; Perlin, Jonathan B.] HCA Healthcare, Clin Serv Grp, Nashville, TN USA; [Septimus, Edward] Texas A&M Coll Med, Div Infect Dis, Houston, TX USA; [Septimus, Edward; Avery, Taliser R.; Haffenreffer, Katherine; Shimelman, Lauren; Kaganov, Rebecca E.; Murphy, Michael V.; Lankiewicz, Julie; Coady, Micaela H.; Platt, Richard] Harvard Pilgrim Hlth Care Inst, Dept Populat Med, Boston, MA USA; [Septimus, Edward; Avery, Taliser R.; Haffenreffer, Katherine; Shimelman, Lauren; Kaganov, Rebecca E.; Murphy, Michael V.; Lankiewicz, Julie; Coady, Micaela H.; Platt, Richard] Harvard Med Sch, Boston, MA 02115 USA; [Kleinman, Ken] Univ Massachusetts, Dept Biostat & Epidemiol, Sch Publ Hlth & Hlth Sci, Amherst, MA 01003 USA; [Hayden, Mary K.; Weinstein, Robert A.; Portillo, Lena; Sarup-Patel, Jalpa] Rush Med Coll, Div Infect Dis, Chicago, IL 60612 USA; [Weinstein, Robert A.] Cook Cty Hlth & Hosp Syst, Dept Med, Chicago, IL USA; [Jernigan, John A.] Ctr Dis Control & Prevent, Off HAI Prevent Res & Evaluat, Atlanta, GA USA	University of California System; University of California Irvine; Hospital Corporation of America; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Harvard Pilgrim Health Care; Harvard University; Harvard Medical School; University of Massachusetts System; University of Massachusetts Amherst; Rush University; John H Stroger Junior Hospital Cook County; Centers for Disease Control & Prevention - USA	Huang, SS (corresponding author), Univ Calif Irvine, Div Infect Dis, Sch Med, Irvine, CA 92697 USA.	sshuang@uci.edu		Hayden, Mary/0000-0002-4603-8501; Kleinman, Ken/0000-0002-5600-5834; Jernigan, John/0000-0001-8163-925X	National Institutes of Health; National Institutes of Health Common Fund; National Institute of Allergy and Infectious Diseases [UH2/UH3 AT007769-0]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UH3AI113337] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Common Fund(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	National Institutes of Health.; This project was funded by the National Institutes of Health Common Fund and administered by the National Institute of Allergy and Infectious Diseases (UH2/UH3 AT007769-0 to SSH). The findings and conclusions expressed in this Article are those of the authors and do not necessarily represent the official position of the National Institutes of Health or the CDC. We thank the following individuals for their invaluable contribution: Laurie Brewer, Jane Englebright, Andrew Ko, Deborah Lilly, Bradley Ninness, Russell Poland, Lorraine Rognstad, Deepak Sharma, and David Vulcano; Dottie White from HCA; and Grace Lee from the Harvard Pilgrim Health Care Institute and Harvard Medical School. We also thank Sage Products for providing bathing demonstrations to the decolonisation group. We especially recognise and thank the unit staff and leadership, infection prevention programmes, nurse educators, microbiology laboratories, and administrative leadership at all of the participating hospitals for their commitment and dedication to this trial: Blake Medical Center (Bradenton, FL), Chippenham Johnston Willis Medical Center (Richmond, VA), Cartersville Medical Center (Cartersville, GA), Clear Lake Regional Medical Center (Webster, TX), Coliseum Northside Hospital (Macon, GA), Colleton Medical Center (Walterboro, SC), Conroe Regional Medical Center (Conroe, TX), Corpus Christi Medical Center (Corpus Christi, TX), Eastside Medical Center (Snellville, GA), Garden Park Medical Center (Gulfport, MS), Hendersonville Medical Center (Hendersonville, TN), Henrico Doctors' Hospital (Richmond, VA), John Randolph Medical Center (Hopewell, VA), Kingwood Medical Center (Kingwood, TX), Las Colinas Medical Center (Irving, TX), Las Palmas Medical Center (El Paso, TX), Lee's Summit Medical Center (Lee's Summit, MO), LewisGale Hospital Alleghany (Low Moor, VA), Medical Center of Plano (Plano, TX), Methodist Hospital (San Antonio, TX), Methodist Specialty and Transplant Hospital (San Antonio, TX), Methodist Stone Oak Hospital (San Antonio, TX), Methodist Texsan Hospital (San Antonio, TX), MountainView Hospital (Las Vegas, NV), North Hills Hospital (North Richland Hills, TX), Northside Hospital (St Petersburg, FL), North Suburban Medical Center (Thornton, CO), Northeast Methodist Hospital (Live Oak, TX), Orange Park Medical Center (Orange Park, FL), Osceola Regional Medical Center (Kissimmee, FL), Overland Park Regional Medical Center (Overland Park, KS), Palms West Hospital (Loxahatchee, FL), Parkland Medical Center (Derry, NH), Parkridge East Hospital (Chattanooga, TN), Parkridge Medical Center (Chattanooga, TN), Plaza Medical Center of Fort Worth (Fort Worth, TX), Portsmouth Regional Hospital (Portsmouth, NH), Regional Medical Center of Acadiana (Lafayette, LA), Research Medical Center (Kansas City, MO), Reston Hospital Center (Reston, VA), Rio Grande Regional Hospital (McAllen, TX), South Bay Hospital (Sun City Center, FL), St David's Medical Center (Austin, TX), St Petersburg General Hospital (St Petersburg, FL), Summit Medical Center (Hermitage, TN), Sunrise Hospital and Medical Center (Las Vegas, NV), Timpanogos Regional Hospital (Orem, UT), TriStar Horizon Medical Center (Dickson, TN), TriStar Southern Hills Medical Center (Nashville, TN), Valley Regional Medical Center (Brownsville, TX), West Florida Hospital (Pensacola, FL), West Hills Hospital & Medical Center (West Hills, CA), and West Palm Hospital (West Palm Beach, FL).	Calfee DP, 2014, INFECT CONT HOSP EP, V35, P772, DOI [10.1086/676534, 10.1017/S0899823X00193882]; Centers for Disease Control and Prevention, 2016, 2014 NAT STAT HEALTH; Climo MW, 2013, NEW ENGL J MED, V368, P533, DOI 10.1056/NEJMoa1113849; Climo MW, 2009, CRIT CARE MED, V37, P1858, DOI 10.1097/CCM.0b013e31819ffe6d; de Smet AMGA, 2009, NEW ENGL J MED, V360, P20, DOI 10.1056/NEJMoa0800394; Derde LPG, 2014, LANCET INFECT DIS, V14, P31, DOI 10.1016/S1473-3099(13)70295-0; DIEHR P, 1995, STAT MED, V14, P1491, DOI 10.1002/sim.4780141309; Edgeworth JD, 2011, J ANTIMICROB CHEMOTH, V66, pII41, DOI 10.1093/jac/dkq325; Edmiston CE, 2008, J AM COLL SURGEONS, V207, P233, DOI 10.1016/j.jamcollsurg.2007.12.054; Edmiston CE, 2007, AM J INFECT CONTROL, V35, P89, DOI 10.1016/j.ajic.2006.06.012; Harris AD, 2013, JAMA-J AM MED ASSOC, V310, P1571, DOI 10.1001/jama.2013.277815; Hayes RJ, 2009, INTERD STAT, P3; Huang SS, 2016, LANCET INFECT DIS, V16, P70, DOI 10.1016/S1473-3099(15)00238-8; Huang SS, 2014, INFECT CONT HOSP EP, V35, pS23, DOI 10.1086/677819; Huang SS, 2013, NEW ENGL J MED, V368, P2255, DOI 10.1056/NEJMoa1207290; Kassakian SZ, 2011, INFECT CONT HOSP EP, V32, P238, DOI 10.1086/658334; Kleinman Ken, 2016, EGEMS (Wash DC), V4, P1202, DOI 10.13063/2327-9214.1202; Lin MY, 2014, INFECT CONT HOSP EP, V35, P440, DOI 10.1086/675613; Liu C, 2011, CLIN INFECT DIS, V53, P319, DOI [10.1093/cid/cir353, 10.1093/cid/ciq146]; Lowe CF, 2017, AM J INFECT CONTROL, V45, P255, DOI 10.1016/j.ajic.2016.09.019; Mahalanobis P.C., 1936, P NATL I SCI INDIA, V2, P49, DOI DOI 10.1145/1390156.1390302; MAKI DG, 1991, LANCET, V338, P339, DOI 10.1016/0140-6736(91)90479-9; Marschall J, 2014, INFECT CONT HOSP EP, V35, P753, DOI [10.1086/676533, 10.1017/S0899823X00193870]; Milstone AM, 2013, LANCET, V381, P1099, DOI 10.1016/S0140-6736(12)61687-0; Mimoz O, 2015, LANCET, V386, P2069, DOI 10.1016/S0140-6736(15)00244-5; Platt R, 2018, JAMA-J AM MED ASSOC, V320, P753, DOI 10.1001/jama.2018.9342; Raad I, 1997, ANN INTERN MED, V127, P267, DOI 10.7326/0003-4819-127-4-199708150-00002; Rhee Y, 2018, INFECT CONT HOSP EP, V39, P405, DOI 10.1017/ice.2017.312; Ripatti S, 2000, BIOMETRICS, V56, P1016, DOI 10.1111/j.0006-341X.2000.01016.x; ROMANO PS, 1993, J CLIN EPIDEMIOL, V46, P1075, DOI 10.1016/0895-4356(93)90103-8; Rupp ME, 2012, INFECT CONT HOSP EP, V33, P1094, DOI 10.1086/668024; Russell D, 2016, INFECT CONT HOSP EP, V37, P36, DOI 10.1017/ice.2015.246; Septimus E, 2016, CLIN INFECT DIS, V63, P172, DOI 10.1093/cid/ciw282; Shuman EK, IDWEEK 2014; Vernon MO, 2006, ARCH INTERN MED, V166, P306, DOI 10.1001/archinte.166.3.306; Weiner LM, 2016, INFECT CONT HOSP EP, V37, P1105, DOI 10.1017/ice.2016.139	36	46	48	0	21	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 23	2019	393	10177					1205	1215		10.1016/S0140-6736(18)32593-5	http://dx.doi.org/10.1016/S0140-6736(18)32593-5			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP9UL	30850112	Green Submitted, Green Accepted			2022-12-28	WOS:000462038400027
J	Grundy, Q; Chiu, K; Held, F; Continella, A; Bero, L; Holz, R				Grundy, Quinn; Chiu, Kellia; Held, Fabian; Continella, Andrea; Bero, Lisa; Holz, Ralph			Data sharing practices of medicines related apps and the mobile ecosystem: traffic, content, and network analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PRIVACY; HEALTH; SECURITY	OBJECTIVES To investigate whether and how user data are shared by top rated medicines related mobile applications (apps) and to characterise privacy risks to app users, both clinicians and consumers. DESIGN Traffic, content, and network analysis. SETTING Top rated medicines related apps for the Android mobile platform available in the Medical store category of Google Play in the United Kingdom, United States, Canada, and Australia. PARTICIPANTS 24 of 821 apps identified by an app store crawling program. Included apps pertained to medicines information, dispensing, administration, prescribing, or use, and were interactive. INTERVENTIONS Laboratory based traffic analysis of each app downloaded onto a smartphone, simulating real world use with four dummy scripts. The app's baseline traffic related to 28 different types of user data was observed. To identify privacy leaks, one source of user data was modified and deviations in the resulting traffic observed. MAIN OUTCOME MEASURES Identities and characterisation of entities directly receiving user data from sampled apps. Secondary content analysis of company websites and privacy policies identified data recipients' main activities; network analysis characterised their data sharing relations. RESULTS 19/24 (79%) of sampled apps shared user data. 55 unique entities, owned by 46 parent companies, received or processed app user data, including developers and parent companies (first parties) and service providers (third parties). 18 (33%) provided infrastructure related services such as cloud services. 37 (67%) provided services related to the collection and analysis of user data, including analytics or advertising, suggesting heightened privacy risks. Network analysis revealed that first and third parties received a median of 3 (interquartile range 1-6, range 1-24) unique transmissions of user data. Third parties advertised the ability to share user data with 216 "fourth parties"; within this network (n= 237), entities had access to a median of 3 (interquartile range 1-11, range 1-140) unique transmissions of user data. Several companies occupied central positions within the network with the ability to aggregate and reidentify user data. CONCLUSIONS Sharing of user data is routine, yet far from transparent. Clinicians should be conscious of privacy risks in their own use of apps and, when recommending apps, explain the potential for loss of privacy as part of informed consent. Privacy regulation should emphasise the accountabilities of those who control and process user data. Developers should disclose all data sharing practices and allow users to choose precisely what data are shared and with whom.	[Grundy, Quinn] Univ Toronto, Fac Nursing, Suite 130,155 Coll St, Toronto, ON M5T 1P8, Canada; [Grundy, Quinn; Chiu, Kellia; Held, Fabian; Bero, Lisa] Univ Sydney, Charles Perkins Ctr, Sch Pharm, Sydney, NSW, Australia; [Continella, Andrea] Univ Calif Santa Barbara, Dept Comp Sci, Santa Barbara, CA 93106 USA; [Holz, Ralph] Univ Sydney, Sch Comp Sci, Sydney, NSW, Australia	University of Toronto; University of Sydney; University of California System; University of California Santa Barbara; University of Sydney	Grundy, Q (corresponding author), Univ Toronto, Fac Nursing, Suite 130,155 Coll St, Toronto, ON M5T 1P8, Canada.; Grundy, Q (corresponding author), Univ Sydney, Charles Perkins Ctr, Sch Pharm, Sydney, NSW, Australia.	quinn.grundy@utoronto.ca	Held, Fabian/AAF-3927-2021	Held, Fabian/0000-0002-5260-5576; Chiu, Kellia/0000-0002-4358-6641	Sydney Policy Lab at The University of Sydney; Canadian Institutes of Health Research	Sydney Policy Lab at The University of Sydney; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was funded by a grant from the Sydney Policy Lab at The University of Sydney. QG was supported by a postdoctoral fellowship from the Canadian Institutes of Health Research. The Sydney Policy Lab had no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication.	Android Developers, 2018, SYST PERM; [Anonymous], 2021, LANG ENV STAT COMP; [Anonymous], 2018, MHEALTH DEV EC MHEAL; Binns R, 2018, WEBSCI'18: PROCEEDINGS OF THE 10TH ACM CONFERENCE ON WEB SCIENCE, P23, DOI 10.1145/3201064.3201089; Blenner SR, 2016, JAMA-J AM MED ASSOC, V315, P1051, DOI 10.1001/jama.2015.19426; Continella A, P 2017 NETW DISTR SY; Dayer L, 2013, J AM PHARM ASSOC, V53, P172, DOI 10.1331/JAPhA.2013.12202; Dehling T, 2015, JMIR MHEALTH UHEALTH, V3, DOI 10.2196/mhealth.3672; Ebeling M., 2016, HEALTHCARE BIG DATA, DOI [10.1057/978-1-137-50221-6, DOI 10.1057/978-1-137-50221-6]; European Union, 2018, OFFICAL J EUROPEAN U; Google Inc, 2018, WHO AR GOOGL PARTN; Grindrod K, 2017, CAN PHARM J, V150, P60, DOI 10.1177/1715163516680226; Grundy Q, 2017, FINDING PEACE MIND N; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Huckvale K, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0444-y; McGrath P, 2018, ABC NEWS; Muthing J, 2019, J MED INTERNET RES, V21, DOI 10.2196/jmir.9818; Papageorgiou A, 2018, IEEE ACCESS, V6, P9390, DOI 10.1109/ACCESS.2018.2799522; Pasquale F., 2015, BLACK BOK SOC SECRET, DOI [10.4159/harvard.9780674736061, DOI 10.4159/HARVARD.9780674736061]; Pedersen T., 2018, TIDYGRAPH TIDY API G; Razaghpanah A, P 2018 NETW DISTR SY; Sunyaev A, 2015, J AM MED INFORM ASSN, V22, pE28, DOI 10.1136/amiajnl-2013-002605; Vallina-Rodriguez N, 2016, 1 DAT ALG TRANSP WOR; Wilson D., 2011, NY TIMES, pB1; Yahoo. Developer Network, 2018, FLURR AN TERMS SERV	25	69	70	1	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 20	2019	364								l920	10.1136/bmj.l920	http://dx.doi.org/10.1136/bmj.l920			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HQ8AJ	30894349	hybrid, Green Published			2022-12-28	WOS:000462645500002
J	Drance, MJ; Sears, JD; Mrse, AM; Moore, CE; Rheingold, AL; Neidig, ML; Figueroa, JS				Drance, Myles J.; Sears, Jeffrey D.; Mrse, Anthony M.; Moore, Curtis E.; Rheingold, Arnold L.; Neidig, Michael L.; Figueroa, Joshua S.			Terminal coordination of diatomic boron monofluoride to iron	SCIENCE			English	Article							INFRARED-SPECTRA; QUADRUPOLE RELAXATION; FLUORINE CHEMISTRY; CORRELATION-ENERGY; METAL-CARBONYLS; CHEMICAL-BOND; BASIS-SETS; CO; BF; COMPLEXES	Boron monofluoride (BF) is a diatomic molecule with 10 valence electrons, isoelectronic to carbon monoxide (CO). Unlike CO, which is a stable molecule at room temperature and readily serves as both a bridging and terminal ligand to transition metals, BF is unstable below 1800 degrees C in the gas phase, and its coordination chemistry is substantially limited. Here, we report the isolation of the iron complex Fe(BF)(CO)(2)(CNArTripp2)(2) [Ar-Tripp2, 2,6-(2,4,6-(i-Pr)(3)C6H2](2)C6H3; i-Pr, iso-propyl], featuring a terminal BF ligand. Single-crystal x-ray diffraction as well as nuclearmagnetic resonance, infrared, and Mossbauer spectroscopic studies on Fe(BF)(CO)(2)(CNArTripp2)(2) and the isoelectronic dinitrogen (N-2) and CO complexes Fe(N-2)(CO)(2)(CNArTripp2)(2) and Fe(CO)(3)(CNArTripp2)(2) demonstrate that the terminal BF ligand possesses particularly strong sigma-donor and pi-acceptor properties. Density functional theory and electron-density topology calculations support this conclusion.	[Drance, Myles J.; Mrse, Anthony M.; Moore, Curtis E.; Rheingold, Arnold L.; Figueroa, Joshua S.] Univ Calif San Diego, Dept Chem & Biochem, 9500 Gilman Dr,Mail Code 0358, La Jolla, CA 92093 USA; [Sears, Jeffrey D.; Neidig, Michael L.] Univ Rochester, Dept Chem, Rochester, NY 14627 USA	University of California System; University of California San Diego; University of Rochester	Figueroa, JS (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, 9500 Gilman Dr,Mail Code 0358, La Jolla, CA 92093 USA.	jsfig@ucsd.edu	Figueroa, Joshua/GSO-0962-2022; Rheingold, Arnold/U-4735-2019	Rheingold, Arnold/0000-0003-4472-8127; Moore, Curtis/0000-0002-3311-7155; Neidig, Michael/0000-0002-2300-3867; Drance, Myles/0000-0003-1682-9828; Sears, Jeffrey/0000-0002-9444-351X	U.S. National Science Foundation [CHE-1802646, CHE-1454370]	U.S. National Science Foundation(National Science Foundation (NSF))	This work was supported by the U.S. National Science Foundation through grants CHE-1802646 (to J.S.F) and CHE-1454370 (to M.L.N).	Alcaraz G, 2008, J AM CHEM SOC, V130, P12878, DOI 10.1021/ja805164n; Armarego W.L.F., 2003, PURIFICATION LAB CHE; BACON J, 1963, CAN J CHEM, V41, P3063, DOI 10.1139/v63-448; BACON J, 1970, MOL PHYS, V18, P561, DOI 10.1080/00268977000100621; BADER RFW, 1991, CHEM REV, V91, P893, DOI 10.1021/cr00005a013; BAX A, 1986, J MAGN RESON, V67, P565, DOI 10.1016/0022-2364(86)90395-1; BECKE AD, 1986, J CHEM PHYS, V84, P4524, DOI 10.1063/1.450025; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Bickelhaupt FM, 1998, NEW J CHEM, V22, P1; Braunschweig H, 2008, ANGEW CHEM INT EDIT, V47, P4931, DOI 10.1002/anie.200800533; Braunschweig H, 2013, CHEM SOC REV, V42, P3197, DOI 10.1039/c3cs35510a; Braunschweig H, 2012, CHEM COMMUN, V48, P2701, DOI 10.1039/c2cc17445f; Braunschweig H, 2010, ANGEW CHEM INT EDIT, V49, P3412, DOI 10.1002/anie.201000841; Braunschweig H, 2010, SCIENCE, V328, P345, DOI 10.1126/science.1186028; Bruno IJ, 2002, ACTA CRYSTALLOGR B, V58, P389, DOI 10.1107/S0108768102003324; Cambridge Crystallographic Data Centre (CCDC), 2017, CAMBR STRUCT DAT CSD, DOI [10.1107/S0108768102003324Medline, DOI 10.1107/S0108768102003324MEDLINE]; Carpenter AE, 2015, INORG CHEM, V54, P2936, DOI 10.1021/ic5030845; CHATT J, 1953, J CHEM SOC, P2939, DOI 10.1039/jr9530002939; CHRISTE KO, 1990, J AM CHEM SOC, V112, P7619, DOI 10.1021/ja00177a025; CHRISTE KO, 1990, J FLUORINE CHEM, V46, P339, DOI 10.1016/S0022-1139(00)81000-3; COLLMAN JP, 1975, ACCOUNTS CHEM RES, V8, P342, DOI 10.1021/ar50094a004; Coombs DL, 2003, J AM CHEM SOC, V125, P6356, DOI 10.1021/ja0346936; COTTON FA, 1962, J AM CHEM SOC, V84, P4432, DOI 10.1021/ja00882a012; DEWAR JS, 1951, B SOC CHIM FR, V18, pC71; Dolomanov OV, 2009, J APPL CRYSTALLOGR, V42, P339, DOI 10.1107/S0021889808042726; Ehlers AW, 1998, CHEM-EUR J, V4, P210, DOI 10.1002/(SICI)1521-3765(19980210)4:2<210::AID-CHEM210>3.0.CO;2-T; Ehlers AW, 1996, ORGANOMETALLICS, V15, P105, DOI 10.1021/om950697a; ELIAN M, 1975, INORG CHEM, V14, P1058, DOI 10.1021/ic50147a021; Esterhuysen C, 2004, THEOR CHEM ACC, V111, P381, DOI 10.1007/s00214-003-0535-2; FOSTER JP, 1980, J AM CHEM SOC, V102, P7211, DOI 10.1021/ja00544a007; Frisch M. J., 2013, GAUSSIAN 09 REVISION, DOI [10.1103/PhysRevB.37.785Medline, DOI 10.1103/PHYSREVB.37.785MEDLINE]; Fulmer GR, 2010, ORGANOMETALLICS, V29, P2176, DOI 10.1021/om100106e; GARBOW JR, 1982, CHEM PHYS LETT, V93, P504, DOI 10.1016/0009-2614(82)83229-6; Gillespie RJ, 2007, J COMPUT CHEM, V28, P87, DOI 10.1002/jcc.20545; Glendening E. D., 2013, N B O VERSION 3 1; Groom CR, 2016, ACTA CRYSTALLOGR B, V72, P171, DOI 10.1107/S2052520616003954; Gutlich P, 2011, MOSSBAUER SPECTROSCOPY AND TRANSITION METAL CHEMISTRY: FUNDAMENTALS AND APPLICATIONS, P1; HASSANZADEH P, 1993, J PHYS CHEM-US, V97, P4910, DOI 10.1021/j100121a008; HERRMANN WA, 1990, J ORGANOMET CHEM, V383, P21, DOI 10.1016/0022-328X(90)85120-N; Keith T. A., 2017, AIMALL VERSION 17 11, DOI [10.1107/S0108767307043930Medline, DOI 10.1107/S0108767307043930MEDLINE]; Kofod P, 1996, J MAGN RESON SER A, V119, P219, DOI 10.1006/jmra.1996.0076; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; LOVAS FJ, 1971, J CHEM PHYS, V55, P41, DOI 10.1063/1.1675537; Molchtarzadeh CC, 2015, INORG CHEM, V54, P5579, DOI 10.1021/acs.inorgchem.5b00730; Mond L., 1890, J CHEM SOC, V57, P749, DOI DOI 10.1039/CT8905700749; MULLER L, 1979, J AM CHEM SOC, V101, P4481; Neese F., 2013, ORCA AN AB INITO DEN, DOI [10.1103/PhysRevB.33.8822Medline, DOI 10.1103/PHYSREVB.33.8822MEDLINE]; NESBET RK, 1964, J CHEM PHYS, V40, P3619, DOI 10.1063/1.1725063; Pangborn AB, 1996, ORGANOMETALLICS, V15, P1518, DOI 10.1021/om9503712; PERDEW JP, 1986, PHYS REV B, V34, P7406, DOI 10.1103/PhysRevB.34.7406; PERDEW JP, 1986, PHYS REV B, V33, P8822, DOI 10.1103/PhysRevB.33.8822; POPLE JA, 1958, MOL PHYS, V1, P168, DOI 10.1080/00268975800100201; Radius U, 1998, INORG CHEM, V37, P1080, DOI 10.1021/ic970897+; Rosenau CP, 2018, ANGEW CHEM INT EDIT, V57, P9528, DOI 10.1002/anie.201802620; SCHAFER A, 1992, J CHEM PHYS, V97, P2571, DOI 10.1063/1.463096; Schutzenberger M. P., 1868, ANNALES PARIS, V15, P100; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; TIMMS PL, 1967, J AM CHEM SOC, V89, P1629, DOI 10.1021/ja00983a018; TIMMS PL, 1973, ACCOUNTS CHEM RES, V6, P118, DOI 10.1021/ar50064a002; TIMMS PL, 1968, J AM CHEM SOC, V90, P4585, DOI 10.1021/ja01019a014; Vidovic D, 2009, ANGEW CHEM INT EDIT, V48, P3669, DOI 10.1002/anie.200901022; VOSKO SH, 1980, CAN J PHYS, V58, P1200, DOI 10.1139/p80-159; Wang XF, 2010, CHEM COMMUN, V46, P1646, DOI 10.1039/b923195a; Wang XF, 2010, ANGEW CHEM INT EDIT, V49, P157, DOI 10.1002/anie.200904797; Weigend F, 2005, PHYS CHEM CHEM PHYS, V7, P3297, DOI 10.1039/b508541a; WERNER H, 1990, ANGEW CHEM INT EDIT, V29, P1077, DOI 10.1002/anie.199010773; Werner HJ, 2003, J CHEM PHYS, V118, P8149, DOI 10.1063/1.1564816; Xu LC, 2010, INORG CHEM, V49, P1046, DOI 10.1021/ic901964f; Zhurko G. A, 2014, CHEMCRAFT	69	36	35	4	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 15	2019	363	6432			SI		1203	+		10.1126/science.aaw6102	http://dx.doi.org/10.1126/science.aaw6102			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP0BC	30872521				2022-12-28	WOS:000461329000045
J	Khullar, D; Chokshi, DA				Khullar, Dhruv; Chokshi, Dave A.			Immigrant Health, Value-Based Care, and Emergency Medicaid Reform	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									[Khullar, Dhruv] New York Presbyterian Hosp, New York, NY USA; [Khullar, Dhruv] Weill Cornell, Dept Med, New York, NY USA; [Khullar, Dhruv] Weill Cornell, Dept Hlth Care Policy, New York, NY USA; [Chokshi, Dave A.] New York City Hlth Hosp, New York, NY 10013 USA	NewYork-Presbyterian Hospital	Chokshi, DA (corresponding author), New York City Hlth Hosp, New York, NY 10013 USA.	Dave.Chokshi@nychhc.org							0	7	7	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 12	2019	321	10					928	929		10.1001/jama.2019.0839	http://dx.doi.org/10.1001/jama.2019.0839			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HO5JE	30860550				2022-12-28	WOS:000460961000003
J	Lindsey, ARI; Newton, ILG				Lindsey, Amelia R. I.; Newton, Irene L. G.			Some Like it HOT: Horizontal Operon Transfer	CELL			English	Editorial Material							GENE-TRANSFER; DNA TRANSFER; BACTERIA	While horizontal gene transfer (HGT) is well documented in bacteria, the role and frequency of HGT across eukaryotes remains poorly understood. Kominek et al. identified a horizontal operon transfer (HOT) event, with clear evidence for selection to facilitate gene expression, that has allowed a group of yeasts to scavenge iron using bacterially derived genes.	[Lindsey, Amelia R. I.; Newton, Irene L. G.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Newton, ILG (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	irnewton@indiana.edu			National Institute of Allergy and Infectious Disease [R21 AI121849, R21 AI137918]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI137918, R21AI121849] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Disease (R21 AI121849 and R21 AI137918 to I.L.G.N.).	BUNDOCK P, 1995, EMBO J, V14, P3206, DOI 10.1002/j.1460-2075.1995.tb07323.x; HEINEMANN JA, 1989, NATURE, V340, P205, DOI 10.1038/340205a0; Hotopp JCD, 2011, TRENDS GENET, V27, P157, DOI 10.1016/j.tig.2011.01.005; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Kominek J, 2019, CELL, V176, P1356, DOI 10.1016/j.cell.2019.01.034; Liu HQ, 2010, J VIROL, V84, P11876, DOI 10.1128/JVI.00955-10; Madsen JS, 2012, FEMS IMMUNOL MED MIC, V65, P183, DOI 10.1111/j.1574-695X.2012.00960.x; Novo M, 2009, P NATL ACAD SCI USA, V106, P16333, DOI 10.1073/pnas.0904673106; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271	10	1	1	3	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 7	2019	176	6					1243	1245		10.1016/j.cell.2019.02.007	http://dx.doi.org/10.1016/j.cell.2019.02.007			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	HN9HD	30849369	Bronze			2022-12-28	WOS:000460509600002
J	Morin, J				Morin, Jamie			Four steps to global management of space traffic	NATURE			English	Editorial Material									[Morin, Jamie] Aerosp Corp, Ctr Space Policy & Strategy, Arlington, VA 22202 USA; [Morin, Jamie] World Econ Forums Global Futures Council Space Te, Arlington, VA USA; [Morin, Jamie] US Dept Def, Arlington, VA USA	Aerospace Corporation - USA; United States Department of Defense	Morin, J (corresponding author), Aerosp Corp, Ctr Space Policy & Strategy, Arlington, VA 22202 USA.; Morin, J (corresponding author), World Econ Forums Global Futures Council Space Te, Arlington, VA USA.; Morin, J (corresponding author), US Dept Def, Arlington, VA USA.	jamie.morin@aero.org						Federal Aviation Administration, 2018, AIR TRAFF NUMB; Gleason M. P., 2018, US SPACE TRAFFIC MAN; Inter-Agency Space Debris Coordination Committee, 2013, IADC1208; Inter-Agency Space Debris Coordination Committee, 2007, IADC SPAC DEBR MIT G; McLeary P., 2018, BREAKING DEFENSE	5	4	5	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 7	2019	567	7746					25	27		10.1038/d41586-019-00732-7	http://dx.doi.org/10.1038/d41586-019-00732-7			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HN8ED	30837736	Bronze			2022-12-28	WOS:000460426900022
J	Rogers, K; Kelleway, JJ; Saintilan, N; Megonigal, JP; Adams, JB; Holmquist, JR; Lu, M; Schile-Beers, L; Zawadzki, A; Mazumder, D; Woodroffe, CD				Rogers, Kerrylee; Kelleway, Jeffrey J.; Saintilan, Neil; Megonigal, J. Patrick; Adams, Janine B.; Holmquist, James R.; Lu, Meng; Schile-Beers, Lisa; Zawadzki, Atun; Mazumder, Debashish; Woodroffe, Colin D.			Wetland carbon storage controlled by millennial-scale variation in relative sea-level rise	NATURE			English	Article							MANGROVE FORESTS; BLUE CARBON; ACCUMULATION; RATES; SOILS	Coastal wetlands (mangrove, tidal marsh and seagrass) sustain the highest rates of carbon sequestration per unit area of all natural systems(1,2), primarily because of their comparatively high productivity and preservation of organic carbon within sedimentary substrates(3). Climate change and associated relative sea-level rise (RSLR) have been proposed to increase the rate of organic-carbon burial in coastal wetlands in the first half of the twenty-first century(4), but these carbon-climate feedback effects have been modelled to diminish over time as wetlands are increasingly submerged and carbon stores become compromised by erosion(4,5). Here we show that tidal marshes on coastlines that experienced rapid RSLR over the past few millennia (in the late Holocene, from about 4,200 years ago to the present) have on average 1.7 to 3.7 times higher soil carbon concentrations within 20 centimetres of the surface than those subject to a long period of sea-level stability. This disparity increases with depth, with soil carbon concentrations reduced by a factor of 4.9 to 9.1 at depths of 50 to 100 centimetres. We analyse the response of a wetland exposed to recent rapid RSLR following subsidence associated with pillar collapse in an underlying mine and demonstrate that the gain in carbon accumulation and elevation is proportional to the accommodation space (that is, the space available for mineral and organic material accumulation) created by RSLR. Our results suggest that coastal wetlands characteristic of tectonically stable coastlines have lower carbon storage owing to a lack of accommodation space and that carbon sequestration increases according to the vertical and lateral accommodation space(6) created by RSLR. Such wetlands will provide long-term mitigating feedback effects that are relevant to global climate-carbon modelling.	[Rogers, Kerrylee; Woodroffe, Colin D.] Univ Wollongong, Sch Earth Atmospher & Life Sci, Wollongong, NSW, Australia; [Kelleway, Jeffrey J.; Saintilan, Neil] Macquarie Univ, Dept Environm Sci, Sydney, NSW, Australia; [Megonigal, J. Patrick; Holmquist, James R.; Lu, Meng; Schile-Beers, Lisa] Smithsonian Environm Res Ctr, POB 28, Edgewater, MD 21037 USA; [Adams, Janine B.] Nelson Mandela Univ, Dept Bot, Port Elizabeth, South Africa; [Lu, Meng] Yunnan Univ, Sch Ecol & Environm Sci, Kunming, Yunnan, Peoples R China; [Zawadzki, Atun; Mazumder, Debashish] Australian Nucl Sci & Technol Org, Sydney, NSW, Australia	University of Wollongong; Macquarie University; Smithsonian Institution; Smithsonian Environmental Research Center; Nelson Mandela University; Yunnan University; Australian Nuclear Science & Technology Organisation	Rogers, K (corresponding author), Univ Wollongong, Sch Earth Atmospher & Life Sci, Wollongong, NSW, Australia.	kerrylee@uow.edu.au	Adams, Janine Barbara/AAA-9865-2021; Woodroffe, Colin D/K-5222-2015; Kelleway, Jeffrey J/H-8032-2019; Rogers, Kerrylee/AAC-8093-2022	Adams, Janine Barbara/0000-0001-7204-123X; Woodroffe, Colin D/0000-0003-4476-6158; Kelleway, Jeffrey J/0000-0002-5145-9466; Megonigal, Patrick/0000-0002-2018-7883; Saintilan, Neil/0000-0001-9226-2005; Lu, Meng/0000-0001-6923-7493; Rogers, Kerrylee/0000-0003-1350-4737	Australian Research Council [FT130100532]; AINSE [ALNGRA13046]; UOW Global Challenges Program; Smithsonian Environmental Research Center; United States National Science Foundation [DEB-1655622]; Global Change Research Wetland [DEB-0950080, DEB-1457100, DEB-1557009]; NASA Carbon Monitoring System programme [NNH14AY67I]; Smithsonian Institution MarineGEO Postdoctoral Fellowship	Australian Research Council(Australian Research Council); AINSE; UOW Global Challenges Program; Smithsonian Environmental Research Center(Smithsonian InstitutionSmithsonian Environmental Research Center); United States National Science Foundation(National Science Foundation (NSF)); Global Change Research Wetland; NASA Carbon Monitoring System programme; Smithsonian Institution MarineGEO Postdoctoral Fellowship	This research was supported by the Australian Research Council (FT130100532), AINSE (ALNGRA13046) and the UOW Global Challenges Program. The Smithsonian Environmental Research Center supported J.P.M., J.R.H, M.L. and L.S.-B. The data curation efforts of J.R.H. and data collection and synthesis efforts of J.P.M. were supported by United States National Science Foundation grants to the Coastal Carbon Research Coordination Network (DEB-1655622) and the Global Change Research Wetland (DEB-0950080, DEB-1457100 and DEB-1557009) and by a NASA Carbon Monitoring System programme grant (NNH14AY67I). L.S.-B. was supported by a Smithsonian Institution MarineGEO Postdoctoral Fellowship. This is contribution number 32 of the Smithsonian's MarineGEO Network. The authors acknowledge J. Curran for assistance with sample preparation, S. Rasel, S. Oyston and M. Rupic for assistance with data collation and the students who undertook fieldwork as part of this research.	Adam P., 1990, SALTMARSH ECOLOGY; Allen JRL, 2000, QUATERNARY SCI REV, V19, P1155, DOI 10.1016/S0277-3791(99)00034-7; [Anonymous], 2011, MITIGATING CLIMATE C; Appleby P.C., 2002, TRACKING ENV CHANGE, P171, DOI [DOI 10.1007/0-306-47669-X_9, 10.1007/0-306-47669-X_9]; Chmura GL, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001917; CLARK JA, 1978, QUATERNARY RES, V9, P265, DOI 10.1016/0033-5894(78)90033-9; CRAFT CB, 1991, ESTUARIES, V14, P175, DOI 10.2307/1351691; DeLaune RD, 2012, CLIMATIC CHANGE, V110, P297, DOI 10.1007/s10584-011-0089-6; Donato DC, 2011, NAT GEOSCI, V4, P293, DOI [10.1038/NGEO1123, 10.1038/ngeo1123]; Duarte CM, 2008, ESTUAR COAST, V31, P233, DOI 10.1007/s12237-008-9038-7; Duarte CM, 2005, BIOGEOSCIENCES, V2, P1, DOI 10.5194/bg-2-1-2005; Duke NC, 2007, SCIENCE, V317, P41, DOI 10.1126/science.317.5834.41b; Hiraishi T., 2014, INTERGOVERNMENTAL PA; Hollins SE, 2011, J PALEOLIMNOL, V46, P579, DOI 10.1007/s10933-011-9555-4; Holmquist JR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26948-7; Kelleway JJ, 2016, GLOBAL CHANGE BIOL, V22, P1097, DOI 10.1111/gcb.13158; Kirwan ML, 2013, NATURE, V504, P53, DOI 10.1038/nature12856; Kirwan ML, 2012, NATURE, V489, P550, DOI 10.1038/nature11440; Kirwan ML, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2009JF001400; Krauss KW, 2014, NEW PHYTOL, V202, P19, DOI 10.1111/nph.12605; LAMBECK K, 1990, GLOBAL PLANET CHANGE, V89, P143, DOI 10.1016/0921-8181(90)90060-P; Langley JA, 2009, P NATL ACAD SCI USA, V106, P6182, DOI 10.1073/pnas.0807695106; Lovelock CE, 2015, NATURE, V526, P559, DOI 10.1038/nature15538; Mcleod E, 2011, FRONT ECOL ENVIRON, V9, P552, DOI 10.1890/110004; Morris JT, 2002, ECOLOGY, V83, P2869, DOI 10.1890/0012-9658(2002)083[2869:ROCWTR]2.0.CO;2; Murray-Wallace C.V., 2014, QUATERNARY SEA LEVEL; Ouyang X, 2014, BIOGEOSCIENCES, V11, P5057, DOI 10.5194/bg-11-5057-2014; PETHICK JS, 1981, J SEDIMENT PETROL, V51, P571; Pluet J., 1991, WORLD ATLAS HOLOCENE, V58; Pontee N, 2013, OCEAN COAST MANAGE, V84, P204, DOI 10.1016/j.ocecoaman.2013.07.010; REDFIELD AC, 1972, ECOL MONOGR, V42, P201, DOI 10.2307/1942263; Saintilan N, 1999, HYDROBIOLOGIA, V413, P95, DOI 10.1023/A:1003886725832; Schuerch M, 2018, NATURE, V561, P231, DOI 10.1038/s41586-018-0476-5; Shennan I, 2002, J QUATERNARY SCI, V17, P511, DOI 10.1002/jqs.710; Sloss CR, 2007, HOLOCENE, V17, P999, DOI 10.1177/0959683607082415; Verbeke G., 1997, LINEAR MIXED MODELS, DOI DOI 10.1007/978-1-4612-2294-1_3; Von Ende CN., 2001, DESIGN ANAL ECOLOGIC, P134; WOODROFFE CD, 1985, NATURE, V317, P711, DOI 10.1038/317711a0	38	186	193	91	525	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 7	2019	567	7746					91	+		10.1038/s41586-019-0951-7	http://dx.doi.org/10.1038/s41586-019-0951-7			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HN8ED	30842636				2022-12-28	WOS:000460426900047
J	Devi, S				Devi, Sharmila			Constitution: al-Sisi's presidency could to be expanded	LANCET			English	Editorial Material																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 2	2019	393	10174					864	864		10.1016/S0140-6736(19)30481-7	http://dx.doi.org/10.1016/S0140-6736(19)30481-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HN4AP	30837136				2022-12-28	WOS:000460126900014
J	Ryan, A; Heath, S; Cook, P				Ryan, Aidan; Heath, Simon; Cook, Paul			Dyslipidaemia and cardiovascular risk	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							VALIDATION		[Ryan, Aidan] Univ Hosp Southampton, Dept Lab Med, Metab Med, Southampton, Hants, England; [Heath, Simon] Hazelwood Grp Practice, Gen Practice, Coleshill, Warwick, England; [Cook, Paul] Univ Hosp Southampton, Dept Lab Med, Chem Pathol & Metab Med, Southampton, Hants, England		Ryan, A (corresponding author), Univ Hosp Southampton, Dept Lab Med, Metab Med, Southampton, Hants, England.	aidan.ryan@uhs.nhs.uk	Ryan, Aidan/GWQ-9352-2022					Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; Hippisley-Cox J, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2099; Rabar S, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4356; Stroes ES, 2015, EUR HEART J, V36, P1012, DOI 10.1093/eurheartj/ehv043; Thompson PD, 2016, J AM COLL CARDIOL, V67, P2395, DOI 10.1016/j.jacc.2016.02.071	5	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 23	2018	360								k835	10.1136/bmj.k835	http://dx.doi.org/10.1136/bmj.k835			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GB1LW	30856096	Green Published			2022-12-28	WOS:000428813300014
J	Sugita, S; Honda, R; Morota, T; Kameda, S; Sawada, H; Tatsumi, E; Yamada, M; Honda, C; Yokota, Y; Kouyama, T; Sakatani, N; Ogawa, K; Suzuki, H; Okada, T; Namiki, N; Tanaka, S; Iijima, Y; Yoshioka, K; Hayakawa, M; Cho, Y; Matsuoka, M; Hirata, N; Hirata, N; Miyamoto, H; Domingue, D; Hirabayashi, M; Nakamura, T; Hiroi, T; Michikami, T; Michel, P; Ballouz, RL; Barnouin, OS; Ernst, CM; Schroder, SE; Kikuchi, H; Hemmi, R; Komatsu, G; Fukuhara, T; Taguchi, M; Arai, T; Senshu, H; Demura, H; Ogawa, Y; Shimaki, Y; Sekiguchi, T; Muller, TG; Hagermann, A; Mizuno, T; Noda, H; Matsumoto, K; Yamada, R; Ishihara, Y; Ikeda, H; Araki, H; Yamamoto, K; Abe, S; Yoshida, F; Higuchi, A; Sasaki, S; Oshigami, S; Tsuruta, S; Asari, K; Tazawa, S; Shizugami, M; Kimura, J; Otsubo, T; Yabuta, H; Hasegawa, S; Ishiguro, M; Tachibana, S; Palmer, E; Gaskell, R; Le Corre, L; Jaumann, R; Otto, K; Schmitz, N; Abell, PA; Barucci, MA; Zolensky, ME; Vilas, F; Thuillet, F; Sugimoto, C; Takaki, N; Suzuki, Y; Kamiyoshihara, H; Okada, M; Nagata, K; Fujimoto, M; Yoshikawa, M; Yamamoto, Y; Shirai, K; Noguchi, R; Ogawa, N; Terui, F; Kikuchi, S; Yamaguchi, T; Oki, Y; Takao, Y; Takeuchi, H; Ono, G; Mimasu, Y; Yoshikawa, K; Takahashi, T; Takei, Y; Fujii, A; Hirose, C; Nakazawa, S; Hosoda, S; Mori, O; Shimada, T; Soldini, S; Iwata, T; Abe, M; Yano, H; Tsukizaki, R; Ozaki, M; Nishiyama, K; Saiki, T; Watanabe, S; Tsuda, Y				Sugita, S.; Honda, R.; Morota, T.; Kameda, S.; Sawada, H.; Tatsumi, E.; Yamada, M.; Honda, C.; Yokota, Y.; Kouyama, T.; Sakatani, N.; Ogawa, K.; Suzuki, H.; Okada, T.; Namiki, N.; Tanaka, S.; Iijima, Y.; Yoshioka, K.; Hayakawa, M.; Cho, Y.; Matsuoka, M.; Hirata, N.; Hirata, N.; Miyamoto, H.; Domingue, D.; Hirabayashi, M.; Nakamura, T.; Hiroi, T.; Michikami, T.; Michel, P.; Ballouz, R. -L.; Barnouin, O. S.; Ernst, C. M.; Schroeder, S. E.; Kikuchi, H.; Hemmi, R.; Komatsu, G.; Fukuhara, T.; Taguchi, M.; Arai, T.; Senshu, H.; Demura, H.; Ogawa, Y.; Shimaki, Y.; Sekiguchi, T.; Mueller, T. G.; Hagermann, A.; Mizuno, T.; Noda, H.; Matsumoto, K.; Yamada, R.; Ishihara, Y.; Ikeda, H.; Araki, H.; Yamamoto, K.; Abe, S.; Yoshida, F.; Higuchi, A.; Sasaki, S.; Oshigami, S.; Tsuruta, S.; Asari, K.; Tazawa, S.; Shizugami, M.; Kimura, J.; Otsubo, T.; Yabuta, H.; Hasegawa, S.; Ishiguro, M.; Tachibana, S.; Palmer, E.; Gaskell, R.; Le Corre, L.; Jaumann, R.; Otto, K.; Schmitz, N.; Abell, P. A.; Barucci, M. A.; Zolensky, M. E.; Vilas, F.; Thuillet, F.; Sugimoto, C.; Takaki, N.; Suzuki, Y.; Kamiyoshihara, H.; Okada, M.; Nagata, K.; Fujimoto, M.; Yoshikawa, M.; Yamamoto, Y.; Shirai, K.; Noguchi, R.; Ogawa, N.; Terui, F.; Kikuchi, S.; Yamaguchi, T.; Oki, Y.; Takao, Y.; Takeuchi, H.; Ono, G.; Mimasu, Y.; Yoshikawa, K.; Takahashi, T.; Takei, Y.; Fujii, A.; Hirose, C.; Nakazawa, S.; Hosoda, S.; Mori, O.; Shimada, T.; Soldini, S.; Iwata, T.; Abe, M.; Yano, H.; Tsukizaki, R.; Ozaki, M.; Nishiyama, K.; Saiki, T.; Watanabe, S.; Tsuda, Y.			The geomorphology, color, and thermal properties of Ryugu: Implications for parent-body processes	SCIENCE			English	Article							SPECTRAL REFLECTANCE PROPERTIES; ASTEROID SPECTROSCOPIC SURVEY; NAVIGATION CAMERA ONC; NEAR-EARTH OBJECTS; 162173 1999 JU3; MAIN-BELT; CARBONACEOUS CHONDRITES; NUMERICAL SIMULATIONS; INFLIGHT CALIBRATION; DYNAMICAL EVOLUTION	The near-Earth carbonaceous asteroid 162173 Ryugu is thought to have been produced from a parent body that contained water ice and organic molecules. The Hayabusa2 spacecraft has obtained global multicolor images of Ryugu. Geomorphological features present include a circum-equatorial ridge, east-west dichotomy, high boulder abundances across the entire surface, and impact craters. Age estimates from the craters indicate a resurfacing age of. 106 years for the top 1-meter layer. Ryugu is among the darkest known bodies in the Solar System. The high abundance and spectral properties of boulders are consistent with moderately dehydrated materials, analogous to thermally metamorphosed meteorites found on Earth. The general uniformity in color across Ryugu's surface supports partial dehydration due to internal heating of the asteroid's parent body.	[Sugita, S.; Tatsumi, E.; Okada, T.; Yoshioka, K.; Cho, Y.; Miyamoto, H.; Kikuchi, H.; Hemmi, R.; Tachibana, S.; Sugimoto, C.; Takaki, N.; Suzuki, Y.; Kamiyoshihara, H.; Okada, M.; Oki, Y.; Takao, Y.] Univ Tokyo, Tokyo 1130033, Japan; [Sugita, S.; Yamada, M.; Komatsu, G.; Senshu, H.; Yoshida, F.] Chiba Inst Technol, Planetary Explorat Res Ctr, Narashino, Chiba 2750016, Japan; [Honda, R.; Yokota, Y.] Kochi Univ, Kochi 7808520, Japan; [Morota, T.; Watanabe, S.] Nagoya Univ, Nagoya, Aichi 4648601, Japan; [Kameda, S.; Fukuhara, T.; Taguchi, M.] Rikkyo Univ, Tokyo 1718501, Japan; [Sawada, H.; Yokota, Y.; Sakatani, N.; Okada, T.; Tanaka, S.; Iijima, Y.; Hayakawa, M.; Matsuoka, M.; Ballouz, R. -L.; Shimaki, Y.; Mizuno, T.; Ishihara, Y.; Hasegawa, S.; Fujimoto, M.; Yoshikawa, M.; Yamamoto, Y.; Shirai, K.; Noguchi, R.; Ogawa, N.; Terui, F.; Kikuchi, S.; Yamaguchi, T.; Takeuchi, H.; Mimasu, Y.; Takahashi, T.; Takei, Y.; Fujii, A.; Nakazawa, S.; Hosoda, S.; Mori, O.; Shimada, T.; Soldini, S.; Iwata, T.; Abe, M.; Yano, H.; Tsukizaki, R.; Ozaki, M.; Nishiyama, K.; Saiki, T.; Watanabe, S.; Tsuda, Y.] Japan Aerosp Explorat Agcy JAXA, ISAS, Sagamihara, Kanagawa 2525210, Japan; [Honda, C.; Kouyama, T.; Demura, H.; Ogawa, Y.; Yamada, R.; Nagata, K.] Univ Aizu, Aizu Wakamatsu, Fukushima 9658580, Japan; [Kouyama, T.; Nagata, K.] Natl Inst Adv Ind Sci & Technol, Tokyo 1350064, Japan; [Ogawa, K.; Hirata, N.; Hirata, N.] Kobe Univ, Kobe, Hyogo 6578501, Japan; [Suzuki, H.] Meiji Univ, Kawasaki, Kanagawa 2148571, Japan; [Namiki, N.; Noda, H.; Matsumoto, K.; Araki, H.; Yamamoto, K.; Higuchi, A.; Oshigami, S.; Tsuruta, S.; Asari, K.; Tazawa, S.; Shizugami, M.] Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan; [Namiki, N.; Tanaka, S.; Matsumoto, K.; Yoshikawa, M.; Yamamoto, Y.; Iwata, T.; Abe, M.; Yano, H.; Ozaki, M.; Tsuda, Y.] SOKENDAI Grad Univ Adv Studies, Hayama 2400193, Japan; [Domingue, D.; Palmer, E.; Gaskell, R.; Le Corre, L.; Vilas, F.] Planetary Sci Inst, Tucson, AZ 85719 USA; [Hirabayashi, M.] Auburn Univ, Auburn, AL 36849 USA; [Nakamura, T.] Tohoku Univ, Sendai, Miyagi 9808578, Japan; [Hiroi, T.] Brown Univ, Providence, RI 02912 USA; [Michikami, T.] Kindai Univ, Higashihiroshima 7392116, Japan; [Michel, P.; Thuillet, F.] Univ Cote Azur, CNRS, Lab Lagrange, Observ Cote Azur, F-06304 Nice, France; [Ballouz, R. -L.] Univ Arizona, Tucson, AZ 85705 USA; [Barnouin, O. S.; Ernst, C. M.] Johns Hopkins Univ, Appl Phys Lab, Johns Hopkins Rd, Laurel, MD 20723 USA; [Schroeder, S. E.; Jaumann, R.; Otto, K.; Schmitz, N.] German Aerosp Ctr DLR, Inst Planetary Res, D-12489 Berlin, Germany; [Komatsu, G.] Univ Annunzio, Int Res Sch Planetary Sci, I-65127 Pescara, Italy; [Arai, T.] Ashikaga Univ, Ashikaga 3268558, Japan; [Sekiguchi, T.] Hokkaido Univ, Asahikawa, Hokkaido 0708621, Japan; [Mueller, T. G.] Max Planck Inst Extraterr Phys, D-85748 Garching, Germany; [Hagermann, A.] Univ Stirling, Stirling FK9 4LA, Scotland; [Ikeda, H.; Ono, G.; Yoshikawa, K.; Takei, Y.; Hirose, C.] JAXA, Res & Dev Directorate, Sagamihara, Kanagawa 2525210, Japan; [Abe, S.] Nihon Univ, Funabashi, Chiba 2748501, Japan; [Sasaki, S.; Kimura, J.] Osaka Univ, Toyonaka, Osaka 5600043, Japan; [Otsubo, T.] Hitotsubashi Univ, Tokyo 1868601, Japan; [Yabuta, H.] Hiroshima Univ, Higashihiroshima 7398526, Japan; [Ishiguro, M.] Seoul Natl Univ, Seoul 08826, South Korea; [Abell, P. A.; Zolensky, M. E.] NASA, Johnson Space Ctr, Houston, TX 77058 USA; [Barucci, M. A.] Univ Paris Diderot, Sorbonne Univ, CNRS, LESIA,Observ Paris,PSL, F-92195 Meudon, France; [Ishihara, Y.] Natl Inst Environm Studies, Tsukuba, Ibaraki 3058506, Japan; [Yamaguchi, T.] Mitsubishi Electr Corp, Kamakura, Kanagawa 2478520, Japan	University of Tokyo; Chiba Institute of Technology; Kochi University; Nagoya University; Rikkyo University; Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); University of Aizu; National Institute of Advanced Industrial Science & Technology (AIST); Kobe University; Meiji University; National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); Graduate University for Advanced Studies - Japan; Auburn University System; Auburn University; Tohoku University; Brown University; Kindai University (Kinki University); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Observatoire de la Cote d'Azur; University of Arizona; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Helmholtz Association; German Aerospace Centre (DLR); G d'Annunzio University of Chieti-Pescara; Hokkaido University; Max Planck Society; University of Stirling; Japan Aerospace Exploration Agency (JAXA); Nihon University; Osaka University; Hitotsubashi University; Hiroshima University; Seoul National University (SNU); National Aeronautics & Space Administration (NASA); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite; Universite Paris Cite; National Institute for Environmental Studies - Japan; Mitsubishi Electric Corporation	Sugita, S (corresponding author), Univ Tokyo, Tokyo 1130033, Japan.; Sugita, S (corresponding author), Chiba Inst Technol, Planetary Explorat Res Ctr, Narashino, Chiba 2750016, Japan.	sugita@eps.s.u-tokyo.ac.jp	Miyamoto, Hideaki/B-9666-2008; Hemmi, Ryodo/AAU-1566-2020; Schröder, Stefan/D-9709-2013; Noguchi, R/AAJ-7141-2020; Matsumoto, Koji/AAF-7825-2021; Hiroi, Takahiro/AAE-9701-2020; Kimura, Jun/D-6050-2013; Barnouin, Olivier S/I-7475-2015; Noguchi, Rina/HCH-0362-2022; Michel, Patrick/AGX-0167-2022; Komatsu, Goro/I-7822-2012; Sugita, Seiji/GQI-1142-2022; Ishihara, Yoshiaki/A-8499-2011; Kouyama, Toru/B-1155-2017; Hasegawa, Sunao/R-4768-2017; Tachibana, Shogo/R-7884-2018; Ernst, Carolyn/I-4902-2012	Miyamoto, Hideaki/0000-0001-8013-6124; Hemmi, Ryodo/0000-0002-9638-6926; Schröder, Stefan/0000-0003-0323-8324; Noguchi, R/0000-0001-8281-2448; Matsumoto, Koji/0000-0003-4319-1970; Hiroi, Takahiro/0000-0003-2866-9091; Kimura, Jun/0000-0002-5825-0454; Barnouin, Olivier S/0000-0002-3578-7750; Noguchi, Rina/0000-0001-8281-2448; Michel, Patrick/0000-0002-0884-1993; Komatsu, Goro/0000-0003-4155-108X; Sugita, Seiji/0000-0001-6076-3614; Arai, Takehiko/0000-0002-5711-7731; Tatsumi, Eri/0000-0002-6142-9842; Honda, Rie/0000-0001-7008-5300; Kouyama, Toru/0000-0002-1060-3986; Tazawa, Seiichi/0000-0002-2536-4623; Hasegawa, Sunao/0000-0001-6366-2608; Tachibana, Shogo/0000-0002-4603-9440; Takeuchi, Hiroshi/0000-0001-5863-4653; Otsubo, Toshimichi/0000-0003-1615-535X; Yamamoto, Yukio/0000-0001-7172-1911; Ernst, Carolyn/0000-0002-9434-7886; Soldini, Stefania/0000-0003-3121-3845; Shimaki, Yuri/0000-0001-8966-7650; Hagermann, Axel/0000-0002-1818-9396; Kikuchi, Hiroshi/0000-0003-0067-4606; Matsuoka, Moe/0000-0003-1091-3041; Kameda, Shingo/0000-0001-9084-2858; Hirata, Naru/0000-0002-2435-604X; Zolensky, Michael/0000-0002-3181-1303; Abe, Shinsuke/0000-0002-6247-4979	KAKENHI from the Japanese Society for Promotion of Science (JSPS) [JP25120006, 17H01175, JP17H06459, JP17K05639, JP16H04059, JP17KK0097, JP26287108, JP16H04044]; JSPS Core-to-Core program "International Network of Planetary Sciences"; French space agency CNES; Complex Systems Academy of Excellence, IDEX JEDI of the Universite Cote d'Azur; Space, Environment, Risk, and Resilience Academy of Excellence, IDEX JEDI of the Universite Cote d'Azur; European Union's Horizon 2020 Research and Innovation Programme [687378]; NASA Hayabusa2 Participating Scientist Program; Center for Planetary Origin; STFC [ST/S001271/1] Funding Source: UKRI	KAKENHI from the Japanese Society for Promotion of Science (JSPS); JSPS Core-to-Core program "International Network of Planetary Sciences"; French space agency CNES(Centre National D'etudes Spatiales); Complex Systems Academy of Excellence, IDEX JEDI of the Universite Cote d'Azur; Space, Environment, Risk, and Resilience Academy of Excellence, IDEX JEDI of the Universite Cote d'Azur; European Union's Horizon 2020 Research and Innovation Programme; NASA Hayabusa2 Participating Scientist Program; Center for Planetary Origin; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	This study was supported by KAKENHI from the Japanese Society for Promotion of Science (JSPS) (grants JP25120006, 17H01175, JP17H06459, JP17K05639, JP16H04059, JP17KK0097, JP26287108, and JP16H04044) and the JSPS Core-to-Core program "International Network of Planetary Sciences." P.M. and M.A.B. acknowledge funding support from the French space agency CNES. P.S. acknowledges funding from the Complex Systems Academy of Excellence and the Space, Environment, Risk, and Resilience Academy of Excellence, part of the IDEX JEDI of the Universite Cote d'Azur in connection with its Center for Planetary Origin. T.M. has received funding from the European Union's Horizon 2020 Research and Innovation Programme (Grant 687378). D.D.L., C.M.E., L.L.C., and M.K. acknowledge funding through the NASA Hayabusa2 Participating Scientist Program.	Abramov O, 2013, CHEM ERDE-GEOCHEM, V73, P227, DOI 10.1016/j.chemer.2013.08.004; Applin DM, 2018, ICARUS, V307, P40, DOI 10.1016/j.icarus.2018.02.012; Bauer JM, 2015, ASTROPHYS J, V814, DOI 10.1088/0004-637X/814/2/85; Binzel RP, 2001, ICARUS, V151, P139, DOI 10.1006/icar.2001.6613; Bischoff A., 2006, METEORITES EARLY SOL, P679; Bottke WF, 2005, ICARUS, V179, P63, DOI 10.1016/j.icarus.2005.05.017; BOTTKE WF, 1994, ICARUS, V107, P255, DOI 10.1006/icar.1994.1021; BOTTKE WF, 1993, GEOPHYS RES LETT, V20, P879, DOI 10.1029/92GL02713; Bottke WF, 2015, ICARUS, V247, P191, DOI 10.1016/j.icarus.2014.09.046; Bus SJ, 2002, ICARUS, V158, P146, DOI 10.1006/icar.2002.6856; Bus SJ, 2002, ICARUS, V158, P106, DOI 10.1006/icar.2002.6857; Cheng AF, 2002, ICARUS, V155, P51, DOI 10.1006/icar.2001.6750; Clark BE, 1999, ICARUS, V140, P53, DOI 10.1006/icar.1999.6124; Cloutis EA, 2012, ICARUS, V220, P586, DOI 10.1016/j.icarus.2012.05.018; Cloutis EA, 2011, ICARUS, V216, P309, DOI 10.1016/j.icarus.2011.09.009; Cloutis EA, 2011, ICARUS, V212, P180, DOI 10.1016/j.icarus.2010.12.009; Cloutis EA, 2018, ICARUS, V305, P203, DOI 10.1016/j.icarus.2018.01.015; Cody GD, 2008, EARTH PLANET SC LETT, V272, P446, DOI 10.1016/j.epsl.2008.05.008; de Leon J, 2018, ICARUS, V313, P25, DOI 10.1016/j.icarus.2018.05.009; Delbo M, 2014, NATURE, V508, P233, DOI 10.1038/nature13153; Demura H, 2006, SCIENCE, V312, P1347, DOI 10.1126/science.1126574; Domingue DL, 2015, ICARUS, V257, P477, DOI 10.1016/j.icarus.2014.11.027; Domingue DL, 2011, PLANET SPACE SCI, V59, P1873, DOI 10.1016/j.pss.2011.03.014; Domingue DL, 2011, PLANET SPACE SCI, V59, P1853, DOI 10.1016/j.pss.2011.04.012; Endo K, 2017, AEROSP CONF PROC; Flynn GJ, 2005, EARTH MOON PLANETS, V95, P361, DOI 10.1007/s11038-005-9025-y; Fornasier S, 2014, ICARUS, V233, P163, DOI 10.1016/j.icarus.2014.01.040; Fukuhara T, 2011, EARTH PLANETS SPACE, V63, P1009, DOI 10.5047/eps.2011.06.019; Guttler C, 2012, ICARUS, V220, P1040, DOI 10.1016/j.icarus.2012.06.041; HAPKE B, 1981, J GEOPHYS RES, V86, P3039, DOI 10.1029/JB086iB04p03039; Hapke B., 2012, THEORY REFLECTANCE E; Herbert F., 1991, SUN TIME, P710; Hirata N, 2009, ICARUS, V200, P486, DOI 10.1016/j.icarus.2008.10.027; Hiroi T, 1996, METORIT PLANET SCI, V31, P321, DOI 10.1111/j.1945-5100.1996.tb02068.x; HOLSAPPLE KA, 1993, ANNU REV EARTH PL SC, V21, P333, DOI 10.1146/annurev.ea.21.050193.002001; Holsapple KA, 2007, ICARUS, V187, P345, DOI 10.1016/j.icarus.2006.08.029; Ishiguro M, 2014, ASTROPHYS J, V792, DOI 10.1088/0004-637X/792/1/74; Jiang Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep16029; Jutzi M, 2008, ICARUS, V198, P242, DOI 10.1016/j.icarus.2008.06.013; Jutzi M, 2019, ICARUS, V317, P215, DOI 10.1016/j.icarus.2018.08.006; Jutzi M, 2010, ICARUS, V207, P54, DOI 10.1016/j.icarus.2009.11.016; Jutzi M, 2009, ICARUS, V201, P802, DOI 10.1016/j.icarus.2009.01.018; Kameda S, 2017, SPACE SCI REV, V208, P17, DOI 10.1007/s11214-015-0227-y; Kitazato K, 2019, SCIENCE, V364, P272, DOI 10.1126/science.aav7432; Koga SC, 2018, ICARUS, V299, P386, DOI 10.1016/j.icarus.2017.08.016; Lantz C, 2018, ICARUS, V302, P10, DOI 10.1016/j.icarus.2017.11.010; Lazzaro D, 2013, ASTRON ASTROPHYS, V549, DOI 10.1051/0004-6361/201220629; Marchi S, 2009, MON NOT R ASTRON SOC, V400, P147, DOI 10.1111/j.1365-2966.2009.15459.x; Matsuoka M, 2017, EARTH PLANETS SPACE, V69, DOI 10.1186/s40623-017-0705-4; Matsuoka M, 2015, ICARUS, V254, P135, DOI 10.1016/j.icarus.2015.02.029; Mazrouei S, 2014, ICARUS, V229, P181, DOI 10.1016/j.icarus.2013.11.010; Melosh H.J., 1989, OXFORD MONOGRAPHS GE; Michel P, 2003, NATURE, V421, P608, DOI 10.1038/nature01364; Michel P, 2009, ICARUS, V200, P503, DOI 10.1016/j.icarus.2008.04.002; Michel P, 2015, PLANET SPACE SCI, V107, P24, DOI 10.1016/j.pss.2014.08.005; Michel P, 2010, ICARUS, V209, P520, DOI 10.1016/j.icarus.2010.05.013; Michikami T, 2008, EARTH PLANETS SPACE, V60, P13, DOI 10.1186/BF03352757; Miyamoto H, 2007, SCIENCE, V316, P1011, DOI 10.1126/science.1134390; Mizuno T, 2017, SPACE SCI REV, V208, P33, DOI 10.1007/s11214-015-0231-2; Morate D, 2016, ASTRON ASTROPHYS, V586, DOI 10.1051/0004-6361/201527453; Moskovitz NA, 2013, ICARUS, V224, P24, DOI 10.1016/j.icarus.2013.02.009; Muller TG, 2017, ASTRON ASTROPHYS, V598, DOI 10.1051/0004-6361/201629584; Nakamura T, 2005, J MINER PETROL SCI, V100, P260, DOI 10.2465/jmps.100.260; O'Brien DP, 2006, ICARUS, V183, P79, DOI 10.1016/j.icarus.2006.02.008; O'Brien DP, 2005, ICARUS, V178, P179, DOI 10.1016/j.icarus.2005.04.001; OBERBECK VR, 1968, ICARUS, V9, P446, DOI 10.1016/0019-1035(68)90039-0; Okada T, 2018, PLANET SPACE SCI, V158, P46, DOI 10.1016/j.pss.2018.05.007; Okada T, 2017, SPACE SCI REV, V208, P255, DOI 10.1007/s11214-016-0286-8; Perna D, 2017, ASTRON ASTROPHYS, V599, DOI 10.1051/0004-6361/201630346; PIETERS CM, 1983, J GEOPHYS RES, V88, P9534, DOI 10.1029/JB088iB11p09534; Richardson DC, 2000, ICARUS, V143, P45, DOI 10.1006/icar.1999.6243; Robbins SJ, 2018, METEORIT PLANET SCI, V53, P583, DOI 10.1111/maps.12956; Sakatani N, 2017, AIP ADV, V7, DOI 10.1063/1.4975153; Suzuki H, 2018, ICARUS, V300, P341, DOI 10.1016/j.icarus.2017.09.011; Tardivel S, 2018, ICARUS, V304, P192, DOI 10.1016/j.icarus.2017.06.037; Tatsumi E, 2019, ICARUS, V325, P153, DOI 10.1016/j.icarus.2019.01.015; Tatsumi E, 2018, ICARUS, V300, P227, DOI 10.1016/j.icarus.2017.09.004; TEDESCO EF, 1982, ASTRON J, V87, P1585, DOI 10.1086/113248; Thomas PC, 2001, NATURE, V413, P394, DOI 10.1038/35096513; Tonui E, 2014, GEOCHIM COSMOCHIM AC, V126, P284, DOI 10.1016/j.gca.2013.10.053; Vernazza P, 2015, ASTROPHYS J, V806, DOI 10.1088/0004-637X/806/2/204; Veverka J, 2001, SCIENCE, V292, P484, DOI 10.1126/science.1058651; Vilas F., 2012, AM ASTR SOC 44 DPS M; Vilas F, 2008, ASTRON J, V135, P1101, DOI 10.1088/0004-6256/135/4/1101; Wakita S, 2011, EARTH PLANETS SPACE, V63, P1193, DOI 10.5047/eps.2011.08.012; Watanabe S, 2019, SCIENCE, V364, P268, DOI 10.1126/science.aav8032	86	232	240	8	129	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2019	364	6437					252	+	eaaw0422	10.1126/science.aaw0422	http://dx.doi.org/10.1126/science.aaw0422			42	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HU0JG	30890587	Green Accepted			2022-12-28	WOS:000464956600039
J	Zhang, B; Wang, KB; Wang, W; Wang, X; Liu, F; Zhu, JP; Shi, J; Li, LY; Han, H; Xu, K; Qiao, HY; Zhang, X; Jiao, RH; Houk, KN; Liang, Y; Tan, RX; Ge, HM				Zhang, Bo; Wang, Kai Biao; Wang, Wen; Wang, Xin; Liu, Fang; Zhu, Jiapeng; Shi, Jing; Li, Ling Yu; Han, Hao; Xu, Kuang; Qiao, Hong Yun; Zhang, Xiao; Jiao, Rui Hua; Houk, Kendall N.; Liang, Yong; Tan, Ren Xiang; Ge, Hui Ming			Enzyme-catalysed [6+4] cycloadditions in the biosynthesis of natural products	NATURE			English	Article							PERICYCLIC-REACTIONS; SPNF	Pericyclic reactions are powerful transformations for the construction of carbon-carbon and carbon-heteroatom bonds in organic synthesis. Their role in biosynthesis is increasingly apparent, and mechanisms by which pericyclases can catalyse reactions are of major interest(1). [4+2] cycloadditions (Diels-Alder reactions) have been widely used in organic synthesis2 for the formation of six-membered rings and are now well-established in biosynthesis(3-6). [6+4] and other 'higher-order' cycloadditions were predicted(7) in 1965, and are now increasingly common in the laboratory despite challenges arising from the generation of a highly strained ten-membered ring system(8,9). However, although enzyme-catalysed [6+4] cycloadditions have been proposed(10-12), they have not been proven to occur. Here we demonstrate a group of enzymes that catalyse a pericyclic [6+4] cycloaddition, which is a crucial step in the biosynthesis of streptoseomycin-type natural products. This type of pericyclase catalyses [6+4] and [4+2] cycloadditions through a single ambimodal transition state, which is consistent with previous proposals(11,12). The [6+4] product is transformed to a less stable [4+2] adduct via a facile Cope rearrangement, and the [4+2] adduct is converted into the natural product enzymatically. Crystal structures of three pericyclases, computational simulations of potential energies and molecular dynamics, and site-directed mutagenesis establish the mechanism of this transformation. This work shows how enzymes are able to catalyse concerted pericyclic reactions involving ambimodal transition states.	[Zhang, Bo; Wang, Kai Biao; Wang, Wen; Shi, Jing; Li, Ling Yu; Han, Hao; Xu, Kuang; Qiao, Hong Yun; Jiao, Rui Hua; Tan, Ren Xiang; Ge, Hui Ming] Nanjing Univ, Inst Funct Biomol, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China; [Wang, Xin; Liu, Fang; Zhang, Xiao; Liang, Yong] Nanjing Univ, State Key Lab Coordinat Chem, Jiangsu Key Lab Adv Organ Mat, Sch Chem & Chem Engn, Nanjing, Jiangsu, Peoples R China; [Zhu, Jiapeng; Tan, Ren Xiang] Nanjing Univ Chinese Med, State Key Lab Cultivat Base TCM Qual & Efficacy, Sch Life Sci & Med, Nanjing, Jiangsu, Peoples R China; [Houk, Kendall N.] Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA	Nanjing University; Nanjing University; Nanjing University of Chinese Medicine; University of California System; University of California Los Angeles	Tan, RX; Ge, HM (corresponding author), Nanjing Univ, Inst Funct Biomol, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China.; Liang, Y (corresponding author), Nanjing Univ, State Key Lab Coordinat Chem, Jiangsu Key Lab Adv Organ Mat, Sch Chem & Chem Engn, Nanjing, Jiangsu, Peoples R China.; Tan, RX (corresponding author), Nanjing Univ Chinese Med, State Key Lab Cultivat Base TCM Qual & Efficacy, Sch Life Sci & Med, Nanjing, Jiangsu, Peoples R China.; Houk, KN (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA.	houk@chem.ucla.edu; yongliang@nju.edu.cn; rxtan@nju.edu.cn; hmge@nju.edu.cn	Liang, Yong/J-4541-2017	Liang, Yong/0000-0001-5026-6710	Ministry of Science and Technology [2018YFC1706200]; National Natural Science Foundation of China [21572100, 21803030, 81522042, 81773591, 81530089, 81673333, 21861142005, 21761142001, 21661140001]; National Thousand Young Talents Program; Jiangsu Specially-Appointed Professor Plan; Natural Science Foundation of Jiangsu Province in China [BK20170631]; US National Institutes of General Medical Sciences, National Institutes of Health [GM 124480]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM124480] Funding Source: NIH RePORTER	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Thousand Young Talents Program; Jiangsu Specially-Appointed Professor Plan; Natural Science Foundation of Jiangsu Province in China(Natural Science Foundation of Jiangsu Province); US National Institutes of General Medical Sciences, National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was financially supported by Ministry of Science and Technology (2018YFC1706200), the National Natural Science Foundation of China (21572100, 21803030, 81522042, 81773591, 81530089, 81673333, 21861142005, 21761142001 and 21661140001), the National Thousand Young Talents Program, the Jiangsu Specially-Appointed Professor Plan, the Natural Science Foundation of Jiangsu Province (BK20170631) in China, and the US National Institutes of General Medical Sciences, National Institutes of Health (GM 124480). We are grateful to the High Performance Computing Center of Nanjing University for doing the numerical calculations in this paper on its blade cluster system. We thank the staff at beamlines BL17U1 and BL18U1 of Shanghai Synchrotron Radiation Facility and the National Supercomputing Center in Wuxi for their support.	Adams PD, 2009, ACTA CRYSTALLOGR D, V65, P567, DOI 10.1107/S0907444909011548; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; CANE DE, 1995, J AM CHEM SOC, V117, P6633, DOI 10.1021/ja00129a044; Cikos A, 2016, ORG LETT, V18, P780, DOI 10.1021/acs.orglett.6b00044; Clarkson WD, 1997, J MOL BIOL, V272, P716, DOI 10.1006/jmbi.1997.1255; Emsley P, 2018, ACTA CRYSTALLOGR D, V74, P256, DOI 10.1107/S2059798318005119; Hare SR, 2017, PURE APPL CHEM, V89, P679, DOI 10.1515/pac-2017-0104; HOFFMANN R, 1965, J AM CHEM SOC, V87, P2046, DOI 10.1021/ja01087a034; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Hong YJ, 2014, NAT CHEM, V6, P104, DOI [10.1038/NCHEM.1843, 10.1038/nchem.1843]; Jamieson CS, 2019, NAT PROD REP, V36, P698, DOI 10.1039/c8np00075a; Jeon BS, 2017, CHEM REV, V117, P5367, DOI 10.1021/acs.chemrev.6b00578; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim HJ, 2011, NATURE, V473, P109, DOI 10.1038/nature09981; LUNDQVIST T, 1994, STRUCTURE, V2, P937, DOI 10.1016/S0969-2126(94)00095-6; Medvedev MG, 2017, J AM CHEM SOC, V139, P3942, DOI 10.1021/jacs.6b13243; Mori T, 2017, NAT CHEM BIOL, V13, P1066, DOI [10.1038/NCHEMBIO.2443, 10.1038/nchembio.2443]; Mose R, 2017, NAT CHEM, V9, P487, DOI [10.1038/NCHEM.2682, 10.1038/nchem.2682]; Ohashi M, 2017, NATURE, V549, P502, DOI 10.1038/nature23882; Palazzo TA, 2017, ANGEW CHEM INT EDIT, V56, P10033, DOI 10.1002/anie.201701085; Patel A, 2016, J AM CHEM SOC, V138, P3631, DOI 10.1021/jacs.6b00017; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; RASMUSSEN RR, 1987, J ANTIBIOT, V40, P1383, DOI 10.7164/antibiotics.40.1383; Sciara G, 2003, EMBO J, V22, P205, DOI 10.1093/emboj/cdg031; SEEMAN JI, 1983, CHEM REV, V83, P83, DOI 10.1021/cr00054a001; Siegel JB, 2010, SCIENCE, V329, P309, DOI 10.1126/science.1190239; SNYDER WC, 1984, J AM CHEM SOC, V106, P787, DOI 10.1021/ja00315a053; Sultana A, 2004, EMBO J, V23, P1911, DOI 10.1038/sj.emboj.7600201; Takao K, 2005, CHEM REV, V105, P4779, DOI 10.1021/cr040632u; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Tian ZH, 2015, NAT CHEM BIOL, V11, P259, DOI [10.1038/NCHEMBIO.1769, 10.1038/nchembio.1769]; WHALEY HA, 1980, TETRAHEDRON LETT, V21, P3659, DOI 10.1016/S0040-4039(00)78737-5; Yang ZY, 2018, J AM CHEM SOC, V140, P3061, DOI 10.1021/jacs.7b13562; Yang ZY, 2018, P NATL ACAD SCI USA, V115, pE848, DOI 10.1073/pnas.1719368115; Yu PY, 2015, J AM CHEM SOC, V137, P13518, DOI 10.1021/jacs.5b06656; Zhang B, 2018, ORG LETT, V20, P2967, DOI 10.1021/acs.orglett.8b01006	36	86	92	11	297	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 4	2019	568	7750					122	+		10.1038/s41586-019-1021-x	http://dx.doi.org/10.1038/s41586-019-1021-x			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR8CZ	30867595	Green Accepted			2022-12-28	WOS:000463384900052
J	Dyer, C				Dyer, Clare			GP who failed to act on red flags for cauda equina syndrome breached duty	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		NICE, CLIN KNOWL SUMM SCIA; Torjesen I, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j1427	2	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 18	2019	364								l1231	10.1136/bmj.l1231	http://dx.doi.org/10.1136/bmj.l1231			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HQ7ZV	30886121				2022-12-28	WOS:000462643800009
J	Kardas-Nelson, M				Kardas-Nelson, Mara			HPV VACCINE Vaccine uptake and prevalence of HPV related cancers in US men	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												marajenn@gmail.com						Centers for Disease Control and Prevention, 2018, HPV VACC VACC YOUR P; Centers for Disease Control and Prevention, 2018, HPV VACC COV DAT; Centers for Disease Control and Prevention, 2017, GEN HPV INF FACH SHE; Han JJ, 2017, JAMA ONCOL, V3, P810, DOI 10.1001/jamaoncol.2016.6192; Kmietowicz Z, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k3237; NHS, 2017, WHO SHOULD HAV HPV V; US Food and Drug Administration, 2018, FDA APPR EXP US GARD; US Food and Drug Administration, 2009, GARD VACC SAF; Young D, 2015, ORAL ONCOL, V51, P727, DOI 10.1016/j.oraloncology.2015.03.015	9	4	4	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 18	2019	364								l1210	10.1136/bmj.l1210	http://dx.doi.org/10.1136/bmj.l1210			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HQ7ZV	30885904				2022-12-28	WOS:000462643800006
J	Januszewicz, W; Corrie, P; Liu, HX; Chan, J; Fitzgerald, RC; Di Pietro, M				Januszewicz, Wladyslaw; Corrie, Pippa; Liu, Hongxiang; Chan, James; Fitzgerald, Rebecca C.; Di Pietro, Massimiliano			A sinister black finding in the stomach	LANCET			English	Editorial Material									[Januszewicz, Wladyslaw; Fitzgerald, Rebecca C.; Di Pietro, Massimiliano] Univ Cambridge, MRC Canc Unit, Cambridge CB2 0XZ, England; [Liu, Hongxiang; Chan, James] Cambridge Univ Hosp NHS Fdn Trust, Cambridge Canc Ctr, Dept Histopathol, Cambridge, England; [Corrie, Pippa] Univ Cambridge, Sch Med, Cambridge, England; [Januszewicz, Wladyslaw] Med Ctr Postgrad Educ, Dept Gastroenterol Hepatol & Clin Oncol, Warsaw, Poland	University of Cambridge; University of Cambridge; University of Cambridge; Centre of Postgraduate Medical Education - Poland	Di Pietro, M (corresponding author), Univ Cambridge, MRC Canc Unit, Cambridge CB2 0XZ, England.	md460@mrc-cu.cam.ac.uk	Januszewicz, Wladyslaw/AAK-2119-2020	Januszewicz, Wladyslaw/0000-0002-8200-2661; Fitzgerald, Rebecca/0000-0002-3434-3568					0	2	2	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 16	2019	393	10176					1149	1149		10.1016/S0140-6736(19)30423-4	http://dx.doi.org/10.1016/S0140-6736(19)30423-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HP1HF	30894270	Green Published			2022-12-28	WOS:000461416600033
J	Chakraborty, AA; Laukka, T; Myllykoski, M; Ringel, AE; Booker, MA; Tolstorukov, MY; Meng, YJ; Meier, SR; Jennings, RB; Creech, AL; Herbert, ZT; McBrayer, SK; Olenchock, BA; Jaffe, JD; Haigis, MC; Beroukhim, R; Signoretti, S; Koivunen, P; Kaelin, WG				Chakraborty, Abhishek A.; Laukka, Tuomas; Myllykoski, Matti; Ringel, Alison E.; Booker, Matthew A.; Tolstorukov, Michael Y.; Meng, Yuzhong Jeff; Meier, Samuel R.; Jennings, Rebecca B.; Creech, Amanda L.; Herbert, Zachary T.; McBrayer, Samuel K.; Olenchock, Benjamin A.; Jaffe, Jacob D.; Haigis, Marcia C.; Beroukhim, Rameen; Signoretti, Sabina; Koivunen, Peppi; Kaelin, William G., Jr.			Histone demethylase KDM6A directly senses oxygen to control chromatin and cell fate	SCIENCE			English	Article							RNA-SEQ; HYPOXIA; DIFFERENTIATION; INHIBITOR; IDH; UTX	Oxygen sensing is central to metazoan biology and has implications for human disease. Mammalian cells express multiple oxygen-dependent enzymes called 2-oxoglutarate (OG)-dependent dioxygenases (2-OGDDs), but they vary in their oxygen affinities and hence their ability to sense oxygen. The 2-OGDD histone demethylases control histone methylation. Hypoxia increases histone methylation, but whether this reflects direct effects on histone demethylases or indirect effects caused by the hypoxic induction of the HIF (hypoxia-inducible factor) transcription factor or the 2-OG antagonist 2-hydroxyglutarate (2-HG) is unclear. Here, we report that hypoxia promotes histone methylation in a HIF-and 2-HG-independent manner. We found that the H3K27 histone demethylase KDM6A/UTX, but not its paralog KDM6B, is oxygen sensitive. KDM6A loss, like hypoxia, prevented H3K27 demethylation and blocked cellular differentiation. Restoring H3K27 methylation homeostasis in hypoxic cells reversed these effects. Thus, oxygen directly affects chromatin regulators to control cell fate.	[Chakraborty, Abhishek A.; Meng, Yuzhong Jeff; McBrayer, Samuel K.; Beroukhim, Rameen; Kaelin, William G., Jr.] Harvard Med Sch, Dept Med Oncol, Dana Farber Canc Inst, Boston, MA 02215 USA; [Chakraborty, Abhishek A.; Meng, Yuzhong Jeff; Herbert, Zachary T.; McBrayer, Samuel K.; Beroukhim, Rameen; Kaelin, William G., Jr.] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02215 USA; [Laukka, Tuomas; Myllykoski, Matti; Koivunen, Peppi] Univ Oulu, Bioctr Oulu, Fac Biochem & Mol Med, Oulu Ctr Cell Matrix Res, FIN-90014 Oulu, Finland; [Ringel, Alison E.; Haigis, Marcia C.] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA; [Booker, Matthew A.; Tolstorukov, Michael Y.] Harvard Med Sch, Dana Farber Canc Inst, Dept Informat, Boston, MA 02215 USA; [Meng, Yuzhong Jeff; Meier, Samuel R.; Creech, Amanda L.; Jaffe, Jacob D.; Beroukhim, Rameen] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Meng, Yuzhong Jeff] Harvard Med Sch, Biol & Biomed Sci, Boston, MA 02115 USA; [Meng, Yuzhong Jeff; Beroukhim, Rameen] Harvard Med Sch, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Meng, Yuzhong Jeff] Harvard Med Sch, Harvard MIT Program Hlth Sci & Technol, Boston, MA 02115 USA; [Jennings, Rebecca B.; Signoretti, Sabina] Harvard Med Sch, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Herbert, Zachary T.] Harvard Med Sch, Dana Farber Canc Inst, Mol Biol Core Facil, Boston, MA 02215 USA; [Olenchock, Benjamin A.] Brigham & Womens Hosp, Div Cardiovasc Med, Dept Med, Boston, MA 02115 USA; [Olenchock, Benjamin A.] Harvard Med Sch, Boston, MA 02115 USA; [Kaelin, William G., Jr.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Oulu; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Kaelin, WG (corresponding author), Harvard Med Sch, Dept Med Oncol, Dana Farber Canc Inst, Boston, MA 02215 USA.; Kaelin, WG (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02215 USA.; Koivunen, P (corresponding author), Univ Oulu, Bioctr Oulu, Fac Biochem & Mol Med, Oulu Ctr Cell Matrix Res, FIN-90014 Oulu, Finland.; Kaelin, WG (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	peppi.karppinen@oulu.fi; william_kaelin@dfci.harvard.edu	Jennings, Rebecca/ABE-7211-2020	Laukka, Tuomas/0000-0003-1152-4515; Jennings, Rebecca/0000-0001-5524-3235; Ringel, Alison/0000-0002-6451-9376; Tolstorukov, Michael/0000-0002-9134-8808; Booker, Matthew/0000-0002-6902-1032; /0000-0002-9044-4777; Myllykoski, Matti/0000-0001-6641-5856	NIH [R01CA068490, P50CA101942, R35CA210068]; Friends of Dana-Farber; NIH (Cancer Biology Training grant) [T32CA009361]; NIH (DF/HCC Kidney SPORE CEP and DRP award) [P50CA101942]; Academy of Finland [266719, 308009]; S. Juselius Foundation; Jane and Aatos Erkko Foundation; Finnish Cancer Organizations; Finnish Medical Foundation; Emil Aaltonen Foundation; American Cancer Society [PF-14-144-01-TBE]; Career Enhancement Project award from the Dana-Farber/Harvard Cancer Center Brain SPORE; NATIONAL CANCER INSTITUTE [R35CA210068] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Friends of Dana-Farber; NIH (Cancer Biology Training grant)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH (DF/HCC Kidney SPORE CEP and DRP award)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Academy of Finland(Academy of Finland); S. Juselius Foundation; Jane and Aatos Erkko Foundation; Finnish Cancer Organizations; Finnish Medical Foundation; Emil Aaltonen Foundation; American Cancer Society(American Cancer Society); Career Enhancement Project award from the Dana-Farber/Harvard Cancer Center Brain SPORE; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	W.G.K. was supported by grants from the NIH (R01CA068490, P50CA101942, and R35CA210068). A.A.C. was supported by grants from the Friends of Dana-Farber and the NIH (Cancer Biology Training grant: T32CA009361 and the DF/HCC Kidney SPORE CEP and DRP award: P50CA101942). P.K. was supported by Academy of Finland grants (266719 and 308009), the S. Juselius Foundation, the Jane and Aatos Erkko Foundation, and the Finnish Cancer Organizations. T.L. was supported by the Finnish Medical Foundation and, with P.K., the Emil Aaltonen Foundation. S.K.M. is supported by an American Cancer Society postdoctoral fellowship (PF-14-144-01-TBE) and by a Career Enhancement Project award from the Dana-Farber/Harvard Cancer Center Brain SPORE. W.G.K. is an HHMI Investigator.	Adriaens ME, 2016, EPIGENET CHROMATIN, V9, DOI 10.1186/s13072-016-0090-4; Batie M, 2019, SCIENCE, V363, P1222, DOI 10.1126/science.aau5870; Carbon S, 2017, NUCLEIC ACIDS RES, V45, pD331, DOI 10.1093/nar/gkw1108; Carey BW, 2015, NATURE, V518, P413, DOI 10.1038/nature13981; Casper J, 2018, NUCLEIC ACIDS RES, V46, pD762, DOI 10.1093/nar/gkx1020; Cho SH, 2016, NATURE, V537, P234, DOI 10.1038/nature19334; Considine MJ, 2017, TRENDS PLANT SCI, V22, P140, DOI 10.1016/j.tplants.2016.11.013; Conway E, 2015, CURR OPIN CELL BIOL, V37, P42, DOI 10.1016/j.ceb.2015.10.003; Cornwell M, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2139-9; Creech AL, 2015, METHODS, V72, P57, DOI 10.1016/j.ymeth.2014.10.033; Deng M, 2017, DATABASE-OXFORD, DOI 10.1093/database/baw160; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Hale LP, 2002, AM J PHYSIOL-HEART C, V282, pH1467, DOI 10.1152/ajpheart.00682.2001; Hancock RL, 2015, EPIGENOMICS-UK, V7, P791, DOI 10.2217/epi.15.24; Higgins DF, 2007, J CLIN INVEST, V117, P3810, DOI 10.1172/JCI30487; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Intlekofer AM, 2017, NAT CHEM BIOL, V13, P494, DOI [10.1038/NCHEMBIO.2307, 10.1038/nchembio.2307]; Intlekofer AM, 2015, CELL METAB, V22, P304, DOI 10.1016/j.cmet.2015.06.023; Kaelin WG, 2005, CELL METAB, V1, P357, DOI 10.1016/j.cmet.2005.05.006; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Kim WY, 2006, EMBO J, V25, P4650, DOI 10.1038/sj.emboj.7601300; KIVIRIKKO KI, 1982, METHOD ENZYMOL, V82, P245; Koivunen P, 2012, NATURE, V483, P485, DOI 10.1038/nature10898; Kruidenier L, 2012, NATURE, V488, P404, DOI 10.1038/nature11262; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Laukka T, 2018, J MOL BIOL, V430, P3081, DOI 10.1016/j.jmb.2018.06.048; Ler LD, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aai8312; Losman JA, 2013, GENE DEV, V27, P836, DOI 10.1101/gad.217406.113; Majmundar AJ, 2012, MOL CELL BIOL, V32, P36, DOI 10.1128/MCB.05857-11; Manna S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9152; Mariani CJ, 2014, CELL REP, V7, P1343, DOI 10.1016/j.celrep.2014.04.040; McDonough MA, 2010, CURR OPIN STRUC BIOL, V20, P659, DOI 10.1016/j.sbi.2010.08.006; Melvin A, 2012, CELL SIGNAL, V24, P35, DOI 10.1016/j.cellsig.2011.08.019; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; NumayamaTsuruta K, 1997, EUR J BIOCHEM, V246, P486, DOI 10.1111/j.1432-1033.1997.00486.x; Oldham WM, 2015, CELL METAB, V22, P291, DOI 10.1016/j.cmet.2015.06.021; Prickaerts P, 2016, EPIGENET CHROMATIN, V9, DOI 10.1186/s13072-016-0086-0; Qin Q, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1274-4; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rohle D, 2013, SCIENCE, V340, P626, DOI 10.1126/science.1236062; Safran M, 2006, P NATL ACAD SCI USA, V103, P105, DOI 10.1073/pnas.0509459103; Seenundun S, 2010, EMBO J, V29, P1401, DOI 10.1038/emboj.2010.37; Sengoku T, 2011, GENE DEV, V25, P2266, DOI 10.1101/gad.172296.111; Shmakova A, 2014, BIOCHEM J, V462, P385, DOI 10.1042/BJ20140754; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thienpont B, 2016, NATURE, V537, P63, DOI 10.1038/nature19081; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tyrakis PA, 2016, NATURE, V540, P236, DOI 10.1038/nature20165; van den Beucken T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6203; Varaljai R, 2015, GENE DEV, V29, P1817, DOI 10.1101/gad.264036.115; Wakimoto H, 2014, CLIN CANCER RES, V20, P2898, DOI 10.1158/1078-0432.CCR-13-3052; Watson CJ, 2014, HUM MOL GENET, V23, P2176, DOI 10.1093/hmg/ddt614; Yun Z, 2005, MOL CELL BIOL, V25, P3040, DOI 10.1128/MCB.25.8.3040-3055.2005	55	169	175	5	105	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 15	2019	363	6432			SI		1217	+		10.1126/science.aaw1026	http://dx.doi.org/10.1126/science.aaw1026			72	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP0BC	30872525	Green Accepted			2022-12-28	WOS:000461329000049
J	Olalde, I; Mallick, S; Patterson, N; Rohland, N; Villalba-Mouco, V; Silva, M; Dulias, K; Edwards, CJ; Gandini, F; Pala, M; Soares, P; Ferrando-Bernal, M; Adamski, N; Broomandkhoshbacht, N; Cheronet, O; Culleton, BJ; Fernandes, D; Lawson, AM; Mah, M; Oppenheimer, J; Stewardson, K; Zhang, Z; Arenas, JMJ; Moyano, IJT; Salazar-Garcia, DC; Castanyer, P; Santos, M; Tremoleda, J; Lozano, M; Borja, PG; Fernandez-Eraso, J; Mujika-Alustiza, JA; Barroso, C; Bermudez, FJ; Minguez, EV; Burch, J; Coromina, N; Vivo, D; Cebria, A; Fullola, JM; Garcia-Puchol, O; Morales, JI; Oms, FX; Majo, T; Verges, JM; Diaz-Carvajal, A; Ollich-Castanyer, I; Lopez-Cachero, FJ; Silva, AM; Alonso-Fernandez, C; De Castro, GD; Echevarria, JJ; Moreno-Marquez, A; Berlanga, GP; Ramos-Garcia, P; Munoz, JR; Vila, EV; Arzo, GA; Arroyo, AE; Lillios, KT; Mack, J; Velasco-Vazquez, J; Waterman, A; Enrich, LBDL; Sanchez, MB; Agusti, B; Codina, F; De Prado, G; Estalrrich, A; Flores, AF; Finlayson, C; Finlayson, G; Finlayson, S; Giles-Guzman, F; Rosas, A; Gonzalez, VB; Atienzar, GG; Perez, MSH; Llanos, A; Marco, YC; Beneyto, IC; Lopez-Serrano, D; Tormo, MS; Valera, AC; Blasco, C; Liesau, C; Rios, P; Daura, J; Micho, MJD; Diez-Castillo, AA; Fernandez, RF; Farre, JF; Garrido-Pena, R; Goncalves, VS; Guerra-Doce, E; Herrero-Corral, AM; Juan-Cabanilles, J; Lopez-Reyes, D; McClure, SB; Perez, MM; Foix, AO; Borras, MS; Sousa, AC; Encinas, JMV; Kennett, DJ; Richards, MB; Alt, KW; Haak, W; Pinhasi, R; Lalueza-Fox, C; Reich, D				Olalde, Inigo; Mallick, Swapan; Patterson, Nick; Rohland, Nadin; Villalba-Mouco, Vanessa; Silva, Marina; Dulias, Katharina; Edwards, Ceiridwen J.; Gandini, Francesca; Pala, Maria; Soares, Pedro; Ferrando-Bernal, Manuel; Adamski, Nicole; Broomandkhoshbacht, Nasreen; Cheronet, Olivia; Culleton, Brendan J.; Fernandes, Daniel; Lawson, Ann Marie; Mah, Matthew; Oppenheimer, Jonas; Stewardson, Kristin; Zhang, Zhao; Arenas, Juan Manuel Jimenez; Moyano, Isidro Jorge Toro; Salazar-Garcia, Domingo C.; Castanyer, Pere; Santos, Marta; Tremoleda, Joaquim; Lozano, Marina; Borja, Pablo Garcia; Fernandez-Eraso, Javier; Mujika-Alustiza, Jose Antonio; Barroso, Cecilio; Bermudez, Francisco J.; Minguez, Enrique Viguera; Burch, Josep; Coromina, Neus; Vivo, David; Cebria, Artur; Fullola, Josep Maria; Garcia-Puchol, Oreto; Morales, Juan Ignacio; Oms, F. Xavier; Majo, Tona; Verges, Josep Maria; Diaz-Carvajal, Antonia; Ollich-Castanyer, Imma; Lopez-Cachero, F. Javier; Silva, Ana Maria; Alonso-Fernandez, Carmen; De Castro, German Delibes; Echevarria, Javier Jimenez; Moreno-Marquez, Adolfo; Berlanga, Guillermo Pascual; Ramos-Garcia, Pablo; Munoz, Jose Ramos; Vila, Eduardo Vijande; Arzo, Gustau Aguilella; Arroyo, Angel Esparza; Lillios, Katina T.; Mack, Jennifer; Velasco-Vazquez, Javier; Waterman, Anna; Enrich, Luis Benitez De Lugo; Sanchez, Maria Benito; Agusti, Bibiana; Codina, Ferran; De Prado, Gabriel; Estalrrich, Almudena; Flores, Alvaro Fernandez; Finlayson, Clive; Finlayson, Geraldine; Finlayson, Stewart; Giles-Guzman, Francisco; Rosas, Antonio; Gonzalez, Virginia Barciela; Atienzar, Gabriel Garcia; Perez, Mauro S. Hernandez; Llanos, Armando; Marco, Yolanda Carrion; Beneyto, Isabel Collado; Lopez-Serrano, David; Tormo, Mario Sanz; Valera, Antonio C.; Blasco, Concepcion; Liesau, Corina; Rios, Patricia; Daura, Joan; de Pedro Micho, Maria Jesus; Diez-Castillo, Agustin A.; Fernandez, Raul Flores; Farre, Joan Frances; Garrido-Pena, Rafael; Goncalves, Victor S.; Guerra-Doce, Elisa; Herrero-Corral, Ana Mercedes; Juan-Cabanilles, Joaquim; Lopez-Reyes, Daniel; McClure, Sarah B.; Perez, Marta Merino; Foix, Arturo Oliver; Borras, Montserrat Sanz; Sousa, Ana Catarina; Encinas, Julio Manuel Vidal; Kennett, Douglas J.; Richards, Martin B.; Alt, Kurt Werner; Haak, Wolfgang; Pinhasi, Ron; Lalueza-Fox, Carles; Reich, David			The genomic history of the Iberian Peninsula over the past 8000 years	SCIENCE			English	Article							CUEVA DEL ANGEL; BRONZE-AGE; EARLY FARMERS; POPULATION-STRUCTURE; COLLECTIVE BURIALS; ANCIENT BONES; ADMIXTURE; EUROPE; SOUTH; MIGRATION	We assembled genome-wide data from 271 ancient Iberians, of whom 176 are from the largely unsampled period after 2000 BCE, thereby providing a high-resolution time transect of the Iberian Peninsula. We document high genetic substructure between northwestern and southeastern hunter-gatherers before the spread of farming. We reveal sporadic contacts between Iberia and North Africa by similar to 2500 BCE and, by similar to 2000 BCE, the replacement of 40% of Iberia's ancestry and nearly 100% of its Y-chromosomes by people with Steppe ancestry. We show that, in the Iron Age, Steppe ancestry had spread not only into Indo-European-speaking regions but also into non-Indo-European-speaking ones, and we reveal that present-day Basques are best described as a typical Iron Age population without the admixture events that later affected the rest of Iberia. Additionally, we document how, beginning at least in the Roman period, the ancestry of the peninsula was transformed by gene flow from North Africa and the eastern Mediterranean.	[Olalde, Inigo; Mallick, Swapan; Rohland, Nadin; Adamski, Nicole; Broomandkhoshbacht, Nasreen; Lawson, Ann Marie; Mah, Matthew; Oppenheimer, Jonas; Stewardson, Kristin; Zhang, Zhao; Reich, David] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Mallick, Swapan; Patterson, Nick; Mah, Matthew; Reich, David] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Mallick, Swapan; Adamski, Nicole; Broomandkhoshbacht, Nasreen; Lawson, Ann Marie; Mah, Matthew; Oppenheimer, Jonas; Stewardson, Kristin; Reich, David] Harvard Med Sch, Howard Hughes Med Inst, Boston, MA 02115 USA; [Villalba-Mouco, Vanessa; Haak, Wolfgang] Max Planck Inst Sci Human Hist, Jena, Germany; [Villalba-Mouco, Vanessa] Univ Zaragoza, Inst Invest Ciencias Ambientales IUCA, Grp Primeros Pobladores Valle Ebro PPVE, Dept Ciencias Antiguedad, Zaragoza, Spain; [Silva, Marina; Dulias, Katharina; Edwards, Ceiridwen J.; Gandini, Francesca; Pala, Maria; Richards, Martin B.] Univ Huddersfield, Sch Appl Sci, Dept Biol & Geog Sci, Huddersfield, W Yorkshire, England; [Soares, Pedro] Univ Minho, Dept Biol, Ctr Mol & Environm Biol, Braga, Portugal; [Ferrando-Bernal, Manuel; Lalueza-Fox, Carles] Univ Pompeu Fabra, CSIC, Inst Evolutionary Biol, Barcelona, Spain; [Cheronet, Olivia; Fernandes, Daniel; Pinhasi, Ron] Univ Vienna, Dept Evolutionary Anthropol, Vienna, Austria; [Culleton, Brendan J.; Kennett, Douglas J.] Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA; [Culleton, Brendan J.; Kennett, Douglas J.] Penn State Univ, Inst Energy, University Pk, PA 16802 USA; [Culleton, Brendan J.; Kennett, Douglas J.] Penn State Univ, Inst Environm, University Pk, PA 16802 USA; [Fernandes, Daniel] Univ Coimbra, Dept Life Sci, Res Ctr Anthropol & Hlth, Coimbra, Portugal; [Arenas, Juan Manuel Jimenez] Univ Granada, Dept Prehist & Arqueol, Granada, Spain; [Arenas, Juan Manuel Jimenez] Univ Granada, Inst Univ Paz & Conflictos, Granada, Spain; [Arenas, Juan Manuel Jimenez] Univ Zurich, Dept Anthropol, Anthropol Inst & Museum, Zurich, Switzerland; [Moyano, Isidro Jorge Toro] Museo Arqueol & Etnol Granada, Granada, Spain; [Salazar-Garcia, Domingo C.] Univ Basque Country, Ikerbasque, Basque Fdn Sci, Dept Geog Prehist & Arqueol,Grp Invest Prehist, Vitoria, Spain; [Castanyer, Pere; Santos, Marta; Tremoleda, Joaquim] Museu Arqueol Catalunya Empuries, Lescala, Spain; [Lozano, Marina; Verges, Josep Maria] Inst Catala Paleoecol Humana & Evolucio Social IP, Tarragona, Spain; [Lozano, Marina; Verges, Josep Maria] Univ Rovira & Virgili, Area Prehist, Tarragona, Spain; [Borja, Pablo Garcia] Univ Nacl Educ Distancia, Dept Prehist & Hist Antigua, Valencia, Spain; [Fernandez-Eraso, Javier; Mujika-Alustiza, Jose Antonio] Univ Basque Country, Dept Geog Prehist & Arqueol, Vitoria, Spain; [Barroso, Cecilio; Bermudez, Francisco J.] Fdn Inst Invest Prehist & Evoluc Humana FIPEH, Lucena, Spain; [Minguez, Enrique Viguera] Univ Malaga, Fac Ciencias, Area Genet, Malaga, Spain; [Burch, Josep; Coromina, Neus; Vivo, David] Univ Girona, Inst Recerca Hist, Girona, Spain; [Cebria, Artur; Fullola, Josep Maria; Morales, Juan Ignacio; Oms, F. Xavier; Lopez-Cachero, F. Javier; Daura, Joan; Borras, Montserrat Sanz] Univ Barcelona, Fac Geog & Hist, Dept Hist & Arqueol, SERP, Barcelona, Spain; [Garcia-Puchol, Oreto] Univ Valencia, Dept Prehist Arqueol & Hist Antiga, PREMEDOC Res Grp, Valencia, Spain; [Majo, Tona] Univ Autonoma Barcelona, Dept Prehist, Archaeom, Cerdanyola Del Valles, Spain; [Diaz-Carvajal, Antonia; Ollich-Castanyer, Imma] Univ Barcelona, GRAMP, Museu Arqueol Esquerda, Roda De Ter, Spain; [Silva, Ana Maria] Univ Coimbra, Dept Life Sci, Res Ctr Anthropol & Hlth, Lab Prehist, Coimbra, Portugal; [Silva, Ana Maria; Goncalves, Victor S.; Sousa, Ana Catarina] Univ Lisbon, Fac Letras, UNIARQ, Lisbon, Portugal; [Silva, Ana Maria] Univ Coimbra, Dept Life Sci, CEF, Coimbra, Portugal; [Alonso-Fernandez, Carmen; Echevarria, Javier Jimenez] Cronos SC Arqueol & Patrimonio, Burgos, Spain; [De Castro, German Delibes; Guerra-Doce, Elisa] Univ Valladolid, Fac Filosofia & Letras, Dept Prehist, Valladolid, Spain; [Moreno-Marquez, Adolfo; Munoz, Jose Ramos; Vila, Eduardo Vijande] Univ Cadiz, Dept Hist Geog & Filosofia, Cadiz, Spain; [Moreno-Marquez, Adolfo] Univ Almeria, Dept Geog Hist & Humanidades, Almeria, Spain; [Ramos-Garcia, Pablo] Univ Granada, Sch Dent, Granada, Spain; [Arzo, Gustau Aguilella; Foix, Arturo Oliver] Serv Invest Arqueol & Prehist Diputac Castellon, Castellon de La Plana, Spain; [Arroyo, Angel Esparza] Univ Salamanca, Dept Prehist Hist Antigua & Arqueol, GIR PrehUSAL, Salamanca, Spain; [Lillios, Katina T.] Univ Iowa, Dept Anthropol, Iowa City, IA USA; [Mack, Jennifer] Univ Iowa, Off State Archaeologist, Iowa City, IA USA; [Velasco-Vazquez, Javier] Univ Las Palmas Gran Canaria, Dept Ciencias Hist, Las Palmas Gran Canaria, Spain; [Waterman, Anna] Mt Mercy Univ, Cedar Rapids, IA USA; [Enrich, Luis Benitez De Lugo; Blasco, Concepcion; Liesau, Corina; Rios, Patricia; Garrido-Pena, Rafael] Univ Autonoma Madrid, Dept Prehist & Arqueol, Madrid, Spain; [Enrich, Luis Benitez De Lugo] Univ Nacl Educ Distancia, Dept Prehist & Arqueol, Madrid, Spain; [Sanchez, Maria Benito] Univ Complutense Madrid, Dept Med Legal Psiquiatria & Anat Patol, Madrid, Spain; [Agusti, Bibiana] INSITU SCP, Centelles, Spain; [Agusti, Bibiana; Codina, Ferran; De Prado, Gabriel] Museu Arqueol Catalunya Ullastret, Ullastret, Spain; [Estalrrich, Almudena] Univ Cantabria, IIIPC, Santander, Spain; [Flores, Alvaro Fernandez] Arqueol & Gest SLL, Fuentes De Andalucia, Spain; [Finlayson, Clive; Finlayson, Geraldine; Finlayson, Stewart; Giles-Guzman, Francisco] Gibraltar Natl Museum, Gibraltar, Gibraltar; [Finlayson, Clive] Univ Toronto, Dept Anthropol, Toronto, ON, Canada; [Finlayson, Clive; Finlayson, Geraldine] Liverpool John Moores Univ, Sch Nat Sci & Psychol, Liverpool, Merseyside, England; [Finlayson, Clive; Finlayson, Geraldine] Univ Gibraltar, Inst Life & Earth Sci, Gibraltar, Gibraltar; [Finlayson, Stewart] Anglia Ruskin Univ, Dept Life Sci, Cambridge, England; [Rosas, Antonio] CSIC, MNCN, Dept Paleobiol, Paleoanthropol Grp, Madrid, Spain; [Gonzalez, Virginia Barciela; Atienzar, Gabriel Garcia; Perez, Mauro S. Hernandez] Univ Alicante, Fac Filosofia & Letras, Dept Prehist Arqueol & Historia Antigua, San Vicente Del Raspeig, Spain; [Gonzalez, Virginia Barciela; Atienzar, Gabriel Garcia; Perez, Mauro S. Hernandez] Inst Univ Invest Arqueol & Patrimonio Hist INAPH, San Vicente Del Raspeig, Spain; [Llanos, Armando] Inst Alaves Arqueol, Vitoria, Spain; [Marco, Yolanda Carrion] Univ Valencia, Dept Prehist Arqueol & Hist Antiga, Valencia, Spain; [Beneyto, Isabel Collado] Museu Arqueol Vicent Casanova, Bocairent, Spain; [Lopez-Serrano, David] Treballs Arqueol SL, Estrats, El Campello, Spain; [Valera, Antonio C.] Era Arqueol, Oeiras, Portugal; [de Pedro Micho, Maria Jesus] Museu Prehist Valencia, Valencia, Spain; [Diez-Castillo, Agustin A.] Univ Valencia, Dept Prehist Arqueol & Hist Antiga, GRAM Res Grp, Valencia, Spain; [Farre, Joan Frances] Museu & Poblat Iber Ca nOliver, Cerdanyola Del Valles, Spain; [Herrero-Corral, Ana Mercedes] Univ Complutense Madrid, Dept Prehist, Madrid, Spain; [Juan-Cabanilles, Joaquim] Museu Prehist SIP, Diputacio Valencia, Valencia, Spain; [Lopez-Reyes, Daniel] Arqueovitis Sccl, Avinyonet Del Penedes, Spain; [McClure, Sarah B.; Kennett, Douglas J.] Univ Calif Santa Barbara, Dept Anthropol, Santa Barbara, CA 93106 USA; [Perez, Marta Merino] Univ Barcelona, Fac Biol, Dept Biol Anim, Unitat Antropol Fis, Barcelona, Spain; [Encinas, Julio Manuel Vidal] Junta Castilla & Leon, Serv Cultura Leon, Leon, Spain; [Alt, Kurt Werner] Danube Private Univ, Ctr Nat & Cultural Human Hist, Krems, Austria; [Alt, Kurt Werner] Basel Univ, Dept Biomed Engn & Integrat Prehist & Archaeol Sc, Basel, Switzerland; [Haak, Wolfgang] Univ Adelaide, Sch Biol Sci, Adelaide, SA, Australia	Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; University of Zaragoza; University of Huddersfield; Universidade do Minho; Consejo Superior de Investigaciones Cientificas (CSIC); Pompeu Fabra University; University of Vienna; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Universidade de Coimbra; University of Granada; University of Granada; University of Zurich; Basque Foundation for Science; University of Basque Country; Universitat Rovira i Virgili; Catalan Institute of Human Paleo-Ecology & Social Evolution (IPHES); Universitat Rovira i Virgili; Universidad Nacional de Educacion a Distancia (UNED); University of Basque Country; Universidad de Malaga; Universitat de Girona; University of Barcelona; University of Valencia; Autonomous University of Barcelona; University of Barcelona; Universidade de Coimbra; Universidade de Lisboa; Universidade de Coimbra; Universidad de Valladolid; Universidad de Cadiz; Universidad de Almeria; University of Granada; University of Salamanca; University of Iowa; University of Iowa; Universidad de Las Palmas de Gran Canaria; Autonomous University of Madrid; Universidad Nacional de Educacion a Distancia (UNED); Complutense University of Madrid; Universidad de Cantabria; Instituto Internacional de Investigaciones Prehistoricas de Cantabria (IIIPC); University of Toronto; Liverpool John Moores University; Anglia Ruskin University; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat d'Alacant; University of Valencia; University of Valencia; Complutense University of Madrid; University of California System; University of California Santa Barbara; University of Barcelona; University of Adelaide	Olalde, I; Reich, D (corresponding author), Harvard Med Sch, Dept Genet, Boston, MA 02115 USA.; Reich, D (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Reich, D (corresponding author), Harvard Med Sch, Howard Hughes Med Inst, Boston, MA 02115 USA.; Lalueza-Fox, C (corresponding author), Univ Pompeu Fabra, CSIC, Inst Evolutionary Biol, Barcelona, Spain.	inigo_olalde@hms.harvard.edu; carles.lalueza@upf.edu; reich@genetics.med.harvard.edu	Soares, Pedro A/G-9422-2011; Morales, Juan/C-2603-2014; Rosas, Antonio/D-9742-2016; Gandini, Francesca/H-8936-2015; Silva, Marina/AAB-6829-2019; Vivo, David/Z-5475-2019; SANZ, MONTSERRAT/AAP-8912-2020; Daura, Joan/C-9827-2016; Fullola, José Maria/U-7904-2019; castanyer, pere/Z-5456-2019; Sanz, Montserrat/I-5549-2017; Valera, António Carlos/AFP-3642-2022; Aguilella, Gustau/ABG-7851-2020; TREMOLEDA, JOAQUIM/Z-5444-2019; Morales, Juan Ignacio/Z-1593-2019; Vijande, Eduardo/AAL-7995-2020; De Freitas Alves B Sousa, Ana Catarina/M-8102-2019; García-Atiénzar, Gabriel/O-3457-2017; Castillo, Agustin Diez/L-6336-2015; Burch, Josep/E-9490-2016; Estalrrich, Almudena/ABF-1891-2020; Olalde, Iñigo/N-6928-2018; Ramos-Garcia, Pablo/N-1735-2019; Mínguez, Enrique Viguera/H-4416-2015; Guerra-Doce, Elisa/P-3332-2019; Marco, Yolanda Carrión/I-3218-2017; Villalba-Mouco, Vanessa/AAA-5724-2022; Puchol, Oreto Garcia/I-2040-2012; Pinhasi, Ron/AAT-1531-2020; Cachero, F. Javier López/K-6561-2017; LALUEZA-FOX, CARLES/AAG-5341-2020; Haak, Wolfgang/Z-4947-2019; Serrano, David López/AAH-2637-2021; Herrero-Corral, Ana Mercedes/I-3756-2015; Barciela González, Virginia/HCH-2035-2022; Benitez de Lugo Enrich, Luis/R-5521-2016; Salazar-García, Domingo C./AAB-1115-2019; Berlanga, Guillermo Pascual/AAT-8112-2021; Moreno-Márquez, Adolfo/N-8416-2019; Silva, Ana Maria/E-6281-2015; Jimenez-Arenas, Juan Manuel/AFP-5493-2022; Ramos-Muñoz, José/AAL-6596-2020; Oms Arias, F. Xavier/E-5156-2015; GARRIDO PENA, RAFAEL/E-8788-2013	Soares, Pedro A/0000-0002-2807-690X; Morales, Juan/0000-0002-8253-414X; Rosas, Antonio/0000-0002-5829-9952; Gandini, Francesca/0000-0001-8930-8295; Silva, Marina/0000-0002-3756-0920; Vivo, David/0000-0003-2254-2292; SANZ, MONTSERRAT/0000-0002-2263-0121; Daura, Joan/0000-0002-8364-3655; Fullola, José Maria/0000-0001-7089-1425; castanyer, pere/0000-0001-5080-3571; Sanz, Montserrat/0000-0002-2263-0121; Valera, António Carlos/0000-0001-5492-3810; Aguilella, Gustau/0000-0002-5197-8274; Morales, Juan Ignacio/0000-0002-8253-414X; Vijande, Eduardo/0000-0002-7591-5112; De Freitas Alves B Sousa, Ana Catarina/0000-0003-2709-3967; García-Atiénzar, Gabriel/0000-0001-9390-8111; Castillo, Agustin Diez/0000-0001-9122-2941; Burch, Josep/0000-0003-4306-6678; Estalrrich, Almudena/0000-0003-2295-5396; Olalde, Iñigo/0000-0002-2660-6807; Ramos-Garcia, Pablo/0000-0001-6942-7772; Mínguez, Enrique Viguera/0000-0001-5475-3807; Guerra-Doce, Elisa/0000-0002-8411-5133; Marco, Yolanda Carrión/0000-0003-4064-249X; Puchol, Oreto Garcia/0000-0001-9716-6039; Pinhasi, Ron/0000-0003-1629-8131; Cachero, F. Javier López/0000-0002-3121-4015; LALUEZA-FOX, CARLES/0000-0002-1730-5914; Haak, Wolfgang/0000-0003-2475-2007; Herrero-Corral, Ana Mercedes/0000-0003-3536-1108; Benitez de Lugo Enrich, Luis/0000-0003-2000-6293; Berlanga, Guillermo Pascual/0000-0001-5567-5142; Moreno-Márquez, Adolfo/0000-0001-7061-2131; Silva, Ana Maria/0000-0002-1912-6581; Jimenez-Arenas, Juan Manuel/0000-0002-4165-0187; Ramos-Muñoz, José/0000-0002-6042-2446; Salazar-Garcia, Domingo C./0000-0002-8017-0194; Alonso-Fernandez, Carmen/0000-0002-8930-9148; Lawson, Ann Marie/0000-0003-0990-2329; Velasco-Vazquez, Javier/0000-0003-0339-3500; Broomandkhoshbacht, Nasreen/0000-0001-5350-1608; Bermudez Miranda, Francisco Jose/0000-0001-8758-9177; Oppenheimer, Jonas/0000-0001-7973-6173; Dulias, Katharina/0000-0002-3938-6663; Edwards, Ceiridwen Jane/0000-0001-9126-1377; Oms Arias, F. Xavier/0000-0002-1642-548X; BARCIELA, VIRGINIA/0000-0002-9623-8982; Waterman, Anna/0000-0002-5321-2539; Goldberg Oppenheimer, Pola/0000-0002-1014-4724; Giles Guzman, Francisco Jose/0000-0002-8092-7302; mallick, swapan/0000-0002-4531-4439; M Fernandes, Daniel/0000-0002-7434-6552; GARRIDO PENA, RAFAEL/0000-0001-8263-2949; Ferrando-Bernal, Manuel/0000-0003-4129-6242	Generalitat de Catalunya, AGAUR agency [HAR2017-86509-P, HAR2017-87695-P, SGR2017-11]; Obra Social La Caixa; FEDER-MINECO [BFU2015-64699-P]; Plan Nacional I+ D+ I, MINECO [REDISCO-HAR2017-88035-P]; MINECO [HAR2016-77600-P, HAR2009-10105, HAR2013-43851-P]; NSF [BCS-1460367, BCS-1153568]; Gobierno Vasco [IT622-13]; Diputacion Foral de Alava; Diputacion Foral de Gipuzkoa; Portuguese Foundation for Science and Technology [PTDC/EPH-ARQ/4164/2014]; FEDER-COMPETE 2020 project [016899]; FCT Investigator Program [IF/01641/2013]; FCT IP; ERDF (COMPETE2020 -POCI); Leverhulme Trust Doctoral Scholarship; Allen Discovery Center grant from the Paul Allen Foundation; NIH [GM100233]; Howard Hughes Medical Institute; Max Planck Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100233] Funding Source: NIH RePORTER	Generalitat de Catalunya, AGAUR agency; Obra Social La Caixa(La Caixa Foundation); FEDER-MINECO(Spanish Government); Plan Nacional I+ D+ I, MINECO; MINECO(Spanish Government); NSF(National Science Foundation (NSF)); Gobierno Vasco(Basque Government); Diputacion Foral de Alava; Diputacion Foral de Gipuzkoa; Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); FEDER-COMPETE 2020 project; FCT Investigator Program(Portuguese Foundation for Science and Technology); FCT IP(Portuguese Foundation for Science and Technology); ERDF (COMPETE2020 -POCI); Leverhulme Trust Doctoral Scholarship(Leverhulme Trust); Allen Discovery Center grant from the Paul Allen Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Max Planck Society(Max Planck SocietyFoundation CELLEX); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	J.M.F., F.J.L.-C., J.I.M., F.X.O., J.D., and M.S.B. were supported by HAR2017-86509-P, HAR2017-87695-P, and SGR2017-11 from the Generalitat de Catalunya, AGAUR agency. C.L.-F. was supported by Obra Social La Caixa and by FEDER-MINECO (BFU2015-64699-P). L.B.d.L.E. was supported by REDISCO-HAR2017-88035-P (Plan Nacional I+ D+ I, MINECO). C.L., P. R., and C. Bl. were supported by MINECO (HAR2016-77600-P). A. Esp., J.V.-V., G.D., and D.C.S.-G. were supported by MINECO (HAR2009-10105 and HAR2013-43851-P). D.J.K. and B.J.C. were supported by NSF BCS-1460367. K.T.L., A.W., and J.M. were supported by NSF BCS-1153568. J.F.-E. and J.A.M.-A. were supported by IT622-13 Gobierno Vasco, Diputacion Foral de Alava, and Diputacion Foral de Gipuzkoa. We acknowledge support from the Portuguese Foundation for Science and Technology (PTDC/EPH-ARQ/4164/2014) and the FEDER-COMPETE 2020 project 016899. P.S. was supported by the FCT Investigator Program (IF/01641/2013), FCT IP, and ERDF (COMPETE2020 -POCI). M.Si. and K.D. were supported by a Leverhulme Trust Doctoral Scholarship awarded to M.B.R. and M.P. D.R. was supported by an Allen Discovery Center grant from the Paul Allen Foundation, NIH grant GM100233, and the Howard Hughes Medical Institute. V.V.-M. and W.H. were supported by the Max Planck Society.	Aguilella Arzo G., 2014, COVA DELS DIABLETS A; Aguilera A. Rodriguez, 2002, ANU ARQUEOL ANDALUCI, V1999, P292; Aguilera A. Rodriguez, 2001, BIBATAUBIN REV PATRI, V2, P33; Allentoft ME, 2015, NATURE, V522, P167, DOI 10.1038/nature14507; Almagro-Basch M., 1951, AMPURIAS HIST CIUDAD; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Alvarez H. J., 2013, REV ESPANOLA ANTROPO, V34, P6; [Anonymous], 3 MONOGR FOIX; [Anonymous], 2008, REV ATL NTICA MEDITE, DOI [10.25267/Rev_atl-mediterr_prehist_arqueol_soc.2008.v10.02, DOI 10.25267/REV_ATL-MEDITERR_PREHIST_ARQUEOL_SOC.2008.V10.02]; Arroyo A. Esparza, 2012, ZEPHYRUS SALAMANCA, VLXIX, P95; Arzo G. Aguilella, 2009, QUADERNS PREHISTRIA, V27, P29; Barandiaran Maestu I., 1971, MUNIBE, V2/3, P255; Barreiro M. J. S., 2003, CRONOLOGIA RADIOMETR, V19; Ruiz CB, 2011, QUATERN INT, V243, P105, DOI 10.1016/j.quaint.2011.02.021; Behar DM, 2012, AM J HUM GENET, V90, P675, DOI 10.1016/j.ajhg.2012.03.002; Benitez de Lugo Enrich L., 2015, MENGA REV PREHIST AN, V6, P112; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Bierling M.R., 2002, PHOENICIANS SPAIN AR; Blasco C., 2005, CAMPANIFORME PENINSU; Borja P. Garcia, 2013, NAIXEMENT POBLE HIST, P47; Borja P. Garcia, 2016, RECERQUES MUSEU ALCO, V25, P31; Bosch J. M. Verges i, 2016, BUTLLETI ARQUEOL R S, V38-39, P17; Briggs AW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1163; Broushaki F, 2016, SCIENCE, V353, P499, DOI 10.1126/science.aaf7943; Burch J., 2006, EXCAVACIONS ARQUEOLO; Busing FMTA, 1999, STAT COMPUT, V9, P3, DOI 10.1023/A:1008800423698; Bycroft C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08272-w; Canyellas J., 1996, QUAD VILANIU, V29, P27; CARLUS X., 2007, CABANES SITGES TOMBE, V4, P137; Cassidy LM, 2016, P NATL ACAD SCI USA, V113, P368, DOI 10.1073/pnas.1518445113; Castanyer I. Ollich i, 2012, MONOGRAFIES OLERDOLA, P275; Castatios P., 1980, EXCAVACIONES ARQUEOL, V116, P65; da Silva C. T., 2009, ESTUDOS ARQUEOLOGICO, V17, P389; da Silva C. T., 1981, PREHISTORIA AREA SIN; Dabney J, 2013, P NATL ACAD SCI USA, V110, P15758, DOI 10.1073/pnas.1314445110; Daley T, 2013, NAT METHODS, V10, P325, DOI 10.1038/nmeth.2375; Daura J, 2010, J HUM EVOL, V59, P109, DOI 10.1016/j.jhevol.2010.04.009; Daura J, 2017, TRABAJOS PREHIST, V74, P149, DOI 10.3989/tp.2017.12188; de Castro G. Delibes, 1978, TRABAJOS PREHIST, V35, P225; Enrich LBD, 2018, SPAL, V27, P61, DOI 10.12795/spal.2018i27.03; Enrich LBD, 2014, TRABAJOS PREHIST, V71, P76, DOI 10.3989/tp.2014.12125; DELIBES G., 1990, B SEMINARIO ESTUDIOS, VLVI, P64; DeLigt L, 2016, STUD GLOB MIGR HIST, P1; Delvene G., 2018, YACIMIENTOS PALEONTO, P31; Castillo AD, 2017, VIRTUAL ARCHAEOL REV, V8, P75, DOI 10.4995/var.2017.7028; Domingo L, 2015, PALAEOGEOGR PALAEOCL, V440, P417, DOI 10.1016/j.palaeo.2015.09.017; Esparza A., 2012, COGOTAS 1 CULTURA ED, P259; Falgueres C, 2019, QUAT GEOCHRONOL, V49, P297, DOI 10.1016/j.quageo.2018.02.003; Fernandez Flores A, 2014, NECROPOLIS EPOCA TAR; Fernandez-Crespo T, 2016, TRABAJOS PREHIST, V73, P325, DOI 10.3989/tp.2016.12177; Fernandez-Eraso J, 2015, QUATERN INT, V364, P162, DOI 10.1016/j.quaint.2014.09.070; Foix A. Oliver, 1994, POBLADO IBERICO PUIG; Fortea J., 1987, 1 COMMUNAUTES PAYSAN, P599; Fregel R, 2018, P NATL ACAD SCI USA, V115, P6774, DOI 10.1073/pnas.1800851115; Fu QM, 2016, NATURE, V534, P200, DOI 10.1038/nature17993; Fu Q, 2015, NATURE, V524, P216, DOI 10.1038/nature14558; Fu QM, 2014, NATURE, V514, P445, DOI 10.1038/nature13810; Fu QM, 2013, CURR BIOL, V23, P553, DOI 10.1016/j.cub.2013.02.044; Gallay G., 1973, MONUMENTO PREHISTORI; Gamba C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6257; Gansauge MT, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx033; Gansauge MT, 2013, NAT PROTOC, V8, P737, DOI 10.1038/nprot.2013.038; Garcia J. J. Alvarez, 2003, ANUARIO ARQUEOLOGICO, V1, P429; Garcia M. T. Bonet, 2010, ANU ARQUEOL ANDALUCI, V6, P1715; Puchol OG, 2015, SAGVNTVM-PAPELES LAB, V47, P251, DOI 10.7203/SAGVNTVM.47.7195; Garcia-Puchol O, 2018, QUATERN INT, V472, P259, DOI 10.1016/j.quaint.2016.10.037; Garcia-Sanchez M., 1960, TRABAJOS I BERNARDIN, V15, P19; Gerber JS, 1992, JEWS SPAIN HIST SEPH; Gil P. A. A., 2014, THESIS; Giles F., 2001, B SEDECK, V2, P86; Guzman FJG, 2017, SAGVNTVM-PAPELES LAB, V49, P29, DOI 10.7203/SAGVNTVM.49.10658; Gomes A. Ribera, 2005, RECER MUS ALCOI, V14, P27; Gomez M. Hoyos, 1980, ESTUDIO GEOLOGICO SE, P23; Gonzalez F. Molina, 2014, REV ATLANTICO MEDITE, V16, P121; Gonzalez Fortes G, 2017, CURR BIOL, V27, P1801, DOI 10.1016/j.cub.2017.05.023; Guiry EJ, 2016, ANTIQUITY, V90, P604, DOI 10.15184/aqy.2016.34; Gunther T, 2015, P NATL ACAD SCI USA, V112, P11917, DOI 10.1073/pnas.1509851112; Guzman F. G., 2017, ACT 1 C INT HIST SER, P323; Haak W, 2015, NATURE, V522, P207, DOI 10.1038/nature14317; Haber M, 2017, AM J HUM GENET, V101, P274, DOI 10.1016/j.ajhg.2017.06.013; Hedges R.E., 1994, ARCHAEOMETRY, V36, P337, DOI DOI 10.1111/J.1475-4754.1994.TB00975.X; Hernandez Perez M. S, 2016, CABEZO REDONDO VILLE; Hernandez-Pacheco E., 1923, VIDA NUESTROS ANTECE; Hofmanova Z, 2016, P NATL ACAD SCI USA, V113, P6886, DOI 10.1073/pnas.1523951113; Hoyos M., 1994, GIBRALTAR DUR QUAT A, V2, P36; Jones ER, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9912; Jorda G. Perez, 2011, SER TRAB VAR SIP, V113, P247; Keller A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1701; Kennett DJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14115; Kilinc GM, 2016, CURR BIOL, V26, P2659, DOI 10.1016/j.cub.2016.07.057; Kircher M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr771; Korlevic P, 2015, BIOTECHNIQUES, V59, P87, DOI 10.2144/000114320; Korneliussen TS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0356-4; Kuhn JMM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195491; Lazaridis I, 2017, NATURE, V548, P214, DOI 10.1038/nature23310; Lazaridis I, 2016, NATURE, V536, P419, DOI 10.1038/nature19310; Lazaridis I, 2014, NATURE, V513, P409, DOI 10.1038/nature13673; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liesau C., 2012, MARFIL ELEFANTES PEN, P87; Lipson M, 2017, NATURE, V551, P368, DOI 10.1038/nature24476; Lizana M. Ramos, 1990, ANU ARQUEOL ANDALUCI, V1996, P258; Pol JL, 2008, ARCH ESPAN ARQUEOL, V81, P289; Llorente MG, 2015, SCIENCE, V350, P820, DOI 10.1126/science.aad2879; Lohse JC, 2014, QUATERNARY SCI REV, V102, P14, DOI 10.1016/j.quascirev.2014.07.021; LONGIN R, 1971, NATURE, V230, P241, DOI 10.1038/230241a0; MacHugh DE., 2000, ANCIENT BIOMOLECULES, V3, P81; Mallick S, 2016, NATURE, V538, P201, DOI 10.1038/nature18964; Martiniano R, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006852; Mathieson I, 2018, NATURE, V555, P197, DOI 10.1038/nature25778; Mathieson I, 2015, NATURE, V528, P499, DOI 10.1038/nature16152; Mestres J. S., 2013, MEMORIA EXCAVACIONS; Micho M. J. de Pedro, 2015, VIVIR JUNTO TURIA HA; Moigne AM, 2016, QUATERN INT, V409, P195, DOI 10.1016/j.quaint.2015.06.059; Montero Ruiz I., 2014, ZEPHYRUS, VLXXIII, P109; Mota R. Benitez, 1995, ANUARIO ARQUEOLOGICO, V1992, P90; Moyano I. Toro, 1987, ANU ARQUEOL ANDALUCI, V1985, P143; Mujika-Alustiza J. A., 2011, 1 AGR GANADEROS GIPU; Navarrete M. I. Martinez, 1980, CUEVA PALOMA SOTO RE, P115; Nunez C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155342; Olalde I, 2018, NATURE, V555, P190, DOI 10.1038/nature25738; Olalde I, 2015, MOL BIOL EVOL, V32, P3132, DOI 10.1093/molbev/msv181; Olalde I, 2014, NATURE, V507, P225, DOI 10.1038/nature12960; Olaria C., 2010, P 15 WORLD C INT UN, P115; Olivieri A, 2006, SCIENCE, V314, P1767, DOI 10.1126/science.1135566; Ollich I., 1995, BANDA BANDA TER HIST; Omrak A, 2016, CURR BIOL, V26, P270, DOI 10.1016/j.cub.2015.12.019; Oms F.X., 2016, JORNADES ARQUEOLOGIA, P109; Ortin T. Majo i, 1996, QUAD PREHISTORIA ARQ, V17, P339; Palma J. E. Ferrer, 1997, NECROPOLIS MEGALITIC; Palomino A. L., 1999, NUMANTIA, V7, P21; Palomo A., 2002, PIR VEINS 3 MILL AC, P275; Palomo T., 2004, TRIBUNA ARQUEOLOGIA, P77; Pardo-Gordo S, 2018, QUATERN INT, V483, P136, DOI 10.1016/j.quaint.2018.05.008; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Perez A. S., 2001, ALMORAIMA, V25, P31; Perez J. Fortea, 1973, MEM SEM PREH ARQ U S; Perez V. Pascual, 1963, ARCH PREHISTORIA LEV, V10, P39; Pericot L., 1945, ARCH PREHISTORIA LEV, V2, P39; Posth C, 2016, CURR BIOL, V26, P827, DOI 10.1016/j.cub.2016.01.037; Punzon J. M. Roman, 2014, CUAD PREHIST U GRANA, V24, P497; Punzon J. M. Roman, 2004, MUNDO FUNERARIO RURA; Raghavan M, 2014, NATURE, V505, P87, DOI 10.1038/nature12736; Rameta A. Romero, 2016, CABEZO REDONDO VILLE, P85; Ramsey C. Bronk, 2013, OXCAL 4 23 ONLINE MA; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Rodr?guez A., 2008, CYPSELA, V17, P115; Rodriguez J. M. Pena, 2016, ANU ARQUEOL ANDALUCI, V97, P309; Rodriguez-Varela R, 2017, CURR BIOL, V27, P3396, DOI 10.1016/j.cub.2017.09.059; Rohland N, 2018, NAT PROTOC, V13, DOI 10.1038/s41596-018-0050-5; Rohland N, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0624; Ruiz Zapatero G., 2014, IBERIA PROTOHISTORY, P195; Salazar-Garcia DC, 2016, RADIOCARBON, V58, P679, DOI 10.1017/RDC.2016.34; Salazar-Garcia DC, 2014, J ARCHAEOL SCI, V42, P231, DOI 10.1016/j.jas.2013.11.006; Sanchez-Polo A, 2014, EUR J ARCHAEOL, V17, P4, DOI 10.1179/1461957113Y.0000000048; Santos GM, 2004, RADIOCARBON, V46, P165, DOI 10.1017/S0033822200039485; Schiffels S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10408; Schubart H., 1975, MADRIDER FORSCHUNGEN, V9, P1; Schuenemann VJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15694; Sikora M, 2017, SCIENCE, V358, P659, DOI 10.1126/science.aao1807; Silva A., 2015, DEATH ARCHAEOLOGY TR, P245; Silva AM, 2017, INT J OSTEOARCHAEOL, V27, P515, DOI 10.1002/oa.2572; Silva A.M., 2016, BULL INT ASSOC PALEO, V10, P31; Silva A. M., 2003, ANTR BIOD ACT 12 C S, P506; Silva A. M., 2003, ANTHROPOL, VXLI, P55; Silva AM, 2002, THESIS; Skoglund P, 2017, CELL, V171, P59, DOI 10.1016/j.cell.2017.08.049; Skoglund P, 2014, SCIENCE, V344, P747, DOI 10.1126/science.1253448; SOARES J., 1998, TRABALHOS ARQUEROLOG, V10, P231; Sole-Morata N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07710-x; Spindler K., 1973, KUPFERZEITLICHE SIED; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; Szecsenyi-Nagy A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15480-9; Trombetta B, 2015, GENOME BIOL EVOL, V7, P1940, DOI 10.1093/gbe/evv118; Valdiosera C, 2018, P NATL ACAD SCI USA, V115, P3428, DOI 10.1073/pnas.1717762115; Valera A.C., 2008, APONTAMENTOS ARQUEOL, V3, P19; Valverde L, 2016, EUR J HUM GENET, V24, P437, DOI 10.1038/ejhg.2015.114; van de Loosdrecht M, 2018, SCIENCE, V360, P548, DOI 10.1126/science.aar8380; van den Brink ECM, 2017, LEVANT, V49, P105, DOI 10.1080/00758914.2017.1368204; Van Klinken GJ, 1999, J ARCHAEOL SCI, V26, P687, DOI 10.1006/jasc.1998.0385; Veeramah KR, 2018, P NATL ACAD SCI USA, V115, P3494, DOI 10.1073/pnas.1719880115; Vila EV, 2015, CR PALEVOL, V14, P147, DOI 10.1016/j.crpv.2014.11.004; Vila E. Vijande, 2009, REV ATLANTICA MEDITE, V11, P265; VOGEL JC, 1986, RADIOCARBON, V28, P935, DOI 10.1017/S0033822200060203; Waterman AJ, 2016, ARCHAEOMETRY, V58, P131, DOI 10.1111/arcm.12159; Weissensteiner H, 2016, NUCLEIC ACIDS RES, V44, pW58, DOI 10.1093/nar/gkw233; Yang DY, 1998, AM J PHYS ANTHROPOL, V105, P539, DOI 10.1002/(SICI)1096-8644(199804)105:4<539::AID-AJPA10>3.3.CO;2-2; Yang MA, 2017, CURR BIOL, V27, P3202, DOI 10.1016/j.cub.2017.09.030; Zalloua PA, 2008, AM J HUM GENET, V83, P633, DOI 10.1016/j.ajhg.2008.10.012	189	185	185	5	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 15	2019	363	6432			SI		1230	+		10.1126/science.aav4040	http://dx.doi.org/10.1126/science.aav4040			136	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP0BC	30872528	Green Published, Green Submitted, Green Accepted			2022-12-28	WOS:000461329000052
J	Lissauer, D; Wilson, A; Hewitt, CA; Middleton, L; Bishop, JRB; Daniels, J; Merriel, A; Weeks, A; Mhango, C; Mataya, R; Taulo, F; Ngalawesa, T; Chirwa, A; Mphasa, C; Tambala, T; Chiudzu, G; Mwalwanda, C; Mboma, A; Qureshi, R; Ahmed, I; Ismail, H; Oladapo, OT; Mbaruku, G; Chibwana, J; Watts, G; Simon, B; Ditai, J; Tom, CO; Acam, JF; Ekunait, J; Unzia, H; Iyaku, M; Makiika, JJ; Zamora, J; Roberts, T; Goranitis, I; Bar-Zeev, S; Desmond, N; Arulkumaran, S; Bhutta, ZA; Gulmezoglu, AM; Coomarasamy, A				Lissauer, D.; Wilson, A.; Hewitt, C. A.; Middleton, L.; Bishop, J. R. B.; Daniels, J.; Merriel, A.; Weeks, A.; Mhango, C.; Mataya, R.; Taulo, F.; Ngalawesa, T.; Chirwa, A.; Mphasa, C.; Tambala, T.; Chiudzu, G.; Mwalwanda, C.; Mboma, A.; Qureshi, R.; Ahmed, I.; Ismail, H.; Oladapo, O. T.; Mbaruku, G.; Chibwana, J.; Watts, G.; Simon, B.; Ditai, J.; Tom, C. Otim; Acam, J. F.; Ekunait, J.; Unzia, H.; Iyaku, M.; Makiika, J. J.; Zamora, J.; Roberts, T.; Goranitis, I.; Bar-Zeev, S.; Desmond, N.; Arulkumaran, S.; Bhutta, Z. A.; Gulmezoglu, A. M.; Coomarasamy, A.			A Randomized Trial of Prophylactic Antibiotics for Miscarriage Surgery	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARE-ASSOCIATED INFECTION; INCOMPLETE ABORTION; MANAGEMENT; CURETTAGE; AFRICA	BACKGROUND Surgical intervention is needed in some cases of spontaneous abortion to remove retained products of conception. Antibiotic prophylaxis may reduce the risk of pelvic infection, which is an important complication of this surgery, particularly in low-resource countries. METHODS We conducted a double-blind, placebo-controlled, randomized trial investigating whether antibiotic prophylaxis before surgery to complete a spontaneous abortion would reduce pelvic infection among women and adolescents in low-resource countries. We randomly assigned patients to a single preoperative dose of 400 mg of oral doxycycline and 400 mg of oral metronidazole or identical placebos. The primary outcome was pelvic infection within 14 days after surgery. Pelvic infection was defined by the presence of two or more of four clinical features (purulent vaginal discharge, pyrexia, uterine tenderness, and leukocytosis) or by the presence of one of these features and the clinically identified need to administer antibiotics. The definition of pelvic infection was changed before the unblinding of the data; the original strict definition was two or more of the clinical features, without reference to the administration of antibiotics. RESULTS We enrolled 3412 patients in Malawi, Pakistan, Tanzania, and Uganda. A total of 1705 patients were assigned to receive antibiotics and 1707 to receive placebo. The risk of pelvic infection was 4.1% (68 of 1676 pregnancies) in the antibiotics group and 5.3% (90 of 1684 pregnancies) in the placebo group (risk ratio, 0.77; 95% confidence interval [CI], 0.56 to 1.04; P = 0.09). Pelvic infection according to original strict criteria was diagnosed in 1.5% (26 of 1700 pregnancies) and 2.6% (44 of 1704 pregnancies), respectively (risk ratio, 0.60; 95% CI, 0.37 to 0.96). There were no significant between-group differences in adverse events. CONCLUSIONS Antibiotic prophylaxis before miscarriage surgery did not result in a significantly lower risk of pelvic infection, as defined by pragmatic broad criteria, than placebo. (Funded by the Medical Research Council and others; AIMS Current Controlled Trials number, ISRCTN97143849.)	[Lissauer, D.; Coomarasamy, A.] Univ Birmingham, Inst Metab & Syst Res, Birmingham, W Midlands, England; [Wilson, A.; Hewitt, C. A.; Middleton, L.; Bishop, J. R. B.] Univ Birmingham, Inst Appl Hlth Res, Birmingham, W Midlands, England; [Roberts, T.; Goranitis, I.] Univ Birmingham, Hlth Econ Unit, Birmingham, W Midlands, England; [Daniels, J.] Univ Nottingham, Fac Med & Hlth Sci, Nottingham, England; [Merriel, A.] Univ Bristol, Populat Hlth Sci, Bristol, Avon, England; [Weeks, A.] Univ Liverpool, Inst Translat Med, Liverpool, Merseyside, England; [Bar-Zeev, S.; Desmond, N.] Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England; [Bar-Zeev, S.; Desmond, N.] Malawi Liverpool Wellcome Trust Clin Res Programm, Liverpool, Merseyside, England; [Arulkumaran, S.] St Georges Univ London, Dept Obstet & Gynaecol, London, England; [Mhango, C.; Mataya, R.; Taulo, F.; Ngalawesa, T.; Chirwa, A.; Mphasa, C.; Tambala, T.] Coll Med, Dept Obstet & Gynaecol, Blantyre, Malawi; [Chiudzu, G.; Mwalwanda, C.; Mboma, A.] Kamuzu Cent Hosp, Lilongwe, Malawi; [Qureshi, R.; Ahmed, I.; Ismail, H.] Aga Khan Univ Hosp & Med Coll Fdn, Karachi, Pakistan; [Oladapo, O. T.; Gulmezoglu, A. M.] WHO, Dept Reprod Hlth & Res, Special Program Res Dev & Res Training Human Repr, Geneva, Switzerland; [Mbaruku, G.; Chibwana, J.; Watts, G.; Simon, B.] Ifakara Hlth Inst, Dar Es Salaam, Tanzania; [Ditai, J.; Tom, C. Otim; Acam, J. F.] Sanyu Africa Res Inst, Mbale, Uganda; [Ditai, J.; Tom, C. Otim; Acam, J. F.] Mbale Reg Referral Hosp, Mbale, Uganda; [Ekunait, J.; Unzia, H.; Iyaku, M.; Makiika, J. J.] Soroti Reg Referral Hosp, Soroti, Uganda; [Zamora, J.] Hosp Univ Ramon y Cajal, Clin Biostat Unit, Ctr Invest Biomed Red Epidemiol & Salud Publ, Madrid, Spain; [Zamora, J.] Inst Invest Sanitaria, Madrid, Spain; [Bhutta, Z. A.] Hosp Sick Children, Res Ctr Global Child Hlth, Toronto, ON, Canada	University of Birmingham; University of Birmingham; University of Birmingham; University of Nottingham; University of Bristol; University of Liverpool; Liverpool School of Tropical Medicine; University of Liverpool; St Georges University London; University of Malawi; World Health Organization; Ifakara Health Institute; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Hospital Universitario Ramon y Cajal; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Lissauer, D (corresponding author), Univ Birmingham, Birmingham Womens Hosp, Inst Metab & Syst Res, Mindelsohn Way, Birmingham B15 2TG, W Midlands, England.	d.m.lissauer@bham.ac.uk	Zamora, Javier/B-1722-2009; Desmond, Nicola/ABA-6504-2020; Zamora, Javier/AEO-0608-2022; Roberts, Tracy/AAO-4610-2021; Desmond, Nicola/GYQ-8574-2022; Wilson, Amie/HHS-0117-2022; Bhutta, Zulfiqar/L-7822-2015	Zamora, Javier/0000-0003-4901-588X; Desmond, Nicola/0000-0002-2874-8569; Zamora, Javier/0000-0003-4901-588X; Roberts, Tracy/0000-0002-0624-0537; Middleton, Lee/0000-0003-4621-1922; Wilson, Amie/0000-0002-1015-3786; Bishop, Jonathan/0000-0003-1789-5886; Weeks, Andrew/0000-0002-1909-337X; Lissauer, David/0000-0002-7878-2327; Daniels, Jane/0000-0003-3324-6771; Bhutta, Zulfiqar/0000-0003-0637-599X	Medical Research Council	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funded by the Medical Research Council and others; AIMS Current Controlled Trials number, ISRCTN97143849.	Abdu M, 2018, INT J GYNECOL OBSTET, V140, P175, DOI 10.1002/ijgo.12350; Allegranzi B, 2011, LANCET, V377, P228, DOI 10.1016/S0140-6736(10)61458-4; [Anonymous], 2015, Obstet Gynecol, V125, P1258, DOI 10.1097/01.AOG.0000465191.27155.25; [Anonymous], 2012, ECT PREGN MISC DIAGN, V154; [Anonymous], 2014, ANT PROPH SURG NAT C, V104; CATES W, 1985, LANCET, V2, P596; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; JOHNSON BR, 1993, SOC SCI MED, V36, P1443, DOI 10.1016/0277-9536(93)90386-I; Lissauer D, 2018, TRIALS, V19, DOI 10.1186/s13063-018-2598-3; Low N, 2012, COCHRANE DB SYST REV, V3; May W, 2007, COCHRANE DB SYST REV, V4; Melese T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0166287; Nejad SB, 2011, B WORLD HEALTH ORGAN, V89, P757, DOI 10.2471/BLT.11.088179; PRIETO JA, 1995, OBSTET GYNECOL, V85, P692, DOI 10.1016/0029-7844(95)00035-P; Ramin K D, 1995, Infect Dis Obstet Gynecol, V2, P213, DOI 10.1155/S1064744995000044; Rothe C, 2013, J HOSP INFECT, V85, P257, DOI 10.1016/j.jhin.2013.09.008; SEERAS R, 1989, East African Medical Journal, V66, P607; Singh S, 2010, STUD FAMILY PLANN, V41, P241, DOI 10.1111/j.1728-4465.2010.00250.x; Titapant Vitaya, 2012, Journal of the Medical Association of Thailand, V95, P1372; Trinder J, 2006, BMJ-BRIT MED J, V332, P1235, DOI 10.1136/bmj.38828.593125.55; Tuncalp O, 2010, COCHRANE DB SYST REV, V9; WHO, 2015, GLOB ACT PLAN ANT RE, DOI DOI 10.1128/MICROBE.10.354.1; WILCOX AJ, 1988, NEW ENGL J MED, V319, P189, DOI 10.1056/NEJM198807283190401; World Health Organization, 2017, ESSE MED LIST; World Health Organization, 2017, MAN COMPL PREGN CHIL	25	10	10	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 14	2019	380	11					1012	1021		10.1056/NEJMoa1808817	http://dx.doi.org/10.1056/NEJMoa1808817			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HO8NL	30865795	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000461210000005
J	Shepherd, A				Shepherd, Alison			The surgeon as puppeteer	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 14	2019	364								l1146	10.1136/bmj.l1146	http://dx.doi.org/10.1136/bmj.l1146			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP5WD	30872282				2022-12-28	WOS:000461752500006
J	Hasenfratz, AP; Jaccard, SL; Martinez-Garcia, A; Sigman, DM; Hodell, DA; Vance, D; Bernasconi, SM; Kleiven, HF; Haumann, FA; Haug, GH				Hasenfratz, Adam P.; Jaccard, Samuel L.; Martinez-Garcia, Alfredo; Sigman, Daniel M.; Hodell, David A.; Vance, Derek; Bernasconi, Stefano M.; Kleiven, Helga (Kikki) F.; Haumann, F. Alexander; Haug, Gerald H.			The residence time of Southern Ocean surface waters and the 100,000-year ice age cycle	SCIENCE			English	Article							FORAMINIFERAL MG/CA PALEOTHERMOMETRY; CARBON-DIOXIDE CONCENTRATION; SEA-ICE; ATMOSPHERIC CO2; PLANKTONIC-FORAMINIFERA; ISOTOPIC COMPOSITION; STABLE-ISOTOPES; ATLANTIC SECTOR; TEMPERATURE; DEEP	From 1.25 million to 700,000 years ago, the ice age cycle deepened and lengthened from 41,000- to 100,000-year periodicity, a transition that remains unexplained. Using surface- and bottom-dwelling foraminifera from the Antarctic Zone of the Southern Ocean to reconstruct the deep-to-surface supply of water during the ice ages of the past 1.5 million years, we found that a reduction in deep water supply and a concomitant freshening of the surface ocean coincided with the emergence of the high-amplitude 100,000-year glacial cycle. We propose that this slowing of deep-to-surface circulation (i.e., a longer residence time for Antarctic surface waters) prolonged ice ages by allowing the Antarctic halocline to strengthen, which increased the resistance of the Antarctic upper water column to orbitally paced drivers of carbon dioxide release.	[Hasenfratz, Adam P.; Bernasconi, Stefano M.; Haug, Gerald H.] Swiss Fed Inst Technol, Inst Geol, Dept Earth Sci, Zurich, Switzerland; [Hasenfratz, Adam P.; Jaccard, Samuel L.] Univ Bern, Inst Geol Sci, Bern, Switzerland; [Hasenfratz, Adam P.; Jaccard, Samuel L.] Univ Bern, Oeschger Ctr Climate Change Res, Bern, Switzerland; [Martinez-Garcia, Alfredo; Haug, Gerald H.] Max Planck Inst Chem, Mainz, Germany; [Sigman, Daniel M.] Princeton Univ, Dept Geosci, Guyot Hall, Princeton, NJ 08544 USA; [Hodell, David A.] Univ Cambridge, Dept Earth Sci, Cambridge, England; [Vance, Derek] Swiss Fed Inst Technol, Inst Geochem & Petrol, Zurich, Switzerland; [Kleiven, Helga (Kikki) F.] Univ Bergen, Dept Earth Sci, Bergen, Norway; [Kleiven, Helga (Kikki) F.] Univ Bergen, Bjerknes Ctr Climate Res, Bergen, Norway; [Haumann, F. Alexander] British Antarctic Survey, Cambridge, England; [Haumann, F. Alexander] Princeton Univ, Atmospher & Ocean Sci, Princeton, NJ 08544 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Bern; University of Bern; Max Planck Society; Princeton University; University of Cambridge; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Bergen; Bjerknes Centre for Climate Research; University of Bergen; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Princeton University	Hasenfratz, AP (corresponding author), Swiss Fed Inst Technol, Inst Geol, Dept Earth Sci, Zurich, Switzerland.; Hasenfratz, AP; Jaccard, SL (corresponding author), Univ Bern, Inst Geol Sci, Bern, Switzerland.; Hasenfratz, AP; Jaccard, SL (corresponding author), Univ Bern, Oeschger Ctr Climate Change Res, Bern, Switzerland.	adam.hasenfratz@geo.unibe.ch; samuel.jaccard@geo.unibe.ch	Haumann, Alexander/J-6679-2014; Sigman, Daniel M/A-2649-2008; Martínez-García, Alfredo/A-6244-2010; Bernasconi, Stefano M/E-5394-2010; Jaccard, Samuel/G-3447-2014	Haumann, Alexander/0000-0002-8218-977X; Sigman, Daniel M/0000-0002-7923-1973; Martínez-García, Alfredo/0000-0002-7206-5079; Bernasconi, Stefano M/0000-0001-7672-8856; Jaccard, Samuel/0000-0002-5793-0896; Hodell, David/0000-0001-8537-1588; Kleiven, Kikki/0000-0002-4956-6182	ETH Research Grant [ETH-04 11-1]; Swiss National Science Foundation [PP00P2_144811, PP00P2_172915, PZ00P2_141424, 175162]; Max Planck Society; NSF [OPP-1401489]; ExxonMobil through Princeton University's Andlinger Center for Energy and the Environment; BNP Paribas Foundation; ACE; Swiss Polar Institute; ACE Foundation; Ferring Pharmaceuticals; NSF; Joint Oceanographic Institutions (JOI) Inc.; NERC [bas0100033] Funding Source: UKRI	ETH Research Grant; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Max Planck Society(Max Planck SocietyFoundation CELLEX); NSF(National Science Foundation (NSF)); ExxonMobil through Princeton University's Andlinger Center for Energy and the Environment; BNP Paribas Foundation; ACE; Swiss Polar Institute; ACE Foundation; Ferring Pharmaceuticals(Ferring Pharmaceuticals); NSF(National Science Foundation (NSF)); Joint Oceanographic Institutions (JOI) Inc.; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Supported by ETH Research Grant ETH-04 11-1 (A.P.H.); Swiss National Science Foundation grants PP00P2_144811 and PP00P2_172915 (S.L.J.), PZ00P2_141424 (A.M.-G.), and 175162 (F.A.H.); the Max Planck Society (A.M.-G. and G.H.H.); and NSF grant OPP-1401489 and ExxonMobil through Princeton University's Andlinger Center for Energy and the Environment (D.M.S.). Modern oxygen isotope sample collection by F.A.H. was supported by the BNP Paribas Foundation and ACE, which was a scientific expedition carried out under the auspices of the Swiss Polar Institute, supported by funding from the ACE Foundation and Ferring Pharmaceuticals. This research used sediment samples provided by the ODP, which is supported by NSF and participating countries under management of Joint Oceanographic Institutions (JOI) Inc.	Abe-Ouchi A, 2013, NATURE, V500, P190, DOI 10.1038/nature12374; Abernathey RP, 2016, NAT GEOSCI, V9, P596, DOI [10.1038/ngeo2749, 10.1038/NGEO2749]; Adkins JF, 2002, SCIENCE, V298, P1769, DOI 10.1126/science.1076252; Annan JD, 2013, CLIM PAST, V9, P367, DOI 10.5194/cp-9-367-2013; Barker S, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2003GC000559; Bates SL, 2014, QUATERNARY SCI REV, V88, P147, DOI 10.1016/j.quascirev.2014.01.020; Boos WR, 2012, J CLIMATE, V25, P992, DOI 10.1175/JCLI-D-11-00010.1; Breitenbach SFM, 2011, RAPID COMMUN MASS SP, V25, P1910, DOI 10.1002/rcm.5052; Brown SJ, 1996, PALEOCEANOGRAPHY, V11, P543, DOI 10.1029/96PA01491; Chalk TB, 2017, P NATL ACAD SCI USA, V114, P13114, DOI 10.1073/pnas.1702143114; Clark PU, 2006, QUATERNARY SCI REV, V25, P3150, DOI 10.1016/j.quascirev.2006.07.008; Craig H., 1965, DEUTERIUM OXYGEN 18, P9, DOI DOI 10.1109/ISSRE.1993.624301; Crosta X, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2000PA000565; DANSGAARD W, 1964, TELLUS, V16, P436; de Boer AM, 2008, J PHYS OCEANOGR, V38, P435, DOI 10.1175/2007JPO3731.1; Depoorter MA, 2013, NATURE, V502, P89, DOI 10.1038/nature12567; DONNER B, 1994, DEEP-SEA RES PT I, V41, P1733, DOI 10.1016/0967-0637(94)90070-1; Elderfield H, 2006, EARTH PLANET SC LETT, V250, P633, DOI 10.1016/j.epsl.2006.07.041; Elderfield H, 2012, SCIENCE, V337, P704, DOI 10.1126/science.1221294; Francois R, 1997, NATURE, V389, P929, DOI 10.1038/40073; Gersonde  R., 1999, P ODP IN REP LEG, V177; Gottschalk J, 2016, PALEOCEANOGRAPHY, V31, P1583, DOI 10.1002/2016PA003029; Gottschalk J, 2015, EARTH PLANET SC LETT, V411, P87, DOI 10.1016/j.epsl.2014.11.051; Greaves M. J., 2008, THESIS; Hain MP, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2010GB003790; Hasenfratz AP, 2017, GEOCHIM COSMOCHIM AC, V217, P365, DOI 10.1016/j.gca.2017.08.038; Hasenfratz AP, 2017, EARTH PLANET SC LETT, V457, P335, DOI 10.1016/j.epsl.2016.10.004; Haug GH, 1999, NATURE, V401, P779, DOI 10.1038/44550; Haumann F. A., 2019, SEAWATER STABLE ISOT; Haumann FA, 2016, NATURE, V537, P89, DOI 10.1038/nature19101; Hernandez-Almeida I, 2012, PALEOCEANOGRAPHY, V27, DOI 10.1029/2011PA002209; Higgins JA, 2015, P NATL ACAD SCI USA, V112, P6887, DOI 10.1073/pnas.1420232112; Hodell D., 2003, P OC DRILL PROGR SCI, V177; Hodell DA, 2016, CLIM PAST, V12, P1805, DOI 10.5194/cp-12-1805-2016; Hodell DA, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2008PA001591; Honisch B, 2009, SCIENCE, V324, P1551, DOI 10.1126/science.1171477; Hoogakker B, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2009PA001870; Jaccard SL, 2013, SCIENCE, V339, P1419, DOI 10.1126/science.1227545; Jouzel J, 2007, SCIENCE, V317, P793, DOI 10.1126/science.1141038; Kanfoush SL, 2002, PALAEOGEOGR PALAEOCL, V182, P329, DOI 10.1016/S0031-0182(01)00502-8; Kemp AES, 2010, QUATERNARY SCI REV, V29, P1993, DOI 10.1016/j.quascirev.2010.04.027; King AL, 2005, MAR MICROPALEONTOL, V56, P1, DOI 10.1016/j.marmicro.2005.02.008; Kleiven H. F., 2003, P OC DRILL PROGR SCI, V177; LeGrande AN, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026011; Lisiecki LE, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2005PA001164; LISIECKI LE, 2005, PALEOCEANOGRAPHY, V0020; Locarnini R. A., 2013, NOAA ATLAS NESDIS, V73; Locarnini R. A., 2013, NOAA ATLAS NESDIS 73; LORIUS C, 1985, NATURE, V316, P591, DOI 10.1038/316591a0; Luthi D, 2008, NATURE, V453, P379, DOI 10.1038/nature06949; Lund DC, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2010PA001938; Mackensen A, 1996, PALEOCEANOGRAPHY, V11, P203, DOI 10.1029/95PA03840; Martinez-Garcia A, 2011, NATURE, V476, P312, DOI 10.1038/nature10310; Masson-Delmotte V, 2008, J CLIMATE, V21, P3359, DOI 10.1175/2007JCLI2139.1; Menviel L, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2009PA001892; Morgan VI, 1982, ANN GLACIOL, V3, P204, DOI DOI 10.1017/S0260305500002780; Mortyn PG, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2001PA000637; Nurnberg D, 1996, GEOCHIM COSMOCHIM AC, V60, P803, DOI 10.1016/0016-7037(95)00446-7; ONEIL JR, 1968, J PHYS CHEM-US, V72, P3683, DOI 10.1021/j100856a060; ORSI AH, 1995, DEEP-SEA RES PT I, V42, P641, DOI 10.1016/0967-0637(95)00021-W; Pena LD, 2014, SCIENCE, V345, P318, DOI 10.1126/science.1249770; PISIAS NG, 1981, EARTH PLANET SC LETT, V52, P450, DOI 10.1016/0012-821X(81)90197-7; Raymo ME, 2008, NATURE, V451, P284, DOI 10.1038/nature06589; Riveiros NV, 2016, GEOCHEM GEOPHY GEOSY, V17, P1249, DOI 10.1002/2015GC006234; Robinson RS, 2008, QUATERNARY SCI REV, V27, P1076, DOI 10.1016/j.quascirev.2008.02.005; Rohling EJ, 2014, NATURE, V508, P477, DOI 10.1038/nature13230; Rosenthal Y, 2000, PALEOCEANOGRAPHY, V15, P135, DOI 10.1029/1999PA000415; SARMIENTO JL, 1984, NATURE, V308, P621, DOI 10.1038/308621a0; Schneider-Mor A, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022543; Shackleton N.J., 1974, Colloques int Cent natn Res Scient, VNo. 219,1974, P203; Shackleton N. J., 1973, Quaternary Research, V3, P39, DOI 10.1016/0033-5894(73)90052-5; Sigman DM, 2000, NATURE, V407, P859, DOI 10.1038/35038000; Srivastava R, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031790; Stephens BB, 2000, NATURE, V404, P171, DOI 10.1038/35004556; Studer AS, 2015, PALEOCEANOGRAPHY, V30, P845, DOI 10.1002/2014PA002745; Toggweiler JR, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001154; Toggweiler JR, 1999, PALEOCEANOGRAPHY, V14, P571, DOI 10.1029/1999PA900033; TOGGWEILER JR, 1995, J PHYS OCEANOGR, V25, P1980, DOI 10.1175/1520-0485(1995)025<1980:EOSIOT>2.0.CO;2; Venz KA, 2002, PALAEOGEOGR PALAEOCL, V182, P197, DOI 10.1016/S0031-0182(01)00496-5; Wang XT, 2017, P NATL ACAD SCI USA, V114, P3352, DOI 10.1073/pnas.1615718114; WEISS RF, 1979, DEEP-SEA RES, V26, P1093, DOI 10.1016/0198-0149(79)90059-1; Yu JM, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2006GC001571; Zweng M., 2013, NOAA ATLAS NESDIS, P74; Zweng MM, 2013, NOAA ATLAS NESDIS, V74	84	40	42	3	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 8	2019	363	6431					1080	+		10.1126/science.aat7067	http://dx.doi.org/10.1126/science.aat7067			43	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO2MV	30846597				2022-12-28	WOS:000460750100043
J	Ladinsky, MS; Araujo, LP; Zhang, X; Veltri, J; Galan-Diez, M; Soualhi, S; Lee, C; Irie, K; Pinker, EY; Narushima, S; Bandyopadhyay, S; Nagayama, M; Elhenawy, W; Coombes, BK; Ferraris, RP; Honda, K; Iliev, ID; Gao, N; Bjorkman, PJ; Ivanov, II				Ladinsky, Mark S.; Araujo, Leandro P.; Zhang, Xiao; Veltri, John; Galan-Diez, Marta; Soualhi, Salima; Lee, Carolyn; Irie, Koichiro; Pinker, Elisha Y.; Narushima, Seiko; Bandyopadhyay, Sheila; Nagayama, Manabu; Elhenawy, Wael; Coombes, Brian K.; Ferraris, Ronaldo P.; Honda, Kenya; Iliev, Iliyan D.; Gao, Nan; Bjorkman, Pamela J.; Ivanov, Ivaylo I.			Endocytosis of commensal antigens by intestinal epithelial cells regulates mucosal T cell homeostasis	SCIENCE			English	Article							SEGMENTED FILAMENTOUS BACTERIA; TH17 CELLS; GUT; DIFFERENTIATION; METABOLITES; ADAPTATIONS; ATTACHMENT; INDUCTION; MICROBES; GENOME	Commensal bacteria influence host physiology, without invading host tissues. We show that proteins from segmented filamentous bacteria (SFB) are transferred into intestinal epithelial cells (IECs) through adhesion-directed endocytosis that is distinct from the clathrin-dependent endocytosis of invasive pathogens. This process transfers microbial cell wall-associated proteins, including an antigen that stimulates mucosal T helper 17 (TH17) cell differentiation, into the cytosol of IECs in a cell division control protein 42 homolog (CDC42)-dependent manner. Removal of CDC42 activity in vivo led to disruption of endocytosis induced by SFB and decreased epithelial antigen acquisition, with consequent loss of mucosal TH17 cells. Our findings demonstrate direct communication between a resident gut microbe and the host and show that under physiological conditions, IECs acquire antigens from commensal bacteria for generation of T cell responses to the resident microbiota.	[Ladinsky, Mark S.; Bjorkman, Pamela J.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Araujo, Leandro P.; Galan-Diez, Marta; Soualhi, Salima; Lee, Carolyn; Irie, Koichiro; Pinker, Elisha Y.; Ivanov, Ivaylo I.] Columbia Univ, Dept Microbiol & Immunol, Vagelos Coll Phys & Surg, New York, NY 10032 USA; [Zhang, Xiao; Bandyopadhyay, Sheila; Gao, Nan] Rutgers State Univ, Dept Biol Sci, Newark, NJ 07102 USA; [Veltri, John; Ferraris, Ronaldo P.] Rutgers State Univ, Dept Pharmacol Physiol & Neurosci, Newark, NJ 07103 USA; [Irie, Koichiro] Okayama Univ, Dept Prevent Dent, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008558, Japan; [Narushima, Seiko; Nagayama, Manabu; Honda, Kenya] RIKEN, Ctr Integrat Med Sci, Yokohama, Kanagawa 2300045, Japan; [Nagayama, Manabu] Jichi Med Univ, Dept Med, Div Gastroenterol, Shimotsuke, Tochigi 3290498, Japan; [Elhenawy, Wael; Coombes, Brian K.] McMaster Univ, Dept Biochem & Biomed Sci, Michael G DeGroote Inst Infect Dis Res, Hamilton, ON, Canada; [Honda, Kenya] Keio Univ, Dept Microbiol & Immunol, Sch Med, Tokyo 1608582, Japan; [Iliev, Iliyan D.] Weill Cornell Med, Dept Microbiol & Immunol, New York, NY 10065 USA; [Iliev, Iliyan D.] Weill Cornell Med, Jill Roberts Inst Res Inflammatory Bowel Dis, New York, NY 10065 USA; [Galan-Diez, Marta] Columbia Univ, Dept Physiol & Cellular Biophys, Vagelos Coll Phys & Surg, New York, NY 10032 USA; [Soualhi, Salima] Boston Childrens Hosp, Div Gastroenterol, Boston, MA 02115 USA; [Soualhi, Salima] Harvard Med Sch, Boston, MA 02115 USA	California Institute of Technology; Columbia University; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Newark; Rutgers State University New Brunswick; Okayama University; RIKEN; Jichi Medical University; McMaster University; Keio University; Cornell University; Cornell University; Columbia University; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Bjorkman, PJ (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.; Ivanov, II (corresponding author), Columbia Univ, Dept Microbiol & Immunol, Vagelos Coll Phys & Surg, New York, NY 10032 USA.	bjorkman@caltech.edu; ii2137@cumc.columbia.edu	Araujo, Leandro Pires/B-3881-2016; Galan-Diez, Marta/A-7037-2019; Zhang, Xiao/L-6674-2013	Araujo, Leandro Pires/0000-0003-4696-692X; Galan-Diez, Marta/0000-0002-2092-3414; Elhenawy, Wael/0000-0002-4599-8500; Pinker, Elisha/0000-0003-2664-6937; SOUALHI, Salima/0000-0003-4708-0282; Zhang, Xiao/0000-0002-8213-6686	ACS Research Scholar Award [15-060-01-TBE]; NSF/BIO/IOS [1456673]; AMED-LEAP [JP17 g0010003]; Takeda Science Foundation; CIHR [324932]; Columbia University Schaefer Research Award; Pew Charitable Trust Innovation Fund [00031379];  [NIH R21 AI126305];  [R01 DK098378];  [P50 GM082545];  [NIH R01 DK102934];  [NIH R01 AT010243]; National Center for Complementary & Integrative Health [R01AT010243] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI126305] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F31DK121428, R01DK102934, R01DK098378, R01DK119198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082545] Funding Source: NIH RePORTER	ACS Research Scholar Award; NSF/BIO/IOS; AMED-LEAP; Takeda Science Foundation(Takeda Science Foundation (TSF)); CIHR(Canadian Institutes of Health Research (CIHR)); Columbia University Schaefer Research Award; Pew Charitable Trust Innovation Fund; ; ; ; ; ; National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funding from the following sources: NIH R21 AI126305 and R01 DK098378 (I. I. I.); P50 GM082545 (P.J.B); NIH R01 DK102934 and ACS Research Scholar Award 15-060-01-TBE (N.G.); NSF/BIO/IOS 1456673 (R.P.F.); NIH R01 AT010243 (N.G. and R.P.F.); AMED-LEAP JP17 g0010003 and Takeda Science Foundation (K.H.); CIHR Grant 324932 (B.K.C.); Columbia University Schaefer Research Award (I. I. I.); and Pew Charitable Trust Innovation Fund Award 00031379 (I. I. I and P.J.B.). Author contributions: P.J.B and I. I. I. conceived and supervised	Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Atarashi K, 2015, CELL, V163, P367, DOI 10.1016/j.cell.2015.08.058; Caselli M, 2010, GUT MICROBES, V1, P367, DOI 10.4161/gmic.1.6.14390; Chai JN, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aal5068; CHASE DG, 1976, J BACTERIOL, V127, P572, DOI 10.1128/JB.127.1.572-583.1976; Chu HT, 2016, SCIENCE, V352, P1116, DOI 10.1126/science.aad9948; Cummings RJ, 2016, NATURE, V539, P565, DOI 10.1038/nature20138; DAVIS CP, 1974, INFECT IMMUN, V10, P948, DOI 10.1128/IAI.10.4.948-956.1974; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Farkas AM, 2015, J IMMUNOL METHODS, V421, P104, DOI 10.1016/j.jim.2015.03.020; Feng T, 2011, MUCOSAL IMMUNOL, V4, P15, DOI 10.1038/mi.2010.60; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Geem D, 2014, J IMMUNOL, V193, P431, DOI 10.4049/jimmunol.1303167; Goto Y, 2014, IMMUNITY, V40, P594, DOI 10.1016/j.immuni.2014.03.005; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; JEPSON MA, 1993, INFECT IMMUN, V61, P4001, DOI 10.1128/IAI.61.9.4001-4004.1993; Jiang L, 2001, AM J PHYSIOL-REG I, V281, pR1274, DOI 10.1152/ajpregu.2001.281.4.R1274; KLAASEN HLBM, 1993, LAB ANIM-UK, V27, P141, DOI 10.1258/002367793780810441; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Mastronarde DN, 2008, J MICROSC-OXFORD, V230, P212, DOI 10.1111/j.1365-2818.2008.01977.x; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Panea C, 2015, CELL REP, V12, P1314, DOI 10.1016/j.celrep.2015.07.040; Prakash T, 2011, CELL HOST MICROBE, V10, P273, DOI 10.1016/j.chom.2011.08.007; Sakamori R, 2012, J CLIN INVEST, V122, P1052, DOI 10.1172/JCI60282; Sczesnak A, 2011, CELL HOST MICROBE, V10, P260, DOI 10.1016/j.chom.2011.08.005; Shen Y, 2012, CELL HOST MICROBE, V12, P509, DOI 10.1016/j.chom.2012.08.004; Shih VFS, 2014, P NATL ACAD SCI USA, V111, P13942, DOI 10.1073/pnas.1323852111; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; SNELLEN JE, 1978, J BACTERIOL, V134, P1099, DOI 10.1128/JB.134.3.1099-1107.1978; Talham GL, 1999, INFECT IMMUN, V67, P1992; Tan TG, 2016, P NATL ACAD SCI USA, V113, pE8141, DOI 10.1073/pnas.1617460113; Xu M, 2018, NATURE, V554, P373, DOI 10.1038/nature25500; Yamauchi KE, 2000, INFECT IMMUN, V68, P6496, DOI 10.1128/IAI.68.11.6496-6504.2000; Yang L, 2007, P NATL ACAD SCI USA, V104, P5091, DOI 10.1073/pnas.0610819104; Yang Y, 2014, NATURE, V510, P152, DOI 10.1038/nature13279; Yu LCH, 2014, AM J PHYSIOL-GASTR L, V307, pG824, DOI 10.1152/ajpgi.00070.2014	40	72	75	9	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 8	2019	363	6431					1058	+	eaat4042	10.1126/science.aat4042	http://dx.doi.org/10.1126/science.aat4042			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO2MV	30846568	Green Accepted			2022-12-28	WOS:000460750100037
J	Bachelez, H; Choon, SE; Marrakchi, S; Burden, AD; Tsai, TF; Morita, A; Turki, H; Hall, DB; Shear, M; Baum, P; Padula, SJ; Thoma, C				Bachelez, Herve; Choon, Siew-Eng; Marrakchi, Slaheddine; Burden, A. David; Tsai, Tsen-Fang; Morita, Akimichi; Turki, Hamida; Hall, David B.; Shear, Michael; Baum, Patrick; Padula, Steven J.; Thoma, Christian			Inhibition of the Interleukin-36 Pathway for the Treatment of Generalized Pustular Psoriasis	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter									[Bachelez, Herve] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Choon, Siew-Eng] Monash Univ Malaysia, Johor Baharu, Malaysia; [Marrakchi, Slaheddine; Turki, Hamida] Hedi Chaker Univ Hosp, Sfax, Tunisia; [Burden, A. David] Univ Glasgow, Glasgow, Lanark, Scotland; [Tsai, Tsen-Fang] Natl Taiwan Univ, Taipei, Taiwan; [Morita, Akimichi] Nagoya City Univ, Nagoya, Aichi, Japan; [Hall, David B.] Boehringer Ingelheim Pharmaceut, Ridgefield, CT USA; [Shear, Michael; Baum, Patrick; Thoma, Christian] Boehringer Ingelheim Int, Biberach, Germany; [Padula, Steven J.] Boehringer Ingelheim Int, Ingelheim, Germany	UDICE-French Research Universities; Universite Paris Cite; Monash University; Monash University Sunway; Universite de Sfax; Hopital Hedi Chaker; University of Glasgow; National Taiwan University; Nagoya City University; Boehringer Ingelheim; Boehringer Ingelheim	Bachelez, H (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, Paris, France.	herve.bachelez@aphp.fr	CHOON, SIEW ENG/AAU-8192-2021	CHOON, SIEW ENG/0000-0002-7796-5746; TSAI, TSEN-FANG/0000-0002-1498-1474	Boehringer Ingelheim	Boehringer Ingelheim(Boehringer Ingelheim)	Supported by Boehringer Ingelheim.	Ganesan R, 2017, MABS-AUSTIN, V9, P1143, DOI 10.1080/19420862.2017.1353853; Johnston A, 2017, J ALLERGY CLIN IMMUN, V140, P109, DOI 10.1016/j.jaci.2016.08.056; Marrakchi S, 2011, NEW ENGL J MED, V365, P620, DOI 10.1056/NEJMoa1013068; Navarini AA, 2017, J EUR ACAD DERMATOL, V31, P1792, DOI 10.1111/jdv.14386; Onoufriadis A, 2011, AM J HUM GENET, V89, P432, DOI 10.1016/j.ajhg.2011.07.022	5	127	132	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 7	2019	380	10					981	983		10.1056/NEJMc1811317	http://dx.doi.org/10.1056/NEJMc1811317			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HN8QX	30855749	Bronze			2022-12-28	WOS:000460461500015
J	Iacobucci, G				Iacobucci, Gareth			Long term hormone therapy may increase Alzheimer's risk, study finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item							MILD COGNITIVE IMPAIRMENT; POSTMENOPAUSAL WOMEN; DEMENTIA											Mikkola TS, 2019, BMJ-BRIT MED J, V364, P1665; Shumaker SA, 2004, JAMA-J AM MED ASSOC, V291, P2947, DOI 10.1001/jama.291.24.2947; Shumaker SA, 2003, JAMA-J AM MED ASSOC, V289, P2651, DOI 10.1001/jama.289.20.2651	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 7	2019	364								l1050	10.1136/bmj.l1050	http://dx.doi.org/10.1136/bmj.l1050			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HO6TA	30846424				2022-12-28	WOS:000461063200008
J	Subramanian, A; Capalbo, A; Iyengar, NR; Rizzo, R; di Campli, A; Di Martino, R; Lo Monte, M; Beccari, AR; Yerudkar, A; del Vecchio, C; Glielmo, L; Turacchio, G; Pirozzi, M; Kim, SG; Henklein, P; Cancino, J; Parashuraman, S; Diviani, D; Fanelli, F; Sallese, M; Luini, A				Subramanian, Advait; Capalbo, Anita; Iyengar, Namrata Ravi; Rizzo, Riccardo; di Campli, Antonella; Di Martino, Rosaria; Lo Monte, Matteo; Beccari, Andrea R.; Yerudkar, Amol; del Vecchio, Carmen; Glielmo, Luigi; Turacchio, Gabriele; Pirozzi, Marinella; Kim, Sang Geon; Henklein, Petra; Cancino, Jorge; Parashuraman, Seetharaman; Diviani, Dario; Fanelli, Francesca; Sallese, Michele; Luini, Alberto			Auto-regulation of Secretory Flux by Sensing and Responding to the Folded Cargo Protein Load in the Endoplasmic Reticulum	CELL			English	Article							ALPHA-SUBUNITS; TRANSPORT; KINASE; CAMP; PATHWAY; CYCLASE; ACTIVATION; RESPONSES; CAPTURE; EXPORT	Maintaining the optimal performance of cell processes and organelles is the task of auto-regulatory systems. Here we describe an auto-regulatory device that helps to maintain homeostasis of the endoplasmic reticulum (ER) by adjusting the secretory flux to the cargo load. The cargo-recruiting subunit of the coatomer protein II (COPII) coat, Sec24, doubles as a sensor of folded cargo and, upon cargo binding, acts as a guanine nucleotide exchange factor to activate the signaling protein G alpha 12 at the ER exit sites (ERESs). This step, in turn, activates a complex signaling network that activates and coordinates the ER export machinery and attenuates proteins synthesis, thus preventing large fluctuations of folded and potentially active cargo that could be harmful to the cell or the organism. We call this mechanism AREX (autoregulation of ER export) and expect that its identification will aid our understanding of human physiology and diseases that develop from secretory dysfunction.	[Subramanian, Advait; Capalbo, Anita; Iyengar, Namrata Ravi; Rizzo, Riccardo; di Campli, Antonella; Di Martino, Rosaria; Lo Monte, Matteo; Beccari, Andrea R.; Turacchio, Gabriele; Pirozzi, Marinella; Parashuraman, Seetharaman; Luini, Alberto] Italian Natl Res Council CNR, Inst Prot Biochem IBP, Naples, Italy; [di Campli, Antonella; Sallese, Michele] G dAnnunzio Univ Chieti Pescara, Dept Med Oral & Biotechnol Sci, Chieti, Italy; [di Campli, Antonella; Sallese, Michele] G dAnnunzio Univ Chieti Pescara, Ctr Res Ageing & Translat Med, CeSI MeT, Chieti, Italy; [Beccari, Andrea R.] Dompe Farmaceut SpA, Milan, Italy; [Yerudkar, Amol; del Vecchio, Carmen; Glielmo, Luigi] Univ Sannio, Dept Engn, Benevento, Italy; [Kim, Sang Geon] Seoul Natl Univ, Coll Pharm, Seoul, South Korea; [Kim, Sang Geon] Seoul Natl Univ, Pharmaceut Sci Res Inst, Seoul, South Korea; [Henklein, Petra] Charite, Inst Biochem, Berlin, Germany; [Cancino, Jorge] Univ San Sebastian, Fac Med & Ciencia, Ctr Biol Celular & Biomed CEBICEM, Lota 2465, Santiago 7510157, Chile; [Diviani, Dario] Univ Lausanne, Dept Pharmacol & Toxicol, Rue Bugnon 27, CH-1011 Lausanne, Switzerland; [Fanelli, Francesca] Univ Modena & Reggio Emilia, Dept Life Sci, Modena, Italy; [Subramanian, Advait] Univ Calif San Francisco, George William Hooper Fdn, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Subramanian, Advait] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); Istituto di Neuroscienze (IN-CNR); G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; Dompe; University of Sannio; Seoul National University (SNU); Seoul National University (SNU); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Universidad San Sebastian; University of Lausanne; Universita di Modena e Reggio Emilia; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Subramanian, A; Luini, A (corresponding author), Italian Natl Res Council CNR, Inst Prot Biochem IBP, Naples, Italy.; Subramanian, A (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	a.subramanian@ibp.cnr.it; a.luini@ibp.cnr.it	capalbo, anita/Q-4678-2018; parashuraman, seetharaman/ABE-2639-2020; Del Vecchio, Carmen/AAH-3139-2021; Yerudkar, Amol/ABB-1140-2020; Sallese, Michele/J-5347-2016; Glielmo, Luigi/D-1379-2014; Fanelli, Francesca/O-8807-2014	parashuraman, seetharaman/0000-0001-5113-4592; Del Vecchio, Carmen/0000-0001-6937-9678; Yerudkar, Amol/0000-0003-3994-3842; Sallese, Michele/0000-0002-2555-3571; Diviani, Dario/0000-0003-4375-3718; PIROZZI, MARINELLA/0000-0002-1714-2000; Glielmo, Luigi/0000-0003-2753-1787; Henklein, Petra/0000-0001-7468-8926; Rizzo, Riccardo/0000-0002-5716-9195; Subramanian, Advait/0000-0003-0557-9771; Fanelli, Francesca/0000-0002-7620-6895	Italian Cystic Fibrosis Research Foundation [6]; AIRC [IG 15767, IG 20786]; MIUR (Project "FaReBio di Qualita''); Italian Node of Euro-Bioimaging (Preparatory Phase II - INFRADEV); CNR (PON Project) [01/00117]; CNR [01-00862, a3-00025]; TERABIO	Italian Cystic Fibrosis Research Foundation(Ministry of Health, ItalyItalian Cystic Fibrosis Research Foundation); AIRC(Fondazione AIRC per la ricerca sul cancro); MIUR (Project "FaReBio di Qualita'')(Ministry of Education, Universities and Research (MIUR)); Italian Node of Euro-Bioimaging (Preparatory Phase II - INFRADEV); CNR (PON Project); CNR(Consiglio Nazionale delle Ricerche (CNR)); TERABIO	We thank all members of the A.L. lab for critical evaluation and discussion of the data. We thank Nina Dathan and Daniela Spano for help with cloning and construct preparation. A.L. acknowledges financial support from the Italian Cystic Fibrosis Research Foundation (Project #6), AIRC (Projects IG 15767 and IG 20786), MIUR (Project "FaReBio di Qualita''), the Italian Node of Euro-Bioimaging (Preparatory Phase II - INFRADEV), TERABIO, and the CNR (PON Project 01/00117 and Projects 01-00862 and a3-00025). We thank the Bioimaging Facility of the IBP for help with EM preparation and image acquisition.	Aridor M, 1999, J BIOL CHEM, V274, P4389, DOI 10.1074/jbc.274.7.4389; Barlowe C, 2016, ANNU REV CELL DEV BI, V32, P197, DOI 10.1146/annurev-cellbio-111315-125016; Blumer JB, 2014, MOL PHARMACOL, V85, P388, DOI 10.1124/mol.113.090068; Boncompain G, 2012, NAT METHODS, V9, P493, DOI [10.1038/NMETH.1928, 10.1038/nmeth.1928]; Bonfanti L, 1998, CELL, V95, P993, DOI 10.1016/S0092-8674(00)81723-7; Cancino J, 2014, DEV CELL, V30, P280, DOI 10.1016/j.devcel.2014.06.018; CARR DW, 1992, J BIOL CHEM, V267, P13376; Choi YH, 2006, J CLIN INVEST, V116, P3240, DOI 10.1172/JCI24867; Choudhary C, 2009, MOL CELL, V36, P326, DOI 10.1016/j.molcel.2009.09.019; Cooper DMF, 2005, BIOCHEM SOC T, V33, P1319, DOI 10.1042/BST0331319; Dolfi SC, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-20; Duan BY, 2010, J IMMUNOL, V185, P335, DOI 10.4049/jimmunol.0903474; Fanelli F, 2008, FEBS LETT, V582, P991, DOI 10.1016/j.febslet.2008.02.041; Farhan H, 2008, EMBO J, V27, P2043, DOI 10.1038/emboj.2008.136; Farhan H, 2010, J CELL BIOL, V189, P997, DOI 10.1083/jcb.200912082; Forster R, 2006, CURR BIOL, V16, P173, DOI 10.1016/j.cub.2005.11.076; Giannotta M, 2012, EMBO J, V31, P2869, DOI 10.1038/emboj.2012.134; Gordon DE, 2010, TRAFFIC, V11, P1191, DOI 10.1111/j.1600-0854.2010.01087.x; Gorur A, 2017, J CELL BIOL, V216, P1745, DOI 10.1083/jcb.201702135; de Opakua AI, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15163; Jiang LI, 2008, J BIOL CHEM, V283, P23429, DOI 10.1074/jbc.M803281200; Koide H, 2015, J BONE MINER RES, V30, P1887, DOI 10.1002/jbmr.2534; Kreutz B, 2006, BIOCHEMISTRY-US, V45, P167, DOI 10.1021/bi051729t; Lee S, 2008, ECS TRANSACTIONS, V12, P13, DOI 10.1149/1.2921528; Lee TH, 2000, MOL BIOL CELL, V11, P2577, DOI 10.1091/mbc.11.8.2577; Ma W, 2017, ELIFE, V6, DOI 10.7554/eLife.26624; Mancias JD, 2008, EMBO J, V27, P2918, DOI 10.1038/emboj.2008.208; Manni S, 2008, J BIOL CHEM, V283, P24145, DOI 10.1074/jbc.M802278200; Manzano-Lopez J, 2015, CURR BIOL, V25, P152, DOI 10.1016/j.cub.2014.11.039; Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3; Mironov AA, 2003, DEV CELL, V5, P583, DOI 10.1016/S1534-5807(03)00294-6; Nehls S, 2000, NAT CELL BIOL, V2, P288, DOI 10.1038/35010558; Nishimura N, 1999, J BIOL CHEM, V274, P15937, DOI 10.1074/jbc.274.22.15937; Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556; Omori K, 2007, CIRC RES, V100, P309, DOI 10.1161/01.RES.0000256354.95791.f1; Pagant S, 2015, CURR BIOL, V25, P403, DOI 10.1016/j.cub.2014.11.070; Pahl HL, 1997, TRENDS BIOCHEM SCI, V22, P63, DOI 10.1016/S0968-0004(96)10073-6; Pakos-Zebrucka K, 2016, EMBO REP, V17, P1374, DOI 10.15252/embr.201642195; Pierce BG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024657; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Pulvirenti T, 2008, NAT CELL BIOL, V10, P912, DOI 10.1038/ncb1751; Ron D, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013177; Rusu L, 2014, BLOOD, V123, P442, DOI 10.1182/blood-2013-03-489351; Saito K, 2009, CELL, V136, P891, DOI 10.1016/j.cell.2008.12.025; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scott JD, 2013, ANNU REV PHARMACOL, V53, P187, DOI 10.1146/annurev-pharmtox-011112-140204; Shafiee-Nick R, 2017, BIOMED PHARMACOTHER, V94, P541, DOI 10.1016/j.biopha.2017.07.084; Simpson JC, 2007, J BIOTECHNOL, V129, P352, DOI 10.1016/j.jbiotec.2006.12.027; Taylor SS, 2008, BBA-PROTEINS PROTEOM, V1784, P16, DOI 10.1016/j.bbapap.2007.10.002; van Anken E, 2003, IMMUNITY, V18, P243, DOI 10.1016/S1074-7613(03)00024-4; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Yamaguchi Y, 2003, J BIOL CHEM, V278, P14936, DOI 10.1074/jbc.M301409200	54	40	40	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 7	2019	176	6					1461	+		10.1016/j.cell.2019.01.035	http://dx.doi.org/10.1016/j.cell.2019.01.035			39	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	HN9HD	30849374	Bronze, Green Published			2022-12-28	WOS:000460509600019
J	Voelker, R				Voelker, Rebecca			A Record Year for Device Approvals	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 5	2019	321	9					827	827		10.1001/jama.2019.1144	http://dx.doi.org/10.1001/jama.2019.1144			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HN7EL	30835295				2022-12-28	WOS:000460351600004
J	Mercer, MP; Singh, MK; Kanzaria, HK				Mercer, Mary P.; Singh, Malini K.; Kanzaria, Hemal K.			Reducing Emergency Department Length of Stay	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE		[Mercer, Mary P.; Singh, Malini K.; Kanzaria, Hemal K.] Univ Calif San Francisco, Zuckerberg San Francisco Gen Hosp & Trauma Ctr, Dept Emergency Med, 1001 Potrero Ave,Room 1E21, San Francisco, CA 94110 USA	University of California System; University of California San Francisco	Mercer, MP (corresponding author), Univ Calif San Francisco, Zuckerberg San Francisco Gen Hosp & Trauma Ctr, Dept Emergency Med, 1001 Potrero Ave,Room 1E21, San Francisco, CA 94110 USA.	mary.mercer@ucsf.edu			University of California San Francisco Department of Emergency Medicine; Zuckerberg San Francisco General Hospital	University of California San Francisco Department of Emergency Medicine; Zuckerberg San Francisco General Hospital	This work was supported by the University of California San Francisco Department of Emergency Medicine and the Zuckerberg San Francisco General Hospital and Trauma Center.	Chow JL, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014721; Dickson EW, 2009, ANN EMERG MED, V54, P504, DOI 10.1016/j.annemergmed.2009.03.024; Holden RJ, 2011, ANN EMERG MED, V57, P265, DOI 10.1016/j.annemergmed.2010.08.001; Kellermann AL, 2013, HEALTH AFFAIR, V32, P2069, DOI 10.1377/hlthaff.2013.0683; Le ST, 2014, JAMA INTERN MED, V174, P1847, DOI 10.1001/jamainternmed.2014.3431; Lukas CV, 2007, HEALTH CARE MANAGE R, V32, P309, DOI 10.1097/01.HMR.0000296785.29718.5d	6	17	17	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 9	2019	321	14					1402	1403		10.1001/jama.2018.21812	http://dx.doi.org/10.1001/jama.2018.21812			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HT5PG	30888416				2022-12-28	WOS:000464615200020
J	Dyer, O				Dyer, Owen			Scientists call for moratorium on editing heritable genes	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		DYER O, 2019, BMJ-BRIT MED J, V364, DOI DOI 10.1136/BMJ.L346; DYER O, 2018, BMJ-BRIT MED J, V363, P4437, DOI DOI 10.1136/BMJ.K5113; Lander E, 2019, NATURE COMMENT	3	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 18	2019	364								l1256	10.1136/bmj.l1256	http://dx.doi.org/10.1136/bmj.l1256			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HQ7ZV	30885905				2022-12-28	WOS:000462643800012
J	Dryzek, JS; Bachtiger, A; Chambers, S; Cohen, J; Druckman, JN; Felicetti, A; Fishkin, JS; Farrell, DM; Fung, A; Gutmann, A; Landemore, H; Mansbridge, J; Marien, S; Neblo, MA; Niemeyer, S; Setala, M; Slothuus, R; Suiter, J; Thompson, D; Warren, ME				Dryzek, John S.; Baechtiger, Andre; Chambers, Simone; Cohen, Joshua; Druckman, James N.; Felicetti, Andrea; Fishkin, James S.; Farrell, David M.; Fung, Archon; Gutmann, Amy; Landemore, Helene; Mansbridge, Jane; Marien, Sofie; Neblo, Michael A.; Niemeyer, Simon; Setala, Maija; Slothuus, Rune; Suiter, Jane; Thompson, Dennis; Warren, Mark E.			The crisis of democracy and the science of deliberation	SCIENCE			English	Editorial Material									[Dryzek, John S.; Niemeyer, Simon] Univ Canberra, Canberra, ACT, Australia; [Baechtiger, Andre] Univ Stuttgart, Stuttgart, Germany; [Chambers, Simone] Univ Calif Irvine, Irvine, CA USA; [Cohen, Joshua] Apple Univ, Cupertino, CA USA; [Druckman, James N.] Northwestern Univ, Evanston, IL USA; [Felicetti, Andrea; Marien, Sofie] Katholieke Univ Leuven, Leuven, Belgium; [Fishkin, James S.] Stanford Univ, Stanford, CA 94305 USA; [Farrell, David M.] Univ Coll Dublin, Dublin, Ireland; [Fung, Archon; Mansbridge, Jane; Thompson, Dennis] Harvard Univ, Cambridge, MA 02138 USA; [Gutmann, Amy] Univ Penn, Phliadelphia, PA USA; [Landemore, Helene] Yale Univ, New Haven, CT USA; [Neblo, Michael A.] Ohio State Univ, Columbus, OH 43210 USA; [Setala, Maija] Univ Turku, Turku, Finland; [Slothuus, Rune] Aarhus Univ, Aarhus, Denmark; [Suiter, Jane] Dublin City Univ, Dublin, Ireland; [Warren, Mark E.] Univ British Columbia, Vancouver, BC, Canada	University of Canberra; University of Stuttgart; University of California System; University of California Irvine; Apple Inc; Northwestern University; KU Leuven; Stanford University; University College Dublin; Harvard University; University of Pennsylvania; Yale University; University System of Ohio; Ohio State University; University of Turku; Aarhus University; Dublin City University; University of British Columbia	Dryzek, JS (corresponding author), Univ Canberra, Canberra, ACT, Australia.	john.dryzek@canberra.edu.au	Felicetti, Andrea/AAL-1244-2021; Niemeyer, Simon/O-2663-2015; Marien, Sofie/M-9247-2016	Niemeyer, Simon/0000-0003-3048-5697; Felicetti, Andrea/0000-0001-7793-1012; Setala, Maija/0000-0002-9341-5584; Fishkin, James/0000-0002-3688-4800; Cohen, Joshua/0000-0003-1227-8416; Dryzek, John/0000-0001-6358-0047; Marien, Sofie/0000-0002-3060-621X	International Center for Cultural and Technological Studies (IZKT) of the University of Stuttgart; Australian Research Council [FL140100154]	International Center for Cultural and Technological Studies (IZKT) of the University of Stuttgart; Australian Research Council(Australian Research Council)	Financial support was provided by the International Center for Cultural and Technological Studies (IZKT) of the University of Stuttgart and the Australian Research Council (FL140100154). Competing interests: A. Fu. serves on the Board of Directors of Common Cause and Everyday Democracy and is an occasional consultant to Apple.	Achen ChristopherH., 2016, DEMOCRACY REALISTS, DOI DOI 10.1515/9781400882731; Bachtiger A., 2018, OXFORD HDB DELIBERAT; Brennan J, 2016, AGAINST DEMOCRACY, P1; Chambers S, 2018, CRIT REV, V30, P36, DOI 10.1080/08913811.2018.1466852; Druckman JN, 2013, AM POLIT SCI REV, V107, P57, DOI 10.1017/S0003055412000500; Druckman JN, 2003, AM J POLIT SCI, V47, P729, DOI 10.1111/1540-5907.00051; Ercan SA, 2019, POLICY POLIT, V47, P19, DOI 10.1332/030557318X15200933925405; Fishkin J.S., 2018, DEMOCRACY PEOPLE ARE; Gerber M, 2018, BRIT J POLIT SCI, V48, P1093, DOI 10.1017/S0007123416000144; Gronlund K, 2015, POLIT BEHAV, V37, P995, DOI 10.1007/s11109-015-9304-x; Landemore H., 2013, DEMOCRATIC REASON PO; Neblo M.A., 2018, POLITICS PEOPLE BUIL, V555; Niemeyer S, 2011, POLIT SOC, V39, P103, DOI 10.1177/0032329210395000; Pennycook G, 2019, P NATL ACAD SCI USA, V116, P2521, DOI 10.1073/pnas.1806781116; Ugarizza J. E., 2014, DEMOCRATIC DELIBERAT	15	134	137	7	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 15	2019	363	6432			SI		1144	1146		10.1126/science.aaw2694	http://dx.doi.org/10.1126/science.aaw2694			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HP0BC	30872504	Green Published			2022-12-28	WOS:000461329000023
J	Barambio, J; Brandariz, L				Barambio, Javier; Brandariz, Lorena			An Umbilical Nodule	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Barambio, Javier; Brandariz, Lorena] Hosp Univ Fdn Jimenez Diaz, Madrid, Spain		Barambio, J (corresponding author), Hosp Univ Fdn Jimenez Diaz, Madrid, Spain.	barambiocu90@gmail.com		Barambio Buendia, Javier/0000-0002-5174-2800					0	0	0	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 14	2019	380	11					1061	1061		10.1056/NEJMicm1809024	http://dx.doi.org/10.1056/NEJMicm1809024			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HO8NL	30865800				2022-12-28	WOS:000461210000010
J	Ray, KK; Bays, HE; Catapano, AL; Lalwani, ND; Bloedon, LT; Sterling, LR; Robinson, PL; Ballantyne, CM				Ray, Kausik K.; Bays, Harold E.; Catapano, Alberico L.; Lalwani, Narendra D.; Bloedon, LeAnne T.; Sterling, Lulu R.; Robinson, Paula L.; Ballantyne, Christie M.		CLEAR Harmony Trial	Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CITRATE LYASE; ROSUVASTATIN; ATORVASTATIN; MANAGEMENT; EZETIMIBE; ETC-1002; DISEASE	BACKGROUND Short-term studies have shown that bempedoic acid, an inhibitor of ATP citrate lyase, reduces levels of low-density lipoprotein (LDL) cholesterol. Data are limited regarding the safety and efficacy of bempedoic acid treatment in long-term studies involving patients with hypercholesterolemia who are receiving guideline-recommended statin therapy. METHODS We conducted a randomized, controlled trial involving patients with atherosclerotic cardiovascular disease, heterozygous familial hypercholesterolemia, or both. Patients had to have an LDL cholesterol level of at least 70 mg per deciliter while they were receiving maximally tolerated statin therapy with or without additional lipid-lowering therapy. (Maximally tolerated statin therapy was defined as the highest intensity statin regimen that a patient was able to maintain, as determined by the investigator.) Patients were randomly assigned in a 2: 1 ratio to receive bempedoic acid or placebo. The primary end point was safety, and the principal secondary end point (principal efficacy end point) was the percentage change in the LDL cholesterol level at week 12 of 52 weeks. RESULTS The trial involved 2230 patients, of whom 1488 were assigned to receive bempedoic acid and 742 to receive placebo. The mean (+/- SD) LDL cholesterol level at baseline was 103.2 +/- 29.4 mg per deciliter. The incidence of adverse events (1167 of 1487 patients [78.5%] in the bempedoic acid group and 584 of 742 [78.7%] in the placebo group) and serious adverse events (216 patients [14.5%] and 104 [14.0%], respectively) did not differ substantially between the two groups during the intervention period, but the incidence of adverse events leading to discontinuation of the regimen was higher in the bempedoic acid group than in the placebo group (162 patients [10.9%] vs. 53 [7.1%]), as was the incidence of gout (18 patients [1.2%] vs. 2 [0.3%]). At week 12, bempedoic acid reduced the mean LDL cholesterol level by 19.2 mg per deciliter, representing a change of -16.5% from baseline (difference vs. placebo in change from baseline, -18.1 percentage points; 95% confidence interval, -20.0 to -16.1; P<0.001). Safety and efficacy findings were consistent, regardless of the intensity of background statin therapy. CONCLUSIONS In this 52-week trial, bempedoic acid added to maximally tolerated statin therapy did not lead to a higher incidence of overall adverse events than placebo and led to significantly lower LDL cholesterol levels. (Funded by Esperion Therapeutics; CLEAR Harmony ClinicalTrials.gov number, NCT02666664.)	[Ray, Kausik K.] Imperial Coll London, Dept Primary Care & Publ Hlth, Imperial Ctr Cardiovasc Dis Prevent, St Dunstans Rd, London W6 8RP, England; [Bays, Harold E.] Louisville Metab & Atherosclerosis Res Ctr, Louisville, KY USA; [Catapano, Alberico L.] Univ Milan, Milan, Italy; [Catapano, Alberico L.] Multimed IRCCS, Milan, Italy; [Lalwani, Narendra D.; Bloedon, LeAnne T.; Sterling, Lulu R.; Robinson, Paula L.] Esper Therapeut, Ann Arbor, MI USA; [Ballantyne, Christie M.] Baylor Coll Med, Houston, TX 77030 USA	Imperial College London; L-MARC Research Center; University of Milan; IRCCS Multimedica; Baylor College of Medicine	Ray, KK (corresponding author), Imperial Coll London, Dept Primary Care & Publ Hlth, Imperial Ctr Cardiovasc Dis Prevent, St Dunstans Rd, London W6 8RP, England.	k.ray@imperial.ac.uk	Ray, Kausik/Z-2055-2019; Catapano, alberico/AAC-2827-2019; Ballantyne, Christie/A-6599-2008; Banach, Maciej/A-1271-2009; Birkenfeld, Andreas L./U-3954-2019	Catapano, alberico/0000-0002-7593-2094; Banach, Maciej/0000-0001-6690-6874; Birkenfeld, Andreas L./0000-0003-1407-9023; Ballantyne, Christie/0000-0002-6432-1730	Esperion Therapeutics	Esperion Therapeutics	Funded by Esperion Therapeutics; CLEAR Harmony ClinicalTrials.gov number, NCT02666664.	Authors/Task Force Members:, 2016, Atherosclerosis, V253, P281, DOI 10.1016/j.atherosclerosis.2016.08.018; Ballantyne CM, 2007, AM J CARDIOL, V99, P673, DOI 10.1016/j.amjcard.2006.10.022; Ballantyne CM, 2018, ATHEROSCLEROSIS, V277, P195, DOI 10.1016/j.atherosclerosis.2018.06.002; Ballantyne CM, 2016, AM J CARDIOL, V117, P1928, DOI 10.1016/j.amjcard.2016.03.043; Ballantyne CM, 2013, J AM COLL CARDIOL, V62, P1154, DOI 10.1016/j.jacc.2013.05.050; Bays HE, 2013, AM J CARDIOL, V112, P1885, DOI 10.1016/j.amjcard.2013.08.031; Danese MD, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013851; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Jacobson TA, 2015, J CLIN LIPIDOL, V9, P129, DOI 10.1016/j.jacl.2015.02.003; Nicholls SJ, 2010, AM J CARDIOL, V105, P69, DOI 10.1016/j.amjcard.2009.08.651; Pinkosky SL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13457; Steen DL, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013255; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Thompson PD, 2016, J CLIN LIPIDOL, V10, P556, DOI 10.1016/j.jacl.2015.12.025; Thompson PD, 2015, J CLIN LIPIDOL, V9, P295, DOI 10.1016/j.jacl.2015.03.003	16	290	297	3	34	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 14	2019	380	11					1022	1032		10.1056/NEJMoa1803917	http://dx.doi.org/10.1056/NEJMoa1803917			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HO8NL	30865796	Bronze, Green Submitted			2022-12-28	WOS:000461210000006
J	Zhao, FH; Qiao, YL				Zhao, Fanghui; Qiao, Youlin			Cervical cancer prevention in China: a key to cancer control	LANCET			English	Editorial Material									[Zhao, Fanghui; Qiao, Youlin] Chinese Acad Med Sci, Natl Canc Ctr, Beijing 100021, Peoples R China; [Zhao, Fanghui; Qiao, Youlin] Chinese Acad Med Sci, Canc Hosp, Beijing 100021, Peoples R China; [Qiao, Youlin] Zhengzhou Univ, Affiliated Canc Hosp, Zhengzhou, Henan, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Zhengzhou University	Zhao, FH (corresponding author), Chinese Acad Med Sci, Natl Canc Ctr, Beijing 100021, Peoples R China.; Zhao, FH (corresponding author), Chinese Acad Med Sci, Canc Hosp, Beijing 100021, Peoples R China.	zhaofangh@cicams.ac.cn	Qiao, You-Lin/B-4139-2012	Qiao, You-Lin/0000-0001-6380-0871; Zhao, Fang-Hui/0000-0001-9294-0005				[Anonymous], 2018, LANCET, p[392, 360]; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Colombara DV, 2013, VACCINE, V31, P4057, DOI 10.1016/j.vaccine.2013.06.031; National Institutes for Food and Drug Control, CHIN NAT I FOOD DRUG; Pan XF, 2016, LANCET INFECT DIS, V16, P1322, DOI 10.1016/S1473-3099(16)30450-9; World Health Organization, WHO PREQ VITR DIAGN; World Health Organization, HLTH CHIN 2030 VIS A; World Health Organization, WHO DIR GEN CALLS AL; Zhang YR, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2873-8	9	59	70	5	45	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 9	2019	393	10175					969	970		10.1016/S0140-6736(18)32849-6	http://dx.doi.org/10.1016/S0140-6736(18)32849-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HO0OW	30860036				2022-12-28	WOS:000460604200010
J	Adepoju, P				Adepoju, Paul			Nigeria's unending war with Lassa fever	LANCET			English	Editorial Material														Adepoju, Paul/0000-0003-1323-3017					0	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 16	2019	393	10172					627	628		10.1016/S0140-6736(19)30357-5	http://dx.doi.org/10.1016/S0140-6736(19)30357-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HL6AX	30833112				2022-12-28	WOS:000458817300013
J	Herguedas, B; Watson, JF; Ho, HZ; Cais, O; Garcia-Nafria, J; Greger, IH				Herguedas, Beatriz; Watson, Jake F.; Ho, Hinze; Cais, Ondrej; Garcia-Nafria, Javier; Greger, Ingo H.			Architecture of the heteromeric GluA1/2 AMPA receptor in complex with the auxiliary subunit TARP gamma 8	SCIENCE			English	Article							HIPPOCAMPAL SYNAPTIC PLASTICITY; GLUTAMATE-RECEPTOR; CRYSTAL-STRUCTURE; POINT MUTATION; STRUCTURAL DETERMINANTS; KINETIC-PROPERTIES; TERMINAL DOMAIN; ION FLOW; ACTIVATION; PORE	AMPA-type glutamate receptors (AMPARs) mediate excitatory neurotransmission and are central regulators of synaptic plasticity, a molecular mechanism underlying learning and memory. Although AMPARs act predominantly as heteromers, structural studies have focused on homomeric assemblies. Here, we present a cryo-electron microscopy structure of the heteromeric GluA1/2 receptor associated with two transmembrane AMPAR regulatory protein (TARP) gamma 8 auxiliary subunits, the principal AMPAR complex at hippocampal synapses. Within the receptor, the core subunits arrange to give the GluA2 subunit dominant control of gating. This structure reveals the geometry of the Q/R site that controls calcium flux, suggests association of TARP-stabilized lipids, and demonstrates that the extracellular loop of gamma 8 modulates gating by selectively interacting with the GluA2 ligand-binding domain. Collectively, this structure provides a blueprint for deciphering the signal transduction mechanisms of synaptic AMPARs.	[Herguedas, Beatriz; Watson, Jake F.; Ho, Hinze; Cais, Ondrej; Greger, Ingo H.] Med Res Council MRC Lab Mol Biol, Neurobiol Div, Cambridge, England; [Garcia-Nafria, Javier] MRC Lab Mol Biol, Struct Studies Div, Cambridge, England	MRC Laboratory Molecular Biology	Herguedas, B; Greger, IH (corresponding author), Med Res Council MRC Lab Mol Biol, Neurobiol Div, Cambridge, England.	hergueda@mrc-lmb.cam.ac.uk; ig@mrc-lmb.cam.ac.uk	Garcia, Javier/R-5524-2019; Herguedas, Beatriz/AAB-8665-2022	Garcia, Javier/0000-0002-4254-3148; Watson, Jake/0000-0002-8698-3823; Herguedas, Beatriz/0000-0003-2044-4795; Greger, Ingo/0000-0002-7291-2581; Ho, Hinze/0000-0003-1082-9851	Medical Research Council [MC_U105174197]; Heptares Therapeutics; MRC [MC_U105197215, MC_U105174197] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Heptares Therapeutics; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the Medical Research Council to I.H.G. (MC_U105174197). J.G.-N. is funded by Heptares Therapeutics.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; BOWIE D, 1995, NEURON, V15, P453, DOI 10.1016/0896-6273(95)90049-7; Burnley T, 2017, ACTA CRYSTALLOGR D, V73, P469, DOI 10.1107/S2059798317007859; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Chen L, 2014, SCIENCE, V345, P1021, DOI 10.1126/science.1258409; Chen SS, 2017, CELL, V170, P1234, DOI 10.1016/j.cell.2017.07.045; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cho CH, 2007, NEURON, V55, P890, DOI 10.1016/j.neuron.2007.08.024; Coombs ID, 2017, CELL REP, V20, P1123, DOI 10.1016/j.celrep.2017.07.014; Davies B, 2017, HUM MOL GENET, V26, P3869, DOI 10.1093/hmg/ddx270; Dawe GB, 2016, NEURON, V89, P1264, DOI 10.1016/j.neuron.2016.01.038; Diaz-Alonso J, 2017, P NATL ACAD SCI USA, V114, P7136, DOI 10.1073/pnas.1707472114; Durr KL, 2014, CELL, V158, P778, DOI 10.1016/j.cell.2014.07.023; Elegheert J, 2016, SCIENCE, V353, P295, DOI 10.1126/science.aae0104; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Garcia-Nafria J, 2016, SCI REP-UK, V6, DOI 10.1038/srep27459; Granger AJ, 2013, NATURE, V493, P495, DOI 10.1038/nature11775; Greger IH, 2002, NEURON, V34, P759, DOI 10.1016/S0896-6273(02)00693-1; Greger IH, 2017, NEURON, V94, P713, DOI 10.1016/j.neuron.2017.04.009; Hastie P, 2013, P NATL ACAD SCI USA, V110, P5163, DOI 10.1073/pnas.1218765110; Hawken NM, 2017, J PHYSIOL-LONDON, V595, P6517, DOI 10.1113/JP274897; Hayashi T, 2005, NEURON, V47, P709, DOI 10.1016/j.neuron.2005.06.035; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; He XY, 2016, P NATL ACAD SCI USA, V113, pE5645, DOI 10.1073/pnas.1524358113; Herguedas B, 2016, SCIENCE, V352, DOI 10.1126/science.aad3873; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; Huganir RL, 2013, NEURON, V80, P704, DOI 10.1016/j.neuron.2013.10.025; HUME RI, 1991, SCIENCE, V253, P1028, DOI 10.1126/science.1653450; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Jin RS, 2009, EMBO J, V28, P1812, DOI 10.1038/emboj.2009.140; KAMBOJ SK, 1995, J PHYSIOL-LONDON, V486, P297, DOI 10.1113/jphysiol.1995.sp020812; Karakas E, 2014, SCIENCE, V344, P992, DOI 10.1126/science.1251915; Kato AS, 2016, NAT MED, V22, P1496, DOI 10.1038/nm.4221; Kato AS, 2010, NEURON, V68, P1082, DOI 10.1016/j.neuron.2010.11.026; Kazi R, 2014, NAT NEUROSCI, V17, P914, DOI 10.1038/nn.3724; KOH DS, 1995, J PHYSIOL-LONDON, V486, P305, DOI 10.1113/jphysiol.1995.sp020813; Kubala MH, 2010, PROTEIN SCI, V19, P2389, DOI 10.1002/pro.519; Lee CH, 2014, NATURE, V511, P191, DOI 10.1038/nature13548; Lee MR, 2017, ACS CHEM NEUROSCI, V8, P2631, DOI 10.1021/acschemneuro.7b00186; Liu HQ, 2015, J STRUCT BIOL, V192, P14, DOI 10.1016/j.jsb.2015.09.001; LOMELI H, 1994, SCIENCE, V266, P1709, DOI 10.1126/science.7992055; Lu W, 2009, NEURON, V62, P254, DOI 10.1016/j.neuron.2009.02.027; Maher MP, 2016, J PHARMACOL EXP THER, V357, P394, DOI 10.1124/jpet.115.231712; Meyerson JR, 2016, NATURE, V537, P567, DOI 10.1038/nature19352; Milstein AD, 2007, NEURON, V55, P905, DOI 10.1016/j.neuron.2007.08.022; MISHINA M, 1991, BIOCHEM BIOPH RES CO, V180, P813, DOI 10.1016/S0006-291X(05)81137-4; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nakagawa T, 2005, NATURE, V433, P545, DOI 10.1038/nature03328; Nicholls RA, 2012, ACTA CRYSTALLOGR D, V68, P404, DOI 10.1107/S090744491105606X; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Riva I, 2017, ELIFE, V6, DOI 10.7554/eLife.28680; Rossmann M, 2011, EMBO J, V30, P959, DOI 10.1038/emboj.2011.16; Rouach N, 2005, NAT NEUROSCI, V8, P1525, DOI 10.1038/nn1551; Schwenk J, 2014, NEURON, V84, P41, DOI 10.1016/j.neuron.2014.08.044; Schwenk J, 2012, NEURON, V74, P621, DOI 10.1016/j.neuron.2012.03.034; Shi Y, 2009, NEURON, V62, P633, DOI 10.1016/j.neuron.2009.05.016; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; Song XQ, 2018, NATURE, V556, P515, DOI 10.1038/s41586-018-0039-9; Sukumaran M, 2011, EMBO J, V30, P972, DOI 10.1038/emboj.2011.17; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Suzuki H, 2014, SCIENCE, V344, P304, DOI 10.1126/science.1248571; Swanson GT, 1997, J NEUROSCI, V17, P58, DOI 10.1523/JNEUROSCI.17-01-00058.1997; Tomita S, 2005, NATURE, V435, P1052, DOI 10.1038/nature03624; Tomita S, 2003, J CELL BIOL, V161, P805, DOI 10.1083/jcb.200212116; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Twomey EC, 2017, NEURON, V94, P569, DOI 10.1016/j.neuron.2017.04.025; Twomey EC, 2016, SCIENCE, V353, P83, DOI 10.1126/science.aaf8411; VERDOORN TA, 1991, SCIENCE, V252, P1715, DOI 10.1126/science.1710829; Watson JF, 2017, ELIFE, V6, DOI 10.7554/eLife.23024; Wilding TJ, 2005, J NEUROSCI, V25, P9470, DOI 10.1523/JNEUROSCI.2826-05.2005; Yelshansky MV, 2004, J NEUROSCI, V24, P4728, DOI 10.1523/JNEUROSCI.0757-04.2004; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805; Zhao HY, 2017, ELIFE, V6, DOI 10.7554/eLife.32056; Zhao Y, 2016, NATURE, V536, P108, DOI 10.1038/nature18961; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zhou ZK, 2018, NAT NEUROSCI, V21, P50, DOI 10.1038/s41593-017-0030-z; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166; 2004, J COMPUT CHEM, V25, P1605, DOI DOI 10.1002/JCC.20084	87	55	55	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 26	2019	364	6438					352	+	eaav9011	10.1126/science.aav9011	http://dx.doi.org/10.1126/science.aav9011			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HU9VW	30872532	Green Accepted			2022-12-28	WOS:000465643400037
J	Wang, SX; Veller, C; Sun, F; Ruiz-Herrera, A; Shang, YL; Liu, HB; Zickler, D; Chen, ZJ; Kleckner, N; Zhang, LR				Wang, Shunxin; Veller, Carl; Sun, Fei; Ruiz-Herrera, Aurora; Shang, Yongliang; Liu, Hongbin; Zickler, Denise; Chen, Zijiang; Kleckner, Nancy; Zhang, Liangran			Per-Nucleus Crossover Covariation and Implications for Evolution	CELL			English	Article							INDIVIDUAL CHROMOSOMES; COHESIN SMC1-BETA; RECOMBINATION; SEX; INTERFERENCE; PROTEIN; ADAPTATION; ANEUPLOIDY; ADVANTAGE; FREQUENCY	Crossing over is a nearly universal feature of sexual reproduction. Here, analysis of crossover numbers on a per-chromosome and per-nucleus basis reveals a fundamental, evolutionarily conserved feature of meiosis: within individual nuclei, crossover frequencies covary across different chromosomes. This effect results from per-nucleus covariation of chromosome axis lengths. Crossovers can promote evolutionary adaptation. However, the benefit of creating favorable new allelic combinations must outweigh the cost of disrupting existing favorable combinations. Covariation concomitantly increases the frequencies of gametes with especially high, or especially low, numbers of crossovers, and thus might concomitantly enhance the benefits of crossing over while reducing its costs. A four-locus population genetic model suggests that such an effect can pertain in situations where the environment fluctuates: hyper-crossover gametes are advantageous when the environment changes while hypo-crossover gametes are advantageous in periods of environmental stasis. These findings reveal a new feature of the basic meiotic program and suggest a possible adaptive advantage.	[Wang, Shunxin; Shang, Yongliang; Liu, Hongbin; Chen, Zijiang; Zhang, Liangran] Shandong Univ, Natl Res Ctr Assisted Reprod Technol & Reprod Gen, Ctr Reprod Med, Minist Educ,Key Lab Reprod Endocrinol, Jinan 250001, Shandong, Peoples R China; [Veller, Carl] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Veller, Carl] Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA; [Sun, Fei] Nantong Univ, Sch Med, Inst Reprod Med, Nantong, Jiangsu, Peoples R China; [Ruiz-Herrera, Aurora] Univ Autonoma Barcelona, IBB, Genome Integr & Instabil Grp, Barcelona, Spain; [Ruiz-Herrera, Aurora] Univ Autonoma Barcelona, Dept Biol Cellular Fisiol & Immunol, Barcelona, Spain; [Zickler, Denise] Univ Paris Saclay, Univ Paris Sud, CEA, CNRS,Inst Integrat Biol Cell I2BC, F-91198 Gif Sur Yvette, France; [Kleckner, Nancy] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Zhang, Liangran] Shandong Univ, Adv Med Res Inst, Jinan 250014, Shandong, Peoples R China; [Zhang, Liangran] Shandong Univ, State Key Lab Microbial Technol, Qingdao 266237, Shandong, Peoples R China	Shandong University; Harvard University; Harvard University; Nantong University; Autonomous University of Barcelona; Autonomous University of Barcelona; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Harvard University; Shandong University; Shandong University	Wang, SX; Zhang, LR (corresponding author), Shandong Univ, Natl Res Ctr Assisted Reprod Technol & Reprod Gen, Ctr Reprod Med, Minist Educ,Key Lab Reprod Endocrinol, Jinan 250001, Shandong, Peoples R China.; Kleckner, N (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.; Zhang, LR (corresponding author), Shandong Univ, Adv Med Res Inst, Jinan 250014, Shandong, Peoples R China.; Zhang, LR (corresponding author), Shandong Univ, State Key Lab Microbial Technol, Qingdao 266237, Shandong, Peoples R China.	shunxinwang@sdu.edu.cn; kleckner@fas.harvard.edu; zhangliangran@sdu.edu.cn	Yan, Junhao/AAH-8310-2019; Chen, Zi-Jiang/GOE-6119-2022; Ruiz-Herrera, Aurora/K-3728-2012; Li, Yuan/GXV-1310-2022	Ruiz-Herrera, Aurora/0000-0003-3868-6151; 	National Key Research & Development Program of China [2018YFC1003400, 2018YFC1003700]; National Natural Science Foundation of China [31671293, 31771385, 81430027]; Taishan Scholars Youth Project of Shandong Province [JQ201605]; Shandong Provincial Natural Science Foundation of China [JQ201605]; NIH [RO1 GM044794]; I2BC; National Key Research and Development Program of China [2018YFC1003500];  [CGL2014-54317-P];  [CGL2017-83802-P];  [BFU2015-71786-REDT]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044794] Funding Source: NIH RePORTER	National Key Research & Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Taishan Scholars Youth Project of Shandong Province; Shandong Provincial Natural Science Foundation of China(Natural Science Foundation of Shandong Province); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); I2BC; National Key Research and Development Program of China; ; ; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Brian Charlesworth, Nate Edelman, David Haig, and Matthew Meselson for suggestions and comments on this manuscript. This work, S.W., Y.S., and L.Z. were supported by National Key Research & Development Program of China (2018YFC1003400 and 2018YFC1003700), National Natural Science Foundation of China (projects 31671293 and 31771385), and Taishan Scholars Youth Project of Shandong Province and Shandong Provincial Natural Science Foundation of China (Project JQ201605). C.V. was supported by a stipend from the Department of Organismic and Evolutionary Biology and the Program for Evolutionary Dynamics, Harvard University. This work was also supported by grants to N.K. and D.Z. (NIH RO1 GM044794), D.Z. (Unite Mixte de Recherche 8621, now I2BC), F.S. (National Key Research and Development Program of China, 2018YFC1003500, National Natural Science Foundation of China, 81430027), and A. R.-H. (CGL2014-54317-P, CGL2017-83802-P, and BFU2015-71786-REDT).	Anderson LK, 2014, P NATL ACAD SCI USA, V111, P13415, DOI 10.1073/pnas.1406846111; [Anonymous], 2019, SCIENCE, DOI [DOI 10.1126/science.aaw2090, DOI 10.1126/SCIENCE.AAW2090]; BARTON NH, 1995, GENET RES, V65, P123, DOI 10.1017/S0016672300033140; Barton NH, 1998, SCIENCE, V281, P1986, DOI 10.1126/science.281.5385.1986; BELL G, 1982, MASTERPIECE NATURE E; Brandvain Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004410; CHARLESWORTH B, 1976, GENETICS, V83, P181; CHARLESWORTH B, 1993, GENETICS, V134, P1289; Cole F, 2012, ANN NY ACAD SCI, V1267, P95, DOI 10.1111/j.1749-6632.2012.06595.x; Cole F, 2012, NAT CELL BIOL, V14, P424, DOI 10.1038/ncb2451; De Muyt A, 2014, GENE DEV, V28, P1111, DOI 10.1101/gad.240408.114; FELSENSTEIN J, 1974, GENETICS, V78, P737; Fung JC, 2004, CELL, V116, P795, DOI 10.1016/S0092-8674(04)00249-1; Gruhn JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085075; Hadany L, 2003, GENETICS, V165, P2167; HAMILTON WD, 1990, P NATL ACAD SCI USA, V87, P3566, DOI 10.1073/pnas.87.9.3566; Harris K, 2016, GENETICS, V203, P881, DOI 10.1534/genetics.116.186890; HILL WG, 1966, GENET RES, V8, P269, DOI 10.1017/S0016672300010156; Hou Y, 2013, CELL, V155, P1492, DOI 10.1016/j.cell.2013.11.040; Hunter N, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016618; Jones GH, 2006, CELL, V126, P246, DOI 10.1016/j.cell.2006.07.010; KARLIN S, 1974, THEOR POPUL BIOL, V5, P59, DOI 10.1016/0040-5809(74)90052-5; Kauppi L, 2011, SCIENCE, V331, P916, DOI 10.1126/science.1195774; Kleckner N, 2006, CHROMOSOMA, V115, P175, DOI 10.1007/s00412-006-0055-7; Kleckner N, 2004, P NATL ACAD SCI USA, V101, P12592, DOI 10.1073/pnas.0402724101; Kleckner N, 2003, TRENDS GENET, V19, P623, DOI 10.1016/j.tig.2003.09.004; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kong A, 2014, NAT GENET, V46, P11, DOI 10.1038/ng.2833; LAURIE DA, 1985, ANN HUM GENET, V49, P189, DOI 10.1111/j.1469-1809.1985.tb01693.x; Lenormand T, 2003, GENETICS, V163, P811; Lhuissier FGP, 2007, PLANT CELL, V19, P862, DOI 10.1105/tpc.106.049106; Lian J, 2008, HUM MOL GENET, V17, P2583, DOI 10.1093/hmg/ddn158; Lu SJ, 2012, SCIENCE, V338, P1627, DOI 10.1126/science.1229112; Lynn A, 2004, ANNU REV GENOM HUM G, V5, P317, DOI 10.1146/annurev.genom.4.070802.110217; Mancera E, 2008, NATURE, V454, P479, DOI 10.1038/nature07135; Marcon E, 2003, GENETICS, V165, P2283; Martin SH, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.2006288; MAYNARD SMITH J., 1978, EVOLUTION SEX; McDonald MJ, 2016, NATURE, V531, P233, DOI 10.1038/nature17143; Mets DG, 2009, CELL, V139, P73, DOI 10.1016/j.cell.2009.07.035; Novak I, 2008, J CELL BIOL, V180, P83, DOI 10.1083/jcb.200706136; Oliver-Bonet M, 2007, MOL HUM REPROD, V13, P837, DOI 10.1093/molehr/gam076; Otto SP, 2009, AM NAT, V174, pS1, DOI 10.1086/599084; Otto SP, 2004, SCIENCE, V304, P1018, DOI 10.1126/science.1094072; Ottolini CS, 2015, NAT GENET, V47, P727, DOI 10.1038/ng.3306; Revenkova E, 2004, NAT CELL BIOL, V6, P555, DOI 10.1038/ncb1135; Ruiz-Herrera A, 2017, CHROMOSOMA, V126, P615, DOI 10.1007/s00412-016-0624-3; SASAKI A, 1987, GENETICS, V115, P377; Schumer M, 2018, SCIENCE, V360, P656, DOI 10.1126/science.aar3684; Segura J, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1945; Sharp NP, 2016, BIOESSAYS, V38, P751, DOI 10.1002/bies.201600074; Stack SM, 2009, CYTOGENET GENOME RES, V124, P339, DOI 10.1159/000218137; Stapley J, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2017.0279; Storlazzi A, 2003, GENE DEV, V17, P2675, DOI 10.1101/gad.275203; Sun F, 2006, HUM MOL GENET, V15, P2376, DOI 10.1093/hmg/ddl162; Tease C, 2004, CYTOGENET GENOME RES, V107, P208, DOI 10.1159/000080599; Tesse S, 2003, P NATL ACAD SCI USA, V100, P12865, DOI 10.1073/pnas.2034282100; Veller C, 2019, P NATL ACAD SCI USA, V116, P1659, DOI 10.1073/pnas.1817482116; Wang JB, 2012, CELL, V150, P402, DOI 10.1016/j.cell.2012.06.030; Wang S, 2017, CELL, V168, P977, DOI 10.1016/j.cell.2017.02.002; Wang SX, 2015, CELL CYCLE, V14, P305, DOI 10.4161/15384101.2014.991185; White MA, 2017, METHODS MOL BIOL, V1471, P305, DOI 10.1007/978-1-4939-6340-9_18; Williams G.C., 1975, Journal Cell Biol, VNo. 8, pi; Wiser MJ, 2013, SCIENCE, V342, P1364, DOI 10.1126/science.1243357; Zhang LR, 2014, P NATL ACAD SCI USA, V111, pE5059, DOI 10.1073/pnas.1416411111; Zhang LR, 2014, NATURE, V511, P551, DOI 10.1038/nature13442; Zhang LR, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004042; ZHAO HY, 1995, GENETICS, V139, P1057; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603	69	39	39	1	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 4	2019	177	2					326	+		10.1016/j.cell.2019.02.021	http://dx.doi.org/10.1016/j.cell.2019.02.021			29	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	HR7PF	30879787	Green Accepted, Bronze			2022-12-28	WOS:000463346200012
J	Robert, M; Espalieu, P; Pelascini, E; Caiazzo, R; Sterkers, A; Khamphommala, L; Poghosyan, T; Chevallier, JM; Malherbe, V; Chouillard, E; Reche, F; Torcivia, A; Maucort-Boulch, D; Bin-Dorel, S; Langlois-Jacques, C; Delaunay, D; Pattou, F; Disse, E				Robert, Maud; Espalieu, Philippe; Pelascini, Elise; Caiazzo, Robert; Sterkers, Adrien; Khamphommala, Lita; Poghosyan, Tigran; Chevallier, Jean-Marc; Malherbe, Vincent; Chouillard, Elie; Reche, Fabian; Torcivia, Adriana; Maucort-Boulch, Delphine; Bin-Dorel, Sylvie; Langlois-Jacques, Carole; Delaunay, Dominique; Pattou, Francois; Disse, Emmanuel			Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass for obesity (YOMEGA): a multicentre, randomised, open-label, non-inferiority trial	LANCET			English	Article							BILIOPANCREATIC LIMB LENGTH; QUALITY-OF-LIFE; BARIATRIC SURGERY; MEDICAL THERAPY; MORBID-OBESITY; WEIGHT-LOSS; FOLLOW-UP; REFLUX; IMPACT; RISK	Background One anastomosis gastric bypass (OAGB) is increasingly used in the treatment of morbid obesity. However, the efficacy and safety outcomes of this procedure remain debated. We report the results of a randomised trial (YOMEGA) comparing the outcomes of OAGB versus standard Roux-en-Y gastric bypass (RYGB). Methods This prospective, multicentre, randomised non-inferiority trial, was held in nine obesity centres in France. Patients were eligible for inclusion if their body-mass index (BMI) was 40 kg/m2 or higher, or 35 kg/m2 or higher with the presence of at least one comorbidity (type 2 diabetes, high blood pressure, obstructive sleep apnoea, dyslipidaemia, or arthritis), and were aged 18-65 years. Key exclusion criteria were a history of oesophagitis, Barrett's oesophagus, severe gastro-oesophageal reflux disease resistant to proton-pump inhibitors, and previous bariatric surgery. Participants were randomly assigned (1:1) to OAGB or RYGB, stratified by centre with blocks of variable size; the study was open-label, with no masking required. RYGB consisted of a 150 cm alimentary limb and a 50 cm biliary limb and OAGB of a single gastrojejunal anastomosis with a 200 cm biliopancreatic limb. The primary endpoint was percentage excess BMI loss at 2 years. The primary endpoint was assessed in the per-protocol population and safety was assessed in all randomised participants. This study is registered with ClinicalTrials.gov, number NCT02139813, and is now completed. Findings From May 13, 2014, to March 2, 2016, of 261 patients screened for eligibility, 253 (97%) were randomly assigned to OAGB (n=129) or RYGB (n=124). Five patients did not undergo their assigned surgery, and after undergoing their surgery 14 were excluded from the per-protocol analysis (seven due to pregnancy, two deaths, one withdrawal, and four revisions from OAGB to RYGB) In the per-protocol population (n=117 OAGB, n=117 RYGB), mean age was 43.5 years (SD 10.8), mean BMI was 43.9 kg/m2 (SD 5.6), 176 (75%) of 234 participants were female, and 58 (27%) of 211 with available data had type 2 diabetes. After 2 years, mean percentage excess BMI loss was 87.9% (SD 23.6) in the OAGB group and 85.8% (SD 23.1) in the RYGB group, confirming non-inferiority of OAGB (mean difference 3.3%, 95% CI 9.1 to 2.6). 66 serious adverse events associated with surgery were reported (24 in the RYGB group vs 42 in the OAGB group; p=0.042), of which nine (21.4%) in the OAGB group were nutritional complications versus none in the RYGB group (p=0.0034). Interpretation OAGB is not inferior to RYGB regarding weight loss and metabolic improvement at 2 years. Higher incidences of diarrhoea, steatorrhoea, and nutritional adverse events were observed with a 200 cm biliopancreatic limb OAGB, suggesting a malabsorptive effect. Funding French Ministry of Health. Copyright (C) 2019 Elsevier Ltd. All rights reserved.	[Robert, Maud; Pelascini, Elise; Delaunay, Dominique] Hosp Civils Lyon, Hop Edouard Herriot, Dept Digest & Bariatr Surg, F-69437 Lyon, France; [Espalieu, Philippe] Hop Prive Loire, St Etienne, France; [Robert, Maud; Disse, Emmanuel] Univ Claude Bernard Lyon 1, INSERM 1060, CarMeN Lab, Lyon, France; [Caiazzo, Robert; Pattou, Francois] Huriez Hosp, Gen & Endocrine Surg Dept, Lille, France; [Caiazzo, Robert; Pattou, Francois] Lille Univ, INSERM Lille, European Genom Inst Diabet, Lille, France; [Sterkers, Adrien; Khamphommala, Lita] Ctr Hosp Prive St Gregoire, Dept Digest, Hepatobiliary Surg, St Gregoire, France; [Poghosyan, Tigran; Chevallier, Jean-Marc] Hop Europeen Georges Pompidou, Digest Surg Dept, Paris, France; [Malherbe, Vincent] Hop Prive Drome & Ardeche, Gen & Endocrine Surg Dept, Guilherand Granges, France; [Chouillard, Elie] Ctr Hosp Intercommunal Poissy St Germain En Laye, Dept Gen & Digest Surg, St Germain En Laye, France; [Reche, Fabian] CHU Grenoble, Digest Surg Dept, Grenoble, France; [Torcivia, Adriana] Hop La Pitie Salpetriere, Dept Digest, Hepatobiliary Surg, Paris, France; [Maucort-Boulch, Delphine; Langlois-Jacques, Carole] Hosp Civils Lyon, Ctr Hosp Lyon Sud, Biostat Dept, Pierre Benite, France; [Disse, Emmanuel] Hosp Civils Lyon, Ctr Hosp Lyon Sud, Specialized Ctr Obes Management, Dept Endocrinol Diabetol & Nutr, Pierre Benite, France; [Bin-Dorel, Sylvie] Hosp Civils Lyon, Clin Res Unit, Lyon, France	CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Universite de Lille - ISITE; CHU Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Lyon; CHU Lyon; CHU Lyon	Robert, M (corresponding author), Hosp Civils Lyon, Hop Edouard Herriot, Dept Digest & Bariatr Surg, F-69437 Lyon, France.	maud.robert@chu-lyon.fr	caiazzo, robert/Y-9692-2019; Pattou, Francois/O-6151-2017; Carmen, Team1/Y-7382-2019	caiazzo, robert/0000-0001-5383-0540; Pattou, Francois/0000-0001-8388-3766; Carmen, Team1/0000-0003-4234-1746; Poghosyan, Tigran/0000-0002-7103-1088; Lab, Carmen/0000-0002-5935-3236	French Ministry of Health	French Ministry of Health	French Ministry of Health.	Ahuja A, 2018, OBES SURG, V28, P3439, DOI 10.1007/s11695-018-3405-7; Betry C, 2017, JPEN-PARENTER ENTER, V41, P258, DOI 10.1177/0148607116637935; Bruzzi M, 2017, OBES SURG, V27, P1119, DOI 10.1007/s11695-017-2577-x; DeMaria EJ, 2010, SURG OBES RELAT DIS, V6, P347, DOI 10.1016/j.soard.2009.11.015; Disse E, 2014, OBES SURG, V24, P841, DOI 10.1007/s11695-014-1180-7; EYPASCH E, 1995, BRIT J SURG, V82, P216, DOI 10.1002/bjs.1800820229; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Fisher BL, 2001, OBES SURG, V11, P773; Fried M, 2007, INT J OBESITY, V31, P569, DOI 10.1038/sj.ijo.0803560; Genser L, 2017, LANGENBECK ARCH SURG, V402, P1263, DOI 10.1007/s00423-017-1615-4; Kolotkin RL, 2001, OBES RES, V9, P102, DOI 10.1038/oby.2001.13; Lee WJ, 2012, OBES SURG, V22, P1827, DOI 10.1007/s11695-012-0726-9; Lee WJ, 2005, ANN SURG, V242, P20, DOI 10.1097/01.sla.0000167762.46568.98; Little R. J. A., 2002, STAT ANAL MISSING DA; Magouliotis DE, 2018, CLIN OBES, V8, P159, DOI 10.1111/cob.12246; Mahawar KK, 2017, OBES SURG, V27, P2222, DOI 10.1007/s11695-017-2663-0; Mahawar KK, 2017, OBES SURG, V27, P1882, DOI 10.1007/s11695-017-2695-5; Mahawar KK, 2018, J MINIM ACCESS SURG, V14, P37, DOI 10.4103/jmas.JMAS_198_16; MASON EE, 1967, SURG CLIN N AM, V47, P1345; Mccarthy T G, 1985, Adv Contracept Deliv Syst, P113; Mechanick JI, 2008, SURG OBES RELAT DIS, V4, pS109, DOI 10.1016/j.soard.2008.08.009; Mingrone G, 2015, LANCET, V386, P964, DOI 10.1016/S0140-6736(15)00075-6; Nini E, 2002, ANN CHIR, V127, P107, DOI 10.1016/S0003-3944(01)00688-5; Nishijima K, 2004, ANN SURG, V240, P57, DOI 10.1097/01.sla.0000130850.31178.8c; Poghosyan T, 2017, SURG OBES RELAT DIS, V13, P988, DOI 10.1016/j.soard.2016.12.003; Ribaric G, 2014, OBES SURG, V24, P437, DOI 10.1007/s11695-013-1160-3; Ruiz-Tovar J, 2019, SURG ENDOSC, V33, P401, DOI 10.1007/s00464-018-6307-9; Rutledge R, 2001, OBES SURG, V11, P276, DOI 10.1381/096089201321336584; Santry HP, 2005, JAMA-J AM MED ASSOC, V294, P1909, DOI 10.1001/jama.294.15.1909; Schauer PR, 2014, NEW ENGL J MED, V370, P2002, DOI [10.1056/NEJMoa1401329, 10.1056/NEJMc1407393]; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Spaniolas K, 2015, OBES SURG, V25, P1544, DOI 10.1007/s11695-015-1764-x; VISTE A, 1986, LANCET, V2, P502	33	184	189	7	52	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 30	2019	393	10178					1299	1309		10.1016/S0140-6736(19)30475-1	http://dx.doi.org/10.1016/S0140-6736(19)30475-1			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HR2LJ	30851879	Green Published			2022-12-28	WOS:000462967700026
J	Dyer, C				Dyer, Clare			Trust did not need to suspend proceedings against anaesthetist while police investigated his actions, say judges	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		DYER C, 2018, BMJ-BRIT MED J, V361, DOI DOI 10.1136/BMJ.K2643	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 20	2019	364								l1300	10.1136/bmj.l1300	http://dx.doi.org/10.1136/bmj.l1300			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HQ8AJ	30894341				2022-12-28	WOS:000462645500017
J	Iacobucci, G				Iacobucci, Gareth			Brexit: GP leaders plead for government to "sort it out" to protect patients	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 20	2019	364								l1295	10.1136/bmj.l1295	http://dx.doi.org/10.1136/bmj.l1295			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HQ8AJ	30894347				2022-12-28	WOS:000462645500016
J	Pike, H				Pike, Harriet			Doctors' access to rest facilities included in GMC annual training surveys	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Chatfield C, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.l481; Health Education England, ENH WORK LIV; RIMMER A, 2018, BMJ-BRIT MED J, V362, DOI DOI 10.1136/BMJ.K3018	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 19	2019	364								l1261	10.1136/bmj.l1261	http://dx.doi.org/10.1136/bmj.l1261			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HQ7ZZ	30885909				2022-12-28	WOS:000462644400009
J	Forrister, DL; Endara, MJ; Younkin, GC; Coley, PD; Kursar, TA				Forrister, Dale L.; Endara, Maria-Jose; Younkin, Gordon C.; Coley, Phyllis D.; Kursar, Thomas A.			Herbivores as drivers of negative density dependence in tropical forest saplings	SCIENCE			English	Article							MASS-SPECTROMETRY DATA; SPECIES COEXISTENCE; LEAF DEVELOPMENT; MECHANISMS; GENUS; COMMUNITIES; SIMILARITY; DIVERSITY; MORTALITY; EVOLUTION	Ecological theory predicts that the high local diversity observed in tropical forests is maintained by negative density-dependent interactions within and between closely related plant species. By using long-term data on tree growth and survival for coexisting Inga (Fabaceae, Mimosoideae) congeners, we tested two mechanisms thought to underlie negative density dependence (NDD): competition for resources and attack by herbivores. We quantified the similarity of neighbors in terms of key ecological traits that mediate these interactions, as well as the similarity of herbivore communities. We show that phytochemical similarity and shared herbivore communities are associated with decreased growth and survival at the sapling stage, a key bottleneck in the life cycle of tropical trees. None of the traits associated with resource acquisition affect plant performance, indicating that competition between neighbors may not shape local tree diversity. These results suggest that herbivore pressure is the primary mechanism driving NDD at the sapling stage.	[Forrister, Dale L.; Endara, Maria-Jose; Younkin, Gordon C.; Coley, Phyllis D.; Kursar, Thomas A.] Univ Utah, Sch Biol Sci, Salt Lake City, UT 84112 USA; [Endara, Maria-Jose] Univ Tecnol Indoamer, Ctr Invest Biodiversidad & Cambio Climat BioCamb, Fac Ciencias Medio Ambiente, Quito, Ecuador; [Coley, Phyllis D.; Kursar, Thomas A.] Smithsonian Trop Res Inst, Balboa, Ancon, Panama	Utah System of Higher Education; University of Utah; Smithsonian Institution; Smithsonian Tropical Research Institute	Forrister, DL (corresponding author), Univ Utah, Sch Biol Sci, Salt Lake City, UT 84112 USA.	dale.forrister@utah.edu	Forrister, Dale/AAC-5164-2019	Forrister, Dale/0000-0001-8170-7187; Endara, Maria-Jose/0000-0002-8805-1456; Younkin, Gordon/0000-0002-3735-3534	NSF [DEB-0640630]; DIMENSIONS of Biodiversity [DEB-1135733]; NSF GRFP	NSF(National Science Foundation (NSF)); DIMENSIONS of Biodiversity(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NSF GRFP(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported by grants from the NSF (DEB-0640630 and DIMENSIONS of Biodiversity DEB-1135733) to P.D.C. and T.A.K. and NSF GRFP to D.L.F.	Agostinelli C, 2017, CIRCULAR STAT; Agrawal AA, 1999, ECOLOGY, V80, P1713, DOI 10.1890/0012-9658(1999)080[1713:IRTHIW]2.0.CO;2; AIDE TM, 1988, NATURE, V336, P574, DOI 10.1038/336574a0; AIDE TM, 1993, ECOLOGY, V74, P455, DOI 10.2307/1939307; Bagchi R, 2014, NATURE, V506, P85, DOI 10.1038/nature12911; Bagchi R, 2010, ECOL LETT, V13, P1262, DOI 10.1111/j.1461-0248.2010.01520.x; Barone JA, 1998, J ANIM ECOL, V67, P400, DOI 10.1046/j.1365-2656.1998.00197.x; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bivand R., 2017, SPATIAL DEPENDENCE W; Carson WP., 2008, TROPICAL FOREST COMM, P210; Cavender-Bares J, 2004, AM NAT, V163, P823, DOI 10.1086/386375; Chazdon Robin L., 1996, P5; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Coley PD, 2018, OECOLOGIA, V187, P361, DOI 10.1007/s00442-018-4080-z; Comita LS, 2014, J ECOL, V102, P845, DOI 10.1111/1365-2745.12232; Condit R., 1998, Tropical forest census plots: methods and results from Barro Colorado Island, Panama and a comparison with other plots.; Condit R., 2012, BARRO COLORADO FORES, DOI 10.5479/data.bci.20130603; CONNELL J H, 1971, P298; De Maesschalck R, 2000, CHEMOMETR INTELL LAB, V50, P1, DOI 10.1016/S0169-7439(99)00047-7; Denslow JS, 1998, J ECOL, V86, P597, DOI 10.1046/j.1365-2745.1998.00295.x; DeWaard Jeremy R., 2008, V410, P275; Dexter KG, 2017, P NATL ACAD SCI USA, V114, P2645, DOI 10.1073/pnas.1613655114; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Endara MJ, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01237; Endara MJ, 2018, NEW PHYTOL, V218, P847, DOI 10.1111/nph.15020; Endara MJ, 2017, P NATL ACAD SCI USA, V114, pE7499, DOI 10.1073/pnas.1707727114; Forister ML, 2015, P NATL ACAD SCI USA, V112, P442, DOI 10.1073/pnas.1423042112; Forrister D. L., 2019, HERBIVORES DRIVERS N, DOI [10.5281/zenodo.2571716, DOI 10.5281/ZENODO.2571716]; Forrister D. L., 2019, HERBIVORES DRIVERS N; Fortunel C, 2018, ECOLOGY, V99, P2272, DOI 10.1002/ecy.2441; Fricke EC, 2014, ECOL LETT, V17, P593, DOI 10.1111/ele.12261; Green PT, 2014, P NATL ACAD SCI USA, V111, P18649, DOI 10.1073/pnas.1321892112; Holt RD, 2017, ANNU REV ECOL EVOL S, V48, P447, DOI 10.1146/annurev-ecolsys-110316-022628; Hubbell S.P., 2010, BARRO COLORADO FORES; Hubbell SP, 1999, SCIENCE, V283, P554, DOI 10.1126/science.283.5401.554; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; JANZEN DH, 1988, BIOTROPICA, V20, P120, DOI 10.2307/2388184; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Jones M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019259; Wright SJ, 2010, ECOLOGY, V91, P3664, DOI 10.1890/09-2335.1; Kraft NJB, 2008, SCIENCE, V322, P580, DOI 10.1126/science.1160662; Kuhl C, 2012, ANAL CHEM, V84, P283, DOI 10.1021/ac202450g; Kursar TA, 2009, P NATL ACAD SCI USA, V106, P18073, DOI 10.1073/pnas.0904786106; Leigh E. G. J., 1999, TROPICAL FOREST ECOL, P46; Mangan SA, 2010, NATURE, V466, P752, DOI 10.1038/nature09273; Metz MR, 2010, ECOLOGY, V91, P3675, DOI 10.1890/08-2323.1; Morellato LPC, 2010, PHENOLOGICAL RESEARCH: METHODS FOR ENVIRONMENTAL AND CLIMATE CHANGE ANALYSIS, P339, DOI 10.1007/978-90-481-3335-2_16; Novotny V, 2004, CONSERV BIOL, V18, P227, DOI 10.1111/j.1523-1739.2004.00293.x; Oksanen J., 2016, VEGAN COMMUNITY ECOL; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Salazar D, 2016, ECOLOGY, V97, P3176, DOI 10.1002/ecy.1536; Schemske DW, 2009, ANNU REV ECOL EVOL S, V40, P245, DOI 10.1146/annurev.ecolsys.39.110707.173430; Sedio BE, 2017, ECOLOGY, V98, P616, DOI 10.1002/ecy.1689; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Swenson NG, 2009, ECOLOGY, V90, P2161, DOI 10.1890/08-1025.1; Swenson NG, 2014, USE R, P1, DOI 10.1007/978-1-4614-9542-0; Terborgh J, 2012, AM NAT, V179, P303, DOI 10.1086/664183; Valencia R, 2004, TROPICAL FOREST DIVERSITY AND DYNAMISM: FINDINGS FROM A LARGE-SCALE PLOT NETWORK, P609; VITOUSEK PM, 1986, J ECOL, V74, P1167, DOI 10.2307/2260241; Vleminckx J, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00836; Wang MX, 2016, NAT BIOTECHNOL, V34, P828, DOI 10.1038/nbt.3597; Webb CO, 2000, AM NAT, V156, P145, DOI 10.1086/303378; Westbrook JW, 2011, AM NAT, V177, P800, DOI 10.1086/659963; Wiggins NL, 2016, ECOL EVOL, V6, P478, DOI 10.1002/ece3.1896; Wills C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156913; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809; Zambrano J, 2017, J ECOL, V105, P616, DOI 10.1111/1365-2745.12765; Zhu Y, 2015, J ECOL, V103, P957, DOI 10.1111/1365-2745.12414	68	49	52	9	113	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 15	2019	363	6432			SI		1213	+		10.1126/science.aau9460	http://dx.doi.org/10.1126/science.aau9460			41	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP0BC	30872524				2022-12-28	WOS:000461329000048
J	Iacobucci, G				Iacobucci, Gareth			Half of councils no longer provide universal specialist stop smoking services	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		IACOBUCCI G, 2018, BMJ-BRIT MED J, V362, DOI DOI 10.1136/BMJ.K3649	1	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 15	2019	364								l1216	10.1136/bmj.l1216	http://dx.doi.org/10.1136/bmj.l1216			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP5WF	30877132				2022-12-28	WOS:000461752800006
J	Li, MY; Su, SK; Wong, HSP; Li, LJ				Li, Ming-Yang; Su, Sheng-Kai; Wong, H. -S. Philip; Li, Lain-Jong			How 2D semiconductors could extend Moore's law	NATURE			English	Editorial Material									[Li, Ming-Yang; Su, Sheng-Kai; Wong, H. -S. Philip; Li, Lain-Jong] Taiwan Semicond Mfg Co, Corp Res, Hsinchu, Taiwan	Taiwan Semiconductor Manufacturing Company	Wong, HSP (corresponding author), Taiwan Semicond Mfg Co, Corp Res, Hsinchu, Taiwan.	hspwong@tsmc.com; ljliv@tsmc.com	Li, Lain-Jong/D-5244-2011	Li, Lain-Jong/0000-0002-4059-7783				Chang HC, 2018, SMALL, V14, DOI 10.1002/smll.201802351; Ly TH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10426; Pei JJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10450	3	132	134	30	144	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 14	2019	567	7747					169	170						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HO7LD	30862924	Bronze			2022-12-28	WOS:000461126600020
J	Nguyen, KH; Glantz, SA; Palmer, CN; Schmidt, LA				Nguyen, Kim H.; Glantz, Stanton A.; Palmer, Casey N.; Schmidt, Laura A.			Tobacco industry involvement in children's sugary drinks market	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CHILDHOOD OBESITY; SWEETENED BEVERAGES; WEIGHT-GAIN; CONSUMPTION		[Nguyen, Kim H.; Palmer, Casey N.; Schmidt, Laura A.] Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA 94148 USA; [Glantz, Stanton A.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Glantz, Stanton A.] Ctr Tobacco Control Res & Educ, San Francisco, CA USA; [Glantz, Stanton A.] Cardiovasc Res Inst, San Francisco, CA USA; [Schmidt, Laura A.] Global Hlth Sci, San Francisco, CA 94158 USA; [Schmidt, Laura A.] Clin & Translat Sci Inst, San Francisco, CA 94143 USA; [Schmidt, Laura A.] Univ Calif San Francisco, Dept Anthropol Hist & Social Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Schmidt, LA (corresponding author), Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA 94148 USA.; Schmidt, LA (corresponding author), Global Hlth Sci, San Francisco, CA 94158 USA.; Schmidt, LA (corresponding author), Clin & Translat Sci Inst, San Francisco, CA 94143 USA.; Schmidt, LA (corresponding author), Univ Calif San Francisco, Dept Anthropol Hist & Social Med, San Francisco, CA 94143 USA.	laura.schmidt@ucsf.edu		Palmer, Casey/0000-0002-1035-5257	Laura and John Arnold Foundation; US National Cancer Institute [CA 087472]; CrossFit Foundation; NATIONAL CANCER INSTITUTE [R01CA087472] Funding Source: NIH RePORTER	Laura and John Arnold Foundation; US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CrossFit Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We have read and understood BMJ policy on declaration of interests and declare that the work was supported by the Laura and John Arnold Foundation, CrossFit Foundation, and the US National Cancer Institute (CA 087472). The funders had no role in design, conduct, collection, management, analysis, and interpretation of the data or in the preparation, review, or approval of the manuscript.	Ahmed A., 2018, NEW YORK TIMES; Alderman J, 2007, J LAW MED ETHICS, V35, P90, DOI 10.1111/j.1748-720X.2007.00115.x; Altria Group, 2007, DISTR KRAFT FOODS CL; [Anonymous], 1996, SPORTS BUSINESS 1210; [Anonymous], 2000, CHIEF MARKETER  0501; [Anonymous], 1997, ADAGE; [Anonymous], 1999, CHIEF MARKETER  0701; [Anonymous], 2009, KOOL AID POINTS 1980; Beverage Industry, 2011, NEW NUTR CRIT CHILD; Biblioteca del Congreso Nacional de Chile/BCN, 2015, COMP NUTR AL PUBL; Brownell KD, 2009, MILBANK Q, V87, P259, DOI 10.1111/j.1468-0009.2009.00555.x; CapriSun, 2017, WHO WE AR; Cavalcade of Awesome, 2010, CAVALCADE OF AWESOME; Cheng K, 1997, NICKELODEONS NOGGLEV; Coughlin P, 1998, CASE RID CALIFORNIA; Crosbie E, 2014, AM J PUBLIC HEALTH, V104, pE7, DOI 10.2105/AJPH.2014.302014; DeBoer MD, 2013, PEDIATRICS, V132, P413, DOI 10.1542/peds.2013-0570; Dorfman L, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001241; Dreyfus C., 1986, PEPSI GENERATION ORA; Ebbeling CB, 2006, PEDIATRICS, V117, P673, DOI 10.1542/peds.2005-0983; Elmore Bartow, 2016, CITIZEN COKE MAKING; FOOTE SB, 1980, PUBLIC INTEREST, P90; Galloway AH, 1970, RJ REYNOLDS IND 1970; Galloway AH, 1972, ANN REPORT 1971; General Foods, 1993, US STRAT PLAN; General Foods, 1987, US ADV REV; General Foods, GEN FOODS 86; Gootman JA, 2006, FOOD MARK CHILDR YOU; Graff S, 2012, HEALTH AFFAIR, V31, P392, DOI 10.1377/hlthaff.2011.0609; Gray B, 1967, REYNOLDS TOBACCO CO; Gray B, 1969, REYNOLDS TOBACCO CO; Hafiz R., 2015, ASIAN BUSINESS REV, V5, P97, DOI [10.18034/abr.v5i3.60, DOI 10.18034/ABR.V5I3.60]; Harris JL, 2009, ANNU REV PUBL HEALTH, V30, P211, DOI 10.1146/annurev.publhealth.031308.100304; Hendershot H, 2004, NICKELODEON NATION H; Hood D, 1999, KRAFT UNTWIST TOONS; Hunter College New York City Food Policy Center, 2018, CHIL BAN CART MASC S; International Trade Administration US Department of Commerce, 2017, CHIL LAB MARK REQ; Klara R., 2011, ADWEEK; Kool-Aid Days, 2013, HIST OF KOOL AID; Kraft Beverage Division, 1996, PRES; Kraft Foods International, 1999, KRAFT FOODS INT 1999; Lazarus G., 1991, CHICAGO TRIBUNE; Ludwig DS, 2001, LANCET, V357, P505, DOI 10.1016/S0140-6736(00)04041-1; Lynch M. R, 1983, RJ REYNOLDS IND MERR; Malik VS, 2013, AM J CLIN NUTR, V98, P1084, DOI 10.3945/ajcn.113.058362; Mehegan S, 1997, SPACE AGE TEENAGE; Miller TE., 1985, RJ REYNOLDS MARKETIN; Milton CH, 1962, RJ REYNOLDS MONTHLY; Milton CH, 1963, RJ REYNOLDS MONTHLY; Mindykowski S, 2000, MARKETING RUGRATS 10; Mondelez International, 2017 FACT SHEET TANG; Mondelez International, 2015, GET REFR DEL ALL NEW; Morris  Philip, 1988, PHIL MORR HIST HIGHL; Morris  Philip, 1993, 5 YEAR PLAN 1993 199; Morris  Philip, 1998, SOFT DRINK BLENDS AR; Morris  Philip, 1999, 1998 ANN REP; Morris  Philip, 1996, MIN CORP PROD COMM M; Morris  Philip, 2000 JAN BOARD PRES; Morris  Philip, 1998, 1998 2002 5 YEAR PLA; Morris  Philip, 1972, MARLB COUNTR STOR; Morris  Philip, 1988, SYN REP; Morris  Philip, ANN M 1 Q REP 1992; Morris  Philip, 1995, PHILIP MORRIS GL JUN; Morris  Philip, 1991, BOARD DIR PHIL MORR; Morris  Philip, 1995, COMMUNICATION; Morris  Philip, 1992, PHAS 1 LOYALT MARK E; Morris  Philip, 1988, PHIL MORR HIST; Morris  Philip, 1988, Q DIR REP; Morris  Philip, 1993, PHILIP MORRIS GLOBE, V8; Morris  Philip, 1989, SPEC ED ADV AG; Moss Michael, 2014, SALT SUGAR FAT FOOD; National Academies of Sciences Engineering and Medicine, 2017, STRAT LIM SUG SWEET; National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health, 2012, PREV TOB UYOUTH YO; Nestle M, 2015, SODA POLITICS TAKING; Nestle M, 2013, FOOD POLITICS FOOD I, DOI DOI 10.1525/9780520955066/HTML; Nielsen A C, 1984, NIELSEN UPDATE 84; Nielson ED, 1962, PROPOSED FIELD DIVER; Office of the United States Trade Representative, AGR US AM UN MEX STA; Peterson JR, 1977, RJ REYNOLDS IND PRES; Pollack J., 1998, BK LINK NICKELODEON; Pomeranz JL, 2016, FOOD LAW PUBLIC HLTH; Reynolds R J, 1983, RJR 1984 1988 PLAN; Reynolds R J, 1977, RJ REYNOLDS TOBACCO; Reynolds R J, 1979, CARAVAN, P13; Reynolds R J, ANN REPORT 1969; Reynolds R J, 1973, PUNCHY IS DIFFERENT; Reynolds R J, 1984, MANAGEMENT PRESENTAT; Reynolds R J, 1985, REPORT 1T Q 1985; Reynolds R J, 1983, RJR REPORT, V2; Reynolds R J, 1977, DISCOVERIES; Reynolds R J, 1996, CATALOG MARKETING MA; Reynolds R J, 1969, COMMUNICATION; Schor JB., 2014, BORN BUY COMMERCIALI; Shaw W, 1987, GEN FOODS DIRECT MAR; Smith AF, 2013, FOOD DRINK AM HIST F; Stabiner K, 1993, L A TIMES; Stokes C, 1978, 1977 ANN REPORT; Storr HG, 1987, 1 BOST BEV TOB C APR; Surowiecki J, 2016, NEW YORKER; Thompson S, 1997, BRANDWEEK, V38, P5; US Department of Health & Human Services, 2009, FAM SMOK PREV TOB CO; Winebrenner JT, 1976, IND MANAGEMENT TWX; World B, 1991, RAD DRINK; World Health Organization, 2003, WHO FRAM CONV TOB CO; World Health Organization UN Food and Agriculture Organization, 2003, TRS; Yoffie DB, 2006, COLA WARS CONTINUE C	106	21	21	2	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 14	2019	364								l736	10.1136/bmj.l736	http://dx.doi.org/10.1136/bmj.l736			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HP5WD	30872273	Green Published			2022-12-28	WOS:000461752500001
J	Wise, J				Wise, Jacqui			The BMJ Awards 2019: Diagnostics Team of the Year	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 11	2019	364								l1117	10.1136/bmj.l1117	http://dx.doi.org/10.1136/bmj.l1117			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP5VO	30858173				2022-12-28	WOS:000461750400005
J	Case, LB; Zhang, X; Ditlev, JA; Rosen, MK				Case, Lindsay B.; Zhang, Xu; Ditlev, Jonathon A.; Rosen, Michael K.			Stoichiometry controls activity of phase-separated clusters of actin signaling proteins	SCIENCE			English	Article							ARP2/3 COMPLEX; PURIFICATION; RECRUITMENT; MEMBRANES; PATHWAY	Biomolecular condensates concentrate macromolecules into foci without a surrounding membrane. Many condensates appear to form through multivalent interactions that drive liquid-liquid phase separation (LLPS). LLPS increases the specific activity of actin regulatory proteins toward actin assembly by the Arp2/3 complex. We show that this increase occurs because LLPS of the Nephrin-Nck-N-WASP signaling pathway on lipid bilayers increases membrane dwell time of N-WASP and Arp2/3 complex, consequently increasing actin assembly. Dwell time varies with relative stoichiometry of the signaling proteins in the phase-separated clusters, rendering N-WASP and Arp2/3 activity stoichiometry dependent. This mechanism of controlling protein activity is enabled by the stoichiometrically undefined nature of biomolecular condensates. Such regulation should be a general feature of signaling systems that assemble through multivalent interactions and drive nonequilibrium outputs.	[Case, Lindsay B.; Ditlev, Jonathon A.; Rosen, Michael K.] Marine Biol Lab, HHMI Summer Inst, Woods Hole, MA 02543 USA; [Case, Lindsay B.; Zhang, Xu; Ditlev, Jonathon A.; Rosen, Michael K.] Univ Texas Southwestern Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA; [Case, Lindsay B.; Zhang, Xu; Ditlev, Jonathon A.; Rosen, Michael K.] Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	Marine Biological Laboratory - Woods Hole; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Rosen, MK (corresponding author), Marine Biol Lab, HHMI Summer Inst, Woods Hole, MA 02543 USA.; Rosen, MK (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA.; Rosen, MK (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA.	michael.rosen@utsouthwestern.edu		Ditlev, Jonathon/0000-0001-8287-7700; Case, Lindsay/0000-0003-3166-1138	Damon Runyon Cancer Research Foundation [DRG-2249-16]; Welch Foundation [I-1544]; National Research Service Award from NIDDK [F32 DK101188]; Howard Hughes Medical Institute Collaborative Innovation Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK101188] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; Welch Foundation(The Welch Foundation); National Research Service Award from NIDDK; Howard Hughes Medical Institute Collaborative Innovation Award(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	L.B.C. is a Robert Black Fellow of the Damon Runyon Cancer Research Foundation (DRG-2249-16). This work was supported by a grant from the Welch Foundation (I-1544 to M.K.R.), a National Research Service Award from NIDDK (F32 DK101188 to J.A.D.), and a Howard Hughes Medical Institute Collaborative Innovation Award.	Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; Banjade S, 2014, ELIFE, V3, DOI 10.7554/eLife.04123; Banjade S, 2015, P NATL ACAD SCI USA, V112, pE6426, DOI 10.1073/pnas.1508778112; Case L. B., 2019, DRYAD DIGITAL REPOSI, DOI [10.5061/DRYAD.HH37793, DOI 10.5061/DRYAD.HH37793]; Case L. B., 2019, DRYAD DIGITAL REPOSI; Castello A, 2013, NAT IMMUNOL, V14, P966, DOI 10.1038/ni.2685; COOPER JA, 1982, METHOD ENZYMOL, V85, P182; Ditlev JA, 2012, J CELL BIOL, V197, P643, DOI 10.1083/jcb.201111113; Doolittle LK, 2013, METHODS MOL BIOL, V1046, P231, DOI 10.1007/978-1-62703-538-5_14; Espinoza-Sanchez S, 2018, P NATL ACAD SCI USA, V115, pE8642, DOI 10.1073/pnas.1717594115; Hansen SD, 2013, METHODS MOL BIOL, V1046, P145, DOI 10.1007/978-1-62703-538-5_9; Huang WYC, 2019, SCIENCE, V363, P1098, DOI 10.1126/science.aau5721; Huang WYC, 2016, P NATL ACAD SCI USA, V113, P8218, DOI 10.1073/pnas.1602602113; Kim S., 2019, 558965 BIORXIV, DOI [10.1101/558965, DOI 10.1101/558965]; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Michalski PJ, 2016, BIOPHYS J, V110, P523, DOI 10.1016/j.bpj.2015.12.026; Oh D, 2012, P NATL ACAD SCI USA, V109, P14024, DOI 10.1073/pnas.1203397109; Padrick SB, 2008, MOL CELL, V32, P426, DOI 10.1016/j.molcel.2008.10.012; Padrick SB, 2011, P NATL ACAD SCI USA, V108, pE472, DOI 10.1073/pnas.1100236108; Picco A, 2015, ELIFE, V4, DOI 10.7554/eLife.04535; Rodnick-Smith M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12226; Shin Y, 2017, SCIENCE, V357, DOI 10.1126/science.aaf4382; Smith BA, 2013, ELIFE, V2, DOI 10.7554/eLife.01008; Smith BA, 2013, P NATL ACAD SCI USA, V110, P1285, DOI 10.1073/pnas.1211164110; Su XL, 2016, SCIENCE, V352, P595, DOI 10.1126/science.aad9964; Sun Yidi, 2017, Elife, V6, DOI 10.7554/eLife.29140; Sun YD, 2017, ELIFE, V6, DOI 10.7554/eLife.29140.001; Yang TL, 2003, J AM CHEM SOC, V125, P4779, DOI 10.1021/ja029469f; Zalevsky J, 2001, CURR BIOL, V11, P1903, DOI 10.1016/S0960-9822(01)00603-0	29	196	197	16	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 8	2019	363	6431					1093	+		10.1126/science.aau6313	http://dx.doi.org/10.1126/science.aau6313			41	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO2MV	30846599	Green Accepted			2022-12-28	WOS:000460750100044
J	Martin, EW; Mittag, T				Martin, Erik W.; Mittag, Tanja			Dwelling at membranes promotes decisive signaling	SCIENCE			English	Editorial Material							RECRUITMENT; LAT		[Martin, Erik W.; Mittag, Tanja] St Jude Childrens Res Hosp, Dept Struct Biol, 262 Danny Thomas Pl, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Mittag, T (corresponding author), St Jude Childrens Res Hosp, Dept Struct Biol, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	tanja.mittag@stjude.org			NIH [R01GM112846]; St. Jude Children's Research Hospital Research Collaborative; American Lebanese Syrian Associated Charities; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112846] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); St. Jude Children's Research Hospital Research Collaborative; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	T.M. acknowledges funding by NIH (R01GM112846), the St. Jude Children's Research Hospital Research Collaborative, and the American Lebanese Syrian Associated Charities.	Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; Banjade S, 2014, ELIFE, V3, DOI 10.7554/eLife.04123; Blanchard SC, 2004, NAT STRUCT MOL BIOL, V11, P1008, DOI 10.1038/nsmb831; Bracha D, 2019, CELL, V176, P407, DOI 10.1016/j.cell.2018.12.026; Case LB, 2019, SCIENCE, V363, P1093, DOI 10.1126/science.aau6313; Harmon TS, 2017, ELIFE, V6, DOI 10.7554/eLife.30294; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; Huang WYC, 2019, SCIENCE, V363, P1098, DOI 10.1126/science.aau5721; Huang WYC, 2017, J AM CHEM SOC, V139, P18009, DOI 10.1021/jacs.7b09387; Huang WYC, 2016, P NATL ACAD SCI USA, V113, P8218, DOI 10.1073/pnas.1602602113; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Shin Y, 2017, SCIENCE, V357, DOI 10.1126/science.aaf4382; Su XL, 2016, SCIENCE, V352, P595, DOI 10.1126/science.aad9964	13	9	9	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 8	2019	363	6431					1036	1037		10.1126/science.aaw6434	http://dx.doi.org/10.1126/science.aaw6434			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HO2MV	30846583				2022-12-28	WOS:000460750100020
J	Pike, H				Pike, Harriet			NICE proposes lower threshold for treating high blood pressure	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		National Institute for Health and Care Excellence, 2011, HYP AD DIAGN MAN; National Institute for Health and Care Excellence, 2019, HYP AD DIAGN MAN DRA; Whelton PK, 2018, J AM COLL CARDIOL, V71, P2275, DOI 10.1016/j.jacc.2018.03.016	3	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 8	2019	364								l1105	10.1136/bmj.l1105	http://dx.doi.org/10.1136/bmj.l1105			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HO6TC	30850358				2022-12-28	WOS:000461063500010
J	Jansen, MHE; Kessels, JPHM; Nelemans, PJ; Kouloubis, N; Arits, AHMM; van Pelt, HPA; Quaedvlieg, PJF; Essers, BAB; Steijlen, PM; Kelleners-Smeets, NWJ; Mosterd, K				Jansen, Maud H. E.; Kessels, Janneke P. H. M.; Nelemans, Patty J.; Kouloubis, Nina; Arits, Aimee H. M. M.; van Pelt, Han P. A.; Quaedvlieg, Patricia J. F.; Essers, Brigitte A. B.; Steijlen, Peter M.; Kelleners-Smeets, Nicole W. J.; Mosterd, Klara			Randomized Trial of Four Treatment Approaches for Actinic Keratosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SQUAMOUS-CELL CARCINOMA; MALIGNANT-TRANSFORMATION; TREATMENT ALGORITHM; SOLAR KERATOSES; DOUBLE-BLIND; REAL-WORLD; CREAM; GUIDELINES; 5-PERCENT; CHEMOPREVENTION	BACKGROUND Actinic keratosis is the most frequent premalignant skin disease in the white population. In current guidelines, no clear recommendations are made about which treatment is preferred. METHODS We investigated the effectiveness of four frequently used field-directed treatments (for multiple lesions in a continuous area). Patients with a clinical diagnosis of five or more actinic keratosis lesions on the head, involving one continuous area of 25 to 100 cm(2), were enrolled at four Dutch hospitals. Patients were randomly assigned to treatment with 5% fluorouracil cream, 5% imiquimod cream, methyl aminolevulinate photodynamic therapy (MAL-PDT), or 0.015% ingenol mebutate gel. The primary outcome was the proportion of patients with a reduction of 75% or more in the number of actinic keratosis lesions from baseline to 12 months after the end of treatment. Both a modified intention-to-treat analysis and a per-protocol analysis were performed. RESULTS A total of 624 patients were included from November 2014 through March 2017. At 12 months after the end of treatment, the cumulative probability of remaining free from treatment failure was significantly higher among patients who received fluorouracil (74.7%; 95% confidence interval [CI], 66.8 to 81.0) than among those who received imiquimod (53.9%; 95% CI, 45.4 to 61.6), MAL-PDT (37.7%; 95% CI, 30.0 to 45.3), or ingenol mebutate (28.9%; 95% CI, 21.8 to 36.3). As compared with fluorouracil, the hazard ratio for treatment failure was 2.03 (95% CI, 1.36 to 3.04) with imiquimod, 2.73 (95% CI, 1.87 to 3.99) with MAL-PDT, and 3.33 (95% CI, 2.29 to 4.85) with ingenol mebutate (P <= 0.001 for all comparisons). No unexpected toxic effects were documented. CONCLUSIONS At 12 months after the end of treatment in patients with multiple actinic keratosis lesions on the head, 5% fluorouracil cream was the most effective of four field-directed treatments.	[Jansen, Maud H. E.; Kessels, Janneke P. H. M.; Kouloubis, Nina; Arits, Aimee H. M. M.; Steijlen, Peter M.; Kelleners-Smeets, Nicole W. J.; Mosterd, Klara] Maastricht Univ, Med Ctr, Dept Dermatol, P Debyelaan 25,POB 5800, NL-6202 AZ Maastricht, Netherlands; [Essers, Brigitte A. B.] Maastricht Univ, Med Ctr, Dept Clin Epidemiol & Med Technol Assessment, Maastricht, Netherlands; [Jansen, Maud H. E.; Kessels, Janneke P. H. M.; Arits, Aimee H. M. M.; Steijlen, Peter M.; Kelleners-Smeets, Nicole W. J.; Mosterd, Klara] Maastricht Univ, GROW Sch Oncol & Dev Biol, Maastricht, Netherlands; [Nelemans, Patty J.] Maastricht Univ, Dept Epidemiol, Maastricht, Netherlands; [Kessels, Janneke P. H. M.; Quaedvlieg, Patricia J. F.] Zuyderland Med Ctr, Dept Dermatol, Heerlen, Netherlands; [Arits, Aimee H. M. M.; Steijlen, Peter M.] Catharina Hosp, Dept Dermatol, Eindhoven, Netherlands; [van Pelt, Han P. A.] VieCuri Med Ctr, Dept Dermatol, Venlo, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University; Maastricht University; Catharina Hospital; VieCuri Medical Center	Jansen, MHE (corresponding author), Maastricht Univ, Med Ctr, Dept Dermatol, P Debyelaan 25,POB 5800, NL-6202 AZ Maastricht, Netherlands.	maud.jansen@mumc.nl	Mosterd, Klara/AAB-1850-2020; Steijlen, Peter/X-2729-2019		Netherlands Organization for Health Research and Development (ZonMw) [80-83600-98-3054]	Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development)	Supported by a grant (80-83600-98-3054) from the Netherlands Organization for Health Research and Development (ZonMw), a governmental institution that finances research to improve health care in the Netherlands.	Ackerman AB, 2006, BRIT J DERMATOL, V155, P9, DOI 10.1111/j.1365-2133.2005.07121.x; [Anonymous], 2017, NED TIJDSCHR DERMATO; Criscione VD, 2009, CANCER-AM CANCER SOC, V115, P2523, DOI 10.1002/cncr.24284; de Berker D, 2017, BRIT J DERMATOL, V176, P20, DOI 10.1111/bjd.15107; Dinehart SM, 1997, CANCER, V79, P920, DOI 10.1002/(SICI)1097-0142(19970301)79:5<920::AID-CNCR8>3.0.CO;2-F; Dirschka T, 2017, J DERMATOL TREAT, V28, P431, DOI 10.1080/09546634.2016.1254328; Flohil SC, 2013, J INVEST DERMATOL, V133, P1971, DOI 10.1038/jid.2013.134; Frost C, 2000, J INVEST DERMATOL, V115, P273, DOI 10.1046/j.1523-1747.2000.00048.x; Glogau RG, 2000, J AM ACAD DERMATOL, V42, pS23, DOI 10.1067/mjd.2000.103339; Gupta AK, 2013, BRIT J DERMATOL, V169, P250, DOI 10.1111/bjd.12343; Gupta AK, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004415.pub2; Gupta AK, 2002, CUTIS, V70, P8; Kirby JS, 2017, JAMA DERMATOL, V153, P264, DOI 10.1001/jamadermatol.2016.4733; Lanoue J, 2016, CUTIS, V97, P415; Lebwohl M, 2004, J AM ACAD DERMATOL, V50, P714, DOI 10.1016/j.jaad.2003.12.010; MARKS R, 1988, LANCET, V1, P795, DOI 10.1016/s0140-6736(88)91658-3; Neugebauer R, 2018, J AM ACAD DERMATOL, V78, P710, DOI 10.1016/j.jaad.2017.12.042; OLSEN EA, 1991, J AM ACAD DERMATOL, V24, P738, DOI 10.1016/0190-9622(91)70113-G; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Pomerantz H, 2015, JAMA DERMATOL, V151, P952, DOI 10.1001/jamadermatol.2015.0502; Rothman KJ, 2012, MODERN EPIDEMIOLOGY; Siegel JA, 2017, BRIT J DERMATOL, V177, P350, DOI 10.1111/bjd.14852; Spencer James M, 2005, J Drugs Dermatol, V4, P296; Stockfleth E, 2006, EUR J DERMATOL, V16, P599, DOI 10.1684/ejd.2006.0017; Stockfleth E, 2008, EUR J DERMATOL, V18, P651, DOI 10.1684/ejd.2008.0514; Vegter S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096829; Weinstock MA, 2018, JAMA DERMATOL, V154, P167, DOI 10.1001/jamadermatol.2017.3631; Werner RN, 2015, J EUR ACAD DERMATOL, V29, P2069, DOI 10.1111/jdv.13180	28	92	92	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 7	2019	380	10					935	946		10.1056/NEJMoa1811850	http://dx.doi.org/10.1056/NEJMoa1811850			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HN8QX	30855743	Green Published			2022-12-28	WOS:000460461500007
J	Luo, S; Yeung, SLA; Zhao, JV; Burgess, S; Schooling, CM				Luo, Shan; Yeung, Shiu Lun Au; Zhao, Jie V.; Burgess, Stephen; Schooling, C. Mary			Association of genetically predicted testosterone with thromboembolism, heart failure, and myocardial infarction: mendelian randomisation study in UK Biobank	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RECURRENT VENOUS THROMBOSIS; HORMONE REPLACEMENT THERAPY; GENOME-WIDE ASSOCIATION; A(2) RECEPTOR DENSITY; IMMORTAL-TIME BIAS; CARDIOVASCULAR-DISEASE; POSTMENOPAUSAL WOMEN; DIFFERENTIAL RISKS; SERUM TESTOSTERONE; SEX-HORMONES	OBJECTIVE To determine whether endogenous testosterone has a causal role in thromboembolism, heart failure, and myocardial infarction. DESIGN Two sample mendelian randomisation study using genetic variants as instrumental variables, randomly allocated at conception, to infer causality as additional randomised evidence. SETTING Reduction by Dutasteride of Prostate Cancer Events (REDUCE) randomised controlled trial, UK Biobank, and CARDIoGRAMplusC4D 1000 Genomes based genome wide association study. PARTICIPANTS 3225 men of European ancestry aged 50-75 in REDUCE; 392 038 white British men and women aged 40-69 from the UK Biobank; and 171 875 participants of about 77% European descent, from CARDIoGRAMplusC4D 1000 Genomes based study for validation. MAIN OUTCOME MEASURES Thromboembolism, heart failure, and myocardial infarction based on self reports, hospital episodes, and death. RESULTS Of the UK Biobank participants, 13 691 had thromboembolism (6208 men, 7483 women), 1688 had heart failure (1186, 502), and 12 882 had myocardial infarction (10 136, 2746). In men, endogenous testosterone genetically predicted by variants in the JMJD1C gene region was positively associated with thromboembolism (odds ratio per unit increase in log transformed testosterone (nmol/L) 2.09, 95% confidence interval 1.27 to 3.46) and heart failure (7.81, 2.56 to 23.8), but not myocardial infarction (1.17, 0.78 to 1.75). Associations were less obvious in women. In the validation study, genetically predicted testosterone (based on JMJD1C gene region variants) was positively associated with myocardial infarction (1.37, 1.03 to 1.82). No excess heterogeneity was observed among genetic variants in their associations with the outcomes. However, testosterone genetically predicted by potentially pleiotropic variants in the SHBG gene region had no association with the outcomes. CONCLUSIONS Endogenous testosterone was positively associated with thromboembolism, heart failure, and myocardial infarction in men. Rates of these conditions are higher in men than women. Endogenous testosterone can be controlled with existing treatments and could be a modifiable risk factor for thromboembolism and heart failure.	[Luo, Shan; Yeung, Shiu Lun Au; Zhao, Jie V.; Schooling, C. Mary] Univ Hong Kong, Sch Publ Hlth, Hong Kong, Peoples R China; [Burgess, Stephen] Univ Cambridge, Dept Publ Hlth & Primary Care, Cardiovasc Epidemiol Unit, Cambridge, England; [Burgess, Stephen] Univ Cambridge, MRC Biostat Unit, Cambridge, England; [Schooling, C. Mary] CUNY, Sch Publ Hlth & Hlth Policy, 55 West 125th St, New York, NY 10027 USA	University of Hong Kong; University of Cambridge; MRC Biostatistics Unit; University of Cambridge; City University of New York (CUNY) System	Schooling, CM (corresponding author), Univ Hong Kong, Sch Publ Hlth, Hong Kong, Peoples R China.; Schooling, CM (corresponding author), CUNY, Sch Publ Hlth & Hlth Policy, 55 West 125th St, New York, NY 10027 USA.	cms1@hku.hk	Luo, Shan/AIC-3411-2022; SL, Au Yeung/ABD-3938-2021	Luo, Shan/0000-0003-3368-9935; SL, Au Yeung/0000-0001-6136-1836; Zhao, Jie/0000-0002-1564-0057; Schooling, Mary/0000-0001-9933-5887; Burgess, Stephen/0000-0001-5365-8760	Small Project Funding, University of Hong Kong [201409176231]; Wellcome Trust [204623/Z/16/Z]; Royal Society [204623/Z/16/Z]; MRC [MC_UU_00002/7] Funding Source: UKRI	Small Project Funding, University of Hong Kong(University of Hong Kong); Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was funded by Small Project Funding, University of Hong Kong (201409176231). Stephen Burgess is supported by a Sir Henry Dale fellowship jointly funded by the Wellcome Trust and the Royal Society (grant number 204623/Z/16/Z). The funders had no role in the design, analyses, interpretation of results, writing of the paper, or decision for publication.	Ajayi AAL, 2005, QJM-INT J MED, V98, P349, DOI 10.1093/qjmed/hci054; AJAYI AAL, 1995, CIRCULATION, V91, P2742, DOI 10.1161/01.CIR.91.11.2742; [Anonymous], 2014, FDA ADDING GEN WARNI; Araujo AB, 2007, ARCH INTERN MED, V167, P1252, DOI 10.1001/archinte.167.12.1252; Baillargeon J, 2018, JAMA-J AM MED ASSOC, V320, P200, DOI 10.1001/jama.2018.7999; Bhasin S, 2018, J CLIN ENDOCR METAB, V103, P1715, DOI 10.1210/jc.2018-00229; Bhatnagar P, 2015, HEART, V101, P1182, DOI 10.1136/heartjnl-2015-307516; Burgess S, 2017, GENET EPIDEMIOL, V41, P714, DOI 10.1002/gepi.22077; Burgess S, 2014, INT J EPIDEMIOL, V43, P922, DOI 10.1093/ije/dyu005; Burgess S, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7325; Cole AP, 2018, BJU INT, V121, P811, DOI 10.1111/bju.14149; Corona G, 2017, WORLD J MENS HEALTH, V35, P65, DOI 10.5534/wjmh.2017.35.2.65; Coviello AD, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002805; DAVIES NM, 2018, BMJ-BRIT MED J, V362, DOI DOI 10.1136/BMJ.K601; Del Greco MF, 2015, STAT MED, V34, P2926, DOI 10.1002/sim.6522; Eriksson J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176277; FDA Drug Safety Communication, 2014, FDA CAUT US TEST PRO; Finkelstein JS, 2013, NEW ENGL J MED, V369, P1011, DOI 10.1056/NEJMoa1206168; Finkle WD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085805; Freeman G, 2013, INT J EPIDEMIOL, V42, P1157, DOI 10.1093/ije/dyt110; Fry A, 2017, AM J EPIDEMIOL, V186, P1026, DOI 10.1093/aje/kwx246; Glymour MM, 2014, EPIDEMIOLOGY, V25, P4, DOI 10.1097/EDE.0000000000000013; Handelsman DJ, 2017, JAMA-J AM MED ASSOC, V317, P699, DOI 10.1001/jama.2017.0129; Handelsman DJ, 2013, MED J AUSTRALIA, V199, P548, DOI 10.5694/mja13.10111; Health Canada, 2014, INF UPD POSS CARD PR; Holmegard HN, 2014, J THROMB HAEMOST, V12, P297, DOI 10.1111/jth.12484; Huang J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9111; INMAN WHW, 1970, BMJ-BRIT MED J, V2, P203, DOI 10.1136/bmj.2.5703.203; Jin GF, 2012, HUM MOL GENET, V21, P5222, DOI 10.1093/hmg/dds361; Joseph P, 2017, CIRC RES, V121, P677, DOI 10.1161/CIRCRESAHA.117.308903; Krieger N, 2005, J EPIDEMIOL COMMUN H, V59, P740, DOI 10.1136/jech.2005.033316; Kuroki S, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.108597; Lawlor DA, 2008, STAT MED, V27, P1133, DOI 10.1002/sim.3034; Layton JB, 2018, CLIN ENDOCRINOL, V88, P719, DOI 10.1111/cen.13574; Layton JB, 2014, J CLIN ENDOCR METAB, V99, P835, DOI 10.1210/jc.2013-3570; Li H, 2017, J SEX MED, V14, P1307, DOI 10.1016/j.jsxm.2017.09.010; Lindstrom S, 2018, HUM GENET, V137, P429, DOI 10.1007/s00439-018-1891-2; Liverman CT, 2004, TESTOSTERONE AGING C; Lowe GDO, 2008, BRIT J HAEMATOL, V140, P488, DOI 10.1111/j.1365-2141.2007.06973.x; Machiela MJ, 2015, BIOINFORMATICS, V31, P3555, DOI 10.1093/bioinformatics/btv402; Martinez C, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5968; Muller RL, 2012, EUR UROL, V62, P757, DOI 10.1016/j.eururo.2012.05.025; Nakajima R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163466; Nikpay M, 2015, NAT GENET, V47, P1121, DOI 10.1038/ng.3396; Ohlsson C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002313; Petitti D, 2004, INT J EPIDEMIOL, V33, P461, DOI 10.1093/ije/dyh192; Roach REJ, 2014, J THROMB HAEMOST, V12, P1593, DOI 10.1111/jth.12678; Roetker NS, 2018, THROMB HAEMOSTASIS, V118, P1940, DOI 10.1055/s-0038-1673613; Sagoe D, 2018, CURR OPIN ENDOCRINOL, V25, P185, DOI 10.1097/MED.0000000000000403; Sagoe D, 2014, ANN EPIDEMIOL, V24, P383, DOI 10.1016/j.annepidem.2014.01.009; Schooling CM, 2018, EBIOMEDICINE, V28, P311, DOI 10.1016/j.ebiom.2018.01.015; Schooling CM, 2018, INT J CARDIOL, V267, P171, DOI 10.1016/j.ijcard.2018.05.051; Schooling CM, 2018, CIRC-GENOM PRECIS ME, V11, DOI 10.1161/CIRCGENETICS.117.002026; Schooling CM, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-57; Shi ZM, 2013, J CLIN ENDOCR METAB, V98, P3289, DOI 10.1210/jc.2012-3842; STOFFER SS, 1973, JAMA-J AM MED ASSOC, V225, P1643, DOI 10.1001/jama.225.13.1643; Subramanya V, 2018, MATURITAS, V108, P37, DOI 10.1016/j.maturitas.2017.11.006; Sudlow C, 2017, DEFINITIONS ACUTE MY; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Suissa S, 2008, AM J EPIDEMIOL, V167, P492, DOI 10.1093/aje/kwm324; Svartberg J, 2014, ANDROLOGY-US, V2, P212, DOI 10.1111/j.2047-2927.2013.00174.x; Svartberg J, 2009, EUR J ENDOCRINOL, V160, P833, DOI 10.1530/EJE-08-0888; Trehearne A, 2016, BUNDESGESUNDHEITSBLA, V59, P361, DOI 10.1007/s00103-015-2297-0; UK Biobank, 2017, ALG DEF HLTH OUTC 20; Vigen R, 2013, JAMA-J AM MED ASSOC, V310, P1829, DOI 10.1001/jama.2013.280386; Wade KH, 2018, OBESITY, V26, P1796, DOI 10.1002/oby.22313; Wallis CJD, 2017, BJU INT, V120, P584, DOI 10.1111/bju.13918; White WB, 2012, AM HEART J, V163, P27, DOI 10.1016/j.ahj.2011.09.021; WILSON JL, 1970, ANAT RECORD, V168, P331, DOI 10.1002/ar.1091680301; Xu L, 2015, J THROMB HAEMOST, V13, P884, DOI 10.1111/jth.12862; Zwadlo C, 2015, CIRCULATION, V131, P1071, DOI 10.1161/CIRCULATIONAHA.114.012066	71	49	52	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 6	2019	364								l476	10.1136/bmj.l476	http://dx.doi.org/10.1136/bmj.l476			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HO6SU	30842065	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000461062400001
J	Oliver, D				Oliver, David			ACUTE PERSPECTIVE David Oliver: Can doctors be too politicised?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						[Anonymous], LEAD CLIN JOIN GIRFT; Cummings KJ, 2007, PUBLIC HEALTH REP, V122, P683, DOI 10.1177/003335490712200517; Department of Health and Social Care, 2009, LIVING WELL DEMENTIA; Fahy N, 2019, LANCET; GRAY AM, 1982, INT J HEALTH SERV, V12, P349, DOI 10.2190/XXMM-JMQU-2A7Y-HX1E; HART JT, 1971, LANCET, V1, P405, DOI 10.1016/S0140-6736(71)92410-X; Ipsos MORI, 2018, IPS MORI VER IND 20; Marmot M, 2010, FAIR SOC HLTH LIVES; McKee M, 2018, BMJ OPINION     1221; MCKEE M, 2017, BMJ-BRIT MED J, V356, DOI DOI 10.1136/BMJ.J1545; Mclellan A, 2018, HLTH SERV J; MOBERLY T, 2019, BMJ-BRIT MED J, V364, DOI DOI 10.1136/BMJ.L707; Royal College of Physicians, 2012, 50 YEARS SMOK HLTH P; Royal College of Physicians, 2018, WHAT RCP THINKS ALC; Royal College of Physicians, 2012, AHA WELC MIN ALC UN; Royal_College_of_Physicians, 2016, EV BREATH WE TAK LIF; Royal College of Physicians, WHAT RCP THINKS TOB; Royal Society of Public Health Faculty of Public Health, 2016, TAK NEW LIN DRUGS	18	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 5	2019	364								l872	10.1136/bmj.l872	http://dx.doi.org/10.1136/bmj.l872			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HO6SS	30837261	Bronze			2022-12-28	WOS:000461062200002
J	Iacobucci, G				Iacobucci, Gareth			Planetary health: WONCA urges family doctors to commit to action	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		WONCA Planetary Health Alliance Clinicians for Planetary Health, 2019, DECL CALL FAM DOCT W	1	2	2	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 4	2019	364								l1002	10.1136/bmj.l1002	http://dx.doi.org/10.1136/bmj.l1002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HO6SQ	30833267				2022-12-28	WOS:000461061900009
J	Adepoju, P				Adepoju, Paul			Health agenda close to absent in Nigeria's election campaign	LANCET			English	Editorial Material														Adepoju, Paul/0000-0003-1323-3017					0	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 2	2019	393	10170					393	394		10.1016/S0140-6736(19)30199-0	http://dx.doi.org/10.1016/S0140-6736(19)30199-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HK1AM	30860057				2022-12-28	WOS:000457636900013
J	Pluymaekers, NAHA; Dudink, EAMP; Luermans, JGLM; Meeder, JG; Lenderink, T; Widdershoven, J; Bucx, JJJ; Rienstra, M; Kamp, O; Van Opstal, JM; Alings, M; Oomen, A; Kirchhof, CJ; Van Dijk, VF; Ramanna, H; Liem, A; Dekker, LR; Essers, BAB; Tijssen, JGP; Van Gelder, IC; Crijns, HJGM				Pluymaekers, Nikki A. H. A.; Dudink, Elton A. M. P.; Luermans, Justin G. L. M.; Meeder, Joan G.; Lenderink, Timo; Widdershoven, Jos; Bucx, Jeroen J. J.; Rienstra, Michiel; Kamp, Otto; Van Opstal, Jurren M.; Alings, Marco; Oomen, Anton; Kirchhof, Charles J.; Van Dijk, Vincent F.; Ramanna, Hemanth; Liem, Anho; Dekker, Lukas R.; Essers, Brigitte A. B.; Tijssen, Jan G. P.; Van Gelder, Isabelle C.; Crijns, Harry J. G. M.		RACE 7 ACWAS Investigators	Early or Delayed Cardioversion in Recent-Onset Atrial Fibrillation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SPONTANEOUS CONVERSION; TEMPORAL RELATIONSHIP; STROKE; ECHOCARDIOGRAPHY; ANTICOAGULATION; GUIDELINES; ABLATION; CATHETER; DESIGN; DEVICE	Background Patients with recent-onset atrial fibrillation commonly undergo immediate restoration of sinus rhythm by pharmacologic or electrical cardioversion. However, whether immediate restoration of sinus rhythm is necessary is not known, since atrial fibrillation often terminates spontaneously. Methods In a multicenter, randomized, open-label, noninferiority trial, we randomly assigned patients with hemodynamically stable, recent-onset (<36 hours), symptomatic atrial fibrillation in the emergency department to be treated with a wait-and-see approach (delayed-cardioversion group) or early cardioversion. The wait-and-see approach involved initial treatment with rate-control medication only and delayed cardioversion if the atrial fibrillation did not resolve within 48 hours. The primary end point was the presence of sinus rhythm at 4 weeks. Noninferiority would be shown if the lower limit of the 95% confidence interval for the between-group difference in the primary end point in percentage points was more than -10. Results The presence of sinus rhythm at 4 weeks occurred in 193 of 212 patients (91%) in the delayed-cardioversion group and in 202 of 215 (94%) in the early-cardioversion group (between-group difference, -2.9 percentage points; 95% confidence interval [CI], -8.2 to 2.2; P=0.005 for noninferiority). In the delayed-cardioversion group, conversion to sinus rhythm within 48 hours occurred spontaneously in 150 of 218 patients (69%) and after delayed cardioversion in 61 patients (28%). In the early-cardioversion group, conversion to sinus rhythm occurred spontaneously before the initiation of cardioversion in 36 of 219 patients (16%) and after cardioversion in 171 patients (78%). Among the patients who completed remote monitoring during 4 weeks of follow-up, a recurrence of atrial fibrillation occurred in 49 of 164 patients (30%) in the delayed-cardioversion group and in 50 of 171 (29%) in the early-cardioversion group. Within 4 weeks after randomization, cardiovascular complications occurred in 10 patients and 8 patients, respectively. Conclusions In patients presenting to the emergency department with recent-onset, symptomatic atrial fibrillation, a wait-and-see approach was noninferior to early cardioversion in achieving a return to sinus rhythm at 4 weeks. (Funded by the Netherlands Organization for Health Research and Development and others; RACE 7 ACWAS ClinicalTrials.gov number, NCT02248753.)	[Pluymaekers, Nikki A. H. A.; Dudink, Elton A. M. P.; Luermans, Justin G. L. M.; Crijns, Harry J. G. M.] Maastricht Univ, Med Ctr, Dept Cardiol, P Debyelaan 25, NL-6229 HX Maastricht, Netherlands; [Essers, Brigitte A. B.] Maastricht Univ, Med Ctr, Dept Clin Epidemiol & Med Technol Assessment, Maastricht, Netherlands; [Pluymaekers, Nikki A. H. A.; Dudink, Elton A. M. P.; Luermans, Justin G. L. M.; Crijns, Harry J. G. M.] Maastricht Univ, Med Ctr, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands; [Meeder, Joan G.] VieCuri Med Ctr Noord Limburg, Venlo, Netherlands; [Lenderink, Timo] Zuyderland Med Ctr, Heerlen, Netherlands; [Widdershoven, Jos] Elisabeth TweeSteden Hosp, Tilburg, Netherlands; [Bucx, Jeroen J. J.] Diakonessen Hosp, Utrecht, Netherlands; [Rienstra, Michiel; Van Gelder, Isabelle C.] Univ Groningen, Groningen, Netherlands; [Kamp, Otto] VU Univ Med Ctr Amsterdam, Amsterdam, Netherlands; [Tijssen, Jan G. P.] Acad Med Ctr, Amsterdam, Netherlands; [Van Opstal, Jurren M.] Med Spectrum Twente, Enschede, Netherlands; [Alings, Marco] Amphia Hosp, Breda, Netherlands; [Oomen, Anton] Antonius Hosp, Sneek, Netherlands; [Kirchhof, Charles J.] Alrijne Hosp, Leiderdorp, Netherlands; [Van Dijk, Vincent F.] St Antonius Hosp, Nieuwegein, Netherlands; [Ramanna, Hemanth] Haga Teaching Hosp, The Hague, Netherlands; [Liem, Anho] St Franciscus Gasthuis, Rotterdam, Netherlands; [Dekker, Lukas R.] Catharina Hosp, Eindhoven, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University; VieCuri Medical Center; Elisabeth-TweeSteden Ziekenhuis (ETZ); Diakonessenhuis; University of Groningen; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Amsterdam; Academic Medical Center Amsterdam; Medical Spectrum Twente; Amphia Hospital; St. Antonius Hospital Utrecht; Haga Hospital; Franciscus Gasthuis; Catharina Hospital	Crijns, HJGM (corresponding author), Maastricht Univ, Med Ctr, Dept Cardiol, P Debyelaan 25, NL-6229 HX Maastricht, Netherlands.	hjgm.crijns@mumc.nl	Dudink, Elton/AAC-9913-2019; Pluymaekers, Nikki/V-4252-2019	Pluymaekers, Nikki/0000-0002-9663-6315; kamp, otto/0000-0003-2707-2090; Meeder, Joan/0000-0003-3261-9361; Rienstra, Michiel/0000-0002-2581-070X; Dudink, Elton/0000-0003-4572-3969	Netherlands Organization for Health Research and Development-Health Care Efficiency Research Program [837002524]; Maastricht University Medical Center	Netherlands Organization for Health Research and Development-Health Care Efficiency Research Program; Maastricht University Medical Center	Supported by a grant (837002524) from the Netherlands Organization for Health Research and Development-Health Care Efficiency Research Program and by the Maastricht University Medical Center. Boehringer Ingelheim provided some of the remote monitoring devices.	Airaksinen KEJ, 2013, J AM COLL CARDIOL, V62, P1187, DOI 10.1016/j.jacc.2013.04.089; Brambatti M, 2014, CIRCULATION, V129, P2094, DOI 10.1161/CIRCULATIONAHA.113.007825; Calkins H, 2017, J ARRYTHM, V33, P369, DOI 10.1016/j.joa.2017.08.001; Camm AJ, 2010, EUR HEART J, V31, P2369, DOI [10.1093/eurheartj/ehq278, 10.1093/europace/euq350]; Charitos EI, 2014, J AM COLL CARDIOL, V63, P2840, DOI 10.1016/j.jacc.2014.04.019; Coll-Vinent B, 2017, STROKE, V48, P1344, DOI 10.1161/STROKEAHA.116.014855; Cotter G, 1999, EUR HEART J, V20, P1833, DOI 10.1053/euhj.1999.1747; Crijns HJGM, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-85; Danias PG, 1998, J AM COLL CARDIOL, V31, P588, DOI 10.1016/S0735-1097(97)00534-2; Daoud EG, 2011, HEART RHYTHM, V8, P1416, DOI 10.1016/j.hrthm.2011.04.022; Decker WW, 2008, ANN EMERG MED, V52, P322, DOI 10.1016/j.annemergmed.2007.12.015; Doyle B, 2011, EMERG MED INT, V2011, DOI 10.1155/2011/545023; Elton D, 2017, AM HEART J, V183, P49, DOI 10.1016/j.ahj.2016.09.009; FARRINGTON CP, 1990, STAT MED, V9, P1447, DOI 10.1002/sim.4780091208; Geleris P, 2001, J Cardiol, V37, P103; January CT, 2014, J AM COLL CARDIOL, V64, P2246, DOI [10.1016/j.jacc.2014.03.022, 10.1016/j.jacc.2014.03.021, 10.1161/CIR.0000000000000041, 10.1161/CIR.0000000000000142]; Kirchhof P, 2016, EUROPACE, V18, DOI [10.1016/j.rec.2016.11.033, 10.1093/europace/euw295, 10.5603/KP.2016.0172]; Klein AL, 2001, NEW ENGL J MED, V344, P1411, DOI 10.1056/NEJM200105103441901; Lindberg S, 2012, INTERN MED J, V42, P1195, DOI 10.1111/j.1445-5994.2011.02600.x; Lip GYH, 2014, AM J CARDIOL, V113, P480, DOI 10.1016/j.amjcard.2013.10.036; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Little RJ, 2012, NEW ENGL J MED, V367, P1355, DOI 10.1056/NEJMsr1203730; Mauri L, 2017, NEW ENGL J MED, V377, P1357, DOI 10.1056/NEJMra1510063; Nieuwlaat R, 2008, EUR HEART J, V29, P915, DOI 10.1093/eurheartj/ehn101; Nuotio I, 2014, JAMA-J AM MED ASSOC, V312, P647, DOI 10.1001/jama.2014.3824; Pisters R, 2012, EUROPACE, V14, P1, DOI 10.1093/europace/eur310; Spertus J, 2011, CIRC-ARRHYTHMIA ELEC, V4, P15, DOI 10.1161/CIRCEP.110.958033; Tieleman RG, 2014, EUROPACE, V16, P1291, DOI 10.1093/europace/euu057; Van Gelder IC, 2010, NEW ENGL J MED, V362, P1363, DOI 10.1056/NEJMoa1001337; Verma A, 2015, NEW ENGL J MED, V372, P1812, DOI 10.1056/NEJMoa1408288	30	90	91	1	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 18	2019	380	16					1499	1508		10.1056/NEJMoa1900353	http://dx.doi.org/10.1056/NEJMoa1900353			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU3AO	30883054	Green Published, Bronze			2022-12-28	WOS:000465144100011
J	Macdonald, FA; Swanson-Hysell, NL; Park, Y; Lisiecki, L; Jagoutz, O				Macdonald, Francis A.; Swanson-Hysell, Nicholas L.; Park, Yuem; Lisiecki, Lorraine; Jagoutz, Oliver			Arc-continent collisions in the tropics set Earth's climate state	SCIENCE			English	Article							EAST SULAWESI OPHIOLITE; LARGE IGNEOUS PROVINCES; PLATE TECTONIC MODEL; PALEOZOIC ICE-AGE; ATMOSPHERIC CO2; LATE ORDOVICIAN; GLOBAL CLIMATE; FORELAND BASIN; NEW-ZEALAND; U-PB	On multimillion-year time scales, Earth has experienced warm ice-free and cold glacial climates, but it is unknown whether transitions between these background climate states were the result of changes in carbon dioxide sources or sinks. Low-latitude arc-continent collisions are hypothesized to drive cooling by exhuming and eroding mafic and ultramafic rocks in the warm, wet tropics, thereby increasing Earth's potential to sequester carbon through chemical weathering. To better constrain global weatherability through time, the paleogeographic position of all major Phanerozoic arc-continent collisions was reconstructed and compared to the latitudinal distribution of ice sheets. This analysis reveals a strong correlation between the extent of glaciation and arc-continent collisions in the tropics. Earth's climate state is set primarily by global weatherability, which changes with the latitudinal distribution of arc-continent collisions.	[Macdonald, Francis A.; Lisiecki, Lorraine] Univ Calif Santa Barbara, Dept Earth Sci, Santa Barbara, CA 93106 USA; [Swanson-Hysell, Nicholas L.; Park, Yuem] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; [Jagoutz, Oliver] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA	University of California System; University of California Santa Barbara; University of California System; University of California Berkeley; Massachusetts Institute of Technology (MIT)	Macdonald, FA (corresponding author), Univ Calif Santa Barbara, Dept Earth Sci, Santa Barbara, CA 93106 USA.	francism@ucsb.edu		Macdonald, Francis/0000-0001-8416-4894; Swanson-Hysell, Nicholas/0000-0003-3215-4648; Park, Yuem/0000-0001-5178-6304	NSF [EAR-1547434]	NSF(National Science Foundation (NSF))	F.A.M., N.L.S.-H., and Y.P. were partially supported by NSF grant EAR-1547434.	ALAVI M, 1994, TECTONOPHYSICS, V229, P211, DOI 10.1016/0040-1951(94)90030-2; Alexeiev DV, 2016, GONDWANA RES, V39, P261, DOI 10.1016/j.gr.2016.02.003; Alexeiev DV, 2011, J ASIAN EARTH SCI, V42, P805, DOI 10.1016/j.jseaes.2010.09.004; Ali JR, 2001, J ASIAN EARTH SCI, V19, P535, DOI 10.1016/S1367-9120(00)00053-5; Allen R, 2008, GEOL SOC AM SPEC PAP, V436, P223, DOI 10.1130/2008.2436(11); Alvarez-Valero AM, 2014, GEOL SOC AM BULL, V126, P1614, DOI 10.1130/B31040.1; Baldwin SL, 2012, ANNU REV EARTH PL SC, V40, P495, DOI 10.1146/annurev-earth-040809-152540; Ballantyne P., 1992, SPECIAL PUBLICATION, V60, P179, DOI [10.1144/GSL.SP.1992.060.01.11, DOI 10.1144/GSL.SP.1992.060.01.11]; BECK RA, 1995, NATURE, V373, P55, DOI 10.1038/373055a0; Bergman S.C., 1996, TECTONIC EVOLUTION S, V106, P391, DOI [10.1144/GSL.SP.1996.106.01.25, DOI 10.1144/GSL.SP.1996.106.01.25, 10]; Berner RA, 1997, GEOLOGY, V25, P955, DOI 10.1130/0091-7613(1997)025<0955:TNFMBA>2.3.CO;2; Berner RA, 1997, SCIENCE, V276, P544, DOI 10.1126/science.276.5312.544; Berner RA, 2001, AM J SCI, V301, P182, DOI 10.2475/ajs.301.2.182; BERNER RA, 1994, AM J SCI, V294, P56, DOI 10.2475/ajs.294.1.56; Bold U, 2016, LITHOSPHERE-US, V8, P729, DOI 10.1130/L549.1; Bouilhol P, 2013, EARTH PLANET SC LETT, V366, P163, DOI 10.1016/j.epsl.2013.01.023; Bozkurt E, 2013, TECTONOPHYSICS, V595, P198, DOI 10.1016/j.tecto.2012.11.005; Brezinski DK, 2008, PALAEOGEOGR PALAEOCL, V268, P143, DOI 10.1016/j.palaeo.2008.03.042; Brooks C.E.P., 1926, CLIMATE AGES STUDY C; Brown D, 2006, EARTH-SCI REV, V79, P261, DOI 10.1016/j.earscirev.2006.08.003; Buchan C, 2001, J GEOL SOC LONDON, V158, P445, DOI 10.1144/jgs.158.3.445; Burchfiel B.C., 2012, GEOL SOC AM MEM, V210, P231; Burchfiel B.C., 1992, CORDILLERAN OROGEN G, V3, P407, DOI DOI 10.1130/DNAG-GNA-G3.407; BURKE K, 1977, TECTONOPHYSICS, V40, P69, DOI 10.1016/0040-1951(77)90030-0; Calderon M, 2016, SPRING EARTH SYST SC, P7, DOI 10.1007/978-3-319-39727-6_2; Cao WR, 2017, EARTH PLANET SC LETT, V461, P85, DOI 10.1016/j.epsl.2016.12.044; Casquet C, 2018, EARTH-SCI REV, V177, P209, DOI 10.1016/j.earscirev.2017.11.013; Cawood PA, 2005, EARTH-SCI REV, V69, P249, DOI 10.1016/j.earscirev.2004.09.001; Chamberlin T.C., 1899, J GEOL, V7, P545, DOI [10.1086/, 10.1086/608449, DOI 10.1086/608449]; Cherkasova T, 2015, IOP C SER EARTH ENV, V27, DOI 10.1088/1755-1315/27/1/012002; Choulet F, 2012, AM J SCI, V312, P1098, DOI 10.2475/10.2012.02; Cloos M, 2005, GEOL SOC AM SPEC PAP, V400, P1, DOI 10.1130/2005.2400; Cluzel D., 1992, J SE ASIAN EARTH SCI, V7, P195, DOI DOI 10.1016/0743-9547(92)90054-F; Cluzel D, 2012, TECTONICS, V31, DOI 10.1029/2011TC003085; Coggon JA, 2011, ECON GEOL, V106, P93, DOI 10.2113/econgeo.106.1.93; Colleps CL, 2018, GEOCHEM GEOPHY GEOSY, V19, P257, DOI 10.1002/2017GC007191; Colpron M., 2007, GSA TODAY, V17, P4, DOI DOI 10.1130/GSAT01704-5A.1; Cramer BS, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2011JC007255; Crowley T. J., 1998, TECTONIC BOUNDARY CO, P3; DALLMEYER RD, 1986, GEOL SOC AM BULL, V97, P1329, DOI 10.1130/0016-7606(1986)97<1329:COTAOI>2.0.CO;2; Davies H., 1984, GEOLOGICAL SOC LONDO, V13, P341, DOI [10.1144/gsl.sp.1984.013.01.27, DOI 10.1144/GSL.SP.1984.013.01.27, 10.1144/GSL.SP.1984.013.01.27]; DAVIES HL, 1971, GEOL SOC AM BULL, V82, P3299, DOI 10.1130/0016-7606(1971)82[3299:GOEP]2.0.CO;2; de Boer B, 2010, ANN GLACIOL, V51, P23, DOI 10.3189/172756410791392736; Dessert C, 2001, EARTH PLANET SC LETT, V188, P459, DOI 10.1016/S0012-821X(01)00317-X; Dessert C, 2003, CHEM GEOL, V202, P257, DOI 10.1016/j.chemgeo.2002.10.001; Diaz-Martinez E, 2007, PALAEOGEOGR PALAEOCL, V245, P62, DOI 10.1016/j.palaeo.2006.02.018; DICKINSON WR, 1972, GEOL SOC AM BULL, V83, P3007, DOI 10.1130/0016-7606(1972)83[3007:PIAPIT]2.0.CO;2; Dilek Y, 2014, ELEMENTS, V10, P93, DOI 10.2113/gselements.10.2.93; Dilek Y, 2011, GEOL SOC AM BULL, V123, P387, DOI 10.1130/B30446.1; Dingle RV, 1998, J GEOL SOC LONDON, V155, P433, DOI 10.1144/gsjgs.155.3.0433; Dobretsov NL, 2007, RUSS GEOL GEOPHYS+, V48, P71, DOI 10.1016/j.rgg.2006.12.006; Domeier M, 2018, GEOSCI FRONT, V9, P789, DOI 10.1016/j.gsf.2017.11.012; Donohoe A, 2017, GEOPHYS MONOGR SER, V226, P115; Donskaya TV, 2013, J ASIAN EARTH SCI, V62, P79, DOI 10.1016/j.jseaes.2012.07.023; Ehlers J, 2007, QUATERN INT, V164-65, P6, DOI 10.1016/j.quaint.2006.10.008; Encarnacion JP, 1995, J PETROL, V36, P1481; Enkelmann E, 2007, TECTONICS, V26, DOI 10.1029/2006TC002078; Ernst RE, 2017, PALAEOGEOGR PALAEOCL, V478, P30, DOI 10.1016/j.palaeo.2017.03.014; Escayola MP, 2007, GEOLOGY, V35, P495, DOI 10.1130/G23549A.1; Escuder-Viruete J, 2011, GEOL ACTA, V9, P307, DOI 10.1344/105.000001716; Evans DAD, 2006, NATURE, V444, P51, DOI 10.1038/nature05203; FARMER GL, 1983, J GEOPHYS RES, V88, P3379, DOI 10.1029/JB088iB04p03379; Fielding C. R., 2008, GEOL SOC AM SPEC PUB, V441; Foster GL, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14845; Frakes L, 1995, INT GEOL REV, V37, P567, DOI DOI 10.1080/00206819509465419; FRAKES LA, 1988, NATURE, V333, P547, DOI 10.1038/333547a0; Fuentes P, 2016, J S AM EARTH SCI, V67, P40, DOI 10.1016/j.jsames.2016.02.001; Furnes H, 2014, GEOSCI FRONT, V5, P571, DOI 10.1016/j.gsf.2014.02.002; Gaillardet J, 1999, CHEM GEOL, V159, P3, DOI 10.1016/S0009-2541(99)00031-5; Garzanti E, 2002, SEDIMENT GEOL, V151, P67, DOI 10.1016/S0037-0738(01)00231-7; Gayer R., 1989, P USSHER SOC, V7, P177; Gee DG, 2008, EPISODES, V31, P44, DOI 10.18814/epiiugs/2008/v31i1/007; GLEASON JD, 1995, GEOL SOC AM BULL, V107, P1192, DOI 10.1130/0016-7606(1995)107<1192:NICOSS>2.3.CO;2; Glen RA, 2005, GEOL SOC SPEC PUBL, V246, P23, DOI 10.1144/GSL.SP.2005.246.01.02; Godderis Y, 2003, EARTH PLANET SC LETT, V211, P1, DOI 10.1016/S0012-821X(03)00197-3; Godderis Y, 2017, NAT GEOSCI, V10, P382, DOI [10.1038/NGEO2931, 10.1038/ngeo2931]; Godderis Y, 2017, GONDWANA RES, V42, P151, DOI 10.1016/j.gr.2016.09.013; Gray DR, 2004, TECTONOPHYSICS, V385, P181, DOI 10.1016/j.tecto.2004.05.001; Hacker BR, 2004, GEOL SOC SPEC PUBL, V226, P157, DOI 10.1144/GSL.SP.2004.226.01.09; Hadley G., 1735, PHILOS T ROY SOC LON, V39, P58, DOI [10.1098/rstl.1735.0014, DOI 10.1098/RSTL.1735.0014]; Haeussler PJ, 2003, GEOL SOC AM BULL, V115, P867, DOI 10.1130/0016-7606(2003)115<0867:LADOTR>2.0.CO;2; Hall R, 2002, J ASIAN EARTH SCI, V20, P353, DOI 10.1016/S1367-9120(01)00069-4; HALL R, 1988, J GEOL SOC LONDON, V145, P65, DOI 10.1144/gsjgs.145.1.0065; Hall R, 2017, ANNU REV EARTH PL SC, V45, P331, DOI 10.1146/annurev-earth-063016-020633; HAMBREY MJ, 1985, PALAEOGEOGR PALAEOCL, V51, P273, DOI 10.1016/0031-0182(85)90089-6; Hamilton W., 1979, GEOLOGICAL SURVEY PR; Han BF, 2010, GEOL SOC AM BULL, V122, P627, DOI 10.1130/B26491.1; HARRIS R.A., 1992, GEOL SOC LOND SPEC P, V60, P301, DOI DOI 10.1144/GSL.SP.1992.060.01.19; Harris R, 2006, GONDWANA RES, V10, P207, DOI 10.1016/j.gr.2006.05.010; Hartley AJ, 2001, J GEOL SOC LONDON, V158, P137, DOI 10.1144/jgs.158.1.137; Hartmann J, 2014, CHEM GEOL, V363, P145, DOI 10.1016/j.chemgeo.2013.10.025; Hartmann J, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2012GC004370; Hebert R, 2012, GONDWANA RES, V22, P377, DOI 10.1016/j.gr.2011.10.013; Hennig J, 2017, TECTONOPHYSICS, V712, P600, DOI 10.1016/j.tecto.2017.06.025; Higgins JA, 2018, GEOCHIM COSMOCHIM AC, V220, P512, DOI 10.1016/j.gca.2017.09.046; Hoffman Paul F., 2009, Geology Today, V25, P100; Holis SP, 2013, J GEOL SOC LONDON, V170, P861, DOI 10.1144/jgs2012-103; Isaacson PE, 2008, PALAEOGEOGR PALAEOCL, V268, P126, DOI 10.1016/j.palaeo.2008.03.047; Ishiwatari A, 2003, GEOL SOC SPEC PUBL, V218, P597, DOI 10.1144/GSL.SP.2003.218.01.30; Ishiwatari A, 2003, ISL ARC, V12, P190, DOI 10.1046/j.1440-1738.2003.00390.x; Isozaki Y, 2010, GONDWANA RES, V18, P82, DOI 10.1016/j.gr.2010.02.015; Ivany LC, 2006, GEOLOGY, V34, P377, DOI 10.1130/G22383.1; Jagoutz O, 2016, P NATL ACAD SCI USA, V113, P4935, DOI 10.1073/pnas.1523667113; Jagoutz O, 2015, NAT GEOSCI, V8, P475, DOI 10.1038/NGEO2418; Jian P, 2009, LITHOS, V113, P767, DOI 10.1016/j.lithos.2009.04.006; Johansson L, 2018, GEOPHYS RES LETT, V45, P5380, DOI 10.1029/2017GL076691; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kent DV, 2013, CLIM PAST, V9, P525, DOI 10.5194/cp-9-525-2013; Kent DV, 2008, P NATL ACAD SCI USA, V105, P16065, DOI 10.1073/pnas.0805382105; Kerr AC, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000790; Kerr AC, 2005, GEOLOGY, V33, P269, DOI 10.1130/G21109.1; Kozakov IK, 2012, GEOTECTONICS+, V46, P16, DOI 10.1134/S0016852112010037; Kroner A, 2012, GONDWANA RES, V21, P901, DOI 10.1016/j.gr.2011.05.010; Kroner A, 2010, AM J SCI, V310, P523, DOI 10.2475/07.2010.01; Kroner U, 2013, GONDWANA RES, V24, P298, DOI 10.1016/j.gr.2013.03.001; Kump L. R., 1997, TECTONIC UPLIFT CLIM, P399, DOI [DOI 10.1007/978-1-4615-5935-1, DOI 10.1007/978-1-4615-5935-1_18]; LACKNER KS, 1995, ENERGY, V20, P1153, DOI 10.1016/0360-5442(95)00071-N; Lazaro C, 2009, J METAMORPH GEOL, V27, P19, DOI 10.1111/j.1525-1314.2008.00800.x; Lee CTA, 2015, ELEMENTS, V11, P125, DOI 10.2113/gselements.11.2.125; Liu H, 2016, GEOL J, V51, P627, DOI 10.1002/gj.2664; Lytwyn J, 1997, J GEOPHYS RES-SOL EA, V102, P10225, DOI 10.1029/96JB03858; Macdonald FA, 2017, AM J SCI, V317, P555, DOI 10.2475/05.2017.02; MANN P, 1999, SED BAS WOR, V4, P3; Marsaglia KM, 2014, NEW ZEAL J GEOL GEOP, V57, P219, DOI 10.1080/00288306.2014.898665; Matthews KJ, 2016, GLOBAL PLANET CHANGE, V146, P226, DOI 10.1016/j.gloplacha.2016.10.002; McClelland WC, 2012, Z DTSCH GES GEOWISS, V163, P251, DOI 10.1127/1860-1804/2012/0163-0251; McKenzie NR, 2016, SCIENCE, V352, P444, DOI 10.1126/science.aad5787; Metcalfe I, 2013, J ASIAN EARTH SCI, V66, P1, DOI 10.1016/j.jseaes.2012.12.020; Michard A, 2002, B SOC GEOL FR, V173, P3, DOI 10.2113/173.1.3; MISRA KC, 1978, AM J SCI, V278, P389, DOI 10.2475/ajs.278.4.389; Moghadam HS, 2015, J ASIAN EARTH SCI, V100, P31, DOI 10.1016/j.jseaes.2014.12.016; Moghadam HS, 2014, J ASIAN EARTH SCI, V91, P19, DOI 10.1016/j.jseaes.2014.04.008; MONNIER C, 1995, GEOLOGY, V23, P851, DOI 10.1130/0091-7613(1995)023<0851:BABOFT>2.3.CO;2; Monnier C, 2003, B SOC GEOL FR, V174, P529, DOI 10.2113/174.6.529; Monnier C, 1999, MINER PETROL, V65, P1, DOI 10.1007/BF01161574; Monnier C, 1999, GEODIN ACTA, V12, P43, DOI 10.1016/S0985-3111(99)80022-9; Montanez IP, 2013, ANNU REV EARTH PL SC, V41, P629, DOI 10.1146/annurev.earth.031208.100118; Montanez IP, 2013, GEOCHIM COSMOCHIM AC, V101, P57, DOI 10.1016/j.gca.2012.10.012; Moore TE, 2015, GEOSPHERE, V11, P93, DOI 10.1130/GES01043.1; Murphy D. C., 2006, GEOLOGICAL ASS CANAD, V45, P75105; Nance RD, 2010, GONDWANA RES, V17, P194, DOI 10.1016/j.gr.2009.08.001; Narkiewicz M, 2007, GEOL Q, V51, P231; Newell AJ, 1999, SEDIMENT GEOL, V127, P11, DOI 10.1016/S0037-0738(99)00009-3; Nicholson KN, 2000, TECTONOPHYSICS, V321, P1, DOI 10.1016/S0040-1951(00)00081-0; Norton KP, 2014, GEOMORPHOLOGY, V204, P510, DOI 10.1016/j.geomorph.2013.08.030; Okay AI, 1999, GEOL SOC SPEC PUBL, V156, P475, DOI 10.1144/GSL.SP.1999.156.01.22; PALLISTER JS, 1989, J GEOPHYS RES-SOLID, V94, P15901, DOI 10.1029/JB094iB11p15901; Parkinson C, 1998, J ASIAN EARTH SCI, V16, P13, DOI 10.1016/S0743-9547(97)00039-1; Parsons AJ, 2019, GEOL SOC AM BULL, V131, P274, DOI 10.1130/B31964.1; Pedersen RB, 2010, J GEOL SOC LONDON, V167, P1105, DOI 10.1144/0016-76492009-151; PEDERSEN RB, 1991, J GEODYN, V13, P183, DOI 10.1016/0264-3707(91)90038-G; Pharaoh TC, 1999, TECTONOPHYSICS, V314, P17, DOI 10.1016/S0040-1951(99)00235-8; PIQUE A, 1992, TECTONICS, V11, P392, DOI 10.1029/91TC01606; PIQUE A, 1989, AM J SCI, V289, P286, DOI 10.2475/ajs.289.3.286; Pownall JM, 2017, GONDWANA RES, V44, P35, DOI 10.1016/j.gr.2016.10.018; Proust JN, 1998, J SEDIMENT RES, V68, P1175, DOI 10.2110/jsr.68.1175; Pubellier M., 1991, J SOUTHE ASIAN EARTH, V6, P239, DOI [DOI 10.1016/0743-9547(91)90070-E, 10.1016/0743-9547(91)90070-E]; Puchkov V, 2016, GFF, V138, P6, DOI 10.1080/11035897.2015.1118406; Ramos VA, 2000, GEOL SOC AM SPEC PAP, P331; RAYMO ME, 1991, GEOLOGY, V19, P344, DOI 10.1130/0091-7613(1991)019<0344:GESTCC>2.3.CO;2; Reusch DN, 2011, GEOLOGY, V39, P807, DOI 10.1130/G31981.1; Rioux M, 2016, EARTH PLANET SC LETT, V451, P185, DOI 10.1016/j.epsl.2016.06.051; Rosenbaum G, 2012, EPISODES, V35, P187, DOI 10.18814/epiiugs/2012/v35i1/018; Royer DL, 2014, AM J SCI, V314, P1259, DOI 10.2475/09.2014.01; Saltzman MR, 2005, GEOLOGY, V33, P109, DOI 10.1130/G21219.1; SCHAFER A, 1989, GEOL RUNDSCH, V78, P499, DOI 10.1007/BF01776188; Schopka HH, 2011, GEOCHIM COSMOCHIM AC, V75, P978, DOI 10.1016/j.gca.2010.11.014; Schwab M, 2004, TECTONICS, V23, DOI 10.1029/2003TC001583; Sengor A. M. C., 1996, TECTONIC EVOLUTION A, P486; Sengor AMC, 2014, GEOSCI CAN, V41, P225; Sepulveda FA, 2008, GONDWANA RES, V13, P238, DOI 10.1016/j.gr.2007.06.004; Shervais JW, 2005, GEOL SOC AM BULL, V117, P633, DOI 10.1130/B25443.1; Sivell WJ, 2000, NEW ZEAL J GEOL GEOP, V43, P133, DOI 10.1080/00288306.2000.9514876; Smith EF, 2016, GEOL SOC AM BULL, V128, P442, DOI 10.1130/B31248.1; SNOW JK, 1991, GEOLOGY, V19, P629, DOI 10.1130/0091-7613(1991)019<0629:PTPATD>2.3.CO;2; Song SG, 2013, GONDWANA RES, V23, P1378, DOI 10.1016/j.gr.2012.02.004; Spadea P, 2006, ISL ARC, V15, P7, DOI 10.1111/j.1440-1738.2006.00514.x; Spaggiari CV, 2003, GEOL SOC SPEC PUBL, V218, P517, DOI 10.1144/GSL.SP.2003.218.01.27; Stampfli GM, 2002, EARTH PLANET SC LETT, V196, P17, DOI 10.1016/S0012-821X(01)00588-X; Straeten CAV, 2010, GEOL SOC AM MEM, V206, P251, DOI 10.1130/2010.1206(12); Swanson-Hysell NL, 2017, GEOLOGY, V45, P719, DOI 10.1130/G38985.1; TIRRUL R, 1983, GEOL SOC AM BULL, V94, P134, DOI 10.1130/0016-7606(1983)94<134:TSSZOE>2.0.CO;2; Torsvik T.H., 2017, EARTH HIST PALAEOGEO, DOI DOI 10.1017/9781316225523; Torsvik TH, 2013, GONDWANA RES, V24, P999, DOI 10.1016/j.gr.2013.06.012; Trettin H.P., 1992, RADIOGENIC AGE ISOTO, V92, P3; Trettin H.P., 1991, GEOLOGY INNUITIAN OR, P241; Troedson AL, 2002, J SEDIMENT RES, V72, P510, DOI 10.1306/110601720510; Tsukanov NV, 2007, ISL ARC, V16, P431, DOI 10.1111/j.1440-1738.2007.00579.x; Van der Meer DG, 2014, P NATL ACAD SCI USA, V111, P4380, DOI 10.1073/pnas.1315657111; Van der Voo R, 2015, GEOL SOC AM SPEC PAP, V513, P589, DOI 10.1130/2015.2513(19); van Staal C. R., 2012, GEOLOGICAL ASS CANAD, V49; van Staal CR, 2013, GEOSCI CAN, V40, P94, DOI 10.12789/geocanj.2013.40.006; van Ufford AQ, 2005, AAPG BULL, V89, P119, DOI 10.1306/08300403073; VEEVERS JJ, 1987, GEOL SOC AM BULL, V98, P475, DOI 10.1130/0016-7606(1987)98<475:LPGEIG>2.0.CO;2; Villeneuve M, 2005, J AFR EARTH SCI, V43, P166, DOI 10.1016/j.jafrearsci.2005.07.012; von Storch H, 1999, ANAL CLIMATE VARIABI, P11, DOI DOI 10.1007/978-3-662-03744-7_2; Wakabayashi J, 2012, TECTONOPHYSICS, V568, P230, DOI 10.1016/j.tecto.2011.11.006; Wakita K, 2000, J ASIAN EARTH SCI, V18, P739, DOI 10.1016/S1367-9120(00)00020-1; WALKER JCG, 1981, J GEOPHYS RES-OCEANS, V86, P9776, DOI 10.1029/JC086iC10p09776; Wang B, 2011, TECTONOPHYSICS, V497, P85, DOI 10.1016/j.tecto.2010.11.004; Whattam SA, 2006, EARTH PLANET SC LETT, V250, P606, DOI 10.1016/j.epsl.2006.07.047; Windley BF, 2007, J GEOL SOC LONDON, V164, P31, DOI 10.1144/0016-76492006-022; WIRTH KR, 1992, GEOLOGY, V20, P75, DOI 10.1130/0091-7613(1992)020<0075:COOCDA>2.3.CO;2; Witts D, 2012, J ASIAN EARTH SCI, V56, P77, DOI 10.1016/j.jseaes.2012.04.022; Xiao WJ, 2015, ANNU REV EARTH PL SC, V43, P477, DOI [10.1146/annurev-earth-060614-1052, 10.1146/annurev-earth-060614-105254]; Xiao WJ, 2002, J GEOL SOC LONDON, V159, P517, DOI 10.1144/0016-764901-093; Yang TN, 2012, TECTONICS, V31, DOI 10.1029/2011TC003044; Yumul GP, 2007, ISL ARC, V16, P306, DOI 10.1111/j.1440-1738.2007.00573.x; Yumul GP, 2013, J ASIAN EARTH SCI, V65, P53, DOI 10.1016/j.jseaes.2012.08.017; Yumul GP, 2009, J ASIAN EARTH SCI, V34, P610, DOI 10.1016/j.jseaes.2008.10.002; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zhai QG, 2011, J ASIAN EARTH SCI, V42, P1356, DOI 10.1016/j.jseaes.2011.07.023; Zhang JX, 2012, TECTONOPHYSICS, V570, P78, DOI 10.1016/j.tecto.2012.08.018; Zhang KJ, 2012, EARTH-SCI REV, V114, P236, DOI 10.1016/j.earscirev.2012.06.001; Zi JW, 2012, LITHOS, V144, P145, DOI 10.1016/j.lithos.2012.04.020; ZONENSHAIN LP, 1984, TECTONOPHYSICS, V109, P95, DOI 10.1016/0040-1951(84)90173-2; Zwart H., 1967, MEDD DAN GEOL FOREN, V17, P504	217	97	100	15	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 12	2019	364	6436					181	+		10.1126/science.aav5300	http://dx.doi.org/10.1126/science.aav5300			57	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HT5RC	30872536	Green Submitted			2022-12-28	WOS:000464620000043
J	Mark, DB; Anstrom, KJ; Sheng, SB; Piccini, JP; Baloch, KN; Monahan, KH; Daniels, MR; Bahnson, TD; Poole, JE; Rosenberg, Y; Lee, KL; Packer, DL; Robb, RA; Rettmann, ME; Martinez, B; Mascette, A; Jeffries, N; Mitchell, LB; Flaker, GG; Al-Khalidi, HR; Silverstein, A; Ellis, A; Ussery, SA; Moretz, KL; Hagen, S; Anstrom, K; Baloch, K; Liu, DM; Blount, J; Cowper, P; Knight, D; O'Neal, EF; Holmes, DR; Breen, J; Wilber, D; Reiffel, J; Kowey, P; Naccarelli, G; DiMarco, JP; Davies, DW; Cappato, R; Kalman, JM; Kuck, KH; Hindricks, G; Calkins, H; Stevenson, WG; Buxton, A; Curtis, AB; Davis, BR; Ulrich, CM; Lazzara, R; Peters, T; Bunch, JT; Daubert, J; Halperin, B; Holshouser, J; Kutalek, S; Michaud, G; Mounsey, P; Wyse, G; Flaker, G; Bell, R; Greenspon, A; Logan, W; Sahota, P; Singh, N; Calkins, H; Schilling, R; Verma, A; Bahnson, T; DeVille, B; Monahan, K; DiMarco, J; Naccarelli, G; Gonzalez, M; Monahan, K; Poole, J; Patton, K; Prutkin, J; Johnson, G; Akoum, N; Auokar, P; Blatt, J; Birgersdotter-Green, U; Cha, YM; Mulpuru, S; Noseworthy, P; Chung, M; Gleva, M; Glotzer, T; Henrikson, C; Stecker, E; Kanjwal, Y; Kron, J; Kuriachan, V; Obel, O; Ranjan, R; Rho, R; Russo, A; Sullivan, R; Tzou, W; van der Zee, S; Serdoz, LV; Wilson, M; Bowen, W; Pokushalov, E; Romanov, A; Meshalkin, E; Bunch, TJ; Bahnson, T; Noelker, G; Packer, D; Hindricks, G; Ardashev, A; Revishvili, A; Matsonashvili, G; Vijayaraman, P; Ince, H; Piorkowski, C; Neumann, T; Veenhuyzen, G; Gehi, A; Wilber, D; Sogade, F; Pappone, C; Berman, A; Shalaby, A; Kuck, KH; Halperin, B; Tholakanahalli, V; Palma, E; Holshouser, J; Badhwar, N; Rashid, H; Cameron, C; Hummel, J; Saavedra, P; Deville, B; Chun, J; Roman-Gonzalez, J; Willems, S; Garan, H; Crespo, EM; Cheung, P; Groenefeld, G; Schuger, C; Salam, T; Yang, YZ; Pappone, C; Wichterle, D; Brachmann, J; Kautzner, J; Jayachandran, J; Kim, YH; Cole, C; Herweg, B; Lowe, M; Dougherty, A; Popov, S; Lowe, M; Spitzer, S; Bernstein, R; Simonson, J; Buch, E; Wu, SL; Khan, M; Shinn, T; Neuzil, P; Mangrum, J; Calkins, H; Gonzalez, M; Mansour, M; Zabel, M; Kalman, J; Sanchez, J; Rothman, S; Bhandari, A; Tracy, C; Mitrani, R; Vorperian, V; Connelly, D; Wells, D; Ma, CS; Verma, A; Robinson, M; Rubenstein, D; Vanoli, E; Zhang, S; Cummings, J; Viswanathan, M; Monir, G; Marchlinski, F; Franklin, J; Koplan, B; Sanders, P; Rashba, E; Gallagher, M; Gonska, B; Chen, M; Leong-Sit, P; Zimmerman, J; Pezeshkian, N; Cohen, A; Kalvaitis, S; Davies, D; Borggrefe, M; Pak, HN; Russo, A; Henrikson, C; Greer, G; Coromilas, J; Khairallah, F; Sosa-Suarez, G; Lindsay, B; Fisher, W; Bailin, S; Tran, A; Starek, Z; Preminger, M; Sheppard, R; Costea, A; Ellenbogen, K; Arentz, T; De Ponti, R; Aleong, R; Colley, B; Baig, K; Krishnan, K; Menon, SD; Simmons, T; Bruce, G; Chinitz, L; Natale, A; Cappato, R				Mark, Daniel B.; Anstrom, Kevin J.; Sheng, Shubin; Piccini, Jonathan P.; Baloch, Khaula N.; Monahan, Kristi H.; Daniels, Melanie R.; Bahnson, Tristram D.; Poole, Jeanne E.; Rosenberg, Yves; Lee, Kerry L.; Packer, Douglas L.; Robb, Richard A.; Rettmann, Maryam E.; Martinez, Beth; Mascette, Alice; Jeffries, Neal; Mitchell, L. Brent; Flaker, Greg G.; Al-Khalidi, Hussein R.; Silverstein, Adam; Ellis, Alicia; Ussery, Sheri A.; Moretz, Kathleen L.; Hagen, Sarah; Anstrom, Kevin; Baloch, Khaula; Liu, Diane M.; Blount, Janet; Cowper, Patricia; Knight, David; O'Neal, Elizabeth F.; Holmes, David R., III; Breen, Jerome; Wilber, David; Reiffel, James; Kowey, Peter; Naccarelli, Gerald; DiMarco, John P.; Davies, D. Wyn; Cappato, Riccardo; Kalman, Jon M.; Kuck, Karl-Heinz; Hindricks, Gerhardt; Calkins, Hugh; Stevenson, William G.; Buxton, Alfred; Curtis, Anne B.; Davis, Barry R.; Ulrich, Connie M.; Lazzara, Ralph; Peters, Terry; Bunch, Jared T.; Daubert, James; Halperin, Blair; Holshouser, John; Kutalek, Steven; Michaud, Greg; Mounsey, Paul; Wyse, George; Flaker, Greg; Bell, Rodney; Greenspon, Amold; Logan, William; Sahota, Pradeep; Singh, Niranjan; Calkins, Hugh; Schilling, Richard; Verma, Atul; Bahnson, Tristram; DeVille, Brian; Monahan, Kristi; DiMarco, John; Naccarelli, Gerald; Gonzalez, Mario; Monahan, Kristi; Poole, Jeanne; Patton, Kris; Prutkin, Jordan; Johnson, George; Akoum, Nazem; Auokar, Pierre; Blatt, Joseph; Birgersdotter-Green, Ulrika (Riki); Cha, Yong-Mei; Mulpuru, Siva; Noseworthy, Peter; Chung, Mina; Gleva, Marye; Glotzer, Taya; Henrikson, Charles; Stecker, Eric; Kanjwal, Yousuf; Kron, Jack; Kuriachan, Vikas; Obel, Owen; Ranjan, Ravi; Rho, Robert; Russo, Andrea; Sullivan, Renee; Tzou, Wendy; van der Zee, Sarina; Serdoz, Laura Vitali; Wilson, Mauri; Bowen, Wayne; Pokushalov, Evgeny; Romanov, Alexander; Meshalkin, E.; Bunch, T. Jared; Bahnson, Tristram; Noelker, Georg; Packer, Douglas; Hindricks, Gerhard; Ardashev, Andrey; Revishvili, Amiran; Matsonashvili, George; Vijayaraman, Pugazhendhi; Ince, Huseyin; Piorkowski, Christopher; Neumann, Thomas; Veenhuyzen, George; Gehi, Anil; Wilber, David; Sogade, Felix; Pappone, Carlo; Berman, Adam; Shalaby, Alaa; Kuck, Karl-Heinz; Halperin, Blair; Tholakanahalli, Venkat; Palma, Eugen; Holshouser, John; Badhwar, Nitish; Rashid, Haroon; Cameron, Craig; Hummel, John; Saavedra, Pablo; Deville, Brian; Chun, Julian; Roman-Gonzalez, Javier; Willems, Stephen; Garan, Hasan; Crespo, Eric Michael; Cheung, Peter; Groenefeld, Gerian; Schuger, Claudio; Salam, Tariq; Yang, Yanzong; Pappone, Carlo; Wichterle, Dan; Brachmann, Johannes; Kautzner, Josef; Jayachandran, John; Kim, Young-Hoon; Cole, Christopher; Herweg, Bengt; Lowe, Martin; Dougherty, Anne; Popov, Sergey; Lowe, Martin; Spitzer, Stefan; Bernstein, Robert; Simonson, Jay; Buch, Eric; Wu, Shulin; Khan, Mohammed; Shinn, Timothy; Neuzil, Petr; Mangrum, James; Calkins, Hugh; Gonzalez, Mario; Mansour, Moussa; Zabel, Markus; Kalman, Jonathan; Sanchez, Jose; Rothman, Steven; Bhandari, Anil; Tracy, Cynthia; Mitrani, Raul; Vorperian, Vicken; Connelly, Derek; Wells, Darryl; Ma, Chang-Sheng; Verma, Atul; Robinson, Melissa; Rubenstein, Donald; Vanoli, Emilio; Zhang, Shu; Cummings, Jennifer; Viswanathan, Mohan; Monir, George; Marchlinski, Francis; Franklin, Jay; Koplan, Bruce; Sanders, Prashanthan; Rashba, Eric; Gallagher, Mark; Gonska, Bernd; Chen, Minglong; Leong-Sit, Peter; Zimmerman, John; Pezeshkian, Nayer; Cohen, Andrew; Kalvaitis, Saulius; Davies, David; Borggrefe, Martin; Pak, Hui-Nam; Russo, Andrea; Henrikson, Charles; Greer, Gerald; Coromilas, James; Khairallah, Farhat; Sosa-Suarez, Guillermo; Lindsay, Bruce; Fisher, Westby; Bailin, Steven; Tran, Andy; Starek, Zdenek; Preminger, Mark; Sheppard, Robert; Costea, Alexandru; Ellenbogen, Kenneth; Arentz, Thomas; De Ponti, Roberto; Aleong, Ryan; Colley, Byron, III; Baig, Khawaja; Krishnan, Kousik; Menon, Syamkumar Divakara; Simmons, Tony; Bruce, Gregory; Chinitz, Larry; Natale, Andrea; Cappato, Riccardo		CABANA Investigators; CABANA Rhythm Monitoring; Clinical Site Principal Investigat	Effect of Catheter Ablation vs Medical Therapy on Quality of Life Among Patients With Atrial Fibrillation The CABANA Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ANTIARRHYTHMIC-DRUG THERAPY; PULMONARY-VEIN ABLATION; RADIOFREQUENCY ABLATION; 1ST-LINE TREATMENT	IMPORTANCE Catheter ablation is more effective than drug therapy in restoring sinus rhythm in patients with atrial fibrillation (AF), but its incremental effect on long-term quality of life (QOL) is uncertain. OBJECTIVE To determine whether catheter ablation is more beneficial than conventional drug therapy for improving QOL in patients with AF. DESIGN, SETTING, AND PARTICIPANTS An open-label randomized clinical trial of catheter ablation vs drug therapy in 2204 symptomatic patients with AF older than 65 years or 65 years or younger with at least 1 risk factor for stroke. Patients were enrolled from November 2009 to April 2016 from 126 centers in 10 countries. Follow-up ended in December 2017. INTERVENTIONS Pulmonary vein isolation, with additional ablation procedures at the discretion of the investigators, for the catheter ablation group (n = 1108) and standard rhythm and/or rate-control drugs selected and managed by investigators for the drug therapy group (n = 1096). MAIN OUTCOMES AND MEASURES Prespecified co-primary QOL end points at 12 months, including the Atrial Fibrillation Effect on Quality of Life (AFEQT) summary score (range, 0-100; 0 indicates complete disability and 100 indicates no disability; patient-level clinically important difference, >= 5 points) and the Mayo AF-Specific Symptom Inventory (MAFSI) frequency score (range, 0-40; 0 indicates no symptoms and 40 indicates the most severe symptoms; patient-level clinically important difference, <=-1.6 points) and severity score (range, 0-30; 0 indicates no symptoms and 30 indicates the most severe symptoms; patient-level clinically important difference, <=-1.3 points). RESULTS Among 2204 randomized patients (median age, 68 years; 1385 patients [63%] were men, 946 [43%] had paroxysmal AF, and 1256 [57%] had persistent AF), the median follow-up was 48.5 months, and 1968 (89%) completed the trial. The mean AFEQT summary score was more favorable in the catheter ablation group than the drug therapy group at 12 months (86.4 points vs 80.9 points) (adjusted difference, 5.3 points [95% CI, 3.7-6.9]; P <.001). The mean MAFSI frequency score was more favorable for the catheter ablation group than the drug therapy group at 12 months (6.4 points vs 8.1 points) (adjusted difference, -1.7 points [95% CI, -2.3 to -1.2]; P <.001) and the mean MAFSI severity score was more favorable for the catheter ablation group than the drug therapy group at 12 months (5.0 points vs 6.5 points) (adjusted difference, -1.5 points [95% CI, -2.0 to -1.1]; P <.001). CONCLUSIONS AND RELEVANCE Among patients with symptomatic atrial fibrillation, catheter ablation, compared with medical therapy, led to clinically important and significant improvements in quality of life at 12 months. These findings can help guide decisions regarding management of atrial fibrillation.	[Mark, Daniel B.; Anstrom, Kevin J.; Sheng, Shubin; Piccini, Jonathan P.; Baloch, Khaula N.; Daniels, Melanie R.; Bahnson, Tristram D.; Lee, Kerry L.; Martinez, Beth; Anstrom, Kevin; Cowper, Patricia; Knight, David; O'Neal, Elizabeth F.; Monahan, Kristi] Duke Univ, Duke Clin Res Inst, Durham, NC USA; [Monahan, Kristi H.; Packer, Douglas L.; Robb, Richard A.; Rettmann, Maryam E.; Monahan, Kristi] Mayo Clin, Rochester, MN USA; [Poole, Jeanne E.] Univ Washington, Med Ctr, Seattle, WA 98195 USA; [Rosenberg, Yves; Mascette, Alice; Jeffries, Neal] NHLBI, NIH, Bldg 10, Bethesda, MD 20892 USA; [Mitchell, L. Brent] Libin Cardiovasc Inst, Calgary, AB, Canada; [Flaker, Greg G.; Sahota, Pradeep; Singh, Niranjan] Univ Missouri, Columbia, MO USA; [Bahnson, Tristram D.; Lee, Kerry L.; Martinez, Beth; Al-Khalidi, Hussein R.; Silverstein, Adam; Ellis, Alicia; Ussery, Sheri A.; Moretz, Kathleen L.] Duke Univ, Duke Clin Res Inst, DCRI Clin Operat Team, Durham, NC USA; [Hagen, Sarah] World Wide Clin Trials, Int Clin Operat Team, Berlin, Germany; [Mark, Daniel B.; Sheng, Shubin; Daniels, Melanie R.; Anstrom, Kevin; Baloch, Khaula; Liu, Diane M.; Blount, Janet] Duke Univ, Duke Clin Res Inst, DCRI Outcomes Call Ctr Staff & Interviewers, Durham, NC USA; [Robb, Richard A.; Rettmann, Maryam E.; Holmes, David R., III; Breen, Jerome] Mayo Clin, Biomed Imaging Resource Core, Rochester, MN USA; [Wilber, David] Loyola Med, Maywood, IL USA; [Reiffel, James] Columbia Univ Coll Phys & Surg, 630 W 168th St, New York, NY 10032 USA; [Kowey, Peter] Lankenau Med Ctr, Wynnewood, PA USA; [Naccarelli, Gerald] Penn State Hershey Cardiovasc Inst, Hershey, PA USA; [DiMarco, John P.] Univ Virginia, Hlth Sci Ctr, Charlottesville, VA USA; [Davies, D. Wyn] St Marys Hosp, London, England; [Kalman, Jon M.] Royal Melbourne Hosp, Parkville, Vic, Australia; [Kuck, Karl-Heinz] Asklepios Klin St George, Hamburg, Germany; [Hindricks, Gerhardt] Herzzentrum Leipzig, Leipzig, Germany; [Calkins, Hugh] Johns Hopkins Univ, Baltimore, MD USA; [Stevenson, William G.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Buxton, Alfred] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Curtis, Anne B.] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Buffalo, NY USA; [Davis, Barry R.] Univ Texas Houston, Sch Publ Hlth, Houston, TX USA; [Ulrich, Connie M.] Univ Penn, Sch Nursing, Philadelphia, PA 19104 USA; [Lazzara, Ralph] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA; [Peters, Terry] Robarts Res Inst, London, ON, Canada; [Mitchell, L. Brent] Univ Calgary, Calgary, AB, Canada; [Bunch, Jared T.] Intermt Med Ctr, Murray, UT USA; [Daubert, James] Duke Univ, Durham, NC USA; [Halperin, Blair] Providence St Vincent Med Ctr, Portland, OR USA; [Holshouser, John] Sanger Clin PA, Charlotte, NC USA; [Kutalek, Steven] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA; [Michaud, Greg] Vanderbilt Univ, 221 Kirkland Hall, Nashville, TN 37235 USA; [Mounsey, Paul] Univ N Carolina, Chapel Hill, NC 27515 USA; [Wyse, George] Univ Calgary, Libin CV Inst, Calgary, AB, Canada; [Flaker, Greg] Univ Missouri, Columbia, MO USA; [Bell, Rodney; Greenspon, Amold] Thomas Jefferson Univ Hosp, Philadelphia, PA 19107 USA; [Logan, William] Mercy Clin, St Louis, MO USA; [Calkins, Hugh] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA; [Schilling, Richard] Queen Mary Univ London, London, England; [Verma, Atul] Newmarket Cardiol Res Grp, Newmarket, ON, Canada; [Bahnson, Tristram] Duke Clin Res Inst, Durham, NC USA; [DeVille, Brian] Heart Hosp Baylor Plano, Plano, TX USA; [Naccarelli, Gerald] Penn State Hershey Cardiovasc Inst, Hershey, PA USA; [Gonzalez, Mario] Milton Hershey Med Ctr, Hershey, PA USA; [Monahan, Kristi; Monahan, Kristi; Cha, Yong-Mei; Mulpuru, Siva; Noseworthy, Peter; Packer, Douglas] Mayo Clin, Rochester, MN USA; [DiMarco, John] Univ Virginia, Hlth Sci Ctr, Charlottesville, VA USA; [Naccarelli, Gerald] Penn State Hershey Cardiovasc Inst, Hershey, PA USA; [Kowey, Peter] Lankenau Med Ctr, Wynnewood, PA USA; [Reiffel, James] Columbia Univ Coll Phys & Surg, New York, NY USA; [Gonzalez, Mario] Milton Hershey Med Ctr, Hershey, PA USA; [Poole, Jeanne; Patton, Kris] Univ Washington, Med Ctr, Seattle, WA USA; [Akoum, Nazem] Univ Washington, Seattle, WA USA; [Auokar, Pierre; Blatt, Joseph] Kaiser Permanente, San Diego, CA USA; [Birgersdotter-Green, Ulrika (Riki)] Univ Calif San Diego, San Diego, CA USA; [Chung, Mina] Cleveland Clin, Cleveland, OH USA; [Gleva, Marye] Washington Univ, Med Ctr, St Louis, MO USA; [Glotzer, Taya] Hackensack Univ, Med Ctr, Hackensack, NJ USA; [Henrikson, Charles; Stecker, Eric] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Kanjwal, Yousuf] Univ Toledo, 2801 W Bancroft St, Toledo, OH 43606 USA; [Kron, Jack] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Kuriachan, Vikas] Alberta Hlth Serv, Calgary, AB, Canada; [Obel, Owen] Univ Texas Southwestern, Dallas, TX USA; [Ranjan, Ravi] Univ Utah, Salt Lake City, UT USA; [Rho, Robert] Virginia Mason Med Ctr, Seattle, WA USA; [Russo, Andrea] Cooper Univ Hosp, Camden, NJ USA; [Sullivan, Renee] Univ Missouri, Columbia, MO USA; [Tzou, Wendy] Univ Colorado Hlth, Denver, CO USA; [van der Zee, Sarina] Pacific Heart Inst, Santa Monica, CA USA; [Serdoz, Laura Vitali] Klinikum Coburg, Coburg, Germany; [Wilson, Mauri; Bowen, Wayne] Medicomp Cardiac Monitoring Ctr, Melbourne, FL USA; [Pokushalov, Evgeny; Romanov, Alexander; Meshalkin, E.] Minist Hlth Russian Federat, Natl Med Res Ctr, Novosibirsk, Russia; [Bunch, Jared T.] Intermountain Med Ctr, Murray, UT USA; [Bahnson, Tristram] Duke Univ, Med Ctr, Durham, NC USA; [Noelker, Georg] Herz & Diabeteszentrum NRW, Bad Oeynhausen, Germany; [Hindricks, Gerhard] Herzzentrum Leipzig, Leipzig, Germany; [Ardashev, Andrey] Fed Med & Biol Agcy, Clin Hosp, Moscow, Russia; [Revishvili, Amiran; Matsonashvili, George] Bakoulev Ctr Cardiovasc Surg, Moscow, Russia; [Vijayaraman, Pugazhendhi] Geisinger Wyoming Valley Med Ctr, Wilkes Barre, PA USA; [Ince, Huseyin] Univ Rostock, Rostock, Germany; [Piorkowski, Christopher] Tech Univ Dresden, Dresden, Germany; [Neumann, Thomas] Kerckhoff Klin, Bad Nauheim, Germany; [Veenhuyzen, George] Univ Calgary, Calgary, AB, Canada; [Gehi, Anil] Univ North Carolina Chapel Hill, Chapel Hill, NC USA; [Wilber, David] Loyola Univ, Med Ctr, 2160 S 1st Ave, Maywood, IL 60153 USA; [Sogade, Felix] Georgia Arrhythmia Consultants, Macon, GA USA; [Pappone, Carlo] Policlin San Donato Ctr Clin Arrhythmia & Elecrop, San Donato Milanese, Italy; [Berman, Adam] Georgia Regents Univ, Augusta, GA USA; [Shalaby, Alaa] Pittsburgh Healthcare Syst, Pittsburgh, PA USA; [Kuck, Karl-Heinz] Asklepios Klin St George, Hamburg, Germany; [Halperin, Blair] Providence St Vincent Med Ctr, Portland, OR USA; [Tholakanahalli, Venkat] Minneapolis VA Med Ctr, Minneapolis, MN USA; [Palma, Eugen] Montefiore Med Ctr, New York, NY USA; [Holshouser, John] Sanger Clin PA, Charlotte, NC USA; [Badhwar, Nitish] Univ Calif San Francisco, Med Ctr, San Francisco, CA 94143 USA; [Rashid, Haroon] Virginia Hosp Ctr, Arlington, VA USA; [Cameron, Craig] Oklahoma Heart Inst, Tulsa, OK USA; [Hummel, John] Ohio State Univ, Med Ctr, Columbus, OH 43210 USA; [Saavedra, Pablo] Vanderbilt Univ, Med Ctr, Nashville, TN USA; [DeVille, Brian] Heart Hosp Baylor Plano, Plano, TX USA; [Chun, Julian] CCB, Frankfurt, Germany; [Roman-Gonzalez, Javier] South Texas Cardiovasc Consultants, San Antonio, TX USA; [Willems, Stephen] Univ Herzzentrum Hamburg, Hamburg, Germany; [Garan, Hasan] Columbia Univ, Med Ctr, New York, NY USA; [Crespo, Eric Michael] Hartford Hosp, Hartford, CT 06115 USA; [Cheung, Peter] Scott & White Mem Hosp & Clin, Temple, TX 76508 USA; [Groenefeld, Gerian] Asklepios Klin Barmbek, Hamburg, Germany; [Schuger, Claudio] Henry Ford Hosp, Detroit, MI 48202 USA; [Salam, Tariq] Cardiac Study Ctr, Tacoma, WA USA; [Yang, Yanzong] Dalian Med Univ, First Affiliated Hosp, Dalian, Peoples R China; [Pappone, Carlo] Maria Cecilia Hosp, Cotignola, Italy; [Wichterle, Dan] Charles Univ Prague, Prague 2, Czech Republic; [Brachmann, Johannes] Klinikum Coburg, Coburg, Germany; [Kautzner, Josef] IKEM Med Inst, Clin Cardiol, Prague 4, Czech Republic; [Jayachandran, John] Baylor All St Med Ctr, Ft Worth, TX USA; [Kim, Young-Hoon] Korea Univ, Anam Hosp, Seoul, South Korea; [Cole, Christopher] Penrose St Francis Hlth Serv, Colorado Springs, CO USA; [Herweg, Bengt] Univ S Florida, Tampa, FL USA; [Lowe, Martin] Heart Hosp, London, England; [Dougherty, Anne] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA; [Popov, Sergey] Russian Acad Med Sci, Siberian Dept, Sci Res Inst Cardiol, Tomsk, Russia; [Lowe, Martin] St Bartholomews Hosp, London, England; [Spitzer, Stefan] Praxisklin Herz & Gefasse, Dresden, Germany; [Bernstein, Robert] Sentara Norfolk Gen Hosp, Norfolk, VA USA; [Simonson, Jay] Methodist Hosp, Pk Nicollet Heart & Vasc Ctr, St Louis Pk, MN USA; [Buch, Eric] Univ Calif Los Angeles, Los Angeles, CA USA; [Wu, Shulin] Guangdong Prov Peoples Hosp, Guangzhou, Guangdong, Peoples R China; [Khan, Mohammed] Alexian Bros Med Ctr, Elk Grove Village, IL USA; [Shinn, Timothy] St Joseph Mercy Hosp, Ann Arbor, MI 48104 USA; [Neuzil, Petr] Na Homolce Hosp, Prague, Czech Republic; [Mangrum, James] Univ Virginia Hlth Syst, Charlottesville, VA USA; [Calkins, Hugh] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA; [Gonzalez, Mario] Penn State Univ, Cardiovasc Ctr, Hershey, PA USA; [Mansour, Moussa] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Zabel, Markus] Georg August Univ, Gottingen, Germany; [Kalman, Jonathan] Royal Melbourne Hosp, Parkville, Vic, Australia; [Sanchez, Jose] St Johns Mercy Heart Hosp, St Louis, MO USA; [Rothman, Steven] Lankenau Med Ctr, Wynnewood, PA USA; [Bhandari, Anil] Good Samaritan Hosp, Los Angeles, CA USA; [Tracy, Cynthia] George Washington Univ, Med Ctr, Washington, DC 20037 USA; [Mitrani, Raul] Univ Miami Hlth Syst, Miami, FL USA; [Vorperian, Vicken] Waukesha Mem Hosp, Waukesha, WI USA; [Connelly, Derek] Golden Jubilee Hosp, Glasgow, Lanark, Scotland; [Wells, Darryl] Swedish Med Ctr, Providence Campus, Seattle, WA USA; [Ma, Chang-Sheng] Beijing Anzhen Hosp, Beijing, Peoples R China; [Verma, Atul] Southlake Reg Hlth Ctr, Newmarket, ON, Canada; Drexel Univ, Coll Med, Philadelphia, PA 19104 USA; [Robinson, Melissa] Univ Washington, Med Ctr, Seattle, WA 98195 USA; [Rubenstein, Donald] Univ Med Ctr, Greenville Hosp Syst, Greenville, SC USA; [Vanoli, Emilio] Policlin Multimed Cardiol & Arrhythmia Ctr, Milan, Italy; [Zhang, Shu] Fuwai Hosp, Beijing, Peoples R China; [Cummings, Jennifer] Univ Toledo, 2801 W Bancroft St, Toledo, OH 43606 USA; [Viswanathan, Mohan] Stanford Univ, Med Ctr, Stanford, CA 94305 USA; [Monir, George] Florida Hosp, Orlando, FL USA; [Marchlinski, Francis] Univ Pennsylvania Hlth Syst, Philadelphia, PA USA; [Franklin, Jay] Baylor Heart & Vasc Hosp, Dallas, TX USA; [Koplan, Bruce] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Sanders, Prashanthan] Royal Adelaide Hosp, Adelaide, SA, Australia; [Rashba, Eric] SUNY Stony Brook, Med Ctr, Stony Brook, NY USA; [Gallagher, Mark] St George Hosp, Sch Med, London, England; [Gonska, Bernd] St Vincentius Kliniken, Karlsruhe, Germany; [Chen, Minglong] Nanjing Med Univ, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Leong-Sit, Peter] Univ Western Ontario, London Hlth Sci Ctr, London, ON, Canada; [Zimmerman, John] Hackensack Univ, Med Ctr, Hackensack, NJ USA; [Pezeshkian, Nayer] Univ Calif Davis, Med Ctr, Sacramento, CA 95817 USA; [Cohen, Andrew] Med Ctr Aurora, Aurora, CO USA; [Kalvaitis, Saulius] St Louis Heart & Vasc, St Louis, MO USA; [Davies, David] St Marys Hosp, London, England; [Borggrefe, Martin] Univ Hosp Mannheim, Mannheim, Germany; [Pak, Hui-Nam] Yonsei Univ, Severance Hosp, Seoul, South Korea; [Russo, Andrea] Cooper Univ Hosp, Camden, NJ USA; [Henrikson, Charles] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Greer, Gerald] Arkansas Cardiol PA, Little Rock, AR USA; [Coromilas, James] Robert Wood Johnson Univ Hosp, New Brunswick, NJ USA; [Khairallah, Farhat] Tallahassee Mem Hosp, Tallahassee, FL USA; [Sosa-Suarez, Guillermo] Albany Associates Cardiol, Albany, NY USA; [Lindsay, Bruce] Cleveland Clin Fdn, Cleveland, OH USA; [Fisher, Westby] North Shore Univ Hlth Syst, Evanston Hosp, Evanston, IL USA; [Bailin, Steven] Mercy Med Ctr, Des Moines, IA USA; [Tran, Andy] Scottsdale Healthcare, Scottsdale, AZ USA; [Starek, Zdenek] St Annes Univ Hosp, ICRC, Brno, Czech Republic; [Preminger, Mark] Valley Hosp, Ridgewood, NJ USA; [Sheppard, Robert] Northside Hosp & Heart Inst, St Petersburg, FL USA; [Sheppard, Robert] Northside Hosp & Heart Inst, St Petersburg, FL USA; [Costea, Alexandru] Univ Cincinnati, Med Ctr, Cincinnati, OH USA; [Ellenbogen, Kenneth] Virginia Commonwealth Univ, Med Ctr, Richmond, VA USA; [Arentz, Thomas] Herz Zentrum Bad Krozingen, Bad Krozingen, Germany; [De Ponti, Roberto] Osped Circolo Fdn Macchi, Varese, Italy; [Aleong, Ryan] Univ Colorado Hosp, Aurora, CO USA; [Colley, Byron, III] Jackson Heart Clin, Jackson, MS USA; [Baig, Khawaja] Medisync, Cincinnati, OH USA; [Krishnan, Kousik] Rush Univ, Med Ctr, Chicago, IL 60612 USA; [Menon, Syamkumar Divakara] Hamilton Hlth Sci, Hamilton, ON, Canada; [Simmons, Tony] Wake Forest Univ Hlth Sci, Winston Salem, NC USA; [Bruce, Gregory] Mem Hlth Care Syst, Chattanooga, TN USA; [Chinitz, Larry] NYU, Tisch Hosp, Langone Med Ctr, New York, NY USA; [Natale, Andrea] Texas Cardiac Arrhythmia, Austin, TX USA; [Cappato, Riccardo] IRCCS Ist Clin Humanitas, Milan, Italy	Duke University; Mayo Clinic; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Libin Cardiovascular Institute Of Alberta; University of Missouri System; University of Missouri Columbia; Duke University; Duke University; Mayo Clinic; Columbia University; Lankenau Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Virginia; Imperial College London; Royal Melbourne Hospital; Asklepios Klinik St. Georg; Heart Center Leipzig GMBH; Johns Hopkins University; Harvard University; Brigham & Women's Hospital; Harvard University; Beth Israel Deaconess Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Pennsylvania; University of Oklahoma System; University of Oklahoma Health Sciences Center; Western University (University of Western Ontario); University of Calgary; Intermountain Healthcare; Intermountain Medical Center; Duke University; Drexel University; Vanderbilt University; University of North Carolina; University of North Carolina Chapel Hill; University of Calgary; University of Missouri System; University of Missouri Columbia; Jefferson University; Johns Hopkins University; Johns Hopkins Medicine; University of London; Queen Mary University London; Duke University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Mayo Clinic; University of Virginia; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Lankenau Medical Center; Columbia University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Kaiser Permanente; University of California System; University of California San Diego; Cleveland Clinic Foundation; Washington University (WUSTL); Hackensack University Medical Center; Oregon Health & Science University; University System of Ohio; University of Toledo; Oregon Health & Science University; Alberta Health Services (AHS); University of Calgary; University of Texas System; University of Texas Southwestern Medical Center Dallas; Utah System of Higher Education; University of Utah; Virginia Mason Medical Center; Cooper University Hospital; University of Missouri System; University of Missouri Columbia; University of Colorado System; University of Colorado Anschutz Medical Campus; Klinikum Coburg; Meshalkin National Medical Research Center; Ministry of Health of the Russian Federation; Intermountain Healthcare; Intermountain Medical Center; Duke University; Ruhr University Bochum; Heart Center Leipzig GMBH; University of Rostock; Technische Universitat Dresden; Kerckhoff Clinic; University of Calgary; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Loyola University Chicago; University System of Georgia; Augusta University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Asklepios Klinik St. Georg; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; Montefiore Medical Center; University of California System; University of California San Francisco; University System of Ohio; Ohio State University; Vanderbilt University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Columbia University; Hartford Hospital; Scott & White Medical Center; Henry Ford Health System; Henry Ford Hospital; Dalian Medical University; Maria Cecilia Hospital; Charles University Prague; Klinikum Coburg; Korea University; Korea University Medicine (KU Medicine); State University System of Florida; University of South Florida; University College London Hospitals NHS Foundation Trust; University of Texas System; University of Texas Health Science Center Houston; Russian Academy of Medical Sciences; Russian Academy of Sciences; Tomsk National Research Medical Center; Cardiology Research Institute - Tomsk; University of London; Queen Mary University London; Technische Universitat Dresden; Sentara Healthcare; University of California System; University of California Los Angeles; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Saint Joseph Mercy Health System (SJMHS); Na Homolce Hospital; University of Virginia; Johns Hopkins University; Johns Hopkins Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Harvard University; Massachusetts General Hospital; University of Gottingen; Royal Melbourne Hospital; Saint Johns Mercy Medical Center; Lankenau Medical Center; George Washington University; Golden Jubilee Hospital; Swedish Medical Center; Capital Medical University; Southlake Regional Health Centre; Drexel University; University of Washington; University of Washington Seattle; Greenville Health System; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; University System of Ohio; University of Toledo; Stanford University; Adventist Health Services; AdventHealth; University of Pennsylvania; Harvard University; Brigham & Women's Hospital; Royal Adelaide Hospital; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; St Georges University London; Nanjing Medical University; London Health Sciences Centre; Western University (University of Western Ontario); Hackensack University Medical Center; University of California System; University of California Davis; Imperial College London; Ruprecht Karls University Heidelberg; Yonsei University; Yonsei University Health System; Cooper University Hospital; Oregon Health & Science University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Cleveland Clinic Foundation; NorthShore University Health System; Scottsdale Healthcare Osborn; St Anne's University Hospital Brno (FNUSA-ICRC); University System of Ohio; University of Cincinnati; Virginia Commonwealth University; Ospedale Circolo & Fondazione Macchi; University of Colorado System; University of Colorado Hospital; Rush University; McMaster University; Wake Forest University; Wake Forest University School of Medicine; New York University; NYU Langone Medical Center; Humanitas University; IRCCS Humanitas Research Hospital	Mark, DB (corresponding author), Duke Clin Res Inst, Outcomes Res, 2400 Pratt St,Room 0311, Durham, NC 27705 USA.	daniel.mark@duke.edu	Stárek, Zdeněk/AAA-3007-2022; Ардашев, Андрей/AAI-9523-2021; Vijayaraman, Pugazhendhi/AAB-8368-2019; Gallagher, Mark/AAG-2787-2020; Akoum, Nazem/ABA-7839-2020; Piorkowski, Christopher/G-2026-2016; Pokushalov, Evgeny A/L-7993-2014; Kim, Young-Hoon/AAO-5792-2021; Jadidi, Amir/AAY-1683-2021; Koplan, Bruce/AAK-8363-2021; Pokushalov, Evgeny/ABA-6205-2020; Brachmann, Johannes/AAD-1499-2021; Mitchell, L. Brent/AAJ-5076-2020; Daubert, James P./ABC-1476-2021; Romanov, Alexander/AAC-4799-2019; Ellenbogen, Kenneth/AAJ-3992-2021	Stárek, Zdeněk/0000-0002-9510-1386; Ардашев, Андрей/0000-0003-1908-9802; Gallagher, Mark/0000-0002-6333-6420; Pokushalov, Evgeny A/0000-0002-2560-5167; Kim, Young-Hoon/0000-0002-4254-647X; Daniels, Melanie/0000-0003-4360-5635	National Heart, Lung, and Blood Institute [U01HL89709, U01HL089786, U01HL089907, U01HL089645]; St Jude Foundation and Corporation; Biosense Webster Inc; Medtronic Inc; Boston Scientific Corporation; Mayo Clinic; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL089786] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); St Jude Foundation and Corporation; Biosense Webster Inc; Medtronic Inc(Medtronic); Boston Scientific Corporation(Boston Scientific); Mayo Clinic; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by grants U01HL89709, U01HL089786, U01HL089907 and U01HL089645 from the National Heart, Lung, and Blood Institute, St Jude Foundation and Corporation, Biosense Webster Inc, Medtronic Inc, Boston Scientific Corporation, and Mayo Clinic.	Bubien RS, 1996, CIRCULATION, V94, P1585, DOI 10.1161/01.CIR.94.7.1585; Coon CD, 2016, THER INNOV REGUL SCI, V50, P22, DOI 10.1177/2168479015622667; Dorian P, 2002, AM HEART J, V143, P984, DOI 10.1067/mhj.2002.122518; Guyatt GH, 1998, BRIT MED J, V316, P690, DOI 10.1136/bmj.316.7132.690; HAISSAGUERRE M, 1994, J CARDIOVASC ELECTR, V5, P1045, DOI 10.1111/j.1540-8167.1994.tb01146.x; HLATKY MA, 1989, AM J CARDIOL, V64, P651, DOI 10.1016/0002-9149(89)90496-7; Jais P, 1997, CIRCULATION, V95, P572, DOI 10.1161/01.CIR.95.3.572; Koopman C, 2002, J OCCUP ENVIRON MED, V44, P14, DOI 10.1097/00043764-200201000-00004; Mark DB, 2016, JAMA CARDIOL, V1, P1048, DOI 10.1001/jamacardio.2016.3312; Mark DB, 2016, NAT REV CARDIOL, V13, P286, DOI 10.1038/nrcardio.2016.10; Morillo CA, 2014, JAMA-J AM MED ASSOC, V311, P692, DOI 10.1001/jama.2014.467; Nielsen JC, 2012, NEW ENGL J MED, V367, P1587, DOI 10.1056/NEJMoa1113566; Oral H, 2006, NEW ENGL J MED, V354, P934, DOI 10.1056/NEJMoa050955; Packer DL, 2019, JAMA-J AM MED ASSOC, V321, P1261, DOI 10.1001/jama.2019.0693; Packer DL, 2018, AM HEART J, V199, P192, DOI 10.1016/j.ahj.2018.02.015; Pappone C, 2006, J AM COLL CARDIOL, V48, P2340, DOI 10.1016/j.jacc.2006.08.037; REILLY MC, 1993, PHARMACOECONOMICS, V4, P353, DOI 10.2165/00019053-199304050-00006; Simon DN, 2018, CIRC CARDIOVASC Q S2, V9, pA130; Spertus J, 2011, CIRC-ARRHYTHMIA ELEC, V4, P15, DOI 10.1161/CIRCEP.110.958033; Ware JE, 1993, SF36 HLTH SURVEY MAN; Wazni OM, 2005, JAMA-J AM MED ASSOC, V293, P2634, DOI 10.1001/jama.293.21.2634; Wilber DJ, 2010, JAMA-J AM MED ASSOC, V303, P333, DOI 10.1001/jama.2009.2029; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Wokhlu A, 2010, J AM COLL CARDIOL, V55, P2308, DOI 10.1016/j.jacc.2010.01.040	24	237	250	6	56	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 2	2019	321	13					1275	1285		10.1001/jama.2019.0692	http://dx.doi.org/10.1001/jama.2019.0692			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HR3XR	30874716	Green Published, Bronze			2022-12-28	WOS:000463076800014
J	Crowe, SE				Crowe, Sheila E.			Helicobacter pylori Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IRON-DEFICIENCY ANEMIA; ERADICATION TREATMENT; BREATH TESTS; ANTIGEN TEST; THERAPY; AMOXICILLIN; METRONIDAZOLE; TETRACYCLINE; RANITIDINE; RECURRENCE		[Crowe, Sheila E.] Univ Calif San Diego, Dept Med, Div Gastroenterol, 9500 Gilman Dr,MC 0063, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Crowe, SE (corresponding author), Univ Calif San Diego, Dept Med, Div Gastroenterol, 9500 Gilman Dr,MC 0063, La Jolla, CA 92093 USA.	secrowe@ucsd.edu						Akyildiz M, 2009, EUR J INTERN MED, V20, P53, DOI 10.1016/j.ejim.2008.04.003; [Anonymous], 2017, BMJ OPEN, V7, pOF12; [Anonymous], 2017, HELICOBACTER, V22, pS1; Bai Y, 2010, GUT, V59, P722, DOI 10.1136/gut.2009.192401; BAMFORD KB, 1993, GUT, V34, P1348, DOI 10.1136/gut.34.10.1348; Braden B, 2000, BRIT MED J, V320, P148, DOI 10.1136/bmj.320.7228.148; Cheung KS, 2018, GUT, V67, P28, DOI 10.1136/gutjnl-2017-314605; Chey WD, 2007, AM J GASTROENTEROL, V102, P1808, DOI 10.1111/j.1572-0241.2007.01393.x; Chey WD, 2017, AM J GASTROENTEROL, V112, P212, DOI 10.1038/ajg.2016.563; Chiba N, 1999, CAN J GASTROENTEROL, V13, P681; Choi IJ, 2018, NEW ENGL J MED, V378, P1085, DOI 10.1056/NEJMoa1708423; Cindoruk M, 2007, HELICOBACTER, V12, P309, DOI 10.1111/j.1523-5378.2007.00516.x; DuBois S, 2005, AM J GASTROENTEROL, V100, P453, DOI 10.1111/j.1572-0241.2005.30252.x; El-Serag HB, 2018, CLIN GASTROENTEROL H, V16, P992, DOI 10.1016/j.cgh.2018.03.013; Fallone CA, 2016, GASTROENTEROLOGY, V151, P51, DOI 10.1053/j.gastro.2016.04.006; Fischbach W, 2013, GASTROENTEROL CLIN N, V42, P371, DOI 10.1016/j.gtc.2013.01.008; FORD AC, 2014, BMJ-BRIT MED J, V348, DOI DOI 10.1136/BMJ.G3320; Franceschi F, 2007, HELICOBACTER, V12, P59, DOI 10.1111/j.1523-5378.2007.00565.x; Gatta L, 2018, ALIMENT PHARM THER, V47, P1261, DOI 10.1111/apt.14597; Gatta L, 2004, AM J GASTROENTEROL, V99, P823, DOI 10.1111/j.1572-0241.2004.30162.x; Gunnarsson M, 2007, CANCER BIOTHER RADIO, V22, P762, DOI 10.1089/cbr.2007.0350; HENTSCHEL E, 1993, NEW ENGL J MED, V328, P308, DOI 10.1056/NEJM199302043280503; Hooi JKY, 2017, GASTROENTEROLOGY, V153, P420, DOI 10.1053/j.gastro.2017.04.022; Hu Y, 2017, ALIMENT PHARM THER, V46, P773, DOI 10.1111/apt.14319; John S, 2018, GASTROENTEROL REP, V6, P215, DOI 10.1093/gastro/goy001; Ki ELL, 2012, CLIN GASTROENTEROL H, V10, P831, DOI 10.1016/j.cgh.2012.04.010; Laine L, 2003, AM J GASTROENTEROL, V98, P562, DOI [10.1016/S0002-9270(02)06010-0, 10.1111/j.1572-0241.2003.t01-1-07288.x]; Laine L, 1998, ANN INTERN MED, V129, P547, DOI 10.7326/0003-4819-129-7-199810010-00007; LANGENBERG W, 1990, J INFECT DIS, V161, P507, DOI 10.1093/infdis/161.3.507; Leung WK, 2018, GASTROENTEROLOGY, V155, P67, DOI 10.1053/j.gastro.2018.03.028; Li M, 2018, HELICOBACTER, V23, DOI 10.1111/hel.12495; Liou Jyh-Ming, 2018, Gastroenterology, V155, P1109, DOI 10.1053/j.gastro.2018.06.047; Malfertheiner P., 2017, Gut, V66, P6, DOI [10.1136/gutjnl-2016-312288, DOI 10.1136/GUTJNL-2016-312288]; Moayyedi P, 2007, BEST PRACT RES CL GA, V21, P347, DOI 10.1016/j.bpg.2006.11.004; Nishikawa K, 2000, GASTROINTEST ENDOSC, V51, P164, DOI 10.1016/S0016-5107(00)70412-3; NOMURA A, 1991, NEW ENGL J MED, V325, P1132, DOI 10.1056/NEJM199110173251604; PARSONNET J, 1994, NEW ENGL J MED, V330, P1267, DOI 10.1056/NEJM199405053301803; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603; Perri F, 2001, AM J GASTROENTEROL, V96, P58; Qu XH, 2010, WORLD J GASTROENTERO, V16, P886, DOI 10.3748/wjg.v16.i7.886; Rostami N, 2008, AM J HEMATOL, V83, P376, DOI 10.1002/ajh.21125; Rubin J, 2018, GASTROENTEROLOGY, V154, pS503; Savoldi A, 2018, GASTROENTEROLOGY, V155, P1372, DOI 10.1053/j.gastro.2018.07.007; Stubljar D, 2018, EXPERT REV VACCINES, V17, P935, DOI 10.1080/14760584.2018.1526680; Sue S, 2018, J GASTROEN HEPATOL; Sugano K, 2015, GUT, V64, P1353, DOI 10.1136/gutjnl-2015-309252; The Lancet Global Health, 2016, COCHRANE DB SYST REV, V4, pe427; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Vaira D, 2002, ANN INTERN MED, V136, P280, DOI 10.7326/0003-4819-136-4-200202190-00007; Veijola L, 2005, WORLD J GASTROENTERO, V11, P7340, DOI 10.3748/wjg.v11.i46.7340	50	154	166	31	115	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 21	2019	380	12					1158	1165		10.1056/NEJMcp1710945	http://dx.doi.org/10.1056/NEJMcp1710945			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP7VK	30893536				2022-12-28	WOS:000461898400011
J	Shang, GJ; Zhang, CG; Chen, ZJJ; Bai, XC; Zhang, XW				Shang, Guijun; Zhang, Conggang; Chen, Zhijian J.; Bai, Xiao-chen; Zhang, Xuewu			Cryo-EM structures of STING reveal its mechanism of activation by cyclic GMP-AMP	NATURE			English	Article							DI-GMP; ADAPTER; RECOGNITION; PATHWAY; SYSTEM; COMPLEX; BINDING; SENSOR	Infections by pathogens that contain DNA trigger the production of type-I interferons and inflammatory cytokines through cyclic GMP-AMP synthase, which produces 2'3'-cyclic GMP-AMP (cGAMP) that binds to and activates stimulator of interferon genes (STING; also known as TMEM173, MITA, ERIS and MPYS)(1-8). STING is an endoplasmic-reticulum membrane protein that contains four transmembrane helices followed by a cytoplasmic ligand-binding and signalling domain(9-13). The cytoplasmic domain of STING forms a dimer, which undergoes a conformational change upon binding to cGAMP(9,14). However, it remains unclear how this conformational change leads to STING activation. Here we present cryo-electron microscopy structures of full-length STING from human and chicken in the inactive dimeric state (about 80 kDa in size), as well as cGAMP-bound chicken STING in both the dimeric and tetrameric states. The structures show that the transmembrane and cytoplasmic regions interact to form an integrated, domain-swapped dimeric assembly. Closure of the ligand-binding domain, induced by cGAMP, leads to a 180 degrees rotation of the ligand-binding domain relative to the transmembrane domain. This rotation is coupled to a conformational change in a loop on the side of the ligand-binding-domain dimer, which leads to the formation of the STING tetramer and higher-order oligomers through side-by-side packing. This model of STING oligomerization and activation is supported by our structure-based mutational analyses.	[Shang, Guijun; Zhang, Xuewu] Univ Texas Southwestern Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Zhang, Conggang; Chen, Zhijian J.] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Chen, Zhijian J.] Univ Texas Southwestern Med Ctr Dallas, Ctr Inflammat Res, Dallas, TX 75390 USA; [Chen, Zhijian J.] Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Bai, Xiao-chen; Zhang, Xuewu] Univ Texas Southwestern Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA; [Bai, Xiao-chen] Univ Texas Southwestern Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Zhang, XW (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA.; Chen, ZJJ (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.; Chen, ZJJ (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Ctr Inflammat Res, Dallas, TX 75390 USA.; Chen, ZJJ (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA.; Bai, XC; Zhang, XW (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA.; Bai, XC (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA.	Zhijian.Chen@UTSouthwestern.edu; Xiaochen.Bai@UTSouthwestern.edu; Xuewu.Zhang@UTSouthwestern.edu	Chen, Zhijian/C-6039-2012; Bai, Xiao-chen/HGV-1244-2022; , tanglang/AAD-3372-2020	Chen, Zhijian/0000-0002-8475-8251; Bai, Xiao-chen/0000-0002-4234-5686; 	Cancer Prevention and Research Institute of Texas (CPRIT) Core Facility Support Award [RP170644]; Howard Hughes Medical Institute; National Institutes of Health [GM088197, R35GM130289]; Welch foundation [I-1389, I-1702, I-1944]; CPRIT [RP150498, RP160082]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM130289] Funding Source: NIH RePORTER	Cancer Prevention and Research Institute of Texas (CPRIT) Core Facility Support Award; Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch foundation(The Welch Foundation); CPRIT; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Hongtao Yu and Ryan Hibbs for sharing intruments and reagents, and Xiang Gui for his contributions on the analysis of some STING mutants. Cryo-EM data were collected at the University of Texas Southwestern Medical Center (UTSW) Cryo-Electron Microscopy Facility, which is funded by the Cancer Prevention and Research Institute of Texas (CPRIT) Core Facility Support Award RP170644. We thank D. Nicastro for facility access and data acquisition. This work is supported in part by the Howard Hughes Medical Institute (Z.J.C.), grants from the National Institutes of Health (GM088197 and R35GM130289 to X.Z.), grants from the Welch foundation (I-1389 to Z.J.C.; I-1702 to X.Z.; I-1944 to X.-c.B.), grants from CPRIT (RP150498 to Z.J.C.; RP160082 to X.-c.B.). X.-c.B. and X.Z. are Virginia Murchison Linthicum Scholars in Medical Research at UTSW. Z.J.C. is an investigator of Howard Hughes Medical Institute.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bai XC, 2015, ELIFE, V4, DOI 10.7554/eLife.11182; Bai XC, 2015, TRENDS BIOCHEM SCI, V40, P49, DOI 10.1016/j.tibs.2014.10.005; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Cai X, 2014, MOL CELL, V54, P289, DOI 10.1016/j.molcel.2014.03.040; Chen Q, 2016, NAT IMMUNOL, V17, P1142, DOI 10.1038/ni.3558; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Danev R, 2016, ELIFE, V5, DOI 10.7554/eLife.13046; Dukkipati A, 2008, PROTEIN EXPRES PURIF, V62, P160, DOI 10.1016/j.pep.2008.08.004; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gao P, 2013, CELL, V154, P748, DOI 10.1016/j.cell.2013.07.023; Haag SM, 2018, NATURE, V559, P269, DOI 10.1038/s41586-018-0287-8; Huang YH, 2012, NAT STRUCT MOL BIOL, V19, P728, DOI 10.1038/nsmb.2333; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Jeremiah N, 2014, J CLIN INVEST, V124, P5516, DOI 10.1172/JCI79100; Jin L, 2008, MOL CELL BIOL, V28, P5014, DOI 10.1128/MCB.00640-08; Kranzusch PJ, 2015, MOL CELL, V59, P891, DOI 10.1016/j.molcel.2015.07.022; Li T, 2018, J EXP MED, V215, P1287, DOI 10.1084/jem.20180139; Li ZX, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004783; Liu HQ, 2015, J STRUCT BIOL, V192, P14, DOI 10.1016/j.jsb.2015.09.001; Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630; Liu Y, 2014, NEW ENGL J MED, V371, P507, DOI 10.1056/NEJMoa1312625; Lu DF, 2014, MOL MICROBIOL, V92, P1092, DOI 10.1111/mmi.12616; Melki I, 2017, J ALLERGY CLIN IMMUN, V140, P543, DOI 10.1016/j.jaci.2016.10.031; Morales-Perez CL, 2016, STRUCTURE, V24, P797, DOI 10.1016/j.str.2016.03.004; Mukai K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11932; Ouyang SY, 2012, IMMUNITY, V36, P1073, DOI 10.1016/j.immuni.2012.03.019; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Shang GJ, 2012, NAT STRUCT MOL BIOL, V19, P725, DOI 10.1038/nsmb.2332; Shi HP, 2015, P NATL ACAD SCI USA, V112, P8947, DOI 10.1073/pnas.1507317112; Shu C, 2012, NAT STRUCT MOL BIOL, V19, P722, DOI 10.1038/nsmb.2331; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; Tanaka Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002521; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Yin Q, 2012, MOL CELL, V46, P735, DOI 10.1016/j.molcel.2012.05.029; Zhang C., 2019, NATURE; Zhang H, 2015, SCI REP-UK, V5, DOI 10.1038/srep18035; Zhang X, 2013, MOL CELL, V51, P226, DOI 10.1016/j.molcel.2013.05.022; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003	42	211	218	13	141	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 21	2019	567	7748					389	+		10.1038/s41586-019-0998-5	http://dx.doi.org/10.1038/s41586-019-0998-5			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP9JT	30842659	Green Accepted			2022-12-28	WOS:000462010000055
J	Fanaroff, AC; Califf, RM; Windecker, S; Smith, SC; Lopes, RD				Fanaroff, Alexander C.; Califf, Robert M.; Windecker, Stephan; Smith, Sidney C., Jr.; Lopes, Renato D.			Levels of Evidence Supporting American College of Cardiology/American Heart Association and European Society of Cardiology Guidelines, 2008-2018	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CLINICAL-PRACTICE GUIDELINES; ACC/AHA/ESC 2006 GUIDELINES; ACUTE MYOCARDIAL-INFARCTION; 2013 ACCF/AHA GUIDELINE; CONFLICTS-OF-INTEREST; SUDDEN CARDIAC DEATH; TASK-FORCE; ESC GUIDELINES; SCIENTIFIC EVIDENCE; ATRIAL-FIBRILLATION	IMPORTANCE Clinical decisions are ideally based on evidence generated from multiple randomized controlled trials (RCTs) evaluating clinical outcomes, but historically, few clinical guideline recommendations have been based entirely on this type of evidence. OBJECTIVE To determine the class and level of evidence (LOE) supporting current major cardiovascular society guideline recommendations, and changes in LOE over time. DATA SOURCES Current American College of Cardiology/American Heart Association (ACC/AHA) and European Society of Cardiology (ESC) clinical guideline documents (2008-2018), as identified on cardiovascular society websites, and immediate predecessors to these guideline documents (1999-2014), as referenced in current guideline documents. STUDY SELECTION Comprehensive guideline documents including recommendations organized by class and LOE. DATA EXTRACTION AND SYNTHESIS The number of recommendations and the distribution of LOE (A [supported by data from multiple RCTs or a single, large RCT], B [supported by data from observational studies or a single RCT], and C [supported by expert opinion only]) were determined for each guideline document. MAIN OUTCOMES AND MEASURES The proportion of guideline recommendations supported by evidence from multiple RCTs (LOE A). RESULTS Across 26 current ACC/AHA guidelines (2930 recommendations; median, 121 recommendations per guideline [25th-75th percentiles, 76-155]), 248 recommendations (8.5%) were classified as LOE A, 1465 (50.0%) as LOE B, and 1217 (41.5%) as LOE C. The median proportion of LOE A recommendations was 7.9%(25th-75th percentiles, 0.9%-15.2%). Across 25 current ESC guideline documents (3399 recommendations; median, 130 recommendations per guideline [25th-75th percentiles, 111-154]), 484 recommendations (14.2%) were classified as LOE A, 1053 (31.0%) as LOE B, and 1862 (54.8%) as LOE C. When comparing current guidelines with prior versions, the proportion of recommendations that were LOE A did not increase in either ACC/AHA (median, 9.0% [current] vs 11.7%[prior]) or ESC guidelines (median, 15.1%[current] vs 17.6%[prior]). CONCLUSIONS AND RELEVANCE Among recommendations in major cardiovascular society guidelines, only a small percentage were supported by evidence from multiple RCTs or a single, large RCT. This pattern does not appear to have meaningfully improved from 2008 to 2018.	[Fanaroff, Alexander C.; Lopes, Renato D.] Duke Univ, Div Cardiol, Durham, NC USA; [Fanaroff, Alexander C.; Lopes, Renato D.] Duke Univ, Duke Clin Res Inst, Durham, NC USA; [Califf, Robert M.] Duke Univ, Sch Med, Durham, NC USA; [Califf, Robert M.] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Califf, Robert M.] Verily Life Sci Alphabet, San Francisco, CA USA; [Windecker, Stephan] Univ Bern, Inselspital, Dept Cardiol, Bern, Switzerland; [Smith, Sidney C., Jr.] Univ N Carolina, Sch Med, Div Cardiol, Chapel Hill, NC 27515 USA	Duke University; Duke University; Duke University; Stanford University; University of Bern; University Hospital of Bern; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Lopes, RD (corresponding author), Duke Clin Res Inst, POB 17969, Durham, NC 27715 USA.	renato.lopes@duke.edu		Fanaroff, Alexander/0000-0002-9060-5307				Aboyans V, 2018, EUR HEART J, V39, P763, DOI 10.1093/eurheartj/ehx095; Adler Y, 2015, REV ESP CARDIOL, V68, P1126, DOI 10.1016/j.rec.2015.10.008; Al-Khatib Sana M, 2018, Circulation, V138, pe272, DOI 10.1161/CIR.0000000000000549; Alseiari M, 2016, AM J KIDNEY DIS, V67, P417, DOI 10.1053/j.ajkd.2015.09.016; American College of Cardiology, 2006, J Am Coll Cardiol, V48, pe1, DOI 10.1016/j.jacc.2006.05.021; Amsterdam EA, 2014, J AM COLL CARDIOL, V64, P2713, DOI 10.1016/j.jacc.2014.10.011; ANDERSON JL, 2007, J AMCOLL CARDIOL, V50, P652, DOI DOI 10.1016/J.JACC.2007.02.013; Antman Elliott M., 2004, J Am Coll Cardiol, V44, pE1, DOI 10.1016/j.jacc.2004.07.014; Baumgartner H, 2010, EUR HEART J, V31, P2915, DOI 10.1093/eurheartj/ehq249; Blomstrom-Lundqvist Carina, 2003, Journal of the American College of Cardiology, V42, P1493, DOI 10.1016/j.jacc.2003.08.013; Brignole M, 2018, KARDIOL POL, V76, P1119, DOI [10.5603/KP.2018.0161, 10.1016/j.recesp.2018.08.018]; Brignole M, 2013, EUR HEART J, V34, P2281, DOI 10.1093/eurheartj/eht150; Brito JP, 2013, J CLIN ENDOCR METAB, V98, P3246, DOI 10.1210/jc.2013-1814; Brott TG, 2012, J AM COLL CARDIOL, V60, P566, DOI 10.1016/j.jacc.2012.06.006; Catapano AL, 2016, EUR HEART J, V37, P2999, DOI 10.1093/eurheartj/ehw272; Duarte-Garcia A, 2018, JAMA INTERN MED, V178, P146, DOI 10.1001/jamainternmed.2017.6680; Eagle Kim A, 2004, Circulation, V110, pe340; Eckel R. H., 2014, Journal of the American College of Cardiology, V63, P2960, DOI [10.1161/01.cir.0000437740.48606.d1, 10.1016/j.jacc.2013.11.003]; Elliott PM, 2014, EUR HEART J, V35, P2733, DOI 10.1093/eurheartj/ehu284; Erbel Raimund, 2014, Kardiol Pol, V72, P1169, DOI 10.5603/KP.2014.0225; *ESC GUID DIAGN, 2012, EUR HEART J, DOI DOI 10.1093/EUHEARTJ/EHS104; Fanaroff AC, 2018, CIRC RES, V123, P495, DOI 10.1161/CIRCRESAHA.118.313261; Fanaroff AC, 2018, EUR HEART J, V39, P2932, DOI 10.1093/eurheartj/ehy236; Feuerstein JD, 2013, ALIMENT PHARM THER, V37, P937, DOI 10.1111/apt.12290; Feuerstein JD, 2014, MAYO CLIN PROC, V89, P16, DOI 10.1016/j.mayocp.2013.09.013; Fihn SD, 2012, J AM COLL CARDIOL, V60, pE44, DOI 10.1016/j.jacc.2012.07.013; Fleisher LA, 2007, J AM COLL CARDIOL, V50, P1707, DOI 10.1016/j.jacc.2007.09.001; Fleisher LA, 2014, J AM COLL CARDIOL, V64, pE77, DOI 10.1016/j.jacc.2014.07.944; Fuster V, 2006, J AM COLL CARDIOL, V48, P854, DOI 10.1016/j.jacc.2006.07.009; Galie N, 2016, EUR HEART J, V37, P67, DOI 10.1093/eurheartj/ehv317; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; Gerhard-Herman MD, 2017, J AM COLL CARDIOL, V69, pE71, DOI 10.1016/j.jacc.2016.11.007; Gersh BJ, 2011, J THORAC CARDIOV SUR, V142, pE153, DOI 10.1016/j.jtcvs.2011.10.020; Gibbons RJ, 1999, J AM COLL CARDIOL, V33, P2092, DOI 10.1016/S0735-1097(99)00150-3; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]; Greenland P, 2010, J AM COLL CARDIOL, V56, pE50, DOI 10.1016/j.jacc.2010.09.001; Gregoratos G, 2002, J AM COLL CARDIOL, V40, P1703, DOI 10.1016/S0735-1097(02)02528-7; Grundy SM, 2019, J AM COLL CARDIOL, V73, pE285, DOI 10.1016/j.jacc.2018.11.003; GUYATT G, 1992, JAMA-J AM MED ASSOC, V268, P2420, DOI 10.1001/jama.1992.03490170092032; Habib G, 2015, EUR HEART J, V36, P3075, DOI [10.1093/eurheartj/ehv319, 10.5603/KP.2015.0227]; Habib G, 2009, EUR HEART J, V30, P2369, DOI 10.1093/eurheartj/ehp285; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Hernandez AF, 2015, ANN INTERN MED, V163, P635, DOI 10.7326/M15-1460; Hillis LD, 2011, J AM COLL CARDIOL, V58, pE123, DOI 10.1016/j.jacc.2011.08.009; Hiratzka LF, 2010, J AM COLL CARDIOL, V55, pE27, DOI 10.1016/j.jacc.2010.02.015; Hirsch AT, 2006, CIRCULATION, V113, pE463, DOI 10.1161/CIRCULATIONAHA.106.174526; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Ibanez B, 2018, KARDIOL POL, V76, P229, DOI 10.5603/KP.2018.0041; James S, 2015, NAT REV CARDIOL, V12, P312, DOI 10.1038/nrcardio.2015.33; January CT, 2014, J AM COLL CARDIOL, V64, P2246, DOI [10.1016/j.jacc.2014.03.022, 10.1016/j.jacc.2014.03.021, 10.1161/CIR.0000000000000041, 10.1161/CIR.0000000000000142]; January CT, 2014, J AM COLL CARDIOL, Ve1, DOI [10.1016/j.jtcvs.2014.05.014, DOI 10.1016/J.JACC.2014.03.022]; Jensen, 2014, CIRCULATION, V129, pS139, DOI 10.1161/CIR.0000000000000070; Jensen MD, 2014, J AM COLL CARDIOL, V63, P2985, DOI 10.1016/j.jacc.2013.11.004; Koh C, 2013, HEPATOLOGY, V58, P2142, DOI 10.1002/hep.26578; Komajda M, 2017, EUR J HEART FAIL, V19, P1495, DOI 10.1002/ejhf.876; Konstantinides SV, 2014, EUR HEART J, V35, P3033, DOI 10.1093/eurheartj/ehu283; Kristensen SD, 2014, EUR HEART J, V35, P2383, DOI 10.1093/eurheartj/ehu282; Kusumoto FM, 2019, J AM COLL CARDIOL, V74, pE51, DOI 10.1016/j.jacc.2018.10.044; Lauer MS, 2013, NEW ENGL J MED, V369, P1579, DOI 10.1056/NEJMp1310102; Lee DH, 2011, ARCH INTERN MED, V171, P18, DOI 10.1001/archinternmed.2010.482; Levine GN, 2011, CIRCULATION, V124, pE574, DOI 10.1161/CIR.0b013e31823ba622; Lip GYH, 2015, EUROPACE, V17, P1777, DOI 10.1093/europace/euv269; Maisch B, 2004, EUR HEART J, V25, P587, DOI 10.1016/j.ehj.2004.02.002; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; Mehta RH, 2015, CIRCULATION, V131, P980, DOI 10.1161/CIRCULATIONAHA.114.013451; Meyer C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204720; Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296; Mosca L, 2007, J AM COLL CARDIOL, V49, P1230, DOI 10.1016/j.jacc.2007.02.020; Mosca L, 2011, J AM COLL CARDIOL, V57, P1404, DOI [10.1016/j.jacc.2011.02.005, 10.1161/CIR.0b013e31820faaf8]; Moya A, 2009, EUR HEART J, V30, P2631, DOI 10.1093/eurheartj/ehp298; Neuman MD, 2014, JAMA-J AM MED ASSOC, V311, P2092, DOI 10.1001/jama.2014.4949; Neumann F.-J., 2018, EUR HEART J, V40, P165, DOI [10.1093/eurheartj/ehy339, 10.1093/eurheartj/ehy394, DOI 10.1093/EURHEARTJ/EHY394]; Nishimura RA, 2014, J AM COLL CARDIOL, V63, P2438, DOI 10.1016/j.jacc.2014.02.537; Page RL, 2016, CIRCULATION, V133, pE506, DOI 10.1161/CIR.0000000000000311; Perk Joep, 2012, Atherosclerosis, V223, P1, DOI [10.1016/j.atherosclerosis.2012.05.007, 10.1007/s12529-012-9242-5, 10.1093/eurheartj/ehs092]; Piepoli MF, 2016, EUR HEART J, V37, P2315, DOI 10.1093/eurheartj/ehw106; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Poonacha TK, 2011, J CLIN ONCOL, V29, P186, DOI 10.1200/JCO.2010.31.6414; Povsic TJ, 2017, CARDIOVASC DRUG THER, V31, P445, DOI 10.1007/s10557-017-6739-9; Priori SG, 2015, EUROPACE, V17, P1601, DOI 10.1093/europace/euv319; Psaty BM, 2014, NEW ENGL J MED, V370, P2165, DOI 10.1056/NEJMp1401664; Regitz-Zagrosek V., 2012, Revista Espanola de Cardiologia, V65, P171, DOI 10.1016/j.rec.2011.11.005; Regitz-Zagrosek V, 2018, EUR HEART J, V39, P3165, DOI 10.1093/eurheartj/ehy340; Reiner Z, 2011, EUR HEART J, V32, P1769, DOI [10.1093/eurheartj/ehr158, 10.1016/j.atherosclerosis.2011.06.012]; Roffi M, 2016, EUR HEART J, V37, P267, DOI 10.1093/eurheartj/ehv320; Ryden L, 2013, EUR HEART J, V34, P3035, DOI 10.1093/eurheartj/eht108; Shen WK, 2017, HEART RHYTHM, V14, pE155, DOI 10.1016/j.hrthm.2017.03.004; Shortell SM, 2007, JAMA-J AM MED ASSOC, V298, P673, DOI 10.1001/jama.298.6.673; Sidney S, 2016, JAMA CARDIOL, V1, P594, DOI 10.1001/jamacardio.2016.1326; Smith SC, 2006, CIRCULATION, V113, pE166, DOI 10.1161/CIRCULATIONAHA.106.173220; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; STONE NJ, 2014, EUR HEART J, V63, P2889, DOI DOI 10.1016/J.JACC.2013.11.002; Stout KK, 2019, J AM COLL CARDIOL, V73, pE81, DOI 10.1016/j.jacc.2018.08.1029; Tendera M, 2011, EUR HEART J, V32, P2851, DOI 10.1093/eurheartj/ehr211; Tricoci P, 2009, JAMA-J AM MED ASSOC, V301, P831, DOI 10.1001/jama.2009.205; Vahanian A, 2021, EUR HEART J, DOI [10.1093/eurheartj/ehab395, 10.1093/ejcts/ezac209, 10.1093/ejcts/ezab389]; Vahanian A, 2012, EUR HEART J, V33, P2451, DOI 10.1093/eurheartj/ehs109; Venkatesh AK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178456; Warnes CA, 2008, J AM COLL CARDIOL, V52, pE1, DOI 10.1016/j.jacc.2008.10.001; Whelton PK, 2018, J AM COLL CARDIOL, V71, pE127, DOI 10.1016/j.jacc.2017.11.006; Williams B, 2018, EUR HEART J, V39, P3021, DOI 10.1093/eurheartj/ehy339; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224, 10.1093/ejcts/ezu366]; Wright JD, 2011, OBSTET GYNECOL, V118, P505, DOI 10.1097/AOG.0b013e3182267f43; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; Zipes DP, 2006, EUROPACE, V8, P746, DOI 10.1093/europace/eul108	105	87	90	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 19	2019	321	11					1069	1080		10.1001/jama.2019.1122	http://dx.doi.org/10.1001/jama.2019.1122			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP4YY	30874755	Green Published, Bronze			2022-12-28	WOS:000461683500015
J	Yamin, AE; Mason, E; Phumaphi, J; Gautam, K; Killen, B; Pkhakadze, G; Alipuri, NK; Kidu, DC; Sen, G; Rios, J				Yamin, Alicia Ely; Mason, Elizabeth; Phumaphi, Joy; Gautam, Kul; Killen, Brenda; Pkhakadze, Giorgi; Alipuri, Nicolas Kojo; Kidu, Dame Carol; Sen, Gita; Rios, Jovana		IAP	Why accountability matters for universal health coverage and meeting the SDGs	LANCET			English	Editorial Material									[Yamin, Alicia Ely] Harvard Univ, Petrie Flom Ctr Hlth Law Policy Biotechnol & Bioe, Harvard Law Sch, Cambridge, MA 02138 USA; [Yamin, Alicia Ely] Harvard Univ, Global Hlth Educ & Learning Incubator, Cambridge, MA 02138 USA; [Mason, Elizabeth] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, Fac Epidemiol & Populat Hlth, London, England	Harvard University; Harvard University; University of London; London School of Hygiene & Tropical Medicine	Yamin, AE (corresponding author), Harvard Univ, Petrie Flom Ctr Hlth Law Policy Biotechnol & Bioe, Harvard Law Sch, Cambridge, MA 02138 USA.; Yamin, AE (corresponding author), Harvard Univ, Global Hlth Educ & Learning Incubator, Cambridge, MA 02138 USA.	ayamin@hsph.harvard.edu						Commission on Information and Accountability for Women's and Children's Health, 2011, COMM INF ACC WOM CHI; Hunt P., 2015, HLTH HUMAN RIGH 0902; Independent Accountability Panel, 2016, OLD CHALL NEW HOP AC; Independent Accountability Panel, 2017, TRANSF ACC AD ACC HL; Independent Accountability Panel, 2018, WHO IS ACC PRIV SECT; United Nations Secretary General, 2010, GLOB STRAT WOM CHILD; United Nations Secretary-General, 2015, GLOB STRAT WOM CHILD; WHO, 2017, LEAD REAL HUM RIGHTS; World Health Organization, INT COD MARK BREAST	9	4	4	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 16	2019	393	10176					1082	1084		10.1016/S0140-6736(19)30434-9	http://dx.doi.org/10.1016/S0140-6736(19)30434-9			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HP1HF	30894258				2022-12-28	WOS:000461416600009
J	Batie, M; Frost, J; Frost, M; Wilson, JW; Schofield, P; Rocha, S				Batie, Michael; Frost, Julianty; Frost, Mark; Wilson, James W.; Schofield, Pieta; Rocha, Sonia			Hypoxia induces rapid changes to histone methylation and reprograms chromatin	SCIENCE			English	Article							R/BIOCONDUCTOR PACKAGE; GENE-EXPRESSION; CELL-TYPES; IDENTIFICATION; GENERATION; ALIGNMENT; ACCURATE	Oxygen is essential for the life of most multicellular organisms. Cells possess enzymes called molecular dioxygenases that depend on oxygen for activity. A subclass of molecular dioxygenases is the histone demethylase enzymes, which are characterized by the presence of a Jumanji-C (JmjC) domain. Hypoxia can alter chromatin, but whether this is a direct effect on JmjC-histone demethylases or due to other mechanisms is unknown. Here, we report that hypoxia induces a rapid and hypoxia-inducible factor-independent induction of histone methylation in a range of human cultured cells. Genomic locations of histone-3 lysine-4 trimethylation (H3K4me3) and H3K36me3 after a brief exposure of cultured cells to hypoxia predict the cell's transcriptional response several hours later. We show that inactivation of one of the JmjC-containing enzymes, lysine demethylase 5A (KDM5A), mimics hypoxia-induced cellular responses. These results demonstrate that oxygen sensing by chromatin occurs via JmjC-histone demethylase inhibition.	[Batie, Michael; Frost, Julianty; Frost, Mark; Wilson, James W.; Rocha, Sonia] Univ Liverpool, Dept Biochem, Inst Integrat Biol, Biosci Bldg,Crown St, Liverpool L69 7ZB, Merseyside, England; [Batie, Michael; Schofield, Pieta; Rocha, Sonia] Univ Dundee, Ctr Gene Regulat & Express, Sch Life Sci, Dow St, Dundee DD1 5EH, Scotland; [Schofield, Pieta] Univ Manchester, Computat Biol Support, CRUK Manchester Inst, Alderley Pk, Macclesfield SK10 4TG, Cheshire, England	University of Liverpool; University of Dundee; University of Manchester	Rocha, S (corresponding author), Univ Liverpool, Dept Biochem, Inst Integrat Biol, Biosci Bldg,Crown St, Liverpool L69 7ZB, Merseyside, England.; Rocha, S (corresponding author), Univ Dundee, Ctr Gene Regulat & Express, Sch Life Sci, Dow St, Dundee DD1 5EH, Scotland.	srocha@liverpool.ac.uk	Batie, Michael/AAL-3116-2020; Schofield, Pieta/Q-4847-2019	Schofield, Pieta/0000-0002-6398-2537; Batie, Michael/0000-0002-7508-6641; Wilson, James/0000-0002-9373-6919; Frost, Mark/0000-0001-7209-2897; Frost, Julianty/0000-0001-8209-2575	Cancer Research UK [C99667/A12918]; Wellcome Trust [097945/B/11/Z, 206293/Z/17/Z]; MRC DTP training grant; Tenovus Scotland small grant; University of Liverpool	Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); MRC DTP training grant; Tenovus Scotland small grant; University of Liverpool	S.R. was supported by grants from Cancer Research UK (C99667/A12918), Wellcome Trust (097945/B/11/Z; 206293/Z/17/Z), an MRC DTP training grant (to M.B.), a Tenovus Scotland small grant, and the University of Liverpool.	Adriaens ME, 2016, EPIGENET CHROMATIN, V9, DOI 10.1186/s13072-016-0090-4; Allan C, 2012, NAT METHODS, V9, P245, DOI [10.1038/NMETH.1896, 10.1038/nmeth.1896]; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Balss J, 2012, ACTA NEUROPATHOL, V124, P883, DOI 10.1007/s00401-012-1060-y; Batie M, 2018, BIOMEDICINES, V6, DOI 10.3390/biomedicines6020047; Batie M, 2017, CELLS-BASEL, V6, DOI 10.3390/cells6010008; Bekker-Jensen DB, 2017, CELL SYST, V4, P587, DOI 10.1016/j.cels.2017.05.009; Benita Y, 2009, NUCLEIC ACIDS RES, V37, P4587, DOI 10.1093/nar/gkp425; Chakraborty AA, 2019, SCIENCE, V363, P1217, DOI 10.1126/science.aaw1026; Chang YY, 2011, BIOCHEM J, V433, P295, DOI 10.1042/BJ20101418; D'Angelo G, 2003, J BIOL CHEM, V278, P38183, DOI 10.1074/jbc.M302244200; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Frost J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13312; Hancock RL, 2017, ACS CHEM BIOL, V12, P1011, DOI 10.1021/acschembio.6b00958; Huang Y, 2016, MOL GENET GENOMICS, V291, P33, DOI 10.1007/s00438-015-1089-4; Jia BL, 2017, BBA-GEN SUBJECTS, V1861, P2922, DOI 10.1016/j.bbagen.2017.08.019; Kaelin WG, 2005, ANNU REV BIOCHEM, V74, P115, DOI 10.1146/annurev.biochem.74.082803.133142; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kenneth NS, 2008, BIOCHEM J, V414, P19, DOI 10.1042/BJ20081055; Klose RJ, 2007, CELL, V128, P889, DOI 10.1016/j.cell.2007.02.013; Laukka T, 2018, J MOL BIOL, V430, P3081, DOI 10.1016/j.jmb.2018.06.048; Levin May, 2018, Oncotarget, V9, P16861, DOI 10.18632/oncotarget.24717; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Lizio M, 2017, NUCLEIC ACIDS RES, V45, pD737, DOI 10.1093/nar/gkw995; Melvin A, 2012, CELL SIGNAL, V24, P35, DOI 10.1016/j.cellsig.2011.08.019; Ortiz-Barahona A, 2010, NUCLEIC ACIDS RES, V38, P2332, DOI 10.1093/nar/gkp1205; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pollard PJ, 2008, BIOCHEM J, V416, P387, DOI 10.1042/BJ20081238; Prickaerts P, 2016, EPIGENET CHROMATIN, V9, DOI 10.1186/s13072-016-0086-0; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Sanchez-Fernandez EM, 2013, BIOCHEM J, V449, P491, DOI 10.1042/BJ20121155; Schumm K, 2006, EMBO J, V25, P4820, DOI 10.1038/sj.emboj.7601343; Shmakova A, 2014, BIOCHEM J, V462, P385, DOI 10.1042/BJ20140754; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sloan CA, 2016, NUCLEIC ACIDS RES, V44, pD726, DOI 10.1093/nar/gkv1160; Smith KA, 2017, REDOX BIOL, V13, P228, DOI 10.1016/j.redox.2017.05.020; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tretter L, 2016, BBA-BIOENERGETICS, V1857, P1086, DOI 10.1016/j.bbabio.2016.03.012; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Yang ZL, 2018, PLANT CELL, V30, P167, DOI 10.1105/tpc.17.00666; Yu GC, 2015, BIOINFORMATICS, V31, P2382, DOI 10.1093/bioinformatics/btv145; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhu LJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-237	50	156	156	12	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 15	2019	363	6432			SI		1222	+		10.1126/science.aau5870	http://dx.doi.org/10.1126/science.aau5870			64	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP0BC	30872526	Green Submitted			2022-12-28	WOS:000461329000050
J	DuBois, SG; Corson, LB; Stegmaier, K; Janeway, KA				DuBois, Steven G.; Corson, Laura B.; Stegmaier, Kimberly; Janeway, Katherine A.			Ushering in the next generation of precision trials for pediatric cancer	SCIENCE			English	Review							INHIBITION; THERAPY; DABRAFENIB; TRAMETINIB; LANDSCAPE; MEDICINE; CEREBLON; LEUKEMIA; SYNERGY; GENOME	Cancer treatment decisions are increasingly based on the genomic profile of the patient's tumor, a strategy called "precision oncology." Over the past few years, a growing number of clinical trials and case reports have provided evidence that precision oncology is an effective approach for at least some children with cancer. Here, we review key factors influencing pediatric drug development in the era of precision oncology. We describe an emerging regulatory framework that is accelerating the pace of clinical trials in children as well as design challenges that are specific to trials that involve young cancer patients. Last, we discuss new drug development approaches for pediatric cancers whose growth relies on proteins that are difficult to target therapeutically, such as transcription factors.	[DuBois, Steven G.; Corson, Laura B.; Stegmaier, Kimberly; Janeway, Katherine A.] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA 02215 USA; [DuBois, Steven G.; Corson, Laura B.; Stegmaier, Kimberly; Janeway, Katherine A.] Harvard Med Sch, Dana Farber Boston Childrens Canc & Blood Disorde, Boston, MA 02215 USA; [DuBois, Steven G.; Stegmaier, Kimberly; Janeway, Katherine A.] Harvard Med Sch, Dept Pediat, Boston, MA 02215 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	Janeway, KA (corresponding author), Harvard Med Sch, Dana Farber Canc Inst, Boston, MA 02215 USA.; Janeway, KA (corresponding author), Harvard Med Sch, Dana Farber Boston Childrens Canc & Blood Disorde, Boston, MA 02215 USA.; Janeway, KA (corresponding author), Harvard Med Sch, Dept Pediat, Boston, MA 02215 USA.	kjaneway@partners.org		Corson, Laura/0000-0003-2772-3375	NCI NIH HHS [R01 CA204915] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allen CE, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djw274; Bagatell R, 2011, CLIN CANCER RES, V17, P611, DOI 10.1158/1078-0432.CCR-10-1731; Bouffet E, 2016, J CLIN ONCOL, V34, P2206, DOI 10.1200/JCO.2016.66.6552; Bresler SC, 2014, CANCER CELL, V26, P682, DOI 10.1016/j.ccell.2014.09.019; Brien GL, 2018, ELIFE, V7, DOI 10.7554/eLife.41305; Buzyn A, 2016, NAT REV CLIN ONCOL, V13, P385, DOI 10.1038/nrclinonc.2016.31; Chen LY, 2018, J CLIN INVEST, V128, P446, DOI 10.1172/JCI90793; Chi SS, 2018, MOL CANCER THER, V17, DOI 10.1158/1535-7163.TARG-17-A175; Chuk MK, 2017, CLIN CANCER RES, V23, P9, DOI 10.1158/1078-0432.CCR-16-1367; dos Santos GA, 2013, J EXP MED, V210, P2793, DOI 10.1084/jem.20131121; Drilon A, 2018, NEW ENGL J MED, V378, P731, DOI 10.1056/NEJMoa1714448; DUMMER R, 2018, J CLIN ONCOL S, V36; Forrest SJ, 2018, CURR OPIN PEDIATR, V30, P17, DOI 10.1097/MOP.0000000000000570; Gaspar N, 2018, ANN ONCOL, V29, P766, DOI 10.1093/annonc/mdy002; Gore L, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.74.4144; Grob JJ, 2015, LANCET ONCOL, V16, P1389, DOI 10.1016/S1470-2045(15)00087-X; Grobner SN, 2018, NATURE, V555, P321, DOI 10.1038/nature25480; Harris MH, 2016, JAMA ONCOL, V2, P608, DOI 10.1001/jamaoncol.2015.5689; Hart LS, 2017, CLIN CANCER RES, V23, P1785, DOI 10.1158/1078-0432.CCR-16-1131; Huang HT, 2018, CELL CHEM BIOL, V25, P88, DOI 10.1016/j.chembiol.2017.10.005; Iasonos A, 2008, CLIN TRIALS, V5, P465, DOI 10.1177/1740774508096474; Kieran MW, 2016, ANN ONCOL, V27, DOI 10.1093/annonc/mdw435.9; Kim KH, 2015, NAT MED, V21, P1491, DOI 10.1038/nm.3968; Kronke J, 2014, SCIENCE, V343, P301, DOI 10.1126/science.1244851; Laetsch TW, 2018, LANCET ONCOL, V19, P705, DOI 10.1016/S1470-2045(18)30119-0; Lo-Coco F, 2013, NEW ENGL J MED, V369, P111, DOI 10.1056/NEJMoa1300874; Loh ML, 2013, BLOOD, V121, P485, DOI 10.1182/blood-2012-04-422691; Long GV, 2017, NEW ENGL J MED, V377, P1813, DOI 10.1056/NEJMoa1708539; Lu G, 2014, SCIENCE, V343, P305, DOI 10.1126/science.1244917; Lu J, 2015, CHEM BIOL, V22, P755, DOI 10.1016/j.chembiol.2015.05.009; Ma XT, 2018, NATURE, V555, P371, DOI 10.1038/nature25795; Michel BC, 2018, NAT CELL BIOL, V20, P1410, DOI 10.1038/s41556-018-0221-1; Miller WH, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.15_suppl.3057; Mody RJ, 2017, PEDIATR BLOOD CANCER, V64, DOI 10.1002/pbc.26288; Moreno L, 2017, NAT REV CLIN ONCOL, V14, P496, DOI 10.1038/nrclinonc.2017.59; Mosse YP, 2017, J CLIN ONCOL, V35, P3215, DOI 10.1200/JCO.2017.73.4830; Olson CM, 2018, NAT CHEM BIOL, V14, P163, DOI [10.1038/nchembio.2538, 10.1038/NCHEMBIO.2538]; Pearson ADJ, 2017, LANCET ONCOL, V18, pE394, DOI 10.1016/S1470-2045(17)30442-4; Place AE, 2018, FUTURE ONCOL, V14, P2115, DOI 10.2217/fon-2018-0121; Roberts KG, 2012, CANCER CELL, V22, P153, DOI 10.1016/j.ccr.2012.06.005; Seibel NL, 2017, CURR PROB CANCER, V41, P194, DOI 10.1016/j.currproblcancer.2017.01.002; Skolnik JM, 2008, J CLIN ONCOL, V26, P190, DOI 10.1200/JCO.2007.12.7712; Stolte B, 2018, J EXP MED, V215, P2137, DOI 10.1084/jem.20171066; Stone RM, 2017, NEW ENGL J MED, V377, P454, DOI 10.1056/NEJMoa1614359; Sweet-Cordero EA, 2019, SCIENCE, V363, P1170, DOI 10.1126/science.aaw3535; Toure M, 2016, ANGEW CHEM INT EDIT, V55, P1966, DOI 10.1002/anie.201507978; Winter GE, 2015, SCIENCE, V348, P1376, DOI 10.1126/science.aab1433	47	29	29	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 15	2019	363	6432			SI		1175	1181		10.1126/science.aaw4153	http://dx.doi.org/10.1126/science.aaw4153			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP0BC	30872517				2022-12-28	WOS:000461329000038
J	Kiberstis, PA				Kiberstis, Paula A.			IT TAKES A VILLAGE	SCIENCE			English	Editorial Material																			0	0	0	1	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 15	2019	363	6432			SI		1164	1165		10.1126/science.aax1736	http://dx.doi.org/10.1126/science.aax1736			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HP0BC	30872514				2022-12-28	WOS:000461329000035
J	Dyer, C				Dyer, Clare			Doctors have authority to assess injuries from alleged torture, says Supreme Court	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 12	2019	364								l1121	10.1136/bmj.l1121	http://dx.doi.org/10.1136/bmj.l1121			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP5VS	30862684				2022-12-28	WOS:000461751000013
J	Lemkes, JS; Janssens, GN; van der Hoeven, NW; Jewbali, LSD; Dubois, EA; Meuwissen, M; Rijpstra, TA; Bosker, HA; Blans, MJ; Bleeker, GB; Baak, R; Vlachojannis, GJ; Eikemans, BJW; van der Harst, P; van der Horst, ICC; Voskuil, M; van der Heijden, JJ; Beishuizen, A; Stoel, M; Camaro, C; van der Hoeven, H; Henriques, JP; Vlaar, APJ; Vink, MA; van den Bogaard, B; Heestermans, TACM; de Ruijter, W; Delnoij, TSR; Crijns, HJGM; Jessurun, GAJ; Oemrawsingh, PV; Gosselink, MTM; Plomp, K; Magro, M; Elbers, PWG; van de Ven, PM; Oudemans-van Straaten, HM; van Royen, N				Lemkes, Jorrit S.; Janssens, Gladys N.; van der Hoeven, Nina W.; Jewbali, Lucia S. D.; Dubois, Eric A.; Meuwissen, Martijn; Rijpstra, Tom A.; Bosker, Hans A.; Blans, Michiel J.; Bleeker, Gabe B.; Baak, Remon; Vlachojannis, Georgios J.; Eikemans, Bob J. W.; van der Harst, Pim; van der Horst, Iwan C. C.; Voskuil, Michiel; van der Heijden, Joris J.; Beishuizen, Albertus; Stoel, Martin; Camaro, Cyril; van der Hoeven, Hans; Henriques, Jose P.; Vlaar, Alexander P. J.; Vink, Maarten A.; van den Bogaard, Bas; Heestermans, Ton A. C. M.; de Ruijter, Wouter; Delnoij, Thijs S. R.; Crijns, Harry J. G. M.; Jessurun, Gillian A. J.; Oemrawsingh, Pranobe V.; Gosselink, Marcel T. M.; Plomp, Koos; Magro, Michael; Elbers, Paul W. G.; van de Ven, Peter M.; Oudemans-van Straaten, Heleen M.; van Royen, Niels			Coronary Angiography after Cardiac Arrest without ST-Segment Elevation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; VENTRICULAR-FIBRILLATION; EUROPEAN-SOCIETY; TASK-FORCE; INTERVENTION; IMMEDIATE; RESUSCITATION; ASSOCIATION; MANAGEMENT; SURVIVORS	Background Ischemic heart disease is a major cause of out-of-hospital cardiac arrest. The role of immediate coronary angiography and percutaneous coronary intervention (PCI) in the treatment of patients who have been successfully resuscitated after cardiac arrest in the absence of ST-segment elevation myocardial infarction (STEMI) remains uncertain. Methods In this multicenter trial, we randomly assigned 552 patients who had cardiac arrest without signs of STEMI to undergo immediate coronary angiography or coronary angiography that was delayed until after neurologic recovery. All patients underwent PCI if indicated. The primary end point was survival at 90 days. Secondary end points included survival at 90 days with good cerebral performance or mild or moderate disability, myocardial injury, duration of catecholamine support, markers of shock, recurrence of ventricular tachycardia, duration of mechanical ventilation, major bleeding, occurrence of acute kidney injury, need for renal-replacement therapy, time to target temperature, and neurologic status at discharge from the intensive care unit. Results At 90 days, 176 of 273 patients (64.5%) in the immediate angiography group and 178 of 265 patients (67.2%) in the delayed angiography group were alive (odds ratio, 0.89; 95% confidence interval [CI], 0.62 to 1.27; P=0.51). The median time to target temperature was 5.4 hours in the immediate angiography group and 4.7 hours in the delayed angiography group (ratio of geometric means, 1.19; 95% CI, 1.04 to 1.36). No significant differences between the groups were found in the remaining secondary end points. Conclusions Among patients who had been successfully resuscitated after out-of-hospital cardiac arrest and had no signs of STEMI, a strategy of immediate angiography was not found to be better than a strategy of delayed angiography with respect to overall survival at 90 days. (Funded by the Netherlands Heart Institute and others; COACT Netherlands Trial Register number, .) Patients who had cardiac arrest without ST-segment elevation were assigned to undergo either immediate coronary angiography or delayed coronary angiography (after neurologic recovery). All patients underwent PCI if indicated. There was no significant between-group difference in overall survival at 90 days.	[Lemkes, Jorrit S.; Janssens, Gladys N.; van der Hoeven, Nina W.; van Royen, Niels] Vrije Univ Amsterdam Med Ctr, Amsterdam Univ Med Ctr, Dept Cardiol, De Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands; [Elbers, Paul W. G.; Oudemans-van Straaten, Heleen M.] Vrije Univ Amsterdam Med Ctr, Amsterdam Univ Med Ctr, Dept Intens Care Med, Amsterdam, Netherlands; [van de Ven, Peter M.] Vrije Univ Amsterdam Med Ctr, Amsterdam Univ Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Henriques, Jose P.] AMC, Amsterdam Univ Med Ctr, Dept Cardiol, Amsterdam, Netherlands; [Vlaar, Alexander P. J.] AMC, Amsterdam Univ Med Ctr, Dept Intens Care Med, Amsterdam, Netherlands; [Vink, Maarten A.] Onze Lieve Vrouw Hosp, Dept Cardiol, Amsterdam, Netherlands; [van den Bogaard, Bas] Onze Lieve Vrouw Hosp, Dept Intens Care Med, Amsterdam, Netherlands; [Jewbali, Lucia S. D.; Dubois, Eric A.] Erasmus MC, Ctr Thorax, Rotterdam, Netherlands; [Vlachojannis, Georgios J.] Maasstad Hosp, Dept Cardiol, Rotterdam, Netherlands; [Eikemans, Bob J. W.] Maasstad Hosp, Dept Intens Care Med, Rotterdam, Netherlands; [Meuwissen, Martijn] Amphia Hosp, Dept Cardiol, Breda, Netherlands; [Rijpstra, Tom A.] Amphia Hosp, Dept Intens Care Med, Breda, Netherlands; [Bosker, Hans A.] Rijnstate Hosp, Dept Cardiol, Arnhem, Netherlands; [Blans, Michiel J.] Rijnstate Hosp, Dept Intens Care Med, Arnhem, Netherlands; [Bleeker, Gabe B.] Haga Hosp, Dept Cardiol, The Hague, Netherlands; [Baak, Remon] Haga Hosp, Dept Intens Care Med, The Hague, Netherlands; [Oemrawsingh, Pranobe V.] Haaglanden Med Ctr, Dept Cardiol, The Hague, Netherlands; [van der Harst, Pim] Univ Groningen, Dept Cardiol, Groningen, Netherlands; [van der Horst, Iwan C. C.] Univ Groningen, Dept Intens Care Med, Groningen, Netherlands; [Voskuil, Michiel] Univ Med Ctr Utrecht, Dept Cardiol, Utrecht, Netherlands; [van der Heijden, Joris J.] Univ Med Ctr Utrecht, Dept Intens Care Med, Utrecht, Netherlands; [Beishuizen, Albertus] Med Spectrum Twente, Dept Intens Care Med, Enschede, Netherlands; [Stoel, Martin] Med Spectrum Twente, Dept Cardiol, Enschede, Netherlands; [Camaro, Cyril; van Royen, Niels] Radboud Univ Nijmegen Med Ctr, Dept Cardiol, Nijmegen, Netherlands; [van der Hoeven, Hans] Radboud Univ Nijmegen Med Ctr, Dept Intens Care Med, Nijmegen, Netherlands; [Heestermans, Ton A. C. M.] Noordwest Ziekenhuisgrp, Dept Cardiol, Alkmaar, Netherlands; [de Ruijter, Wouter] Noordwest Ziekenhuisgrp, Dept Intens Care Med, Alkmaar, Netherlands; [Delnoij, Thijs S. R.] Maastricht Univ, Med Ctr, Dept Intens Care Med, Maastricht, Netherlands; [Crijns, Harry J. G. M.] Maastricht Univ, Med Ctr, Dept Cardiol, Maastricht, Netherlands; [Jessurun, Gillian A. J.] Scheper Hosp, Dept Cardiol, Emmen, Netherlands; [Gosselink, Marcel T. M.] Isala Hosp, Dept Cardiol, Zwolle, Netherlands; [Plomp, Koos] Tergooi Hosp, Dept Cardiol, Blaricum, Netherlands; [Magro, Michael] Elisabeth Tweesteden Hosp, Dept Cardiol, Tilburg, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Onze Lieve Vrouwe Gasthuis Hospital; Onze Lieve Vrouwe Gasthuis Hospital; Erasmus University Rotterdam; Erasmus MC; Maasstad Hospital; Maasstad Hospital; Amphia Hospital; Amphia Hospital; Rijnstate Hospital; Rijnstate Hospital; Haga Hospital; Haga Hospital; Haaglanden Medical Center; University of Groningen; University of Groningen; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Medical Spectrum Twente; Medical Spectrum Twente; Radboud University Nijmegen; Radboud University Nijmegen; Medical Center Of Alkmaar; Medical Center Of Alkmaar; Maastricht University; Maastricht University; Tergooi Blaricum; Elisabeth-TweeSteden Ziekenhuis (ETZ)	Lemkes, JS (corresponding author), Vrije Univ Amsterdam Med Ctr, Amsterdam Univ Med Ctr, Dept Cardiol, De Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands.	j.lemkes@vumc.nl	van Royen, Niels/Q-1097-2017; Camaro, Cyril/L-4241-2015; Elbers, Paul/AHA-0344-2022; Meuwissen, martijn/GWV-1891-2022	Camaro, Cyril/0000-0001-6170-8318; Elbers, Paul/0000-0003-0447-6893; Vlaar, Alexander/0000-0002-3453-7186; Henriques, Jose PS/0000-0002-8969-7929; van der Heijden, Joris/0000-0002-1730-3521	Netherlands Heart Institute; COACT Netherlands	Netherlands Heart Institute; COACT Netherlands	Funded by the Netherlands Heart Institute and others; COACT Netherlands Trial Register number, NTR4973.	Bernard SA, 2010, CIRCULATION, V122, P737, DOI 10.1161/CIRCULATIONAHA.109.906859; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Bro-Jeppesen J, 2012, EUR HEART J-ACUTE CA, V1, P291, DOI 10.1177/2048872612465588; Dankiewicz J, 2015, INTENS CARE MED, V41, P856, DOI 10.1007/s00134-015-3735-z; Dumas F, 2016, JACC-CARDIOVASC INTE, V9, P1011, DOI 10.1016/j.jcin.2016.02.001; Erlinge D, 2014, J AM COLL CARDIOL, V63, P1857, DOI 10.1016/j.jacc.2013.12.027; Hollenbeck RD, 2014, RESUSCITATION, V85, P88, DOI 10.1016/j.resuscitation.2013.07.027; Ibanez B, 2018, KARDIOL POL, V76, P229, DOI 10.5603/KP.2018.0041; Khan MS, 2017, RESUSCITATION, V121, P127, DOI 10.1016/j.resuscitation.2017.10.019; Kim F, 2014, JAMA-J AM MED ASSOC, V311, P45, DOI 10.1001/jama.2013.282173; Larsen JM, 2012, RESUSCITATION, V83, P1427, DOI 10.1016/j.resuscitation.2012.08.337; Laver S, 2004, INTENS CARE MED, V30, P2126, DOI 10.1007/s00134-004-2425-z; Lemkes JS, 2016, AM HEART J, V180, P39, DOI 10.1016/j.ahj.2016.06.025; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Milosevic A, 2016, JACC-CARDIOVASC INTE, V9, P541, DOI 10.1016/j.jcin.2015.11.018; Montalescot G, 2009, JAMA-J AM MED ASSOC, V302, P947, DOI 10.1001/jama.2009.1267; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519; Noc M, 2014, EUROINTERVENTION, V10, P31, DOI 10.4244/EIJV10I1A7; Nolan JP, 2015, INTENS CARE MED, V41, P2039, DOI 10.1007/s00134-015-4051-3; O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI [10.1016/j.jacc.2012.11.019, 10.1161/CIR.0b013e3182742cf6]; Patel N, 2016, JAMA CARDIOL, V1, P890, DOI 10.1001/jamacardio.2016.2860; Rab T, 2015, J AM COLL CARDIOL, V66, P62, DOI 10.1016/j.jacc.2015.05.009; Riezebos RK, 2009, HEART, V95, P807, DOI 10.1136/hrt.2008.154815; Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626; Spaulding CM, 1997, NEW ENGL J MED, V336, P1629, DOI 10.1056/NEJM199706053362302; Staudachera II, 2018, RESUSCITATION, V123, P98, DOI 10.1016/j.resuscitation.2017.11.046; Thiele H, 2012, EUR HEART J, V33, P2035, DOI 10.1093/eurheartj/ehr418; Welsford M, 2015, CIRCULATION, V132, pS146, DOI 10.1161/CIR.0000000000000274	28	248	251	1	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 11	2019	380	15					1397	1407		10.1056/NEJMoa1816897	http://dx.doi.org/10.1056/NEJMoa1816897			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HT5NG	30883057	Green Published, Bronze			2022-12-28	WOS:000464610000007
J	Barak, R; Yom-Tov, G; Guez-Haddad, J; Gasri-Plotnitsky, L; Maimon, R; Cohen-Berkman, M; McCarthy, AA; Perlson, E; Henis-Korenblit, S; Isupov, MN; Opatowsky, Y				Barak, Reut; Yom-Tov, Galit; Guez-Haddad, Julia; Gasri-Plotnitsky, Lital; Maimon, Roy; Cohen-Berkman, Moran; McCarthy, Andrew A.; Perlson, Eran; Henis-Korenblit, Sivan; Isupov, Michail N.; Opatowsky, Yarden			Structural Principles in Robo Activation and Auto-inhibition	CELL			English	Article							AXON GUIDANCE; MOLECULAR-REPLACEMENT; BIVALENT BINDING; HEPARAN-SULFATE; KIT RECEPTOR; SLIT; ROUNDABOUT; DIMERIZATION; SPECIFICITY; REFINEMENT	Proper brain function requires high-precision neuronal expansion and wiring, processes controlled by the transmembrane Roundabout (Robo) receptor family and their Slit ligands. Despite their great importance, the molecular mechanism by which Robos' switch from "off" to "on" states remains unclear. Here, we report a 3.6 (A) over dot crystal structure of the intact human Robo2 ectodomain (domains D1-8). We demonstrate that Robo cis dimerization via D4 is conserved through hRobo1, 2, and 3 and the C. elegans homolog SAX-3 and is essential for SAX-3 function in vivo. The structure reveals two levels of auto-inhibition that prevent premature activation: (1) cis blocking of the D4 dimerization interface and (2) trans interactions between opposing Robo receptors that fasten the D4-blocked conformation. Complementary experiments in mouse primary neurons and C. elegans support the auto-inhibition model. These results suggest that Slit stimulation primarily drives the release of Robo auto-inhibition required for dimerization and activation.	[Barak, Reut; Yom-Tov, Galit; Guez-Haddad, Julia; Gasri-Plotnitsky, Lital; Cohen-Berkman, Moran; Henis-Korenblit, Sivan; Opatowsky, Yarden] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel; [Maimon, Roy; Perlson, Eran] Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, Tel Aviv, Israel; [McCarthy, Andrew A.] European Mol Biol Lab, Grenoble, France; [Isupov, Michail N.] Univ Exeter, Biosci, Exeter, Devon, England	Bar Ilan University; Tel Aviv University; Sackler Faculty of Medicine; European Molecular Biology Laboratory (EMBL); University of Exeter	Opatowsky, Y (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel.	yarden.opatowsky@biu.ac.il	Isupov, Mikhail/AAA-8280-2019; Henis-Korenblit, Sivan/AAE-4575-2022	Perlson, Eran/0000-0001-6047-9613; Isupov, Michail/0000-0001-6842-4289	ICRF; ISF [182/10, 1425/15]	ICRF; ISF(Israel Science Foundation)	We thank Prof. Abdussalam Azem from Tel-Aviv University for AUC measurements and analysis. We thank Drs. Avi Jacob and Irit Shoval from the Bar Ilan University scientific equipment center for help in light microscopy image acquisition and ImageStream FACS analysis and Jennifer Israel Cohen Benichou for C. elegans data statistical analysis. We thank members of the Opatowsky and Henis-Korenblit laboratories for technical assistance, Dr. Einav Gross of the Hebrew University Faculty of Medicine and Dr. Moshe Dessau of Bar-Ilan University Faculty of Medicine for useful advice, Prof. Cornelia Bargmann of the Chan Zuckerberg Initiative for the gift of sax-3 template DNA, and Dr. David Sprinzak of Tel Aviv University for the gift of Notch and Delta expression vectors. Some nematode strains used in this work were provided by the Caenorhabditis Genetics Center. We thank the staff of the ESRF and EMBL-Grenoble ID30B, ID23, and ID29 of ESRF and the staff of BESSY II for assistance in using beamlines BL14.1 and 14.2. This work was supported by funds from ICRF (to Y.O.) and ISF (grant nos. 182/10 and 1425/15) (to Y.O.).	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Alavi M, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002560; Aleksandrova N, 2018, STRUCTURE, V26, P320, DOI 10.1016/j.str.2017.12.003; Atanasova M, 2012, CRIT REV BIOCHEM MOL, V47, P502, DOI 10.3109/10409238.2012.729561; Ba-Charvet KTN, 2001, J NEUROSCI, V21, P4281; Ballard MS, 2012, ADV CANCER RES, V114, P187, DOI 10.1016/B978-0-12-386503-8.00005-3; Barak R, 2014, J STRUCT BIOL, V186, P283, DOI 10.1016/j.jsb.2014.02.019; Barak R, 2013, ACTA CRYSTALLOGR F, V69, P771, DOI 10.1107/S1744309113014863; Blockus H, 2016, DEVELOPMENT, V143, P3037, DOI 10.1242/dev.132829; BRENNER S, 1974, GENETICS, V77, P71; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Challa AK, 2001, MECH DEVELOP, V101, P249, DOI 10.1016/S0925-4773(00)00570-0; Chang JL, 2015, J HEPATOL, V63, P1413, DOI 10.1016/j.jhep.2015.07.033; Chen JH, 2000, NEUROSCIENCE, V96, P231, DOI 10.1016/S0306-4522(99)00408-X; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; Dascenco D, 2015, CELL, V162, P1140, DOI 10.1016/j.cell.2015.08.003; Delloye-Bourgeois C, 2015, NAT NEUROSCI, V18, P36, DOI 10.1038/nn.3893; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans TA, 2015, ELIFE, V4, DOI 10.7554/eLife.08407; Evans TA, 2012, DEV BIOL, V363, P266, DOI 10.1016/j.ydbio.2011.12.046; Evans TA, 2010, CURR BIOL, V20, P567, DOI 10.1016/j.cub.2010.02.021; Fan XP, 2012, CELL REPORTS, V2, P52, DOI 10.1016/j.celrep.2012.06.002; Fukuhara N, 2008, J BIOL CHEM, V283, P16226, DOI 10.1074/jbc.M800688200; Gabrielson JP, 2007, ANAL BIOCHEM, V361, P24, DOI 10.1016/j.ab.2006.11.012; Gara RK, 2015, DRUG DISCOV TODAY, V20, P156, DOI 10.1016/j.drudis.2014.09.008; Gerlach M, 2016, J LARGE SCALE RES FA, V2, P1; Gibson DA, 2014, NEURON, V81, P1040, DOI 10.1016/j.neuron.2014.01.009; Gohrig A, 2014, CANCER RES, V74, P1529, DOI 10.1158/0008-5472.CAN-13-1012; Goodman KM, 2017, P NATL ACAD SCI USA, V114, pE9829, DOI 10.1073/pnas.1713449114; Gu F, 2015, FRONT MED-PRC, V9, P431, DOI 10.1007/s11684-015-0416-9; Hammond R, 2005, DEVELOPMENT, V132, P4483, DOI 10.1242/dev.02038; Hao JC, 2001, NEURON, V32, P25, DOI 10.1016/S0896-6273(01)00448-2; Hivert B, 2002, MOL CELL NEUROSCI, V21, P534, DOI 10.1006/mcne.2002.1193; Hohenester E, 2008, BIOCHEM SOC T, V36, P251, DOI 10.1042/BST0360251; Howitt JA, 2004, EMBO J, V23, P4406, DOI 10.1038/sj.emboj.7600446; Hu HY, 2001, NAT NEUROSCI, V4, P695, DOI 10.1038/89482; Huang TT, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1984-4; Hussain SA, 2006, J BIOL CHEM, V281, P39693, DOI 10.1074/jbc.M609384200; Hwang DY, 2015, HUM GENET, V134, P905, DOI 10.1007/s00439-015-1570-5; Joosten RP, 2012, ACTA CRYSTALLOGR D, V68, P484, DOI 10.1107/S0907444911054515; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kingston Robert E, 2003, Curr Protoc Mol Biol, VChapter 9, DOI 10.1002/0471142727.mb0901s63; Krug M, 2012, J APPL CRYSTALLOGR, V45, P568, DOI 10.1107/S0021889812011715; LANGLEY KE, 1994, ARCH BIOCHEM BIOPHYS, V311, P55, DOI 10.1006/abbi.1994.1208; Lemmon MA, 1997, J BIOL CHEM, V272, P6311, DOI 10.1074/jbc.272.10.6311; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; LEV S, 1992, J BIOL CHEM, V267, P15970; Lewis MS, 2000, METHOD ENZYMOL, V321, P136; Liu Z, 2004, MOL CELL NEUROSCI, V26, P232, DOI 10.1016/j.mcn.2004.01.002; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mehlen P, 2011, NAT REV CANCER, V11, P188, DOI 10.1038/nrc3005; Morlot C, 2007, P NATL ACAD SCI USA, V104, P14923, DOI 10.1073/pnas.0705310104; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Opatowsky Y, 2014, P NATL ACAD SCI USA, V111, P1772, DOI 10.1073/pnas.1323254111; Ordan E, 2015, DEVELOPMENT, V142, P3512, DOI 10.1242/dev.128157; Pandey A, 2018, JOVE-J VIS EXP, DOI 10.3791/56919; Rama N, 2015, NAT MED, V21, P483, DOI 10.1038/nm.3849; Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604; Schuck P, 2014, ANALYST, V139, P79, DOI 10.1039/c3an01507f; Seiradake E, 2016, ANNU REV CELL DEV BI, V32, P577, DOI 10.1146/annurev-cellbio-111315-125008; Seiradake E, 2009, EMBO REP, V10, P736, DOI 10.1038/embor.2009.95; Shaya O, 2017, DEV CELL, V40, P505, DOI 10.1016/j.devcel.2017.02.009; Sporny M, 2016, ACTA CRYSTALLOGR D, V72, P1241, DOI 10.1107/S2059798316016697; Sprinzak D, 2010, NATURE, V465, P86, DOI 10.1038/nature08959; Tickle I.J., 2018, STARANISO; Vagin AA, 2001, ACTA CRYSTALLOGR D, V57, P1451, DOI 10.1107/S0907444901012409; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7; Xu R, 2018, NAT MED, V24, P823, DOI 10.1038/s41591-018-0020-z; Yom-Tov G, 2017, J MOL BIOL, V429, P3606, DOI 10.1016/j.jmb.2017.10.002; Yu TW, 2002, NAT NEUROSCI, V5, P1147, DOI 10.1038/nn956; Yuan WL, 1999, DEV BIOL, V212, P290, DOI 10.1006/dbio.1999.9371; Zakrys L, 2014, BIOCHEM J, V461, P61, DOI 10.1042/BJ20140190; Zallen JA, 1998, CELL, V92, P217, DOI 10.1016/S0092-8674(00)80916-2; Zelina P, 2014, NEURON, V84, P1258, DOI 10.1016/j.neuron.2014.11.004	80	22	22	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 4	2019	177	2					272	+		10.1016/j.cell.2019.02.004	http://dx.doi.org/10.1016/j.cell.2019.02.004			30	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	HR7PF	30853216	Bronze, Green Accepted			2022-12-28	WOS:000463346200008
J	Lauretta, DS; DellaGiustina, DN; Bennett, CA; Golish, DR; Becker, KJ; Balram-Knutson, SS; Barnouin, OS; Becker, TL; Bottke, WF; Boynton, WV; Campins, H; Clark, BE; Connolly, HC; d'Aubigny, CYD; Dworkin, JP; Emery, JP; Enos, HL; Hamilton, VE; Hergenrother, CW; Howell, ES; Izawa, MRM; Kaplan, HH; Nolan, MC; Rizk, B; Roper, HL; Scheeres, DJ; Smith, PH; Walsh, KJ; Wolner, CWV; Highsmith, DE; Small, J; Vokrouhlicky, D; Bowles, NE; Brown, E; Hanna, KLD; Warren, T; Brunet, C; Chicoine, RA; Desjardins, S; Gaudreau, D; Haltigin, T; Millington-Veloza, S; Rubi, A; Aponte, J; Gorius, N; Lunsford, A; Allen, B; Grindlay, J; Guevel, D; Hoak, D; Hong, J; Schrader, DL; Bayron, J; Golubov, O; Sanchez, P; Stromberg, J; Hirabayashi, M; Hartzell, CM; Oliver, S; Rascon, M; Harch, A; Joseph, J; Squyres, S; Richardson, D; McGraw, L; Ghent, R; Binzel, RP; Al Asad, MM; Johnson, CL; Philpott, L; Susorney, HCM; Cloutis, EA; Hanna, RD; Ciceri, F; Hildebrand, AR; Ibrahim, EM; Breitenfeld, L; Glotch, T; Rogers, AD; Ferrone, S; Thomas, CA; Fernandez, Y; Chang, W; Cheuvront, A; Trang, D; Tachibana, S; Yurimoto, H; Brucato, JR; Poggiali, G; Pajola, M; Dotto, E; Epifani, EM; Crombie, MK; Lantz, C; de Leon, J; Licandro, J; Garcia, JLR; Clemett, S; Thomas-Keprta, K; Van Wal, S; Yoshikawa, M; Bellerose, J; Bhaskaran, S; Boyles, C; Chesley, SR; Elder, CM; Farnocchia, D; Harbison, A; Kennedy, B; Knight, A; Martinez-Vlasoff, N; Mastrodemos, N; McElrath, T; Owen, W; Park, R; Rush, B; Swanson, L; Takahashi, Y; Velez, D; Yetter, K; Thayer, C; Adam, C; Antreasian, P; Bauman, J; Bryan, C; Carcich, B; Corvin, M; Geeraert, J; Hoffman, J; Leonard, JM; Lessac-Chenen, E; Levine, A; McAdams, J; McCarthy, L; Nelson, D; Page, B; Pelgrift, J; Sahr, E; Stakkestad, K; Stanbridge, D; Wibben, D; Williams, B; Williams, K; Wolff, P; Hayne, P; Kubitschek, D; Barucci, MA; Deshapriya, JDP; Fornasier, S; Fulchignoni, M; Hasselmann, P; Merlin, F; Praet, A; Bierhaus, EB; Billett, O; Boggs, A; Buck, B; Carlson-Kelly, S; Cerna, J; Chaffin, K; Church, E; Coltrin, M; Daly, J; Deguzman, A; Dubisher, R; Eckart, D; Ellis, D; Falkenstern, P; Fisher, A; Fisher, ME; Fleming, P; Fortney, K; Francis, S; Freund, S; Gonzales, S; Haas, P; Hasten, A; Hauf, D; Hilbert, A; Howell, D; Jaen, F; Jayakody, N; Jenkins, M; Johnson, K; Lefevre, M; Ma, H; Mario, C; Martin, K; May, C; Mcgee, M; Miller, B; Miller, C; Miller, G; Mirfakhrai, A; Muhle, E; Norman, C; Olds, R; Parish, C; Ryle, M; Schmitzer, M; Sherman, P; Skeen, M; Susak, M; Sutter, B; Tran, Q; Welch, C; Witherspoon, R; Wood, J; Zareski, J; Arvizu-Jakubicki, M; Asphaug, E; Audi, E; Ballouz, RL; Bandrowski, R; Bendall, S; Bloomenthal, H; Blum, D; Brodbeck, J; Burke, KN; Chojnacki, M; Colpo, A; Contreras, J; Cutts, J; Dean, D; Diallo, B; Drinnon, D; Drozd, K; Enos, R; Fellows, C; Ferro, T; Fisher, MR; Fitzgibbon, G; Fitzgibbon, M; Forelli, J; Forrester, T; Galinsky, I; Garcia, R; Gardner, A; Habib, N; Hamara, D; Hammond, D; Hanley, K; Harshman, K; Herzog, K; Hill, D; Hoekenga, C; Hooven, S; Huettner, E; Janakus, A; Jones, J; Kareta, TR; Kidd, J; Kingsbury, K; Koelbel, L; Kreiner, J; Lambert, D; Lewin, C; Lovelace, B; Loveridge, M; Lujan, M; Maleszewski, CK; Malhotra, R; Marchese, K; McDonough, E; Mogk, N; Morrison, V; Morton, E; Munoz, R; Nelson, J; Padilla, J; Pennington, R; Polit, A; Ramos, N; Reddy, V; Riehl, M; Salazar, S; Schwartz, SR; Selznick, S; Shultz, N; Stewart, S; Sutton, S; Swindle, T; Tang, YH; Westermann, M; Worden, D; Zega, T; Zeszut, Z; Bjurstrom, A; Bloomquist, L; Dickinson, C; Keates, E; Liang, J; Nifo, V; Taylor, A; Teti, F; Caplinger, M; Bowles, H; Carter, S; Dickenshied, S; Doerres, D; Fisher, T; Hagee, W; Hill, J; Miner, M; Noss, D; Piacentine, N; Smith, M; Toland, A; Wren, P; Bernacki, M; Munoz, DP; Watanabe, SI; Sandford, SA; Aqueche, A; Ashman, B; Barker, M; Bartels, A; Berry, K; Bos, B; Burns, R; Calloway, A; Carpenter, R; Castro, N; Cosentino, R; Donaldson, J; Cook, JE; Emr, C; Everett, D; Fennell, D; Fleshman, K; Folta, D; Gallagher, D; Garvin, J; Getzandanner, K; Glavin, D; Hull, S; Hyde, K; Ido, H; Ingegneri, A; Jones, N; Kaotira, P; Lim, LF; Liounis, A; Lorentson, C; Lorenz, D; Lyzhoft, J; Mazarico, EM; Mink, R; Moore, W; Moreau, M; Mullen, S; Nagy, J; Neumann, G; Nuth, J; Poland, D; Reuter, DC; Rhoads, L; Rieger, S; Rowlands, D; Sallitt, D; Scroggins, A; Shaw, G; Simon, AA; Swenson, J; Vasudeva, P; Wasser, M; Zellar, R; Grossman, J; Johnston, G; Morris, M; Wendel, J; Burton, A; Keller, LP; McNamara, L; Messenger, S; Nakamura-Messenger, K; Nguyen, A; Righter, K; Queen, E; Bellamy, K; Dill, K; Gardner, S; Giuntini, M; Key, B; Kissell, J; Patterson, D; Vaughan, D; Wright, B; Gaskell, RW; Le Corre, L; Li, JY; Molaro, JL; Palmer, EE; Siegler, MA; Tricarico, P; Weirich, JR; Zou, XD; Ireland, T; Tait, K; Bland, P; Anwar, S; Bojorquez-Murphy, N; Christensen, PR; Haberle, CW; Mehall, G; Rios, K; Franchi, I; Rozitis, B; Beddingfield, CB; Marshall, J; Brack, DN; French, AS; McMahon, JW; Jawin, ER; Mccoy, TJ; Russell, S; Killgore, M; Bandfield, JL; Clark, BC; Chodas, M; Lambert, M; Masterson, RA; Daly, MG; Freemantle, J; Seabrook, JA; Craft, K; Daly, RT; Ernst, C; Espiritu, RC; Holdridge, M; Jones, M; Nair, AH; Nguyen, L; Peachey, J; Perry, ME; Plescia, J; Roberts, JH; Steele, R; Turner, R; Backer, J; Edmundson, K; Mapel, J; Milazzo, M; Sides, S; Manzoni, C; May, B; Delbo, M; Libourel, G; Michel, P; Ryan, A; Thuillet, F; Marty, B				Lauretta, D. S.; DellaGiustina, D. N.; Bennett, C. A.; Golish, D. R.; Becker, K. J.; Balram-Knutson, S. S.; Barnouin, O. S.; Becker, T. L.; Bottke, W. F.; Boynton, W. V.; Campins, H.; Clark, B. E.; Connolly, H. C., Jr.; d'Aubigny, C. Y. Drouet; Dworkin, J. P.; Emery, J. P.; Enos, H. L.; Hamilton, V. E.; Hergenrother, C. W.; Howell, E. S.; Izawa, M. R. M.; Kaplan, H. H.; Nolan, M. C.; Rizk, B.; Roper, H. L.; Scheeres, D. J.; Smith, P. H.; Walsh, K. J.; Wolner, C. W. V.; Highsmith, D. E.; Small, J.; Vokrouhlicky, D.; Bowles, N. E.; Brown, E.; Hanna, K. L. Donaldson; Warren, T.; Brunet, C.; Chicoine, R. A.; Desjardins, S.; Gaudreau, D.; Haltigin, T.; Millington-Veloza, S.; Rubi, A.; Aponte, J.; Gorius, N.; Lunsford, A.; Allen, B.; Grindlay, J.; Guevel, D.; Hoak, D.; Hong, J.; Schrader, D. L.; Bayron, J.; Golubov, O.; Sanchez, P.; Stromberg, J.; Hirabayashi, M.; Hartzell, C. M.; Oliver, S.; Rascon, M.; Harch, A.; Joseph, J.; Squyres, S.; Richardson, D.; McGraw, L.; Ghent, R.; Binzel, R. P.; Al Asad, M. M.; Johnson, C. L.; Philpott, L.; Susorney, H. C. M.; Cloutis, E. A.; Hanna, R. D.; Ciceri, F.; Hildebrand, A. R.; Ibrahim, E. -M.; Breitenfeld, L.; Glotch, T.; Rogers, A. D.; Ferrone, S.; Thomas, C. A.; Fernandez, Y.; Chang, W.; Cheuvront, A.; Trang, D.; Tachibana, S.; Yurimoto, H.; Brucato, J. R.; Poggiali, G.; Pajola, M.; Dotto, E.; Epifani, E. Mazzotta; Crombie, M. K.; Lantz, C.; de Leon, J.; Licandro, J.; Rizos Garcia, J. L.; Clemett, S.; Thomas-Keprta, K.; Van Wal, S.; Yoshikawa, M.; Bellerose, J.; Bhaskaran, S.; Boyles, C.; Chesley, S. R.; Elder, C. M.; Farnocchia, D.; Harbison, A.; Kennedy, B.; Knight, A.; Martinez-Vlasoff, N.; Mastrodemos, N.; McElrath, T.; Owen, W.; Park, R.; Rush, B.; Swanson, L.; Takahashi, Y.; Velez, D.; Yetter, K.; Thayer, C.; Adam, C.; Antreasian, P.; Bauman, J.; Bryan, C.; Carcich, B.; Corvin, M.; Geeraert, J.; Hoffman, J.; Leonard, J. M.; Lessac-Chenen, E.; Levine, A.; McAdams, J.; McCarthy, L.; Nelson, D.; Page, B.; Pelgrift, J.; Sahr, E.; Stakkestad, K.; Stanbridge, D.; Wibben, D.; Williams, B.; Williams, K.; Wolff, P.; Hayne, P.; Kubitschek, D.; Barucci, M. A.; Deshapriya, J. D. P.; Fornasier, S.; Fulchignoni, M.; Hasselmann, P.; Merlin, F.; Praet, A.; Bierhaus, E. B.; Billett, O.; Boggs, A.; Buck, B.; Carlson-Kelly, S.; Cerna, J.; Chaffin, K.; Church, E.; Coltrin, M.; Daly, J.; Deguzman, A.; Dubisher, R.; Eckart, D.; Ellis, D.; Falkenstern, P.; Fisher, A.; Fisher, M. E.; Fleming, P.; Fortney, K.; Francis, S.; Freund, S.; Gonzales, S.; Haas, P.; Hasten, A.; Hauf, D.; Hilbert, A.; Howell, D.; Jaen, F.; Jayakody, N.; Jenkins, M.; Johnson, K.; Lefevre, M.; Ma, H.; Mario, C.; Martin, K.; May, C.; Mcgee, M.; Miller, B.; Miller, C.; Miller, G.; Mirfakhrai, A.; Muhle, E.; Norman, C.; Olds, R.; Parish, C.; Ryle, M.; Schmitzer, M.; Sherman, P.; Skeen, M.; Susak, M.; Sutter, B.; Tran, Q.; Welch, C.; Witherspoon, R.; Wood, J.; Zareski, J.; Arvizu-Jakubicki, M.; Asphaug, E.; Audi, E.; Ballouz, R. -L.; Bandrowski, R.; Bendall, S.; Bloomenthal, H.; Blum, D.; Brodbeck, J.; Burke, K. N.; Chojnacki, M.; Colpo, A.; Contreras, J.; Cutts, J.; Dean, D.; Diallo, B.; Drinnon, D.; Drozd, K.; Enos, R.; Fellows, C.; Ferro, T.; Fisher, M. R.; Fitzgibbon, G.; Fitzgibbon, M.; Forelli, J.; Forrester, T.; Galinsky, I.; Garcia, R.; Gardner, A.; Habib, N.; Hamara, D.; Hammond, D.; Hanley, K.; Harshman, K.; Herzog, K.; Hill, D.; Hoekenga, C.; Hooven, S.; Huettner, E.; Janakus, A.; Jones, J.; Kareta, T. R.; Kidd, J.; Kingsbury, K.; Koelbel, L.; Kreiner, J.; Lambert, D.; Lewin, C.; Lovelace, B.; Loveridge, M.; Lujan, M.; Maleszewski, C. K.; Malhotra, R.; Marchese, K.; McDonough, E.; Mogk, N.; Morrison, V.; Morton, E.; Munoz, R.; Nelson, J.; Padilla, J.; Pennington, R.; Polit, A.; Ramos, N.; Reddy, V.; Riehl, M.; Salazar, S.; Schwartz, S. R.; Selznick, S.; Shultz, N.; Stewart, S.; Sutton, S.; Swindle, T.; Tang, Y. H.; Westermann, M.; Worden, D.; Zega, T.; Zeszut, Z.; Bjurstrom, A.; Bloomquist, L.; Dickinson, C.; Keates, E.; Liang, J.; Nifo, V.; Taylor, A.; Teti, F.; Caplinger, M.; Bowles, H.; Carter, S.; Dickenshied, S.; Doerres, D.; Fisher, T.; Hagee, W.; Hill, J.; Miner, M.; Noss, D.; Piacentine, N.; Smith, M.; Toland, A.; Wren, P.; Bernacki, M.; Munoz, D. Pino; Watanabe, S. -I.; Sandford, S. A.; Aqueche, A.; Ashman, B.; Barker, M.; Bartels, A.; Berry, K.; Bos, B.; Burns, R.; Calloway, A.; Carpenter, R.; Castro, N.; Cosentino, R.; Donaldson, J.; Cook, J. Elsila; Emr, C.; Everett, D.; Fennell, D.; Fleshman, K.; Folta, D.; Gallagher, D.; Garvin, J.; Getzandanner, K.; Glavin, D.; Hull, S.; Hyde, K.; Ido, H.; Ingegneri, A.; Jones, N.; Kaotira, P.; Lim, L. F.; Liounis, A.; Lorentson, C.; Lorenz, D.; Lyzhoft, J.; Mazarico, E. M.; Mink, R.; Moore, W.; Moreau, M.; Mullen, S.; Nagy, J.; Neumann, G.; Nuth, J.; Poland, D.; Reuter, D. C.; Rhoads, L.; Rieger, S.; Rowlands, D.; Sallitt, D.; Scroggins, A.; Shaw, G.; Simon, A. A.; Swenson, J.; Vasudeva, P.; Wasser, M.; Zellar, R.; Grossman, J.; Johnston, G.; Morris, M.; Wendel, J.; Burton, A.; Keller, L. P.; McNamara, L.; Messenger, S.; Nakamura-Messenger, K.; Nguyen, A.; Righter, K.; Queen, E.; Bellamy, K.; Dill, K.; Gardner, S.; Giuntini, M.; Key, B.; Kissell, J.; Patterson, D.; Vaughan, D.; Wright, B.; Gaskell, R. W.; Le Corre, L.; Li, J. -Y.; Molaro, J. L.; Palmer, E. E.; Siegler, M. A.; Tricarico, P.; Weirich, J. R.; Zou, X. -D.; Ireland, T.; Tait, K.; Bland, P.; Anwar, S.; Bojorquez-Murphy, N.; Christensen, P. R.; Haberle, C. W.; Mehall, G.; Rios, K.; Franchi, I.; Rozitis, B.; Beddingfield, C. B.; Marshall, J.; Brack, D. N.; French, A. S.; McMahon, J. W.; Jawin, E. R.; Mccoy, T. J.; Russell, S.; Killgore, M.; Bandfield, J. L.; Clark, B. C.; Chodas, M.; Lambert, M.; Masterson, R. A.; Daly, M. G.; Freemantle, J.; Seabrook, J. A.; Craft, K.; Daly, R. T.; Ernst, C.; Espiritu, R. C.; Holdridge, M.; Jones, M.; Nair, A. H.; Nguyen, L.; Peachey, J.; Perry, M. E.; Plescia, J.; Roberts, J. H.; Steele, R.; Turner, R.; Backer, J.; Edmundson, K.; Mapel, J.; Milazzo, M.; Sides, S.; Manzoni, C.; May, B.; Delbo, M.; Libourel, G.; Michel, P.; Ryan, A.; Thuillet, F.; Marty, B.		OSIRIS-REx Team	The unexpected surface of asteroid (101955) Bennu	NATURE			English	Article							LIGHTCURVE; REGOLITH; ORIGIN	NASA'S Origins, Spectral Interpretation, Resource Identification and Security-Regolith Explorer (OSIRIS-REx) spacecraft recently arrived at the near-Earth asteroid (101955) Bennu, a primitive body that represents the objects that may have brought prebiotic molecules and volatiles such as water to Earth(1). Bennu is a lowalbedo B-type asteroid(2) that has been linked to organic-rich hydrated carbonaceous chondrites(3). Such meteorites are altered by ejection from their parent body and contaminated by atmospheric entry and terrestrial microbes. Therefore, the primary mission objective is to return a sample of Bennu to Earth that is pristine-that is, not affected by these processes(4). The OSIRIS-REx spacecraft carries a sophisticated suite of instruments to characterize Bennu's global properties, support the selection of a sampling site and document that site at a sub-centimetre scale(5-11). Here we consider early OSIRIS-REx observations of Bennu to understand how the asteroid's properties compare to pre-encounter expectations and to assess the prospects for sample return. The bulk composition of Bennu appears to be hydrated and volatile-rich, as expected. However, in contrast to pre-encounter modelling of Bennu's thermal inertia(12) and radar polarization ratios(13)-which indicated a generally smooth surface covered by centimetre-scale particles-resolved imaging reveals an unexpected surficial diversity. The albedo, texture, particle size and roughness are beyond the spacecraft design specifications. On the basis of our pre-encounter knowledge, we developed a sampling strategy to target 50-metre-diameter patches of loose regolith with grain sizes smaller than two centimetres(4). We observe only a small number of apparently hazard-free regions, of the order of 5 to 20 metres in extent, the sampling of which poses a substantial challenge to mission success.	[Lauretta, D. S.; DellaGiustina, D. N.; Bennett, C. A.; Golish, D. R.; Becker, K. J.; Balram-Knutson, S. S.; Becker, T. L.; Boynton, W. V.; d'Aubigny, C. Y. Drouet; Enos, H. L.; Hergenrother, C. W.; Howell, E. S.; Nolan, M. C.; Rizk, B.; Roper, H. L.; Smith, P. H.; Wolner, C. W. V.; Arvizu-Jakubicki, M.; Asphaug, E.; Audi, E.; Ballouz, R. -L.; Bandrowski, R.; Bendall, S.; Bloomenthal, H.; Blum, D.; Brodbeck, J.; Burke, K. N.; Chojnacki, M.; Colpo, A.; Contreras, J.; Cutts, J.; Dean, D.; Diallo, B.; Drinnon, D.; Drozd, K.; Enos, R.; Fellows, C.; Ferro, T.; Fisher, M. R.; Fitzgibbon, G.; Fitzgibbon, M.; Forelli, J.; Forrester, T.; Galinsky, I.; Garcia, R.; Gardner, A.; Habib, N.; Hamara, D.; Hammond, D.; Hanley, K.; Harshman, K.; Herzog, K.; Hill, D.; Hoekenga, C.; Hooven, S.; Huettner, E.; Janakus, A.; Jones, J.; Kareta, T. R.; Kidd, J.; Kingsbury, K.; Koelbel, L.; Kreiner, J.; Lambert, D.; Lewin, C.; Lovelace, B.; Loveridge, M.; Lujan, M.; Maleszewski, C. K.; Malhotra, R.; Marchese, K.; McDonough, E.; Mogk, N.; Morrison, V.; Morton, E.; Munoz, R.; Nelson, J.; Padilla, J.; Pennington, R.; Polit, A.; Ramos, N.; Reddy, V.; Riehl, M.; Salazar, S.; Schwartz, S. R.; Selznick, S.; Shultz, N.; Stewart, S.; Sutton, S.; Swindle, T.; Tang, Y. H.; Westermann, M.; Worden, D.; Zega, T.; Zeszut, Z.] Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; [Barnouin, O. S.; Craft, K.; Daly, R. T.; Ernst, C.; Espiritu, R. C.; Holdridge, M.; Jones, M.; Nair, A. H.; Nguyen, L.; Peachey, J.; Perry, M. E.; Plescia, J.; Roberts, J. H.; Steele, R.; Turner, R.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD USA; [Bottke, W. F.; Hamilton, V. E.; Kaplan, H. H.; Walsh, K. J.] Southwest Res Inst, Boulder, CO USA; [Campins, H.; Fernandez, Y.] Univ Cent Florida, Dept Phys, Orlando, FL USA; [Clark, B. E.; Ferrone, S.] Ithaca Coll, Dept Phys & Astron, Ithaca, NY 14850 USA; [Connolly, H. C., Jr.] Rowan Univ, Dept Geol, Glassboro, NJ USA; [Dworkin, J. P.; Aqueche, A.; Ashman, B.; Barker, M.; Bartels, A.; Berry, K.; Bos, B.; Burns, R.; Calloway, A.; Carpenter, R.; Castro, N.; Cosentino, R.; Donaldson, J.; Cook, J. Elsila; Emr, C.; Everett, D.; Fennell, D.; Fleshman, K.; Folta, D.; Gallagher, D.; Garvin, J.; Getzandanner, K.; Glavin, D.; Hull, S.; Hyde, K.; Ido, H.; Ingegneri, A.; Jones, N.; Kaotira, P.; Lim, L. F.; Liounis, A.; Lorentson, C.; Lorenz, D.; Lyzhoft, J.; Mazarico, E. M.; Mink, R.; Moore, W.; Moreau, M.; Mullen, S.; Nagy, J.; Neumann, G.; Nuth, J.; Poland, D.; Reuter, D. C.; Rhoads, L.; Rieger, S.; Rowlands, D.; Sallitt, D.; Scroggins, A.; Shaw, G.; Simon, A. A.; Swenson, J.; Vasudeva, P.; Wasser, M.; Zellar, R.] NASA, Goddard Space Flight Ctr, Greenbelt, MD USA; [Emery, J. P.; McGraw, L.] Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN USA; [Izawa, M. R. M.] Okayama Univ Misasa, Inst Planetary Mat, Misasa, Tottori, Japan; [Scheeres, D. J.; Brack, D. N.; French, A. S.; McMahon, J. W.] Univ Colorado, Smead Dept Aerosp Engn, Boulder, CO 80309 USA; [Highsmith, D. E.; Small, J.] Aerosp Corp, Chantilly, VA USA; [Vokrouhlicky, D.] Charles Univ Prague, Astron Inst, Prague, Czech Republic; [Bowles, N. E.; Brown, E.; Hanna, K. L. Donaldson; Warren, T.] Univ Oxford, Atmospher Ocean & Planetary Phys, Oxford, England; [Brunet, C.; Chicoine, R. A.; Desjardins, S.; Gaudreau, D.; Haltigin, T.; Millington-Veloza, S.; Rubi, A.] Canadian Space Agcy, St Hubert, PQ, Canada; [Aponte, J.; Gorius, N.; Lunsford, A.] Catholic Univ Amer, Washington, DC 20064 USA; [Allen, B.; Grindlay, J.; Guevel, D.; Hoak, D.; Hong, J.] Harvard Univ, Ctr Astrophys, Cambridge, MA 02138 USA; [Schrader, D. L.] Arizona State Univ, Ctr Meteorite Studies, Tempe, AZ USA; [Bayron, J.] CUNY, New York, NY 10021 USA; [Golubov, O.; Sanchez, P.] Univ Colorado, Colorado Ctr Astrodynam Res, Boulder, CO 80309 USA; [Stromberg, J.] CSIRO, Canberra, ACT, Australia; [Hirabayashi, M.] Auburn Univ, Dept Aerosp Engn, Auburn, AL 36849 USA; [Hartzell, C. M.] Univ Maryland, Dept Aerosp Engn, College Pk, MD 20742 USA; [Oliver, S.; Rascon, M.] Univ Arizona, Dept Astron, Tucson, AZ USA; [Oliver, S.; Rascon, M.] Univ Arizona, Steward Observ, Tucson, AZ USA; [Harch, A.; Joseph, J.; Squyres, S.] Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; [Richardson, D.] Univ Maryland, Dept Astron, College Pk, MD 20742 USA; [Ghent, R.] Univ Toronto, Dept Earth Sci, Toronto, ON, Canada; [Binzel, R. P.] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA USA; [Al Asad, M. M.; Johnson, C. L.; Philpott, L.; Susorney, H. C. M.] Univ British Columbia, Dept Earth Ocean & Atmospher Sci, Vancouver, BC, Canada; [Johnson, C. L.; Gaskell, R. W.; Le Corre, L.; Li, J. -Y.; Molaro, J. L.; Palmer, E. E.; Siegler, M. A.; Tricarico, P.; Weirich, J. R.; Zou, X. -D.] Planetary Sci Inst, Tucson, AZ USA; [Cloutis, E. A.] Univ Winnipeg, Dept Geog, Winnipeg, MB, Canada; [Hanna, R. D.] Univ Texas Austin, Dept Geol Sci, Jackson Sch Geosci, Austin, TX USA; [Ciceri, F.; Hildebrand, A. R.; Ibrahim, E. -M.] Univ Calgary, Dept Geosci, Calgary, AB, Canada; [Breitenfeld, L.; Glotch, T.; Rogers, A. D.] SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA; [Thomas, C. A.] No Arizona Univ, Dept Phys, Flagstaff, AZ 86011 USA; [Chang, W.] Edge Space Syst, Greenbelt, MD USA; [Cheuvront, A.] Gen Dynam C4 Syst, Denver, CO USA; [Trang, D.] Univ Hawaii Manoa, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA; [Tachibana, S.; Yurimoto, H.] Hokkaido Univ, Sapporo, Hokkaido, Japan; [Brucato, J. R.; Poggiali, G.] INAF Astrophys Observ Arcetri, Florence, Italy; [Pajola, M.] INAF Osservatorio Astron Padova, Padua, Italy; [Dotto, E.] INAF Osservatorio Astron Roma, Rome, Italy; [Epifani, E. Mazzotta; Crombie, M. K.] Indigo Informat Serv, Tucson, AZ USA; [Lantz, C.] Univ Paris Sud, CNRS, Inst Astrophys Spatiale, Orsay, France; [de Leon, J.; Licandro, J.; Rizos Garcia, J. L.] Univ La Laguna, Inst Astrofis Canarias, Tenerife, Spain; [de Leon, J.; Licandro, J.; Rizos Garcia, J. L.] Univ La Laguna, Dept Astrofis, Tenerife, Spain; [Clemett, S.; Thomas-Keprta, K.] Jacobs Technol, Houston, TX USA; [Van Wal, S.; Yoshikawa, M.; Watanabe, S. -I.] JAXA Inst Space & Astronaut Sci, Sagamihara, Kanagawa, Japan; [Bellerose, J.; Bhaskaran, S.; Boyles, C.; Chesley, S. R.; Elder, C. M.; Farnocchia, D.; Harbison, A.; Kennedy, B.; Knight, A.; Martinez-Vlasoff, N.; Mastrodemos, N.; McElrath, T.; Owen, W.; Park, R.; Rush, B.; Swanson, L.; Takahashi, Y.; Velez, D.; Yetter, K.] CALTECH, Jet Prop Lab, Pasadena, CA USA; [Thayer, C.] MIT, Kavli Inst Astrophys & Space Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Adam, C.; Antreasian, P.; Bauman, J.; Bryan, C.; Carcich, B.; Corvin, M.; Geeraert, J.; Hoffman, J.; Leonard, J. M.; Lessac-Chenen, E.; Levine, A.; McAdams, J.; McCarthy, L.; Nelson, D.; Page, B.; Pelgrift, J.; Sahr, E.; Stakkestad, K.; Stanbridge, D.; Wibben, D.; Williams, B.; Williams, K.; Wolff, P.] KinetX Aerosp Inc, Simi Valley, CA USA; [Hayne, P.; Kubitschek, D.] Univ Colorado, Atmospher & Space Phys Lab, Campus Box 392, Boulder, CO 80309 USA; [Barucci, M. A.; Deshapriya, J. D. P.; Fornasier, S.; Fulchignoni, M.; Hasselmann, P.; Merlin, F.; Praet, A.] Univ Paris Diderot, Sorbonne Univ, Sorbonne Paris Cite, LESIA,Observ Paris,Univ PSL,CNRS, Meudon, France; [Bierhaus, E. B.; Billett, O.; Boggs, A.; Buck, B.; Carlson-Kelly, S.; Cerna, J.; Chaffin, K.; Church, E.; Coltrin, M.; Daly, J.; Deguzman, A.; Dubisher, R.; Eckart, D.; Ellis, D.; Falkenstern, P.; Fisher, A.; Fisher, M. E.; Fleming, P.; Fortney, K.; Francis, S.; Freund, S.; Gonzales, S.; Haas, P.; Hasten, A.; Hauf, D.; Hilbert, A.; Howell, D.; Jaen, F.; Jayakody, N.; Jenkins, M.; Johnson, K.; Lefevre, M.; Ma, H.; Mario, C.; Martin, K.; May, C.; Mcgee, M.; Miller, B.; Miller, C.; Miller, G.; Mirfakhrai, A.; Muhle, E.; Norman, C.; Olds, R.; Parish, C.; Ryle, M.; Schmitzer, M.; Sherman, P.; Skeen, M.; Susak, M.; Sutter, B.; Tran, Q.; Welch, C.; Witherspoon, R.; Wood, J.; Zareski, J.] Lockheed Martin Space, Littleton, CO USA; [Bjurstrom, A.; Bloomquist, L.; Dickinson, C.; Keates, E.; Liang, J.; Nifo, V.; Taylor, A.; Teti, F.] Macdonald Dettwiler & Associates Ltd, Brampton, ON, Canada; [Caplinger, M.] Malin Space Sci Syst, San Diego, CA USA; [Bowles, H.; Carter, S.; Dickenshied, S.; Doerres, D.; Fisher, T.; Hagee, W.; Hill, J.; Miner, M.; Noss, D.; Piacentine, N.; Smith, M.; Toland, A.; Wren, P.] Arizona State Univ, Mars Space Flight Facil, Tempe, AZ USA; [Bernacki, M.; Munoz, D. Pino] Mines ParisTech, Paris, France; [Watanabe, S. -I.] Nagoya Univ, Nagoya, Aichi, Japan; [Sandford, S. A.] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Grossman, J.; Johnston, G.; Morris, M.; Wendel, J.] NASA Headquarters, Washington, DC USA; [Burton, A.; Keller, L. P.; McNamara, L.; Messenger, S.; Nakamura-Messenger, K.; Nguyen, A.; Righter, K.] NASA, Johnson Space Ctr, Houston, TX USA; [Queen, E.] NASA, Langley Res Ctr, Hampton, VA 23665 USA; [Bellamy, K.; Dill, K.; Gardner, S.; Giuntini, M.; Key, B.; Kissell, J.; Patterson, D.; Vaughan, D.; Wright, B.] NASA, Marshall Space Flight Ctr, Huntsville, AL USA; [Ireland, T.] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT, Australia; [Tait, K.] Royal Ontario Museum, Toronto, ON, Canada; [Bland, P.] Curtin Univ, Sch Earth & Planetary Sci, Perth, WA, Australia; [Anwar, S.; Bojorquez-Murphy, N.; Christensen, P. R.; Haberle, C. W.; Mehall, G.; Rios, K.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ USA; [Franchi, I.; Rozitis, B.] Open Univ, Sch Phys Sci, Milton Keynes, Bucks, England; [Beddingfield, C. B.; Marshall, J.] SETI Inst, Mountain View, CA USA; [Jawin, E. R.; Mccoy, T. J.; Russell, S.] Smithsonian Inst, Natl Museum Nat Hist, Washington, DC 20560 USA; [Killgore, M.] Southwest Meteorite Lab, Payson, AZ USA; [Bandfield, J. L.; Clark, B. C.] Space Sci Inst, Boulder, CO USA; [Chodas, M.; Lambert, M.; Masterson, R. A.] MIT, Dept Aeronaut & Astronaut, Space Syst Lab, Cambridge, MA 02139 USA; [Daly, M. G.; Freemantle, J.; Seabrook, J. A.] York Univ, Ctr Res Earth & Space Sci, Toronto, ON, Canada; [Backer, J.; Edmundson, K.; Mapel, J.; Milazzo, M.; Sides, S.] US Geol Survey, Astrogeol Sci Ctr, Flagstaff, AZ 86001 USA; [Manzoni, C.; May, B.] London Stereoscop Co, London, England; [Cheuvront, A.; Delbo, M.; Libourel, G.; Michel, P.; Ryan, A.; Thuillet, F.] Univ Cote Azur, Observ Cote Azur, CNRS, Lab Lagrange, Nice, France; [Marty, B.] Univ Lorraine, Nancy, France	University of Arizona; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Southwest Research Institute; State University System of Florida; University of Central Florida; Rowan University; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Tennessee System; University of Tennessee Knoxville; Okayama University; University of Colorado System; University of Colorado Boulder; Aerospace Corporation - USA; Charles University Prague; University of Oxford; Canadian Space Agency; Catholic University of America; Harvard University; Arizona State University; Arizona State University-Tempe; City University of New York (CUNY) System; University of Colorado System; University of Colorado Boulder; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Auburn University System; Auburn University; University System of Maryland; University of Maryland College Park; University of Arizona; University of Arizona; Cornell University; University System of Maryland; University of Maryland College Park; University of Toronto; Massachusetts Institute of Technology (MIT); University of British Columbia; University of Winnipeg; University of Texas System; University of Texas Austin; University of Calgary; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Northern Arizona University; University of Hawaii System; University of Hawaii Manoa; Hokkaido University; Istituto Nazionale Astrofisica (INAF); Istituto Nazionale Astrofisica (INAF); Istituto Nazionale Astrofisica (INAF); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; Instituto de Astrofisica de Canarias; Universidad de la Laguna; Universidad de la Laguna; Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Massachusetts Institute of Technology (MIT); University of Colorado System; University of Colorado Boulder; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite; Universite Paris Cite; Arizona State University; Arizona State University-Tempe; UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; Nagoya University; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; National Aeronautics & Space Administration (NASA); National Aeronautics & Space Administration (NASA); National Aeronautics & Space Administration (NASA); NASA Langley Research Center; National Aeronautics & Space Administration (NASA); Australian National University; Royal Ontario Museum; Curtin University; Arizona State University; Arizona State University-Tempe; Open University - UK; Smithsonian Institution; Smithsonian National Museum of Natural History; Massachusetts Institute of Technology (MIT); York University - Canada; United States Department of the Interior; United States Geological Survey; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Observatoire de la Cote d'Azur; Universite de Lorraine	Lauretta, DS (corresponding author), Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA.	lauretta@orex.lpl.arizona.edu	de León, Julia/H-7569-2015; Johnson, Catherine L./AAZ-7295-2020; Pajola, Maurizio/N-5574-2018; Hanna, Kerri Donaldson/AAC-9941-2020; Pino Muñoz, Daniel/I-5879-2018; Daly, Michael/AAO-6623-2021; Ireland, Trevor R/A-4993-2008; Dworkin, Jason P./C-9417-2012; Neumann, Gregory A/I-5591-2013; bernacki, marc/O-1811-2019; Licandro, Javier/L-7667-2014; Lim, Lucy F/C-9557-2012; Burton, Aaron/H-2212-2011; Sánchez, Paul/F-9818-2010; Yurimoto, Hisayoshi/S-9938-2018; Elder, Catherine M/AAF-3926-2020; Rizos, Juan Luis/ABH-3584-2020; Molaro, Jamie/AAP-5013-2020; Asphaug, Erik/AAC-9455-2020; Glavin, Daniel P/D-6194-2012; Simon, Amy/C-8020-2012; Barnouin, Olivier S/I-7475-2015; Ireland, Trevor R./GSJ-1884-2022; Golubov, Oleksiy/N-6397-2018; Bland, Phil/M-9392-2018; Nolan, Michael/H-4980-2012	de León, Julia/0000-0002-0696-0411; Pajola, Maurizio/0000-0002-3144-1277; Pino Muñoz, Daniel/0000-0003-3969-6204; Daly, Michael/0000-0002-3733-2530; Ireland, Trevor R/0000-0001-7617-3889; Dworkin, Jason P./0000-0002-3961-8997; Neumann, Gregory A/0000-0003-0644-9944; bernacki, marc/0000-0002-6677-2850; Licandro, Javier/0000-0002-9214-337X; Lim, Lucy F/0000-0002-9696-9654; Burton, Aaron/0000-0002-1194-4336; Sánchez, Paul/0000-0003-3610-5480; Yurimoto, Hisayoshi/0000-0003-0702-0533; Elder, Catherine M/0000-0002-9993-8861; Rizos, Juan Luis/0000-0002-9789-1203; Molaro, Jamie/0000-0002-5867-9410; Glavin, Daniel P/0000-0001-7779-7765; Simon, Amy/0000-0003-4641-6186; Barnouin, Olivier S/0000-0002-3578-7750; Golubov, Oleksiy/0000-0002-2427-9101; Thomas, Cristina/0000-0003-3091-5757; Schwartz, Stephen/0000-0001-5475-9379; Bland, Phil/0000-0002-4681-7898; Antreasian, Peter/0000-0001-9040-310X; Edmundson, Kenneth/0000-0003-3666-0927; Nolan, Michael/0000-0001-8316-0680; DellaGiustina, Daniella/0000-0002-5643-1956; Jawin, Erica/0000-0002-2341-8819; McCoy, Timothy/0000-0002-4573-3553; Steele, Josh/0000-0001-8323-9874; Warren, Tristram/0000-0003-3877-0046; Lantz, Cateline/0000-0003-0974-4770; Hayne, Paul/0000-0003-4399-0449; Susorney, Hannah/0000-0002-1363-792X; Dotto, Elisabetta/0000-0002-9335-1656; Nguyen, Lillian/0000-0002-7893-1943	NASA [NNM10AA11C]	NASA(National Aeronautics & Space Administration (NASA))	This material is based on work supported by NASA under contract NNM10AA11C, issued through the New Frontiers Program.	Barnouin OS, 2019, NAT GEOSCI, V12, P247, DOI 10.1038/s41561-019-0330-x; Bierhaus EB, 2018, SPACE SCI REV, V214, DOI 10.1007/s11214-018-0521-6; Binzel RP, 2015, ICARUS, V256, P22, DOI 10.1016/j.icarus.2015.04.011; Bischoff A., 2006, METEORITES EARLY SOL, P679; Brearley A.J., 2006, METEORITES EARLY SOL, P587; Campins H, 2018, PRIMITIVE METEORITES AND ASTEROIDS: PHYSICAL, CHEMICAL, AND SPECTROSCOPIC OBSERVATIONS PAVING THE WAY TO EXPLORATION, P345, DOI 10.1016/B978-0-12-813325-5.00005-7; Christensen PR, 2018, SPACE SCI REV, V214, DOI 10.1007/s11214-018-0513-6; Clark BE, 2011, ICARUS, V216, P462, DOI 10.1016/j.icarus.2011.08.021; Daly MG, 2017, SPACE SCI REV, V212, P899, DOI 10.1007/s11214-017-0375-3; Delbo M, 2014, NATURE, V508, P233, DOI 10.1038/nature13153; DellaGiustina DN, 2019, NAT ASTRON, V3, P341, DOI 10.1038/s41550-019-0731-1; DellaGiustina DN, 2018, EARTH SPACE SCI, V5, P929, DOI 10.1029/2018EA000382; Emery JP, 2014, ICARUS, V234, P17, DOI 10.1016/j.icarus.2014.02.005; Gundlach B, 2013, ICARUS, V223, P479, DOI 10.1016/j.icarus.2012.11.039; Hergenrother CW, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09213-x; Hergenrother C. W., 2014, PREPRINT; Hergenrother CW, 2013, ICARUS, V226, P663, DOI 10.1016/j.icarus.2013.05.044; Izawa MRM, 2019, ICARUS, V319, P525, DOI 10.1016/j.icarus.2018.10.002; KERRIDGE JF, 1979, SCIENCE, V205, P395, DOI 10.1126/science.205.4404.395; Lantz C, 2018, ICARUS, V302, P10, DOI 10.1016/j.icarus.2017.11.010; Lauretta DS, 2017, SPACE SCI REV, V212, P925, DOI 10.1007/s11214-017-0405-1; Lauretta DS, 2015, METEORIT PLANET SCI, V50, P834, DOI 10.1111/maps.12353; Li J. - Y., 2015, ASTEROIDS, P129, DOI DOI 10.1016/J.ICARUS.2017.02.030; Masterson RA, 2018, SPACE SCI REV, V214, DOI 10.1007/s11214-018-0483-8; McMahon JW, 2018, SPACE SCI REV, V214, DOI 10.1007/s11214-018-0480-y; Nolan MC, 2013, ICARUS, V226, P629, DOI 10.1016/j.icarus.2013.05.028; Reuter DC, 2018, SPACE SCI REV, V214, DOI 10.1007/s11214-018-0482-9; Rizk B, 2018, SPACE SCI REV, V214, DOI 10.1007/s11214-017-0460-7; Rubin AE, 2007, GEOCHIM COSMOCHIM AC, V71, P2361, DOI 10.1016/j.gca.2007.02.008; Scheeres DJ, 2019, NAT ASTRON, V3, P352, DOI 10.1038/s41550-019-0721-3; Scheeres DJ, 2016, ICARUS, V276, P116, DOI 10.1016/j.icarus.2016.04.013; Simon A.A., 2019, BENNU NAT ASTRON, DOI [10.1038/s41550- 019-0722-2, DOI 10.1038/S41550-019-0722-2]; Thompson MS, 2019, ICARUS, V319, P499, DOI 10.1016/j.icarus.2018.09.022; Walsh KJ, 2019, NAT GEOSCI, V12, P242, DOI 10.1038/s41561-019-0326-6	34	222	227	10	95	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 4	2019	568	7750					55	+		10.1038/s41586-019-1033-6	http://dx.doi.org/10.1038/s41586-019-1033-6			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR8CZ	30890786	Green Accepted, Green Published			2022-12-28	WOS:000463384900038
J	Zhang, CG; Shang, GJ; Gui, X; Zhang, XW; Bai, XC; Chen, ZJJ				Zhang, Conggang; Shang, Guijun; Gui, Xiang; Zhang, Xuewu; Bai, Xiao-chen; Chen, Zhijian J.			Structural basis of STING binding with and phosphorylation by TBK1	NATURE			English	Article							CYCLIC GMP-AMP; ADAPTER; ACTIVATION; INSIGHTS; PATHWAY; COMPLEX; SYSTEM; SENSOR	The invasion of mammalian cytoplasm by microbial DNA from infectious pathogens or by self DNA from the nucleus or mitochondria represents a danger signal that alerts the host immune system(1). Cyclic GMP-AMP synthase (cGAS) is a sensor of cytoplasmic DNA that activates the type-I interferon pathway(2). On binding to DNA, cGAS is activated to catalyse the synthesis of cyclic GMP-AMP (cGAMP) from GTP and ATP3. cGAMP functions as a second messenger that binds to and activates stimulator of interferon genes (STING)(3-9). STING then recruits and activates tank-binding kinase 1 (TBK1), which phosphorylates STING and the transcription factor IRF3 to induce type-I interferons and other cytokines(10,11). However, how cGAMP-bound STING activates TBK1 and IRF3 is not understood. Here we present the cryo-electron microscopy structure of human TBK1 in complex with cGAMP-bound, full-length chicken STING. The structure reveals that the C-terminal tail of STING adopts a beta-strand-like conformation and inserts into a groove between the kinase domain of one TBK1 subunit and the scaffold and dimerization domain of the second subunit in the TBK1 dimer. In this binding mode, the phosphorylation site Ser366 in the STING tail cannot reach the kinase-domain active site of bound TBK1, which suggests that STING phosphorylation by TBK1 requires the oligomerization of both proteins. Mutational analyses validate the interaction mode between TBK1 and STING and support a model in which high-order oligomerization of STING and TBK1, induced by cGAMP, leads to STING phosphorylation by TBK1.	[Zhang, Conggang; Gui, Xiang; Chen, Zhijian J.] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Shang, Guijun; Zhang, Xuewu] Univ Texas Southwestern Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Zhang, Xuewu; Bai, Xiao-chen] Univ Texas Southwestern Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA; [Bai, Xiao-chen] Univ Texas Southwestern Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Chen, Zhijian J.] Univ Texas Southwestern Med Ctr Dallas, Ctr Inflammat Res, Dallas, TX 75390 USA; [Chen, Zhijian J.] Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Chen, ZJJ (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.; Zhang, XW (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA.; Zhang, XW; Bai, XC (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA.; Bai, XC (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA.; Chen, ZJJ (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Ctr Inflammat Res, Dallas, TX 75390 USA.; Chen, ZJJ (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA.	Xuewu.Zhang@UTSouthwestern.edu; Xiaochen.Bai@UTSouthwestern.edu; Zhijian.Chen@UTSouthwestern.edu	Bai, Xiao-chen/HGV-1244-2022; Chen, Zhijian/C-6039-2012; , tanglang/AAD-3372-2020	Bai, Xiao-chen/0000-0002-4234-5686; Chen, Zhijian/0000-0002-8475-8251; 	Cancer Prevention and Research Institute of Texas (CPRIT) Core Facility Support Award [RP170644]; Howard Hughes Medical Institute; National Institutes of Health [GM088197, R35GM130289]; Welch foundation [I-1389, I-1702, I-1944]; CPRIT [RP150498, RP160082]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM130289] Funding Source: NIH RePORTER	Cancer Prevention and Research Institute of Texas (CPRIT) Core Facility Support Award; Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch foundation(The Welch Foundation); CPRIT; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Yu and R. Hibbs for sharing instruments and reagents, and X. Tan for contributing to the analysis of some STING mutants. Cryo-EM data were collected at the University of Texas Southwestern Medical Center (UTSW) Cryo-Electron Microscopy Facility, which is funded by the Cancer Prevention and Research Institute of Texas (CPRIT) Core Facility Support Award RP170644. We thank D. Nicastro for facility access and data acquisition. This work is supported in part by the Howard Hughes Medical Institute (Z.J.C.), grants from the National Institutes of Health (GM088197 and R35GM130289 to X.Z), grants from the Welch foundation (I-1389 to Z.J.C.; I-1702 to X.Z; I-1944 to X.-c.B) and grants from CPRIT (RP150498 to Z.J.C.; RP160082 to X.-c.B.). X-c.B. and X.Z. are Virginia Murchison Linthicum Scholars in Medical Research at UTSW. Z.J.C. is an investigator of the Howard Hughes Medical Institute.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bai XC, 2015, ELIFE, V4, DOI 10.7554/eLife.11182; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Cai X, 2014, MOL CELL, V54, P289, DOI 10.1016/j.molcel.2014.03.040; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Jin L, 2008, MOL CELL BIOL, V28, P5014, DOI 10.1128/MCB.00640-08; Larabi A, 2013, CELL REP, V3, P734, DOI 10.1016/j.celrep.2013.01.034; Li T, 2018, J EXP MED, V215, P1287, DOI 10.1084/jem.20180139; Liu HQ, 2015, J STRUCT BIOL, V192, P14, DOI 10.1016/j.jsb.2015.09.001; Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630; Lu DF, 2014, MOL MICROBIOL, V92, P1092, DOI 10.1111/mmi.12616; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Shang GJ, 2019, NATURE, V567, P389, DOI 10.1038/s41586-019-0998-5; Shu C, 2013, STRUCTURE, V21, P1137, DOI 10.1016/j.str.2013.04.025; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Tu DQ, 2013, CELL REP, V3, P747, DOI 10.1016/j.celrep.2013.01.033; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Zhang X, 2013, MOL CELL, V51, P226, DOI 10.1016/j.molcel.2013.05.022; Zhao BY, 2016, P NATL ACAD SCI USA, V113, pE3403, DOI 10.1073/pnas.1603269113; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003	26	277	289	23	207	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 21	2019	567	7748					394	+		10.1038/s41586-019-1000-2	http://dx.doi.org/10.1038/s41586-019-1000-2			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP9JT	30842653	Green Accepted			2022-12-28	WOS:000462010000056
J	Shepherd, A				Shepherd, Alison			THE BIG PICTURE Crisis in Venezuela	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Grillet ME, 2019, LANCET INFECT DIS, DOI 10.1016/S1473-3099(18)30757-6.30799251	1	2	2	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 20	2019	364								l1277	10.1136/bmj.l1277	http://dx.doi.org/10.1136/bmj.l1277			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HQ8AJ	30894338				2022-12-28	WOS:000462645500010
J	Kumbhare, D				Kumbhare, Dinesh			An exercise intervention during acute hospitalization improved function and cognition at discharge in older adults	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Kumbhare, Dinesh] Univ Toronto, Toronto, ON, Canada	University of Toronto	Kumbhare, D (corresponding author), Univ Toronto, Toronto, ON, Canada.		Izquierdo, Mikel/O-8049-2019; Izquierdo, Mikel/A-4894-2010	Izquierdo, Mikel/0000-0002-1506-4272; Kumbhare, Dinesh/0000-0003-3889-7557					0	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 19	2019	170	6					JC33	JC33		10.7326/ACPJ201903190-033	http://dx.doi.org/10.7326/ACPJ201903190-033			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP1ZR	30884503				2022-12-28	WOS:000461468300010
J	Chakarov, S; Lim, HY; Tan, L; Lim, SY; See, P; Lum, J; Zhang, XM; Foo, S; Nakamizo, S; Duan, K; Kong, WT; Gentek, R; Balachander, A; Carbajo, D; Bleriot, C; Malleret, B; Tam, JKC; Baig, S; Shabeer, M; Toh, SAES; Schlitzer, A; Larbi, A; Marichal, T; Malissen, B; Chen, JM; Poidinger, M; Kabashima, K; Bajenoff, M; Ng, LG; Angeli, V; Ginhoux, F				Chakarov, Svetoslav; Lim, Hwee Ying; Tan, Leonard; Lim, Sheau Yng; See, Peter; Lum, Josephine; Zhang, Xiao-Meng; Foo, Shihui; Nakamizo, Satoshi; Duan, Kaibo; Kong, Wan Ting; Gentek, Rebecca; Balachander, Akhila; Carbajo, Daniel; Bleriot, Camille; Malleret, Benoit; Tam, John Kit Chung; Baig, Sonia; Shabeer, Muhammad; Toh, Sue-Anne Ee Shiow; Schlitzer, Andreas; Larbi, Anis; Marichal, Thomas; Malissen, Bernard; Chen, Jinmiao; Poidinger, Michael; Kabashima, Kenji; Bajenoff, Marc; Ng, Lai Guan; Angeli, Veronique; Ginhoux, Florent			Two distinct interstitial macrophage populations coexist across tissues in specific subtissular niches	SCIENCE			English	Article							RESIDENT CARDIAC MACROPHAGES; INDUCED PULMONARY-FIBROSIS; DENDRITIC CELLS; FETAL MONOCYTES; LYVE-1-POSITIVE MACROPHAGES; EXPRESSION; IDENTIFICATION; RECEPTOR; REVEALS; FATE	Macrophages are a heterogeneous cell population involved in tissue homeostasis, inflammation, and various pathologies. Although the major tissue-resident macrophage populations have been extensively studied, interstitial macrophages (IMs) residing within the tissue parenchyma remain poorly defined. Here we studied IMs from murine lung, fat, heart, and dermis. We identified two independent IM subpopulations that are conserved across tissues: Lyve1(lo)MHCII(hi)CX3CR1(hi) (Lyve1(lo)MHCII(hi)) and Lyve1(hi)MHCII(lo)CX3CR1(lo) (Lyve1(hi)MHCII(lo)) monocyte-derived IMs, with distinct gene expression profiles, phenotypes, functions, and localizations. Using a new mouse model of inducible macrophage depletion (Slco2b1(flox/DTR)), we found that the absence of Lyve1(hi)MHCII(lo) IMs exacerbated experimental lung fibrosis. Thus, we demonstrate that two independent populations of IMs coexist across tissues and exhibit conserved niche-dependent functional programming.	[Chakarov, Svetoslav; Tan, Leonard; See, Peter; Lum, Josephine; Zhang, Xiao-Meng; Foo, Shihui; Nakamizo, Satoshi; Duan, Kaibo; Kong, Wan Ting; Balachander, Akhila; Carbajo, Daniel; Bleriot, Camille; Malleret, Benoit; Larbi, Anis; Chen, Jinmiao; Poidinger, Michael; Kabashima, Kenji; Ng, Lai Guan; Ginhoux, Florent] ASTAR, Singapore Immunol Network SIgN, 8A Biomed Grove,Immunos Bldg,Level 3, Singapore 138648, Singapore; [Lim, Hwee Ying; Lim, Sheau Yng; Malleret, Benoit; Angeli, Veronique] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol & Immunol, Singapore 119228, Singapore; [Gentek, Rebecca; Malissen, Bernard; Bajenoff, Marc] Aix Marseille Univ, Ctr Immunol Marseille Luminy, INSERM, CNRS, F-13288 Marseille, France; [Tam, John Kit Chung] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Surg, 1E Kent Ridge Rd, Singapore 119228, Singapore; [Baig, Sonia; Shabeer, Muhammad; Toh, Sue-Anne Ee Shiow] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 119228, Singapore; [Schlitzer, Andreas] Univ Bonn, Myeloid Cell Biol Life & Med Sci Inst, D-53115 Bonn, Germany; [Marichal, Thomas] Univ Liege, Lab Cellular & Mol Immunol, GIGA Res, B-4000 Liege, Belgium; [Marichal, Thomas] Univ Liege, Fac Vet Med, B-4000 Liege, Belgium; [Marichal, Thomas] Walloon Excellence Life Sci & Biotechnol, WELBIO, B-1300 Wallonia, Belgium; [Malissen, Bernard] Aix Marseille Univ, Ctr Immunophenom, INSERM, CNRS UMR, F-13288 Marseille, France; [Kabashima, Kenji] Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto 6068507, Japan	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); National University of Singapore; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; National University of Singapore; National University of Singapore; University of Bonn; University of Liege; University of Liege; WELBIO; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Kyoto University	Ginhoux, F (corresponding author), ASTAR, Singapore Immunol Network SIgN, 8A Biomed Grove,Immunos Bldg,Level 3, Singapore 138648, Singapore.	florent_ginhoux@immunol.a-star.edu.sg	Malleret, Benoit/E-9159-2011; Tan, Leonard/GXG-9931-2022; Nakamizo, Satoshi/ABH-2121-2021; Larbi, Anis/ABE-5868-2020; Ng, Lai Guan/N-6980-2019; Chakarov, Svetoslav/AAC-9283-2019; Chen, Jinmiao/ABE-5601-2021; Lim, Hwee Ying/Q-1463-2019; Ng, Lai Guan/E-5673-2011; Malissen, Bernard/AAK-4659-2020	Malleret, Benoit/0000-0001-9658-7528; Nakamizo, Satoshi/0000-0001-9332-0369; Ng, Lai Guan/0000-0003-1905-3586; Chakarov, Svetoslav/0000-0002-0665-5417; Lim, Hwee Ying/0000-0003-3991-7855; Ng, Lai Guan/0000-0003-1905-3586; Malissen, Bernard/0000-0003-1340-9342; Gentek, Rebecca/0000-0001-6574-7242; Kong, Wan Ting/0000-0002-9271-841X; See, Peter/0000-0003-4428-7763; Tan, Leonard/0000-0002-6923-1021; BLERIOT, Camille/0000-0002-4298-2888; Poidinger, Michael/0000-0002-1047-2277	BMRC [IAF 311006]; BMRC transition funds [H16/99/b0/011]; EMBO YIP; Singapore Immunology Network core funding; Agency for Science, Technology and Research (A*STAR); Singapore NRF Senior Investigatorship [NRFI2017-02]; AXA Research Fund; NMRC [CBRGnov094]; NRF; Emmy Noether fellowship of the German Research Foundation [SCHL 2116/1-1]; Young Investigator Award of the Biomedical Research Council Singapore	BMRC(Agency for Science Technology & Research (A*STAR)); BMRC transition funds(Agency for Science Technology & Research (A*STAR)); EMBO YIP(European Molecular Biology Organization (EMBO)); Singapore Immunology Network core funding; Agency for Science, Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR)); Singapore NRF Senior Investigatorship(National Research Foundation, Singapore); AXA Research Fund(AXA Research Fund); NMRC(National Medical Research Council, Singapore); NRF; Emmy Noether fellowship of the German Research Foundation(German Research Foundation (DFG)); Young Investigator Award of the Biomedical Research Council Singapore	The CyTOF, bioinformatics, and immunogenomics platforms are part of the SIgN Immunomonitoring platform (supported by a BMRC IAF 311006 grant and BMRC transition funds #H16/99/b0/011). This work was supported by EMBO YIP, Singapore Immunology Network core funding, Agency for Science, Technology and Research (A*STAR), and Singapore NRF Senior Investigatorship (NRFI2017-02) to F.G.; AXA Research Fund (F.G. and B.Mali.); and NMRC (CBRGnov094) and NRF grants to V.A. A.S. is funded by an Emmy Noether fellowship (SCHL 2116/1-1) of the German Research Foundation and a Young Investigator Award of the Biomedical Research Council Singapore.	Abtin A, 2014, NAT IMMUNOL, V15, P45, DOI 10.1038/ni.2769; Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789; Barreiro O, 2016, ELIFE, V5, DOI 10.7554/eLife.15251; Bedoret D, 2009, J CLIN INVEST, V119, P3723, DOI 10.1172/JCI39717; Belperio JA, 2004, J IMMUNOL, V173, P4692, DOI 10.4049/jimmunol.173.7.4692; BENJAMIN IJ, 1989, CIRC RES, V65, P657, DOI 10.1161/01.RES.65.3.657; Cho CH, 2007, CIRC RES, V100, pE47, DOI 10.1161/01.RES.0000259564.92792.93; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Dick SA, 2019, NAT IMMUNOL, V20, P29, DOI [10.1038/s41590-019-0363-8, 10.1038/s41590-018-0272-2]; Ensan S, 2016, NAT IMMUNOL, V17, P159, DOI 10.1038/ni.3343; Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Gerhardt H, 2003, CELL TISSUE RES, V314, P15, DOI 10.1007/s00441-003-0745-x; Gibbings SL, 2017, AM J RESP CELL MOL, V57, P66, DOI 10.1165/rcmb.2016-0361OC; Ginhoux F, 2016, IMMUNITY, V44, P439, DOI 10.1016/j.immuni.2016.02.024; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Gottschalk RA, 2010, J EXP MED, V207, P1701, DOI 10.1084/jem.20091999; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Hagimoto N, 1997, AM J RESP CELL MOL, V16, P91, DOI 10.1165/ajrcmb.16.1.8998084; Han XP, 2018, CELL, V172, P1091, DOI 10.1016/j.cell.2018.02.001; Haniffa M, 2012, IMMUNITY, V37, P60, DOI 10.1016/j.immuni.2012.04.012; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Hoeffel G, 2015, IMMUNITY, V42, P665, DOI 10.1016/j.immuni.2015.03.011; Hulsmans M, 2017, CELL, V169, P510, DOI 10.1016/j.cell.2017.03.050; Ishida Y, 2007, AM J PATHOL, V170, P843, DOI 10.2353/ajpath.2007.051213; Jiang XB, 2000, DEVELOPMENT, V127, P1607; Jin X, 2012, J SOFTWARE, V7, P6, DOI DOI 10.1371/J0URNAL.P0NE.0041892; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Koronyo-Hamaoui M, 2009, J NEUROCHEM, V111, P1409, DOI 10.1111/j.1471-4159.2009.06402.x; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lambrechts D, 2018, NAT MED, V24, P1277, DOI 10.1038/s41591-018-0096-5; LAMPUGNANI MG, 1992, J CELL BIOL, V118, P1511, DOI 10.1083/jcb.118.6.1511; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Lee LK, 2016, CELL REP, V17, P2286, DOI 10.1016/j.celrep.2016.10.080; Lim HY, 2018, IMMUNITY, V49, P326, DOI [10.1016/j.immuni.2018.06.008, 10.1016/j.immuni.2018.12.009]; Lim HY, 2013, CELL METAB, V17, P671, DOI 10.1016/j.cmet.2013.04.002; Lim HY, 2009, AM J PATHOL, V175, P1328, DOI 10.2353/ajpath.2009.080963; Looney MR, 2011, NAT METHODS, V8, P91, DOI 10.1038/NMETH.1543; Meredith MM, 2012, J EXP MED, V209, P1153, DOI 10.1084/jem.20112675; Nadal P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035253; Onodera T, 2015, SCI REP-UK, V5, DOI 10.1038/srep16801; Pettitt SJ, 2009, NAT METHODS, V6, P493, DOI 10.1038/nmeth.1342; Pham THM, 2010, J EXP MED, V207, P17, DOI 10.1084/jem.20091619; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/nmeth.2639, 10.1038/NMETH.2639]; Pirzgalska RM, 2017, NAT MED, V23, P1309, DOI 10.1038/nm.4422; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Roth M, 2012, BRIT J PHARMACOL, V165, P1260, DOI 10.1111/j.1476-5381.2011.01724.x; Sabatel C, 2017, IMMUNITY, V46, P457, DOI 10.1016/j.immuni.2017.02.016; Satoh T, 2017, NATURE, V541, P96, DOI 10.1038/nature20611; Satpathy AT, 2012, J EXP MED, V209, P1135, DOI 10.1084/jem.20120030; Schlitzer A, 2015, NAT IMMUNOL, V16, P718, DOI 10.1038/ni.3200; Schlitzer A, 2013, IMMUNITY, V38, P970, DOI 10.1016/j.immuni.2013.04.011; Schneider C, 2014, NAT IMMUNOL, V15, P1026, DOI 10.1038/ni.3005; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Scott CL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10321; Tamai I, 2000, BIOCHEM BIOPH RES CO, V273, P251, DOI 10.1006/bbrc.2000.2922; Tamoutounour S, 2013, IMMUNITY, V39, P925, DOI 10.1016/j.immuni.2013.10.004; van de Laar L, 2016, IMMUNITY, V44, P755, DOI 10.1016/j.immuni.2016.02.017; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; Wolf Y, 2017, NAT IMMUNOL, V18, P665, DOI 10.1038/ni.3746; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Xu HP, 2007, INVEST OPHTH VIS SCI, V48, P2162, DOI 10.1167/iovs.06-0783; Yokoyama T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182072; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001	67	347	352	16	122	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 15	2019	363	6432			SI		1190	+	eaau0964	10.1126/science.aau0964	http://dx.doi.org/10.1126/science.aau0964			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP0BC	30872492				2022-12-28	WOS:000461329000040
J	Haigis, KM; Cichowski, K; Elledge, SJ				Haigis, Kevin M.; Cichowski, Karen; Elledge, Stephen J.			Tissue-specificity in cancer: The rule, not the exception	SCIENCE			English	Editorial Material							INHIBITION		[Haigis, Kevin M.] Beth Israel Deaconess Med Ctr, Canc Res Inst, Boston, MA 02115 USA; [Haigis, Kevin M.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02115 USA; [Haigis, Kevin M.; Cichowski, Karen; Elledge, Stephen J.] Harvard Med Sch, Boston, MA 02115 USA; [Cichowski, Karen; Elledge, Stephen J.] Brigham & Womens Hosp, Dept Med, Div Genet, 75 Francis St, Boston, MA 02115 USA; [Cichowski, Karen; Elledge, Stephen J.] Harvard Med Sch, Ludwig Ctr Harvard, Boston, MA 02215 USA; [Elledge, Stephen J.] Harvard Med Sch, Howard Hughes Med Inst, Dept Genet, Program Virol, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Elledge, SJ (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Elledge, SJ (corresponding author), Brigham & Womens Hosp, Dept Med, Div Genet, 75 Francis St, Boston, MA 02115 USA.; Elledge, SJ (corresponding author), Harvard Med Sch, Ludwig Ctr Harvard, Boston, MA 02215 USA.; Elledge, SJ (corresponding author), Harvard Med Sch, Howard Hughes Med Inst, Dept Genet, Program Virol, Boston, MA 02115 USA.	selledge@genetics.med.harvard.edu		Elledge, Stephen/0000-0001-7923-6283	Cancer Research UK Grand Challenge; Mark Foundation	Cancer Research UK Grand Challenge(Cancer Research UK); Mark Foundation	This work is supported by an award from the Cancer Research UK Grand Challenge and the Mark Foundation to the SPECIFICANCER team.	Chou J, 2010, J CELL PHYSIOL, V222, P42, DOI 10.1002/jcp.21943; Corcoran RB, 2012, CANCER DISCOV, V2, P227, DOI 10.1158/2159-8290.CD-11-0341; Davoli T, 2013, CELL, V155, P948, DOI 10.1016/j.cell.2013.10.011; Elledge SJ, 2002, CANCER CELL, V1, P129, DOI 10.1016/S1535-6108(02)00041-7; Hyman DM, 2018, NATURE, V554, P189, DOI 10.1038/nature25475; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Niederst MJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7377; Prados MD, 2015, NEURO-ONCOLOGY, V17, P1051, DOI 10.1093/neuonc/nov031; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Sack LM, 2018, CELL, V173, P499, DOI 10.1016/j.cell.2018.02.037; Schneider G, 2017, NAT REV CANCER, V17, P239, DOI 10.1038/nrc.2017.5; Wassef M, 2017, J MOL BIOL, V429, P1978, DOI 10.1016/j.jmb.2016.10.012	12	80	83	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 15	2019	363	6432			SI		1150	1151		10.1126/science.aaw3472	http://dx.doi.org/10.1126/science.aaw3472			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HP0BC	30872507				2022-12-28	WOS:000461329000026
J	Gui, X; Yang, H; Li, T; Tan, XJ; Shi, PQ; Li, MH; Du, FH; Chen, ZJJ				Gui, Xiang; Yang, Hui; Li, Tuo; Tan, Xiaojun; Shi, Peiqing; Li, Minghao; Du, Fenghe; Chen, Zhijian J.			Autophagy induction via STING trafficking is a primordial function of the cGAS pathway	NATURE			English	Article							CYCLIC GMP-AMP; SYNTHASE; PROTEIN; ADAPTER; SENSOR; ROLES; MAVS	Cyclic GMP-AMP (cGAMP) synthase (cGAS) detects infections or tissue damage by binding to microbial or self DNA in the cytoplasm(1). Upon binding DNA, cGAS produces cGAMP that binds to and activates the adaptor protein STING, which then activates the kinases IKK and TBK1 to induce interferons and other cytokines(2-6). Here we report that STING also activates autophagy through a mechanism that is independent of TBK1 activation and interferon induction. Upon binding cGAMP, STING translocates to the endoplasmic reticulum-Golgi intermediate compartment (ERGIC) and the Golgi in a process that is dependent on the COP-II complex and ARF GTPases. STING-containing ERGIC serves as a membrane source for LC3 lipidation, which is a key step in autophagosome biogenesis. cGAMP induced LC3 lipidation through a pathway that is dependent on WIPI2 and ATG5 but independent of the ULK and VPS34-beclin kinase complexes. Furthermore, we show that cGAMP-induced autophagy is important for the clearance of DNA and viruses in the cytosol. Interestingly, STING from the sea anemone Nematostella vectensis induces autophagy but not interferons in response to stimulation by cGAMP, which suggests that induction of autophagy is a primordial function of the cGAS-STING pathway.	[Gui, Xiang; Yang, Hui; Li, Tuo; Tan, Xiaojun; Shi, Peiqing; Li, Minghao; Du, Fenghe; Chen, Zhijian J.] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, Ctr Inflammat Res, Dallas, TX 75390 USA; [Du, Fenghe; Chen, Zhijian J.] Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Chen, ZJJ (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, Ctr Inflammat Res, Dallas, TX 75390 USA.; Chen, ZJJ (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA.	Zhijian.Chen@UTSouthwestern.edu	Yang, Hui/ABG-0952-2022; Yang, Hui/AAM-4564-2021; Chen, Zhijian/C-6039-2012; Tan, Xiaojun/N-2142-2017	Yang, Hui/0000-0002-2865-5311; Chen, Zhijian/0000-0002-8475-8251; Li, Minghao/0000-0002-1456-2691; Tan, Xiaojun/0000-0003-3300-2240	Cancer Prevention and Research Institute of Texas [RP120718, RP150498]; Welch Foundation [I-1389]; National Institute of Allergy and Infectious Diseases of the National Institutes of Health [T32AI005284]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI005284] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021685] Funding Source: NIH RePORTER	Cancer Prevention and Research Institute of Texas; Welch Foundation(The Welch Foundation); National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank C. Roy (Yale University) for providing the RavZ expression plasmids, B. Levine (UT Southwestern) for providing tissues from beclin 1-knockout mice, and A. Darehshouri at UT Southwestern Electron Microscopy Core Facility for training in electron microscopy sample preparation and image processing. We are grateful for suggestions and technical supports from Chen Laboratory members, especially L. Sun, Y. Wu and S. Hu. This work was supported by grants from the Cancer Prevention and Research Institute of Texas (RP120718 and RP150498) and the Welch Foundation (I-1389). M.L. was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (T32AI005284). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. T.L. and X.T. are Cancer Research Institute Irvington Postdoctoral Fellows. Z.J.C. is an Investigator of Howard Hughes Medical Institute.	Brandizzi F, 2013, NAT REV MOL CELL BIO, V14, P382, DOI 10.1038/nrm3588; Choy A, 2012, SCIENCE, V338, P1072, DOI 10.1126/science.1227026; Crowl JT, 2017, ANNU REV IMMUNOL, V35, P313, DOI 10.1146/annurev-immunol-051116-052331; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Dooley HC, 2014, MOL CELL, V55, P238, DOI 10.1016/j.molcel.2014.05.021; Gao DX, 2015, P NATL ACAD SCI USA, V112, pE5699, DOI 10.1073/pnas.1516465112; Gao DX, 2013, SCIENCE, V341, P903, DOI 10.1126/science.1240933; Ge L, 2014, CURR OPIN CELL BIOL, V29, P18, DOI 10.1016/j.ceb.2014.02.005; Ge L, 2013, ELIFE, V2, DOI 10.7554/eLife.00947; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Kranzusch PJ, 2015, MOL CELL, V59, P891, DOI 10.1016/j.molcel.2015.07.022; Li XD, 2013, SCIENCE, V341, P1390, DOI 10.1126/science.1244040; Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630; Sauer JD, 2011, INFECT IMMUN, V79, P688, DOI 10.1128/IAI.00999-10; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Tanaka Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002521; Wu JX, 2014, ANNU REV IMMUNOL, V32, P461, DOI 10.1146/annurev-immunol-032713-120156; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Yang H, 2017, P NATL ACAD SCI USA, V114, pE4612, DOI 10.1073/pnas.1705499114; Zhang X, 2013, MOL CELL, V51, P226, DOI 10.1016/j.molcel.2013.05.022; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003	23	371	385	34	224	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 14	2019	567	7747					262	+		10.1038/s41586-019-1006-9	http://dx.doi.org/10.1038/s41586-019-1006-9			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7LD	30842662	Green Accepted			2022-12-28	WOS:000461126600047
J	Stepanek, J; Blue, RS; Parazynski, S				Stepanek, Jan; Blue, Rebecca S.; Parazynski, Scott			Space Medicine in the Era of Civilian Spaceflight	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							LONG-DURATION SPACEFLIGHT; ASTRONAUTS; MICROGRAVITY; BONE; PARTICIPANT; PERFORMANCE; TOLERANCE; EXERCISE; SHIFTS; SPINE		[Stepanek, Jan; Blue, Rebecca S.] Mayo Clin, Aerosp Med & Vestibular Res Lab, Scottsdale, AZ USA; [Parazynski, Scott] Fluid Technol, Houston, TX USA	Mayo Clinic; Mayo Clinic Phoenix	Stepanek, J (corresponding author), Mayo Clin, Aerosp Med Program, 13400 E Shea Blvd, Scottsdale, AZ 85259 USA.	stepanek.jan@mayo.edu		Blue, Rebecca/0000-0003-3564-3324				[Anonymous], 2008, STUD INF CONS SPAC F; [Anonymous], 2006, HUM SPAC FLIGHT REQ; Antonsen EL, 2018, AEROSP MED HUM PERF, V89, P108, DOI 10.3357/AMHP.4959.2018; Antunano MJ, 2001, AVIAT SPACE ENVIR MD, V72, P948; Baisden DL, 2008, AVIAT SPACE ENVIR MD, V79, P629, DOI 10.3357/ASEM.2314.2008; Barger LK, 2014, LANCET NEUROL, V13, P904, DOI 10.1016/S1474-4422(14)70122-X; Basner M, 2014, LANCET NEUROL, V13, P860, DOI 10.1016/S1474-4422(14)70176-0; Blue RS, 2017, AEROSP MED HUM PERF, V88, P641, DOI 10.3357/AMHP.4807.2017; Blue RS, 2014, AVIAT SPACE ENVIR MD, V85, P721, DOI 10.3357/ASEM.3956.2014; Blue RS, 2012, AVIAT SPACE ENVIR MD, V83, P929, DOI 10.3357/ASEM.3351.2012; Bogomolov VV, 2007, AVIAT SPACE ENVIR MD, V78, P1162, DOI 10.3357/ASEM.2175.2007; Buckey JC, 2018, AM J PHYSIOL-REG I, V315, pR496, DOI 10.1152/ajpregu.00086.2018; Center of Excellence for Commercial Space Transportation, 2012, FLIGHT CREW MED STAN; Chang DG, 2016, SPINE, V41, P1917, DOI 10.1097/BRS.0000000000001873; Cohrs RJ, 2008, J MED VIROL, V80, P1116, DOI 10.1002/jmv.21173; Cooke WH, 2000, J APPL PHYSIOL, V89, P1039; Crucian B, 2009, J LEUKOCYTE BIOL, V86, P1017, DOI 10.1189/jlb.0709500; Federal Aviation Administration, 2014, REC PRACT HUM SPAC F; FRITSCH JM, 1992, J APPL PHYSIOL, V73, P664, DOI 10.1152/jappl.1992.73.2.664; Harris BA, 1997, MAYO CLIN PROC, V72, P301, DOI 10.4065/72.4.301; Henry W.L., 1977, BIOMEDICAL RESULTS S, V377, P366; Jennings RT, 2010, AVIAT SPACE ENVIR MD, V81, P597, DOI 10.3357/ASEM.2742.2010; Jennings RT, 2010, AVIAT SPACE ENVIR MD, V81, P136, DOI 10.3357/ASEM.2706.2010; Jennings RT, 2006, AVIAT SPACE ENVIR MD, V77, P475; Jennings RT, 1998, J VESTIBUL RES-EQUIL, V8, P67, DOI 10.1016/S0957-4271(97)00042-6; Kerstman EL, 2012, AVIAT SPACE ENVIR MD, V83, P2, DOI 10.3357/ASEM.2876.2012; Komorowski M, 2016, CURR OPIN ANESTHESIO, V29, P649, DOI 10.1097/ACO.0000000000000390; Lang T, 2004, J BONE MINER RES, V19, P1006, DOI 10.1359/JBMR.040307; Langston SM, 2017, PROCEEDINGS OF 8TH INTERNATIONAL CONFERENCE ON RECENT ADVANCES IN SPACE TECHNOLOGIES (RAST 2017), P489, DOI 10.1109/RAST.2017.8002956; Langston SM, 2016, NEW SPACE, V4, P83, DOI 10.1089/space.2015.0015; LeBlanc A, 2013, OSTEOPOROSIS INT, V24, P2105, DOI 10.1007/s00198-012-2243-z; Lee AG, 2018, EYE, V32, P1164, DOI 10.1038/s41433-018-0070-y; Lee AG, 2017, JAMA OPHTHALMOL, V135, P992, DOI 10.1001/jamaophthalmol.2017.2396; Lee SMC, 2017, EVIDENCE REPORT RISK; Mader TH, 2011, OPHTHALMOLOGY, V118, P2058, DOI 10.1016/j.ophtha.2011.06.021; NASA, 2017, RISK ADV HLTH OUTC D; NASA, 2011, NASASTD3001, V2; National Aeronautics and Space Administration, 2016, NASA SPAC FLIGHT HUM; PARAZYNSKI SE, 1991, J APPL PHYSIOL, V71, P2469, DOI 10.1152/jappl.1991.71.6.2469; PRISK GK, 1995, J APPL PHYSIOL, V79, P1290, DOI 10.1152/jappl.1995.79.4.1290; Prisk GK, 2000, J APPL PHYSIOL, V89, P385, DOI 10.1152/jappl.2000.89.1.385; Rayman RB, 2002, AVIAT SPACE ENVIR MD, V73, P1132; Rayman RB, 2009, AVIAT SPACE ENVIR MD, V80, P824, DOI 10.3357/ASEM.2595.2009; Sides MB, 2005, AVIAT SPACE ENVIR MD, V76, P877; Smith SM, 2012, J BONE MINER RES, V27, P1896, DOI 10.1002/jbmr.1647; Stepaniak PC, 2007, AVIAT SPACE ENVIR MD, V78, pA5; Sugita T, 2016, MED MYCOL, V54, P232, DOI [10.1093/mmy/myv121, 10.109]; Thornton W.E., 1977, BIOMEDICAL RESULTS S, P191; Vanderploeg J, 2011, AVIAT SPACE ENVIR MD, V82, P475, DOI 10.3357/ASEM.3015.2011; Wilson JW, 2007, P NATL ACAD SCI USA, V104, P16299, DOI 10.1073/pnas.0707155104; Zhang LF, 2018, PHYSIOL REV, V98, P59, DOI 10.1152/physrev.00017.2016; Zwart SR, 2017, FASEB J, V31, P3746, DOI 10.1096/fj.201700294; Zwart SR, 2014, AVIAT SPACE ENVIR MD, V85, P897, DOI 10.3357/ASEM.3979.2014	53	41	44	5	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 14	2019	380	11					1053	1060		10.1056/NEJMra1609012	http://dx.doi.org/10.1056/NEJMra1609012			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HO8NL	30865799				2022-12-28	WOS:000461210000009
J	Dyer, O				Dyer, Owen			Canada: tobacco companies must pay C$16bn to Quebec smokers, appeal court rules	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 6	2019	364								l1044	10.1136/bmj.l1044	http://dx.doi.org/10.1136/bmj.l1044			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HO6SU	30842106				2022-12-28	WOS:000461062400010
J	Assady, S; Benzing, T; Kretzler, M; Skorecki, KL				Assady, Suheir; Benzing, Thomas; Kretzler, Matthias; Skorecki, Karl L.			Glomerular podocytes in kidney health and disease	LANCET			English	Editorial Material									[Assady, Suheir; Skorecki, Karl L.] Rambam Hlth Care Campus, Dept Nephrol, Haifa, Israel; [Assady, Suheir; Skorecki, Karl L.] Technion Israel Inst Technol, Rappaport Fac Med, Haifa, Israel; [Benzing, Thomas] Dept II Internal Med, Cologne, Germany; [Benzing, Thomas] Ctr Mol Med Cologne, Cologne, Germany; [Kretzler, Matthias] Dept Internal Med, Appl Syst Biol Core, Div Nephrol, Dept Internal Med, Ann Arbor, MI USA; [Kretzler, Matthias] Univ Michigan, Med Ctr, Ann Arbor, MI USA; [Skorecki, Karl L.] Bar Ilan Univ, Azrieli Fac Med, Safed, Israel	Rambam Health Care Campus; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; University of Cologne; University of Michigan System; University of Michigan; Bar Ilan University	Assady, S (corresponding author), Rambam Hlth Care Campus, Dept Nephrol, Haifa, Israel.; Assady, S (corresponding author), Technion Israel Inst Technol, Rappaport Fac Med, Haifa, Israel.	s_assady@rambam.health.gov.il	Benzing, Thomas/X-5476-2019					Beck LH, 2009, NEW ENGL J MED, V361, P11, DOI 10.1056/NEJMoa0810457; De Vriese AS, 2018, J AM SOC NEPHROL, V29, P759, DOI 10.1681/ASN.2017090958; Freedman BI, 2018, CLIN J AM SOC NEPHRO, V13, P940, DOI 10.2215/CJN.01510218; Friedman DJ, 2017, SEMIN NEPHROL, V37, P508, DOI 10.1016/j.semnephrol.2017.07.003; Groopman EE, 2018, NAT REV NEPHROL, V14, P83, DOI 10.1038/nrneph.2017.167; Hahm E, 2017, NAT MED, V23, P100, DOI 10.1038/nm.4242; Levin Adeera, 2017, Lancet, V390, P1888, DOI 10.1016/S0140-6736(17)30788-2; Mariani LH, 2016, CLIN J AM SOC NEPHRO, V11, P2054, DOI 10.2215/CJN.13651215; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Pullen N, 2016, KIDNEY INT, V89, P1211, DOI 10.1016/j.kint.2015.12.058; Tomas NM, 2014, NEW ENGL J MED, V371, P2277, DOI 10.1056/NEJMoa1409354; Warejko JK, 2018, CLIN J AM SOC NEPHRO, V13, P53, DOI 10.2215/CJN.04120417; Wiggins RC, 2007, KIDNEY INT, V71, P1205, DOI 10.1038/sj.ki.5002222; Zhou Y, 2017, SCIENCE, V358, P1332, DOI 10.1126/science.aal4178	14	13	13	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 2	2019	393	10174					856	858		10.1016/S0140-6736(18)33000-9	http://dx.doi.org/10.1016/S0140-6736(18)33000-9			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HN4AP	30837131				2022-12-28	WOS:000460126900008
J	Popma, JJ; Deeb, GM; Yakubov, SJ; Mumtaz, M; Gada, H; O'Hair, D; Bajwa, T; Heiser, JC; Merhi, W; Kleiman, NS; Askew, J; Sorajja, P; Rovin, J; Chetcuti, SJ; Adams, DH; Teirstein, PS; Zorn, GL; Forrest, JK; Tchetche, D; Resar, J; Walton, A; Piazza, N; Ramlawi, B; Robinson, N; Petrossian, G; Gleason, TG; Oh, JK; Boulware, MJ; Qiao, HY; Mugglin, AS; Reardon, MJ				Popma, Jeffrey J.; Deeb, G. Michael; Yakubov, Steven J.; Mumtaz, Mubashir; Gada, Hemal; O'Hair, Daniel; Bajwa, Tanvir; Heiser, John C.; Merhi, William; Kleiman, Neal S.; Askew, Judah; Sorajja, Paul; Rovin, Joshua; Chetcuti, Stanley J.; Adams, David H.; Teirstein, Paul S.; Zorn, George L., III; Forrest, John K.; Tchetche, Didier; Resar, Jon; Walton, Antony; Piazza, Nicolo; Ramlawi, Basel; Robinson, Newell; Petrossian, George; Gleason, Thomas G.; Oh, Jae K.; Boulware, Michael J.; Qiao, Hongyan; Mugglin, Andrew S.; Reardon, Michael J.		Evolut Low Risk Trial Investigator	Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OUTCOMES; STENOSIS; SOCIETY	BACKGROUND Transcatheter aortic-valve replacement (TAVR) is an alternative to surgery in patients with severe aortic stenosis who are at increased risk for death from surgery; less is known about TAVR in low-risk patients. METHODS We performed a randomized noninferiority trial in which TAVR with a self-expanding supraannular bioprosthesis was compared with surgical aortic-valve replacement in patients who had severe aortic stenosis and were at low surgical risk. When 850 patients had reached 12-month follow-up, we analyzed data regarding the primary end point, a composite of death or disabling stroke at 24 months, using Bayesian methods. RESULTS Of the 1468 patients who underwent randomization, an attempted TAVR or surgical procedure was performed in 1403. The patients' mean age was 74 years. The 24-month estimated incidence of the primary end point was 5.3% in the TAVR group and 6.7% in the surgery group (difference, -1.4 percentage points; 95% Bayesian credible interval for difference, -4.9 to 2.1; posterior probability of noninferiority >0.999). At 30 days, patients who had undergone TAVR, as compared with surgery, had a lower incidence of disabling stroke (0.5% vs. 1.7%), bleeding complications (2.4% vs. 7.5%), acute kidney injury (0.9% vs. 2.8%), and atrial fibrillation (7.7% vs. 35.4%) and a higher incidence of moderate or severe aortic regurgitation (3.5% vs. 0.5%) and pacemaker implantation (17.4% vs. 6.1%). At 12 months, patients in the TAVR group had lower aortic-valve gradients than those in the surgery group (8.6 mm Hg vs. 11.2 mm Hg) and larger effective orifice areas (2.3 cm(2) vs. 2.0 cm(2)). CONCLUSIONS In patients with severe aortic stenosis who were at low surgical risk, TAVR with a self-expanding supraannular bioprosthesis was noninferior to surgery with respect to the composite end point of death or disabling stroke at 24 months.	[Popma, Jeffrey J.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Deeb, G. Michael; Chetcuti, Stanley J.] Univ Michigan Hosp, Ann Arbor, MI 48109 USA; [Heiser, John C.; Merhi, William] Spectrum Hlth Hosp, Grand Rapids, MI USA; [Yakubov, Steven J.] Riverside Methodist Ohio Hlth, Columbus, OH USA; [Mumtaz, Mubashir; Gada, Hemal] Univ Pittsburgh, Med Ctr Pinnacle Hlth, Harrisburg, PA USA; [Gleason, Thomas G.] Univ Pittsburgh, Pittsburgh, PA USA; [O'Hair, Daniel; Bajwa, Tanvir] Aurora St Lukes Med Ctr, Milwaukee, WI USA; [Kleiman, Neal S.; Reardon, Michael J.] Houston Methodist Debakey Heart & Vasc Ctr, Houston, TX USA; [Askew, Judah; Sorajja, Paul] Abbott NW Hosp, Minneapolis, MN 55407 USA; [Boulware, Michael J.; Qiao, Hongyan] Medtronic, Minneapolis, MN USA; [Oh, Jae K.] Mayo Clin, Rochester, MN USA; [Mugglin, Andrew S.] Paradigm Biostat, Anoka, MN USA; [Rovin, Joshua] Morton Plant Hosp, Clearwater, FL USA; [Adams, David H.] Mt Sinai Hlth Syst, New York, NY USA; [Robinson, Newell; Petrossian, George] St Francis Hosp, Roslyn, NY USA; [Teirstein, Paul S.] Scripps Res Inst, La Jolla, CA USA; [Zorn, George L., III] Univ Kansas Hosp, Kansas City, KS USA; [Forrest, John K.] Yale New Haven Med Ctr, 20 York St, New Haven, CT 06504 USA; [Tchetche, Didier] Clin Pasteur, Toulouse, France; [Resar, Jon] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA; [Walton, Antony] Alfred Hosp, Melbourne, Vic, Australia; [Piazza, Nicolo] McGill Univ, Hlth Ctr, Montreal, PQ, Canada; [Ramlawi, Basel] Winchester Med Ctr, Winchester, VA USA	Harvard University; Beth Israel Deaconess Medical Center; University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; The Methodist Hospital System; The Methodist Hospital - Houston; Methodist DeBakey Heart & Vascular Center; Medtronic; Mayo Clinic; Icahn School of Medicine at Mount Sinai; Scripps Research Institute; University of Kansas; University of Kansas Medical Center; Yale University; Johns Hopkins University; Johns Hopkins Medicine; Florey Institute of Neuroscience & Mental Health; McGill University	Popma, JJ (corresponding author), Beth Israel Deaconess Med Ctr, Intervent Cardiol, 185 Pilgrim Rd, Boston, MA 02215 USA.	jpopma@bidmc.harvard.edu	Doğan, Ali/AAN-5331-2020; Reardon, Michael/ABF-8880-2021; Coisne, Augustin/R-6567-2018	Saji, Mike/0000-0003-2057-109X; Sanon, Saurabh/0000-0002-7600-4388; Gheorghe, Livia Luciana/0000-0001-8291-6095; DEO, SALIL/0000-0002-4729-1461; Mattace-Raso, Francesco/0000-0002-1688-6497; Samad, Zainab/0000-0003-2422-3199; Coisne, Augustin/0000-0002-1662-7874; Jansz, Paul/0000-0002-4721-5549; Berthoumieu, Pierre/0000-0003-1041-2992	Medtronic	Medtronic(Medtronic)	Funded by Medtronic; ClinicalTrials.gov number, NCT02701283.	Adams DH, 2014, NEW ENGL J MED, V370, P1790, DOI 10.1056/NEJMoa1400590; [Anonymous], 2019, CIRCULATION; Baumgartner H, 2017, EUR HEART J, V38, P2739, DOI 10.1093/eurheartj/ehx391; D'Agostino RS, 2019, ANN THORAC SURG, V107, P24, DOI 10.1016/j.athoracsur.2018.10.004; Gleason TG, 2018, J AM COLL CARDIOL, V72, P2687, DOI 10.1016/j.jacc.2018.08.2146; Gleason TG, 2016, J THORAC CARDIOV SUR, V152, P85, DOI 10.1016/j.jtcvs.2016.02.073; Green CP, 2000, J AM COLL CARDIOL, V35, P1245, DOI 10.1016/S0735-1097(00)00531-3; Grover FL, 2017, ANN THORAC SURG, V103, P1021, DOI 10.1016/j.athoracsur.2016.12.001; Hahn RT, 2019, JACC-CARDIOVASC IMAG, V12, P25, DOI 10.1016/j.jcmg.2018.04.010; Head SJ, 2012, EUR HEART J, V33, P1518, DOI 10.1093/eurheartj/ehs003; Herrmann HC, 2018, J AM COLL CARDIOL, V72, P2701, DOI 10.1016/j.jacc.2018.09.001; Kleiman NS, 2016, CIRC-CARDIOVASC INTE, V9, DOI 10.1161/CIRCINTERVENTIONS.115.003551; Little SH, 2016, CIRC-CARDIOVASC INTE, V9, DOI 10.1161/CIRCINTERVENTIONS.115.003426; Nishimura RA, 2017, CIRCULATION, V135, pE1159, DOI 10.1161/CIR.0000000000000503; Popma JJ, 2014, J AM COLL CARDIOL, V63, P1972, DOI 10.1016/j.jacc.2014.02.556; Reardon MJ, 2017, NEW ENGL J MED, V376, P1321, DOI 10.1056/NEJMoa1700456; Reardon MJ, 2016, JAMA CARDIOL, V1, P945, DOI 10.1001/jamacardio.2016.2257; Reardon MJ, 2015, J AM COLL CARDIOL, V66, P113, DOI 10.1016/j.jacc.2015.05.017; Sondergaard L, 2016, CIRC-CARDIOVASC INTE, V9, DOI 10.1161/CIRCINTERVENTIONS.115.003665; Spertus J, 2005, AM HEART J, V150, P707, DOI 10.1016/j.ahj.2004.12.010; Thyregod HGH, 2015, J AM COLL CARDIOL, V65, P2184, DOI 10.1016/j.jacc.2015.03.014	21	1661	1714	9	47	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 2	2019	380	18					1706	1715		10.1056/NEJMoa1816885	http://dx.doi.org/10.1056/NEJMoa1816885			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HX9ZK	30883053	Bronze			2022-12-28	WOS:000467767800006
J	Byrd, JB; Chertow, GM; Bhalla, V				Byrd, J. Brian; Chertow, Glenn M.; Bhalla, Vivek			Hypertension Hot Potato - Anatomy of the Angiotensin-Receptor Blocker Recalls	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A spate of recalls of angiotensin-receptor blockers highlights several issues related to the readiness of our health systems to respond to drug recalls, trust between patients and providers, uncertain drug-dose equivalences, and the regulation of drug manufacturing in the global marketplace.	[Byrd, J. Brian] Univ Michigan, Div Cardiovasc Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Byrd, J. Brian] Univ Michigan, Hypertens Ctr, Ann Arbor, MI 48109 USA; [Chertow, Glenn M.; Bhalla, Vivek] Stanford Univ, Sch Med, Div Nephrol, Dept Med, Stanford, CA 94305 USA; [Chertow, Glenn M.; Bhalla, Vivek] Stanford Univ, Sch Med, Stanford Hypertens Ctr, Stanford, CA 94305 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Stanford University; Stanford University	Byrd, JB (corresponding author), Univ Michigan, Div Cardiovasc Med, Dept Internal Med, Ann Arbor, MI 48109 USA.; Byrd, JB (corresponding author), Univ Michigan, Hypertens Ctr, Ann Arbor, MI 48109 USA.		Byrd, James Brian/H-6674-2019	Byrd, James Brian/0000-0002-0509-3520; Bhalla, Vivek/0000-0002-5420-9657; Chertow, Glenn/0000-0002-7599-0534	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL128909] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Loftus P., 2019, WALL STREET J; Muntner P, 2018, J AM COLL CARDIOL, V71, P109, DOI 10.1016/j.jacc.2017.10.073; [No title captured]; [No title captured]	4	22	24	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 25	2019	380	17					1589	1591		10.1056/NEJMp1901657	http://dx.doi.org/10.1056/NEJMp1901657			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HU9FC	30865819	Green Accepted, Bronze			2022-12-28	WOS:000465598600004
J	Sanders, GD; Maciejewski, ML; Basu, A				Sanders, Gillian D.; Maciejewski, Matthew L.; Basu, Anirban			Overview of Cost-effectiveness Analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							UK COLLABORATIVE TRIAL		[Sanders, Gillian D.; Maciejewski, Matthew L.] Duke Univ, Sch Med, Dept Populat Hlth Sci, Durham, NC USA; [Sanders, Gillian D.] Duke Univ, Duke Clin Res Inst, Durham, NC USA; [Sanders, Gillian D.] Duke Univ, Duke Margolis Ctr Hlth Policy, Durham, NC USA; [Maciejewski, Matthew L.] Durham Vet Affairs Hlth Care Syst, Durham Ctr Innovat Accelerate Discovery & Practic, Durham, NC USA; [Maciejewski, Matthew L.] Duke Univ, Sch Med, Dept Med, Div Gen Internal Med, Durham, NC 27706 USA; [Basu, Anirban] Univ Washington, Dept Pharm Hlth Serv & Econ, Comparat Hlth Outcomes Policy & Econ CHOICE Inst, Seattle, WA 98195 USA	Duke University; Duke University; Duke University; Duke University; University of Washington; University of Washington Seattle	Sanders, GD (corresponding author), Duke Univ, Med Ctr, 100 Fuqua Dr,Box 90120, Durham, NC 27710 USA.	gillian.sanders@duke.edu			HSRD VA [IK6 HX003157] Funding Source: Medline	HSRD VA		Jacobs IJ, 2016, LANCET, V387, P945, DOI 10.1016/S0140-6736(15)01224-6; Moss HA, 2018, JAMA ONCOL, V4, P190, DOI 10.1001/jamaoncol.2017.4211; Neumann PJ, 2018, JAMA-J AM MED ASSOC, V319, P2473, DOI 10.1001/jama.2018.6072; Sanders GD, 2016, JAMA-J AM MED ASSOC, V316, P1093, DOI 10.1001/jama.2016.12195	4	36	38	2	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 9	2019	321	14					1400	1401		10.1001/jama.2019.1265	http://dx.doi.org/10.1001/jama.2019.1265			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HT5PG	30855638				2022-12-28	WOS:000464615200019
J	Skolnik, N				Skolnik, Neil			Reexamining Recommendations for Treatment of Hypercholesterolemia in Older Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Skolnik, Neil] Thomas Jefferson Univ, Family & Community Med, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA; [Skolnik, Neil] Abington Jefferson Hlth, Family Med Residency Program, Jenkintown, PA USA	Jefferson University; Abington Memorial Hospital	Skolnik, N (corresponding author), Abington Family Med, 500 Old York Rd,Ste 108, Jenkintown, PA 19025 USA.	nskolnik@comcast.net						BRUGTS JJ, 2009, BMJ-BRIT MED J, V338, DOI DOI 10.1136/BMJ.B2376; Fulcher J, 2019, LANCET, V393, P407, DOI 10.1016/S0140-6736(18)31942-1; Grundy SM, 2019, J AM COLL CARDIOL, V73, P3168, DOI 10.1016/j.jacc.2018.11.002; Han BH, 2017, JAMA INTERN MED, V177, P955, DOI 10.1001/jamainternmed.2017.1442; Klasco RS, 2017, JAMA-J AM MED ASSOC, V317, P583, DOI 10.1001/jama.2016.20670; Patterson SM, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008165.pub3, 10.1002/14651858.CD008165.pub4]; Ramos R, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k3359; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; Werner CA, 2011, OLDER POPULATION 201; Wilt TJ, 2004, ARCH INTERN MED, V164, P1427, DOI 10.1001/archinte.164.13.1427	10	5	5	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 2	2019	321	13					1249	1250		10.1001/jama.2019.1676	http://dx.doi.org/10.1001/jama.2019.1676			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HR3XR	30855637				2022-12-28	WOS:000463076800008
J	Pichler, K; Kuhmayer, M; Bohm, J; Brandstotter, A; Ambichl, P; Kuhl, U; Rotter, S				Pichler, Kevin; Kuhmayer, Matthias; Bohm, Julian; Brandstoetter, Andre; Ambichl, Philipp; Kuhl, Ulrich; Rotter, Stefan			Random anti-lasing through coherent perfect absorption in a disordered medium	NATURE			English	Article							TIME; PHYSICS	Non-Hermitian wave engineering is a recent and fast-moving field that examines both fundamental and application-oriented phenomena(1-7). One such phenomenon is coherent perfect absorption(8-11)-an effect commonly referred to as 'anti-lasing' because it corresponds to the time-reversed process of coherent emission of radiation at the lasing threshold (where all radiation losses are exactly balanced by the optical gain). Coherent perfect absorbers (CPAs) have been experimentally realized in several setups(10-18), with the notable exception of a CPA in a disordered medium (a medium without engineered structure). Such a 'random CPA' would be the time-reverse of a 'random laser'(19,20), in which light is resonantly enhanced by multiple scattering inside a disorder. Because of the complexity of this scattering process, the light field emitted by a random laser is also spatially complex and not focused like a regular laser beam. Realizing a random CPA (or 'random anti-laser') is therefore challenging because it requires the equivalent of time-reversing such a light field in all its degrees of freedom to create coherent radiation that is perfectly absorbed when impinging on a disordered medium. Here we use microwave technology to build a random anti-laser and demonstrate its ability to absorb suitably engineered incoming radiation fields with near-perfect efficiency. Because our approach to determining these field patterns is based solely on far-field measurements of the scattering properties of a disordered medium, it could be suitable for other applications in which waves need to be perfectly focused, routed or absorbed.	[Pichler, Kevin; Kuhmayer, Matthias; Brandstoetter, Andre; Ambichl, Philipp; Rotter, Stefan] Vienna Univ Technol TU Wien, Inst Theoret Phys, Vienna, Austria; [Bohm, Julian; Kuhl, Ulrich] Univ Cote Azur, CNRS, Inst Phys Nice, Nice, France	Technische Universitat Wien; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Rotter, S (corresponding author), Vienna Univ Technol TU Wien, Inst Theoret Phys, Vienna, Austria.; Kuhl, U (corresponding author), Univ Cote Azur, CNRS, Inst Phys Nice, Nice, France.	ulrich.kuhl@unice.fr; stefan.rotter@tuwien.ac.at	Rotter, Stefan/E-1997-2011	Rotter, Stefan/0000-0002-4123-1417; Brandstotter, Andre/0000-0003-4354-4895; Kuhmayer, Matthias/0000-0001-9994-5562	Austrian Science Fund (FWF) [I 1142-N27]; French Science Fund (ANR) through project GePartWave; European Union via the H2020 project OpenFet NEMF21	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); French Science Fund (ANR) through project GePartWave; European Union via the H2020 project OpenFet NEMF21	K.P., M.K., A.B., P.A. and S.R. were supported by the Austrian Science Fund (FWF) through project I 1142-N27 (GePartWave). J.B. and U. K. were supported by the French Science Fund (ANR) through project GePartWave and by the European Union via the H2020 project OpenFet NEMF21. The computational results presented here were achieved in part using the Vienna Scientific Cluster (VSC).	Baranov DG, 2017, NAT REV MATER, V2, DOI 10.1038/natrevmats.2017.64; Bender CM, 2007, REP PROG PHYS, V70, P947, DOI 10.1088/0034-4885/70/6/R03; Berry MV, 2004, CZECH J PHYS, V54, P1039, DOI 10.1023/B:CJOP.0000044002.05657.04; Bruck R, 2013, OPT EXPRESS, V21, P27652, DOI 10.1364/OE.21.027652; Cai M, 2000, PHYS REV LETT, V85, P74, DOI 10.1103/PhysRevLett.85.74; Cao H, 2003, WAVE RANDOM MEDIA, V13, pR1, DOI 10.1088/0959-7174/13/3/201; Chong YD, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.163901; Chong YD, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.053901; El-Ganainy R, 2018, NAT PHYS, V14, P11, DOI 10.1038/NPHYS4323; Feng L, 2017, NAT PHOTONICS, V11, P752, DOI 10.1038/s41566-017-0031-1; Fyodorov YV, 2017, J PHYS A-MATH THEOR, V50, DOI 10.1088/1751-8121/aa793a; Gerlach D, 1996, SIGNAL PROCESS, V54, P59, DOI 10.1016/0165-1684(96)00093-X; Heiss WD, 2012, J PHYS A-MATH THEOR, V45, DOI 10.1088/1751-8113/45/44/444016; Jackson J. D., 2009, CLASSICAL ELECTRODYN; Kaina N, 2015, SCI REP-UK, V5, DOI 10.1038/srep07966; Kaina N, 2014, SCI REP-UK, V4, DOI 10.1038/srep06693; Lerosey G, 2007, SCIENCE, V315, P1120, DOI 10.1126/science.1134824; Li HA, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.044101; Longhi S, 2017, EPL-EUROPHYS LETT, V120, DOI 10.1209/0295-5075/120/64001; Longhi S, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.031801; Ma GC, 2018, P NATL ACAD SCI USA, V115, P6638, DOI 10.1073/pnas.1801175115; Meng C, 2017, SCI REP-UK, V7, DOI 10.1038/srep43574; Moiseyev N., 2011, NONHERMITIAN QUANTUM; Mosk AP, 2012, NAT PHOTONICS, V6, P283, DOI [10.1038/NPHOTON.2012.88, 10.1038/nphoton.2012.88]; Pu MB, 2012, OPT EXPRESS, V20, P2246, DOI 10.1364/OE.20.002246; Richoux O, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30287-y; Roger T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8031; Rotter S, 2017, REV MOD PHYS, V89, DOI 10.1103/RevModPhys.89.015005; Sun Y, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.143903; Tischler JR, 2006, OPT LETT, V31, P2045, DOI 10.1364/OL.31.002045; Wan WJ, 2011, SCIENCE, V331, P889, DOI 10.1126/science.1200735; Wiersma DS, 2008, NAT PHYS, V4, P359, DOI 10.1038/nphys971; Wong ZJ, 2016, NAT PHOTONICS, V10, P796, DOI [10.1038/NPHOTON.2016.216, 10.1038/nphoton.2016.216]	33	63	63	12	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 21	2019	567	7748					351	+		10.1038/s41586-019-0971-3	http://dx.doi.org/10.1038/s41586-019-0971-3			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP9JT	30833737				2022-12-28	WOS:000462010000048
J	Iacobucci, G				Iacobucci, Gareth			Private health screening: NHS must not be left to "pick up the pieces," say LMCs	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 20	2019	364								l1289	10.1136/bmj.l1289	http://dx.doi.org/10.1136/bmj.l1289			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HQ8AJ	30894355				2022-12-28	WOS:000462645500014
J	Wise, J				Wise, Jacqui			The BMJ Awards 2019: Diabetes Team of the Year	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 20	2019	364								l1232	10.1136/bmj.l1232	http://dx.doi.org/10.1136/bmj.l1232			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HQ8AJ	30894350				2022-12-28	WOS:000462645500009
J	Martin, EJ				Martin, Emily J.			Bearing Witness and Finding Meaning	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Martin, Emily J.] Univ Calif Los Angeles, 757 Westwood Plaza,Ste 7501, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Martin, EJ (corresponding author), Univ Calif Los Angeles, 757 Westwood Plaza,Ste 7501, Los Angeles, CA 90095 USA.	ejmartin@mednet.ucla.edu							0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 19	2019	321	11					1051	1052		10.1001/jama.2019.1292	http://dx.doi.org/10.1001/jama.2019.1292			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP4YY	30874759				2022-12-28	WOS:000461683500010
J	Alonge, M; Schatz, MC				Alonge, Michael; Schatz, Michael C.			A master regulator of regeneration	SCIENCE			English	Editorial Material							PIONEER TRANSCRIPTION FACTORS; CHROMATIN; GENOME		[Alonge, Michael; Schatz, Michael C.] Johns Hopkins Univ, Dept Comp Sci, Baltimore, MD 21218 USA; [Schatz, Michael C.] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Schatz, Michael C.] Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA	Johns Hopkins University; Johns Hopkins University; Cold Spring Harbor Laboratory	Schatz, MC (corresponding author), Johns Hopkins Univ, Dept Comp Sci, Baltimore, MD 21218 USA.; Schatz, MC (corresponding author), Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA.; Schatz, MC (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	mschatz@cs.jhu.edu						Baron V, 2006, CANCER GENE THER, V13, P115, DOI 10.1038/sj.cgt.7700896; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Gehrke AR, 2019, SCIENCE, V363, P1191, DOI 10.1126/science.aau6173; Grohme MA, 2018, NATURE, V554, P56, DOI 10.1038/nature25473; Gualdi R, 1996, GENE DEV, V10, P1670, DOI 10.1101/gad.10.13.1670; Katoh M, 2013, CANCER LETT, V328, P198, DOI 10.1016/j.canlet.2012.09.017; Putnam NH, 2016, GENOME RES, V26, P342, DOI 10.1101/gr.193474.115; Sedlazeck FJ, 2018, NAT REV GENET, V19, P329, DOI 10.1038/s41576-018-0003-4; Sherwood RI, 2014, NAT BIOTECHNOL, V32, P171, DOI 10.1038/nbt.2798; Srivastava M, 2014, CURR BIOL, V24, P1107, DOI 10.1016/j.cub.2014.03.042; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wasik K, 2015, P NATL ACAD SCI USA, V112, P12462, DOI 10.1073/pnas.1516718112; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111	14	0	0	2	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 15	2019	363	6432			SI		1152	1153		10.1126/science.aaw6258	http://dx.doi.org/10.1126/science.aaw6258			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HP0BC	30872508				2022-12-28	WOS:000461329000027
J	Gehrke, AR; Neverett, E; Luo, YJ; Brandt, A; Ricci, L; Hulett, RE; Gompers, A; Ruby, JG; Rokhsar, DS; Reddien, PW; Srivastava, M				Gehrke, Andrew R.; Neverett, Emily; Luo, Yi-Jyun; Brandt, Alexander; Ricci, Lorenzo; Hulett, Ryan E.; Gompers, Annika; Ruby, J. Graham; Rokhsar, Daniel S.; Reddien, Peter W.; Srivastava, Mansi			Acoel genome reveals the regulatory landscape of whole-body regeneration	SCIENCE			English	Article							PIONEER TRANSCRIPTION FACTORS; HEAD; MODULATION; ACTIVATION; CHROMATIN; NOTUM; WNT	Whole-body regeneration is accompanied by complex transcriptomic changes, yet the chromatin regulatory landscapes that mediate this dynamic response remain unexplored. To decipher the regulatory logic that orchestrates regeneration, we sequenced the genome of the acoel worm Hofstenia miamia, a highly regenerative member of the sister lineage of other bilaterians. Epigenomic profiling revealed thousands of regeneration-responsive chromatin regions and identified dynamically bound transcription factor motifs, with the early growth response (EGR) binding site as the most variably accessible during Hofstenia regeneration. Combining egr inhibition with chromatin profiling suggests that Egr functions as a pioneer factor to directly regulate early wound-induced genes. The genetic connections inferred by this approach allowed the construction of a gene regulatory network for whole-body regeneration, enabling genomics-based comparisons of regeneration across species.	[Gehrke, Andrew R.; Neverett, Emily; Luo, Yi-Jyun; Ricci, Lorenzo; Hulett, Ryan E.; Gompers, Annika; Srivastava, Mansi] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Brandt, Alexander] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94703 USA; [Ruby, J. Graham] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Rokhsar, Daniel S.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94703 USA; [Reddien, Peter W.] MIT, Whitehead Inst Biomed Res, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Reddien, Peter W.] MIT, Dept Biol, Cambridge, MA 02138 USA; [Srivastava, Mansi] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA	Harvard University; University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California Berkeley; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Harvard University	Srivastava, M (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.; Srivastava, M (corresponding author), Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA.	mansi@oeb.harvard.edu	Luo, Yi-Jyun/G-8020-2012	Luo, Yi-Jyun/0000-0002-3418-3146; Rokhsar, Daniel/0000-0002-8704-2224; Ricci, Lorenzo/0000-0002-1547-0844; Gehrke, Andrew/0000-0002-6588-3890; Hulett, Ryan/0000-0001-9288-7099; /0000-0002-5569-333X; Gompers, Annika/0000-0002-2591-3477	Milton Fund of Harvard University; Searle Scholars Program; Smith Family Foundation; National Science Foundation [1652104]; Helen Hay Whitney Foundation; Human Frontier Science Program; NIH [1R01HD080708-01, 5T32LM012417-03]; Biomedical Big Training Program at UC Berkeley; Marthella Foskett Brown Chair in Biological Sciences; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD080708] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T32LM012417] Funding Source: NIH RePORTER	Milton Fund of Harvard University; Searle Scholars Program; Smith Family Foundation; National Science Foundation(National Science Foundation (NSF)); Helen Hay Whitney Foundation; Human Frontier Science Program(Human Frontier Science Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biomedical Big Training Program at UC Berkeley; Marthella Foskett Brown Chair in Biological Sciences; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	M.S. is supported by the Milton Fund of Harvard University, Searle Scholars Program, Smith Family Foundation, and the National Science Foundation (award no. 1652104). A.R.G. is supported by the Helen Hay Whitney Foundation. Y.-J.L. is supported by the Human Frontier Science Program. D.S.R. and A.B. were supported by NIH grant 1R01HD080708-01, and A.B. was supported by the Biomedical Big Training Program at UC Berkeley and NIH grant 5T32LM012417-03. D.S.R acknowledges support from the Marthella Foskett Brown Chair in Biological Sciences. P.W.R. is an investigator of the Howard Hughes Medical Institute.	Bahrami Shahram, 2016, Advances in Biological Regulation, V62, P37, DOI 10.1016/j.jbior.2016.05.001; Bely AE, 2010, TRENDS ECOL EVOL, V25, P161, DOI 10.1016/j.tree.2009.08.005; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Cannon JT, 2016, NATURE, V530, P89, DOI 10.1038/nature16520; Cary GA, 2019, BMC BIOL, V17, DOI 10.1186/s12915-019-0633-9; Elran R, 2014, MOL ECOL, V23, P4722, DOI 10.1111/mec.12891; Farkas JE, 2016, DEVELOPMENT, V143, P2724, DOI 10.1242/dev.133363; Fraguas S, 2014, DEVELOPMENT, V141, P1835, DOI 10.1242/dev.101345; Gavino MA, 2013, ELIFE, V2, DOI 10.7554/eLife.00247; Gehrke A. R., 2019, ZENODO, DOI [10.5281/zenodo.2547750, DOI 10.5281/ZENODO.2547750]; Gemberling M, 2015, ELIFE, V4, DOI 10.7554/eLife.05871; Goldman JA, 2017, DEV CELL, V40, P392, DOI 10.1016/j.devcel.2017.01.013; Gomez-Martin D, 2010, AUTOIMMUN REV, V9, P454, DOI 10.1016/j.autrev.2009.12.006; Gurley KA, 2008, SCIENCE, V319, P323, DOI 10.1126/science.1150029; Harris RE, 2016, ELIFE, V5, DOI 10.7554/eLife.11588; Kang JS, 2016, NATURE, V532, P201, DOI 10.1038/nature17644; Khachigian LM, 2006, CIRC RES, V98, P186, DOI 10.1161/01.RES.0000200177.53882.c3; Lei K, 2016, DEV CELL, V38, P413, DOI 10.1016/j.devcel.2016.07.012; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Perez-Cadahia B, 2011, BIOCHEM CELL BIOL, V89, P61, DOI 10.1139/O10-138; Petersen CP, 2008, SCIENCE, V319, P327, DOI 10.1126/science.1149943; Petersen CP, 2011, SCIENCE, V332, P852, DOI 10.1126/science.1202143; Pritchard MT, 2005, ALCOHOL CLIN EXP RES, V29, p146S, DOI 10.1097/01.alc.0000189286.81943.51; Putnam NH, 2016, GENOME RES, V26, P342, DOI 10.1101/gr.193474.115; Raz AA, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01148-5; Roberts-Galbraith RH, 2013, P NATL ACAD SCI USA, V110, P1363, DOI 10.1073/pnas.1214053110; Rouse GW, 2016, NATURE, V530, P94, DOI 10.1038/nature16545; Ruby JG, 2013, G3-GENES GENOM GENET, V3, P865, DOI 10.1534/g3.113.005967; Schep AN, 2017, NAT METHODS, V14, P975, DOI [10.1038/NMETH.4401, 10.1038/nmeth.4401]; Scimone ML, 2017, NATURE, V551, P623, DOI 10.1038/nature24660; Sherwood RI, 2014, NAT BIOTECHNOL, V32, P171, DOI 10.1038/nbt.2798; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Srivastava M, 2014, CURR BIOL, V24, P1107, DOI 10.1016/j.cub.2014.03.042; Stanke M, 2008, BIOINFORMATICS, V24, P637, DOI 10.1093/bioinformatics/btn013; Wenemoser D, 2012, GENE DEV, V26, P988, DOI 10.1101/gad.187377.112; Wurtzel O, 2015, DEV CELL, V35, P632, DOI 10.1016/j.devcel.2015.11.004; Zaret KS, 2016, CURR OPIN GENET DEV, V37, P76, DOI 10.1016/j.gde.2015.12.003; Zhu SJ, 2016, CURR OPIN GENET DEV, V40, P74, DOI 10.1016/j.gde.2016.06.007	39	59	62	5	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 15	2019	363	6432			SI		1191	+	eaau6173	10.1126/science.aau6173	http://dx.doi.org/10.1126/science.aau6173			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP0BC	30872491				2022-12-28	WOS:000461329000041
J	Liu, K; Vuckovac, M; Latikka, M; Huhtamaki, T; Ras, RHA				Liu, Kai; Vuckovac, Maja; Latikka, Mika; Huhtamaki, Tommi; Ras, Robin H. A.			Improving surface-wetting characterization	SCIENCE			English	Editorial Material							CONTACT-ANGLE		[Liu, Kai; Vuckovac, Maja; Latikka, Mika; Huhtamaki, Tommi; Ras, Robin H. A.] Aalto Univ, Sch Sci, Dept Appl Phys, Espoo 02150, Finland; [Ras, Robin H. A.] Aalto Univ, Sch Chem Engn, Dept Bioprod & Biosyst, Espoo 02150, Finland	Aalto University; Aalto University	Ras, RHA (corresponding author), Aalto Univ, Sch Sci, Dept Appl Phys, Espoo 02150, Finland.; Ras, RHA (corresponding author), Aalto Univ, Sch Chem Engn, Dept Bioprod & Biosyst, Espoo 02150, Finland.	robin.ras@aalto.fi	Latikka, Mika T/H-8749-2013; Ras, Robin/F-7680-2010	Latikka, Mika T/0000-0002-5060-158X; Ras, Robin/0000-0002-2076-242X; Vuckovac, Maja/0000-0001-5895-7612	European Research Council [ERC-2016-CoG (725513-SuperRepel)]; Academy of Finland Centres of Excellence Programme 2014-2019	European Research Council(European Research Council (ERC)European Commission); Academy of Finland Centres of Excellence Programme 2014-2019	Supported by European Research Council grant ERC-2016-CoG (725513-SuperRepel) and the Academy of Finland Centres of Excellence Programme 2014-2019. The source codes and functions used in this work are available at Zenodo (16).	Artus GRJ, 2014, ADV COLLOID INTERFAC, V209, P144, DOI 10.1016/j.cis.2014.03.007; Butt HJ, 2014, CURR OPIN COLLOID IN, V19, P343, DOI 10.1016/j.cocis.2014.04.009; Cabezas MG, 2006, LANGMUIR, V22, P10053, DOI 10.1021/la061928t; Della Volpe C, 2018, SURF INNOV, V6, P120, DOI 10.1680/jsuin.17.00059; Gao N, 2018, NAT PHYS, V14, P191, DOI 10.1038/NPHYS4305; Huhtamaki T, 2018, NAT PROTOC, V13, P1521, DOI 10.1038/s41596-018-0003-z; Kalantarian A, 2009, LANGMUIR, V25, P14146, DOI 10.1021/la902016j; Konduru V., 2010, THESIS; Korhonen JT, 2014, SURF INNOV, V2, P116, DOI 10.1680/si.13.00047; Korhonen JT, 2013, LANGMUIR, V29, P3858, DOI 10.1021/la400009m; Larmour IA, 2007, ANGEW CHEM INT EDIT, V46, P1710, DOI 10.1002/anie.200604596; Liimatainen V, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01510-7; Liu MJ, 2017, NAT REV MATER, V2, DOI 10.1038/natrevmats.2017.36; Pierce E, 2008, COLLOID SURFACE A, V323, P73, DOI 10.1016/j.colsurfa.2007.09.032; Simpson JT, 2015, REP PROG PHYS, V78, DOI 10.1088/0034-4885/78/8/086501; Srinivasan S, 2011, LANGMUIR, V27, P13582, DOI 10.1021/la2031208; Timonen JVI, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3398; Vuckovac M., 2019, ZENODO, DOI [10.5281/zenodo.2573078, DOI 10.5281/ZENODO.2573078]; Young T., 1805, PHILOS T R SOC LONDO, V95, P65, DOI [10.1098/rstl.1805.0005, DOI 10.1098/RSTL.1805.0005]	19	51	54	10	116	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 15	2019	363	6432			SI		1147	+		10.1126/science.aav5388	http://dx.doi.org/10.1126/science.aav5388			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HP0BC	30872505	Green Submitted			2022-12-28	WOS:000461329000024
J	Yee, A				Yee, Amy			NOWHERE TO HIDE	SCIENCE			English	Editorial Material																			0	1	1	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 15	2019	363	6432			SI		1142	1143		10.1126/science.363.6432.1142	http://dx.doi.org/10.1126/science.363.6432.1142			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HP0BC	30872503				2022-12-28	WOS:000461329000022
J	Dyer, C				Dyer, Clare			Paediatrician is criticised for failing to report on care cases	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2019, RE X DELAY PROFESSIO	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 14	2019	364								l1206	10.1136/bmj.l1206	http://dx.doi.org/10.1136/bmj.l1206			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP5WD	30872281				2022-12-28	WOS:000461752500010
J	Zeng, C; Dubreuil, M; LaRochelle, MR; Lu, N; Wei, J; Choi, HK; Lei, GH; Zhang, YQ				Zeng, Chao; Dubreuil, Maureen; LaRochelle, Marc R.; Lu, Na; Wei, Jie; Choi, Hyon K.; Lei, Guanghua; Zhang, Yuqing			Association of Tramadol With All-Cause Mortality Among Patients With Osteoarthritis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COMPARATIVE SAFETY; UNITED-STATES; CHRONIC PAIN; PRESCRIPTION; OPIOIDS; RISK; GUIDELINE; TRENDS; HIP	IMPORTANCE An American Academy of Orthopaedic Surgeons guideline recommends tramadol for patients with knee osteoarthritis, and an American College of Rheumatology guideline conditionally recommends tramadol as first-line therapy for patients with knee osteoarthritis, along with nonsteroidal anti-inflammatory drugs. OBJECTIVE To examine the association of tramadol prescription with all-cause mortality among patients with osteoarthritis. DESIGN, SETTING, AND PARTICIPANTS Sequential, propensity score-matched cohort study at a general practice in the United Kingdom. Individuals aged at least 50 years with a diagnosis of osteoarthritis in the Health Improvement Network database from January 2000 to December 2015, with follow-up to December 2016, EXPOSURES Initial prescription of tramadol (n = 44451), naproxen (n = 12 397), diclofenac (n = 6512), celecoxib (n = 5674), etoricoxib (n = 2946), or codeine (n = 16 922), MAIN OUTCOMES AND MEASURES All-cause mortality within 1 year after initial tramadol prescription, compared with 5 other pain relief medications. RESULTS After propensity score matching, 88 902 patients were included (mean [SD] age, 70.1 [9.5] years; 61.2% were women). During the 1-year follow-up, 278 deaths (23.5(1000 person-years) occurred in the tramadol cohort and 164 (13.8(1000 person-years) occurred in the naproxen cohort (rate difference, 9.7 deaths/1000 person-years [95% CI, 6.3-13.2]; hazard ratio [HR], 1.71 [95% CI, 1.41-2.07]), and mortality was higher for tramadol compared with diclofenac (36.2/1000 vs 19.2/1000 person-years; HR, 1.88 [95% CI, 1.51-2.35]). Tramadol was also associated with a higher all-cause mortality rate compared with celecoxib (31.2/1000 vs 18.4/1000 person-years; HR, 1.70 [95% CI, 1.33-2.17]) and etoricoxib (25.7/1000 vs 12.8/1000 person-years; HR, 2.04 [95% CI, 1.37-3.03]). No statistically significant difference in all-cause mortality was observed between tramadol and codeine (32.2/1000 vs 34.6/1000 person-years; HR, 0.94 [95% CI, 0.83-1.05]). CONCLUSIONS AND RELEVANCE Among patients aged 50 years and older with osteoarthritis, initial prescription of tramadol was associated with a significantly higher rate of mortality over 1 year of follow-up compared with commonly prescribed nonsteroidal anti-inflammatory drugs, but not compared with codeine. However, these findings may be susceptible to confounding by indication, and further research is needed to determine if this association is causal.	[Zeng, Chao; Lei, Guanghua] Cent S Univ, Xiangya Hosp, Dept Orthopaed, 87 Xiangya Rd, Changsha 410008, Hunan, Peoples R China; [Zeng, Chao; Lu, Na; Wei, Jie; Choi, Hyon K.; Zhang, Yuqing] Harvard Med Sch, Div Rheumatol Allergy & Immunol, Dept Med, Massachusetts Gen Hosp, 55 Fruit St, Boston, MA 02114 USA; [Dubreuil, Maureen; Zhang, Yuqing] Boston Univ, Sch Med, Boston, MA 02118 USA; [Dubreuil, Maureen] VA Boston Healthcare Syst, Boston, MA USA; [LaRochelle, Marc R.] Boston Univ, Sch Med, Clin Addict Res & Educ Unit, Boston Med Ctr, Boston, MA 02118 USA	Central South University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Boston University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Boston Medical Center; Boston University	Lei, GH (corresponding author), Cent S Univ, Xiangya Hosp, Dept Orthopaed, 87 Xiangya Rd, Changsha 410008, Hunan, Peoples R China.; Zhang, YQ (corresponding author), Harvard Med Sch, Div Rheumatol Allergy & Immunol, Dept Med, Massachusetts Gen Hosp, 55 Fruit St, Boston, MA 02114 USA.	lei_guanghua@csu.edu.cn; yzhang108@mgh.harvard.edu	Wei, Jie/ACR-8087-2022; Dubreuil, Maureen/X-2001-2019	Wei, Jie/0000-0003-3510-8241; Dubreuil, Maureen/0000-0002-6253-1515	National Institute of Arthritis and Musculoskeletal and Skin Diseases [K23 AR069127, P60 AR047785]; National Natural Science Foundation of China [81772413, 81702207, 81702206]	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (K23 AR069127, P60 AR047785), and the National Natural Science Foundation of China (81772413, 81702207, 81702206).	[Anonymous], 2020, NICE GUIDEL; Beaulieu AD, 2008, PAIN RES MANAG, V13, P103, DOI 10.1155/2008/903784; Brouquet A, 2010, ANN SURG, V251, P759, DOI 10.1097/SLA.0b013e3181c1cfc9; Burr NE, 2018, CLIN GASTROENTEROL H, V16, P534, DOI 10.1016/j.cgh.2017.10.022; Chen TC, 2018, PHARMACOEPIDEM DR S, V27, P487, DOI 10.1002/pds.4320; Costa-Dias MJ, 2014, NURS EDUC TODAY, V34, P171, DOI 10.1016/j.nedt.2013.05.016; Dart RC, 2015, NEW ENGL J MED, V372, P241, DOI [10.1056/NEJMsa1406143, 10.1056/NEJMc1501822]; Dowell D, 2016, JAMA-J AM MED ASSOC, V315, P1624, DOI 10.1001/jama.2016.1464; Fournier JP, 2015, JAMA INTERN MED, V175, P186, DOI 10.1001/jamainternmed.2014.6512; Fournier JP, 2015, AM J MED, V128, P418, DOI 10.1016/j.amjined.2014.10.046; Glyn-Jones S, 2015, LANCET, V386, P376, DOI 10.1016/S0140-6736(14)60802-3; Hakkinen M, 2012, FORENSIC SCI INT, V222, P327, DOI 10.1016/j.forsciint.2012.07.011; Handley SA, 2014, CLIN TOXICOL, V52, P1, DOI 10.3109/15563650.2013.872791; Harstedt M, 2016, J ORTHOP SURG RES, V11, DOI 10.1186/s13018-016-0486-7; Hassamal S, 2018, AM J MED, V131, DOI 10.1016/j.amjmed.2018.04.025; Hicks BM, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4209; Hochberg MC, 2012, ARTHRIT CARE RES, V64, P465, DOI 10.1002/acr.21596; Jevsevar DS, 2013, J AM ACAD ORTHOP SUR, V21, P571, DOI 10.5435/JAAOS-21-09-571; Katz JN, 2016, OSTEOARTHR CARTILAGE, V24, P409, DOI 10.1016/j.joca.2015.10.006; Katz WA, 1996, DRUGS, V52, P39, DOI 10.2165/00003495-199600523-00007; Kimmel PL, 2017, J AM SOC NEPHROL, V28, P3658, DOI 10.1681/ASN.2017010098; Latimer N, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2538; LIN DY, 1993, BIOMETRIKA, V80, P557, DOI 10.2307/2337177; McAlindon TE, 2014, OSTEOARTHR CARTILAGE, V22, P363, DOI 10.1016/j.joca.2014.01.003; Ogdie A, 2017, RHEUMATOLOGY, V56, P907, DOI 10.1093/rheumatology/kew502; Randall C, 2014, J FORENSIC LEG MED, V23, P32, DOI 10.1016/j.jflm.2014.01.006; Ray WA, 2016, JAMA-J AM MED ASSOC, V315, P2415, DOI 10.1001/jama.2016.7789; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI [10.1002/9780470316696, DOI 10.1002/9780470316696]; Scarpignato C, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0285-8; Seeger JD, 2005, PHARMACOEPIDEM DR S, V14, P465, DOI 10.1002/pds.1062; Smith SR, 2016, OSTEOARTHR CARTILAGE, V24, P962, DOI 10.1016/j.joca.2016.01.135; Solomon DH, 2010, ARCH INTERN MED, V170, P1979, DOI 10.1001/archinternmed.2010.450; Solomon DH, 2010, ARCH INTERN MED, V170, P1968, DOI 10.1001/archinternmed.2010.391; Sturmer T, 2010, AM J EPIDEMIOL, V172, P843, DOI 10.1093/aje/kwq198; Tjaderborn M, 2007, FORENSIC SCI INT, V173, P107, DOI 10.1016/j.forsciint.2007.02.007; Torring ML, 2008, BRIT J CLIN PHARMACO, V65, P565, DOI 10.1111/j.1365-2125.2007.03038.x; Vestergaard P, 2006, J INTERN MED, V260, P76, DOI 10.1111/j.1365-2796.2006.01667.x; Wright EA, 2014, ARTHRIT CARE RES, V66, P1489, DOI 10.1002/acr.22360	38	108	113	9	36	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 12	2019	321	10					969	982		10.1001/jama.2019.1347	http://dx.doi.org/10.1001/jama.2019.1347			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HO5JE	30860559	Green Published			2022-12-28	WOS:000460961000015
J	Menon, BK; Goyal, M				Menon, Bijoy K.; Goyal, Mayank			Thrombus aspiration or retrieval in acute ischaemic stroke	LANCET			English	Editorial Material							LARGE VESSEL OCCLUSION; ENDOVASCULAR THROMBECTOMY; STENT RETRIEVER		[Menon, Bijoy K.; Goyal, Mayank] Univ Calgary, Hotchkiss Brain Inst, Cumming Sch Med, Calgary Stroke Program,Dept Clin Neurosci, Calgary, AB, Canada; [Menon, Bijoy K.; Goyal, Mayank] Univ Calgary, Hotchkiss Brain Inst, Cumming Sch Med, Calgary Stroke Program,Dept Radiol, Calgary, AB, Canada; [Menon, Bijoy K.] Univ Calgary, Hotchkiss Brain Inst, Cumming Sch Med, Dept Community Hlth Sci, Calgary, AB, Canada; [Goyal, Mayank] Foothills Med Ctr, Seaman Family MR Res Ctr, Calgary, AB T2N 2T9, Canada	University of Calgary; University of Calgary; University of Calgary; University of Calgary	Goyal, M (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Cumming Sch Med, Calgary Stroke Program,Dept Clin Neurosci, Calgary, AB, Canada.; Goyal, M (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Cumming Sch Med, Calgary Stroke Program,Dept Radiol, Calgary, AB, Canada.; Goyal, M (corresponding author), Foothills Med Ctr, Seaman Family MR Res Ctr, Calgary, AB T2N 2T9, Canada.	mgoyal@ucalgary.ca	Goyal, Mayank/AAE-7323-2019; MENON, BIJOY K/B-7718-2014					D'Agostino RB, 2003, STAT MED, V22, P169, DOI 10.1002/sim.1425; Goyal M, 2016, LANCET, V387, P1723, DOI 10.1016/S0140-6736(16)00163-X; Kunz WG, 2019, STROKE S1, V50, P174; Lapergue B, 2017, JAMA-J AM MED ASSOC, V318, P443, DOI 10.1001/jama.2017.9644; Maus V, 2019, CLIN NEURORADIOL, V29, P669, DOI 10.1007/s00062-018-0702-4; McTaggart RA, 2017, J NEUROINTERV SURG, V9, P1154, DOI 10.1136/neurintsurg-2016-012838; McTaggart RA, 2017, J NEUROINTERV SURG, V9, P316, DOI 10.1136/neurintsurg-2015-011984; Menon BK, 2019, CIRCULATION, V139, P169, DOI 10.1161/CIRCULATIONAHA.118.036701; Sacks D, 2018, J VASC INTERV RADIOL, V29, P441, DOI [10.1016/j.jvir.2017.11.026, 10.1177/1747493018778713]; Saver JL, 2016, JAMA-J AM MED ASSOC, V316, P1279, DOI 10.1001/jama.2016.13647; Smith EE, 2017, CIRCULATION, V136, P2303, DOI 10.1161/CIRCULATIONAHA.117.031097; Turk AS, 2019, LANCET, V393, P998, DOI 10.1016/S0140-6736(19)30297-1	12	3	3	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 9	2019	393	10175					962	963		10.1016/S0140-6736(19)30476-3	http://dx.doi.org/10.1016/S0140-6736(19)30476-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HO0OW	30860035				2022-12-28	WOS:000460604200006
J	Walker, E				Walker, Erin			PATIENT COMMENTARY My three livers: how transplants gave me my life back	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Walker, Erin] UCLPartners, London, England	University of London; University College London	Walker, E (corresponding author), UCLPartners, London, England.	erin.walker@uclpartners.com						Zarrinpar A, 2013, NAT REV GASTRO HEPAT, V10, P434, DOI 10.1038/nrgastro.2013.88	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 6	2019	364								l1004	10.1136/bmj.l1004	http://dx.doi.org/10.1136/bmj.l1004			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HO6SU	30842094	Bronze			2022-12-28	WOS:000461062400009
J	Davies, M				Davies, Marika			LIFE What should medical students do during a winter crisis?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												daviesburdett@gmail.com						General Medical Council, 2016, ACHIEVING GOOD MEDIC; Gregory J, 2018, PULSE TODAY; Rimmer A, 2018, BMJ	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 5	2019	364								l518	10.1136/bmj.l518	http://dx.doi.org/10.1136/bmj.l518			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HO6SS	30837215				2022-12-28	WOS:000461062200001
J	Magnus, CJ; Lee, PH; Bonaventura, J; Zemla, R; Gomez, JL; Ramirez, MH; Hu, X; Galvan, A; Basu, J; Michaelides, M; Sternson, SM				Magnus, Christopher J.; Lee, Peter H.; Bonaventura, Jordi; Zemla, Roland; Gomez, Juan L.; Ramirez, Melissa H.; Hu, Xing; Galvan, Adriana; Basu, Jayeeta; Michaelides, Michael; Sternson, Scott M.			Ultrapotent chemogenetics for research and potential clinical applications	SCIENCE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; SMOKING-CESSATION; PARTIAL AGONISTS; IN-VIVO; DISCRIMINATIVE STIMULUS; GLOBUS-PALLIDUS; WHOLE-BLOOD; VARENICLINE; ALPHA-4-BETA-2; NEURONS	Chemogenetics enables noninvasive chemical control over cell populations in behaving animals. However, existing small-molecule agonists show insufficient potency or selectivity. There is also a need for chemogenetic systems compatible with both research and human therapeutic applications. We developed a new ion channel-based platform for cell activation and silencing that is controlled by low doses of the smoking cessation drug varenicline. We then synthesized subnanomolar-potency agonists, called uPSEMs, with high selectivity for the chemogenetic receptors. uPSEMs and their receptors were characterized in brains of mice and a rhesus monkey by in vivo electrophysiology, calcium imaging, positron emission tomography, behavioral efficacy testing, and receptor counterscreening. This platform of receptors and selective ultrapotent agonists enables potential research and clinical applications of chemogenetics.	[Magnus, Christopher J.; Lee, Peter H.; Ramirez, Melissa H.; Sternson, Scott M.] Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA; [Bonaventura, Jordi; Gomez, Juan L.; Michaelides, Michael] NIDA, Biobehav Imaging & Mol Neuropsychopharmacol Unit, Intramural Res Program, Baltimore, MD 21224 USA; [Zemla, Roland; Basu, Jayeeta] NYU, Inst Neurosci, 550 1st Ave, New York, NY 10016 USA; [Zemla, Roland] NYU, Sch Med, Med Scientist Training Program, New York, NY 10016 USA; [Hu, Xing; Galvan, Adriana] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA; [Hu, Xing; Galvan, Adriana] Emory Univ, Dept Neurol, Atlanta, GA 30329 USA; [Basu, Jayeeta] NYU, Dept Neurosci & Physiol, Langone Med Ctr, 550 1st Ave, New York, NY 10016 USA; [Michaelides, Michael] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); New York University; New York University; Emory University; Emory University; New York University; NYU Langone Medical Center; Johns Hopkins University	Sternson, SM (corresponding author), Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA.	sternsons@janelia.hhmi.org	Bonaventura, Jordi/A-5229-2019; Michaelides, Mike/V-5199-2019	Bonaventura, Jordi/0000-0002-4745-0151; Zemla, Roland/0000-0003-3377-1322; Lee, Peter H/0000-0003-4177-4099; Magnus, Christopher/0000-0001-5640-0116	HHMI; NIH [ORIP OD P51-OD011132, NINDS 1R01 NS109362-01]; Alfred P. Sloan Foundation; Klingenstein-Simons Foundation; Whitehall Foundation; National Institute for Drug Abuse Intramural Research Program [ZIA000069]; Resource for Molecular Imaging Agents in Precision Medicine at JHU [P41EB024495]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS109994, R01NS109362] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000069] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Klingenstein-Simons Foundation; Whitehall Foundation; National Institute for Drug Abuse Intramural Research Program; Resource for Molecular Imaging Agents in Precision Medicine at JHU; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by HHMI (S.M.S., C.J.M., P.H.L., and M.H.R.); NIH grant ORIP OD P51-OD011132 to the Yerkes National Primate Research Center (X.H. and A.G.); the Alfred P. Sloan Foundation, Klingenstein-Simons Foundation, NIH grant NINDS 1R01 NS109362-01, and Whitehall Foundation (J.Ba.); and National Institute for Drug Abuse Intramural Research Program ZIA000069 with support via the Resource for Molecular Imaging Agents in Precision Medicine (P41EB024495) at JHU (M.M.).	Alexander GM, 2009, NEURON, V63, P27, DOI 10.1016/j.neuron.2009.06.014; ALLEN SR, 1973, PSYCHOPHARMACOLOGIA, V32, P1, DOI 10.1007/BF00421703; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Atasoy D, 2018, PHYSIOL REV, V98, P391, DOI 10.1152/physrev.00009.2017; Atasoy D, 2012, NATURE, V488, P172, DOI 10.1038/nature11270; Audiffred JF, 2010, BIOTECHNOL BIOENG, V106, P784, DOI 10.1002/bit.22728; Baraka OZ, 1996, EUR J CLIN PHARMACOL, V50, P407, DOI 10.1007/s002280050131; Besnard J, 2012, NATURE, V492, P215, DOI 10.1038/nature11691; Brewer GJ, 1997, J NEUROSCI METH, V71, P143, DOI 10.1016/S0165-0270(96)00136-7; Campling BG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079653; Chen X, 2015, ACS CHEM NEUROSCI, V6, P476, DOI 10.1021/cn500325v; Coe JW, 2005, BIOORG MED CHEM LETT, V15, P4889, DOI 10.1016/j.bmcl.2005.08.035; Cunningham CS, 2013, PSYCHOPHARMACOLOGY, V228, P321, DOI 10.1007/s00213-013-3037-5; Cunningham CS, 2012, J PHARMACOL EXP THER, V341, P840, DOI 10.1124/jpet.112.193078; Dana H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108697; Danielson NB, 2016, NEURON, V91, P652, DOI 10.1016/j.neuron.2016.06.020; de Moura FB, 2017, PSYCHOPHARMACOLOGY, V234, P781, DOI 10.1007/s00213-016-4514-4; DELONG MR, 1971, J NEUROPHYSIOL, V34, P414, DOI 10.1152/jn.1971.34.3.414; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; English JG, 2015, JAMA NEUROL, V72, P1361, DOI 10.1001/jamaneurol.2015.1921; Faessel HM, 2008, EUR J CLIN PHARMACOL, V64, P1101, DOI 10.1007/s00228-008-0530-6; Frazier SJ, 2013, J BIOL CHEM, V288, P21029, DOI 10.1074/jbc.M112.423921; Galvan A, 2005, J NEUROPHYSIOL, V94, P990, DOI 10.1152/jn.00068.2005; Galvan A, 2016, J NEUROSCI, V36, P3519, DOI 10.1523/JNEUROSCI.4363-15.2016; Galvan A, 2014, J NEUROPHYSIOL, V112, P467, DOI 10.1152/jn.00849.2013; Galvan A, 2011, EXP NEUROL, V229, P429, DOI 10.1016/j.expneurol.2011.03.010; Galvan A, 2010, EXP NEUROL, V223, P505, DOI 10.1016/j.expneurol.2010.01.018; Garber JC, 2011, GUIDE CARE USE LAB A; Giovannucci A, 2019, ELIFE, V8, DOI 10.7554/eLife.38173; Gomez JL, 2017, SCIENCE, V357, P503, DOI 10.1126/science.aan2475; Griffith CA, 2010, ANN CLIN BIOCHEM, V47, P56, DOI 10.1258/acb.2009.008191; Grutter T, 2005, P NATL ACAD SCI USA, V102, P18207, DOI 10.1073/pnas.0509024102; Guler AD, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1749; Hibbs RE, 2009, EMBO J, V28, P3040, DOI 10.1038/emboj.2009.227; Hirschberg S, 2017, ELIFE, V6, DOI 10.7554/eLife.29808; Hitchcock SA, 2012, J MED CHEM, V55, P4877, DOI 10.1021/jm201136z; Hooker JM, 2008, NEUROIMAGE, V41, P1044, DOI 10.1016/j.neuroimage.2008.03.003; Horti AG, 2014, J NUCL MED, V55, P672, DOI 10.2967/jnumed.113.132068; JANN MW, 1994, ARCH INT PHARMACOD T, V328, P243; Jia HB, 2011, NAT PROTOC, V6, P28, DOI 10.1038/nprot.2010.169; Katzel D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4847; Kaur K, 2009, CURR THER RES CLIN E, V70, P35, DOI 10.1016/j.curtheres.2009.02.004; Kay K, 2016, NATURE, V531, P185, DOI 10.1038/nature17144; Kliem MA, 2004, J NEUROSCI METH, V138, P45, DOI 10.1016/j.jneumeth.2004.03.015; Kuryatov A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062246; Kwei GY, 1999, DRUG METAB DISPOS, V27, P581; Lummis SCR, 2011, J PHARMACOL EXP THER, V339, P125, DOI 10.1124/jpet.111.185306; MacLaren D. A., 2016, ENEURO, DOI [10.1126/science.aan2475, DOI 10.1523/ENEUR0.0219-16.2016]; MacLaren DAA, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0219-16.2016; Macor JE, 2001, BIOORG MED CHEM LETT, V11, P319, DOI 10.1016/S0960-894X(00)00670-3; Magnus CJ, 2011, SCIENCE, V333, P1292, DOI 10.1126/science.1206606; Mihalak KB, 2006, MOL PHARMACOL, V70, P801, DOI 10.1124/mol.106.025130; Nakamura M, 2007, CLIN THER, V29, P1040, DOI 10.1016/j.clinthera.2007.06.012; Obach RS, 2006, DRUG METAB DISPOS, V34, P121, DOI 10.1124/dmd.105.006767; Ortiz NC, 2012, NICOTINE TOB RES, V14, P711, DOI 10.1093/ntr/ntr284; Osborne JE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089007; Parikh V, 2007, NEURON, V56, P141, DOI 10.1016/j.neuron.2007.08.025; Pouliot JF, 1997, BIOCHEM PHARMACOL, V53, P17, DOI 10.1016/S0006-2952(96)00656-9; Raper J, 2017, ACS CHEM NEUROSCI, V8, P1570, DOI 10.1021/acschemneuro.7b00079; Rollema H, 2010, BRIT J PHARMACOL, V160, P334, DOI 10.1111/j.1476-5381.2010.00682.x; Roth BL, 2016, NEURON, V89, P683, DOI 10.1016/j.neuron.2016.01.040; Rucktooa P, 2012, J BIOL CHEM, V287, P23283, DOI 10.1074/jbc.M112.360347; Samson AL, 2015, SCI REP-UK, V5, DOI 10.1038/srep16171; SCHEELKRUGER J, 1977, NEUROSCI LETT, V4, P351, DOI 10.1016/0304-3940(77)90183-5; Slimko EM, 2002, J NEUROSCI, V22, P7373; Song WF, 2006, J NEUROPHYSIOL, V95, P2366, DOI 10.1152/jn.00386.2005; Sternson SM, 2014, ANNU REV NEUROSCI, V37, DOI 10.1146/annurev-neuro-071013-014048; Suter BA, 2010, FRONT NEURAL CIRCUIT, V4, P100, DOI DOI 10.3389/FNCIR.2010.00100; Trailovic SM, 2011, J VET MED SCI, V73, P591, DOI 10.1292/jvms.10-0424; Uutela P, 2005, RAPID COMMUN MASS SP, V19, P2950, DOI 10.1002/rcm.2160; Vardy E, 2015, NEURON, V86, P936, DOI 10.1016/j.neuron.2015.03.065; Vong L, 2011, NEURON, V71, P142, DOI 10.1016/j.neuron.2011.05.028; Weir GA, 2017, BRAIN, V140, P2570, DOI 10.1093/brain/awx201; Wenthur CJ, 2013, ACS CHEM NEUROSCI, V4, P1018, DOI 10.1021/cn400121z; Wong DF, 2014, MOL IMAGING BIOL, V16, P730, DOI 10.1007/s11307-014-0779-3; Yue BF, 2008, CLIN CHEM, V54, P590, DOI 10.1373/clinchem.2007.094201; Zaremba JD, 2017, NAT NEUROSCI, V20, P1612, DOI 10.1038/nn.4634	79	59	60	4	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 12	2019	364	6436					146	+	eaav5282	10.1126/science.aav5282	http://dx.doi.org/10.1126/science.aav5282			69	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HT5RC	30872534	Green Accepted			2022-12-28	WOS:000464620000033
J	Wesson, DE; Mathur, V; Tangri, N; Stasiv, Y; Parsell, D; Li, E; Klaerner, G; Bushinsky, DA				Wesson, Donald E.; Mathur, Vandana; Tangri, Navdeep; Stasiv, Yuri; Parsell, Dawn; Li, Elizabeth; Klaerner, Gerrit; Bushinsky, David A.			Veverimer versus placebo in patients with metabolic acidosis associated with chronic kidney disease: a multicentre, randomised, double-blind, controlled, phase 3 trial	LANCET			English	Article							QUALITY-OF-LIFE; ORAL SODIUM-BICARBONATE; SERUM BICARBONATE; NACL TOLERANCE; PROTEIN; SUPPLEMENTATION; MUSCLE; CKD; PROGRESSION; STAGE-3	Background Patients with advanced chronic kidney disease lose the capacity to fully excrete endogenous acid, resulting in chronic metabolic acidosis that increases the risk of disease progression and causes muscle catabolism and bone resorption. Veverimer, a non-absorbed, counterion-free, polymeric drug, selectively binds and removes hydrochloric acid from the gastrointestinal lumen, unlike current oral sodium bicarbonate therapy for metabolic acidosis that only neutralises accumulated acid. We assessed the efficacy and safety of veverimer as a treatment for metabolic acidosis in patients with chronic kidney disease. Methods We did a multicentre, parallel, randomised, double-blind, placebo-controlled study at 37 sites (hospitals and specialty clinics) in Bulgaria, Croatia, Georgia, Hungary, Serbia, Slovenia, Ukraine, and the USA. Eligible participants were patients aged 18-85 years with non-dialysis-dependent chronic kidney disease (estimated glomerular filtration rate of 20-40 mL/min per 1.73 m(2)) and metabolic acidosis (serum bicarbonate concentration of 12-20 mmol/L). Patients were randomly assigned (4:3) to veverimer 6 g/day or placebo for 12 weeks while they consumed their typical diet. Both drugs were taken as oral suspensions in water with lunch. Randomisation was done by study site personnel with a computer-generated randomisation code with balanced permuted blocks (block size of seven) and stratified by baseline bicarbonate (<= 18 mmol/L vs >18 mmol/L). Patients and investigators were masked to treatment allocation; however, because the appearance of placebo differed from veverimer, a non-masked site staff member who had no other role in the study dispensed, prepared, and supervised dosing of the study drugs. The composite primary efficacy endpoint was the difference (veverimer-placebo) in the proportion of patients achieving at week 12 either an increase of 4 mmol/L or more from baseline in serum bicarbonate concentration or serum bicarbonate in the normal range of 22-29 mmol/L, assessed in the modified intention-to-treat population (all patients with a baseline and at least one post-baseline serum bicarbonate value). Patients fasted for at least 4 h (consuming only water) before measurements of bicarbonate. Safety was assessed in all patients who received any amount of study drug. This trial is registered with ClinicalTrials.gov, number NCT03317444. Findings Between Sept 26, 2017, and Feb 9, 2018, we randomly assigned 124 participants to veverimer and 93 to placebo. The composite primary endpoint was met by 71 (59%) of 120 patients in the veverimer group versus 20 (22%) of 89 patients in the placebo group (a difference of 37%, 95% CI 23-49; p<0.0001). The most common body system in which adverse events in the veverimer group occurred was gastrointestinal; of these, non-treatment limiting diarrhoea was the most common event (11 [9%] vs three [3%] in the veverimer and placebo groups, respectively). The most common treatment-related adverse events were gastrointestinal (diarrhoea, flatulence, nausea, and constipation) occurring in 16 (13%) patients with veverimer and five (5%) patients with placebo. Two deaths occurred during the study, both in the placebo group (unstable angina and pneumonia). Interpretation Veverimer effectively and safely corrected metabolic acidosis. Longer-term studies are warranted to assess the effects of veverimer on physical functioning and to assess other deleterious consequences of metabolic acidosis including progression of chronic kidney disease and bone health. Copyright (C) 2019 by Elsevier Ltd. All rights reserved.	[Wesson, Donald E.] Baylor Scott & White Hlth & Wellness Ctr, Dallas, TX 75210 USA; [Mathur, Vandana] Mathur Consulting, Woodside, CA USA; [Tangri, Navdeep] Univ Manitoba, Div Nephrol, Winnipeg, MB, Canada; [Stasiv, Yuri; Parsell, Dawn; Klaerner, Gerrit] Tricida, San Francisco, CA USA; [Li, Elizabeth] PharmaStat LLC, Newark, CA USA; [Bushinsky, David A.] Univ Rochester, Sch Med, Rochester, NY USA	Baylor University Medical Center; University of Manitoba; University of Rochester	Wesson, DE (corresponding author), Baylor Scott & White Hlth & Wellness Ctr, Dallas, TX 75210 USA.	donald.wesson@bswhealth.org			Tricida	Tricida	Tricida.	Abramowitz MK, 2013, CLIN J AM SOC NEPHRO, V8, P714, DOI 10.2215/CJN.08340812; Bushinsky DA, 2015, NUTR BONE HLTH, P335; Bushinsky DA, 2019, AM J KIDNEY DIS, V73, P858, DOI 10.1053/j.ajkd.2018.09.004; Bushinsky DA, 2018, CLIN J AM SOC NEPHRO, V13, P26, DOI 10.2215/CJN.07300717; Clement FM, 2009, ARCH INTERN MED, V169, P1104, DOI 10.1001/archinternmed.2009.112; Collister D, 2016, ANN INTERN MED, V164, P472, DOI 10.7326/M15-1839; Cunningham J, 2005, KIDNEY INT, V68, P1793, DOI 10.1111/j.1523-1755.2005.00596.x; Dawson-Hughes B, 2010, OSTEOPOROSIS INT, V21, P1171, DOI 10.1007/s00198-009-1049-0; de Brito-Ashurst I, 2009, J AM SOC NEPHROL, V20, P2075, DOI 10.1681/ASN.2008111205; Dobre M, 2013, AM J KIDNEY DIS, V62, P670, DOI 10.1053/j.ajkd.2013.01.017; Garneata L, 2016, J AM SOC NEPHROL, V27, P2164, DOI 10.1681/ASN.2015040369; Goraya N, 2014, KIDNEY INT, V86, P1031, DOI 10.1038/ki.2014.83; Goraya N, 2013, CURR OPIN NEPHROL HY, V22, P193, DOI 10.1097/MNH.0b013e32835dcbbe; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; HUSTED FC, 1975, J CLIN INVEST, V56, P414, DOI 10.1172/JCI108107; HUSTED FC, 1977, CLIN NEPHROL, V7, P21; Inker LA, 2011, J AM SOC NEPHROL, V22, P2322, DOI 10.1681/ASN.2010111181; Kraut JA, 2017, ADV CHRONIC KIDNEY D, V24, P289, DOI 10.1053/j.ackd.2017.06.005; Leaf DE, 2009, KIDNEY INT, V75, P15, DOI 10.1038/ki.2008.414; Loniewski I, 2014, KIDNEY INT, V85, P529, DOI 10.1038/ki.2013.401; Mahajan A, 2010, KIDNEY INT, V78, P303, DOI 10.1038/ki.2010.129; MAY RC, 1987, J CLIN INVEST, V79, P1099, DOI 10.1172/JCI112924; MAY RC, 1986, J CLIN INVEST, V77, P614, DOI 10.1172/JCI112344; Navaneethan SD, 2011, CLIN J AM SOC NEPHRO, V6, P2395, DOI 10.2215/CJN.03730411; Phisitkul S, 2010, KIDNEY INT, V77, P617, DOI 10.1038/ki.2009.519; PRICE SR, 1994, SEMIN NEPHROL, V14, P232; Raphael KL, 2017, J AM SOC NEPHROL, V28, P1672, DOI 10.1681/ASN.2017020133; Ratitch B, 2011, P PHARMASUG 2011 PHA; REAICH D, 1992, AM J PHYSIOL, V263, pE735, DOI 10.1152/ajpendo.1992.263.4.E735; Samsa G, 1999, PHARMACOECONOMICS, V15, P141, DOI 10.2165/00019053-199915020-00003; SCHMITT MG, 1977, AM J DIG DIS, V22, P340, DOI 10.1007/BF01072192; Siegler JC, 2012, J STRENGTH COND RES, V26, P1953, DOI 10.1519/JSC.0b013e3182392960; Tangri N, 2011, JAMA-J AM MED ASSOC, V305, P1553, DOI 10.1001/jama.2011.451	33	43	44	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 6	2019	393	10179					1417	1427		10.1016/S0140-6736(18)32562-5	http://dx.doi.org/10.1016/S0140-6736(18)32562-5			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HS0OU	30857647				2022-12-28	WOS:000463561000027
J	Mateo, LJ; Murphy, SE; Hafner, A; Cinquini, IS; Walker, CA; Boettiger, AN				Mateo, Leslie J.; Murphy, Sedona E.; Hafner, Antonina; Cinquini, Isaac S.; Walker, Carly A.; Boettiger, Alistair N.			Visualizing DNA folding and RNA in embryos at single-cell resolution	NATURE			English	Article							BITHORAX COMPLEX; SPATIAL-ORGANIZATION; CHROMATIN DOMAINS; DROSOPHILA; PRINCIPLES; ENHANCERS; GENOME; SHH	The establishment of cell types during development requires precise interactions between genes and distal regulatory sequences. We have a limited understanding of how these interactions look in three dimensions, vary across cell types in complex tissue, and relate to transcription. Here we describe optical reconstruction of chromatin architecture (ORCA), a method that can trace the DNA path in single cells with nanoscale accuracy and genomic resolution reaching two kilobases. We used ORCA to study a Hox gene cluster in cryosectioned Drosophila embryos and labelled around 30 RNA species in parallel. We identified cell-type-specific physical borders between active and Polycomb-repressed DNA, and unexpected Polycomb-independent borders. Deletion of Polycomb-independent borders led to ectopic enhancer-promoter contacts, aberrant gene expression, and developmental defects. Together, these results illustrate an approach for high-resolution, single-cell DNA domain analysis in vivo, identify domain structures that change with cell identity, and show that border elements contribute to the formation of physical domains in Drosophila.	[Mateo, Leslie J.; Murphy, Sedona E.; Hafner, Antonina; Cinquini, Isaac S.; Walker, Carly A.; Boettiger, Alistair N.] Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; [Murphy, Sedona E.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Cinquini, Isaac S.] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Boettiger, AN (corresponding author), Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA.	boettiger@stanford.edu	t, lf/AAJ-4924-2020	Murphy, Sedona/0000-0001-8345-1955; Boettiger, Alistair/0000-0002-3554-5196; Valencia, Leslie/0000-0001-7110-3187; Hafner, Antonina/0000-0003-4927-5227	Searle Scholars Program; Burroughs Wellcome Careers at the Scientific Interface Award; Dale Frey Award; Beckman Young Investigator Program; NIH New Innovator Award DP2 [DGM132935A]; Packard Fellows Program; Stanford School of Medicine Dean's Fund; Stanford Genome Training Program; Walter V. and Idun Berry Postdoctoral Fellowship; Stanford Bio-X; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP2GM132935] Funding Source: NIH RePORTER	Searle Scholars Program; Burroughs Wellcome Careers at the Scientific Interface Award; Dale Frey Award; Beckman Young Investigator Program; NIH New Innovator Award DP2(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Packard Fellows Program; Stanford School of Medicine Dean's Fund; Stanford Genome Training Program; Walter V. and Idun Berry Postdoctoral Fellowship; Stanford Bio-X; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank W. Bender for providing the Fub and Fab-7 mutants, and for discussions; N. Sinnott-Armstrong for help with assembly and programming of the fluid handling robot; D. Kingsley, P. Beachy, M. Fuller, A. Villeneuve, A. Rajpurkar, and T.C. Hung for critical reading of the manuscript; J. Wysocka for the mESCs; and B. Gu for assistance with cell culture. This work was supported by the Searle Scholars Program, Burroughs Wellcome Careers at the Scientific Interface Award, Dale Frey Award, Beckman Young Investigator Program, NIH New Innovator Award DP2 (DGM132935A), and the Packard Fellows Program (A.N.B.). L.J.M. is supported by the Stanford School of Medicine Dean's Fund, S.E.M. is supported by the Stanford Genome Training Program, A.H. is supported by a Walter V. and Idun Berry Postdoctoral Fellowship, and I.S.C. was supported by a summer training grant from Stanford Bio-X.	Andrey G, 2013, SCIENCE, V340, P1195, DOI 10.1126/science.1234167; Babcock Hazen, 2012, Opt Nanoscopy, V1, DOI 10.1186/2192-2853-1-6; Bantignies F, 2011, CELL, V144, P214, DOI 10.1016/j.cell.2010.12.026; Bartholomew NR, 2015, SCI REP-UK, V5, DOI 10.1038/srep15298; Beliveau BJ, 2017, METHODS MOL BIOL, V1663, P231, DOI 10.1007/978-1-4939-7265-4_19; Beliveau BJ, 2012, P NATL ACAD SCI USA, V109, P21301, DOI 10.1073/pnas.1213818110; Bender W, 2000, DEVELOPMENT, V127, P3981; Bender W, 2013, GENETICS, V193, P1135, DOI 10.1534/genetics.112.146340; Bintu B, 2018, SCIENCE, V362, P419, DOI 10.1126/science.aau1783; Boettiger AN, 2016, NATURE, V529, P418, DOI 10.1038/nature16496; Bonev B, 2017, CELL, V171, P557, DOI 10.1016/j.cell.2017.09.043; Bowman SK, 2014, ELIFE, V3, DOI 10.7554/eLife.02833; Briggs JA, 2018, SCIENCE, V360, P980, DOI 10.1126/science.aar5780; Gizzi AMC, 2019, MOL CELL, V74, P212, DOI 10.1016/j.molcel.2019.01.011; Cattoni DI, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01962-x; Chambeyron S, 2004, GENE DEV, V18, P1119, DOI 10.1101/gad.292104; Chen HT, 2018, NAT GENET, V50, P1296, DOI 10.1038/s41588-018-0175-z; Chen KH, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6090; Cheutin T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05945-4; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Eskeland R, 2010, MOL CELL, V38, P452, DOI 10.1016/j.molcel.2010.02.032; Ester M., 1996, KDD-96 Proceedings. Second International Conference on Knowledge Discovery and Data Mining, P226; Fabre PJ, 2015, P NATL ACAD SCI USA, V112, P13964, DOI 10.1073/pnas.1517972112; Furlong EEM, 2018, SCIENCE, V361, P1341, DOI 10.1126/science.aau0320; Gambetta MC, 2018, GENETICS, V210, P129, DOI 10.1534/genetics.118.301350; Ghavi-Helm Y, 2014, NATURE, V512, P96, DOI 10.1038/nature13417; Gu B, 2018, SCIENCE, V359, P1050, DOI 10.1126/science.aao3136; GYURKOVICS H, 1990, EMBO J, V9, P2579, DOI 10.1002/j.1460-2075.1990.tb07439.x; Kragesteen BK, 2018, NAT GENET, V50, P1463, DOI 10.1038/s41588-018-0221-x; Kundu S, 2017, MOL CELL, V65, P432, DOI 10.1016/j.molcel.2017.01.009; Kyrchanova O, 2015, MECH DEVELOP, V138, P122, DOI 10.1016/j.mod.2015.07.002; Levine M, 2014, CELL, V157, P13, DOI 10.1016/j.cell.2014.02.009; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Long HK, 2016, CELL, V167, P1170, DOI 10.1016/j.cell.2016.09.018; Maeda RK, 2006, DEVELOPMENT, V133, P1413, DOI 10.1242/dev.02323; Maeda RK, 2015, CHROMOSOMA, V124, P293, DOI 10.1007/s00412-015-0522-0; Maeda RK, 2009, CURR TOP DEV BIOL, V88, P1, DOI 10.1016/S0070-2153(09)88001-0; Moffitt JR, 2016, P NATL ACAD SCI USA, V113, P14456, DOI 10.1073/pnas.1617699113; Moffitt JR, 2016, P NATL ACAD SCI USA, V113, P11046, DOI 10.1073/pnas.1612826113; Narendra V, 2016, GENE DEV, V30, P2657, DOI 10.1101/gad.288324.116; Narendra V, 2015, SCIENCE, V347, P1017, DOI 10.1126/science.1262088; Nir G, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007872; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Perry MW, 2010, CURR BIOL, V20, P1562, DOI 10.1016/j.cub.2010.07.043; Phanstiel DH, 2017, MOL CELL, V67, P1037, DOI 10.1016/j.molcel.2017.08.006; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Rivera J, 2019, NUCLEIC ACIDS RES, V47, pD828, DOI 10.1093/nar/gky957; Rowley MJ, 2018, NAT REV GENET, V19, P789, DOI 10.1038/s41576-018-0060-8; Rowley MJ, 2017, MOL CELL, V67, P837, DOI 10.1016/j.molcel.2017.07.022; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Schuettengruber B, 2014, CELL REP, V9, P219, DOI 10.1016/j.celrep.2014.08.072; Schwartz YB, 2017, GENETICS, V205, P5, DOI 10.1534/genetics.115.185132; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Spielmann M, 2018, NAT REV GENET, V19, P453, DOI 10.1038/s41576-018-0007-0; Symmons O, 2016, DEV CELL, V39, P529, DOI 10.1016/j.devcel.2016.10.015; Symmons O, 2014, GENOME RES, V24, P390, DOI 10.1101/gr.163519.113; Szabo Q, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar8082; Tokunaga M, 2008, NAT METHODS, V5, P159, DOI 10.1038/nmeth1171; Van Bortle K, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-5-r82; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Wang SY, 2016, SCIENCE, V353, P598, DOI 10.1126/science.aaf8084; Williamson I, 2016, DEVELOPMENT, V143, P2994, DOI 10.1242/dev.139188	62	167	173	4	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 4	2019	568	7750					49	+		10.1038/s41586-019-1035-4	http://dx.doi.org/10.1038/s41586-019-1035-4			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR8CZ	30886393	Green Accepted			2022-12-28	WOS:000463384900037
J	Rueda, OM; Sammut, SJ; Seoane, JA; Chin, SF; Caswell-Jin, JL; Callari, M; Batra, R; Pereira, B; Bruna, A; Ali, HR; Provenzano, E; Liu, B; Parisien, M; Gillett, C; McKinney, S; Green, AR; Murphy, L; Purushotham, A; Ellis, IO; Pharoah, PD; Rueda, C; Aparicio, S; Caldas, C; Curtis, C				Rueda, Oscar M.; Sammut, Stephen-John; Seoane, Jose A.; Chin, Suet-Feung; Caswell-Jin, Jennifer L.; Callari, Maurizio; Batra, Rajbir; Pereira, Bernard; Bruna, Alejandra; Ali, H. Raza; Provenzano, Elena; Liu, Bin; Parisien, Michelle; Gillett, Cheryl; McKinney, Steven; Green, Andrew R.; Murphy, Leigh; Purushotham, Arnie; Ellis, Ian O.; Pharoah, Paul D.; Rueda, Cristina; Aparicio, Samuel; Caldas, Carlos; Curtis, Christina			Dynamics of breast-cancer relapse reveal late-recurring ER-positive genomic subgroups	NATURE			English	Article							PROGNOSTIC-FACTORS; R/BIOCONDUCTOR PACKAGE; COMPETING RISKS; 1ST RECURRENCE; SURVIVAL; AMPLIFICATION; PREDICTION; CHEMOTHERAPY; REGRESSION; THERAPY	The rates and routes of lethal systemic spread in breast cancer are poorly understood owing to a lack of molecularly characterized patient cohorts with long-term, detailed follow-up data. Longterm follow-up is especially important for those with oestrogen-receptor (ER)-positive breast cancers, which can recur up to two decades after initial diagnosis(1-6). It is therefore essential to identify patients who have a high risk of late relapse(7-9). Here we present a statistical framework that models distinct disease stages (locoregional recurrence, distant recurrence, breast-cancer-related death and death from other causes) and competing risks of mortality from breast cancer, while yielding individual risk-of-recurrence predictions. We apply this model to 3,240 patients with breast cancer, including 1,980 for whom molecular data are available, and delineate spatiotemporal patterns of relapse across different categories of molecular information (namely immunohistochemical subtypes; PAM50 subtypes, which are based on gene-expression patterns(10,11); and integrative or IntClust subtypes, which are based on patterns of genomic copy-number alterations and gene expression(12,13)). We identify four late-recurring integrative subtypes, comprising about one quarter (26%) of tumours that are both positive for ER and negative for human epidermal growth factor receptor 2, each with characteristic tumour-driving alterations in genomic copy number and a high risk of recurrence (mean 47-62%) up to 20 years after diagnosis. We also define a subgroup of triple-negative breast cancers in which cancer rarely recurs after five years, and a separate subgroup in which patients remain at risk. Use of the integrative subtypes improves the prediction of late, distant relapse beyond what is possible with clinical covariates (nodal status, tumour size, tumour grade and immunohistochemical subtype). These findings highlight opportunities for improved patient stratification and biomarker-driven clinical trials.	[Rueda, Oscar M.; Sammut, Stephen-John; Chin, Suet-Feung; Callari, Maurizio; Batra, Rajbir; Pereira, Bernard; Bruna, Alejandra; Ali, H. Raza; Liu, Bin; Pharoah, Paul D.; Caldas, Carlos] Univ Cambridge, Li Ka Shing Ctr, Canc Res UK Cambridge Inst, Cambridge, England; [Rueda, Oscar M.; Sammut, Stephen-John; Chin, Suet-Feung; Callari, Maurizio; Batra, Rajbir; Pereira, Bernard; Bruna, Alejandra; Ali, H. Raza; Liu, Bin; Pharoah, Paul D.; Caldas, Carlos] Univ Cambridge, Li Ka Shing Ctr, Dept Oncol, Cambridge, England; [Seoane, Jose A.; Caswell-Jin, Jennifer L.; Curtis, Christina] Stanford Univ, Dept Med, Div Oncol, Sch Med, Stanford, CA 94305 USA; [Seoane, Jose A.; Curtis, Christina] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Seoane, Jose A.; Curtis, Christina] Stanford Univ, Sch Med, Stanford Canc Inst, Stanford, CA 94305 USA; [Provenzano, Elena; Pharoah, Paul D.; Caldas, Carlos] Cambridge Univ Hosp NHS Fdn Trust, Addenbrookes Hosp, Cambridge Breast Unit, Cambridge, England; [Provenzano, Elena; Pharoah, Paul D.; Caldas, Carlos] Cambridge Univ Hosp NHS Fdn Trust, NIHR Cambridge Biomed Res Ctr, Cambridge, England; [Provenzano, Elena; Pharoah, Paul D.; Caldas, Carlos] Cambridge Univ Hosp NHS Fdn Trust, Cambridge Expt Canc Med Ctr, Cambridge, England; [Parisien, Michelle; Murphy, Leigh] Res Inst Oncol & Hematol, Winnipeg, MB, Canada; [Gillett, Cheryl; Purushotham, Arnie] Kings Coll London, Canc Div, Guys & St Thomas NHS Fdn Trust & Res Oncol, NIHR Comprehens Biomed Res Ctr, London, England; [McKinney, Steven; Aparicio, Samuel] British Columbia Canc Res Ctr, Dept Mol Oncol, Vancouver, BC, Canada; [Green, Andrew R.; Ellis, Ian O.] Univ Nottingham, Sch Med, Div Canc & Stem Cells, Nottingham, England; [Green, Andrew R.; Ellis, Ian O.] Nottingham Univ Hosp NHS Trust, Nottingham, England; [Pharoah, Paul D.] Univ Cambridge, Strangeways Res Lab, Cambridge, England; [Rueda, Cristina] Univ Valladolid, Dept Estadist & Invest Operat, Valladolid, Spain	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; CRUK Cambridge Institute; University of Cambridge; Stanford University; Stanford University; Stanford Cancer Institute; Stanford University; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; University of Cambridge; University of London; King's College London; British Columbia Cancer Agency; University of Nottingham; Nottingham University Hospital NHS Trust; University of Cambridge; Universidad de Valladolid	Caldas, C (corresponding author), Univ Cambridge, Li Ka Shing Ctr, Canc Res UK Cambridge Inst, Cambridge, England.; Caldas, C (corresponding author), Univ Cambridge, Li Ka Shing Ctr, Dept Oncol, Cambridge, England.; Curtis, C (corresponding author), Stanford Univ, Dept Med, Div Oncol, Sch Med, Stanford, CA 94305 USA.; Curtis, C (corresponding author), Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.; Curtis, C (corresponding author), Stanford Univ, Sch Med, Stanford Canc Inst, Stanford, CA 94305 USA.; Caldas, C (corresponding author), Cambridge Univ Hosp NHS Fdn Trust, Addenbrookes Hosp, Cambridge Breast Unit, Cambridge, England.; Caldas, C (corresponding author), Cambridge Univ Hosp NHS Fdn Trust, NIHR Cambridge Biomed Res Ctr, Cambridge, England.; Caldas, C (corresponding author), Cambridge Univ Hosp NHS Fdn Trust, Cambridge Expt Canc Med Ctr, Cambridge, England.	Carlos.Caldas@cruk.cam.ac.uk; cncurtis@stanford.edu	Seoane, Jose A./A-5926-2011; Rueda, Oscar/ABF-5479-2020; Green, Andrew/AAF-1991-2020; Callari, Maurizio/AAF-7089-2019; Caldas, Carlos/U-7250-2019; Pharoah, Paul/V-6658-2019; Batra, Rajbir/I-2443-2014	Seoane, Jose A./0000-0002-3856-9177; Rueda, Oscar/0000-0003-0008-4884; Callari, Maurizio/0000-0001-5239-0918; Caldas, Carlos/0000-0003-3547-1489; Pharoah, Paul/0000-0001-8494-732X; Ellis, Ian/0000-0001-5292-8474; Rueda Sabater, Cristina/0000-0001-9179-3154; Sammut, Stephen John/0000-0003-4472-904X; Caswell-Jin, Jennifer/0000-0002-5711-8355; Purushotham, Arnie/0000-0001-8577-9655; Batra, Rajbir/0000-0001-7010-8189; Bruna, Alejandra/0000-0003-1214-9665; Green, Andrew/0000-0002-0488-5913; Aparicio, Samuel/0000-0002-0487-9599	Cancer Research UK (CRUK) [SWAH/047]; ECMC; NIHR; Mark Foundation for Cancer Research; Cancer Research UK Cambridge Centre [C9685/A25177]; National Institutes of Health [DP1-CA238296]; American Association for Cancer Research; Breast Cancer Research Foundation;  [MTM2015-71217-R]; NATIONAL CANCER INSTITUTE [DP1CA238296] Funding Source: NIH RePORTER	Cancer Research UK (CRUK)(Cancer Research UK); ECMC; NIHR(National Institute for Health Research (NIHR)); Mark Foundation for Cancer Research; Cancer Research UK Cambridge Centre; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Association for Cancer Research; Breast Cancer Research Foundation; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the women who participated in this study and the UK Cancer Registry. O.M.R. was supported by a Cancer Research UK (CRUK) travel grant (SWAH/047) to visit C. Curtis' laboratory. C.R. is supported by award MTM2015-71217-R. C. Caldas is supported by ECMC, NIHR, the Mark Foundation for Cancer Research and Cancer Research UK Cambridge Centre (C9685/A25177). C. Curtis is supported by the National Institutes of Health through the NIH Director's Pioneer Award (DP1-CA238296), the American Association for Cancer Research and the Breast Cancer Research Foundation. This study is dedicated to J.M.W. and J.N.W.	Aalen OO, 2008, STAT BIOL HEALTH, P1; Ali HR, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0431-1; Blows FM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000279; Broet P, 1999, BREAST CANCER RES TR, V54, P83, DOI 10.1023/A:1006197524405; CLARK GM, 1987, J CLIN ONCOL, V5, P55, DOI 10.1200/JCO.1987.5.1.55; Clarke C, 2013, CARCINOGENESIS, V34, P2300, DOI 10.1093/carcin/bgt208; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Davies C, 2013, LANCET, V381, P805, DOI 10.1016/S0140-6736(12)61963-1; de Wreede LC, 2011, J STAT SOFTW, V38, P1; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Dowsett M, 2018, J CLIN ONCOL, V36, P1941, DOI 10.1200/JCO.2017.76.4258; DUNNETT CW, 1955, J AM STAT ASSOC, V50, P1096, DOI 10.2307/2281208; Fiocco M, 2008, STAT MED, V27, P4340, DOI 10.1002/sim.3305; FISHER B, 1991, LANCET, V338, P327, DOI 10.1016/0140-6736(91)90475-5; FIX EVELYN, 1951, HUMAN BIOL, V23, P205; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gendoo DMA, 2016, BIOINFORMATICS, V32, P1097, DOI 10.1093/bioinformatics/btv693; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; Harris LN, 2016, J CLIN ONCOL, V34, P1134, DOI 10.1200/JCO.2015.65.2289; Holland DG, 2011, EMBO MOL MED, V3, P167, DOI 10.1002/emmm.201100122; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Insa A, 1999, BREAST CANCER RES TR, V56, P67, DOI 10.1023/A:1006285726561; Kennecke H, 2010, J CLIN ONCOL, V28, P3271, DOI 10.1200/JCO.2009.25.9820; KLEIN JP, 1993, STAT MED, V12, P2315, DOI 10.1002/sim.4780122408; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Li Y, 2010, NAT MED, V16, P214, DOI 10.1038/nm.2090; Liu HQ, 2017, CELL REP, V18, P2088, DOI 10.1016/j.celrep.2017.02.022; Loi S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-239; Meier-Hirmer C, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-80; Michaelson JS, 2011, BREAST CANCER RES TR, V128, P827, DOI 10.1007/s10549-011-1366-9; Miller LD, 2005, P NATL ACAD SCI USA, V102, P17882, DOI 10.1073/pnas.0509474102; Nagalla S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r34; Ormandy CJ, 2003, BREAST CANCER RES TR, V78, P323, DOI 10.1023/A:1023033708204; Pan HC, 2017, NEW ENGL J MED, V377, P1836, DOI 10.1056/NEJMoa1701830; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Pearson A, 2016, CANCER DISCOV, V6, P838, DOI 10.1158/2159-8290.CD-15-1246; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; PRENTICE RL, 1981, BIOMETRIKA, V68, P373, DOI 10.1093/biomet/68.2.373; Putter H, 2007, STAT MED, V26, P2389, DOI 10.1002/sim.2712; Putter H, 2006, BIOMETRICAL J, V48, P366, DOI 10.1002/bimj.200510218; Reis JS, 2006, CLIN CANCER RES, V12, P6652, DOI 10.1158/1078-0432.CCR-06-1164; Richman J, 2019, NAT REV CLIN ONCOL, V16, P296, DOI 10.1038/s41571-018-0145-5; Sanchez-Garcia F, 2014, CELL, V159, P1461, DOI 10.1016/j.cell.2014.10.048; Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206; Schroder MS, 2011, BIOINFORMATICS, V27, P3206, DOI 10.1093/bioinformatics/btr511; Sestak I, 2013, JNCI-J NATL CANCER I, V105, P1504, DOI 10.1093/jnci/djt244; Sgroi DC, 2013, LANCET ONCOL, V14, P1067, DOI 10.1016/S1470-2045(13)70387-5; Shrestha Y, 2012, ONCOGENE, V31, P3397, DOI 10.1038/onc.2011.515; Sledge GW, 2014, J CLIN ONCOL, V32, P1979, DOI 10.1200/JCO.2014.55.4139; Team RC., 2013, R LANG ENV STAT COMP; Therneau TM, 2000, MODELING SURVIVAL DA; Wapnir IL, 2008, CLIN BREAST CANCER, V8, P287, DOI 10.3816/CBC.2008.n.035; Wishart GC, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2464	54	127	129	4	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 21	2019	567	7748					399	+		10.1038/s41586-019-1007-8	http://dx.doi.org/10.1038/s41586-019-1007-8			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP9JT	30867590	Green Submitted, Green Accepted			2022-12-28	WOS:000462010000057
J	Glover, RE; Dangoor, M; Mays, N				Glover, Rebecca E.; Dangoor, Margaret; Mays, Nicholas			PERSONAL VIEW Antibiotic resistance: don't blame patients	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Glover, Rebecca E.; Mays, Nicholas] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London, England	University of London; London School of Hygiene & Tropical Medicine	Glover, RE (corresponding author), London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London, England.	rebecca.glover@lshtm.ac.uk		Glover, Rebecca/0000-0001-9150-9977				Cole A, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5238; Gaarslev C, 2016, ANTIMICROB RESIST IN, V5, DOI 10.1186/s13756-016-0134-3; Gjelstad S, 2011, J ANTIMICROB CHEMOTH, V66, P2425, DOI 10.1093/jac/dkr295; Jabaley CS, 2018, CRIT CARE, V22, DOI 10.1186/s13054-017-1914-8; Masiero G, 2010, INT J PUBLIC HEALTH, V55, P469, DOI 10.1007/s00038-010-0167-y; Murphy M, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X593820; Public Health England, 2018, ENGL SURV PROGR ANT; Tangcharoensathien V, 2018, B WORLD HEALTH ORGAN, V96, P141, DOI 10.2471/BLT.17.199687	8	6	7	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 19	2019	364								l1218	10.1136/bmj.l1218	http://dx.doi.org/10.1136/bmj.l1218			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HQ7ZZ	30890532	Green Submitted			2022-12-28	WOS:000462644400004
J	Mayor, S				Mayor, Susan			Catheter ablation for atrial fibrillation no better than drug therapy for reducing death or disabling stroke, trial finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item															National Institutes of Health, the National Heart, Lung and Blood Institute; Biosense Webster; Boston Scientific Corp.; Mayo Clinic; St Jude Medical Foundation; St Jude Foundation and Corporation; Medtronic	National Institutes of Health, the National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Biosense Webster; Boston Scientific Corp.(Boston Scientific); Mayo Clinic; St Jude Medical Foundation(St. Jude Medical); St Jude Foundation and Corporation; Medtronic(Medtronic)	The research was funded by awards from the National Institutes of Health, the National Heart, Lung and Blood Institute, Mayo Clinic, St Jude Medical Foundation, St Jude Foundation and Corporation, Biosense Webster, Medtronic, and Boston Scientific Corp.	Albert CM, 2019, JAMA-J AM MED ASSOC, DOI [10.1001/jama.2018.17478.30874732, DOI 10.1001/JAMA.2018.17478.30874732]; Mark DB, 2019, JAMA-J AM MED ASSOC, DOI [10.1001/jama.2019.0692.30874716, DOI 10.1001/JAMA.2019.0692.30874716]; Packer DL, 2019, JAMA-J AM MED ASSOC, DOI [10.1001/jama.2019.0693.30874766, DOI 10.1001/JAMA.2019.0693.30874766]	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 18	2019	364								l1254	10.1136/bmj.l1254	http://dx.doi.org/10.1136/bmj.l1254			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HQ7ZV	30885895				2022-12-28	WOS:000462643800011
J	Shitara, K; Chen, XQ				Shitara, Kohei; Chen, Xinqun			The KEYNOTE-061 trial Reply	LANCET			English	Letter									[Shitara, Kohei] Natl Canc Ctr Hosp East, Kashiwa, Chiba 2770882, Japan; [Chen, Xinqun] Merck & Co Inc, Biostat & Res Decis Sci, Kenilworth, NJ USA	National Cancer Center - Japan; Merck & Company	Shitara, K (corresponding author), Natl Canc Ctr Hosp East, Kashiwa, Chiba 2770882, Japan.	kshitara@east.ncc.go.jp	Shitara, Kohei/AAA-3877-2021					Moher David, 2012, Int J Surg, V10, P28, DOI 10.1016/j.ijsu.2011.10.001; Shitara K, 2018, LANCET, V392, P123, DOI 10.1016/S0140-6736(18)31257-1	2	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 16	2019	393	10176					1099	1099		10.1016/S0140-6736(18)33076-9	http://dx.doi.org/10.1016/S0140-6736(18)33076-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP1HF	30894266				2022-12-28	WOS:000461416600022
J	Mildner, A; Yona, S				Mildner, Alexander; Yona, Simon			Mapping the lung	SCIENCE			English	Editorial Material							MACROPHAGES		[Mildner, Alexander] Max Delbruck Ctr Mol Med, Berlin, Germany; [Yona, Simon] Hebrew Univ Jerusalem, Fac Dent Med, Jerusalem, Israel	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Hebrew University of Jerusalem	Yona, S (corresponding author), Hebrew Univ Jerusalem, Fac Dent Med, Jerusalem, Israel.	s.yona@mail.huji.ac.il	mildner, alexander/AAF-9451-2022; Mildner, Alexander/ABG-6122-2020; Yona, Simon/ABE-6572-2020; mildner, alexander/GQA-3761-2022; mildner, alexander/AFK-2161-2022	mildner, alexander/0000-0002-2019-8427; mildner, alexander/0000-0002-2019-8427; mildner, alexander/0000-0002-2019-8427; Yona, Simon/0000-0002-3984-2008	DFG [MI1328]	DFG(German Research Foundation (DFG))	A.M. is a Heisenberg fellow supported by the DFG (MI1328).	Chakarov S, 2019, SCIENCE, V363, P1190, DOI 10.1126/science.aau0964; Cronk JC, 2018, J EXP MED, V215, P1627, DOI 10.1084/jem.20180247; De Schepper S, 2018, CELL, V175, P400, DOI 10.1016/j.cell.2018.07.048; Gibbings SL, 2017, AM J RESP CELL MOL, V57, P66, DOI 10.1165/rcmb.2016-0361OC; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Guilliams M, 2018, IMMUNITY, V49, P595, DOI 10.1016/j.immuni.2018.10.005; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Jenkins RG, 2017, AM J RESP CELL MOL, V56, P667, DOI 10.1165/rcmb.2017-0096ST; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Lim HY, 2018, IMMUNITY, V49, P326, DOI [10.1016/j.immuni.2018.06.008, 10.1016/j.immuni.2018.12.009]; Pirzgalska RM, 2017, NAT MED, V23, P1309, DOI 10.1038/nm.4422; Shaw TN, 2018, J EXP MED, V215, P1507, DOI 10.1084/jem.20180019; Shemer A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07548-5; Wolf Y, 2017, NAT IMMUNOL, V18, P665, DOI 10.1038/ni.3746	14	0	0	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 15	2019	363	6432			SI		1154	1155		10.1126/science.aaw6775	http://dx.doi.org/10.1126/science.aaw6775			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HP0BC	30872510				2022-12-28	WOS:000461329000029
J	Nkengasong, JN				Nkengasong, John N.			How Africa can quell the next disease outbreaks	NATURE			English	Editorial Material									[Nkengasong, John N.] Africa Ctr Dis Control & Prevent, Addis Ababa, Ethiopia		Nkengasong, JN (corresponding author), Africa Ctr Dis Control & Prevent, Addis Ababa, Ethiopia.	nkengasongj@africa-union.org							0	9	9	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 14	2019	567	7747					147	147						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HO7LD	30858557	Bronze			2022-12-28	WOS:000461126600012
J	Rosenbaum, JT; Rifkin, LM; Buch, KA; Barshak, MB; Hoang, MP				Rosenbaum, James T.; Rifkin, Lana M.; Buch, Karen A.; Barshak, Miriam B.; Hoang, Mai P.			Case 8-2019: A 58-Year-Old Woman with Vision Loss, Headaches, and Oral Ulcers	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SYPHILITIC UVEITIS; OUTCOMES		[Rosenbaum, James T.] Oregon Hlth & Sci Univ, Dept Ophthalmol, Portland, OR 97201 USA; [Rosenbaum, James T.] Oregon Hlth & Sci Univ, Dept Med, Portland, OR 97201 USA; [Rosenbaum, James T.] Oregon Hlth & Sci Univ, Dept Cell Biol, Portland, OR 97201 USA; [Rosenbaum, James T.] Legacy Devers Eye Inst, Portland, OR 97210 USA; [Rifkin, Lana M.] Ophthalm Consultants Boston, Dept Ophthalmol, Boston, MA USA; [Buch, Karen A.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA; [Barshak, Miriam B.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Buch, Karen A.] Harvard Med Sch, Dept Radiol, Boston, MA 02115 USA; [Barshak, Miriam B.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Hoang, Mai P.] Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Devers Eye Institute; Ophthalmic Consultants of Boston; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Rosenbaum, JT (corresponding author), Oregon Hlth & Sci Univ, Dept Ophthalmol, Portland, OR 97201 USA.; Rosenbaum, JT (corresponding author), Oregon Hlth & Sci Univ, Dept Med, Portland, OR 97201 USA.; Rosenbaum, JT (corresponding author), Oregon Hlth & Sci Univ, Dept Cell Biol, Portland, OR 97201 USA.; Rosenbaum, JT (corresponding author), Legacy Devers Eye Inst, Portland, OR 97210 USA.			Buch, Karen/0000-0001-9579-8921				Amaratunge BC, 2010, CLIN EXP OPHTHALMOL, V38, P68, DOI 10.1111/j.1442-9071.2010.02203.x; [Anonymous], 2002, NEW ENGL J MED, V347, P1350; Conrady CD, 2018, GRAEF ARCH CLIN EXP, V256, P187, DOI 10.1007/s00417-017-3835-2; Davis JL, 2014, CURR OPIN OPHTHALMOL, V25, P513, DOI 10.1097/ICU.0000000000000099; de Menthon M, 2009, ARTHRIT CARE RES, V61, P1287, DOI 10.1002/art.24642; Furtado JM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30559-7; GASS JDM, 1990, OPHTHALMOLOGY, V97, P1288; Hall WJ, 2015, AM J PUBLIC HEALTH, V105, pE60, DOI 10.2105/AJPH.2015.302903; Hook EW, 2017, LANCET, V389, P1550, DOI 10.1016/S0140-6736(16)32411-4; Jabs DA, 1999, J CLIN MICROBIOL, V37, P1431, DOI 10.1128/JCM.37.5.1431-1435.1999; Okada AA, 2012, ARCH OPHTHALMOL-CHIC, V130, P592, DOI 10.1001/archophthalmol.2011.2698; Patel DV, 2013, OPHTHALMOLOGY, V120, P773, DOI 10.1016/j.ophtha.2012.10.028; Rosenbaum J, 2017, UVEITIS ETIOLOGY CLI; Shalaby IA, 1997, ARCH OPHTHALMOL-CHIC, V115, P469, DOI 10.1001/archopht.1997.01100150471003; Smith JR, 2004, BRIT J OPHTHALMOL, V88, P1498, DOI 10.1136/bjo.2003.040519; Smith JR, 2007, NAT CLIN PRACT RHEUM, V3, P219, DOI 10.1038/ncprheum0454; Thi HCT, 2005, GRAEF ARCH CLIN EXP, V243, P863, DOI 10.1007/s00417-005-1137-6; Touitou V, 2015, CURR OPIN OPHTHALMOL, V26, P526, DOI 10.1097/ICU.0000000000000213; Westeneng AC, 2007, AM J OPHTHALMOL, V144, P781, DOI 10.1016/j.ajo.2007.06.034; Wickremasinghe S, 2009, OPHTHALMOLOGY, V116, P1195, DOI 10.1016/j.ophtha.2008.12.055; Workowski KA, 2015, MMWR RECOMM REP, V64, P1, DOI 10.15585/mmwr.rr7004a1	21	1	1	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 14	2019	380	11					1062	1071		10.1056/NEJMcpc1810395	http://dx.doi.org/10.1056/NEJMcpc1810395			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HO8NL	30865802				2022-12-28	WOS:000461210000012
J	Swindells, S; Ramchandani, R; Gupta, A; Benson, CA; Leon-Cruz, J; Mwelase, N; Juste, MAJ; Lama, JR; Valencia, J; Omoz-Oarhe, A; Supparatpinyo, K; Masheto, G; Mohapi, L; Escada, ROD; Mawlana, S; Banda, P; Severe, P; Hakim, J; Kanyama, C; Langat, D; Moran, L; Andersen, J; Fletcher, V; Nuermberger, E; Chaisson, RE				Swindells, S.; Ramchandani, R.; Gupta, A.; Benson, C. A.; Leon-Cruz, J.; Mwelase, N.; Juste, M. A. Jean; Lama, J. R.; Valencia, J.; Omoz-Oarhe, A.; Supparatpinyo, K.; Masheto, G.; Mohapi, L.; Escada, R. O. da Silva; Mawlana, S.; Banda, P.; Severe, P.; Hakim, J.; Kanyama, C.; Langat, D.; Moran, L.; Andersen, J.; Fletcher, V.; Nuermberger, E.; Chaisson, R. E.		BRIEF TB A5279 Study Team	One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RIO-DE-JANEIRO; ANTIRETROVIRAL THERAPY; LATENT TUBERCULOSIS; INFECTED PATIENTS; PEOPLE; ADULTS; PYRAZINAMIDE; PROPHYLAXIS; DEATH; RISK	BACKGROUND Tuberculosis is the leading killer of patients with human immunodeficiency virus (HIV) infection. Preventive therapy is effective, but current regimens are limited by poor implementation and low completion rates. METHODS We conducted a randomized, open-label, phase 3 noninferiority trial comparing the efficacy and safety of a 1-month regimen of daily rifapentine plus isoniazid (1-month group) with 9 months of isoniazid alone (9-month group) in HIV-infected patients who were living in areas of high tuberculosis prevalence or who had evidence of latent tuberculosis infection. The primary end point was the first diagnosis of tuberculosis or death from tuberculosis or an unknown cause. Noninferiority would be shown if the upper limit of the 95% confidence interval for the between-group difference in the number of events per 100 person-years was less than 1.25. RESULTS A total of 3000 patients were enrolled and followed for a median of 3.3 years. Of these patients, 54% were women; the median CD4+ count was 470 cells per cubic millimeter, and half the patients were receiving antiretroviral therapy. The primary end point was reported in 32 of 1488 patients (2%) in the 1-month group and in 33 of 1498 (2%) in the 9-month group, for an incidence rate of 0.65 per 100 person-years and 0.67 per 100 person-years, respectively (rate difference in the 1-month group, -0.02 per 100 person-years; upper limit of the 95% confidence interval, 0.30). Serious adverse events occurred in 6% of the patients in the 1-month group and in 7% of those in the 9-month group (P= 0.07). The percentage of treatment completion was significantly higher in the 1-month group than in the 9-month group (97% vs. 90%, P<0.001). CONCLUSIONS A 1-month regimen of rifapentine plus isoniazid was noninferior to 9 months of isoniazid alone for preventing tuberculosis in HIV-infected patients. The percentage of patients who completed treatment was significantly higher in the 1-month group. (Funded by the National Institute of Allergy and Infectious Diseases; BRIEF TB/A5279 ClinicalTrials.gov number, NCT01404312.)	[Swindells, S.] Univ Nebraska Med Ctr, Omaha, NE USA; [Swindells, S.; Leon-Cruz, J.; Andersen, J.] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Gupta, A.; Nuermberger, E.; Chaisson, R. E.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Moran, L.] Social & Sci Syst, Silver Spring, MD USA; [Benson, C. A.] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA; [Juste, M. A. Jean; Severe, P.] GHESKIO, Port Au Prince, Haiti; [Lama, J. R.; Valencia, J.] Asociac Civil Impacta Salud & Educ, Lima, Peru; [Omoz-Oarhe, A.; Masheto, G.] Botswana Harvard AIDS Partnership, Gaborone, Botswana; [Supparatpinyo, K.] Chiang Mai Univ, Chiang Mai, Thailand; [Mwelase, N.] Helen Joseph Hosp, Johannesburg, South Africa; [Mohapi, L.] Perinatal HIV Res Unit, Soweto, South Africa; [Mawlana, S.] Univ KwaZulu Natal, Durban, South Africa; [Escada, R. O. da Silva] Inst Pesquisa Clin Evandro Chagas, Rio De Janeiro, Brazil; [Banda, P.] Johns Hopkins Blantyre Clin Trials Unit, Blantyre, Malawi; [Kanyama, C.] Univ N Carolina, Lilongwe Clin Res Site, Lilongwe, Malawi; [Hakim, J.] Univ Zimbabwe, Harare, Zimbabwe; [Langat, D.] Kenya Govt Med Res Ctr, Walter Reed Clin Res Site, Nairobi, Kenya	University of Nebraska System; University of Nebraska Medical Center; Harvard University; Harvard T.H. Chan School of Public Health; Johns Hopkins University; Social & Scientific Systems; University of California System; University of California San Diego; Chiang Mai University; University of Kwazulu Natal; University of Zimbabwe; Kenya Medical Research Institute	Chaisson, RE (corresponding author), Johns Hopkins Univ, Sch Med, Ctr TB Res, 1550 Orleans St,1M-08, Baltimore, MD 21287 USA.	rchaiss@jhmi.edu		Gupta, Amita/0000-0001-7036-2718; VALENCIA HUAMANI, JAVIER/0000-0002-3635-1107	National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069423, UM1AI069436, UM1AI069399, UM1AI068634, UM1AI069456, UM1AI068636, UM1AI108568, UM1AI069481, P30AI094189, UM1AI069453, UM1AI106701, UM1AI069463] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by the National Institute of Allergy and Infectious Diseases; BRIEF TB/A5279 ClinicalTrials.gov number, NCT01404312.	Akolo C., 2010, COCHRANE DB SYST REV, V1, P1, DOI DOI 10.1002/14651858.CD000171.PUB3); [Anonymous], 2000, MMWR-MORBID MORTAL W, V50, P289; [Anonymous], 2015, NEW ENGL J MED, V373, P808; Badje A, 2017, LANCET GLOB HEALTH, V5, pE1080, DOI 10.1016/S2214-109X(17)30372-8; Brooks KM, 2018, CLIN INFECT DIS, V67, P193, DOI 10.1093/cid/ciy082; Chaisson RE, 2017, LANCET GLOB HEALTH, V5, pE1048, DOI 10.1016/S2214-109X(17)30390-X; Chesney MA, 2000, AIDS CARE, V12, P255, DOI 10.1080/09540120050042891; Dooley KE, 2019, C RETR OPP INF CROI, P4037; Durovni B, 2013, LANCET INFECT DIS, V13, P852, DOI 10.1016/S1473-3099(13)70187-7; Eldred LJ, 2010, AIDS, V24, pS1, DOI 10.1097/01.aids.0000391009.95149.ec; Fiske CT, 2014, INT J TUBERC LUNG D, V18, P421, DOI 10.5588/ijtld.13.0688; Getahun H, 2010, AIDS, V24, pS57, DOI 10.1097/01.aids.0000391023.03037.1f; Golub JE, 2007, AIDS, V21, P1441, DOI 10.1097/QAD.0b013e328216f441; Golub JE, 2015, CLIN INFECT DIS, V60, P639, DOI 10.1093/cid/ciu849; Gordin F, 2000, JAMA-J AM MED ASSOC, V283, P1445, DOI 10.1001/jama.283.11.1445; Hakim J, 2017, NEW ENGL J MED, V377, P233, DOI 10.1056/NEJMoa1615822; Halsey NA, 1998, LANCET, V351, P786, DOI 10.1016/S0140-6736(97)06532-X; KOPANOFF DE, 1978, AM REV RESPIR DIS, V117, P991; Lawn SD, 2012, INT J TUBERC LUNG D, V16, P995, DOI 10.5588/ijtld.12.0364; Martinson NA, 2011, NEW ENGL J MED, V365, P11, DOI 10.1056/NEJMoa1005136; Podany AT, 2015, CLIN INFECT DIS, V61, P1322, DOI 10.1093/cid/civ464; Rangaka MX, 2014, LANCET, V384, P682, DOI 10.1016/S0140-6736(14)60162-8; Samandari T, 2015, AIDS, V29, P351, DOI 10.1097/QAD.0000000000000535; Sandul AL, 2017, CLIN INFECT DIS, V65, P1085, DOI 10.1093/cid/cix505; Schechter M, 2006, AM J RESP CRIT CARE, V173, P922, DOI 10.1164/rccm.200512-1953OC; Sterling TR, 2016, AIDS, V30, P1607, DOI 10.1097/QAD.0000000000001098; Sterling TR, 2015, CLIN INFECT DIS, V61, P527, DOI 10.1093/cid/civ323; WHO, 2021, B WORLD HEALTH ORGAN, DOI DOI 10.2471/BLT.21.286807; Zhang TY, 2011, AM J RESP CRIT CARE, V184, P732, DOI 10.1164/rccm.201103-0397OC; Zhang TY, 2009, AM J RESP CRIT CARE, V180, P1151, DOI 10.1164/rccm.200905-0795OC	30	153	160	0	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 14	2019	380	11					1001	1011		10.1056/NEJMoa1806808	http://dx.doi.org/10.1056/NEJMoa1806808			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HO8NL	30865794	Green Accepted, Bronze			2022-12-28	WOS:000461210000004
J	Oliver, D				Oliver, David			David Oliver: Contentious comments from NHS England's chair	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Appleby J, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.l845; Cabinet Office, 2018, HM GOV PUBL APP CHAI; Campbell, 2014, GUARDIAN; Campbell D., 2019, GUARDIAN; Cowper A, 2019, HLTH SERV J; Donnelly L, 2013, TELEGRAPH, DOI 10340209/Cameron-extends-fund-for-cancer-drugs.html; Mclellan A, 2019, HLTH SERV J; Moss R, 2019, PERSONNEL TODAY; Smyth C., 2019, TIMES; Smyth C, 2013, TIMES	10	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 13	2019	364								l1082	10.1136/bmj.l1082	http://dx.doi.org/10.1136/bmj.l1082			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP5VW	30867153	Bronze			2022-12-28	WOS:000461751600007
J	Bosk, CL; Pedersen, KZ				Bosk, Charles L.; Pedersen, Kirstine Z.			Blind spots in the science of safety	LANCET			English	Editorial Material							QUALITY		[Bosk, Charles L.] Univ Penn, Dept Sociol, Philadelphia, PA 19072 USA; [Bosk, Charles L.] Univ Penn, Dept Anaesthesiol, Philadelphia, PA 19072 USA; [Bosk, Charles L.] Univ Penn, Dept Crit Care, Philadelphia, PA 19072 USA; [Bosk, Charles L.] Univ Penn, Leonard Davis Inst Hlth Policy, Philadelphia, PA 19072 USA; [Pedersen, Kirstine Z.] Copenhagen Business Sch, Dept Org, DK-2000 Frederiksberg, Denmark	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Copenhagen Business School	Bosk, CL (corresponding author), Univ Penn, Dept Sociol, Philadelphia, PA 19072 USA.; Bosk, CL (corresponding author), Univ Penn, Dept Anaesthesiol, Philadelphia, PA 19072 USA.; Bosk, CL (corresponding author), Univ Penn, Dept Crit Care, Philadelphia, PA 19072 USA.; Bosk, CL (corresponding author), Univ Penn, Leonard Davis Inst Hlth Policy, Philadelphia, PA 19072 USA.	cbosk@upenn.edu		Pedersen, Kirstine Zinck/0000-0002-7058-131X				Bosk CL, 2003, FORGIVE REMEMBER MAN; Dixon-Woods M, 2012, BMJ QUAL SAF, V21, P876, DOI 10.1136/bmjqs-2011-000760; Kohn KT, 2000, ERR IS HUMAN BUILDIN; Makary MA, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2139; Pedersen K.Z., 2018, ORG PATIENT SAFETY F; Power M., 1997, AUDIT SOC RITUALS VE; RELMAN AS, 1980, NEW ENGL J MED, V303, P963, DOI 10.1056/NEJM198010233031703; Waring J, 2016, SOCIOL HEALTH ILL, V38, P198, DOI 10.1111/1467-9566.12391	8	2	2	2	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 9	2019	393	10175					978	979		10.1016/S0140-6736(19)30441-6	http://dx.doi.org/10.1016/S0140-6736(19)30441-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HO0OW	30860042	Green Published			2022-12-28	WOS:000460604200016
J	Tanne, JH				Tanne, Janice Hopkins			AMA and Planned Parenthood sue to halt new US restrictions on abortion	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2019, AMA SUIT BLOCK ADM T	1	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 8	2019	364								l1102	10.1136/bmj.l1102	http://dx.doi.org/10.1136/bmj.l1102			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HO6TC	30850357				2022-12-28	WOS:000461063500009
J	Dyer, O				Dyer, Owen			Philippines to charge Sanofi staff and government officials over dengue vaccine	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		DYER O, 2017, BMJ-BRIT MED J, V359, DOI DOI 10.1136/BMJ.J5759; Republic of the Philippines Department of Justice, 2019, DOJ PAN FINDS PROB C	2	2	6	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 7	2019	364								l1088	10.1136/bmj.l1088	http://dx.doi.org/10.1136/bmj.l1088			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HO6TA	30846440				2022-12-28	WOS:000461063200012
J	Acholonu, R; Mangurian, C; Linos, E				Acholonu, Rhonda; Mangurian, Christina; Linos, Eleni			TIME'S UP Healthcare: Can we put an end to gender inequality and harassment in medicine?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SEXUAL-HARASSMENT; SALARY		[Acholonu, Rhonda; Mangurian, Christina] TIMES Healthcare, New York, NY USA; Albert Einstein Coll Med, New York, NY USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Weill Inst Neurosci, San Francisco, CA USA; [Linos, Eleni] Stanford Univ, Stanford, CA 94305 USA	Yeshiva University; University of California System; University of California San Francisco; Stanford University	Linos, E (corresponding author), Stanford Univ, Stanford, CA 94305 USA.	linos@stanford.edu						Choo EK, 2019, LANCET, V393, P499, DOI 10.1016/S0140-6736(19)30251-X; Choo EK, 2018, NEW ENGL J MED, V379, P1592, DOI 10.1056/NEJMp1809351; Girgis C, 2019, JAMA INTERN MED, V179, P279, DOI 10.1001/jamainternmed.2018.7974; Halley MC, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4926; Jagsi R, 2018, NEW ENGL J MED, V378, P209, DOI 10.1056/NEJMp1715962; Jena AB, 2016, JAMA INTERN MED, V176, P1294, DOI 10.1001/jamainternmed.2016.3284; Jenner S, 2019, JAMA INTERN MED, V179, P108, DOI 10.1001/jamainternmed.2018.4859; Muench U, 2015, JAMA-J AM MED ASSOC, V313, P1265, DOI 10.1001/jama.2015.1487; National Academies of Sciences Engineering and Medicine, 2018, SEX HAR WOM CLIM CUL; Nelson R, 2018, AM J NURS, V118, P19, DOI 10.1097/01.NAJ.0000532826.47647.42; Viglianti EM, 2018, LANCET, V392, P368, DOI 10.1016/S0140-6736(18)31502-2	11	5	5	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 5	2019	364								l987	10.1136/bmj.l987	http://dx.doi.org/10.1136/bmj.l987			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HO6SS	30837216				2022-12-28	WOS:000461062200008
J	[Anonymous]				[Anonymous]			The MMR Vaccine Is Not Associated With Risk for Autism	ANNALS OF INTERNAL MEDICINE			English	Editorial Material																			0	0	0	0	20	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 16	2019	170	8					I16	I16		10.7326/P19-0002	http://dx.doi.org/10.7326/P19-0002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HU7YQ	30831599				2022-12-28	WOS:000465499900002
J	Diamond, EL; Durham, BH; Ulaner, GA; Drill, E; Buthorn, J; Ki, M; Bitner, L; Cho, H; Young, RJ; Francis, JH; Rampal, R; Lacouture, M; Brody, LA; Ozkaya, N; Dogan, A; Rosen, N; Iasonos, A; Abdel-Wahab, O; Hyman, DM				Diamond, Eli L.; Durham, Benjamin H.; Ulaner, Gary A.; Drill, Esther; Buthorn, Justin; Ki, Michelle; Bitner, Lillian; Cho, Hana; Young, Robert J.; Francis, Jasmine H.; Rampal, Raajit; Lacouture, Mario; Brody, Lynn A.; Ozkaya, Neval; Dogan, Ahmet; Rosen, Neal; Iasonos, Alexia; Abdel-Wahab, Omar; Hyman, David M.			Efficacy of MEK inhibition in patients with histiocytic neoplasms	NATURE			English	Article							ERDHEIM-CHESTER DISEASE; HIGH PREVALENCE; BRAF MUTATIONS; CELL; VEMURAFENIB; MAP2K1; COBIMETINIB; ACTIVATION; TRAMETINIB	Histiocytic neoplasms are a heterogeneous group of clonal haematopoietic disorders that are marked by diverse mutations in the mitogen-activated protein kinase (MAPK) pathway(1,2). For the 50% of patients with histiocytosis who have BRAF(V600) mutations(3-5), RAF inhibition is highly efficacious and has markedly altered the natural history of the disease(6,7). However, no standard therapy exists for the remaining 50% of patients who lack BRAF(V600) mutations. Although ERK dependence has been hypothesized to be a consistent feature across histiocytic neoplasms, this remains clinically unproven and many of the kinase mutations that are found in patients who lack BRAF(V600) mutations have not previously been biologically characterized. Here we show ERK dependency in histiocytoses through a proof-of-concept clinical trial of cobimetinib, an oral inhibitor of MEK1 and MEK2, in patients with histiocytoses. Patients were enrolled regardless of their tumour genotype. In parallel, MAPK alterations that were identified in treated patients were characterized for their ability to activate ERK. In the 18 patients that we treated, the overall response rate was 89% (90% confidence interval of 73-100). Responses were durable, with no acquired resistance to date. At one year, 100% of responses were ongoing and 94% of patients remained progression-free. Cobimetinib treatment was efficacious regardless of genotype, and responses were observed in patients with ARAF, BRAF, RAF1, NRAS, KRAS, MEK1 (also known as MAP2K1) and MEK2 (also known as MAP2K2) mutations. Consistent with the observed responses, the characterization of the mutations that we identified in these patients confirmed that the MAPK-pathway mutations were activating. Collectively, these data demonstrate that histiocytic neoplasms are characterized by a notable dependence on MAPK signalling-and that they are consequently responsive to MEK inhibition. These results extend the benefits of molecularly targeted therapy to the entire spectrum of patients with histiocytosis.	[Diamond, Eli L.; Buthorn, Justin] Mem Sloan Kettering Canc Ctr, Dept Neurol, 1275 York Ave, New York, NY 10021 USA; [Diamond, Eli L.; Ulaner, Gary A.; Young, Robert J.; Rampal, Raajit; Lacouture, Mario; Rosen, Neal; Iasonos, Alexia; Abdel-Wahab, Omar; Hyman, David M.] Weill Cornell Med Coll, New York, NY 10065 USA; [Durham, Benjamin H.; Ozkaya, Neval; Dogan, Ahmet] Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA; [Durham, Benjamin H.; Ki, Michelle; Bitner, Lillian; Cho, Hana; Abdel-Wahab, Omar] Mem Sloan Kettering Canc Ctr, Dept Med, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA; [Ulaner, Gary A.; Young, Robert J.; Brody, Lynn A.] Mem Sloan Kettering Canc Ctr, Dept Radiol, 1275 York Ave, New York, NY 10021 USA; [Drill, Esther; Iasonos, Alexia] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Francis, Jasmine H.] Mem Sloan Kettering Canc Ctr, Dept Med, Ophthalm Oncol Serv, 1275 York Ave, New York, NY 10021 USA; [Rampal, Raajit; Rosen, Neal; Abdel-Wahab, Omar; Hyman, David M.] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA; [Lacouture, Mario] Mem Sloan Kettering Canc Ctr, Dept Med, Dermatol Serv, New York, NY 10021 USA; [Ozkaya, Neval] NCI, Lab Pathol, Bethesda, MD 20892 USA; [Rosen, Neal] Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, 1275 York Ave, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Memorial Sloan Kettering Cancer Center	Abdel-Wahab, O; Hyman, DM (corresponding author), Weill Cornell Med Coll, New York, NY 10065 USA.; Abdel-Wahab, O (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA.; Abdel-Wahab, O; Hyman, DM (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA.	abdelwao@mskcc.org; hymand@mskcc.org	Rosen, Neal/ABF-2677-2020; Young, Robert J/AAD-9823-2020	Young, Robert J/0000-0001-7003-3017; Francis, Jasmine/0000-0002-7637-3108; Durham, Benjamin/0000-0001-8090-5448	Genentech; Histiocyte Society; Erdheim-Chester Disease Global Alliance; Functional Genomics Initiative of Memorial Sloan Kettering Cancer Center; Society of Memorial Sloan Kettering Cancer Center; Histiocytosis Association; Translational and Integrative Medicine Award of Memorial Sloan Kettering Cancer Center; Geoffrey Beene Center of Memorial Sloan Kettering Cancer Center; American Society of Hematology; Leukemia & Lymphoma Society; Frame Fund; Nonna's Garden Foundation; National Institutions of Health [P30 CA008748, 1 R01 CA201247, K08 CA218901]; NATIONAL CANCER INSTITUTE [R01CA201247, K08CA218901, P30CA008748] Funding Source: NIH RePORTER	Genentech(Roche HoldingGenentech); Histiocyte Society; Erdheim-Chester Disease Global Alliance; Functional Genomics Initiative of Memorial Sloan Kettering Cancer Center; Society of Memorial Sloan Kettering Cancer Center; Histiocytosis Association; Translational and Integrative Medicine Award of Memorial Sloan Kettering Cancer Center; Geoffrey Beene Center of Memorial Sloan Kettering Cancer Center; American Society of Hematology; Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); Frame Fund; Nonna's Garden Foundation; National Institutions of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the patients and their families for participating in this study. We thank Z. J. Tang for assisting with whole-exome genomic analysis and R. Kundra for assisting with the cBioPortal. This work was supported by Genentech and grants from the Histiocyte Society, the Erdheim-Chester Disease Global Alliance, the Functional Genomics Initiative of Memorial Sloan Kettering Cancer Center, the Society of Memorial Sloan Kettering Cancer Center, the Histiocytosis Association, the Translational and Integrative Medicine Award of Memorial Sloan Kettering Cancer Center, the Geoffrey Beene Center of Memorial Sloan Kettering Cancer Center, the American Society of Hematology, the Leukemia & Lymphoma Society, Frame Fund, Nonna's Garden Foundation and National Institutions of Health (P30 CA008748, 1 R01 CA201247 and K08 CA218901).	Abla O, 2018, BLOOD, V131, P2877, DOI 10.1182/blood-2018-03-839753; Allen CE, 2018, NEW ENGL J MED, V379, P856, DOI 10.1056/NEJMra1607548; Allen CE, 2015, BLOOD, V126, P26, DOI 10.1182/blood-2014-12-569301; Arnaud L, 2011, BLOOD, V117, P2778, DOI 10.1182/blood-2010-06-294108; Aubart FC, 2017, BLOOD, V130, P1377, DOI 10.1182/blood-2017-03-771873; Badalian-Very G, 2010, BLOOD, V116, P1919, DOI 10.1182/blood-2010-04-279083; Brown NA, 2014, BLOOD, V124, P1655, DOI 10.1182/blood-2014-05-577361; Chakraborty R, 2016, BLOOD, V128, P2533, DOI 10.1182/blood-2016-08-733790; Chakraborty R, 2014, BLOOD, V124, P3007, DOI 10.1182/blood-2014-05-577825; Cheng DT, 2015, J MOL DIAGN, V17, P251, DOI 10.1016/j.jmoldx.2014.12.006; Diamond EL, 2018, JAMA ONCOL, V4, P384, DOI 10.1001/jamaoncol.2017.5029; Diamond EL, 2016, CANCER DISCOV, V6, P154, DOI [10.1158/2159-8290.CD-15-0913, 10.1158/2159-8290.CD-NB2016-001]; Diamond EL, 2014, BLOOD, V124, P483, DOI 10.1182/blood-2014-03-561381; Durham BH, 2017, BLOOD, V130, P1644, DOI [10.1182/blood-2017-01765107, 10.1182/blood-2017-01-765107]; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Emery CM, 2009, P NATL ACAD SCI USA, V106, P20411, DOI 10.1073/pnas.0905833106; Emile JF, 2014, BLOOD, V124, P3016, DOI 10.1182/blood-2014-04-570937; Emile JF, 2013, J CLIN ONCOL, V31, P398, DOI 10.1200/JCO.2012.46.9676; Falchook GS, 2012, LANCET ONCOL, V13, P782, DOI 10.1016/S1470-2045(12)70269-3; Gao Y, 2018, CANCER DISCOV, V8, P648, DOI 10.1158/2159-8290.CD-17-1452; Gounder MM, 2018, NEW ENGL J MED, V378, P1945, DOI 10.1056/NEJMc1511490; Haroche J, 2017, LANCET ONCOL, V18, pE113, DOI 10.1016/S1470-2045(17)30031-1; Haroche J, 2012, BLOOD, V120, P2700, DOI 10.1182/blood-2012-05-430140; Hyman DM, 2015, NEW ENGL J MED, V373, P726, DOI 10.1056/NEJMoa1502309; Jacobsen E, 2017, NEW ENGL J MED, V377, P2398, DOI 10.1056/NEJMc1713676; Larkin J, 2014, NEW ENGL J MED, V371, P1867, DOI 10.1056/NEJMoa1408868; Nelson DS, 2014, BLOOD, V123, P3152, DOI 10.1182/blood-2013-06-511139; Pratilas CA, 2008, CANCER RES, V68, P9375, DOI 10.1158/0008-5472.CAN-08-2223; Rosen LS, 2016, INVEST NEW DRUG, V34, P604, DOI 10.1007/s10637-016-0374-3; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Zheng ZL, 2014, NAT MED, V20, P1479, DOI 10.1038/nm.3729	31	139	141	2	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 28	2019	567	7749					521	+		10.1038/s41586-019-1012-y	http://dx.doi.org/10.1038/s41586-019-1012-y			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ8EC	30867592	Green Accepted			2022-12-28	WOS:000462655800049
J	Glickman, A; DiMagno, SP; Emanuel, EJ				Glickman, Aaron; DiMagno, SarahS. P.; Emanuel, Ezekiel J.			Next Phase in Effective Cost Control in Health Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Glickman, Aaron; DiMagno, SarahS. P.; Emanuel, Ezekiel J.] Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, Philadelphia, PA 19104 USA; [Emanuel, Ezekiel J.] Univ Penn, Wharton Sch, Dept Hlth Care Management, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Emanuel, EJ (corresponding author), Univ Penn, Perelman Sch Med, 423 Guardian Dr,Blockley Hall,Ste 1412, Philadelphia, PA 19104 USA.	mehpchair@upenn.edu						Cooper Z, 2019, HEALTH AFFAIR, V38, P230, DOI 10.1377/hlthaff.2018.05245; Cooper Z, 2019, HEALTH AFFAIR, V38, P184, DOI 10.1377/hlthaff.2018.05424; Gallup, HEALTHC SYST; Henry J., 2018 EMPL HLTH BEN S; Martin AB, 2019, HEALTH AFFAIR, V38, P96, DOI 10.1377/hlthaff.2018.05085; Massachusetts Health Policy Commission, 2017 ANN HLTH CAR CO; Miller J, HLTH CARE REFORMS GR; Navathe AS, 2018, JAMA-J AM MED ASSOC, V320, P901, DOI 10.1001/jama.2018.12345	8	8	8	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 26	2019	321	12					1151	1152		10.1001/jama.2019.1608	http://dx.doi.org/10.1001/jama.2019.1608			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HR3XE	30844028				2022-12-28	WOS:000463074900005
J	McKenna, M				McKenna, Maryn			ANTIBIOTICS HIT THE ORCHARD	NATURE			English	News Item																			0	23	23	5	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 21	2019	567	7748					302	303		10.1038/d41586-019-00878-4	http://dx.doi.org/10.1038/d41586-019-00878-4			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HP9JT	30890811	Bronze			2022-12-28	WOS:000462010000032
J	Piana, S; Longo, C				Piana, Simonetta; Longo, Caterina			Diffuse Melanosis and Melanuria	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Piana, Simonetta; Longo, Caterina] Azienda Unita Sanit Locale Reggio Emilia IRCCS, Reggio Emilia, Italy		Piana, S (corresponding author), Azienda Unita Sanit Locale Reggio Emilia IRCCS, Reggio Emilia, Italy.	simonetta.piana@ausl.re.it	PIANA, SIMONETTA/AAC-9158-2019	PIANA, SIMONETTA/0000-0003-4875-6977					0	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 21	2019	380	12					1166	1166		10.1056/NEJMicm1810151	http://dx.doi.org/10.1056/NEJMicm1810151			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HP7VK	30893538				2022-12-28	WOS:000461898400012
J	Sancar, F				Sancar, Feyza			Breast Implant-Associated Lymphoma	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 19	2019	321	11					1042	1042		10.1001/jama.2019.1936	http://dx.doi.org/10.1001/jama.2019.1936			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JJ1JG	30874740				2022-12-28	WOS:000493916400002
J	Kmietowicz, Z				Kmietowicz, Zosia			BMA backs doctors fighting government over "discriminating" NHS pension scheme	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 12	2019	364								l1145	10.1136/bmj.l1145	http://dx.doi.org/10.1136/bmj.l1145			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP5VS	30862740				2022-12-28	WOS:000461751000018
J	Wise, J				Wise, Jacqui			The BMJ Awards 2019: Cancer Care Team of the Year	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 12	2019	364								l1116	10.1136/bmj.l1116	http://dx.doi.org/10.1136/bmj.l1116			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP5VS	30862640				2022-12-28	WOS:000461751000012
J	Bentzinger, CF				Bentzinger, C. Florian			Best supporting actors	SCIENCE			English	Editorial Material							STEM-CELL NICHE; REGENERATIVE CAPACITY; SKELETAL-MUSCLE; FIBRONECTIN		[Bentzinger, C. Florian] Univ Sherbrooke, Dept Pharmacol Physiol, Sherbrooke, PQ J1H 5N4, Canada	University of Sherbrooke	Bentzinger, CF (corresponding author), Univ Sherbrooke, Dept Pharmacol Physiol, Sherbrooke, PQ J1H 5N4, Canada.	cf.bentzinger@usherbrooke.ca	Bentzinger, C. Florian/A-1151-2015	Bentzinger, C. Florian/0000-0003-0422-9622				[Anonymous], 2015, Patent, Patent No. [PCT/US2015/022992, 2015022992]; [Anonymous], 2010, Patent, Patent No. [PCT/CA2010/000601, 2010000601]; [Anonymous], 2012, Patent, Patent No. [PCT/US2012/055396, 2012055396]; Bentzinger CF, 2014, J CELL BIOL, V205, P97, DOI 10.1083/jcb.201310035; Bentzinger CF, 2013, EMBO REP, V14, P1062, DOI 10.1038/embor.2013.182; Bentzinger CF, 2013, CELL STEM CELL, V12, P75, DOI 10.1016/j.stem.2012.09.015; Bentzinger CF, 2005, FASEB J, V19, P934, DOI 10.1096/fj.04-3376com; Dumont NA, 2015, NAT MED, V21, P1455, DOI 10.1038/nm.3990; Lukjanenko L, 2016, NAT MED, V22, P897, DOI 10.1038/nm.4126; Mashinchian O, 2018, CURR TOP DEV BIOL, V126, P23, DOI 10.1016/bs.ctdb.2017.08.003; von Maltzahn J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3869; von Maltzahn J, 2012, P NATL ACAD SCI USA, V109, P20614, DOI 10.1073/pnas.1215765109; von Maltzahn J, 2012, NAT CELL BIOL, V14, P186, DOI 10.1038/ncb2404	13	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 8	2019	363	6431					1051	1051		10.1126/science.aaw3613	http://dx.doi.org/10.1126/science.aaw3613			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HO2MV	30846594				2022-12-28	WOS:000460750100033
J	Srivastava, R				Srivastava, Ranjana			Through the Undulations of a Long Career - A Mentor's Legacy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Srivastava, Ranjana] Monash Hlth, Dept Med Oncol, Melbourne, Vic, Australia		Srivastava, R (corresponding author), Monash Hlth, Dept Med Oncol, Melbourne, Vic, Australia.								0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 7	2019	380	10					902	903		10.1056/NEJMp1812613	http://dx.doi.org/10.1056/NEJMp1812613			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HN8QX	30855739				2022-12-28	WOS:000460461500003
J	Balducci, S; D'Errico, V; Haxhi, J; Sacchetti, M; Orlando, G; Cardelli, P; Vitale, M; Bollanti, L; Conti, F; Zanuso, S; Lucisano, G; Nicolucci, A; Pugliese, G				Balducci, Stefano; D'Errico, Valeria; Haxhi, Jonida; Sacchetti, Massimo; Orlando, Giorgio; Cardelli, Patrizia; Vitale, Martina; Bollanti, Lucilla; Conti, Francesco; Zanuso, Silvano; Lucisano, Giuseppe; Nicolucci, Antonio; Pugliese, Giuseppe		Italian Diabet Exercise Study 2	Effect of a Behavioral Intervention Strategy on Sustained Change in Physical Activity and Sedentary Behavior in Patients With Type 2 Diabetes The IDES_2 Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LIFE-STYLE INTERVENTION; ALL-CAUSE MORTALITY; CARDIORESPIRATORY FITNESS; CARDIOVASCULAR-DISEASE; GLYCEMIC CONTROL; EXERCISE; PEOPLE; MEN; ADULTS; RISK	IMPORTANCE There is no definitive evidence that changes in physical activity/sedentary behavior can be maintained long term in individuals with type 2 diabetes. OBJECTIVE To investigate whether a behavioral intervention strategy can produce a sustained increase in physical activity and reduction in sedentary time among individuals with type 2 diabetes. DESIGN, SETTING, AND PARTICIPANTS The Italian Diabetes and Exercise Study 2 was an open-label, assessor-blinded, randomized clinical superioritytrial, with recruitment from October 2012 to February 2014 and follow-up until February 2017. In 3 outpatient diabetes clinics in Rome, 300 physically inactive and sedentary patients with type 2 diabetes were randomized 1: 1(stratified by center, age, and diabetes treatment) to receive a behavioral intervention or standard care for 3 years. INTERVENTIONS All participants received usual care targeted to meet American Diabetes Association guideline recommendations. Participants in the behavioral intervention group (n = 150) received 1 individual theoretical counseling session and 8 individual biweekly theoretical and practical counseling sessions each year. Participants in the standard care group (n = 150) received only general physician recommendations. MAIN OUTCOMES AND MEASURES Co-primary end points were sustained change in physical activity volume, time spent in light-intensity and moderate-to vigorous-intensity physical activity, and sedentary time, measured by an accelerometer. RESULTS Of the 300 randomized participants (mean [SD] age, 61.6 [8.5] years; 116 women [38.7%]), 267 completed the study (133 in the behavioral intervention group and 134 in the standard care group). Median follow-up was 3.0 years. Participants in the behavioral intervention and standard care groups accumulated, respectively, 13.8 vs 10.5 metabolic equivalent-h/wk of physical activity volume (difference, 3.3 [95% Cl, 2.2-4.4]; P < .001), 18.9 vs 12.5 min/d of moderate-to vigorous-intensity physical activity (difference, 6.4 [95% Cl, 5.0-7.8]; P < .001), 4.6 vs 3.8 h/d of light-intensity physical activity (difference, 0.8 [95% Cl, 0.5-1.1]; P < .001), and 10.9 vs 11.7 h/d of sedentary time (difference, -0.8 [95% Cl, -1.0 to -0.5]; P < .001). Significant between-group differences were maintained throughout the study, but the between-group difference in moderate-to vigorous-intensity physical activity decreased during the third year from 6.5 to 3.6 min/d. There were 41 adverse events in the behavioral intervention group and 59 in the standard care group outside of the sessions; participants in the behavioral intervention group experienced 30 adverse events during the sessions (most commonly musculoskeletal injury/discomfort and mild hypoglycemia). CONCLUSIONS AND RELEVANCE Among patients with type 2 diabetes at 3 diabetes clinics in Rome who were followed up for 3 years, a behavioral intervention strategy compared with standard care resulted in a sustained increase in physical activity and decrease in sedentary time. Further research is needed to assess the generalizability of these findings.	[Balducci, Stefano; D'Errico, Valeria; Haxhi, Jonida; Cardelli, Patrizia; Vitale, Martina; Bollanti, Lucilla; Conti, Francesco; Pugliese, Giuseppe] Univ Roma La Sapienza, Dept Clin & Mol Med, Via Grottarossa 1035-1039, I-00189 Rome, Italy; [Balducci, Stefano; D'Errico, Valeria; Haxhi, Jonida; Vitale, Martina; Bollanti, Lucilla; Conti, Francesco; Pugliese, Giuseppe] St Andrea Univ Hosp, Diabet Unit, Rome, Italy; [Balducci, Stefano; D'Errico, Valeria; Haxhi, Jonida] Metab Fitness Assoc, Rome, Italy; [Sacchetti, Massimo; Orlando, Giorgio] Foro Italico Univ, Dept Human Movement & Sport Sci, Rome, Italy; [Cardelli, Patrizia] St Andrea Univ Hosp, Clin Chem Lab, Rome, Italy; [Zanuso, Silvano] Univ Greenwich, Ctr Human Performance & Sport, Chatham, England; [Zanuso, Silvano] Coventry Univ, Fac Hlth & Life Sci, Ctr Appl Biol & Exercise Sci, Coventry, W Midlands, England; [Lucisano, Giuseppe; Nicolucci, Antonio] Consorzio Mario Negri Sud, Dept Clin Pharmacol & Epidemiol, Santa Maria Imbaro, Italy; [Lucisano, Giuseppe; Nicolucci, Antonio] Ctr Outcomes Res & Clin Epidemiol CORES, Pescara, Italy; [Balducci, Stefano] Metab Fitness Assoc ONLUS, Rome, Italy	Sapienza University Rome; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea; Foro Italico University of Rome; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea; University of Greenwich; Coventry University; Consorzio Mario Negri Sud	Pugliese, G (corresponding author), Univ Roma La Sapienza, Dept Clin & Mol Med, Via Grottarossa 1035-1039, I-00189 Rome, Italy.	giuseppe.pugliese@uniromal.it	Orlando, Giorgio/AAK-9159-2020; haxhi, jonida/M-4545-2013	Orlando, Giorgio/0000-0001-6721-8248; haxhi, jonida/0000-0003-2319-869X; Sacchetti, Massimo/0000-0002-5365-5161	Metabolic Fitness Association, Monterotondo, Rome, Italy	Metabolic Fitness Association, Monterotondo, Rome, Italy	This work was supported by the Metabolic Fitness Association, Monterotondo, Rome, Italy.	Andrews RC, 2011, LANCET, V378, P129, DOI 10.1016/S0140-6736(11)60442-X; [Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc12-s011, 10.2337/dc35-S011, 10.2337/dc12-s004]; Balducci S, 2017, DIABETES CARE, V40, P1444, DOI 10.2337/dc17-0594; Balducci S, 2015, TRIALS, V16, DOI 10.1186/s13063-015-1088-0; Balducci S, 2010, ARCH INTERN MED, V170, P1794, DOI 10.1001/archinternmed.2010.380; Balducci S, 2008, NUTR METAB CARDIOVAS, V18, P585, DOI 10.1016/j.numecd.2007.07.006; Barnes J, 2012, APPL PHYSIOL NUTR ME, V37, P540, DOI [10.1139/H2012-024, 10.1139/h2012-024]; Baskerville R, 2017, DIABETIC MED, V34, P612, DOI 10.1111/dme.13331; Batacan RB, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/596367; Blair SN, 1996, JAMA-J AM MED ASSOC, V276, P205, DOI 10.1001/jama.276.3.205; Church TS, 2004, DIABETES CARE, V27, P83, DOI 10.2337/diacare.27.1.83; Colberg SR, 2016, DIABETES CARE, V39, P2065, DOI 10.2337/dc16-1728; Cooper AR, 2012, DIABETOLOGIA, V55, P589, DOI 10.1007/s00125-011-2408-x; Harris T, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002526; Herrmann SD, 2011, BRIT J SPORT MED, V45, P109, DOI 10.1136/bjsm.2009.062182; Hobbs N, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-75; Inoue M, 2008, ANN EPIDEMIOL, V18, P522, DOI 10.1016/j.annepidem.2008.03.008; Johansen MY, 2017, JAMA-J AM MED ASSOC, V318, P637, DOI 10.1001/jama.2017.10169; King NA, 2012, BRIT J SPORT MED, V46, P315, DOI 10.1136/bjsm.2010.082495; Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681; Marcus BH, 2006, CIRCULATION, V114, P2739, DOI 10.1161/CIRCULATIONAHA.106.179683; McGinley SK, 2015, APPL PHYSIOL NUTR ME, V40, P1193, DOI 10.1139/apnm-2015-0169; Morrato EH, 2007, DIABETES CARE, V30, P203, DOI 10.2337/dc06-1128; Pahor M, 2014, JAMA-J AM MED ASSOC, V311, P2387, DOI 10.1001/jama.2014.5616; Prince SA, 2014, OBES REV, V15, P905, DOI 10.1111/obr.12215; Ried-Larsen M, 2018, DIABETES-METAB RES, V34, DOI 10.1002/dmrr.2999; Ross R, 2016, CIRCULATION, V134, pE653, DOI 10.1161/CIR.0000000000000461; Ruiz JR, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a439; Shephard RJ, 2003, BRIT J SPORT MED, V37, P197, DOI 10.1136/bjsm.37.3.197; Sieverdes John C, 2013, Clin Epidemiol, V5, P13, DOI 10.2147/CLEP.S38370; Singer J.D., 2003, APPL LONGITUDINAL DA; Stevens RJ, 2001, CLIN SCI, V101, P671, DOI 10.1042/CS20000335; Unick JL, 2016, MED SCI SPORT EXER, V48, P2437, DOI 10.1249/MSS.0000000000001054; van der Velde JHPM, 2018, DIABETOLOGIA, V61, P2561, DOI 10.1007/s00125-018-4719-7; Van der Velde JHPM, 2017, MED SCI SPORT EXER, V49, P1583, DOI 10.1249/MSS.0000000000001262; Wing RR, 2010, ARCH INTERN MED, V170, P1566, DOI 10.1001/archinternmed.2010.334	36	51	53	5	28	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 5	2019	321	9					880	890		10.1001/jama.2019.0922	http://dx.doi.org/10.1001/jama.2019.0922			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HN7EL	30835309	Bronze			2022-12-28	WOS:000460351600018
J	Dyer, C				Dyer, Clare			Former NHS England director pleads guilty to voyeurism	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		DYER C, 2017, BMJ-BRIT MED J, V356, DOI DOI 10.1136/BMJ.J997; RIMMER A, 2017, BMJ-BRIT MED J, V358, DOI DOI 10.1136/BMJ.J3637	2	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 4	2019	364								l1003	10.1136/bmj.l1003	http://dx.doi.org/10.1136/bmj.l1003			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HO6SQ	30833273				2022-12-28	WOS:000461061900010
J	Blanco, C; Volkow, ND				Blanco, Carlos; Volkow, Nora D.			Management of opioid use disorder in the USA: present status and future directions	LANCET			English	Review							EXTENDED-RELEASE NALTREXONE; NEONATAL ABSTINENCE SYNDROME; HEPATITIS-C VIRUS; BUPRENORPHINE-NALOXONE TREATMENT; SUBSTANCE USE DISORDERS; METHADONE-MAINTENANCE; UNITED-STATES; DRUG-USE; RISK-FACTORS; DEPENDENCE	Opioid use disorder is characterised by the persistent use of opioids despite the adverse consequences of its use. The disorder is associated with a range of mental and general medical comorbid disorders, and with increased mortality. Although genetics are important in opioid use disorder, younger age, male sex, and lower educational attainment level and income, increase the risk of opioid use disorder, as do certain psychiatric disorders (eg, other substance use disorders and mood disorders). The medications for opioid use disorder, which include methadone, buprenorphine, and extended-release naltrexone, significantly improve opioid use disorder outcomes. However, the effectiveness of medications for opioid use disorder is limited by problems at all levels of the care cascade, including diagnosis, entry into treatment, and retention in treatment. There is an urgent need for expanding the use of medications for opioid use disorder, including training of health-care professionals in the treatment and prevention of opioid use disorder, and for development of alternative medications and new models of care to expand capabilities for personalised interventions.	[Blanco, Carlos; Volkow, Nora D.] NIDA, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Blanco, C (corresponding author), NIDA, Bethesda, MD 20892 USA.	carlos.blanco2@nih.gov			NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000550] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Albert S, 2011, PAIN MED, V12, pS77, DOI 10.1111/j.1526-4637.2011.01128.x; Amato L, 2005, J SUBST ABUSE TREAT, V28, P321, DOI 10.1016/j.jsat.2005.02.007; Amato L, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005031.pub4; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Arora S, 2011, NEW ENGL J MED, V364, P2199, DOI 10.1056/NEJMoa1009370; Arora S, 2010, HEPATOLOGY, V52, P1124, DOI 10.1002/hep.23802; Auriacombe M, 2004, AM J ADDICTION, V13, pS17, DOI 10.1080/10550490490440780; Barnett ML, 2017, NEW ENGL J MED, V376, P663, DOI 10.1056/NEJMsa1610524; Baser O, 2011, AM J MANAG CARE, V17, pS6; Bisaga A, 2018, AM J ADDICTION, V27, P177, DOI 10.1111/ajad.12711; Blanco C, 2007, DRUG ALCOHOL DEPEN, V90, P252, DOI 10.1016/j.drugalcdep.2007.04.005; Blanco C, 2013, DRUG ALCOHOL DEPEN, V131, P143, DOI 10.1016/j.drugalcdep.2012.12.013; Bremer PT, 2014, MOL PHARMACEUT, V11, P1075, DOI 10.1021/mp400631w; Brooklyn JR, 2017, J ADDICT MED, V11, P286, DOI 10.1097/ADM.0000000000000310; Charlson FJ., 2016, MENTAL NEUROLOGICAL, P41, DOI DOI 10.1596/978-1-4648-0426-7; Chou R, 2017, COMP EFFECTIVENESS R; Cicero TJ, 2017, ADDICT BEHAV, V74, P63, DOI 10.1016/j.addbeh.2017.05.030; Collins FS, 2018, JAMA-J AM MED ASSOC, V320, P129, DOI 10.1001/jama.2018.8826; Comer SD, 2006, ARCH GEN PSYCHIAT, V63, P210, DOI 10.1001/archpsyc.63.2.210; Compton WM, 2016, NEW ENGL J MED, V374, P154, DOI 10.1056/NEJMra1508490; Compton WM JC, AJPH; Connock M, 2007, HEALTH TECHNOL ASSES, V11, P1; Crettol S, 2006, CLIN PHARMACOL THER, V80, P668, DOI 10.1016/j.clpt.2006.09.012; Crist RC, 2018, CNS DRUGS, V32, P305, DOI 10.1007/s40263-018-0513-9; CUSHMAN P, 1978, AM J MED, V65, P46, DOI 10.1016/0002-9343(78)90691-5; D'Onofrio G, 2015, JAMA-J AM MED ASSOC, V313, P1636, DOI 10.1001/jama.2015.3474; Davis JM, 2018, JAMA PEDIATR, V172, P741, DOI 10.1001/jamapediatrics.2018.1307; Dennis BB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086114; DeWire SM, 2013, J PHARMACOL EXP THER, V344, P708, DOI 10.1124/jpet.112.201616; Ducci F, 2009, AM J PSYCHIAT, V166, P1031, DOI 10.1176/appi.ajp.2009.08071068; Faggiano F., 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002208; Fajemirokun-Odudeyi O, 2006, EUR J OBSTET GYN R B, V126, P170, DOI 10.1016/j.ejogrb.2005.08.010; Falcon E, 2016, NEUROPSYCHOPHARMACOL, V41, P2344, DOI 10.1038/npp.2016.38; Fareed A, 2010, J ADDICT DIS, V29, P1, DOI 10.1080/10550880903436010; Ferri M, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003410.pub4; Fiellin DA, 2006, NEW ENGL J MED, V355, P365, DOI 10.1056/NEJMoa055255; Fiellin DA, 2014, JAMA INTERN MED, V174, P1947, DOI 10.1001/jamainternmed.2014.5302; Freeman PR, 2018, DRUG ALCOHOL DEPEN, V191, P361, DOI 10.1016/j.drugalcdep.2018.07.017; Gibson A, 2008, ADDICTION, V103, P462, DOI 10.1111/j.1360-0443.2007.02090.x; Gowing L, 2017, COCHRANE DB SYST REV, V5, DOI DOI 10.1002/14651858.CD002021.PUB4; Grall-Bronnec M, 2014, NEUROSCI BIOBEHAV R, V47, P592, DOI 10.1016/j.neubiorev.2014.10.013; Hadland SE, 2017, JAMA PEDIATR, V171, P747, DOI 10.1001/jamapediatrics.2017.0745; Han B, 2018, ANN INTERN MED, V168, P383, DOI 10.7326/L17-0700; HANDELSMAN L, 1987, AM J DRUG ALCOHOL AB, V13, P293, DOI 10.3109/00952998709001515; Heidebrecht F, 2018, ADDICT BEHAV, V77, P210, DOI 10.1016/j.addbeh.2017.10.013; Holmes AV, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-2929; Hurd YL, 2018, AM J PSYCHIAT, V175, P935, DOI 10.1176/appi.ajp.2018.18030352; Jones CM, 2017, ADDICT BEHAV, V65, P229, DOI 10.1016/j.addbeh.2016.08.027; Kauppi K, 2018, AM J PSYCHIAT, V175, P674, DOI 10.1176/appi.ajp.2017.17040410; Kay ES, 2016, AIDS RES THER, V13, DOI 10.1186/s12981-016-0120-0; Kendler KS, 2003, AM J PSYCHIAT, V160, P687, DOI 10.1176/appi.ajp.160.4.687; Khanna IK, 2015, J PAIN RES, V8, DOI 10.2147/JPR.S85951; Klevens RM, 2012, CLIN INFECT DIS, V55, pS3, DOI 10.1093/cid/cis393; Knudsen HK, 2015, J STUD ALCOHOL DRUGS, V76, P644, DOI 10.15288/jsad.2015.76.644; Komaromy M, 2016, SUBST ABUS, V37, P20, DOI 10.1080/08897077.2015.1129388; Kraft WK, 2017, NEW ENGL J MED, V376, P2341, DOI 10.1056/NEJMoa1614835; Krans EE, 2016, OBSTET GYNECOL, V128, P4, DOI 10.1097/AOG.0000000000001446; Krupitsky E, 2011, LANCET, V377, P1506, DOI 10.1016/S0140-6736(11)60358-9; Lee JD, 2018, LANCET, V391, P309, DOI 10.1016/S0140-6736(17)32812-X; Lee JD, 2016, NEW ENGL J MED, V374, P1232, DOI 10.1056/NEJMoa1505409; Levin FR, 2016, AM J ADDICTION, V25, P603, DOI 10.1111/ajad.12454; Ling W, 2005, ADDICTION, V100, P1090, DOI 10.1111/j.1360-0443.2005.01154.x; Lofwall MR, 2014, J ADDICT MED, V8, P315, DOI 10.1097/ADM.0000000000000045; Lopes M, 2012, J CLIN PSYCHIAT, V73, P384, DOI 10.4088/JCP.10m06304; Lupi M, 2017, J ECT, V33, P203, DOI 10.1097/YCT.0000000000000401; Lynch FL, 2014, ADDICT SCI CLIN PRAC, V9, DOI 10.1186/1940-0640-9-16; Mattick RP, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002207.pub3; Mattick RP, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002209.pub2; McDermott KA, 2015, J CLIN PSYCHIAT, V76, P189, DOI 10.4088/JCP.14m09096; McNeely J, 2016, ANN INTERN MED, V165, P690, DOI 10.7326/M16-0317; McNeely J, 2015, J GEN INTERN MED, V30, P1757, DOI 10.1007/s11606-015-3391-6; Merrall ELC, 2010, ADDICTION, V105, P1545, DOI 10.1111/j.1360-0443.2010.02990.x; Meyer-Lindenberg A, 2011, NAT REV NEUROSCI, V12, P524, DOI 10.1038/nrn3044; Moore BA, 2016, J SUBST ABUSE TREAT, V71, P54, DOI 10.1016/j.jsat.2016.08.016; Morgan JR, 2018, J SUBST ABUSE TREAT, V85, P90, DOI 10.1016/j.jsat.2017.07.001; Nelson EC, 2016, MOL PSYCHIATR, V21, P608, DOI 10.1038/mp.2015.102; Nielsen S, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011117.pub2; Nosyk B, 2012, ADDICTION, V107, P1621, DOI 10.1111/j.1360-0443.2012.03870.x; Nunes EV, 2015, J ADDICT MED, V9, P238, DOI 10.1097/ADM.0000000000000125; Olfson M, 2018, JAMA PSYCHIAT, V75, P820, DOI 10.1001/jamapsychiatry.2018.1471; Oquendo MA, 2018, NEW ENGL J MED, V378, P1567, DOI 10.1056/NEJMp1801417; Oviedo-Joekes E, 2016, JAMA PSYCHIAT, V73, P447, DOI 10.1001/jamapsychiatry.2016.0109; Patient Self-Management Education and Support members, 2014, PATIENT SELF MANAGEM; Peris J, 2017, J COMP NEUROL, V525, P1094, DOI 10.1002/cne.24116; PINCUS HA, 2017, CONFRONTING OUR NATI, P23; Pravetoni M, 2013, J MED CHEM, V56, P915, DOI 10.1021/jm3013745; Proctor SL, 2015, PSYCHOL ADDICT BEHAV, V29, P906, DOI 10.1037/adb0000090; Rosenblatt RA, 2015, ANN FAM MED, V13, P23, DOI 10.1370/afm.1735; Rosenthal RN, 2016, JAMA-J AM MED ASSOC, V316, P282, DOI 10.1001/jama.2016.9382; Saha TD, 2016, J CLIN PSYCHIAT, V77, P772, DOI 10.4088/JCP.15m10386; Saitz R, 2019, ASAM PRINCIPLES ADDI, P1109; Sandweiss AJ, 2015, SUBST ABUSE REHABIL, V6, P93, DOI 10.2147/SAR.S70350; Schwartz RP, 2014, J SUBST ABUSE TREAT, V46, P306, DOI 10.1016/j.jsat.2013.10.003; Schwartz RP, 2013, AM J PUBLIC HEALTH, V103, P917, DOI 10.2105/AJPH.2012.301049; Sees KL, 2000, JAMA-J AM MED ASSOC, V283, P1303, DOI 10.1001/jama.283.10.1303; Sharma A, 2017, CURR PSYCHIAT REP, V19, DOI 10.1007/s11920-017-0783-9; Sigmon SC, 2017, NEW ENGL J MED, V376, P1000, DOI 10.1056/NEJMc1700539; Singla N, 2016, J PAIN, V17, pS82, DOI 10.1016/j.jpain.2016.01.409; SKINNER HA, 1982, ADDICT BEHAV, V7, P363, DOI 10.1016/0306-4603(82)90005-3; Smid M, 2018, OBSTET GYNECOL, V131, P163, DOI 10.1097/AOG.0000000000002426; Smith PC, 2010, ARCH INTERN MED, V170, P1155, DOI 10.1001/archinternmed.2010.140; Smyth B P, 2010, Ir Med J, V103, P176; Socias ME, 2018, DRUG ALCOHOL DEPEN, V189, P90, DOI 10.1016/j.drugalcdep.2018.04.026; Sordo L, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1550; STIMMEL B, 1977, JAMA-J AM MED ASSOC, V237, P1216, DOI 10.1001/jama.237.12.1216; Stone AL, 2012, ADDICT BEHAV, V37, P747, DOI 10.1016/j.addbeh.2012.02.014; Substance Abuse and Mental Health Services Administration, 2017, REP DET TABL 2017 NA; Substance Abuse and Mental Health Services Administration, 2018, 185054 SMA; Substance Abuse and Mental Health Services Administration, 2018, MED OP US DIS TREATM, V63; Substance Abuse and Mental Health Services Administration, 2018, OP OV PREV TOOLK; Sullivan M, 2017, AM J PSYCHIAT, V174, P459, DOI 10.1176/appi.ajp.2016.16050548; Sun EC, 2016, JAMA INTERN MED, V176, P1286, DOI 10.1001/jamainternmed.2016.3298; Supervised Injectable Opioid Agonist Treatment Guidance Committee, 2017, GUID INJ OP AG TREAT; Tanum L, 2017, JAMA PSYCHIAT, V74, P1197, DOI 10.1001/jamapsychiatry.2017.3206; Perez-Warnisher MT, 2019, ANN GLOB HEALTH, V85, DOI 10.5334/aogh.2417; Tesema L, 2018, SUBST ABUS, V39, P434, DOI 10.1080/08897077.2018.1449047; The American College of Obstetricians and Gynecologists Women's Health Care Physicians, 2017, OP US OP US DIS PREG; Tiet QQ, 2015, JAMA INTERN MED, V175, P1371, DOI 10.1001/jamainternmed.2015.2438; Timko C, 2016, J ADDICT DIS, V35, P22, DOI 10.1080/10550887.2016.1100960; Tolia VN, 2015, NEW ENGL J MED, V372, P2118, DOI 10.1056/NEJMsa1500439; Tsui JI, 2014, JAMA INTERN MED, V174, P1974, DOI 10.1001/jamainternmed.2014.5416; US Food and Drug Administration, 2016, EVZIO FULL PRESCR IN; US Food and Drug Administration, 2015, NARC NAS SPRAY NAL; US Food and Drug Administration Center for Drug Evaluation and Research, 2018, PAT FOC DRUG DEV PUB; Volkow ND, 2018, JAMA PSYCHIAT, DOI [10.1001/jamapsychiatry.2008.3126, DOI 10.1001/JAMAPSYCHIATRY.2008.3126]; Volkow ND, 2018, AM J PSYCHIAT, V175, P729, DOI 10.1176/appi.ajp.2018.17101174; Volkow ND, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan2595; Wachman EM, 2018, JAMA-J AM MED ASSOC, V319, P1362, DOI 10.1001/jama.2018.2640; Walley Alexander Y, 2013, BMJ, V346, pf174, DOI 10.1136/bmj.f174; Weerts EM, 2008, NEUROPSYCHOPHARMACOL, V33, P653, DOI 10.1038/sj.npp.1301440; Weiss RD, 2011, ARCH GEN PSYCHIAT, V68, P1238, DOI 10.1001/archgenpsychiatry.2011.121; Wetherill L, 2015, ADDICT BIOL, V20, P617, DOI 10.1111/adb.12153; WHO, 2018, HIV AIDS PEOPL WHO I; Woody GE, 2014, JAIDS-J ACQ IMM DEF, V66, P288, DOI 10.1097/QAI.0000000000000165; World Health Organiztion, 2018, INT CLASSIFICATION D; Wu LT, 2016, DRUG ALCOHOL DEPEN, V169, P117, DOI 10.1016/j.drugalcdep.2016.10.015; Xu J, 2014, J NEUROSCI, V34, P11048, DOI 10.1523/JNEUROSCI.3986-13.2014; Zedler BK, 2016, ADDICTION, V111, P2115, DOI 10.1111/add.13462; 2018, AM J PSYCHIAT, V175, P47, DOI DOI 10.1176/APPI.AJP.2017.17040413; 2017, ANN INTERN MED, V167, P293, DOI DOI 10.7326/M17-0865; 2009, DRUG ALCOHOL DEPEN, V105, P9, DOI DOI 10.1016/J.DRUGALCDEP.2009.05.021; 2018, J NEUROIMMUNE PHARM, V13, P488, DOI DOI 10.1007/S11481-018-9801-X; 2016, J SUBST ABUSE TREAT, V60, P6, DOI DOI 10.1016/J.JSAT.2015.06.010; 2018, J SUBST ABUSE TREAT, V91, P57, DOI DOI 10.1016/J.JSAT.2018.06.001; 2016, ANGEW CHEM INT EDIT, V55, P3772, DOI DOI 10.1002/ANIE.201511654	145	179	180	3	38	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 27	2019	393	10182					1760	1772		10.1016/S0140-6736(18)33078-2	http://dx.doi.org/10.1016/S0140-6736(18)33078-2			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HV8PQ	30878228				2022-12-28	WOS:000466244500033
J	Sainadh, US; Xu, H; Wang, XS; Atia-Tul-Noor, A; Wallace, WC; Douguet, N; Bray, A; Ivanov, I; Bartschat, K; Kheifets, A; Sang, RT; Litvinyuk, IV				Sainadh, U. Satya; Xu, Han; Wang, Xiaoshan; Atia-Tul-Noor, A.; Wallace, William C.; Douguet, Nicolas; Bray, Alexander; Ivanov, Igor; Bartschat, Klaus; Kheifets, Anatoli; Sang, R. T.; Litvinyuk, I. V.			Attosecond angular streaking and tunnelling time in atomic hydrogen	NATURE			English	Article							ATTOCLOCK MEASUREMENTS; MATRIX	The tunnelling of a particle through a potential barrier is a key feature of quantum mechanics that goes to the core of wave-particle duality. The phenomenon has no counterpart in classical physics, and there are no well constructed dynamical observables that could be used to determine 'tunnelling times'. The resulting debate(1-5) about whether a tunnelling quantum particle spends a finite and measurable time under a potential barrier was reignited in recent years by the advent of ultrafast lasers and attosecond metrology(6). Particularly important is the attosecond angular streaking ('attoclock') technique(7), which can time the release of electrons in strong-field ionization with a precision of a few attoseconds. Initial measurements(7-10) confirmed the prevailing view that tunnelling is instantaneous, but later studies(11,12) involving multi-electron atoms-which cannot be accurately modelled, complicating interpretation of the ionization dynamics-claimed evidence for finite tunnelling times. By contrast, the simplicity of the hydrogen atom enables precise experimental measurements and calculations(13-15) and makes it a convenient benchmark. Here we report attoclock and momentum-space imaging(16) experiments on atomic hydrogen and compare these results with accurate simulations based on the three-dimensional time-dependent Schrodinger equation and our experimental laser pulse parameters. We find excellent agreement between measured and simulated data, confirming the conclusions of an earlier theoretical study(17) of the attoclock technique in atomic hydrogen that presented a compelling argument for instantaneous tunnelling. In addition, we identify the Coulomb potential as the sole cause of the measured angle between the directions of electron emission and peak electric field: this angle had been attributed(11,12) to finite tunnelling times. We put an upper limit of 1.8 attoseconds on any tunnelling delay, in agreement with recent theoretical findings(18) and ruling out the interpretation of all commonly used 'tunnelling times'(19) as 'time spent by an electron under the potential barrier'(20).	[Sainadh, U. Satya; Xu, Han; Atia-Tul-Noor, A.; Wallace, William C.; Kheifets, Anatoli; Sang, R. T.; Litvinyuk, I. V.] Griffith Univ, Australian Attosecond Sci Facil, Ctr Quantum Dynam, Nathan, Qld, Australia; [Wang, Xiaoshan] Lanzhou Univ, Sch Nucl Sci & Technol, Lanzhou, Gansu, Peoples R China; [Douguet, Nicolas; Bartschat, Klaus] Drake Univ, Dept Phys & Astron, Des Moines, IA 50311 USA; [Bray, Alexander; Kheifets, Anatoli] Australian Natl Univ, Res Sch Phys & Engn, Canberra, ACT, Australia; [Ivanov, Igor] Inst Basic Sci, Ctr Relativist Laser Sci, Gwangju, South Korea; [Douguet, Nicolas] Univ Cent Florida, Dept Phys, Orlando, FL USA	Griffith University; Lanzhou University; Australian National University; Institute for Basic Science - Korea (IBS); State University System of Florida; University of Central Florida	Xu, H; Sang, RT; Litvinyuk, IV (corresponding author), Griffith Univ, Australian Attosecond Sci Facil, Ctr Quantum Dynam, Nathan, Qld, Australia.	h.xu@griffith.edu.au; r.sang@griffith.edu.au; i.litvinyuk@griffith.edu.au	Bray, Alexander William/AAU-9479-2020; Kheifets, Anatoli/C-9131-2009; Atia tul Noor, Atia/AGI-0468-2022; Litvinyuk, Igor V/A-5739-2009; Undurti, Satya Sainadh/X-2244-2019; Ivanov, Igor/GLU-5581-2022; Undurti, Satya Sainadh/O-8083-2017	Bray, Alexander William/0000-0002-3780-3312; Kheifets, Anatoli/0000-0001-8318-9408; Atia tul Noor, Atia/0000-0001-6614-3256; Litvinyuk, Igor V/0000-0002-4306-1669; Undurti, Satya Sainadh/0000-0002-7136-0324; Undurti, Satya Sainadh/0000-0002-7136-0324; Sang, Robert/0000-0002-4582-8544; Ivanov, Igor/0000-0003-3856-1658; xu, han/0000-0002-2104-0154	Griffith University International Postgraduate Research Scholarships (GUIPRS); Australian Research Council Discovery Early Career Researcher Award [ARC DECRA: DE130101628]; United States National Science Foundation [PHY-1430245]; XSEDE [PHY-090031]; Institute for Basic Science [IBS-R012-D1]	Griffith University International Postgraduate Research Scholarships (GUIPRS); Australian Research Council Discovery Early Career Researcher Award(Australian Research Council); United States National Science Foundation(National Science Foundation (NSF)); XSEDE; Institute for Basic Science	The experiments were performed at the Australian Attosecond Science Facility at Griffith University. We acknowledge the traditional custodians of the land on which this work was undertaken at Griffith University, the Yuggera people, and at ANU, the Ngunnawal people. U.S.S. and A.A.-T.-N. were supported by Griffith University International Postgraduate Research Scholarships (GUIPRS). H.X. was supported by an Australian Research Council Discovery Early Career Researcher Award (ARC DECRA: DE130101628). The work of N.D. and K.B. was supported by the United States National Science Foundation under grant no. PHY-1430245 and XSEDE allocation PHY-090031: their calculations were performed on SuperMIC at the Center for Computation and Technology at Louisiana State University. I.I. was supported by the Institute for Basic Science under grant number IBS-R012-D1.	Bethe H. A., 1957, QUANTUM MECH ONE 2 E; BUTTIKER M, 1982, PHYS REV LETT, V49, P1739, DOI 10.1103/PhysRevLett.49.1739; Camus N, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.023201; CORKUM PB, 1993, PHYS REV LETT, V71, P1994, DOI 10.1103/PhysRevLett.71.1994; Dorner R, 2000, PHYS REP, V330, P95, DOI 10.1016/S0370-1573(99)00109-X; Douguet N, 2016, PHYS REV A, V93, DOI 10.1103/PhysRevA.93.033402; Eckle P, 2008, SCIENCE, V322, P1525, DOI 10.1126/science.1163439; Eckle P, 2008, NAT PHYS, V4, P565, DOI 10.1038/nphys982; Hentschel M, 2001, NATURE, V414, P509, DOI 10.1038/35107000; Ivanov IA, 2014, PHYS REV A, V90, DOI 10.1103/PhysRevA.90.013418; Khurmi C, 2017, PHYS REV A, V96, DOI 10.1103/PhysRevA.96.013404; Kielpinski D, 2014, J PHYS B-AT MOL OPT, V47, DOI 10.1088/0953-4075/47/20/204003; KULANDER KC, 1993, NATO ADV SCI INST SE, V316, P95, DOI 10.1007/978-1-4615-7963-2_10; Landsman AS, 2014, OPTICA, V1, P343, DOI 10.1364/OPTICA.1.000343; Mandelstam L., 1945, J PHYS USSR, V9, P249, DOI DOI 10.1007/978-3-642-74626-0_8; Ni HC, 2018, PHYS REV A, V97, DOI 10.1103/PhysRevA.97.013426; Ni HC, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.023002; Nurhuda M, 1999, PHYS REV A, V60, P3125, DOI 10.1103/PhysRevA.60.3125; Pfeiffer AN, 2013, CHEM PHYS, V414, P84, DOI 10.1016/j.chemphys.2012.02.005; Pfeiffer AN, 2012, NAT PHYS, V8, P76, DOI 10.1038/nphys2125; Pullen M G, 2011, THESIS; SELLIN IA, 1964, PHYS REV A-GEN PHYS, V136, P1245; SLEVIN J, 1981, REV SCI INSTRUM, V52, P1780, DOI 10.1063/1.1136497; SMITH FT, 1960, PHYS REV, V118, P349, DOI 10.1103/PhysRev.118.349; Torlina L, 2015, NAT PHYS, V11, P503, DOI [10.1038/NPHYS3340, 10.1038/nphys3340]; Wallace WC, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.053001; WIGNER EP, 1955, PHYS REV, V98, P145, DOI 10.1103/PhysRev.98.145; Yamada N, 1999, PHYS REV LETT, V83, P3350, DOI 10.1103/PhysRevLett.83.3350; Zimmermann T, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.233603	29	130	130	8	112	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 4	2019	568	7750					75	+		10.1038/s41586-019-1028-3	http://dx.doi.org/10.1038/s41586-019-1028-3			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR8CZ	30886392	Green Submitted, Green Published			2022-12-28	WOS:000463384900042
J	Madsbad, S; Hoist, JJ				Madsbad, Sten; Hoist, Jens J.			Bariatric surgery-which procedure is the optimal choice?	LANCET			English	Editorial Material							METABOLIC SURGERY; GASTRIC BYPASS		[Madsbad, Sten] Univ Copenhagen, Dept Endocrinol, Hvidovre Hosp, Hvidovre, Denmark; [Madsbad, Sten; Hoist, Jens J.] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn, Ctr Basic Metab Res, Copenhagen, Denmark; [Hoist, Jens J.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Biomed Sci, Copenhagen, Denmark	University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen	Madsbad, S (corresponding author), Univ Copenhagen, Dept Endocrinol, Hvidovre Hosp, Hvidovre, Denmark.; Madsbad, S (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn, Ctr Basic Metab Res, Copenhagen, Denmark.	sten.madsbad@regionh.dk	Holst, Jens/AAA-8022-2022	Holst, Jens Juul/0000-0001-6853-3805				Ahuja A, 2018, OBES SURG, V28, P3439, DOI 10.1007/s11695-018-3405-7; Buchwald H, 2002, OBES SURG, V12, P705, DOI 10.1381/096089202321019747; Madsbad S, 2014, LANCET DIABETES ENDO, V2, P152, DOI 10.1016/S2213-8587(13)70218-3; Mahawar KK, 2018, J MINIM ACCESS SURG, V14, P37, DOI 10.4103/jmas.JMAS_198_16; Pareek M, 2018, J AM COLL CARDIOL, V71, P670, DOI 10.1016/j.jacc.2017.12.014; Robert M, 2019, LANCET, V393, P1299, DOI 10.1016/S0140-6736(19)30475-1; Rubino F, 2017, OBES SURG, V27, P2, DOI 10.1007/s11695-016-2457-9; Rutledge R, 2001, OBES SURG, V11, P276, DOI 10.1381/096089201321336584; Schulman AR, 2017, AM J GASTROENTEROL, V112, P1640, DOI 10.1038/ajg.2017.241; Worm D, 2015, OBES SURG, V25, P1647, DOI 10.1007/s11695-014-1568-4	10	5	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 30	2019	393	10178					1263	1264		10.1016/S0140-6736(19)30489-1	http://dx.doi.org/10.1016/S0140-6736(19)30489-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HR2LJ	30851878				2022-12-28	WOS:000462967700004
J	Aung, K				Aung, Koko			Guideline: Panel recommends maintaining SpO(2) at no higher than 96% in most acutely ill hospitalized patients	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							MANAGEMENT		[Aung, Koko] Paul L Foster Sch Med, El Paso, TX 79905 USA		Aung, K (corresponding author), Paul L Foster Sch Med, El Paso, TX 79905 USA.		Aung, KoKo/I-1236-2019	Aung, KoKo/0000-0002-3152-0610				Carvalho C R, 1998, Curr Opin Pulm Med, V4, P300, DOI 10.1097/00063198-199809000-00010; Chu DK, 2018, LANCET, V391, P1693, DOI 10.1016/S0140-6736(18)30479-3; KELLOGG RH, 1978, RESP PHYSIOL, V34, P1, DOI 10.1016/0034-5687(78)90046-4; O'Brien Jennifer, 2013, AANA J, V81, P205; O'Gara PT, 2013, CIRCULATION, V127, P529, DOI 10.1161/CIR.0b013e3182742c84; Powers WJ, 2018, STROKE, V49, pE46, DOI 10.1161/STR.0000000000000158; SASSOON CSH, 1987, AM REV RESPIR DIS, V135, P907, DOI 10.1164/arrd.1987.135.4.907	7	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 19	2019	170	6					JC26	JC26		10.7326/ACPJ201903190-026	http://dx.doi.org/10.7326/ACPJ201903190-026			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP1ZR	30884496				2022-12-28	WOS:000461468300003
J	Rimmer, A				Rimmer, Abi			Clinical oncology trainee numbers must double to fill workforce shortfall, says college	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Royal College of Radiologists, CLIN ONC UK WORKF CE	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 19	2019	364								l1276	10.1136/bmj.l1276	http://dx.doi.org/10.1136/bmj.l1276			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HQ7ZZ	30890529				2022-12-28	WOS:000462644400011
J	Mayor, S				Mayor, Susan			Higher intake of cholesterol or eggs linked to increased risk of cardiovascular disease and death, finds study	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Eckel RH, 2019, JAMA-J AM MED ASSOC, V321, P1055, DOI 10.1001/jama.2019.1850; Zhong VW, 2019, JAMA-J AM MED ASSOC, V321, P1081, DOI 10.1001/jama.2019.1572	2	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 15	2019	364								l1214	10.1136/bmj.l1214	http://dx.doi.org/10.1136/bmj.l1214			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP5WF	30877091				2022-12-28	WOS:000461752800004
J	Iacobucci, G				Iacobucci, Gareth			Satisfaction with NHS is lowest for over a decade, BSA survey finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Robertson R, 2019, PUBLIC SATISFACTION	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 7	2019	364								l1027	10.1136/bmj.l1027	http://dx.doi.org/10.1136/bmj.l1027			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HO6TA	30846432				2022-12-28	WOS:000461063200007
J	Mouterde, T; Keerthi, A; Poggioli, AR; Dar, SA; Siria, A; Geim, AK; Bocquet, L; Radha, B				Mouterde, T.; Keerthi, A.; Poggioli, A. R.; Dar, S. A.; Siria, A.; Geim, A. K.; Bocquet, L.; Radha, B.			Molecular streaming and its voltage control in angstrom-scale channels	NATURE			English	Article							BORON-NITRIDE; GRAPHENE; TRANSPORT; WATER; PERMEABILITY; MEMBRANES; SLIPPAGE; IONS	Over the past decade, the ability to reduce the dimensions of fluidic devices to the nanometre scale (by using nanotubes(1-5) or nanopores(6-11), for example) has led to the discovery of unexpected water- and ion-transport phenomena(12-14). More recently, van der Waals assembly of two-dimensional materials(15) has allowed the creation of artificial channels with angstrom-scale precision(16). Such channels push fluid confinement to the molecular scale, wherein the limits of continuum transport equations(17) are challenged. Water films on this scale can rearrange into one or two layers with strongly suppressed dielectric permittivity(18,19) or form a room-temperature ice phase(20). Ionic motion in such confined channels(21) is affected by direct interactions between the channel walls and the hydration shells of the ions, and water transport becomes strongly dependent on the channel wall material(22). We explore how water and ionic transport are coupled in such confinement. Here we report measurements of ionic fluid transport through molecular-sized slit-like channels. The transport, driven by pressure and by an applied electric field, reveals a transistor-like electrohydrodynamic effect. An applied bias of a fraction of a volt increases the measured pressure-driven ionic transport (characterized by streaming mobilities) by up to 20 times. This gating effect is observed in both graphite and hexagonal boron nitride channels but exhibits marked material-dependent differences. We use a modified continuum framework accounting for the material-dependent frictional interaction of water molecules, ions and the confining surfaces to explain the differences observed between channels made of graphene and hexagonal boron nitride. This highly nonlinear gating of fluid transport under molecular-scale confinement may offer new routes to control molecular and ion transport, and to explore electromechanical couplings that may have a role in recently discovered mechanosensitive ionic channels(23).	[Mouterde, T.; Poggioli, A. R.; Siria, A.; Bocquet, L.] Sorbonne Univ, Univ Paris Diderot, Univ PSL, Lab Phys,Ecole Normale Super,ENS,Sorbonne Paris C, Paris, France; [Keerthi, A.; Dar, S. A.; Geim, A. K.; Radha, B.] Univ Manchester, Sch Phys & Astron, Manchester, Lancs, England; [Keerthi, A.; Dar, S. A.; Geim, A. K.; Radha, B.] Univ Manchester, Natl Graphene Inst, Manchester, Lancs, England; [Dar, S. A.] Univ Engn & Technol KSK, Dept Basic Sci & Humanities, Lahore, Pakistan	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; Universite Paris Cite; University of Manchester; University of Manchester	Bocquet, L (corresponding author), Sorbonne Univ, Univ Paris Diderot, Univ PSL, Lab Phys,Ecole Normale Super,ENS,Sorbonne Paris C, Paris, France.; Geim, AK; Radha, B (corresponding author), Univ Manchester, Sch Phys & Astron, Manchester, Lancs, England.; Geim, AK; Radha, B (corresponding author), Univ Manchester, Natl Graphene Inst, Manchester, Lancs, England.	geim@manchester.ac.uk; lyderic.bocquet@ens.fr; radha.boya@manchester.ac.uk	Geim, Andre K/J-7888-2012; bocquet, lyderic/A-2241-2012; Keerthi, Ashok/T-4643-2018; Keerthi, Ashok/J-1291-2014; Boya, Radha/A-2602-2012; Mouterde, Timothée/O-7729-2019; Boya, Radha/G-7794-2017	Geim, Andre K/0000-0003-2861-8331; bocquet, lyderic/0000-0003-3577-5335; Keerthi, Ashok/0000-0002-8479-4762; Boya, Radha/0000-0002-1495-1961; Mouterde, Timothée/0000-0002-1166-1723; Boya, Radha/0000-0003-1345-7029; Dar, Sidra Abbas/0000-0002-5048-6147	ANR project Neptune; Royal Society Fellowship; L'Oreal Fellowship for Women in Science; EPSRC [EP/R013063/1]; European Union's Horizon 2020 (EU H2020) Framework Programme/ERC Starting Grant [637748-NanoSOFT]; EU H2020 Framework Programme/ERC Advanced Grant [785911-Shadoks]; EU H2020 Framework Programme/European Training Programme [674979-NanoTRANS]; University of Engineering and Technology, Lahore Pakistan; Lloyd's Register Foundation; European Research Council; EPSRC [EP/K005014/1] Funding Source: UKRI	ANR project Neptune(French National Research Agency (ANR)); Royal Society Fellowship(Royal Society of London); L'Oreal Fellowship for Women in Science; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Union's Horizon 2020 (EU H2020) Framework Programme/ERC Starting Grant; EU H2020 Framework Programme/ERC Advanced Grant; EU H2020 Framework Programme/European Training Programme; University of Engineering and Technology, Lahore Pakistan; Lloyd's Register Foundation; European Research Council(European Research Council (ERC)European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	T.M. and L.B. acknowledge funding from ANR project Neptune. B.R. acknowledges a Royal Society Fellowship, a L'Oreal Fellowship for Women in Science, and EPSRC grant EP/R013063/1. A.S. acknowledges funding from the European Union's Horizon 2020 (EU H2020) Framework Programme/ERC Starting Grant agreement number 637748-NanoSOFT. L.B. acknowledges funding from the EU H2020 Framework Programme/ERC Advanced Grant agreement number 785911-Shadoks. A.R.P. acknowledges funding from the EU H2020 Framework Programme/European Training Programme 674979-NanoTRANS. S.A.D. was funded by a scholarship from the University of Engineering and Technology, Lahore Pakistan. A.K., B.R. and A.K.G. were supported by Lloyd's Register Foundation and European Research Council (ARTIMATTER). T.M. thanks S. Blin and H. Yoshida for assistance.	Abraham J, 2017, NAT NANOTECHNOL, V12, P546, DOI [10.1038/nnano.2017.21, 10.1038/NNANO.2017.21]; Algara-Siller G, 2015, NATURE, V519, P443, DOI 10.1038/nature14295; Bocquet L, 2010, CHEM SOC REV, V39, P1073, DOI 10.1039/b909366b; Coste B, 2012, NATURE, V483, P176, DOI 10.1038/nature10812; Eijkel JCT, 2005, MICROFLUID NANOFLUID, V1, P249, DOI 10.1007/s10404-004-0012-9; Esfandiar A, 2017, SCIENCE, V358, P511, DOI 10.1126/science.aan5275; Feng JD, 2016, NATURE, V536, P197, DOI 10.1038/nature18593; Fornasiero F, 2008, P NATL ACAD SCI USA, V105, P17250, DOI 10.1073/pnas.0710437105; Fumagalli L, 2018, SCIENCE, V360, P1339, DOI 10.1126/science.aat4191; Futamura R, 2017, NAT MATER, V16, P1225, DOI [10.1038/NMAT4974, 10.1038/nmat4974]; Garaj S, 2010, NATURE, V467, P190, DOI 10.1038/nature09379; Geim AK, 2013, NATURE, V499, P419, DOI 10.1038/nature12385; Geismann C, 2007, LANGMUIR, V23, P76, DOI 10.1021/la0603774; Hong S, 2017, NANO LETT, V17, P728, DOI 10.1021/acs.nanolett.6b03837; Howorka S, 2009, CHEM SOC REV, V38, P2360, DOI 10.1039/b813796j; Jain T, 2015, NAT NANOTECHNOL, V10, P1053, DOI [10.1038/NNANO.2015.222, 10.1038/nnano.2015.222]; Jiang ZJ, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.031203; Joshi RK, 2014, SCIENCE, V343, P752, DOI 10.1126/science.1245711; Jubin L, 2018, P NATL ACAD SCI USA, V115, P4063, DOI 10.1073/pnas.1721987115; Karnik R, 2005, NANO LETT, V5, P943, DOI 10.1021/nl050493b; Keerthi A, 2018, NATURE, V558, P420, DOI 10.1038/s41586-018-0203-2; Kim SJ, 2009, LANGMUIR, V25, P7759, DOI 10.1021/la900332v; Pang P, 2011, ACS NANO, V5, P7277, DOI 10.1021/nn202115s; Radha B, 2016, NATURE, V538, P222, DOI 10.1038/nature19363; Schasfoort RBM, 1999, SCIENCE, V286, P942, DOI 10.1126/science.286.5441.942; Schlaich A, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.048001; Schoch RB, 2008, REV MOD PHYS, V80, P839, DOI 10.1103/RevModPhys.80.839; Secchi E, 2016, NATURE, V537, P210, DOI 10.1038/nature19315; Secchi E, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.154501; Siria A, 2013, NATURE, V494, P455, DOI 10.1038/nature11876; Sze A, 2003, J COLLOID INTERF SCI, V261, P402, DOI 10.1016/S0021-9797(03)00142-5; Tocci G, 2014, NANO LETT, V14, P6872, DOI 10.1021/nl502837d; Tunuguntla RH, 2017, SCIENCE, V357, P792, DOI 10.1126/science.aan2438; Xie Q, 2018, NAT NANOTECHNOL, V13, P238, DOI 10.1038/s41565-017-0031-9	34	111	112	37	478	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 7	2019	567	7746					87	+		10.1038/s41586-019-0961-5	http://dx.doi.org/10.1038/s41586-019-0961-5			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HN8ED	30842639	Green Submitted			2022-12-28	WOS:000460426900046
J	Adepoju, P				Adepoju, Paul			Hospital attack in anglophone Cameroon kills four patients	LANCET			English	Editorial Material								The attack on the hospital comes as tensions run high between the Cameroonian Government and the anglophone Cameroon separatists. Paul Adepoju reports.						Adepoju, Paul/0000-0003-1323-3017					0	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 23	2019	393	10173					731	731		10.1016/S0140-6736(19)30407-6	http://dx.doi.org/10.1016/S0140-6736(19)30407-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HN1KI	30846239				2022-12-28	WOS:000459945500013
J	Tarakji, KG; Mittal, S; Kennergren, C; Corey, R; Poole, JE; Schloss, E; Gallastegui, J; Pickett, RA; Evonich, R; Philippon, F; McComb, JM; Roark, SF; Sorrentino, D; Sholevar, D; Cronin, E; Berman, B; Riggio, D; Biffi, M; Khan, H; Silver, MT; Collier, J; Eldadah, Z; Wright, DJ; Lande, JD; Lexcen, DR; Cheng, A; Wilkoff, BL				Tarakji, Khaldoun G.; Mittal, Suneet; Kennergren, Charles; Corey, Ralph; Poole, Jeanne E.; Schloss, Edward; Gallastegui, Jose; Pickett, Robert A.; Evonich, Rudolph; Philippon, Francois; McComb, Janet M.; Roark, Steven F.; Sorrentino, Denise; Sholevar, Darius; Cronin, Edmond; Berman, Brett; Riggio, David; Biffi, Mauro; Khan, Hafiza; Silver, Marc T.; Collier, Jack; Eldadah, Zayd; Wright, David J.; Lande, Jeff D.; Lexcen, Daniel R.; Cheng, Alan; Wilkoff, Bruce L.		WRAP-IT Investigators	Antibacterial Envelope to Prevent Cardiac Implantable Device Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TRANSVENOUS LEAD EXTRACTION; RISK-FACTORS; 1-YEAR MORTALITY; MANAGEMENT; STATEMENT; EFFICACY; OUTCOMES; TRIAL	Background Infections after placement of cardiac implantable electronic devices (CIEDs) are associated with substantial morbidity and mortality. There is limited evidence on prophylactic strategies, other than the use of preoperative antibiotics, to prevent such infections. Methods We conducted a randomized, controlled clinical trial to assess the safety and efficacy of an absorbable, antibiotic-eluting envelope in reducing the incidence of infection associated with CIED implantations. Patients who were undergoing a CIED pocket revision, generator replacement, or system upgrade or an initial implantation of a cardiac resynchronization therapy defibrillator were randomly assigned, in a 1:1 ratio, to receive the envelope or not. Standard-of-care strategies to prevent infection were used in all patients. The primary end point was infection resulting in system extraction or revision, long-term antibiotic therapy with infection recurrence, or death, within 12 months after the CIED implantation procedure. The secondary end point for safety was procedure-related or system-related complications within 12 months. Results A total of 6983 patients underwent randomization: 3495 to the envelope group and 3488 to the control group. The primary end point occurred in 25 patients in the envelope group and 42 patients in the control group (12-month Kaplan-Meier estimated event rate, 0.7% and 1.2%, respectively; hazard ratio, 0.60; 95% confidence interval [CI], 0.36 to 0.98; P=0.04). The safety end point occurred in 201 patients in the envelope group and 236 patients in the control group (12-month Kaplan-Meier estimated event rate, 6.0% and 6.9%, respectively; hazard ratio, 0.87; 95% CI, 0.72 to 1.06; P<0.001 for noninferiority). The mean (+/- SD) duration of follow-up was 20.7 +/- 8.5 months. Major CIED-related infections through the entire follow-up period occurred in 32 patients in the envelope group and 51 patients in the control group (hazard ratio, 0.63; 95% CI, 0.40 to 0.98). Conclusions Adjunctive use of an antibacterial envelope resulted in a significantly lower incidence of major CIED infections than standard-of-care infection-prevention strategies alone, without a higher incidence of complications.	[Tarakji, Khaldoun G.; Wilkoff, Bruce L.] Cleveland Clin, 9500 Euclid Ave,J2-2, Cleveland, OH 44195 USA; [Schloss, Edward] Lindner Res Ctr, Cincinnati, OH USA; [Mittal, Suneet] Valley Hlth Syst, Ridgewood, NJ USA; [Sholevar, Darius] Lourdes Cardiol Serv, Cherry Hill, NJ USA; [Kennergren, Charles] Sahlgrens Univ Hosp, Gothenburg, Sweden; [Corey, Ralph] Duke Clin Res Inst, Durham, NC USA; [Silver, Marc T.] WakeMed Hlth & Hosp, WakeMed Heart & Vasc, Raleigh, NC USA; [Poole, Jeanne E.] Univ Washington, Sch Med, Seattle, WA 98195 USA; [Gallastegui, Jose] Clearwater Cardiovasc & Intervent Consultants, Safety Harbor, FL USA; [Roark, Steven F.] Cardiol Associates Gainesville, Gainesville, FL USA; [Pickett, Robert A.] St Thomas Res Inst, Nashville, TN USA; [Evonich, Rudolph] Upper Michigan Cardiovasc Associates, Marquette, MI USA; [Philippon, Francois] Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada; [McComb, Janet M.] Newcastle Upon Tyne Hosp, Newcastle Upon Tyne, Tyne & Wear, England; [Wright, David J.] Liverpool Heart & Chest Hosp, Liverpool, Merseyside, England; [Sorrentino, Denise] Iowa Heart Ctr, W Des Moines, IA USA; [Cronin, Edmond] Hartford Hosp, Hartford, CT 06115 USA; [Berman, Brett] Chula Vista Cardiac Ctr, Chula Vista, CA USA; [Riggio, David] Arizona Arrhythmia Consultants, Scottsdale, AZ USA; [Biffi, Mauro] Policlin St Orsola Malpighi, Bologna, Italy; [Khan, Hafiza] Baylor Res Inst, Plano, TX USA; [Collier, Jack] Oklahoma Heart Hosp, Oklahoma City, OK USA; [Eldadah, Zayd] MedStar Heart & Vasc Inst, Washington, DC USA; [Lande, Jeff D.; Lexcen, Daniel R.; Cheng, Alan] Medtronic, Mounds View, MN USA	Cleveland Clinic Foundation; Sahlgrenska University Hospital; Duke University; University of Washington; University of Washington Seattle; Newcastle University - UK; Liverpool Heart & Chest Hospital; Hartford Hospital; IRCCS Azienda Ospedaliero-Universitaria di Bologna; Baylor Scott & White Health; Baylor University Medical Center; Medtronic	Tarakji, KG (corresponding author), Cleveland Clin, 9500 Euclid Ave,J2-2, Cleveland, OH 44195 USA.	tarakjk@ccf.org	Hillock, Nadine T/AAD-4995-2019; Kennergren, Charles/AAQ-4871-2020	Hillock, Nadine T/0000-0003-2245-3740; jamaly, shabbar/0000-0002-5219-1297; Pickett, Robert/0000-0002-7764-3800; Cronin, Edmond/0000-0001-5824-9106; Kostis, William/0000-0002-0543-9798; Pruvot, Etienne/0000-0003-1386-9285	Medtronic	Medtronic(Medtronic)	(Funded by Medtronic; WRAP-IT ClinicalTrials.gov number, NCT02277990.	Baddour LM, 2010, CIRCULATION, V121, P458, DOI 10.1161/CIRCULATIONAHA.109.192665; Baman TS, 2009, CIRC-ARRHYTHMIA ELEC, V2, P129, DOI 10.1161/CIRCEP.108.816868; Bloom HL, 2011, PACE, V34, P133, DOI 10.1111/j.1540-8159.2010.02931.x; Brunner MP, 2014, HEART RHYTHM, V11, P419, DOI 10.1016/j.hrthm.2013.12.004; de Oliveira JC, 2009, CIRC-ARRHYTHMIA ELEC, V2, P29, DOI 10.1161/CIRCEP.108.795906; Deckx S, 2014, EUROPACE, V16, P1218, DOI 10.1093/europace/eut410; Habib G, 2015, EUR HEART J, V36, P3075, DOI [10.1093/eurheartj/ehv319, 10.5603/KP.2015.0227]; Head SJ, 2012, EUR HEART J, V33, P1318, DOI 10.1093/eurheartj/ehs099; Henrikson CA, 2017, JACC-CLIN ELECTROPHY, V3, P1158, DOI [10. 1016/j. jacep. 2017. 02. 016, DOI 10.1016/J.JACEP.2017.02.016]; Kay G, 2018, J MED ECON, V21, P294, DOI 10.1080/13696998.2017.1409227; Kolek MJ, 2015, J CARDIOVASC ELECTR, V26, P1111, DOI 10.1111/jce.12768; Kolek MJ, 2013, PACE, V36, P354, DOI 10.1111/pace.12063; Krahn AD, 2018, J AM COLL CARDIOL, V72, P3098, DOI 10.1016/j.jacc.2018.09.068; Kusumoto FM, 2017, HEART RHYTHM, V14, pE503, DOI 10.1016/j.hrthm.2017.09.001; Mittal S, 2014, HEART RHYTHM, V11, P595, DOI 10.1016/j.hrthm.2013.12.013; Mond HG, 2011, PACE, V34, P1013, DOI 10.1111/j.1540-8159.2011.03150.x; Polyzos KA, 2015, EUROPACE, V17, P767, DOI 10.1093/europace/euv053; Romeyer-Bouchard C, 2010, EUR HEART J, V31, P203, DOI 10.1093/eurheartj/ehp421; Shariff N, 2015, J CARDIOVASC ELECTR, V26, P783, DOI 10.1111/jce.12684; Sohail MR, 2015, PACE, V38, P231, DOI 10.1111/pace.12518; Tarakji KG, 2016, AM HEART J, V180, P12, DOI 10.1016/j.ahj.2016.06.010; Tarakji KG, 2014, EUROPACE, V16, P1490, DOI 10.1093/europace/euu147; Wazni O, 2010, J AM COLL CARDIOL, V55, P579, DOI 10.1016/j.jacc.2009.08.070	23	138	141	1	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 16	2019	380	20					1895	1905		10.1056/NEJMoa1901111	http://dx.doi.org/10.1056/NEJMoa1901111			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HY3WU	30883056	Green Published, Bronze			2022-12-28	WOS:000468059200008
J	Page, KR; Doocy, S; Ganteaume, FR; Castro, JS; Spiegel, P; Beyrer, C				Page, Kathleen R.; Doocy, Shannon; Ganteaume, Feliciano Reyna; Castro, Julio S.; Spiegel, Paul; Beyrer, Chris			Venezuela's public health crisis: a regional emergency	LANCET			English	Review								The economic crisis in Venezuela has eroded the country's health-care infrastructure and threatened the public health of its people. Shortages in medications, health supplies, interruptions of basic utilities at health-care facilities, and the emigration of health-care workers have led to a progressive decline in the operational capacity of health care. The effect of the crisis on public health has been difficult to quantify since the Venezuelan Ministry of Health stopped publishing crucial public health statistics in 2016. We prepared a synthesis of health information, beyond what is available from other sources, and scholarly discussion of engagement strategies for the international community. Data were identified through searches in MEDLINE, PubMed, and the grey literature, through references from relevant articles, and governmental and non-governmental reports, and publicly available databases. Articles published in English and Spanish until Dec 1, 2018, were included. Over the past decade, public health measures in Venezuela have substantially declined. From 2012 to 2016, infant deaths increased by 63% and maternal mortality more than doubled. Since 2016, outbreaks of the vaccine-preventable diseases measles and diphtheria have spread throughout the region. From 2016 to 2017, Venezuela had the largest rate of increase of malaria in the world, and in 2015, tuberculosis rates were the highest in the country in 40 years. Between 2017 and 2018, most patients who were infected with HIV interrupted therapy because of a lack of medications. The Venezuelan economic crisis has shattered the health-care system and resulted in rising morbidity and mortality. Outbreaks and expanding epidemics of infectious diseases associated with declines in basic public health services are threatening the health of the country and the region.	[Page, Kathleen R.] Johns Hopkins Sch Med, Baltimore, MD 21287 USA; [Doocy, Shannon; Spiegel, Paul; Beyrer, Chris] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Ganteaume, Feliciano Reyna] Acc Solidaria, Caracas, Venezuela; [Castro, Julio S.] Univ Cent Venezuela, Sch Med, Caracas, Venezuela	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Central Venezuela	Page, KR (corresponding author), Johns Hopkins Sch Med, Baltimore, MD 21287 USA.; Doocy, S (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.	kpage2@jhmi.edu; doocy1@jhu.edu	Spiegel, Paul/AAL-3238-2021	Spiegel, Paul/0000-0002-6158-6661	Desmond Tutu Professorship in Public Health and Human Rights at the Johns Hopkins Bloomberg School of Public Health and Human Rights Watch	Desmond Tutu Professorship in Public Health and Human Rights at the Johns Hopkins Bloomberg School of Public Health and Human Rights Watch	This Review was made possible by the generous support of the Desmond Tutu Professorship in Public Health and Human Rights at the Johns Hopkins Bloomberg School of Public Health and Human Rights Watch.	Albaladejo A., 2018, BMJ-BRIT MED J, V360, P1; [Anonymous], 2018, RESULTADOS ENCUESTA; [Anonymous], 2018, EL NACL          MAY; Caritas, BOLETIN, V7; Daniels JP, 2018, LANCET HIV, V5, pE549, DOI 10.1016/S2352-3018(18)30263-7; Garcia J, 2019, LANCET GLOB HEALTH, V7, pE331, DOI 10.1016/S2214-109X(18)30479-0; Gobierno Bolivariano de Venezuela, 2012, B EP SEM EP, V52; Gobierno Bolivariano de Venezuela, 2014, B EP SEM EP, V52; Gobierno Bolivariano de Venezuela, 2016, B EP SEM EP, V52; Medicos por la Salud Asamblea Nacional, 2018, ENC NAC HOSP; Nelson RM, 2018, VENEZEULAS EC CRISIS; Observatorio Venezolano de Conflictividad Social, 2018, EM HUM VEN CONFL SOC; Observatorio Venezolano de la Salud, AN EST VIT NAC DEF; PAHO, INT MAL STAT; PAHO, 2019, EP UPD MEASL; PAHO, MORT DAT; PAHO, 2018, EP UPD MEASL; PAHO WHO, 2018, 162 SESS EX COMM JUN; PAHO WHO, 2019, EP UPD DIPHTH DIPHTH; PAHO WHO, 2018, VEN LAUNCH VACC CAMP; PAHO WHO, 2018, EP UPD INCR MAL AM; PAHO WHO UNAIDS Gobierno BDV, PLAN MAESTR FORT RES; Roa AC, 2018, CAD SAUDE PUBLICA, V34, DOI [10.1590/0102-311X00058517, 10.1590/0102-311x00058517]; UN Refugee Agency International Organization for Migration, 2019, NUMB REF MIGR VEN RE; UNICEF, 2018, CHILD MORT EST; United Nations Central Emergency Fund Response, 2018, 2018 ALL COUNTR; United Nations Office of the High Commissioner of Human Rights, 2018, HUM RIGHTS BOL REP V; US Department of State, VEN REL SANCT; US Energy Information Administration, 2000, OIL REV DAT VEN; World Bank, 2000, WORLD DEV IND HLTH I, P2000; World Health Organization, VACC PREV DIS MON SY; World Health Organization, TRENDS MAT MORT 1990	32	61	64	3	29	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 23	2019	393	10177					1254	1260		10.1016/S0140-6736(19)30344-7	http://dx.doi.org/10.1016/S0140-6736(19)30344-7			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP9UL	30871722				2022-12-28	WOS:000462038400032
J	Magnus, MC; Wilcox, AJ; Morken, NH; Weinberg, CR; Haberg, SE				Magnus, Maria C.; Wilcox, Allen J.; Morken, Nils-Halvdan; Weinberg, Clarice R.; Haberg, Siri E.			Role of maternal age and pregnancy history in risk of miscarriage: prospective register based study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PERINATAL OUTCOMES; RECURRENT MISCARRIAGE; SPONTANEOUS-ABORTION; WOMEN	OBJECTIVES To estimate the burden of miscarriage in the Norwegian population and to evaluate the associations with maternal age and pregnancy history. DESIGN Prospective register based study. SETTING Medical Birth Register of Norway, the Norwegian Patient Register, and the induced abortion register. PARTICIPANTS All Norwegian women that were pregnant between 2009-13. MAIN OUTCOME MEASURE Risk of miscarriage according to the woman's age and pregnancy history estimated by logistic regression. RESULTS There were 421 201 pregnancies during the study period. The risk of miscarriage was lowest in women aged 25-29 (10%), and rose rapidly after age 30, reaching 53% in women aged 45 and over. There was a strong recurrence risk of miscarriage, with age adjusted odds ratios of 1.54 (95% confidence interval 1.48 to 1.60) after one miscarriage, 2.21 (2.03 to 2.41) after two, and 3.97 (3.29 to 4.78) after three consecutive miscarriages. The risk of miscarriage was modestly increased if the previous birth ended in a preterm delivery (adjusted odds ratio 1.22, 95% confidence interval 1.12 to 1.29), stillbirth (1.30, 1.11 to 1.53), caesarean section (1.16, 1.12 to 1.21), or if the woman had gestational diabetes in the previous pregnancy (1.19, 1.05 to 1.36). The risk of miscarriage was slightly higher in women who themselves had been small for gestational age (1.08, 1.04 to 1.13). CONCLUSIONS The risk of miscarriage varies greatly with maternal age, shows a strong pattern of recurrence, and is also increased after some adverse pregnancy outcomes. Miscarriage and other pregnancy complications might share underlying causes, which could be biological conditions or unmeasured common risk factors.	[Magnus, Maria C.; Wilcox, Allen J.; Morken, Nils-Halvdan; Haberg, Siri E.] Norwegian Inst Publ Hlth, Ctr Fertil & Hlth, POB 222, N-0213 Oslo, Norway; [Magnus, Maria C.] Univ Bristol, MRC Integrat Epidemiol Unit, Bristol, Avon, England; [Magnus, Maria C.] Univ Bristol Sch Med, Dept Populat Hlth Sci, Bristol, Avon, England; [Wilcox, Allen J.] Natl Inst Environm Hlth Sci, Epidemiol Branch, Durham, NC USA; [Morken, Nils-Halvdan] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Morken, Nils-Halvdan] Haukeland Hosp, Dept Obstet & Gynecol, Bergen, Norway; [Weinberg, Clarice R.] Natl Inst Environm Hlth Sci, Biostat & Computat Biol Branch, Durham, NC USA	Norwegian Institute of Public Health (NIPH); University of Bristol; University of Bristol; University of Bergen; University of Bergen; Haukeland University Hospital	Magnus, MC (corresponding author), Norwegian Inst Publ Hlth, Ctr Fertil & Hlth, POB 222, N-0213 Oslo, Norway.; Magnus, MC (corresponding author), Univ Bristol, MRC Integrat Epidemiol Unit, Bristol, Avon, England.; Magnus, MC (corresponding author), Univ Bristol Sch Med, Dept Populat Hlth Sci, Bristol, Avon, England.	Maria.Christine.Magnus@fhi.no		Weinberg, Clarice/0000-0002-7713-8556	Research Council of Norway through its Centres of Excellence funding scheme [262700]; Intramural Program of the National Institute of Environmental Health Sciences, NIH; UK MRC [MR/M009351/1, MC_UU_00011/6]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES040006] Funding Source: NIH RePORTER	Research Council of Norway through its Centres of Excellence funding scheme; Intramural Program of the National Institute of Environmental Health Sciences, NIH; UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by the Research Council of Norway through its Centres of Excellence funding scheme, project number 262700. The work was also supported by the Intramural Program of the National Institute of Environmental Health Sciences, NIH (AJW and CRW). MCM works at the Medical Research Council (MRC) Integrative Epidemiology Unit at the University of Bristol which receives infrastructure funding from the UK MRC (MC_UU_00011/6), and she is also supported by a fellowship from the UK MRC (MR/M009351/1). The funders had no role in the completion of the research project, the writing of the manuscript for publication, or the decision to publish the results.	Adolfsson A, 2006, ACTA OBSTET GYN SCAN, V85, P741, DOI 10.1080/00016340600627022; Agenor A, 2015, WOMENS HEALTH, V11, P527, DOI [10.2217/WHE.15.19, 10.2217/whe.15.19]; Almeida ND, 2016, EPIDEMIOLOGY, V27, P538, DOI 10.1097/EDE.0000000000000484; Andersen AMN, 2000, BRIT MED J, V320, P1708, DOI 10.1136/bmj.320.7251.1708; Avalos LA, 2012, BIRTH DEFECTS RES A, V94, P417, DOI 10.1002/bdra.23014; Bhattacharya S, 2008, BJOG-INT J OBSTET GY, V115, P1623, DOI 10.1111/j.1471-0528.2008.01943.x; Bhattacharya S, 2010, EUR J OBSTET GYN R B, V150, P24, DOI 10.1016/j.ejogrb.2010.02.015; Buchmayer SM, 2004, AM J OBSTET GYNECOL, V191, P1225, DOI 10.1016/j.ajog.2004.02.066; de La Rochebrochard E, 2002, HUM REPROD, V17, P1649, DOI 10.1093/humrep/17.6.1649; Dempsey MA, 2015, J MATERN-FETAL NEO M, V28, P522, DOI 10.3109/14767058.2014.923394; Di Renzo GC, 2011, EUR J OBSTET GYN R B, V159, P342, DOI 10.1016/j.ejogrb.2011.09.024; Eskild A, 2009, ACTA OBSTET GYN SCAN, V88, P569, DOI 10.1080/00016340902814567; Field K, 2015, HUM REPROD, V30, P1239, DOI 10.1093/humrep/dev044; Garrido-Gimenez C, 2015, POSTGRAD MED J, V91, P151, DOI 10.1136/postgradmedj-2014-132672; Hemminki E, 1999, AM J OBSTET GYNECOL, V181, P396, DOI 10.1016/S0002-9378(99)70568-5; Kawakita T, 2016, AM J PERINAT, V33, P1300, DOI 10.1055/s-0036-1586506; McGrogan A, 2014, DIABETIC MED, V31, P357, DOI 10.1111/dme.12332; North RA, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1875; O'Neill SM, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001670; O'Neill SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054588; Oliver-Williams C, 2015, BJOG-INT J OBSTET GY, V122, P1525, DOI 10.1111/1471-0528.13276; Oliver-Williams CT, 2015, INT J GYNECOL OBSTET, V129, P207, DOI 10.1016/j.ijgo.2015.01.004; Olubunmi O, 2019, EUR J OBSTET GYN R B, V232, P87, DOI 10.1016/j.ejogrb.2018.10.042; Rossen LM, 2018, PAEDIATR PERINAT EP, V32, P19, DOI 10.1111/ppe.12417; Sneider K, 2016, ACTA OBSTET GYN SCAN, V95, P1383, DOI 10.1111/aogs.13027; Statistics Norway (SSB), 2019, 14 PROS BEF INNV; SUSSER E, 1983, AM J EPIDEMIOL, V117, P305, DOI 10.1093/oxfordjournals.aje.a113542; Tanner LD, 2018, EUR J OBSTET GYN R B, V221, P156, DOI 10.1016/j.ejogrb.2017.12.009; THOMAS DC, 1992, EPIDEMIOLOGY, V3, P32, DOI 10.1097/00001648-199201000-00007; Trogstad L, 2008, INT J EPIDEMIOL, V37, P1333, DOI 10.1093/ije/dyn167; Wahabi Hayfaa A, 2012, BMC Res Notes, V5, P496, DOI 10.1186/1756-0500-5-496; Wang YH, 2011, GYNECOL OBSTET INVES, V72, P245, DOI 10.1159/000325165; Weintraub Adi Y., 2005, Archives of Gynecology and Obstetrics, V271, P350, DOI 10.1007/s00404-004-0640-z; Weintraub AY, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.053; WILCOX AJ, 1988, NEW ENGL J MED, V319, P189, DOI 10.1056/NEJM198807283190401	35	189	194	10	29	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 20	2019	364								l869	10.1136/bmj.l869	http://dx.doi.org/10.1136/bmj.l869			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HQ8AJ	30894356	Green Published, hybrid			2022-12-28	WOS:000462645500001
J	Beaser, AD; Cifu, AS				Beaser, Andrew D.; Cifu, Adam S.			Management of Patients With Atrial Fibrillation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							WARFARIN; EDOXABAN		[Beaser, Andrew D.; Cifu, Adam S.] Univ Chicago, 5841 S Maryland Ave,MC 3051, Chicago, IL 60637 USA	University of Chicago	Cifu, AS (corresponding author), Univ Chicago, 5841 S Maryland Ave,MC 3051, Chicago, IL 60637 USA.	adamcifu@uchicago.edu						Cappato R, 2014, EUR HEART J, V35, P3346, DOI 10.1093/eurheartj/ehu367; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Ezekowitz MD, 2018, EUR HEART J, V39, P2959, DOI 10.1093/eurheartj/ehy148; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Goette A, 2016, LANCET, V388, P1995, DOI 10.1016/S0140-6736(16)31474-X; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Holmes DR, 2015, J AM COLL CARDIOL, V65, P2614, DOI 10.1016/j.jacc.2015.04.025; January CT, 2019, CIRCULATION, V140, pE125, DOI 10.1161/CIR.0000000000000665; Marrouche NF, 2018, NEW ENGL J MED, V378, P417, DOI 10.1056/NEJMoa1707855; Patel MR, 2010, NEW ENGL J MED, V362, P886, DOI 10.1056/NEJMoa0907272	10	9	10	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 19	2019	321	11					1100	1101		10.1001/jama.2019.1264	http://dx.doi.org/10.1001/jama.2019.1264			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP4YY	30874742				2022-12-28	WOS:000461683500019
J	Cook, R; Lamont, T; Taft, R				Cook, Rob; Lamont, Tara; Taft, Rachel		NIHR Dissemination Ctr	Patient centred care for multimorbidity improves patient experience, but quality of life is unchanged	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material								The study A patient-centred intervention to improve the management of multimorbidity in general practice: the 3D RCT. Salisbury C, Man M-S, Chaplin K, et al. Published in Health Serv Deliv Res 2019; 7(5). This study was funded by the National Institute for Health Research Health Services and Delivery Programme (project number 12/130/15). To read the full NIHR Signal, go to: https://discover.dc.nihr.ac.uk/content/signal-000658/patient-centred-care-for-multimorbidity-improves-patientexperience-but-quality-of-life-is-unchanged	[Cook, Rob; Taft, Rachel] Bazian, Economist Intelligence Unit Healthcare, London, England; [Lamont, Tara] Univ Southampton, Wessex Inst, Southampton, Hants, England	University of Southampton	Cook, R (corresponding author), Bazian, Economist Intelligence Unit Healthcare, London, England.	rob.cook@bazian.com		Cook, Robert/0000-0002-2210-3989; Lamont, Tara/0000-0003-4405-8637				Kingston A, 2018, AGE AGEING, V47, P374, DOI 10.1093/ageing/afx201; National Institute for Health and Care Excellence Multimorbidity, 2016, CLIN ASS MAN NG56; NHS Employers, 2018, QUAL OUTC FRAM; Salisbury C, 2018, LANCET, V392, P41, DOI 10.1016/S0140-6736(18)31308-4; Smith SM, 2016, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD006560.pub3, 10.1002/14651858.CD006560.pub4]	5	2	2	2	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 15	2019	364								k4439	10.1136/bmj.k4439	http://dx.doi.org/10.1136/bmj.k4439			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP5WF	30877128				2022-12-28	WOS:000461752800009
J	Gruber, N; Clement, D; Carter, BR; Feely, RA; van Heuven, S; Hoppema, M; Ishii, M; Key, RM; Kozyr, A; Lauvset, SK; Lo Monaco, C; Mathis, JT; Murata, A; Olsen, A; Perez, FF; Sabine, CL; Tanhua, T; Wanninkhof, R				Gruber, Nicolas; Clement, Dominic; Carter, Brendan R.; Feely, Richard A.; van Heuven, Steven; Hoppema, Mario; Ishii, Masao; Key, Robert M.; Kozyr, Alex; Lauvset, Siv K.; Lo Monaco, Claire; Mathis, Jeremy T.; Murata, Akihiko; Olsen, Are; Perez, Fiz F.; Sabine, Christopher L.; Tanhua, Toste; Wanninkhof, Rik			The oceanic sink for anthropogenic CO2 from 1994 to 2007	SCIENCE			English	Article							MERIDIONAL OVERTURNING CIRCULATION; GLOBAL OCEAN; CARBON FLUXES; LAND-USE; STORAGE; ACIDIFICATION; VENTILATION; PERTURBATION; DISSOCIATION; CONSTANTS	We quantify the oceanic sink for anthropogenic carbon dioxide (CO2) over the period 1994 to 2007 by using observations from the global repeat hydrography program and contrasting them to observations from the 1990s. Using a linear regression-based method, we find a global increase in the anthropogenic CO2 inventory of 34 +/- 4 petagrams of carbon (Pg C) between 1994 and 2007. This is equivalent to an average uptake rate of 2.6 +/- 0.3 Pg C year-1 and represents 31 +/- 4% of the global anthropogenic CO2 emissions over this period. Although this global ocean sink estimate is consistent with the expectation of the ocean uptake having increased in proportion to the rise in atmospheric CO2, substantial regional differences in storage rate are found, likely owing to climate variability-driven changes in ocean circulation.	[Gruber, Nicolas; Clement, Dominic] Swiss Fed Inst Technol, Environm Phys, Inst Biogeochem & Pollutant Dynam, Zurich, Switzerland; [Carter, Brendan R.; Feely, Richard A.] NOAA, Pacific Marine Environm Lab, 7600 Sand Point Way Ne, Seattle, WA 98115 USA; [Carter, Brendan R.] Univ Washington, Joint Inst Study Atmosphere & Ocean, Seattle, WA 98195 USA; [van Heuven, Steven] Univ Groningen, Ctr Isotope Res, Fac Sci & Engn, Groningen, Netherlands; [Hoppema, Mario] Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Bremerhaven, Germany; [Ishii, Masao] Japan Meteorol Agcy, Meteorol Res Inst, Tsukuba, Ibaraki, Japan; [Key, Robert M.] Princeton Univ, Atmospher & Ocean Sci, Princeton, NJ 08544 USA; [Kozyr, Alex] NOAA, Natl Ctr Environm Informat, Silver Spring, MD USA; [Lauvset, Siv K.] Bjerknes Ctr Climate Res, NORCE Norwegian Res Ctr, Bergen, Norway; [Lauvset, Siv K.; Olsen, Are] Univ Bergen, Geophys Inst, Bergen, Norway; [Lauvset, Siv K.; Olsen, Are] Bjerknes Ctr Climate Res, Bergen, Norway; [Lo Monaco, Claire] Sorbonne Univ, LOCEAN, CNRS, Paris, France; [Mathis, Jeremy T.] NOAA, Arctic Res Program, Silver Spring, MD USA; [Murata, Akihiko] Japan Agcy Marine Earth Sci & Technol, Res & Dev Ctr Global Change, Yokosuka, Kanagawa, Japan; [Perez, Fiz F.] CSIC, IIM, Vigo, Spain; [Sabine, Christopher L.] Univ Hawaii Manoa, Dept Oceanog, Honolulu, HI 96822 USA; [Tanhua, Toste] GEOMAR Helmholtz Ctr Ocean Res Kiel, Kiel, Germany; [Wanninkhof, Rik] NOAA, Atlantic Oceanog & Meteorol Lab, Miami, FL 33149 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; National Oceanic Atmospheric Admin (NOAA) - USA; University of Washington; University of Washington Seattle; University of Groningen; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Japan Meteorological Agency; Meteorological Research Institute - Japan; Princeton University; National Oceanic Atmospheric Admin (NOAA) - USA; Bjerknes Centre for Climate Research; Norwegian Research Centre (NORCE); University of Bergen; Bjerknes Centre for Climate Research; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; National Oceanic Atmospheric Admin (NOAA) - USA; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM); University of Hawaii System; University of Hawaii Manoa; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; National Oceanic Atmospheric Admin (NOAA) - USA; Atlantic Oceanographic & Meteorological Laboratory (AOML)	Gruber, N (corresponding author), Swiss Fed Inst Technol, Environm Phys, Inst Biogeochem & Pollutant Dynam, Zurich, Switzerland.	nicolas.gruber@env.ethz.ch	Feely, Richard A./ABI-5740-2020; Carter, Brendan/AAB-1327-2021; Olsen, Are/A-1511-2011; Hoppema, Mario/I-6286-2013; Carter, Brendan/ABG-9706-2021; Gruber, Nicolas/B-7013-2009; Fernandez Perez, Fiz/B-9001-2011	Olsen, Are/0000-0003-1696-9142; Hoppema, Mario/0000-0002-2326-619X; Gruber, Nicolas/0000-0002-2085-2310; Fernandez Perez, Fiz/0000-0003-4836-8974; Carter, Brendan/0000-0003-2445-0711	U.S. National Science Foundation; National Oceanic and Atmospheric Administration (NOAA); GO-SHIP program; ETH; FP7 project CarboChange [264879]; FP7 project Geocarbon [283080]; CarboChange [264879]; Oceanic and Atmospheric Research NOAA; U.S. Department of Commerce; Japan Meteorological Agency; MEXT KAKENHI [24121003, JP16H01594]; Research Council of Norway [214513]; Ministerio de Economia y Competitividad through the ARIOS project - Fondo Europeo de Desarrollo Regional 2014-2020 (FEDER) [CTM2016-76146-C3-1-R]; EU Horizon 2020 through the AtlantOS project [633211]; International ocean carbon coordination project (IOCCP); NOAA Global Ocean Monitoring and Observations Division [100007298]	U.S. National Science Foundation(National Science Foundation (NSF)); National Oceanic and Atmospheric Administration (NOAA)(National Oceanic Atmospheric Admin (NOAA) - USA); GO-SHIP program; ETH(ETH Zurich); FP7 project CarboChange; FP7 project Geocarbon; CarboChange; Oceanic and Atmospheric Research NOAA; U.S. Department of Commerce; Japan Meteorological Agency; MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Research Council of Norway(Research Council of Norway); Ministerio de Economia y Competitividad through the ARIOS project - Fondo Europeo de Desarrollo Regional 2014-2020 (FEDER); EU Horizon 2020 through the AtlantOS project; International ocean carbon coordination project (IOCCP); NOAA Global Ocean Monitoring and Observations Division	We are grateful to the many funding agencies in the various countries that financially supported the global ship-based surveys that underpin much of this work. In particular, we acknowledge funding from the U.S. National Science Foundation and from the National Oceanic and Atmospheric Administration (NOAA), and the GO-SHIP program together with the International ocean carbon coordination project (IOCCP), for their efforts to initiate and coordinate the repeat hydrography program. The work of N.G. and D.C. was supported by ETH and the FP7 projects CarboChange (264879) and Geocarbon (283080). S.v.H. also received support from CarboChange (264879). R.W., R.A.F., and B.R.C. acknowledge the support of Oceanic and Atmospheric Research NOAA and the U.S. Department of Commerce, including resources from the NOAA Global Ocean Monitoring and Observations Division (fund reference 100007298). This is contribution no. 4796 from the NOAA Pacific Marine Environmental Laboratory and JISAO contribution 2018-0185. M.I. acknowledges support from the Japan Meteorological Agency and MEXT KAKENHI grant no. 24121003 "NEOPS" and JP16H01594 "OMIX". S.K.L. acknowledges support from the Research Council of Norway (214513). F.F.P. was supported by Ministerio de Economia y Competitividad through the ARIOS (CTM2016-76146-C3-1-R) project cofunded by the Fondo Europeo de Desarrollo Regional 2014-2020 (FEDER) and EU Horizon 2020 through the AtlantOS project (grant agreement 633211).	[Anonymous], [No title captured]; Aoyama M, 2012, ANAL SCI, V28, P911; Bopp L, 2015, GEOPHYS RES LETT, V42, P6416, DOI 10.1002/2015GL065073; Broecker WS, 1991, GLOBAL BIOGEOCHEM CY, V5, P87, DOI 10.1029/90GB02279; Carter BR, 2017, GLOBAL BIOGEOCHEM CY, V31, P306, DOI 10.1002/2016GB005485; Clement D, 2018, GLOBAL BIOGEOCHEM CY, V32, P654, DOI 10.1002/2017GB005819; DeVries T, 2017, NATURE, V542, P215, DOI 10.1038/nature21068; DeVries T, 2014, GLOBAL BIOGEOCHEM CY, V28, P631, DOI 10.1002/2013GB004739; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Dlugokencky, 2017, TRENDS ATMOSPHERIC C; Dlugokencky E., 2017, TRENDS ATMOSPHERIC C, DOI [10.1146/annurev.marine.010908.163834Medline, DOI 10.1146/ANNUREV.MARINE.010908.163834MEDLINE]; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Fletcher SEM, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002530; Friis K, 2005, DEEP-SEA RES PT I, V52, P681, DOI 10.1016/j.dsr.2004.11.017; Frob F, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13244; GAMMON RH, 1982, J GEOPHYS RES-OCEANS, V87, P9441, DOI 10.1029/JC087iC12p09441; Gruber N, 1998, GLOBAL BIOGEOCHEM CY, V12, P165, DOI 10.1029/97GB03658; Gruber N, 1996, GLOBAL BIOGEOCHEM CY, V10, P809, DOI 10.1029/96GB01608; Gruber N., 2009, CYCLES, V23; Gruber N, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003349; Hanawa K., 2001, OCEAN CIRCULATION CL, P373, DOI DOI 10.1016/S0074-6142(01)80129-7; Hansis E, 2015, GLOBAL BIOGEOCHEM CY, V29, P1230, DOI 10.1002/2014GB004997; Hoppema M, 2001, GEOPHYS RES LETT, V28, P1747, DOI 10.1029/2000GL012443; Houghton RA, 2017, GLOBAL BIOGEOCHEM CY, V31, P456, DOI 10.1002/2016GB005546; Jackett DR, 1997, J PHYS OCEANOGR, V27, P237, DOI 10.1175/1520-0485(1997)027<0237:ANDVFT>2.0.CO;2; Jacobson AR, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2005GB002556; Keeling RF, 2005, SCIENCE, V308, DOI 10.1126/science.1109620; Key R. M., 2010, EARTH SYST SCI DATA, V2, P105, DOI [DOI 10.5194/ESSD-2-105-2010, 10.5194/essd-2-105-2010]; Key RM, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002247; Khatiwala S, 2013, BIOGEOSCIENCES, V10, P2169, DOI 10.5194/bg-10-2169-2013; Khatiwala S, 2009, NATURE, V462, P346, DOI 10.1038/nature08526; Kouketsu S, 2014, GEOPHYS RES LETT, V41, P4594, DOI 10.1002/2014GL060516; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Landschutzer P, 2016, GLOBAL BIOGEOCHEM CY, V30, P1396, DOI 10.1002/2015GB005359; Lauvset SK, 2016, EARTH SYST SCI DATA, V8, P325, DOI 10.5194/essd-8-325-2016; Le Quere C, 2018, EARTH SYST SCI DATA, V10, P405, DOI 10.5194/essd-10-405-2018; Locarnini R. A., 2013, WORLD OCEAN ATLAS 20, V1; Marshall J, 2012, NAT GEOSCI, V5, P171, DOI [10.1038/ngeo1391, 10.1038/NGEO1391]; Martiny AC, 2013, NAT GEOSCI, V6, P279, DOI [10.1038/NGEO1757, 10.1038/ngeo1757]; Matsumoto K, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002397; McNeil BI, 2013, BIOGEOSCIENCES, V10, P2219, DOI 10.5194/bg-10-2219-2013; McNeil BI, 2003, SCIENCE, V299, P235, DOI 10.1126/science.1077429; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Olsen A, 2016, EARTH SYST SCI DATA, V8, P297, DOI 10.5194/essd-8-297-2016; Olsen A, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005488; Perez FF, 2018, NATURE, V554, P515, DOI 10.1038/nature25493; Perez FF, 2013, NAT GEOSCI, V6, P146, DOI [10.1038/ngeo1680, 10.1038/NGEO1680]; Plancherel Y, 2013, BIOGEOSCIENCES, V10, P4801, DOI 10.5194/bg-10-4801-2013; Regnier P, 2013, NAT GEOSCI, V6, P597, DOI [10.1038/NGEO1830, 10.1038/ngeo1830]; Resplandy L, 2018, NAT GEOSCI, V11, P504, DOI 10.1038/s41561-018-0151-3; Sabine C, 2005, SCIENCE, V308, DOI 10.1126/science.1109949; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Sarmiento J.L., 2013, OCEAN BIOGEOCHEMICAL, DOI [DOI 10.2307/J.CTT3FGXQX, 10.1515/9781400849079, DOI 10.1515/9781400849079]; SARMIENTO JL, 1995, GLOBAL BIOGEOCHEM CY, V9, P121, DOI 10.1029/94GB01779; SARMIENTO JL, 1992, J GEOPHYS RES-OCEANS, V97, P3621, DOI 10.1029/91JC02849; Sarmiento JL, 2002, SEA BIOL PHYSICAL IN, V12, P337; Schneider A, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2010JC006171; Sonnerup RE, 2000, GLOBAL BIOGEOCHEM CY, V14, P903, DOI 10.1029/1999GB001244; Steinfeldt R, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003311; Talley LD, 2016, ANNU REV MAR SCI, V8, P185, DOI 10.1146/annurev-marine-052915-100829; Tanhua T, 2010, EARTH SYST SCI DATA, V2, P17, DOI [10.5194/essd-2-17-2010, DOI 10.5194/ESSD-2-17-2010]; Tanhua T, 2007, P NATL ACAD SCI USA, V104, P3037, DOI 10.1073/pnas.0606574104; Tanhua T, 2017, DEEP-SEA RES PT II, V138, P26, DOI 10.1016/j.dsr2.2016.10.004; Tanhua T, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC004868; Thompson DWJ, 2002, SCIENCE, V296, P895, DOI 10.1126/science.1069270; van Heuven S., 2011, MATLAB PROGRAM DEV C, DOI 10.3334/CDIAC/otg.CO2SYS_MATLAB_v1.1; Wanninkhof R, 2013, DEEP-SEA RES PT I, V74, P48, DOI 10.1016/j.dsr.2012.12.005; Wanninkhof R, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2010JC006251; Waugh DW, 2013, SCIENCE, V339, P568, DOI 10.1126/science.1225411; Weng M. M., 2013, WORLD OCEAN ATLAS 20, V2; Woosley RJ, 2016, GLOBAL BIOGEOCHEM CY, V30, P70, DOI 10.1002/2015GB005248	72	287	290	40	372	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 15	2019	363	6432			SI		1193	+		10.1126/science.aau5153	http://dx.doi.org/10.1126/science.aau5153			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP0BC	30872519	Green Submitted, Green Accepted, Green Published			2022-12-28	WOS:000461329000043
J	Suggitt, A				Suggitt, Andy			Preparing for Brexit	SCIENCE			English	Editorial Material								The hubbub of conversation fills the air as 50 early-career researchers (ECRs) discuss our futures after Brexit. Flipboards around the room fill with sticky notes, each with a scribbled thought or idea. A board labeled "What will Brexit mean for your career?" highlights the toll it has already taken. One scientist abandoned their application for the European Union's Horizon 2020 funding program. Others are reluctantly making plans to leave the United Kingdom. A note with the word "uncertainty" stands out in the middle of the board. And yet, a month before the official Brexit date, the atmosphere is surprisingly positive. Coming together to discuss these challenges seems to be giving us confidence that we will find a way forward.	[Suggitt, Andy] Univ York, York, N Yorkshire, England	University of York - UK	Suggitt, A (corresponding author), Univ York, York, N Yorkshire, England.			Suggitt, Andrew/0000-0001-7697-7633					0	0	0	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 15	2019	363	6432			SI		1246	1246		10.1126/science.363.6432.1246	http://dx.doi.org/10.1126/science.363.6432.1246			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HP0BC	30872529				2022-12-28	WOS:000461329000053
J	Ference, BA; Ray, KK; Catapano, AL; Ference, TB; Burgess, S; Neff, DR; Oliver-Williams, C; Wood, AM; Butterworth, AS; Di Angelantonio, E; Danesh, J; Kastelein, JJP; Nicholls, SJ				Ference, Brian A.; Ray, Kausik K.; Catapano, Alberico L.; Ference, Thatcher B.; Burgess, Stephen; Neff, David R.; Oliver-Williams, Clare; Wood, Angela M.; Butterworth, Adam S.; Di Angelantonio, Emanuele; Danesh, John; Kastelein, John J. P.; Nicholls, Stephen J.			Mendelian Randomization Study of ACLY and Cardiovascular Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DENSITY-LIPOPROTEIN-CHOLESTEROL; GENOME-WIDE ASSOCIATION; CORONARY-HEART-DISEASE; CITRATE LYASE; RISK; SAFETY; METAANALYSIS; INHIBITION; EFFICACY; PCSK9	BACKGROUND ATP citrate lyase is an enzyme in the cholesterol-biosynthesis pathway upstream of 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR), the target of statins. Whether the genetic inhibition of ATP citrate lyase is associated with deleterious outcomes and whether it has the same effect, per unit decrease in the low-density lipoprotein (LDL) cholesterol level, as the genetic inhibition of HMGCR is unclear. METHODS We constructed genetic scores composed of independently inherited variants in the genes encoding ATP citrate lyase (ACLY) and HMGCR to create instruments that mimic the effect of ATP citrate lyase inhibitors and HMGCR inhibitors (statins), respectively. We then compared the associations of these genetic scores with plasma lipid levels, lipoprotein levels, and the risk of cardiovascular events and cancer. RESULTS A total of 654,783 participants, including 105,429 participants who had major cardiovascular events, were included in the study. The ACLY and HMGCR scores were associated with similar patterns of changes in plasma lipid and lipoprotein levels and with similar effects on the risk of cardiovascular events per decrease of 10 mg per deciliter in the LDL cholesterol level: odds ratio for cardiovascular events, 0.823 (95% confidence interval [CI], 0.78 to 0.87; P = 4.0x10(-14)) for the ACLY score and 0.836 (95% CI, 0.81 to 0.87; P = 3.9x10(-19)) for the HMGCR score. Neither lifelong genetic inhibition of ATP citrate lyase nor lifelong genetic inhibition of HMGCR was associated with an increased risk of cancer. CONCLUSIONS Genetic variants that mimic the effect of ATP citrate lyase inhibitors and statins appeared to lower plasma LDL cholesterol levels by the same mechanism of action and were associated with similar effects on the risk of cardiovascular disease per unit decrease in the LDL cholesterol level. (Funded by Esperion Therapeutics and others.)	[Ference, Brian A.; Ference, Thatcher B.] Univ Cambridge, Ctr Nat Randomized Trials, 2 Worts Causeway, Cambridge CB1 8RN, England; [Ference, Brian A.; Burgess, Stephen; Oliver-Williams, Clare; Wood, Angela M.; Butterworth, Adam S.; Di Angelantonio, Emanuele; Danesh, John] Univ Cambridge, British Heart Fdn, Cardiovasc Epidemiol Unit, Dept Publ Hlth & Primary Care,Med Res Council, Cambridge, England; [Burgess, Stephen] Univ Cambridge, Med Res Council, Biostat Unit, Cambridge, England; [Butterworth, Adam S.; Di Angelantonio, Emanuele; Danesh, John] Univ Cambridge, NIHR Blood & Transplant Res Unit Donor Hlth & Gen, Cambridge, England; [Ray, Kausik K.] Imperial Coll London, Sch Publ Hlth, Ctr Cardiovasc Dis Prevent, Dept Primary Care & Publ Hlth, London, England; [Catapano, Alberico L.] Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy; [Catapano, Alberico L.] Multimed IRCCS, Milan, Italy; [Neff, David R.] Michigan State Univ, E Lansing, MI 48824 USA; [Kastelein, John J. P.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, Amsterdam, Netherlands; [Nicholls, Stephen J.] Monash Univ, Clayton, Vic, Australia	University of Cambridge; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Cambridge; MRC Biostatistics Unit; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Cambridge; University of Cambridge; Imperial College London; University of Milan; IRCCS Multimedica; Michigan State University; University of Amsterdam; Academic Medical Center Amsterdam; Monash University	Ference, BA (corresponding author), Univ Cambridge, Ctr Nat Randomized Trials, 2 Worts Causeway, Cambridge CB1 8RN, England.	baf29@medschl.cam.ac.uk	Wood, Angela/GZA-5762-2022; Kastelein, John/AAF-7950-2020; Catapano, alberico/AAC-2827-2019; Ray, Kausik/Z-2055-2019; DiAngelantonio, Emanuele/ABE-6852-2020	Wood, Angela/0000-0002-7937-304X; Catapano, alberico/0000-0002-7593-2094; Di Angelantonio, Emanuele/0000-0001-8776-6719; Nicholls, Stephen/0000-0002-9668-4368; Burgess, Stephen/0000-0001-5365-8760	Esperion Therapeutics; MRC [MC_UU_00002/7] Funding Source: UKRI	Esperion Therapeutics; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funded by Esperion Therapeutics and others.	Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Ballantyne CM, 2018, ATHEROSCLEROSIS, V277, P195, DOI 10.1016/j.atherosclerosis.2018.06.002; Ballantyne CM, 2016, AM J CARDIOL, V117, P1928, DOI 10.1016/j.amjcard.2016.03.043; Ballantyne CM, 2013, J AM COLL CARDIOL, V62, P1154, DOI 10.1016/j.jacc.2013.05.050; Burgess S, 2016, STAT MED, V35, P1880, DOI 10.1002/sim.6835; Di Angelantonio E, 2017, LANCET, V390, P2360, DOI 10.1016/S0140-6736(17)31928-1; Emberson JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029849; Ference BA, 2018, EUR HEART J, V39, P360, DOI 10.1093/eurheartj/ehx462; Ference BA, 2017, JAMA-J AM MED ASSOC, V318, P947, DOI 10.1001/jama.2017.11467; Ference BA, 2017, EUR HEART J, V38, P2459, DOI 10.1093/eurheartj/ehx144; Ference BA, 2016, NEW ENGL J MED, V375, P2144, DOI 10.1056/NEJMoa1604304; Ference BA, 2015, J AM COLL CARDIOL, V65, P1552, DOI 10.1016/j.jacc.2015.02.020; Ference BA, 2012, J AM COLL CARDIOL, V60, P2631, DOI 10.1016/j.jacc.2012.09.017; Liu DJ, 2017, NAT GENET, V49, P1758, DOI 10.1038/ng.3977; Machiela MJ, 2015, BIOINFORMATICS, V31, P3555, DOI 10.1093/bioinformatics/btv402; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Nikpay M, 2015, NAT GENET, V47, P1121, DOI 10.1038/ng.3396; Pinkosky SL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13457; Ray KK, 2019, NEW ENGL J MED, V380, P1022, DOI 10.1056/NEJMoa1803917; Scott RA, 2017, DIABETES, V66, P2888, DOI 10.2337/db16-1253; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Wang YF, 2014, NAT GENET, V46, P736, DOI 10.1038/ng.3002; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Wurtz P, 2016, J AM COLL CARDIOL, V67, P1200, DOI 10.1016/j.jacc.2015.12.060	24	134	136	4	32	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 14	2019	380	11					1033	1042		10.1056/NEJMoa1806747	http://dx.doi.org/10.1056/NEJMoa1806747			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HO8NL	30865797	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000461210000007
J	Rimmer, A				Rimmer, Abi			GMC chair calls for more frontline consultant presence in hospitals	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Chana P, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014484	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 8	2019	364								l1109	10.1136/bmj.l1109	http://dx.doi.org/10.1136/bmj.l1109			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HO6TC	30850361				2022-12-28	WOS:000461063500011
J	Shepherd, A				Shepherd, Alison			THE BIG PICTURE Abortion in Northern Ireland: women march in London	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 5	2019	364								l999	10.1136/bmj.l999	http://dx.doi.org/10.1136/bmj.l999			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HO6SS	30837241				2022-12-28	WOS:000461062200012
J	Weinreb, RN; Moghimi, S				Weinreb, Robert N.; Moghimi, Sasan			Prophylactic laser iridotomy in primary angle-closure suspects	LANCET			English	Editorial Material							OCULAR HYPERTENSION; GLAUCOMA; IRIS; RISK		[Weinreb, Robert N.; Moghimi, Sasan] Univ Calif San Diego, Shiley Eye Inst, Hamilton Glaucoma Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Weinreb, RN (corresponding author), Univ Calif San Diego, Shiley Eye Inst, Hamilton Glaucoma Ctr, La Jolla, CA 92093 USA.	rweinreb@ucsd.edu						Azuara-Blanco A, 2016, LANCET, V388, P1389, DOI 10.1016/S0140-6736(16)30956-4; Gordon MO, 2002, ARCH OPHTHALMOL-CHIC, V120, P714; He MG, 2019, LANCET, V393, P1609, DOI 10.1016/S0140-6736(18)32607-2; Kumar RS, 2008, OPHTHALMOLOGY, V115, P430, DOI 10.1016/j.ophtha.2007.07.026; Lee RY, 2013, J GLAUCOMA, V22, P673, DOI 10.1097/IJG.0b013e318264ba68; Medeiros FA, 2005, ARCH OPHTHALMOL-CHIC, V123, P1351, DOI 10.1001/archopht.123.10.1351; Moghimi S, 2016, AM J OPHTHALMOL, V166, P133, DOI 10.1016/j.ajo.2016.03.032; Moghimi S, 2013, AM J OPHTHALMOL, V155, P664, DOI 10.1016/j.ajo.2012.10.014; Thomas R, 2003, ACTA OPHTHALMOL SCAN, V81, P480, DOI 10.1034/j.1600-0420.2003.00135.x; WILENSKY JT, 1993, AM J OPHTHALMOL, V115, P338, DOI 10.1016/S0002-9394(14)73585-8	10	1	1	1	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 20	2019	393	10181					1572	1574		10.1016/S0140-6736(18)33059-9	http://dx.doi.org/10.1016/S0140-6736(18)33059-9			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HU0DL	30878227				2022-12-28	WOS:000464941500006
J	Martorell, AJ; Paulson, AL; Suk, HJ; Abdurrob, F; Drummond, GT; Guan, W; Young, JZ; Kim, DNW; Kritskiy, O; Barker, SJ; Mangena, V; Prince, SM; Brown, EN; Chung, K; Boyden, ES; Singer, AC; Tsai, LH				Martorell, Anthony J.; Paulson, Abigail L.; Suk, Ho-Jun; Abdurrob, Fatema; Drummond, Gabrielle T.; Guan, Webster; Young, Jennie Z.; Kim, David Nam-Woo; Kritskiy, Oleg; Barker, Scarlett J.; Mangena, Vamsi; Prince, Stephanie M.; Brown, Emery N.; Chung, Kwanghun; Boyden, Edward S.; Singer, Annabelle C.; Tsai, Li-Huei			Multi-sensory Gamma Stimulation Ameliorates Alzheimer's-Associated Pathology and Improves Cognition	CELL			English	Article							AMYLOID-BETA; PARVALBUMIN NEURONS; PYRAMIDAL CELLS; WATER-MAZE; MICROGLIA; ACTIVATION; DISEASE; CORTEX; NEURODEGENERATION; INTERNEURONS	We previously reported that inducing gamma oscillations with a non-invasive light flicker (gamma entrainment using sensory stimulus or GENUS) impacted pathology in the visual cortex of Alzheimer's disease mouse models. Here, we designed auditory tone stimulation that drove gamma frequency neural activity in auditory cortex (AC) and hippocampal CA1. Seven days of auditory GENUS improved spatial and recognition memory and reduced amyloid in AC and hippocampus of 5XFAD mice. Changes in activation responses were evident in microglia, astrocytes, and vasculature. Auditory GENUS also reduced phosphorylated tau in the P301S tauopathy model. Furthermore, combined auditory and visual GENUS, but not either alone, produced microglial-clustering responses, and decreased amyloid in medial prefrontal cortex. Whole brain analysis using SHIELD revealed widespread reduction of amyloid plaques throughout neocortex after multi-sensory GENUS. Thus, GENUS can be achieved through multiple sensory modalities with wide-ranging effects across multiple brain areas to improve cognitive function.	[Martorell, Anthony J.; Abdurrob, Fatema; Drummond, Gabrielle T.; Young, Jennie Z.; Kim, David Nam-Woo; Kritskiy, Oleg; Barker, Scarlett J.; Brown, Emery N.; Chung, Kwanghun; Tsai, Li-Huei] MIT, Picower Inst Learning & Memory, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Martorell, Anthony J.; Abdurrob, Fatema; Drummond, Gabrielle T.; Young, Jennie Z.; Kim, David Nam-Woo; Kritskiy, Oleg; Barker, Scarlett J.; Brown, Emery N.; Chung, Kwanghun; Boyden, Edward S.; Tsai, Li-Huei] MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA; [Paulson, Abigail L.; Prince, Stephanie M.; Singer, Annabelle C.] Georgia Inst Technol, Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Paulson, Abigail L.; Prince, Stephanie M.; Singer, Annabelle C.] Emory Univ, Sch Med, Atlanta, GA 30332 USA; [Suk, Ho-Jun; Boyden, Edward S.] MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Suk, Ho-Jun; Boyden, Edward S.] MIT, Media Lab, Dept Biol Engn, Cambridge, MA 02139 USA; [Suk, Ho-Jun; Boyden, Edward S.] MIT, Dept Brain & Cognit Sci, Media Lab, E25-618, Cambridge, MA 02139 USA; [Suk, Ho-Jun; Mangena, Vamsi] Harvard MIT Hlth Sci & Technol, Cambridge, MA 02139 USA; [Guan, Webster; Chung, Kwanghun] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Brown, Emery N.; Chung, Kwanghun] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Chung, Kwanghun; Tsai, Li-Huei] Broad Inst Harvard & MIT, Cambridge, MA 02139 USA; [Brown, Emery N.] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA; [Brown, Emery N.] Harvard Med Sch, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Northwell Health; Massachusetts Institute of Technology (MIT); University System of Georgia; Georgia Institute of Technology; Emory University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Tsai, LH (corresponding author), MIT, Picower Inst Learning & Memory, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Tsai, LH (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.; Tsai, LH (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA 02139 USA.	lhtsai@mit.edu		Singer, Annabelle C./0000-0001-6003-0488; Paulson, Abigail/0000-0002-7640-850X	NIH [R01-NS109226, T32 NS007480-18, RF1-AG047661, U01-NS090473, U01MH117072, T32 GM007484, R01-EY023173, R01-GM104948, DP1-OD003646]; Packard Award in Science and Engineering; Friends and Alumni of Georgia Tech, Lane Family; Fulton County Elder Health Science Fellowship, Wright Family; Robert and Renee Belfer Family Foundation; Halis Family Foundation; JPB Foundation; Burroughs Wellcome Fund Career Awards at the Scientific Interface; Searle Scholars Program; NARSAD Young Investigator Award; NCSOFT Cultural Foundation; MIT Champions of the Brain Fellowship; Henry E. Singleton Fellowship; William C. and Margaret H. Rousseau Fellowship; SITA Foundation Fellowship; Samsung Fellowship; MIT Aging Brain Initiative; HHMI-Simons Fellowship; Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, Massachusetts; Integrative Neuronal Systems; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104948, T32GM007484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH117072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007480, U01NS090473, R01NS109226] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Packard Award in Science and Engineering; Friends and Alumni of Georgia Tech, Lane Family; Fulton County Elder Health Science Fellowship, Wright Family; Robert and Renee Belfer Family Foundation; Halis Family Foundation; JPB Foundation; Burroughs Wellcome Fund Career Awards at the Scientific Interface(Burroughs Wellcome Fund); Searle Scholars Program; NARSAD Young Investigator Award(NARSAD); NCSOFT Cultural Foundation; MIT Champions of the Brain Fellowship; Henry E. Singleton Fellowship; William C. and Margaret H. Rousseau Fellowship; SITA Foundation Fellowship; Samsung Fellowship(Samsung); MIT Aging Brain Initiative; HHMI-Simons Fellowship; Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, Massachusetts; Integrative Neuronal Systems; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful tomembers of the Tsai, Singer, and Boyden laboratories for technical assistance and comments on the paper. This work was supported by NIH (R01-NS109226 to A.C.S., T32 NS007480-18 to A.L.P., RF1-AG047661 to L.-H.T., U01-NS090473 to K.C., U01MH117072 to K.C., T32 GM007484 to A.J.M., R01-EY023173 to E.S.B., and R01-GM104948 and DP1-OD003646 to E.N.B.); Packard Award in Science and Engineering (to A.C.S. and K.C.); Friends and Alumni of Georgia Tech, Lane Family (to A.C.S.); Fulton County Elder Health Science Fellowship, Wright Family (to A.L.P.); Robert and Renee Belfer Family Foundation (to L.-H.T.); Halis Family Foundation (to L.-H.T.); JPB Foundation (to L.-H.T. and PIIF and PNDRF to K.C.); Burroughs Wellcome Fund Career Awards at the Scientific Interface (to K.C.); Searle Scholars Program (to K.C.); NARSAD Young Investigator Award (to K.C.); NCSOFT Cultural Foundation (to K.C.); Integrative Neuronal Systems (to A.J.M.); MIT Champions of the Brain Fellowship (to A.J.M.); Henry E. Singleton Fellowship (to A.J.M.); William C. and Margaret H. Rousseau Fellowship (to W.G.); SITA Foundation Fellowship (to V.M.); Samsung Fellowship (to H.-J.S.); MIT Aging Brain Initiative (to L.-H.T. and E.S.B.), John Doerr, Edward and Kay Poitras (to E.S.B.); HHMI-Simons Fellowship (to E.S.B.); Open Philanthropy, Charles Hieken (to E.S.B.); and Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, Massachusetts (to E.N.B.).	Allen NJ, 2005, CURR OPIN NEUROBIOL, V15, P542, DOI 10.1016/j.conb.2005.08.006; Aronov D, 2017, NATURE, V543, P719, DOI 10.1038/nature21692; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; Bero AW, 2011, NAT NEUROSCI, V14, P750, DOI 10.1038/nn.2801; Canter RG, 2016, NATURE, V539, P187, DOI 10.1038/nature20412; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Chung JE, 2017, NEURON, V95, P1381, DOI 10.1016/j.neuron.2017.08.030; Chung WS, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020370; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Filosa JA, 2013, AM J PHYSIOL-HEART C, V305, pH609, DOI 10.1152/ajpheart.00359.2013; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; Gillespie AK, 2016, NEURON, V90, P740, DOI 10.1016/j.neuron.2016.04.009; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Heneka MT, 2014, NAT REV IMMUNOL, V14, P463, DOI 10.1038/nri3705; Holmes BB, 2014, P NATL ACAD SCI USA, V111, pE4376, DOI 10.1073/pnas.1411649111; Iaccarino HF, 2016, NATURE, V540, P230, DOI 10.1038/nature20587; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Kanekiyo T, 2013, J NEUROSCI, V33, P19276, DOI 10.1523/JNEUROSCI.3487-13.2013; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Kim H, 2016, CELL, V164, P208, DOI 10.1016/j.cell.2015.11.038; Kim SY, 2015, P NATL ACAD SCI USA, V112, pE6274, DOI 10.1073/pnas.1510133112; Kisler K, 2017, NAT REV NEUROSCI, V18, P419, DOI 10.1038/nrn.2017.48; Knoblich U, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00185; Kyrtsos CR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139574; Leger M, 2013, NAT PROTOC, V8, P2531, DOI 10.1038/nprot.2013.155; Lu T, 2001, J NEUROPHYSIOL, V85, P2364, DOI 10.1152/jn.2001.85.6.2364; Ma LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064288; Mathys H, 2017, CELL REP, V21, P366, DOI 10.1016/j.celrep.2017.09.039; Mears RP, 2006, NEUROSCIENCE, V141, P47, DOI 10.1016/j.neuroscience.2006.03.040; MILLER CL, 1995, NEUROSCIENCE, V69, P371, DOI 10.1016/0306-4522(95)00249-I; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Mosher KI, 2014, BIOCHEM PHARMACOL, V88, P594, DOI 10.1016/j.bcp.2014.01.008; Murray E, 2015, CELL, V163, P1500, DOI 10.1016/j.cell.2015.11.025; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Park YG, 2019, NAT BIOTECHNOL, V37, P73, DOI 10.1038/nbt.4281; Rager G, 1998, EUR J NEUROSCI, V10, P1856, DOI 10.1046/j.1460-9568.1998.00197.x; Ransohoff RM, 2010, NATURE, V468, P253, DOI 10.1038/nature09615; Rodriguez JJ, 2009, CELL DEATH DIFFER, V16, P378, DOI 10.1038/cdd.2008.172; Saijo K, 2011, NAT REV IMMUNOL, V11, P775, DOI 10.1038/nri3086; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Selkoe DJ, 1996, ANN NY ACAD SCI, V777, P57, DOI 10.1111/j.1749-6632.1996.tb34401.x; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Spellman T, 2015, NATURE, V522, P309, DOI 10.1038/nature14445; Sperling RA, 2010, NEUROMOL MED, V12, P27, DOI 10.1007/s12017-009-8109-7; Storck SE, 2016, J CLIN INVEST, V126, P123, DOI 10.1172/JCI81108; Verret L, 2012, CELL, V149, P708, DOI 10.1016/j.cell.2012.02.046; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Walker DG, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0139-9; Wolf SA, 2017, ANNU REV PHYSIOL, V79, P619, DOI 10.1146/annurev-physiol-022516-034406; Yamamoto J, 2014, CELL, V157, P845, DOI 10.1016/j.cell.2014.04.009; Yankner BA, 2009, J BIOL CHEM, V284, P4754, DOI 10.1074/jbc.R800018200; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010	55	212	223	31	191	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 4	2019	177	2					256	+		10.1016/j.cell.2019.02.014	http://dx.doi.org/10.1016/j.cell.2019.02.014			38	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	HR7PF	30879788	Green Accepted, Green Published, Green Submitted, Bronze			2022-12-28	WOS:000463346200007
J	Sundaram, ME; Guterman, LB; Omer, SB				Sundaram, Maria E.; Guterman, L. Beryl; Omer, Saad B.			The True Cost of Measles Outbreaks During the Postelimination Era	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Sundaram, Maria E.; Guterman, L. Beryl; Omer, Saad B.] Emory Univ, Hubert Dept Global Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Omer, Saad B.] Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Omer, Saad B.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA; [Omer, Saad B.] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA USA	Emory University; Rollins School Public Health; Emory University; Rollins School Public Health; Emory University; Emory University	Omer, SB (corresponding author), Emory Univ, Rollins Sch Publ Hlth, 1518 Clifton Rd,7017 Claudia Nance Rollins Bldg, Atlanta, GA 30329 USA.	somer@emory.edu	Sundaram, Maria/W-2575-2019	Sundaram, Maria/0000-0001-8056-3302	Emory Vaccinology Training Program of the National Institute of Allergy and Infectious Diseases [T32AI074492]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI125405, T32AI074492] Funding Source: NIH RePORTER	Emory Vaccinology Training Program of the National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by award T32AI074492 from the Emory Vaccinology Training Program of the National Institute of Allergy and Infectious Diseases (Dr Sundaram).	Mina MJ, 2015, SCIENCE, V348, P694, DOI 10.1126/science.aaa3662; Omer SB, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-2364; Orenstein WA, 2004, J INFECT DIS, V189, pS1, DOI 10.1086/377693; Phadke VK, 2016, JAMA-J AM MED ASSOC, V315, P1149, DOI 10.1001/jama.2016.1353; US Centers for Disease Control and Prevention, 2018, MEASL DAT STAT; US Centers for Disease Control and Prevention, MEASL CAS OUTBR; Washington State Department of Health, MEASL OUTBR 2019	7	15	15	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 26	2019	321	12					1155	1156		10.1001/jama.2019.1506	http://dx.doi.org/10.1001/jama.2019.1506			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HR3XE	30844023	Green Accepted			2022-12-28	WOS:000463074900007
J	Chen, JA; Ptaszek, LM; Celano, CM; Beach, SR				Chen, Justin A.; Ptaszek, Leon M.; Celano, Christopher M.; Beach, Scott R.			Case 9-2019: A 62-Year-Old Man with Atrial Fibrillation, Depression, and Worsening Anxiety	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TORSADES-DE-POINTES; SEROTONIN REUPTAKE INHIBITORS; COGNITIVE-BEHAVIORAL THERAPY; QUALITY-OF-LIFE; MYOCARDIAL-INFARCTION; QTC PROLONGATION; HEART-FAILURE; RISK; CITALOPRAM; MORTALITY		[Chen, Justin A.; Celano, Christopher M.; Beach, Scott R.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Ptaszek, Leon M.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Chen, Justin A.; Celano, Christopher M.; Beach, Scott R.] Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA; [Ptaszek, Leon M.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Chen, JA (corresponding author), Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA.; Chen, JA (corresponding author), Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA.		Chen, Justin/K-5943-2019; Chen, Justin/ABC-2815-2021	Celano, Christopher Michael/0000-0003-0547-2851				Angermann CE, 2016, JAMA-J AM MED ASSOC, V315, P2683, DOI 10.1001/jama.2016.7635; [Anonymous], 2014, PLOS ONE, V39, pe1; Austin James, 2014, Psychiatr Danub, V26 Suppl 1, P226; Beach SR, 2018, PSYCHOSOMATICS, V59, P105, DOI 10.1016/j.psym.2017.10.009; Beach SR, 2014, J CLIN PSYCHIAT, V75, pE441, DOI 10.4088/JCP.13r08672; Beach SR, 2013, PSYCHOSOMATICS, V54, P1, DOI 10.1016/j.psym.2012.11.001; Berkman LF, 2003, JAMA-J AM MED ASSOC, V289, P3106; Brojmohun A, 2013, PSYCHOSOMATICS, V54, P407, DOI 10.1016/j.psym.2013.02.011; Castro VM, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f288; Celano CM, 2016, CURR PSYCHIAT REP, V18, DOI 10.1007/s11920-016-0739-5; Chen LY, 2018, CIRCULATION, V137, pE623, DOI 10.1161/CIR.0000000000000568; Cheng YF, 2013, PSYCHOSOM MED, V75, P30, DOI 10.1097/PSY.0b013e318273393a; Cipriani A, 2018, LANCET, V391, P1357, DOI 10.1016/S0140-6736(17)32802-7; Efremidis M, 2014, PACE, V37, P703, DOI 10.1111/pace.12420; EPSTEIN AE, 1993, JAMA-J AM MED ASSOC, V270, P2451, DOI 10.1001/jama.270.20.2451; FDA, 2012, FDA DRUG SAF COMM RE; Freedland KE, 2009, ARCH GEN PSYCHIAT, V66, P387, DOI 10.1001/archgenpsychiatry.2009.7; Friesen KJ, 2015, DRUG HEALTHC PATIENT, V7, P139, DOI 10.2147/DHPS.S91046; Gehi AK, 2012, J CARDIOVASC ELECTR, V23, P473, DOI 10.1111/j.1540-8167.2011.02264.x; Gerlach LB, 2017, AM J GERIAT PSYCHIAT, V25, P407, DOI 10.1016/j.jagp.2016.11.010; Girardin FR, 2013, AM J PSYCHIAT, V170, P1468, DOI 10.1176/appi.ajp.2013.12060860; Glassman AH, 2002, JAMA-J AM MED ASSOC, V288, P701, DOI 10.1001/jama.288.6.701; Godemann F, 2004, CLIN CARDIOL, V27, P321, DOI 10.1002/clc.4960270604; Hategan A, 2014, J CLIN PSYCHOPHARM, V34, P766, DOI 10.1097/JCP.0000000000000213; Jeyanantham K, 2017, HEART FAIL REV, V22, P731, DOI 10.1007/s10741-017-9640-5; Kim JM, 2018, JAMA-J AM MED ASSOC, V320, P350, DOI 10.1001/jama.2018.9422; Lesperance F, 2007, JAMA-J AM MED ASSOC, V297, P367, DOI 10.1001/jama.297.4.367; Leucht S, 2013, LANCET, V382, P951, DOI 10.1016/S0140-6736(13)60733-3; Maljuric NM, 2015, BRIT J CLIN PHARMACO, V80, P698, DOI 10.1111/bcp.12681; Nelson S, 2013, ANN PHARMACOTHER, V47, DOI 10.1345/aph.1R387; O'Connor CM, 2010, J AM COLL CARDIOL, V56, P692, DOI 10.1016/j.jacc.2010.03.068; Page RL, 2000, J AM COLL CARDIOL, V36, P147, DOI 10.1016/S0735-1097(00)00676-8; Polcwiartek C, 2015, PSYCHOPHARMACOLOGY, V232, P3297, DOI 10.1007/s00213-015-4024-9; Quinn GR, 2014, AM J CARDIOL, V114, P583, DOI 10.1016/j.amjcard.2014.05.037; Ray WA, 2017, J CLIN PSYCHIAT, V78, P190, DOI 10.4088/JCP.15m10324; Rector TS, 2016, AM J PSYCHIAT, V173, P896, DOI 10.1176/appi.ajp.2016.15111444; Rothe AFV, 2014, EUROPACE, V16, P812, DOI 10.1093/europace/eut361; Schnabel RB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079109; Smolderen KG, 2017, CIRCULATION, V135, P1681, DOI 10.1161/CIRCULATIONAHA.116.025140; Substance Abuse and Mental Health Services Administration, 2017, KEY SUBST US MENT HL; Thompson TS, 2014, PACE, V37, P439, DOI 10.1111/pace.12292; Thrall G, 2007, CHEST, V132, P1259, DOI 10.1378/chest.07-0036; Tully PJ, 2011, HEART LUNG, V40, P4, DOI 10.1016/j.hrtlng.2009.12.010; Twomey C, 2015, FAM PRACT, V32, P3, DOI 10.1093/fampra/cmu060; Weintraub RG, 2017, LANCET, V390, P400, DOI 10.1016/S0140-6736(16)31713-5; Wyse DG, 2002, NEW ENGL J MED, V347, P1825, DOI 10.1056/nejmoa021328; Zivin K, 2013, AM J PSYCHIAT, V170, P642, DOI 10.1176/appi.ajp.2013.12030408	47	0	0	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 21	2019	380	12					1167	1174		10.1056/NEJMcpc1900140	http://dx.doi.org/10.1056/NEJMcpc1900140			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP7VK	30893540				2022-12-28	WOS:000461898400013
J	von Ehrenstein, OS; Ling, CX; Cui, X; Cockburn, M; Park, AS; Yu, F; Wu, J; Ritz, B				von Ehrenstein, Ondine S.; Ling, Chenxiao; Cui, Xin; Cockburn, Myles; Park, Andrew S.; Yu, Fei; Wu, Jun; Ritz, Beate			Prenatal and infant exposure to ambient pesticides and autism spectrum disorder in children: population based case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GLYPHOSATE-BASED HERBICIDE; PERINATAL EXPOSURE; ORGANOPHOSPHATE PESTICIDE; RESIDENTIAL PROXIMITY; ENVIRONMENTAL-FACTORS; AIR-POLLUTANTS; LONG-TERM; CHLORPYRIFOS; PREGNANCY; CALIFORNIA	Objective To examine associations between early developmental exposure to ambient pesticides and autism spectrum disorder. Design Population based case-control study. Setting California's main agricultural region, Central Valley, using 1998-2010 birth data from the Office of Vital Statistics. Population 2961 individuals with a diagnosis of autism spectrum disorder based on the Diagnostic and Statistical Manual of Mental Disorders, fourth edition, revised (up to 31 December 2013), including 445 with intellectual disability comorbidity, were identified through records maintained at the California Department of Developmental Services and linked to their birth records. Controls derived from birth records were matched to cases 10: 1 by sex and birth year. Exposure Data from California state mandated Pesticide Use Reporting were integrated into a geographic information system tool to estimate prenatal and infant exposures to pesticides (measured as pounds of pesticides applied per acre/month within 2000 m from the maternal residence). 11 high use pesticides were selected for examination a priori according to previous evidence of neurodevelopmental toxicity in vivo or in vitro (exposure defined as ever v never for each pesticide during specific developmental periods). Main outcome measure Odds ratios and 95% confidence intervals using multivariable logistic regression were used to assess associations between pesticide exposure and autism spectrum disorder (with or without intellectual disabilities) in offspring, adjusting for confounders. Results Risk of autism spectrum disorder was associated with prenatal exposure to glyphosate (odds ratio 1.16, 95% confidence interval 1.06 to 1.27), chlorpyrifos (1.13, 1.05 to 1.23), diazinon (1.11, 1.01 to 1.21), malathion (1.11, 1.01 to 1.22), avermectin (1.12, 1.04 to 1.22), and permethrin (1.10, 1.01 to 1.20). For autism spectrum disorder with intellectual disability, estimated odds ratios were higher (by about 30%) for prenatal exposure to glyphosate (1.33, 1.05 to 1.69), chlorpyrifos (1.27, 1.04 to 1.56), diazinon (1.41, 1.15 to 1.73), permethrin (1.46, 1.20 to 1.78), methyl bromide (1.33, 1.07 to 1.64), and myclobutanil (1.32, 1.09 to 1.60); exposure in the first year of life increased the odds for the disorder with comorbid intellectual disability by up to 50% for some pesticide substances. Conclusion Findings suggest that an offspring's risk of autism spectrum disorder increases following prenatal exposure to ambient pesticides within 2000 m of their mother's residence during pregnancy, compared with offspring of women from the same agricultural region without such exposure. Infant exposure could further increase risks for autism spectrum disorder with comorbid intellectual disability.	[von Ehrenstein, Ondine S.] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Community Hlth Sci, POB 951772, Los Angeles, CA 90095 USA; [von Ehrenstein, Ondine S.; Ling, Chenxiao; Cui, Xin; Park, Andrew S.; Ritz, Beate] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90095 USA; [Cui, Xin] Stanford Univ, Sch Med, Perinatal Epidemiol & Hlth Outcomes Res Unit, Div Neonatol,Dept Pediat, Palo Alto, CA 94304 USA; [Cui, Xin] Lucile Packard Childrens Hosp, Palo Alto, CA USA; [Cui, Xin] Calif Perinatal Qual Care Collaborat, Palo Alto, CA USA; [Cockburn, Myles] Univ Southern Calif, Prevent Med, Los Angeles, CA USA; [Yu, Fei] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Biostat, Los Angeles, CA USA; [Wu, Jun] Univ Calif Irvine, Susan & Henry Samueli Coll Hlth Sci, Program Publ Hlth, Irvine, CA USA; [Ritz, Beate] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Environm Hlth Sci, Los Angeles, CA USA; [Ritz, Beate] Univ Calif Los Angeles, Dept Neurol, Geffen Sch Med, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Stanford University; Lucile Packard Children's Hospital (LPCH); University of Southern California; University of California System; University of California Los Angeles; University of California System; University of California Irvine; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	von Ehrenstein, OS (corresponding author), Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Community Hlth Sci, POB 951772, Los Angeles, CA 90095 USA.; von Ehrenstein, OS (corresponding author), Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90095 USA.	ovehren@ucla.edu	Cui, Xin/ABB-8606-2021		US National Institute of Environmental Health Sciences [R21ES022389, R21ES025558]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES025558] Funding Source: NIH RePORTER	US National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the US National Institute of Environmental Health Sciences (grants R21ES022389; R21ES025558). The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the funders.	American Psychiatric Association, 2015, DIAGN STAT MAN MENT; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Becerra TA, 2013, ENVIRON HEALTH PERSP, V121, P380, DOI 10.1289/ehp.1205827; Beghoul A, 2017, ENVIRON SCI POLLUT R, V24, P19714, DOI 10.1007/s11356-017-9675-0; Bell ML, 2012, J EXPO SCI ENV EPID, V22, P429, DOI 10.1038/jes.2012.42; BENSON PE, 1992, ATMOS ENVIRON B-URB, V26, P379, DOI 10.1016/0957-1272(92)90013-I; Cao FJ, 2018, NEUROTOXICOL TERATOL, V70, P18, DOI 10.1016/j.ntt.2018.10.001; Cattani D, 2017, TOXICOLOGY, V387, P67, DOI 10.1016/j.tox.2017.06.001; Cockburn M, 2011, AM J EPIDEMIOL, V173, P1280, DOI 10.1093/aje/kwr003; Curwin BD, 2007, ANN OCCUP HYG, V51, P53, DOI [10.1093/annhug/mel062, 10.1093/annhyg/mel062]; De Coster S, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/713696; De Felice A, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0617-4; De Felice A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121663; de Souza A, 2013, J NEUROL SCI, V335, P36, DOI 10.1016/j.jns.2013.09.022; de Souza JS, 2017, TOXICOLOGY, V377, P25, DOI 10.1016/j.tox.2016.11.005; Defarge N, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13030264; dos Santos AA, 2016, ARCH TOXICOL, V90, P647, DOI 10.1007/s00204-015-1466-0; Eskenazi B, 2010, ENVIRON HEALTH PERSP, V118, P1775, DOI 10.1289/ehp.1002234; Fenske RA, 2005, ENVIRON HEALTH PERSP, V113, P1651, DOI 10.1289/ehp.8022; Fernandes LS, 2015, TOXICOL IN VITRO, V29, P522, DOI 10.1016/j.tiv.2015.01.001; Fiorino E, 2018, ENVIRON SCI POLLUT R, V25, P8542, DOI 10.1007/s11356-017-1141-5; Gallegos CE, 2016, NEUROTOXICOLOGY, V53, P20, DOI 10.1016/j.neuro.2015.11.015; Gandal MJ, 2018, SCIENCE, V359, P693, DOI 10.1126/science.aad6469; Geschwind DH, 2011, TRENDS COGN SCI, V15, P409, DOI 10.1016/j.tics.2011.07.003; Goldberg DW, 2012, SPAT SPATIO-TEMPORAL, V3, P1, DOI 10.1016/j.sste.2012.02.001; Grandjean P, 2014, LANCET NEUROL, V13, P330, DOI 10.1016/S1474-4422(13)70278-3; GREENLAND S, 1992, STAT MED, V11, P219, DOI 10.1002/sim.4780110208; GREENLAND S, 1991, EPIDEMIOLOGY, V2, P387, DOI 10.1097/00001648-199109000-00015; Gunier RB, 2017, ENVIRON RES, V158, P358, DOI 10.1016/j.envres.2017.06.036; Gunier RB, 2017, ENVIRON HEALTH PERSP, V125, DOI 10.1289/EHP504; Gunier RB, 2011, ENVIRON HEALTH PERSP, V119, P970, DOI 10.1289/ehp.1002532; Hallmayer J, 2011, ARCH GEN PSYCHIAT, V68, P1095, DOI 10.1001/archgenpsychiatry.2011.76; Hertz-Picciotto I, 2006, ENVIRON HEALTH PERSP, V114, P1119, DOI 10.1289/ehp.8483; Horton MK, 2011, PEDIATRICS, V127, pE699, DOI 10.1542/peds.2010-0133; Kalkbrenner AE, 2010, EPIDEMIOLOGY, V21, P631, DOI 10.1097/EDE.0b013e3181e65d76; Karmakar S, 2016, PESTIC BIOCHEM PHYS, V126, P49, DOI 10.1016/j.pestbp.2015.07.006; Kim S, 2017, FOOD CHEM TOXICOL, V110, P402, DOI 10.1016/j.fct.2017.10.007; Kioumourtzoglou MA, 2019, EPIDEMIOLOGY, V30, P4, DOI 10.1097/EDE.0000000000000918; Lan A, 2017, ENVIRON HEALTH-GLOB, V16, DOI 10.1186/s12940-017-0251-3; Lee I, 2015, TOXICOLOGY, V335, P1, DOI 10.1016/j.tox.2015.06.010; Levitin J, 2005, ATMOS ENVIRON, V39, P4439, DOI 10.1016/j.atmosenv.2005.03.046; Liu XY, 2018, CHEMOSPHERE, V199, P16, DOI 10.1016/j.chemosphere.2018.01.176; Lu CS, 2000, ENVIRON RES, V84, P290, DOI 10.1006/enrs.2000.4076; Lyall K, 2017, ENVIRON HEALTH PERSP, V125, P474, DOI 10.1289/EHP277; Nielsen LN, 2018, ENVIRON POLLUT, V233, P364, DOI 10.1016/j.envpol.2017.10.016; Pandey SP, 2017, NEUROTOXICOLOGY, V60, P16, DOI 10.1016/j.neuro.2017.02.010; Pandey SP, 2017, PHYSIOL BEHAV, V173, P15, DOI 10.1016/j.physbeh.2017.01.030; Paul KC, 2018, SCI TOTAL ENVIRON, V645, P1135, DOI 10.1016/j.scitotenv.2018.07.143; Pearson BL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11173; Philippat C, 2018, INT J HYG ENVIR HEAL, V221, P548, DOI 10.1016/j.ijheh.2018.02.004; Quiros-Alcala L, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-19; Rauh V, 2011, ENVIRON HEALTH PERSP, V119, P1196, DOI 10.1289/ehp.1003160; Rauh VA, 2006, PEDIATRICS, V118, pE1845, DOI 10.1542/peds.2006-0338; Regulation CDoP, 2009, SUMM PEST US REP DAT; Ritz B, 2006, ANN NY ACAD SCI, V1076, P378, DOI 10.1196/annals.1371.074; Roberts AL, 2013, ENVIRON HEALTH PERSP, V121, P978, DOI 10.1289/ehp.1206187; Roberts EM, 2007, ENVIRON HEALTH PERSP, V115, P1482, DOI 10.1289/ehp.10168; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Saillenfait AM, 2015, INT J HYG ENVIR HEAL, V218, P281, DOI 10.1016/j.ijheh.2015.01.002; Sandhu KS, 2010, EPIGENETICS-US, V5, P627, DOI 10.4161/epi.5.7.12883; Sandin S, 2017, JAMA-J AM MED ASSOC, V318, P1182, DOI 10.1001/jama.2017.12141; Shelton JF, 2014, ENVIRON HEALTH PERSP, V122, P1103, DOI 10.1289/ehp.1307044; Slotkin TA, 2008, ENVIRON HEALTH PERSP, V116, P340, DOI 10.1289/ehp.11005; Sullivan SG, 2013, INT J EPIDEMIOL, V42, P308, DOI 10.1093/ije/dys213; Sun YJ, 2010, TOXICOL LETT, V192, P206, DOI 10.1016/j.toxlet.2009.10.021; Timofeeva OA, 2008, NEUROTOXICOL TERATOL, V30, P38, DOI 10.1016/j.ntt.2007.10.002; Tong VT, 2013, MMWR SURVEILL SUMM, V62, P1; US Census Buero, CENS 2000 GAT; US Department of Health and Human Services National Center for Chronic Disease Prevention and Health Promotion, 2010, REG PLUS SUIT PUBL A; Viel JF, 2017, OCCUP ENVIRON MED, V74, P275, DOI 10.1136/oemed-2016-104035; von Ehrenstein OS, 2014, EPIDEMIOLOGY, V25, P851, DOI 10.1097/EDE.0000000000000150; Wagner-Schuman M, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/s12940-015-0030-y; Ward MH, 2006, ENVIRON HEALTH PERSP, V114, P893, DOI 10.1289/ehp.8770; Weichert FG, 2017, CHEMOSPHERE, V186, P43, DOI 10.1016/j.chemosphere.2017.07.136; Whitehead TP, 2015, ENVIRON SCI TECHNOL, V49, P9331, DOI 10.1021/acs.est.5b02078; Wu J, 2016, 188 HLTH EFF I; Yen J, 2011, NEUROTOXICOL TERATOL, V33, P735, DOI 10.1016/j.ntt.2011.10.004; Yost K, 2001, CANCER CAUSE CONTROL, V12, P703, DOI 10.1023/A:1011240019516; Zhu B, 2014, ENVIRON SCI POLLUT R, V21, P13625, DOI 10.1007/s11356-014-3317-6	79	109	110	7	45	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 20	2019	364								l962	10.1136/bmj.l962	http://dx.doi.org/10.1136/bmj.l962			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HQ8AJ	30894343	hybrid, Green Published			2022-12-28	WOS:000462645500003
J	Pike, H				Pike, Harriet			Third of patients with lower GI cancers face delays	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Iacobucci G, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.l1148; NHS England, 2019, COMB PERF SUMM	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 18	2019	364								l1252	10.1136/bmj.l1252	http://dx.doi.org/10.1136/bmj.l1252			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HQ7ZV	30885890				2022-12-28	WOS:000462643800010
J	Trivedi, D				Trivedi, Daksha			Assuming the worst	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Trivedi, Daksha] Univ Hertfordshire, Ctr Res Publ Hlth & Community Care, Hatfield, Herts, England	University of Hertfordshire	Trivedi, D (corresponding author), Univ Hertfordshire, Ctr Res Publ Hlth & Community Care, Hatfield, Herts, England.	d.trivedi@herts.ac.uk							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 13	2019	364								l788	10.1136/bmj.l788	http://dx.doi.org/10.1136/bmj.l788			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP5VW	30867151	Bronze			2022-12-28	WOS:000461751600004
J	Dyer, C				Dyer, Clare			Irish GP admits prescribing opioids inappropriately to feed his addiction	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 7	2019	364								l1081	10.1136/bmj.l1081	http://dx.doi.org/10.1136/bmj.l1081			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HO6TA	30846422				2022-12-28	WOS:000461063200009
J	Sneller, MC; Reilly, C; Badio, M; Bishop, RJ; Eghrari, AO; Moses, SJ; Johnson, KL; Gayedyu-Dennis, D; Hensley, LE; Higgs, ES; Nath, A; Tuznik, K; Varughese, J; Jensen, KS; Dighero-Kemp, B; Neaton, JD; Lane, HC; Fallah, MP				Sneller, Michael C.; Reilly, Cavan; Badio, Moses; Bishop, Rachel J.; Eghrari, Allen O.; Moses, Soka J.; Johnson, Kumblytee L.; Gayedyu-Dennis, Dehkontee; Hensley, Lisa E.; Higgs, Elizabeth S.; Nath, Avindra; Tuznik, Kaylie; Varughese, Justin; Jensen, Kenneth S.; Dighero-Kemp, Bonnie; Neaton, James D.; Lane, H. Clifford; Fallah, Mosoka P.		PREVAIL III Study Grp	A Longitudinal Study of Ebola Sequelae in Liberia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; VIRUS DISEASE SURVIVORS; QUALITY-OF-LIFE; SEXUAL TRANSMISSION; FOLLOW-UP; MANIFESTATIONS; EPIDEMIC; KIKWIT; UGANDA; SEMEN	BACKGROUND Multiple health problems have been reported in survivors of Ebola virus disease (EVD). Attribution of these problems to the disease without a control group for analysis is difficult. METHODS We enrolled a cohort of EVD survivors and their close contacts and prospectively collected data on symptoms, physical examination findings, and laboratory results. A subset of participants underwent ophthalmologic examinations. Persistence of Ebola virus (EBOV) RNA in semen samples from survivors was determined. RESULTS A total of 966 EBOV antibody-positive survivors and 2350 antibody-negative close contacts (controls) were enrolled, and 90% of these participants were followed for 12 months. At enrollment (median time to baseline visit, 358 days after symptom onset), six symptoms were reported significantly more often among survivors than among controls: urinary frequency (14.7% vs. 3.4%), headache (47.6% vs. 35.6%), fatigue (18.4% vs. 6.3%), muscle pain (23.1% vs. 10.1%), memory loss (29.2% vs. 4.8%), and joint pain (47.5% vs. 17.5%). On examination, more survivors than controls had abnormal abdominal, chest, neurologic, and musculoskeletal findings and uveitis. Other than uveitis (prevalence at enrollment, 26.4% vs. 12.1%; at year 1, 33.3% vs. 15.4%), the prevalence of these conditions declined during follow-up in both groups. The incidence of most symptoms, neurologic findings, and uveitis was greater among survivors than among controls. EBOV RNA was detected in semen samples from 30% of the survivors tested, with a maximum time from illness to detection of 40 months. CONCLUSIONS A relatively high burden of symptoms was seen in all participants, but certain symptoms and examination findings were more common among survivors. With the exception of uveitis, these conditions declined in prevalence during follow-up in both groups. Viral RNA in semen persisted for a maximum of 40 months.	[Sneller, Michael C.; Bishop, Rachel J.; Hensley, Lisa E.; Higgs, Elizabeth S.; Nath, Avindra; Tuznik, Kaylie; Varughese, Justin; Jensen, Kenneth S.; Dighero-Kemp, Bonnie; Lane, H. Clifford] NIH, Bldg 10, Bethesda, MD 20892 USA; [Eghrari, Allen O.] Johns Hopkins Univ, Ophthalmol, Baltimore, MD USA; [Reilly, Cavan; Neaton, James D.] Univ Minnesota, Div Biostat, 2221 Univ Ave SE,Suite 200, Minneapolis, MN 55414 USA; [Badio, Moses; Fallah, Mosoka P.] Liberian Minist Hlth, Monrovia, CA USA; [Moses, Soka J.] John F Kennedy Med Ctr, Monrovia, Liberia; [Gayedyu-Dennis, Dehkontee] Duport Rd Clin, Paynesville, Liberia; [Johnson, Kumblytee L.] CH Rennie Hosp, Kakata, Liberia	National Institutes of Health (NIH) - USA; Johns Hopkins University; University of Minnesota System; University of Minnesota Twin Cities	Reilly, C (corresponding author), Univ Minnesota, Div Biostat, 2221 Univ Ave SE,Suite 200, Minneapolis, MN 55414 USA.	cavanr@biostat.umn.edu	Eghrari, Allen/AAI-9282-2021; Eghrari, Allen/ABH-4964-2020; Moses, J Soka/GVU-2515-2022	Eghrari, Allen/0000-0003-2798-038X; Moses, J Soka/0000-0001-5773-5292; Hensley, Lisa/0000-0003-1188-4342	National Institute of Allergy and Infectious Diseases; National Eye Institute; NATIONAL EYE INSTITUTE [K12EY015025] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZICAI009006, ZIAAI000936] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the National Institute of Allergy and Infectious Diseases and the National Eye Institute.	Baker DG, 1997, ARCH INTERN MED, V157, P2076, DOI 10.1001/archinte.157.18.2076; Carson PJ, 2006, CLIN INFECT DIS, V43, P723, DOI 10.1086/506939; Clark DV, 2015, LANCET INFECT DIS, V15, P905, DOI 10.1016/S1473-3099(15)70152-0; Deen GF, 2017, NEW ENGL J MED, V377, P1428, DOI 10.1056/NEJMoa1511410; Etard JF, 2017, LANCET INFECT DIS, V17, P545, DOI 10.1016/S1473-3099(16)30516-3; Hickie I, 2006, BRIT MED J, V333, P575, DOI 10.1136/bmj.38933.585764.AE; Kennedy SB, 2017, NEW ENGL J MED, V377, P1438, DOI 10.1056/NEJMoa1614067; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kibadi K, 1999, J INFECT DIS, V179, pS13, DOI 10.1086/514288; Lettinga KD, 2002, CLIN INFECT DIS, V35, P11, DOI 10.1086/340738; Mate SE, 2015, NEW ENGL J MED, V373, P2448, DOI 10.1056/NEJMoa1509773; Mattia JG, 2016, LANCET INFECT DIS, V16, P331, DOI 10.1016/S1473-3099(15)00489-2; Nanyonga M, 2016, CLIN INFECT DIS, V62, P125, DOI 10.1093/cid/civ795; Pettitt J, 2017, J INFECT DIS, V215, P547, DOI 10.1093/infdis/jiw599; Qureshi AI, 2015, CLIN INFECT DIS, V61, P1035, DOI 10.1093/cid/civ453; RONDAY MJH, 1994, BRIT J OPHTHALMOL, V78, P690, DOI 10.1136/bjo.78.9.690; Rowe AK, 1999, J INFECT DIS, V179, pS28, DOI 10.1086/514318; Scott JT, 2016, EMERG INFECT DIS, V22, P641, DOI 10.3201/eid2204.151302; Shantha JG, 2017, OPHTHALMOLOGY, V124, P170, DOI 10.1016/j.ophtha.2016.10.011; Soka MJ, 2016, LANCET GLOB HEALTH, V4, pE736, DOI 10.1016/S2214-109X(16)30175-9; Thorson A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-008859; Tiffany A, 2016, CLIN INFECT DIS, V62, P1360, DOI 10.1093/cid/ciw158; Uyeki TM, 2016, CLIN INFECT DIS, V62, P1552, DOI 10.1093/cid/ciw202; Wendo C, 2001, LANCET, V358, P1350, DOI 10.1016/S0140-6736(01)06467-4; WHO, 2016, INT ADV SEX TRANSM E; Wills AB, 2016, CLIN INFECT DIS, V62, P1546, DOI 10.1093/cid/ciw189; World Health Organisation, 2016, EB SIT REP 30 MARCH; World Health Organization, 2012, GLOB DAT VIS IMP	28	73	74	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 7	2019	380	10					924	934		10.1056/NEJMoa1805435	http://dx.doi.org/10.1056/NEJMoa1805435			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HN8QX	30855742	Green Accepted, Bronze			2022-12-28	WOS:000460461500006
J	Pike, H				Pike, Harriet			HIV-1 remission achieved in second patient, report UK researchers	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Gupta RK, 2019, NATURE	1	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 5	2019	364								l1019	10.1136/bmj.l1019	http://dx.doi.org/10.1136/bmj.l1019			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HO6SS	30837210				2022-12-28	WOS:000461062200014
J	Dusetzina, SB; Bach, PB				Dusetzina, Stacie B.; Bach, Peter B.			Prescription Drugs-List Price, Net Price, and the Rebate Caught in the Middle	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Dusetzina, Stacie B.] Vanderbilt Univ, Sch Med, Dept Hlth Policy, 2525 West End Ave,Ste 1203, Nashville, TN 37203 USA; [Dusetzina, Stacie B.] Vanderbilt Ingram Canc Ctr, Nashville, TN USA; [Bach, Peter B.] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA	Vanderbilt University; Vanderbilt University; Memorial Sloan Kettering Cancer Center	Dusetzina, SB (corresponding author), Vanderbilt Univ, Sch Med, Dept Hlth Policy, 2525 West End Ave,Ste 1203, Nashville, TN 37203 USA.	s.dusetzina@vanderbilt.edu						Bach PB, 2015, JAMA-J AM MED ASSOC, V314, P2503, DOI 10.1001/jama.2015.16843; 2017, JAMA INTERN MED, V177, P1185, DOI DOI 10.1001/JAMAINTERNMED.2017.1885	2	27	27	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 23	2019	321	16					1563	1564		10.1001/jama.2019.2445	http://dx.doi.org/10.1001/jama.2019.2445			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HV7BZ	30840047				2022-12-28	WOS:000466137800007
J	Hamada, H; Suzuki, H; Onouchi, Y; Ebata, R; Terai, M; Fuse, S; Okajima, Y; Kurotobi, S; Hirai, K; Soga, T; Ishiguchi, Y; Okuma, Y; Takada, N; Yanai, M; Sato, J; Nakayashiro, M; Ayusawa, M; Yamamoto, E; Nomura, Y; Hashimura, Y; Ouchi, K; Masuda, H; Takatsuki, S; Hirono, K; Ariga, T; Higaki, T; Otsuki, A; Terauchi, M; Aoyagi, R; Sato, T; Fujii, Y; Fujiwara, T; Hanaoka, H; Hata, A				Hamada, Hiromichi; Suzuki, Hiroyuki; Onouchi, Yoshihiro; Ebata, Ryota; Terai, Masaru; Fuse, Shigeto; Okajima, Yoshitomo; Kurotobi, Shunji; Hirai, Katsuki; Soga, Takashi; Ishiguchi, Yukiko; Okuma, Yoshiaki; Takada, Nobuyuki; Yanai, Masaaki; Sato, Junichi; Nakayashiro, Mami; Ayusawa, Mamoru; Yamamoto, Eiichi; Nomura, Yuichi; Hashimura, Yuya; Ouchi, Kazunobu; Masuda, Hiroshi; Takatsuki, Shinichi; Hirono, Keiichi; Ariga, Tadashi; Higaki, Takashi; Otsuki, Akio; Terauchi, Moe; Aoyagi, Reiko; Sato, Takatoshi; Fujii, Yasuhisa; Fujiwara, Tadami; Hanaoka, Hideki; Hata, Akira		KAICA Trial Investigators	Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a randomised controlled, open-label, blinded-endpoints, phase 3 trial	LANCET			English	Article							SUSCEPTIBILITY; EPIDEMIOLOGY; GUIDELINES; THERAPY	Background Genetic studies have indicated possible involvement of the upregulated calcium-nuclear factor of activated T cells pathway in the pathogenesis of Kawasaki disease. We aimed to assess safety and efficacy of ciclosporin, an immunosuppressant targeting this pathway, for protection of patients with Kawasaki disease against coronary artery abnormalities. Methods We did a randomised, open-label, blinded endpoints trial involving 22 hospitals in Japan between May 29, 2014, and Dec 27, 2016. Eligible patients predicted to be at higher risk for intravenous immunoglobulin (IVIG) resistance were randomly assigned to IVIG plus ciclosporin (5 mg/ kg per day for 5 days; study treatment) or IVIG (conventional treatment) groups, stratified by risk score, age, and sex. The primary endpoint was incidence of coronary artery abnormalities using Japanese criteria during the 12-week trial, assessed in participants who received at least one dose of study drug and who visited the study institution at least once during treatment. This trial is registered to Center for Clinical Trials, Japan Medical Association, number JMA-IIA00174. Findings We enrolled 175 participants. One patient withdrew consent after enrolment and was excluded and one patient (in the study treatment group) was excluded from analysis because of lost echocardiography data. Incidence of coronary artery abnormalities was lower in the study treatment group than in the conventional treatment group (12 [14%] of 86 patients vs 27 [31%] of 87 patients; risk ratio 0.46; 95% CI 0.25-0.86; p=0.010). No difference was found in the incidence of adverse events between the groups (9% vs 7%; p=0.78). Interpretation Combined primary therapy with IVIG and ciclosporin was safe and effective for favourable coronary artery outcomes in Kawasaki disease patients who were predicted to be unresponsive to IVIG. Funding Japan Agency for Medical Research and Development (grant CCT-B-2503). Copyright (c) 2019 Elsevier Ltd. All rights reserved.	[Onouchi, Yoshihiro; Hata, Akira] Chiba Univ, Dept Publ Hlth, Chiba, Japan; [Ebata, Ryota] Chiba Univ, Dept Pediat, Chiba, Japan; [Hamada, Hiromichi] Chiba Univ, Grad Sch Med, Chiba, Japan; [Hamada, Hiromichi; Terai, Masaru] Tokyo Womens Med Univ, Yachiyo Med Ctr, Dept Pediat, Chiba, Japan; [Suzuki, Hiroyuki] Wakayama Med Univ Med, Dept Pediat, Wakayama, Japan; [Fuse, Shigeto] NTT Sapporo Med Ctr, Dept Pediat, Sapporo, Hokkaido, Japan; [Okajima, Yoshitomo] Chiba Cardiovasc Ctr, Dept Pediat, Chiba, Japan; [Kurotobi, Shunji] Oriono Clin, Sakai, Osaka, Japan; [Hirai, Katsuki] Japanese Red Cross Kumamoto Hosp, Dept Pediat, Kumamoto, Japan; [Soga, Takashi] Showa Univ, Northern Yokohama Hosp, Dept Pediat, Yokohama, Kanagawa, Japan; [Ishiguchi, Yukiko] Hiroshima City Hiroshima Citizens Hosp, Dept Pediat Cardiol, Hiroshima, Japan; [Okuma, Yoshiaki] Natl Ctr Global Hlth & Med, Dept Pediat, Tokyo, Japan; [Takada, Nobuyuki] Kimitsu Chuo Hosp, Dept Pediat, Chiba, Japan; [Yanai, Masaaki] Kumamoto Reg Med Ctr, Dept Pediat, Kumamoto, Japan; [Sato, Junichi] Funabashi Municipal Med Ctr, Dept Pediat, Funabashi, Chiba, Japan; [Nakayashiro, Mami] Okinawa Prefectural Nanbu Med Ctr, Dept Pediat Cardiol, Okinawa, Japan; [Nakayashiro, Mami] Childrens Med Ctr, Okinawa, Japan; [Ayusawa, Mamoru] Nihon Univ, Itabashi Hosp, Dept Pediat, Tokyo, Japan; [Yamamoto, Eiichi] Ehime Prefectural Cent Hosp, Dept Pediat, Matsuyama, Ehime, Japan; [Nomura, Yuichi] Kagoshima City Hosp, Dept Pediat, Kagoshima, Japan; [Hashimura, Yuya] Takatsuki Gen Hosp, Dept Pediat, Osaka, Japan; [Ouchi, Kazunobu] Kawasaki Med Sch Hosp, Dept Pediat, Okayama, Japan; [Masuda, Hiroshi] Natl Ctr Child Hlth & Dev, Dept Gen Pediat & Interdisciplinary Med, Tokyo, Japan; [Takatsuki, Shinichi] Toho Univ, Dept Pediat, Tokyo, Japan; [Hirono, Keiichi] Univ Toyama, Grad Sch Med, Dept Pediat, Toyama, Japan; [Ariga, Tadashi] Hokkaido Univ Hosp, Dept Pediat, Sapporo, Hokkaido, Japan; [Higaki, Takashi] Ehime Univ, Grad Sch Med, Dept Reg Pediat & Perinatol, Matsuyama, Ehime, Japan; [Otsuki, Akio] Komatsu Municipal Hosp, Dept Pediat, Komatsu, Ishikawa, Japan; [Terauchi, Moe; Aoyagi, Reiko; Sato, Takatoshi; Fujii, Yasuhisa; Fujiwara, Tadami; Hanaoka, Hideki] Chiba Univ Hosp, Clin Res Ctr, Chiba, Japan	Chiba University; Chiba University; Chiba University; Tokyo Women's Medical University; Showa University; Hiroshima City Hospital; National Center for Global Health & Medicine - Japan; Nihon University; Kagoshima City Hospital; Kawasaki Medical School; National Center for Child Health & Development - Japan; Toho University; University of Toyama; Hokkaido University; Ehime University; Chiba University	Hata, A (corresponding author), Chiba Univ, Grad Sch Med, Dept Publ Hlth, Chiba 2608670, Japan.	ahata@faculty.chiba-u.jp	Ebata, Ryota/AAQ-5832-2021; HANAOKA, Hideki/T-9026-2019	Ebata, Ryota/0000-0001-8471-1042; 	Japan Agency for Medical Research and Development [CCT-B-2503]	Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	Japan Agency for Medical Research and Development (grant CCT-B-2503).	Alphonse MP, 2016, J IMMUNOL, V197, P3481, DOI 10.4049/jimmunol.1600388; Aoyagi R, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009562; Ayusawa M, 2005, PEDIATR INT, V47, P232, DOI 10.1111/j.1442-200x.2005.02033.x; Burns JC, 1998, PEDIATR INFECT DIS J, V17, P1144, DOI 10.1097/00006454-199812000-00009; FURUSHO K, 1983, LANCET, V2, P1359; Fuse S, 2018, CIRC J, V82, P247, DOI 10.1253/circj.CJ-17-0046; Gordon JB, 2009, J AM COLL CARDIOL, V54, P1911, DOI 10.1016/j.jacc.2009.04.102; Jaggi P, 2015, PEDIATR INFECT DIS J, V34, P1315, DOI 10.1097/INF.0000000000000891; Kanegaye JT, 2009, PEDIATRICS, V123, pE783, DOI 10.1542/peds.2008-1871; Kawasaki T., 1967, PEDIATR INFECT DIS J, V16, P178; Kobayashi T, 2006, CIRCULATION, V113, P2606, DOI 10.1161/CIRCULATIONAHA.105.592865; Kobayashi T, 2016, J AM SOC ECHOCARDIOG, V29, P794, DOI 10.1016/j.echo.2016.03.017; Kobayashi T, 2012, LANCET, V379, P1613, DOI 10.1016/S0140-6736(11)61930-2; Makino N, 2015, J EPIDEMIOL, V25, P239, DOI 10.2188/jea.JE20140089; McCrindle BW, 2017, CIRCULATION, V135, pE927, DOI 10.1161/CIR.0000000000000484; Newburger JW, 2007, NEW ENGL J MED, V356, P663, DOI 10.1056/NEJMoa061235; Newburger JW, 2016, J AM COLL CARDIOL, V67, P1738, DOI 10.1016/j.jacc.2015.12.073; NEWBURGER JW, 1986, NEW ENGL J MED, V315, P341, DOI 10.1056/NEJM198608073150601; Onouchi Y, 2013, PHARMACOGENOMICS J, V13, P52, DOI 10.1038/tpj.2011.45; Onouchi Y, 2008, NAT GENET, V40, P35, DOI 10.1038/ng.2007.59; Onouchi Y, 2010, HUM MOL GENET, V19, P2898, DOI 10.1093/hmg/ddq176; Research Committee on Kawasaki Disease, 1984, REP SUB STAND DIAGN; Saji T, 2014, PEDIATR INT, V56, P135, DOI 10.1111/ped.12317; Sleeper LA, 2011, J PEDIATR-US, V158, P831, DOI 10.1016/j.jpeds.2010.10.031; Suzuki H, 2011, PEDIATR INFECT DIS J, V30, P871, DOI 10.1097/INF.0b013e318220c3cf; Takahashi K, 2005, PEDIATR INT, V47, P305, DOI 10.1111/j.1442-200x.2005.02049.x; Tremoulet AH, 2014, LANCET, V383, P1731, DOI 10.1016/S0140-6736(13)62298-9; Tremoulet AH, 2012, J PEDIATR-US, V161, P506, DOI 10.1016/j.jpeds.2012.02.048; Uehara R, 2012, J EPIDEMIOL, V22, P79, DOI 10.2188/jea.JE20110131	29	84	84	1	22	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 16	2019	393	10176					1128	1137		10.1016/S0140-6736(18)32003-8	http://dx.doi.org/10.1016/S0140-6736(18)32003-8			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP1HF	30853151				2022-12-28	WOS:000461416600031
J	Weiss, HA; Ferrand, RA				Weiss, Helen A.; Ferrand, Rashida A.			Improving adolescent health: an evidence-based call to action	LANCET			English	Editorial Material							RISK; DISEASE		[Weiss, Helen A.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, MRC Trop Epidemiol Grp, London WC1E 7HT, England; [Ferrand, Rashida A.] London Sch Hyg & Trop Med, Clin Res Dept, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Weiss, HA (corresponding author), London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, MRC Trop Epidemiol Grp, London WC1E 7HT, England.	helen.weiss@lshtm.ac.uk	weiss, helen/ABC-7823-2021	weiss, helen/0000-0003-3547-7936	Medical Research Council [MR/R010161/1] Funding Source: Medline; MRC [MR/R010161/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Azzopardi PS, 2019, LANCET; Bright T, 2018, TROP MED INT HEALTH, V23, P476, DOI 10.1111/tmi.13044; Bundy DAP, 2018, LANCET, V391, P687, DOI 10.1016/S0140-6736(17)32417-0; Every Woman Every Child, 2015, GLOBAL STRATEGY WOME; Kessler RC, 2007, CURR OPIN PSYCHIATR, V20, P359, DOI 10.1097/YCO.0b013e32816ebc8c; Kotchick BA, 2001, CLIN PSYCHOL REV, V21, P493, DOI 10.1016/S0272-7358(99)00070-7; Mokdad AH, 2016, LANCET, V387, P2383, DOI 10.1016/S0140-6736(16)00648-6; Patton GC, 2016, LANCET, V387, P2423, DOI 10.1016/S0140-6736(16)00579-1; Patton GC, 2012, LANCET, V379, P1665, DOI 10.1016/S0140-6736(12)60203-7; Salam RA, 2016, J ADOLESCENT HEALTH, V59, pS88, DOI 10.1016/j.jadohealth.2016.05.006; Santelli JS, 2013, J ADOLESCENT HEALTH, V52, pS41, DOI 10.1016/j.jadohealth.2013.02.017; United Nations Department of Economic and Social Affairs, 2015, WORLD POPULATION PRO; WHO, 2017, GLOB ACC ACT HLTH AD; WHO, 2014, HLTH WORLDS AD 2 CHA	14	15	15	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 16	2019	393	10176					1073	1075		10.1016/S0140-6736(18)32996-9	http://dx.doi.org/10.1016/S0140-6736(18)32996-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HP1HF	30876704	hybrid, Green Accepted			2022-12-28	WOS:000461416600004
J	Lander, E; Baylis, F; Zhang, F; Charpentier, E; Berg, P				Lander, Eric; Baylis, Francoise; Zhang, Feng; Charpentier, Emmanuelle; Berg, Paul			Adopt a moratorium on heritable genome editing	NATURE			English	Editorial Material									[Lander, Eric; Zhang, Feng] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Baylis, Francoise] Dalhousie Univ, Halifax, NS, Canada; [Charpentier, Emmanuelle] Max Planck Unit Sci Pathogens, Berlin, Germany; [Berg, Paul] Stanford Univ, Biochem Dept, Stanford, CA 94305 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Dalhousie University; Stanford University	Lander, E (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	lander@broadinstitute.org; francoise.baylis@dal.ca; zhang@broadinstitute.org; pr-charpentier@mpiib-berlin.mpg.de; pberg@stanford.edu	Wei, Wensheng/AAF-1325-2020; Baylis, Francoise/AAP-4565-2021; Bourgain, Catherine/L-1505-2017	Bourgain, Catherine/0000-0002-6761-0140; Wei, Wensheng/0000-0002-8053-2423; NALDINI, Luigi/0000-0002-7835-527X				[Anonymous], 2017, HUM GEN ED SCI ETH G; Araki M, 2014, REPROD BIOL ENDOCRIN, V12, P1, DOI 10.1186/1477-7827-12-108; Baylis F, 2017, NAT HUM BEHAV, V1, DOI 10.1038/s41562-017-0103; Burall S, 2018, NATURE, V555, P438, DOI 10.1038/d41586-018-03269-3; Costas J, 2018, AM J MED GENET B, V177, P274, DOI 10.1002/ajmg.b.32545; Hurlbut JB, 2019, NATURE, V565, P135, DOI 10.1038/d41586-018-07881-1; Hurlbut JB, 2018, TRENDS BIOTECHNOL, V36, P639, DOI 10.1016/j.tibtech.2018.04.009; Jasanoff S, 2018, NATURE, V555, P435, DOI 10.1038/d41586-018-03270-w; Joy MT, 2019, CELL, V176, P1143, DOI 10.1016/j.cell.2019.01.044; Langlois A, 2017, PALGR COMMUN, V3, DOI 10.1057/palcomms.2017.19; Pontin Jason, 2018, WIRED; Regalado Antonio, 2019, MIT TECHNOL REV; Saha K, 2018, TRENDS BIOTECHNOL, V36, P741, DOI 10.1016/j.tibtech.2018.04.008; Steffann J, 2018, CELL STEM CELL, V22, P481, DOI 10.1016/j.stem.2018.01.004	14	203	211	9	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 14	2019	567	7747					165	168		10.1038/d41586-019-00726-5	http://dx.doi.org/10.1038/d41586-019-00726-5			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HO7LD	30867611	Bronze			2022-12-28	WOS:000461126600019
J	Jaffe, S				Jaffe, Susan			US lawmakers seek cuts in prescription drug prices	LANCET			English	Editorial Material																			0	1	1	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 9	2019	393	10175					975	976		10.1016/S0140-6736(19)30537-9	http://dx.doi.org/10.1016/S0140-6736(19)30537-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HO0OW	30860040				2022-12-28	WOS:000460604200014
J	Kobayashi, A				Kobayashi, Akira			"Doughnut" Lesions	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kobayashi, Akira] Nanmei Kai Miyagami Hosp, Kagoshima, Japan		Kobayashi, A (corresponding author), Nanmei Kai Miyagami Hosp, Kagoshima, Japan.	akirakobachan@msn.com							0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 7	2019	380	10					E11	E11		10.1056/NEJMicm1810556	http://dx.doi.org/10.1056/NEJMicm1810556			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HN8QX	30855746				2022-12-28	WOS:000460461500010
J	Wilcock, J; Savage, Y				Wilcock, Jane; Savage, Yvonne			SPOT DIAGNOSIS Just a cutaneous (keratotic) horn?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Wilcock, Jane; Savage, Yvonne] Silverdale Med Practice, Manchester, Lancs, England		Wilcock, J (corresponding author), Silverdale Med Practice, Manchester, Lancs, England.	jane.wilcock@nhs.net	Wilcock, Jane/E-7237-2019	Wilcock, Jane/0000-0003-0086-4688				[Anonymous], SEB KER PAT INF LEAF; [Anonymous], BOW DIS; Brewer JD, 2015, J AM ACAD DERMATOL, V72, P302, DOI 10.1016/j.jaad.2014.10.028; de Berker D, 2017, BRIT ASS DERMATOLOGI; Kwiek B, 2016, J AM ACAD DERMATOL, V74, P1220, DOI 10.1016/j.jaad.2015.11.033; Motley RJ, MULTIPROFESSIONAL GU; Pyne John, 2013, Dermatol Pract Concept, V3, P3, DOI 10.5826/dpc.0302a02; Samsanavicius D, 2018, J PLAST RECONSTR AES, V71, P597, DOI 10.1016/j.bjps.2017.10.019; Sterling JC, 2014, BRIT ASS DERMATOLOGI	9	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 7	2019	364								l595	10.1136/bmj.l595	http://dx.doi.org/10.1136/bmj.l595			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HO6TA	30846426				2022-12-28	WOS:000461063200002
J	Rimmer, A				Rimmer, Abi			Measures aim to promote SAS doctors as a "genuine alternative" to postgraduate training	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Health Education England, 2019, MAX POT ESS MEAS SUP	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 5	2019	364								l1028	10.1136/bmj.l1028	http://dx.doi.org/10.1136/bmj.l1028			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HO6SS	30837212				2022-12-28	WOS:000461062200016
J	Epstein, H				Epstein, Helen			Good news for democracy	LANCET			English	Editorial Material									[Epstein, Helen] Bard Coll, Annandale On Hudson, NY 12504 USA		Epstein, H (corresponding author), Bard Coll, Annandale On Hudson, NY 12504 USA.	hepstein@bard.edu						Almond D, 2006, 0704 MIT DEP EC; Bollyky TJ, 2019, LANCET, V393, P1628, DOI 10.1016/S0140-6736(19)30235-1; Bollyky TJ., 2018, PLAGUES PARADOX PROG; Deaton A, 2015, GREAT ESCAPE HLTH WE; Epstein H., 2018, NATION; Epstein H.C., 2017, COLUMBIA GLOBAL REPO; Fifield Adam, 2015, MIGHTY PURPOSE JIM G; Nyaaba GN, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4199-6; Przeworski A., 2000, DEMOCRACY DEV; Qian N, 2009, J EUR ECON ASSOC, V7, P446, DOI 10.1162/JEEA.2009.7.2-3.446; Smith A., 1776, INQUIRY NATURE CAUSE; Szreter S, 2003, AM J PUBLIC HEALTH, V93, P421, DOI 10.2105/AJPH.93.3.421; Virchow R., 1848, MEDICINISCHE REFORM, V18, P125	13	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 20	2019	393	10181					1576	1577		10.1016/S0140-6736(19)30431-3	http://dx.doi.org/10.1016/S0140-6736(19)30431-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HU0DL	30878224	hybrid			2022-12-28	WOS:000464941500008
J	Lee, J; Yesilkanal, AE; Wynne, JP; Frankenberger, C; Liu, J; Yan, JL; Elbaz, M; Rabe, DC; Rustandy, FD; Tiwari, P; Grossman, EA; Hart, PC; Kang, C; Sanderson, SM; Andrade, J; Nomura, DK; Bonini, MG; Locasale, JW; Rosner, MR				Lee, Jiyoung; Yesilkanal, Ali E.; Wynne, Joseph P.; Frankenberger, Casey; Liu, Juan; Yan, Jielin; Elbaz, Mohamad; Rabe, Daniel C.; Rustandy, Felicia D.; Tiwari, Payal; Grossman, Elizabeth A.; Hart, Peter C.; Kang, Christie; Sanderson, Sydney M.; Andrade, Jorge; Nomura, Daniel K.; Bonini, Marcelo G.; Locasale, Jason W.; Rosner, Marsha Rich			Effective breast cancer combination therapy targeting BACH1 and mitochondrial metabolism	NATURE			English	Article							CELL SENSITIVITY; GENE-EXPRESSION; METASTASIS; METFORMIN; TRANSCRIPTION; COMPLEX; AVAILABILITY; REGULATOR; REVEALS; NETWORK	Mitochondrial metabolism is an attractive target for cancer therapy(1,2). Reprogramming metabolic pathways could improve the ability of metabolic inhibitors to suppress cancers with limited treatment options, such as triple-negative breast cancer (TNBC)(1,3). Here we show that BTB and CNC homology1 (BACH1)(4), a haem-binding transcription factor that is increased in expression in tumours from patients with TNBC, targets mitochondrial metabolism. BACH1 decreases glucose utilization in the tricarboxylic acid cycle and negatively regulates transcription of electron transport chain (ETC) genes. BACH1 depletion by shRNA or degradation by hemin sensitizes cells to ETC inhibitors such as metformin(5,6), suppressing growth of both cell line and patient-derived tumour xenografts. Expression of a haem-resistant BACH1 mutant in cells that express a short hairpin RNA for BACH1 rescues the BACH1 phenotype and restores metformin resistance in hemin-treated cells and tumours(7). Finally, BACH1 gene expression inversely correlates with ETC gene expression in tumours from patients with breast cancer and in other tumour types, which highlights the clinical relevance of our findings. This study demonstrates that mitochondrial metabolism can be exploited by targeting BACH1 to sensitize breast cancer and potentially other tumour tissues to mitochondrial inhibitors.	[Lee, Jiyoung; Yesilkanal, Ali E.; Wynne, Joseph P.; Frankenberger, Casey; Yan, Jielin; Elbaz, Mohamad; Rabe, Daniel C.; Rustandy, Felicia D.; Tiwari, Payal; Rosner, Marsha Rich] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Liu, Juan; Sanderson, Sydney M.; Locasale, Jason W.] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC USA; [Grossman, Elizabeth A.; Nomura, Daniel K.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Grossman, Elizabeth A.; Nomura, Daniel K.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Grossman, Elizabeth A.; Nomura, Daniel K.] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA; [Hart, Peter C.; Kang, Christie; Bonini, Marcelo G.] Univ Illinois, Dept Med, Chicago, IL USA; [Andrade, Jorge] Univ Chicago, Ctr Res Informat, Chicago, IL 60637 USA; [Bonini, Marcelo G.] Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA	University of Chicago; Duke University; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Chicago; Medical College of Wisconsin	Rosner, MR (corresponding author), Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA.	m-rosner@uchicago.edu	Yesilkanal, Ali/AAV-7954-2021; Locasale, Jason W/ABE-6505-2020; Rabe, Daniel/F-2420-2018	Yesilkanal, Ali/0000-0003-4988-1294; Locasale, Jason W/0000-0002-7766-3502; Hart, Peter/0000-0003-1843-9102; Rabe, Daniel/0000-0001-6126-2280; Tiwari, Payal/0000-0002-7822-6857	NIH [R01CA172667, R01CA184494, R01GM121735, 1R01AI131267, 1R56ES028149, R01CA193256]; DoD Breakthrough Breast Cancer [BC161588]; NATIONAL CANCER INSTITUTE [R01CA172667, R01CA184494, T32CA009594, R01CA193256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI131267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R56ES028149] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM121735] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DoD Breakthrough Breast Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Greene and members of his laboratory for sharing the PDX tumors. This study was supported by NIH R01CA184494 (M.R.R.), R01GM121735 (M.R.R.), NIH R01CA172667 (D.K.N.), DoD Breakthrough Breast Cancer BC161588 (J. Lee), NIH 1R01AI131267 (M.G.B.), 1R56ES028149 (M.G.B.) and NIH R01CA193256 (J.W.L.). We also thank G. Balazsi and members of the Rosner laboratory for careful reading of the manuscript.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Benjamin DI, 2013, P NATL ACAD SCI USA, V110, P14912, DOI 10.1073/pnas.1310894110; Bianchini G, 2016, NAT REV CLIN ONCOL, V13, P674, DOI 10.1038/nrclinonc.2016.66; Birsoy K, 2014, NATURE, V508, P108, DOI 10.1038/nature13110; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chandel NS, 2016, CELL METAB, V23, P569, DOI 10.1016/j.cmet.2016.03.010; Colaprico A, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1507; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dangi-Garimella S, 2009, EMBO J, V28, P347, DOI 10.1038/emboj.2008.294; DeBerardinis RJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600200; DHAR GJ, 1975, ANN INTERN MED, V83, P20, DOI 10.7326/0003-4819-83-1-20; Dowling RJO, 2016, CELL METAB, V23, P567, DOI 10.1016/j.cmet.2016.03.006; Efron B, 2007, ANN APPL STAT, V1, P107, DOI 10.1214/07-AOAS101; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gao X, 2018, CELL REP, V22, P3507, DOI 10.1016/j.celrep.2018.03.017; Gui DY, 2016, CELL METAB, V24, P716, DOI 10.1016/j.cmet.2016.09.006; Igarashi K, 1998, J BIOL CHEM, V273, P11783, DOI 10.1074/jbc.273.19.11783; Jitrapakdee S, 2006, CELL MOL LIFE SCI, V63, P843, DOI 10.1007/s00018-005-5410-y; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Klil-Drori AJ, 2017, NAT REV CLIN ONCOL, V14, P85, DOI 10.1038/nrclinonc.2016.120; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lee J, 2014, P NATL ACAD SCI USA, V111, pE364, DOI 10.1073/pnas.1304840111; Lee U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082125; Liang HY, 2006, ADV PHYSIOL EDUC, V30, P145, DOI 10.1152/advan.00052.2006; Liang YJ, 2012, J BIOL CHEM, V287, P33533, DOI 10.1074/jbc.M112.392332; Liu XJ, 2017, TRENDS BIOCHEM SCI, V42, P274, DOI 10.1016/j.tibs.2017.01.004; Liu XJ, 2016, CELL METAB, V24, P728, DOI 10.1016/j.cmet.2016.09.005; Louie SM, 2016, CELL CHEM BIOL, V23, P567, DOI 10.1016/j.chembiol.2016.03.017; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Murai M, 2016, BBA-BIOENERGETICS, V1857, P884, DOI 10.1016/j.bbabio.2015.11.009; Ogawa K, 2001, EMBO J, V20, P2835, DOI 10.1093/emboj/20.11.2835; Oyake T, 1996, MOL CELL BIOL, V16, P6083; Riedmaier AE, 2013, TRENDS PHARMACOL SCI, V34, P126, DOI 10.1016/j.tips.2012.11.005; Schell JC, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-6; Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206; Sun JY, 2002, EMBO J, V21, P5216, DOI 10.1093/emboj/cdf516; Suzuki H, 2004, EMBO J, V23, P2544, DOI 10.1038/sj.emboj.7600248; Vander Heiden MG, 2017, CELL, V168, DOI 10.1016/j.cell.2016.12.039; Wan Q, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav019; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Weinberg SE, 2015, NAT CHEM BIOL, V11, P9, DOI 10.1038/nchembio.1712; Wheaton WW, 2014, ELIFE, V3, DOI 10.7554/eLife.02242; Wu JQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep45235; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Yun JU, 2011, EMBO J, V30, P4500, DOI 10.1038/emboj.2011.312; Zenke-Kawasaki Y, 2007, MOL CELL BIOL, V27, P6962, DOI 10.1128/MCB.02415-06; Zhang XM, 2013, CANCER RES, V73, P4885, DOI 10.1158/0008-5472.CAN-12-4081	47	149	153	8	166	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 11	2019	568	7751					254	+		10.1038/s41586-019-1005-x	http://dx.doi.org/10.1038/s41586-019-1005-x			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HT2SH	30842661	Green Accepted			2022-12-28	WOS:000464412700053
J	Lee, DYD; Galera-Laporta, L; Bialecka-Fornal, M; Moon, EC; Shen, ZX; Briggs, SP; Garcia-Ojalvo, J; Suel, GM				Lee, Dong-Yeon D.; Galera-Laporta, Leticia; Bialecka-Fornal, Maja; Moon, Eun Chae; Shen, Zhouxin; Briggs, Steven P.; Garcia-Ojalvo, Jordi; Suel, Gurol M.			Magnesium Flux Modulates Ribosomes to Increase Bacterial Survival	CELL			English	Article							PROTEIN; CALCIUM; GROWTH; DEPENDENCE; BIOFILMS; SUBUNIT; REVEALS; NOISE; MG2+; 30S	Bacteria exhibit cell-to-cell variability in their resilience to stress, for example, following antibiotic exposure. Higher resilience is typically ascribed to "dormant" non-growing cellular states. Here, by measuring membrane potential dynamics of Bacillus subtilis cells, we show that actively growing bacteria can cope with ribosome-targeting antibiotics through an alternative mechanism based on ion flux modulation. Specifically, we observed two types of cellular behavior: growth-defective cells exhibited a mathematically predicted transient increase in membrane potential (hyperpolarization), followed by cell death, whereas growing cells lacked hyperpolarization events and showed elevated survival. Using structural perturbations of the ribosome and proteomic analysis, we uncovered that stress resilience arises from magnesium influx, which prevents hyperpolarization. Thus, ion flux modulation provides a distinct mechanism to cope with ribosomal stress. These results suggest new approaches to increase the effectiveness of ribosome-targeting antibiotics and reveal an intriguing connection between ribosomes and the membrane potentiel two fundamental properties of cells.	[Lee, Dong-Yeon D.; Bialecka-Fornal, Maja; Moon, Eun Chae; Suel, Gurol M.] Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA; [Galera-Laporta, Leticia; Garcia-Ojalvo, Jordi] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Barcelona 08003, Spain; [Shen, Zhouxin; Briggs, Steven P.] Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; [Suel, Gurol M.] Univ Calif San Diego, San Diego Ctr Syst Biol, La Jolla, CA 92093 USA; [Suel, Gurol M.] Univ Calif San Diego, Ctr Microbiome Innovat, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Pompeu Fabra University; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Suel, GM (corresponding author), Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA.; Suel, GM (corresponding author), Univ Calif San Diego, San Diego Ctr Syst Biol, La Jolla, CA 92093 USA.; Suel, GM (corresponding author), Univ Calif San Diego, Ctr Microbiome Innovat, La Jolla, CA 92093 USA.	gsuel@ucsd.edu	Garcia-Ojalvo, Jordi/A-4574-2009	Garcia-Ojalvo, Jordi/0000-0002-3716-7520; Galera-Laporta, Leticia/0000-0002-2453-896X	Spanish Ministry of Economy and Competitiveness [FIS2015-66503-C3-1-P]; FEDER [FIS2015-66503-C3-1-P]; ICREA Academia program; Maria de Maeztu Program for Units of Excellence in Research and Development (Spanish Ministry of Economy and Competitiveness) [MDM-2014-0370]; San Diego Center for Systems Biology [NIH P50 GM085764]; National Institute of General Medical Sciences [R01GM121888]; Howard Hughes Medical Institute-Simons Foundation Faculty Scholars program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM121888, P50GM085764] Funding Source: NIH RePORTER	Spanish Ministry of Economy and Competitiveness(Spanish Government); FEDER(European Commission); ICREA Academia program(ICREA); Maria de Maeztu Program for Units of Excellence in Research and Development (Spanish Ministry of Economy and Competitiveness); San Diego Center for Systems Biology; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute-Simons Foundation Faculty Scholars program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Weacknowledge Steve Lockless, Munehiro Asally, Tolga Cagatay, Akif Tezcan, Michael Elowitz, Erdal Toprak, Arthur Prindle, Katherine Suel, and Joe Pogliano for helpful discussions. We acknowledge SamanthaHammack and Kwang-Tao Chou for assistance during strain verification, and Ruan Hattingh and the Scripps Isotope Geochemistry Laboratory (http://sigl.ucsd.edu/) for their assistance with preparing the samples and access to the ICP-OES. This work was supported by funding from The Spanish Ministry of Economy and Competitiveness and FEDER (project FIS2015-66503-C3-1-P) (to J.G.-O.), the ICREA Academia program (to J.G.-O.), and the Maria de Maeztu Program for Units of Excellence in Research and Development (Spanish Ministry of Economy and Competitiveness, MDM-2014-0370) (to J.G.-O.), the San Diego Center for Systems Biology (NIH P50 GM085764) (to G.M.S), National Institute of General Medical Sciences (R01GM121888) (to G.M.S), and theHoward Hughes Medical Institute-Simons Foundation Faculty Scholars program (to G.M.S.).	Akanuma G, 2014, J BACTERIOL, V196, P3820, DOI 10.1128/JB.01896-14; Akanuma G, 2012, J BACTERIOL, V194, P6282, DOI 10.1128/JB.01544-12; Arganda-Carreras I, 2017, BIOINFORMATICS, V33, P2424, DOI 10.1093/bioinformatics/btx180; Armitano J, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01888; Balaban NQ, 2013, NAT REV MICROBIOL, V11, P587, DOI 10.1038/nrmicro3076; Balazsi G, 2011, CELL, V144, P910, DOI 10.1016/j.cell.2011.01.030; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Banks ED, 2010, GEOMICROBIOL J, V27, P444, DOI 10.1080/01490450903485136; Bosdriesz E, 2015, FEBS J, V282, P2029, DOI 10.1111/febs.13258; Bruni GN, 2017, P NATL ACAD SCI USA, V114, P9445, DOI 10.1073/pnas.1703084114; Carter AP, 2000, NATURE, V407, P340, DOI 10.1038/35030019; Chiba S, 2009, EMBO J, V28, P3461, DOI 10.1038/emboj.2009.280; DAVIS BD, 1987, MICROBIOL REV, V51, P341, DOI 10.1128/MMBR.51.3.341-350.1987; Dost B, 2012, J COMPUT BIOL, V19, P337, DOI 10.1089/cmb.2009.0267; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Ferrell JE, 2016, CELL SYST, V2, P62, DOI 10.1016/j.cels.2016.02.006; GANGOLA P, 1987, J BIOL CHEM, V262, P12570; Gefen O, 2008, P NATL ACAD SCI USA, V105, P6145, DOI 10.1073/pnas.0711712105; Geiler-Samerotte KA, 2013, CURR OPIN BIOTECH, V24, P752, DOI 10.1016/j.copbio.2013.03.010; HAROLD FM, 1977, ANNU REV MICROBIOL, V31, P181, DOI 10.1146/annurev.mi.31.100177.001145; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hohle TH, 2014, MOL MICROBIOL, V93, P736, DOI 10.1111/mmi.12687; Humphries J, 2017, CELL, V168, P200, DOI 10.1016/j.cell.2016.12.014; Klein DJ, 2004, RNA, V10, P1366, DOI 10.1261/rna.7390804; Kuchina A, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.88; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Kwon E. J., 2017, ADV MATER, V29, P1; Larkin JW, 2018, CELL SYST, V7, P137, DOI 10.1016/j.cels.2018.06.005; Liu JT, 2017, SCIENCE, V356, P638, DOI 10.1126/science.aah4204; Liu JT, 2015, NATURE, V523, P550, DOI 10.1038/nature14660; Maisonneuve E, 2014, CELL, V157, P539, DOI 10.1016/j.cell.2014.02.050; Martinez-Corral R, 2018, P NATL ACAD SCI USA, V115, pE8333, DOI 10.1073/pnas.1805004115; Nierhaus KH, 2014, J BACTERIOL, V196, P3817, DOI 10.1128/JB.02297-14; Pelkmans L, 2012, SCIENCE, V336, P425, DOI 10.1126/science.1222161; Prindle A, 2015, NATURE, V527, P59, DOI 10.1038/nature15709; Reyes J, 2018, CURR OPIN BIOTECH, V51, P109, DOI 10.1016/j.copbio.2017.12.007; Romani AMP, 2011, ARCH BIOCHEM BIOPHYS, V512, P1, DOI 10.1016/j.abb.2011.05.010; SCHAECHTER M, 1958, J GEN MICROBIOL, V19, P592, DOI 10.1099/00221287-19-3-592; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sharma A, 2012, EXPERT OPIN DRUG DEL, V9, P1325, DOI 10.1517/17425247.2012.717927; Stecchini ML, 2013, INDIAN J EXP BIOL, V51, P905; Suel GM, 2007, SCIENCE, V315, P1716, DOI 10.1126/science.1137455; Wakeman CA, 2014, J BACTERIOL, V196, P1206, DOI 10.1128/JB.01238-13; WEISS RL, 1973, BIOCHEMISTRY-US, V12, P450, DOI 10.1021/bi00727a014; Wood TK, 2013, APPL ENVIRON MICROB, V79, P7116, DOI 10.1128/AEM.02636-13	45	50	51	7	68	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 4	2019	177	2					352	+		10.1016/j.cell.2019.01.042	http://dx.doi.org/10.1016/j.cell.2019.01.042			22	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	HR7PF	30853217	Green Accepted, Bronze			2022-12-28	WOS:000463346200014
J	Farrelly, LA; Thompson, RE; Zhao, S; Lepack, AE; Lyu, Y; Bhanu, NV; Zhang, BC; Loh, YHE; Ramakrishnan, A; Vadodaria, KC; Heard, KJ; Erikson, G; Nakadai, T; Bastle, RM; Lukasak, BJ; Zebroski, H; Alenina, N; Bader, M; Berton, O; Roeder, RG; Molina, H; Gage, FH; Shen, L; Garcia, BA; Li, HT; Muir, TW; Maze, I				Farrelly, Lorna A.; Thompson, Robert E.; Zhao, Shuai; Lepack, Ashley E.; Lyu, Yang; Bhanu, Natarajan V.; Zhang, Baichao; Loh, Yong-Hwee E.; Ramakrishnan, Aarthi; Vadodaria, Krishna C.; Heard, Kelly J.; Erikson, Galina; Nakadai, Tomoyoshi; Bastle, Ryan M.; Lukasak, Bradley J.; Zebroski, Henry, III; Alenina, Natalia; Bader, Michael; Berton, Olivier; Roeder, Robert G.; Molina, Henrik; Gage, Fred H.; Shen, Li; Garcia, Benjamin A.; Li, Haitao; Muir, Tom W.; Maze, Ian			Histone serotonylation is a permissive modification that enhances TFIID binding to H3K4me3	NATURE			English	Article							SEROTONIN; QUANTIFICATION; TRANSCRIPTION; EXPRESSION; ENRICHMENT; PEPTIDES; DATABASE; NUCLEUS; CELLS	Chemical modifications of histones can mediate diverse DNA-templated processes, including gene transcription(1-3). Here we provide evidence for a class of histone post-translational modification, serotonylation of glutamine, which occurs at position 5 (Q5ser) on histone H3 in organisms that produce serotonin (also known as 5-hydroxytryptamine (5-HT)). We demonstrate that tissue transglutaminase 2 can serotonylate histone H3 tri-methylated lysine 4 (H3K4me3)-marked nucleosomes, resulting in the presence of combinatorial H3K4me3Q5ser in vivo. H3K4me3Q5ser displays a ubiquitous pattern of tissue expression in mammals, with enrichment observed in brain and gut, two organ systems responsible for the bulk of 5-HT production. Genome-wide analyses of human serotonergic neurons, developing mouse brain and cultured serotonergic cells indicate that H3K4me3Q5ser nucleosomes are enriched in euchromatin, are sensitive to cellular differentiation and correlate with permissive gene expression, phenomena that are linked to the potentiation of TFIID4-6 interactions with H3K4me3. Cells that ectopically express a H3 mutant that cannot be serotonylated display significantly altered expression of H3K4me3Q5ser-target loci, which leads to deficits in differentiation. Taken together, these data identify a direct role for 5-HT, independent from its contributions to neurotransmission and cellular signalling, in the mediation of permissive gene expression.	[Farrelly, Lorna A.; Lepack, Ashley E.; Lyu, Yang; Loh, Yong-Hwee E.; Ramakrishnan, Aarthi; Bastle, Ryan M.; Berton, Olivier; Shen, Li; Maze, Ian] Icahn Sch Med Mt Sinai, Fishberg Dept Neurosci, Friedman Brain Inst, New York, NY 10029 USA; [Thompson, Robert E.; Lukasak, Bradley J.; Muir, Tom W.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Zhao, Shuai; Zhang, Baichao; Li, Haitao] Tsinghua Univ, Beijing Adv Innovat Ctr Struct Biol, MOE Key Lab Prot Sci, Dept Basic Med Sci, Beijing, Peoples R China; [Zhao, Shuai; Zhang, Baichao; Li, Haitao] Tsinghua Univ, Tsinghua Peking Joint Ctr Life Sci, Beijing, Peoples R China; [Bhanu, Natarajan V.; Garcia, Benjamin A.] Univ Penn, Dept Biochem & Biophys, Epigenet Inst, Perelman Sch Med, Philadelphia, PA 19104 USA; [Vadodaria, Krishna C.; Heard, Kelly J.; Erikson, Galina; Gage, Fred H.] Salk Inst Biol Sci, Genet Lab, La Jolla, CA USA; [Nakadai, Tomoyoshi; Roeder, Robert G.] Rockefeller Univ, Lab Biochem & Mol Biol, 1230 York Ave, New York, NY 10021 USA; [Zebroski, Henry, III; Molina, Henrik] Rockefeller Univ, Prote Resource Ctr, 1230 York Ave, New York, NY 10021 USA; [Alenina, Natalia; Bader, Michael] Max Delbruck Ctr Mol Med MDC, Berlin, Germany; [Maze, Ian] Icahn Sch Med Mt Sinai, Dept Pharmacol Sci, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Princeton University; Tsinghua University; Tsinghua University; University of Pennsylvania; Pennsylvania Medicine; Salk Institute; Rockefeller University; Rockefeller University; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Icahn School of Medicine at Mount Sinai	Maze, I (corresponding author), Icahn Sch Med Mt Sinai, Fishberg Dept Neurosci, Friedman Brain Inst, New York, NY 10029 USA.; Maze, I (corresponding author), Icahn Sch Med Mt Sinai, Dept Pharmacol Sci, New York, NY 10029 USA.	ian.maze@mssm.edu	Bader, Michael/K-2124-2013; Muir, Tom/AHD-0860-2022; Li, Haitao/B-2668-2012	Muir, Tom/0000-0001-9635-0344; Li, Haitao/0000-0001-6741-293X; Heard, Kelly/0000-0001-7719-7225; Lukasak, Bradley/0000-0002-8793-7773; Bader, Michael/0000-0003-4780-4164; Zhao, Shuai/0000-0003-4240-2430; Ramakrishnan, Aarthi/0000-0002-6329-6502	National Institutes of Health [DP1 DA042078, R01 MH116900, R21 DA044767, P50 MH096890, R37 GM086868, P01 CA196539, R01 GM110174, R21 DA040837, R01 CA129325, R01 CA204639, T32 DA007135]; MQ Mental Health Research Charity [MQ15FIP100011]; Alfred P. Sloan Foundation, Fellowship in Neuroscience; JPB Foundation; Bob and Mary Jane Engman Foundation; Volkswagen Foundation; National Natural Science Foundation of China [31430020, 31621092]; NATIONAL CANCER INSTITUTE [P01CA196539, R01CA204639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM086868, R01GM110174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH116900, P50MH096890] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007135, DP1DA042078, T32DA028874, R21DA040837, R21DA044767] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MQ Mental Health Research Charity; Alfred P. Sloan Foundation, Fellowship in Neuroscience(Alfred P. Sloan Foundation); JPB Foundation; Bob and Mary Jane Engman Foundation; Volkswagen Foundation(Volkswagen); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank R. Cagan (ISMMS), J. Coplan (SUNY Downstate) and C. Tamminga (UTSW) for providing Drosophila, macaque and human samples, respectively, for analysis of H3K4me3Q5ser (Fig. 1e), and G. Johnson (University of Rochester Medical Center) for wild-type and catalytically dead TGM2 constructs. This work was supported by grants from the National Institutes of Health: DP1 DA042078 (I.M.), R01 MH116900 (I.M.), R21 DA044767 (I.M.), P50 MH096890 (I.M.), R37 GM086868 (T.W.M.), P01 CA196539 (T.W.M. and B.A.G.), R01 GM110174 (B.A.G.), R21 DA040837 (B.A.G.), R01 CA129325 (R. G. R.), R01 CA204639 (R. G. R.), T32 DA007135 (R.M.B.), as well as awards from: MQ Mental Health Research Charity, MQ15FIP100011 (I.M.), Alfred P. Sloan Foundation, Fellowship in Neuroscience (I.M.), the JPB Foundation (F.H.G.), the Bob and Mary Jane Engman Foundation (F.H.G.), the Volkswagen Foundation (N.A.) and the National Natural Science Foundation of China (31430020 and 31621092, H.L.).	Ballestar E, 1996, J BIOL CHEM, V271, P18817, DOI 10.1074/jbc.271.31.18817; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Colgan LA, 2009, J NEUROSCI, V29, P15878, DOI 10.1523/JNEUROSCI.4210-09.2009; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Dann GP, 2017, NATURE, V548, P607, DOI 10.1038/nature23671; Daubert EA, 2010, TRENDS NEUROSCI, V33, P424, DOI 10.1016/j.tins.2010.05.005; Debelouchina GT, 2017, NAT CHEM BIOL, V13, P105, DOI [10.1038/NCHEMBIO.2235, 10.1038/nchembio.2235]; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Eaton M, 1996, EXP NEUROL, V140, P105, DOI 10.1006/exnr.1996.0121; Gundemir S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006123; Hummerich R, 2015, ACS CHEM NEUROSCI, V6, P1130, DOI 10.1021/cn5003286; Hummerich R, 2012, FEBS LETT, V586, P3421, DOI 10.1016/j.febslet.2012.07.062; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Kim JH, 2002, BIOCHEM BIOPH RES CO, V293, P1453, DOI 10.1016/S0006-291X(02)00393-5; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Lauberth SM, 2013, CELL, V152, P1021, DOI 10.1016/j.cell.2013.01.052; Lin JCY, 2014, J PROTEOME RES, V13, P3523, DOI 10.1021/pr5003438; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Lu JF, 2016, NAT BIOTECHNOL, V34, P89, DOI 10.1038/nbt.3435; Maze I, 2015, NEURON, V87, P77, DOI 10.1016/j.neuron.2015.06.014; Nguyen UTT, 2014, NAT METHODS, V11, P834, DOI [10.1038/NMETH.3022, 10.1038/nmeth.3022]; Nurminskaya MV, 2012, INT REV CEL MOL BIO, V294, P1, DOI 10.1016/B978-0-12-394305-7.00001-X; Ollivier N, 2014, J PEPT SCI, V20, P92, DOI 10.1002/psc.2580; Peterson AC, 2012, MOL CELL PROTEOMICS, V11, P1475, DOI 10.1074/mcp.O112.020131; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065598; Sidoli S, 2016, JOVE-J VIS EXP, DOI 10.3791/54112; Sileno S, 2014, J PROTEOMICS, V96, P314, DOI 10.1016/j.jprot.2013.11.011; Simon MD, 2012, METHOD ENZYMOL, V512, P57, DOI 10.1016/B978-0-12-391940-3.00003-2; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tessarz P, 2014, NATURE, V505, P564, DOI 10.1038/nature12819; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; van Ingen H, 2008, STRUCTURE, V16, P1245, DOI 10.1016/j.str.2008.04.015; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Vizcaino JA, 2009, PROTEOMICS, V9, P4276, DOI 10.1002/pmic.200900402; Walther DJ, 2003, CELL, V115, P851, DOI 10.1016/S0092-8674(03)01014-6; Watts SW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005682; WHITE LA, 1994, J NEUROSCI, V14, P6744; Wojcik F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03895-5; YOUNG AB, 1971, SCIENCE, V173, P247, DOI 10.1126/science.173.3993.247; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	49	165	170	11	122	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 28	2019	567	7749					535	+		10.1038/s41586-019-1024-7	http://dx.doi.org/10.1038/s41586-019-1024-7			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ8EC	30867594	Green Accepted			2022-12-28	WOS:000462655800052
J	Katz, I; Jha, AK				Katz, Ingrid; Jha, Ashish K.			HIV in the United States Getting to Zero Transmissions by 2030	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Katz, Ingrid; Jha, Ashish K.] Harvard Global Hlth Inst, 42 Church St, Cambridge, MA 02138 USA; [Katz, Ingrid] Harvard Med Sch, Cambridge, MA USA; [Jha, Ashish K.] Harvard Sch Publ Hlth, Cambridge, MA USA	Harvard University; Harvard T.H. Chan School of Public Health	Jha, AK (corresponding author), Harvard Global Hlth Inst, 42 Church St, Cambridge, MA 02138 USA.	ajha@hsph.harvard.edu						[Anonymous], GUID US ANT AG AD AD; [Anonymous], 2019, HIV US DEP AR; Clemenzi-Allen A, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofy035; Department of Health and Human Services, 2019, END HIV EP PLAN AM; Eisinger RW, 2019, JAMA-J AM MED ASSOC, V321, P451, DOI 10.1001/jama.2018.21167; Fauci AS, 2019, JAMA-J AM MED ASSOC, V321, P844, DOI 10.1001/jama.2019.1343; Henry J, 2016, MED AND HIV; Landovitz RJ, 2016, JAMA INTERN MED, V176, P85, DOI 10.1001/jamainternmed.2015.6530; Metsch LR, 2018, JAMA INTERN MED, V178, P553, DOI 10.1001/jamainternmed.2018.0096; Saag MS, 2018, JAMA-J AM MED ASSOC, V320, P379, DOI 10.1001/jama.2018.8431	10	18	18	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 26	2019	321	12					1153	1154		10.1001/jama.2019.1817	http://dx.doi.org/10.1001/jama.2019.1817			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HR3XE	30848778				2022-12-28	WOS:000463074900006
J	Davies, S				Davies, Sally			Sally Davies: Silk, noir, and diplomacy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Davies, Sally] Cent Middlesex Hosp, London, England	Imperial College London									0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 20	2019	364								l1201	10.1136/bmj.l1201	http://dx.doi.org/10.1136/bmj.l1201			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HQ8AJ	30894352				2022-12-28	WOS:000462645500006
J	Kahan, S				Kahan, Scott			During weight-loss maintenance, energy expenditure was higher with lower-carbohydrate diets	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							MANAGEMENT; OBESITY		[Kahan, Scott] Johns Hopkins Bloomberg Sch Publ Hlth, Washington, DC USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Kahan, S (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Washington, DC USA.							Hall KD, 2018, BIORXIV, DOI [10.1101/476655, DOI 10.1101/476655]; Hall KD, 2018, MED CLIN N AM, V102, P183, DOI 10.1016/j.mcna.2017.08.012; Hall KD, 2017, GASTROENTEROLOGY, V152, P1718, DOI 10.1053/j.gastro.2017.01.052; Jensen MD, 2014, CIRCULATION, V129, pS102, DOI 10.1161/01.cir.0000437739.71477.ee	4	0	0	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 19	2019	170	6					JC31	JC31		10.7326/ACPJ201903190-031	http://dx.doi.org/10.7326/ACPJ201903190-031			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP1ZR	30884501				2022-12-28	WOS:000461468300008
J	Sancar, F				Sancar, Feyza			New Treatment for Rare Blood Clotting Disorder	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 19	2019	321	11					1042	1042		10.1001/jama.2019.1826	http://dx.doi.org/10.1001/jama.2019.1826			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP4YY	30874739				2022-12-28	WOS:000461683500005
J	Wise, J				Wise, Jacqui			BMJ Awards 2019: Dermatology Team of the Year	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 19	2019	364								l1229	10.1136/bmj.l1229	http://dx.doi.org/10.1136/bmj.l1229			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HQ7ZZ	30890541				2022-12-28	WOS:000462644400006
J	Mayor, S				Mayor, Susan			Behavioural therapy is often more effective than drugs for urinary incontinence in women, finds review	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Balk EM, 2019, ANN INTERN MED, V170, P465, DOI 10.7326/M18-3227	1	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 18	2019	364								l1223	10.1136/bmj.l1223	http://dx.doi.org/10.1136/bmj.l1223			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HQ7ZV	30885908				2022-12-28	WOS:000462643800007
J	Bhutta, ZA; Victora, C; Boerma, T; Kruk, ME; Patton, G; Black, MM; Sawyer, S; Horton, S; Black, RE; Horton, R				Bhutta, Zulfiqar A.; Victora, Cesar; Boerma, Ties; Kruk, Margaret E.; Patton, George; Black, Maureen M.; Sawyer, Susan; Horton, Susan; Black, Robert E.; Horton, Richard		Lancet Optimising Child Hlth Serie	Optimising the continuum of child and adolescent health and development	LANCET			English	Editorial Material							INTERVENTIONS; SURVIVAL; NEWBORN		[Bhutta, Zulfiqar A.] Hosp Sick Children, Ctr Global Child Hlth, Toronto, ON M5G 0A4, Canada; [Bhutta, Zulfiqar A.] Univ Toronto, Toronto, ON, Canada; [Bhutta, Zulfiqar A.] Aga Khan Univ, Ctr Excellence Women & Child Hlth, Karachi, Pakistan; [Victora, Cesar] Univ Fed Pelotas, Int Ctr Equ Hlth, Pelotas, Brazil; [Boerma, Ties] Univ Manitoba, Winnipeg, MB, Canada; [Kruk, Margaret E.] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA; [Patton, George; Sawyer, Susan] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Patton, George; Sawyer, Susan] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Black, Maureen M.] RTI Int, Res Triangle Pk, NC USA; [Black, Maureen M.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Sawyer, Susan] Royal Childrens Hosp Melbourne, Ctr Adolescent Hlth, Melbourne, Vic, Australia; [Horton, Susan] Univ Waterloo, Sch Publ Hlth & Hlth Syst, Waterloo, ON, Canada; [Black, Robert E.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Horton, Richard] The Lancet, London, England	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Aga Khan University; Universidade Federal de Pelotas; University of Manitoba; Harvard University; Harvard T.H. Chan School of Public Health; Murdoch Children's Research Institute; University of Melbourne; Research Triangle Institute; University System of Maryland; University of Maryland Baltimore; Royal Children's Hospital Melbourne; University of Waterloo; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Bhutta, ZA (corresponding author), Hosp Sick Children, Ctr Global Child Hlth, Toronto, ON M5G 0A4, Canada.; Bhutta, ZA (corresponding author), Univ Toronto, Toronto, ON, Canada.; Bhutta, ZA (corresponding author), Aga Khan Univ, Ctr Excellence Women & Child Hlth, Karachi, Pakistan.	zulfiqar.bhutta@sickkids.ca	Ribeiro, Ana Cristina/HHN-7466-2022; Victora, Cesar Gomes/Y-2455-2019; Patton, George C/B-5246-2013; Bhutta, Zulfiqar/L-7822-2015	Ribeiro, Ana Cristina/0000-0002-0493-8376; Victora, Cesar Gomes/0000-0002-2465-2180; Patton, George C/0000-0001-5039-8326; Bhutta, Zulfiqar/0000-0003-0637-599X; Black, Maureen/0000-0002-6427-4639	Centre for Global Child Health, The Hospital for Sick Children, Toronto, ON, Canada; Countdown to 2030 consortium	Centre for Global Child Health, The Hospital for Sick Children, Toronto, ON, Canada; Countdown to 2030 consortium	We are the members of the Lancet Optimising Child Health Series Steering Committee. We declare no competing interests. Start-up funding for this Series has been provided by the Centre for Global Child Health, The Hospital for Sick Children, Toronto, ON, Canada, and the Countdown to 2030 consortium.	[Anonymous], 2018, NURT CAR EARL CHILD; Bhutta ZA, 2008, LANCET, V372, P972, DOI 10.1016/S0140-6736(08)61407-5; Bhutta ZA, 2014, LANCET, V384, P347, DOI 10.1016/S0140-6736(14)60792-3; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Boerma T, 2018, LANCET, V391, P1538, DOI 10.1016/S0140-6736(18)30104-1; Claeson M, 2003, LANCET, V362, P323, DOI 10.1016/S0140-6736(03)13977-3; Cousens S, 2011, LANCET, V377, P1319, DOI 10.1016/S0140-6736(10)62310-0; Every Women Every Child, 2017, GLOB STRAT WOM CHILD; Kim JY, 2018, FOREIGN AFFAIRS; Kruk ME, 2018, LANCET GLOB HEALTH, V6, pE1196, DOI 10.1016/S2214-109X(18)30386-3; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Patton GC, 2018, NATURE, V554, P458, DOI 10.1038/nature25759; Richter LM, 2017, LANCET, V389, P103, DOI 10.1016/S0140-6736(16)31698-1; Victora CG, 2003, LANCET, V362, P233, DOI 10.1016/S0140-6736(03)13917-7	14	6	6	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 16	2019	393	10176					1080	1082		10.1016/S0140-6736(19)30488-X	http://dx.doi.org/10.1016/S0140-6736(19)30488-X			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HP1HF	30878221				2022-12-28	WOS:000461416600008
J	McCrindle, BW; Rowley, AH				McCrindle, Brian W.; Rowley, Anne H.			Improving coronary artery outcomes for children with Kawasaki disease	LANCET			English	Editorial Material							SUSCEPTIBILITY		[McCrindle, Brian W.] Univ Toronto, Labatt Family Heart Ctr, Hosp Sick Children, Dept Pediat, Toronto, ON M5G 1X8, Canada; [Rowley, Anne H.] Northwestern Univ, Dept Pediat, Ann & Robert H Lurie Childrens Hosp Chicago, Feinberg Sch Med, Chicago, IL 60611 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine	McCrindle, BW (corresponding author), Univ Toronto, Labatt Family Heart Ctr, Hosp Sick Children, Dept Pediat, Toronto, ON M5G 1X8, Canada.	brian.mccrindle@sickkids.ca		Rowley, Anne/0000-0003-4695-6676				Cameron SA, 2017, CLIN EXP IMMUNOL, V190, P244, DOI 10.1111/cei.13010; Coutinho AE, 2011, MOL CELL ENDOCRINOL, V335, P2, DOI 10.1016/j.mce.2010.04.005; Hamada H, 2019, LANCET, V393, P1128, DOI 10.1016/S0140-6736(18)32003-8; Kim Gi Beom, 2017, Pediatr Infect Dis J, V36, P482, DOI [10.1097/INF.0000000000001474, 10.1097/inf.0000000000001474]; Kim JJ, 2013, J HUM GENET, V58, P521, DOI 10.1038/jhg.2013.43; Kim JJ, 2011, HUM GENET, V129, P487, DOI 10.1007/s00439-010-0937-x; Kobayashi T, 2012, LANCET, V379, P1613, DOI 10.1016/S0140-6736(11)61930-2; McCrindle BW, 2017, CIRCULATION, V135, pE927, DOI 10.1161/CIR.0000000000000484; Onouchi Y, 2008, NAT GENET, V40, P35, DOI 10.1038/ng.2007.59; Onouchi Y, 2018, INT J RHEUM DIS, V21, P26, DOI 10.1111/1756-185X.13218; Rowley AH, 2017, J PEDIAT INF DIS SOC, V6, pE94, DOI 10.1093/jpids/pix025; Rowley AH, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2323-5; Sleeper LA, 2011, J PEDIATR-US, V158, P831, DOI 10.1016/j.jpeds.2010.10.031	13	7	7	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 16	2019	393	10176					1077	1078		10.1016/S0140-6736(18)33133-7	http://dx.doi.org/10.1016/S0140-6736(18)33133-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HP1HF	30853152				2022-12-28	WOS:000461416600006
J	Stein, A; Dalton, L; Rapa, E; Bluebond-Langner, M; Hanington, L; Stein, KF; Ziebland, S; Rochat, T; Harrop, E; Kelly, B; Bland, R; Betancourt, T; D'Souza, C; Fazel, M; Netsi, E; Hochhauser, D; Kolucki, B; Lowney, AC; Richter, L; Yousafzai, A				Stein, Alan; Dalton, Louise; Rapa, Elizabeth; Bluebond-Langner, Myra; Hanington, Lucy; Stein, Kim Fredman; Ziebland, Sue; Rochat, Tamsen; Harrop, Emily; Kelly, Brenda; Bland, Ruth; Betancourt, T.; D'Souza, C.; Fazel, M.; Netsi, E.; Hochhauser, D.; Kolucki, B.; Lowney, A. C.; Richter, L.; Yousafzai, A.		Commun Expert Grp	Communication with children and adolescents about the diagnosis of their own life-threatening condition	LANCET			English	Review							PEDIATRIC HIV DISCLOSURE; SIOP WORKING COMMITTEE; INFECTED CHILDREN; ANTIRETROVIRAL THERAPY; DEPRESSIVE SYMPTOMS; DEATH CONCEPTS; MENTAL-HEALTH; YOUNG-ADULTS; CANCER CARE; OF-LIFE	When a child is diagnosed with a life-threatening condition, one of the most challenging tasks facing health-care professionals is how to communicate this to the child, and to their parents or caregivers. Evidence-based guidelines are urgently needed for all health-care settings, from tertiary referral centres in high-income countries to resource limited environments in low-income and middle-income countries, where rates of child mortality are high. We place this Review in the context of children's developing understanding of illness and death. We review the effect of communication on children's emotional, behavioural, and social functioning, as well as treatment adherence, disease progression, and wider family relationships. We consider the factors that influence the process of communication and the preferences of children, families, and health-care professionals about how to convey the diagnosis. Critically, the barriers and challenges to effective communication are explored. Finally, we outline principles for communicating with children, parents, and caregivers, generated from a workshop of international experts.	[Stein, Alan; Dalton, Louise; Rapa, Elizabeth; Hanington, Lucy] Univ Oxford, Dept Psychiat, Oxford OX3 7JX, England; [Kelly, Brenda] Univ Oxford, Nuffield Dept Womens & Reprod Hlth, Oxford, England; [Ziebland, Sue] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England; [Stein, Alan; Bland, Ruth] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, South Africa; [Rochat, Tamsen] Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, Dept Paediat, Johannesburg, South Africa; [Bluebond-Langner, Myra] UCL Great Ormond St Inst Child Hlth, Louis Dundas Ctr Childrens Palliat Care, London, England; [Stein, Kim Fredman] Univ Bath, Dept Psychol, Bath, Avon, England; [Rochat, Tamsen] Human Sci Res Council, Johannesburg, South Africa; [Harrop, Emily; Kelly, Brenda] Oxford Univ Hosp NHS Fdn Trust, Oxford, England; [Harrop, Emily] Helen & Douglas House, Oxford, England; [Bland, Ruth] Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland; [Bland, Ruth] Univ Glasgow, Glasgow, Lanark, Scotland; [Bland, Ruth] Royal Hosp Children, Glasgow, Lanark, Scotland; [Betancourt, T.] Boston Coll, Boston, MA USA; [D'Souza, C.] South Canterbury Dist Hlth Board, Timaru, New Zealand; [Fazel, M.; Netsi, E.] Univ Oxford, Oxford, England; [Hochhauser, D.] UCL Canc Inst, London, England; [Kolucki, B.] UNICEF, Commun & Children Difficult Circumstances, New York, NY USA; [Lowney, A. C.] Oxford Univ Hosp NHS Fdn Trust, Oxford, England; [Lowney, A. C.] Sir Michael Sobell House, Oxford, England; [Richter, L.] Univ Witwatersrand, Johannesburg, South Africa; [Yousafzai, A.] Harvard TH Chan Sch Publ Hlth, Boston, MA USA	University of Oxford; University of Oxford; University of Oxford; University of Witwatersrand; University of Witwatersrand; University of London; University College London; University of Bath; Human Sciences Research Council-South Africa; Oxford University Hospitals NHS Foundation Trust; University of Glasgow; Boston College; University of Oxford; University of London; University College London; UNICEF; Oxford University Hospitals NHS Foundation Trust; University of Oxford; University of Witwatersrand; Harvard University; Harvard T.H. Chan School of Public Health	Stein, A (corresponding author), Univ Oxford, Dept Psychiat, Oxford OX3 7JX, England.	alan.stein@psych.ox.ac.uk	Rochat, Tamsen/AAU-5756-2021	Rochat, Tamsen/0000-0002-5223-770X; Stein, Alan/0000-0001-8207-2822; Ziebland, Sue/0000-0002-6496-4859; Harrop, Emily/0000-0002-2480-2062; Bluebond-Langner, Myra/0000-0001-9281-5431; Hochhauser, Daniel/0000-0001-5522-9281; Dalton, Louise/0000-0003-1923-5769; Rapa, Elizabeth/0000-0001-8818-8148; Bland, Ruth/0000-0003-1675-9268; Netsi, Elena/0000-0003-0448-0104	John Fell Fund, University of Oxford; Sheila Kitzinger Programme, Green Templeton College, Oxford	John Fell Fund, University of Oxford; Sheila Kitzinger Programme, Green Templeton College, Oxford	The study was funded by The John Fell Fund, University of Oxford and The Sheila Kitzinger Programme, Green Templeton College, Oxford supported the workshop. We thank Duncan West and Melissa de Lusignan for facilitating the expert workshop, and Valerie West, Mike Beckles, Nia Roberts, Hannah DeJong, Elise Sellars, and the patient and public involvement from Meriel Flint, who had cancer as an adolescent, and a young adult with a life-threatening condition (written permission obtained).	Abadia-Barrero CE, 2006, AIDS PATIENT CARE ST, V20, P36, DOI 10.1089/apc.2006.20.36; Adduci A, 2012, PEDIATR BLOOD CANCER, V59, P290, DOI 10.1002/pbc.24165; Aldridge J, 2017, ARCH DIS CHILDHOOD-E, V102, P182, DOI 10.1136/archdischild-2016-311974; Amery J, 2009, CHILDRENS PALLIATIVE, P289; Arun S, 2009, INDIAN J PEDIATR, V76, P805, DOI 10.1007/s12098-009-0177-z; Badarau DO, 2015, PEDIATR BLOOD CANCER, V62, P2177, DOI 10.1002/pbc.25680; Bates AT, 2015, CURR OPIN SUPPORT PA, V9, P40, DOI 10.1097/SPC.0000000000000118; Beima-Sofie K, 2014, AIDS PATIENT CARE ST, V28, P555, DOI 10.1089/apc.2014.0040; Berg Astrid, 2003, Transcult Psychiatry, V40, P194, DOI 10.1177/1363461503402004; Biadgilign S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017572; Bikaako-Kajura W, 2006, AIDS BEHAV, V10, pS85, DOI 10.1007/s10461-006-9141-3; BINGER CM, 1969, NEW ENGL J MED, V280, P414, DOI 10.1056/NEJM196902202800804; Blakemore SJ, 2012, NAT NEUROSCI, V15, P1184, DOI 10.1038/nn.3177; Blasini I, 2004, J DEV BEHAV PEDIATR, V25, P181, DOI 10.1097/00004703-200406000-00007; Bluebond-Langner M., 1978, PRIVATE WORLDS DYING; BLUEBONDLANGNER M, 1989, DEATH STUD, V13, P1, DOI 10.1080/07481188908252274; Boon-yasidhi V, 2016, INT J STD AIDS, V27, P288, DOI 10.1177/0956462415579590; British Medical Association, 2017, CHANG FAC MED ROL DO; Britto C, 2016, J DEV BEHAV PEDIATR, V37, P496, DOI 10.1097/DBP.0000000000000303; Brown BJ, 2011, AIDS CARE, V23, P1053, DOI 10.1080/09540121.2011.554523; Butow P, 2010, J CLIN ONCOL, V28, P4800, DOI 10.1200/JCO.2009.22.2802; Caldwell PHY, 2004, LANCET, V364, P803, DOI 10.1016/S0140-6736(04)16942-0; CLAFLIN CJ, 1991, J PEDIATR PSYCHOL, V16, P169, DOI 10.1093/jpepsy/16.2.169; Clarke SA, 2005, PSYCHO-ONCOL, V14, P274, DOI 10.1002/pon.843; Cluver Lucie D, 2015, AIDS, V29 Suppl 1, pS57, DOI 10.1097/QAD.0000000000000695; COTTON CR, 1990, J CLIN CHILD PSYCHOL, V19, P123, DOI 10.1207/s15374424jccp1902_3; Coyne I, 2016, EUR J CANCER CARE, V25, P141, DOI 10.1111/ecc.12411; Davidson LL, 2015, NATURE, V527, pS161, DOI 10.1038/nature16030; Dunsmore J, 1995, J PSYCHOSOC ONCOL, V13, P39; Eiser C, 1989, PSYCHOL HEALTH, V3, P93; El Malla H, 2013, PSYCHO-ONCOLOGY, V22, P548, DOI 10.1002/pon.3028; Essig S, 2016, PEDIATR BLOOD CANCER, V63, P1423, DOI 10.1002/pbc.26012; Fallowfield L, 2004, LANCET, V363, P312, DOI 10.1016/S0140-6736(03)15392-5; Ferris M, 2007, AIDS CARE, V19, P1088, DOI 10.1080/09540120701367124; Fetzer BC, 2011, AIDS PATIENT CARE ST, V25, P611, DOI 10.1089/apc.2011.0083; Fortier MA, 2013, J PEDIAT HEMATOL ONC, V35, P366, DOI 10.1097/MPH.0b013e318290cfdb; FRITZ GK, 1988, AM J ORTHOPSYCHIAT, V58, P552, DOI 10.1111/j.1939-0025.1988.tb01619.x; Gibson F, 2010, INT J NURS STUD, V47, P1397, DOI 10.1016/j.ijnurstu.2010.03.019; GOLDMAN A, 1993, PEDIATR HEMAT ONCOL, V10, P223, DOI 10.3109/08880019309029488; Haberer JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018505; Hunter SB, 2008, OMEGA-J DEATH DYING, V57, P143, DOI 10.2190/OM.57.2.b; Hynson JL, 2006, PALLIATIVE MED, V20, P805, DOI 10.1177/0269216306072349; Jacobs S, 2015, PEDIATR BLOOD CANCER, V62, P710, DOI 10.1002/pbc.25358; JAY SM, 1987, J CLIN CHILD PSYCHOL, V16, P301, DOI 10.1207/s15374424jccp1604_2; John-Stewart GC, 2013, AIDS CARE, V25, P1067, DOI 10.1080/09540121.2012.749333; Johnston DL, 2011, PEDIATR BLOOD CANCER, V56, P506, DOI 10.1002/pbc.22896; Kajubi P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147119; Kearney MK, 2009, JAMA-J AM MED ASSOC, V301, pE1; Knaul FM, 2018, LANCET, V391, P1391, DOI 10.1016/S0140-6736(17)32513-8; Kreicbergs U, 2004, NEW ENGL J MED, V351, P1175, DOI 10.1056/NEJMoa040366; Last BF, 1996, EUR J CANCER, V32A, P290, DOI 10.1016/0959-8049(95)00576-5; Lester P, 2002, JAIDS-J ACQ IMM DEF, V31, P309, DOI 10.1097/00126334-200211010-00006; LEVENSON PM, 1982, J ADOLESCENT HEALTH, V3, P9, DOI 10.1016/S0197-0070(82)80021-1; Levetown M, 2008, PEDIATRICS, V121, pE1441, DOI 10.1542/peds.2008-0565; Lorenz R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148950; Mack JW, 2006, J CLIN ONCOL, V24, P5265, DOI 10.1200/JCO.2006.06.5326; Mahon M M, 1993, J Pediatr Nurs, V8, P335; Marhefka SL, 2016, CLIN GUIDE PEDIAT HI, P189; Masera G, 1997, MED PEDIATR ONCOL, V28, P382, DOI 10.1002/(SICI)1096-911X(199705)28:5<382::AID-MPO12>3.0.CO;2-D; Mellins CA., 2002, CLIN CHILD PSYCHOL P, V7, P101, DOI [10.1177/1359104502007001008, DOI 10.1177/1359104502007001008]; Menon A, 2007, JAIDS-J ACQ IMM DEF, V46, P349, DOI 10.1097/QAI.0b013e3181565df0; Merzel C, 2008, AIDS PATIENT CARE ST, V22, P977, DOI 10.1089/apc.2008.0048; Moodley K, 2006, SAMJ S AFR MED J, V96, pA201; Morgan S, 2010, J CLIN ONCOL, V28, P4825, DOI 10.1200/JCO.2009.22.5474; Myer L, 2006, J TROP PEDIATRICS, V52, P293, DOI 10.1093/tropej/fml004; NORDMARKLINDBERG I, 1979, ACTA PAEDIATR SCAND, V68, P645, DOI 10.1111/j.1651-2227.1979.tb18432.x; Oberdorfer P, 2006, J PAEDIATR CHILD H, V42, P283, DOI 10.1111/j.1440-1754.2006.00855.x; Oulton K, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-2970-8; Panagiotaki G, 2018, J EXP CHILD PSYCHOL, V166, P96, DOI 10.1016/j.jecp.2017.07.014; Pinzon-Iregui MC, 2013, J TROP PEDIATRICS, V59, P84, DOI 10.1093/tropej/fms052; Rodriguez EM, 2013, J PEDIATR PSYCHOL, V38, P732, DOI 10.1093/jpepsy/jst018; Roscigno CI, 2013, BRAIN INJURY, V27, P1536, DOI 10.3109/02699052.2013.831122; Rotenstein LS, 2016, JAMA-J AM MED ASSOC, V316, P2214, DOI 10.1001/jama.2016.17324; Sahler OJZ, 2000, PEDIATRICS, V105, P575, DOI 10.1542/peds.105.3.575; Santamaria EK, 2011, AIDS PATIENT CARE ST, V25, P257, DOI 10.1089/apc.2010.0161; Sawyer SM, 2018, LANCET CHILD ADOLESC, V2, P223, DOI 10.1016/S2352-4642(18)30022-1; Schonfeld D J, 1993, J Pediatr Health Care, V7, P269, DOI 10.1016/S0891-5245(06)80008-8; Sharkey S, 2016, HEALTH EXPECT, V19, P738, DOI 10.1111/hex.12254; Sherman BF, 2000, PSYCHOSOM MED, V62, P238, DOI 10.1097/00006842-200003000-00016; Shields L, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004811.pub3; Sisk BA, 2018, PEDIATR BLOOD CANCER, V65, DOI 10.1002/pbc.26727; Sisk BA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-1278; Slaughter V, 2005, AUST PSYCHOL, V40, P179, DOI 10.1080/00050060500243426; Spinetta JJ, 2002, MED PEDIATR ONCOL, V38, P114, DOI 10.1002/mpo.1283; Su YH, 2007, CANC NURS, V30, P82; Su YH, 2007, CANCER NURS, V30, P362, DOI 10.1097/01.NCC.0000290817.37442.e6; Surbone A, 2004, CRIT REV ONCOL HEMAT, V52, P165, DOI 10.1016/j.critrevonc.2004.09.002; UNAIDS, 2018, GLOB HIV AIDS STAT; UNICEF, 1989, UN CONV RIGHTS CHILD; van der Geest IMM, 2015, J PEDIATR-US, V167, P1320, DOI 10.1016/j.jpeds.2015.08.066; Vaz L, 2008, AIDS CARE, V20, P842, DOI 10.1080/09540120701742276; Vaz LME, 2011, J DEV BEHAV PEDIATR, V32, P307, DOI 10.1097/DBP.0b013e31820f7a47; Vaz LME, 2010, AIDS PATIENT CARE ST, V24, P247, DOI 10.1089/apc.2009.0217; Vreeman Rachel C, 2015, AIDS, V29 Suppl 1, pS47, DOI 10.1097/QAD.0000000000000669; WASSERMAN AL, 1987, AM J DIS CHILD, V141, P626, DOI 10.1001/archpedi.1987.04460060044029; Wiener L, 2013, PALLIAT SUPPORT CARE, V11, P47, DOI 10.1017/S1478951511001027; Wiener LS, 1996, PEDIATR AIDS HIV INF, V7, P310; Wolfe J, 2000, JAMA-J AM MED ASSOC, V284, P2469, DOI 10.1001/jama.284.19.2469; WOOLLEY H, 1989, BRIT MED J, V298, P1623, DOI 10.1136/bmj.298.6688.1623; WOOLLEY H, 1989, ARCH DIS CHILD, V64, P114, DOI 10.1136/adc.64.1.114; Young B, 2003, BRIT MED J, V326, P305, DOI 10.1136/bmj.326.7384.305; Young B, 2011, PEDIATRICS, V127, pE1230, DOI 10.1542/peds.2010-2402; Zwaanswijk M, 2011, PSYCHO-ONCOLOGY, V20, P269, DOI 10.1002/pon.1721; Zwaanswijk Marieke, 2007, BMC Pediatr, V7, P35, DOI 10.1186/1471-2431-7-35	104	48	48	3	19	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 16	2019	393	10176					1150	1163		10.1016/S0140-6736(18)33201-X	http://dx.doi.org/10.1016/S0140-6736(18)33201-X			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HP1HF	30894271	Green Submitted			2022-12-28	WOS:000461416600034
J	Clery, D				Clery, Daniel			FLASHES IN THE SCAN	SCIENCE			English	Editorial Material														Clery, Daniel/0000-0002-8742-3596					0	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 15	2019	363	6432			SI		1138	1141		10.1126/science.363.6432.1138	http://dx.doi.org/10.1126/science.363.6432.1138			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HP0BC	30872502				2022-12-28	WOS:000461329000021
J	Mayor, S				Mayor, Susan			More than a third of CCGs and trusts fail to show value for money, says public spending watchdog	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 15	2019	364								l1205	10.1136/bmj.l1205	http://dx.doi.org/10.1136/bmj.l1205			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP5WF	30872275				2022-12-28	WOS:000461752800003
J	Vander Linden, M				Vander Linden, Marc			Toward a clearer view into human prehistory	SCIENCE			English	Editorial Material									[Vander Linden, Marc] Univ Cambridge, Dept Archaeol, Cambridge, England	University of Cambridge	Vander Linden, M (corresponding author), Univ Cambridge, Dept Archaeol, Cambridge, England.	mv297@cam.ac.uk	Linden, Marc Vander/AFO-2422-2022	Linden, Marc Vander/0000-0002-0120-7754	European Research Council [ERC-2012-Stg 313716-EUROFARM]	European Research Council(European Research Council (ERC)European Commission)	I thank T.C. O'Connell and D. Meltzer for discussion and comments. Financial support was provided by the European Research Council (ERC-2012-Stg 313716-EUROFARM).	Amorim CEG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06024-4; Balsera V, 2015, QUATERN INT, V386, P208, DOI 10.1016/j.quaint.2015.06.022; Cappellini E, 2018, ANNU REV BIOCHEM, V87, P1029, DOI 10.1146/annurev-biochem-062917-012002; Gonzalez Fortes G, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2018.2288; Johanssen N., 2017, SCIENCE, V356, P1119; Knipper C, 2017, P NATL ACAD SCI USA, V114, P10083, DOI 10.1073/pnas.1706355114; Kristiansen K., 2014, CURRENT SWEDISH ARCH, V22, P11; Kuhn JMM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195491; Margaryan A, 2018, ECOL EVOL, V8, P3534, DOI 10.1002/ece3.3924; Mondal M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08089-7; Olalde I, 2019, SCIENCE, V363, P1230, DOI 10.1126/science.aav4040; Olalde I, 2018, NATURE, V555, P190, DOI 10.1038/nature25738; Reich D, 2018, WHO WE ARE WE GOT HE; Silva F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12318-2	14	5	5	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 15	2019	363	6432			SI		1153	1154		10.1126/science.aaw8020	http://dx.doi.org/10.1126/science.aaw8020			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HP0BC	30872509	Green Submitted, Green Accepted			2022-12-28	WOS:000461329000028
J	Schmidt, BZ				Schmidt, Bela Z.			Crowd-sourced career wisdom	NATURE			English	Editorial Material									[Schmidt, Bela Z.] Katholieke Univ Leuven, Leuven, Belgium	KU Leuven				Schmidt, Bela Z/0000-0003-1085-9372					0	0	0	2	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 14	2019	567	7747					273	275		10.1038/d41586-019-00560-9	http://dx.doi.org/10.1038/d41586-019-00560-9			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HO7LD	30837694	Bronze, Green Accepted			2022-12-28	WOS:000461126600049
J	O'Donnell, M; Mente, A; Rangarajan, S; McQueen, MJ; O'Leary, N; Yin, L; Liu, XY; Swaminathan, S; Khatib, R; Rosengren, A; Ferguson, J; Smyth, A; Lopez-Jaramillo, P; Diaz, R; Avezum, A; Lanas, F; Ismail, N; Yusoff, K; Dans, A; Iqbal, R; Szuba, A; Mohammadifard, N; Oguz, A; Yusufali, AH; Alhabib, KF; Kruger, IM; Yusuf, R; Chifamba, J; Yeates, K; Dagenais, G; Wielgosz, A; Lear, SA; Teo, K; Yusuf, S				O'Donnell, Martin; Mente, Andrew; Rangarajan, Sumathy; McQueen, Matthew J.; O'Leary, Neil; Yin, Lu; Liu, Xiaoyun; Swaminathan, Sumathi; Khatib, Rasha; Rosengren, Annika; Ferguson, John; Smyth, Andrew; Lopez-Jaramillo, Patricio; Diaz, Rafael; Avezum, Alvaro; Lanas, Fernando; Ismail, Noorhassim; Yusoff, Khalid; Dans, Antonio; Iqbal, Romaina; Szuba, Andrzej; Mohammadifard, Noushin; Oguz, Atyekin; Yusufali, Afzal Hussein; Alhabib, Khalid F.; Kruger, Iolanthe M.; Yusuf, Rita; Chifamba, Jephat; Yeates, Karen; Dagenais, Gilles; Wielgosz, Andreas; Lear, Scott A.; Teo, Koon; Yusuf, Salim		PURE Investigators	Joint association of urinary sodium and potassium excretion with cardiovascular events and mortality: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LOW-INCOME COUNTRIES; DIETARY-SODIUM; BLOOD-PRESSURE; RISK; HYPERTENSION; DISEASE; MIDDLE; SALT; INDIVIDUALS; VALIDATION	OBJECTIVE To evaluate the joint association of sodium and potassium urinary excretion (as surrogate measures of intake) with cardiovascular events and mortality, in the context of current World Health Organization recommendations for daily intake (< 2.0 g sodium, > 3.5 g potassium) in adults. DESIGN International prospective cohort study. SETTING 18 high, middle, and low income countries, sampled from urban and rural communities. PARTICIPANTS 103 570 people who provided morning fasting urine samples. MAIN OUTCOME MEASURES Association of estimated 24 hour urinary sodium and potassium excretion (surrogates for intake) with all cause mortality and major cardiovascular events, using multivariable Cox regression. A six category variable for joint sodium and potassium was generated: sodium excretion (low (< 3 g/day), moderate (3-5 g/day), and high (> 5 g/day) sodium intakes) by potassium excretion (greater/equal or less than median 2.1 g/day). RESULTS Mean estimated sodium and potassium urinary excretion were 4.93 g/day and 2.12 g/day, respectively. After a median follow-up of 8.2 years, 7884 (6.1%) participants had died or experienced a major cardiovascular event. Increasing urinary sodium excretion was positively associated with increasing potassium excretion (unadjusted r=0.34), and only 0.002% had a concomitant urinary excretion of < 2.0 g/day of sodium and > 3.5 g/day of potassium. A J-shaped association was observed of sodium excretion and inverse association of potassium excretion with death and cardiovascular events. For joint sodium and potassium excretion categories, the lowest risk of death and cardiovascular events occurred in the group with moderate sodium excretion (3-5 g/day) and higher potassium excretion (21.9% of cohort). Compared with this reference group, the combinations of low potassium with low sodium excretion (hazard ratio 1.23, 1.11 to 1.37; 7.4% of cohort) and low potassium with high sodium excretion (1.21, 1.11 to 1.32; 13.8% of cohort) were associated with the highest risk, followed by low sodium excretion (1.19, 1.02 to 1.38; 3.3% of cohort) and high sodium excretion (1.10, 1.02 to 1.18; 29.6% of cohort) among those with potassium excretion greater than the median. Higher potassium excretion attenuated the increased cardiovascular risk associated with high sodium excretion (P for interaction=0.007). CONCLUSIONS These findings suggest that the simultaneous target of low sodium intake (< 2 g/day) with high potassium intake (> 3.5 g/day) is extremely uncommon. Combined moderate sodium intake (3-5 g/day) with high potassium intake is associated with the lowest risk of mortality and cardiovascular events.	[O'Donnell, Martin; Mente, Andrew; Rangarajan, Sumathy; McQueen, Matthew J.; Teo, Koon; Yusuf, Salim] McMaster Univ, DBCVS Res Inst, Populat Hlth Res Inst, 237 Barton St East, Hamilton, ON L8L 2X2, Canada; [O'Donnell, Martin; O'Leary, Neil; Ferguson, John; Smyth, Andrew] Galway Univ Hosp, NUI Galway, HRB Clin Res Facil, Galway, Ireland; [Yin, Lu; Liu, Xiaoyun] Natl Ctr Cardiovasc Dis Cardiovasc, Med Res & Biometr Ctr, Beijing, Peoples R China; [Swaminathan, Sumathi] St Johns Res Inst, Div Nutr, Bangalore, Karnataka, India; [Khatib, Rasha] Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA; [Rosengren, Annika] Univ Gothenburg, Sahlgrenska Acad, Gothenburg, Region Vastra G, Sweden; [Rosengren, Annika] Sahlgrens Univ Hosp, Gothenburg, Region Vastra G, Sweden; [Lopez-Jaramillo, Patricio] Univ Santander, Med Sch, Fdn Oftalmol Santander FOSCAL, Floridablanca Santander, Colombia; [Diaz, Rafael] Inst Cardiovasc Rosario, Estud Clin Latinoamer ECLA, Rosario, Santa Fe, Argentina; [Avezum, Alvaro] Dante Pazzanese Inst Cardiol, Sao Paulo, Brazil; [Lanas, Fernando] Univ La Frontera, Temuco, Chile; [Ismail, Noorhassim] Univ Kebangsaan Malaysia, Med Ctr, Dept Community Health, Bangi, Malaysia; [Yusoff, Khalid] UCSI Univ, Fac Med & Hlth Sci, Kuala Lumpur, Malaysia; [Dans, Antonio] Univ Philippines Manila, Manila, Philippines; [Iqbal, Romaina] Aga Khan Univ, Dept Community Hlth Sci, Karachi, Pakistan; [Iqbal, Romaina] Aga Khan Univ, Dept Med, Karachi, Pakistan; [Szuba, Andrzej] Wroclaw Med Univ, Div Angiol, Wroclaw, Poland; [Mohammadifard, Noushin] Isfahan Univ Med Sci, Cardiovasc Res Inst, Isfahan Cardiovasc Res Ctr, Esfahan, Iran; [Oguz, Atyekin] Istanbul Medeniyet Univ, Fac Med, Dept Internal Med, Istanbul, Turkey; [Yusufali, Afzal Hussein] Dubai Med Univ, Hatta Hosp, Dubai Hlth Author, Dubai, U Arab Emirates; [Alhabib, Khalid F.] King Saud Univ, King Fahad Cardiac Ctr, Coll Med, Dept Cardiac Sci, Riyadh, Saudi Arabia; [Kruger, Iolanthe M.] North West Univ, Fac Hlth Sci, Potchefstroom Campus, Potchefstroom, South Africa; [Yusuf, Rita] Independent Univ, Sch Life Sci, Dhaka, Bangladesh; [Yusuf, Rita] Independent Univ, Ctr Hlth Populat & Dev, Dhaka, Bangladesh; [Chifamba, Jephat] Univ Zimbabwe, Coll Hlth Sci, Physiol Dept, Harare, Zimbabwe; [Yeates, Karen] Queens Univ, Div Nephrol, Dept Med, Kingston, ON, Canada; [Dagenais, Gilles] Laval Univ, Heart & Lungs Inst, Quebec City, PQ, Canada; [Wielgosz, Andreas] Univ Ottawa, Fac Med, Ottawa, ON, Canada; [Lear, Scott A.] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC, Canada; [Lear, Scott A.] Providence Hlth Care, Div Cardiol, Vancouver, BC, Canada	McMaster University; Population Health Research Institute; Health Research Board - Ireland; Ollscoil na Gaillimhe-University of Galway; St. John's National Academy of Health Sciences; St. John's Research Institute; Northwestern University; Feinberg School of Medicine; University of Gothenburg; Sahlgrenska University Hospital; Universidad Industrial de Santander; Instituto Dante Pazzanese de Cardiologia; Universidad de La Frontera; Universiti Kebangsaan Malaysia; UCSI University; University of the Philippines System; University of the Philippines Manila; Aga Khan University; Aga Khan University; Wroclaw Medical University; Isfahan University Medical Science; Istanbul Medeniyet University; King Saud University; North West University - South Africa; Independent University Bangladesh (IUB); Independent University Bangladesh (IUB); University of Zimbabwe; Queens University - Canada; Laval University; University of Ottawa; Simon Fraser University	O'Donnell, M (corresponding author), McMaster Univ, DBCVS Res Inst, Populat Hlth Res Inst, 237 Barton St East, Hamilton, ON L8L 2X2, Canada.; O'Donnell, M (corresponding author), Galway Univ Hosp, NUI Galway, HRB Clin Res Facil, Galway, Ireland.	odonnm@mcmaster.ca	Kruger, Iolanthe M/G-8698-2015; Swaminathan, Sumathi/AGI-7678-2022; Chifamba, Jephat/AHE-4535-2022; O'Donnell, Martin/ABE-7459-2020; ISMAIL, ROSNAH/V-2910-2017; Khatib, Rasha/GXV-8883-2022; Avezum, Alvaro/AAP-7687-2020; Oguz, Aytekin/AAJ-2732-2021; Mohammadifard, Noushin/M-2244-2018; Lanas, Fernando/AAE-8842-2022; Szuba, Andrzej/AAY-1162-2020; Rozanska, Dorota/S-5239-2018	Kruger, Iolanthe M/0000-0002-8636-7174; Chifamba, Jephat/0000-0001-8166-1182; O'Donnell, Martin/0000-0002-7347-7761; ISMAIL, ROSNAH/0000-0002-8178-3822; Oguz, Aytekin/0000-0002-2595-5167; Mohammadifard, Noushin/0000-0003-1776-1060; Yusufali, Afzalhussein/0000-0003-3378-2646; Lopez-Jaramillo, Patricio/0000-0002-9122-8742; Yusuf, Salim/0000-0003-4776-5601; Lanas, Fernando/0000-0003-3595-9759; Zatonska, Katarzyna/0000-0002-3772-5588; Rosengren, Annika/0000-0002-5409-6605; Alhabib, Khalid/0000-0002-6692-3874; Szuba, Andrzej/0000-0002-7555-6201; AVEZUM, ALVARO/0000-0002-3073-6890; Wolyniec, Maria/0000-0003-2054-1691; Ferguson, John/0000-0001-8475-398X; Ismail, Noor Hassim/0000-0003-1547-7904; Regulska-Ilow, Bozena/0000-0002-5941-1715; Rozanska, Dorota/0000-0002-0561-2749; O'Leary, Neil/0000-0002-2765-7016	European Research Council (COSIP grant) [640580]; Heart and Stroke Foundation of Ontario; Mary W Burke endowed chair of the Heart and Stroke Foundation of Ontario; Population Health Research Institute; Canadian Institutes of Health Research; CIHR's Strategy for Patient Oriented Research, through the Ontario SPOR Support Unit; Ontario Ministry of Health and Long-Term Care; Astra Zeneca (Canada); Sanofi-Aventis (France); Sanofi-Aventis (Canada); Boehringer Ingelheim (Germany); Boehringer Ingelheim (Canada); Servier; GSK; Novartis; King Pharma; Fundacion ECLA; Independent University, Bangladesh; Mitra and Associates; Unilever Health Institute, Brazil; Public Health Agency of Canada; Champlain Cardiovascular Disease Prevention Network, Canadian Institutes of Health Research [126524]; Universidad de La Frontera [DI13-PE11]; National Center for Cardiovascular Diseases; Colciencias [6566-04-18062]; Indian Council of Medical Research; Ministry of Science, Technology and Innovation of Malaysia [100-IRDC/BIOTEK 16/6/21 (13/2007), 07-05-IFN-BPH 010]; Ministry of Higher Education of Malaysia [600-RMI/LRGS/5/3 (2/2011)]; Universiti Teknologi MARA; Faculty of Medicine, Universiti Kebangsaan Malaysia; Kuala Lumpur Malaysia; CRIM, University Kebangsaan Malaysia; Occupied Palestinian Territory: The United Nations Relief and Works Agency for Palestine Refugees in the Near East (UNRWA), occupied Palestinian territory; International Development Research Centre (IDRC), Canada; National Heart, Lung and Blood Institute [HHSN268200900033C]; National Cancer Institute [1P20CA217231]; Wellcome [103994/Z/14/Z]; Philippine Council for Health Research & Development (PCHRD); Polish Ministry of Science and Higher Education [290/W-PURE/2008/0]; Wroclaw Medical University; Saudi Heart Association; Deanship of Scientific Research at King Saud University, Riyadh, Saudi Arabia [RG -1436-013]; North-West University; SANPAD (SA and Netherlands Programme for Alternative Development); National Research Foundation; Medical Research Council of SA; SA Sugar Association (SASA); Faculty of Community and Health Sciences (UWC); Swedish state under the Agreement concerning research and education of doctors; Swedish Heart and Lung Foundation; Swedish Research Council; Swedish Council for Health, Working Life and Welfare; King Gustaf V:s and Queen Victoria Freemason's Foundation; AFA Insurance; Pamoja Tunaweza Health Research Centre (Tanzania); Queen's University, Department of Medicine; Metabolic Syndrome Society; Astra Zeneca, Turkey; Sheikh Hamdan Bin Rashid Al Maktoum Award for Medical Sciences; Dubai Health Authority, Dubai UAE; NATIONAL CANCER INSTITUTE [P20CA217231] Funding Source: NIH RePORTER	European Research Council (COSIP grant); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Mary W Burke endowed chair of the Heart and Stroke Foundation of Ontario; Population Health Research Institute; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); CIHR's Strategy for Patient Oriented Research, through the Ontario SPOR Support Unit(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario); Astra Zeneca (Canada)(AstraZeneca); Sanofi-Aventis (France)(Sanofi-Aventis); Sanofi-Aventis (Canada)(Sanofi-Aventis); Boehringer Ingelheim (Germany)(Boehringer Ingelheim); Boehringer Ingelheim (Canada)(Boehringer Ingelheim); Servier(Servier); GSK(GlaxoSmithKline); Novartis(Novartis); King Pharma; Fundacion ECLA; Independent University, Bangladesh; Mitra and Associates; Unilever Health Institute, Brazil(Unilever); Public Health Agency of Canada; Champlain Cardiovascular Disease Prevention Network, Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Universidad de La Frontera; National Center for Cardiovascular Diseases; Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Ministry of Science, Technology and Innovation of Malaysia(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia); Ministry of Higher Education of Malaysia(Ministry of Education, Malaysia); Universiti Teknologi MARA; Faculty of Medicine, Universiti Kebangsaan Malaysia; Kuala Lumpur Malaysia; CRIM, University Kebangsaan Malaysia; Occupied Palestinian Territory: The United Nations Relief and Works Agency for Palestine Refugees in the Near East (UNRWA), occupied Palestinian territory; International Development Research Centre (IDRC), Canada(CGIAR); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Wellcome; Philippine Council for Health Research & Development (PCHRD); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Wroclaw Medical University; Saudi Heart Association; Deanship of Scientific Research at King Saud University, Riyadh, Saudi Arabia; North-West University; SANPAD (SA and Netherlands Programme for Alternative Development); National Research Foundation; Medical Research Council of SA; SA Sugar Association (SASA); Faculty of Community and Health Sciences (UWC); Swedish state under the Agreement concerning research and education of doctors; Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Council for Health, Working Life and Welfare; King Gustaf V:s and Queen Victoria Freemason's Foundation; AFA Insurance; Pamoja Tunaweza Health Research Centre (Tanzania); Queen's University, Department of Medicine; Metabolic Syndrome Society; Astra Zeneca, Turkey(AstraZeneca); Sheikh Hamdan Bin Rashid Al Maktoum Award for Medical Sciences; Dubai Health Authority, Dubai UAE; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The funders of the study had no role in its design or conduct, in the collection, analysis, or interpretation of the data, or in the writing of the manuscript. The current analyses were supported by funding from the European Research Council (COSIP grant, 640580) and Heart and Stroke Foundation of Ontario. SY is supported by the Mary W Burke endowed chair of the Heart and Stroke Foundation of Ontario. The PURE study is an investigator initiated study that is funded by the Population Health Research Institute, the Canadian Institutes of Health Research, Heart and Stroke Foundation of Ontario, Support from CIHR's Strategy for Patient Oriented Research, through the Ontario SPOR Support Unit, as well as the Ontario Ministry of Health and Long-Term Care and through unrestricted grants from several pharmaceutical companies (with major contributions from Astra Zeneca (Canada), Sanofi-Aventis (France and Canada), Boehringer Ingelheim (Germany and Canada), Servier, and GSK), and additional contributions from Novartis and King Pharma and from various national or local organisations in participating countries. These include Argentina: Fundacion ECLA; Bangladesh: Independent University, Bangladesh and Mitra and Associates; Brazil: Unilever Health Institute, Brazil; Canada: Public Health Agency of Canada and Champlain Cardiovascular Disease Prevention Network, Canadian Institutes of Health Research (Catalyst Grant: eHealth Innovations-grant No: 126524); Chile: Universidad de La Frontera (Internal Registry DI13-PE11); China: National Center for Cardiovascular Diseases; Colombia: Colciencias, grant No: 6566-04-18062; India: Indian Council of Medical Research; Malaysia: Ministry of Science, Technology and Innovation of Malaysia grant No 100-IRDC/BIOTEK 16/6/21 (13/2007), grant No 07-05-IFN-BPH 010, Ministry of Higher Education of Malaysia grant No 600-RMI/LRGS/5/3 (2/2011), Universiti Teknologi MARA, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur Malaysia. CRIM, University Kebangsaan Malaysia; Occupied Palestinian Territory: The United Nations Relief and Works Agency for Palestine Refugees in the Near East (UNRWA), occupied Palestinian territory; International Development Research Centre (IDRC), Canada; Peru: National Heart, Lung and Blood Institute (HHSN268200900033C), National Cancer Institute (1P20CA217231), Wellcome (103994/Z/14/Z); Philippines: Philippine Council for Health Research & Development (PCHRD); Poland: Polish Ministry of Science and Higher Education grant No 290/W-PURE/2008/0, Wroclaw Medical University, Wroclaw Medical University, statutory activity Saudi Arabia: Saudi Heart Association, The Deanship of Scientific Research at King Saud University, Riyadh, Saudi Arabia (Research group No: RG -1436-013); South Africa: The North-West University, SANPAD (SA and Netherlands Programme for Alternative Development), National Research Foundation, Medical Research Council of SA. The SA Sugar Association (SASA), Faculty of Community and Health Sciences (UWC); Sweden: grants from the Swedish state under the Agreement concerning research and education of doctors; the Swedish Heart and Lung Foundation; the Swedish Research Council; the Swedish Council for Health, Working Life and Welfare, King Gustaf V:s and Queen Victoria Freemason's Foundation, AFA Insurance; Tanzania: Pamoja Tunaweza Health Research Centre (Tanzania), Queen's University, Department of Medicine; Turkey: Metabolic Syndrome Society, Astra Zeneca, Turkey; UAE: Sheikh Hamdan Bin Rashid Al Maktoum Award for Medical Sciences, and Dubai Health Authority, Dubai UAE.	Aburto NJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1326; Aburto NJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1378; Binia A, 2015, J HYPERTENS, V33, P1509, DOI 10.1097/HJH.0000000000000611; Chang HY, 2006, AM J CLIN NUTR, V83, P1289, DOI 10.1093/ajcn/83.6.1289; Cogswell ME, 2018, JAMA-J AM MED ASSOC, V319, P1209, DOI 10.1001/jama.2018.1156; Cogswell ME, 2013, AM J CLIN NUTR, V98, P1502, DOI 10.3945/ajcn.113.059436; Cook NR, 2009, ARCH INTERN MED, V169, P32, DOI 10.1001/archinternmed.2008.523; Drewnowski A, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006625; Ekinci EI, 2011, DIABETES CARE, V34, P703, DOI 10.2337/dc10-1723; Estruch R, 2018, NEW ENGL J MED, V378, DOI [10.1056/NEJMoa1800389, 10.1056/nejmoa1800389]; Geleijnse JM, 2007, EUR J EPIDEMIOL, V22, P763, DOI 10.1007/s10654-007-9186-2; Graudal N, 2014, AM J HYPERTENS, V27, P1129, DOI 10.1093/ajh/hpu028; Graudal NA, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004022.pub4; Han WZ, 2015, AM J HYPERTENS, V28, P1368, DOI 10.1093/ajh/hpv037; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; HOLBROOK JT, 1984, AM J CLIN NUTR, V40, P786, DOI 10.1093/ajcn/40.4.786; KAWASAKI T, 1993, CLIN EXP PHARMACOL P, V20, P7, DOI 10.1111/j.1440-1681.1993.tb01496.x; Kotchen TA, 2013, NEW ENGL J MED, V368, P1229, DOI 10.1056/NEJMra1212606; KRISHNA GG, 1991, ANN INTERN MED, V115, P77, DOI 10.7326/0003-4819-115-2-77; KRISHNA GG, 1993, KIDNEY INT, V43, P1097, DOI 10.1038/ki.1993.154; Li N, 2013, AM HEART J, V166, P815, DOI 10.1016/j.ahj.2013.07.009; McCarron DA, 2013, AM J HYPERTENS, V26, P1218, DOI 10.1093/ajh/hpt139; Mente A, 2016, LANCET, V388, P465, DOI 10.1016/S0140-6736(16)30467-6; Mente A, 2014, NEW ENGL J MED, V371, P601, DOI 10.1056/NEJMoa1311989; Mente A, 2014, J HYPERTENS, V32, P1005, DOI 10.1097/HJH.0000000000000122; Mente A, 2009, J NUTR, V139, P743, DOI 10.3945/jn.108.098319; Mercado CI, 2017, NUTRIENTS, V9, DOI 10.3390/nu9111164; Morris RC, 2006, J AM COLL NUTR, V25, p262S, DOI 10.1080/07315724.2006.10719576; Morris RC, 1999, HYPERTENSION, V33, P18, DOI 10.1161/01.HYP.33.1.18; O'Donnell M, 2014, NEW ENGL J MED, V371, P612, DOI 10.1056/NEJMoa1311889; O'Donnell MJ, 2011, JAMA-J AM MED ASSOC, V306, P2229, DOI 10.1001/jama.2011.1729; Okayama A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011632; Palmer BF, 2015, CLIN J AM SOC NEPHRO, V10, P1050, DOI 10.2215/CJN.08580813; Penton D, 2015, PFLUG ARCH EUR J PHY, V467, P513, DOI 10.1007/s00424-014-1673-1; Pfister R, 2014, EUR J HEART FAIL, V16, P394, DOI 10.1002/ejhf.56; Powles J, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003733; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; Serra-Majem L, 2009, BRIT J NUTR, V101, pS21, DOI 10.1017/S0007114509990559; Smyth A, 2015, NEUROLOGY, V84, P2258, DOI 10.1212/WNL.0000000000001638; Stolarz-Skrzypek K, 2011, JAMA-J AM MED ASSOC, V305, P1777, DOI 10.1001/jama.2011.574; Teo K, 2013, JAMA-J AM MED ASSOC, V309, P1613, DOI 10.1001/jama.2013.3519; Teo K, 2009, AM HEART J, V158, P1, DOI 10.1016/j.ahj.2009.04.019; Thomas MC, 2011, DIABETES CARE, V34, P861, DOI 10.2337/dc10-1722; Trieu K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130247; Vasara E, 2017, NUTRIENTS, V9, DOI 10.3390/nu9040417; WHO, 2012, GUID SOD INT AD CHIL; Willey J, 2017, STROKE, V48, P2979, DOI 10.1161/STROKEAHA.117.017963; World Health Organisation, 2011, STRAT MON EV POP SOD; World Health Organization, 2012, GUID POT INT AD CHIL; Yang QH, 2011, ARCH INTERN MED, V171, P1183, DOI 10.1001/archinternmed.2011.257; Yusuf S, 2014, NEW ENGL J MED, V371, P818, DOI 10.1056/NEJMoa1311890; Yusuf S, 2011, LANCET, V378, P1231, DOI 10.1016/S0140-6736(11)61215-4	52	63	62	3	23	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 13	2019	364								l772	10.1136/bmj.l772	http://dx.doi.org/10.1136/bmj.l772			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP5VW	30867146	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000461751600003
J	Abramowicz, M; Zuccotti, G; Pflomm, JM				Abramowicz, Mark; Zuccotti, Gianna; Pflomm, Jean-Marie			Dupilumab (Dupixent) for Asthma (Reprinted from Medical Letter on Drugs and Therapeutics, vol 61, pg 6-8, 2019)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint							PERSISTENT ASTHMA						Pflomm, Jean-Marie/HDO-0765-2022					[Anonymous], 2018, MED LETT DRUGS THER, V60, P33; [Anonymous], 2017, MED LETT DRUGS THER, V59, P139; [Anonymous], 2017, MED LETT DRUGS THER, V59, P64; [Anonymous], 2016, MED LETT DRUGS THER, V58, P81; [Anonymous], 2016, MED LETT DRUGS THER, V58, P11; Castro M, 2018, NEW ENGL J MED, V378, P2486, DOI 10.1056/NEJMoa1804092; Rabe KF, 2018, NEW ENGL J MED, V378, P2475, DOI 10.1056/NEJMoa1804093; Wenzel S, 2016, LANCET, V388, P31, DOI 10.1016/S0140-6736(16)30307-5; Wenzel S, 2013, NEW ENGL J MED, V368, P2455, DOI 10.1056/NEJMoa1304048; 2019, MED LETT DRUGS THER, V61, P6	10	12	12	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 12	2019	321	10					1000	1001		10.1001/jama.2019.0080	http://dx.doi.org/10.1001/jama.2019.0080			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HO5JE	30860558				2022-12-28	WOS:000460961000018
J	Torjesen, I				Torjesen, Ingrid			Pregabalin and gabapentin: what impact will reclassification have on doctors and patients?	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Atkins V, 2018, PREG GAB CONTR CLASS; Chen TC, 2018, PHARMACOEPIDEM DR S, V27, P487, DOI 10.1002/pds.4320; IACOBUCCI G, 2017, BMJ-BRIT MED J, V358, P1454, DOI DOI 10.1136/BMJ.J4441; MAYOR S, 2018, BMJ-BRIT MED J, V363, P1454, DOI DOI 10.1136/BMJ.K4364; Morrison EE, 2017, J ROY COLL PHYS EDIN, V47, P310, DOI 10.4997/JRCPE.2017.402; Nahar LK, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5312	6	6	6	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 11	2019	364								l1107	10.1136/bmj.l1107	http://dx.doi.org/10.1136/bmj.l1107			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP5VO	30858150				2022-12-28	WOS:000461750400004
J	Rimmer, A				Rimmer, Abi			WORKFORCE RETENTION How can the NHS offer fulfilling, lifelong careers?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												arimmer@bmj.com							0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 8	2019	364								l1100	10.1136/bmj.l1100	http://dx.doi.org/10.1136/bmj.l1100			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HO6TC	30850384				2022-12-28	WOS:000461063500008
J	Tauriello, DVF				Tauriello, Daniele V. F.			From poor prognosis to promising treatment	SCIENCE			English	Editorial Material							CANCER; MEMBER; CELLS; PD-1		[Tauriello, Daniele V. F.] Barcelona Inst Sci & Technol, IRB Barcelona, Baldiri & Reixac 10, Barcelona 08028, Spain; [Tauriello, Daniele V. F.] Ctr Invest Biomed Red Canc CIBERONC, Madrid 28029, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC	Tauriello, DVF (corresponding author), Barcelona Inst Sci & Technol, IRB Barcelona, Baldiri & Reixac 10, Barcelona 08028, Spain.; Tauriello, DVF (corresponding author), Ctr Invest Biomed Red Canc CIBERONC, Madrid 28029, Spain.	daniele.tauriello@irbbarcelona.org	Tauriello, Daniele/H-4644-2018	Tauriello, Daniele/0000-0003-1522-3496				Calon A, 2012, CANCER CELL, V22, P571, DOI 10.1016/j.ccr.2012.08.013; Drost J, 2015, NATURE, V521, P43, DOI 10.1038/nature14415; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; ISHIDA Y, 1992, EMBO J, V11, P3887, DOI 10.1002/j.1460-2075.1992.tb05481.x; Iwai Y, 2002, P NATL ACAD SCI USA, V99, P12293, DOI 10.1073/pnas.192461099; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Tauriello DVF, 2018, NATURE, V554, P538, DOI 10.1038/nature25492; Tauriello DVF, 2016, TRENDS CANCER, V2, P495, DOI 10.1016/j.trecan.2016.08.001; Tauriello DVF, 2017, MOL ONCOL, V11, P97, DOI 10.1002/1878-0261.12018	11	5	5	2	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 8	2019	363	6431					1051	1051		10.1126/science.aaw3609	http://dx.doi.org/10.1126/science.aaw3609			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HO2MV	30846592				2022-12-28	WOS:000460750100031
J	Alexeev, EM; Ruiz-Tijerina, DA; Danovich, M; Hamer, MJ; Terry, DJ; Nayak, PK; Ahn, S; Pak, S; Lee, J; Sohn, JI; Molas, MR; Koperski, M; Watanabe, K; Taniguchi, T; Novoselov, KS; Gorbachev, RV; Shin, HS; Fal'ko, VI; Tartakovskii, AI				Alexeev, Evgeny M.; Ruiz-Tijerina, David A.; Danovich, Mark; Hamer, Matthew J.; Terry, Daniel J.; Nayak, Pramoda K.; Ahn, Seongjoon; Pak, Sangyeon; Lee, Juwon; Sohn, Jung Inn; Molas, Maciej R.; Koperski, Maciej; Watanabe, Kenji; Taniguchi, Takashi; Novoselov, Kostya S.; Gorbachev, Roman V.; Shin, Hyeon Suk; Fal'ko, Vladimir I.; Tartakovskii, Alexander I.			Resonantly hybridized excitons in moire superlattices in van der Waals heterostructures	NATURE			English	Article							INTERLAYER EXCITONS; GRAPHENE	Atomically thin layers of two-dimensional materials can be assembled in vertical stacks that are held together by relatively weak van der Waals forces, enabling coupling between monolayer crystals with incommensurate lattices and arbitrary mutual rotation(1,2). Consequently, an overarching periodicity emerges in the local atomic registry of the constituent crystal structures, which is known as a moire superlattice(3). In graphene/hexagonal boron nitride structures(4), the presence of a moire superlattice can lead to the observation of electronic minibands(5-7), whereas in twisted graphene bilayers its effects are enhanced by interlayer resonant conditions, resulting in a superconductor-insulator transition at magic twist angles(8). Here, using semiconducting heterostructures assembled from incommensurate molybdenum diselenide (MoSe2) and tungsten disulfide (WS2) monolayers, we demonstrate that excitonic bands can hybridize, resulting in a resonant enhancement of moire superlattice effects. MoSe2 and WS2 were chosen for the near-degeneracy of their conduction-band edges, in order to promote the hybridization of intra- and interlayer excitons. Hybridization manifests through a pronounced exciton energy shift as a periodic function of the interlayer rotation angle, which occurs as hybridized excitons are formed by holes that reside in MoSe2 binding to a twist-dependent superposition of electron states in the adjacent monolayers. For heterostructures in which the monolayer pairs are nearly aligned, resonant mixing of the electron states leads to pronounced effects of the geometrical moire pattern of the heterostructure on the dispersion and optical spectra of the hybridized excitons. Our findings underpin strategies for bandstructure engineering in semiconductor devices based on van der Waals heterostructures(9).	[Alexeev, Evgeny M.; Tartakovskii, Alexander I.] Univ Sheffield, Dept Phys & Astron, Sheffield, S Yorkshire, England; [Ruiz-Tijerina, David A.; Danovich, Mark; Hamer, Matthew J.; Terry, Daniel J.; Koperski, Maciej; Novoselov, Kostya S.; Gorbachev, Roman V.; Fal'ko, Vladimir I.] Univ Manchester, Sch Phys & Astron, Oxford Rd, Oxford, England; [Ruiz-Tijerina, David A.; Danovich, Mark; Hamer, Matthew J.; Terry, Daniel J.; Molas, Maciej R.; Koperski, Maciej; Novoselov, Kostya S.; Gorbachev, Roman V.; Fal'ko, Vladimir I.] Univ Manchester, Natl Graphene Inst, Manchester, Lancs, England; [Ruiz-Tijerina, David A.] Univ Nacl Autonoma Mexico, Ctr Nanociencias & Nanotecnol, Ensenada, Baja California, Mexico; [Nayak, Pramoda K.; Ahn, Seongjoon; Shin, Hyeon Suk] Ulsan Natl Inst Sci & Technol, Dept Energy Engn, Ulsan, South Korea; [Nayak, Pramoda K.; Ahn, Seongjoon; Shin, Hyeon Suk] Ulsan Natl Inst Sci & Technol, Dept Chem, Ulsan, South Korea; [Nayak, Pramoda K.] Indian Inst Technol Madras, Dept Phys, Chennai, Tamil Nadu, India; [Pak, Sangyeon; Lee, Juwon; Sohn, Jung Inn] Univ Oxford, Dept Engn Sci, Oxford, England; [Sohn, Jung Inn] Dongguk Univ Seoul, Div Phys & Semicond Sci, Seoul, South Korea; [Molas, Maciej R.] Univ Warsaw, Inst Expt Phys, Fac Phys, Warsaw, Poland; [Watanabe, Kenji; Taniguchi, Takashi] Natl Inst Mat Sci, Tsukuba, Ibaraki, Japan; [Gorbachev, Roman V.; Fal'ko, Vladimir I.] Henry Royce Inst Adv Mat, Manchester, Lancs, England	University of Sheffield; University of Manchester; University of Manchester; Universidad Nacional Autonoma de Mexico; Ulsan National Institute of Science & Technology (UNIST); Ulsan National Institute of Science & Technology (UNIST); Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras; University of Oxford; Dongguk University; University of Warsaw; National Institute for Materials Science	Tartakovskii, AI (corresponding author), Univ Sheffield, Dept Phys & Astron, Sheffield, S Yorkshire, England.; Fal'ko, VI (corresponding author), Univ Manchester, Sch Phys & Astron, Oxford Rd, Oxford, England.; Fal'ko, VI (corresponding author), Univ Manchester, Natl Graphene Inst, Manchester, Lancs, England.; Fal'ko, VI (corresponding author), Henry Royce Inst Adv Mat, Manchester, Lancs, England.	vladimir.falko@manchester.ac.uk; a.tartakovskii@sheffield.ac.uk	Tartakovskii, Alexander/GLU-4305-2022; Ruiz-Tijerina, David/F-8677-2015; Molas, Maciej/B-8661-2017; Ahn, Seongjoon/AAI-8547-2021; Pak, Sangyeon/K-6638-2018; Molas, Maciej/ABA-9638-2021; Shin, Hyeon Suk/E-5901-2010; Gorbachev, Roman/I-2512-2013; Novoselov, Kostya S/G-9581-2014; Koperski, Maciej/U-6206-2018	Ruiz-Tijerina, David/0000-0001-7688-2511; Molas, Maciej/0000-0002-5516-9415; Pak, Sangyeon/0000-0003-1765-3043; Molas, Maciej/0000-0002-5516-9415; Gorbachev, Roman/0000-0003-3604-5617; Novoselov, Kostya S/0000-0003-4972-5371; Koperski, Maciej/0000-0002-8301-914X; hai yan, he/0000-0003-0366-6185; Tartakovskii, Alexander/0000-0002-4169-5510; Fal'ko, Vladimir/0000-0003-0828-0310; Hamer, Matthew/0000-0003-3121-6536	European Graphene Flagship Project, EC Project 2D-SIPC [696656]; EPSRC [EP/P026850/1, EP/M012727/1, EP/N010345]; European Union's Horizon 2020 research and innovation programme under ITN Spin-NANO Marie Sklodowska-Curie grant [676108]; ERC Synergy Grant Hetero2D; Lloyd Register Foundation Nanotechnology grant; Royal Society; EPSRC; US Army Research Office; National Research Foundation by the Ministry of Science and ICT, South Korea [NRF-2017R1E1A1A01074493]; National Science Centre [UMO-2017/24/C/ST3/00119]; EPSRC CDT Graphene-NOWNANO [EP/L01548X]; Elemental Strategy Initiative by the MEXT, Japan; CREST, JST [JPMJCR15F3]; Royal Society Fellowship Scheme; EPSRC [EP/N010345/1, EP/K005014/1, EP/P025021/1] Funding Source: UKRI	European Graphene Flagship Project, EC Project 2D-SIPC; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Union's Horizon 2020 research and innovation programme under ITN Spin-NANO Marie Sklodowska-Curie grant; ERC Synergy Grant Hetero2D; Lloyd Register Foundation Nanotechnology grant; Royal Society(Royal Society of London); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); US Army Research Office; National Research Foundation by the Ministry of Science and ICT, South Korea; National Science Centre(National Science Centre, Poland); EPSRC CDT Graphene-NOWNANO(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Elemental Strategy Initiative by the MEXT, Japan; CREST, JST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Royal Society Fellowship Scheme; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We acknowledge financial support from the European Graphene Flagship Project under grant agreement 696656, EC Project 2D-SIPC and EPSRC grant EP/P026850/1. E.M.A. and A.I.T. acknowledge support from EPSRC grants EP/M012727/1 and the European Union's Horizon 2020 research and innovation programme under ITN Spin-NANO Marie Sklodowska-Curie grant agreement 676108. D.A.R.-T. and V.I.F. acknowledge support from ERC Synergy Grant Hetero2D, EPSRC EP/N010345 and the Lloyd Register Foundation Nanotechnology grant. K.S.N. acknowledges financial support from the Royal Society, EPSRC, US Army Research Office and ERC Synergy Grant Hetero2D. H.S.S. acknowledges a research fund (NRF-2017R1E1A1A01074493) from the National Research Foundation by the Ministry of Science and ICT, South Korea. M.R.M. acknowledges support from the National Science Centre (UMO-2017/24/C/ST3/00119). R.V.G. acknowledges financial support from the Royal Society Fellowship Scheme and EPSRC CDT Graphene-NOWNANO EP/L01548X. K.W. and T.T. acknowledge support from the Elemental Strategy Initiative conducted by the MEXT, Japan and the CREST (JPMJCR15F3), JST.	Alexeev EM, 2017, NANO LETT, V17, P5342, DOI 10.1021/acs.nanolett.7b01763; Cao Y, 2018, NATURE, V556, P43, DOI 10.1038/nature26160; Danovich M, 2018, PHYS REV B, V97, DOI 10.1103/PhysRevB.97.195452; Dean CR, 2013, NATURE, V497, P598, DOI 10.1038/nature12186; Deilmann T, 2018, NANO LETT, V18, P2984, DOI 10.1021/acs.nanolett.8b00438; Geim AK, 2013, NATURE, V499, P419, DOI 10.1038/nature12385; Gerber IC, 2019, PHYS REV B, V99, DOI 10.1103/PhysRevB.99.035443; Gong C, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4817409; Heo H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8372; Hsu WT, 2014, ACS NANO, V8, P2951, DOI 10.1021/nn500228r; Hunt B, 2013, SCIENCE, V340, P1427, DOI 10.1126/science.1237240; Kang J, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4774090; Tran K, 2019, NATURE, V567, P71, DOI 10.1038/s41586-019-0975-z; Kormanyos A, 2015, 2D MATER, V2, DOI 10.1088/2053-1583/2/2/022001; Kozawa D, 2016, NANO LETT, V16, P4087, DOI 10.1021/acs.nanolett.6b00801; Kunstmann J, 2018, NAT PHYS, V14, P801, DOI 10.1038/s41567-018-0123-y; KUWABARA M, 1990, APPL PHYS LETT, V56, P2396, DOI 10.1063/1.102906; Liu KH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5966; Mak KF, 2016, NAT PHOTONICS, V10, P216, DOI [10.1038/NPHOTON.2015.282, 10.1038/nphoton.2015.282]; Mishchenko A, 2014, NAT NANOTECHNOL, V9, P808, DOI [10.1038/NNANO.2014.187, 10.1038/nnano.2014.187]; Nayak PK, 2017, ACS NANO, V11, P4041, DOI 10.1021/acsnano.7b00640; Novoselov KS, 2016, SCIENCE, V353, DOI 10.1126/science.aac9439; Rivera P, 2018, NAT NANOTECHNOL, V13, P1004, DOI 10.1038/s41565-018-0193-0; Ruiz-Tijerina D. A., 2018, PREPRINT; Seyler KL, 2019, NATURE, V567, P66, DOI 10.1038/s41586-019-0957-1; Slobodeniuk A. O., 2018, PREPRINT; van der Zande AM, 2014, NANO LETT, V14, P3869, DOI 10.1021/nl501077m; van der Zande AM, 2013, NAT MATER, V12, P554, DOI [10.1038/NMAT3633, 10.1038/nmat3633]; Withers F, 2015, NAT MATER, V14, P301, DOI 10.1038/nmat4205; Wu FC, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.147401; Yu HY, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1701696; Zhai YX, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700704; Zhang N, 2018, NANO LETT, V18, P7651, DOI 10.1021/acs.nanolett.8b03266; Zhu DC, 2017, NPJ 2D MATER APPL, V1, P1, DOI 10.1038/s41699-017-0010-x	36	431	435	51	627	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 7	2019	567	7746					81	+		10.1038/s41586-019-0986-9	http://dx.doi.org/10.1038/s41586-019-0986-9			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HN8ED	30842637	Green Submitted, Green Accepted			2022-12-28	WOS:000460426900045
J	Marcandalli, J; Fiala, B; Ols, S; Perotti, M; de van der Schueren, WD; Snijder, J; Hodge, E; Benhaim, M; Ravichandran, R; Carter, L; Sheffler, W; Brunner, L; Lawrenz, M; Dubois, P; Lanzavecchia, A; Sallusto, F; Lee, KK; Veesler, D; Correnti, CE; Stewart, LJ; Baker, D; Lore, K; Perez, L; King, NP				Marcandalli, Jessica; Fiala, Brooke; Ols, Sebastian; Perotti, Michela; de van der Schueren, Willem; Snijder, Joost; Hodge, Edgar; Benhaim, Mark; Ravichandran, Rashmi; Carter, Lauren; Sheffler, Will; Brunner, Livia; Lawrenz, Maria; Dubois, Patrice; Lanzavecchia, Antonio; Sallusto, Federica; Lee, Kelly K.; Veesler, David; Correnti, Colin E.; Stewart, Lance J.; Baker, David; Lore, Karin; Perez, Laurent; King, Neil P.			Induction of Potent Neutralizing Antibody Responses by a Designed Protein Nanoparticle Vaccine for Respiratory Syncytial Virus	CELL			English	Article							FUSION-GLYCOPROTEIN VACCINE; RATIONAL DESIGN; ACCURATE DESIGN; INFECTION; MALARIA; IMMUNOGENICITY; MICROSCOPY; PARTICLES; IMMUNITY; CELLS	Respiratory syncytial virus (RSV) is a worldwide public health concern for which no vaccine is available. Elucidation of the prefusion structure of the RSV F glycoprotein and its identification as the main target of neutralizing antibodies have provided new opportunities for development of an effective vaccine. Here, we describe the structure-based design of a self-assembling protein nanoparticle presenting a prefusion-stabilized variant of the F glycoprotein trimer (DS-Cav1) in a repetitive array on the nanoparticle exterior. The two-component nature of the nanoparticle scaffold enabled the production of highly ordered, monodisperse immunogens that display DS-Cav1 at controllable density. In mice and nonhuman primates, the full-valency nanoparticle immunogen displaying 20 DS-Cav1 trimers induced neutralizing antibody responses similar to 10-fold higher than trimeric DS-Cav1. These results motivate continued development of this promising nanoparticle RSV vaccine candidate and establish computationally designed two-component nanoparticles as a robust and customizable platform for structure-based vaccine design.	[Marcandalli, Jessica; Perotti, Michela; Lanzavecchia, Antonio; Sallusto, Federica; Perez, Laurent] Univ Svizzera Italiana, Inst Res Biomed, Fac Biomed Sci, Bellinzona, Switzerland; [Fiala, Brooke; Snijder, Joost; Ravichandran, Rashmi; Carter, Lauren; Sheffler, Will; Veesler, David; Stewart, Lance J.; Baker, David; King, Neil P.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Fiala, Brooke; Ravichandran, Rashmi; Carter, Lauren; Sheffler, Will; Stewart, Lance J.; Baker, David; King, Neil P.] Univ Washington, Inst Prot Design, Seattle, WA 98195 USA; [Ols, Sebastian; Lore, Karin] Karolinska Inst, Div Immunol & Allergy, Dept Med Solna, Stockholm, Sweden; [Ols, Sebastian; Lore, Karin] Karolinska Inst, Ctr Mol Med, Stockholm, Sweden; [Perotti, Michela; Sallusto, Federica] Swiss Fed Inst Technol, Inst Microbiol, Zurich, Switzerland; [de van der Schueren, Willem; Correnti, Colin E.] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA; [Hodge, Edgar; Benhaim, Mark; Lee, Kelly K.] Univ Washington, Dept Med Chem, Seattle, WA 98195 USA; [Brunner, Livia] Univ Lausanne, Vaccine Formulat Lab, Epalinges, Switzerland; [Lawrenz, Maria; Dubois, Patrice] Vaccine Formulat Inst, Godalming, Surrey, England; [Lee, Kelly K.] Univ Washington, Biol Phys Struct & Design Program, Seattle, WA 98195 USA; [Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Perez, Laurent] European Virus Bioinformat Ctr, Jena, Germany; [de van der Schueren, Willem] Bluebird Bio, Seattle, WA USA	Universita della Svizzera Italiana; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Karolinska Institutet; Karolinska Institutet; Swiss Federal Institutes of Technology Domain; ETH Zurich; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Lausanne; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Perez, L (corresponding author), Univ Svizzera Italiana, Inst Res Biomed, Fac Biomed Sci, Bellinzona, Switzerland.; King, NP (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.; King, NP (corresponding author), Univ Washington, Inst Prot Design, Seattle, WA 98195 USA.; Perez, L (corresponding author), European Virus Bioinformat Ctr, Jena, Germany.	laurent.perez@irb.usi.ch; neilking@uw.edu	Veesler, David/HCH-3986-2022; Perez, Laurent/ABA-4145-2021	Perez, Laurent/0000-0002-8860-7928; Ols, Sebastian/0000-0001-9784-7176	Bill and Melinda Gates Foundation [OPP1120319, OPP1126258, OPP1162875]; state of Washington; Howard Hughes Medical Institute; Netherlands Organization for Scientific Research (NWO) [Rubicon 019.2015.2.310.006]; European Molecular Biology Organisation (EMBO) [ALTF 933-2015]; Swedish Research Council [Vetenskapsradet 2015-02608]; Karolinska Institutet; NIAID [HHSN272201700059C]; NIGMS [R01GM120553]; Pew Biomedical Scholars Award; Investigators in the Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI140868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008268, R01GM120553, R01GM099989] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); state of Washington; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); European Molecular Biology Organisation (EMBO)(European Molecular Biology Organization (EMBO)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet(Karolinska Institutet); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Pew Biomedical Scholars Award; Investigators in the Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors wish to thank Ratika Krishnamurty for project management support and helpful suggestions, David Jarrossay for scientific advice with flow cytometry data acquisition and cell sorting, the IRB animal house for supporting immunization studies, Drs. Mats Spangberg and Bengt Eriksson and their personnel at the Astrid Fagraeus laboratory at Karolinska Institutet for expert assistance and care of the nonhuman primates, Daniel Ellis for advice in protein production and in vitro assembly, Barney Graham for helpful discussions and advice, and Amy Weiner and Lynda Stuart for support and advice. This work was supported by the Bill and Melinda Gates Foundation (OPP1120319 to D.B., N.P.K., L.P., and K.L.; OPP1126258 to K.K.L.; OPP1162875 to P.D.), the state of Washington (to D.B.), the Howard Hughes Medical Institute (to D.B.), the Netherlands Organization for Scientific Research (NWO; Rubicon 019.2015.2.310.006 to J.S.), the European Molecular Biology Organisation (EMBO; ALTF 933-2015 to J.S.), the Swedish Research Council (Vetenskapsradet 2015-02608 to K.L.), an intramural faculty salary grant from Karolinska Institutet (to S.O.), NIAID (HHSN272201700059C to D.V.), NIGMS (R01GM120553 to D.V.), a Pew Biomedical Scholars Award (to D.V.), and an Investigators in the Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund (to D.V.).	Abbott RK, 2018, IMMUNITY, V48, P133, DOI 10.1016/j.immuni.2017.11.023; Afonso CL, 2016, ARCH VIROL, V161, P2351, DOI 10.1007/s00705-016-2880-1; Aide P, 2011, VACCINE, V29, P6059, DOI 10.1016/j.vaccine.2011.03.041; August A, 2017, VACCINE, V35, P3749, DOI 10.1016/j.vaccine.2017.05.045; Bachmann MF, 2010, NAT REV IMMUNOL, V10, P787, DOI 10.1038/nri2868; Bale JB, 2016, SCIENCE, V353, P389, DOI 10.1126/science.aaf8818; Bandaranayake AD, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr706; Blanco JCG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04216-6; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Collins KA, 2017, SCI REP-UK, V7, DOI 10.1038/srep46621; Collins PL, 2013, CURR TOP MICROBIOL, V372, P3, DOI 10.1007/978-3-642-38919-1_1; Corti D, 2013, NATURE, V501, P439, DOI 10.1038/nature12442; Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004; Duan HY, 2018, IMMUNITY, V49, P301, DOI 10.1016/j.immuni.2018.07.005; Falsey AR, 1998, J INFECT DIS, V177, P463, DOI 10.1086/517376; Frietze KM, 2016, CURR OPIN VIROL, V18, P44, DOI 10.1016/j.coviro.2016.03.001; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gause KT, 2017, ACS NANO, V11, P54, DOI 10.1021/acsnano.6b07343; Gilman MSA, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aaj1879; GLEZEN WP, 1986, AM J DIS CHILD, V140, P543, DOI 10.1001/archpedi.1986.02140200053026; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; Graham BS, 2016, VACCINE, V34, P3535, DOI 10.1016/j.vaccine.2016.04.083; Guttman M, 2013, J AM SOC MASS SPECTR, V24, P1906, DOI 10.1007/s13361-013-0727-5; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Harrison SC, 2015, VIROLOGY, V479, P498, DOI 10.1016/j.virol.2015.03.043; He LL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12041; Huang PS, 2016, NATURE, V537, P320, DOI 10.1038/nature19946; Irvine DJ, 2015, CHEM REV, V115, P11109, DOI 10.1021/acs.chemrev.5b00109; Irvine DJ, 2013, NAT MATER, V12, P978, DOI [10.1038/NMAT3775, 10.1038/nmat3775]; Jardine JG, 2015, SCIENCE, V349, P156, DOI 10.1126/science.aac5894; Joyce MG, 2016, NAT STRUCT MOL BIOL, V23, P811, DOI 10.1038/nsmb.3267; Kanekiyo M, 2015, CELL, V162, P1090, DOI 10.1016/j.cell.2015.07.043; Kanekiyo M, 2013, NATURE, V499, P102, DOI 10.1038/nature12202; Kimanius D, 2016, ELIFE, V5, DOI 10.7554/eLife.18722; King NP, 2014, NATURE, V510, P103, DOI 10.1038/nature13404; King NP, 2012, SCIENCE, V336, P1171, DOI 10.1126/science.1219364; Krarup A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9143; Kwakkenbos MJ, 2010, NAT MED, V16, P123, DOI 10.1038/nm.2071; Langley JM, 2017, J INFECT DIS, V215, P24, DOI 10.1093/infdis/jiw453; Lopez-Sagaseta J, 2016, COMPUT STRUCT BIOTEC, V14, P58, DOI 10.1016/j.csbj.2015.11.001; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Magro M, 2012, P NATL ACAD SCI USA, V109, P3089, DOI 10.1073/pnas.1115941109; McGuire AT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10618; McLellan JS, 2013, SCIENCE, V342, P592, DOI 10.1126/science.1243283; McLellan JS, 2013, SCIENCE, V340, P1113, DOI 10.1126/science.1234914; McLellan JS, 2011, J VIROL, V85, P7788, DOI 10.1128/JVI.00555-11; Moon JJ, 2012, P NATL ACAD SCI USA, V109, P1080, DOI 10.1073/pnas.1112648109; Ngwuta JO, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4241; Palomo C, 2016, J VIROL, V90, P5485, DOI 10.1128/JVI.00338-16; Piedra PA, 2003, VACCINE, V21, P3479, DOI 10.1016/S0264-410X(03)00355-4; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Schrodinger L.L.C.,, 2015, PYMOL MOL GRAPHICS S; Sliepen K, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0210-4; Smith G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050852; Snijder J, 2017, J STRUCT BIOL, V198, P38, DOI 10.1016/j.jsb.2017.02.008; Steff AM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01092-4; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Swanson KA, 2011, P NATL ACAD SCI USA, V108, P9619, DOI 10.1073/pnas.1106536108; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Ventura R, 2013, VACCINE, V31, P1641, DOI 10.1016/j.vaccine.2012.07.074; Verkerke HP, 2016, J VIROL, V90, P9471, DOI 10.1128/JVI.01351-16; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; Weis DD, 2006, J AM SOC MASS SPECTR, V17, P1700, DOI 10.1016/j.jasms.2006.07.025; Wen XW, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.272; Widmer K, 2012, J INFECT DIS, V206, P56, DOI 10.1093/infdis/jis309; Yassine HM, 2015, NAT MED, V21, P1065, DOI 10.1038/nm.3927; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	68	186	193	15	89	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 7	2019	176	6					1420	+		10.1016/j.cell.2019.01.046	http://dx.doi.org/10.1016/j.cell.2019.01.046			29	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	HN9HD	30849373	Green Published, hybrid			2022-12-28	WOS:000460509600016
J	Payne, D; Safayi, S; Persson, T; Blackford, S; Hilditch-Maguire, P; Matrone, M				Payne, David; Safayi, Sina; Persson, Tina; Blackford, Sarah; Hilditch-Maguire, Paige; Matrone, Michael			Insider knowledge	NATURE			English	Editorial Material									[Safayi, Sina] Rush Univ, Student Profess Dev, Chicago, IL 60612 USA; [Hilditch-Maguire, Paige] Queensland Univ Technol, Grad Res Educ & Dev, Brisbane, Qld, Australia; [Matrone, Michael] Univ Calif San Francisco, Off Career & Profess Dev, San Francisco, CA 94143 USA	Rush University; Queensland University of Technology (QUT); University of California System; University of California San Francisco			Safayi, Sina/H-7978-2013	Safayi, Sina/0000-0002-1783-9713					0	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 7	2019	567	7746					135	137		10.1038/d41586-019-00747-0	http://dx.doi.org/10.1038/d41586-019-00747-0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HN8ED	30837728	Bronze			2022-12-28	WOS:000460426900058
J	Smallman, M				Smallman, Melanie			Policies designed for drugs won't work for AI	NATURE			English	Editorial Material									[Smallman, Melanie] UCL, Responsible Res & Innovat Hub, London, England	University of London; University College London	Smallman, M (corresponding author), UCL, Responsible Res & Innovat Hub, London, England.	m.smallman@ucl.ac.uk							0	7	7	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 7	2019	567	7746					7	7		10.1038/d41586-019-00737-2	http://dx.doi.org/10.1038/d41586-019-00737-2			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HN8ED	30842640	Green Submitted, Bronze			2022-12-28	WOS:000460426900013
J	Tanne, JH				Tanne, Janice Hopkins			Scott Gottlieb resigns as head of FDA	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Kaplan S, 2019, NY TIMES; LENZER J, 2017, BMJ-BRIT MED J, V356, DOI DOI 10.1136/BMJ.J1339; Straehley S, 2017, COMMISSIONER FOOD DR	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 7	2019	364								l1086	10.1136/bmj.l1086	http://dx.doi.org/10.1136/bmj.l1086			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HO6TA	30846430				2022-12-28	WOS:000461063200011
J	Cook, R; Davidson, P; Martin, R				Cook, Rob; Davidson, Peter; Martin, Rosie		NIHR Dissemination Ctr	NIHR SIGNALS Adrenaline can restart the heart, but is no good for the brain	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material								The study A randomised trial of epinephrine in out-of-hospital cardiac arrest Perkins GD, Ji C, Deakin CD, Quinn T, Nolan JP, Scomparin C, Regan S, Long J, Slowther A, Pocock H, Black JJM, Moore F, Fothergill RT, Rees N, O'Shea L, Docherty M, Gunson I, Han K, Charlton K, Finn J, Petrou S, Stallard N, Gates S, Lall R for the PARAMEDIC2 Collaborators Published on 18 July 2018 N Engl J Med 2018; 379: 711-21. This project was funded by the National Institute for Health Research HTA Programme (project number 12/127/126). To read the full NIHR Signal, go to: https://discover.dc.nihr.ac.uk/content/signal-000639/adrenaline-can-restart-the-heart-but-is-no-good-for-thebrain	[Cook, Rob; Martin, Rosie] Bazian, Intelligence Unit Healthcare, London, England; [Davidson, Peter] Univ Southampton, Wessex Inst, Southampton, Hants, England	University of Southampton	Cook, R (corresponding author), Bazian, Intelligence Unit Healthcare, London, England.	rob.cook@bazian.com		Cook, Robert/0000-0002-2210-3989				Deakin C, 2015, PREHOSPITAL RESUSCIT; Monsieurs KG, 2015, RESUSCITATION, V95, P1, DOI 10.1016/j.resuscitation.2015.07.038; Resuscitation Council (UK), 2017, RES REC; Soar J, 2015, ADULT ADV LIFE SUPPO	4	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 4	2019	364								k4259	10.1136/bmj.k4259	http://dx.doi.org/10.1136/bmj.k4259			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HO6SQ	30833377	Green Accepted			2022-12-28	WOS:000461061900013
J	Chaccour, C; Rabinovich, NR				Chaccour, Carlos; Rabinovich, N. Regina			Advancing the repurposing of ivermectin for malaria	LANCET			English	Editorial Material									[Chaccour, Carlos; Rabinovich, N. Regina] Univ Barcelona, Hosp Clin, ISGlobal, Barcelona, Spain; [Chaccour, Carlos] Univ Navarra, Inst Salud Trop, Pamplona, Spain; [Chaccour, Carlos] Ifakara Hlth Inst, Ifakara, Tanzania; [Rabinovich, N. Regina] Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA	ISGlobal; University of Barcelona; Hospital Clinic de Barcelona; University of Navarra; Ifakara Health Institute; Harvard University; Harvard T.H. Chan School of Public Health	Rabinovich, NR (corresponding author), Univ Barcelona, Hosp Clin, ISGlobal, Barcelona, Spain.; Rabinovich, NR (corresponding author), Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA.	rrabinov@hsph.harvard.edu	Chaccour, Carlos/I-4149-2018	Chaccour, Carlos/0000-0001-9812-050X				Alonso P, 2017, LANCET, V390, P2532, DOI 10.1016/S0140-6736(17)33080-5; Alonso P, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1835-7; Bill & Melinda Gates Foundation, GRANTS DAT; Chaccour C, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1801-4; Chaccour CJ, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-153; Foy BD, 2019, LANCET, V393, P1517, DOI 10.1016/S0140-6736(18)32321-3; Killeen GF, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2016-000211; Killeen GF, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2016-000198; Richards FO, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1830-z; Smit MR, 2018, LANCET INFECT DIS, V18, P615, DOI 10.1016/S1473-3099(18)30163-4; World Health Organization, 2021, GLOB TECHN STRAT MAL	11	10	10	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 13	2019	393	10180					1480	1481		10.1016/S0140-6736(18)32613-8	http://dx.doi.org/10.1016/S0140-6736(18)32613-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HU0DA	30878223	Green Published, hybrid			2022-12-28	WOS:000464940400005
J	Young, JW; Caprioli, J				Young, Jonathan W.; Caprioli, Joseph			Laser trabeculoplasty as first-line glaucoma treatment	LANCET			English	Editorial Material							INTRAOCULAR-PRESSURE; OCULAR HYPERTENSION; MULTICENTER		[Young, Jonathan W.; Caprioli, Joseph] Univ Calif Los Angeles, Stein Eye Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Caprioli, J (corresponding author), Univ Calif Los Angeles, Stein Eye Inst, Los Angeles, CA 90095 USA.	caprioli@jsei.ucla.edu						BECKMAN H, 1990, OPHTHALMOLOGY, V97, P1403; Damji KF, 2003, CAN J OPHTHALMOL, V38, P189, DOI 10.1016/S0008-4182(03)80060-1; Gazzard G, 2019, LANCET, V393, P1505, DOI 10.1016/S0140-6736(18)32213-X; Gazzard G, 2018, BRIT J OPHTHALMOL, V102, P593, DOI 10.1136/bjophthalmol-2017-310877; Juzych MS, 2004, OPHTHALMOLOGY, V111, P1853, DOI 10.1016/j.ophtha.2004.04.030; Katz LJ, 2012, J GLAUCOMA, V21, P460, DOI 10.1097/IJG.0b013e318218287f; Latina MA, 1998, OPHTHALMOLOGY, V105, P2082, DOI 10.1016/S0161-6420(98)91129-0; Nagar M, 2005, BRIT J OPHTHALMOL, V89, P1413, DOI 10.1136/bjo.2004.052795; Richard, 2010, J NURSING HEALTHCARE, V2, P63, DOI [10.1111/j.1752-9824.2010.01048.x, DOI 10.1111/J.1752-9824.2010.01048.X]; SHINGLETON BJ, 1993, OPHTHALMOLOGY, V100, P1324	10	5	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 13	2019	393	10180					1479	1480		10.1016/S0140-6736(18)32553-4	http://dx.doi.org/10.1016/S0140-6736(18)32553-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HU0DA	30862378	hybrid			2022-12-28	WOS:000464940400004
J	Yan, RH; Zhao, X; Lei, JL; Zhou, Q				Yan, Renhong; Zhao, Xin; Lei, Jianlin; Zhou, Qiang			Structure of the human LAT1-4F2hc heteromeric amino acid transporter complex	NATURE			English	Article							MECHANISM; SYSTEM; LAT1; EXPRESSION	The L-type amino acid transporter 1 (LAT1; also known as SLC7A5) catalyses the cross-membrane flux of large neutral amino acids in a sodium-and pH-independent manner(1-3). LAT1, an antiporter of the amino acid-polyamine-organocation superfamily, also catalyses the permeation of thyroid hormones, pharmaceutical drugs, and hormone precursors such as l-3, 4-dihydroxyphenylalanine across membranes(2-6). Overexpression of LAT1 has been observed in a wide range of tumour cells, and it is thus a potential target for anti-cancer drugs(7-11). LAT1 forms a heteromeric amino acid transporter complex with 4F2 cellsurface antigen heavy chain (4F2hc; also known as SLC3A2)-a type II membrane glycoprotein that is essential for the stability of LAT1 and for its localization to the plasma membrane(8,9). Despite extensive cell-based characterization of the LAT1-4F2hc complex and structural determination of its homologues in bacteria, the interactions between LAT1 and 4F2hc and the working mechanism of the complex remain largely unknown(12-19). Here we report the cryo-electron microscopy structures of human LAT1-4F2hc alone and in complex with the inhibitor 2-amino-2-norbornanecarboxylic acid at resolutions of 3.3 A and 3.5 A, respectively. LAT1 exhibits an inward open conformation. Besides a disulfide bond association, LAT1 also interacts extensively with 4F2hc on the extracellular side, within the membrane, and on the intracellular side. Biochemical analysis reveals that 4F2hc is essential for the transport activity of the complex. Together, our characterizations shed light on the architecture of the LAT1-4F2hc complex, and provide insights into its function and the mechanisms through which it might be associated with disease.	[Yan, Renhong; Zhao, Xin] Tsinghua Univ, Beijing Adv Innovat Ctr Struct Biol, Tsinghua Peking Joint Ctr Life Sci, Sch Life Sci, Beijing, Peoples R China; [Lei, Jianlin] Tsinghua Univ, Technol Ctr Prot Sci, Minist Educ, Sch Life Sci,Key Lab Prot Sci, Beijing, Peoples R China; [Zhou, Qiang] Westlake Univ, Sch Life Sci, Inst Biol, Westlake Inst Adv Study, Hangzhou, Zhejiang, Peoples R China	Tsinghua University; Tsinghua University; Westlake University	Zhou, Q (corresponding author), Westlake Univ, Sch Life Sci, Inst Biol, Westlake Inst Adv Study, Hangzhou, Zhejiang, Peoples R China.	zhouqiang@westlake.edu.cn		Yan, Renhong/0000-0002-7122-6547	National Key Basic Research (973) Program [2015CB910101]; National Key R&D Program from the Ministry of Science and Technology of China [2016YFA0500402]; National Natural Science Foundation of China [31621092, 31630017, 81861138009]	National Key Basic Research (973) Program(National Basic Research Program of China); National Key R&D Program from the Ministry of Science and Technology of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank the Tsinghua University branch of China National Center for Protein Sciences (Beijing) for cryo-EM and computational facility support, and X. Li for technical support in electron microscopy data acquisition. This work was funded by the National Key Basic Research (973) Program (2015CB910101) and the National Key R&D Program (2016YFA0500402) from the Ministry of Science and Technology of China, and by the National Natural Science Foundation of China (projects 31621092, 31630017, and 81861138009).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; del Amo EM, 2008, EUR J PHARM SCI, V35, P161, DOI 10.1016/j.ejps.2008.06.015; Dickens D, 2017, SCI REP-UK, V7, DOI 10.1038/srep43580; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fang YL, 2009, NATURE, V460, P1040, DOI 10.1038/nature08201; Fort J, 2007, J BIOL CHEM, V282, P31444, DOI 10.1074/jbc.M704524200; Fotiadis D, 2013, MOL ASPECTS MED, V34, P139, DOI 10.1016/j.mam.2012.10.007; Friesema ECH, 2001, ENDOCRINOLOGY, V142, P4339, DOI 10.1210/en.142.10.4339; Gao X, 2010, NATURE, V463, P828, DOI 10.1038/nature08741; Gao X, 2009, SCIENCE, V324, P1565, DOI 10.1126/science.1173654; GARCIA ML, 1983, BIOCHEMISTRY-US, V22, P2524, DOI 10.1021/bi00279a033; Gong DS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06075-7; Grant T, 2015, ELIFE, V4, DOI 10.7554/eLife.06980; Jungnickel KEJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03066-6; Kageyama T, 2000, BRAIN RES, V879, P115, DOI 10.1016/S0006-8993(00)02758-X; Kanai Y, 1998, J BIOL CHEM, V273, P23629, DOI 10.1074/jbc.273.37.23629; Kandasamy P, 2018, TRENDS BIOCHEM SCI, V43, P752, DOI 10.1016/j.tibs.2018.05.003; Kim D, 2002, BBA-BIOMEMBRANES, V1565, P112, DOI 10.1016/S0005-2736(02)00516-3; Kimanius D, 2016, ELIFE, V5, DOI 10.7554/eLife.18722; Lei JL, 2005, J STRUCT BIOL, V150, P69, DOI 10.1016/j.jsb.2005.01.002; Ma D, 2012, NATURE, V483, P632, DOI 10.1038/nature10917; Meury M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109882; Napolitano L, 2017, BBA-GEN SUBJECTS, V1861, P727, DOI 10.1016/j.bbagen.2017.01.013; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rosell A, 2014, P NATL ACAD SCI USA, V111, P2966, DOI 10.1073/pnas.1323779111; Scalise M, 2018, FRONT CHEM, V6, DOI 10.3389/fchem.2018.00243; Scheres SHW, 2015, J STRUCT BIOL, V189, P114, DOI 10.1016/j.jsb.2014.11.010; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, J MOL BIOL, V415, P406, DOI 10.1016/j.jmb.2011.11.010; Tarlungeanu DC, 2016, CELL, V167, P1481, DOI 10.1016/j.cell.2016.11.013; Verrey F, 2004, PFLUG ARCH EUR J PHY, V447, P532, DOI 10.1007/s00424-003-1086-z; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yanagida O, 2001, BBA-BIOMEMBRANES, V1514, P291, DOI 10.1016/S0005-2736(01)00384-4; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zhou NY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02725-w	38	137	140	15	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 4	2019	568	7750					127	+		10.1038/s41586-019-1011-z	http://dx.doi.org/10.1038/s41586-019-1011-z			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HR8CZ	30867591				2022-12-28	WOS:000463384900053
J	Bhutta, ZA; Black, RE				Bhutta, Zulfiqar A.; Black, Robert E.			Current and Future Challenges for Children Across the World	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Bhutta, Zulfiqar A.] Hosp Sick Children, Ctr Global Child Hlth, 686 Bay St,Ste 11-9805, Toronto, ON M5G 0A4, Canada; [Bhutta, Zulfiqar A.] Aga Khan Univ, Ctr Excellence Women & Child Hlth, Karachi, Pakistan; [Black, Robert E.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Aga Khan University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Bhutta, ZA (corresponding author), Hosp Sick Children, Ctr Global Child Hlth, 686 Bay St,Ste 11-9805, Toronto, ON M5G 0A4, Canada.	Zulfiqar.bhutta@sickkids.ca	Bhutta, Zulfiqar/L-7822-2015	Bhutta, Zulfiqar/0000-0003-0637-599X				Bhutta ZA, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4884; Burke M, 2016, LANCET GLOB HEALTH, V4, pE936, DOI [10.1016/s2214-109x(16)30212-1, 10.1016/S2214-109X(16)30212-1]; Ghebreyesus TA, TRANSFORMING IMPACT; Jimba M, 2018, LANCET, V392, P2551, DOI 10.1016/S0140-6736(18)32518-2; Kim JY, 2018, FOREIGN AFFAIRS; Kristoff N, 2019, NY TIMES; UN Interagency Group on Mortality Estimation, 2018, LEV TRENDS CHILD MOR; United Nations, SUST DEV AG 17 GOALS; Vaivada T, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2016-4308; World Health Organization, 2019, DRAFT RES PRIM HLTH	10	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 2	2019	321	13					1251	1252		10.1001/jama.2019.1840	http://dx.doi.org/10.1001/jama.2019.1840			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HR3XR	30882845				2022-12-28	WOS:000463076800009
J	Obradovic, MMS; Hamelin, B; Manevski, N; Couto, JP; Sethi, A; Coissieux, MM; Munst, S; Okamoto, R; Kohler, H; Schmidt, A; Bentires-Alj, M				Obradovic, Milan M. S.; Hamelin, Baptiste; Manevski, Nenad; Couto, Joana Pinto; Sethi, Atul; Coissieux, Marie-May; Munst, Simone; Okamoto, Ryoko; Kohler, Hubertus; Schmidt, Alexander; Bentires-Alj, Mohamed			Glucocorticoids promote breast cancer metastasis	NATURE			English	Article							TUMOR HETEROGENEITY; INHIBITION; RECEPTOR; GROWTH; QUANTIFICATION; GENOMICS; REVEALS; PATHWAY; WOMEN	Diversity within or between tumours and metastases (known as intra-patient tumour heterogeneity) that develops during disease progression is a serious hurdle for therapy(1-3). Metastasis is the fatal hallmark of cancer and the mechanisms of colonization, the most complex step in the metastatic cascade(4), remain poorly defined. A clearer understanding of the cellular and molecular processes that underlie both intra-patient tumour heterogeneity and metastasis is crucial for the success of personalized cancer therapy. Here, using transcriptional profiling of tumours and matched metastases in patient-derived xenograft models in mice, we show cancer-site-specific phenotypes and increased glucocorticoid receptor activity in distant metastases. The glucocorticoid receptor mediates the effects of stress hormones, and of synthetic derivatives of these hormones that are used widely in the clinic as anti-inflammatory and immunosuppressive agents. We show that the increase in stress hormones during breast cancer progression results in the activation of the glucocorticoid receptor at distant metastatic sites, increased colonization and reduced survival. Our transcriptomics, proteomics and phospho-proteomics studies implicate the glucocorticoid receptor in the activation of multiple processes in metastasis and in the increased expression of kinase ROR1, both of which correlate with reduced survival. The ablation of ROR1 reduced metastatic outgrowth and prolonged survival in preclinical models. Our results indicate that the activation of the glucocorticoid receptor increases heterogeneity and metastasis, which suggests that caution is needed when using glucocorticoids to treat patients with breast cancer who have developed cancer-related complications.	[Obradovic, Milan M. S.; Hamelin, Baptiste; Couto, Joana Pinto; Sethi, Atul; Coissieux, Marie-May; Okamoto, Ryoko; Bentires-Alj, Mohamed] Univ Basel, Dept Biomed, Dept Surg, Univ Basel Hosp, Basel, Switzerland; [Obradovic, Milan M. S.; Couto, Joana Pinto; Sethi, Atul; Coissieux, Marie-May; Okamoto, Ryoko; Kohler, Hubertus; Bentires-Alj, Mohamed] Friedrich Miescher Inst Biomed Res, Basel, Switzerland; [Manevski, Nenad] Univ Helsinki, Div Pharmaceut Chem & Technol, Fac Pharm, Helsinki, Finland; [Sethi, Atul] Swiss Inst Bioinformat, Basel, Switzerland; [Munst, Simone] Univ Basel, Inst Pathol, Univ Basel Hosp, Basel, Switzerland; [Schmidt, Alexander] Univ Basel, Prote Core Facil, Biozentrum, Basel, Switzerland; [Obradovic, Milan M. S.] Wellmera AG, Basel, Switzerland; [Manevski, Nenad] UCB Celltech, Dev Sci, Slough, Berks, England; [Couto, Joana Pinto] Novartis Inst BioMed Res, Basel, Switzerland	University of Basel; Friedrich Miescher Institute for Biomedical Research; University of Helsinki; Swiss Institute of Bioinformatics; University of Basel; University of Basel; Celltech Group Ltd; Novartis	Bentires-Alj, M (corresponding author), Univ Basel, Dept Biomed, Dept Surg, Univ Basel Hosp, Basel, Switzerland.; Bentires-Alj, M (corresponding author), Friedrich Miescher Inst Biomed Res, Basel, Switzerland.	m.bentires-alj@unibas.ch	; Bentires-Alj, Mohamed/F-4484-2015	Coissieux, Marie-May/0000-0001-5017-5253; Obradovic, Milan/0000-0002-6313-6226; Muenst, Simone/0000-0001-7973-1401; Bentires-Alj, Mohamed/0000-0001-6344-1127	National Cancer Institute; Swiss Initiative for Systems Biology-SystemsX; European Research Council; Swiss National Science Foundation; Novartis; Krebsliga Beider Basel; Swiss Cancer League; Swiss Personalized Health Network (Swiss Personalized Oncology driver project); Department of Surgery of the University Hospital Basel	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Swiss Initiative for Systems Biology-SystemsX; European Research Council(European Research Council (ERC)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novartis(Novartis); Krebsliga Beider Basel; Swiss Cancer League; Swiss Personalized Health Network (Swiss Personalized Oncology driver project); Department of Surgery of the University Hospital Basel	We thank members of the Bentires-Alj laboratory for advice and discussion. Tissue samples that correspond to PDX1, PDX2 and PDX4-PDX11 were provided by the Cooperative Human Tissue Network, which is funded by the National Cancer Institute. Other investigators may have received specimens from the same subjects. We thank A. L. Welm (University of Utah) for the PDX3 and PDX12-PDX16 models; H.-R. Hotz for offering the QuasR and edgeR tools in the FMI Galaxy server; and S. Bichet and P. Hirschmann for help with immunohistochemistry. We are grateful for the support of the FMI, DBM and Biozentrum core facilities. Research in the Bentires-Alj laboratory is supported by the Swiss Initiative for Systems Biology-SystemsX, the European Research Council, the Swiss National Science Foundation, Novartis, the Krebsliga Beider Basel, the Swiss Cancer League, the Swiss Personalized Health Network (Swiss Personalized Oncology driver project) and the Department of Surgery of the University Hospital Basel.	Ahrne E, 2016, J PROTEOME RES, V15, P2537, DOI 10.1021/acs.jproteome.6b00066; Alizadeh AA, 2015, NAT MED, V21, P846, DOI 10.1038/nm.3915; Almendro V, 2013, ANNU REV PATHOL-MECH, V8, P277, DOI 10.1146/annurev-pathol-020712-163923; Arora VK, 2013, CELL, V155, P1309, DOI 10.1016/j.cell.2013.11.012; Balwierz PJ, 2014, GENOME RES, V24, P869, DOI 10.1101/gr.169508.113; Bonapace L, 2014, NATURE, V515, DOI 10.1038/nature13862; Bonapace L, 2012, J MAMMARY GLAND BIOL, V17, P125, DOI 10.1007/s10911-012-9250-8; Braun S, 2005, NEW ENGL J MED, V353, P793, DOI 10.1056/NEJMoa050434; Britschgi A, 2017, NATURE, V541, P541, DOI 10.1038/nature20829; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chaffer CL, 2016, CANCER METAST REV, V35, P645, DOI 10.1007/s10555-016-9648-7; Chien HP, 2016, VIRCHOWS ARCH, V468, P589, DOI 10.1007/s00428-016-1911-3; Cui B, 2013, CANCER RES, V73, P3649, DOI 10.1158/0008-5472.CAN-12-3832; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; DeRose YS, 2011, NAT MED, V17, P1514, DOI 10.1038/nm.2454; Gaidatzis D, 2015, BIOINFORMATICS, V31, P1130, DOI 10.1093/bioinformatics/btu781; Gao H, 2015, NAT MED, V21, P1318, DOI 10.1038/nm.3954; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hosseini H, 2016, NATURE, V540, P552, DOI 10.1038/nature20785; Koren S, 2015, MOL CELL, V60, P537, DOI 10.1016/j.molcel.2015.10.031; Lawson DA, 2015, NATURE, V526, P131, DOI 10.1038/nature15260; Li CL, 2017, NAT CELL BIOL, V19, P106, DOI 10.1038/ncb3464; Lindstrom LS, 2012, J CLIN ONCOL, V30, P2601, DOI 10.1200/JCO.2011.37.2482; Liu JL, 2018, J PATHOL, V244, P71, DOI 10.1002/path.4995; Marotta LLC, 2011, J CLIN INVEST, V121, P2723, DOI 10.1172/JCI44745; Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261; Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624; Obenauf AC, 2015, TRENDS CANCER, V1, P76, DOI 10.1016/j.trecan.2015.07.009; Pang D, 2006, CANCER BIOL THER, V5, P933, DOI 10.4161/cbt.5.8.2875; Pereira B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11479; Polzer B, 2013, NAT MED, V19, P274, DOI 10.1038/nm.3121; Pongor L, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0228-1; Post H, 2017, J PROTEOME RES, V16, P728, DOI 10.1021/acs.jproteome.6b00753; Robinson DR, 2017, NATURE, V548, P297, DOI 10.1038/nature23306; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saxena M, 2013, MOL ONCOL, V7, P283, DOI 10.1016/j.molonc.2013.02.009; Sephton SE, 2000, J NATL CANCER I, V92, P994, DOI 10.1093/jnci/92.12.994; Skor MN, 2013, CLIN CANCER RES, V19, P6163, DOI 10.1158/1078-0432.CCR-12-3826; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; vanderPompe G, 1996, PSYCHONEUROENDOCRINO, V21, P361, DOI 10.1016/0306-4530(96)00009-1; Vanharanta S, 2013, CANCER CELL, V24, P410, DOI 10.1016/j.ccr.2013.09.007; Wang YX, 2011, PROTEOMICS, V11, P2019, DOI 10.1002/pmic.201000722; West DC, 2018, CLIN CANCER RES, V24, P3433, DOI 10.1158/1078-0432.CCR-17-2793; Wyckoff Jeffrey, 2011, Cold Spring Harb Protoc, V2011, P1167, DOI 10.1101/pdb.top065904	46	177	183	4	150	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 28	2019	567	7749					540	+		10.1038/s41586-019-1019-4	http://dx.doi.org/10.1038/s41586-019-1019-4			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HQ8EC	30867597	Green Accepted			2022-12-28	WOS:000462655800053
J	Moran, LV; Ongur, D; Hsu, J; Castro, VM; Perlis, RH; Schneeweiss, S				Moran, Lauren V.; Ongur, Dost; Hsu, John; Castro, Victor M.; Perlis, Roy H.; Schneeweiss, Sebastian			Psychosis with Methylphenidate or Amphetamine in Patients with ADHD	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; STIMULANT MEDICATION; COLLEGE-STUDENTS; DOPAMINE; SYMPTOMS; CHILDREN; INHIBITORS; SEROTONIN; DIVERSION; PATTERNS	Background The prescription use of the stimulants methylphenidate and amphetamine for the treatment of attention deficit-hyperactivity disorder (ADHD) has been increasing. In 2007, the Food and Drug Administration mandated changes to drug labels for stimulants on the basis of findings of new-onset psychosis. Whether the risk of psychosis in adolescents and young adults with ADHD differs among various stimulants has not been extensively studied. Methods We used data from two commercial insurance claims databases to assess patients 13 to 25 years of age who had received a diagnosis of ADHD and who started taking methylphenidate or amphetamine between January 1, 2004, and September 30, 2015. The outcome was a new diagnosis of psychosis for which an antipsychotic medication was prescribed during the first 60 days after the date of the onset of psychosis. To estimate hazard ratios for psychosis, we used propensity scores to match patients who received methylphenidate with patients who received amphetamine in each database, compared the incidence of psychosis between the two stimulant groups, and then pooled the results across the two databases. Results We assessed 337,919 adolescents and young adults who received a prescription for a stimulant for ADHD. The study population consisted of 221,846 patients with 143,286 person-years of follow up; 110,923 patients taking methylphenidate were matched with 110,923 patients taking amphetamines. There were 343 episodes of psychosis (with an episode defined as a new diagnosis code for psychosis and a prescription for an antipsychotic medication) in the matched populations (2.4 per 1000 person-years): 106 episodes (0.10%) in the methylphenidate group and 237 episodes (0.21%) in the amphetamine group (hazard ratio with amphetamine use, 1.65; 95% confidence interval, 1.31 to 2.09). Conclusions Among adolescents and young adults with ADHD who were receiving prescription stimulants, new-onset psychosis occurred in approximately 1 in 660 patients. Amphetamine use was associated with a greater risk of psychosis than methylphenidate.	[Moran, Lauren V.; Schneeweiss, Sebastian] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA; [Moran, Lauren V.; Ongur, Dost] McLean Hosp, Div Psychot Disorders, 115 Mill St, Belmont, MA 02178 USA; [Hsu, John] Harvard Med Sch, Dept Hlth Care Policy, Boston, MA 02115 USA; [Moran, Lauren V.; Ongur, Dost; Hsu, John; Perlis, Roy H.; Schneeweiss, Sebastian] Harvard Med Sch, Boston, MA 02115 USA; [Hsu, John] Massachusetts Gen Hosp, Mongan Inst Hlth Policy Ctr, Boston, MA 02114 USA; [Perlis, Roy H.] Massachusetts Gen Hosp, Dept Psychiat, Ctr Quantitat Hlth, Boston, MA 02114 USA; [Castro, Victor M.] Partners HealthCare Syst, Partners Res Comp, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; McLean Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Partners Healthcare System	Moran, LV (corresponding author), McLean Hosp, 115 Mill St, Belmont, MA 02478 USA.	lmoran4@partners.org	Castro, Victor M/CAF-9395-2022; Moran, Lauren/AAV-6688-2020; Castro, Victor M/CAH-3428-2022	Castro, Victor M/0000-0001-7390-6354; Moran, Lauren/0000-0002-5185-1767; Castro, Victor M/0000-0001-7390-6354	National Institute of Mental Health [K23MH110564, K24MH104449]; Patient-Centered Outcomes Research Institute; National Institutes of Health; Food and Drug Administration; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH110564, K24MH104449] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Patient-Centered Outcomes Research Institute(Patient-Centered Outcomes Research Institute - PCORI); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Food and Drug Administration(United States Department of Health & Human Services); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Supported by grants (K23MH110564 [to Dr. Moran] and K24MH104449 [to Dr. Ongur]) from the National Institute of Mental Health. The data and analytics for the study were provided by the Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital. Dr. Schneeweiss was partially supported by the Patient-Centered Outcomes Research Institute, the National Institutes of Health, and the Food and Drug Administration.	Advokat CD, 2008, J AM COLL HEALTH, V56, P601, DOI 10.3200/JACH.56.6.601-606; Aldridge AP, 2011, PHARMACOECONOMICS, V29, P621, DOI 10.2165/11584590-000000000-00000; Azofeifa A, 2016, MMWR SURVEILL SUMM, V65, P1, DOI 10.15585/mmwr.ss6511a1; Benson K, 2015, CLIN CHILD FAM PSYCH, V18, P50, DOI 10.1007/s10567-014-0177-z; Borschuk AP, 2018, J ASTHMA, V55, P66, DOI 10.1080/02770903.2017.1306549; Chen Q, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3769; DeSantis AD, 2013, SUBST USE MISUSE, V48, P446, DOI 10.3109/10826084.2013.778281; Fralick M, 2017, NEW ENGL J MED, V376, P2300, DOI 10.1056/NEJMc1701990; Franklin JM, 2014, STAT MED, V33, P1685, DOI 10.1002/sim.6058; Gallucci AR, 2015, PSYCHOL ADDICT BEHAV, V29, P154, DOI 10.1037/adb0000012; Garnier LM, 2010, J CLIN PSYCHIAT, V71, P262, DOI 10.4088/JCP.09m05189ecr; Hodgkins P, 2011, CLIN THER, V33, P188, DOI 10.1016/j.clinthera.2011.03.001; Howes OD, 2012, ARCH GEN PSYCHIAT, V69, P776, DOI 10.1001/archgenpsychiatry.2012.169; Jauhar S, 2017, JAMA PSYCHIAT, V74, P1206, DOI 10.1001/jamapsychiatry.2017.2943; Jensen PS, 2001, J DEV BEHAV PEDIATR, V22, P60, DOI 10.1097/00004703-200102000-00008; John CE, 2007, NEUROPHARMACOLOGY, V52, P1596, DOI 10.1016/j.neuropharm.2007.03.004; Johnson ES, 2013, PHARMACOEPIDEM DR S, V22, P1, DOI 10.1002/pds.3334; Kim SC, 2017, ARTHRITIS RHEUMATOL, V69, P1154, DOI 10.1002/art.40084; Kuczenski R, 1997, J NEUROCHEM, V68, P2032; LEWIS DA, 1983, J AFFECT DISORDERS, V5, P319, DOI 10.1016/0165-0327(83)90022-8; Lookatch SJ, 2012, J PSYCHOACTIVE DRUGS, V44, P86, DOI 10.1080/02791072.2012.662083; Marconi A, 2016, SCHIZOPHRENIA BULL, V42, P1262, DOI 10.1093/schbul/sbw003; McAfee AT, 2007, EPILEPSIA, V48, P1075, DOI 10.1111/j.1528-1167.2007.01108.x; McCarthy NL, 2013, VACCINE, V31, P5975, DOI 10.1016/j.vaccine.2013.10.031; Mosholder AD, 2009, PEDIATRICS, V123, P611, DOI 10.1542/peds.2008-0185; Olfson M, 2013, J CLIN PSYCHIAT, V74, P45, DOI 10.4088/JCP.12m07975; Rassen JA, 2012, PHARMACOEPIDEM DR S, V21, P69, DOI 10.1002/pds.3263; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Ross RG, 2006, AM J PSYCHIAT, V163, P1149, DOI 10.1176/appi.ajp.163.7.1149; Schiffer WK, 2006, SYNAPSE, V59, P243, DOI 10.1002/syn.20235; Schneeweiss S, 2005, J CLIN EPIDEMIOL, V58, P323, DOI 10.1016/j.jclinepi.2004.10.012; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Sepulveda Dalissa R, 2011, J Pharm Pract, V24, P551, DOI 10.1177/0897190011426558; Sohn H, 2017, POPUL RES POLICY REV, V36, P181, DOI 10.1007/s11113-016-9416-y; Wang R, 2007, NEW ENGL J MED, V357, P2189, DOI 10.1056/NEJMsr077003; Wang SV, 2016, CLIN PHARMACOL THER, V99, P325, DOI 10.1002/cpt.329; Wolraich M, 2011, PEDIATRICS, V128, P1007, DOI 10.1542/peds.2011-2654; Zuvekas SH, 2012, AM J PSYCHIAT, V169, P160, DOI 10.1176/appi.ajp.2011.11030387	38	56	58	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 21	2019	380	12					1128	1138		10.1056/NEJMoa1813751	http://dx.doi.org/10.1056/NEJMoa1813751			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HP7VK	30893533	Green Accepted, Bronze			2022-12-28	WOS:000461898400008
J	Kneebone, R				Kneebone, Roger			Looking and seeing	LANCET			English	Editorial Material									[Kneebone, Roger] Imperial Coll London, Dept Surg & Canc, Fac Med, Surg Educ,Div Surg, London, England; [Kneebone, Roger] Chelsea & Westminster Hosp, Acad Surg, Ctr Engagement & Simulat Sci, London SW10 9NH, England	Imperial College London; Imperial College London	Kneebone, R (corresponding author), Imperial Coll London, Dept Surg & Canc, Fac Med, Surg Educ,Div Surg, London, England.; Kneebone, R (corresponding author), Chelsea & Westminster Hosp, Acad Surg, Ctr Engagement & Simulat Sci, London SW10 9NH, England.	r.kneebone@imperial.ac.uk							0	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 16	2019	393	10176					1091	1091		10.1016/S0140-6736(19)30507-0	http://dx.doi.org/10.1016/S0140-6736(19)30507-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HP1HF	30894260	Green Submitted			2022-12-28	WOS:000461416600014
J	Iacobucci, G				Iacobucci, Gareth			NHS hospitals could be fined if they miss new sepsis targets	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Inada-Kim M, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k1260; National Institute for Health and Care Excellence (NICE), 2016, SEPS REC DIAGN EARL	2	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 12	2019	364								l1124	10.1136/bmj.l1124	http://dx.doi.org/10.1136/bmj.l1124			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP5VS	30862628				2022-12-28	WOS:000461751000014
J	Friesen, C; Osterhage, H; Friedlein, J; Schlenhoff, A; Wiesendanger, R; Krause, S				Friesen, Cody; Osterhage, Hermann; Friedlein, Johannes; Schlenhoff, Anika; Wiesendanger, Roland; Krause, Stefan			Magneto-Seebeck tunneling on the atomic scale	SCIENCE			English	Article							THERMAL-EXPANSION; THERMOVOLTAGE; THERMOPOWER; JUNCTION; FE(110)	The tunneling of spin-polarized electrons across a magnetic tunnel junction driven by a temperature gradient is a fundamental process for the thermal control of electron spin transport. We experimentally investigated the atomic-scale details of this magnetoSeebeck tunneling by placing a magnetic probe tip in close proximity to a magnetic sample at cryogenic temperature, with a vacuum as the tunneling barrier. Heating the tip and measuring the thermopower of the junction while scanning across the spin texture of the sample lead to spin-resolved Seebeck coefficients that can be mapped at atomic-scale lateral resolution. We propose a spin detector for spintronics applications that is driven solely by waste heat, using magneto-Seebeck tunneling to convert spin information into a voltage that can be used for further data processing.	[Friesen, Cody; Osterhage, Hermann; Friedlein, Johannes; Schlenhoff, Anika; Wiesendanger, Roland; Krause, Stefan] Univ Hamburg, Dept Phys, Jungiusstr 11A, D-20355 Hamburg, Germany	University of Hamburg	Friesen, C; Krause, S (corresponding author), Univ Hamburg, Dept Phys, Jungiusstr 11A, D-20355 Hamburg, Germany.	cfriesen@physnet.uni-hamburg.de; skrause@physnet.uni-hamburg.de	Krause, Stefan/M-6384-2019; Wiesendanger, Roland/P-9726-2016	Krause, Stefan/0000-0002-0677-8468; Wiesendanger, Roland/0000-0002-0472-4183; Friesen, Cody/0000-0003-1366-3973; Osterhage, Hermann/0000-0002-7765-3507	Deutsche Forschungsgemeinschaft (DFG) [SPP1538, KR3771/1-1, SFB668, SCHL2096/1-1/2]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	We acknowledge financial support from the Deutsche Forschungsgemeinschaft (DFG), via the following projects: SPP1538 Spin Caloric Transport, project KR3771/1-1; SFB668 Magnetism from Single Atoms to Nanostructures, part project B04; and SCHL2096/1-1/2.	[Anonymous], 2000, 11 INT CRYOC C, DOI DOI 10.1007/0-306-47112-4_84; ARNOLD L, 1987, APPL PHYS LETT, V51, P786, DOI 10.1063/1.98866; Bauer GEW, 2012, NAT MATER, V11, P391, DOI [10.1038/nmat3301, 10.1038/NMAT3301]; BETHGE H, 1995, SURF SCI, V331, P878, DOI 10.1016/0039-6028(95)00166-2; Bode M, 2007, SURF SCI, V601, P3308, DOI 10.1016/j.susc.2007.06.017; Bode M, 2003, J PHYS-CONDENS MAT, V15, pS679, DOI 10.1088/0953-8984/15/5/320; Bode M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.237205; Boehnke A, 2015, SCI REP-UK, V5, DOI 10.1038/srep08945; Boehnke A, 2013, REV SCI INSTRUM, V84, DOI 10.1063/1.4811130; Boona SR, 2014, ENERG ENVIRON SCI, V7, P885, DOI 10.1039/c3ee43299h; Friesen C, 2018, J PHYS D APPL PHYS, V51, DOI 10.1088/1361-6463/aacfab; GRADMANN U, 1990, HYPERFINE INTERACT, V57, P1845, DOI 10.1007/BF02405732; Grafstrom S, 2002, J APPL PHYS, V91, P1717, DOI 10.1063/1.1432113; Hauschild J, 1998, APPL PHYS LETT, V72, P3211, DOI 10.1063/1.121552; Heinze S, 2011, NAT PHYS, V7, P713, DOI [10.1038/NPHYS2045, 10.1038/nphys2045]; Hoffmann D, 2000, J ELECTRON SPECTROSC, V109, P117, DOI 10.1016/S0368-2048(00)00111-0; Huber R, 1998, APPL PHYS LETT, V73, P2521, DOI 10.1063/1.122502; Huebner T, 2017, PHYS REV B, V96, DOI 10.1103/PhysRevB.96.214435; Huebner T, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.224433; Johnson M, 2010, SOLID STATE COMMUN, V150, P543, DOI 10.1016/j.ssc.2009.10.027; Kittel C., 2004, INTRO SOLID STATE PH; KOCHANSKI GP, 1989, PHYS REV LETT, V62, P2285, DOI 10.1103/PhysRevLett.62.2285; Kohler M., 1940, ANN PHYS LPZ, V430, P542; Kubetzka A, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.020401; Kubetzka A, 2003, APPL PHYS A-MATER, V76, P873, DOI 10.1007/s00339-002-1967-6; Lee ES, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.136601; Liebing N, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.177201; Lopez-Monis C, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.174426; Maksymovych P, 2014, ACS NANO, V8, P12110, DOI 10.1021/nn506123g; Meckler S, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.157201; MURALT P, 1986, APPL PHYS LETT, V48, P514, DOI 10.1063/1.96491; Naydenova T, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.197201; NGUYEN HQ, 1989, IEEE T ELECTRON DEV, V36, P2671, DOI 10.1109/16.43771; Park J, 2013, NANO LETT, V13, P3269, DOI 10.1021/nl401473j; PARK SH, 1992, SURF SCI, V266, P265, DOI 10.1016/0039-6028(92)91031-6; RETTENBERGER A, 1995, APPL PHYS LETT, V67, P1217, DOI 10.1063/1.115012; Schneider A, 1998, APPL PHYS A-MATER, V66, pS161, DOI 10.1007/s003390051122; Seifritz J, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3095662; Sonntag A, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.077202; STOVNENG JA, 1990, PHYS REV B, V42, P9214, DOI 10.1103/PhysRevB.42.9214; Walter M, 2011, NAT MATER, V10, P742, DOI [10.1038/nmat3076, 10.1038/NMAT3076]; WHITE GK, 1986, J PHYS F MET PHYS, V16, P449, DOI 10.1088/0305-4608/16/4/009; Wiesendanger R, 2009, REV MOD PHYS, V81, P1495, DOI 10.1103/RevModPhys.81.1495; WILLIAMS CC, 1990, NATURE, V344, P317, DOI 10.1038/344317a0	45	15	15	2	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 8	2019	363	6431					1065	+		10.1126/science.aat7234	http://dx.doi.org/10.1126/science.aat7234			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO2MV	30846595				2022-12-28	WOS:000460750100039
J	D'Silva, K; Brown, S; Hunninghake, GM; Vivero, M; Loscalzo, J				D'Silva, Kristin; Brown, Sarah; Hunninghake, Gary M.; Vivero, Marina; Loscalzo, Joseph			Gasping for a Diagnosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							COLONY-STIMULATING FACTOR; PULMONARY ALVEOLAR PROTEINOSIS; EFFICACY; THERAPY; MICE		[D'Silva, Kristin; Brown, Sarah; Hunninghake, Gary M.; Loscalzo, Joseph] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Vivero, Marina] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Loscalzo, J (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.	jloscalzo@rics.bwh.harvard.edu	Loscalzo, Joseph/ABD-8980-2021	D'Silva, Kristin/0000-0001-8370-4166	NIAMS NIH HHS [T32 AR007258] Funding Source: Medline	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		De Wever W, 2011, INSIGHTS IMAGING, V2, P117, DOI 10.1007/s13244-010-0060-5; Doerschuk CM, 2015, NEW ENGL J MED, V372, P1762, DOI 10.1056/NEJMcibr1413035; DRANOFF G, 1994, SCIENCE, V264, P713, DOI 10.1126/science.8171324; Ikegami M, 1996, AM J PHYSIOL-LUNG C, V270, pL650, DOI 10.1152/ajplung.1996.270.4.L650; Kitamura T, 1999, J EXP MED, V190, P875, DOI 10.1084/jem.190.6.875; Kumar A, 2018, LANCET RESP MED, V6, P554, DOI 10.1016/S2213-2600(18)30043-2; Michaud G, 2009, CHEST, V136, P1678, DOI 10.1378/chest.09-2295; Seymour JF, 2001, AM J RESP CRIT CARE, V163, P524, DOI 10.1164/ajrccm.163.2.2003146; Seymour JF, 1996, NEW ENGL J MED, V335, P1924, DOI 10.1056/NEJM199612193352513; STANLEY E, 1994, P NATL ACAD SCI USA, V91, P5592, DOI 10.1073/pnas.91.12.5592; Suzuki T, 2016, CLIN CHEST MED, V37, P431, DOI 10.1016/j.ccm.2016.04.006; Tazawa R, 2010, AM J RESP CRIT CARE, V181, P1345, DOI 10.1164/rccm.200906-0978OC; Trapnell BC, 2003, NEW ENGL J MED, V349, P2527, DOI 10.1056/NEJMra023226; Venkateshiah SB, 2006, CHEST, V130, P227, DOI 10.1378/chest.130.1.227	14	0	0	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 7	2019	380	10					961	967		10.1056/NEJMcps1809942	http://dx.doi.org/10.1056/NEJMcps1809942			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HN8QX	30855747	Green Accepted			2022-12-28	WOS:000460461500011
J	Kwok, R				Kwok, Roberta			AI EMPOWERS CONSERVATION BIOLOGY	NATURE			English	Editorial Material																			0	20	20	2	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 7	2019	567	7746					133	134		10.1038/d41586-019-00746-1	http://dx.doi.org/10.1038/d41586-019-00746-1			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HN8ED	30833739	Bronze			2022-12-28	WOS:000460426900057
J	O'Brien, A; Kaar, S; Ibison, J; Chalmers, J				O'Brien, Aileen; Kaar, Stephen; Ibison, Judith; Chalmers, Julie			PRACTICE POINTER Assessing an acutely disturbed person in the community	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SCHIZOPHRENIA		[O'Brien, Aileen] St Georges Univ London, Psychiat & Educ, London, England; [Ibison, Judith] St Georges Univ London, Primary Care, London, England; [Ibison, Judith] St Georges Univ London, Gen Practice, London, England; [Kaar, Stephen] Inst Psychiat Psychol & Neurosci, Dept Psychosis Studies, London, England; [Chalmers, Julie] Elms Ctr, Banbury, England	St Georges University London; St Georges University London; St Georges University London	O'Brien, A (corresponding author), St Georges Univ London, Psychiat & Educ, London, England.	aobrien@sgul.ac.uk						Blightman K, 2014, BJA EDUC, V14, P52, DOI 10.1093/bjaceaccp/mkt032; CARPENTER WT, 1973, SCIENCE, V182, P1275, DOI 10.1126/science.182.4118.1275; Hayes JF, 2017, BRIT J PSYCHIAT, V211, P175, DOI 10.1192/bjp.bp.117.202606; Kirkbride JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031660; NHS Digital, 2016, INP FORM DET HOSP ME; NICE, 2015, VIOLENCE AGGRESSION; Richmond JS, 2012, WEST J EMERG MED, V13, P17, DOI 10.5811/westjem.2011.9.6864; Royal College of Psychiatrists, 2018, CR213 FREQ ASK QUEST; Zangrilli A, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-178	9	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 7	2019	364								l578	10.1136/bmj.l578	http://dx.doi.org/10.1136/bmj.l578			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HO6TA	30846425				2022-12-28	WOS:000461063200001
J	Green, A				Green, Andrew			Germany's Global Health hub	LANCET			English	Editorial Material																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 2	2019	393	10174					862	862		10.1016/S0140-6736(19)30479-9	http://dx.doi.org/10.1016/S0140-6736(19)30479-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HN4AP	30837134				2022-12-28	WOS:000460126900012
J	Kitazato, K; Milliken, RE; Iwata, T; Abe, M; Ohtake, M; Matsuura, S; Arai, T; Nakauchi, Y; Nakamura, T; Matsuoka, M; Senshu, H; Hirata, N; Hiroi, T; Pilorget, C; Brunetto, R; Poulet, F; Riu, L; Bibring, JP; Takir, D; Domingue, DL; Vilas, F; Barucci, MA; Perna, D; Palomba, E; Galiano, A; Tsumura, K; Osawa, T; Komatsu, M; Nakato, A; Arai, T; Takato, N; Matsunaga, T; Takagi, Y; Matsumoto, K; Kouyama, T; Yokota, Y; Tatsumi, E; Sakatani, N; Yamamoto, Y; Okada, T; Sugita, S; Honda, R; Morota, T; Kameda, S; Sawada, H; Honda, C; Yamada, M; Suzuki, H; Yoshioka, K; Hayakawa, M; Ogawa, K; Cho, Y; Shirai, K; Shimaki, Y; Hirata, N; Yamaguchi, A; Ogawa, N; Terui, F; Yamaguchi, T; Takei, Y; Saiki, T; Nakazawa, S; Tanaka, S; Yoshikawa, M; Watanabe, S; Tsuda, Y				Kitazato, K.; Milliken, R. E.; Iwata, T.; Abe, M.; Ohtake, M.; Matsuura, S.; Arai, T.; Nakauchi, Y.; Nakamura, T.; Matsuoka, M.; Senshu, H.; Hirata, N.; Hiroi, T.; Pilorget, C.; Brunetto, R.; Poulet, F.; Riu, L.; Bibring, J. -P.; Takir, D.; Domingue, D. L.; Vilas, F.; Barucci, M. A.; Perna, D.; Palomba, E.; Galiano, A.; Tsumura, K.; Osawa, T.; Komatsu, M.; Nakato, A.; Arai, T.; Takato, N.; Matsunaga, T.; Takagi, Y.; Matsumoto, K.; Kouyama, T.; Yokota, Y.; Tatsumi, E.; Sakatani, N.; Yamamoto, Y.; Okada, T.; Sugita, S.; Honda, R.; Morota, T.; Kameda, S.; Sawada, H.; Honda, C.; Yamada, M.; Suzuki, H.; Yoshioka, K.; Hayakawa, M.; Ogawa, K.; Cho, Y.; Shirai, K.; Shimaki, Y.; Hirata, N.; Yamaguchi, A.; Ogawa, N.; Terui, F.; Yamaguchi, T.; Takei, Y.; Saiki, T.; Nakazawa, S.; Tanaka, S.; Yoshikawa, M.; Watanabe, S.; Tsuda, Y.			The surface composition of asteroid 162173 Ryugu from Hayabusa2 near-infrared spectroscopy	SCIENCE			English	Article							SPECTRAL REFLECTANCE PROPERTIES; CARBONACEOUS CHONDRITES; TARGETS; MISSION; ORGANICS; ICE; CM	The near-Earth asteroid 162173 Ryugu, the target of the Hayabusa2 sample-return mission, is thought to be a primitive carbonaceous object. We report reflectance spectra of Ryugu's surface acquired with the Near-Infrared Spectrometer (NIRS3) on Hayabusa2, to provide direct measurements of the surface composition and geological context for the returned samples. A weak, narrow absorption feature centered at 2.72 micrometers was detected across the entire observed surface, indicating that hydroxyl (OH)-bearing minerals are ubiquitous there. The intensity of the OH feature and low albedo are similar to thermally and/or shock-metamorphosed carbonaceous chondrite meteorites. There are few variations in the OH-band position, which is consistent with Ryugu being a compositionally homogeneous rubble-pile object generated from impact fragments of an undifferentiated aqueously altered parent body.	[Kitazato, K.; Hirata, N.; Honda, C.] Univ Aizu, Fukushima, Japan; [Milliken, R. E.; Hiroi, T.] Brown Univ, Providence, RI 02912 USA; [Iwata, T.; Abe, M.; Ohtake, M.; Nakauchi, Y.; Matsuoka, M.; Riu, L.; Nakato, A.; Yokota, Y.; Sakatani, N.; Yamamoto, Y.; Okada, T.; Sawada, H.; Hayakawa, M.; Shirai, K.; Shimaki, Y.; Ogawa, N.; Terui, F.; Takei, Y.; Saiki, T.; Nakazawa, S.; Tanaka, S.; Yoshikawa, M.; Watanabe, S.; Tsuda, Y.] Japan Aerosp Explorat Agcy JAXA, ISAS, Sagamihara, Kanagawa, Japan; [Iwata, T.; Abe, M.; Ohtake, M.; Komatsu, M.; Takato, N.; Matsumoto, K.; Yamamoto, Y.; Yamaguchi, A.; Tanaka, S.; Yoshikawa, M.; Tsuda, Y.] Grad Univ Adv Studies SOKENDAI, Kanagawa, Japan; [Matsuura, S.] Kwansei Gakuin Univ, Nishinomiya, Hyogo, Japan; [Arai, T.] Ashikaga Univ, Ashikaga, Tochigi, Japan; [Nakamura, T.; Tsumura, K.] Tohoku Univ, Sendai, Miyagi, Japan; [Senshu, H.; Poulet, F.; Arai, T.; Yamada, M.] Chiba Inst Technol, Chiba, Japan; [Pilorget, C.; Brunetto, R.; Bibring, J. -P.] Univ Paris Sud, Inst Astrophys Spatial, Orsay, France; [Takir, D.] NASA, Astromat Res & Explorat Sci, Johnson Space Ctr, Houston, TX USA; [Domingue, D. L.; Vilas, F.] Planetary Sci Inst, Tucson, AZ USA; [Barucci, M. A.; Perna, D.] Observ Paris, LESIA, Meudon, France; [Perna, D.] Ist Nazl Astrofis INAF, Osserv Astronomico Roma, Osservatorio Astron Roma, Monte Porzio Catone, Italy; [Palomba, E.; Galiano, A.] INAF, Ist Astrofis Planetol Spaziali, Rome, Italy; [Tsumura, K.] Tokyo City Univ, Tokyo, Japan; [Osawa, T.] Japan Atom Energy Agcy, Ibaraki, Japan; [Takato, N.; Matsumoto, K.] Natl Astron Observ Japan, Tokyo, Japan; [Matsunaga, T.] Natl Inst Environm Studies, Ibaraki, Japan; [Takagi, Y.] Aichi Toho Univ, Nagoya, Aichi, Japan; [Kouyama, T.] Natl Inst Adv Ind Sci & Technol, Tokyo, Japan; [Yokota, Y.; Honda, R.] Kochi Univ, Kochi, Japan; [Tatsumi, E.; Okada, T.; Sugita, S.; Yoshioka, K.; Cho, Y.] Univ Tokyo, Tokyo, Japan; [Morota, T.; Watanabe, S.] Nagoya Univ, Nagoya, Aichi, Japan; [Kameda, S.] Rikkyo Univ, Tokyo, Japan; [Suzuki, H.] Meiji Univ, Tokyo, Japan; [Ogawa, K.; Hirata, N.] Kobe Univ, Kobe, Hyogo, Japan; [Yamaguchi, A.] Natl Inst Polar Res, Tokyo, Japan; [Yamaguchi, T.] Mitsubishi Electr Corp, Kanagawa, Japan	University of Aizu; Brown University; Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); Graduate University for Advanced Studies - Japan; Kwansei Gakuin University; Tohoku University; Chiba Institute of Technology; UDICE-French Research Universities; Universite Paris Saclay; National Aeronautics & Space Administration (NASA); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Istituto Nazionale Astrofisica (INAF); Istituto Nazionale Astrofisica (INAF); Tokyo City University; Japan Atomic Energy Agency; National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); National Institute for Environmental Studies - Japan; National Institute of Advanced Industrial Science & Technology (AIST); Kochi University; University of Tokyo; Nagoya University; Rikkyo University; Meiji University; Kobe University; Research Organization of Information & Systems (ROIS); National Institute of Polar Research (NIPR) - Japan; Mitsubishi Electric Corporation	Kitazato, K (corresponding author), Univ Aizu, Fukushima, Japan.	kitazato@u-aizu.ac.jp	Sugita, Seiji/GQI-1142-2022; Tsumura, Kohji/AAK-2603-2021; Hiroi, Takahiro/AAE-9701-2020; Matsuura, Shuji/B-5658-2016; Matsunaga, Tsuneo/H-3040-2018; Matsumoto, Koji/AAF-7825-2021; Kouyama, Toru/B-1155-2017	Sugita, Seiji/0000-0001-6076-3614; Tsumura, Kohji/0000-0001-7143-6520; Hiroi, Takahiro/0000-0003-2866-9091; Matsuura, Shuji/0000-0002-5698-9634; Matsunaga, Tsuneo/0000-0002-3380-5230; Matsumoto, Koji/0000-0003-4319-1970; Yamamoto, Yukio/0000-0001-7172-1911; Arai, Takehiko/0000-0002-5711-7731; Tatsumi, Eri/0000-0002-6142-9842; Komatsu, Mutsumi/0000-0003-4659-8418; Shimaki, Yuri/0000-0001-8966-7650; Nakauchi, Yusuke/0000-0002-3745-460X; Kitazato, Kohei/0000-0002-4809-7492; Galiano, Anna/0000-0001-8740-0653; Kouyama, Toru/0000-0002-1060-3986; Abe, Masanao/0000-0003-4780-800X; Takagi, Yasuhiko/0000-0003-2232-3065; , Lucie/0000-0002-0614-430X; Hirata, Naru/0000-0002-2435-604X; Matsuoka, Moe/0000-0003-1091-3041	JAXA; Hayabusa2 project; CNES; ASI; NASA Hayabusa2 Participating Scientist Program [NNX17AL02G, NNX16AL34G]; JSPS [16H04044, 17H06459, 17K05639]; JSPS Core-to-Core Program [17H01175]; NASA's Emerging Worlds Program [NNX17AK46G]; European Union's H2020 program [664931]	JAXA; Hayabusa2 project; CNES(Centre National D'etudes Spatiales); ASI(Agenzia Spaziale Italiana (ASI)); NASA Hayabusa2 Participating Scientist Program; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS Core-to-Core Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NASA's Emerging Worlds Program; European Union's H2020 program	The NIRS3 instrument was funded and coordinated by JAXA and built by Meisei Electric, Genesia, and Hamamatsu Photonics. K.K. and the Japanese coauthors acknowledge support from JAXA and the Hayabusa2 project. The French coauthors acknowledge support from CNES. The Italian coauthors acknowledge support from ASI. D.T. and D.L.D. have been supported by the NASA Hayabusa2 Participating Scientist Program (NNX17AL02G, NNX16AL34G). M.A., T.N., N.H., T.Ok., T.Mo., and S.W. have been supported by Grant-in-Aid for Scientific Research from JSPS (16H04044, 17H06459, 17K05639). Y.N., M.M., E.T., N.S., and S.S. have been supported by the JSPS Core-to-Core Program (17H01175). The work of T.H. is funded by NASA's Emerging Worlds Program (NNX17AK46G). The work of D.P. is funded by the European Union's H2020 program (664931).	Acton CH, 1996, PLANET SPACE SCI, V44, P65, DOI 10.1016/0032-0633(95)00107-7; [Anonymous], NASA REFL EXP LAB RE; Beck P, 2010, GEOCHIM COSMOCHIM AC, V74, P4881, DOI 10.1016/j.gca.2010.05.020; Binzel RP, 2001, ICARUS, V151, P139, DOI 10.1006/icar.2001.6613; Bradley JP, 1996, METORIT PLANET SCI, V31, P394, DOI 10.1111/j.1945-5100.1996.tb02077.x; Burbine T. H., 2002, ASTEROIDS, VIII, P653, DOI DOI 10.2307/J.CTV1V7ZDN4.50; Campins H, 2009, ASTRON ASTROPHYS, V503, pL17, DOI 10.1051/0004-6361/200912374; Campins H, 2010, NATURE, V464, P1320, DOI 10.1038/nature09029; Ciarniello M, 2015, ASTRON ASTROPHYS, V583, DOI 10.1051/0004-6361/201526307; CLARK RN, 1983, J GEOPHYS RES, V88, P635, DOI 10.1029/JB088iB12p10635; Clark RN, 2011, J GEOPHYS RES-PLANET, V116, DOI 10.1029/2010JE003751; Cloutis EA, 2012, ICARUS, V221, P984, DOI 10.1016/j.icarus.2012.10.008; Cloutis EA, 2011, ICARUS, V216, P309, DOI 10.1016/j.icarus.2011.09.009; Cloutis EA, 2011, ICARUS, V212, P180, DOI 10.1016/j.icarus.2010.12.009; Cloutis EA, 2018, ICARUS, V305, P203, DOI 10.1016/j.icarus.2018.01.015; Fornasier S, 2015, ASTRON ASTROPHYS, V583, DOI 10.1051/0004-6361/201525901; Hapke B., 1993, THEORY REFLECTANCE E; Henyey LG, 1941, ASTROPHYS J, V93, P70, DOI 10.1086/144246; Hiroi T., 1996, LUNAR PLANETARY SCI, VXXVII, P551; Ishiguro M, 2014, ASTROPHYS J, V792, DOI 10.1088/0004-637X/792/1/74; Iwata T, 2017, SPACE SCI REV, V208, P317, DOI 10.1007/s11214-017-0341-0; Kouyama T, 2016, PLANET SPACE SCI, V124, P76, DOI 10.1016/j.pss.2016.02.003; Lantz C, 2017, ICARUS, V285, P43, DOI 10.1016/j.icarus.2016.12.019; Le Corre L, 2018, MON NOT R ASTRON SOC, V475, P614, DOI 10.1093/mnras/stx3236; Michel P, 2010, ICARUS, V209, P520, DOI 10.1016/j.icarus.2010.05.013; Moskovitz NA, 2013, ICARUS, V224, P24, DOI 10.1016/j.icarus.2013.02.009; Nakamura T., 2016, GOLDSCHMIDT; Nakauchi Y., 2018, 49 LUN PLAN SCI C; Perna D, 2017, ASTRON ASTROPHYS, V599, DOI 10.1051/0004-6361/201630346; Rivkin AS, 2010, NATURE, V464, P1322, DOI 10.1038/nature09028; Sugita S, 2019, SCIENCE, V364, P252, DOI 10.1126/science.aaw0422; Takir D, 2013, METEORIT PLANET SCI, V48, P1618, DOI 10.1111/maps.12171; Takir D, 2012, ICARUS, V219, P641, DOI 10.1016/j.icarus.2012.02.022; Tsuda Y, 2013, ACTA ASTRONAUT, V91, P356, DOI 10.1016/j.actaastro.2013.06.028; Usui F., 2018, PUBL ASTRON SOC JPN, V71; Vilas F, 2008, ASTRON J, V135, P1101, DOI 10.1088/0004-6256/135/4/1101; Watanabe S, 2019, SCIENCE, V364, P268, DOI 10.1126/science.aav8032	38	191	199	7	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2019	364	6437					272	+		10.1126/science.aav7432	http://dx.doi.org/10.1126/science.aav7432			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HU0JG	30890589				2022-12-28	WOS:000464956600047
J	Hirose, K; Payumo, AY; Cutie, S; Hoang, A; Zhang, H; Guyot, R; Lunn, D; Bigley, RB; Yu, HY; Wang, JJ; Smith, M; Gillett, E; Muroy, SE; Schmid, T; Wilson, E; Field, KA; Reeder, DM; Maden, M; Yartsev, MM; Wolfgang, MJ; Grutzner, F; Scanlan, TS; Szweda, LI; Buffenstein, R; Hu, G; Flamant, F; Olgin, JE; Huang, GN				Hirose, Kentaro; Payumo, Alexander Y.; Cutie, Stephen; Hoang, Alison; Zhang, Hao; Guyot, Romain; Lunn, Dominic; Bigley, Rachel B.; Yu, Hongyao; Wang, Jiajia; Smith, Megan; Gillett, Ellen; Muroy, Sandra E.; Schmid, Tobias; Wilson, Emily; Field, Kenneth A.; Reeder, DeeAnn M.; Maden, Malcom; Yartsev, Michael M.; Wolfgang, Michael J.; Grutzner, Frank; Scanlan, Thomas S.; Szweda, Luke I.; Buffenstein, Rochelle; Hu, Guang; Flamant, Frederic; Olgin, Jeffrey E.; Huang, Guo N.			Evidence for hormonal control of heart regenerative capacity during endothermy acquisition	SCIENCE			English	Article							METABOLIC-RATE; ENERGY-EXPENDITURE; ADULT NEWT; TEMPERATURE; ZEBRAFISH; LIZARDS; PROLIFERATION; RECOMBINATION; CONSUMPTION; ACTIVATION	Tissue regenerative potential displays striking divergence across phylogeny and ontogeny, but the underlying mechanisms remain enigmatic. Loss of mammalian cardiac regenerative potential correlates with cardiomyocyte cell-cycle arrest and polyploidization as well as the development of postnatal endothermy. We reveal that diploid cardiomyocyte abundance across 41 species conforms to Kleiber's law-the 3/4 -power law scaling of metabolism with bodyweight-and inversely correlates with standard metabolic rate, body temperature, and serum thyroxine level. Inactivation of thyroid hormone signaling reduces mouse cardiomyocyte polyploidization, delays cell-cycle exit, and retains cardiac regenerative potential in adults. Conversely, exogenous thyroid hormones inhibit zebrafish heart regeneration. Thus, our findings suggest that loss of heart regenerative capacity in adult mammals is triggered by increasing thyroid hormones and may be a trade-off for the acquisition of endothermy.	[Hirose, Kentaro; Payumo, Alexander Y.; Cutie, Stephen; Hoang, Alison; Lunn, Dominic; Bigley, Rachel B.; Olgin, Jeffrey E.; Huang, Guo N.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Hirose, Kentaro; Payumo, Alexander Y.; Cutie, Stephen; Hoang, Alison; Lunn, Dominic; Bigley, Rachel B.; Olgin, Jeffrey E.; Huang, Guo N.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; [Hirose, Kentaro; Payumo, Alexander Y.; Cutie, Stephen; Hoang, Alison; Lunn, Dominic; Bigley, Rachel B.; Huang, Guo N.] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94158 USA; [Zhang, Hao; Wilson, Emily; Olgin, Jeffrey E.] Univ Calif San Francisco, Dept Med, Div Cardiol, San Francisco, CA 94158 USA; [Guyot, Romain; Flamant, Frederic] Univ Lyon 1, Dept Internal Med, Inst Genom Fonct Lyon, INRA,CNRS,Ecole Normale Super Lyon, F-69007 Lyon, France; [Yu, Hongyao; Wang, Jiajia; Hu, Guang] NIEHS, Epigenet & Stem Cell Biol Lab, POB 12233, Res Triangle Pk, NC 27709 USA; [Smith, Megan; Buffenstein, Rochelle] Calico Life Sci, 1170 Vet Blvd, San Francisco, CA 94080 USA; [Gillett, Ellen; Grutzner, Frank] Univ Adelaide, Sch Biol Sci, Adelaide, SA 5005, Australia; [Muroy, Sandra E.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94708 USA; [Schmid, Tobias; Yartsev, Michael M.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94708 USA; [Schmid, Tobias; Yartsev, Michael M.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94708 USA; [Field, Kenneth A.; Reeder, DeeAnn M.] Bucknell Univ, Dept Biol, Lewisburg, PA 17837 USA; [Maden, Malcom] Univ Florida, Dept Biol, Gainesville, FL 32611 USA; [Maden, Malcom] Univ Florida, UF Genet Inst, Gainesville, FL 32611 USA; [Wolfgang, Michael J.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Scanlan, Thomas S.] Oregon Hlth & Sci Univ, Dept Physiol & Pharmacol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA; [Szweda, Luke I.] Univ Texas Southwestern Med Ctr Dallas, Div Cardiol, Dallas, TX 75390 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Adelaide; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Bucknell University; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Johns Hopkins University; Oregon Health & Science University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Huang, GN (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA.; Huang, GN (corresponding author), Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA.; Huang, GN (corresponding author), Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94158 USA.	guo.huang@ucsf.edu	Grutzner, Frank/ABB-2820-2021; Grutzner, Frank/AAD-5834-2020	Grutzner, Frank/0000-0002-3088-7314; Yu, Hongyao/0000-0003-3752-8442; Lunn, Dominic/0000-0002-5156-3773; Yartsev, Michael/0000-0003-0952-2801; Payumo, Alexander/0000-0002-7733-9622; Cutie, Stephen/0000-0002-8554-452X; Huang, Guo/0000-0002-4335-9123; Field, Kenneth/0000-0001-7417-4386; Guyot, Romain/0000-0002-0029-6222; Hirose, Kentaro/0000-0002-0634-3173	JSPS Overseas Research Fellowships; UCSF-IRACDA postdoctoral fellowship; NIGMS IMSD fellowship; Hillblom fellowship; ARC fellowship; Agence Nationale de Recherche Thyromut2 program [ANR-15-CE14-0011-01]; Intramural Research Program of the NIH, National Institute of Environmental Health Sciences [1ZIAES102745]; NIH [R01HL13845, R00HL114738]; Edward Mallinckrodt Jr. Foundation; March of Dimes Basil O'Conner Scholar Award; American Heart Association; American Federation for Aging Research; Life Sciences Research Foundation; Program for Breakthrough Biomedical Research; UCSF Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research Seed Grant; UCSF Academic Senate Committee on Research; REAC Award (Harris Fund); Department of Defense; Cardiovascular Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F31HL145935, R01HL138456, R00HL114738] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102745] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM081266] Funding Source: NIH RePORTER	JSPS Overseas Research Fellowships; UCSF-IRACDA postdoctoral fellowship; NIGMS IMSD fellowship; Hillblom fellowship; ARC fellowship(Australian Research Council); Agence Nationale de Recherche Thyromut2 program(French National Research Agency (ANR)); Intramural Research Program of the NIH, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edward Mallinckrodt Jr. Foundation; March of Dimes Basil O'Conner Scholar Award; American Heart Association(American Heart Association); American Federation for Aging Research; Life Sciences Research Foundation; Program for Breakthrough Biomedical Research; UCSF Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research Seed Grant; UCSF Academic Senate Committee on Research; REAC Award (Harris Fund); Department of Defense(United States Department of Defense); Cardiovascular Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by JSPS Overseas Research Fellowships (to K.H.), a UCSF-IRACDA postdoctoral fellowship (to A. P.), a NIGMS IMSD fellowship and Hillblom fellowship (to S. C.), an ARC fellowship (to F. G.), the Agence Nationale de Recherche Thyromut2 program, ANR-15-CE14-0011-01 (to F. F.), Intramural Research Program of the NIH, National Institute of Environmental Health Sciences 1ZIAES102745 (to G. H.), NIH (R01HL13845) Pathway to Independence Award (R00HL114738), Edward Mallinckrodt Jr. Foundation, March of Dimes Basil O'Conner Scholar Award, American Heart Association Beginning Grant-in-Aid, American Federation for Aging Research, Life Sciences Research Foundation, Program for Breakthrough Biomedical Research, UCSF Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research Seed Grant, UCSF Academic Senate Committee on Research, REAC Award (Harris Fund), Department of Defense, and Cardiovascular Research Institute (to G. N. H.).	Agah R, 1997, J CLIN INVEST, V100, P169, DOI 10.1172/JCI119509; Alkass K, 2015, CELL, V163, P1026, DOI 10.1016/j.cell.2015.10.035; Anatskaya OV, 2004, GENOME, V47, P565, DOI 10.1139/G04-015; Barrionuevo WR, 1999, AM J PHYSIOL-REG I, V276, pR505, DOI 10.1152/ajpregu.1999.276.2.R505; Bartlett HI, 2010, COMPARATIVE MED, V60, P107; Beatty DT, 2006, J ANIM SCI, V84, P972, DOI 10.2527/2006.844972x; Blei I., 2005, GEN ORGANIC BIOCH CO; CAREY C, 1979, OECOLOGIA, V39, P213, DOI 10.1007/BF00348070; Ceccarelli SM, 2011, J MED CHEM, V54, P3109, DOI 10.1021/jm100809g; Chattergoon NN, 2007, J ENDOCRINOL, V192, pR1, DOI 10.1677/JOE-06-0114; DAMASSA DA, 1995, AM J PHYSIOL-REG I, V268, pR1303; Dawson TH, 2014, SYSTEMS, V2, P168, DOI 10.3390/systems2020168; de Oliveira H. S. T., 2007, RITMO BIOL TEMPERATU; Deem S. L., 2015, FOWLERS ZOO WILD ANI, V8; DEMBINSKI TC, 1985, CANCER RES, V45, P3083; FRANCIS C, 1970, COMP BIOCHEM PHYSIOL, V35, P463, DOI 10.1016/0010-406X(70)90609-2; Friedrichsen S, 2003, ENDOCRINOLOGY, V144, P777, DOI 10.1210/en.2002-220715; Garamszegi LZ, 2014, MODERN PHYLOGENETIC; Gauthier K, 2001, MOL CELL BIOL, V21, P4748, DOI 10.1128/MCB.21.14.4748-4760.2001; George JC, 2009, THESIS; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Gonzalez-Rosa JM, 2018, DEV CELL, V44, P433, DOI 10.1016/j.devcel.2018.01.021; GRANT TR, 1978, PHYSIOL ZOOL, V51, P315, DOI 10.1086/physzool.51.4.30160956; Hirose K, 2013, EPIGENETICS-US, V8, P899, DOI 10.4161/epi.25653; HOLLIDAY MA, 1967, PEDIATR RES, V1, P185, DOI 10.1203/00006450-196705000-00005; Holm ACBS, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12182; Huang GN, 2012, SCIENCE, V338, P1599, DOI 10.1126/science.1229765; Hulbert AJ, 2000, BIOL REV, V75, P519, DOI 10.1017/S146479310000556X; JIANG SP, 1993, COMP BIOCHEM PHYS A, V104, P805, DOI 10.1016/0300-9629(93)90158-Z; JOHNALDER HB, 1990, GEN COMP ENDOCR, V77, P52, DOI 10.1016/0016-6480(90)90205-Z; KLEIBER MAX, 1932, HILGARDIA, V6, P315; LAGERSPETZ KY, 1966, HELGOLAND WISS MEER, V14, P559, DOI 10.1007/BF01611645; Lee J, 2015, CELL REP, V10, P266, DOI 10.1016/j.celrep.2014.12.023; LELOUP J, 1977, CR ACAD SCI D NAT, V284, P2261; Lewandoski M, 1997, COLD SPRING HARB SYM, V62, P159; LICHT P, 1988, GEN COMP ENDOCR, V70, P355, DOI 10.1016/0016-6480(88)90109-8; Little AG, 2014, J EXP BIOL, V217, P1642, DOI 10.1242/jeb.088880; Makarieva AM, 2008, P NATL ACAD SCI USA, V105, P16994, DOI 10.1073/pnas.0802148105; Matrone G, 2017, CELL MOL LIFE SCI, V74, P1367, DOI 10.1007/s00018-016-2404-x; MCNAB BK, 1963, ECOL MONOGR, V33, P63, DOI 10.2307/1948477; MCNAB BK, 1988, Q REV BIOL, V63, P25, DOI 10.1086/415715; Naqvi N, 2014, CELL, V157, P795, DOI 10.1016/j.cell.2014.03.035; Neuweiler G., 2000, BIOL BATS; Nguyen NH, 2002, J MED CHEM, V45, P3310, DOI 10.1021/jm0201013; OBERPRILLER JO, 1988, CELL TISSUE RES, V253, P619; OBERPRILLER JO, 1974, J EXP ZOOL, V187, P249, DOI 10.1002/jez.1401870208; Orrell KS, 2004, PHYSIOL BIOCHEM ZOOL, V77, P50, DOI 10.1086/383497; Patterson M, 2017, NAT GENET, V49, P1346, DOI 10.1038/ng.3929; Pereyra AS, 2017, J BIOL CHEM, V292, P18443, DOI 10.1074/jbc.M117.800839; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Puente BN, 2014, CELL, V157, P565, DOI 10.1016/j.cell.2014.03.032; Quignodon L, 2007, MOL ENDOCRINOL, V21, P2350, DOI 10.1210/me.2007-0176; Rebrin I, 2003, FREE RADICAL BIO MED, V35, P626, DOI 10.1016/S0891-5849(03)00388-5; Rumyantsev PP., 1991, GROWTH HYPERPLASIA C; Schmidt-Nielsen K., 1980, COMP PHYSL PRIMITIVE; Segar JL, 2013, EXP PHYSIOL, V98, P722, DOI 10.1113/expphysiol.2012.069435; Seymour RS, 2000, PHYSIOL BIOCHEM ZOOL, V73, P389, DOI 10.1086/317741; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Soonpaa MH, 2015, CELL, V163, P781, DOI 10.1016/j.cell.2015.10.037; Tao G, 2016, NATURE, V534, P119, DOI 10.1038/nature17959; TSUJI JS, 1988, PHYSIOL ZOOL, V61, P230, DOI 10.1086/physzool.61.3.30161236; van der Ven LTM, 2006, ENVIRON SCI TECHNOL, V40, P74, DOI 10.1021/es050972c; White CR, 2014, EVOLUTION, V68, P901, DOI 10.1111/evo.12298; Xin M, 2013, NAT REV MOL CELL BIO, V14, P529, DOI 10.1038/nrm3619; Yang XL, 2014, J MOL CELL CARDIOL, V72, P296, DOI 10.1016/j.yjmcc.2014.04.005	65	154	157	7	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 12	2019	364	6436					184	+		10.1126/science.aar2038	http://dx.doi.org/10.1126/science.aar2038			57	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HT5RC	30846611	Green Accepted			2022-12-28	WOS:000464620000044
J	Gupta, RK; Abdul-Jawad, S; Mccoy, LE; Mok, HP; Peppa, D; Salgado, M; Martinez-Picado, J; Nijhuis, M; Wensing, AMJ; Lee, H; Grant, P; Nastouli, E; Lambert, J; Pace, M; Salasc, F; Monit, C; Innes, AJ; Muir, L; Waters, L; Frater, J; Lever, AML; Edwards, SG; Gabriel, IH; Olavarria, E				Gupta, Ravindra K.; Abdul-Jawad, Sultan; Mccoy, Laura E.; Mok, Hoi Ping; Peppa, Dimitra; Salgado, Maria; Martinez-Picado, Javier; Nijhuis, Monique; Wensing, Annemarie M. J.; Lee, Helen; Grant, Paul; Nastouli, Eleni; Lambert, Jonathan; Pace, Matthew; Salasc, Fanny; Monit, Christopher; Innes, Andrew J.; Muir, Luke; Waters, Laura; Frater, John; Lever, Andrew M. L.; Edwards, Simon G.; Gabriel, Ian H.; Olavarria, Eduardo			HIV-1 remission following CCR5 Delta 32/Delta 32 haematopoietic stem-cell transplantation	NATURE			English	Article							CCR5; CORECEPTOR; PREDICTION; TROPISM	A cure for HIV-1 remains unattainable as only one case has been reported, a decade ago(1,2). The individual-who is known as the 'Berlin patient'-underwent two allogeneic haematopoietic stem-cell transplantation (HSCT) procedures using a donor with a homozygous mutation in the HIV coreceptor CCR5 (CCR5 Delta 32/Delta 32) to treat his acute myeloid leukaemia. Total body irradiation was given with each HSCT. Notably, it is unclear which treatment or patient parameters contributed to this case of long-term HIV remission. Here we show that HIV-1 remission may be possible with a less aggressive and toxic approach. An adult infected with HIV-1 underwent allogeneic HSCT for Hodgkin's lymphoma using cells from a CCR5 Delta 32/Delta 32 donor. He experienced mild gut graft-versus-host disease. Antiretroviral therapy was interrupted 16 months after transplantation. HIV-1 remission has been maintained over a further 18 months. Plasma HIV-1 RNA has been undetectable at less than one copy per millilitre along with undetectable HIV-1 DNA in peripheral CD4 T lymphocytes. Quantitative viral outgrowth assays from peripheral CD4 T lymphocytes show no reactivatable virus using a total of 24 million resting CD4 T cells. CCR5-tropic, but not CXCR4-tropic, viruses were identified in HIV-1 DNA from CD4 T cells of the patient before the transplant. CD4 T cells isolated from peripheral blood after transplantation did not express CCR5 and were susceptible only to CXCR4-tropic virus ex vivo. HIV-1 Gag-specific CD4 and CD8 T cell responses were lost after transplantation, whereas cytomegalovirus-specific responses were detectable. Similarly, HIV-1-specific antibodies and avidities fell to levels comparable to those in the Berlin patient following transplantation. Although at 18 months after the interruption of treatment it is premature to conclude that this patient has been cured, these data suggest that a single allogeneic HSCT with homozygous CCR5 Delta 32 donor cells may be sufficient to achieve HIV-1 remission with reduced intensity conditioning and no irradiation, and the findings provide further support for the development of HIV-1 remission strategies based on preventing CCR5 expression.	[Gupta, Ravindra K.; Abdul-Jawad, Sultan; Mccoy, Laura E.; Monit, Christopher; Muir, Luke] UCL, Div Infect & Immun, London, England; [Gupta, Ravindra K.] UCLH, Dept Infect, London, England; [Gupta, Ravindra K.; Peppa, Dimitra; Waters, Laura; Edwards, Simon G.] CNWL NHS Trust, Dept HIV, Mortimer Market Ctr, London, England; [Gupta, Ravindra K.; Mok, Hoi Ping; Salasc, Fanny; Lever, Andrew M. L.] Univ Cambridge, Dept Med, Cambridge, England; [Gupta, Ravindra K.] Africa Hlth Res Inst, Durban, South Africa; [Peppa, Dimitra; Pace, Matthew; Frater, John] Univ Oxford, Nuffield Dept Med, Oxford, England; [Salgado, Maria; Martinez-Picado, Javier] IrsiCaixa AIDS Res Inst, Badalona, Spain; [Martinez-Picado, Javier] Univ Vic Cent Univ Catalonia UVic UCC, Vic, Spain; [Martinez-Picado, Javier] Catalan Inst Res & Adv Studies ICREA, Barcelona, Spain; [Nijhuis, Monique; Wensing, Annemarie M. J.] Univ Med Ctr, Dept Med Microbiol, Translat Virol, Utrecht, Netherlands; [Lee, Helen] Univ Cambridge, Dept Haematol, Cambridge, England; [Grant, Paul; Nastouli, Eleni] UCLH, Dept Virol, London, England; [Lambert, Jonathan] UCLH, Dept Haematol, London, England; [Innes, Andrew J.; Gabriel, Ian H.; Olavarria, Eduardo] Imperial Coll Healthcare NHS Trust, Hammersmith Hosp, Dept Clin Haematol, London, England; [Innes, Andrew J.; Gabriel, Ian H.; Olavarria, Eduardo] Imperial Coll London, London, England; [Frater, John] NIHR Oxford Biomed Res Ctr, Oxford, England; [Lever, Andrew M. L.] Natl Univ Singapore, Dept Med, Singapore, Singapore; [Gabriel, Ian H.] Chelsea & Westminster Hosp Fdn NHS Trust, Dept Haematol, London, England	University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of Cambridge; Africa Health Research Institute; University of Oxford; Institut de Recerca de la Sida - IrsiCaixa; Universitat de Vic - Universitat Central de Catalunya (UVic-UCC); ICREA; Utrecht University; Utrecht University Medical Center; University of Cambridge; University College London Hospitals NHS Foundation Trust; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; Imperial College London; Imperial College London; University of Oxford; National University of Singapore	Gupta, RK (corresponding author), UCL, Div Infect & Immun, London, England.; Gupta, RK (corresponding author), UCLH, Dept Infect, London, England.; Gupta, RK (corresponding author), CNWL NHS Trust, Dept HIV, Mortimer Market Ctr, London, England.; Gupta, RK (corresponding author), Univ Cambridge, Dept Med, Cambridge, England.; Gupta, RK (corresponding author), Africa Hlth Res Inst, Durban, South Africa.	rkg20@cam.ac.uk	Salgado, Maria/G-3462-2016; Mok, Hoi Ping/AAF-1653-2020; Martinez-Picado, Javier/G-5507-2012; Gupta, Ravindra/G-5529-2015	Salgado, Maria/0000-0003-1551-7216; Martinez-Picado, Javier/0000-0002-4916-2129; Frater, John/0000-0001-7163-7277; Pace, Matthew/0000-0002-5703-3984; peppa, dimitra/0000-0002-9281-5471; Innes, Andrew/0000-0003-0918-8882; Muir, Luke/0000-0002-7834-6066; Mok, Hoi Ping/0000-0003-1402-7194; SALASC, Fanny/0000-0002-6574-1358; Gupta, Ravindra/0000-0001-9751-1808	Wellcome Trust Senior Fellowship in Clinical Science; research capability funding (RCF) from UCLH BRC; Cambridge Biomedical Research Centres (BRC); amfAR (The Foundation for AIDS Research), through the amfAR Research Consortium on HIV Eradication (ARCHE) program [AmfAR 109858-64-RSRL]; MRC [MR/R008698/1, MRM008614/2]; NIHR Clinical Lectureship; Imperial Biomedical Research Centre (BRC); University College London Hospitals NHS Trust (UCLH)/University College London (UCL) National Institute for Health Research (NIHR) Biomedical Research Centre; ViiV Healthcare UK as part of the EPIICAL Consortium; Oxford Biomedical Research Centres (BRC); NIHR Biomedical Research Centre (BRC); CHERUB; IciStem Consortia; MRC [MR/L006588/1, MR/N02043X/1, MR/M008614/2, MR/M008614/1, MR/P011233/1] Funding Source: UKRI	Wellcome Trust Senior Fellowship in Clinical Science(Wellcome Trust); research capability funding (RCF) from UCLH BRC; Cambridge Biomedical Research Centres (BRC); amfAR (The Foundation for AIDS Research), through the amfAR Research Consortium on HIV Eradication (ARCHE) program; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Clinical Lectureship; Imperial Biomedical Research Centre (BRC); University College London Hospitals NHS Trust (UCLH)/University College London (UCL) National Institute for Health Research (NIHR) Biomedical Research Centre; ViiV Healthcare UK as part of the EPIICAL Consortium; Oxford Biomedical Research Centres (BRC); NIHR Biomedical Research Centre (BRC); CHERUB; IciStem Consortia; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by a Wellcome Trust Senior Fellowship in Clinical Science to R.K.G., research capability funding (RCF) from UCLH BRC to R.K.G., as well as funding from Oxford and Cambridge Biomedical Research Centres (BRC), amfAR (The Foundation for AIDS Research), through the amfAR Research Consortium on HIV Eradication (ARCHE) program (AmfAR 109858-64-RSRL), the MRC (MR/R008698/1 to L.E.M. and MRM008614/2 to D.P.). A.J.I. is supported by an NIHR Clinical Lectureship, and acknowledges support from the NIHR and Imperial Biomedical Research Centre (BRC). E. N. received funding from the University College London Hospitals NHS Trust (UCLH)/University College London (UCL) National Institute for Health Research (NIHR) Biomedical Research Centre and research funding through an independent grant by ViiV Healthcare UK as part of the EPIICAL Consortium. We thank the CHERUB (http://www.cherub.uk.net) and IciStem Consortia (https://www.icistem.org/) for support and continuous discussion of results; N. Parmahand, M. Bandara, I. Jarvis, A. Fun, M. Lee, L. Hedley, K. Ardeshna, A. Hill, N. Goel, R. Szydlo, D. Slade, S. Griffith and C. Galvez, A. Hernandez Rodriguez, V. Gonzalez Soler and B. Rivaya Sanchez, E. van Maarseveen, L. Huyveneers, P. Schipper and D. de Jong; J. Apperley, Z. Allwood and S. Loaiza and all the nurses in the BMT Unit that looked after the patient.	Allers K, 2011, BLOOD, V117, P2791, DOI 10.1182/blood-2010-09-309591; Amendola A, 2011, J CLIN VIROL, V52, P17, DOI 10.1016/j.jcv.2011.04.012; [Anonymous], 2017, UNAIDS DAT 2017; Avert, 2017, FUND HIV AIDS; Barth RE, 2010, LANCET INFECT DIS, V10, P155, DOI 10.1016/S1473-3099(09)70328-7; Bosman KJ, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25185; Bronnimann MP, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00020; Cummins NW, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002461; Duarte RF, 2015, LANCET HIV, V2, pE236, DOI 10.1016/S2352-3018(15)00083-1; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fun A, 2017, SCI REP-UK, V7, DOI 10.1038/srep43231; Gregson J, 2016, LANCET INFECT DIS, V16, P565, DOI 10.1016/S1473-3099(15)00536-8; Gupta RK, 2018, LANCET INFECT DIS, V18, P346, DOI [10.1016/s1473-3099(17)30702-8, 10.1016/S1473-3099(17)30702-8]; Hamilton BK, 2013, BONE MARROW TRANSPL, V48, P1578, DOI 10.1038/bmt.2013.89; Henrich TJ, 2014, ANN INTERN MED, V161, P319, DOI 10.7326/M14-1027; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Jensen MA, 2006, J VIROL, V80, P4698, DOI 10.1128/JVI.80.10.4698-4704.2006; Kordelas L, 2014, NEW ENGL J MED, V371, P880, DOI 10.1056/NEJMc1405805; Laird GM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003398; Lengauer T, 2007, NAT BIOTECHNOL, V25, P1407, DOI 10.1038/nbt1371; Pavlu J, 2011, HEMATOL ONCOL, V29, P75, DOI 10.1002/hon.956; Ritchie AV, 2016, J VIROL METHODS, V237, P143, DOI 10.1016/j.jviromet.2016.08.017; Salgado M, 2018, ANN INTERN MED, V169, P674, DOI 10.7326/M18-0759; Simmons G, 1996, J VIROL, V70, P8355, DOI 10.1128/JVI.70.12.8355-8360.1996; Smith NMG, 2015, CLIN INFECT DIS, V61, P120, DOI 10.1093/cid/civ219; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Symons J, 2012, CLIN MICROBIOL INFEC, V18, P606, DOI 10.1111/j.1469-0691.2011.03631.x; Symons J, 2014, CLIN INFECT DIS, V59, P596, DOI 10.1093/cid/ciu284; Verheyen J, 2019, CLIN INFECT DIS, V68, P684, DOI 10.1093/cid/ciy565; Watters SA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158854; Yukl SA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003347	31	300	313	4	172	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 11	2019	568	7751					244	+		10.1038/s41586-019-1027-4	http://dx.doi.org/10.1038/s41586-019-1027-4			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HT2SH	30836379	Green Accepted, Green Submitted			2022-12-28	WOS:000464412700051
J	Song, S; Chertow, GM				Song, Shen; Chertow, Glenn M.			Treatment of metabolic acidosis with an intestinal binder	LANCET			English	Editorial Material									[Song, Shen; Chertow, Glenn M.] Stanford Univ, Sch Med, Dept Med, Div Nephrol, Palo Alto, CA 94034 USA	Stanford University	Chertow, GM (corresponding author), Stanford Univ, Sch Med, Dept Med, Div Nephrol, Palo Alto, CA 94034 USA.	gchertow@stanford.edu		Chertow, Glenn/0000-0002-7599-0534				Abramowitz MK, 2013, CLIN J AM SOC NEPHRO, V8, P714, DOI 10.2215/CJN.08340812; Kendrick J, 2018, CLIN J AM SOC NEPHRO, V13, P1463, DOI 10.2215/CJN.00380118; Kraut JA, 2018, CURR OPIN NEPHROL HY, V27, P94, DOI 10.1097/MNH.0000000000000386; MITCH WE, 1994, J CLIN INVEST, V93, P2127, DOI 10.1172/JCI117208; Wesson DE, 2019, LANCET, V393, P1417, DOI 10.1016/S0140-6736(18)32562-5; Workeneh BT, 2010, AM J CLIN NUTR, V91, p1128S, DOI 10.3945/ajcn.2010.28608B	6	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 6	2019	393	10179					1387	1388		10.1016/S0140-6736(19)30230-2	http://dx.doi.org/10.1016/S0140-6736(19)30230-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HS0OU	30857645				2022-12-28	WOS:000463561000005
J	Guldvog, I; Reitsma, LC; Johnsen, L; Lauzike, A; Gibbs, C; Carlsen, E; Lende, TH; Narvestad, JK; Omdal, R; Kvaloy, JT; Hoff, G; Bernklev, T; Soiland, H				Guldvog, Ivar; Reitsma, Laurens Cornelus; Johnsen, Lene; Lauzike, Andromeda; Gibbs, Charlotte; Carlsen, Eivind; Lende, Tone Hoel; Narvestad, Jon Kristian; Omdal, Roald; Kvaloy, Jan Terje; Hoff, Geir; Bernklev, Tomm; Soiland, Havard			Thyroidectomy Versus Medical Management for Euthyroid Patients With Hashimoto Disease and Persisting Symptoms A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-LIFE; SF-36 HEALTH SURVEY; CHRONIC-FATIGUE; SYNOVIAL-FLUID; NORMATIVE DATA; SURGERY; THYROIDITIS; AUTOIMMUNITY; LYMPHOCYTE; SIGNATURE	Background: Hashimoto disease is a chronic autoimmune thyroiditis. Despite adequate hormone substitution, some patients have persistent symptoms that may be the result of immunologic pathophysiology. Objective: To determine whether thyroidectomy improves symptoms in patients with Hashimoto thyroiditis who still have symptoms despite having normal thyroid gland function while receiving medical therapy. Design: Randomized trial. (ClinicalTrials.gov:NCT02319538) Setting: Secondary care hospital in Norway. Patients: 150 patients aged 18 to 79 years with persistent Hashimoto-related symptoms despite euthyroid status while receiving hormone replacement therapy and with serum antithyroid peroxidase (anti-TPO) antibody titers greater than 1000 IU/mL. Intervention: Total thyroidectomy or medical management with hormone substitution to secure euthyroid status in both groups. Measurements: The primary outcome was general health score on the Short Form-36 Health Survey (SF-36) at 18 months. Secondary outcomes were adverse effects of surgery, the other 7 SF-36 subscores, fatigue questionnaire scores, and serum antiTPO antibody titers at 6, 12, and 18 months. Results: During follow-up, only the surgical group demonstrated improvement: Mean general health score increased from 38 to 64 points, for a between-group difference of 29 points (95% CI, 22 to 35 points) at 18 months. Fatigue score decreased from 23 to 14 points, for a between-group difference of 9.3 points (CI, 7.4 to 11.2 points). Chronic fatigue frequency decreased from 82% to 35%, for a between-group difference of 39 percentage points (CI, 23 to 53 percentage points). Median serum anti-TPO antibody titers decreased from 2232 to 152 IU/mL, for a between-group difference of 1148 IU/mL (CI, 1080 to 1304 IU/mL). In multivariable regression analyses, the adjusted treatment effects remained similar to the unadjusted effects. Limitation: Results are applicable only to a subgroup of patients with Hashimoto disease, and follow-up was limited to 18 months. Conclusion: Total thyroidectomy improved health-related quality of life and fatigue, whereas medical therapy did not. This improvement, along with concomitant elimination of serum antiTPO antibodies, may elucidate disease mechanisms. Primary Funding Source: Telemark Hospital.	[Guldvog, Ivar; Reitsma, Laurens Cornelus; Lauzike, Andromeda] Telemark Hosp, Dept Breast & Endocrine Surg, Ulefossvegen 55, N-3710 Skien, Norway; [Gibbs, Charlotte] Telemark Hosp, Dept Endocrinol, Ulefossvegen 55, N-3710 Skien, Norway; [Carlsen, Eivind] Telemark Hosp, Dept Pathol, Ulefossvegen 55, N-3710 Skien, Norway; [Hoff, Geir; Bernklev, Tomm] Telemark Hosp, Dept Res, Ulefossvegen 55, N-3710 Skien, Norway; [Johnsen, Lene; Lende, Tone Hoel; Soiland, Havard] Stavanger Univ Hosp, Dept Breast & Endocrine Surg, Helse Stavanger HF, POB 8100, N-4068 Stavanger, Norway; [Narvestad, Jon Kristian] Stavanger Univ Hosp, Dept Gastrointestinal Surg, Helse Stavanger HF, POB 8100, N-4068 Stavanger, Norway; [Omdal, Roald] Stavanger Univ Hosp, Dept Internal Med, Helse Stavanger HF, Clin Immunol Unit, POB 8100, N-4068 Stavanger, Norway; [Johnsen, Lene; Lende, Tone Hoel] Univ Bergen, Dept Clin Med, Jonas Lies V 65, N-5021 Bergen, Norway; [Omdal, Roald; Soiland, Havard] Univ Bergen, Dept Clin Sci, Jonas Lies V 87, N-5021 Bergen, Norway; [Kvaloy, Jan Terje] Univ Stavanger, Dept Math & Phys, POB 8600 Forus, N-4036 Stavanger, Norway; [Kvaloy, Jan Terje] Stavanger Univ Hosp, Dept Res, POB 8100, N-4068 Stavanger, Norway; [Bernklev, Tomm] Vestfold Hosp, Dept Res, POB 2168, N-3103 Tonsberg, Norway; [Bernklev, Tomm] Univ Oslo, Fac Med, Inst Clin Med, POB 1171, N-0318 Oslo, Norway	Telemark Hospital Trust; Telemark Hospital Trust; Telemark Hospital Trust; Telemark Hospital Trust; Stavanger University Hospital; Stavanger University Hospital; Stavanger University Hospital; University of Bergen; University of Bergen; Universitetet i Stavanger; Stavanger University Hospital; University of Oslo	Guldvog, I (corresponding author), Telemark Hosp, Dept Breast & Endocrine Surg, Ulefossvegen 55, N-3710 Skien, Norway.	ivaguld@online.no			Inge Steenslands Stiftelse, Stavanger, Norway; Telemark Hospital	Inge Steenslands Stiftelse, Stavanger, Norway; Telemark Hospital	From Inge Steenslands Stiftelse, Stavanger, Norway, and Telemark Hospital.	[Anonymous], 2021, LANG ENV STAT COMP; Bardsen K, 2016, INNATE IMMUN-LONDON, V22, P162, DOI 10.1177/1753425916633236; Bergenfelz A, 2008, LANGENBECK ARCH SURG, V393, P667, DOI 10.1007/s00423-008-0366-7; BLAKE DR, 1979, LANCET, V2, P224; BOTTAZZO GF, 1986, IMMUNOL REV, V94, P137, DOI 10.1111/j.1600-065X.1986.tb01168.x; Bower JE, 2000, J CLIN ONCOL, V18, P743, DOI 10.1200/JCO.2000.18.4.743; Caturegli P, 2014, AUTOIMMUN REV, V13, P391, DOI 10.1016/j.autrev.2014.01.007; CHALDER T, 1993, J PSYCHOSOM RES, V37, P147, DOI 10.1016/0022-3999(93)90081-P; Chiovato L, 2003, ANN INTERN MED, V139, P346, DOI 10.7326/0003-4819-139-5_Part_1-200309020-00010; Dayan CM, 1996, NEW ENGL J MED, V335, P99, DOI 10.1056/NEJM199607113350206; Guldvog I, 2015, 15 INT THYR C LAK BU; Hashimoto H., 1912, ARCH KLIN CHIR, V97, P219; Hayward NJ, 2013, ANZ J SURG, V83, P15, DOI 10.1111/j.1445-2197.2012.06247.x; Jeannon JP, 2009, INT J CLIN PRACT, V63, P624, DOI 10.1111/j.1742-1241.2008.01875.x; Jonklaas J, 2014, THYROID, V24, P1670, DOI 10.1089/thy.2014.0028; Karanikas G, 2005, CLIN ENDOCRINOL, V63, P191, DOI 10.1111/j.1365-2265.2005.02324.x; Krysiak R, 2011, J CLIN ENDOCR METAB, V96, P2206, DOI 10.1210/jc.2010-2986; Loge JH, 1998, J PSYCHOSOM RES, V45, P53, DOI 10.1016/S0022-3999(97)00291-2; Loge JH, 1998, SCAND J SOC MED, V26, P250; MCLEOD RS, 1991, GASTROENTEROLOGY, V101, P1307, DOI 10.1016/0016-5085(91)90081-U; McManus C, 2012, J SURG RES, V178, P529, DOI 10.1016/j.jss.2012.09.017; Montoya JG, 2017, P NATL ACAD SCI USA, V114, pE7150, DOI 10.1073/pnas.1710519114; Moseley JB, 2002, NEW ENGL J MED, V347, P81, DOI 10.1056/NEJMoa013259; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Norheim KB, 2011, RHEUMATOLOGY, V50, P1009, DOI 10.1093/rheumatology/keq454; Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004; Omdal R, 2017, ANN RHEUM DIS, V76, P184, DOI 10.1136/annrheumdis-2017-eular.3973; Orgiazzi J, 2012, PRESSE MED, V41, pE611, DOI 10.1016/j.lpm.2012.10.002; Ott J, 2011, THYROID, V21, P161, DOI 10.1089/thy.2010.0191; Pearce EN, 2003, NEW ENGL J MED, V348, P2646, DOI 10.1056/NEJMra021194; Promberger R, 2014, AM J SURG, V207, P974, DOI 10.1016/j.amjsurg.2013.05.005; Promberger R, 2012, EXPERT REV ENDOCRINO, V7, P175, DOI [10.1586/EEM.12.3, 10.1586/eem.12.3]; Punzi L, 2004, JOINT BONE SPINE, V71, P275, DOI 10.1016/j.jbspin.2003.06.005; PUNZI L, 1991, CLIN RHEUMATOL, V10, P181, DOI 10.1007/BF02207661; Saravanan P, 2002, CLIN ENDOCRINOL, V57, P577, DOI 10.1046/j.1365-2265.2002.01654.x; Savulescu J, 2016, J MED ETHICS, V42, P776, DOI 10.1136/medethics-2015-103333; Tanda ML, 2009, HORM METAB RES, V41, P436, DOI 10.1055/s-0029-1215568; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P903, DOI 10.1016/S0895-4356(98)00081-X; Wartolowska K, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3253; Watt T, 2015, THYROID, V25, P1069, DOI 10.1089/thy.2015.0209; Watt T, 2010, EUR J ENDOCRINOL, V162, P161, DOI 10.1530/EJE-09-0521; WEETMAN AP, 1982, CLIN EXP IMMUNOL, V48, P196; WIKLUND I, 1990, CONTROL CLIN TRIALS, V11, P169, DOI 10.1016/0197-2456(90)90011-P; Zivaljevic VR, 2015, INT J SURG, V21, P150, DOI 10.1016/j.ijsu.2015.08.001	44	32	34	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 2	2019	170	7					453	+		10.7326/M18-0284	http://dx.doi.org/10.7326/M18-0284			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HR3WA	30856652				2022-12-28	WOS:000463070700004
J	Friedrich, MJ				Friedrich, M. J.			WHO's Top Health Threats for 2019	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	16	16	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 19	2019	321	11					1041	1041		10.1001/jama.2019.1934	http://dx.doi.org/10.1001/jama.2019.1934			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JJ1JG	30874765				2022-12-28	WOS:000493916400003
J	Ip, JE				Ip, James E.			Evaluation of Cardiac Rhythm Abnormalities From Wearable Devices	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Ip, James E.] Cornell Univ, Med Ctr, Dept Med, Div Cardiol,New York Presbyterian Hosp, New York, NY 10021 USA	Cornell University; NewYork-Presbyterian Hospital	Ip, JE (corresponding author), Cornell Univ, Med Ctr, Div Cardiol, New York Presbyterian Hosp, 525 E 68th St,Starr 4, New York, NY 10021 USA.	jei9008@med.cornell.edu	Ip, James E./I-1235-2019	Ip, James E./0000-0002-3461-505X				Apple, US APPL WATCH ARRH D; Calkins H, 2019, CIRCULATION, DOI 10.1016/j.hrthm.2019.01.024; Ip JE, 2019, JAMA-J AM MED ASSOC, V321, P337, DOI 10.1001/jama.2018.20437; Ip JE, 2018, TRENDS CARDIOVAS MED, V28, P295, DOI 10.1016/j.tcm.2017.11.004; Koshy AN, 2018, INT J CARDIOL, V266, P124, DOI 10.1016/j.ijcard.2018.02.073; Kusumoto FM, 2019, CIRCULATION, V140, pE382, DOI 10.1161/CIR.0000000000000628	6	10	10	1	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 19	2019	321	11					1098	1099		10.1001/jama.2019.1681	http://dx.doi.org/10.1001/jama.2019.1681			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP4YY	30874744				2022-12-28	WOS:000461683500018
J	Mayor, S				Mayor, Susan			Renal denervation achieves sustained blood pressure reduction, finds trial	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Azizi M, 2019, CIRCULATION, V139, P2542, DOI 10.1161/CIRCULATIONAHA.119.040451; Azizi M, 2018, LANCET, V391, P2335, DOI 10.1016/S0140-6736(18)31082-1	2	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 19	2019	364								l1274	10.1136/bmj.l1274	http://dx.doi.org/10.1136/bmj.l1274			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HQ7ZZ	30890519				2022-12-28	WOS:000462644400010
J	Scheingross, JS; Lamb, MP; Fuller, BM				Scheingross, Joel S.; Lamb, Michael P.; Fuller, Brian M.			Self-formed bedrock waterfalls	NATURE			English	Article							EROSION; KNICKPOINT; LANDSCAPE; INCISION; RIVERS; FLUME; BED	Waterfalls are inspiring landforms that set the pace of landscape evolution as a result of bedrock incision(1-3). They communicate changes in sea level or tectonic uplift throughout landscapes(2,4) or stall river incision, disconnecting landscapes from downstream perturbations(3,5). Here we use a flume experiment with constant water discharge and sediment feed to show that waterfalls can form from a planar, homogeneous bedrock bed in the absence of external perturbations. In our experiment, instabilities between flow hydraulics, sediment transport and bedrock erosion lead to undulating bedforms, which grow to become waterfalls. We propose that it is plausible that the origin of some waterfalls in natural systems can be attributed to this intrinsic formation process and we suggest that investigations to distinguish self-formed from externally forced waterfalls may help to improve the reconstruction of Earth history from landscapes.	[Scheingross, Joel S.; Lamb, Michael P.; Fuller, Brian M.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Scheingross, Joel S.] GFZ German Res Ctr Geosci, Potsdam, Germany; [Scheingross, Joel S.] Univ Nevada, Dept Geol Sci & Engn, Reno, NV 89557 USA	California Institute of Technology; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences; Nevada System of Higher Education (NSHE); University of Nevada Reno	Scheingross, JS (corresponding author), CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA.; Scheingross, JS (corresponding author), GFZ German Res Ctr Geosci, Potsdam, Germany.; Scheingross, JS (corresponding author), Univ Nevada, Dept Geol Sci & Engn, Reno, NV 89557 USA.	jscheingross@unr.edu		Scheingross, Joel/0000-0002-7220-8084	National Science Foundation [EAR-1147381]; NASA [12PGG120107]; Alexander von Humboldt Foundation; National Science Foundation under NSF Award [1557484, 1557319, 1557330, EAR-1043051]	National Science Foundation(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); National Science Foundation under NSF Award(National Science Foundation (NSF))	We thank J. Preimesberger for assistance with preliminary experiments, R. DiBiase, W. Dietrich, N. Izumi, G. Parker, J. Prancevic, J. Turowski and M. Yokokawa for discussion, and A. Wickert for a review. We acknowledge funding from the National Science Foundation (grant EAR-1147381 to M.P.L. and a Graduate Research Fellowship to J.S.S.), NASA (grant 12PGG120107 to M.P.L.), and the Alexander von Humboldt Foundation (postdoctoral fellowship to J.S.S.). This work includes data services provided by the OpenTopography Facility with support from the National Science Foundation under NSF Award Numbers 1557484, 1557319 and 1557330, and EAR-1043051.	[Anonymous], 2013, ADV RIVER SEDIMENT R, DOI DOI 10.14863/GEOSOCABST.2013.0_177; Baynes ERC, 2018, GEOLOGY, V46, P499, DOI 10.1130/G40071.1; Baynes ERC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20767-6; Brooks P. C., 2001, THESIS; Crosby BT, 2006, GEOMORPHOLOGY, V82, P16, DOI 10.1016/j.geomorph.2005.08.023; DiBiase RA, 2015, GEOL SOC AM BULL, V127, P539, DOI 10.1130/B31113.1; DiBiase RA, 2010, EARTH PLANET SC LETT, V289, P134, DOI 10.1016/j.epsl.2009.10.036; Finnegan NJ, 2005, GEOLOGY, V33, P229, DOI 10.1130/G21171.1; GARDNER TW, 1983, GEOL SOC AM BULL, V94, P664, DOI 10.1130/0016-7606(1983)94<664:ESOKAL>2.0.CO;2; Gilbert G.K., 1890, HIST NIAGARA RIVER E; Grimaud JL, 2016, EARTH SURF DYNAM, V4, P11, DOI 10.5194/esurf-4-11-2016; Hasbargen LE, 2000, GEOLOGY, V28, P1067, DOI 10.1130/0091-7613(2000)28<1067:LIIAED>2.0.CO;2; Haviv I, 2006, J GEOPHYS RES-EARTH, V111, DOI 10.1029/2006JF000461; HOLLAND WN, 1976, GEOL SOC AM BULL, V87, P76, DOI 10.1130/0016-7606(1976)87<76:FSOKDI>2.0.CO;2; HOWARD AD, 1994, J GEOPHYS RES-SOL EA, V99, P13971, DOI 10.1029/94JB00744; Izumi N, 2017, J GEOPHYS RES-EARTH, V122, P130, DOI 10.1002/2016JF003847; Lamb MP, 2007, GEOL SOC AM BULL, V119, P805, DOI 10.1130/B25986.1; Lamb MP, 2015, GEOMORPHOLOGY, V244, P33, DOI 10.1016/j.geomorph.2015.03.003; Lamb MP, 2009, GEOL SOC AM BULL, V121, P1123, DOI 10.1130/B26482.1; Lamb MP, 2008, J GEOPHYS RES-EARTH, V113, DOI 10.1029/2007JF000915; Lave J, 2004, J GEOPHYS RES-EARTH, V109, DOI 10.1029/2003JF000023; Malatesta LC, 2018, GEOL SOC AM BULL, V130, P522, DOI [10.1130/b31743.1, 10.1130/B31743.1]; Matthes F.E., 1930, US GEOLOGICAL SURVEY; Palucis MC, 2017, GEOPHYS RES LETT, V44, P7245, DOI 10.1002/2017GL074198; Paola C, 2009, EARTH-SCI REV, V97, P1, DOI 10.1016/j.earscirev.2009.05.003; Portenga E, 2011, GSA TODAY, V21, P4, DOI DOI 10.1130/G111A.1; Roberts GG, 2013, GEOMORPHOLOGY, V198, P177, DOI 10.1016/j.geomorph.2013.05.026; Scheingross JS, 2017, J GEOPHYS RES-EARTH, V122, P2079, DOI 10.1002/2017JF004195; Scheingross JS, 2014, GEOLOGY, V42, P523, DOI 10.1130/G35432.1; Taki K, 2005, J HYDRAUL RES, V43, P488, DOI 10.1080/00221680509500147; Weissel JK, 1998, GEOPH MONOG SERIES, V107, P189; Whipple K.X., 2013, TREATISE GEOMORPHOLO, P550, DOI DOI 10.1016/B978-0-12-374739-6.00254-2; Yanites BJ, 2010, GEOLOGY, V38, P639, DOI 10.1130/G30883.1; YERKES RF, 2005, 20051019 US GEOL SUR	34	21	21	6	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 14	2019	567	7747					229	+		10.1038/s41586-019-0991-z	http://dx.doi.org/10.1038/s41586-019-0991-z			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7LD	30867607	Green Submitted			2022-12-28	WOS:000461126600040
J	Rule, S; LeGouill, S				Rule, Simon; LeGouill, Steven			Bureaucracy is strangling clinical research	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Rule, Simon] Plymouth Univ, Peninsula Sch Med & Dent, Haematol, Plymouth, Devon, England; [LeGouill, Steven] Univ Nantes, Haematol, Nantes, France	University of Plymouth; Nantes Universite	Rule, S (corresponding author), Plymouth Univ, Peninsula Sch Med & Dent, Haematol, Plymouth, Devon, England.	simon.rule@nhs.net		le gouill, steven/0000-0001-9840-2128					0	18	18	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 13	2019	364								l1097	10.1136/bmj.l1097	http://dx.doi.org/10.1136/bmj.l1097			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP5VW	30867145				2022-12-28	WOS:000461751600010
J	Basner, M; Asch, DA; Shea, JA; Bellini, LM; Carlin, M; Ecker, AJ; Malone, SK; Desai, SV; Sternberg, AL; Tonascia, J; Shade, DM; Katz, JT; Bates, DW; Even-Shoshan, O; Silber, JH; Small, DS; Volpp, KG; Mott, CG; Coats, S; Mollicone, DJ; Dinges, DF				Basner, Mathias; Asch, David A.; Shea, Judy A.; Bellini, Lisa M.; Carlin, Michele; Ecker, Adrian J.; Malone, Susan K.; Desai, Sanjay V.; Sternberg, Alice L.; Tonascia, James; Shade, David M.; Katz, Joel T.; Bates, David W.; Even-Shoshan, Orit; Silber, Jeffrey H.; Small, Dylan S.; Volpp, Kevin G.; Mott, Christopher G.; Coats, Sara; Mollicone, Daniel J.; Dinges, David F.		iCOMPARE Res Grp	Sleep and Alertness in a Duty-Hour Flexibility Trial in Internal Medicine	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							JOINT CONSENSUS STATEMENT; VIGILANCE TEST PVT; RECOMMENDED AMOUNT; AMERICAN ACADEMY; RANDOMIZED-TRIAL; HEALTHY ADULT; PATIENT-CARE; WORK SHIFTS; RESIDENT; RESTRICTION	BACKGROUND A purpose of duty-hour regulations is to reduce sleep deprivation in medical trainees, but their effects on sleep, sleepiness, and alertness are largely unknown. METHODS We randomly assigned 63 internal-medicine residency programs in the United States to follow either standard 2011 duty-hour policies or flexible policies that maintained an 80-hour workweek without limits on shift length or mandatory time off between shifts. Sleep duration and morning sleepiness and alertness were compared between the two groups by means of a noninferiority design, with outcome measures including sleep duration measured with actigraphy, the Karolinska Sleepiness Scale (with scores ranging from 1 [extremely alert] to 9 [extremely sleepy, fighting sleep]), and a brief computerized Psychomotor Vigilance Test (PVT-B), with long response times (lapses) indicating reduced alertness. RESULTS Data were obtained over a period of 14 days for 205 interns at six flexible programs and 193 interns at six standard programs. The average sleep time per 24 hours was 6.85 hours (95% confidence interval [CI], 6.61 to 7.10) among those in flexible programs and 7.03 hours (95% CI, 6.78 to 7.27) among those in standard programs. Sleep duration in flexible programs was noninferior to that in standard programs (between-group difference, -0.17 hours per 24 hours; one-sided lower limit of the 95% confidence interval, -0.45 hours; noninferiority margin, -0.5 hours; P = 0.02 for noninferiority), as was the score on the Karolinska Sleepiness Scale (between-group difference, 0.12 points; one-sided upper limit of the 95% confidence interval, 0.31 points; noninferiority margin, 1 point; P<0.001). Noninferiority was not established for alertness according to the PVT-B (between-group difference, -0.3 lapses; one-sided upper limit of the 95% confidence interval, 1.6 lapses; noninferiority margin, 1 lapse; P = 0.10). CONCLUSIONS This noninferiority trial showed no more chronic sleep loss or sleepiness across trial days among interns in flexible programs than among those in standard programs. Noninferiority of the flexible group for alertness was not established.	[Basner, Mathias; Asch, David A.; Shea, Judy A.; Bellini, Lisa M.; Carlin, Michele; Ecker, Adrian J.; Malone, Susan K.; Small, Dylan S.; Volpp, Kevin G.; Dinges, David F.] Univ Penn, Philadelphia, PA 19104 USA; [Asch, David A.; Volpp, Kevin G.] Corporal Michael J Crescenz Vet Affairs Med Ctr, Philadelphia, PA USA; [Even-Shoshan, Orit; Silber, Jeffrey H.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Mott, Christopher G.; Coats, Sara; Mollicone, Daniel J.] Pulsar Informat, Philadelphia, PA USA; [Desai, Sanjay V.; Sternberg, Alice L.; Tonascia, James; Shade, David M.] Johns Hopkins Univ, Baltimore, MD USA; [Katz, Joel T.; Bates, David W.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Johns Hopkins University; Harvard University; Brigham & Women's Hospital	Basner, M (corresponding author), Univ Penn, Perelman Sch Med, Dept Psychiat, Unit Expt Psychiat,Div Sleep & Chronobiol, 1019 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.	basner@pennmedicine.upenn.edu	Bates, David/AAE-7283-2019; Vyas, Jatin/Q-1627-2016; Dinges, David/P-7183-2019	Vyas, Jatin/0000-0002-9985-9565; Patton, Jill/0000-0003-2904-4106; Asch, David/0000-0002-7970-286X	National Heart, Lung, and Blood Institute [U01HL125388, U01HL126088]; American Council for Graduate Medical Education; (Silber); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007953, U01HL126088, U01HL125388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [K99NR017416, P20NR018075] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Council for Graduate Medical Education; (Silber); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	Supported by grants (U01HL125388, to Dr. Asch; and U01HL126088, to Dr. Tonascia) from the National Heart, Lung, and Blood Institute and grants from the American Council for Graduate Medical Education (to Drs. Desai, Shea, and Silber).	AKERSTEDT T, 1990, INT J NEUROSCI, V52, P29, DOI 10.3109/00207459008994241; Akerstedt T, 2017, J SLEEP RES, V26, P559, DOI 10.1111/jsr.12528; Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; Ayas NT, 2006, JAMA-J AM MED ASSOC, V296, P1055, DOI 10.1001/jama.296.9.1055; Banks S, 2007, J CLIN SLEEP MED, V3, P519; Barger LK, 2006, PLOS MED, V3, P2440, DOI 10.1371/journal.pmed.0030487; Barger LK, 2009, CURR NEUROL NEUROSCI, V9, P155, DOI 10.1007/s11910-009-0024-7; Barger LK, 2005, NEW ENGL J MED, V352, P125, DOI 10.1056/NEJMoa041401; Basner M, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx027; Basner M, 2014, SLEEP, V37, P1889, DOI 10.5665/sleep.4238; Basner M, 2013, CURR OPIN NEUROBIOL, V23, P854, DOI 10.1016/j.conb.2013.02.008; Basner M, 2011, ACTA ASTRONAUT, V69, P949, DOI 10.1016/j.actaastro.2011.07.015; Basner M, 2011, SLEEP, V34, P581, DOI 10.1093/sleep/34.5.581; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bilimoria KY, 2016, JAMA SURG, V151, P273, DOI 10.1001/jamasurg.2015.4990; Bilimoria KY, 2016, NEW ENGL J MED, V374, P713, DOI 10.1056/NEJMoa1515724; Desai SV, 2018, NEW ENGL J MED, V378, P1494, DOI 10.1056/NEJMoa1800965; Desai SV, 2013, JAMA INTERN MED, V173, P649, DOI 10.1001/jamainternmed.2013.2973; Levine AC, 2010, SLEEP, V33, P1043, DOI 10.1093/sleep/33.8.1043; Lockley SW, 2006, CLIN ORTHOP RELAT R, P116, DOI 10.1097/01.blo.0000224057.32367.84; Malmberg B, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-239; Moore TM, 2017, AEROSP MED HUM PERF, V88, P937, DOI 10.3357/AMHP.4801.2017; Nasca TJ, 2010, NEW ENGL J MED, V363, DOI 10.1056/NEJMsb1005800; Patel MS, 2014, JAMA-J AM MED ASSOC, V312, P2364, DOI 10.1001/jama.2014.15273; Rajaram R, 2014, JAMA-J AM MED ASSOC, V312, P2374, DOI 10.1001/jama.2014.15277; Reed DA, 2010, ANN INTERN MED, V153, P829, DOI 10.7326/0003-4819-153-12-201012210-00010; Shea JA, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-021711; Shea JA, 2014, ACAD MED, V89, P452, DOI 10.1097/ACM.0000000000000144; Silber JH, 2019, NEW ENGL J MED, V380, P905, DOI 10.1056/NEJMoa1810642; Spellberg B, 2013, JAMA INTERN MED, V173, P707, DOI 10.1001/jamainternmed.2013.2968; Tassi P, 2000, SLEEP MED REV, V4, P341, DOI 10.1053/smrv.2000.0098; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; Van Dongen HPA, 2001, SLEEP, V24, P813, DOI 10.1093/sleep/24.7.813; Volpp KG, 2007, JAMA-J AM MED ASSOC, V298, P984, DOI 10.1001/jama.298.9.984; Volpp KG, 2012, JAMA-J AM MED ASSOC, V308, P2208, DOI 10.1001/jama.2012.34490; Watson NF, 2015, SLEEP, V38, P1161, DOI 10.5665/sleep.4886; Watson NF, 2015, SLEEP, V38, P843, DOI 10.5665/sleep.4716	38	34	35	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 7	2019	380	10					915	923		10.1056/NEJMoa1810641	http://dx.doi.org/10.1056/NEJMoa1810641			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HN8QX	30855741	Green Accepted, Bronze			2022-12-28	WOS:000460461500005
J	Porteus, MH				Porteus, Matthew H.			A New Class of Medicines through DNA Editing	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							TARGETED GENE ADDITION; ZINC-FINGER NUCLEASES; DOUBLE-STRAND BREAKS; HOMOLOGOUS RECOMBINATION; HEMATOPOIETIC STEM; MOUSE MODEL; GENOMIC DNA; T-CELLS; CRISPR-CAS9; EXPRESSION		[Porteus, Matthew H.] Stanford Univ, Dept Pediat Stem Cell Transplantat, Stanford, CA 94305 USA	Stanford University	Porteus, MH (corresponding author), Dept Pediat, Lorry Lokey Stem Cell Res Bldg,MC 5462, Stanford, CA 94305 USA.	mporteus@stanford.edu		Porteus, Matthew/0000-0002-3850-4648				Bak RO, 2018, NAT PROTOC, V13, P358, DOI 10.1038/nprot.2017.143; Bak RO, 2017, ELIFE, V6, DOI 10.7554/eLife.27873.001; Barker JC, 2014, PLAST RECONSTR SURG, V134, p389E, DOI 10.1097/PRS.0000000000000427; Barrangou R, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.92; Benabdallah BF, 2010, CYTOTHERAPY, V12, P394, DOI 10.3109/14653240903583803; Betermier M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004086; Bibikova M, 2003, SCIENCE, V300, P764, DOI 10.1126/science.1079512; Bibikova M, 2002, GENETICS, V161, P1169; Canny MD, 2018, NAT BIOTECHNOL, V36, P95, DOI 10.1038/nbt.4021; Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521; Carroll D, 2014, ANNU REV BIOCHEM, V83, P409, DOI 10.1146/annurev-biochem-060713-035418; Casini A, 2018, NAT BIOTECHNOL, V36, P265, DOI 10.1038/nbt.4066; Certo MT, 2011, NAT METHODS, V8, P671, DOI [10.1038/nmeth.1648, 10.1038/NMETH.1648]; Charlesworth CT, 2018, BIORXIV; Chen FQ, 2011, NAT METHODS, V8, P753, DOI 10.1038/nmeth.1653; Chen JS, 2017, NATURE, V550, P407, DOI 10.1038/nature24268; CHOULIKA A, 1995, MOL CELL BIOL, V15, P1968; Cromer MK, 2018, MOL THER, V26, P2431, DOI 10.1016/j.ymthe.2018.06.002; Cyranoski D, 2016, NATURE, V539, P479, DOI 10.1038/nature.2016.20988; De Ravin SS, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah3480; De Ravin SS, 2016, NAT BIOTECHNOL, V34, P424, DOI 10.1038/nbt.3513; Dever DP, 2016, NATURE, V539, P384, DOI 10.1038/nature20134; DeWitt MA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf9336; DiGiusto DL, 2016, MOL THER-METH CLIN D, V3, DOI 10.1038/mtm.2016.67; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Durai S, 2005, NUCLEIC ACIDS RES, V33, P5978, DOI 10.1093/nar/gki912; Eyquem J, 2017, NATURE, V543, P113, DOI 10.1038/nature21405; Gaudelli NM, 2017, NATURE, V551, P464, DOI 10.1038/nature24644; Hendel A, 2015, NAT BIOTECHNOL, V33, P985, DOI 10.1038/nbt.3290; Hendel A, 2014, CELL REP, V7, P293, DOI 10.1016/j.celrep.2014.02.040; Holt N, 2010, NAT BIOTECHNOL, V28, P839, DOI 10.1038/nbt.1663; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hu Z, 2015, J CLIN INVEST, V125, P425, DOI 10.1172/JCI78206; Hubbard N, 2016, BLOOD, V127, P2513, DOI 10.1182/blood-2015-11-683235; Ihry RJ, 2018, NAT MED, V24, P939, DOI 10.1038/s41591-018-0050-6; Kanaar R, 1998, TRENDS CELL BIOL, V8, P483, DOI 10.1016/S0962-8924(98)01383-X; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Li HJ, 2011, NATURE, V475, P217, DOI 10.1038/nature10177; Lin YF, 2001, GENETICS, V158, P1665; Lombardo A, 2011, NAT METHODS, V8, P861, DOI [10.1038/NMETH.1674, 10.1038/nmeth.1674]; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Nakade S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6560; National Academy of Sciences and National Academy of Medicine, 2017, HUM GEN ED SCI ETH G; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Paulsen BS, 2017, NAT BIOMED ENG, V1, P878, DOI 10.1038/s41551-017-0145-2; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Poirot L, 2015, CANCER RES, V75, P3853, DOI 10.1158/0008-5472.CAN-14-3321; Porteus M, 2016, ANNU REV PHARMACOL, V56, P163, DOI 10.1146/annurev-pharmtox-010814-124454; Porteus MH, 2005, NAT BIOTECHNOL, V23, P967, DOI 10.1038/nbt1125; Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; Potts PR, 2006, EMBO J, V25, P3377, DOI 10.1038/sj.emboj.7601218; Qasim W, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaj2013; Ricciardi AS, 2018, MOLECULES, V23, DOI 10.3390/molecules23030632; Richardson C. D., 2017, BIORXIV; ROUET P, 1994, MOL CELL BIOL, V14, P8096, DOI 10.1128/MCB.14.12.8096; ROUET P, 1994, P NATL ACAD SCI USA, V91, P6064, DOI 10.1073/pnas.91.13.6064; Russell DW, 1998, NAT GENET, V18, P325, DOI 10.1038/ng0498-325; Sather BD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5530; Schiroli G, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan0820; Sharma R, 2015, BLOOD, V126, P1777, DOI 10.1182/blood-2014-12-615492; SMITHIES O, 1985, NATURE, V317, P230, DOI 10.1038/317230a0; Suzuki K, 2016, NATURE, V540, P144, DOI 10.1038/nature20565; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Tsai SQ, 2016, NAT REV GENET, V17, P300, DOI 10.1038/nrg.2016.28; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Vakulskas CA, 2018, NAT MED, V24, P1216, DOI 10.1038/s41591-018-0137-0; Voit RA, 2013, MOL THER, V21, P786, DOI 10.1038/mt.2012.284; VVAA, 2018, GEN ED HUM REPR SOC; Wagner DL, 2018, BIORXIV; Wang JB, 2015, NAT BIOTECHNOL, V33, P1256, DOI 10.1038/nbt.3408; Wang LL, 2018, NAT BIOTECHNOL, V36, P717, DOI 10.1038/nbt.4182; West SC, 2000, COLD SPRING HARB SYM, V65, P315, DOI 10.1101/sqb.2000.65.315; Yang Y, 2016, NAT BIOTECHNOL, V34, P334, DOI 10.1038/nbt.3469; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884	76	109	110	4	71	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 7	2019	380	10					947	959		10.1056/NEJMra1800729	http://dx.doi.org/10.1056/NEJMra1800729			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HN8QX	30855744				2022-12-28	WOS:000460461500008
J	Armstrong, S; Goldstone, AR				Armstrong, Stephen; Goldstone, Antony R.			PERSONAL FINANCE Three weeks to find 25 pound 000: the NHS doctors remortgaging to pay punitive pension tax bills	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Goldstone, Antony R.] Castle Hill Hosp, Cottingham, E Yorkshire, England	University of Hull		stephen.armstrong@me.com						ARMSTRONG S, 2019, BMJ-BRIT MED J, V364, P50357, DOI DOI 10.1136/BMJ.L206; Baska M, 2019, PEOPLE MANAGEMENT	2	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 5	2019	364								l998	10.1136/bmj.l998	http://dx.doi.org/10.1136/bmj.l998			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HO6SS	30837244				2022-12-28	WOS:000461062200011
J	Lifflander, AL				Lifflander, Anne Lucy			Hard Times and Hard Stops	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Lifflander, Anne Lucy] Gotham Hlth New York City Hlth Hosp, 335 Cent Ave,Second Floor, Brooklyn, NY 11221 USA		Lifflander, AL (corresponding author), Gotham Hlth New York City Hlth Hosp, 335 Cent Ave,Second Floor, Brooklyn, NY 11221 USA.	analif@rcn.com							0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 5	2019	321	9					837	838		10.1001/jama.2019.1208	http://dx.doi.org/10.1001/jama.2019.1208			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HN7EL	30835312				2022-12-28	WOS:000460351600011
J	Newman, M				Newman, Melanie			INVESTIGATION Questions over future of global diabetes group as founding members resign	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												melanienewman999@gmail.com						COHEN D, 2011, BMJ-BRIT MED J, V343, DOI DOI 10.1136/bmj.d5782	1	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 5	2019	364								l995	10.1136/bmj.l995	http://dx.doi.org/10.1136/bmj.l995			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HO6SS	30837211				2022-12-28	WOS:000461062200010
J	Jaffe, S				Jaffe, Susan			USA sets goal to end the HIV epidemic in a decade	LANCET			English	Editorial Material																			0	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 16	2019	393	10172					625	626		10.1016/S0140-6736(19)30356-3	http://dx.doi.org/10.1016/S0140-6736(19)30356-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HL6AX	30833111				2022-12-28	WOS:000458817300012
J	Mack, MJ; Leon, MB; Thourani, VH; Makkar, R; Kodali, SK; Russo, M; Kapadia, SR; Malaisrie, SC; Cohen, DJ; Pibarot, P; Leipsic, J; Hahn, RT; Blanke, P; Williams, MR; McCabe, JM; Brown, DL; Babaliaros, V; Goldman, S; Szeto, WY; Genereux, P; Pershad, A; Pocock, SJ; Alu, MC; Webb, JG; Smith, CR				Mack, M. J.; Leon, M. B.; Thourani, V. H.; Makkar, R.; Kodali, S. K.; Russo, M.; Kapadia, S. R.; Malaisrie, S. C.; Cohen, D. J.; Pibarot, P.; Leipsic, J.; Hahn, R. T.; Blanke, P.; Williams, M. R.; McCabe, J. M.; Brown, D. L.; Babaliaros, V.; Goldman, S.; Szeto, W. Y.; Genereux, P.; Pershad, A.; Pocock, S. J.; Alu, M. C.; Webb, J. G.; Smith, C. R.		PARTNER 3 Investigators	Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PERMANENT PACEMAKER IMPLANTATION; SUBCLINICAL LEAFLET THROMBOSIS; INTERMEDIATE-RISK; OUTCOMES; STENOSIS; PREDICTORS; COLLEGE; SOCIETY; TRIAL	BACKGROUND Among patients with aortic stenosis who are at intermediate or high risk for death with surgery, major outcomes are similar with transcatheter aortic-valve replacement (TAVR) and surgical aortic-valve replacement. There is insufficient evidence regarding the comparison of the two procedures in patients who are at low risk. METHODS We randomly assigned patients with severe aortic stenosis and low surgical risk to undergo either TAVR with transfemoral placement of a balloon-expandable valve or surgery. The primary end point was a composite of death, stroke, or rehospitalization at 1 year. Both noninferiority testing (with a prespecified margin of 6 percentage points) and superiority testing were performed in the as-treated population. RESULTS At 71 centers, 1000 patients underwent randomization. The mean age of the patients was 73 years, and the mean Society of Thoracic Surgeons risk score was 1.9% (with scores ranging from 0 to 100% and higher scores indicating a greater risk of death within 30 days after the procedure). The Kaplan-Meier estimate of the rate of the primary composite end point at 1 year was significantly lower in the TAVR group than in the surgery group (8.5% vs. 15.1%; absolute difference, -6.6 percentage points; 95% confidence interval [CI], -10.8 to -2.5; P<0.001 for noninferiority; hazard ratio, 0.54; 95% CI, 0.37 to 0.79; P = 0.001 for superiority). At 30 days, TAVR resulted in a lower rate of stroke than surgery (P = 0.02) and in lower rates of death or stroke (P = 0.01) and new-onset atrial fibrillation (P<0.001). TAVR also resulted in a shorter index hospitalization than surgery (P<0.001) and in a lower risk of a poor treatment outcome (death or a low Kansas City Cardiomyopathy Questionnaire score) at 30 days (P<0.001). There were no significant between-group differences in major vascular complications, new permanent pacemaker insertions, or moderate or severe paravalvular regurgitation. CONCLUSIONS Among patients with severe aortic stenosis who were at low surgical risk, the rate of the composite of death, stroke, or rehospitalization at 1 year was significantly lower with TAVR than with surgery.	[Mack, M. J.; Brown, D. L.] Baylor Scott & White Hlth, Plano, TX USA; [Leon, M. B.; Kodali, S. K.; Hahn, R. T.; Alu, M. C.; Smith, C. R.] Columbia Univ, Irving Med Ctr, New York, NY USA; [Leon, M. B.; Kodali, S. K.; Hahn, R. T.; Alu, M. C.; Smith, C. R.] New York Presbyterian Hosp, New York, NY USA; [Williams, M. R.] NYU, Langone Med Ctr, New York, NY USA; [Thourani, V. H.] Georgetown Univ, Medstar Heart & Vasc Inst, Washington, DC USA; [Makkar, R.] Cedars Sinai Heart Inst, Los Angeles, CA USA; [Russo, M.] Rutgers State Univ, Robert Wood Johnson Med Sch, New Brunswick, NJ USA; [Genereux, P.] Morristown Med Ctr, Gagnon Cardiovasc Inst, Morristown, NJ USA; [Kapadia, S. R.] Cleveland Clin, Cleveland, OH 44106 USA; [Malaisrie, S. C.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Cohen, D. J.] St Lukes Mid Amer Heart Inst, Kansas City, MO USA; [Pibarot, P.] Laval Univ, Quebec Heart & Lung Inst, Quebec City, PQ, Canada; [Leipsic, J.; Blanke, P.; Webb, J. G.] Univ British Columbia, St Pauls Hosp, Vancouver, BC, Canada; [McCabe, J. M.] Univ Washington, Seattle, WA 98195 USA; [Babaliaros, V.] Emory Univ Hosp, 1364 Clifton Rd NE, Atlanta, GA 30322 USA; [Goldman, S.] Lankenau Med Ctr, Wynnewood, PA USA; [Szeto, W. Y.] Hosp Univ Penn, 3400 Spruce St, Philadelphia, PA 19104 USA; [Pershad, A.] Banner Univ, Med Ctr, Phoenix, AZ USA; [Pocock, S. J.] London Sch Hyg & Trop Med, London, England	Baylor Health Care System; Columbia University; NewYork-Presbyterian Hospital; NewYork-Presbyterian Hospital; New York University; NYU Langone Medical Center; Georgetown University; Cedars Sinai Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Atlantic Health System; Cleveland Clinic Foundation; Northwestern University; Feinberg School of Medicine; Saint Luke's Mid America Heart Institute; Laval University; Quebec Heart & Lung Institute; St. Paul's Hospital; University of British Columbia; University of Saskatchewan; University of Washington; University of Washington Seattle; Emory University; Lankenau Medical Center; University of Pennsylvania; Pennsylvania Medicine; University of London; London School of Hygiene & Tropical Medicine	Mack, MJ (corresponding author), Baylor Scott & White Hlth Heart Hosp Plano, 1100 Allied Dr, Plano, TX 75093 USA.	michael.mack@bswhealth.org	thourani, vinod/AAP-5968-2020; Hahn, Rebecca/ABE-6221-2020; Doğan, Ali/AAN-5331-2020; Wu, Jean/O-6972-2019; Pibarot, Philippe/ABD-5300-2021; Leipsic, Jonathon/ABE-6194-2020; Cohen, David/AAF-1648-2019	Douglas, Pamela/0000-0001-9876-4049; Nazif, Tamim/0000-0003-1239-2489; Williams, Mathew/0000-0003-2055-8741; Spies, Claudia/0000-0002-1062-0495	Edwards Lifesciences; PARTNER 3 ClinicalTrials.gov [NCT02675114]	Edwards Lifesciences; PARTNER 3 ClinicalTrials.gov	Funded by Edwards Lifesciences; PARTNER 3 ClinicalTrials.gov number, NCT02675114.	Adams DH, 2014, NEW ENGL J MED, V370, P1790, DOI 10.1056/NEJMoa1400590; Bagur R, 2018, EUROINTERVENTION, V14, P846, DOI 10.4244/EIJV14I8A151; Baumgartner H, 2017, EUR HEART J, V38, P2739, DOI 10.1093/eurheartj/ehx391; Bekeredjian R, 2018, EUR HEART J; Capodanno D, 2017, EUR HEART J, V38, P3382, DOI 10.1093/eurheartj/ehx303; Carroll JD, 2017, J AM COLL CARDIOL, V70, P29, DOI 10.1016/j.jacc.2017.04.056; Chakravarty T, 2017, LANCET, V389, P2383, DOI 10.1016/S0140-6736(17)30757-2; Cribier A, 2002, CIRCULATION, V106, P3006, DOI 10.1161/01.CIR.0000047200.36165.B8; Dvir D, 2018, CIRCULATION, V137, P388, DOI 10.1161/CIRCULATIONAHA.117.030729; Fadahunsi OO, 2016, JACC-CARDIOVASC INTE, V9, P2189, DOI 10.1016/j.jcin.2016.07.026; Finkelstein A, 2019, AM J CARDIOL, V123, P644, DOI 10.1016/j.amjcard.2018.11.010; Frank D, 2018, CLIN RES CARDIOL; Gleason TG, 2018, J AM COLL CARDIOL, V72, P2687, DOI 10.1016/j.jacc.2018.08.2146; Kapadia SR, 2018, J AM COLL CARDIOL, V72, P2415, DOI 10.1016/j.jacc.2018.08.2172; Kapadia SR, 2015, LANCET, V385, P2485, DOI 10.1016/S0140-6736(15)60290-2; Kodali S, 2016, EUR HEART J, V37, P2252, DOI 10.1093/eurheartj/ehw112; Kodali S, 2015, EUR HEART J, V36, P449, DOI 10.1093/eurheartj/ehu384; Leon MB, 2016, NEW ENGL J MED, V374, P1609, DOI 10.1056/NEJMoa1514616; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Makkar RR, 2015, NEW ENGL J MED, V373, P2015, DOI 10.1056/NEJMoa1509233; Nazif TM, 2015, JACC-CARDIOVASC INTE, V8, P60, DOI 10.1016/j.jcin.2014.07.022; Nishimura RA, 2017, J AM COLL CARDIOL, V70, P252, DOI 10.1016/j.jacc.2017.03.011; Otto CM, 2017, J AM COLL CARDIOL, V69, P1313, DOI 10.1016/j.jacc.2016.12.006; Pocock SJ, 2012, EUR HEART J, V33, P176, DOI 10.1093/eurheartj/ehr352; Popma JJ, 2014, J AM COLL CARDIOL, V63, P1972, DOI 10.1016/j.jacc.2014.02.556; Reardon MJ, 2017, NEW ENGL J MED, V376, P1321, DOI 10.1056/NEJMoa1700456; Rosato S, 2016, CIRC-CARDIOVASC INTE, V9, DOI 10.1161/CIRCINTERVENTIONS.115.003326; SAVR TAVR volumes, 2019, M SOC THOR SURG AM C; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510; Sondergaard L, 2019, J AM COLL CARDIOL, V73, P546, DOI 10.1016/j.jacc.2018.10.083; Thourani VH, 2016, LANCET, V387, P2218, DOI 10.1016/S0140-6736(16)30073-3; Thourani VH, 2015, ANN THORAC SURG, V99, P55, DOI 10.1016/j.athoracsur.2014.06.050; Vandvik PO, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i5085; Waksman R, 2018, J AM COLL CARDIOL, V72, P2095, DOI 10.1016/j.jacc.2018.08.1033; Wassef AWA, 2018, JACC-CARDIOVASC INTE, V11, P1669, DOI 10.1016/j.jcin.2018.06.044; Webb JG, 2015, JACC-CARDIOVASC INTE, V8, P1797, DOI 10.1016/j.jcin.2015.08.017; 2012, J AM COLL CARDIOL, V60, P1043, DOI DOI 10.1016/J.JACC.2012.07.003; 2015, CATHETER CARDIOVASC, V86, P738, DOI DOI 10.1002/CCD.25866; 2015, LANCET, V385, P2477, DOI DOI 10.1016/S0140-6736(15)60308-7	39	2159	2226	4	57	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 2	2019	380	18					1695	1705		10.1056/NEJMoa1814052	http://dx.doi.org/10.1056/NEJMoa1814052			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HX9ZK	30883058	Bronze, Green Accepted			2022-12-28	WOS:000467767800005
J	Bollyky, TJ; Templin, T; Cohen, M; Schoder, D; Dieleman, JL; Wigley, S				Bollyky, Thomas J.; Templin, Tara; Cohen, Matthew; Schoder, Diana; Dieleman, Joseph L.; Wigley, Simon			The relationships between democratic experience, adult health, and cause-specific mortality in 170 countries between 1980 and 2016: an observational analysis	LANCET			English	Article							CROSS-NATIONAL ANALYSIS; NONCOMMUNICABLE DISEASES; UNDER-5 MORTALITY; GLOBAL BURDEN; INCOME; POOR; PROVISION; IMPACT; WORST; AID	Background Previous analyses of democracy and population health have focused on broad measures, such as life expectancy at birth and child and infant mortality, and have shown some contradictory results. We used a panel of data spanning 170 countries to assess the association between democracy and cause-specific mortality and explore the pathways connecting democratic rule to health gains. Methods We extracted cause-specific mortality and HIV-free life expectancy estimates from the Global Burden of Diseases, Injuries, and Risk Factors Study 2016 and information on regime type from the Varieties of Democracy project. These data cover 170 countries and 46 years. From the Financing Global Health database, we extracted gross domestic product (GDP) per capita, also covering 46 years, and Development Assistance for Health estimates starting from 1990 and domestic health spending estimates starting from 1995. We used a diverse set of empirical methods-synthetic control, within-country variance decomposition, structural equation models, and fixed-effects regression-which together provide a robust analysis of the association between democratisation and population health. Findings HIV-free life expectancy at age 15 years improved significantly during the study period (1970-2015) in countries after they transitioned to democracy, on average by 3% after 10 years. Democratic experience explains 22.27% of the variance in mortality within a country from cardiovascular diseases, 16.53% for tuberculosis, and 17.78% for transport injuries, and a smaller percentage for other diseases included in the study. For cardiovascular diseases, transport injuries, cancers, cirrhosis, and other non-communicable diseases, democratic experience explains more of the variation in mortality than GDP. Over the past 20 years, the average country's increase in democratic experience had direct and indirect effects on reducing mortality from cardiovascular disease (-9.64%, 95% CI -6.38 to -12.90), other non-communicable diseases (-9.14%, -4.26 to -14.02), and tuberculosis (-8.93%, -2.08 to -15.77). Increases in a country's democratic experience were not correlated with GDP per capita between 1995 and 2015 (rho= -0.1036; p=0.1826), but were correlated with declines in mortality from cardiovascular disease (rho=-0.3873; p<0.0001) and increases in government health spending (rho= 0.4002; p<0.0001). Removal of free and fair elections from the democratic experience variable resulted in loss of association with age-standardised mortality from non-communicable diseases and injuries. Interpretation When enforced by free and fair elections, democracies are more likely than autocracies to lead to health gains for causes of mortality (eg, cardiovascular diseases and transport injuries) that have not been heavily targeted by foreign aid and require health-care delivery infrastructure. International health agencies and donors might increasingly need to consider the implications of regime type in their efforts to maximise health gains, particularly in the context of ageing populations and the growing burden of non-communicable diseases. Funding Bloomberg Philanthropies and the Bill & Melinda Gates Foundation. Copyright (c) 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.	[Bollyky, Thomas J.; Cohen, Matthew; Schoder, Diana] Council Foreign Relat, Washington, DC 20006 USA; [Templin, Tara] Stanford Univ, Dept Hlth Res & Policy, Sch Med, Stanford, CA 94305 USA; [Dieleman, Joseph L.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Wigley, Simon] Bilkent Univ, Dept Philosophy, Ankara, Turkey	Stanford University; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; Ihsan Dogramaci Bilkent University	Bollyky, TJ (corresponding author), Council Foreign Relat, Washington, DC 20006 USA.	tbollyky@cfr.org	Wigley, Simon D/A-6664-2013	Wigley, Simon D/0000-0001-9181-0129; Cohen, Matthew/0000-0001-9087-2678	Bloomberg Philanthropies; Bill & Melinda Gates Foundation	Bloomberg Philanthropies; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Bloomberg Philanthropies and the Bill & Melinda Gates Foundation.	Abadie A, 2003, AM ECON REV, V93, P113, DOI 10.1257/000282803321455188; [Anonymous], 2018, LANCET, V392, P986; [Anonymous], 1999, DEV FREEDOM; Barber L., 2017, FINANCIAL TIMES; Bennett JE, 2018, LANCET, V392, P1072, DOI 10.1016/S0140-6736(18)31992-5; Besley T, 2006, AM ECON REV, V96, P313, DOI 10.1257/000282806777212053; Bloom BR, 2017, MAJOR INFECT DIS; Bollyky TJ, 2017, HEALTH AFFAIR, V36, P1866, DOI 10.1377/hlthaff.2017.0708; Bollyky TJ., 2018, PLAGUES PARADOX PROG; Carothers T., 2013, DEV AID CONFRONTS PO; Carothers Thomas., 2015, CLOSING SPACE CHALLE; Cavallo E, 2013, REV ECON STAT, V95, P1549, DOI 10.1162/REST_a_00413; Cornell Agnes, 2018, V DEM COUNTRY YEAR C; Daniels ME, 2014, EMERGING GLOBAL HLTH; Deacon RT, 2009, PUBLIC CHOICE, V139, P241, DOI 10.1007/s11127-008-9391-x; Dieleman JL, 2018, LANCET, V391, P1799, DOI 10.1016/S0140-6736(18)30698-6; Dreher A, 2015, CAN J ECON, V48, P988, DOI 10.1111/caje.12166; Easterly W, 2008, J ECON PERSPECT, V22, P29, DOI 10.1257/jep.22.2.29; Easterly W, 2011, WORLD DEV, V39, P1930, DOI 10.1016/j.worlddev.2011.07.027; Ezzati M, 2012, SCIENCE, V337, P1482, DOI 10.1126/science.1227001; Fitzmaurice C, 2017, JAMA ONCOL, V3, P524, DOI 10.1001/jamaoncol.2016.5688; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Gaziano TA, 2013, ANNU REV PUBL HEALTH, V34, P317, DOI 10.1146/annurev-publhealth-031912-114402; Gerring J, 2012, J POLIT, V74, P1, DOI 10.1017/S0022381611001113; Global Burden of Disease Collaborative Network, 2017, GLOB BURD DIS STUD 2; Global Burden of Disease Health Financing Collaborator Network, 2017, GLOB HLTH SPEND 1995; Hallerod B, 2013, WORLD DEV, V48, P19, DOI 10.1016/j.worlddev.2013.03.007; Houweling TAJ, 2005, INT J EPIDEMIOL, V34, P1257, DOI 10.1093/ije/dyi190; Human Rights Watch, 2010, HUMAN RIGHTS WATCH; Institute for Health Metrics and Evaluation, 2018, GLOB HUM CAP EST 199; Institute for Health Metrics and Evaluation, 2017, DEV ASS HLTH DAT 199; Institute for Health Metrics and Evaluation, 2018, FIN GLOB HLTH 2017 F; International Monetary Fund, 2017, WORLD EC OUTL DAT AP; James SL, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-12; Khemani S., 2015, J DEV EC; Kiadaliri AA, 2017, BMC MUSCULOSKEL DIS, V18, DOI 10.1186/s12891-017-1428-1; Kruk ME, 2018, LANCET GLOB HEALTH, V6, pE1196, DOI 10.1016/S2214-109X(18)30386-3; Kruk ME, 2018, LANCET; Kudamatsu M, 2012, J EUR ECON ASSOC, V10, P1294, DOI 10.1111/j.1542-4774.2012.01092.x; Lake DA, 2001, COMP POLIT STUD, V34, P587, DOI 10.1177/0010414001034006001; Lloyd L, 2010, INT J, V65, P547, DOI 10.1177/002070201006500302; Mackenbach JP, 2013, SOC SCI MED, V93, P166, DOI 10.1016/j.socscimed.2013.05.010; Maddison Angus, 2010, STAT WORLD POPULATIO; Marquardt KL, 2018, POLIT ANAL, V26, P431, DOI 10.1017/pan.2018.28; McGuire JW, 2013, CONTEMP POLIT, V19, P55, DOI 10.1080/13569775.2013.773203; Muka T, 2015, EUR J EPIDEMIOL, V30, P251, DOI 10.1007/s10654-014-9984-2; Naghavi M, 2017, LANCET, V390, P1151, DOI 10.1016/S0140-6736(17)32152-9; National Academy of Sciences Engineering and Medicine, 2018, CROSS GLOB QUAL CHAS; Ottersen T, 2017, HEALTH ECON POLICY L, V12, P223, DOI [10.1017/S1744133116000475, 10.1017/s1744133116000475]; Pieters H, 2016, LANCET GLOB HEALTH, V4, pE627, DOI 10.1016/S2214-109X(16)30104-8; Reid MJA, 2018, BMJ-BRIT MED J, V362, P3918; Ross M, 2006, AM J POLIT SCI, V50, P860, DOI 10.1111/j.1540-5907.2006.00220.x; Safaei J, 2006, INT J HEALTH SERV, V36, P767, DOI 10.2190/6V5W-0N36-AQNF-GPD1; Scarpetta S., 2018, WORLD BANK, V1, P1; Shandra JM, 2004, SOC SCI MED, V59, P321, DOI 10.1016/j.socscimed.2003.10.022; Summers R, 2017, PENN WORLD TABLE VER; Truex R., 2015, ST COMP INT DEV, V52, P261; UN President of the General Assembly, 2018, POL DECL HIGH LEV M; UN President of the General Assembly, 2018, POL DECL 3 HIGH LEV; Wang HD, 2017, LANCET, V390, P1084, DOI 10.1016/S0140-6736(17)31833-0; Wang HD, 2016, LANCET HIV, V3, pE361, DOI 10.1016/S2352-3018(16)30087-X; Whiteford HA, 2010, GLOBAL BURDEN MENTAL; Wigley S, 2017, SOC SCI MED, V190, P237, DOI 10.1016/j.socscimed.2017.08.023; World Bank, 2017, WORLD DEV IND 2017, DOI DOI 10.1596/26447; World Health Organisation, 2018, NONC DIS COUNTR PROF	65	74	74	3	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 20	2019	393	10181					1628	1640		10.1016/S0140-6736(19)30235-1	http://dx.doi.org/10.1016/S0140-6736(19)30235-1			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HU0DL	30878225	hybrid, Green Published			2022-12-28	WOS:000464941500034
J	Nguyen, VK				Vinh-Kim Nguyen			An Epidemic of Suspicion - Ebola and Violence in the DRC	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Vinh-Kim Nguyen] Med Sans Frontieres, Kinshasa, DEM REP CONGO		Nguyen, VK (corresponding author), Med Sans Frontieres, Kinshasa, DEM REP CONGO.								0	37	36	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 4	2019	380	14					1298	1299		10.1056/NEJMp1902682	http://dx.doi.org/10.1056/NEJMp1902682			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HR8DR	30840790	Bronze			2022-12-28	WOS:000463386900004
J	Wan, RX; Bai, R; Yan, CY; Lei, JL; Shi, YG				Wan, Ruixue; Bai, Rui; Yan, Chuangye; Lei, Jianlin; Shi, Yigong			Structures of the Catalytically Activated Yeast Spliceosome Reveal the Mechanism of Branching	CELL			English	Article							PRE-MESSENGER-RNA; CRYO-EM STRUCTURE; DEPENDENT ATPASE; 1ST STEP; PRP2; PROTEIN; INTRON; SITE; COMPLEX; CATALYSIS	Pre-mRNA splicing is executed by the spliceosome. Structural characterization of the catalytically activated complex (B*) is pivotal for understanding the branching reaction. In this study, we assembled the B*complexes on two different pre-mRNAs from Saccharomyces cerevisiae and determined the cryo-EM structures of four distinct B* complexes at overall resolutions of 2.9-3.8 angstrom. The duplex between U2 small nuclear RNA (snRNA) and the branch point sequence (BPS) is discretely away from the 5'-splice site (5'SS) in the three B* complexes that are devoid of the step I splicing factors Yju2 and Cwc25. Recruitment of Yju2 into the active site brings the U2/BPS duplex into the vicinity of 5'SS, with the BPS nucleophile positioned 4 angstrom away from the catalytic metal M2. This analysis reveals the functional mechanism of Yju2 and Cwc25 in branching. These structures on different pre-mRNAs reveal substrate-specific conformations of the spliceosome in a major functional state.	[Wan, Ruixue; Bai, Rui; Yan, Chuangye; Lei, Jianlin; Shi, Yigong] Tsinghua Univ, Sch Life Sci, Tsinghua Peking Joint Ctr Life Sci, Beijing Adv Innovat Ctr Struct Biol, Beijing 100084, Peoples R China; [Wan, Ruixue; Bai, Rui; Yan, Chuangye; Lei, Jianlin; Shi, Yigong] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Lei, Jianlin] Tsinghua Univ, Sch Life Sci, Minist Educ, Technol Ctr Prot Sci,Key Lab Prot Sci, Beijing 100084, Peoples R China; [Shi, Yigong] Westlake Univ, Sch Life Sci, Westlake Inst Adv Study, Inst Biol, 18 Shilongshan Rd, Hangzhou 310024, Zhejiang, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University; Westlake University	Shi, YG (corresponding author), Tsinghua Univ, Sch Life Sci, Tsinghua Peking Joint Ctr Life Sci, Beijing Adv Innovat Ctr Struct Biol, Beijing 100084, Peoples R China.; Shi, YG (corresponding author), Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China.; Shi, YG (corresponding author), Westlake Univ, Sch Life Sci, Westlake Inst Adv Study, Inst Biol, 18 Shilongshan Rd, Hangzhou 310024, Zhejiang, Peoples R China.	shi-lab@tsinghua.edu.cn	Yan, Chuangye/AAJ-5832-2021	Shi, Yigong/0000-0003-2030-168X; Yan, Chuangye/0000-0001-9338-8048	National Natural Science Foundation of China, China [31430020, 31621092]; National Postdoctoral Program for Innovative Talents, China [BX20180174]; Ministry of Science and Technology, China [2016YFA0501100]	National Natural Science Foundation of China, China(National Natural Science Foundation of China (NSFC)); National Postdoctoral Program for Innovative Talents, China; Ministry of Science and Technology, China(Ministry of Science and Technology, China)	We thank the Tsinghua University Branch of China National Center for Protein Sciences (Beijing) for providing the facility support. The computation was completed on the "Explorer 100'' cluster system of Tsinghua National Laboratory for Information Science and Technology. This work was supported by funds from the National Natural Science Foundation of China, China (31430020 and 31621092), the National Postdoctoral Program for Innovative Talents, China (BX20180174 to R.W.), and the Ministry of Science and Technology, China (2016YFA0501100 to J.L.).	Abelson J, 2010, METHOD ENZYMOL, V472, P31, DOI [10.1016/S0076-6879(10)72017_6, 10.1016/S0076-6879(10)72017-6]; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AEBI M, 1987, CELL, V50, P237, DOI 10.1016/0092-8674(87)90219-4; AEBI M, 1986, CELL, V47, P555, DOI 10.1016/0092-8674(86)90620-3; Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; Bai R, 2018, SCIENCE, V360, P1423, DOI 10.1126/science.aau0325; Bai R, 2017, CELL, V171, P1589, DOI 10.1016/j.cell.2017.10.038; Bao PH, 2017, RNA, V23, P1770, DOI 10.1261/rna.063115.117; Bertram K, 2017, CELL, V170, P701, DOI 10.1016/j.cell.2017.07.011; Bertram K, 2017, NATURE, V542, P318, DOI 10.1038/nature21079; BRODY E, 1985, SCIENCE, V228, P963, DOI 10.1126/science.3890181; BURGESS SM, 1993, CELL, V73, P1377, DOI 10.1016/0092-8674(93)90363-U; Campion Y, 2010, EMBO J, V29, P1817, DOI 10.1038/emboj.2010.70; Chang KJ, 2009, RNA, V15, P1729, DOI 10.1261/rna.1625309; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Chiu YF, 2009, MOL CELL BIOL, V29, P5671, DOI 10.1128/MCB.00773-09; Clark TA, 2002, SCIENCE, V296, P907, DOI 10.1126/science.1069415; Cordin O, 2012, CURR OPIN CELL BIOL, V24, P431, DOI 10.1016/j.ceb.2012.03.004; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fica SM, 2019, SCIENCE, V363, P710, DOI 10.1126/science.aaw5569; Fica SM, 2017, NATURE, V542, P377, DOI 10.1038/nature21078; Fica SM, 2014, NAT STRUCT MOL BIOL, V21, P464, DOI 10.1038/nsmb.2815; Fica SM, 2013, NATURE, V503, P229, DOI 10.1038/nature12734; FRENDEWEY D, 1985, CELL, V42, P355, DOI 10.1016/S0092-8674(85)80131-8; Galej WP, 2016, NATURE, V537, P197, DOI 10.1038/nature19316; Gietz RD, 2007, NAT PROTOC, V2, P35, DOI 10.1038/nprot.2007.14; GRABOWSKI PJ, 1984, CELL, V37, P415, DOI 10.1016/0092-8674(84)90372-6; GRABOWSKI PJ, 1985, CELL, V42, P345, DOI 10.1016/S0092-8674(85)80130-6; Hang J, 2015, SCIENCE, V349, P1191, DOI 10.1126/science.aac8159; Haselbach D, 2018, CELL, V172, P454, DOI 10.1016/j.cell.2018.01.010; Hilliker AK, 2007, GENE DEV, V21, P821, DOI 10.1101/gad.1536107; Jankowsky E, 2011, TRENDS BIOCHEM SCI, V36, P19, DOI 10.1016/j.tibs.2010.07.008; Kawashima T, 2009, RNA, V15, P2236, DOI 10.1261/rna.1736809; Keating KS, 2010, RNA, V16, P1, DOI 10.1261/rna.1791310; KIM SH, 1993, P NATL ACAD SCI USA, V90, P888, DOI 10.1073/pnas.90.3.888; Kim SH, 1996, MOL CELL BIOL, V16, P6810; Kimanius D, 2016, ELIFE, V5, DOI 10.7554/eLife.18722; KING DS, 1990, NUCLEIC ACIDS RES, V18, P6559, DOI 10.1093/nar/18.22.6559; Koodathingal P, 2010, MOL CELL, V39, P385, DOI 10.1016/j.molcel.2010.07.014; Krishnan R, 2013, NAT STRUCT MOL BIOL, V20, P1450, DOI 10.1038/nsmb.2704; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; LAMOND AI, 1987, GENE DEV, V1, P532, DOI 10.1101/gad.1.6.532; Lardelli RM, 2010, RNA, V16, P516, DOI 10.1261/rna.2030510; Lei JL, 2005, J STRUCT BIOL, V150, P69, DOI 10.1016/j.jsb.2005.01.002; Liu HL, 2012, MOL CELL BIOL, V32, P5056, DOI 10.1128/MCB.01109-12; Liu SH, 2017, SCIENCE, V358, P1278, DOI 10.1126/science.aar3462; Liu YC, 2007, MOL CELL BIOL, V27, P5403, DOI 10.1128/MCB.00346-07; Liu YC, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0161-z; Mayas RM, 2006, NAT STRUCT MOL BIOL, V13, P482, DOI 10.1038/nsmb1093; Nicholls RA, 2014, ACTA CRYSTALLOGR D, V70, P2487, DOI 10.1107/S1399004714016241; Ohrt T, 2013, RNA, V19, P902, DOI 10.1261/rna.039024.113; Ohrt T, 2012, RNA, V18, P1244, DOI 10.1261/rna.033316.112; PADGETT RA, 1984, SCIENCE, V225, P898, DOI 10.1126/science.6206566; Park JW, 2004, P NATL ACAD SCI USA, V101, P15974, DOI 10.1073/pnas.0407004101; Perriman RJ, 2007, GENE DEV, V21, P811, DOI 10.1101/gad.1524307; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plaschka C, 2017, NATURE, V546, P617, DOI 10.1038/nature22799; Pleiss JA, 2007, PLOS BIOL, V5, P745, DOI 10.1371/journal.pbio.0050090; Query CC, 2004, MOL CELL, V14, P343, DOI 10.1016/S1097-2765(04)00217-5; Rauhut R, 2016, SCIENCE, V353, P1399, DOI 10.1126/science.aag1906; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; ROY J, 1995, RNA, V1, P375; RUSKIN B, 1984, CELL, V38, P317, DOI 10.1016/0092-8674(84)90553-1; Saltzman AL, 2011, GENE DEV, V25, P373, DOI 10.1101/gad.2004811; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schneider C, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005539; Semlow DR, 2016, CELL, V164, P985, DOI 10.1016/j.cell.2016.01.025; Shcherbakova I, 2013, CELL REP, V5, P151, DOI 10.1016/j.celrep.2013.08.026; Shi YG, 2017, NAT REV MOL CELL BIO, V18, P655, DOI 10.1038/nrm.2017.86; Shi YG, 2017, J MOL BIOL, V429, P2640, DOI 10.1016/j.jmb.2017.07.010; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Tseng CK, 2017, RNA, V23, P546, DOI 10.1261/rna.059204.116; Villa T, 2005, GENE DEV, V19, P1894, DOI 10.1101/gad.1336305; Wan RX, 2017, CELL, V171, P120, DOI 10.1016/j.cell.2017.08.029; Wan RX, 2016, SCIENCE, V353, P895, DOI 10.1126/science.aag2235; Wang F, 2016, J STRUCT BIOL, V195, P325, DOI 10.1016/j.jsb.2016.07.006; Warkocki Z, 2015, GENE DEV, V29, P94, DOI 10.1101/gad.253070.114; Warkocki Z, 2009, NAT STRUCT MOL BIOL, V16, P1237, DOI 10.1038/nsmb.1729; Wilkinson ME, 2017, SCIENCE, V358, P1283, DOI 10.1126/science.aar3729; Will CL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003707; Yan CY, 2017, SCIENCE, V355, P149, DOI 10.1126/science.aak9979; Yan CY, 2016, SCIENCE, V353, P904, DOI 10.1126/science.aag0291; Yan CY, 2015, SCIENCE, V349, P1182, DOI 10.1126/science.aac7629; Yean SL, 2000, NATURE, V408, P881, DOI 10.1038/35048617; Zhan XC, 2018, CELL RES, V28, P1129, DOI 10.1038/s41422-018-0094-7; Zhan XC, 2018, SCIENCE, V359, P537, DOI 10.1126/science.aar6401; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zhang XF, 2019, CELL RES, V29, P274, DOI 10.1038/s41422-019-0143-x; Zhang XF, 2018, CELL RES, V28, P307, DOI 10.1038/cr.2018.14; Zhang XF, 2017, CELL, V169, P918, DOI 10.1016/j.cell.2017.04.033; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	93	36	38	8	162	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 4	2019	177	2					339	+		10.1016/j.cell.2019.02.006	http://dx.doi.org/10.1016/j.cell.2019.02.006			26	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	HR7PF	30879786	Green Submitted, Bronze			2022-12-28	WOS:000463346200013
J	Torjesen, I				Torjesen, Ingrid			Reclassifying cannabis based drugs has not made accessing them easier, MPs hear	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		HAWKES N, 2018, BMJ-BRIT MED J, V362, P76556, DOI DOI 10.1136/BMJ.K2957; HURLEY R, 2018, BMJ-BRIT MED J, V361, DOI DOI 10.1136/BMJ.K2780; HURLEY R, 2019, BMJ-BRIT MED J, V364, DOI DOI 10.1136/BMJ.L753; HURLEY R, 2018, BMJ-BRIT MED J, V363, DOI DOI 10.1136/BMJ.K4654	4	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 20	2019	364								l1302	10.1136/bmj.l1302	http://dx.doi.org/10.1136/bmj.l1302			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HQ8AJ	30894360				2022-12-28	WOS:000462645500018
J	Blomstrom-Lundqvist, C; Gizurarson, S; Schwieler, J; Jensen, SM; Bergfeldt, L; Kenneback, G; Rubulis, A; Malmborg, H; Raatikainen, P; Lonnerholm, S; Hoglund, N; Mortsell, D				Blomstrom-Lundqvist, Carina; Gizurarson, Sigfus; Schwieler, Jonas; Jensen, Steen M.; Bergfeldt, Lennart; Kenneback, Goran; Rubulis, Aigars; Malmborg, Helena; Raatikainen, Pekka; Lonnerholm, Stefan; Hoglund, Niklas; Mortsell, David			Effect of Catheter Ablation vs Antiarrhythmic Medication on Quality of Life in Patients With Atrial Fibrillation The CAPTAF Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PULMONARY-VEIN ABLATION; RADIOFREQUENCY ABLATION; 1ST-LINE TREATMENT; INITIAL THERAPY; DRUG THERAPY; COMPLICATIONS; MULTICENTER; PERFORMANCE; DURATION	IMPORTANCE Quality of life is not a standard primary outcome in ablation trials, even though symptoms drive the indication. OBJECTIVE To assess quality of life with catheter ablation vs antiarrhythmic medication at 12 months in patients with atrial fibrillation. DESIGN, SETTING, AND PARTICIPANTS Randomized clinical trial at 4 university hospitals in Sweden and 1 in Finland of 155 patients aged 30-70 years with more than 6 months of atrial fibrillation and treatment failure with 1 antiarrhythmic drug or beta-blocker, with 4-year follow-up. Study dateswere July 2008-September 2017. Major exclusionswere ejection fraction <35%, left atrial diameter > 60 mm, ventricular pacing dependency, and previous ablation. INTERVENTIONS Pulmonary vein isolation ablation (n= 79) or previously untested antiarrhythmic drugs (n= 76). MAIN OUTCOMES AND MEASURES Primary outcomewas the General Health subscale score (Medical Outcomes Study 36-Item Short-Form Health Survey) at baseline and 12 months, assessed unblinded (range, 0 [worst] to 100 [best]). There were 26 secondary outcomes, including atrial fibrillation burden (% of time) from baseline to 12 months, measured by implantable cardiac monitors. The first 3 months were excluded from rhythm analysis. RESULTS Among 155 randomized patients (mean age, 56.1 years; 22.6% women), 97% completed the trial. Of 79 patients randomized to receive ablation, 75 underwent ablation, including 2 who crossed over to medication and 14 who underwent repeated ablation procedures. Of 76 patients randomized to receive antiarrhythmic medication, 74 received it, including 8 who crossed over to ablation and 43 for whom the first drug used failed. General Health score increased from 61.8 to 73.9 points in the ablation group vs 62.7 to 65.4 points in the medication group (between-group difference, 8.9 points; 95% CI, 3.1-14.7; P=.003). Of 26 secondary end points, 5 were analyzed; 2 were null and 2 were statistically significant, including decrease in atrial fibrillation burden (from 24.9% to 5.5% in the ablation group vs 23.3% to 11.5% in the medication group; difference -6.8%[95% CI, -12.9% to -0.7%]; P=.03). Of the Health Survey subscales, 5 of 7 improved significantly. Most common adverse events were urosepsis (5.1%) in the ablation group and atrial tachycardia (3.9%) in the medication group. CONCLUSIONS AND RELEVANCE Among patients with symptomatic atrial fibrillation despite use of antiarrhythmic medication, the improvement in quality of life at 12 months was greater for those treated with catheter ablation compared with antiarrhythmic medication. Although the study was limited by absence of blinding, catheter ablation may offer an advantage for quality of life.	[Blomstrom-Lundqvist, Carina; Malmborg, Helena; Lonnerholm, Stefan; Mortsell, David] Uppsala Univ, Dept Med Sci & Cardiol, S-75185 Uppsala, Sweden; [Gizurarson, Sigfus; Bergfeldt, Lennart; Rubulis, Aigars] Univ Gothenburg, Sahlgrenska Acad, Dept Mol & Clin Med Cardiol, Inst Med, Gothenburg, Sweden; [Gizurarson, Sigfus; Bergfeldt, Lennart; Rubulis, Aigars] Sahlgrens Univ Hosp, Dept Cardiol, Gothenburg, Sweden; [Schwieler, Jonas; Kenneback, Goran] Karolinska Univ Hosp, Heart & Vasc Theme, Stockholm, Sweden; [Jensen, Steen M.; Hoglund, Niklas] Umea Univ, Ctr Heart, Umea, Sweden; [Jensen, Steen M.; Hoglund, Niklas] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Raatikainen, Pekka] Tampere Univ Hosp, Dept Cardiol, Ctr Heart, Tampere, Finland	Uppsala University; University of Gothenburg; Sahlgrenska University Hospital; Karolinska Institutet; Karolinska University Hospital; Umea University; Umea University; Tampere University; Tampere University Hospital	Blomstrom-Lundqvist, C (corresponding author), Uppsala Univ, Dept Med Sci & Cardiol, S-75185 Uppsala, Sweden.	carina.blomstrom.lundqvist@akademiska.se	Raatikainen, Pekka/AAM-7759-2020	Mortsell, David/0000-0002-2485-6044	Swedish Heart-Lung Foundation [20150751]; Swedish Research Council [2014-36708-117759-70]; Medtronic AB	Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Medtronic AB	The study received unrestricted grants from the Swedish Heart-Lung Foundation (20150751), the Swedish Research Council (2014-36708-117759-70), and Medtronic AB.	Bjorkenheim A, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.008362; Botto GL, 2009, J CARDIOVASC ELECTR, V20, P241, DOI 10.1111/j.1540-8167.2008.01320.x; Calkins H, 2017, J ARRYTHM, V33, P369, DOI 10.1016/j.joa.2017.08.001; Dagres N, 2009, J CARDIOVASC ELECTR, V20, P1014, DOI 10.1111/j.1540-8167.2009.01493.x; Forleo GB, 2009, J CARDIOVASC ELECTR, V20, P22, DOI 10.1111/j.1540-8167.2008.01275.x; Harden M, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-65; Hindricks G, 2005, CIRCULATION, V112, P307, DOI 10.1161/CIRCULATIONAHA.104.518837; Hindricks G, 2010, CIRC-ARRHYTHMIA ELEC, V3, P141, DOI 10.1161/CIRCEP.109.877852; Hoyt H, 2011, HEART RHYTHM, V8, P1869, DOI 10.1016/j.hrthm.2011.07.025; Jais P, 2008, CIRCULATION, V118, P2498, DOI 10.1161/CIRCULATIONAHA.108.772582; Kirchhof P, 2016, EUR HEART J, V37, P2893, DOI 10.1093/eurheartj/ehw210; Kottkamp H, 2004, J AM COLL CARDIOL, V44, P869, DOI 10.1016/j.jacc.2004.047.049; Lim HS, 2008, J CARDIOVASC ELECTR, V19, P891, DOI 10.1111/j.1540-8167.2008.01194.x; Lonnerholm S, 2000, CIRCULATION, V101, P2607, DOI 10.1161/01.CIR.101.22.2607; Mont L, 2014, EUR HEART J, V35, P501, DOI 10.1093/eurheartj/eht457; Morillo CA, 2014, JAMA-J AM MED ASSOC, V311, P692, DOI 10.1001/jama.2014.467; Nielsen JC, 2012, NEW ENGL J MED, V367, P1587, DOI 10.1056/NEJMoa1113566; Oral H, 2006, NEW ENGL J MED, V354, P934, DOI 10.1056/NEJMoa050955; Packer DL, 2013, J AM COLL CARDIOL, V61, P1713, DOI 10.1016/j.jacc.2012.11.064; Pappone C, 2006, J AM COLL CARDIOL, V48, P2340, DOI 10.1016/j.jacc.2006.08.037; Piorkowski C, 2005, J CARDIOVASC ELECTR, V16, P1286, DOI 10.1111/j.1540-8167.2005.00245.x; Pontoppidan J, 2009, PACE, V32, P717, DOI 10.1111/j.1540-8159.2009.02357.x; Ricci R, 2004, J CARDIOVASC ELECTR, V15, P44, DOI 10.1046/j.1540-8167.2004.03317.x; Singh SN, 2006, J AM COLL CARDIOL, V48, P721, DOI 10.1016/j.jacc.2006.03.051; Stabile G, 2006, EUR HEART J, V27, P216, DOI 10.1093/eurheartj/ehi583; SULLIVAN M, 1995, SOC SCI MED, V41, P1349, DOI 10.1016/0277-9536(95)00125-Q; Walfridsson H, 2015, EUROPACE, V17, P215, DOI 10.1093/europace/euu342; Ware JE, 1993, SF36 HLTH SURVEY MAN; Wazni OM, 2005, JAMA-J AM MED ASSOC, V293, P2634, DOI 10.1001/jama.293.21.2634; Wilber DJ, 2010, JAMA-J AM MED ASSOC, V303, P333, DOI 10.1001/jama.2009.2029; Ziegler PD, 2006, HEART RHYTHM, V3, P1445, DOI 10.1016/j.hrthm.2006.07.030	31	129	132	2	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 19	2019	321	11					1059	1068		10.1001/jama.2019.0335	http://dx.doi.org/10.1001/jama.2019.0335			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP4YY	30874754	Green Published, Bronze			2022-12-28	WOS:000461683500014
J	Iacobucci, G				Iacobucci, Gareth			Tax social media firms to protect young people's health, MPs urge	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2019, NEWFILTERS MAN IMP S; HAWKES N, 2019, BMJ-BRIT MED J, V364, DOI DOI 10.1136/BMJ.L643; PIKE H, 2019, BMJ-BRIT MED J, V364, DOI DOI 10.1136/BMJ.L73; Royal College of Paediatrics and Child Health, HLTH IMP SCREEN TIM; WISE J, 2019, BMJ-BRIT MED J, V364, DOI DOI 10.1136/BMJ.L486	5	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 18	2019	364								l1263	10.1136/bmj.l1263	http://dx.doi.org/10.1136/bmj.l1263			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HQ7ZV	30886029				2022-12-28	WOS:000462643800014
J	Dalton, L; Rapa, E; Ziebland, S; Rochat, T; Kelly, B; Hanington, L; Bland, R; Yousafzai, A; Stein, A; Betancourt, T; Bluebond-Langner, M; D'Souza, C; Fazel, M; Netsi, E; Stein, KF; Harrop, E; Hochhauser, D; Kolucki, B; Lowney, AC; Richter, L				Dalton, Louise; Rapa, Elizabeth; Ziebland, Sue; Rochat, Tamsen; Kelly, Brenda; Hanington, Lucy; Bland, Ruth; Yousafzai, Aisha; Stein, Alan; Betancourt, T.; Bluebond-Langner, M.; D'Souza, C.; Fazel, M.; Netsi, E.; Stein, K. F.; Harrop, E.; Hochhauser, D.; Kolucki, B.; Lowney, A. C.; Richter, L.		Commun Expert Grp	Communication with children and adolescents about the diagnosis of a life-threatening condition in their parent	LANCET			English	Review							MATERNAL HIV DISCLOSURE; BREAST-CANCER; QUALITATIVE INTERVIEW; AMAGUGU INTERVENTION; POSITIVE MOTHERS; SOUTH-AFRICA; EXPERIENCES; SUPPORT; FAMILY; DEATH	Many adults diagnosed with a life-threatening condition have children living at home; they and their partners face the dual challenge of coping with the diagnosis while trying to maintain a parenting role. Parents are often uncertain about how, when, and what to tell their children about the condition, and are fearful of the effect on their family. There is evidence that children are often aware that something is seriously wrong and want honest information. Health-care professionals have a key role in supporting and guiding parents and caregivers to communicate with their children about the diagnosis. However, the practical and emotional challenges of communicating with families are compounded by a scarcity of evidence-based guidelines. This Review considers children's awareness and understanding of their parents' condition, the effect of communication around parental life-threatening condition on their wellbeing, factors that influence communication, and the challenges to achieving effective communication. Children's and parents' preferences about communication are outlined. An expert workshop was convened to generate principles for health-care professionals, intended as practical guidance in the current absence of empirically derived guidelines.	[Dalton, Louise; Rapa, Elizabeth; Hanington, Lucy; Stein, Alan; Fazel, M.] Univ Oxford, Dept Psychiat, Oxford OX3 7JX, England; [Kelly, Brenda] Univ Oxford, Nuffield Dept Womens & Reprod Hlth, Oxford, England; [Ziebland, Sue] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England; [Bland, Ruth; Stein, Alan] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, South Africa; [Rochat, Tamsen] Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, Dept Paediat, Johannesburg, South Africa; [Stein, K. F.] Univ Bath, Dept Psychol, Bath, Avon, England; [Rochat, Tamsen] Human Sci Res Council, Johannesburg, South Africa; [Kelly, Brenda; Harrop, E.; Lowney, A. C.] Oxford Univ Hosp NHS Fdn Trust, Oxford, England; [Harrop, E.] Helen & Douglas House, Oxford, England; [Bland, Ruth] Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland; [Bland, Ruth] Univ Glasgow, Glasgow, Lanark, Scotland; [Bland, Ruth] Royal Hosp Children, Glasgow, Lanark, Scotland; [Yousafzai, Aisha] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Betancourt, T.] Boston Coll, Boston, MA USA; [Bluebond-Langner, M.] UCL Great Ormond St Inst Child Hlth, London, England; [D'Souza, C.] South Canterbury Dist Hlth Board, Timaru, New Zealand; [Hochhauser, D.] UCL Canc Inst, London, England; [Kolucki, B.] UNICEF, Commun & Children Difficult Circumstances, New York, NY USA; [Lowney, A. C.] Sir Michael Sobell House, Oxford, England; [Richter, L.] Univ Witwatersrand, Johannesburg, South Africa	University of Oxford; University of Oxford; University of Oxford; University of Witwatersrand; University of Witwatersrand; University of Bath; Human Sciences Research Council-South Africa; Oxford University Hospitals NHS Foundation Trust; University of Glasgow; Harvard University; Harvard T.H. Chan School of Public Health; Boston College; University of London; University College London; University of London; University College London; UNICEF; University of Oxford; University of Witwatersrand	Stein, A (corresponding author), Univ Oxford, Dept Psychiat, Oxford OX3 7JX, England.	alan.stein@psych.ox.ac.uk	Rochat, Tamsen/AAU-5756-2021	Rochat, Tamsen/0000-0002-5223-770X; Dalton, Louise/0000-0003-1923-5769; Ziebland, Sue/0000-0002-6496-4859; Rapa, Elizabeth/0000-0001-8818-8148; Harrop, Emily/0000-0002-2480-2062; Netsi, Elena/0000-0003-0448-0104; Stein, Alan/0000-0001-8207-2822; Bland, Ruth/0000-0003-1675-9268; Hochhauser, Daniel/0000-0001-5522-9281	John Fell Fund, University of Oxford; Sheila Kitzinger Programme, Green Templeton College, Oxford	John Fell Fund, University of Oxford; Sheila Kitzinger Programme, Green Templeton College, Oxford	The study was funded by The John Fell Fund, University of Oxford and The Sheila Kitzinger Programme, Green Templeton College, Oxford supported the workshop. We are grateful to Duncan West and Melissa de Lusignan for facilitating the expert workshop, and to Valerie West, Mike Beckles, Nia Roberts, Hannah DeJong, Elise Sellars, and patient and public involvement from a parent with cancer (written permission obtained).	Amery J, 2009, CHILDRENS PALLIATIVE, P289; Armistead L, 2001, J PEDIATR PSYCHOL, V26, P11, DOI 10.1093/jpepsy/26.1.11; Barnes J, 2000, BRIT MED J, V321, P479, DOI 10.1136/bmj.321.7259.479; Barnes J, 2002, J PSYCHOSOM RES, V52, P209, DOI 10.1016/S0022-3999(02)00296-9; Beale Estela A, 2004, Palliat Support Care, V2, P387; Betancourt TS, 2017, J CHILD PSYCHOL PSYC, V58, P922, DOI 10.1111/jcpp.12729; Bugge KE, 2009, J CLIN NURS, V18, P3480, DOI 10.1111/j.1365-2702.2009.02871.x; Bylund-Grenklo T, 2015, ACTA ONCOL, V54, P944, DOI 10.3109/0284186X.2014.978891; Chaudhury S, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00138; Chowns G, 2013, BEREAVE CARE, V32, P23, DOI 10.1080/02682621.2013.779822; CHRIST GH, 1993, AM J ORTHOPSYCHIAT, V63, P417, DOI 10.1037/h0079451; Christ GH, 2005, J SOC WORK END-LIFE, V1, P57, DOI 10.1300/J457v01n03_05; Christ GH, 2006, CA-CANCER J CLIN, V56, P197, DOI 10.3322/canjclin.56.4.197; Clark SJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001409; Davey MP, 2011, PSYCHO-ONCOLOGY, V20, P77, DOI 10.1002/pon.1712; De Bacts AJ, 2008, SOC SCI MED, V66, P479, DOI 10.1016/j.socscimed.2007.08.028; Edwards L, 2008, PSYCHO-ONCOL, V17, P1039, DOI 10.1002/pon.1323; Ellis J, 2013, J ROY SOC MED, V106, P57, DOI 10.1177/0141076812472623; Ellis S J, 2017, Eur J Cancer Care (Engl), V26, DOI 10.1111/ecc.12432; Ernst JC, 2013, CANCER-AM CANCER SOC, V119, P2333, DOI 10.1002/cncr.28021; Fallowfield L, 2004, LANCET, V363, P312, DOI 10.1016/S0140-6736(03)15392-5; Forrest G, 2006, BMJ-BRIT MED J, V332, P998, DOI 10.1136/bmj.38793.567801.AE; Forrest G, 2009, PSYCHO-ONCOLOGY, V18, P96, DOI 10.1002/pon.1387; Giesbers J, 2010, PSYCHO-ONCOLOGY, V19, P887, DOI 10.1002/pon.1636; Greening Karen, 1992, Journal of Psychosocial Oncology, V10, P47, DOI 10.1300/J077v10n01_05; Harris CA, 2003, PSYCHO-ONCOL, V12, P173, DOI 10.1002/pon.631; HARRIS ES, 1991, CHILD PSYCHIAT HUM D, V21, P267, DOI 10.1007/BF00705931; Helseth S, 2005, J ADV NURS, V52, P38, DOI 10.1111/j.1365-2648.2005.03562.x; Huizinga GA, 2005, ANN ONCOL, V16, P1956, DOI 10.1093/annonc/mdi395; Huizinga GA, 2005, EUR J CANCER, V41, P288, DOI 10.1016/j.ejca.2004.10.005; Inhestern L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156967; Kennedy VL, 2009, J AFFECT DISORDERS, V114, P149, DOI 10.1016/j.jad.2008.06.022; Krauel K, 2012, EXPERT REV PHARM OUT, V12, P795, DOI [10.1586/ERP.12.62, 10.1586/erp.12.62]; Kristjanson LJ, 2004, ONCOL NURS FORUM, V31, P111, DOI 10.1188/04.ONF.111-119; Lee MB, 2002, AIDS, V16, P2201, DOI 10.1097/00002030-200211080-00013; Letteney S, 2004, SOC WORK HEALTH CARE, V38, P105, DOI 10.1300/J010v38n03_06; Levetown M, 2008, PEDIATRICS, V121, pE1441, DOI 10.1542/peds.2008-0565; Lewis FM, 2015, J CONSULT CLIN PSYCH, V83, P12, DOI 10.1037/a0038219; Maynard A, 2013, J PSYCHOSOC ONCOL, V31, P675, DOI 10.1080/07347332.2013.835021; Mkwanazi NB, 2017, HEALTH POLICY PLANN, V32, P1231, DOI 10.1093/heapol/czx056; Mkwanazi NB, 2012, FUTURE VIROL, V7, P1159, DOI 10.2217/FVL.12.109; Murphy D, 2003, J CHILD FAM STUD, V12, P307, DOI DOI 10.1023/A:1023939827449; Murphy DA, 2001, J FAM PSYCHOL, V15, P441, DOI 10.1037/0893-3200.15.3.441; Murphy DA, 2011, J CONSULT CLIN PSYCH, V79, P203, DOI 10.1037/a0022896; Murphy Debra A, 2008, Clin Child Psychol Psychiatry, V13, P105, DOI 10.1177/1359104507087464; Nam SL, 2009, AIDS CARE, V21, P389, DOI 10.1080/09540120802270276; Nelson E, 2002, J PSYCHOSOC ONCOL, V20, P15, DOI 10.1300/J077v20n01_02; Niemela M, 2012, INT J CANCER, V131, P2117, DOI 10.1002/ijc.27466; O'Malley G, 2015, JAIDS-J ACQ IMM DEF, V68, pE1, DOI 10.1097/QAI.0000000000000387; Ostrom RA, 2006, AIDS CARE, V18, P60, DOI 10.1080/09540120500161769; Palin FL, 2009, AIDS BEHAV, V13, P1241, DOI 10.1007/s10461-008-9447-4; Paliokosta E, 2009, FAM SYST HEALTH, V27, P64, DOI 10.1037/a0015226; Patenaude AF, 2005, J PEDIATR PSYCHOL, V30, P9, DOI 10.1093/jpepsy/jsi012; Phillips F, 2015, PALLIATIVE MED, V29, P851, DOI 10.1177/0269216315578989; Qiao S, 2013, AIDS BEHAV, V17, P369, DOI 10.1007/s10461-011-0069-x; Rochat TJ, 2017, LANCET HIV, V4, pE566, DOI 10.1016/S2352-3018(17)30133-9; Rochat TJ, 2017, SOC SCI MED, V172, P124, DOI 10.1016/j.socscimed.2016.10.031; Rochat Tamsen J, 2015, AIDS, V29 Suppl 1, pS67, DOI 10.1097/QAD.0000000000000668; Rochat TJ, 2014, AIDS, V28, pS331, DOI 10.1097/QAD.0000000000000333; Rochat TJ, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-147; ROSENHEIM E, 1985, J CHILD PSYCHOL PSYC, V26, P995, DOI 10.1111/j.1469-7610.1985.tb00613.x; Rotheram-Borus MJ, 2001, AM J PUBLIC HEALTH, V91, P1294, DOI 10.2105/AJPH.91.8.1294; Sheehan DK, 2014, J PALLIAT MED, V17, P512, DOI 10.1089/jpm.2013.0344; Shields L, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004811.pub3; Sipsma H, 2013, AIDS CARE, V25, P721, DOI 10.1080/09540121.2013.779627; Stein A, 2019, LANCET, V393, P1038; Stokes J, 2012, BIG IT GETS SUPPORTI; Su YH, 2007, CANCER NURS, V30, P362, DOI 10.1097/01.NCC.0000290817.37442.e6; Thastum Mikael, 2006, Clin Child Psychol Psychiatry, V11, P529, DOI 10.1177/1359104506067875; Thastum Mikael, 2008, Clin Child Psychol Psychiatry, V13, P123, DOI 10.1177/1359104507086345; Thomas B, 2009, AIDS BEHAV, V13, P989, DOI 10.1007/s10461-008-9478-x; UNAIDS, GLOB HIV AIDS STAT 2; UNICEF, 1989, UN CONV RIGHTS CHILD; Vallerand AH, 2005, AIDS PATIENT CARE ST, V19, P100, DOI 10.1089/apc.2005.19.100; Weaver KE, 2010, CANCER-AM CANCER SOC, V116, P4395, DOI 10.1002/cncr.25368; WHO, 2005, HIV AIDS; Withell B, 2009, INT J PALLIAT NURS, V15, P128, DOI 10.12968/ijpn.2009.15.3.41091; Wood K, 2006, SOC SCI MED, V63, P1923, DOI 10.1016/j.socscimed.2006.04.027; World Health Organization, 2011, GUID HIV DISCL COUNS; World Health Organization, 2018, CANC FACT SHEET; Xu T, 2007, VULNERABLE CHILD YOU, V2, P100, DOI 10.1080/17450120701335791; Zhao JF, 2015, AIDS CARE, V27, P416, DOI 10.1080/09540121.2014.978733; Zhou Y, 2013, CHILD CARE HLTH DEV, V39, P816, DOI 10.1111/j.1365-2214.2012.01394.x	83	57	57	1	23	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 16	2019	393	10176					1164	1176		10.1016/S0140-6736(18)33202-1	http://dx.doi.org/10.1016/S0140-6736(18)33202-1			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HP1HF	30894272	Green Submitted			2022-12-28	WOS:000461416600035
J	Hanifi, DA; Bronstein, ND; Koscher, BA; Nett, Z; Swabeck, JK; Takano, K; Schwartzberg, AM; Maserati, L; Vandewal, K; van de Burgt, Y; Salleo, A; Alivisatos, AP				Hanifi, David A.; Bronstein, Noah D.; Koscher, Brent A.; Nett, Zach; Swabeck, Joseph K.; Takano, Kaori; Schwartzberg, Adam M.; Maserati, Lorenzo; Vandewal, Koen; van de Burgt, Yoeri; Salleo, Alberto; Alivisatos, A. Paul			Redefining near-unity luminescence in quantum dots with photothermal threshold quantum yield	SCIENCE			English	Article							SOLAR CONCENTRATORS; NANOCRYSTALS; EMISSION	A variety of optical applications rely on the absorption and reemission of light. The quantum yield of this process often plays an essential role. When the quantum yield deviates from unity by significantly less than 1%, applications such as luminescent concentrators and optical refrigerators become possible. To evaluate such high performance, we develop a measurement technique for luminescence efficiency with sufficient accuracy below one part per thousand. Photothermal threshold quantum yield is based on the quantization of light to minimize overall measurement uncertainty. This technique is used to guide a procedure capable of making ensembles of near-unity emitting cadmium selenide/cadmium sulfide (CdSe/CdS) core-shell quantum dots. We obtain a photothermal threshold quantum yield luminescence efficiency of 99.6 +/- 0.2%, indicating nearly complete suppression of nonradiative decay channels.	[Hanifi, David A.; Salleo, Alberto] Stanford Univ, Dept Mat Sci & Engn, Stanford, CA 94305 USA; [Bronstein, Noah D.; Koscher, Brent A.; Nett, Zach; Swabeck, Joseph K.; Alivisatos, A. Paul] Lawrence Berkeley Natl Lab, Mat Sci Div, Berkeley, CA 94720 USA; [Koscher, Brent A.; Swabeck, Joseph K.; Alivisatos, A. Paul] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Koscher, Brent A.; Swabeck, Joseph K.; Alivisatos, A. Paul] Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA; [Takano, Kaori] JXTG Nippon Oil & Energy Corp, Mat R&D Grp, HPM Res & Dev Dept, High Performance Mat Co,Naka Ku, 8 Chidori Cho, Yokohama, Kanagawa 2310815, Japan; [Schwartzberg, Adam M.; Maserati, Lorenzo] Lawrence Berkeley Natl Lab, Mol Foundry, Berkeley, CA 94720 USA; [Vandewal, Koen] Hasselt Univ, IMO IMOMEC, Wetenschapspk 1, B-3590 Diepenbeek, Belgium; [Vandewal, Koen] Hasselt Univ, Inst Mat Res, Wetenschapspk 1, B-3590 Diepenbeek, Belgium; [van de Burgt, Yoeri] Eindhoven Univ Technol, Inst Complex Mol Syst, Microsyst, NL-5612 AJ Eindhoven, Netherlands; [Alivisatos, A. Paul] Kavli Energy NanoSci Inst, Berkeley, CA 94720 USA; [Maserati, Lorenzo] Ist Italiano Tecnol, Ctr Nano Sci & Technol PoliMi, Via Giovanni Pascoli 70-3, I-20133 Milan, Italy	Stanford University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; ENEOS Corporation; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Hasselt University; Hasselt University; Eindhoven University of Technology; Istituto Italiano di Tecnologia - IIT	Salleo, A (corresponding author), Stanford Univ, Dept Mat Sci & Engn, Stanford, CA 94305 USA.; Alivisatos, AP (corresponding author), Lawrence Berkeley Natl Lab, Mat Sci Div, Berkeley, CA 94720 USA.; Alivisatos, AP (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.; Alivisatos, AP (corresponding author), Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA.; Alivisatos, AP (corresponding author), Kavli Energy NanoSci Inst, Berkeley, CA 94720 USA.	asalleo@stanford.edu; paul.alivisatos@berkeley.edu	van de Burgt, Yoeri/GVU-5837-2022; Schwartzberg, Adam/AAN-7630-2020; Vandewal, Koen/P-8285-2019; Alivisatos, Paul/N-8863-2015; Maserati, Lorenzo/Q-9147-2016	van de Burgt, Yoeri/0000-0003-3472-0148; Schwartzberg, Adam/0000-0001-6335-0719; Vandewal, Koen/0000-0001-5471-383X; Alivisatos, Paul/0000-0001-6895-9048; Maserati, Lorenzo/0000-0002-9938-8935; Nett, Zachary/0000-0002-8086-4380; , test account bib/0000-0003-0088-6801; Swabeck, Joseph/0000-0003-2235-2472; Bronstein, Noah/0000-0003-3657-2652; Takano, Kaori/0000-0001-7963-9664	U.S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences [DE-SC0019140]; DOE, Office of Science, Office of Basic Energy Sciences [DE-AC02-05CH11231]; European Research Council under the European Union's Horizon 2020 research and innovation program [802615]; JXTG Nippon Oil Energy	U.S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); European Research Council under the European Union's Horizon 2020 research and innovation program; JXTG Nippon Oil Energy	This work is part of the 'Photonics at Thermodynamic Limits' Energy Frontier Research Center funded by the U.S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences, under award DE-SC0019140. Work at the Molecular Foundry by A.M.S. and L.M. (transient absorption measurements) was supported by the DOE, Office of Science, Office of Basic Energy Sciences, under contract DE-AC02-05CH11231. Y.v.d.B. (modeling and analysis) acknowledges funding from the European Research Council under the European Union's Horizon 2020 research and innovation program (grant 802615). K.T. (synthesis methodology) acknowledges funding from JXTG Nippon Oil & Energy.	Anderson NC, 2013, J AM CHEM SOC, V135, P18536, DOI 10.1021/ja4086758; Bender DA, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4811759; Bronstein ND, 2015, ACS PHOTONICS, V2, P1576, DOI 10.1021/acsphotonics.5b00334; Chen O, 2013, NAT MATER, V12, P445, DOI [10.1038/nmat3539, 10.1038/NMAT3539]; Hammam M, 2007, DESALINATION, V209, P244, DOI 10.1016/j.desal.2007.04.034; Hanifi D., 2019, SOFTWARE DATA REDEFI, DOI [10.6078/D1XM30, DOI 10.6078/D1XM30]; JACKSON WB, 1981, APPL OPTICS, V20, P1333, DOI 10.1364/AO.20.001333; Jasieniak J, 2009, J PHYS CHEM C, V113, P19468, DOI 10.1021/jp906827m; Jones M, 2009, P NATL ACAD SCI USA, V106, P3011, DOI 10.1073/pnas.0809316106; KUSHIDA T, 1968, PHYS REV LETT, V21, P1172, DOI 10.1103/PhysRevLett.21.1172; Meinardi F, 2014, NAT PHOTONICS, V8, P392, DOI 10.1038/nphoton.2014.54; Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274; Needell DR, 2018, IEEE J PHOTOVOLT, V8, P1560, DOI 10.1109/JPHOTOV.2018.2861751; Olshansky JH, 2015, J AM CHEM SOC, V137, P15567, DOI 10.1021/jacs.5b10856; Rabouw FT, 2016, NANO LETT, V16, P2047, DOI 10.1021/acs.nanolett.6b00053; Rabouw FT, 2015, NANO LETT, V15, P7718, DOI 10.1021/acs.nanolett.5b03818; Sansonetti JE, 2005, J PHYS CHEM REF DATA, V34, P1559, DOI 10.1063/1.1800011; SCHNITZER I, 1993, APPL PHYS LETT, V62, P131, DOI 10.1063/1.109348; Sheik-Bahae M, 2007, NAT PHOTONICS, V1, P693, DOI 10.1038/nphoton.2007.244; Shirasaki Y, 2013, NAT PHOTONICS, V7, P13, DOI 10.1038/nphoton.2012.328; Song HJ, 2018, NANO LETT, V18, P395, DOI 10.1021/acs.nanolett.7b04263; Swanson R. M., 1980, INT EL DEV M WASH DC, DOI [10.1109/IEDM.1980.189789, DOI 10.1109/IEDM.1980.189789]; Vandewal K, 2006, EUR PHYS J-APPL PHYS, V36, P281, DOI 10.1051/epjap:2006140; Vandewal K, 2014, NAT MATER, V13, P63, DOI [10.1038/NMAT3807, 10.1038/nmat3807]; WEBER WH, 1976, APPL OPTICS, V15, P2299, DOI 10.1364/AO.15.002299; Wurth C, 2013, NAT PROTOC, V8, P1535, DOI 10.1038/nprot.2013.087; Xiao TP, 2018, J APPL PHYS, V123, DOI 10.1063/1.5019764; Zhong T, 2017, SCIENCE, V357, P1392, DOI 10.1126/science.aan5959	28	124	124	19	238	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 15	2019	363	6432			SI		1199	+		10.1126/science.aat3803	http://dx.doi.org/10.1126/science.aat3803			62	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP0BC	30872520	Green Submitted			2022-12-28	WOS:000461329000044
J	Lu, E; Wolfreys, FD; Muppidi, JR; Xu, Y; Cyster, JG				Lu, Erick; Wolfreys, Finn D.; Muppidi, Jagan R.; Xu, Ying; Cyster, Jason G.			S-Geranylgeranyl-L-glutathione is a ligand for human B cell-confinement receptor P2RY8	NATURE			English	Article							GERMINAL CENTER CONFINEMENT; MASS-SPECTROMETRY; SOMATIC MUTATIONS; LEUKOTRIENE C-4; LYMPHOMA; PATHOGENESIS; SYNTHASE	Germinal centres are important sites for antibody diversification and affinity maturation, and are also a common origin of B cell malignancies. Despite being made up of motile cells, germinal centres are tightly confined within B cell follicles. The cues that promote this confinement are incompletely understood. P2RY8 is a G alpha(13)-coupled receptor that mediates the inhibition of migration and regulates the growth of B cells in lymphoid tissues(1,2). P2RY8 is frequently mutated in germinal-centre B cell-like diffuse large B cell lymphoma (GCB-DLBCL) and Burkitt lymphoma(1,3-6), and the ligand for this receptor has not yet been identified. Here we perform a search for P2RY8 ligands and find P2RY8 bioactivity in bile and in culture supernatants of several mouse and human cell lines. Using a seven-step biochemical fractionation procedure and a drop-out mass spectrometry approach, we show that a previously undescribed biomolecule, S-geranylgeranyl-l-glutathione (GGG), is a potent P2RY8 ligand that is detectable in lymphoid tissues at the nanomolar level. GGG inhibited the chemokine-mediated migration of human germinal-centre B cells and T follicular helper cells, and antagonized the induction of phosphorylated AKT in germinal-centre B cells. We also found that the enzyme gamma-glutamyltransferase-5 (GGT5), which was highly expressed by follicular dendritic cells, metabolized GGG to a form that did not activate the receptor. Overexpression of GGT5 disrupted the ability of P2RY8 to promote B cell confinement to germinal centres, which indicates that GGT5 establishes a GGG gradient in lymphoid tissues. This work defines GGG as an intercellular signalling molecule that is involved in organizing and controlling germinal-centre responses. As the P2RY8 locus is modified in several other types of cancer in addition to GCB-DLBCL and Burkitt lymphoma, we speculate that GGG might have organizing and growth-regulatory roles in multiple human tissues.	[Lu, Erick; Wolfreys, Finn D.; Muppidi, Jagan R.; Xu, Ying; Cyster, Jason G.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Lu, Erick; Wolfreys, Finn D.; Muppidi, Jagan R.; Xu, Ying; Cyster, Jason G.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Muppidi, Jagan R.] NCI, Lymphoid Malignancies Branch, NIH, Bethesda, MD 20892 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Cyster, JG (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.; Cyster, JG (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.	jason.cyster@ucsf.edu		Muppidi, Jagan/0000-0002-2639-4226; Lu, Erick/0000-0001-8175-5146	UCSF Biomedical Sciences Graduate Program; NSF [1144247]; NIH [RO1 AI45073]; NATIONAL CANCER INSTITUTE [ZIABC011772] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045073, T32AI007334] Funding Source: NIH RePORTER	UCSF Biomedical Sciences Graduate Program; NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank E. Bess and P. Turnbaugh for providing access to their HPLC equipment; Z. Zhang and K. Shokat for providing access to their chemistry equipment and quadrupole time-of-flight mass spectrometer; J. Jespersen and J. Baron for helping to coordinate tonsil specimens; L. Staudt for DLBCL cell lines; N. Barclay for the OX56 hybridoma; J. An for assistance with mouse husbandry; and D. Russell, J. McDonald and J. Wu for discussions. J.G.C. is an investigator of the Howard Hughes Medical Institute. E.L. was supported by the UCSF Biomedical Sciences Graduate Program and NSF grant 1144247. This work was supported in part by NIH grant RO1 AI45073.	Allen CDC, 2008, SEMIN IMMUNOL, V20, P14, DOI 10.1016/j.smim.2007.12.001; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Brune V, 2008, J EXP MED, V205, P2251, DOI 10.1084/jem.20080809; Carter BZ, 1997, J BIOL CHEM, V272, P12305, DOI 10.1074/jbc.272.19.12305; CYSTER JG, 1991, EMBO J, V10, P893, DOI 10.1002/j.1460-2075.1991.tb08022.x; Dieckhaus CM, 2005, CHEM RES TOXICOL, V18, P630, DOI 10.1021/tx049741u; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Green JA, 2012, IMMUNOL REV, V247, P36, DOI 10.1111/j.1600-065X.2012.01114.x; Green JA, 2011, NAT IMMUNOL, V12, P672, DOI 10.1038/ni.2047; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Heisterkamp N, 2008, HUM GENET, V123, P321, DOI 10.1007/s00439-008-0487-7; Justus CR, 2015, EXP CELL RES, V334, P100, DOI 10.1016/j.yexcr.2015.03.022; Kridel R, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002197; Lee M, 2014, NAT IMMUNOL, V15, P982, DOI 10.1038/ni.2983; Liu WJ, 2013, TETRAHEDRON LETT, V54, P6208, DOI 10.1016/j.tetlet.2013.09.004; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Morin RD, 2013, BLOOD, V122, P1256, DOI 10.1182/blood-2013-02-483727; Mullighan CG, 2009, NAT GENET, V41, P1243, DOI 10.1038/ng.469; Muppidi JR, 2015, J EXP MED, V212, P2213, DOI 10.1084/jem.20151250; Muppidi JR, 2014, NATURE, V516, P254, DOI 10.1038/nature13765; Niegowski D, 2014, J BIOL CHEM, V289, P5199, DOI 10.1074/jbc.M113.534628; Rodda L. B, IMMUNITY, V48; Schmitz R, 2018, NEW ENGL J MED, V378, P1396, DOI 10.1056/NEJMoa1801445; Shimizu T, 2009, ANNU REV PHARMACOL, V49, P123, DOI 10.1146/annurev.pharmtox.011008.145616; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Wiemer AJ, 2011, CLIN PHARMACOL THER, V90, P804, DOI 10.1038/clpt.2011.215; Xie C, 2013, ANAL CHIM ACTA, V788, P89, DOI 10.1016/j.aca.2013.06.022	27	41	43	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 14	2019	567	7747					244	+		10.1038/s41586-019-1003-z	http://dx.doi.org/10.1038/s41586-019-1003-z			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7LD	30842656	Green Submitted, Green Accepted			2022-12-28	WOS:000461126600043
J	Pietrzynski, G; Graczyk, D; Gallenne, A; Gieren, W; Thompson, IB; Pilecki, B; Karczmarek, P; Gorski, M; Suchomska, K; Taormina, M; Zgirski, B; Wielgorski, P; Kolaczkowski, Z; Konorski, P; Villanova, S; Nardetto, N; Kervella, P; Bresolin, F; Kudritzki, RP; Storm, J; Smolec, R; Narloch, W				Pietrzynski, G.; Graczyk, D.; Gallenne, A.; Gieren, W.; Thompson, I. B.; Pilecki, B.; Karczmarek, P.; Gorski, M.; Suchomska, K.; Taormina, M.; Zgirski, B.; Wielgorski, P.; Kolaczkowski, Z.; Konorski, P.; Villanova, S.; Nardetto, N.; Kervella, P.; Bresolin, F.; Kudritzki, R. P.; Storm, J.; Smolec, R.; Narloch, W.			A distance to the Large Magellanic Cloud that is precise to one per cent	NATURE			English	Article							BINARY; ACCURATE; CATALOG; STELLAR; ORBIT; UBV; CALIBRATION; PHOTOMETRY; CEPHEIDS; COLORS	In the era of precision cosmology, it is essential to determine the Hubble constant empirically with an accuracy of one per cent or better(1). At present, the uncertainty on this constant is dominated by the uncertainty in the calibration of the Cepheid period-luminosity relationship(2,3) (also known as the Leavitt law). The Large Magellanic Cloud has traditionally served as the best galaxy with which to calibrate Cepheid period-luminosity relations, and as a result has become the best anchor point for the cosmic distance scale(4,5). Eclipsing binary systems composed of late-type stars offer the most precise and accurate way to measure the distance to the Large Magellanic Cloud. Currently the limit of the precision attainable with this technique is about two per cent, and is set by the precision of the existing calibrations of the surface brightness-colour relation(5,6). Here we report a calibration of the surface brightness-colour relation with a precision of 0.8 per cent. We use this calibration to determine a geometrical distance to the Large Magellanic Cloud that is precise to 1 per cent based on 20 eclipsing binary systems. The final distance is 49.59 +/- 0.09 (statistical) +/- 0.54 (systematic) kiloparsecs.	[Pietrzynski, G.; Graczyk, D.; Pilecki, B.; Taormina, M.; Zgirski, B.; Wielgorski, P.; Kolaczkowski, Z.; Smolec, R.; Narloch, W.] Nicolaus Copernicus Astron Ctr, Warsaw, Poland; [Pietrzynski, G.; Graczyk, D.; Gieren, W.; Gorski, M.; Villanova, S.] Univ Concepcion, Dept Astron, Concepcion, Chile; [Graczyk, D.] Millennium Inst Astrophys MAS, Santiago, Chile; [Gallenne, A.] European Southern Observ, Santiago, Chile; [Gallenne, A.; Nardetto, N.] Univ Cote Azur, CNRS, Lab Lagrange, Observ Cote Azur, Nice, France; [Thompson, I. B.] Carnegie Observ, Pasadena, CA USA; [Karczmarek, P.; Suchomska, K.; Konorski, P.] Univ Warsaw Observ, Warsaw, Poland; [Kolaczkowski, Z.] Wroclaw Univ, Astron Inst, Wroclaw, Poland; [Kervella, P.] Sorbonne Univ, Univ Paris Diderot, Univ PSL, CNRS,Sorbonne Paris Cite,Observ Paris,LESIA, Meudon, France; [Bresolin, F.; Kudritzki, R. P.] Inst Astron, Honolulu, HI USA; [Kudritzki, R. P.] Munich Univ Observ, Munich, Germany; [Storm, J.] Leibniz Inst Astrophys, Potsdam, Germany	Polish Academy of Sciences; Nicolaus Copernicus Astronomical Center of the Polish Academy of Sciences; Universidad de Concepcion; European Southern Observatory; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Observatoire de la Cote d'Azur; Carnegie Institution for Science; University of Warsaw; Warsaw University Observatory; University of Wroclaw; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite; Universite Paris Cite; University of Munich; Leibniz Institut fur Astrophysik Potsdam (AIP)	Pietrzynski, G (corresponding author), Nicolaus Copernicus Astron Ctr, Warsaw, Poland.; Pietrzynski, G (corresponding author), Univ Concepcion, Dept Astron, Concepcion, Chile.	pietrzyn@camk.edu.pl	Karczmarek, Paulina/B-5696-2015; Smolec, Radoslaw/F-1435-2013; Nardetto, Nicolas/GSE-2085-2022; Storm, Jesper/AAM-7106-2021; Kervella, Pierre/A-6098-2012	Smolec, Radoslaw/0000-0001-7217-4884; Storm, Jesper/0000-0002-8627-6096; Gorski, Marek/0000-0002-3125-9088; Narloch, Weronika/0000-0003-2335-2060; Pilecki, Bogumil/0000-0003-3861-8124; Graczyk, Dariusz/0000-0002-7355-9775; Bresolin, Fabio/0000-0002-5068-9833; Wielgorski, Piotr/0000-0002-1662-5756; Taormina, Monica/0000-0002-1560-8620; Pietrzynski, Grzegorz/0000-0002-9443-4138; Suchomska, Ksenia/0000-0001-6118-5844; Kervella, Pierre/0000-0003-0626-1749; Zgirski, Bartlomiej/0000-0003-1515-6107	European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme [695099]; Polish Ministry of Science and Higher Education [IdP II 2015 0002 64, DIR/WK/2018/09]; BASAL Centro de Astrofisica y Tecnologias Afines (CATA) [AFB-170002]; Millennium Institute for Astrophysics (MAS) of the Iniciativa Milenio del Ministerio de Economia, Fomento y Turismo de Chile [IC120009]; Polish National Science Center [MAESTRO DEC-2012/06/A/ST9/00269]; French Agence Nationale de la Recherche (ANR) [ANR-15-CE31-0012-01]; Fondecyt [1170518]; ESO [092.D-0297, 094.D-0074, 098.D-0263(A, B), 097.D-0400(A), 097.D-0150(A), 097.D-0151(A)]; CNTAC [CN2016B-38, CN2016A-22, CN2015B-2, CN2015A-18]; Munich Institute for Astro-and Particle Physics (MIAPP) of the DFG cluster of excellence "Origin and Structure of the Universe"	European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme(European Research Council (ERC)); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); BASAL Centro de Astrofisica y Tecnologias Afines (CATA)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/BASAL); Millennium Institute for Astrophysics (MAS) of the Iniciativa Milenio del Ministerio de Economia, Fomento y Turismo de Chile; Polish National Science Center; French Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); ESO; CNTAC; Munich Institute for Astro-and Particle Physics (MIAPP) of the DFG cluster of excellence "Origin and Structure of the Universe"	The research leading to these results has received funding from the Polish Ministry of Science and Higher Education. We also gratefully acknowledge financial support for this work from the BASAL Centro de Astrofisica y Tecnologias Afines (CATA, AFB-170002), and from the Millennium Institute for Astrophysics (MAS) of the Iniciativa Milenio del Ministerio de Economia, Fomento y Turismo de Chile, project IC120009. We also acknowledge support from the Polish National Science Center grant MAESTRO DEC-2012/06/A/ST9/00269. We acknowledge the support of the French Agence Nationale de la Recherche (ANR), under grant ANR-15-CE31-0012-01 (project UnlockCepheids). S.V. gratefully acknowledges the support provided by Fondecyt reg. no. 1170518. This work is based on observations made with ESO telescopes under programmes 092.D-0297, 094.D-0074, 098.D-0263(A, B), 097.D-0400(A), 097.D-0150(A), 097.D-0151(A) and CNTAC programmes CN2016B-38, CN2016A-22, CN2015B-2 and CN2015A-18. This research was supported by the Munich Institute for Astro-and Particle Physics (MIAPP) of the DFG cluster of excellence "Origin and Structure of the Universe".	Alonso A, 1999, ASTRON ASTROPHYS SUP, V140, P261, DOI 10.1051/aas:1999521; ANDERSEN J, 1991, ASTRON ASTROPHYS, V246, P99; APPENZEL.I, 1966, Z ASTROPHYS, V64, P269; Arenou F, 2018, ASTRON ASTROPHYS, V616, DOI 10.1051/0004-6361/201833234; ARGUE AN, 1966, MON NOT R ASTRON SOC, V133, P475, DOI 10.1093/mnras/133.4.475; Bessell MS, 2000, PUBL ASTRON SOC PAC, V112, P961, DOI 10.1086/316598; BREGER M, 1968, ASTRON J, V73, P84, DOI 10.1086/110602; Clementini G, 2017, ASTRON ASTROPHYS, V605, DOI 10.1051/0004-6361/201629925; Corben P. M., 1971, Monthly Notes of the Astronomical Society of Southern Africa, V30, P37; Corben P. M., 1968, Monthly Notes of the Astronomical Society of Southern Africa, V27, P11; Corben P. M., 1966, MONTHLY NOTES ASTRON, V25, P44; Cousins A. W. J., 1973, Memoirs of the Royal Astronomical Society, V77, P223; Cousins A.W.J., 1962, ROYAL GREENWICH OBSE, V64, P103; Cousins A. W. J, 1983, SAAO7 CIRC, P36; Cousins A. W. J., 1977, S AFR ASTRON OBS CIR, P51; Cousins A. W. J., 1962, R OBS B, V49, P3; COUSINS AWJ, 1962, MNS SJ, V21, P20; COUSINS AWJ, 1963, MNS SJ, V22, P58; COUSINS AWJ, 1963, MNS SJ, V22, P12; Di Benedetto GP, 2005, MON NOT R ASTRON SOC, V357, P174, DOI 10.1111/j.1365-2966.2005.08632.x; Elvius T, 1965, ARK ASTRON, V3, P467; EVANS DS, 1966, RGOB, V0110, P00185; Feinstein A, 1966, INF B SO HEMISPHERE, V8, P30; Flower PJ, 1996, ASTROPHYS J, V469, P355, DOI 10.1086/177785; Freedman WL, 2010, ANNU REV ASTRON ASTR, V48, P673, DOI 10.1146/annurev-astro-082708-101829; Gallenne A, 2018, ASTROPHYS J, V867, DOI 10.3847/1538-4357/aae373; Gallenne A, 2018, ASTRON ASTROPHYS, V616, DOI 10.1051/0004-6361/201833341; Gallenne A, 2017, ASTRON ASTROPHYS, V608, DOI 10.1051/0004-6361/201731589; Gallenne A, 2016, ASTRON ASTROPHYS, V586, DOI 10.1051/0004-6361/201526764; Gieren W., 2005, MESSENGER, V121, P23; Glass I. S., 1985, Irish Astronomical Journal, V17, P1; Graczyk D, 2011, ACTA ASTRONOM, V61, P103; Graczyk D., 2019, PREPRINT; Graczyk D, 2018, ASTROPHYS J, V860, DOI 10.3847/1538-4357/aac2bf; Graczyk D, 2014, ASTROPHYS J, V780, DOI 10.1088/0004-637X/780/1/59; Haschke R, 2012, ASTRON J, V144, DOI 10.1088/0004-6256/144/4/106; Irwin J.B., 1961, ASTROPHYS J SUPPL S, V6, P253, DOI [10.1086/190066, DOI 10.1086/190066]; Jacyszyn-Dobrzeniecka AM, 2016, ACTA ASTRONOM, V66, P149; JENNENS PA, 1975, MON NOT R ASTRON SOC, V172, P667, DOI 10.1093/mnras/172.3.667; Johnson H. L., 1966, COMMUN LUNAR PLANET, V4, P99; Komatsu E, 2011, ASTROPHYS J SUPPL S, V192, DOI 10.1088/0067-0049/192/2/18; Laney CD, 2012, MON NOT R ASTRON SOC, V419, P1637, DOI 10.1111/j.1365-2966.2011.19826.x; LANEY CD, 1992, ASTRON ASTROPHYS SUP, V93, P93; Lindegren L, 2018, ASTRON ASTROPHYS, V616, DOI 10.1051/0004-6361/201832727; Mazzarella JM, 2007, ASTR SOC P, V376, P153; Mermilliod J.-C., 1986, CATALOGUE EGGENS UBV; Mermilliod JC, 1997, ASTRON ASTROPHYS SUP, V124, P349, DOI 10.1051/aas:1997197; Perryman M. A. C., 1998, SP1200 ESA; Persson SE, 2004, ASTRON J, V128, P2239, DOI 10.1086/424934; PFLEIDERER J, 1966, Z ASTROPHYS, V64, P116; Pietrzynski G, 2013, NATURE, V495, P76, DOI 10.1038/nature11878; POPPER DM, 1980, ANNU REV ASTRON ASTR, V18, P115, DOI 10.1146/annurev.aa.18.090180.000555; Riess AG, 2018, ASTROPHYS J, V855, DOI 10.3847/1538-4357/aaadb7; Schlafly EF, 2011, ASTROPHYS J, V737, DOI 10.1088/0004-637X/737/2/103; Schlegel DJ, 1998, ASTROPHYS J, V500, P525, DOI 10.1086/305772; Soszynski I, 2017, ACTA ASTRONOM, V67, P103, DOI 10.32023/0001-5237/67.2.1; Southworth J, 2008, MON NOT R ASTRON SOC, V386, P1644, DOI 10.1111/j.1365-2966.2008.13145.x; Stoy R. H., 1968, Monthly Notes of the Astronomical Society of Southern Africa, V27, P119; Stoy R. H., 1966, R OBS B, P1; Suchomska K, 2015, MON NOT R ASTRON SOC, V451, P651, DOI 10.1093/mnras/stv951; Thompson IB, 2001, ASTRON J, V121, P3089, DOI 10.1086/321084; Torres G, 2009, ASTROPHYS J, V700, P1349, DOI 10.1088/0004-637X/700/2/1349; Walker AR, 2012, ASTROPHYS SPACE SCI, V341, P43, DOI 10.1007/s10509-011-0961-x; Wild P. A. T., 1969, Monthly Notes of the Astronomical Society of Southern Africa, V28, P123; WILSON RE, 1971, ASTROPHYS J, V166, P605, DOI 10.1086/150986; Worthey G, 2011, ASTROPHYS J SUPPL S, V193, DOI 10.1088/0067-0049/193/1/1; Wright EL, 2010, ASTRON J, V140, P1868, DOI 10.1088/0004-6256/140/6/1868; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	76	241	241	0	9	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 14	2019	567	7747					200	+		10.1038/s41586-019-0999-4	http://dx.doi.org/10.1038/s41586-019-0999-4			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7LD	30867610	Green Submitted			2022-12-28	WOS:000461126600035
J	Iacobucci, G				Iacobucci, Gareth			Sixty seconds on ... reversing type 2 diabetes	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		KMIETOWICZ Z, 2017, BMJ-BRIT MED J, V359, DOI DOI 10.1136/BMJ.J5641; Lean MEJ, 2019, LANCET DIABETES ENDO, V5, DOI [10.1016/S2213-8587(19)30068-3.30852132, DOI 10.1016/S2213-8587(19)30068-3.30852132]	2	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 12	2019	364								l1128	10.1136/bmj.l1128	http://dx.doi.org/10.1136/bmj.l1128			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP5VS	30862641				2022-12-28	WOS:000461751000015
J	Mueller, MM; Van Remoortel, H; Meybohm, P; Aranko, K; Aubron, C; Burger, R; Carson, JL; Cichutek, K; De Buck, E; Devine, D; Fergusson, D; Follea, G; French, C; Frey, KP; Gammon, R; Levy, JH; Murphy, MF; Ozier, Y; Pavenski, K; So-Osman, C; Tiberghien, P; Volmink, J; Waters, JH; Wood, EM; Seifried, E; Albaladejo, P; Allard, S; Gabriel, C; Greinacher, A; van Kraaij, M; Levy, J; Liumbruno, G; Saxon, B; Shehata, N; Velati, C; Bischof, D; Hamilton, J; Lasocki, S; Gomez, MM; Schmitz-Rixen, T; Serve, H; Thomson, A; Beckers, E; Benson, K; Carson, J; Juffermans, N; Maze, D; Mirski, M; Murphy, G; Ries, JJ; Walsh, T; Anthony, L; Bielby, L; Donald, G; Frank, S; Freedman, J; Humbrecht, C				Mueller, Markus M.; Van Remoortel, Hans; Meybohm, Patrick; Aranko, Kari; Aubron, Cecile; Burger, Reinhard; Carson, Jeffrey L.; Cichutek, Klaus; De Buck, Emmy; Devine, Dana; Fergusson, Dean; Follea, Gilles; French, Craig; Frey, Kathrine P.; Gammon, Richard; Levy, Jerrold H.; Murphy, Michael F.; Ozier, Yves; Pavenski, Katerina; So-Osman, Cynthia; Tiberghien, Pierre; Volmink, Jimmy; Waters, Jonathan H.; Wood, Erica M.; Seifried, Erhard; Albaladejo, Pierre; Allard, Shubha; Gabriel, Christian; Greinacher, Andreas; van Kraaij, Marian; Levy, Jerrold; Liumbruno, Giancarlo; Saxon, Ben; Shehata, Nadine; Velati, Claudio; Bischof, Danielle; Hamilton, Jennifer; Lasocki, Sigismond; Munoz Gomez, Manuel; Schmitz-Rixen, Thomas; Serve, Hubert; Thomson, Amanda; Beckers, Erik; Benson, Kaaron; Carson, Jeffrey; Juffermans, Nicole; Maze, Dawn; Mirski, Marek; Murphy, Gavin; Ries, Jean-Jacques; Walsh, Tim; Anthony, Lauren; Bielby, Linley; Donald, Graham; Frank, Steven; Freedman, John; Humbrecht, Catherine		ICC PBM Frankfurt 2018 Grp	Patient Blood Management Recommendations From the 2018 Frankfurt Consensus Conference	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							RECOMBINANT-HUMAN-ERYTHROPOIETIN; CORONARY-ARTERY-BYPASS; LIBERAL TRANSFUSION STRATEGY; TOTAL KNEE ARTHROPLASTY; IN-HOSPITAL MORTALITY; TOTAL HIP-REPLACEMENT; RED-CELL TRANSFUSION; PREOPERATIVE ANEMIA; CARDIAC-SURGERY; RESTRICTIVE TRANSFUSION	IMPORTANCE Blood transfusion is one of the most frequently used therapies worldwide and is associated with benefits, risks, and costs. OBJECTIVE To develop a set of evidence-based recommendations for patient blood management (PBM) and for research. EVIDENCE REVIEW The scientific committee developed 17 Population/Intervention/ Comparison/Outcome (PICO) questions for red blood cell (RBC) transfusion in adult patients in 3 areas: preoperative anemia (3 questions), RBC transfusion thresholds (11 questions), and implementation of PBM programs (3 questions). These questions guided the literature search in 4 biomedical databases (MEDLINE, EMBASE, Cochrane Library, Transfusion Evidence Library), searched from inception to January 2018. Meta-analyses were conducted with the GRADE (Grading of Recommendations, Assessment, Development, and Evaluation) methodology and the Evidence-to-Decision framework by 3 panels including clinical and scientific experts, nurses, patient representatives, and methodologists, to develop clinical recommendations during a consensus conference in Frankfurt/Main, Germany, in April 2018. FINDINGS From 17 607 literature citations associated with the 17 PICO questions, 145 studies, including 63 randomized clinical trials with 23 143 patients and 82 observational studies with more than 4 million patients, were analyzed. For preoperative anemia, 4 clinical and 3 research recommendations were developed, including the strong recommendation to detect and manage anemia sufficiently early before major elective surgery. For RBC transfusion thresholds, 4 clinical and 6 research recommendations were developed, including 2 strong clinical recommendations for critically ill but clinically stable intensive care patients with or without septic shock (recommended threshold for RBC transfusion, hemoglobin concentration <7 g/dL) as well as for patients undergoing cardiac surgery (recommended threshold for RBC transfusion, hemoglobin concentration <7.5 g/dL). For implementation of PBM programs, 2 clinical and 3 research recommendations were developed, including recommendations to implement comprehensive PBM programs and to use electronic decision support systems (both conditional recommendations) to improve appropriate RBC utilization. CONCLUSIONS AND RELEVANCE The 2018 PBM International Consensus Conference defined the current status of the PBM evidence base for practice and research purposes and established 10 clinical recommendations and 12 research recommendations for preoperative anemia, RBC transfusion thresholds for adults, and implementation of PBM programs. The relative paucity of strong evidence to answer many of the PICO questions supports the need for additional research and an international consensus for accepted definitions and hemoglobin thresholds, as well as clinically meaningful end points for multicenter trials.	[Mueller, Markus M.; Seifried, Erhard] German Red Cross Blood Transfus Serv, Frankfurt, Germany; [Mueller, Markus M.; Seifried, Erhard] Goethe Univ Clin, Frankfurt, Germany; [Van Remoortel, Hans; De Buck, Emmy] Belgian Red Cross, Ctr Evidence Based Practice CEBaP, Mechelen, Belgium; [Meybohm, Patrick] Univ Hosp Frankfurt, Intens Care Med & Pain Therapy, Dept Anaesthesiol, Frankfurt, Germany; [Aranko, Kari; Murphy, Michael F.; Tiberghien, Pierre; Seifried, Erhard; van Kraaij, Marian; Liumbruno, Giancarlo; Velati, Claudio] EBA, Amsterdam, Netherlands; [Aubron, Cecile; Ozier, Yves] Univ Hosp Brest, Dept Intens Care, Brest, France; [Aubron, Cecile; Ozier, Yves] Univ Hosp Brest, Dept Anesthesia, Brest, France; [Burger, Reinhard] RKI, Berlin, Germany; [Carson, Jeffrey L.] Rutgers State Univ, Robert Wood Johnson Med Sch, New Brunswick, NJ USA; [Cichutek, Klaus] PEI, Langen, Germany; [De Buck, Emmy] Katholieke Univ Leuven, Fac Med, Dept Publ Hlth & Primary Care, Leuven, Belgium; [Devine, Dana] Canadian Blood Serv, Ottawa, ON, Canada; [Fergusson, Dean] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Fergusson, Dean] Univ Ottawa, Dept Surg, Ottawa, ON, Canada; [Fergusson, Dean] Univ Ottawa, Dept Epidemiol & Publ Hlth, Ottawa, ON, Canada; [Aubron, Cecile; Follea, Gilles] SFTS, Paris, France; [French, Craig] Western Hlth, Intens Care, Melbourne, Vic, Australia; [Frey, Kathrine P.] Fairview Hlth Serv, Minneapolis, MN USA; [Gammon, Richard] OneBlood, Orlando, FL USA; [Levy, Jerrold H.] Duke Univ, Med Ctr, Dept Cardiothorac Intens Care Med, Durham, NC USA; [Murphy, Gavin] Natl Hlth Serv Blood & Transplant, Oxford, England; [Pavenski, Katerina] St Michaels Hosp, Toronto, ON, Canada; [Pavenski, Katerina] Univ Toronto, Toronto, ON, Canada; [So-Osman, Cynthia] Sanquin Blood Bank, Leiden, Netherlands; [So-Osman, Cynthia] Groene Hart Hosp, Dept Haematol, Gouda, Netherlands; [So-Osman, Cynthia; Wood, Erica M.; Seifried, Erhard; Allard, Shubha] ISBT, Amsterdam, Netherlands; [Tiberghien, Pierre] EFS, St Denis, Reunion, France; [Volmink, Jimmy] Stellenbosch Univ, Fac Med & Hlth Sci, Dept Clin Epidemiol, Stellenbosch, South Africa; [Waters, Jonathan H.] Univ Pittsburgh, Med Ctr, Dept Anesthesiol, Pittsburgh, PA USA; [Waters, Jonathan H.] Univ Pittsburgh, Med Ctr, Dept Bioengn, Pittsburgh, PA USA; [Wood, Erica M.] Monash Univ, Dept Epidemiol & Prevent Med, Transfus Res Unit, Melbourne, Vic, Australia; [Albaladejo, Pierre] Grenoble Univ Hosp, Grenoble, France; [Albaladejo, Pierre] ISTH, Amsterdam, Netherlands; [Devine, Dana] Canadian Blood Serv, Ottawa, ON, Canada; [Frey, Kathrine P.] Fairview Hlth Serv, Minneapolis, MN USA; [Frey, Kathrine P.; Gammon, Richard] AABB, Bethesda, MD USA; [Gabriel, Christian] Ludwig Boltzmann Inst Clin & Expt Traumatol, Vienna, Austria; [Gabriel, Christian] DGTI, Ulm, Germany; [Greinacher, Andreas] Inst Immunol & Transfusionsmed, Greifswald, Germany; [Greinacher, Andreas; Shehata, Nadine] ICTMG, Greifswald, Germany; [van Kraaij, Marian] Sanquin Blood Bank, Amsterdam, Netherlands; [Liumbruno, Giancarlo] Italian Natl Inst Hlth, Rome, Italy; [Meybohm, Patrick] Univ Hosp Frankfurt, Dept Anaesthesiol Intens Care Med & Pain Therapy, Frankfurt, Germany; [Mueller, Markus M.] German Red Cross Blood Transfus Serv, Frankfurt, Germany; Natl Hlth Serv Blood & Transplant, Oxford, England; Univ Oxford, Oxford, England; [Van Remoortel, Hans] Belgian Red Cross, Ctr Evidence Based Practice CEBaP, Mechelen, Belgium; [Saxon, Ben] Australian Red Cross Blood Serv, Melbourne, Vic, Australia; [Shehata, Nadine] Mt Sinai Hosp, Toronto, ON, Canada; [Tiberghien, Pierre] Etab Francais Sang, Paris, France; [Velati, Claudio] Societa Italiana Med Trasfus & Immunoematol, Milan, Italy; [Cichutek, Klaus] PEI, Langen, Germany; [Volmink, Jimmy] Stellenbosch Univ, Fac Med & Hlth Sci, Dept Clin Epidemiol, Stellenbosch, South Africa; [Van Remoortel, Hans] Belgian Red Cross, CEBaP, Mechelen, Belgium	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; CHU Brest; Universite de Bretagne Occidentale; CHU Brest; Universite de Bretagne Occidentale; Robert Koch Institute; Rutgers State University New Brunswick; Rutgers State University Medical Center; Paul Ehrlich Institute; KU Leuven; Canadian Blood Services; University of Ottawa; University of Ottawa; University of Ottawa; Duke University; NHS Blood & Transplant (NHSBT); University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Stellenbosch University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Monash University; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Canadian Blood Services; Ludwig Boltzmann Institute; Istituto Superiore di Sanita (ISS); Goethe University Frankfurt; Goethe University Frankfurt Hospital; NHS Blood & Transplant (NHSBT); University of Oxford; Australian Red Cross Blood Service; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Paul Ehrlich Institute; Stellenbosch University	Mueller, MM; Seifried, E (corresponding author), Goethe Univ, Univ Hosp, Inst Transfus Med & Immunohematol, German Red Cross Blood Transfus Serv Baden Wuertt, Sandhofstr 1, D-60528 Frankfurt, Germany.	m.mueller@blutspende.de; e.seifried@blutspende.de	lasocki, sigismond/G-9443-2016; liumbruno, giancarlo/AAA-7581-2022; Shehata, Nadine/AAG-1124-2019; Tiberghien, Pierre/AAH-5878-2019; Van Remoortel, Hans/AAH-2425-2019; Liumbruno, Giancarlo Maria/AAC-4918-2019; FRENCH, CRAIG/HGA-5299-2022; Gabriel, Christian/A-1689-2014; French, Craig/ABF-5087-2020	liumbruno, giancarlo/0000-0002-3021-0338; Gabriel, Christian/0000-0003-2043-9320; French, Craig/0000-0003-1363-9711; Saxon, Benjamin/0000-0003-1598-5343; Shehata, Nadine/0000-0002-9267-6256; Tiberghien, Pierre/0000-0002-9310-8322; Devine, Dana/0000-0002-9059-0344; Estcourt, Lise/0000-0003-4309-9162				Adams ES, 2011, PEDIATRICS, V127, pE1112, DOI 10.1542/peds.2010-3252; Alan N, 2014, J NEUROSURG, V120, P764, DOI 10.3171/2013.10.JNS131028; [Anonymous], 2004, ASS IR STAT POP INCL; Beattie WS, 2009, ANESTHESIOLOGY, V110, P574, DOI 10.1097/ALN.0b013e31819878d3; Bedair H, 2015, CLIN ORTHOP RELAT R, V473, P590, DOI 10.1007/s11999-014-3819-z; Bergamin FS, 2017, CRIT CARE MED, V45, P766, DOI 10.1097/CCM.0000000000002283; BLAIR SD, 1986, BRIT J SURG, V73, P783, DOI 10.1002/bjs.1800731007; Blaudszun G, 2018, ANAESTHESIA, V73, P572, DOI 10.1111/anae.14185; Bracey AW, 1999, TRANSFUSION, V39, P1070, DOI 10.1046/j.1537-2995.1999.39101070.x; Bydon Mohamad, 2014, Surg Neurol Int, V5, P156, DOI 10.4103/2152-7806.143754; Carrascal Y, 2010, INTERACT CARDIOV TH, V10, P249, DOI 10.1510/icvts.2009.220160; Carson JL, 2018, AM HEART J, V200, P96, DOI 10.1016/j.ahj.2018.04.007; Carson JL, 2016, JAMA-J AM MED ASSOC, V316, P2025, DOI 10.1001/jama.2016.9185; Carson JL, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002042.pub4; Carson JL, 2011, NEW ENGL J MED, V365, P2453, DOI 10.1056/NEJMoa1012452; Carson JL, 1998, TRANSFUSION, V38, P522, DOI 10.1046/j.1537-2995.1998.38698326331.x; Chamieh JS, 2016, J ARTHROPLASTY, V31, P766, DOI 10.1016/j.arth.2015.10.035; Christodoulakis M, 2005, ANN SURG ONCOL, V12, P718, DOI 10.1245/ASO.2005.06.031; Cladellas M, 2006, EUR HEART J, V27, P1093, DOI 10.1093/eurheartj/ehi830; Dai L, 2018, ANN THORAC SURG, V105, P100, DOI 10.1016/j.athoracsur.2017.06.074; De Buck E, 2014, INT J EVID-BASED HEA, V12, P39, DOI 10.1097/01.XEB.0000444637.88465.a3; DELEEUW NKM, 1966, MEDICINE, V45, P291, DOI 10.1097/00005792-196607000-00002; DeMaeyer E, 1985, World Health Stat Q, V38, P302; Desborough MJR, 2017, THROMB HAEMOSTASIS, V117, P889, DOI 10.1160/TH17-01-0015; Dousias V, 2003, Clin Exp Obstet Gynecol, V30, P235; Edwards TJ, 2009, BRIT J SURG, V96, P1122, DOI 10.1002/bjs.6688; Elmistekawy E, 2013, EUR J CARDIO-THORAC, V44, P1051, DOI 10.1093/ejcts/ezt143; Fan YX, 2014, ARCH GERONTOL GERIAT, V59, P181, DOI 10.1016/j.archger.2014.03.009; Faris PM, 1996, J BONE JOINT SURG AM, V78A, P62, DOI 10.2106/00004623-199601000-00009; Feagan BG, 2000, ANN INTERN MED, V133, P845, DOI 10.7326/0003-4819-133-11-200012050-00008; FISHER M R, 1956, Br J Clin Pract, V10, P770; Food and Agriculture Organization of the United Nations World Health Organization (WHO), 1992, WHO WORLD DECL PLAN; Foss NB, 2009, TRANSFUSION, V49, P227, DOI 10.1111/j.1537-2995.2008.01967.x; Frank SM, 2017, ANESTHESIOLOGY, V127, P754, DOI 10.1097/ALN.0000000000001851; Frew N, 2016, ANN ROY COLL SURG, V98, P380, DOI 10.1308/rcsann.2016.0139; Froessler B, 2016, ANN SURG, V264, P41, DOI 10.1097/SLA.0000000000001646; Gabriel RA, 2018, WORLD J SURG, V42, P1939, DOI 10.1007/s00268-017-4359-y; Gani F, 2019, ANN SURG, V269, P1073, DOI 10.1097/SLA.0000000000002585; Goodnough LT, 2014, TRANSFUSION, V54, P2753, DOI 10.1111/trf.12723; Goodnough LT, 2012, ANESTHESIOLOGY, V116, P1367, DOI 10.1097/ALN.0b013e318254d1a3; Greenky M, 2012, CLIN ORTHOP RELAT R, V470, P2695, DOI 10.1007/s11999-012-2435-z; Gregersen M, 2015, ACTA ORTHOP, V86, P363, DOI 10.3109/17453674.2015.1006980; Gross I, 2016, ONCOLOGIST, V21, P327, DOI 10.1634/theoncologist.2015-0406; Gross I, 2015, TRANSFUSION, V55, P1075, DOI 10.1111/trf.12946; Grover M, 2006, VOX SANG, V90, P105, DOI 10.1111/j.1423-0410.2006.00730.x; Gupta PK, 2013, ANN SURG, V258, P1096, DOI 10.1097/SLA.0b013e318288e957; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.06.004, 10.1016/j.jclinepi.2011.03.017]; Hajjar LA, 2010, JAMA-J AM MED ASSOC, V304, P1559, DOI 10.1001/jama.2010.1446; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; HEBERT PC, 1995, JAMA-J AM MED ASSOC, V273, P1439, DOI 10.1001/jama.273.18.1439; Heiss MM, 1996, SURGERY, V119, P523, DOI 10.1016/S0039-6060(96)80261-3; Hiscock R, 2015, ANAESTH INTENS CARE, V43, P341, DOI 10.1177/0310057X1504300310; Holst LB, 2014, NEW ENGL J MED, V371, P1381, DOI 10.1056/NEJMoa1406617; HOLST LB, 2015, BMJ-BRIT MED J, V350, DOI DOI 10.1136/BMJ.111354; Hovaguimian F, 2016, ANESTHESIOLOGY, V125, P46, DOI 10.1097/ALN.0000000000001162; Hung M, 2011, ANAESTHESIA, V66, P812, DOI 10.1111/j.1365-2044.2011.06819.x; Hunt BJ, 2015, BRIT J HAEMATOL, V170, P788, DOI 10.1111/bjh.13580; Jairath V, 2015, LANCET, V386, P137, DOI 10.1016/S0140-6736(14)61999-1; JOHNSON RG, 1992, J THORAC CARDIOV SUR, V104, P307; Joshi SS, 2015, ANN CARD ANAESTH, V18, P373, DOI 10.4103/0971-9784.159808; Kansagra A, 2017, AM J MED QUAL, V32, P668, DOI 10.1177/1062860616687035; Kassakian SZ, 2016, AM J MED, V129, DOI 10.1016/j.amjmed.2016.01.024; Kettelhack C, 1998, BRIT J SURG, V85, P63; KILPATRICK G, 1961, BRIT MED J, V1, P778, DOI 10.1136/bmj.1.5228.778; Kim BD, 2014, SPINE, V39, P1981, DOI 10.1097/BRS.0000000000000568; Koch CG, 2017, ANN THORAC SURG, V104, P1243, DOI 10.1016/j.athoracsur.2017.05.048; Kopanidis P, 2016, J ORTHOP SURG RES, V11, DOI 10.1186/s13018-016-0358-1; Kosmadakis N, 2003, ANN SURG, V237, P417, DOI 10.1097/00000658-200303000-00017; Laine A, 2018, J CARDIOTHOR VASC AN, V32, P132, DOI 10.1053/j.jvca.2017.08.039; Larson B, 2001, ACTA OBSTET GYN SCAN, V80, P559, DOI 10.1034/j.1600-0412.2001.080006559.x; LAUPACIS A, 1993, LANCET, V342, P378, DOI 10.1016/0140-6736(93)91527-S; Leahy MF, 2017, TRANSFUSION, V57, P2189, DOI 10.1111/trf.14191; Leahy MF, 2017, TRANSFUSION, V57, P1347, DOI 10.1111/trf.14006; Leahy MF, 2014, TRANSFUSION, V54, P1133, DOI 10.1111/trf.12362; Lidder PG, 2007, ANN ROY COLL SURG, V89, P418, DOI 10.1308/003588407X183364; Loftus TJ, 2016, J ARTHROPLASTY, V31, P11, DOI 10.1016/j.arth.2015.07.040; Lotke PA, 1999, J ARTHROPLASTY, V14, P647, DOI 10.1016/S0883-5403(99)90216-4; Mao TL, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000007326; Matsuda S, 2013, ANN THORAC SURG, V95, P854, DOI 10.1016/j.athoracsur.2012.10.005; Mazer CD, 2017, NEW ENGL J MED, V377, P2133, DOI 10.1056/NEJMoa1711818; Mehra T, 2015, TRANSFUSION, V55, P2807, DOI 10.1111/trf.13260; Melis M, 2009, J SURG RES, V153, P114, DOI 10.1016/j.jss.2008.06.005; Meybohm P, 2016, ANN SURG, V264, P203, DOI 10.1097/SLA.0000000000001747; MICELI A, 2014, J CARDIOTHORAC SURG, V9, DOI DOI 10.1186/1749-8000-9-137; Mirhosseini Seyed Jalil, 2012, Acta Med Iran, V50, P615; Moberg J, 2018, HEALTH RES POLICY SY, V16, DOI 10.1186/s12961-018-0320-2; Munoz M, 2006, TRANSFUSION MED, V16, P137, DOI 10.1111/j.1365-3148.2005.00629.x; MunozM, 2010, TRANSFUS ALTERN TRAN, V11, P47, DOI DOI 10.1111/J.1778-428X.2010.01126.X; Murphy GJ, 2015, NEW ENGL J MED, V372, P997, DOI 10.1056/NEJMoa1403612; Musallam KM, 2011, LANCET, V378, P1396, DOI 10.1016/S0140-6736(11)61381-0; Na HS, 2011, TRANSFUSION, V51, P118, DOI 10.1111/j.1537-2995.2010.02783.x; Nair R, 2011, SEMIN ARTHRITIS RHEU, V41, P95, DOI 10.1016/j.semarthrit.2010.12.001; NATVIG K, 1966, ACTA MED SCAND, V180, P613; Nielsen K, 2014, BMC ANESTHESIOL, V14, DOI 10.1186/1471-2253-14-89; Nuis RJ, 2013, CIRC-CARDIOVASC INTE, V6, P625, DOI 10.1161/CIRCINTERVENTIONS.113.000409; Okuyama M, 2005, SURG TODAY, V35, P36, DOI 10.1007/s00595-004-2888-0; Oshin OA, 2013, VASC ENDOVASC SURG, V47, P449, DOI 10.1177/1538574413493679; Padmanabhan Hari, 2016, Asian Cardiovasc Thorac Ann, V24, P12, DOI 10.1177/0218492315618032; Palmieri TL, 2017, ANN SURG, V266, P595, DOI 10.1097/SLA.0000000000002408; Parker MJ, 2013, INJURY, V44, P1916, DOI 10.1016/j.injury.2013.04.033; Phan K, 2017, GLOB SPINE J, V7, P787, DOI 10.1177/2192568217705654; Phan K, 2017, GLOB SPINE J, V7, P441, DOI 10.1177/2192568217699404; Qvist N, 1999, WORLD J SURG, V23, P30, DOI 10.1007/s002689900561; Rineau E, 2016, TRANSFUSION, V56, P673, DOI 10.1111/trf.13468; Rothschild JM, 2007, TRANSFUSION, V47, P228, DOI 10.1111/j.1537-2995.2007.01093.x; Saager L, 2013, ANESTH ANALG, V117, P909, DOI 10.1213/ANE.0b013e31828b347d; Scott SN, 2002, LARYNGOSCOPE, V112, P1221, DOI 10.1097/00005537-200207000-00015; Seicean A, 2013, SPINE, V38, P1331, DOI 10.1097/BRS.0b013e3182912c6b; Shehata N, 2012, TRANSFUSION, V52, P91, DOI 10.1111/j.1537-2995.2011.03236.x; Sher GD, 2007, TRANSFUSION, V47, P2176, DOI 10.1111/j.1537-2995.2007.01540.x; Shirzad M, 2010, CENT EUR J MED, V5, P308, DOI 10.2478/s11536-009-0094-6; So-Osman C, 2014, ANESTHESIOLOGY, V120, P852, DOI 10.1097/ALN.0000000000000135; So-Osman C, 2013, BLOOD TRANSFUS-ITALY, V11, P289, DOI 10.2450/2013.0172-12; Stowell CP, 2009, SPINE, V34, P2479, DOI 10.1097/BRS.0b013e3181bd163f; STURGEON P, 1959, BRIT J HAEMATOL, V5, P31, DOI 10.1111/j.1365-2141.1959.tb04011.x; Tee MC, 2015, SURGERY, V158, P1027, DOI 10.1016/j.surg.2015.06.004; Ternstrom L, 2014, INTERACT CARDIOV TH, V19, P788, DOI 10.1093/icvts/ivu266; Thakkar RN, 2016, TRANSFUSION, V56, P2212, DOI 10.1111/trf.13718; Theusinger OM, 2014, BLOOD TRANSFUS-ITALY, V12, P195, DOI 10.2450/2014.0306-13; Tohme S, 2016, HPB, V18, P255, DOI 10.1016/j.hpb.2015.09.002; Van Mieghem NM, 2011, EUROINTERVENTION, V7, P184, DOI 10.4244/EIJV7I2A32; Velescu A, 2016, EUR J VASC ENDOVASC, V51, P543, DOI 10.1016/j.ejvs.2015.12.006; Verdecchia NM, 2016, HEMATOLOGY, V21, P490, DOI 10.1080/10245332.2015.1112496; Villanueva C, 2013, NEW ENGL J MED, V368, P11, DOI 10.1056/NEJMoa1211801; Walsh TS, 2013, CRIT CARE MED, V41, P2354, DOI 10.1097/CCM.0b013e318291cce4; Weber EWG, 2005, EUR J ANAESTH, V22, P249, DOI 10.1017/S0265021505000426; Weltert L, 2015, TRANSFUSION, V55, P1644, DOI 10.1111/trf.13027; Weltert L, 2010, J THORAC CARDIOV SUR, V139, P621, DOI 10.1016/j.jtcvs.2009.10.012; (WHO) WHO, 2011, WHO GLOB FOR BLOOD S; Wittenmeier E, 2015, PEDIATR ANESTH, V25, P1046, DOI 10.1111/pan.12683; Wu WC, 2007, JAMA-J AM MED ASSOC, V297, P2481, DOI 10.1001/jama.297.22.2481; Wurnig C, 2001, EUR SURG RES, V33, P303, DOI 10.1159/000049723; Xydas S, 2012, J THORAC CARDIOV SUR, V143, P926, DOI 10.1016/j.jtcvs.2012.01.003; Yaffee DW, 2014, ANN THORAC SURG, V97, P95, DOI 10.1016/j.athoracsur.2013.09.057; Yoo YC, 2011, ANESTHESIOLOGY, V115, P929, DOI 10.1097/ALN.0b013e318232004b; Zhang L, 2013, ANN THORAC SURG, V95, P542, DOI 10.1016/j.athoracsur.2012.07.011	137	252	259	11	64	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 12	2019	321	10					983	997		10.1001/jama.2019.0554	http://dx.doi.org/10.1001/jama.2019.0554			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HO5JE	30860564				2022-12-28	WOS:000460961000016
J	Weston, G				Weston, Gabriel			Gabriel Weston: A window on to a hopeful landscape	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												gabriel.weston@nhs.net						DOBSON J, 2018, BMJ-BRIT MED J, V363, DOI DOI 10.1136/BMJ.K4235; Jack HE, 2018, LANCET PSYCHIAT, V5, P391, DOI 10.1016/S2215-0366(18)30127-5; National Audit Office, 2017, MENT HLTH PRIS	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 12	2019	364								l1048	10.1136/bmj.l1048	http://dx.doi.org/10.1136/bmj.l1048			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP5VS	30862626	Bronze			2022-12-28	WOS:000461751000007
J	Aguillon, SM				Aguillon, Stepfanie M.			Fighting through the gray	SCIENCE			English	Editorial Material								roll over in bed and reach for my phone to check the time. " It's 8: 30 a. m.!" I say to myself. " How did that happen? I must have turned my alarm off and fallen back to sleep." After some deep breaths, I manage to drag myself out of bed, get dressed, and make breakfast. At work I try to focus, but most of the day I just sit in a fog, struggling to stay awake. When I head home, I lack the motivation to go to the gym, do errands, or hang out with friends. Instead, I fall asleep on the couch shortly after dinner, only making it to bed after some gentle prodding from my dog.	[Aguillon, Stepfanie M.] Cornell Univ, Ithaca, NY 14850 USA	Cornell University	Aguillon, SM (corresponding author), Cornell Univ, Ithaca, NY 14850 USA.	SciCareerEditor@aaas.org		Aguillon, Stepfanie/0000-0002-8254-6124					0	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 8	2019	363	6431					1114	1114		10.1126/science.363.6431.1114	http://dx.doi.org/10.1126/science.363.6431.1114			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HO2MV	30846602				2022-12-28	WOS:000460750100047
J	Hart, AJ; Rao, A				Hart, A. John; Rao, Abhinav			How to print a 3D object all at once	SCIENCE			English	Editorial Material									[Hart, A. John; Rao, Abhinav] MIT, Dept Mech Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Hart, AJ (corresponding author), MIT, Dept Mech Engn, Cambridge, MA 02139 USA.	ajhart@mit.edu	Hart, A. John/A-9027-2010	Hart, A. John/0000-0002-7372-3512				BORTFELD T, 1990, PHYS MED BIOL, V35, P1423, DOI 10.1088/0031-9155/35/10/007; de Beer MP, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau8723; Go J, 2017, ADDIT MANUF, V18, P276, DOI 10.1016/j.addma.2017.10.016; Hagenau W. R., 2000, U. S. Patent, Patent No. [6,051,179, 6051179]; Hendrik J., 2006, U. S. Patent, Patent No. [7,052,263, 7052263]; Hull C., 1985, U.S. Patent, Patent No. 4575330; Kelly BE, 2019, SCIENCE, V363, P1075, DOI 10.1126/science.aau7114; KODAMA H, 1981, REV SCI INSTRUM, V52, P1770, DOI 10.1063/1.1136492; O'Brien AK, 2006, MACROMOLECULES, V39, P2501, DOI 10.1021/ma051863l; Sachs E.M., 1989, US Patent, Patent No. [5204055A, 5204055]; Thompson A, 2016, MEAS SCI TECHNOL, V27, DOI 10.1088/0957-0233/27/7/072001; Tumbleston JR, 2015, SCIENCE, V347, P1349, DOI 10.1126/science.aaa2397	12	5	5	3	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 8	2019	363	6431					1042	1043		10.1126/science.aaw7062	http://dx.doi.org/10.1126/science.aaw7062			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HO2MV	30846587				2022-12-28	WOS:000460750100024
J	Bot, M; Brouwer, IA; Roca, M; Kohls, E; Penninx, BWJH; Watkins, E; van Grootheest, G; Cabout, M; Hegerl, U; Gili, M; Owens, M; Visser, M; Verkerk, B; Paans, N; Thesing, C; Gibson-Smith, D; Horsfall, M; Weiss, L; Romijn, A; Bunce, H; Winfield, O; Bunker-Smith, H; Durbridge, F; Molinares, CV; Sapar, A; Tortella, M; Covas, CH; Perez-Ara, MA; Gracia, AC; Reig, JL; Hoesel, J; Dogan, E; Baldofski, S; Mauche, N				Bot, Mariska; Brouwer, Ingeborg A.; Roca, Miquel; Kohls, Elisabeth; Penninx, Brenda W. J. H.; Watkins, Ed; van Grootheest, Gerard; Cabout, Mieke; Hegerl, Ulrich; Gili, Margalida; Owens, Matthew; Visser, Marjolein; Verkerk, Bep; Paans, Nadine; Thesing, Carisha; Gibson-Smith, Deborah; Horsfall, Melany; Weiss, Lena; Romijn, Amy; Bunce, Hannah; Winfield, Owain; Bunker-Smith, Harriet; Durbridge, Fern; Molinares, Caterina Versari; Sapar, Atikah; Tortella, Miquel; Homar Covas, Clara; Angeles Perez-Ara, M.; Castro Gracia, Adoracion; Luis Reig, Jose; Hoesel, Jana; Dogan, Ezgi; Baldofski, Sabrina; Mauche, Nicole		MooDFOOD Prevention Trial	Effect of Multinutrient Supplementation and Food-Related Behavioral Activation Therapy on Prevention of Major Depressive Disorder Among Overweight or Obese Adults With Subsyndromal Depressive Symptoms The MooDFOOD Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FOLIC-ACID; ONSET; ANXIETY; INTERVENTIONS; QUESTIONNAIRE; PATTERNS; VALIDITY; QUALITY; IMPACT; RISK	IMPORTANCE Effects of nutritional interventions on the prevention of major depressive disorder (MDD) in overweight adults are unknown. OBJECTIVE To examine the effect of 2 nutritional strategies (multinutrient supplementation, food-related behavioral activation therapy) and their combination for prevention of a new MDD episode in overweight adults with subsyndromal depressive symptoms. DESIGN, SETTING, AND PARTICIPANTS This multicenter 2 x 2 factorial randomized clinical trial included overweight adults (body mass index, 25-40) with elevated depressive symptoms (Patient Health Questionnaire-9 [PHQ-9] scores >= 5) and no MDD episode in the past 6 months from 4 European countries. A total of 1025 adults were randomized (July 30, 2015-October 12, 2016) and followed up for 1 year (October 13, 2017). INTERVENTIONS Daily multinutrient supplements (1412-mg omega-3 fatty acids, 30-mu g selenium, 400-mu g folic acid, and 20-mu g vitamin D-3 plus 100-mg calcium) vs placebo and 21 individual or group therapy sessions vs none (blinded to researchers) for 1 year. Participants were allocated to placebo without therapy (n = 257), placebo with therapy (n = 256), supplements without therapy (n = 256), and supplements with therapy (n = 256). MAIN OUTCOME AND MEASURES Cumulative 1-year onset of MDD via the Mini International Neuropsychiatric Interview at 3, 6, and 12 months. Logistic regression using effect-coded variables (-1 indicating control, 1 indicating intervention) evaluated intervention effects both individually and in combination (interaction) on MDD onset. RESULTS Among 1025 participants (meanage, 46.5 years; 772 women [75%]; mean BMI, 31.4), 779 (76%) completed the trial. During the 12-month follow-up, 105 (10%) developed MDD: 25 (9.7%) patients in the placebo without therapy, 26 (10.2%) in the placebo with therapy, 32 (12.5%) in the supplement without therapy, and 22 (8.6%) in the supplement with therapy group. None of the treatment strategies affected MDD onset. The odds ratio (OR) for supplements was 1.06 (95% CI, 0.87-1.29); for therapy, 0.93 (95% CI, 0.76-1.13); and for their combination, 0.93 (95% CI, 0.76-1.14; P for interaction, .48). One person in the supplementation with therapy group, died. Twenty-four patients in each of the placebo groups and 24 patients in the supplementation with therapy group were hospitalized, and 26 patients in the supplementation-only group were hospitalized. CONCLUSIONS AND RELEVANCE Among overweight or obese adults with subsyndromal depressive symptoms, multinutrient supplementation compared with placebo and food-related behavioral activation therapy compared with no therapy did not reduce episodes of major depressive disorder during 1 year. These findings do not support the use of these interventions for prevention of major depressive disorder.	[Visser, Marjolein] Vrije Univ Amsterdam, Fac Sci, Dept Hlth Sci, De Boelelaan 1085, NL-1081 HV Amsterdam, Netherlands; [Visser, Marjolein] Vrije Univ Amsterdam, Amsterdam Publ Hlth Res Inst, De Boelelaan 1085, NL-1081 HV Amsterdam, Netherlands; [Bot, Mariska; Penninx, Brenda W. J. H.; van Grootheest, Gerard] Vrije Univ, Amsterdam UMC, Psychiat, Amsterdam Publ Hlth Res Inst,GGZ inGeest Speciali, Amsterdam, Netherlands; [Roca, Miquel; Gili, Margalida] Univ Balearic Isl, Inst Univ Invest Ciencies Salut, Idisba, Rediapp, Palma De Mallorca, Spain; [Kohls, Elisabeth; Hegerl, Ulrich] Univ Leipzig, Fac Med, Dept Psychiat & Psychotherapy, Leipzig, Germany; [Watkins, Ed; Owens, Matthew] Univ Exeter, Dept Psychol, Exeter, Devon, England; [Verkerk, Bep; Horsfall, Melany] GGZ inGeest Specialized Mental Hlth Care, Amsterdam, Netherlands; [Paans, Nadine; Thesing, Carisha; Gibson-Smith, Deborah; Weiss, Lena] Vrije Univ, Amsterdam UMC, Amsterdam, Netherlands; [Romijn, Amy; Bunce, Hannah; Winfield, Owain; Bunker-Smith, Harriet; Durbridge, Fern; Molinares, Caterina Versari; Sapar, Atikah] Univ Exeter, Exeter, Devon, England; [Tortella, Miquel; Homar Covas, Clara; Angeles Perez-Ara, M.; Castro Gracia, Adoracion; Luis Reig, Jose] UIB, Palma De Mallorca, Spain; [Hoesel, Jana; Dogan, Ezgi; Baldofski, Sabrina] ULEI, Leipzig, Germany	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Institut Investigacio Sanitaria Illes Balears (IdISBa); Universitat de les Illes Balears; Leipzig University; University of Exeter; University of Amsterdam; Vrije Universiteit Amsterdam; University of Exeter; Universitat de les Illes Balears	Visser, M (corresponding author), Vrije Univ Amsterdam, Fac Sci, Dept Hlth Sci, De Boelelaan 1085, NL-1081 HV Amsterdam, Netherlands.; Visser, M (corresponding author), Vrije Univ Amsterdam, Amsterdam Publ Hlth Res Inst, De Boelelaan 1085, NL-1081 HV Amsterdam, Netherlands.	m.visser@vu.nl	Visser, Marjolein/AAP-3224-2020; Owens, Matthew/GPW-7887-2022; Gili, Margalida/H-7680-2013; Penninx, Brenda WJH/S-7627-2017; van Grootheest, Gerard/C-6942-2014	Owens, Matthew/0000-0001-7407-6540; Visser, Marjolein/0000-0002-5136-298X; Gili, Margalida/0000-0002-0535-6773; Penninx, Brenda WJH/0000-0001-7779-9672; Watkins, Edward/0000-0002-2432-5577; van Grootheest, Gerard/0000-0003-4350-6661; Brouwer, Ingeborg/0000-0002-8762-382X	European Union FP7 MooDFOOD Project Multi-country Collaborative Project on the Role of Diet, Food-related Behavior, and Obesity in the Prevention of Depression [613598]; National Institute for Health Research (NIHR), through the Primary Care Research Network; NIHR Exeter Clinical Research Facility	European Union FP7 MooDFOOD Project Multi-country Collaborative Project on the Role of Diet, Food-related Behavior, and Obesity in the Prevention of Depression; National Institute for Health Research (NIHR), through the Primary Care Research Network; NIHR Exeter Clinical Research Facility	Funding for this article was provided by the European Union FP7 MooDFOOD Project Multi-country Collaborative Project on the Role of Diet, Food-related Behavior, and Obesity in the Prevention of Depression (grant agreement 613598). This work is supported in the United Kingdom by the National Institute for Health Research (NIHR), through the Primary Care Research Network and the NIHR Exeter Clinical Research Facility.	Bellon JA, 2015, PREV MED, V76, pS22, DOI 10.1016/j.ypmed.2014.11.003; Angrist JD, 1996, J AM STAT ASSOC, V91, P444, DOI 10.2307/2291629; Buntrock C, 2016, JAMA-J AM MED ASSOC, V315, P1854, DOI 10.1001/jama.2016.4326; Collins LM, 2014, AM J PREV MED, V47, P498, DOI 10.1016/j.amepre.2014.06.021; Cuijpers P, 2008, AM J PSYCHIAT, V165, P1272, DOI 10.1176/appi.ajp.2008.07091422; Cuijpers P, 2012, JAMA-J AM MED ASSOC, V307, P1033, DOI 10.1001/jama.2012.271; de Lauzon B, 2004, J NUTR, V134, P2372; Devlin NJ, 2018, HEALTH ECON, V27, P7, DOI 10.1002/hec.3564; Ekers D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100100; Emsley R, 2010, STAT METHODS MED RES, V19, P237, DOI 10.1177/0962280209105014; Ford AH, 2008, J CLIN PSYCHIAT, V69, P1203, DOI 10.4088/JCP.v69n0801; Garcia-Larsen V, 2011, EUR J CLIN NUTR, V65, P750, DOI 10.1038/ejcn.2011.15; Jacka FN, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0791-y; Kessler RC, 2008, ANNU REV PUBL HEALTH, V29, P115, DOI 10.1146/annurev.publhealth.29.020907.090847; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Milaneschi Y, 2014, MOL PSYCHIATR, V19, P444, DOI 10.1038/mp.2013.36; Milaneschi Y, 2019, MOL PSYCHIATR, V24, P18, DOI 10.1038/s41380-018-0017-5; Mocking RJT, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.29; Molendijk M, 2018, J AFFECT DISORDERS, V226, P346, DOI 10.1016/j.jad.2017.09.022; Morris SB, 2008, ORGAN RES METHODS, V11, P364, DOI 10.1177/1094428106291059; Okereke OI, 2016, J AFFECT DISORDERS, V198, P1, DOI 10.1016/j.jad.2016.03.022; Okereke OI, 2015, BRIT J PSYCHIAT, V206, P324, DOI 10.1192/bjp.bp.114.148361; Opie RS, 2015, PUBLIC HEALTH NUTR, V18, P2074, DOI 10.1017/S1368980014002614; Paans NPG, 2018, J PSYCHIATR RES, V97, P38, DOI 10.1016/j.jpsychires.2017.11.003; Parletta N, 2019, NUTR NEUROSCI, V22, P474, DOI 10.1080/1028415X.2017.1411320; Rayman M, 2006, BIOL PSYCHIAT, V59, P147, DOI 10.1016/j.biopsych.2005.06.019; Roca M, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0900-z; Rogers PJ, 2008, BRIT J NUTR, V99, P421, DOI 10.1017/S0007114507801097; Rubin D. B., 2004, MULTIPLE IMPUTATION; Rush AJ, 1996, PSYCHOL MED, V26, P477, DOI 10.1017/S0033291700035558; Sarris J, 2016, AM J PSYCHIAT, V173, P575, DOI 10.1176/appi.ajp.2016.15091228; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; STUNKARD AJ, 1983, USE DANISH ADOPTION; Twisk J, 2018, CONT CLIN TRIAL COMM, V10, P80, DOI 10.1016/j.conctc.2018.03.008; van Zoonen K, 2014, INT J EPIDEMIOL, V43, P318, DOI 10.1093/ije/dyt175; van't Veer-Tazelaar PJ, 2009, ARCH GEN PSYCHIAT, V66, P297, DOI 10.1001/archgenpsychiatry.2008.555; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wendel-Vos GCW, 2003, J CLIN EPIDEMIOL, V56, P1163, DOI 10.1016/S0895-4356(03)00220-8; WILLIAMS A, 1990, HEALTH POLICY, V16, P199	40	62	64	4	35	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 5	2019	321	9					858	868		10.1001/jama.2019.0556	http://dx.doi.org/10.1001/jama.2019.0556			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HN7EL	30835307	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000460351600016
J	Hale, AJ; Ricotta, DN; Freed, JA				Hale, Andrew J.; Ricotta, Daniel N.; Freed, Jason A.			Evaluating the Erythrocyte Sedimentation Rate	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PATIENT		[Hale, Andrew J.] Univ Vermont, Dept Infect Dis, Med Ctr, Burlington, VT USA; [Hale, Andrew J.] Univ Vermont, Dept Med, Larner Coll Med, Burlington, VT USA; [Ricotta, Daniel N.; Freed, Jason A.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA	University of Vermont; University of Vermont Medical Center; University of Vermont; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Hale, AJ (corresponding author), Univ Vermont, Med Ctr, Infect Dis Unit, 111 Colchester Ave,Mailstop 115 SM2, Burlington, VT 05401 USA.	andrew.hale@UVMhealth.org		Freed, Jason/0000-0002-9123-8107				BEDELL SE, 1985, AM J MED, V78, P1001, DOI 10.1016/0002-9343(85)90224-4; BULL BS, 1972, BLOOD-J HEMATOL, V40, P550, DOI 10.1182/blood.V40.4.550.550; FINCHER RME, 1986, ARCH INTERN MED, V146, P1581, DOI 10.1001/archinte.146.8.1581; Jurado RL, 2001, CLIN INFECT DIS, V33, P548, DOI 10.1086/322605; Kermani TA, 2012, SEMIN ARTHRITIS RHEU, V41, P866, DOI 10.1016/j.semarthrit.2011.10.005; Markanday A, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv098; Niederkohr RD, 2005, OPHTHALMOLOGY, V112, P744, DOI 10.1016/j.ophtha.2005.01.031; Smetana GW, 2002, JAMA-J AM MED ASSOC, V287, P92, DOI 10.1001/jama.287.1.92; VILASECA J, 1987, ANN RHEUM DIS, V46, P282, DOI 10.1136/ard.46.4.282; Walvick MD, 2011, OPHTHALMOLOGY, V118, P1201, DOI 10.1016/j.ophtha.2010.10.002	10	8	9	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 9	2019	321	14					1404	1405		10.1001/jama.2019.1178	http://dx.doi.org/10.1001/jama.2019.1178			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HT5PG	30888397				2022-12-28	WOS:000464615200021
J	Jue, JJ; Cunningham, S; Lohr, K; Shekelle, P; Shiffman, R; Robbins, C; Nix, M; Coates, V; Schoelles, K				Jue, J. Jane; Cunningham, Sarah; Lohr, Kathleen; Shekelle, Paul; Shiffman, Richard; Robbins, Craig; Nix, Mary; Coates, Vivian; Schoelles, Karen			Developing and Testing the Agency for Healthcare Research and Quality's National Guideline Clearinghouse Extent of Adherence to Trustworthy Standards (NEATS) Instrument	ANNALS OF INTERNAL MEDICINE			English	Article							CLINICAL-PRACTICE GUIDELINES; AGREE II	In 2011, the Institute of Medicine (IOM) (now the National Academy of Medicine) published standards for trustworthy guidelines and recommended that the National Guideline Clearinghouse (NGC) of the Agency for Healthcare Research and Quality clearly indicate the extent to which guidelines adhere to these standards. To accomplish this, the authors developed and tested the NGC Extent of Adherence to Trustworthy Standards (NEATS) instrument. The standards were operationalized as an instrument containing 15 items that cover disclosure of the funding source; disclosure and management of conflicts of interest; multidisciplinary input; incorporation of patient perspectives; rigorous systematic review; recommendations accompanied by rationale, assessment of benefits and harms, clear linkage to the evidence, and assessment of strength of evidence and strength of recommendation; clear articulation of recommendations; external re-view by diverse stakeholders; and plans for updating. After multiple rounds of feedback from experts on clinical practice guideline development, the external validity and interrater reliability of the instrument were evaluated. For each item, 80% to 100% of survey respondents judged it to be a good measure of the IOM standards. All external stakeholders stated that NEATS was suitable for its intended goal. Interrater reliability for the final NEATS instrument had a weighted kappa of 0.73. The NEATS instrument is a focused tool that provides a concise evaluation of a guideline's adherence to the IOM standards for trustworthy guidelines. It has good external validity among guideline developers and good interrater reliability across trained reviewers.	[Jue, J. Jane; Cunningham, Sarah; Schoelles, Karen] ECRI Inst, Ctr Clin Evidence & Guidelines, 5200 Butler Pike, Plymouth Meeting, PA 19462 USA; [Lohr, Kathleen] RTI Int, Chapel Hill, NC USA; [Shekelle, Paul] West Los Angeles Vet Affairs Med Ctr, Los Angeles, CA USA; [Shiffman, Richard] Yale Ctr Med Informat, 300 George St,Suite 501, New Haven, CT 06510 USA; [Robbins, Craig] Kaiser Permanente Care Management Inst, Aurora, CO USA; [Nix, Mary] Agcy Healthcare Res & Qual, 5600 Fishers Lane,Room 06E14 Mailstop 06E53A, Rockville, MD USA	Research Triangle Institute; US Department of Veterans Affairs; Veterans Health Administration (VHA); West Los Angeles VA Medical Center; Yale University; Kaiser Permanente; Agency for Healthcare Research & Quality	Jue, JJ (corresponding author), ECRI Inst, Ctr Clin Evidence & Guidelines, 5200 Butler Pike, Plymouth Meeting, PA 19462 USA.	jjue@ecri.org		Lohr, Kathleen/0000-0002-3825-0713	AHRQ [290-2013-00006C]	AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	By AHRQ under contract 290-2013-00006C to ECRI Institute for NGC.	Brawley O, 2011, JAMA-J AM MED ASSOC, V306, P2495, DOI 10.1001/jama.2011.1800; Brouwers MC, 2010, CAN MED ASSOC J, V182, pE839, DOI 10.1503/cmaj.090449; Brouwers MC, 2010, J CLIN EPIDEMIOL, V63, P1308, DOI 10.1016/j.jclinepi.2010.07.001; Brouwers MC, 2010, PREV MED, V51, P421, DOI 10.1016/j.ypmed.2010.08.005; Brouwers MC, 2010, CAN MED ASSOC J, V182, pE472, DOI 10.1503/cmaj.091716; Brouwers MC, 2010, CAN MED ASSOC J, V182, P1045, DOI 10.1503/cmaj.091714; Cifu AS, 2014, JAMA-J AM MED ASSOC, V312, P1208, DOI 10.1001/jama.2014.12712; Cluzeau FA, 1999, INT J QUAL HEALTH C, V11, P21, DOI 10.1093/intqhc/11.1.21; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; Cooke CR, 2013, AM J RESP CRIT CARE, V187, P910, DOI 10.1164/rccm.201301-0009PP; Dans AL, 2010, J CLIN EPIDEMIOL, V63, P1281, DOI 10.1016/j.jclinepi.2010.06.005; Hayward R S, 1993, Ann Intern Med, V118, P731; Hollon SD, 2014, ANNU REV CLIN PSYCHO, V10, P213, DOI 10.1146/annurev-clinpsy-050212-185529; Institute of Medicine, 2011, CLIN PRACTICE GUIDEL; Jefferson AA, 2017, JAMA INTERN MED, V177, P352, DOI 10.1001/jamainternmed.2016.8439; Kung J, 2012, ARCH INTERN MED, V172, P1628, DOI 10.1001/2013.jamainternmed.56; Mitchell M, 2013, BMJ QUAL SAF, V22, pA75, DOI [DOI 10.1136/BMJQS-2013-002293.226, 10.1136/bmjqs-2013-002293.226]; Ransohoff DF, 2013, JAMA-J AM MED ASSOC, V309, P139, DOI 10.1001/jama.2012.156703; Shaneyfelt TM, 1999, JAMA-J AM MED ASSOC, V281, P1900, DOI 10.1001/jama.281.20.1900; Shaughnessy AF, 2016, J AM BOARD FAM MED, V29, P644, DOI 10.3122/jabfm.2016.06.160115; Shekelle PG, 2018, JAMA-J AM MED ASSOC, V320, P757, DOI 10.1001/jama.2018.9660; Shiffman RN, 2003, ANN INTERN MED, V139, P493, DOI 10.7326/0003-4819-139-6-200309160-00013	22	17	18	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 2	2019	170	7					480	+		10.7326/M18-2950	http://dx.doi.org/10.7326/M18-2950			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HR3WA	30884527				2022-12-28	WOS:000463070700006
J	Moyo, P; Zhao, XH; Thorpe, CT; Thorpe, JM; Sileanu, FE; Cashy, JP; Hale, JA; Mor, MK; Radomski, TR; Donohue, JM; Hausmann, LRM; Hanlon, JT; Good, CB; Fine, MJ; Gellad, WF				Moyo, Patience; Zhao, Xinhua; Thorpe, Carolyn T.; Thorpe, Joshua M.; Sileanu, Florentina E.; Cashy, John P.; Hale, Jennifer A.; Mor, Maria K.; Radomski, Thomas R.; Donohue, Julie M.; Hausmann, Leslie R. M.; Hanlon, Joseph T.; Good, Chester B.; Fine, Michael J.; Gellad, Walid F.			Dual Receipt of Prescription Opioids From the Department of Veterans Affairs and Medicare Part D and Prescription Opioid Overdose Death Among Veterans A Nested Case-Control Study	ANNALS OF INTERNAL MEDICINE			English	Article							UNITED-STATES; SYSTEM USE; HEALTH; RISK; CARE; ADJUSTMENT; MORTALITY; ENROLLEES; BENEFITS; IMPACT	Background: More than half of enrollees in the U.S. Department of Veterans Affairs (VA) are also covered by Medicare and can choose to receive their prescriptions from VA or from Medicare-participating providers. Such dual-system care may lead to unsafe opioid use if providers in these 2 systems do not coordinate care or if prescription use is not tracked between systems. Objective: To evaluate the association between dual-system opioid prescribing and death from prescription opioid overdose. Design: Nested case-control study. Setting: VA and Medicare Part D. Participants: Case and control patients were identified from all veterans enrolled in both VA and Part D who filled at least 1 opioid prescription from either system. The 215 case patients who died of a prescription opioid overdose in 2012 or 2013 were matched (up to 1: 4) with 833 living control patients on the basis of date of death (that is, index date), using age, sex, race/ethnicity, disability, enrollment in Medicaid or low-income subsidies, managed care enrollment, region and rurality of residence, and a medication-based measure of comorbid conditions. Measurements: The exposure was the source of opioid prescriptions within 6 months of the index date, categorized as VA only, Part D only, or VA and Part D (that is, dual use). The outcome was unintentional or undetermined-intent death from prescription opioid overdose, identified from the National Death Index. The association between this outcome and source of opioid prescriptions was estimated using conditional logistic regression with adjustment for age, marital status, prescription drug monitoring programs, and use of other medications. Results: Among case patients, the mean age was 57.3 years (SD, 9.1), 194 (90%) were male, and 181 (84%) were non-Hispanic white. Overall, 60 case patients (28%) and 117 control patients (14%) received dual opioid prescriptions. Dual users had significantly higher odds of death from prescription opioid overdose than those who received opioids from VA only (odds ratio [OR], 3.53 [95% CI, 2.17 to 5.75]; P < 0.001) or Part D only (OR, 1.83 [CI, 1.20 to 2.77]; P = 0.005). Limitation: Data are from 2012 to 2013 and cannot capture prescriptions obtained outside the VA or Medicare Part D systems. Conclusion: Among veterans enrolled in VA and Part D, dual use of opioid prescriptions was independently associated with death from prescription opioid overdose. This risk factor for fatal overdose among veterans underscores the importance of care coordination across health care systems to improve opioid prescribing safety. Primary Funding Source: U. S. Department of Veterans Affairs.	[Moyo, Patience] Brown Univ, Sch Publ Hlth, 121 South Main St,Box G-S121-6, Providence, RI 02912 USA; [Zhao, Xinhua; Sileanu, Florentina E.; Cashy, John P.; Hale, Jennifer A.; Mor, Maria K.; Hausmann, Leslie R. M.; Fine, Michael J.; Gellad, Walid F.] VA Pittsburgh Healthcare Syst, Ctr Hlth Equ Res & Promot, Univ Dr 151C,Bldg 30, Pittsburgh, PA 15240 USA; [Thorpe, Carolyn T.; Thorpe, Joshua M.; Radomski, Thomas R.; Donohue, Julie M.] VA Pittsburgh Healthcare Syst, Univ Dr 151C, Pittsburgh, PA 15240 USA; [Thorpe, Carolyn T.; Thorpe, Joshua M.] Univ N Carolina, Eshelman Sch Pharm, Div Pharmaceut Outcomes & Policy, 301 Pharm Lane, Chapel Hill, NC 27599 USA; [Mor, Maria K.] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA; [Donohue, Julie M.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Hlth Policy & Management, Public Hlth Bldg,130 De Soto St, Pittsburgh, PA 15261 USA; [Radomski, Thomas R.] Univ Pittsburgh, Sch Med, Div Gen Internal Med, 200 Lothrop St, Pittsburgh, PA 15213 USA; [Hausmann, Leslie R. M.; Good, Chester B.; Fine, Michael J.; Gellad, Walid F.] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; [Hanlon, Joseph T.] Univ Pittsburgh, Hlth Policy Inst, Ctr Pharmaceut Policy & Prescribing, 311 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA; [Good, Chester B.] UPMC Hlth Plan, Ctr Value Based Pharmaceut Initiat, 600 Grant St, Pittsburgh, PA 15219 USA	Brown University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; University of North Carolina; University of North Carolina Chapel Hill; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gellad, WF (corresponding author), VA Pittsburgh Healthcare Syst, Univ Dr 151C, Pittsburgh, PA 15240 USA.	walid.gellad@va.gov		Hausmann, Leslie/0000-0002-3909-6009; Radomski, Thomas/0000-0002-7279-188X	VA Health Services Research Development [I01 HX001765-01]; VA Information Resource Center [SDR 02-237, 98-004]; Veterans Affairs [I01HX001765, I01HX002237] Funding Source: NIH RePORTER	VA Health Services Research Development(US Department of Veterans Affairs); VA Information Resource Center; Veterans Affairs(US Department of Veterans Affairs)	By grant I01 HX001765-01 from VA Health Services Research & Development. Support for VA-Centers for Medicare & Medicaid Services data is provided by VA, Veterans Health Administration, Office of Research and Development, Health Services Research and Development, VA Information Resource Center (project numbers SDR 02-237 and 98-004).	Bohnert ASB, 2012, AM J PSYCHIAT, V169, P64, DOI 10.1176/appi.ajp.2011.10101476; Bohnert ASB, 2011, JAMA-J AM MED ASSOC, V305, P1315, DOI 10.1001/jama.2011.370; Bohnert ASB, 2011, MED CARE, V49, P393, DOI 10.1097/MLR.0b013e318202aa27; Britton PC, 2010, DRUG ALCOHOL DEPEN, V107, P51, DOI 10.1016/j.drugalcdep.2009.09.005; Byrne MM, 2006, MED CARE, V44, P768, DOI 10.1097/01.mlr.0000218786.44722.14; Carico R, 2018, ANN INTERN MED, V169, P593, DOI 10.7326/M18-0852; Cowper DC, 2002, ANN EPIDEMIOL, V12, P462, DOI 10.1016/S1047-2797(01)00285-X; Department of Veterans Affairs, 2015, Fed Regist, V80, P66419; Dunn KM, 2010, ANN INTERN MED, V152, P85, DOI 10.7326/0003-4819-152-2-201001190-00006; Fink DS, 2018, ANN INTERN MED, V168, P783, DOI 10.7326/M17-3074; Gellad WF, 2018, AM J PUBLIC HEALTH, V108, P248, DOI [10.2105/AJPH.2017.304174, 10.2105/ajph.2017.304174]; Gellad WF, 2017, JAMA INTERN MED, V177, P611, DOI 10.1001/jamainternmed.2017.0147; Gellad WF, 2017, SUBST ABUS, V38, P22, DOI 10.1080/08897077.2016.1267071; Gellad WF, 2016, J GEN INTERN MED, V31, P153, DOI 10.1007/s11606-015-3492-2; Gellad WF, 2015, JAMA INTERN MED, V175, P26, DOI 10.1001/jamainternmed.2014.5405; Gomes T, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002396; Huang G., 2018, 2017 SURVEY VET ENRO; Jones CM, 2013, JAMA-J AM MED ASSOC, V309, P657, DOI 10.1001/jama.2013.272; Kabiri M, 2017, HEALTHCARE-J DEL SCI, V5, P105, DOI 10.1016/j.hjdsi.2016.11.001; Kizer KW, 2012, JAMA-J AM MED ASSOC, V307, P789, DOI 10.1001/jama.2012.196; Kupfer J, 2018, ANN INTERN MED, V169, P487, DOI 10.7326/M18-1539; Lin LWA, 2017, PAIN, V158, P833, DOI 10.1097/j.pain.0000000000000837; Minegishi T, 2018, J GEN INTERN MED, V33, P781, DOI 10.1007/s11606-018-4352-7; Morgan RO, 2009, AM J MANAG CARE, V15, pE1; O'Donnell JK, 2017, MMWR-MORBID MORTAL W, V66, P897, DOI 10.15585/mmwr.mm6634a2; Oliva EM, 2017, PSYCHOL SERV, V14, P34, DOI 10.1037/ser0000099; Park TW, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2698; Passik Steven D, 2014, J Opioid Manag, V10, P263, DOI 10.5055/jom.2014.0214; Pizer SD, 2011, INQUIRY-J HEALTH CAR, V48, P109, DOI 10.5034/inquiryjrnl_48.02.02; Prescription Drug Abuse Policy System, 2016, PDMP REP AUTH US; Psaty BM, 1999, J AM GERIATR SOC, V47, P749, DOI 10.1111/j.1532-5415.1999.tb01603.x; Radomski TR, 2017, J GEN INTERN MED, V32, P967, DOI 10.1007/s11606-017-4064-4; Radomski TR, 2016, JAMA-J AM MED ASSOC, V316, P345, DOI 10.1001/jama.2016.5391; Radomski TR, 2016, J GEN INTERN MED, V31, P524, DOI 10.1007/s11606-016-3631-4; Robards J, 2012, MATURITAS, V73, P295, DOI 10.1016/j.maturitas.2012.08.007; Rosen AK, 2005, AM J MED QUAL, V20, P182, DOI 10.1177/1062860605275791; Ruhm CJ, 2018, ADDICTION, V113, P1339, DOI 10.1111/add.14144; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Stroupe KT, 2013, AM J HEALTH-SYST PH, V70, P804, DOI 10.2146/ajhp120222; Suda KJ, 2017, J AM PHARM ASSOC, V57, P333, DOI 10.1016/j.japh.2017.02.018; Thorpe CT, 2018, HEALTH SERV RES, V53, P5375, DOI 10.1111/1475-6773.13055; Thorpe JM, 2017, ANN INTERN MED, V166, P157, DOI 10.7326/M16-0551; Trivedi AN, 2012, JAMA-J AM MED ASSOC, V308, P67, DOI 10.1001/jama.2012.7115; Warner M, 2013, ACAD FORENSIC PATHOL, V3, P231, DOI [DOI 10.23907/2013.029, 10.23907/2013.029]; Webster LR, 2011, PAIN MED, V12, pS26, DOI 10.1111/j.1526-4637.2011.01134.x; West AN, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1069-8; Wong ES, 2016, MED CARE RES REV, V73, P493, DOI 10.1177/1077558715617382; Zedler B, 2015, PAIN MED, V16, P1566, DOI 10.1111/pme.12777	48	18	18	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 2	2019	170	7					433	+		10.7326/M18-2574	http://dx.doi.org/10.7326/M18-2574			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HR3WA	30856660	Green Accepted			2022-12-28	WOS:000463070700002
J	Mimoz, O; Guenezan, J				Mimoz, Olivier; Guenezan, Jeremy			No benefit of chlorhexidine bathing in non-critical care units	LANCET			English	Editorial Material							VANCOMYCIN-RESISTANT ENTEROCOCCUS; STAPHYLOCOCCUS-AUREUS; SKIN ANTISEPSIS; INFECTIONS		[Mimoz, Olivier; Guenezan, Jeremy] CHU Poitiers, Serv Urgences Adultes, F-86021 Poitiers, France; [Mimoz, Olivier; Guenezan, Jeremy] CHU Poitiers, SAMU 86, F-86021 Poitiers, France; [Mimoz, Olivier] Univ Poitiers, Poitiers, France; [Mimoz, Olivier] INSERM, U1070, Poitiers, France	CHU Poitiers; Universite de Poitiers; CHU Poitiers; Universite de Poitiers; Universite de Poitiers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Poitiers	Mimoz, O (corresponding author), CHU Poitiers, Serv Urgences Adultes, F-86021 Poitiers, France.; Mimoz, O (corresponding author), CHU Poitiers, SAMU 86, F-86021 Poitiers, France.; Mimoz, O (corresponding author), Univ Poitiers, Poitiers, France.; Mimoz, O (corresponding author), INSERM, U1070, Poitiers, France.	olivier.mimoz@chu-poitiers.fr	GUENEZAN, Jérémy/ABA-6839-2021	GUENEZAN, Jérémy/0000-0002-4736-1490; mimoz, olivier/0000-0003-1737-7915				Bhardwaj P, 2017, ANTIMICROB AGENTS CH, V62; Frost SA, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1553-5; Huang SS, 2019, LANCET, V393, P1205, DOI 10.1016/S0140-6736(18)32593-5; Kampf G, 2016, J HOSP INFECT, V94, P213, DOI 10.1016/j.jhin.2016.08.018; Lowe CF, 2017, AM J INFECT CONTROL, V45, P255, DOI 10.1016/j.ajic.2016.09.019; Mimoz O, 2016, INTENS CARE MED, V42, P2043, DOI 10.1007/s00134-016-4490-5; Mimoz O, 2015, LANCET, V386, P2069, DOI 10.1016/S0140-6736(15)00244-5; Musuuza JS, 2017, INFECT CONT HOSP EP, V38, P729, DOI 10.1017/ice.2017.53; Timsit JF, 2012, AM J RESP CRIT CARE, V186, P1272, DOI 10.1164/rccm.201206-1038OC; Vanhoozer G, 2019, AM J INFECT CONTROL, V47, P349, DOI 10.1016/j.ajic.2018.08.002; Xiao GB, 2018, INFECT DRUG RESIST, V11, P1473, DOI 10.2147/IDR.S170497; Zimlichman E, 2013, JAMA INTERN MED, V173, P2039, DOI 10.1001/jamainternmed.2013.9763	12	0	0	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 23	2019	393	10177					1179	1180		10.1016/S0140-6736(18)33130-1	http://dx.doi.org/10.1016/S0140-6736(18)33130-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HP9UL	30850113				2022-12-28	WOS:000462038400005
J	Schneeweiss, S; Rassen, JA; Brown, JS; Rothman, KJ; Happe, L; Arlett, P; Dal Pan, G; Goettsch, W; Murk, W; Wang, SV				Schneeweiss, Sebastian; Rassen, Jeremy A.; Brown, Jeffrey S.; Rothman, Kenneth J.; Happe, Laura; Arlett, Peter; Dal Pan, Gerald; Goettsch, Wim; Murk, William; Wang, Shirley V.			Graphical Depiction of Longitudinal Study Designs in Health Care Databases	ANNALS OF INTERNAL MEDICINE			English	Article							REAL-WORLD EVIDENCE; IMMORTAL TIME BIAS; SAFETY; RISK; INHIBITORS	Pharmacoepidemiologic and pharmacoeconomic analysis of health care databases has become a vital source of evidence to support health care decision making and efficient management of health care organizations. However, decision makers often consider studies done in nonrandomized health care databases more difficult to review than randomized trials because many design choices need to be considered. This is perceived as an important barrier to decision making about the effectiveness and safety of medical products. Design flaws in longitudinal database studies are avoidable but can be unintentionally obscured in the convoluted prose of methods sections, which often lack specificity. We propose a simple framework of graphical representation that visualizes study design implementations in a comprehensive, unambiguous, and intuitive way; contains a level of detail that enables reproduction of key study design variables; and uses standardized structure and terminology to simplify review and communication to a broad audience of decision makers. Visualization of design details will make database studies more reproducible, quicker to review, and easier to communicate to a broad audience of decision makers.	[Schneeweiss, Sebastian; Wang, Shirley V.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Schneeweiss, Sebastian; Brown, Jeffrey S.; Wang, Shirley V.] Harvard Med Sch, Boston, MA 02115 USA; [Rassen, Jeremy A.; Murk, William] Aetion, New York, NY USA; [Brown, Jeffrey S.] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Rothman, Kenneth J.] RTI Hlth Solut, Durham, NC USA; [Happe, Laura] Journal Managed Care & Specialty Pharm, Alexandria, VA USA; [Arlett, Peter] European Med Agcy, Dept Pharmacovigilance & Epidemiol, 30 Churchill Pl, London E14 5EU, England; [Dal Pan, Gerald] US FDA, Silver Spring, MD USA; [Goettsch, Wim] Natl Hlth Care Inst, Diemen, Netherlands; [Goettsch, Wim] Univ Utrecht, Utrecht, Netherlands	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Research Triangle Institute; US Food & Drug Administration (FDA); Utrecht University	Wang, SV (corresponding author), 1620 Tremont St,Suite 303, Boston, MA 02120 USA.	swang1@bwh.harvard.edu		Rassen, Jeremy/0000-0003-4369-7381	Division of Pharmacoepidemiology and Pharmacoeconomics of the Department of Medicine at Brigham and Women's Hospital; Harvard Medical School	Division of Pharmacoepidemiology and Pharmacoeconomics of the Department of Medicine at Brigham and Women's Hospital; Harvard Medical School	Writing of this manuscript was supported by internal funds from the Division of Pharmacoepidemiology and Pharmacoeconomics of the Department of Medicine at Brigham and Women's Hospital and Harvard Medical School.	Azoulay L, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3645; Baker MA, 2015, AM J EPIDEMIOL, V181, P608, DOI 10.1093/aje/kwu322; Ball R, 2016, CLIN PHARMACOL THER, V99, P265, DOI 10.1002/cpt.320; Berger ML, 2017, PHARMACOEPIDEM DR S, V26, P1033, DOI 10.1002/pds.4297; Brookhart MA, 2015, AM J EPIDEMIOL, V182, P840, DOI 10.1093/aje/kwv214; Brunelli SM, 2013, PHARMACOEPIDEM DR S, V22, P542, DOI 10.1002/pds.3434; Bykov K, 2017, DRUG SAFETY, V40, P923, DOI 10.1007/s40264-017-0556-8; Curtis LH, 2012, PHARMACOEPIDEM DR S, V21, P23, DOI 10.1002/pds.2336; Douglas IJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1936; Gagne J.J., 2015, MINISENTINEL METHODS; Gagne JJ, 2011, J CLIN EPIDEMIOL, V64, P749, DOI 10.1016/j.jclinepi.2010.10.004; Gini Rosa, 2016, EGEMS (Wash DC), V4, P1189, DOI 10.13063/2327-9214.1189; Goodman SN, 2017, JAMA-J AM MED ASSOC, V317, P705, DOI 10.1001/jama.2016.19970; Gruber S, 2016, PHARMACOEPIDEM DR S, V25, P973, DOI 10.1002/pds.4065; Hallas J, 1996, EPIDEMIOLOGY, V7, P478, DOI 10.1097/00001648-199609000-00005; Hampson G, 2018, REAL WORLD EVIDENCE; Hartzema AG, 2011, PHARMACOEPIDEM DR S, V20, P684, DOI 10.1002/pds.2143; Hemkens LG, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i493; Hernan MA, 2008, EPIDEMIOLOGY, V19, P766, DOI 10.1097/EDE.0b013e3181875e61; Hernan MA, 2012, CLIN TRIALS, V9, P48, DOI 10.1177/1740774511420743; Jena AB, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1393; Kim SC, 2017, ARTHRITIS RHEUMATOL, V69, P1154, DOI 10.1002/art.40084; Langan SM, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k3532; Layton JB, 2013, AM J CARDIOL, V111, P823, DOI 10.1016/j.amjcard.2012.11.047; Maclure M, 2001, EPIDEMIOLOGY, V12, P114, DOI 10.1097/00001648-200101000-00019; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; Maclure M, 2012, PHARMACOEPIDEM DR S, V21, P50, DOI 10.1002/pds.2330; Makady A, 2017, VALUE HEALTH, V20, P520, DOI 10.1016/j.jval.2016.12.003; Malone DC, 2018, VALUE HEALTH, V21, P326, DOI 10.1016/j.jval.2017.08.3013; Matcho A, 2014, DRUG SAFETY, V37, P945, DOI 10.1007/s40264-014-0214-3; Meier CR, 1998, LANCET, V351, P1467, DOI 10.1016/S0140-6736(97)11084-4; Nakasian SS, 2017, PHARMACOEPIDEM DR S, V26, P890, DOI 10.1002/pds.4210; Rassen JA, 2009, CIRCULATION, V120, P2322, DOI 10.1161/CIRCULATIONAHA.109.873497; ROMANO PS, 1993, J CLIN EPIDEMIOL, V46, P1075, DOI 10.1016/0895-4356(93)90103-8; ROTHMAN KJ, 1981, AM J EPIDEMIOL, V114, P253, DOI 10.1093/oxfordjournals.aje.a113189; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Schneeweiss S, 2007, MED CARE, V45, pS131, DOI 10.1097/MLR.0b013e318070c08e; Schneeweiss S, 2018, CLIN EPIDEMIOL, V10, P771, DOI 10.2147/CLEP.S166545; Schneeweiss S, 2010, PHARMACOEPIDEM DR S, V19, P858, DOI 10.1002/pds.1926; Suissa S, 2008, AM J EPIDEMIOL, V168, P329, DOI 10.1093/aje/kwn135; Suissa S, 2008, AM J EPIDEMIOL, V167, P492, DOI 10.1093/aje/kwm324; Suissa S, 2007, PHARMACOEPIDEM DR S, V16, P241, DOI 10.1002/pds.1357; Toh S, 2012, ARCH INTERN MED, V172, P1582, DOI 10.1001/2013.jamainternmed.34; Wang SV, 2018, PHARMACOEPIDEM DR S, V27, P405, DOI 10.1002/pds.4399; Wang SV, 2017, PHARMACOEPIDEM DR S, V26, P1018, DOI 10.1002/pds.4295; Whitaker HJ, 2006, STAT MED, V25, P1768, DOI 10.1002/sim.2302; YOLA M, 1994, J CLIN EPIDEMIOL, V47, P731, DOI 10.1016/0895-4356(94)90170-8	47	83	82	1	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 19	2019	170	6					398	+		10.7326/M18-3079	http://dx.doi.org/10.7326/M18-3079			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP1ZR	30856654				2022-12-28	WOS:000461468300017
J	Wu, RA; Semlow, DR; Kamimae-Lanning, AN; Kochenova, OV; Chistol, G; Hodskinson, MR; Amunugama, R; Sparks, JL; Wang, M; Deng, L; Mimoso, CA; Low, E; Patel, KJ; Walter, JC				Wu, R. Alex; Semlow, Daniel R.; Kamimae-Lanning, Ashley N.; Kochenova, Olga V.; Chistol, Gheorghe; Hodskinson, Michael R.; Amunugama, Ravindra; Sparks, Justin L.; Wang, Meng; Deng, Lin; Mimoso, Claudia A.; Low, Emily; Patel, Ketan J.; Walter, Johannes C.			TRAIP is a master regulator of DNA interstrand crosslink repair	NATURE			English	Article							FANCONI-ANEMIA; REPLICATION TERMINATION; PROMOTES; NEIL3; MECHANISM; HELICASE; REPLISOME; MCM2-7; MOUSE; CDC45	Cells often use multiple pathways to repair the same DNA lesion, and the choice of pathway has substantial implications for the fidelity of genome maintenance. DNA interstrand crosslinks covalently link the two strands of DNA, and thereby block replication and transcription; the cytotoxicity of these crosslinks is exploited for chemotherapy. In Xenopus egg extracts, the collision of replication forks with interstrand crosslinks initiates two distinct repair pathways. NEIL3 glycosylase can cleave the crosslink(1); however, if this fails, Fanconi anaemia proteins incise the phosphodiester backbone that surrounds the interstrand crosslink, generating a double-strand-break intermediate that is repaired by homologous recombination(2). It is not known how the simpler NEIL3 pathway is prioritized over the Fanconi anaemia pathway, which can cause genomic rearrangements. Here we show that the E3 ubiquitin ligase TRAIP is required for both pathways. When two replisomes converge at an interstrand crosslink, TRAIP ubiquitylates the replicative DNA helicase CMG (the complex of CDC45, MCM2-7 and GINS). Short ubiquitin chains recruit NEIL3 through direct binding, whereas longer chains are required for the unloading of CMG by the p97 ATPase, which enables the Fanconi anaemia pathway. Thus, TRAIP controls the choice between the two known pathways of replication-coupled interstrand-crosslink repair. These results, together with our other recent findings(3,4) establish TRAIP as a master regulator of CMG unloading and the response of the replisome to obstacles.	[Wu, R. Alex; Semlow, Daniel R.; Kochenova, Olga V.; Chistol, Gheorghe; Amunugama, Ravindra; Sparks, Justin L.; Deng, Lin; Mimoso, Claudia A.; Low, Emily; Walter, Johannes C.] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Kamimae-Lanning, Ashley N.; Hodskinson, Michael R.; Wang, Meng; Patel, Ketan J.] MRC Lab Mol Biol, Cambridge Biomed Campus, Cambridge, England; [Wang, Meng] Univ Cambridge, Dept Haematol, Cambridge, England; [Deng, Lin] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Deng, Lin] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA; [Patel, Ketan J.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge, England; [Walter, Johannes C.] Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; MRC Laboratory Molecular Biology; University of Cambridge; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Howard Hughes Medical Institute	Walter, JC (corresponding author), Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.; Walter, JC (corresponding author), Howard Hughes Med Inst, Boston, MA 02115 USA.	johannes_walter@hms.harvard.edu		Chistol, Gheorghe/0000-0003-4868-3667; Walter, Johannes/0000-0002-4186-7570; Kamimae-Lanning, Ashley/0000-0002-7516-4881; Wu, R. Alex/0000-0003-4190-4615	NIH [F31GM122277, HL098316, K99GM129422]; American Cancer Society [131415-PF-17-168-01-DMC]; Jane Coffin Childs postdoctoral fellowships; Damon Runyon postdoctoral fellowship; Cancer Research UK Clinician Scientist Fellowship; MRC [MC_U105178811] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098316] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM129422, F31GM122277] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Jane Coffin Childs postdoctoral fellowships; Damon Runyon postdoctoral fellowship; Cancer Research UK Clinician Scientist Fellowship(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Pellman and members of the Walter laboratory for comments on the manuscript, and K. Arnett for help with biolayer interferometry experiments. J.C.W. is supported by NIH grant HL098316 and a gift from the family of Jonathan G. Wiseman. R.A.W. is supported by American Cancer Society postdoctoral fellowship 131415-PF-17-168-01-DMC, D.R.S. by NIH award K99GM129422, D.R.S. and G.C. by Jane Coffin Childs postdoctoral fellowships, J.L.S. by a Damon Runyon postdoctoral fellowship, M.W. by the Cancer Research UK Clinician Scientist Fellowship, and E.L. by NIH award F31GM122277. J.C.W. is a Howard Hughes Medical Institute Investigator and an American Cancer Society Research Professor.	Amunugama R, 2018, CELL REP, V23, P3419, DOI 10.1016/j.celrep.2018.05.061; Budzowska M, 2015, EMBO J, V34, P1971, DOI 10.15252/embj.201490878; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; Chapard C, 2012, EXP DERMATOL, V21, P321, DOI 10.1111/j.1600-0625.2012.01477.x; Deng L, MOL CELL; Derheimer FA, 2009, MOL PHARMACOL, V75, P599, DOI 10.1124/mol.108.051698; Dewar JM, 2017, GENE DEV, V31, P275, DOI 10.1101/gad.291799.116; Dewar JM, 2015, NATURE, V525, P345, DOI 10.1038/nature14887; DUTRILLAUX B, 1982, HUM GENET, V62, P327, DOI 10.1007/BF00304549; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Fu YV, 2011, CELL, V146, P930, DOI 10.1016/j.cell.2011.07.045; Fullbright G, 2016, MOL CELL BIOL, V36, P2983, DOI 10.1128/MCB.00434-16; Graham TGW, 2016, MOL CELL, V61, P850, DOI 10.1016/j.molcel.2016.02.010; Harley ME, 2016, NAT GENET, V48, P36, DOI 10.1038/ng.3451; HEMSLEY A, 1989, NUCLEIC ACIDS RES, V17, P6545, DOI 10.1093/nar/17.16.6545; Hoffmann S, 2016, J CELL BIOL, V212, P63, DOI 10.1083/jcb.201506071; Huang J, 2013, MOL CELL, V52, P434, DOI 10.1016/j.molcel.2013.09.021; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Joukov V, 2001, P NATL ACAD SCI USA, V98, P12078, DOI 10.1073/pnas.211427098; Klein D. D., 2014, CELL, V54, P460, DOI DOI 10.1016/j.molcel.2014.03.015; Knipscheer Puck, 2012, Methods Mol Biol, V920, P221, DOI 10.1007/978-1-61779-998-3_16; Knipscheer P, 2009, SCIENCE, V326, P1698, DOI 10.1126/science.1182372; Kochaniak AB, 2009, J BIOL CHEM, V284, P17700, DOI 10.1074/jbc.M109.008706; Kottemann MC, 2013, NATURE, V493, P356, DOI 10.1038/nature11863; Larsen NB, 2019, MOL CELL, V73, P574, DOI 10.1016/j.molcel.2018.11.024; Lebofsky Ronald, 2009, V521, P229, DOI [10.1007/978-1-60327-817-5_13, 10.1007/978-1-60327-815-7_13]; Liu MM, 2012, PROTEIN EXPRES PURIF, V84, P130, DOI 10.1016/j.pep.2012.04.022; Liu MM, 2010, P NATL ACAD SCI USA, V107, P4925, DOI 10.1073/pnas.0908307107; Long DT, 2014, MOL CELL, V56, P174, DOI 10.1016/j.molcel.2014.08.012; Long DT, 2011, SCIENCE, V333, P84, DOI 10.1126/science.1204258; Massaad MJ, 2016, J CLIN INVEST, V126, P4219, DOI 10.1172/JCI85647; Michel MA, 2015, MOL CELL, V58, P95, DOI 10.1016/j.molcel.2015.01.042; Moreno SP, 2014, SCIENCE, V346, P477, DOI 10.1126/science.1253585; Mutreja K, 2018, CELL REP, V24, P2629, DOI 10.1016/j.celrep.2018.08.019; Pacek M, 2006, MOL CELL, V21, P581, DOI 10.1016/j.molcel.2006.01.030; Parmar K, 2009, MUTAT RES-FUND MOL M, V668, P133, DOI 10.1016/j.mrfmmm.2009.03.015; Price NE, 2015, NUCLEIC ACIDS RES, V43, P3434, DOI 10.1093/nar/gkv174; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Raschle M, 2015, SCIENCE, V348, DOI 10.1126/science.1253671; Rosado IV, 2011, NAT STRUCT MOL BIOL, V18, P1432, DOI 10.1038/nsmb.2173; Sejersted Y, 2011, P NATL ACAD SCI USA, V108, P18802, DOI 10.1073/pnas.1106880108; Semlow DR, 2016, CELL, V167, P498, DOI 10.1016/j.cell.2016.09.008; Sonneville R, 2017, NAT CELL BIOL, V19, P468, DOI 10.1038/ncb3500; Sparks JL, 2019, CELL, V176, P167, DOI 10.1016/j.cell.2018.10.053; Torisu K, 2005, J BIOCHEM, V138, P763, DOI 10.1093/jb/mvi168; Trowitzsch S, 2010, J STRUCT BIOL, V172, P45, DOI 10.1016/j.jsb.2010.02.010; VOS JMH, 1987, CELL, V50, P789, DOI 10.1016/0092-8674(87)90337-0; Wallace BD, 2017, P NATL ACAD SCI USA, V114, P304, DOI 10.1073/pnas.1610011114; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; Walter J, 1998, MOL CELL, V1, P519, DOI 10.1016/S1097-2765(00)80052-0; Wang B, 2003, J BIOL CHEM, V278, P20225, DOI 10.1074/jbc.M300459200; Wohlschlegel JA, 2002, MOL CELL, V9, P233, DOI 10.1016/S1097-2765(02)00456-2; Zhang JQ, 2015, NAT STRUCT MOL BIOL, V22, P242, DOI 10.1038/nsmb.2956	53	85	91	5	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 14	2019	567	7747					267	+		10.1038/s41586-019-1002-0	http://dx.doi.org/10.1038/s41586-019-1002-0			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7LD	30842657	Green Accepted			2022-12-28	WOS:000461126600048
J	Kmietowicz, Z				Kmietowicz, Zosia			SAS doctors to be asked about their workplace experiences for the first time	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		General Medical Council, 2019, WHAT DO WE KNOW SPEC	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 12	2019	364								l1140	10.1136/bmj.l1140	http://dx.doi.org/10.1136/bmj.l1140			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP5VS	30862689				2022-12-28	WOS:000461751000017
J	Kuehn, B				Kuehn, Bridget			Transgender Youth Victimization	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 12	2019	321	10					931	931		10.1001/jama.2019.1463	http://dx.doi.org/10.1001/jama.2019.1463			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HO5JE	30860567				2022-12-28	WOS:000460961000028
J	van Dongen, MJP; Kadam, RU; Juraszek, J; Lawson, E; Brandenburg, B; Schmitz, F; Schepens, WBG; Stoops, B; van Diepen, HA; Jongeneelen, M; Tang, C; Vermond, J; Real, AVO; Blokland, S; Garg, D; Yu, WL; Goutier, W; Lanckacker, E; Klap, JM; Peeters, DCG; Wu, J; Buyck, C; Jonckers, THM; Roymans, D; Roevens, P; Vogels, R; Koudstaal, W; Friesen, RHE; Raboisson, P; Dhanak, D; Goudsmit, J; Wilson, IA				van Dongen, Maria J. P.; Kadam, Rameshwar U.; Juraszek, Jarek; Lawson, Edward; Brandenburg, Boerries; Schmitz, Frederike; Schepens, Wim B. G.; Stoops, Bart; van Diepen, Harry A.; Jongeneelen, Mandy; Tang, Chan; Vermond, Jan; Real, Alida van Eijgen-Obregoso; Blokland, Sven; Garg, Divita; Yu, Wenli; Goutier, Wouter; Lanckacker, Ellen; Klap, Jaco M.; Peeters, Danielle C. G.; Wu, Jin; Buyck, Christophe; Jonckers, Tim H. M.; Roymans, Dirk; Roevens, Peter; Vogels, Ronald; Koudstaal, Wouter; Friesen, Robert H. E.; Raboisson, Pierre; Dhanak, Dashyant; Goudsmit, Jaap; Wilson, Ian A.			A small-molecule fusion inhibitor of influenza virus is orally active in mice	SCIENCE			English	Article							BROADLY NEUTRALIZING ANTIBODIES; HEMAGGLUTININ STRUCTURES; STRUCTURAL BASIS; STEM; PROTEINS; EPITOPES; IMMUNITY; BINDING; DESIGN; CELLS	Recent characterization of broadly neutralizing antibodies (bnAbs) against influenza virus identified the conserved hemagglutinin (HA) stem as a target for development of universal vaccines and therapeutics. Although several stem bnAbs are being evaluated in clinical trials, antibodies are generally unsuited for oral delivery. Guided by structural knowledge of the interactions and mechanism of anti-stem bnAb CR6261, we selected and optimized small molecules that mimic the bnAb functionality. Our lead compound neutralizes influenza A group 1 viruses by inhibiting HA-mediated fusion in vitro, protects mice against lethal and sublethal influenza challenge after oral administration, and effectively neutralizes virus infection in reconstituted three-dimensional cell culture of fully differentiated human bronchial epithelial cells. Cocrystal structures with H1 and H5 HAs reveal that the lead compound recapitulates the bnAb hotspot interactions.	[van Dongen, Maria J. P.; Juraszek, Jarek; Brandenburg, Boerries; Schmitz, Frederike; van Diepen, Harry A.; Jongeneelen, Mandy; Tang, Chan; Vermond, Jan; Real, Alida van Eijgen-Obregoso; Blokland, Sven; Goutier, Wouter; Klap, Jaco M.; Vogels, Ronald; Koudstaal, Wouter; Friesen, Robert H. E.; Goudsmit, Jaap] Janssen Pharmaceut Companies Johnson & Johnson, Janssen Prevent Ctr, Archimedesweg 6, Leiden, Netherlands; [van Dongen, Maria J. P.; Schepens, Wim B. G.; Stoops, Bart; Peeters, Danielle C. G.; Buyck, Christophe; Roevens, Peter; Dhanak, Dashyant] Janssen Res & Dev, Discovery Sci, Turnhoutseweg 30, Beerse, Belgium; [Kadam, Rameshwar U.; Yu, Wenli; Wilson, Ian A.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Lawson, Edward; Dhanak, Dashyant] Janssen Res & Dev, Discovery Sci, 1400 McKean Rd, Spring House, PA USA; [Brandenburg, Boerries; Jongeneelen, Mandy; Tang, Chan; Blokland, Sven; Vogels, Ronald] Janssen Res & Dev, Janssen Infect Dis & Vaccines, Archimedesweg 4-6, Leiden, Netherlands; [Garg, Divita] Scripps Res Inst, Dept Mol Med, La Jolla, CA 92037 USA; [Lanckacker, Ellen; Wu, Jin; Jonckers, Tim H. M.; Roymans, Dirk; Raboisson, Pierre] Janssen Res & Discovery, Janssen Infect Dis & Vaccines, Turnhoutseweg 30, Beerse, Belgium; [Goudsmit, Jaap] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Koudstaal, Wouter] Lucid Biomed Consulting, Calle Emir 11, Granada, Spain; [Friesen, Robert H. E.] Kiadis Pharma, Paasheuvelweg 25A, Amsterdam, Netherlands; [Raboisson, Pierre] Bio Incubator Leuven NV, Aligos Bvba, Gaston Geenslaan 1, Leuven, Belgium; [Dhanak, Dashyant] Incyte Corp, 1801 Augustine Cut Off, Wilmington, DE USA	Johnson & Johnson; Janssen Pharmaceuticals; Johnson & Johnson; Janssen Pharmaceuticals; Scripps Research Institute; Johnson & Johnson; Janssen Pharmaceuticals; Johnson & Johnson; Janssen Pharmaceuticals; Scripps Research Institute; Harvard University; Harvard T.H. Chan School of Public Health; Scripps Research Institute; Incyte	van Dongen, MJP (corresponding author), Janssen Pharmaceut Companies Johnson & Johnson, Janssen Prevent Ctr, Archimedesweg 6, Leiden, Netherlands.; van Dongen, MJP (corresponding author), Janssen Res & Dev, Discovery Sci, Turnhoutseweg 30, Beerse, Belgium.; Wilson, IA (corresponding author), Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA.; Wilson, IA (corresponding author), Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA.	mvandon@its.jnj.com; wilson@scripps.edu	Klap, Jaco M/L-3512-2013; Roymans, Dirk/AFQ-3892-2022	Klap, Jaco M/0000-0003-1188-3008; Lawson, Edward/0000-0002-3015-0232; Juraszek, Jarek/0000-0001-7430-2771; Brandenburg, Boerries/0000-0002-5025-3802; van Diepen, Harry/0000-0002-4822-7445; Schmitz, Frederike/0000-0003-2303-9517	NIH [R56 AI117675, R56 AI127371]; Swiss National Science Foundation; U.S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; National Institutes of Health, National Institute of General Medical Sciences [P41GM103393]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI127371, UM1AI100663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); U.S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported in part by NIH grants R56 AI117675 and R56 AI127371 (to I.A.W.). R.U.K is grateful to the Swiss National Science Foundation for an Early Postdoc. Mobility fellowship. X-ray datasets were collected at the Stanford Synchrotron Radiation Lightsource (SSRL beamline 12-2). Use of the SSRL, SLAC National Accelerator Laboratory, is supported by the U.S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences, under contract no. DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research and by the National Institutes of Health, National Institute of General Medical Sciences (including P41GM103393).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Boda B, 2018, ANTIVIR RES, V156, P72, DOI 10.1016/j.antiviral.2018.06.007; Bommakanti G, 2010, P NATL ACAD SCI USA, V107, P13701, DOI 10.1073/pnas.1007465107; Brandenburg B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080034; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; Burton DR, 2012, SCIENCE, V337, P183, DOI 10.1126/science.1225416; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cho A, 2016, CURR OPIN VIROL, V17, P110, DOI 10.1016/j.coviro.2016.03.002; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; De Clercq E, 2006, NAT REV DRUG DISCOV, V5, P1015, DOI 10.1038/nrd2175; Dreyfus C, 2012, SCIENCE, V337, P1343, DOI 10.1126/science.1222908; Ekiert DC, 2012, NATURE, V489, P526, DOI 10.1038/nature11414; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617; Guan Y, 2005, LANCET, V366, P1139, DOI 10.1016/S0140-6736(05)67340-0; Ha Y, 2002, EMBO J, V21, P865, DOI 10.1093/emboj/21.5.865; Hu YM, 2017, ANTIVIR RES, V140, P45, DOI 10.1016/j.antiviral.2017.01.006; Hwang H, 2010, PROTEINS, V78, P3111, DOI 10.1002/prot.22830; Ilyushina NA, 2006, ANTIVIR RES, V70, P121, DOI 10.1016/j.antiviral.2006.01.012; Impagliazzo A, 2015, SCIENCE, V349, P1301, DOI 10.1126/science.aac7263; Joyce MG, 2016, CELL, V166, P609, DOI 10.1016/j.cell.2016.06.043; Jubb H, 2015, PROG BIOPHYS MOL BIO, V119, P2, DOI 10.1016/j.pbiomolbio.2015.01.009; Kadam RU, 2017, SCIENCE, V358, P496, DOI 10.1126/science.aan0516; Kadam RU, 2017, P NATL ACAD SCI USA, V114, P206, DOI 10.1073/pnas.1617020114; Kadam RU, 2013, ACS CHEM BIOL, V8, P1925, DOI 10.1021/cb400303w; Kallewaard NL, 2016, CELL, V166, P596, DOI 10.1016/j.cell.2016.05.073; Kashyap AK, 2008, P NATL ACAD SCI USA, V105, P5986, DOI 10.1073/pnas.0801367105; Kikuchi T, 2019, RESPIR INVESTIG, V57, P1, DOI 10.1016/j.resinv.2018.10.002; Koday MT, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005409; Koshimichi H, 2018, CLIN DRUG INVEST, V38, P1189, DOI 10.1007/s40261-018-0710-9; Koudstaal W, 2009, VACCINE, V27, P2588, DOI 10.1016/j.vaccine.2009.02.033; Krammer F, 2014, J VIROL, V88, P3432, DOI 10.1128/JVI.03004-13; Krammer F, 2013, J VIROL, V87, P6542, DOI [10.1128/JVI.00641-13, 10.1128/JVI.03183-13]; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lang SS, 2017, CELL REP, V20, P2935, DOI 10.1016/j.celrep.2017.08.084; Laursen NS, 2018, SCIENCE, V362, P598, DOI 10.1126/science.aaq0620; Ledgerwood JE, 2011, LANCET INFECT DIS, V11, P916, DOI 10.1016/S1473-3099(11)70240-7; Liu WC, 2016, J VIROL, V90, P8496, DOI 10.1128/JVI.00880-16; Loregian A, 2014, CELL MOL LIFE SCI, V71, P3659, DOI 10.1007/s00018-014-1615-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Nishio M, 1998, METH STEREO, P1; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Popp Maximilian Wei-Lin, 2015, Methods Mol Biol, V1266, P185, DOI 10.1007/978-1-4939-2272-7_13; Russell RJ, 2004, VIROLOGY, V325, P287, DOI 10.1016/j.virol.2004.04.040; Schmidt AC, 2004, DRUGS, V64, P2031, DOI 10.2165/00003495-200464180-00003; Sparrow E, 2016, VACCINE, V34, P5442, DOI 10.1016/j.vaccine.2016.08.057; Stevens J, 2004, SCIENCE, V303, P1866, DOI 10.1126/science.1093373; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Valkenburg SA, 2016, SCI REP-UK, V6, DOI 10.1038/srep22666; Whittle JRR, 2011, P NATL ACAD SCI USA, V108, P14216, DOI 10.1073/pnas.1111497108; World Health Organization (WHO), 2018, WHO INFL SEAS FACT S; Wu Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8708; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430; Yassine HM, 2015, NAT MED, V21, P1065, DOI 10.1038/nm.3927; Yasugi M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003150	60	67	70	10	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 8	2019	363	6431					1056	+	eaar6221	10.1126/science.aar6221	http://dx.doi.org/10.1126/science.aar6221			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO2MV	30846569	Green Accepted			2022-12-28	WOS:000460750100035
J	Petljak, M; Alexandrov, LB; Brammeld, JS; Price, S; Wedge, DC; Grossmann, S; Dawson, KJ; Ju, YS; Iorio, F; Tubio, JMC; Koh, CC; Georgakopoulos-Soares, I; Rodriguez-Martin, B; Otlu, B; O'Meara, S; Butler, AP; Menzies, A; Bhosle, SG; Raine, K; Jones, DR; Teague, JW; Beal, K; Latimer, C; O'Neill, L; Zamora, J; Anderson, E; Patel, N; Maddison, M; Ng, BL; Graham, J; Garnett, MJ; McDermott, U; Nik-Zainal, S; Campbell, PJ; Stratton, MR				Petljak, Mia; Alexandrov, Ludmil B.; Brammeld, Jonathan S.; Price, Stacey; Wedge, David C.; Grossmann, Sebastian; Dawson, Kevin J.; Ju, Young Seok; Iorio, Francesco; Tubio, Jose M. C.; Koh, Ching Chiek; Georgakopoulos-Soares, Ilias; Rodriguez-Martin, Bernardo; Otlu, Burcak; O'Meara, Sarah; Butler, Adam P.; Menzies, Andrew; Bhosle, Shriram G.; Raine, Keiran; Jones, David R.; Teague, Jon W.; Beal, Kathryn; Latimer, Calli; O'Neill, Laura; Zamora, Jorge; Anderson, Elizabeth; Patel, Nikita; Maddison, Mark; Ng, Bee Ling; Graham, Jennifer; Garnett, Mathew J.; McDermott, Ultan; Nik-Zainal, Serena; Campbell, Peter J.; Stratton, Michael R.			Characterizing Mutational Signatures in Human Cancer Cell Lines Reveals Episodic APOBEC Mutagenesis	CELL			English	Article							HYPERMUTATION; ASSOCIATION; MECHANISMS; EXPRESSION; LANDSCAPE; EVOLUTION; PATTERNS; GENOMES	Multiple signatures of somatic mutations have been identified in cancer genomes. Exome sequences of 1,001 human cancer cell lines and 577 xenografts revealed most common mutational signatures, indicating past activity of the underlying processes, usually in appropriate cancer types. To investigate ongoing patterns of mutational-signature generation, cell lines were cultured for extended periods and subsequently DNA sequenced. Signatures of discontinued exposures, including tobacco smoke and ultraviolet light, were not generated in vitro. Signatures of normal and defective DNA repair and replication continued to be generated at roughly stable mutation rates. Signatures of APOBEC cytidine deaminase DNA-editing exhibited substantial fluctuations in mutation rate over time with episodic bursts of mutations. The initiating factors for the bursts are unclear, although retrotransposon mobilization may contribute. The examined cell lines constitute a resource of live experimental models of mutational processes, which potentially retain patterns of activity and regulation operative in primary human cancers.	[Petljak, Mia; Alexandrov, Ludmil B.; Brammeld, Jonathan S.; Price, Stacey; Grossmann, Sebastian; Dawson, Kevin J.; Iorio, Francesco; Tubio, Jose M. C.; Koh, Ching Chiek; Georgakopoulos-Soares, Ilias; O'Meara, Sarah; Butler, Adam P.; Menzies, Andrew; Bhosle, Shriram G.; Raine, Keiran; Jones, David R.; Teague, Jon W.; Beal, Kathryn; Latimer, Calli; O'Neill, Laura; Anderson, Elizabeth; Patel, Nikita; Maddison, Mark; Garnett, Mathew J.; McDermott, Ultan; Nik-Zainal, Serena; Campbell, Peter J.; Stratton, Michael R.] Wellcome Sanger Inst, Canc Ageing & Somat Mutat, Hinxton CB10 1SA, Cambs, England; [Alexandrov, Ludmil B.; Otlu, Burcak] Univ Calif San Diego, Moores Canc Ctr, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Alexandrov, Ludmil B.; Otlu, Burcak] Univ Calif San Diego, Moores Canc Ctr, Dept Bioengn, La Jolla, CA 92093 USA; [Wedge, David C.] Oxford Big Data Inst, Old Rd Campus, Oxford OX3 7LF, England; [Wedge, David C.] Oxford NIHR Biomed Res Ctr, Oxford OX4 2PG, England; [Ju, Young Seok] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Daejeon 305701, South Korea; [Iorio, Francesco] European Bioinformat Inst, European Mol Biol Lab, Hinxton CB10 1SA, Cambs, England; [Tubio, Jose M. C.; Rodriguez-Martin, Bernardo; Zamora, Jorge] Univ Santiago de Compostela, Mobile Genomes & Dis Mol Med & Chron Dis Ctr CIMU, Santiago De Compostela 15706, Spain; [Tubio, Jose M. C.; Rodriguez-Martin, Bernardo; Zamora, Jorge] Univ Santiago de Compostela, Dept Zool Genet & Phys Anthropol, Santiago De Compostela 15706, Spain; [Tubio, Jose M. C.; Rodriguez-Martin, Bernardo; Zamora, Jorge] Univ Vigo, Biomed Res Ctr CINBIO, Vigo 36310, Spain; [Ng, Bee Ling; Graham, Jennifer] Wellcome Sanger Inst, Cytometry Core Facil, Hinxton CB10 1SA, Cambs, England; [Nik-Zainal, Serena] Univ Cambridge, Sch Clin, Dept Med Genet, Cambridge CB2 0QQ, England	Wellcome Trust Sanger Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Oxford; Korea Advanced Institute of Science & Technology (KAIST); European Molecular Biology Laboratory (EMBL); Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; Universidade de Vigo; CINBIO; Wellcome Trust Sanger Institute; University of Cambridge	Stratton, MR (corresponding author), Wellcome Sanger Inst, Canc Ageing & Somat Mutat, Hinxton CB10 1SA, Cambs, England.	mrs@sanger.ac.uk	Tubio, Jose M.C./H-5076-2015; Wedge, David/AAC-4977-2021; Alexandrov, Ludmil/AAS-1454-2021; Iorio, Francesco/H-3284-2019; Nik-Zainal, Serena/ABD-4437-2020; Ju, Young Seok/E-1324-2012	Tubio, Jose M.C./0000-0003-3540-2459; Alexandrov, Ludmil/0000-0003-3596-4515; Iorio, Francesco/0000-0001-7063-8913; Wedge, David/0000-0002-7572-3196; McDermott, Ultan/0000-0001-9032-4700; Ju, Young Seok/0000-0002-5514-4189; Rodriguez-Martin, Bernardo/0000-0003-4693-3140; Nik-Zainal, Serena/0000-0001-5054-1727; Raine, Keiran/0000-0002-5634-1539	Wellcome [098051, 206194]; Cancer Research UK Grand Challenge Award [C98/A24032]; Li Ka Shing Foundation; National Institute for Health Research Oxford Biomedical Research Centre; Xunta de Galicia [ED481A-2016/151]	Wellcome; Cancer Research UK Grand Challenge Award; Li Ka Shing Foundation; National Institute for Health Research Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); Xunta de Galicia(Xunta de GaliciaEuropean Commission)	This work was supported by Wellcome grants 098051 and 206194; Cancer Research UK Grand Challenge Award C98/A24032 to L.B.A. and B.O.; the Li Ka Shing Foundation and National Institute for Health Research Oxford Biomedical Research Centre to D.C.W.; ED481A-2016/151 from Xunta de Galicia to B.R.-M. The use of pre-embargo PCAWG project mutational signatures data was approved by the PCAWG Steering Committee (excluding co-author P.J.C.) and the Mutational Signatures Working Group. Particular thanks to Jaegil Kim, Nicholas Haradhvala, Gaddy Getz, Steve Rozen, and other members of the PCAWG Working Group and to Graham Bignell for annotating mutation catalogs from 1,001 cell lines.	Alexandrov LB, 2019, BIORXIV, DOI [10.1101/322859, DOI 10.1101/322859]; Alexandrov LB, 2015, NAT GENET, V47, P1402, DOI 10.1038/ng.3441; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Alexandrov LB, 2013, CELL REP, V3, P246, DOI 10.1016/j.celrep.2012.12.008; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Auer PL, 2010, GENETICS, V185, P405, DOI 10.1534/genetics.110.114983; Blokzijl F, 2016, NATURE, V538, P260, DOI 10.1038/nature19768; Boot A, 2018, GENOME RES, V28, P654, DOI 10.1101/gr.230219.117; Burns MB, 2013, NAT GENET, V45, P977, DOI 10.1038/ng.2701; Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; Byrd RH, 1999, SIAM J OPTIMIZ, V9, P877, DOI 10.1137/S1052623497325107; Callahan J, 1999, VIROLOGY, V262, P18, DOI 10.1006/viro.1999.9876; Campbell P.J., 2017, BIORXIV, DOI [DOI 10.1101/162784, 10.1101/162784]; Cannon JS, 2000, J VIROL, V74, P10187, DOI 10.1128/JVI.74.21.10187-10193.2000; Caval V, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6129; CESARMAN E, 1995, BLOOD, V86, P2708, DOI 10.1182/blood.V86.7.2708.bloodjournal8672708; Chan K, 2015, NAT GENET, V47, P1067, DOI 10.1038/ng.3378; Chan K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003149; Conticello SG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-229; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Elstrodt F, 2006, CANCER RES, V66, P41, DOI 10.1158/0008-5472.CAN-05-2853; Forbes SA, 2017, NUCLEIC ACIDS RES, V45, pD777, DOI 10.1093/nar/gkw1121; Freitas TAK, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv180; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Gawad C, 2016, NAT REV GENET, V17, P175, DOI 10.1038/nrg.2015.16; Gerstung M., 2018, BIORXIV, DOI [10.1101/161562, DOI 10.1101/161562]; Haradhvala NJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04002-4; Helleday T, 2014, NAT REV GENET, V15, P585, DOI 10.1038/nrg3729; Iorio F, 2016, CELL, V166, P740, DOI 10.1016/j.cell.2016.06.017; Jamal-Hanjani M, 2017, NEW ENGL J MED, V376, P2109, DOI 10.1056/NEJMoa1616288; Jarvis M. C., 2018, JNCI CANC SPECTR, V2, DOI [10.1093/pky002, DOI 10.1093/PKY002]; Jones D, 2016, CURR PROTOC BIOINFOR, V56; Kanu N, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1042-9; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Lee JK, 2017, J CLIN ONCOL, V35, P3065, DOI 10.1200/JCO.2016.71.9096; Leung ML, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0616-2; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li Y., 2017, PATTERNS STRUCTURAL, DOI [10.1101/181339, DOI 10.1101/181339]; McGranahan N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1408; Middlebrooks CD, 2016, NAT GENET, V48, P1330, DOI 10.1038/ng.3670; Nik-Zainal S, 2016, NATURE, V534, P47, DOI 10.1038/nature17676; Nik-Zainal S, 2014, NAT GENET, V46, P487, DOI 10.1038/ng.2955; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Nilsen G, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-591; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Petljak M, 2016, CARCINOGENESIS, V37, P531, DOI 10.1093/carcin/bgw055; Pfeifer GP, 2006, CURR TOP MICROBIOL, V301, P259; Pilati C, 2017, J PATHOL, V242, P10, DOI 10.1002/path.4880; Poon SL, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006086; Rahbari R, 2016, NAT GENET, V48, P126, DOI 10.1038/ng.3469; Raine K. M., 2015, CURR PROTOC BIOINFOR, V52, P15, DOI [10.1002/0471250953.bi1507s52Medline, DOI 10.1002/0471250953.BI1507S52MEDLINE]; Roberts SA, 2014, NAT REV CANCER, V14, P786, DOI 10.1038/nrc3816; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; Roberts SA, 2012, MOL CELL, V46, P424, DOI 10.1016/j.molcel.2012.03.030; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rodriguez-Martin B., 2017, BIORXIV, DOI [10.1101/179705, DOI 10.1101/179705]; Rouhani FJ, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005932; SCHNEIDERGADICKE A, 1986, EMBO J, V5, P2285, DOI 10.1002/j.1460-2075.1986.tb04496.x; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Starrett GJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12918; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Sudmant PH, 2015, NATURE, V526, P75, DOI 10.1038/nature15394; Taylor BJM, 2013, ELIFE, V2, DOI 10.7554/eLife.00534; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tubio JMC, 2014, SCIENCE, V345, P531, DOI 10.1126/science.1251343; Vieira VC, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/683095; Viel A, 2017, EBIOMEDICINE, V20, P39, DOI 10.1016/j.ebiom.2017.04.022; Waszak SM, 2017, BIORXIV, DOI [10.1101/208330, DOI 10.1101/208330]; Yates LR, 2017, CANCER CELL, V32, P169, DOI 10.1016/j.ccell.2017.07.005; YEE C, 1985, AM J PATHOL, V119, P361	74	169	170	2	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 7	2019	176	6					1282	+		10.1016/j.cell.2019.02.012	http://dx.doi.org/10.1016/j.cell.2019.02.012			33	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	HN9HD	30849372	Green Published, hybrid			2022-12-28	WOS:000460509600006
J	Elton, C				Elton, Caroline			ESSAY Doctors can't care for patients if the system doesn't care for them-an essay by Caroline Elton	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DISTRESS		[Elton, Caroline] London Deanery, Careers Unit, London, England		Elton, C (corresponding author), London Deanery, Careers Unit, London, England.	drcarolineelton@gmail.com						Balint E., 1969, J R COLL GEN PRACT, V17; Balint E., 1993, DOCTOR PATIENT GROUP; FIRTHCOZENS J, 1987, BRIT MED J, V295, P533, DOI 10.1136/bmj.295.6597.533; Halpern J, 2012, STRESS HEALTH, V28, P51, DOI 10.1002/smi.1401; Health Foundation, 2018, PERS CTR CAR MAD SIM; Massachusetts Medical Society. Massachusetts Health and Hospital Association Harvard TH Chan School of Public Health Harvard Global Health Institute, 2018, CRIS HLTH CAR CALL A; Policy Research Unit in Commissioning and the Healthcare System, 2018, NUMB GPS WHO WANT OU; Shanafelt TD, 2017, MAYO CLIN PROC, V92, P129, DOI 10.1016/j.mayocp.2016.10.004; Shem S., 1985, HOUSE GOD; Sweeney K, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2862; Tresolini C. P., 1994, HLTH PROFESSIONS ED; Warfa Nasir, 2014, BMC Psychol, V2, P56, DOI 10.1186/s40359-014-0056-x; Winnicott DW, 1949, INT J PSYCHOANAL, V30, P69; World Health Organization, MAT MENT HLTH	14	6	6	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 6	2019	364								l968	10.1136/bmj.l968	http://dx.doi.org/10.1136/bmj.l968			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HO6SU	30842081				2022-12-28	WOS:000461062400008
J	Christie, B				Christie, Bryan			Scotland needs 82 extra paediatricians to deliver safe care, college warns	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Royal College of Paediatrics and Child Health, 2019, RCPCH STAT CHILD HLT	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 5	2019	364								l1023	10.1136/bmj.l1023	http://dx.doi.org/10.1136/bmj.l1023			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HO6SS	30837219				2022-12-28	WOS:000461062200015
J	Mehra, MR; Uriel, N; Naka, Y; Cleveland, JC; Yuzefpolskaya, M; Salerno, CT; Walsh, MN; Milano, CA; Patel, CB; Hutchins, SW; Ransom, J; Ewald, GA; Itoh, A; Raval, NY; Silvestry, SC; Cogswell, R; John, R; Bhimaraj, A; Bruckner, BA; Lowes, BD; Um, JY; Jeevanandam, V; Sayer, G; Mangi, AA; Molina, EJ; Sheikh, F; Aaronson, K; Pagani, FD; Cotts, WG; Tatooles, AJ; Babu, A; Chomsky, D; Katz, JN; Tessmann, PB; Dean, D; Krishnamoorthy, A; Chuang, J; Topuria, I; Sood, P; Goldstein, DJ				Mehra, M. R.; Uriel, N.; Naka, Y.; Cleveland, J. C., Jr.; Yuzefpolskaya, M.; Salerno, C. T.; Walsh, M. N.; Milano, C. A.; Patel, C. B.; Hutchins, S. W.; Ransom, J.; Ewald, G. A.; Itoh, A.; Raval, N. Y.; Silvestry, S. C.; Cogswell, R.; John, R.; Bhimaraj, A.; Bruckner, B. A.; Lowes, B. D.; Um, J. Y.; Jeevanandam, V.; Sayer, G.; Mangi, A. A.; Molina, E. J.; Sheikh, F.; Aaronson, K.; Pagani, F. D.; Cotts, W. G.; Tatooles, A. J.; Babu, A.; Chomsky, D.; Katz, J. N.; Tessmann, P. B.; Dean, D.; Krishnamoorthy, A.; Chuang, J.; Topuria, I.; Sood, P.; Goldstein, D. J.		MOMENTUM 3 Investigators	A Fully Magnetically Levitated Left Ventricular Assist Device - Final Report	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VON-WILLEBRAND-FACTOR; SIDED HEART-FAILURE; CIRCULATORY PUMP; RATIONALE; SUPPORT; DESIGN	Background In two interim analyses of this trial, patients with advanced heart failure who were treated with a fully magnetically levitated centrifugal-flow left ventricular assist device were less likely to have pump thrombosis or nondisabling stroke than were patients treated with a mechanical-bearing axial-flow left ventricular assist device. Methods We randomly assigned patients with advanced heart failure to receive either the centrifugal-flow pump or the axial-flow pump irrespective of the intended goal of use (bridge to transplantation or destination therapy). The composite primary end point was survival at 2 years free of disabling stroke or reoperation to replace or remove a malfunctioning device. The principal secondary end point was pump replacement at 2 years. Results This final analysis included 1028 enrolled patients: 516 in the centrifugal-flow pump group and 512 in the axial-flow pump group. In the analysis of the primary end point, 397 patients (76.9%) in the centrifugal-flow pump group, as compared with 332 (64.8%) in the axial-flow pump group, remained alive and free of disabling stroke or reoperation to replace or remove a malfunctioning device at 2 years (relative risk, 0.84; 95% confidence interval [CI], 0.78 to 0.91; P<0.001 for superiority). Pump replacement was less common in the centrifugal-flow pump group than in the axial-flow pump group (12 patients [2.3%] vs. 57 patients [11.3%]; relative risk, 0.21; 95% CI, 0.11 to 0.38; P<0.001). The numbers of events per patient-year for stroke of any severity, major bleeding, and gastrointestinal hemorrhage were lower in the centrifugal-flow pump group than in the axial-flow pump group. Conclusions Among patients with advanced heart failure, a fully magnetically levitated centrifugal-flow left ventricular assist device was associated with less frequent need for pump replacement than an axial-flow device and was superior with respect to survival free of disabling stroke or reoperation to replace or remove a malfunctioning device. (Funded by Abbott; MOMENTUM 3 ClinicalTrials.gov number, .) Patients with advanced heart failure were randomly assigned to receive a centrifugal-flow or an axial-flow LVAD. At 2 years, the centrifugal-flow LVAD was associated with less pump replacement and with longer survival free of disabling stroke or reoperation to replace or remove a malfunctioning device.	[Mehra, M. R.] Brigham & Womens Hosp, Heart & Vasc Ctr, 75 Francis St, Boston, MA 02115 USA; [Mehra, M. R.] Harvard Med Sch, Boston, MA 02115 USA; [Uriel, N.; Jeevanandam, V.; Sayer, G.] Univ Chicago, Sch Med, Chicago, IL 60637 USA; [Uriel, N.; Jeevanandam, V.; Sayer, G.] Med Ctr, Chicago, IL 60637 USA; [Cotts, W. G.; Tatooles, A. J.] Advocate Christ Med Ctr, Oak Lawn, IL USA; [Naka, Y.; Yuzefpolskaya, M.] Columbia Univ, Coll Phys & Surg, New York, NY 10027 USA; [Naka, Y.; Yuzefpolskaya, M.] New York Presbyterian Hosp, New York, NY USA; [Goldstein, D. J.] Montefiore Einstein Ctr Heart & Vasc Care, New York, NY USA; [Cleveland, J. C., Jr.] Univ Colorado, Sch Med, Aurora, CO USA; [Salerno, C. T.; Walsh, M. N.] St Vincent Heart Ctr, Durham, NC USA; [Milano, C. A.; Patel, C. B.] Duke Univ, Med Ctr, Durham, NC USA; [Katz, J. N.; Tessmann, P. B.] Univ N Carolina, Chapel Hill, NC USA; [Hutchins, S. W.; Ransom, J.] Baptist Hlth Med Ctr, Little Rock, AR USA; [Ewald, G. A.; Itoh, A.] Washington Univ, Sch Med, St Louis, MO USA; [Raval, N. Y.; Silvestry, S. C.] Advent Hlth Transplant Inst, Orlando, FL USA; [Cogswell, R.; John, R.] Univ Minnesota, Minneapolis, MN USA; [Bhimaraj, A.; Bruckner, B. A.] Houston Methodist Hosp, Houston, TX USA; [Lowes, B. D.; Um, J. Y.] Univ Nebraska Med Ctr, Omaha, NE USA; [Mangi, A. A.] Yale Med Sch, New Haven, CT USA; [Molina, E. J.; Sheikh, F.] MedStar Washington Hosp Ctr, Washington, DC USA; [Aaronson, K.; Pagani, F. D.] Univ Michigan, Ann Arbor, MI 48109 USA; [Babu, A.; Chomsky, D.] St Thomas Hosp, Nashville, TN USA; [Dean, D.; Krishnamoorthy, A.] Piedmont Hosp, Atlanta, GA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Chicago; Columbia University; NewYork-Presbyterian Hospital; University of Colorado System; University of Colorado Anschutz Medical Campus; Duke University; University of North Carolina; University of North Carolina Chapel Hill; Washington University (WUSTL); Adventist Health Services; AdventHealth; University of Minnesota System; University of Minnesota Twin Cities; The Methodist Hospital System; The Methodist Hospital - Houston; University of Nebraska System; University of Nebraska Medical Center; Yale University; MedStar Washington Hospital Center; University of Michigan System; University of Michigan; Saint Thomas Hospital	Mehra, MR (corresponding author), Brigham & Womens Hosp, Heart & Vasc Ctr, Ctr Adv Heart Dis, 75 Francis St, Boston, MA 02115 USA.	mmehra@bwh.harvard.edu	Mahr, Claudius/I-2374-2019; Lowes, Brian/M-9020-2017	Mahr, Claudius/0000-0001-8409-8030; Lowes, Brian/0000-0002-5919-2540; Lima, Brian/0000-0002-2555-2229; Entwistle, John/0000-0002-1492-6483; Molina, Ezequiel/0000-0001-7332-7483; Mehra, Mandeep/0000-0001-8683-7044	Abbott	Abbott(Abbott Laboratories)	Funded by Abbott	Ankersmit HJ, 1999, LANCET, V354, P550, DOI 10.1016/S0140-6736(98)10359-8; [Anonymous], 2017, CIRC-HEART FAIL, V10, ps1; Bourque K, 2016, ASAIO J, V62, P375, DOI 10.1097/MAT.0000000000000388; Colombo PC, 2019, CIRCULATION, V139, P155, DOI 10.1161/CIRCULATIONAHA.118.037231; Drazner MH, 2018, NEW ENGL J MED, V378, P1442, DOI 10.1056/NEJMe1802639; Heatley G, 2016, J HEART LUNG TRANSPL, V35, P528, DOI 10.1016/j.healun.2016.01.021; Kimball PM, 2008, ANN THORAC SURG, V85, P1656, DOI 10.1016/j.athoracsur.2008.01.050; Konstam MA, 2018, CIRCULATION, V137, pE578, DOI 10.1161/CIR.0000000000000560; Mehra MR, 2018, NEW ENGL J MED, V378, P1386, DOI 10.1056/NEJMoa1800866; Mehra MR, 2018, J HEART LUNG TRANSPL, V37, P1281, DOI 10.1016/j.healun.2018.08.011; Mehra MR, 2018, CIRCULATION, V138, P1923, DOI 10.1161/CIRCULATIONAHA.118.035722; Mehra MR, 2019, EUR HEART J, V40, P673, DOI 10.1093/eurheartj/ehx036; Mehra MR, 2017, NEW ENGL J MED, V376, P440, DOI 10.1056/NEJMoa1610426; Netuka I, 2018, J HEART LUNG TRANSPL, V37, P579, DOI 10.1016/j.healun.2018.03.002; Netuka I, 2016, J HEART LUNG TRANSPL, V35, P860, DOI 10.1016/j.healun.2016.05.019; Pagani FD, 2016, J HEART LUNG TRANSPL, V35, P1277, DOI 10.1016/j.healun.2016.09.002; Potapov EV, 2018, J HEART LUNG TRANSPL, V37, P670, DOI 10.1016/j.healun.2018.03.014; Proudfoot AG, 2017, J HEART LUNG TRANSPL, V36, P1155, DOI 10.1016/j.healun.2017.06.004; Pya Y, 2019, J HEART LUNG TRANSPL; Rich JD, 2017, J HEART LUNG TRANSPL, V36, P50, DOI 10.1016/j.healun.2016.08.010; Rogers JG, 2017, NEW ENGL J MED, V376, P451, DOI 10.1056/NEJMoa1602954; Shah P, 2017, J HEART LUNG TRANSPL, V36, P1164, DOI 10.1016/j.healun.2017.05.008; Slaughter MS, 2009, NEW ENGL J MED, V361, P2241, DOI 10.1056/NEJMoa0909938; Tabit CE, 2018, J HEART LUNG TRANSPL, V37, P107, DOI 10.1016/j.healun.2017.06.001; Tabit CE, 2016, CIRCULATION, V134, P141, DOI 10.1161/CIRCULATIONAHA.115.019692; Uriel N, 2010, J AM COLL CARDIOL, V56, P1207, DOI 10.1016/j.jacc.2010.05.016; Waters BH, 2018, J HEART LUNG TRANSPL, V37, P1467, DOI 10.1016/j.healun.2018.08.007	27	504	507	11	41	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 25	2019	380	17					1618	1627		10.1056/NEJMoa1900486	http://dx.doi.org/10.1056/NEJMoa1900486			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU9FC	30883052	Bronze			2022-12-28	WOS:000465598600009
J	Li, MJ; Xia, X; Tian, YY; Jia, Q; Liu, XY; Lu, Y; Li, M; Li, XM; Chen, ZC				Li, Meijing; Xia, Xian; Tian, Yuanyuan; Jia, Qi; Liu, Xiaoyu; Lu, Ying; Li, Ming; Li, Xueming; Chen, Zhucheng			Mechanism of DNA translocation underlying chromatin remodelling by Snf2	NATURE			English	Article							PARTICLE; VISUALIZATION; NUCLEOSOMES	Chromatin remodellers include diverse enzymes with distinct biological functions, but nucleosome-sliding activity appears to be a common theme(1,2). Among the remodelling enzymes, Snf2 serves as the prototype to study the action of this protein family. Snf2 and related enzymes share two conserved RecA-like lobes(3), which by themselves are able to couple ATP hydrolysis to chromatin remodelling. The mechanism by which these enzymes couple ATP hydrolysis to translocate the nucleosome along the DNA remains unclear(2,4-8). Here we report the structures of Saccharomyces cerevisiae Snf2 bound to the nucleosome in the presence of ADP and ADP-BeFx. Snf2 in the ADP-bound state adopts an open conformation similar to that in the apo state, and induces a one-base-pair DNA bulge at superhelix location 2 (SHL2), with the tracking strand showing greater distortion than the guide strand. The DNA distortion propagates to the proximal end, leading to staggered translocation of the two strands. The binding of ADP-BeFx triggers a closed conformation of the enzyme, resetting the nucleosome to a relaxed state. Snf2 shows altered interactions with the DNA in different nucleotide states, providing the structural basis for DNA translocation. Together, our findings suggest a fundamental mechanism for the DNA translocation that underlies chromatin remodelling.	[Li, Meijing; Xia, Xian; Tian, Yuanyuan; Liu, Xiaoyu; Li, Xueming; Chen, Zhucheng] Tsinghua Univ, MOE Key Lab Prot Sci, Beijing, Peoples R China; [Li, Meijing; Xia, Xian; Tian, Yuanyuan; Liu, Xiaoyu; Li, Xueming; Chen, Zhucheng] Tsinghua Univ, Sch Life Sci, Beijing, Peoples R China; [Li, Meijing; Tian, Yuanyuan; Liu, Xiaoyu; Li, Xueming; Chen, Zhucheng] Tsinghua Peking Joint Ctr Life Sci, Beijing, Peoples R China; [Li, Meijing; Xia, Xian; Tian, Yuanyuan; Liu, Xiaoyu; Li, Xueming; Chen, Zhucheng] Beijing Adv Innovat Ctr Struct Biol, Beijing, Peoples R China; [Jia, Qi; Lu, Ying; Li, Ming] Chinese Acad Sci, Beijing Natl Lab Condensed Matter Phys, Inst Phys, Beijing, Peoples R China; [Jia, Qi; Lu, Ying; Li, Ming] Chinese Acad Sci, CAS Key Lab Soft Matter Phys, Inst Phys, Beijing, Peoples R China	Tsinghua University; Tsinghua University; Chinese Academy of Sciences; Institute of Physics, CAS; Chinese Academy of Sciences; Institute of Physics, CAS	Li, XM; Chen, ZC (corresponding author), Tsinghua Univ, MOE Key Lab Prot Sci, Beijing, Peoples R China.; Li, XM; Chen, ZC (corresponding author), Tsinghua Univ, Sch Life Sci, Beijing, Peoples R China.; Li, XM; Chen, ZC (corresponding author), Tsinghua Peking Joint Ctr Life Sci, Beijing, Peoples R China.; Li, XM; Chen, ZC (corresponding author), Beijing Adv Innovat Ctr Struct Biol, Beijing, Peoples R China.; Li, M (corresponding author), Chinese Acad Sci, Beijing Natl Lab Condensed Matter Phys, Inst Phys, Beijing, Peoples R China.; Li, M (corresponding author), Chinese Acad Sci, CAS Key Lab Soft Matter Phys, Inst Phys, Beijing, Peoples R China.	mingli@iphy.ac.cn; lixueming@mail.tsinghua.edu.cn; zhucheng_chen@tsinghua.edu.cn	Lu, Ying/AAC-9602-2020	Lu, Ying/0000-0002-8421-7228; Xia, Xian/0000-0001-9833-5017; Liu, Xiaoyu/0000-0002-6594-9677; Li, ming/0000-0002-5328-5826	Chinese MOST [2017YFA0102900]; National Natural Science Foundation of China [31825016, 31570731, 31630046, 11834018]	Chinese MOST(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank J. Lei and the staff at the Tsinghua University Branch of China National Center for Protein Sciences Beijing for providing facility support. This work was supported by the Chinese MOST (2017YFA0102900), the National Natural Science Foundation of China (31825016, 31570731, 31630046) to Z.C. and (11834018) to Ming Li.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; Bharat TAM, 2015, STRUCTURE, V23, P1743, DOI 10.1016/j.str.2015.06.026; Bowman GD, 2010, CURR OPIN STRUC BIOL, V20, P73, DOI 10.1016/j.sbi.2009.12.002; Clapier CR, 2017, NAT REV MOL CELL BIO, V18, P407, DOI 10.1038/nrm.2017.26; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Deindl S, 2013, CELL, V152, P442, DOI 10.1016/j.cell.2012.12.040; Farnung L, 2017, NATURE, V550, P539, DOI 10.1038/nature24046; Flaus A, 2003, BIOPOLYMERS, V68, P563, DOI 10.1002/bip.10323; Frouws TD, 2016, P NATL ACAD SCI USA, V113, P1214, DOI 10.1073/pnas.1524607113; Gangaraju VK, 2009, MOL CELL, V35, P58, DOI 10.1016/j.molcel.2009.05.013; Gu MG, 2010, P NATL ACAD SCI USA, V107, P521, DOI 10.1073/pnas.0913380107; Hall MA, 2009, NAT STRUCT MOL BIOL, V16, P124, DOI 10.1038/nsmb.1526; Harada BT, 2016, ELIFE, V5, DOI 10.7554/eLife.10051; Hu MX, 2018, NAT METHODS, V15, P1083, DOI 10.1038/s41592-018-0223-8; Hwang WL, 2014, NATURE, V512, P213, DOI 10.1038/nature13380; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; Li XM, 2015, J STRUCT BIOL, V192, P174, DOI 10.1016/j.jsb.2015.09.003; Lin WX, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.138102; Liu XY, 2017, NATURE, V544, P440, DOI 10.1038/nature22036; Lorch Y, 2010, P NATL ACAD SCI USA, V107, P3458, DOI 10.1073/pnas.1000398107; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Makde RD, 2010, NATURE, V467, P562, DOI 10.1038/nature09321; Narlikar GJ, 2013, CELL, V154, P490, DOI 10.1016/j.cell.2013.07.011; Ngo TTM, 2015, CELL, V160, P1135, DOI 10.1016/j.cell.2015.02.001; Nodelman IM, 2017, MOL CELL, V65, P447, DOI 10.1016/j.molcel.2016.12.011; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; Saha A, 2005, NAT STRUCT MOL BIOL, V12, P747, DOI 10.1038/nsmb973; Saha A, 2006, NAT REV MOL CELL BIO, V7, P437, DOI 10.1038/nrm1945; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Suto RK, 2003, J MOL BIOL, V326, P371, DOI 10.1016/S0022-2836(02)01407-9; Tan S, 2011, CURR OPIN STRUC BIOL, V21, P128, DOI 10.1016/j.sbi.2010.11.006; Winger J, 2018, ELIFE, V7, DOI 10.7554/eLife.34100; Xia X, 2016, NAT STRUCT MOL BIOL, V23, P722, DOI 10.1038/nsmb.3259; Yan CY, 2016, SCIENCE, V353, P904, DOI 10.1126/science.aag0291; Yan L, NAT STRUCT MOL BIOL; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng GH, 2009, NUCLEIC ACIDS RES, V37, pW240, DOI 10.1093/nar/gkp358; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zofall M, 2006, NAT STRUCT MOL BIOL, V13, P339, DOI 10.1038/nsmb1071	41	57	58	1	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 21	2019	567	7748					409	+		10.1038/s41586-019-1029-2	http://dx.doi.org/10.1038/s41586-019-1029-2			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP9JT	30867599				2022-12-28	WOS:000462010000059
J	Madaras, L; Stonington, S; Seda, CH; Garcia, D; Zuroweste, E				Madaras, Laszlo; Stonington, Scott; Seda, Claire H.; Garcia, Deliana; Zuroweste, Ed			Social Distance and Mobility - A 39-Year-Old Pregnant Migrant Farmworker	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Madaras, Laszlo; Seda, Claire H.; Garcia, Deliana; Zuroweste, Ed] Migrant Clinicians Network, Austin, TX 78746 USA; [Madaras, Laszlo] Penn State Coll Med, Hershey, PA 17033 USA; [Stonington, Scott] Univ Michigan, Ann Arbor, MI 48109 USA; [Zuroweste, Ed] Johns Hopkins Sch Med, Baltimore, MD USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Michigan System; University of Michigan; Johns Hopkins University; Johns Hopkins Medicine	Madaras, L (corresponding author), Migrant Clinicians Network, Austin, TX 78746 USA.; Madaras, L (corresponding author), Penn State Coll Med, Hershey, PA 17033 USA.			Stonington, Scott/0000-0002-0472-3885				Durkheim E, 2014, DIVISION LABOR SOC; United Nations Department of Economic and Social Affairs Population Division, 2017, WORLD COUNT 258 MILL; Urry J., 2000, SOCIOLOGY SOC MOBILI	3	3	3	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 21	2019	380	12					1093	1096		10.1056/NEJMp1811501	http://dx.doi.org/10.1056/NEJMp1811501			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HP7VK	30893530				2022-12-28	WOS:000461898400003
J	Prsa, M; Morandell, K; Cuenu, G; Huber, D				Prsa, Mario; Morandell, Karin; Cuenu, Geraldine; Huber, Daniel			Feature-selective encoding of substrate vibrations in the forelimb somatosensory cortex	NATURE			English	Article							PACINIAN CORPUSCLES; SEISMIC COMMUNICATION; FLUTTER-VIBRATION; WHISKER VIBRATION; FREQUENCY; NEURONS; INFORMATION; HAND; PERIODICITY; MECHANISMS	The spectral content of skin vibrations, produced by either displacing the finger across a surface texture(1) or passively sensing external movements through the solid substrate(2,3), provides fundamental information about our environment. Low-frequency flutter (below 50 Hz) applied locally to the primate fingertip evokes cyclically entrained spiking in neurons of the primary somatosensory cortex (S1), and thus spike rates in these neurons increase linearly with frequency(4,5). However, the same local vibrations at high frequencies (over 100 Hz) cannot be discriminated on the basis of differences in discharge rates of S1 neurons(4,6), because spiking is only partially entrained at these frequencies(6). Here we investigated whether high-frequency substrate vibrations applied broadly to the mouse forelimb rely on a different cortical coding scheme. We found that forelimb S1 neurons encode vibration frequency similarly to sound pitch representation in the auditory cortex(7,8): their spike rates are selectively tuned to a preferred value of a low-level stimulus feature without any temporal entrainment. This feature, identified as the product of frequency and a power function of amplitude, was also found to be perceptually relevant as it predicted behaviour in a frequency discrimination task. Using histology, peripheral deafferentation and optogenetic receptor tagging, we show that these selective responses are inherited from deep Pacinian corpuscles located adjacent to bones, most densely around the ulna and radius and only sparsely along phalanges. This mechanoreceptor arrangement and the tuned cortical rate code suggest that the mouse forelimb constitutes a sensory channel best adapted for passive 'listening' to substrate vibrations, rather than for active texture exploration.	[Prsa, Mario; Morandell, Karin; Cuenu, Geraldine; Huber, Daniel] Univ Geneva, Dept Basic Neurosci, Geneva, Switzerland	University of Geneva	Huber, D (corresponding author), Univ Geneva, Dept Basic Neurosci, Geneva, Switzerland.	daniel.huber@unige.ch	Huber, Daniel/C-2932-2013; Prsa, Mario/P-1818-2015	Prsa, Mario/0000-0001-5012-2506; Morandell, Karin/0000-0001-7147-8165; Huber, Daniel/0000-0002-0744-7679	Swiss National Science Foundation [PP00P3_133710]; European Research Council (OPTOMOT); New York Stem Cell Foundation; International Foundation for Paraplegia Research	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council (OPTOMOT); New York Stem Cell Foundation; International Foundation for Paraplegia Research	We thank V. Hayward and S. Bensmaia for advice and comments on the manuscript; R. Zimmerman and G. Galinanes for help with histology; S. Crochet for advice on electrophysiology experiments; and C. Bonardi for help with training mice on the forelimb reaching task. This work was supported by the Swiss National Science Foundation (PP00P3_133710), the European Research Council (OPTOMOT), the New York Stem Cell Foundation and the International Foundation for Paraplegia Research. D.H. is a New York Stem Cell Foundation-Robertson Investigator.	Abraira VE, 2013, NEURON, V79, P618, DOI 10.1016/j.neuron.2013.07.051; Andermann ML, 2004, NEURON, V42, P451, DOI 10.1016/S0896-6273(04)00198-9; Arabzadeh E, 2004, J NEUROSCI, V24, P6011, DOI 10.1523/JNEUROSCI.1389-04.2004; Arabzadeh E, 2003, J NEUROSCI, V23, P9146; BELL J, 1994, PROG NEUROBIOL, V42, P79, DOI 10.1016/0301-0082(94)90022-1; Butts DA, 2006, PLOS BIOL, V4, P639, DOI 10.1371/journal.pbio.0040092; Butts DA, 2003, NETWORK-COMP NEURAL, V14, P177, DOI 10.1088/0954-898X/14/2/301; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Curthoys IS, 2011, ANN NY ACAD SCI, V1233, P231, DOI 10.1111/j.1749-6632.2011.06147.x; Delmas P, 2011, NAT REV NEUROSCI, V12, P139, DOI 10.1038/nrn2993; Fleming MS, 2016, J NEUROSCI, V36, P10337, DOI 10.1523/JNEUROSCI.2160-16.2016; Harvey MA, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001558; HUNT CC, 1961, J PHYSIOL-LONDON, V155, P175, DOI 10.1113/jphysiol.1961.sp006621; JOHANSSON RS, 1982, BRAIN RES, V244, P17, DOI 10.1016/0006-8993(82)90899-X; KUMAMOTO K, 1993, J ANAT, V183, P149; KUMAMOTO K, 1993, J ANAT, V182, P23; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Manfredi LR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031203; Montgomery N, 2010, J NEUROSCI, V30, P13362, DOI 10.1523/JNEUROSCI.2899-10.2010; MOUNTCASTLE VB, 1969, J NEUROPHYSIOL, V32, P452, DOI 10.1152/jn.1969.32.3.452; Narins PM, 2018, CURR BIOL, V28, pR1333, DOI 10.1016/j.cub.2018.10.056; O'Connell-Rodwell CE, 2007, PHYSIOLOGY, V22, P287, DOI 10.1152/physiol.00008.2007; Pawson L, 2000, SOMATOSENS MOT RES, V17, P159; PEASE DC, 1957, J BIOPHYS BIOCHEM CY, V3, P331, DOI 10.1083/jcb.3.3.331; Pnevmatikakis EA, 2016, NEURON, V89, P285, DOI 10.1016/j.neuron.2015.11.037; Rado R, 1998, J COMP PHYSIOL A, V183, P503, DOI 10.1007/s003590050275; Reuter T, 1998, J ACOUST SOC AM, V104, P1122, DOI 10.1121/1.423341; Salinas E, 2000, J NEUROSCI, V20, P5503, DOI 10.1523/JNEUROSCI.20-14-05503.2000; Schutt HH, 2016, VISION RES, V122, P105, DOI 10.1016/j.visres.2016.02.002; Shao YT, 2016, P NATL ACAD SCI USA, V113, P4188, DOI 10.1073/pnas.1520866113; SHERRICK CE, 1990, J ACOUST SOC AM, V88, P169, DOI 10.1121/1.399937; Stevens SS, 1935, J ACOUST SOC AM, V6, P150, DOI 10.1121/1.1915715; TALBOT WH, 1968, J NEUROPHYSIOL, V31, P301, DOI 10.1152/jn.1968.31.2.301; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Tao C, 2017, SCI REP-UK, V7, DOI 10.1038/srep44493; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Zelena J, 1976, Prog Brain Res, V43, P59; Zwislocki JJ, 1999, ACTA OTO-LARYNGOL, V119, P140	38	24	24	2	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 21	2019	567	7748					384	+		10.1038/s41586-019-1015-8	http://dx.doi.org/10.1038/s41586-019-1015-8			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP9JT	30867600				2022-12-28	WOS:000462010000054
J	Bindman, A				Bindman, Andrew			Shaking Things Up in California	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									[Bindman, Andrew] Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, Med & Epidemiol & Biostat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Bindman, A (corresponding author), Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, Med & Epidemiol & Biostat, San Francisco, CA 94143 USA.	andrew.bindman@ucsf.edu							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 19	2019	321	11					1039	1040		10.1001/jama.2019.1472	http://dx.doi.org/10.1001/jama.2019.1472			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP4YY	30874745	Bronze			2022-12-28	WOS:000461683500003
J	Hawkes, N				Hawkes, Nigel			Sixty seconds on ... democracy	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Bollyky TJ, 2019, LANCET	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 18	2019	364								l1225	10.1136/bmj.l1225	http://dx.doi.org/10.1136/bmj.l1225			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HQ7ZV	30885894				2022-12-28	WOS:000462643800008
J	Blasi, DE; Moran, S; Moisik, SR; Widmer, P; Dediu, D; Bickel, B				Blasi, D. E.; Moran, S.; Moisik, S. R.; Widmer, P.; Dediu, D.; Bickel, B.			Human sound systems are shaped by post-Neolithic changes in bite configuration	SCIENCE			English	Article							TOOTH WEAR; DENTAL PATHOLOGY; R PACKAGE; LANGUAGE; MUSCLE; POTTERY	Linguistic diversity, now and in the past, is widely regarded to be independent of biological changes that took place after the emergence of Homo sapiens. We show converging evidence from paleoanthropology, speech biomechanics, ethnography, and historical linguistics that labiodental sounds (such as "f" and "v") were innovated after the Neolithic. Changes in diet attributable to food-processing technologies modified the human bite from an edge-to-edge configuration to one that preserves adolescent overbite and overjet into adulthood. This change favored the emergence and maintenance of labiodentals. Our findings suggest that language is shaped not only by the contingencies of its history, but also by culturally induced changes in human biology.	[Blasi, D. E.; Moran, S.; Widmer, P.; Bickel, B.] Univ Zurich, Dept Comparat Linguist, CH-8032 Zurich, Switzerland; [Blasi, D. E.; Moran, S.; Widmer, P.; Bickel, B.] Univ Zurich, Ctr Interdisciplinary Study Language Evolut, CH-8032 Zurich, Switzerland; [Blasi, D. E.] Max Planck Inst Sci Human Hist, Dept Linguist & Cultural Evolut, D-07745 Jena, Germany; [Blasi, D. E.] Yale Univ, Human Relat Area Files, New Haven, CT 06511 USA; [Blasi, D. E.] Kazan Fed Univ, Lab Quantitat Linguist, Kazan 420000, Russia; [Moisik, S. R.] Nanyang Technol Univ, Div Linguist & Multilingual Studies, Singapore 637332, Singapore; [Dediu, D.] Univ Lumiere Lyon 2, Lab Dynam Langage UMR 5596, F-69363 Lyon 07, France; [Dediu, D.] Max Planck Inst Psycholinguist, Language & Genet Dept, NL-6525 XD Nijmegen, Netherlands	University of Zurich; University of Zurich; Yale University; Kazan Federal University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Max Planck Society	Blasi, DE (corresponding author), Univ Zurich, Dept Comparat Linguist, CH-8032 Zurich, Switzerland.; Blasi, DE (corresponding author), Univ Zurich, Ctr Interdisciplinary Study Language Evolut, CH-8032 Zurich, Switzerland.; Blasi, DE (corresponding author), Max Planck Inst Sci Human Hist, Dept Linguist & Cultural Evolut, D-07745 Jena, Germany.; Blasi, DE (corresponding author), Yale Univ, Human Relat Area Files, New Haven, CT 06511 USA.; Blasi, DE (corresponding author), Kazan Fed Univ, Lab Quantitat Linguist, Kazan 420000, Russia.	damian.blasi@uzh.ch	Moisik, Scott/AAF-9003-2020; Dediu, Dan/E-3279-2012; Blasi, Damián Ezequiel/AAD-6049-2019; Widmer, Paul/B-8448-2018	Moisik, Scott/0000-0003-1540-1790; Dediu, Dan/0000-0002-0704-6365; Blasi, Damián Ezequiel/0000-0002-9885-1414; Widmer, Paul/0000-0002-9949-5212; Moran, Steven/0000-0002-3969-6549	NWO VIDI grant [276-70-022]; EURIAS fellowship 2017-2018; IDEXLyon Fellowship 2018-2021; Russian Government	NWO VIDI grant(Netherlands Organization for Scientific Research (NWO)); EURIAS fellowship 2017-2018; IDEXLyon Fellowship 2018-2021; Russian Government	Supported by NWO VIDI grant 276-70-022, an EURIAS fellowship 2017-2018, and an IDEXLyon Fellowship 2018-2021 (D.D.) and by a subsidy of the Russian Government to support the Programme of Competitive Development of Kazan Federal University (D.E.B.).	Allen W. S., 1961, PHONETICS ANCIENT IN; Allen W. S., 2004, VOX LATINA GUIDE PRO; Anderson CA, 2016, THESIS; [Anonymous], 1896, ALTINDISCHE GRAMMATI; [Anonymous], 2009, THE CELTIC LANGUAGES; [Anonymous], 2011, BRYTHONIC CELTIC BRI; Anton SC, 2014, SCIENCE, V345, P45, DOI 10.1126/science.1236828; Awbery G, 2010, ROUTL LANG FAM SER, P359; Beach Douglas Martyn, 1938, PHONETICS HOTTENTOT; Bickel B., 2019, LANGUAGE HUNTER GATH, DOI [10.1002/ajpa.22153, DOI 10.1002/AJPA.22153]; Bickel B., 2019, LANGUAGE HUNTER GATH; Bickel Balthasar., 2015, OXFORD HDB LINGUISTI, V2nd edn., P901; Blevins Juliette, 2004, EVOLUTIONARY PHONOLO; Botha D, 2015, HOMO, V66, P187, DOI 10.1016/j.jchb.2015.02.004; Bouckaert R, 2012, SCIENCE, V337, P957, DOI 10.1126/science.1219669; Bowern C, 2010, LANG LINGUIST COMPAS, V4, P665, DOI 10.1111/j.1749-818x.2010.00220.x; Brace C. L., 1977, BIOL OCCLUSAL DEV, P179, DOI 10.1126/science.1218643; BRACE CL, 1986, AM ANTHROPOL, V88, P695, DOI 10.1525/aa.1986.88.3.02a00150; Burkner PC, 2017, J STAT SOFTW, V80, P1, DOI 10.18637/jss.v080.i01; Butcher Andrew., 2006, SPEECH PRODUCTION MO, P187, DOI DOI 10.4324/9780203782989; Bybee J.L., 2012, OXFORD HDB LANGUAGE, DOI [10.1093/oxfordhb/9780199541119.013.0055, DOI 10.1093/OXFORDHB/9780199541119.013.0055]; Cardona G., 1976, PANINI; Chandralal D, 2010, LOND ORIENT AFR LANG, V15, P1; Chang W, 2015, LANGUAGE, V91, P194, DOI 10.1353/lan.2015.0005; Chekalin E, 2019, MOL BIOL EVOL, V36, P127, DOI 10.1093/molbev/msy201; Clement A, 2009, ARCHAEOLOGY INT, V11, P37; Clement AF, 2012, AM J PHYS ANTHROPOL, V149, P517, DOI 10.1002/ajpa.22153; Craig OE, 2013, NATURE, V496, P351, DOI 10.1038/nature12109; Croft W., 2003, TYPOLOGY UNIVERSALS, V2; Dediu D, 2017, LANG COMMUN, V54, P9, DOI 10.1016/j.langcom.2016.10.002; Deter CA, 2009, AM J PHYS ANTHROPOL, V138, P247, DOI 10.1002/ajpa.20922; Dickens P., 1994, ENGLISH JU HOAN JU H, V8; Dorais L.-J., 1990, INUIT UQAUSIQATIGIIT; Dum-Tragut Jasmine, 2009, ARMENIAN MODERN E AR; Dunne J, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2016.194; Eaton Helen., 2006, J INT PHON ASSOC, V36, P235, DOI [DOI 10.1017/S0025100306002647, 10.1017/S0025100306002647]; Elfenbein J., 1997, PHONOLOGIES ASIA AFR, V1, P733; Endzelins J., 1971, COMP PHONOLOGY MORPH; Eshed V, 2006, AM J PHYS ANTHROPOL, V130, P145, DOI 10.1002/ajpa.20362; Fitch WT, 2017, PSYCHON B REV, V24, P3, DOI 10.3758/s13423-017-1236-5; Fortescue M., 1984, W GREENLANDIC; Fortescue M. D., 2000, LANGUES ESKALEOUTES, P71; FORTESCUE MICHAEL, 1994, COMP ESKIMO DICT ALE; Fortescue Michael, 1998, LANGUAGE RELATIONS B; Fortson I. V., 2010, INDO EUROPEAN LANGUA; Garrett A., 2013, ORIGINS SOUND CHANGE, P51, DOI DOI 10.1093/ACPROF:OSO/9780199573745.003.0003; Gasser E., 2014, P 2013 ANN M PHON; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Gick B., 2011, CAN ACOUST, V39, P178; Gonda Jan, 1980, VEDIC RITUAL NONSOLE; Guldemann T., 2010, KHOISAN LANGUAGES LI, P15; Guldemann T., 2018, LANGUAGE HUNTER GATH; Guldemann T., 2019, LANGUAGE HUNTER GATH; Haacke W. H. G., 2013, KHOESAN LANGUAGES, P325; Haas, 1994, GESCH HETHITISCHEN R; Hammarstrom H., 2014, GLOTTOLOG 2 3; Hammarstrom H, 2016, J LANG EVOL, V1, P19, DOI 10.1093/jole/lzw002; Heikinheimo K, 2012, EUR J ORTHODONT, V34, P418, DOI 10.1093/ejo/cjr025; HINTON RJ, 1981, AM J PHYS ANTHROPOL, V54, P555, DOI 10.1002/ajpa.1330540409; HOCKETT CF, 1985, AM ANTHROPOL, V87, P263, DOI 10.1525/aa.1985.87.2.02a00020; Hoddinott W.G., 1988, NGANKIKURUNGKURR LAN; Hoffner Harry A. Jr., 2008, GRAMMAR HITTITE LANG, V1; Huelsenbeck JP, 2003, SYST BIOL, V52, P641, DOI 10.1080/10635150390235467; Hunziker D. A., 2008, SIL ELECT WORKING PA, P1; Jackson KennethHurlstone., 1967, HIST PHONOLOGY BRETO; Kaidonis JA, 2008, CLIN ORAL INVEST, V12, pS21, DOI 10.1007/s00784-007-0154-8; Kaifu Y, 2003, YEARB PHYS ANTHROPOL, V46, P47, DOI 10.1002/ajpa.10329; Kaifu Y, 2000, ANTHROPOL SCI, V108, P371, DOI 10.1537/ase.108.371; Kaifu Y, 2000, AM J PHYS ANTHROPOL, V111, P369, DOI 10.1002/(SICI)1096-8644(200003)111:3<369::AID-AJPA6>3.0.CO;2-#; Katz DC, 2017, P NATL ACAD SCI USA, V114, P9050, DOI 10.1073/pnas.1702586114; Kirchner Robert, 2001, EFFORT BASED APPROAC; Kleinschmidt S. P., 1851, GRAMMATIK GRONLANDIS; Korn A., 2005, STUDIES BALOCHI HIST; Krauss M. E., 1976, NATIVE LANGUAGES AM, P175; Kummel Martin Joachim, 2007, KONSONANTENWANDEL BA; Kuzmin YV, 2013, WORLD ARCHAEOL, V45, P539, DOI 10.1080/00438243.2013.821669; Labov W., 1971, LANGUAGE SOC, V1, P97, DOI DOI 10.1017/S0047404500006576; LABOV William, 2001, PRINCIPLES LINGUISTI; Lass Roger, 1997, HIST LINGUISTICS LAN; Laver J., 1980, PHONETIC DESCRIPTION; Lavoie L.M., 2001, CONSONANT STRENGTH P; Lewis M. J. T., 1997, MILLSTONE AND HAMMER; Lewis Paul, 2016, ETHNOLOGUE LANGUAGES, V19th; Lindblom Bjorn E. F., 1995, RIV LINGUISTICA, V7, P5; Lloyd J., 2012, SOFT ISSUE BIOMECHAN, P355, DOI DOI 10.1002/hed.23909; Lukacs J R, 1990, Anthropol Anz, V48, P351; LUKACS JR, 1981, P AM PHILOS SOC, V125, P220; Lunt HoraceG., 2001, OLD CHURCH SLAVONIC; MacDonald MC, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00226; Maddieson, 1996, SOUNDS WORLDS LANGUA; Maddieson I., 2005, STUD AFR LINGUIST, V35, P159; Magnusson A., 2016, GLMMTMB GEN LINEAR M; Malzahn M., 2007, INSTRUMENTA TOCHARIC, P255; Margvelashvili A, 2013, P NATL ACAD SCI USA, V110, P17278, DOI 10.1073/pnas.1316052110; Matras Y., 2002, ROMANI LINGUISTIC IN; McMahon AprilM.S., 1994, UNDERSTANDING LANGUA, DOI [10.1017/CBO9781139166591, DOI 10.1017/CBO9781139166591]; Mennecier P., 1995, TUNUMIISUT DIALECTE; Moisik SR, 2017, J LANG EVOL, V2, P37, DOI 10.1093/jole/lzx004; MORAN STEVEN, 2014, PHOIBLE ONLINE; Napoli DJ, 2014, LANGUAGE, V90, P424, DOI 10.1353/lan.2014.0026; Nazari MA, 2010, COMPUT METHOD BIOMEC, V13, P469, DOI 10.1080/10255840903505147; Newmeyer Frederick J., 2002, TRANSITION LANGUAGE, P359; Nielsen R, 2002, SYST BIOL, V51, P729, DOI 10.1080/10635150290102393; Noreen Adolf, 1904, ALTSCHWEDISCHE GRAMM; O CurnuYin, 2007, IRISH IORRAS AITHNEA; Oberlies T., 2012, PALI GRAMMAR LANGUAG; PAGEL M., 2014, BAYESTRAITS V2 0; PEDERSEN PO, 1947, P ROY SOC MED, V40, P726, DOI 10.1177/003591574704001216; Philippaki-Warburton Irene., 2012, GREEK COMPREHENSIVE; Prokosch Eduard., 1939, COMP GERMANIC GRAMMA; Reid N, 1990, THESIS; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Rischel J, 1974, TOPICS W GREENLANDIC; Robson B, 2009, IRANIAN LANGUAGES, P721; Ruster C., 1989, STUDIEN BOGAZKOY TEX, V2; Salas A, 2002, AM J HUM GENET, V71, P1082, DOI 10.1086/344348; Schmitt Rudiger, 2007, GRAMMATIK KLASSISCH, V2nd; Schultz-Lorentzen C. W., 1945, GRAMMAR W GREENLAND; Schumacher S., 2013, VERBEN ALTALBANISCHE; Schwyzer E., 1931, GRIECHISCHE GRAMMATI, V1; Shapiro Michael C, 2003, INDOARYAN LANGUAGES, P250; Skjaervo P. O., 2009, IRANIAN LANGUAGES, P197; Skjaervo Prods Oktor, 2009, IRANIAN LANGUAGES, P43; Sommer B. A., 1969, KUNJEN PHONOLOGY SYN; Stavness I, 2013, J SPEECH LANG HEAR R, V56, P878, DOI 10.1044/1092-4388(2012/12-0200); Stavness I, 2012, J BIOMECH, V45, P2841, DOI 10.1016/j.jbiomech.2012.08.031; Stavness I, 2011, INT J NUMER METH BIO, V27, P367, DOI 10.1002/cnm.1423; Stevens K.N., 2000, ACOUSTIC PHONETICS, V30; STEVENS KN, 1989, J PHONETICS, V17, P3, DOI 10.1016/S0095-4470(19)31520-7; Stifter D, 2010, ROUTL LANG FAM SER, P55; Swadesh M., 1946, LINGUISTIC STRUCTURE, V7, P30; Swadesh M., 1946, VIKING FUND PUBLICAT, V7, P30; Team RC., 2013, R LANG ENV STAT COMP; Traill A., 1994, A XOO DICT; UTMAN JA, 1994, PHONETICA, V51, P221, DOI 10.1159/000261978; VALLINO LD, 1993, J ORAL MAXIL SURG, V51, P850, DOI 10.1016/S0278-2391(10)80101-6; von Cramon-Taubadel N, 2011, P NATL ACAD SCI USA, V108, P19546, DOI 10.1073/pnas.1113050108; Vyslozil O., 2001, ANN NATURHISTORISC A, V201, P245; WAGNER M.L., 1984, FONETICA STORICA SAR; Weinreich Uriel, 1968, DIRECTIONS HIST LING, P95; Widmer M, 2017, LANGUAGE, V93, P799, DOI 10.1353/lan.2017.0058; Wikander O., 2000, HDB ANCIENT WATER TE, DOI [10.1093/molbev/msy201, DOI 10.1093/MOLBEV/MSY201]; Wikander o, 2000, HDB ANCIENT WATER TE; Wilson A, 2002, J ROMAN STUD, V92, P1, DOI 10.2307/3184857; Witzlack-Makarevich A., 2017, AUTOTYP TYPOLOGICAL; Wu XH, 2012, SCIENCE, V336, P1696, DOI 10.1126/science.1218643; Yao YL, 2018, BAYESIAN ANAL, V13, P917, DOI 10.1214/17-BA1091	147	55	56	6	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 15	2019	363	6432			SI		1192	+	aav3218	10.1126/science.aav3218	http://dx.doi.org/10.1126/science.aav3218			67	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HP0BC	30872490				2022-12-28	WOS:000461329000042
J	Dyer, O				Dyer, Owen			Medtronic subsidiary pays $17m to settle allegations of kickbacks to US doctors	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		DYER O, 2016, BMJ-BRIT MED J, V352, DOI DOI 10.1136/BMJ.I1195	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 15	2019	364								l1217	10.1136/bmj.l1217	http://dx.doi.org/10.1136/bmj.l1217			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP5WF	30877131				2022-12-28	WOS:000461752800007
J	Lee, JW; Stone, ML; Porrett, PM; Thomas, SK; Komar, CA; Li, JH; Delman, D; Graham, K; Gladney, WL; Hua, X; Black, TA; Chien, AL; Majmundar, KS; Thompson, JC; Yee, SS; O'Hara, MH; Aggarwal, C; Xin, D; Shaked, A; Gao, MM; Liu, DX; Borad, MJ; Ramanathan, RK; Carpenter, EL; Ji, AL; de Beer, MC; de Beer, FC; Webb, NR; Beatty, GL				Lee, Jae W.; Stone, Meredith L.; Porrett, Paige M.; Thomas, Stacy K.; Komar, Chad A.; Li, Joey H.; Delman, Devora; Graham, Kathleen; Gladney, Whitney L.; Hua, Xia; Black, Taylor A.; Chien, Austin L.; Majmundar, Krishna S.; Thompson, Jeffrey C.; Yee, Stephanie S.; O'Hara, Mark H.; Aggarwal, Charu; Xin, Dong; Shaked, Abraham; Gao, Mingming; Liu, Dexi; Borad, Mitesh J.; Ramanathan, Ramesh K.; Carpenter, Erica L.; Ji, Ailing; de Beer, Maria C.; de Beer, Frederick C.; Webb, Nancy R.; Beatty, Gregory L.			Hepatocytes direct the formation of a pro-metastatic niche in the liver	NATURE			English	Article							PANCREATIC DUCTAL ADENOCARCINOMA; CHEMOTHERAPY EFFICACY; PREMETASTATIC NICHE; TISSUE INHIBITOR; GENE ONTOLOGY; CYTOSCAPE; PATHWAY; RECRUITMENT; EXPRESSION; COOPERATE	The liver is the most common site of metastatic disease(1). Although this metastatic tropism may reflect the mechanical trapping of circulating tumour cells, liver metastasis is also dependent, at least in part, on the formation of a 'pro-metastatic' niche that supports the spread of tumour cells to the liver(2,3). The mechanisms that direct the formation of this niche are poorly understood. Here we show that hepatocytes coordinate myeloid cell accumulation and fibrosis within the liver and, in doing so, increase the susceptibility of the liver to metastatic seeding and outgrowth. During early pancreatic tumorigenesis in mice, hepatocytes show activation of signal transducer and activator of transcription 3 (STAT3) signalling and increased production of serum amyloid A1 and A2 (referred to collectively as SAA). Overexpression of SAA by hepatocytes also occurs in patients with pancreatic and colorectal cancers that have metastasized to the liver, and many patients with locally advanced and metastatic disease show increases in circulating SAA. Activation of STAT3 in hepatocytes and the subsequent production of SAA depend on the release of interleukin 6 (IL-6) into the circulation by non-malignant cells. Genetic ablation or blockade of components of IL-6-STAT3-SAA signalling prevents the establishment of a pro-metastatic niche and inhibits liver metastasis. Our data identify an intercellular network underpinned by hepatocytes that forms the basis of a pro-metastatic niche in the liver, and identify new therapeutic targets.	[Lee, Jae W.; Stone, Meredith L.; Thomas, Stacy K.; Komar, Chad A.; Li, Joey H.; Delman, Devora; Graham, Kathleen; Gladney, Whitney L.; Hua, Xia; Black, Taylor A.; Majmundar, Krishna S.; Thompson, Jeffrey C.; Yee, Stephanie S.; O'Hara, Mark H.; Aggarwal, Charu; Carpenter, Erica L.; Beatty, Gregory L.] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Lee, Jae W.; Stone, Meredith L.; Thomas, Stacy K.; Komar, Chad A.; Li, Joey H.; Delman, Devora; Graham, Kathleen; Gladney, Whitney L.; Hua, Xia; Black, Taylor A.; Chien, Austin L.; Majmundar, Krishna S.; Thompson, Jeffrey C.; Yee, Stephanie S.; O'Hara, Mark H.; Aggarwal, Charu; Carpenter, Erica L.; Beatty, Gregory L.] Univ Penn, Dept Med, Perelman Sch Med, Div Hematol Oncol, Philadelphia, PA 19104 USA; [Porrett, Paige M.; Xin, Dong; Shaked, Abraham] Univ Penn, Dept Surg, Perelman Sch Med, Div Transplant Surg, Philadelphia, PA 19104 USA; [Gao, Mingming; Liu, Dexi] Univ Georgia, Coll Pharm, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA; [Borad, Mitesh J.; Ramanathan, Ramesh K.] Mayo Clin, Canc Ctr, Phoenix, AZ USA; [Ji, Ailing; de Beer, Frederick C.] Univ Kentucky, Dept Internal Med, Lexington, KY USA; [Ji, Ailing; de Beer, Maria C.; de Beer, Frederick C.; Webb, Nancy R.] Univ Kentucky, Saha Cardiovasc Res Ctr, Lexington, KY USA; [de Beer, Maria C.] Univ Kentucky, Dept Physiol, Lexington, KY USA; [Webb, Nancy R.] Univ Kentucky, Dept Pharmacol & Nutr Sci, Lexington, KY USA; [Ramanathan, Ramesh K.] Merck Res Labs, Rahway, NJ USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University System of Georgia; University of Georgia; Mayo Clinic; Mayo Clinic Phoenix; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; Merck & Company	Beatty, GL (corresponding author), Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA.; Beatty, GL (corresponding author), Univ Penn, Dept Med, Perelman Sch Med, Div Hematol Oncol, Philadelphia, PA 19104 USA.	gregory.beatty@uphs.upenn.edu	Webb, Nancy/AAL-7030-2021; Porrett, Paige/AAU-8992-2020	Chien, Austin/0000-0001-9463-5944; Thomas, Stacy/0000-0002-6703-5246; Lee, Jae/0000-0002-0735-5707; HUA, XIA/0000-0003-0923-6493; Li, Joey/0000-0002-3865-5876	National Institutes of Health [F30 CA196106, T32 HL007439, T32 CA009140, R01 CA197916, R01 HL134731]; University of Pennsylvania Molecular Pathology and Imaging Core of the Center for Molecular Studies in Digestive and Liver Diseases [P30 DK050306]; 2015 Pancreatic Cancer Action Network-AACR Career Development Award [15-20-25-BEAT]; 2017 Stand Up to Cancer (SU2C) Innovative Research Grant [SU2C-AACR-IRG 13-17]; University of Kentucky Office of the Vice President for Research; American Surgical Association Foundation Fellowship; University of Pennsylvania Pancreatic Cancer Research Center; Abramson Cancer Center Translational Centers of Excellence; NATIONAL CANCER INSTITUTE [T32CA009140, F30CA196106, P30CA016520, R01CA197916] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007439, R01HL134731] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK050306] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pennsylvania Molecular Pathology and Imaging Core of the Center for Molecular Studies in Digestive and Liver Diseases; 2015 Pancreatic Cancer Action Network-AACR Career Development Award; 2017 Stand Up to Cancer (SU2C) Innovative Research Grant; University of Kentucky Office of the Vice President for Research; American Surgical Association Foundation Fellowship; University of Pennsylvania Pancreatic Cancer Research Center; Abramson Cancer Center Translational Centers of Excellence; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank members of the Zaret laboratory for assistance with isolation and culture of primary hepatocytes and members of the Genomics Facility (Wistar Institute) and the Molecular Pathology and Imaging Core (University of Pennsylvania) for technical support; E. J. Wherry, D. J. Powell, J. R. Conejo-Garcia, I. E. Brodsky, and E. L. Stone for discussions and advice; and the Mayo Clinic Arizona for provision of liver tissue sections collected from patients with pancreatic cancer. This work was supported by National Institutes of Health grants F30 CA196106 (J.W.L.), T32 HL007439 (J.W.L.), T32 CA009140 (M.L.S.), R01 CA197916 (G.L.B.), R01 HL134731 (N.R.W. and F.C.d.B.), the University of Pennsylvania Molecular Pathology and Imaging Core of the Center for Molecular Studies in Digestive and Liver Diseases grant P30 DK050306, the 2015 Pancreatic Cancer Action Network-AACR Career Development Award 15-20-25-BEAT supported by an anonymous foundation (G.L.B.), the 2017 Stand Up to Cancer (SU2C) Innovative Research Grant SU2C-AACR-IRG 13-17 (G.L.B.), a Research Support Grant from the University of Kentucky Office of the Vice President for Research (N.R.W.), the American Surgical Association Foundation Fellowship (P.M.P.), the University of Pennsylvania Pancreatic Cancer Research Center (E.L.C.), and the Abramson Cancer Center Translational Centers of Excellence (E.L.C.).	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Becker A, 2016, CANCER CELL, V30, P836, DOI 10.1016/j.ccell.2016.10.009; Bindea G, 2013, BIOINFORMATICS, V29, P661, DOI 10.1093/bioinformatics/btt019; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Carbon S, 2017, NUCLEIC ACIDS RES, V45, pD331, DOI 10.1093/nar/gkw1108; Corcoran RB, 2011, CANCER RES, V71, P5020, DOI 10.1158/0008-5472.CAN-11-0908; Costa-Silva B, 2015, NAT CELL BIOL, V17, P816, DOI 10.1038/ncb3169; de Beer MC, 2010, J LIPID RES, V51, P3117, DOI 10.1194/jlr.M005413; Eckhardt ERM, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-133; Fukuda A, 2011, CANCER CELL, V19, P441, DOI 10.1016/j.ccr.2011.03.002; Grunwald B, 2016, GASTROENTEROLOGY, V151, P1011, DOI 10.1053/j.gastro.2016.07.043; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hiratsuka S, 2008, NAT CELL BIOL, V10, P1349, DOI 10.1038/ncb1794; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Hoshino A, 2015, NATURE, V527, P329, DOI 10.1038/nature15756; Kalbasi A, 2017, CLIN CANCER RES, V23, P137, DOI 10.1158/1078-0432.CCR-16-0870; Klaas M, 2016, SCI REP-UK, V6, DOI 10.1038/srep27398; Kowanetz M, 2010, P NATL ACAD SCI USA, V107, P21248, DOI 10.1073/pnas.1015855107; Lee J. W., 2016, CURR PROTOC PHARM, V73; Lesina M, 2011, CANCER CELL, V19, P456, DOI 10.1016/j.ccr.2011.03.009; Liang WS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043192; Long KB, 2017, MOL CANCER THER, V16, P1898, DOI 10.1158/1535-7163.MCT-16-0899; Long KB, 2016, CANCER DISCOV, V6, P400, DOI 10.1158/2159-8290.CD-15-1032; Ma YJ, 2015, BBA-MOL BASIS DIS, V1852, P1001, DOI 10.1016/j.bbadis.2015.01.017; Notta F, 2016, NATURE, V538, P378, DOI 10.1038/nature19823; Reichert M, 2018, DEV CELL, V45, P696, DOI 10.1016/j.devcel.2018.05.025; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Sceneay J, 2013, CANCER METAST REV, V32, P449, DOI 10.1007/s10555-013-9420-1; Schmidt-Arras D, 2016, J HEPATOL, V64, P1403, DOI 10.1016/j.jhep.2016.02.004; Seubert B, 2015, HEPATOLOGY, V61, P238, DOI 10.1002/hep.27378; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Soares Kevin C, 2014, J Vis Exp, P51677, DOI 10.3791/51677; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun Y, 2011, ARCH PATHOL LAB MED, V135, P1335, DOI 10.5858/arpa.2010-0549-OA; Tseng William, 2007, J Vis Exp, P484, DOI 10.3791/484; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Urieli-Shoval S, 2000, CURR OPIN HEMATOL, V7, P64, DOI 10.1097/00062752-200001000-00012; Webb NR, 2015, ARTERIOSCL THROM VAS, V35, P1156, DOI 10.1161/ATVBAHA.114.304776; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515	40	155	162	5	129	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 14	2019	567	7747					249	+		10.1038/s41586-019-1004-y	http://dx.doi.org/10.1038/s41586-019-1004-y			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7LD	30842658	Green Accepted			2022-12-28	WOS:000461126600044
J	Robertson, SA				Robertson, Sarah A.			Preventing Preeclampsia by Silencing Soluble Flt-1?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SFLT1		[Robertson, Sarah A.] Univ Adelaide, Robinson Res Inst, Adelaide, SA, Australia; [Robertson, Sarah A.] Univ Adelaide, Adelaide Med Sch, Adelaide, SA, Australia	Robinson Research Institute; University of Adelaide; University of Adelaide	Robertson, SA (corresponding author), Univ Adelaide, Robinson Res Inst, Adelaide, SA, Australia.; Robertson, SA (corresponding author), Univ Adelaide, Adelaide Med Sch, Adelaide, SA, Australia.		Robertson, Sarah A/C-8182-2009	Robertson, Sarah A/0000-0002-9967-0084				Charnock-Jones DS, 2016, J REPROD IMMUNOL, V114, P81, DOI 10.1016/j.jri.2015.07.004; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Nakakita B, 2015, J OBSTET GYNAECOL RE, V41, P1661, DOI 10.1111/jog.12760; Redman CWG, 2010, AM J REPROD IMMUNOL, V63, P534, DOI 10.1111/j.1600-0897.2010.00831.x; Turanov A.A., 2018, NAT BIOTECHNOL	5	14	15	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 14	2019	380	11					1080	1082		10.1056/NEJMcibr1817501	http://dx.doi.org/10.1056/NEJMcibr1817501			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HO8NL	30865806				2022-12-28	WOS:000461210000016
J	Akbaraly, TN; Singh-Manoux, A; Dugravot, A; Brunner, EJ; Kivimaki, M; Sabia, S				Akbaraly, Tasnime N.; Singh-Manoux, Archana; Dugravot, Aline; Brunner, Eric J.; Kivimaki, Mika; Sabia, Severine			Association of Midlife Diet With Subsequent Risk for Dementia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ALZHEIMERS-DISEASE; MEDITERRANEAN DIET; COGNITIVE FUNCTION; FOLLOW-UP; PATTERNS; DECLINE; INTERVENTION; VALIDITY; HEALTH; MEMORY	IMPORTANCE Observational studies suggest that diet is linked to cognitive health. However, the duration of follow-up in many studies is not sufficient to take into account the long preclinical phase of dementia, and the evidence from interventional studies is not conclusive. OBJECTIVE To examine whether midlife die is associated with subsequentrisk for dementia. DESIGN, SETTING, AND PARTICIPANTS Population-based cohort study established in 1985-1988 that had dietary intake assessed in 1991-1993, 1997-1999, and 2002-2004 and follow-up for incident dementia until March 31, 2017. EXPOSURES Food frequency questionnaire to derive the Alternate Healthy Eating Index (AHEI), an 11-component diet quality score (score range, 0-110), with higher scores indicating a healthier diet. MAIN OUTCOME AND MEASURES Incident dementia ascertained through linkage to electronic health records. RESULTS Among 8225 participants without dementia in 1991-1993 (mean age, 50.2 years [SD, 6] years]; 5686 [69]%] were men), a total of 344 cases of incident dementia were recorded during a median follow-up of 24.8 years finterquartile range, 24.2-25.1 years). No significant difference in the incidence rate for dementia was observed in tertiles of AHEI exposure during 1991-1993, 1997-1999 (median follow-up, 19.1years), and 2002-2004 (median follow-up, 13.5 years). Compared with an incidence rate for dementia of 1.76 (95% CI, 1.47-2.12) per 1000 person-years in the worst tertile of AHEI (lowest tertile of diet quality) in 1991-1993, the absolute rate difference for the intermediate tertile was 0.03 (95% CI, -0.43 to 0.49) per 1000 person-years and for the best tertile was 0.04 (95% CI, -0.42 to 0.51) per 1000 person-years. Compared with the worst AHEI tertile in 1997-1999 (incidence rate for dementia, 2.06 [95% CI, 1.62 to 2.61] per 1000 person-years), the absolute rate difference for the intermediate AHEI tertile was 0.14 (95% CI, -0.58 to 0.86) per 1000 person-years and for the best AHEI tertile was 0.14 (95% CI, -0.58 to 0.85) per 1000 person-years. Compared with the worst AHEI tertile in 2002-2004 (incidence rate for dementia, 3.12 [95% [I, 2.49 to 3.92] per 1000 person-years), the absolute rate difference for the intermediate AHEI tertile was -0.61(95% CI, -1.56 to 0.33) per 1000 person-years and for the best AHEI tertile was -0.73 (95% CI, -1.67 to 0.22) per 1000 person-years. In the multivariable analysis, the adjusted hazard ratios (HRs) for dementia per 1-SD (10-point) AHEI increment were not significant as assessed in 1991-1993 (adjusted HR, 0.97 [95% CI, 0.87 to 1.08]), in 1997-1999 (adjusted HR, 0.97 [95% CI, 0.83 to 1.12]), or in 2002-2004 (adjusted HR, 0.87 [95% CI, 0.75 to 1.00]). CONCLUSIONS AND RELEVANCE In this long-term prospective cohort study, diet quality assessed during midlife was not significantly associated with subsequent risk for dementia.	[Akbaraly, Tasnime N.] Univ Montpellier, Ecole Prat Hautes Etud, INSERM, U1198, Montpellier, France; [Akbaraly, Tasnime N.; Singh-Manoux, Archana; Brunner, Eric J.; Kivimaki, Mika; Sabia, Severine] UCL, Dept Epidemiol & Publ Hlth, London, England; [Akbaraly, Tasnime N.] Univ Res & Hosp Ctr Montpellier, Dept Psychiat, INSERM, Montpellier, France; [Akbaraly, Tasnime N.] Univ Res & Hosp Ctr Montpellier, Autism Resources Ctr, INSERM, Montpellier, France; [Singh-Manoux, Archana; Dugravot, Aline; Sabia, Severine] Univ Paris 05, INSERM, U1153, Epidemiol Ageing & Neurodegenerat Dis, Paris, France; [Kivimaki, Mika] Univ Helsinki, Clinicum, Fac Med, Helsinki, Finland	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universite de Montpellier; University of London; University College London; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Helsinki	Akbaraly, TN (corresponding author), Univ Res & Hosp Ctr Montpellier, 291 Ave Doyen Gaston Giraud, F-34295 Montpellier 5, France.	tasnime.akbaraly@inserm.fr	Kivimaki, Mika/B-3607-2012; AKBARALY, Tasnime/H-1389-2018; Brunner, Eric/H-2114-2011; Sabia, Séverine/G-2966-2017; Singh-Manoux, Archana/F-6804-2013	Kivimaki, Mika/0000-0002-4699-5627; AKBARALY, Tasnime/0000-0002-2150-4190; Brunner, Eric/0000-0002-0595-4474; Sabia, Séverine/0000-0003-3109-9720; Singh-Manoux, Archana/0000-0002-1244-5037	UK Medical Research Council [K013351, R024227, S011676]; British Heart Foundation [PG/11/63/29011, RG/13/2/30098]; British Health and Safety Executive; British Department of Health; National Heart, Lung, and Blood Institute [R01HL036310]; National Institute on Aging [R01AG056477, R01AG034454]; Economic and Social Research Council [ES/J023299/1]; Center of Excellence for Neurodegenerative Disorders (Hospital Center of Montpellier); Academy of Finland [311492]; Helsinki Institute of Life Sciences [H970]; Nordic Programme on Health and Welfare [75021]; NordForsk; ESRC [ES/J023299/1] Funding Source: UKRI; NATIONAL INSTITUTE ON AGING [RF1AG062553, R01AG056477] Funding Source: NIH RePORTER	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); British Health and Safety Executive; British Department of Health; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Center of Excellence for Neurodegenerative Disorders (Hospital Center of Montpellier); Academy of Finland(Academy of Finland); Helsinki Institute of Life Sciences; Nordic Programme on Health and Welfare; NordForsk; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Whitehall II study has been supported by grants K013351, R024227, and S011676 from the UK Medical Research Council; grants PG/11/63/29011 and RG/13/2/30098 from the British Heart Foundation; funding from the British Health and Safety Executive; funding from the British Department of Health; grant R01HL036310 from the National Heart, Lung, and Blood Institute; grants R01AG056477 and R01AG034454 from the National Institute on Aging; and grant ES/J023299/1 from the Economic and Social Research Council. Dr Akbaraly is supported by the Center of Excellence for Neurodegenerative Disorders (Hospital Center of Montpellier). Mr Kivimaki is supported by grant 311492 from the Academy of Finland, grant H970 from the Helsinki Institute of Life Sciences, grant 75021 from the Nordic Programme on Health and Welfare, and funding from NordForsk.	Akbaraly T, 2018, AM J MED, V131, P1372, DOI 10.1016/j.amjmed.2018.07.001; Alles B, 2012, NUTR RES REV, V25, P207, DOI 10.1017/S0954422412000133; Andrieu S, 2017, LANCET NEUROL, V16, P377, DOI 10.1016/S1474-4422(17)30040-6; Balding DJ, 2004, APPL LONGITUDINAL AN; Baquero M, 2015, WORLD J CLIN CASES, V3, P682, DOI 10.12998/wjcc.v3.i8.682; Bingham SA, 1997, INT J EPIDEMIOL, V26, pS137, DOI 10.1093/ije/26.suppl_1.S137; BORKOWSKI JG, 1967, NEUROPSYCHOLOGIA, V5, P135, DOI 10.1016/0028-3932(67)90015-2; Brunner E, 2001, BRIT J NUTR, V86, P405, DOI 10.1079/BJN2001414; Cao L, 2016, MOL NEUROBIOL, V53, P6144, DOI 10.1007/s12035-015-9516-4; Chiuve SE, 2012, J NUTR, V142, P1009, DOI 10.3945/jn.111.157222; Commission on the Future of Health and Social Care in England, UK PRIV HLTH MARK; Gomez-Pinilla F, 2008, NAT REV NEUROSCI, V9, P568, DOI 10.1038/nrn2421; Hardman RJ, 2016, FRONT NUTR, V3, DOI 10.3389/fnut.2016.00022; Haring B, 2016, J ACAD NUTR DIET, V116, P921, DOI 10.1016/j.jand.2015.12.017; Heim A.W., 1970, AH 4 GROUP TEST GEN; Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; Kesse-Guyot E, 2013, AM J CLIN NUTR, V97, P369, DOI 10.3945/ajcn.112.047993; Knight A, 2016, NUTRIENTS, V8, DOI 10.3390/nu8090579; Livingston G, 2017, LANCET, V390, P2673, DOI 10.1016/S0140-6736(17)31363-6; Luciano M, 2017, NEUROLOGY, V88, P449, DOI 10.1212/WNL.0000000000003559; Marmot M, 2005, INT J EPIDEMIOL, V34, P251, DOI 10.1093/ije/dyh372; Marseglia A, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00349; Olsson E, 2015, J ALZHEIMERS DIS, V43, P109, DOI 10.3233/JAD-140867; Ozawa M, 2013, AM J CLIN NUTR, V97, P1076, DOI 10.3945/ajcn.112.045575; Psaltopoulou T, 2013, ANN NEUROL, V74, P580, DOI 10.1002/ana.23944; Shatenstein B, 2012, EXP GERONTOL, V47, P353, DOI 10.1016/j.exger.2012.02.002; Soininen H, 2017, LANCET NEUROL, V16, P965, DOI 10.1016/S1474-4422(17)30332-0; Solfrizzi V, 2017, J ALZHEIMERS DIS, V59, P815, DOI [10.3233/jad-170248, 10.3233/JAD-170248]; Sommerlad A, 2018, ALZHEIMERS DEMENT, V14, P933, DOI 10.1016/j.jalz.2018.02.012; Valls-Pedret C, 2015, JAMA INTERN MED, V175, P1094, DOI 10.1001/jamainternmed.2015.1668; van de Rest O, 2015, ADV NUTR, V6, P154, DOI 10.3945/an.114.007617; Wagner M, 2018, AM J EPIDEMIOL, V187, P845, DOI 10.1093/aje/kwx293; Wengreen H, 2013, AM J CLIN NUTR, V98, P1263, DOI 10.3945/ajcn.112.051276; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; Wilson RS, 2010, NEUROLOGY, V75, P1070, DOI 10.1212/WNL.0b013e3181f39adc; Winblad B, 2016, LANCET NEUROL, V15, P455, DOI 10.1016/S1474-4422(16)00062-4; Wu L, 2017, SCI REP-UK, V7, DOI 10.1038/srep41317	38	41	41	2	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 12	2019	321	10					957	968		10.1001/jama.2019.1432	http://dx.doi.org/10.1001/jama.2019.1432			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HO5JE	30860560	Green Accepted, Green Published			2022-12-28	WOS:000460961000014
J	Bax, JJ; Di Carli, M; Narula, J; Delgado, V				Bax, Jeroen J.; Di Carli, Marcelo; Narula, Jagat; Delgado, Victoria			Multimodality imaging in ischaemic heart failure	LANCET			English	Article							CORONARY-ARTERY-DISEASE; FRACTIONAL FLOW RESERVE; GLOBAL LONGITUDINAL STRAIN; COMPUTED-TOMOGRAPHY ANGIOGRAPHY; FUNCTIONAL MITRAL REGURGITATION; CARDIOVASCULAR MAGNETIC-RESONANCE; NATIVE VALVULAR REGURGITATION; LATE GADOLINIUM ENHANCEMENT; OPTIMAL MEDICAL THERAPY; ASSOCIATION TASK-FORCE	In heart failure, extensive evaluation with modern non-invasive imaging modalities is needed to assess causes, pathophysiology, and haemodynamics, to determine prognosis and consider therapeutic options. This systematic evaluation includes a stepwise assessment of left ventricular size and function, the presence and severity of coronary artery disease, mitral regurgitation, pulmonary hypertension, right ventricular dilation and dysfunction, and tricuspid regurgitation. Based on this imaging-derived information, the need for specific therapies besides optimised medical therapy can be determined. The need for revascularisation, implantation of an implantable cardiac defibrillator, and mitral or tricuspid valve repair or replacement, can be (partially) guided by non-invasive imaging. Importantly, randomised controlled trials on the use of non-inasive imaging to guide therapy are scarce in this field and most non-pharmacological therapies are based on expert-consensus, but whenever trials are available, they will be addressed in this paper.	[Bax, Jeroen J.; Delgado, Victoria] Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands; [Di Carli, Marcelo] Harvard Med Sch, Brigham & Womens Hosp, Dept Radiol, Boston, NY USA; [Di Carli, Marcelo] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Boston, NY USA; [Narula, Jagat] Icahn Sch Med Mt Sinai, New York, NY 10029 USA	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Icahn School of Medicine at Mount Sinai	Bax, JJ (corresponding author), Leiden Univ, Med Ctr, Heart Lung Ctr, Dept Cardiol, Albinusdreef 2, NL-2333 ZA Leiden, Netherlands.	j.j.bax@lumc.nl	Delgado, Victoria/AAL-4731-2021	Delgado, Victoria/0000-0002-9841-2737				Ambale-Venkatesh B, 2015, NAT REV CARDIOL, V12, P18, DOI 10.1038/nrcardio.2014.159; [Anonymous], 2017, Circulation, V136, pe196, DOI 10.1161/CIR.0000000000000530; Baumgartner H, 2017, EUR HEART J, V38, P2739, DOI 10.1093/eurheartj/ehx391; Bax JJ, 2015, J NUCL CARDIOL, V22, P229, DOI 10.1007/s12350-015-0096-5; Bax JJ, 2008, CIRC-CARDIOVASC IMAG, V1, P131, DOI 10.1161/CIRCIMAGING.108.782433; Beanlands RSB, 2007, J AM COLL CARDIOL, V50, P2002, DOI 10.1016/j.jacc.2007.09.006; Bertini M, 2012, CIRC-CARDIOVASC IMAG, V5, P383, DOI 10.1161/CIRCIMAGING.111.970434; Bhattacharyya S, 2013, EUR HEART J-CARD IMG, V14, P550, DOI 10.1093/ehjci/jes212; Biering-Sorensen T, 2013, CIRC-CARDIOVASC IMAG, V6, P457, DOI 10.1161/CIRCIMAGING.112.000230; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Bonow RO, 2011, NEW ENGL J MED, V364, P1617, DOI 10.1056/NEJMoa1100358; Boogers MJ, 2010, J AM COLL CARDIOL, V55, P2769, DOI 10.1016/j.jacc.2009.12.066; Budoff MJ, 2010, J AM COLL CARDIOL, V56, P613, DOI 10.1016/j.jacc.2010.03.056; Carluccio E, 2018, CIRC-CARDIOVASC IMAG, V11, DOI 10.1161/CIRCIMAGING.117.006894; Choi J, 2014, CIRC-CARDIOVASC IMAG, V7, P535, DOI 10.1161/CIRCIMAGING.113.001457; Chow BJW, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-443; Ciarka A, 2010, AM J CARDIOL, V106, P395, DOI 10.1016/j.amjcard.2010.03.042; Danad I, 2017, EUR HEART J, V38, P991, DOI 10.1093/eurheartj/ehw095; Dandel M, 2016, INT J CARDIOL, V221, P1132, DOI 10.1016/j.ijcard.2016.07.014; Daubert JP, 2008, J AM COLL CARDIOL, V51, P1357, DOI 10.1016/j.jacc.2007.09.073; De Bruyne B, 2012, NEW ENGL J MED, V367, P991, DOI 10.1056/NEJMoa1205361; Di Carli MF, 2007, J NUCL MED, V48, P783, DOI 10.2967/jnumed.106.032789; Fairbairn TA, 2018, EUR HEART J, V39, P3701, DOI 10.1093/eurheartj/ehy530; Fallavollita JA, 2014, J AM COLL CARDIOL, V63, P141, DOI 10.1016/j.jacc.2013.07.096; Fent GJ, 2017, INT J CARDIOVAS IMAG, V33, P1561, DOI 10.1007/s10554-017-1138-7; Flaherty JD, 2009, J AM COLL CARDIOL, V53, P254, DOI 10.1016/j.jacc.2008.08.072; Fonarow GC, 2010, CIRCULATION, V122, P585, DOI 10.1161/CIRCULATIONAHA.109.934471; Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2; Frye RL, 2009, NEW ENGL J MED, V360, P2503, DOI [DOI 10.1056/NEJMOA0805796, 10.1056/NEJMoa0805796]; Gaemperli O, 2012, EUR HEART J-CARD IMG, V13, P51, DOI 10.1093/ejechocard/jer240; Gheorghiade M, 2006, CIRCULATION, V114, P1202, DOI 10.1161/CIRCULATIONAHA.106.623199; Goliasch G, 2018, EUR HEART J, V39, P39, DOI 10.1093/eurheartj/ehx402; Greenwood JP, 2012, LANCET, V379, P453, DOI 10.1016/S0140-6736(11)61335-4; Guihaire J, 2013, EUR HEART J-CARD IMG, V14, P1140, DOI 10.1093/ehjci/jet092; Haeck MLA, 2012, CIRC-CARDIOVASC IMAG, V5, P628, DOI 10.1161/CIRCIMAGING.111.971465; Halliday BP, 2017, CIRCULATION, V135, P2106, DOI 10.1161/CIRCULATIONAHA.116.026910; Haugaa KH, 2010, JACC-CARDIOVASC IMAG, V3, P247, DOI 10.1016/j.jcmg.2009.11.012; Jacobson AF, 2010, J AM COLL CARDIOL, V55, P2212, DOI 10.1016/j.jacc.2010.01.014; Jugdutt BI, 2003, CIRCULATION, V108, P1395, DOI 10.1161/01.CIR.0000085658.98621.49; Kalam K, 2014, HEART, V100, P1673, DOI 10.1136/heartjnl-2014-305538; Kim RJ, 2000, NEW ENGL J MED, V343, P1445, DOI 10.1056/NEJM200011163432003; Konstam MA, 2011, JACC-CARDIOVASC IMAG, V4, P98, DOI 10.1016/j.jcmg.2010.10.008; Kramer DG, 2010, J AM COLL CARDIOL, V56, P392, DOI 10.1016/j.jacc.2010.05.011; Lancellotti P, 2013, EUR HEART J-CARD IMG, V14, P611, DOI 10.1093/ehjci/jet105; Lu MT, 2017, JACC-CARDIOVASC IMAG, V10, P1350, DOI 10.1016/j.jcmg.2016.11.024; Magne J, 2007, CIRCULATION, V115, P782, DOI 10.1161/CIRCULATIONAHA.106.649236; Marsan NA, 2009, JACC-CARDIOVASC IMAG, V2, P1245, DOI 10.1016/j.jcmg.2009.07.006; Messroghli DR, 2017, J CARDIOVASC MAGN R, V19, DOI 10.1186/s12968-017-0389-8; Min JK, 2012, JAMA-J AM MED ASSOC, V308, P1237, DOI 10.1001/2012.jama.11274; Mogelvang R, 2009, CIRCULATION, V119, P2679, DOI 10.1161/CIRCULATIONAHA.108.793471; Mooij CF, 2008, J MAGN RESON IMAGING, V28, P67, DOI 10.1002/jmri.21407; Mordi I, 2015, JACC-CARDIOVASC IMAG, V8, P540, DOI 10.1016/j.jcmg.2015.02.005; Moss AJ, 2004, CIRCULATION, V110, P3760, DOI 10.1161/01.CIR.0000150390.04704.B7; Myerburg RJ, 2017, JAMA CARDIOL, V2, P689, DOI 10.1001/jamacardio.2017.0266; Naeije R, 2014, EUR RESPIR REV, V23, P476, DOI 10.1183/09059180.00007414; Nath J, 2004, J AM COLL CARDIOL, V43, P405, DOI 10.1016/j.jacc.2003.09.036; Ng ACT, 2010, CIRCULATION, V122, P2538, DOI 10.1161/CIRCULATIONAHA.110.955542; Nishimura RA, 2014, CIRCULATION, V129, P2440, DOI 10.1161/CIR.0000000000000029; Norgaard BL, 2014, J AM COLL CARDIOL, V63, P1145, DOI 10.1016/j.jacc.2013.11.043; O'Meara E, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-218; Obadia JF, 2018, NEW ENGL J MED, V379, P2297, DOI 10.1056/NEJMoa1805374; Pijls NHJ, 2007, J AM COLL CARDIOL, V49, P2105, DOI 10.1016/j.jacc.2007.01.087; Polonsky TS, 2010, JAMA-J AM MED ASSOC, V303, P1610, DOI 10.1001/jama.2010.461; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Prihadi EA, 2018, JACC-CARDIOVASC IMAG, V11, P736, DOI 10.1016/j.jcmg.2017.10.029; Rief M, 2018, RADIOLOGY, V286, P461, DOI 10.1148/radiol.2017162447; Rochitte CE, 2014, EUR HEART J, V35, P1120, DOI 10.1093/eurheartj/eht488; Roes SD, 2009, CIRC-CARDIOVASC IMAG, V2, P183, DOI 10.1161/CIRCIMAGING.108.826529; Roger VL, 2004, JAMA-J AM MED ASSOC, V292, P344, DOI 10.1001/jama.292.3.344; Romano S, 2018, JACC-CARDIOVASC IMAG, V11, P1419, DOI 10.1016/j.jcmg.2017.10.024; Romero J, 2012, JACC-CARDIOVASC IMAG, V5, P494, DOI 10.1016/j.jcmg.2012.02.009; Rossi A, 2011, HEART, V97, P1675, DOI 10.1136/hrt.2011.225789; Sabe MA, 2016, CIRCULATION, V134, P656, DOI 10.1161/CIRCULATIONAHA.116.022339; Salavati A, 2012, J CARDIOVASC COMPUT, V6, P78, DOI 10.1016/j.jcct.2011.10.018; Schelbert EB, 2017, CIRC-CARDIOVASC IMAG, V10, DOI 10.1161/CIRCIMAGING.116.005619; Schelbert EB, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002613; Schelbert EB, 2014, J AM COLL CARDIOL, V63, P2188, DOI 10.1016/j.jacc.2014.01.068; Schinkel AFL, 2007, J NUCL MED, V48, P1135, DOI 10.2967/jnumed.106.038851; Schuijf JD, 2006, EUR J NUCL MED MOL I, V33, P93, DOI 10.1007/s00259-005-1965-y; Schwartzkopff B, 2000, HYPERTENSION, V36, P220, DOI 10.1161/01.HYP.36.2.220; Sengelov M, 2015, JACC-CARDIOVASC IMAG, V8, P1351, DOI 10.1016/j.jcmg.2015.07.013; Senior R, 2017, EUR HEART J-CARD IMG, V18, P1205, DOI 10.1093/ehjci/jex182; Shaw LJ, 2008, CIRCULATION, V117, P1283, DOI 10.1161/CIRCULATIONAHA.107.743963; Shaw LJ, 2004, J NUCL CARDIOL, V11, P171, DOI 10.1016/j.nuclcard.2003.12.004; Stone GW, 2018, NEW ENGL J MED, V379, P2307, DOI 10.1056/NEJMoa1806640; TAYLOR GJ, 1980, CIRCULATION, V62, P960, DOI 10.1161/01.CIR.62.5.960; ten Kate GJR, 2013, EUR J HEART FAIL, V15, P1028, DOI 10.1093/eurjhf/hft090; Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611; Tops LF, 2017, EUR J HEART FAIL, V19, P307, DOI 10.1002/ejhf.694; Uretsky S, 2015, J AM COLL CARDIOL, V65, P1078, DOI 10.1016/j.jacc.2014.12.047; Van de Veire NR, 2011, J THORAC CARDIOV SUR, V141, P1431, DOI 10.1016/j.jtcvs.2010.05.050; van Nunen LX, 2015, LANCET, V386, P1853, DOI 10.1016/S0140-6736(15)00057-4; van Rosendael AR, 2017, EUR HEART J-CARD IMG, V18, P969, DOI 10.1093/ehjci/jex055; van Rosendael PJ, 2017, EUR HEART J, V38, P665, DOI 10.1093/eurheartj/ehw499; Verma A, 2008, JACC-CARDIOVASC IMAG, V1, P582, DOI 10.1016/j.jcmg.2008.05.012; von Ballmoos MW, 2011, ANN INTERN MED, V154, P413, DOI 10.7326/0003-4819-154-6-201103150-00007; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Whellan DJ, 2006, AM HEART J, V152, P340, DOI 10.1016/j.ahj.2005.12.001; WHITE HD, 1987, CIRCULATION, V76, P44, DOI 10.1161/01.CIR.76.1.44; Wolk MJ, 2014, J CARD FAIL, V20, P65, DOI 10.1016/j.cardfail.2013.12.002; Wong ML, 2004, J AM COLL CARDIOL, V43, P2022, DOI 10.1016/j.jacc.2003.12.053; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; Zoghbi WA, 2017, J AM SOC ECHOCARDIOG, V30, P303, DOI 10.1016/j.echo.2017.01.007	103	14	16	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 9	2019	393	10175					1056	1070		10.1016/S0140-6736(18)33207-0	http://dx.doi.org/10.1016/S0140-6736(18)33207-0			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HO0OW	30860031				2022-12-28	WOS:000460604200039
J	Rimmer, A				Rimmer, Abi			Senior male leaders must act as allies to help women succeed, says report	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Health and Care Women Leaders Network, 2019, MEN ALL REP HLTH CAR	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 8	2019	364								l1099	10.1136/bmj.l1099	http://dx.doi.org/10.1136/bmj.l1099			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HO6TC	30850355				2022-12-28	WOS:000461063500007
J	Hampton, T				Hampton, Tracy			Vaccine Protects Mice From Emerging Tick-Borne Flaviviruses	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 5	2019	321	9					825	826		10.1001/jama.2019.0920	http://dx.doi.org/10.1001/jama.2019.0920			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HN7EL	30835293				2022-12-28	WOS:000460351600003
J	Oliveira, DFM; Ma, YF; Woodruff, TK; Uzzi, B				Oliveira, Diego F. M.; Ma, Yifang; Woodruff, Teresa K.; Uzzi, Brian			Comparison of National Institutes of Health Grant Amounts to First-Time Male and Female Principal Investigators	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							SEX-DIFFERENCES		[Oliveira, Diego F. M.; Ma, Yifang] Northwestern Univ, Northwestern Inst Complex Syst, Evanston, IL USA; [Woodruff, Teresa K.] Northwestern Univ, Feinberg Sch Med, 303 E Super St,Ste 10-121, Chicago, IL 60611 USA; [Uzzi, Brian] Northwestern Univ, Kellogg Sch Management, Evanston, IL USA	Northwestern University; Northwestern University; Feinberg School of Medicine; Northwestern University	Woodruff, TK (corresponding author), Northwestern Univ, Feinberg Sch Med, 303 E Super St,Ste 10-121, Chicago, IL 60611 USA.; Woodruff, TK (corresponding author), Northwestern Univ, Womens Hlth Res Inst, 303 E Super St,Ste 10-121, Chicago, IL 60611 USA.	tkw@northwestern.edu	Ma, Yifang/Y-1265-2019	Ma, Yifang/0000-0003-0326-7993	National Institutes of Health [R01GM112938]; National Science Foundation [1747631]; Northwestern Institution on Complex Systems; Kellogg School of Management; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112938] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Northwestern Institution on Complex Systems; Kellogg School of Management; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study is based on work supported by grant R01GM112938 from the National Institutes of Health, grant 1747631 from the National Science Foundation, and funding from the Northwestern Institution on Complex Systems and the Kellogg School of Management.	Association of American Medical Colleges, TABL B 11 TOT MD PHD; Duch J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051332; Etzkowitz H, 2000, ATHENA UNBOUND ADVAN, DOI [10.1017/CB09780511541414, DOI 10.1017/CB09780511541414]; Jagsi R, 2009, ANN INTERN MED, V151, P804, DOI 10.7326/0003-4819-151-11-200912010-00009; Sege R, 2015, JAMA-J AM MED ASSOC, V314, P1175, DOI 10.1001/jama.2015.8517; Wuchty S, 2007, SCIENCE, V316, P1036, DOI 10.1126/science.1136099	6	109	109	1	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 5	2019	321	9					898	900		10.1001/jama.2018.21944	http://dx.doi.org/10.1001/jama.2018.21944			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HN7EL	30835300	Green Published, Bronze			2022-12-28	WOS:000460351600022
J	Wise, J				Wise, Jacqui			The BMJ Awards 2019: Care of the Older Person Team of the Year	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material															Dunhill Medical Trust	Dunhill Medical Trust(Dunhill Medical Trust)	The Care of the Older Person Team of the Year award is sponsored by the Dunhill Medical Trust. The winners will be announced at the awards ceremony on 24 April 2019 at the Park Plaza Hotel, Westminster. To find out more go to thebmjawards. bmj.com		0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 5	2019	364								l989	10.1136/bmj.l989	http://dx.doi.org/10.1136/bmj.l989			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HO6SS	30837240				2022-12-28	WOS:000461062200009
J	Watanabe, S; Hirabayashi, M; Hirata, N; Hirata, N; Noguchi, R; Shimaki, Y; Ikeda, H; Tatsumi, E; Yoshikawa, M; Kikuchi, S; Yabuta, H; Nakamura, T; Tachibana, S; Ishihara, Y; Morota, T; Kitazato, K; Sakatani, N; Matsumoto, K; Wada, K; Senshu, H; Honda, C; Michikami, T; Takeuchi, H; Kouyama, T; Honda, R; Kameda, S; Fuse, T; Miyamoto, H; Komatsu, G; Sugita, S; Okada, T; Namiki, N; Arakawa, M; Ishiguro, M; Abe, M; Gaskell, R; Palmer, E; Barnouin, OS; Michel, P; French, AS; McMahon, JW; Scheeres, DJ; Abell, PA; Yamamoto, Y; Tanaka, S; Shirai, K; Matsuoka, M; Yamada, M; Yokota, Y; Suzuki, H; Yoshioka, K; Cho, Y; Tanaka, S; Nishikawa, N; Sugiyama, T; Kikuchi, H; Hemmi, R; Yamaguchi, T; Ogawa, N; Ono, G; Mimasu, Y; Yoshikawa, K; Takahashi, T; Takei, Y; Fujii, A; Hirose, C; Iwata, T; Hayakawa, M; Hosoda, S; Mori, O; Sawada, H; Shimada, T; Soldini, S; Yano, H; Tsukizaki, R; Ozaki, M; Iijima, Y; Ogawa, K; Fujimoto, M; Ho, TM; Moussi, A; Jaumann, R; Bibring, JP; Krause, C; Terui, F; Saiki, T; Nakazawa, S; Tsuda, Y				Watanabe, S.; Hirabayashi, M.; Hirata, N.; Hirata, Na.; Noguchi, R.; Shimaki, Y.; Ikeda, H.; Tatsumi, E.; Yoshikawa, M.; Kikuchi, S.; Yabuta, H.; Nakamura, T.; Tachibana, S.; Ishihara, Y.; Morota, T.; Kitazato, K.; Sakatani, N.; Matsumoto, K.; Wada, K.; Senshu, H.; Honda, C.; Michikami, T.; Takeuchi, H.; Kouyama, T.; Honda, R.; Kameda, S.; Fuse, T.; Miyamoto, H.; Komatsu, G.; Sugita, S.; Okada, T.; Namiki, N.; Arakawa, M.; Ishiguro, M.; Abe, M.; Gaskell, R.; Palmer, E.; Barnouin, O. S.; Michel, P.; French, A. S.; McMahon, J. W.; Scheeres, D. J.; Abell, P. A.; Yamamoto, Y.; Tanaka, S.; Shirai, K.; Matsuoka, M.; Yamada, M.; Yokota, Y.; Suzuki, H.; Yoshioka, K.; Cho, Y.; Tanaka, S.; Nishikawa, N.; Sugiyama, T.; Kikuchi, H.; Hemmi, R.; Yamaguchi, T.; Ogawa, N.; Ono, G.; Mimasu, Y.; Yoshikawa, K.; Takahashi, T.; Takei, Y.; Fujii, A.; Hirose, C.; Iwata, T.; Hayakawa, M.; Hosoda, S.; Mori, O.; Sawada, H.; Shimada, T.; Soldini, S.; Yano, H.; Tsukizaki, R.; Ozaki, M.; Iijima, Y.; Ogawa, K.; Fujimoto, M.; Ho, T. -M.; Moussi, A.; Jaumann, R.; Bibring, J. -P.; Krause, C.; Terui, F.; Saiki, T.; Nakazawa, S.; Tsuda, Y.			Hayabusa2 arrives at the carbonaceous asteroid 162173 Ryugu-A spinning top-shaped rubble pile	SCIENCE			English	Article							SURFACE; SAMPLES; CAMERA; CALIBRATION; ITOKAWA; MISSION; ONBOARD; ORIGIN; RADAR; ONC	The Hayabusa2 spacecraft arrived at the near-Earth carbonaceous asteroid 162173 Ryugu in 2018. We present Hayabusa2 observations of Ryugu's shape, mass, and geomorphology. Ryugu has an oblate "spinning top" shape, with a prominent circular equatorial ridge. Its bulk density, 1.19 +/- 0.02 grams per cubic centimeter, indicates a high-porosity (> 50%) interior. Large surface boulders suggest a rubble-pile structure. Surface slope analysis shows Ryugu's shape may have been produced from having once spun at twice the current rate. Coupled with the observed global material homogeneity, this suggests that Ryugu was reshaped by centrifugally induced deformation during a period of rapid rotation. From these remote-sensing investigations, we identified a suitable sample collection site on the equatorial ridge.	[Watanabe, S.; Morota, T.] Nagoya Univ, Nagoya, Aichi 4648601, Japan; [Watanabe, S.; Noguchi, R.; Shimaki, Y.; Yoshikawa, M.; Kikuchi, S.; Tachibana, S.; Ishihara, Y.; Sakatani, N.; Takeuchi, H.; Okada, T.; Abe, M.; Yamamoto, Y.; Tanaka, S.; Shirai, K.; Matsuoka, M.; Yokota, Y.; Yamaguchi, T.; Ogawa, N.; Mimasu, Y.; Takahashi, T.; Takei, Y.; Fujii, A.; Iwata, T.; Hayakawa, M.; Hosoda, S.; Mori, O.; Sawada, H.; Shimada, T.; Soldini, S.; Yano, H.; Tsukizaki, R.; Ozaki, M.; Iijima, Y.; Fujimoto, M.; Terui, F.; Saiki, T.; Nakazawa, S.; Tsuda, Y.] Japan Aerosp Explorat Agcy JAXA, ISAS, Sagamihara, Kanagawa 2525210, Japan; [Hirabayashi, M.] Auburn Univ, Auburn, AL 36849 USA; [Hirata, N.; Kitazato, K.; Honda, C.; Sugiyama, T.] Univ Aizu, Aizu Wakamatsu, Fukushima 9658580, Japan; [Hirata, Na.; Arakawa, M.; Tanaka, S.; Nishikawa, N.; Ogawa, K.] Kobe Univ, Kobe, Hyogo 6578501, Japan; [Ikeda, H.; Ono, G.; Yoshikawa, K.; Hirose, C.] JAXA, Res & Dev Directorate, Sagamihara, Kanagawa 2525210, Japan; [Tatsumi, E.; Tachibana, S.; Miyamoto, H.; Sugita, S.; Okada, T.; Yoshioka, K.; Cho, Y.; Kikuchi, H.; Hemmi, R.] Univ Tokyo, Tokyo 1130033, Japan; [Yoshikawa, M.; Matsumoto, K.; Takeuchi, H.; Namiki, N.; Abe, M.; Yamamoto, Y.; Tanaka, S.; Iwata, T.; Yano, H.; Ozaki, M.; Tsuda, Y.] Grad Univ Adv Studies, SOKENDAI, Hayama 2400193, Japan; [Yabuta, H.] Hiroshima Univ, Higashihiroshima 7398526, Japan; [Nakamura, T.] Tohoku Univ, Sendai, Miyagi 9808578, Japan; [Matsumoto, K.; Namiki, N.] Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan; [Wada, K.; Senshu, H.; Komatsu, G.; Yamada, M.] Chiba Inst Technol, Narashino, Chiba 2750016, Japan; [Michikami, T.] Kindai Univ, Higashihiroshima 7392116, Japan; [Kouyama, T.] Natl Inst Adv Ind Sci & Technol, Tokyo 1350064, Japan; [Honda, R.; Yokota, Y.] Kochi Univ, Kochi 7808520, Japan; [Kameda, S.] Rikkyo Univ, Tokyo 1718501, Japan; [Fuse, T.] Natl Inst Informat & Commun Technol, Kashima 3148501, Japan; [Komatsu, G.] Univ Annunzio, I-65127 Pescara, Italy; [Ishiguro, M.] Seoul Natl Univ, Seoul 08826, South Korea; [Gaskell, R.; Palmer, E.] Planetary Sci Inst, Tucson, AZ 85710 USA; [Barnouin, O. S.] Johns Hopkins Univ, Appl Phys Lab, Johns Hopkins Rd, Laurel, MD 20707 USA; [Michel, P.] Univ Cote Azur, Observ Cote Azur, CNRS, Lab Lagrange, F-06304 Nice, France; [French, A. S.; McMahon, J. W.; Scheeres, D. J.] Univ Colorado, Boulder, CO 80309 USA; [Abell, P. A.] NASA, Johnson Space Ctr, Houston, TX 77058 USA; [Suzuki, H.] Meiji Univ, Kawasaki, Kanagawa 2148571, Japan; [Ho, T. -M.] DLR German Aerosp Ctr, Inst Space Syst, D-28359 Bremen, Germany; [Moussi, A.] CNES, F-31401 Toulouse, France; [Jaumann, R.] Inst Planetary Res, DLR, D-12489 Berlin, Germany; [Bibring, J. -P.] Inst Astrophys Spatiale, F-91405 Orsay, France; [Krause, C.] Micrograv User Support Ctr, DLR, D-51147 Cologne, Germany; [Ishihara, Y.] Natl Inst Environm Studies, Tsukuba, Ibaraki 3058506, Japan; [Yamaguchi, T.] Mitsubishi Electr Corp, Kamakura, Kanagawa 2478520, Japan	Nagoya University; Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); Auburn University System; Auburn University; University of Aizu; Kobe University; Japan Aerospace Exploration Agency (JAXA); University of Tokyo; Graduate University for Advanced Studies - Japan; Hiroshima University; Tohoku University; National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); Chiba Institute of Technology; Kindai University (Kinki University); National Institute of Advanced Industrial Science & Technology (AIST); Kochi University; Rikkyo University; National Institute of Information & Communications Technology (NICT) - Japan; G d'Annunzio University of Chieti-Pescara; Seoul National University (SNU); Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Observatoire de la Cote d'Azur; University of Colorado System; University of Colorado Boulder; National Aeronautics & Space Administration (NASA); Meiji University; Helmholtz Association; German Aerospace Centre (DLR); Helmholtz Association; German Aerospace Centre (DLR); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; Helmholtz Association; German Aerospace Centre (DLR); National Institute for Environmental Studies - Japan; Mitsubishi Electric Corporation	Watanabe, S (corresponding author), Nagoya Univ, Nagoya, Aichi 4648601, Japan.; Watanabe, S (corresponding author), Japan Aerosp Explorat Agcy JAXA, ISAS, Sagamihara, Kanagawa 2525210, Japan.	seicoro@eps.nagoya-u.ac.jp	Noguchi, R/AAJ-7141-2020; Matsumoto, Koji/AAF-7825-2021; Hemmi, Ryodo/AAU-1566-2020; Ishihara, Yoshiaki/A-8499-2011; Noguchi, Rina/HCH-0362-2022; Barnouin, Olivier S/I-7475-2015; Miyamoto, Hideaki/B-9666-2008; Sugita, Seiji/GQI-1142-2022; Komatsu, Goro/I-7822-2012; Tachibana, Shogo/R-7884-2018; Kouyama, Toru/B-1155-2017	Noguchi, R/0000-0001-8281-2448; Matsumoto, Koji/0000-0003-4319-1970; Hemmi, Ryodo/0000-0002-9638-6926; Noguchi, Rina/0000-0001-8281-2448; Barnouin, Olivier S/0000-0002-3578-7750; Miyamoto, Hideaki/0000-0001-8013-6124; Sugita, Seiji/0000-0001-6076-3614; Komatsu, Goro/0000-0003-4155-108X; Matsuoka, Moe/0000-0003-1091-3041; Takeuchi, Hiroshi/0000-0001-5863-4653; Hirata, Naru/0000-0002-2435-604X; Kikuchi, Hiroshi/0000-0003-0067-4606; Tachibana, Shogo/0000-0002-4603-9440; Soldini, Stefania/0000-0003-3121-3845; Kouyama, Toru/0000-0002-1060-3986; Tatsumi, Eri/0000-0002-6142-9842; Yamamoto, Yukio/0000-0001-7172-1911; Shimaki, Yuri/0000-0001-8966-7650	KAKENHI from the Japan Society for the Promotion of Science (JSPS) [JP17H06459, JP17K05639, JP16H04059, JP17KK0097, JP26287108, JP16H04044]; JSPS Core-to-Core program "International Network of Planetary Sciences"; National Institutes of Natural Sciences [AB302006]; NASA New Frontier Program [NNM10AA11C]; French space agency CNES	KAKENHI from the Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS Core-to-Core program "International Network of Planetary Sciences"; National Institutes of Natural Sciences; NASA New Frontier Program; French space agency CNES(Centre National D'etudes Spatiales)	This study was supported by KAKENHI from the Japan Society for the Promotion of Science (JSPS) (grants JP17H06459, JP17K05639, JP16H04059, JP17KK0097, JP26287108, JP16H04044, and JP16H04044), the JSPS Core-to-Core program "International Network of Planetary Sciences", and the National Institutes of Natural Sciences (AB302006). O.S.B. acknowledges funding support from NASA New Frontier Program (NNM10AA11C). P.M. acknowledges funding support from the French space agency CNES.	Alexander CMO, 2012, SCIENCE, V337, P721, DOI 10.1126/science.1223474; Bibring JP, 2017, SPACE SCI REV, V208, P401, DOI 10.1007/s11214-017-0335-y; Boggs DH, 2014, 42196 IPN; Busch MW, 2008, ICARUS, V195, P614, DOI 10.1016/j.icarus.2008.01.020; Busch MW, 2007, ICARUS, V190, P608, DOI 10.1016/j.icarus.2007.03.032; Busch MW, 2011, ICARUS, V212, P649, DOI 10.1016/j.icarus.2011.01.013; Chandrasekhar S., 1969, Ellipsoidal figures of equilibrium; Consolmagno GJ, 2013, PLANET SPACE SCI, V87, P146, DOI 10.1016/j.pss.2013.07.009; Fujiwara A, 2006, SCIENCE, V312, P1330, DOI 10.1126/science.1125841; Gaskell RW, 2008, METEORIT PLANET SCI, V43, P1049, DOI 10.1111/j.1945-5100.2008.tb00692.x; Giorgini J.D, 2019, NASA JPL HORIZONS ON; HAMILTON DP, 1992, ICARUS, V96, P43, DOI 10.1016/0019-1035(92)90005-R; HAPKE B, 1986, ICARUS, V67, P264, DOI 10.1016/0019-1035(86)90108-9; Hirabayashi M, 2019, ICARUS, V317, P354, DOI 10.1016/j.icarus.2018.08.003; Hirabayashi M, 2015, ASTROPHYS J, V808, DOI 10.1088/0004-637X/808/1/63; Hirabayashi M, 2015, ASTROPHYS J LETT, V798, DOI 10.1088/2041-8205/798/1/L8; Ishiguro M, 2014, ASTROPHYS J, V792, DOI 10.1088/0004-637X/792/1/74; Jaumann R, 2017, SPACE SCI REV, V208, P375, DOI 10.1007/s11214-016-0263-2; Kahn E. G., 2011, P LUNAR PLANET SCI C, V43; Kameda S, 2017, SPACE SCI REV, V208, P17, DOI 10.1007/s11214-015-0227-y; Kitazato K, 2019, SCIENCE, V364, P272, DOI 10.1126/science.aav7432; Kominato T., 2006, P AIAA AAS ASTR SPEC, P6535; Lambe T.W., 1969, SOIL MECH; Lambe T.W., 1969, SOIL MECH; Lauretta DS, 2017, SPACE SCI REV, V212, P925, DOI 10.1007/s11214-017-0405-1; Macke RJ, 2011, METEORIT PLANET SCI, V46, P1842, DOI 10.1111/j.1945-5100.2011.01298.x; MARSDEN BG, 1973, ASTRON J, V78, P211, DOI 10.1086/111402; MCEWEN AS, 1991, ICARUS, V92, P298, DOI 10.1016/0019-1035(91)90053-V; Michel P, 2001, SCIENCE, V294, P1696, DOI 10.1126/science.1065189; Michikami T, 2008, EARTH PLANETS SPACE, V60, P13, DOI 10.1186/BF03352757; MIGNARD F, 1982, ICARUS, V49, P347, DOI 10.1016/0019-1035(82)90041-0; Mizuno T, 2017, SPACE SCI REV, V208, P33, DOI 10.1007/s11214-015-0231-2; Morita H., 2006, AIAA AAS ASTR SPEC C; Muller TG, 2017, ASTRON ASTROPHYS, V598, DOI 10.1051/0004-6361/201629584; Nolan MC, 2013, ICARUS, V226, P629, DOI 10.1016/j.icarus.2013.05.028; Okada T, 2017, SPACE SCI REV, V208, P255, DOI 10.1007/s11214-016-0286-8; Ostro SJ, 2006, SCIENCE, V314, P1276, DOI 10.1126/science.1133622; Sakatani N, 2018, ICARUS, V309, P13, DOI 10.1016/j.icarus.2018.02.027; Sanchez P, 2016, ICARUS, V271, P453, DOI 10.1016/j.icarus.2016.01.016; Scheeres DJ, 2016, ICARUS, V276, P116, DOI 10.1016/j.icarus.2016.04.013; Scheeres DJ, 2015, ICARUS, V247, P1, DOI 10.1016/j.icarus.2014.09.017; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Si H, 2015, ACM T MATH SOFTWARE, V41, DOI 10.1145/2629697; Sugita S, 2019, SCIENCE, V364, P252, DOI 10.1126/science.aaw0422; Szeliski R., 2010, COMPUTER VISION ALGO, DOI DOI 10.1007/978-3-030-34372-9; Tachibana S, 2014, GEOCHEM J, V48, P571, DOI 10.2343/geochemj.2.0350; Tatsumi E, 2019, ICARUS, V325, P153, DOI 10.1016/j.icarus.2019.01.015; Terui F, 2016, ADV ASTRONAUT SCI, V157, P667; Tsuchiyama A, 2011, SCIENCE, V333, P1125, DOI 10.1126/science.1207807; Tsuda Y, 2013, ACTA ASTRONAUT, V91, P356, DOI 10.1016/j.actaastro.2013.06.028; Vernazza P, 2015, ASTROPHYS J, V806, DOI 10.1088/0004-637X/806/2/204; Wada K, 2018, PROG EARTH PLANET SC, V5, DOI 10.1186/s40645-018-0237-y; Walsh KJ, 2008, NATURE, V454, P188, DOI 10.1038/nature07078; Walsh KJ, 2018, ANNU REV ASTRON ASTR, V56, P593, DOI 10.1146/annurev-astro-081817-052013; Watanabe S, 2017, SPACE SCI REV, V208, P3, DOI 10.1007/s11214-017-0377-1; Werner RA, 1996, CELEST MECH DYN ASTR, V65, P313; Zhang Y, 2018, ASTROPHYS J, V857, DOI 10.3847/1538-4357/aab5b2	58	268	280	43	99	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2019	364	6437					268	+		10.1126/science.aav8032	http://dx.doi.org/10.1126/science.aav8032			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HU0JG	30890588				2022-12-28	WOS:000464956600046
J	Nunn, AJ; Phillips, PPJ; Meredith, SK; Chiang, CY; Conradie, F; Dalai, D; van Deun, A; Dat, PT; Lan, N; Master, I; Mebrahtu, T; Meressa, D; Moodliar, R; Ngubane, N; Sanders, K; Squire, SB; Torrea, G; Tsogt, B; Rusen, ID				Nunn, Andrew J.; Phillips, Patrick P. J.; Meredith, Sarah K.; Chiang, Chen-Yuan; Conradie, Francesca; Dalai, Doljinsuren; van Deun, Armand; Phan-Thuong Dat; Ngoc Lan; Master, Iqbal; Mebrahtu, Tesfamarium; Meressa, Daniel; Moodliar, Ronelle; Ngubane, Nosipho; Sanders, Karen; Squire, Stephen Bertel; Torrea, Gabriela; Tsogt, Bazarragchaa; Rusen, I. D.		STREAM Study Collaborators	A Trial of a Shorter Regimen for Rifampin-Resistant Tuberculosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article								BACKGROUND Cohort studies in Bangladesh showed promising cure rates among patients with multidrug-resistant tuberculosis who received existing drugs in regimens shorter than that recommended by the World Health Organization (WHO) in 2011. METHODS We conducted a phase 3 noninferiority trial in participants with rifampin-resistant tuberculosis that was susceptible to fluoroquinolones and aminoglycosides. Participants were randomly assigned, in a 2:1 ratio, to receive a short regimen (9 to 11 months) that included high-dose moxifloxacin or a long regimen (20 months) that followed the 2011 WHO guidelines. The primary efficacy outcome was a favorable status at 132 weeks, defined by cultures negative for Mycobacterium tuberculosis at 132 weeks and at a previous occasion, with no intervening positive culture or previous unfavorable outcome. An upper 95% confidence limit for the between-group difference in favorable status that was 10 percentage points or less was used to determine noninferiority. RESULTS Of 424 participants who underwent randomization, 383 were included in the modified intention-to-treat population. Favorable status was reported in 79.8% of participants in the long-regimen group and in 78.8% of those in the short-regimen group - a difference, with adjustment for human immunodeficiency virus status, of 1.0 percentage point (95% confidence interval [CI], -7.5 to 9.5) (P=0.02 for noninferiority). The results with respect to noninferiority were consistent among the 321 participants in the per-protocol population (adjusted difference, -0.7 percentage points; 95% CI, -10.5 to 9.1). An adverse event of grade 3 or higher occurred in 45.4% of participants in the long-regimen group and in 48.2% in the short-regimen group. Prolongation of either the QT interval or the corrected QT interval (calculated with Fridericia's formula) to 500 msec occurred in 11.0% of participants in the short-regimen group, as compared with 6.4% in the long-regimen group (P=0.14); because of the greater incidence in the short-regimen group, participants were closely monitored and some received medication adjustments. Death occurred in 8.5% of participants in the short-regimen group and in 6.4%in the long-regimen group, and acquired resistance to fluoroquinolones or aminoglycosides occurred in 3.3% and 2.3%, respectively. CONCLUSIONS In persons with rifampin-resistant tuberculosis that was susceptible to fluoroquinolones and aminoglycosides, a short regimen was noninferior to a long regimen with respect to the primary efficacy outcome and was similar to the long regimen in terms of safety.	[Nunn, Andrew J.; Phillips, Patrick P. J.; Meredith, Sarah K.; Sanders, Karen] UCL, MRC, Clin Trials Unit, London, England; [Squire, Stephen Bertel] Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England; [Chiang, Chen-Yuan; van Deun, Armand; Rusen, I. D.] The Union, Int Union TB & Lung Dis, Paris, France; [Chiang, Chen-Yuan] Wanfang Hosp, Dept Internal Med, Taipei, Taiwan; [Chiang, Chen-Yuan] Taipei Med Univ, Sch Med, Taipei, Taiwan; [Conradie, Francesca] Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa; [Master, Iqbal; Ngubane, Nosipho] King Dinizulu Hosp Complex, Kwa Zulu, South Africa; [Moodliar, Ronelle] Think TB & HIV Invest Network, Durban, South Africa; [Dalai, Doljinsuren] Natl Ctr Communicable Dis, Ulaanbaatar, Mongolia; [Tsogt, Bazarragchaa] Mongolian TB Coalit, Ulaanbaatar, Mongolia; [van Deun, Armand; Torrea, Gabriela] Inst Trop Med, Antwerp, Belgium; [Phan-Thuong Dat; Ngoc Lan] Pham Ngoc Thach Hosp, Ho Chi Minh City, Vietnam; [Mebrahtu, Tesfamarium] Armauer Hansen Res Inst, Addis Ababa, Ethiopia; [Meressa, Daniel] St Peters TB Specialized Hosp, Addis Ababa, Ethiopia; [Meressa, Daniel] Global Hlth Comm, Addis Ababa, Ethiopia; [Rusen, I. D.] Vital Strategies, Div Res & Dev, New York, NY USA; [Rusen, I. D.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada	Medical Research Council Clinical Trials Unit; University of London; University College London; Liverpool School of Tropical Medicine; Taipei Municipal WanFang Hospital; Taipei Medical University; University of Witwatersrand; National Center for Communicable Diseases of Mongolia; Institute of Tropical Medicine (ITM); University of Toronto	Nunn, AJ (corresponding author), UCL, MRC, Clin Trials Unit, Inst Clin Trials & Methodol, 90 High Holborn,2nd Fl, London WC1V 6LJ, England.	a.nunn@ucl.ac.uk	Aseffa, Abraham/J-3248-2016; Ahmed, Saiam/AAE-2755-2021	Aseffa, Abraham/0000-0002-8028-1150; Ahmed, Saiam/0000-0001-7543-5031; Langley, Ivor/0000-0002-9275-6731; Squire, Stephen/0000-0001-7173-9038	U.S. Agency for International Development; MRC [MR/J012513/1, MC_UU_12023/27] Funding Source: UKRI	U.S. Agency for International Development(United States Agency for International Development (USAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funded by the U.S. Agency for International Development and others; Current Controlled Trials number, ISRCTN78372190; ClinicalTrials. gov number, NCT02409290.	Ahmad Khan F, 2017, EUR RESPIR J, V50; [Anonymous], 2018, DR TB CLIN TRIAL PRO; [Anonymous], 2012, GLOB TUB REP 2012; [Anonymous], 2018, WHOCDSTB201815; Aung KJM, 2014, INT J TUBERC LUNG D, V18, P1180, DOI 10.5588/ijtld.14.0100; Brossier F, 2010, J CLIN MICROBIOL, V48, P1683, DOI 10.1128/JCM.01947-09; Burki TK, 2017, LANCET RESP MED, V5, P250, DOI 10.1016/S2213-2600(17)30086-3; Cellamare M, 2017, CLIN TRIALS, V14, P17, DOI 10.1177/1740774516665090; Diacon AH, 2015, AM J RESP CRIT CARE, V191, P943, DOI 10.1164/rccm.201410-1801OC; Florian JA, 2011, J CLIN PHARMACOL, V51, P1152, DOI 10.1177/0091270010381498; Joy JP, 2011, CLIN PHARMACOL THER, V90, P243, DOI 10.1038/clpt.2011.107; Kuaban C, 2015, INT J TUBERC LUNG D, V19, P517, DOI 10.5588/ijtld.14.0535; Laptook AR, 2017, JAMA-J AM MED ASSOC, V318, P1550, DOI 10.1001/jama.2017.14972; Mohamed K, 2011, PHARM STAT, V10, P461, DOI 10.1002/pst.520; Moodley R, 2016, EUR RESPIR REV, V25, DOI 10.1183/16000617.0080-2015; *NAT I ALL INF DIS, 1992, DIV AIDS TABL GRAD S; Nunn AJ, 2017, 48 UN WORLD C LUNG H; Nunn AJ, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-353; Piubello A, 2014, INT J TUBERC LUNG D, V18, P1188, DOI 10.5588/ijtld.13.0075; STOP TB Department, 2011, GUID PROGR MAN DRUG; Van Deun A, 2010, AM J RESP CRIT CARE, V182, P684, DOI 10.1164/rccm.201001-0077OC; WHO, 2017, GLOB TUB REP 2017	22	183	198	2	33	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 28	2019	380	13					1201	1213		10.1056/NEJMoa1811867	http://dx.doi.org/10.1056/NEJMoa1811867			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HR6HX	30865791	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000463251600005
J	Iacobucci, G				Iacobucci, Gareth			GP suicides: LMCs call for action to reduce "appalling" numbers	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Burnett A, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1878	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 20	2019	364								l1286	10.1136/bmj.l1286	http://dx.doi.org/10.1136/bmj.l1286			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HQ8AJ	30894348				2022-12-28	WOS:000462645500013
J	Bromham, N; Dworzynski, K; Eunson, P; Fairhurst, C; Ani, O; Berendse, S; Bromham, N; Hawkins, J; Marcano-Belisario, J; Marceniuk, G; O'Brien, F; Pandey, A; Pelone, F; Rowland, V; Simons, G				Bromham, Nathan; Dworzynski, Katharina; Eunson, Paul; Fairhurst, Charlie; Ani, Offiong; Berendse, Sabine; Bromham, Nathan; Hawkins, James; Marcano-Belisario, Jose; Marceniuk, Gemma; O'Brien, Fionnuala; Pandey, Anuja; Pelone, Ferruccio; Rowland, Victoria; Simons, Gemma		Guideline Comm	GUIDELINES Cerebral palsy in adults: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							GROSS MOTOR FUNCTION; SYSTEM		[Bromham, Nathan; Dworzynski, Katharina; Fairhurst, Charlie] Natl Guideline Alliance, Royal Coll Obstetricians & Gynaecologists, London NW1 4RG, England; [Eunson, Paul] Royal Hosp Sick Children, Edinburgh EH9 1LF, Midlothian, Scotland; [Fairhurst, Charlie] Evelina London Childrens Hosp, London SE1 7EF, England		Eunson, P (corresponding author), Royal Hosp Sick Children, Edinburgh EH9 1LF, Midlothian, Scotland.				NICE	NICE	NB and KD are employees of the National Guideline Alliance, which is commissioned and funded by NICE to develop clinical guidelines and write this BMJ summary. No authors received special funding from any other source to write this summary.	Benigni I, 2011, CLIN NUTR, V30, P769, DOI 10.1016/j.clnu.2011.06.008; Colver A, 2014, LANCET, V383, P1240, DOI 10.1016/S0140-6736(13)61835-8; McCormick A, 2007, DEV MED CHILD NEUROL, V49, P265, DOI 10.1111/j.1469-8749.2007.00265.x; Mcphee PG, 2018, DEV MED CHILD NEUROL, DOI [10.1111/dmcn.1402830221763, DOI 10.1111/DMCN.1402830221763]; National Institute for Health and Care Excellence, 2019, CER PALS AD; National Institute for Health and Care Excellence, 2012, OST ASS RISK FRAG FR; National Institute for Health and Care Excellence, 2014, OB ID ASS MAN; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; Smith KJ, 2018, JAMA NEUROL; Whitney DG, 2018, BONE, V114, P285, DOI 10.1016/j.bone.2018.07.002	10	9	9	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 19	2019	364								l806	10.1136/bmj.l806	http://dx.doi.org/10.1136/bmj.l806			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HQ7ZZ	30890528				2022-12-28	WOS:000462644400001
J	Christie, B				Christie, Bryan			Group opposed to RCP assisted dying poll lacks transparency, claims report	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		ADF International, 2019, UK DOCT FIL LEG CHAL; [Anonymous], 2019, BMJ, V364, pl207; Dignity in Dying, 2019, EXP ANT NETW TRYING; HURLEY R, 2019, BMJ-BRIT MED J, V364, P23086, DOI DOI 10.1136/BMJ.L559; Smythe C., 2019, TIMES	5	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 19	2019	364								l1278	10.1136/bmj.l1278	http://dx.doi.org/10.1136/bmj.l1278			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HQ7ZZ	30890534				2022-12-28	WOS:000462644400012
J	Jillella, D; Uchino, K				Jillella, Dinesh; Uchino, Ken			Guideline: 8 professional organizations recommend percutaneous closure of patent foramen ovale in selected patients	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Jillella, Dinesh; Uchino, Ken] Cleveland Clin, Cleveland, OH 44106 USA	Cleveland Clinic Foundation	Jillella, D (corresponding author), Cleveland Clin, Cleveland, OH 44106 USA.		Jillella, Dinesh/S-7623-2019; Uchino, Ken/ABC-1611-2021	Jillella, Dinesh/0000-0002-5399-0170; Uchino, Ken/0000-0001-9468-4172				Alexandrov AV, 2012, J NEUROIMAGING, V22, P215, DOI 10.1111/j.1552-6569.2010.00523.x; HAGEN PT, 1984, MAYO CLIN PROC, V59, P17, DOI 10.1016/S0025-6196(12)60336-X	2	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 19	2019	170	6					JC27	JC27		10.7326/ACPJ201903190-027	http://dx.doi.org/10.7326/ACPJ201903190-027			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP1ZR	30884497				2022-12-28	WOS:000461468300004
J	Cook, R; Thomas, V; Martin, R				Cook, Rob; Thomas, Vaughan; Martin, Rosie		NIHR Dissemination Ctr	Negative pressure dressings are no better than standard dressings for open fractures	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material								The study Effect of negative pressure wound therapy vs standard wound management on 12-month disability among adults with severe open fracture of the lower limb: the WOLLF randomised clinical trial. Costa ML, Achten J, Bruce J, et al; UK WOLLF Collaboration Published on 9 October 2018 JAMA 2018;319:2280-8. This project was funded by the National Institute for Health Research Health Technology Assessment Programme ( project number 10/57/20). To read the full NIHR Signal, go to: https://discover.dc.nihr.ac.uk/content/signal-000655/negative-pressure-dressings-are-no-better-than-standard-dressings-for-open-fractures	[Cook, Rob; Martin, Rosie] Bazian, Economist Intelligence Unit Healthcare, London, England; [Thomas, Vaughan] Univ Southampton, Wessex Inst, Southampton, Hants, England	University of Southampton	Cook, R (corresponding author), Bazian, Economist Intelligence Unit Healthcare, London, England.	rob.cook@bazian.com		Cook, Robert/0000-0002-2210-3989				Iheozor-Ejiofor Z, 2018, COCHRANE DB SYST REV, V7; National Institute for Health and Care Excellence, FRACT COMPL ASS MAN; Stannard JP, 2009, J ORTHOP TRAUMA, V23, P552, DOI 10.1097/BOT.0b013e3181a2e2b6	3	4	4	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 13	2019	364								k4411	10.1136/bmj.k4411	http://dx.doi.org/10.1136/bmj.k4411			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP5VW	30867157				2022-12-28	WOS:000461751600019
J	Rubinstein, SM; de Zoete, A; van Middelkoop, M; Assendelft, WJJ; de Boer, MR; van Tulder, MW				Rubinstein, Sidney M.; de Zoete, Annemarie; van Middelkoop, Marienke; Assendelft, Willem J. J.; de Boer, Michiel R.; van Tulder, Maurits W.			Benefits and harms of spinal manipulative therapy for the treatment of chronic low back pain: systematic review and meta-analysis of randomised controlled trials	BMJ-BRITISH MEDICAL JOURNAL			English	Review							FOLLOW-UP OUTCOMES; MANUAL THERAPY; CLINICAL-TRIAL; MEDICAL-CARE; COST-EFFECTIVENESS; TERM EFFECTIVENESS; CHIROPRACTIC CARE; MCKENZIE METHOD; NECK PAIN; PHYSIOTHERAPY	OBJECTIVE To assess the benefits and harms of spinal manipulative therapy (SMT) for the treatment of chronic low back pain. DESIGN Systematic review and meta-analysis of randomised controlled trials. DATA SOURCES Medline, PubMed, Embase, Cochrane Central Register of Controlled Trials (CENTRAL), CINAHL, Physiotherapy Evidence Database (PEDro), Index to Chiropractic Literature, and trial registries up to 4 May 2018, including reference lists of eligible trials and related reviews. ELIGIBILITY CRITERIA FOR SELECTING STUDIES Randomised controlled trials examining the effect of spinal manipulation or mobilisation in adults (>= 18 years) with chronic low back pain with or without referred pain. Studies that exclusively examined sciatica were excluded, as was grey literature. No restrictions were applied to language or setting. REVIEW METHODS Two reviewers independently selected studies, extracted data, and assessed risk of bias and quality of the evidence. The effect of SMT was compared with recommended therapies, non-recommended therapies, sham (placebo) SMT, and SMT as an adjuvant therapy. Main outcomes were pain and back specific functional status, examined as mean differences and standardised mean differences (SMD), respectively. Outcomes were examined at 1, 6, and 12 months. Quality of evidence was assessed using GRADE. A random effects model was used and statistical heterogeneity explored. RESULTS 47 randomised controlled trials including a total of 9211 participants were identified, who were on average middle aged (35-60 years). Most trials compared SMT with recommended therapies. Moderate quality evidence suggested that SMT has similar effects to other recommended therapies for short term pain relief (mean difference -3.17, 95% confidence interval -7.85 to 1.51) and a small, clinically better improvement in function (SMD -0.25, 95% confidence interval -0.41 to -0.09). High quality evidence suggested that compared with non-recommended therapies SMT results in small, not clinically better effects for short term pain relief (mean difference -7.48, -11.50 to -3.47) and small to moderate clinically better improvement in function (SMD -0.41, -0.67 to -0.15). In general, these results were similar for the intermediate and long term outcomes as were the effects of SMT as an adjuvant therapy. Evidence for sham SMT was low to very low quality; therefore these effects should be considered uncertain. Statistical heterogeneity could not be explained. About half of the studies examined adverse and serious adverse events, but in most of these it was unclear how and whether these events were registered systematically. Most of the observed adverse events were musculoskeletal related, transient in nature, and of mild to moderate severity. One study with a low risk of selection bias and powered to examine risk (n=183) found no increased risk of an adverse event (relative risk 1.24, 95% confidence interval 0.85 to 1.81) or duration of the event (1.13, 0.59 to 2.18) compared with sham SMT. In one study, the Data Safety Monitoring Board judged one serious adverse event to be possibly related to SMT. CONCLUSION SMT produces similar effects to recommended therapies for chronic low back pain, whereas SMT seems to be better than non-recommended interventions for improvement in function in the short term. Clinicians should inform their patients of the potential risks of adverse events associated with SMT.	[Rubinstein, Sidney M.; de Zoete, Annemarie; de Boer, Michiel R.; van Tulder, Maurits W.] Vrije Univ Amsterdam, Fac Sci, Dept Hlth Sci, Boelelaan 1085, NL-1081 HV Amsterdam, Netherlands; [van Middelkoop, Marienke] Erasmus MC, Dept Gen Practice, Rotterdam, Netherlands; [Assendelft, Willem J. J.] Radboud Univ Nijmegen, Med Ctr, Dept Primary & Community Care, Nijmegen, Netherlands; [van Tulder, Maurits W.] Aarhus Univ Hosp, Dept Physiotherapy & Occupat Therapy, Aarhus, Denmark	Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus MC; Radboud University Nijmegen; Aarhus University	Rubinstein, SM (corresponding author), Vrije Univ Amsterdam, Fac Sci, Dept Hlth Sci, Boelelaan 1085, NL-1081 HV Amsterdam, Netherlands.	s.m.rubinstein@vu.nl	van Tulder, Maurits/AAB-9785-2022; de Zoete, Annemarie/J-3865-2014; Assendelft, W.J.J./H-8008-2014	van Tulder, Maurits/0000-0002-7589-8471; Assendelft, W.J.J./0000-0002-2966-3778; Rubinstein, Sidney/0000-0002-4819-994X; van Middelkoop, Marienke/0000-0001-6926-0618; de Zoete, Annemarie/0000-0002-1421-3862; de Boer, Michiel/0000-0001-9240-0199				Airaksinen O, 2006, EUR SPINE J, V15, pS192, DOI 10.1007/s00586-006-1072-1; Andronis L, 2017, APPL HEALTH ECON HEA, V15, P173, DOI 10.1007/s40258-016-0268-8; Balthazard P, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-162; Bialosky JE, 2014, J PAIN, V15, P136, DOI 10.1016/j.jpain.2013.10.005; Bialosky JE, 2009, PHYS THERAPY, V89, P1292, DOI 10.2522/ptj.20090058; Bialosky JE, 2009, MANUAL THER, V14, P531, DOI 10.1016/j.math.2008.09.001; Bons SCS, 2017, NHG GUIDELINE ASPECI; Bronfort G, 1996, J Manipulative Physiol Ther, V19, P570; Bronfort G, 2011, SPINE J, V11, P585, DOI 10.1016/j.spinee.2011.01.036; Cecchi F, 2010, CLIN REHABIL, V24, P26, DOI 10.1177/0269215509342328; Chou R, 2016, AHRQ COMP EFFECTIVEN; Chown M, 2008, PHYSIOTHERAPY, V94, P21, DOI 10.1016/j.physio.2007.04.014; Cohen J., 1988, STAT POWER ANAL BEHA, V2, P1, DOI DOI 10.4324/9780203771587; Cook C, 2013, MANUAL THER, V18, P191, DOI 10.1016/j.math.2012.08.005; Coronado RA, 2012, J ELECTROMYOGR KINES, V22, P752, DOI 10.1016/j.jelekin.2011.12.013; Currie SJ, 2016, J MANIP PHYSIOL THER, V39, P288, DOI 10.1016/j.jmpt.2016.02.011; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dima A, 2013, BRIT J GEN PRACT, V63, pE490, DOI 10.3399/bjgp13X669211; Dorron SL, 2016, CHIROPR MAN THER, V24, DOI 10.1186/s12998-016-0128-5; Dougherty PE, 2014, CHIROPR MAN THER, V22, DOI 10.1186/s12998-014-0041-8; EVANS DP, 1978, RHEUMATOL REHABIL, V17, P46, DOI 10.1093/rheumatology/17.1.46; Ferreira ML, 2007, PAIN, V131, P31, DOI 10.1016/j.pain.2006.12.008; Foster NE, PREVENTION TREATMENT; Franke H, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-286; Fryer G, 2017, INT J OSTEOPATH MED, V25, P30, DOI 10.1016/j.ijosm.2017.05.002; Furlan AD, 2009, SPINE, V34, P1929, DOI 10.1097/BRS.0b013e3181b1c99f; Ghroubi S., 2007, Annales de Readaptation et de Medecine Physique, V50, P570, DOI 10.1016/j.annrmp.2007.02.012; GIBSON T, 1985, LANCET, V1, P1258; GILBERT JR, 1985, BRIT MED J, V291, P791, DOI 10.1136/bmj.291.6498.791; Goldby LJ, 2006, SPINE, V31, P1083, DOI 10.1097/01.brs.0000216464.37504.64; Gudavalli MR, 2006, EUR SPINE J, V15, P1070, DOI 10.1007/s00586-005-0021-8; Haas M, 2014, SPINE J, V14, P1106, DOI 10.1016/j.spinee.2013.07.468; Hebert JJ, 2015, J MANIP PHYSIOL THER, V38, P677, DOI 10.1016/j.jmpt.2013.05.009; Hemmila HM, 2002, J MANIP PHYSIOL THER, V25, P99, DOI 10.1067/mmt.2002.122329; Hidalgo B, 2015, J MANIP PHYSIOL THER, V38, P365, DOI 10.1016/j.jmpt.2015.06.013; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Hondras MA, 2009, J MANIP PHYSIOL THER, V32, P330, DOI 10.1016/j.jmpt.2009.04.012; Hsieh CYJ, 2002, SPINE, V27, P1142, DOI 10.1097/00007632-200206010-00003; Hurwitz EL, 2002, SPINE, V27, P2193, DOI 10.1097/00007632-200210150-00002; Hurwitz EL, 2006, SPINE, V31, P611, DOI 10.1097/01.brs.0000202559.41193.b2; IntHout J, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010247; Koes BW, 2010, EUR SPINE J, V19, P2075, DOI 10.1007/s00586-010-1502-y; KOES BW, 1992, SPINE, V17, P28, DOI 10.1097/00007632-199201000-00005; Krekoukias G, 2017, J MAN MANIP THER, V25, P66, DOI 10.1080/10669817.2016.1184435; Licciardone JC, 2003, SPINE, V28, P1355, DOI 10.1097/00007632-200307010-00002; Licciardone JC, 2013, ANN FAM MED, V11, P122, DOI 10.1370/afm.1468; Manca A, 2004, BMJ-BRIT MED J, V329, P1381, DOI 10.1136/bmj.38282.607859.AE; Castro-Sanchez AM, 2016, SPINE J, V16, P302, DOI 10.1016/j.spinee.2015.08.057; Michaleff ZA, 2012, J ELECTROMYOGR KINES, V22, P655, DOI 10.1016/j.jelekin.2012.02.011; Mohseni-Bandpei MA, 2006, PHYSIOTHERAPY, V92, P34, DOI 10.1016/j.physio.2005.05.005; Muller R, 2005, J MANIP PHYSIOL THER, V28, P3, DOI 10.1016/j.jmpt.2004.12.004; NICE guideline, 2016, LOW BACK PAIN SCI 16; Niemisto L, 2005, SPINE, V30, P1109, DOI 10.1097/01.brs.0000162569.00685.7b; Paatelma M, 2008, J REHABIL MED, V40, P858, DOI 10.2340/16501977-0262; Petersen T, 2011, SPINE, V36, P1999, DOI 10.1097/BRS.0b013e318201ee8e; POPE MH, 1994, SPINE, V19, P2571, DOI 10.1097/00007632-199411001-00013; Postacchini F, 1988, NEURO-ORTHOPEDICS, V6, P28; Qaseem A, 2017, ANN INTERN MED, V166, P514, DOI 10.7326/M16-2367; Randoll C, 2017, NEUROSCIENCE, V349, P220, DOI 10.1016/j.neuroscience.2017.03.006; Rasmussen J, 2008, JOINT BONE SPINE, V75, P708, DOI 10.1016/j.jbspin.2007.12.011; Rasmussen-Barr E, 2003, MANUAL THER, V8, P233, DOI 10.1016/S1356-689X(03)00053-5; Rubinstein SM, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008112.pub2; Rubinstein SM, 2014, J MANIP PHYSIOL THER, V37, P523, DOI 10.1016/j.jmpt.2014.07.007; Ruddock JK, 2016, J CHIROPR MED, V15, P165, DOI 10.1016/j.jcm.2016.04.014; Samir SM, 2016, INT J PHARMTECH RES, V9, P92; Sandoz R, 1969, ANN SWISS CHIRO ASS, V4, P47; Sarker KK, 2017, INT J PHARM BIO SCI, V7, P992; Savovic J, 2018, AM J EPIDEMIOL, V187, P1113, DOI 10.1093/aje/kwx344; Senna MK, 2011, SPINE, V36, P1427, DOI 10.1097/BRS.0b013e3181f5dfe0; Skillgate E, 2007, CLIN J PAIN, V23, P431, DOI 10.1097/AJP.0b013e31805593d8; Stochkendahl MJ, 2018, EUR SPINE J, V27, P60, DOI 10.1007/s00586-017-5099-2; Swait G, 2017, CHIROPR MAN THER, V25, DOI 10.1186/s12998-017-0168-5; Ulger O, 2017, J BACK MUSCULOSKELET, V30, P1303, DOI 10.3233/BMR-169673; Underwood M, 2004, BMJ-BRIT MED J, V329, P1377, DOI 10.1136/bmj.38282.669225AE; Verma Y, 2013, INT J PHYSIOTHER RES, V3, P48; Vismara L, 2012, MANUAL THER, V17, P451, DOI 10.1016/j.math.2012.05.002; Vos T, 2017, LANCET, V390, P1211, DOI 10.1016/S0140-6736(17)32154-2; Waagen GN, 1986, MANUAL MED, V2, P63; Walker BF, 2013, SPINE, V38, P2071, DOI 10.1097/01.brs.0000435032.73187.c7; Walker BF, 2013, SPINE, V38, P1723, DOI 10.1097/BRS.0b013e31829fefe4; Waqqar S, 2016, PAK J MED SCI, V32, P476, DOI 10.12669/pjms.322.9127; Wilkey A, 2008, J ALTERN COMPLEM MED, V14, P465, DOI 10.1089/acm.2007.0796; Wong AYL, 2015, SPINE, V40, P1329, DOI 10.1097/BRS.0000000000000981; Xia T, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1821-1; Xia T, 2016, SPINE, V41, pE702, DOI 10.1097/BRS.0000000000001373; Zaproudina N, 2009, COMPLEMENT THER MED, V17, P23, DOI 10.1016/j.ctim.2008.08.005	86	91	96	3	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 13	2019	364								l689	10.1136/bmj.l689	http://dx.doi.org/10.1136/bmj.l689			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP5VW	30867144	hybrid, Green Published			2022-12-28	WOS:000461751600001
J	Matheny, MH; Emenheiser, J; Fon, W; Chapman, A; Salova, A; Rohden, M; Li, J; de Badyn, MH; Posfai, M; Duenas-Osorio, L; Mesbahi, M; Crutchfield, JP; Cross, MC; D'Souza, RM; Roukes, ML				Matheny, Matthew H.; Emenheiser, Jeffrey; Fon, Warren; Chapman, Airlie; Salova, Anastasiya; Rohden, Martin; Li, Jarvis; de Badyn, Mathias Hudoba; Posfai, Marton; Duenas-Osorio, Leonardo; Mesbahi, Mehran; Crutchfield, James P.; Cross, M. C.; D'Souza, Raissa M.; Roukes, Michael L.			Exotic states in a simple network of nanoelectromechanical oscillators	SCIENCE			English	Article							CHIMERA STATES; SYNCHRONIZATION; DYNAMICS; POPULATIONS; TRANSITIONS; COHERENCE; MODEL	Synchronization of oscillators, a phenomenon found in a wide variety of natural and engineered systems, is typically understood through a reduction to a first-order phase model with simplified dynamics. Here, by exploiting the precision and flexibility of nanoelectromechanical systems, we examined the dynamics of a ring of quasi-sinusoidal oscillators at and beyond first order. Beyond first order, we found exotic states of synchronization with highly complex dynamics, including weak chimeras, decoupled states, traveling waves, and inhomogeneous synchronized states. Through theory and experiment, we show that these exotic states rely on complex interactions emerging out of networks with simple linear nearest-neighbor coupling. This work provides insight into the dynamical richness of complex systems with weak nonlinearities and local interactions.	[Matheny, Matthew H.; Fon, Warren; Cross, M. C.; Roukes, Michael L.] CALTECH, Dept Phys, Pasadena, CA 91125 USA; [Matheny, Matthew H.; Fon, Warren; Li, Jarvis; Roukes, Michael L.] CALTECH, Kavli Nanosci Inst, Pasadena, CA 91125 USA; [Emenheiser, Jeffrey; Salova, Anastasiya; Crutchfield, James P.] Univ Calif Davis, Dept Phys, Davis, CA 95616 USA; [Emenheiser, Jeffrey; Salova, Anastasiya; Rohden, Martin; Posfai, Marton; Crutchfield, James P.; D'Souza, Raissa M.] Univ Calif Davis, Complex Sci Ctr, Davis, CA 95616 USA; [Chapman, Airlie] Univ Melbourne, Dept Mech Engn, Melbourne, Vic 3010, Australia; [Rohden, Martin; Posfai, Marton; D'Souza, Raissa M.] Univ Calif Davis, Dept Comp Sci, Davis, CA 95616 USA; [Li, Jarvis; Roukes, Michael L.] CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA; [de Badyn, Mathias Hudoba; Mesbahi, Mehran] Univ Washington, William E Boeing Dept Aeronaut & Astronaut, Seattle, WA 98195 USA; [Duenas-Osorio, Leonardo] Rice Univ, Dept Civil & Environm Engn, Houston, TX 77005 USA; [Crutchfield, James P.; D'Souza, Raissa M.] Santa Fe Inst, Santa Fe, NM 87501 USA; [D'Souza, Raissa M.] Univ Calif Davis, Dept Mech & Aerosp Engn, Davis, CA 95616 USA; [Roukes, Michael L.] CALTECH, Dept Bioengn, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; University of California System; University of California Davis; University of California System; University of California Davis; University of Melbourne; University of California System; University of California Davis; California Institute of Technology; University of Washington; University of Washington Seattle; Rice University; The Santa Fe Institute; University of California System; University of California Davis; California Institute of Technology	Roukes, ML (corresponding author), CALTECH, Dept Phys, Pasadena, CA 91125 USA.; Roukes, ML (corresponding author), CALTECH, Kavli Nanosci Inst, Pasadena, CA 91125 USA.; Roukes, ML (corresponding author), CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA.; Roukes, ML (corresponding author), CALTECH, Dept Bioengn, Pasadena, CA 91125 USA.	roukes@caltech.edu	de Badyn, Mathias Hudoba/AAE-6276-2020	de Badyn, Mathias Hudoba/0000-0003-0955-2381; CHAPMAN, AIRLIE/0000-0002-8946-552X	U.S. Army Research Laboratory; U.S. Army Research Office under MURI award [W911NF-13-1-0340, W911NF-18-1-0028]; Intel Corporation	U.S. Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); U.S. Army Research Office under MURI award; Intel Corporation(Intel Corporation)	This material is based on work supported by, or in part by, the U.S. Army Research Laboratory and the U.S. Army Research Office under MURI award W911NF-13-1-0340 and W911NF-18-1-0028 and Intel Corporation support of CSC as an Intel Parallel Computing Center.	Abrams DM, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.174102; Acebron JA, 2005, REV MOD PHYS, V77, P137, DOI 10.1103/RevModPhys.77.137; ALEXANDER JC, 1986, ARCH RATION MECH AN, V93, P253, DOI 10.1007/BF00281500; Ashwin P, 2015, CHAOS, V25, DOI 10.1063/1.4905197; Bera BK, 2016, PHYS REV E, V93, DOI 10.1103/PhysRevE.93.012205; Blasius B, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.084101; Chen C, 2017, NATURE, V542, P210, DOI 10.1038/nature20817; Cho YS, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.084101; Clusella P, 2016, NEW J PHYS, V18, DOI 10.1088/1367-2630/18/9/093037; Coletta T, 2016, NEW J PHYS, V18, DOI 10.1088/1367-2630/18/10/103042; CROSS MC, 1993, REV MOD PHYS, V65, P851, DOI 10.1103/RevModPhys.65.851; Cross MC, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.224101; Cross MC, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.036205; Dinstein I, 2011, NEURON, V70, P1218, DOI 10.1016/j.neuron.2011.04.018; Emenheiser J, 2016, CHAOS, V26, DOI 10.1063/1.4960191; Feng XL, 2008, NAT NANOTECHNOL, V3, P342, DOI 10.1038/nnano.2008.125; Fon W, 2017, NANO LETT, V17, P5977, DOI 10.1021/acs.nanolett.7b02026; Gambuzza LV, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.032905; Grigoriev RO, 1997, PHYS REV LETT, V79, P2795, DOI 10.1103/PhysRevLett.79.2795; Hagerstrom AM, 2012, NAT PHYS, V8, P658, DOI [10.1038/nphys2372, 10.1038/NPHYS2372]; Hart J. D., 2016, J NONLINEAR SCI, V26, P94801, DOI DOI 10.1063/1.4953662; Helbing D, 2001, REV MOD PHYS, V73, P1067, DOI 10.1103/RevModPhys.73.1067; HONEYCUTT RL, 1992, PHYS REV A, V45, P600, DOI 10.1103/PhysRevA.45.600; Kaka S, 2005, NATURE, V437, P389, DOI 10.1038/nature04035; Karabalin RB, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.236101; Karabalin RB, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3216586; KERNER BS, 1993, PHYS REV E, V48, pR2335, DOI 10.1103/PhysRevE.48.R2335; Kerner BS, 1996, AIP CONF PROC, P777, DOI 10.1063/1.51016; Kiss IZ, 2007, SCIENCE, V316, P1886, DOI 10.1126/science.1140858; Kiss IZ, 2002, SCIENCE, V296, P1676, DOI 10.1126/science.1070757; Kuramoto Y., 1975, International Symposium on Mathematical Problems in Theoretical Physics, P420, DOI 10.1007/BFb0013365; Lerner E. J., 2006, GRAVITATIONAL ELECT, P41; Lifshitz M.C., 2009, REV NONLINEAR DYNAMI, P1, DOI DOI 10.1002/9783527626359.CH1; Martens EA, 2013, P NATL ACAD SCI USA, V110, P10563, DOI 10.1073/pnas.1302880110; Matheny MH, 2013, NANO LETT, V13, P1622, DOI 10.1021/nl400070e; Matheny MH, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.014101; Mesbahi M, 2010, GRAPH THEORETIC METHODS IN MULTIAGENT NETWORKS, P1; Motsch S, 2014, SIAM REV, V56, P577, DOI 10.1137/120901866; Motter AE, 2013, NAT PHYS, V9, P191, DOI 10.1038/nphys2535; Olfati-Saber R, 2007, P IEEE, V95, P215, DOI 10.1109/JPROC.2006.887293; Omelchenko I, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.022917; Panaggio MJ, 2016, PHYS REV E, V93, DOI 10.1103/PhysRevE.93.012218; Panaggio MJ, 2015, NONLINEARITY, V28, pR67, DOI 10.1088/0951-7715/28/3/R67; Pecora LM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5079; Pikovsky A., 2003, SYNCHRONIZATION UNIV; Pikovsky A, 2006, PHYSICA D, V218, P56, DOI 10.1016/j.physd.2006.04.015; Pikovsky A, 2009, PHYSICA D, V238, P27, DOI 10.1016/j.physd.2008.08.018; Ronellenfitsch H, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.208301; Rosin DP, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.030902; SAKAGUCHI H, 1986, PROG THEOR PHYS, V76, P576, DOI 10.1143/PTP.76.576; Skardal PS, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.036208; Soriano MC, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.134101; Susuki Y, 2011, J NONLINEAR SCI, V21, P403, DOI 10.1007/s00332-010-9087-5; Temirbayev AA, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.015204; Tinsley MR, 2012, NAT PHYS, V8, P662, DOI [10.1038/nphys2371, 10.1038/NPHYS2371]; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Villanueva LG, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.177208; Villanueva LG, 2011, NANO LETT, V11, P5054, DOI 10.1021/nl2031162; Wiesenfeld K, 1996, PHYS REV LETT, V76, P404, DOI 10.1103/PhysRevLett.76.404; Wiley DA, 2006, CHAOS, V16, DOI 10.1063/1.2165594; Yamaguchi TJ, 2003, IEEE T CIRCUITS-II, V50, P288, DOI 10.1109/TCSII.2003.812916	64	83	83	6	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 8	2019	363	6431					1057	+	eaav7932	10.1126/science.aav7932	http://dx.doi.org/10.1126/science.aav7932			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO2MV	30846570	Green Submitted			2022-12-28	WOS:000460750100036
J	Lewis, D				Lewis, Dyani			THE FIGHT FOR CONTROL OVER VIRTUAL FOSSILS	NATURE			English	News Item																		Berger LR, 2015, ELIFE, V4, DOI 10.7554/eLife.09560; Copes LE, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.1; Davies TG, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.0194; Fuss J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177127; Kappelman J, 2016, NATURE, V537, P503, DOI 10.1038/nature19332; Skinner MM, 2013, J HUM EVOL, V64, P434, DOI 10.1016/j.jhevol.2013.01.007; Xing LD, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aat5042	7	7	7	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 7	2019	567	7746					20	23		10.1038/d41586-019-00739-0	http://dx.doi.org/10.1038/d41586-019-00739-0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HN8ED	30842642	Bronze			2022-12-28	WOS:000460426900021
J	Rappuoli, R; Serruto, D				Rappuoli, Rino; Serruto, Davide			Self-Assembling Nanoparticles Usher in a New Era of Vaccine Design	CELL			English	Editorial Material							PARTICLES	In this issue, Marcandalli et al. (2019) report a self-assembling nanoparticle bearing an antigen from respiratory syncytial virus. This is the first time the structure, stability, and adjuvanticity of an antigen have been rationally designed at the atomic level and incorporated in one vaccine.	[Rappuoli, Rino; Serruto, Davide] GSK, I-53100 Siena, Italy; [Rappuoli, Rino] Imperial Coll, London, England	GlaxoSmithKline; Imperial College London	Rappuoli, R (corresponding author), GSK, I-53100 Siena, Italy.; Rappuoli, R (corresponding author), Imperial Coll, London, England.	rino.r.rappuoli@gsk.com						Jenner E., 1798, THE HARVARD CLASSICS, V38, P1909; Kanekiyo M, 2013, NATURE, V499, P102, DOI 10.1038/nature12202; Ludwig C, 2007, CURR OPIN BIOTECH, V18, P537, DOI 10.1016/j.copbio.2007.10.013; Marcandalli J, 2019, CELL, V176, P1420, DOI 10.1016/j.cell.2019.01.046; McLellan JS, 2013, SCIENCE, V342, P592, DOI 10.1126/science.1243283; PIZZA M, 1989, SCIENCE, V246, P497, DOI 10.1126/science.2683073; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; Schiller JT, 1996, SEMIN CANCER BIOL, V7, P373, DOI 10.1006/scbi.1996.0046; Serruto D, 2006, FEBS LETT, V580, P2985, DOI 10.1016/j.febslet.2006.04.084; VALENZUELA P, 1982, NATURE, V298, P347, DOI 10.1038/298347a0	10	10	10	1	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 7	2019	176	6					1245	1247		10.1016/j.cell.2019.02.008	http://dx.doi.org/10.1016/j.cell.2019.02.008			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	HN9HD	30849370	Bronze			2022-12-28	WOS:000460509600003
J	Chettih, SN; Harvey, CD				Chettih, Selmaan N.; Harvey, Christopher D.			Single-neuron perturbations reveal feature-specific competition in V1	NATURE			English	Article							PRIMARY VISUAL-CORTEX; RECEPTIVE-FIELDS; INHIBITION; EXCITATION; SPARSE; CONNECTIVITY; ORIENTATION; NETWORK; MICROCIRCUITS; INTERNEURONS	The computations performed by local neural populations, such as a cortical layer, are typically inferred from anatomical connectivity and observations of neural activity. Here we describe a method-influence mapping-that uses single-neuron perturbations to directly measure how cortical neurons reshape sensory representations. In layer 2/3 of the primary visual cortex (V1), we use two-photon optogenetics to trigger action potentials in a targeted neuron and calcium imaging to measure the effect on spiking in neighbouring neurons in awake mice viewing visual stimuli. Excitatory neurons on average suppressed other neurons and had a centre-surround influence profile over anatomical space. A neuron's influence on its neighbour depended on their similarity in activity. Notably, neurons suppressed activity in similarly tuned neurons more than in dissimilarly tuned neurons. In addition, photostimulation reduced the population response, specifically to the targeted neuron's preferred stimulus, by around 2%. Therefore, V1 layer 2/3 performed feature competition, in which a like-suppresses-like motif reduces redundancy in population activity and may assist with inference of the features that underlie sensory input. We anticipate that influence mapping can be extended to investigate computations in other neural populations.	[Chettih, Selmaan N.; Harvey, Christopher D.] Harvard Med Sch, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Harvey, CD (corresponding author), Harvard Med Sch, Dept Neurobiol, Boston, MA 02115 USA.	harvey@hms.harvard.edu			Burroughs-Wellcome Fund Career Award at the Scientific Interface; Searle Scholars Program; New York Stem Cell Foundation; NIH grants from the NIMH BRAINS program [R01 MH107620]; NINDS [R01 NS089521, R01 NS108410]; Armenise-Harvard Foundation Junior Faculty Grant; NSF Graduate Research Fellowship;  [P30 EY012196]; NATIONAL EYE INSTITUTE [P30EY012196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH107620] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS108410, R01NS089521] Funding Source: NIH RePORTER	Burroughs-Wellcome Fund Career Award at the Scientific Interface(Burroughs Wellcome Fund); Searle Scholars Program; New York Stem Cell Foundation; NIH grants from the NIMH BRAINS program; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Armenise-Harvard Foundation Junior Faculty Grant; NSF Graduate Research Fellowship(National Science Foundation (NSF)); ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Drugowitsch, M. Andermann, R. Born, O. Mazor, L. Orefice, and members of the Harvey laboratory for discussions; H. Nyitrai, L. Bickford, and P. Kaeser for help testing soma localization of opsins; and the Research Instrumentation Core and machine shop at Harvard Medical School (supported by grant P30 EY012196). This work was supported by a Burroughs-Wellcome Fund Career Award at the Scientific Interface, the Searle Scholars Program, the New York Stem Cell Foundation, NIH grants from the NIMH BRAINS program (R01 MH107620) and NINDS (R01 NS089521, R01 NS108410), an Armenise-Harvard Foundation Junior Faculty Grant, and an NSF Graduate Research Fellowship.	Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Baker CA, 2016, ELIFE, V5, DOI 10.7554/eLife.14193; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; Bonin V, 2011, J NEUROSCI, V31, P18506, DOI 10.1523/JNEUROSCI.2974-11.2011; Carrillo-Reid L, 2016, SCIENCE, V353, P691, DOI 10.1126/science.aaf7560; Chen I.-W, 2018, PARALLEL HOLOGRAPHIC, DOI DOI 10.1101/250795V1; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Coen-Cagli R, 2015, NAT NEUROSCI, V18, P1648, DOI 10.1038/nn.4128; Cossell L, 2015, NATURE, V518, P399, DOI 10.1038/nature14182; Ding C, 2005, SIAM PROC S, P606; Driscoll LN, 2017, CELL, V170, P986, DOI 10.1016/j.cell.2017.07.021; Feldt S, 2011, TRENDS NEUROSCI, V34, P225, DOI 10.1016/j.tins.2011.02.007; Friedrich J, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005685; Friedrich J, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005423; GILBERT CD, 1989, J NEUROSCI, V9, P2432; Greenberg DS, 2009, J NEUROSCI METH, V176, P1, DOI 10.1016/j.jneumeth.2008.08.020; Guizar-Sicairos M, 2008, OPT LETT, V33, P156, DOI 10.1364/OL.33.000156; Haider B, 2013, NATURE, V493, P97, DOI 10.1038/nature11665; Haider B, 2010, NEURON, V65, P107, DOI 10.1016/j.neuron.2009.12.005; Harris KD, 2013, NATURE, V503, P51, DOI 10.1038/nature12654; Harvey CD, 2012, NATURE, V484, P62, DOI 10.1038/nature10918; Hofer SB, 2011, NAT NEUROSCI, V14, P1045, DOI 10.1038/nn.2876; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Jouhanneau JS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03995-2; Kerlin AM, 2010, NEURON, V67, P858, DOI 10.1016/j.neuron.2010.08.002; Klapoetke NC, 2014, NAT METHODS, V11, P338, DOI [10.1038/NMETH.2836, 10.1038/nmeth.2836]; Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880; Komai S, 2006, NAT PROTOC, V1, P648, DOI 10.1038/nprot.2006.100; Koulakov AA, 2011, NEURON, V72, P124, DOI 10.1016/j.neuron.2011.07.031; Kwan AC, 2012, CURR BIOL, V22, P1459, DOI 10.1016/j.cub.2012.06.007; Lee WCA, 2016, NATURE, V532, P370, DOI 10.1038/nature17192; Lien AD, 2013, NAT NEUROSCI, V16, P1315, DOI 10.1038/nn.3488; Lim ST, 2000, NEURON, V25, P385, DOI 10.1016/S0896-6273(00)80902-2; Lochmann T, 2012, J NEUROSCI, V32, P4179, DOI 10.1523/JNEUROSCI.0817-11.2012; Lochmann T, 2011, CURR OPIN NEUROBIOL, V21, P774, DOI 10.1016/j.conb.2011.05.018; London M, 2010, NATURE, V466, P123, DOI 10.1038/nature09086; Mardinly AR, 2018, NAT NEUROSCI, V21, P881, DOI 10.1038/s41593-018-0139-8; Moreno-Bote R, 2015, SCI REP-UK, V5, DOI 10.1038/srep17531; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Olshausen BA, 2004, CURR OPIN NEUROBIOL, V14, P481, DOI 10.1016/j.conb.2004.07.007; Olshausen BA, 1997, VISION RES, V37, P3311, DOI 10.1016/S0042-6989(97)00169-7; Packer AM, 2015, NAT METHODS, V12, P140, DOI 10.1038/nmeth.3217; Packer AM, 2011, J NEUROSCI, V31, P13260, DOI 10.1523/JNEUROSCI.3131-11.2011; PNEVMATIKAKIS E. A., 2014, STRUCTURED MATRIX FA; Pnevmatikakis EA, 2016, NEURON, V89, P285, DOI 10.1016/j.neuron.2015.11.037; Prakash R, 2012, NAT METHODS, V9, P1171, DOI 10.1038/NMETH.2215; Rasmussen CE, 2005, ADAPT COMPUT MACH LE, P1; Rickgauer JP, 2014, NAT NEUROSCI, V17, P1816, DOI 10.1038/nn.3866; Rickgauer JP, 2009, P NATL ACAD SCI USA, V106, P15025, DOI 10.1073/pnas.0907084106; Rosenbaum R, 2017, NAT NEUROSCI, V20, P107, DOI 10.1038/nn.4433; Runyan CA, 2010, NEURON, V67, P847, DOI 10.1016/j.neuron.2010.08.006; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Sun WZ, 2016, NAT NEUROSCI, V19, P308, DOI 10.1038/nn.4196; Tan AYY, 2011, J NEUROSCI, V31, P12339, DOI 10.1523/JNEUROSCI.2039-11.2011; Trott AR, 2015, J NEUROSCI, V35, P4973, DOI 10.1523/JNEUROSCI.4000-14.2015; Vinje WE, 2002, J NEUROSCI, V22, P2904, DOI 10.1523/JNEUROSCI.22-07-02904.2002; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; WELIKY M, 1995, NEURON, V15, P541, DOI 10.1016/0896-6273(95)90143-4; Wilson NR, 2012, NATURE, V488, P343, DOI 10.1038/nature11347; Wu CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066332; Yatsenko D, 2015, DATAJOINT MANAGING B, DOI DOI 10.1101/031658V1; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Yoshimura Y, 2005, NAT NEUROSCI, V8, P1552, DOI 10.1038/nn1565; Yu BM, 2009, J NEUROPHYSIOL, V102, P614, DOI 10.1152/jn.90941.2008; Znamenskiy P, 2018, FUNCTIONAL SELECTIVI, DOI DOI 10.1101/294835V2	66	77	77	0	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 21	2019	567	7748					334	+		10.1038/s41586-019-0997-6	http://dx.doi.org/10.1038/s41586-019-0997-6			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP9JT	30842660	Green Accepted			2022-12-28	WOS:000462010000045
J	Silberner, J				Silberner, Joanne			Overcoming vaccine hesitancy: five minutes with ... Heidi Larson	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Public Health England, 2018, 50 YEARS MEASL VACC; Tanne JH, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.l1172; Verger P, 2015, EBIOMEDICINE, V2, P891, DOI 10.1016/j.ebiom.2015.06.018	3	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 18	2019	364								l1259	10.1136/bmj.l1259	http://dx.doi.org/10.1136/bmj.l1259			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HQ7ZV	30885893				2022-12-28	WOS:000462643800013
J	Grosmaire, M; Launay, C; Siegwald, M; Brugiere, T; Estrada-Virrueta, L; Berger, D; Burny, C; Modolo, L; Blaxter, M; Meister, P; Felix, MA; Gouyon, PH; Delattre, M				Grosmaire, Manon; Launay, Caroline; Siegwald, Marion; Brugiere, Thibault; Estrada-Virrueta, Lilia; Berger, Duncan; Burny, Claire; Modolo, Laurent; Blaxter, Mark; Meister, Peter; Felix, Marie-Anne; Gouyon, Pierre-Henri; Delattre, Marie			Males as somatic investment in a parthenogenetic nematode	SCIENCE			English	Article							LOCAL MATE COMPETITION; READ ALIGNMENT; SEX-RATIOS; GENOME; ANNOTATION; EVOLUTION; GENETICS	We report the reproductive strategy of the nematode Mesorhabditis belari. This species produces only 9% males, whose sperm is necessary to fertilize and activate the eggs. However, most of the fertilized eggs develop without using the sperm DNA and produce female individuals. Only in 9% of eggs is the male DNA utilized, producing sons. We found that mixing of parental genomes only gives rise to males because the Y-bearing sperm of males are much more competent than the X-bearing sperm for penetrating the eggs. In this previously unrecognized strategy, asexual females produce few sexual males whose genes never reenter the female pool. Here, production of males is of interest only if sons are more likely to mate with their sisters. Using game theory, we show that in this context, the production of 9% males by M. belari females is an evolutionary stable strategy.	[Grosmaire, Manon; Launay, Caroline; Brugiere, Thibault; Estrada-Virrueta, Lilia; Burny, Claire; Modolo, Laurent; Delattre, Marie] Univ Lyon, Lab Biol & Modelisat Cellule, UMR 5239, ENS,UCBL,CNRS,INSERM,U1210, F-69364 Lyon, France; [Siegwald, Marion; Gouyon, Pierre-Henri] UA, Inst Systemat Evolut Biodiversite ISYEB, Museum Natl Hist Nat, CNRS,SU,EPHE, CP 39,57 Rue Cuvier, F-75005 Paris, France; [Berger, Duncan; Blaxter, Mark] Univ Edinburgh, Ashworth Labs, Inst Evolutionary Biol, Edinburgh EH9 3FL, Midlothian, Scotland; [Meister, Peter] Univ Bern, Inst Cell Biol, Cell Fate & Nucl Org, CH-3012 Bern, Switzerland; [Felix, Marie-Anne] PSL Res Univ, Dept Biol, Ecole Normale Super, IBENS,CNRS,Inserm, F-75005 Paris, France; [Berger, Duncan] Wellcome Sanger Inst, Hinxton CB10 1SA, Cambs, England; [Burny, Claire] Vetmeduni Vienna, Inst Populat Genet, A-1210 Vienna, Austria; [Burny, Claire] Vetmeduni Vienna, Vienna Grad Sch Populat Genet, A-1210 Vienna, Austria	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Universite Jean Monnet; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Sorbonne Universite; University of Edinburgh; University of Bern; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Wellcome Trust Sanger Institute; University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna	Delattre, M (corresponding author), Univ Lyon, Lab Biol & Modelisat Cellule, UMR 5239, ENS,UCBL,CNRS,INSERM,U1210, F-69364 Lyon, France.	marie.delattre@ens-lyon.fr	Meister, Peter/B-4770-2010; Delattre, Marie/CAG-5526-2022; Delattre, Marie/AAJ-1491-2020; Blaxter, Mark/O-2535-2019	Meister, Peter/0000-0002-6230-4216; Delattre, Marie/0000-0003-1640-0300; Delattre, Marie/0000-0003-1640-0300; Estrada Virrueta, Lilia/0000-0003-3500-9737; launay, caroline/0000-0002-6587-6631; laurent, MODOLO/0000-0002-7606-4110; Berger, Duncan/0000-0002-2017-6623	PEPS CNRS (2014-2015); Ecole Normale Superieure de Lyon (2015-2016); ANR [ANR-17-ERC2-0012-01]; French ministry of research (2015-2018); Swiss National Science Foundation [31003A_176226]	PEPS CNRS (2014-2015); Ecole Normale Superieure de Lyon (2015-2016); ANR(French National Research Agency (ANR)); French ministry of research (2015-2018); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work has been supported by a grant from the PEPS CNRS (2014-2015) to M.D. and M.-A.F., the Ecole Normale Superieure de Lyon (2015-2016) to M.D., the ANR (ANR-17-ERC2-0012-01 in 2017-2018) to M.D., and a Ph.D. fellowship to M.G. from the French ministry of research (2015-2018). P.M. is funded by the Swiss National Science Foundation (31003A_176226).	Belar K., 1924, Zeitschrift fuer Wissenschaftliche Biologie Berlin B, V1, P1, DOI 10.1007/BF02583458; Beukeboom LW, 1998, J EVOLUTION BIOL, V11, P755, DOI 10.1007/s000360050117; Bolstad B, 2018, PREPROCESSCORE COLLE; BRENNER S, 1974, GENETICS, V77, P71; Clark SC, 2013, BIOINFORMATICS, V29, P435, DOI 10.1093/bioinformatics/bts723; De Coster W, 2018, BIOINFORMATICS, V34, P2666, DOI 10.1093/bioinformatics/bty149; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Ewels P, 2016, BIOINFORMATICS, V32, P3047, DOI 10.1093/bioinformatics/btw354; Faust GG, 2014, BIOINFORMATICS, V30, P2503, DOI 10.1093/bioinformatics/btu314; Felix MA, 1996, DEVELOPMENT, V122, P2129; Goubert C, 2015, GENOME BIOL EVOL, V7, P1192, DOI 10.1093/gbe/evv050; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; HAIG D, 1993, J EVOLUTION BIOL, V6, P69, DOI 10.1046/j.1420-9101.1993.6010069.x; Hamilton W.D., 1979, P167; HAMILTON WD, 1967, SCIENCE, V156, P477, DOI 10.1126/science.156.3774.477; Heng L., 2017, BIOAWK, DOI [10.1093/bioinformatics/btu314Medline, DOI 10.1093/BIOINFORMATICS/BTU314MEDLINE]; Hoff KJ, 2016, BIOINFORMATICS, V32, P767, DOI 10.1093/bioinformatics/btv661; Hubley R., 2013, REPEATMASKER OPEN 40; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lehtonen J, 2013, TRENDS ECOL EVOL, V28, P297, DOI 10.1016/j.tree.2012.12.006; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Neiman M, 2014, J EVOLUTION BIOL, V27, P1346, DOI 10.1111/jeb.12357; Neph S, 2012, BIOINFORMATICS, V28, P1919, DOI 10.1093/bioinformatics/bts277; Nigon V., 1949, ANN SCI NATURELLES, V11; Nigon Victor Marc, 2017, WormBook, V2017, P1, DOI 10.1895/wormbook.1.181.1; Riche S, 2013, J CELL BIOL, V201, P653, DOI 10.1083/jcb.201210110; Sharma R, 2014, GENE DEV, V28, P2591, DOI 10.1101/gad.248864.114; Shuker DM, 2005, AM NAT, V166, P301, DOI 10.1086/432562; SOMMER RJ, 1994, SCIENCE, V265, P114, DOI 10.1126/science.8016644; Sudhaus W., 2011, Journal of Nematode Morphology and Systematics, V14, P113; Tarasov A, 2015, BIOINFORMATICS, V31, P2032, DOI 10.1093/bioinformatics/btv098; TAYLOR PD, 1980, J THEOR BIOL, V86, P409, DOI 10.1016/0022-5193(80)90342-2; Ye CX, 2016, SCI REP-UK, V6, DOI 10.1038/srep31900	35	9	9	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 15	2019	363	6432			SI		1210	+		10.1126/science.aau0099	http://dx.doi.org/10.1126/science.aau0099			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP0BC	30872523	Green Submitted			2022-12-28	WOS:000461329000047
J	Ma, J; Rosas, LG; Lv, N; Xiao, L; Snowden, MB; Venditti, EM; Lewis, MA; Goldhaber-Fiebert, JD; Lavori, PW				Ma, Jun; Rosas, Lisa Goldman; Lv, Nan; Xiao, Lan; Snowden, Mark B.; Venditti, Elizabeth M.; Lewis, Megan A.; Goldhaber-Fiebert, Jeremy D.; Lavori, Philip W.			Effect of Integrated Behavioral Weight Loss Treatment and Problem-Solving Therapy on Body Mass Index and Depressive Symptoms Among Patients With Obesity and Depression The RAINBOW Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DIABETES PREVENTION PROGRAM; LIFE-STYLE INTERVENTION; PRIMARY-CARE; MAJOR DEPRESSION; COMORBID OBESITY; HEALTH; VALIDATION; ADULTS; WOMEN; PHQ-9	IMPORTANCE Coexisting obesity and depression exacerbate morbidity and disability, but effective treatments remain elusive. OBJECTIVE To test the hypothesis that an integrated collaborative care intervention would significantly improve both obesity and depression at 12 months compared with usual care. DESIGN, SETTING, AND PARTICIPANTS The Research Aimed at Improving Both Mood and Weight (RAINBOW) randomized clinical trial enrolled 409 adults with body mass indices (BMIs) of 30 or greater (>= 27 for Asian adults) and 9-item Patient Health Questionnaire (PHQ-9) scores of 10 or greater. Primary care patients at a health system in Northern California were recruited from September 30, 2014, to January 12, 2017; the date of final 12-month follow-up was January 17, 2018. INTERVENTIONS All participants randomly assigned to the intervention (n = 204) or the usual care control group (n = 205) received medical care from their personal physicians as usual, received information on routine services for obesity and depression at their clinic, and received wireless physical activity trackers. Intervention participants also received a 12-month intervention that integrated a Diabetes Prevention Program-based behavioral weight loss treatment with problem-solving therapy for depression and, if indicated, antidepressant medications. MAIN OUTCOMES AND MEASURES The co-primary outcome measures were BMI and 20-item Depression Symptom Checklist (SCL-20) scores (range, 0 [best] to 4 [worst]) at 12 months. RESULTS Among 409 participants randomized (mean age of 51.0 years [SD, 12.1 years]; 70% were women; mean BMI of 36.7 [SD, 6.4]; mean PHQ-9 score of 13.8 [SD, 3.1]; and mean SCL-20 score of 1.5 [SD, 0.5]), 344 (84.1%) completed 12-month follow-up. At 12 months, mean BMI declined from 36.7 (SD, 6.9) to 35.9 (SD, 7.1) among intervention participants compared with a change in mean BMI from 36.6 (SD, 5.8) to 36.6 (SD, 6.0) among usual care participants (between-group mean difference, -0.7 [95% CI, -1.1 to -0.2]; P = .01). Mean SCL-20 score declined from 1.5 (SD, 0.5) to 1.1 (SD, 1.0) at 12 months among intervention participants compared with a change in mean SCL-20 score from 1.5 (SD, 0.6) to 1.4 (SD, 1.3) among usual care participants (between-group mean difference, -0.2 [95% CI, -0.4 to 0]; P = .01). There were 47 adverse events or serious adverse events that involved musculoskeletal injuries (27 in the intervention group and 20 in the usual care group). CONCLUSIONS AND RELEVANCE Among adults with obesity and depression, a collaborative care intervention integrating behavioral weight loss treatment, problem-solving therapy, and as-needed antidepressant medications significantly improved weight loss and depressive symptoms at 12 months compared with usual care; however, the effect sizes were modest and of uncertain clinical importance.	[Ma, Jun; Lv, Nan] Univ Illinois, Dept Med, Chicago, IL USA; [Ma, Jun; Lv, Nan] Univ Illinois, Inst Hlth Res & Policy, 1747 W Roosevelt Rd,Room 586,MC 275, Chicago, IL 60608 USA; [Rosas, Lisa Goldman] Stanford Univ, Dept Hlth Res & Policy & Med, Palo Alto, CA 94304 USA; [Xiao, Lan; Goldhaber-Fiebert, Jeremy D.] Stanford Univ, Dept Med, Palo Alto, CA 94304 USA; [Snowden, Mark B.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Venditti, Elizabeth M.] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA; [Lewis, Megan A.] RTI Int, Ctr Commun Sci, Seattle, WA USA; [Lavori, Philip W.] Stanford Univ, Dept Biomed Data Sci, Stanford, CA 94305 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Stanford University; Stanford University; University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Research Triangle Institute; Stanford University	Ma, J (corresponding author), Univ Illinois, Inst Hlth Res & Policy, 1747 W Roosevelt Rd,Room 586,MC 275, Chicago, IL 60608 USA.	maj2015@uic.edu		Lewis, Megan/0000-0002-1670-9298; Goldhaber-Fiebert, Jeremy/0000-0002-4007-5192	National Heart, Lung, and Blood Institute [R01HL119453]; Palo Alto Medical Foundation Research Institute; University of Illinois, Chicago; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119453] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Palo Alto Medical Foundation Research Institute; University of Illinois, Chicago; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by award R01HL119453 from the National Heart, Lung, and Blood Institute and internal funding from the Palo Alto Medical Foundation Research Institute and the University of Illinois, Chicago.	[Anonymous], 1999, STAT MED, V18, P1905; [Anonymous], 1993, 9 ANN M INT SOC TRAU; Arroll B, 2010, ANN FAM MED, V8, P348, DOI 10.1370/afm.1139; Bandura A., 1986, SOCIAL FDN THOUGHT A; Berwick DM, 2008, HEALTH AFFAIR, V27, P759, DOI 10.1377/hlthaff.27.3.759; Ciechanowski P, 2004, JAMA-J AM MED ASSOC, V291, P1569, DOI 10.1001/jama.291.13.1569; Ciechanowski P, 2010, EPILEPSY BEHAV, V19, P225, DOI 10.1016/j.yebeh.2010.06.003; DiCiccio TJ, 1996, STAT SCI, V11, P189; EFRON B, 1971, BIOMETRIKA, V58, P403, DOI 10.2307/2334377; GLASS RM, 1978, ARCH GEN PSYCHIAT, V35, P1189; Hales CM, 2018, JAMA-J AM MED ASSOC, V319, P1723, DOI 10.1001/jama.2018.3060; Inter-university Consortium for Political and Social Research, NAT COM SURV REPL NC; Katon WJ, 2010, NEW ENGL J MED, V363, P2611, DOI 10.1056/NEJMoa1003955; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kramer MK, 2009, AM J PREV MED, V37, P505, DOI 10.1016/j.amepre.2009.07.020; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Ladwig KH, 2006, INT J OBESITY, V30, P1408, DOI 10.1038/sj.ijo.0803285; LeBlanc ES, 2018, JAMA-J AM MED ASSOC, V320, P1172, DOI 10.1001/jama.2018.7777; Linde JA, 2011, ANN BEHAV MED, V41, P119, DOI 10.1007/s12160-010-9232-2; Ma Jun, 2017, Prev Med Rep, V8, P42, DOI 10.1016/j.pmedr.2017.07.010; Ma J, 2015, CONTEMP CLIN TRIALS, V43, P260, DOI 10.1016/j.cct.2015.06.010; Ma J, 2015, ANN AM THORAC SOC, V12, P1, DOI 10.1513/AnnalsATS.201406-271OC; Ma J, 2013, JAMA INTERN MED, V173, P113, DOI 10.1001/2013.jamainternmed.987; National Institute of Health, MAJ DEPR 2017; Nigatu YT, 2017, EUR J PUBLIC HEALTH, V27, P965, DOI 10.1093/eurpub/ckx126; Pagoto S, 2013, INT J OBESITY, V37, P1427, DOI 10.1038/ijo.2013.25; Peirson Leslea, 2014, CMAJ Open, V2, pE306, DOI 10.9778/cmajo.20140012; Pereira-Miranda E, 2017, J AM COLL NUTR, V36, P223, DOI 10.1080/07315724.2016.1261053; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Press MJ, 2017, NEW ENGL J MED, V376, P405, DOI 10.1056/NEJMp1614134; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Tice JA, DIAB PREV PROGR EFF; University of Washington, PEARLS PROGR 2016; Wadden TA, 2014, JAMA-J AM MED ASSOC, V312, P1779, DOI 10.1001/jama.2014.14173; Xiao L, 2017, OBESITY, V25, P363, DOI 10.1002/oby.21737; Xiao L, 2013, J MED INTERNET RES, V15, P279, DOI 10.2196/jmir.2392; Zhang AA, 2018, J AM BOARD FAM MED, V31, P139, DOI 10.3122/jabfm.2018.01.170270	38	62	62	0	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 5	2019	321	9					869	879		10.1001/jama.2019.0557	http://dx.doi.org/10.1001/jama.2019.0557			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HN7EL	30835308	Green Published, Bronze			2022-12-28	WOS:000460351600017
J	Nayfach, S; Shi, ZJ; Seshadri, R; Pollard, KS; Kyrpides, NC				Nayfach, Stephen; Shi, Zhou Jason; Seshadri, Rekha; Pollard, Katherine S.; Kyrpides, Nikos C.			New insights from uncultivated genomes of the global human gut microbiome	NATURE			English	Article							METAGENOME; GENES; ALGORITHM; ALIGNMENT; REVEALS; CATALOG; TOOL	The genome sequences of many species of the human gut microbiome remain unknown, largely owing to challenges in cultivating microorganisms under laboratory conditions. Here we address this problem by reconstructing 60,664 draft prokaryotic genomes from 3,810 faecal metagenomes, from geographically and phenotypically diverse humans. These genomes provide reference points for 2,058 newly identified species-level operational taxonomic units (OTUs), which represents a 50% increase over the previously known phylogenetic diversity of sequenced gut bacteria. On average, the newly identified OTUs comprise 33% of richness and 28% of species abundance per individual, and are enriched in humans from rural populations. A meta-analysis of clinical gut-microbiome studies pinpointed numerous disease associations for the newly identified OTUs, which have the potential to improve predictive models. Finally, our analysis revealed that uncultured gut species have undergone genome reduction that has resulted in the loss of certain biosynthetic pathways, which may offer clues for improving cultivation strategies in the future.	[Nayfach, Stephen; Seshadri, Rekha; Kyrpides, Nikos C.] USDA, Joint Genome Inst, Walnut Creek, CA 94597 USA; [Nayfach, Stephen; Seshadri, Rekha; Kyrpides, Nikos C.] Lawrence Berkeley Natl Lab, Environm Genom & Syst Biol Div, Berkeley, CA 94720 USA; [Shi, Zhou Jason; Pollard, Katherine S.] Gladstone Inst, San Francisco, CA USA; [Shi, Zhou Jason; Pollard, Katherine S.] Chan Zuckerberg Biohub, San Francisco, CA USA; [Pollard, Katherine S.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Pollard, Katherine S.] Univ Calif San Francisco, Inst Computat Hlth Sci, San Francisco, CA 94143 USA; [Pollard, Katherine S.] Univ Calif San Francisco, Quantitat Biol Inst, San Francisco, CA 94143 USA; [Pollard, Katherine S.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	United States Department of Agriculture (USDA); United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Nayfach, S; Kyrpides, NC (corresponding author), USDA, Joint Genome Inst, Walnut Creek, CA 94597 USA.; Nayfach, S; Kyrpides, NC (corresponding author), Lawrence Berkeley Natl Lab, Environm Genom & Syst Biol Div, Berkeley, CA 94720 USA.	snayfach@lbl.gov; nckyrpides@lbl.gov	Kyrpides, Nikos C./A-6305-2014; Shi, Zhou Jason/AAW-5365-2021	Kyrpides, Nikos C./0000-0002-6131-0462; Seshadri, Rekha/0000-0003-3219-2900	NSF [DMS-1563159]; Chan-Zuckerberg Biohub; Gladstone Institutes;  [DE-AC02-05CH11231]	NSF(National Science Foundation (NSF)); Chan-Zuckerberg Biohub; Gladstone Institutes(University of California System); 	The authors thank S. Jungbluth, E. Borenstein, P. Turnbaugh, M. Fishbach and J. Bisanz for feedback and suggestions, and P. Bradley for advice on phylogenetic regression. The work conducted by the US Department of Energy Joint Genome Institute (JGI), a US Department of Energy Office of Science User Facility, is supported under contract no. DE-AC02-05CH11231. This work was also supported by funding from the NSF (grant no. DMS-1563159), the Chan-Zuckerberg Biohub and the Gladstone Institutes.	Almeida A, 2019, NATURE, V568, P499, DOI 10.1038/s41586-019-0965-1; Alneberg J, 2014, NAT METHODS, V11, P1144, DOI [10.1038/NMETH.3103, 10.1038/nmeth.3103]; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Anantharaman K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13219; Backhed F, 2015, CELL HOST MICROBE, V17, P690, DOI [10.1016/j.chom.2015.05.012, 10.1016/j.chom.2015.04.004]; Barrett T, 2012, NUCLEIC ACIDS RES, V40, pD57, DOI 10.1093/nar/gkr1163; Bedarf JR, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0428-y; Bowers RM, 2017, NAT BIOTECHNOL, V35, P725, DOI 10.1038/nbt.3893; Bradley PH, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006242; Brito IL, 2016, NATURE, V535, P435, DOI 10.1038/nature18927; Brown CT, 2016, NAT BIOTECHNOL, V34, P1256, DOI 10.1038/nbt.3704; Brown CT, 2015, NATURE, V523, P208, DOI 10.1038/nature14486; Browne HP, 2016, NATURE, V533, P543, DOI 10.1038/nature17645; Cao Y, 2014, BIOINFORMATICS, V30, P1674, DOI 10.1093/bioinformatics/btu104; Chen IMA, 2019, NUCLEIC ACIDS RES, V47, pD666, DOI 10.1093/nar/gky901; Chen Y, 2015, NUCLEIC ACIDS RES, V43, P7762, DOI 10.1093/nar/gkv784; Cronan JE, 2014, MOL MICROBIOL, V92, P217, DOI 10.1111/mmi.12558; Deorowicz S, 2016, SCI REP-UK, V6, DOI 10.1038/srep33964; Di Rienzi Sara C, 2013, Elife, V2, pe01102, DOI 10.7554/eLife.01102; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Feng Q, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7528; Fenn K, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0380-5; Fodor AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041294; Forster SC, 2019, NAT BIOTECHNOL, V37, P186, DOI 10.1038/s41587-018-0009-7; Haft DH, 2013, NUCLEIC ACIDS RES, V41, pD387, DOI 10.1093/nar/gks1234; HAZLEWOOD G, 1979, J GEN MICROBIOL, V112, P15, DOI 10.1099/00221287-112-1-15; Ho LST, 2014, SYST BIOL, V63, P397, DOI 10.1093/sysbio/syu005; Human Microbiome Project Consortium, 2012, Nature, V486, P207, DOI 10.1038/nature11234; Jie ZY, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00900-1; Kang DWD, 2015, PEERJ, V3, DOI 10.7717/peerj.1165; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Kielbasa SM, 2011, GENOME RES, V21, P487, DOI 10.1101/gr.113985.110; Kyrpides NC, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001920; Lagier JC, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.203, 10.1038/nmicrobiol.2016.203]; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD19, DOI 10.1093/nar/gkq1019; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Li JH, 2014, NAT BIOTECHNOL, V32, P834, DOI 10.1038/nbt.2942; Liu WJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep34826; Loewenstein Y, 2008, BIOINFORMATICS, V24, pI41, DOI 10.1093/bioinformatics/btn174; Loomba R, 2017, CELL METAB, V25, P1054, DOI 10.1016/j.cmet.2017.04.001; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Luo CW, 2012, ISME J, V6, P898, DOI 10.1038/ismej.2011.147; Lynch SV, 2016, NEW ENGL J MED, V375, P2369, DOI 10.1056/NEJMra1600266; Morris JJ, 2012, MBIO, V3, DOI 10.1128/mBio.00036-12; Nayfach S, 2016, GENOME RES, V26, P1612, DOI 10.1101/gr.201863.115; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Nielsen HB, 2014, NAT BIOTECHNOL, V32, P822, DOI 10.1038/nbt.2939; Obregon-Tito AJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7505; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Olm MR, 2017, ISME J, V11, P2864, DOI 10.1038/ismej.2017.126; Ondov BD, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0997-x; Parks DH, 2018, NAT BIOTECHNOL, V36, P996, DOI 10.1038/nbt.4229; Parks DH, 2017, NAT MICROBIOL, V2, P1533, DOI 10.1038/s41564-017-0012-7; Parks DH, 2015, GENOME RES, V25, P1043, DOI 10.1101/gr.186072.114; Pasolli E, 2019, CELL, V176, P649, DOI 10.1016/j.cell.2019.01.001; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pehrsson EC, 2016, NATURE, V533, P212, DOI 10.1038/nature17672; Podar M, 2007, APPL ENVIRON MICROB, V73, P3205, DOI 10.1128/AEM.02985-06; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Qin N, 2014, NATURE, V513, P59, DOI 10.1038/nature13568; Rampelli S, 2015, CURR BIOL, V25, P1682, DOI 10.1016/j.cub.2015.04.055; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Rossello-Mora R, 2001, FEMS MICROBIOL REV, V25, P39, DOI 10.1016/S0168-6445(00)00040-1; Sczyrba A, 2017, NAT METHODS, V14, P1063, DOI [10.1038/NMETH.4458, 10.1038/nmeth.4458]; Seemann T., 2013, BARRNAP 0 8 RAPID RI; Sieber CMK, 2018, NAT MICROBIOL, V3, P836, DOI 10.1038/s41564-018-0171-1; Smits SA, 2017, SCIENCE, V357, P802, DOI 10.1126/science.aan4834; Stewart RD, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03317-6; Sunagawa S, 2013, NAT METHODS, V10, P1196, DOI [10.1038/NMETH.2693, 10.1038/nmeth.2693]; Truong DT, 2015, NAT METHODS, V12, P902, DOI 10.1038/nmeth.3589; Tully BJ, 2018, SCI DATA, V5, DOI 10.1038/sdata.2017.203; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Varghese NJ, 2015, NUCLEIC ACIDS RES, V43, P6761, DOI 10.1093/nar/gkv657; Vatanen T, 2016, CELL, V165, P842, DOI 10.1016/j.cell.2016.04.007; Wattam AR, 2014, NUCLEIC ACIDS RES, V42, pD581, DOI 10.1093/nar/gkt1099; Wen CP, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1271-6; Wu DY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077033; Wu YW, 2016, BIOINFORMATICS, V32, P605, DOI 10.1093/bioinformatics/btv638; Yuan C, 2015, BIOINFORMATICS, V31, P35, DOI 10.1093/bioinformatics/btv231; Zhang X, 2015, NAT MED, V21, P895, DOI 10.1038/nm.3914; Zhu YL, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-19; Zou Y., NAT BIOTECHNOL, V37, P179	86	259	260	11	111	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 25	2019	568	7753					505	+		10.1038/s41586-019-1058-x	http://dx.doi.org/10.1038/s41586-019-1058-x			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HU9DR	30867587	Green Published, hybrid			2022-12-28	WOS:000465594200042
J	He, MG; Jiang, YZ; Huang, SS; Chang, DS; Munoz, B; Aung, T; Foster, PJ; Friedman, DS				He, Mingguang; Jiang, Yuzhen; Huang, Shengsong; Chang, Dolly S.; Munoz, Beatriz; Aung, Tin; Foster, Paul J.; Friedman, David S.			Laser peripheral iridotomy for the prevention of angle closure: a single-centre, randomised controlled trial	LANCET			English	Article							POPULATION-BASED-SURVEY; PROPHYLACTIC TREATMENT; CHINESE POPULATION; ADULT CHINESE; 5-YEAR RISK; GLAUCOMA; PREVALENCE; PROGRESSION; SUSPECTS; EYE	Background Primary angle-closure glaucoma affects 20 million people worldwide. People classified as primary angle closure suspects have a higher but poorly quantified risk of developing glaucoma. We aimed to assess efficacy and safety of laser peripheral iridotomy prophylaxis against primary angle-closure glaucoma in Chinese people classified as primary angle closure suspects. Methods In this randomised controlled trial, bilateral primary angle closure suspects aged 50-70 years were enrolled at the Zhongshan Ophthalmic Center, a tertiary specialised hospital in Guangzhou, China. Eligible patients received laser peripheral iridotomy in one randomly selected eye, with the other remaining untreated. The primary outcome was incident primary angle closure disease as a composite endpoint of elevation of intraocular pressure, peripheral anterior synechiae, or acute angle-closure during 72 months of follow-up in an intention-to-treat analysis between treated eyes and contralateral controls. This trial is registered with the ISRCTN registry, number ISRCTN45213099. Findings Of 11 991 screened individuals, 889 individuals were randomly assigned from June 19, 2008 (889 treated and 889 untreated eyes). Incidence of the primary outcome was 4.19 per 1000 eye-years in treated eyes compared with 7.97 per 1000 eye-years in untreated eyes (hazard ratio 0.53; 95% CI 0.30-0.92; p=0.024). A primary outcome event occurred in 19 treated eyes and 36 untreated eyes with a statistically significant difference using pair-wise analysis (p=0.0041). No serious adverse events were observed during follow-up. Interpretation Incidence of angle-closure disease was very low among individuals classified as primary angle closure suspects identified through community-based screening. Laser peripheral iridotomy had a modest, albeit significant, prophylactic effect. In view of the low incidence rate of outcomes that have no immediate threat to vision, the benefit of prophylactic laser peripheral iridotomy is limited; therefore, widespread prophylactic laser peripheral iridotomy for primary angle-closure suspects is not recommended. Funding Fight for Sight, the Sun Yat-Sen University 5010 Project Fund, Moorfields Eye Charity, and the National Natural Science Foundation of China. Copyright (c) 2019 Elsevier Ltd. All rights reserved.	[He, Mingguang; Huang, Shengsong] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, Clin Res Ctr, State Key Lab Ophthalmol, Guangzhou 510060, Guangdong, Peoples R China; [He, Mingguang] Univ Melbourne, Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, East Melbourne, Vic, Australia; [He, Mingguang; Jiang, Yuzhen; Foster, Paul J.] Moorfields Eye Hosp, Biomed Res Ctr, Natl Inst Hlth Res, London, England; [He, Mingguang; Jiang, Yuzhen; Foster, Paul J.] UCL Inst Ophthalmol, London EC1V 9EL, England; [Chang, Dolly S.; Munoz, Beatriz; Friedman, David S.] Wilmer Eye Inst, Dana Ctr Prevent Ophthalmol, Baltimore, MD 21287 USA; [Chang, Dolly S.; Munoz, Beatriz; Friedman, David S.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Aung, Tin] Natl Univ Singapore, Singapore Eye Res Inst, Singapore Natl Eye Ctr, Singapore Yong Loo Lin Sch Med, Singapore, Singapore	Sun Yat Sen University; Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National University of Singapore; Singapore National Eye Center	He, MG (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, Clin Res Ctr, State Key Lab Ophthalmol, Guangzhou 510060, Guangdong, Peoples R China.; Foster, PJ (corresponding author), UCL Inst Ophthalmol, London EC1V 9EL, England.	mingguang_he@yahoo.com; p.foster@ucl.ac.uk	Foster, Paul/V-7288-2019; He, Mingguang/AAY-5239-2020	Foster, Paul/0000-0002-4755-177X; He, Mingguang/0000-0002-6912-2810; Friedman, David/0000-0002-2055-5797	Fight for Sight; Sun Yat-Sen University 5010 Project Fund; Moorfields Eye Charity; National Natural Science Foundation of China	Fight for Sight; Sun Yat-Sen University 5010 Project Fund; Moorfields Eye Charity; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Fight for Sight, the Sun Yat-Sen University 5010 Project Fund, Moorfields Eye Charity, and the National Natural Science Foundation of China.	Ang LPK, 2000, OPHTHALMOLOGY, V107, P2092, DOI 10.1016/S0161-6420(00)00360-2; Arora KS, 2015, OPHTHALMOLOGY, V122, P1615, DOI 10.1016/j.ophtha.2015.04.015; Azuara-Blanco A, 2016, LANCET, V388, P1389, DOI 10.1016/S0140-6736(16)30956-4; Baskaran M, 2015, JAMA OPHTHALMOL, V133, P874, DOI 10.1001/jamaophthalmol.2015.1110; Congdon N, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.01.015; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Foster PJ, 2001, BRIT J OPHTHALMOL, V85, P1277, DOI 10.1136/bjo.85.11.1277; He MG, 2006, INVEST OPHTH VIS SCI, V47, P2782, DOI 10.1167/iovs.06-0051; Jiang YZ, 2014, OPHTHALMOLOGY, V121, P1699, DOI 10.1016/j.ophtha.2014.03.039; Jiang YZ, 2010, OPHTHAL EPIDEMIOL, V17, P321, DOI 10.3109/09286586.2010.508353; Keenan TDL, 2009, J GLAUCOMA, V18, P201, DOI 10.1097/IJG.0b013e318181540a; Liang YB, 2011, INVEST OPHTH VIS SCI, V52, P8672, DOI 10.1167/iovs.11-7480; LOWE RF, 1967, BRIT J OPHTHALMOL, V51, P727, DOI 10.1136/bjo.51.11.727; Narayanaswamy A, 2013, INVEST OPHTH VIS SCI, V54, P4621, DOI 10.1167/iovs.13-11950; Nolan WP, 2003, BRIT J OPHTHALMOL, V87, P271, DOI 10.1136/bjo.87.3.271; Office for National Statistics, 2016, EST POP UK ENGL WAL; Pakravan M, 2013, OPHTHALMOLOGY, V120, P1977, DOI 10.1016/j.ophtha.2013.02.029; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; ROBIN AL, 1982, ARCH OPHTHALMOL-CHIC, V100, P919, DOI 10.1001/archopht.1982.01030030927004; Sheth HG, 2005, EYE, V19, P981, DOI 10.1038/sj.eye.6701696; Song WL, 2011, OPHTHALMOLOGY, V118, P1982, DOI 10.1016/j.ophtha.2011.02.050; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; The Health and Social Care Information Centre Office for National Statistics, 2015, MAIN PROC INT ATT TY; Thomas R, 2003, ACTA OPHTHALMOL SCAN, V81, P480, DOI 10.1034/j.1600-0420.2003.00135.x; Thomas R, 2003, BRIT J OPHTHALMOL, V87, P450, DOI 10.1136/bjo.87.4.450; WILENSKY JT, 1993, AM J OPHTHALMOL, V115, P338, DOI 10.1016/S0002-9394(14)73585-8; Ye T, 1998, Zhonghua Yan Ke Za Zhi, V34, P167; Yip JLY, 2010, BRIT J OPHTHALMOL, V94, P1472, DOI 10.1136/bjo.2009.168682	28	87	97	4	38	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 20	2019	393	10181					1609	1618		10.1016/S0140-6736(18)32607-2	http://dx.doi.org/10.1016/S0140-6736(18)32607-2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU0DL	30878226	Green Submitted			2022-12-28	WOS:000464941500032
J	Hupert, N; Person, M; Hanfling, D; Traxler, RM; Bower, WA; Hendricks, K				Hupert, Nathaniel; Person, Marissa; Hanfling, Dan; Traxler, Rita M.; Bower, William A.; Hendricks, Katherine			Development and Performance of a Checklist for Initial Triage After an Anthrax Mass Exposure Event	ANNALS OF INTERNAL MEDICINE			English	Article							INHALATIONAL ANTHRAX; BIOTERRORISM; GUIDELINES; FRAMEWORK; OUTBREAK; SURGE	Background: Population exposure to Bacillus anthracis spores could cause mass casualties requiring complex medical care. Rapid identification of patients needing anthrax-specific therapies will improve patient outcomes and resource use. Objective: To develop a checklist that rapidly distinguishes most anthrax from nonanthrax illnesses on the basis of clinical presentation and identifies patients requiring diagnostic testing after a population exposure. Design: Comparison of published anthrax case reports from 1880 through 2013 that included patients seeking anthrax-related care at 2 epicenters of the 2001 U.S. anthrax attacks. Setting: Outpatient and inpatient. Patients: 408 case patients with inhalation, ingestion, and cutaneous anthrax and primary anthrax meningitis, and 657 control patients. Measurements: Diagnostic test characteristics, including positive and negative likelihood ratios (LRs) and patient triage assignation. Results: Checklist-directed triage without diagnostic testing correctly classified 95% (95% CI, 93% to 97%) of 353 adult anthrax case patients and 76% (CI, 73% to 79%) of 647 control patients (positive LR, 3.96 [CI, 3.45 to 4.55]; negative LR, 0.07 [CI, 0.04 to 0.11]; false-negative rate, 5%; false-positive rate, 24%). Diagnostic testing was needed for triage in up to 5% of case patients and 15% of control patients and improved overall test characteristics (positive LR, 8.90 [CI, 7.05 to 11.24]; negative LR, 0.06 [CI, 0.04 to 0.09]; false-negative rate, 5%; false-positive rate, 11%). Checklist sensitivity and specificity were minimally affected by inclusion of pediatric patients. Sensitivity increased to 97% (CI, 94% to 100%) and 98% (CI, 96% to 100%), respectively, when only inhalation anthrax cases or higher-quality case reports were investigated. Limitations: Data on case patients were limited to nonstandardized, published observational reports, many of which lacked complete data on symptoms and signs of interest. Reporting bias favoring more severe cases and lack of intercurrent outbreaks (such as influenza) in the control populations may have improved test characteristics. Conclusion: A brief checklist covering symptoms and signs can distinguish anthrax from other conditions with minimal need for diagnostic testing after known or suspected population exposure.	[Hupert, Nathaniel] Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Div Preparedness & Emerging Infect, 1600 Clifton Rd NE, Atlanta, GA 30329 USA; [Person, Marissa; Traxler, Rita M.; Bower, William A.; Hendricks, Katherine] Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Div High Consequence Pathogens & Pathol, 1600 Clifton Rd NE,MS H24-12, Atlanta, GA 30329 USA; [Hupert, Nathaniel] Weill Cornell Med, Dept Healthcare Policy & Res, 402 East 67th St,LA-219, New York, NY 10065 USA; [Hupert, Nathaniel] Weill Cornell Med, Dept Med, 402 East 67th St,LA-219, New York, NY 10065 USA; [Hupert, Nathaniel] NewYork Presbyterian Hosp, New York, NY USA; [Hanfling, Dan] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Hanfling, Dan] George Washington Univ, Washington, DC USA; [Hanfling, Dan] Inova Fairfax Hosp, Dept Emergency Med, 3300 Gallows Rd, Falls Church, VA 22042 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Cornell University; Cornell University; NewYork-Presbyterian Hospital; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; George Washington University; Inova Fairfax Hospital	Hendricks, K (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Div High Consequence Pathogens & Pathol, 1600 Clifton Rd NE,MS H24-12, Atlanta, GA 30329 USA.	wnu6@cdc.gov; kah1@cdc.gov			U.S. Department of Health and Human Services Assignment Agreement [IPA 1608836]	U.S. Department of Health and Human Services Assignment Agreement	Dr. Hupert was funded under U.S. Department of Health and Human Services Assignment Agreement IPA 1608836 to work on this project.	ABRAMOVA FA, 1993, P NATL ACAD SCI USA, V90, P2291, DOI 10.1073/pnas.90.6.2291; Barakat LA, 2002, JAMA-J AM MED ASSOC, V287, P863, DOI 10.1001/jama.287.7.863; Bower WA, 2015, MMWR RECOMM REP, V64, P1, DOI 10.15585/mmwr.rr6404a1; BRACHMAN PS, 1962, AM J PUBLIC HEALTH N, V52, P632, DOI 10.2105/AJPH.52.4.632; Centers for Disease Control and Prevention, 2001, 2000 2001 INFL SEAS; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P941; Cinti SK, 2004, ARCH INTERN MED, V164, P674, DOI 10.1001/archinte.164.6.674; Gagnier JJ, 2014, J CLIN EPIDEMIOL, V67, P46, DOI 10.1016/j.jclinepi.2013.08.003; Gostin LO, 2009, JAMA-J AM MED ASSOC, V302, P2365, DOI 10.1001/jama.2009.1780; Hanfling D., 2012, CRISIS STANDARDS CAR; Hanfling D, 2012, JAMA-J AM MED ASSOC, V308, P675, DOI 10.1001/jama.2012.8171; Hendricks Katherine A, 2014, Emerg Infect Dis, V20, DOI 10.3201/eid2002.130687; Hick JL, 2004, ANN EMERG MED, V44, P253, DOI 10.1016/j.annemergmed.2004.04.011; Holty JEC, 2006, ANN EMERG MED, V48, P200, DOI 10.1016/j.annemergmed.2005.11.035; Hupert N, 2003, ANN INTERN MED, V139, P337, DOI 10.7326/0003-4819-139-5_Part_1-200309020-00009; Hupert N, 2009, MED DECIS MAKING, V29, P424, DOI 10.1177/0272989X09341389; Inglesby TV, 2002, JAMA-J AM MED ASSOC, V287, P2236, DOI 10.1001/jama.287.17.2236; Jernigan DB, 2002, EMERG INFECT DIS, V8, P1019, DOI 10.3201/eid0810.020353; Jernigan JA, 2001, EMERG INFECT DIS, V7, P933, DOI 10.3201/eid0706.010604; Katharios-Lanwermeyer S, 2016, CLIN INFECT DIS, V62, P1537, DOI 10.1093/cid/ciw184; Kuehnert MJ, 2003, CLIN INFECT DIS, V36, P328, DOI 10.1086/346035; Kyriacou DN, 2004, LANCET, V364, P449, DOI 10.1016/S0140-6736(04)16769-X; Lavergne V, 2014, SEMIN DIALYSIS, V27, P407, DOI 10.1111/sdi.12251; Martin GF, 2015, MANDELL DOUGLAS BENN, P2391; Mayer TA, 2003, CLIN INFECT DIS, V36, P1275, DOI 10.1086/374843; Mayo L., 2010, Morbidity and Mortality Weekly Report, V59, P872; MESELSON M, 1994, SCIENCE, V266, P1202, DOI 10.1126/science.7973702; Pillai SK, 2015, HEALTH SECUR, V13, P355, DOI 10.1089/hs.2015.0033; Puerini R, 2015, HEALTH SECUR, V13, P54, DOI 10.1089/hs.2014.0078; Schmitt K, 2012, BIOSECUR BIOTERROR, V10, P98, DOI 10.1089/bsp.2010.0053; Simel DL, 2009, RATIONAL CLIN EXAMIN; Sox HC, 2003, ANN INTERN MED, V139, P379, DOI 10.7326/0003-4819-139-5_Part_1-200309020-00014; World Health Organization, 1970, HLTH ASP CHEM BIOL W; 2012, J AM MED INFORM ASSN, V19, P1075, DOI DOI 10.1136/AMIAJNL-2011-000793; 2004, CLIN INFECT DIS, V39, P1842; 2006, ANN INTERN MED, V144, P270, DOI DOI 10.7326/0003-4819-144-4-200602210-00009	36	5	5	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 16	2019	170	8					521	+		10.7326/M18-1817	http://dx.doi.org/10.7326/M18-1817			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU7YQ	30884525				2022-12-28	WOS:000465499900015
J	Gazzard, G; Konstantakopoulou, E; Garway-Heath, D; Garg, A; Vickerstaff, V; Hunter, R; Ambler, G; Bunce, C; Wormald, R; Nathwani, N; Barton, K; Rubin, G; Buszewicz, M; Bourne, R; Broadway, D; Bunce, C; Buszewicz, M; Davis, A; Jayaram, H; Jiang, YZ; Lim, S; Liput, J; Manners, T; Morris, S; Strouthidis, N; Wilson, S; Wormald, R; Zhu, HG				Gazzard, Gus; Konstantakopoulou, Evgenia; Garway-Heath, David; Garg, Anurag; Vickerstaff, Victoria; Hunter, Rachael; Ambler, Gareth; Bunce, Catey; Wormald, Richard; Nathwani, Neil; Barton, Keith; Rubin, Gary; Buszewicz, Marta; Bourne, Rupert; Broadway, David; Bunce, Catey; Buszewicz, Marta; Davis, Amanda; Jayaram, Hari; Jiang, Yuzhen; Lim, Sheng; Liput, Joanna; Manners, Timothy; Morris, Stephen; Strouthidis, Nicholas; Wilson, Sarah; Wormald, Richard; Zhu, Haogang		LiGHT Trial Study Grp	Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial	LANCET			English	Article							VISUAL-FIELD LOSS; QUALITY-OF-LIFE; INTRAOCULAR-PRESSURE; MEDICATION; INDEX	Background Primary open angle glaucoma and ocular hypertension are habitually treated with eye drops that lower intraocular pressure. Selective laser trabeculoplasty is a safe alternative but is rarely used as first-line treatment. We compared the two. Methods In this observer-masked, randomised controlled trial treatment-naive patients with open angle glaucoma or ocular hypertension and no ocular comorbidities were recruited between 2012 and 2014 at six UK hospitals. They were randomly allocated (web-based randomisation) to initial selective laser trabeculoplasty or to eye drops. An objective target intraocular pressure was set according to glaucoma severity. The primary outcome was health-related quality of life (HRQoL) at 3 years (assessed by EQ-5D). Secondary outcomes were cost and cost-effectiveness, disease-specific HRQoL, clinical effectiveness, and safety. Analysis was by intention to treat. This study is registered at controlled-trials.com (ISRCTN32038223). Findings Of 718 patients enrolled, 356 were randomised to the selective laser trabeculoplasty and 362 to the eye drops group. 652 (91%) returned the primary outcome questionnaire at 36 months. Average EQ-5D score was 0.89 (SD 0.18) in the selective laser trabeculoplasty group versus 0.90 (SD 0.16) in the eye drops group, with no significant difference (difference 0.01, 95% CI -0.01 to 0.03; p=0.23). At 36 months, 74.2% (95% CI 69.3-78.6) of patients in the selective laser trabeculoplasty group required no drops to maintain intraocular pressure at target. Eyes of patients in the selective laser trabeculoplasty group were within target intracoluar pressure at more visits (93.0%) than in the eye drops group (91.3%), with glaucoma surgery to lower intraocular pressure required in none versus 11 patients. Over 36 months, from an ophthalmology cost perspective, there was a 97% probability of selective laser trabeculoplasty as first treatment being more cost-effective than eye drops first at a willingness to pay of 20 pound 000 per quality-adjusted life-year gained. Interpretation Selective laser trabeculoplasty should be offered as a first-line treatment for open angle glaucoma and ocular hypertension, supporting a change in clinical practice. Copyright (C) 2019 The Author(s). Published by Elsevier Ltd.	[Gazzard, Gus; Konstantakopoulou, Evgenia; Garway-Heath, David; Garg, Anurag; Bunce, Catey; Wormald, Richard; Nathwani, Neil; Barton, Keith] Moorfields Eye Hosp NHS Fdn Trust, NIHR Biomed Res Ctr, London EC1V 2PD, England; [Gazzard, Gus; Konstantakopoulou, Evgenia; Garway-Heath, David; Garg, Anurag; Wormald, Richard; Barton, Keith; Rubin, Gary] UCL, Inst Ophthalmol, London, England; [Vickerstaff, Victoria] UCL, Marie Curie Palliat Care Res Dept, UCL Div Psychiat, London, England; [Vickerstaff, Victoria; Hunter, Rachael; Buszewicz, Marta] UCL, Res Dept Primary Care & Populat Hlth, London, England; [Ambler, Gareth] UCL, Dept Stat Sci, London, England; [Bunce, Catey] Kings Coll London, Sch Populat Hlth & Environm Sci, Fac Life Sci & Med, London, England; [Wormald, Richard] London Sch Hyg & Trop Med, London, England	University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of London; King's College London; University of London; London School of Hygiene & Tropical Medicine	Gazzard, G (corresponding author), Moorfields Eye Hosp NHS Fdn Trust, NIHR Biomed Res Ctr, London EC1V 2PD, England.	gus.gazzard@moorfields.nhs.uk	Domingue, Amayah/AAZ-5106-2020; Konstantakopoulou, Evgenia/AAL-2831-2021; Jayaram, Hari/H-7016-2019; Hunter, Rachael Maree/H-7846-2019; Konstantakopoulou, Evgenia/AAA-9492-2021	Konstantakopoulou, Evgenia/0000-0001-8215-2689; Jayaram, Hari/0000-0003-1998-0670; Hunter, Rachael Maree/0000-0002-7447-8934; Konstantakopoulou, Evgenia/0000-0001-8215-2689; Vickerstaff, Victoria/0000-0002-3119-670X; Bunce, Catey/0000-0002-0935-3713; Gazzard, Gus/0000-0003-1982-5005; Brady, Tony/0000-0003-4751-7616; Barton, Keith/0000-0001-9345-7410	National Institute for Health Research, Health and Technology Assessment Programme; National Institute of Health Research (NIHR) Health Technology Assessment Panel [09/104/40]; Moorfields Eye Hospital NHS Foundation Trust; NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust; Moorfields Eye Charity; Fight for Sight; International Glaucoma Association; British Council for the Prevention of Blindness	National Institute for Health Research, Health and Technology Assessment Programme; National Institute of Health Research (NIHR) Health Technology Assessment Panel; Moorfields Eye Hospital NHS Foundation Trust; NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust; Moorfields Eye Charity; Fight for Sight; International Glaucoma Association; British Council for the Prevention of Blindness	National Institute for Health Research, Health and Technology Assessment Programme.; The trial was funded by National Institute of Health Research (NIHR) Health Technology Assessment Panel (project reference number 09/104/40) and was sponsored by Moorfields Eye Hospital NHS Foundation Trust. This report presents independent research commissioned by the NIHR; the views and opinions expressed in this publication are those of the authors and do not necessarily reflect those of the NHS, the NIHR, the Medical Research Council, Central Commissioning Facility, NIHR Evaluation, Trials and Studies Coordinating Centre, the Health Technology Assessment programme, or the Department of Health. We thank the NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust for supporting the trial and Moorfields Eye Charity, Fight for Sight, International Glaucoma Association, and the British Council for the Prevention of Blindness for funding ancillary studies and staff. We thank Prof Stephen Morris for his contribution to the design of the cost-effectiveness analysis, Dr Amanda Davis for supporting trial management, and Emily Dowse and Karine Girard-Glaudon for clinical support. We are grateful to Prof John Sparrow (Trial Steering Committee chair) and John Salmon (Data Monitoring Committee chair). We also thank the LiGHT participants and all recruiting sites. Our particular recognitions and remembrances are for Dominic Carrington (Moorfields research technician) who sadly and suddenly passed away, shortly before the completion of the study.	Alliance James Lind, GLAUCOMA TOP 10; American Academy of Ophthalmology, 2003, PREF PRACT PATT PRIM; [Anonymous], 2018, BRIT NATL FORMULARY; Aspinall PA, 2008, INVEST OPHTH VIS SCI, V49, P1907, DOI 10.1167/iovs.07-0559; BROADWAY DC, 1994, ARCH OPHTHALMOL-CHIC, V112, P1446, DOI 10.1001/archopht.1994.01090230060021; Bunce C, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-58; Burr JM, 2007, OPTOMETRY VISION SCI, V84, P797, DOI 10.1097/OPX.0b013e3181339f30; Cantor LB, 2008, CURR MED RES OPIN, V24, P2905, DOI 10.1185/03007990802379996 ; Damji KF, 2003, CAN J OPHTHALMOL, V38, P189, DOI 10.1016/S0008-4182(03)80060-1; European Glaucoma Society, 2020, TERM GUID GLAUC; Garg A, 2018, EYE, V32, P863, DOI 10.1038/eye.2017.273; Garway-Heath DF, 2015, LANCET, V385, P1295, DOI 10.1016/S0140-6736(14)62111-5; Gazzard G, 2018, BRIT J OPHTHALMOL, V102, P593, DOI 10.1136/bjophthalmol-2017-310877; GREENIDGE KC, 1983, OPHTHALMOLOGY, V90, P800; Haymes SA, 2008, INVEST OPHTH VIS SCI, V49, P3035, DOI 10.1167/iovs.07-1609; Haymes SA, 2007, INVEST OPHTH VIS SCI, V48, P1149, DOI 10.1167/iovs.06-0886; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; Kirwan JF, 2002, BRIT MED J, V325, P1396, DOI 10.1136/bmj.325.7377.1396; Konstantakopoulou E, 2018, BRIT J OPHTHALMOL, V102, P599, DOI 10.1136/bjophthalmol-2017-310870; Lee BL, 1998, ARCH OPHTHALMOL-CHIC, V116, P861, DOI 10.1001/archopht.116.7.861; Lee R, 2006, CAN J OPHTHALMOL, V41, P449, DOI 10.1016/S0008-4182(06)80006-2; Li XY, 2015, BMC OPHTHALMOL, V15, DOI 10.1186/s12886-015-0091-2; McIlraith I, 2006, J GLAUCOMA, V15, P124, DOI 10.1097/00061198-200604000-00009; Medeiros FA, 2015, OPHTHALMOLOGY, V122, P293, DOI 10.1016/j.ophtha.2014.08.014; Medicines and Healthcare products Regulatory Agency, 2010, GOOD CLIN PRACT; Mills RP, 2006, AM J OPHTHALMOL, V141, P24, DOI 10.1016/j.ajo.2005.07.044; Nagar M, 2005, BRIT J OPHTHALMOL, V89, P1413, DOI 10.1136/bjo.2004.052795; Nagar M, 2009, BRIT J OPHTHALMOL, V93, P497, DOI 10.1136/bjo.2008.148510; National Institute for Health and Clinical Excellence, 2010, NICE GUID GLAUC DIAG; Nordmann Jean-Philippe, 2003, Health Qual Life Outcomes, V1, P75, DOI 10.1186/1477-7525-1-75; Office of Health Economics, OHE SEM LAUNCH AN EQ; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Saunders LJ, 2014, INVEST OPHTH VIS SCI, V55, P102, DOI 10.1167/iovs.13-13006; Saunders LJ, 2012, BRIT J OPHTHALMOL, V96, P1185, DOI 10.1136/bjophthalmol-2012-301827; Schwartz GR, 2008, SURV OPHTHALMOL, V53, pS57, DOI 10.1016/j.survophthal.2008.08.002; South East Asia Gluacoma Interest Group (SEAGIG), 2003, S E AS GLUAC INT GRO; Vickerstaff V, 2015, TRIALS, V16, DOI 10.1186/s13063-015-1047-9; Wong MOM, 2015, SURV OPHTHALMOL, V60, P36, DOI 10.1016/j.survophthal.2014.06.006	39	201	209	9	36	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 13	2019	393	10180					1505	1516		10.1016/S0140-6736(18)32213-X	http://dx.doi.org/10.1016/S0140-6736(18)32213-X			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU0DA	30862377	Green Published, hybrid			2022-12-28	WOS:000464940400026
J	Chapron, G; Epstein, Y; Lopez-Bao, JV				Chapron, Guillaume; Epstein, Yaffa; Lopez-Bao, Jose Vicente			A rights revolution for nature	SCIENCE			English	Editorial Material									[Chapron, Guillaume] Swedish Univ Agr Sci, Dept Ecol, S-73091 Riddarhyttan, Sweden; [Epstein, Yaffa] Uppsala Univ, Fac Law, Box 512, S-75120 Uppsala, Sweden; [Lopez-Bao, Jose Vicente] Oviedo Univ, Res Unit Biodivers, Mieres 33600, Spain	Swedish University of Agricultural Sciences; Uppsala University	Chapron, G (corresponding author), Swedish Univ Agr Sci, Dept Ecol, S-73091 Riddarhyttan, Sweden.	guillaume.chapron@slu.se; yaffa.epstein@jur.uu.se			Swedish Research Council Formas; Ragnar Soderberg Foundation; Ramon y Cajal fellowship from the Spanish Ministry of Economy, Industry, and Competitiveness	Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Ragnar Soderberg Foundation; Ramon y Cajal fellowship from the Spanish Ministry of Economy, Industry, and Competitiveness	G.C. is supported by the Swedish Research Council Formas, Y.E. by the Ragnar Soderberg Foundation, and J.V.L.-B. by a Ramon y Cajal fellowship from the Spanish Ministry of Economy, Industry, and Competitiveness.	Berry T., 2015, EVENING THOUGHTS REF; BOYD DAVID, 2017, RIGHTS NATURE LEGAL; Bradshaw K., 2018, U COLO LAW REV, V89, P809; Chapron G, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0086; Hadley J., 2015, ANIMAL PROPERTY RIGH; Houck Oliver A., 2017, TUL ENV LJ, V31, P16; Jones Peter, 2018, HUMAN RIGHTS MORAL P, P441; Kotze LJ, 2017, TRANSNATL ENVIRON LA, V6, P401, DOI 10.1017/S2047102517000061; Mace GM, 2018, NAT SUSTAIN, V1, P448, DOI 10.1038/s41893-018-0130-0; Nussbaum M., 2006, DISABILITY NATL SPEC; Pascual U, 2017, CURR OPIN ENV SUST, V26-27, P7, DOI 10.1016/j.cosust.2016.12.006; Raz J., 1986, MORALITY FREEDOM, P166; Regan T., 2004, CASE ANIMAL RIGHTS; Schaefer S. J., 2018, J ENERGY ENV LAW, V9, P70; Stone C.D., 2010, SHOULD TREES HAVE ST, VThird Edition	15	57	58	4	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 29	2019	363	6434					1392	1393		10.1126/science.aav5601	http://dx.doi.org/10.1126/science.aav5601			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ9HP	30872530				2022-12-28	WOS:000462738000014
J	Landoni, G; Lomivorotov, VV; Neto, CN; Monaco, F; Pasyuga, VV; Bradic, N; Lembo, R; Gazivoda, G; Likhvantsev, VV; Lei, C; Lozovskiy, A; Di Tomasso, N; Bukamal, NAR; Silva, FS; Bautin, AE; Ma, J; Crivellari, M; Farag, AMGA; Uvaliev, NS; Carollo, C; Pieri, M; Kunstyr, J; Wang, CY; Belletti, A; Hajjar, LA; Grigoryev, EV; Agro, FE; Riha, H; El-Tahan, MR; Scandroglio, AM; Elnakera, AM; Baiocchi, M; Navalesi, P; Shmyrev, VA; Severi, L; Hegazy, MA; Crescenzi, G; Ponomarev, DN; Brazzi, L; Arnoni, R; Tarasov, DG; Jovic, M; Calabro, MG; Bove, T; Bellomo, R; Zangrillo, A				Landoni, Giovanni; Lomivorotov, Vladimir V.; Neto, Caetano Nigro; Monaco, Fabrizio; Pasyuga, Vadim V.; Bradic, Nikola; Lembo, Rosalba; Gazivoda, Gordana; Likhvantsev, Valery V.; Lei, Chong; Lozovskiy, Andrey; Di Tomasso, Nora; Bukamal, Nazar A. R.; Silva, Fernanda S.; Bautin, Andrey E.; Ma, Jun; Crivellari, Martina; Farag, Ahmed M. G. A.; Uvaliev, Nikolay S.; Carollo, Cristiana; Pieri, Marina; Kunstyr, Jan; Wang, Chew Yin; Belletti, Alessandro; Hajjar, Ludhmila A.; Grigoryev, Evgeny V.; Agro, Felice E.; Riha, Hynek; El-Tahan, Mohamed R.; Scandroglio, A. Mara; Elnakera, Abeer M.; Baiocchi, Massimo; Navalesi, Paolo; Shmyrev, Vladimir A.; Severi, Luca; Hegazy, Mohammed A.; Crescenzi, Giuseppe; Ponomarev, Dmitry N.; Brazzi, Luca; Arnoni, Renato; Tarasov, Dmitry G.; Jovic, Miomir; Calabro, Maria G.; Bove, Tiziana; Bellomo, Rinaldo; Zangrillo, Alberto		MYRIAD Study Grp	Volatile Anesthetics versus Total Intravenous Anesthesia for Cardiac Surgery	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; ARTERY-BYPASS SURGERY; MYOCARDIAL PROTECTION; RANDOMIZED EVIDENCE; ON-PUMP; SEVOFLURANE; MORTALITY; COMPLICATIONS; REVASCULARIZATION; CARDIOPROTECTION	BACKGROUND Volatile (inhaled) anesthetic agents have cardioprotective effects, which might improve clinical outcomes in patients undergoing coronary-artery bypass grafting (CABG). METHODS We conducted a pragmatic, multicenter, single-blind, controlled trial at 36 centers in 13 countries. Patients scheduled to undergo elective CABG were randomly assigned to an intraoperative anesthetic regimen that included a volatile anesthetic (desflurane, isoflurane, or sevoflurane) or to total intravenous anesthesia. The primary outcome was death from any cause at 1 year. RESULTS A total of 5400 patients were randomly assigned: 2709 to the volatile anesthetics group and 2691 to the total intravenous anesthesia group. On-pump CABG was performed in 64% of patients, with a mean duration of cardiopulmonary bypass of 79 minutes. The two groups were similar with respect to demographic and clinical characteristics at baseline, the duration of cardiopulmonary bypass, and the number of grafts. At the time of the second interim analysis, the data and safety monitoring board advised that the trial should be stopped for futility. No significant difference between the groups with respect to deaths from any cause was seen at 1 year (2.8% in the volatile anesthetics group and 3.0% in the total intravenous anesthesia group; relative risk, 0.94; 95% confidence interval [CI], 0.69 to 1.29; P=0.71), with data available for 5353 patients (99.1%), or at 30 days (1.4% and 1.3%, respectively; relative risk, 1.11; 95% CI, 0.70 to 1.76), with data available for 5398 patients (99.9%). There were no significant differences between the groups in any of the secondary outcomes or in the incidence of prespecified adverse events, including myocardial infarction. CONCLUSIONS Among patients undergoing elective CABG, anesthesia with a volatile agent did not result in significantly fewer deaths at 1 year than total intravenous anesthesia.	[Landoni, Giovanni; Monaco, Fabrizio; Lembo, Rosalba; Di Tomasso, Nora; Crivellari, Martina; Pieri, Marina; Belletti, Alessandro; Scandroglio, A. Mara; Calabro, Maria G.; Zangrillo, Alberto] IRCCS San Raffaele Sci Inst, Dept Anesthesia & Intens Care, Via Olgettina 60, I-20132 Milan, Italy; [Landoni, Giovanni; Zangrillo, Alberto] Univ Vita Salute San Raffaele, Milan, Italy; [Carollo, Cristiana] Azienda Osped Padova, Ist Anestesia & Rianimaz, Padua, Italy; [Agro, Felice E.] Univ Campus Biomed Rome, Anesthesia & Intens Care Dept, Rome, Italy; [Severi, Luca] Azienda Osped San Camillo Forlanini, Dipartimento Cardiovasc, Anestesia & Rianimaz, Rome, Italy; [Baiocchi, Massimo] Univ Hosp Policlin S Orsola, Dept Cardiothorac & Vasc Anesthesia & Intens Care, Bologna, Italy; [Navalesi, Paolo] Magna Graecia Univ Catanzaro, Dipartimento Sci Med & Chirurg, Catanzaro, Italy; [Crescenzi, Giuseppe] Ist Clin Humanitas, Anestesia & Terapia Intens Cardiochirurg, Rozzano, Italy; [Brazzi, Luca] Citta Salute Sci Hosp, Dept Anesthesia Intens Care & Emergency, Turin, Italy; [Brazzi, Luca] Univ Turin, Dept Surg Sci, Turin, Italy; [Bove, Tiziana] Univ Udine, Dept Med, Anesthesiol & Intens Care Clin, Udine, Italy; [Lomivorotov, Vladimir V.; Shmyrev, Vladimir A.; Ponomarev, Dmitry N.] E Meshalkin Natl Med Res Ctr, Dept Anesthesiol & Intens Care, Novosibirsk, Russia; [Pasyuga, Vadim V.] Fed Ctr Cardiovasc Surg Astrakhan, Dept Anesthesiol & Intens Care, Astrakhan, Russia; [Tarasov, Dmitry G.] Fed Ctr Cardiovasc Surg Astrakhan, Dept Cardiac Surg, Astrakhan, Russia; [Pasyuga, Vadim V.; Likhvantsev, Valery V.] First Moscow State Med Univ, Dept Anesthesia & Intens Care, Moscow, Russia; [Likhvantsev, Valery V.] Moscow Reg Clin & Res Inst, Dept Intens Care, Moscow, Russia; [Lozovskiy, Andrey] Ural Inst Cardiol, Dept Anesthesia & Intens Care, Ekaterinburg, Russia; [Bautin, Andrey E.] Almazov Natl Med Res Ctr, Lab Anesthesiol & Intens Care, St Petersburg, Russia; [Grigoryev, Evgeny V.] Sci Res Inst Complex Issues Cardiovasc Dis, Intens Care Unit, Kemerovo, Russia; [Neto, Caetano Nigro] Univ Sao Paulo, Anesthesia Sect, Dept Surg, Dante Pazzanese Inst Cardiol, Sao Paulo, Brazil; Univ Sao Paulo, Dept Cardiopneumol, Inst Coracao, Sao Paulo, Brazil; [Hajjar, Ludhmila A.] Hosp SirioLibanes, Intens Care Unit, Sao Paulo, Brazil; [Arnoni, Renato] Dante Pazzanese Inst Cardiol, Dept Surg, Cardiac Surg Sect, Sao Paulo, Brazil; [Bradic, Nikola] Univ Hosp Dubrava, Dept Cardiovasc Anesthesiol & Intens Care Med, Zagreb, Croatia; [Bradic, Nikola] Univ Hosp Dubrava, Clin Dept Anesthesiol Resuscitat & Intens Care Me, Zagreb, Croatia; [Bradic, Nikola] Univ North, Dept Biomed Sci, Varazhdin, Croatia; [Gazivoda, Gordana; Jovic, Miomir] Univ Belgrade, Cardiovasc Inst Dedinje, Dept Anesthesia & Intens Care, Belgrade, Serbia; [Jovic, Miomir] Univ Belgrade, Sch Med, Belgrade, Serbia; [Lei, Chong] Fourth Mil Med Univ, Xijing Hosp, Dept Anesthesiol & Perioperat Med, Xian, Shaanxi, Peoples R China; [Ma, Jun] Capital Med Univ, Beijing Anzhen Hosp, Ctr Anesthesiol, Beijing, Peoples R China; [Bukamal, Nazar A. R.] Mohammed Bin Khalifa Cardiac Ctr, Cardiothorac Intens Care Unit, Riffa, Bahrain; [Bukamal, Nazar A. R.] Mohammed Bin Khalifa Cardiac Ctr, Dept Anesthesia, Riffa, Bahrain; [Silva, Fernanda S.] Hosp Santa Maria, Dept Anesthesiol, Lisbon, Portugal; [Farag, Ahmed M. G. A.] King Abdullah Med City Holy Capital, Dept Anesthesia, Mecca, Saudi Arabia; [El-Tahan, Mohamed R.] Imam Abdulrahman Bin Faisal Univ, Coll Med, Dept Anesthesiol, Dammam, Saudi Arabia; [Uvaliev, Nikolay S.] Acibadem City Clin Cardiac Surg Ctr, Anesthesia & Intens Care, Burgas, Bulgaria; [Kunstyr, Jan] Charles Univ Prague, Dept Anesthesiol Resuscitat & Intens Med, Fac Med 1, Prague, Czech Republic; [Kunstyr, Jan] Gen Teaching Hosp, Prague, Czech Republic; [Riha, Hynek] Inst Clin & Expt Med, Cardiothorac Anesthesiol & Intens Care, Dept Anesthesiol & Intens Care Med, Prague, Czech Republic; [Wang, Chew Yin] Univ Malaya, Dept Anesthesiol, Fac Med, Kuala Lumpur, Malaysia; [Elnakera, Abeer M.] Zagazig Univ Hosp, Anesthesia & Surg Intens Care Dept, Fac Med, Zagazig, Egypt; [Hegazy, Mohammed A.] Mansoura Univ, Dept Anesthesia & Surg Intens Care, Mansoura, Egypt; [Bellomo, Rinaldo] Univ Melbourne, Sch Med, Melbourne, Vic, Australia	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; University of Padua; Azienda Ospedaliera - Universita di Padova; University Campus Bio-Medico - Rome Italy; Azienda Ospedaliera San Camillo-Forlanini; IRCCS Azienda Ospedaliero-Universitaria di Bologna; Magna Graecia University of Catanzaro; IRCCS Humanitas Research Hospital; A.O.U. Citta della Salute e della Scienza di Torino; University of Turin; University of Udine; Meshalkin National Medical Research Center; Sechenov First Moscow State Medical University; Almazov National Medical Research Centre; Russian Academy of Medical Sciences; Research Institute for Complex Issues of Cardiovascular Diseases; Instituto Dante Pazzanese de Cardiologia; Universidade de Sao Paulo; Universidade de Sao Paulo; Hospital Sirio Libanes; Instituto Dante Pazzanese de Cardiologia; University North - Croatia; University of Belgrade; University of Belgrade; Air Force Military Medical University; Capital Medical University; Universidade de Lisboa; Hospital Santa Maria; King Abdullah Medical City; Imam Abdulrahman Bin Faisal University; Charles University Prague; General University Hospital Prague; General University Hospital Prague; Institute for Clinical & Experimental Medicine (IKEM); Universiti Malaya; Egyptian Knowledge Bank (EKB); Zagazig University; Egyptian Knowledge Bank (EKB); Mansoura University; University of Melbourne	Landoni, G (corresponding author), IRCCS San Raffaele Sci Inst, Dept Anesthesia & Intens Care, Via Olgettina 60, I-20132 Milan, Italy.	landoni.giovanni@hsr.it	Monaco, Fabrizio/GZA-9167-2022; Grigoryev, Evgeny/A-2321-2017; Baiocchi, Massimo/AGJ-6047-2022; Navalesi, Paolo/F-9559-2010; Tahan, Mohamed R El/A-3124-2015; Ovezov, Alexey M/A-8069-2016; Giovanni, Landoni/AAH-1881-2019; Bradic, Nikola/HDL-9677-2022; Pisano, Antonio/AAG-1028-2020; Belletti, Alessandro/I-1981-2019; Navalesi, Paolo/I-9584-2019; Crescenzi, Giuseppe/AAB-5922-2022; Arnoni, Renato/R-5006-2016; Zangrillo, Alberto/AAH-2037-2019; Di Tomasso, Nora/ABD-7006-2020; Brazzi, Luca/AAS-4978-2020; Ovezov, Alexey Muradovich/AAP-3404-2021; Bove, Tiziana/AAC-2109-2022; Farag, Ahmed M. G. A./C-9014-2019; Wang, Chew Yin/F-7573-2010; Neto, Caetano Nigro/M-4649-2016; Adel, Mohammed/G-4791-2019; Likhvantsev, Valery/A-4893-2016	Monaco, Fabrizio/0000-0001-5186-1976; Grigoryev, Evgeny/0000-0001-8370-3083; Baiocchi, Massimo/0000-0001-7909-6399; Navalesi, Paolo/0000-0002-3733-3453; Tahan, Mohamed R El/0000-0002-9730-6406; Ovezov, Alexey M/0000-0001-7629-6280; Giovanni, Landoni/0000-0002-8594-5980; Bradic, Nikola/0000-0002-7653-1698; Pisano, Antonio/0000-0002-5118-444X; Belletti, Alessandro/0000-0003-3131-0565; Navalesi, Paolo/0000-0002-3733-3453; Crescenzi, Giuseppe/0000-0001-7408-118X; Arnoni, Renato/0000-0002-4623-7834; Zangrillo, Alberto/0000-0002-7687-7648; Di Tomasso, Nora/0000-0001-5706-8928; Brazzi, Luca/0000-0001-7059-0622; Ovezov, Alexey Muradovich/0000-0001-7629-6280; Neto, Caetano Nigro/0000-0001-8134-3440; Adel, Mohammed/0000-0002-2482-718X; BOVE, Tiziana/0000-0002-5489-2898; Shmyrev, Vladimir/0000-0002-3883-2596; Bautin, Andrei/0000-0001-5031-7637; Likhvantsev, Valery/0000-0002-5442-6950; AGRO', FELICE EUGENIO/0000-0001-8208-1120; Riha, Hynek/0000-0002-9861-7361; Abrahao Hajjar, Ludhmila/0000-0001-5645-2055; Kunst, Gudrun/0000-0002-9789-1334; Barreiros, Catarina/0000-0002-7189-2072	Italian Ministry of Health	Italian Ministry of Health(Ministry of Health, Italy)	Funded by the Italian Ministry of Health; MYRIAD ClinicalTrials.gov number, NCT02105610.	Alexander JH, 2016, NEW ENGL J MED, V374, P1954, DOI 10.1056/NEJMra1406944; Benjamin EJ, 2018, CIRCULATION, V137, pE67, DOI 10.1161/CIR.0000000000000558; Conzen PF, 2003, ANESTHESIOLOGY, V99, P826, DOI 10.1097/00000542-200310000-00013; De Hert S, 2009, ANAESTHESIA, V64, P953, DOI 10.1111/j.1365-2044.2009.06008.x; DeMets DL, 1999, LANCET, V354, P1983, DOI 10.1016/S0140-6736(99)03464-9; Farkouh ME, 2012, NEW ENGL J MED, V367, P2375, DOI 10.1056/NEJMoa1211585; Garcia C, 2005, BRIT J ANAESTH, V94, P159, DOI 10.1093/bja/aei026; Guarracino F, 2006, J CARDIOTHOR VASC AN, V20, P477, DOI 10.1053/j.jvca.2006.05.012; Head SJ, 2013, EUR HEART J, V34, P2862, DOI 10.1093/eurheartj/eht330; Hillis LD, 2011, CIRCULATION, V124, pE652, DOI 10.1161/CIR.0b013e31823c074e; Jakobsen CJ, 2007, J CARDIOTHOR VASC AN, V21, P664, DOI 10.1053/j.jvca.2007.03.002; Kapur A, 2010, J AM COLL CARDIOL, V55, P432, DOI 10.1016/j.jacc.2009.10.014; Kunst G, 2015, ANAESTHESIA, V70, P467, DOI 10.1111/anae.12975; Landoni G, 2014, BRIT J ANAESTH, V113, P955, DOI 10.1093/bja/aeu290; Landoni G, 2013, BRIT J ANAESTH, V111, P886, DOI 10.1093/bja/aet231; Landoni G, 2007, J CARDIOTHOR VASC AN, V21, P502, DOI 10.1053/j.jvca.2007.02.013; Landoni G, 2017, CONTEMP CLIN TRIALS, V59, P38, DOI 10.1016/j.cct.2017.05.011; Landoni G, 2017, J CARDIOTHOR VASC AN, V31, P719, DOI 10.1053/j.jvca.2016.07.017; Landoni G, 2012, J CARDIOTHOR VASC AN, V26, P764, DOI 10.1053/j.jvca.2012.04.018; Lee MC, 2006, EUR J ANAESTH, V23, P841, DOI 10.1017/S0265021506000354; Likhvantsev VV, 2016, J CARDIOTHOR VASC AN, V30, P1221, DOI 10.1053/j.jvca.2016.02.030; Meco M, 2007, EUR J CARDIO-THORAC, V32, P319, DOI 10.1016/j.ejcts.2007.05.005; Moazzami K, 2017, J CARDIOTHOR VASC AN, V31, P19, DOI 10.1053/j.jvca.2016.08.008; Muntean DM, 2013, FUND CLIN PHARMACOL, V27, P21, DOI 10.1111/j.1472-8206.2012.01055.x; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Ovize M, 2013, CIRC RES, V113, P439, DOI 10.1161/CIRCRESAHA.113.300764; Pagel PS, 2018, J CARDIOTHOR VASC AN, V32, P1112, DOI 10.1053/j.jvca.2017.12.029; Pagel PS, 2013, J CARDIOTHOR VASC AN, V27, P972, DOI 10.1053/j.jvca.2012.10.011; Park SJ, 2015, NEW ENGL J MED, V372, P1204, DOI 10.1056/NEJMoa1415447; Ridgeon E, 2016, CRIT CARE RESUSC, V18, P50; Seccareccia F, 2006, EUR J CARDIO-THORAC, V29, P56, DOI 10.1016/j.ejcts.2005.07.017; Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626; Shroyer AL, 2009, NEW ENGL J MED, V361, P1827, DOI 10.1056/NEJMoa0902905; Sousa-Uva M, 2018, EUR J CARDIO-THORAC, V53, P5, DOI 10.1093/ejcts/ezx314; Symons JA, 2006, BRIT J ANAESTH, V97, P127, DOI 10.1093/bja/ael149; Tempe DK, 2011, J CARDIOTHOR VASC AN, V25, P59, DOI 10.1053/j.jvca.2010.03.002; Uhlig C, 2016, ANESTHESIOLOGY, V124, P1230, DOI 10.1097/ALN.0000000000001120; Wang J, 2013, SCAND CARDIOVASC J, V47, P175, DOI 10.3109/14017431.2012.760749; Weiser TG, 2008, LANCET, V372, P139, DOI 10.1016/S0140-6736(08)60878-8; Yu CH, 2006, CAN J ANAESTH, V53, P906, DOI 10.1007/BF03022834	40	102	108	4	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 28	2019	380	13					1214	1225		10.1056/NEJMoa1816476	http://dx.doi.org/10.1056/NEJMoa1816476			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HR6HX	30888743	Green Published, Bronze			2022-12-28	WOS:000463251600006
J	Schucht, P; Fischer, U; Fung, C; Bernasconi, C; Fichtner, J; Vulcu, S; Schoni, D; Nowacki, A; Wanderer, S; Eisenring, C; Krahenbuhl, AK; Mattle, HP; Arnold, M; Soll, N; Tochtermann, L; Z'Graggen, W; Junger, ST; Gralla, J; Mordasini, P; Dahlweid, FM; Raabe, A; Beck, J				Schucht, Philippe; Fischer, Urs; Fung, Christian; Bernasconi, Corrado; Fichtner, Jens; Vulcu, Sonja; Schoni, Daniel; Nowacki, Andreas; Wanderer, Stefan; Eisenring, Christian; Kraehenbuehl, Anna K.; Mattle, Heinrich P.; Arnold, Marcel; Soell, Nicole; Tochtermann, Lucas; Z'Graggen, Werner; Juenger, Stefanie T.; Gralla, Jan; Mordasini, Pasquale; Dahlweid, F. Michael; Raabe, Andreas; Beck, Juergen			Follow-up Computed Tomography after Evacuation of Chronic Subdural Hematoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter							RECURRENCE; SURGERY		[Schucht, Philippe; Fischer, Urs; Fung, Christian; Bernasconi, Corrado; Fichtner, Jens; Vulcu, Sonja; Schoni, Daniel; Nowacki, Andreas; Wanderer, Stefan; Eisenring, Christian; Kraehenbuehl, Anna K.; Mattle, Heinrich P.; Arnold, Marcel; Soell, Nicole; Tochtermann, Lucas; Z'Graggen, Werner; Juenger, Stefanie T.; Gralla, Jan; Mordasini, Pasquale; Dahlweid, F. Michael; Raabe, Andreas; Beck, Juergen] Univ Freiburg, Freiburg, Germany	University of Freiburg	Schucht, P (corresponding author), Univ Freiburg, Freiburg, Germany.	philippe.schucht@insel.ch	Mordasini, Pasquale/H-8321-2015; Eisenring, Christian/GLU-7719-2022	Eisenring, Christian/0000-0002-0208-3220; Schoni, Daniel/0000-0003-0625-5445; Z'Graggen, Werner/0000-0002-5684-4419; Bernasconi, Corrado/0000-0002-1019-5468; Fischer, Urs/0000-0003-0521-4051	Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung [32003B_150009, 32003B_159648, 320030_135477] Funding Source: Medline	Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung		Dudoit T, 2016, ACTA NEUROCHIR, V158, P1241, DOI 10.1007/s00701-016-2820-6; Mori K, 2001, NEUROL MED-CHIR, V41, P371, DOI 10.2176/nmc.41.371; Santarius T, 2009, LANCET, V374, P1067, DOI 10.1016/S0140-6736(09)61115-6; Torihashi K, 2008, NEUROSURGERY, V63, P1125, DOI 10.1227/01.NEU.0000335782.60059.17; Weigel R, 2003, J NEUROL NEUROSUR PS, V74, P937, DOI 10.1136/jnnp.74.7.937	5	31	31	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 21	2019	380	12					1186	1187		10.1056/NEJMc1812507	http://dx.doi.org/10.1056/NEJMc1812507			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP7VK	30893542				2022-12-28	WOS:000461898400017
J	van der Pol, LM; Tromeur, C; Bistervels, IM; Ni Ainle, F; van Bemmel, T; Bertoletti, L; Couturaud, F; van Dooren, YPA; Elias, A; Faber, LM; Hofstee, HMA; van der Hulle, T; Kruip, MJHA; Maignan, M; Mairuhu, ATA; Middeldorp, S; Nijkeuter, M; Roy, PM; Sanchez, O; Schmidt, J; ten Wolde, M; Klok, FA; Huisman, MV				van der Pol, Liselotte M.; Tromeur, Cecile; Bistervels, Ingrid M.; Ni Ainle, Fionnuala; van Bemmel, Thomas; Bertoletti, Laurent; Couturaud, Francis; van Dooren, Yordi P. A.; Elias, Antoine; Faber, Laura M.; Hofstee, Herman M. A.; van der Hulle, Tom; Kruip, Marieke J. H. A.; Maignan, Maxime; Mairuhu, Albert T. A.; Middeldorp, Saskia; Nijkeuter, Mathilde; Roy, Pierre-Marie; Sanchez, Olivier; Schmidt, Jeannot; ten Wolde, Marije; Klok, Frederikus A.; Huisman, Menno V.		Artemis Study Investigators	Pregnancy-Adapted YEARS Algorithm for Diagnosis of Suspected Pulmonary Embolism	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							D-DIMER; VENOUS THROMBOEMBOLISM; CLINICAL PROBABILITY; DECISION RULE; WELLS RULE; MANAGEMENT; POSTPARTUM; GUIDELINES	Background Pulmonary embolism is one of the leading causes of maternal death in the Western world. Because of the low specificity and sensitivity of the d-dimer test, all pregnant women with suspected pulmonary embolism undergo computed tomographic (CT) pulmonary angiography or ventilation-perfusion scanning, both of which involve radiation exposure to the mother and fetus. Whether a pregnancy-adapted algorithm could be used to safely avoid diagnostic imaging in pregnant women with suspected pulmonary embolism is unknown. Methods In a prospective study involving pregnant women with suspected pulmonary embolism, we assessed three criteria from the YEARS algorithm (clinical signs of deep-vein thrombosis, hemoptysis, and pulmonary embolism as the most likely diagnosis) and measured the d-dimer level. Pulmonary embolism was ruled out if none of the three criteria were met and the d-dimer level was less than 1000 ng per milliliter or if one or more of the three criteria were met and the d-dimer level was less than 500 ng per milliliter. Adaptation of the YEARS algorithm for pregnant women involved compression ultrasonography for women with symptoms of deep-vein thrombosis; if the results were positive (i.e., a clot was present), CT pulmonary angiography was not performed. All patients in whom pulmonary embolism had not been ruled out underwent CT pulmonary angiography. The primary outcome was the incidence of venous thromboembolism at 3 months. The secondary outcome was the proportion of patients in whom CT pulmonary angiography was not indicated to safely rule out pulmonary embolism. Results A total of 510 women were screened, of whom 12 (2.4%) were excluded. Pulmonary embolism was diagnosed in 20 patients (4.0%) at baseline. During follow-up, popliteal deep-vein thrombosis was diagnosed in 1 patient (0.21%; 95% confidence interval [CI], 0.04 to 1.2); no patient had pulmonary embolism. CT pulmonary angiography was not indicated, and thus was avoided, in 195 patients (39%; 95% CI, 35 to 44). The efficiency of the algorithm was highest during the first trimester of pregnancy and lowest during the third trimester; CT pulmonary angiography was avoided in 65% of patients who began the study in the first trimester and in 32% who began the study in the third trimester. Conclusions Pulmonary embolism was safely ruled out by the pregnancy-adapted YEARS diagnostic algorithm across all trimesters of pregnancy. CT pulmonary angiography was avoided in 32 to 65% of patients.	[van der Pol, Liselotte M.; van der Hulle, Tom; Klok, Frederikus A.; Huisman, Menno V.] Leiden Univ, Med Ctr, Dept Thrombosis & Hemostasis, Rm C7-68g,Albinusdreef 2, NL-2300 RC Leiden, Netherlands; [van der Pol, Liselotte M.; Mairuhu, Albert T. A.] Haga Teaching Hosp, Dept Internal Med, Houten, Netherlands; [Hofstee, Herman M. A.] Haaglanden Med Ctr, Dept Internal Med, The Hague, Netherlands; [Bistervels, Ingrid M.; Middeldorp, Saskia] Univ Amsterdam, Amsterdam Cardiovasc Sci, Amsterdam Univ Med Ctr, Dept Vasc Med, Amsterdam, Netherlands; [Bistervels, Ingrid M.; ten Wolde, Marije] Flevo Hosp, Dept Internal Med, Almere, Netherlands; [van Bemmel, Thomas] Gelre Hosp, Dept Internal Med, Apeldoorn, Netherlands; [van Dooren, Yordi P. A.] Groene Hart Hosp, Dept Pulmonol, Gouda, Netherlands; [Faber, Laura M.] Red Cross Hosp, Dept Internal Med, Beverwijk, Netherlands; [Kruip, Marieke J. H. A.] Erasmus MC, Dept Hematol, Rotterdam, Netherlands; [Nijkeuter, Mathilde] Univ Med Ctr Utrecht, Dept Internal Med, Utrecht, Netherlands; [Tromeur, Cecile; Couturaud, Francis] Univ Brest, Grp Etud Thrombose Bretagne Occidentale, Dept Internal Med & Chest Dis, Brest Hosp Ctr,EA 3878,CIC 1412,INSERM, Brest, France; [Bertoletti, Laurent] Univ Jean Monnet, Ctr Hosp Univ CHU St Etienne, Equipe Dysfonct Vasc & Hemostase,Unite 1059, Serv Med Vasc & Therapeut,INSERM,CIC 1408, St Etienne, France; [Elias, Antoine] St Musse Hosp, Dept Vasc Med, Toulon, France; [Maignan, Maxime] CHU Grenoble Alpes, Emergency Dept, Hypoxy Physiopathol Lab HP2, INSERM 1042, Grenoble, France; [Roy, Pierre-Marie] Univ Angers, CHU Angers, Emergency Dept, Inst Mitovasc,UMR 6015,CNRS,UMR 1083,INSERM, Angers, France; [Sanchez, Olivier] Univ Paris 05, Univ Sorbonne Paris Cite, Hop Europeen Georges Pompidou, Fac Med,AP HP,INSERM,UMR S 1140,Dept Pulm Dis, Paris, France; [Sanchez, Olivier] Univ Paris 05, Univ Sorbonne Paris Cite, Hop Europeen Georges Pompidou, Fac Med,AP HP,INSERM,UMR S 1140,Intens Care Unit, Paris, France; [Schmidt, Jeannot] CHU Clermont Ferrand, Emergency Dept, Clermont Ferrand, France; [Ni Ainle, Fionnuala] Univ Coll Dublin, Sch Med, Dublin, Ireland; [Ni Ainle, Fionnuala] Rotunda Hosp Dublin, INViTE Network, Dept Haematol, Dublin, Ireland	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Haga Hospital; Haaglanden Medical Center; University of Amsterdam; Gelre Hospitals; Erasmus University Rotterdam; Erasmus MC; Utrecht University; Utrecht University Medical Center; CHU Brest; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; CHU de St Etienne; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Grenoble Alpes; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Clermont Ferrand; University College Dublin	Huisman, MV (corresponding author), Leiden Univ, Med Ctr, Dept Thrombosis & Hemostasis, Rm C7-68g,Albinusdreef 2, NL-2300 RC Leiden, Netherlands.	m.v.huisman@lumc.nl	Roy, Pierre-Marie/AAA-7737-2022; Bertoletti, Laurent/X-1319-2019; Couturaud, Francis/Q-1366-2019; Middeldorp, Saskia/ABI-8197-2020; Klok, Erik/U-4870-2019	Bertoletti, Laurent/0000-0001-8214-3010; Couturaud, Francis/0000-0002-1855-8032; Middeldorp, Saskia/0000-0002-1006-6420; Klok, Erik/0000-0001-9961-0754; Merviel, Philippe/0000-0003-0184-0880; Hofstee, Herman/0000-0002-7203-3704; Hannigsberg, Jacob/0000-0002-5893-5541; Ni Ainle, Fionnuala/0000-0003-0163-792X; tromeur, cecile/0000-0001-9161-7521; van der Hulle, Tom/0000-0002-2296-1828; NONENT, Michel/0000-0002-1317-8997	Leiden University Medical Center	Leiden University Medical Center	Funded by Leiden University Medical Center and 17 other participating hospitals; Artemis Netherlands Trial Register number, NL5726.	Bourjeily G, 2010, LANCET, V375, P500, DOI 10.1016/S0140-6736(09)60996-X; Burton KR, 2018, J THROMB HAEMOST, V16, P876, DOI 10.1111/jth.13980; Campbell IA, 2003, THORAX, V58, P470; Chan WS, 2002, ARCH INTERN MED, V162, P1170, DOI 10.1001/archinte.162.10.1170; Douma RA, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-11-201106070-00002; Douma RA, 2010, THROMB RES, V126, pE271, DOI 10.1016/j.thromres.2010.07.008; Dronkers CEA, 2017, J THROMB HAEMOST, V15, P1040, DOI 10.1111/jth.13654; Gibson NS, 2010, THROMB HAEMOSTASIS, V103, P849, DOI 10.1160/TH08-09-0564; Goodacre S, 2019, BJOG-INT J OBSTET GY, V126, P383, DOI 10.1111/1471-0528.15286; Greer IA, 2015, NEW ENGL J MED, V373, P540, DOI 10.1056/NEJMcp1407434; Heit JA, 2005, ANN INTERN MED, V143, P697, DOI 10.7326/0003-4819-143-10-200511150-00006; Huisman MV, 2013, J THROMB HAEMOST, V11, P412, DOI 10.1111/jth.12124; James AH, 2006, AM J OBSTET GYNECOL, V194, P1311, DOI 10.1016/j.ajog.2005.11.008; Kabrhel C, 2018, ACAD EMERG MED, V25, P987, DOI 10.1111/acem.13417; Kabrhel C, 2009, ACAD EMERG MED, V16, P325, DOI 10.1111/j.1553-2712.2009.00368.x; Kearon C, 2016, CHEST, V149, P315, DOI 10.1016/j.chest.2015.11.026; Kline JA, 2014, ACAD EMERG MED, V21, P949, DOI 10.1111/acem.12471; Klok FA, 2008, THROMB HAEMOSTASIS, V99, P244, DOI [10.1160/THO7-09-0560, 10.1160/TH07-09-0560]; Konstantinides SV, 2014, EUR HEART J, V35, P3145, DOI 10.1093/eurheartj/ehu393; Mos ICM, 2014, THROMB RES, V133, P1039, DOI 10.1016/j.thromres.2014.03.050; Righini M, 2018, ANN INTERN MED, V169, P766, DOI 10.7326/M18-1670; Righini M, 2014, JAMA-J AM MED ASSOC, V311, P1117, DOI 10.1001/jama.2014.2135; Roy PM, 2006, ANN INTERN MED, V144, P157, DOI 10.7326/0003-4819-144-3-200602070-00003; The Lancet Planetary Health, 2017, COCHRANE DB SYST REV, V1, pe209; Tromeur C, 2019, HAEMATOLOGICA, V104, P176, DOI 10.3324/haematol.2018.196121; van Belle A, 2006, JAMA-J AM MED ASSOC, V295, P172; van der Hulle T, 2017, LANCET, V390, P289, DOI 10.1016/S0140-6736(17)30885-1; van der Pol LM, 2018, J THROMB HAEMOST, V16, P725, DOI 10.1111/jth.13972; Van der Pol LM, 2017, BLOOD REV, V31, P31, DOI 10.1016/j.blre.2016.09.003; van der Pol LM, 2018, BRIT J HAEMATOL, V183, P629, DOI 10.1111/bjh.15556; Van Es J, 2015, J THROMB HAEMOST, V13, P1428, DOI 10.1111/jth.13011; van Es N, 2016, ANN INTERN MED, V165, P253, DOI 10.7326/M16-0031; Wells PS, 2000, THROMB HAEMOSTASIS, V83, P416	33	130	130	5	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 21	2019	380	12					1139	1149		10.1056/NEJMoa1813865	http://dx.doi.org/10.1056/NEJMoa1813865			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP7VK	30893534	Bronze, Green Published			2022-12-28	WOS:000461898400009
J	Govindan, S; Simpson, SQ				Govindan, Sushant; Simpson, Steven Q.			Inpatient Notes: Choosing a Central Line in the ICU-What's New and What's True?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							BLOOD-STREAM INFECTIONS; PREVENTION; PREVALENCE		[Govindan, Sushant; Simpson, Steven Q.] Kansas City Vet Affairs Hosp, Kansas City, MO USA; [Govindan, Sushant; Simpson, Steven Q.] Univ Kansas, Dept Internal Med, Kansas City, KS USA	University of Kansas	Govindan, S (corresponding author), 4801 Linwood Blvd, Kansas City, MO 64128 USA.	sushant.govindan@va.gov	Simpson, Steven/GVT-5914-2022					Blot K, 2014, CLIN INFECT DIS, V59, P96, DOI 10.1093/cid/ciu239; Chopra V, 2015, ANN INTERN MED, V163, pS1, DOI 10.7326/M15-0744; Chopra V, 2014, AM J MED, V127, P319, DOI 10.1016/j.amjmed.2014.01.001; Climo M, 2003, INFECT CONT HOSP EP, V24, P942, DOI 10.1086/502163; Govindan S, 2018, CRIT CARE MED, V46, pE1136, DOI 10.1097/CCM.0000000000003423	5	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 19	2019	170	6					HO2	HO3		10.7326/M19-0447	http://dx.doi.org/10.7326/M19-0447			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP1ZR	30884520				2022-12-28	WOS:000461468300001
J	Salisbury, H				Salisbury, Helen			PRIMARY COLOUR Helen Salisbury: Dis-integration of cancer care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												helen.salisbury@phc.ox.ac.uk						Campbell D., 2019, GUARDIAN	1	0	0	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 19	2019	364								l1220	10.1136/bmj.l1220	http://dx.doi.org/10.1136/bmj.l1220			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HQ7ZZ	30890526	Bronze			2022-12-28	WOS:000462644400005
J	Gallipoli, P; Huntly, BJP				Gallipoli, Paolo; Huntly, Brian J. P.			Histone modifiers are oxygen sensors	SCIENCE			English	Editorial Material							DEMETHYLASES; CANCER		[Huntly, Brian J. P.] Wellcome Trust MRC Cambridge Stem Cell Inst, Cambridge, England; Univ Cambridge, Dept Haematol, Cambridge, England; Cambridge Univ Hosp NHS Trust, Dept Haematol, Cambridge, England	University of Cambridge	Huntly, BJP (corresponding author), Wellcome Trust MRC Cambridge Stem Cell Inst, Cambridge, England.	bjph2@cam.ac.uk	Gallipoli, Paolo/AAA-7094-2019	Gallipoli, Paolo/0000-0001-7254-2253	ERC Consolidator award [COMAL-647685]; CRUK program grant [C18680/A25508]; MRC; Bloodwise; KKLF; CRUK Advanced Clinician Scientist Fellowship [C57799/A27964]; ASH Global Research Award; MRC [MR/R009708/1] Funding Source: UKRI	ERC Consolidator award; CRUK program grant; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Bloodwise; KKLF; CRUK Advanced Clinician Scientist Fellowship; ASH Global Research Award; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Research in the Huntly lab is funded by an ERC Consolidator award (COMAL-647685), a CRUK program grant (C18680/A25508), MRC, Bloodwise, and KKLF. P.G. is funded by a CRUK Advanced Clinician Scientist Fellowship (C57799/A27964) and an ASH Global Research Award.	Adriaens ME, 2016, EPIGENET CHROMATIN, V9, DOI 10.1186/s13072-016-0090-4; Arcipowski KM, 2016, CURR OPIN GENET DEV, V36, P59, DOI 10.1016/j.gde.2016.03.010; Batie M, 2019, SCIENCE, V363, P1222, DOI 10.1126/science.aau5870; Chakraborty AA, 2019, SCIENCE, V363, P1217, DOI 10.1126/science.aaw1026; Gallipoli P, 2018, SEMIN CANCER BIOL, V51, P198, DOI 10.1016/j.semcancer.2017.07.005; Hancock RL, 2015, EPIGENOMICS-UK, V7, P791, DOI 10.2217/epi.15.24; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Melvin A, 2012, CELL SIGNAL, V24, P35, DOI 10.1016/j.cellsig.2011.08.019; Planavsky NJ, 2014, SCIENCE, V346, P635, DOI 10.1126/science.1258410; Prickaerts P, 2016, EPIGENET CHROMATIN, V9, DOI 10.1186/s13072-016-0086-0; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shih AH, 2012, NAT REV CANCER, V12, P599, DOI 10.1038/nrc3343	13	11	11	2	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 15	2019	363	6432			SI		1148	+		10.1126/science.aaw8373	http://dx.doi.org/10.1126/science.aaw8373			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HP0BC	30872506	Green Submitted			2022-12-28	WOS:000461329000025
J	Dolgin, E				Dolgin, Elie			The secret conversations inside cells	NATURE			English	News Item							CONTACT SITES; MITOCHONDRIA; VACUOLES											Area Gomez E., 2018, CELL DEATH DIS, V9, P335; Arruda AP, 2014, NAT MED, V20, P1427, DOI 10.1038/nm.3735; Elbaz-Alon Y, 2014, DEV CELL, V30, P95, DOI 10.1016/j.devcel.2014.06.007; Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385; Honscher C, 2014, DEV CELL, V30, P86, DOI 10.1016/j.devcel.2014.06.006; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Lackner LL, 2013, P NATL ACAD SCI USA, V110, pE458, DOI 10.1073/pnas.1215232110; Lees JA, 2017, SCIENCE, V355, DOI 10.1126/science.aah6171; Manford AG, 2012, DEV CELL, V23, P1129, DOI 10.1016/j.devcel.2012.11.004; Rowland AA, 2014, CELL, V159, P1027, DOI 10.1016/j.cell.2014.10.023; Shai N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03957-8; Valm AM, 2017, NATURE, V546, P162, DOI 10.1038/nature22369; VANCE JE, 1990, J BIOL CHEM, V265, P7248; Wu YM, 2017, P NATL ACAD SCI USA, V114, pE4859, DOI 10.1073/pnas.1701078114	14	16	16	3	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 14	2019	567	7747					162	164		10.1038/d41586-019-00792-9	http://dx.doi.org/10.1038/d41586-019-00792-9			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7LD	30858558	Bronze			2022-12-28	WOS:000461126600018
J	Cowper, A				Cowper, Andy			Musical chairs in the NHS leadership waltz	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												andycowper@hotmail.com						Cowper A, 2019, HLTH SERV J; Department of Health and Social Care, 2019, NHS FIN SUST; Department of Health and Social Care. HM Treasury Hunt J, 2018, PRIME MINISTER SETS; Johnstone R, 2018, CIVIL SERV WORL 1114; McGeown C, 2019, HLTH SERV J; Mclellan A, 2019, HLTH SERV J; NHS England, 2019, M COMM BOARDS NHS EN; NHS England, 2018, NHS ENGL NHS IMPR WO; NHS England, 2014, 5 YEAR FORW VIEW; Nuffield Trust, 2017, NHS HOSP DEEP RED RE; West D, 2018, HLTH SERV J	11	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 13	2019	364								l1093	10.1136/bmj.l1093	http://dx.doi.org/10.1136/bmj.l1093			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP5VW	30867155				2022-12-28	WOS:000461751600009
J	Horton, R				Horton, Richard			Offline: Has global health lost it?	LANCET			English	Editorial Material												richard.horton@lancet.com							0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 9	2019	393	10175					972	972		10.1016/S0140-6736(19)30490-8	http://dx.doi.org/10.1016/S0140-6736(19)30490-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HO0OW	30860038	Bronze			2022-12-28	WOS:000460604200012
J	Rossignol, P; Hernandez, AF; Solomon, SD; Zannad, F				Rossignol, Patrick; Hernandez, Adrian F.; Solomon, Scott D.; Zannad, Faiez			Heart failure drug treatment	LANCET			English	Review							PRESERVED EJECTION FRACTION; 2013 ACCF/AHA GUIDELINE; VALVE DISEASE-CURRENT; MYOCARDIAL-INFARCTION; EUROPEAN-SOCIETY; FOLLOW-UP; HIGH-RISK; CARDIOVASCULAR OUTCOMES; FERRIC CARBOXYMALTOSE; EXERCISE CAPACITY	Heart failure is the most common cardiovascular reason for hospital admission for people older than 60 years of age. Few areas in medicine have progressed as remarkably as heart failure treatment over the past three decades. However, progress has been consistent only for chronic heart failure with reduced ejection fraction. In acutely decompensated heart failure and heart failure with preserved ejection fraction, none of the treatments tested to date have been definitively proven to improve survival. Delaying or preventing heart failure has become increasingly important in patients who are prone to heart failure. The prevention of worsening chronic heart failure and hospitalisations for acute decompensation is also of great importance. The objective of this Series paper is to provide a concise and practical summary of the available drug treatments for heart failure. We support the implementation of the international guidelines. We offer views on the basis of our personal experience in research areas that have insufficient evidence. The best possible evidence-based drug treatment (including inhibitors of the renin-angiotensin-aldosterone system and beta blockers) is useful only when optimally implemented. However, implementation might be challenging. We believe that disease management programmes can be helpful in providing a multidisciplinary, holistic approach to the delivery of optimal medical care.	[Rossignol, Patrick; Zannad, Faiez] Univ Lorraine, CHRU Nancy, INSERM, Ctr Invest Clin Plurithemat 1433,U1116, Nancy, France; [Rossignol, Patrick; Zannad, Faiez] French Clin Res Network Invest Network Initiat Ca, Nancy, France; [Hernandez, Adrian F.] Duke Univ, Med Ctr, Dept Med, Div Cardiol, Durham, NC 27710 USA; [Solomon, Scott D.] Brigham & Womens Hosp, Cardiovasc Div, 75 Francis St, Boston, MA 02115 USA	CHU de Nancy; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; Duke University; Harvard University; Brigham & Women's Hospital	Rossignol, P (corresponding author), CHRU Nancy, Ctr Invest Clin, F-54500 Vandoeuvre Les Nancy, France.	p.rossignol@chru-nancy.fr	Hernandez, Adrian F/A-7818-2016	Hernandez, Adrian F/0000-0003-3387-9616	French National Research Agency [ANR-15-RHU-0004, ANR-15-IDEX-04-LUE]; Contrat de Plan Etat Region Lorraine; FEDER [IT2MP]; Centre Hospitalier Regional Universitaire de Nancy	French National Research Agency(French National Research Agency (ANR)); Contrat de Plan Etat Region Lorraine; FEDER(European Commission); Centre Hospitalier Regional Universitaire de Nancy	The authors acknowledge the contributions of Wendy Gattis Stough, who was funded by Centre Hospitalier Regional Universitaire de Nancy, for editing and assisting with the preparation of the manuscript. PR and FZ are supported by the French National Research Agency (Fight heart failure programme ANR-15-RHU-0004 and GEENAGE Impact programme Lorraine University d'Excellence ANR-15-IDEX-04-LUE), the Contrat de Plan Etat Region Lorraine and FEDER IT2MP.	Abraham WT, 2011, LANCET, V377, P658, DOI 10.1016/S0140-6736(11)60101-3; Agrinier N, 2013, INT J CARDIOL, V168, P3652, DOI 10.1016/j.ijcard.2013.05.090; Alla F, 2018, EUR J HEART FAIL, V20, P1066, DOI 10.1002/ejhf.1193; Anker SD, 2011, LANCET, V378, P731, DOI 10.1016/S0140-6736(11)61229-4; Anker SD, 2009, NEW ENGL J MED, V361, P2436, DOI 10.1056/NEJMoa0908355; Arrigo M, 2017, EUR J HEART FAIL, V19, P201, DOI 10.1002/ejhf.682; Bergethon KE, 2016, CIRC-HEART FAIL, V9, DOI 10.1161/CIRCHEARTFAILURE.115.002594; Bhatia RS, 2006, NEW ENGL J MED, V355, P260, DOI 10.1056/NEJMoa051530; Boehmer JP, 2017, JACC-HEART FAIL, V5, P216, DOI 10.1016/j.jchf.2016.12.011; Bonow RO, 2016, LANCET, V387, P1312, DOI 10.1016/S0140-6736(16)00586-9; Braunwald E, 2013, JACC-HEART FAIL, V1, P1, DOI 10.1016/j.jchf.2012.10.002; Burnett H, 2017, CIRC-HEART FAIL, V10, DOI 10.1161/CIRCHEARTFAILURE.116.003529; Butler J, 2017, EUR J HEART FAIL, V19, P1390, DOI 10.1002/ejhf.933; Campbell RT, 2014, HEART FAIL CLIN, V10, P481, DOI 10.1016/j.hfc.2014.04.009; Cheema B, 2018, EUR J HEART FAIL, V20, P630, DOI 10.1002/ejhf.1042; Chioncel O, 2017, EUR J HEART FAIL, V19, P1242, DOI 10.1002/ejhf.890; Christ M, 2016, EUR J HEART FAIL, V18, P1009, DOI 10.1002/ejhf.567; Cleland JGF, 2006, EUR HEART J, V27, P2338, DOI 10.1093/eurheartj/ehl250; Colin-Ramirez E, 2016, CURR OPIN CARDIOL, V31, P196, DOI 10.1097/HCO.0000000000000253; Cooper LB, 2015, JAMA-J AM MED ASSOC, V314, P1973, DOI 10.1001/jama.2015.11904; Costanzo MR, 2017, J AM COLL CARDIOL, V69, P2428, DOI 10.1016/j.jacc.2017.03.528; Crespo-Leiro MG, 2016, EUR J HEART FAIL, V18, P613, DOI 10.1002/ejhf.566; Dagenais GR, 2006, LANCET, V368, P581, DOI 10.1016/S0140-6736(06)69201-5; Dalos D, 2016, J AM COLL CARDIOL, V68, P189, DOI 10.1016/j.jacc.2016.04.052; Damasceno Albertino, 2012, Arch Intern Med, V172, P1386; Djousse L, 2009, JAMA-J AM MED ASSOC, V302, P394, DOI 10.1001/jama.2009.1062; Dokainish H, 2017, LANCET GLOB HEALTH, V5, pE665, DOI [10.1016/s2214-109x(17)30196-1, 10.1016/S2214-109X(17)30196-1]; Epstein M, 2015, AM J MANAG CARE, V21, pS212; Eschalier R, 2013, J AM COLL CARDIOL, V62, P1585, DOI 10.1016/j.jacc.2013.04.086; Felker GM, 2017, JAMA-J AM MED ASSOC, V318, P713, DOI 10.1001/jama.2017.10565; Ferrari R, 2018, EUR J HEART FAIL, V20, P842, DOI 10.1002/ejhf.1169; Ferreira JP, 2018, ESC HEART FAIL, V5, P139, DOI 10.1002/ehf2.12218; Ferreira JP, 2016, EUR HEART J, V37, P2455, DOI 10.1093/eurheartj/ehw213; Fitchett D, 2018, EUR HEART J, V39, P363, DOI 10.1093/eurheartj/ehx511; Florido R, 2018, CIRCULATION, V137, P2142, DOI 10.1161/CIRCULATIONAHA.117.030226; Fraiche AM, 2017, JACC-HEART FAIL, V5, P297, DOI 10.1016/j.jchf.2016.11.013; Gayat E, 2018, EUR J HEART FAIL, V20, P345, DOI 10.1002/ejhf.932; Gerber Y, 2013, AM J EPIDEMIOL, V178, P1272, DOI 10.1093/aje/kwt109; Girerd N, 2018, JACC-HEART FAIL, V6, P273, DOI 10.1016/j.jchf.2017.09.023; Harjola VP, 2018, EUR J HEART FAIL, V20, P1081, DOI 10.1002/ejhf.1204; Harjola VP, 2017, EUR J HEART FAIL, V19, P821, DOI 10.1002/ejhf.872; Heidenreich PA, 2013, CIRC-HEART FAIL, V6, P606, DOI 10.1161/HHF.0b013e318291329a; Hernandez AF, 2010, JAMA-J AM MED ASSOC, V303, P1716, DOI 10.1001/jama.2010.533; Hoendermis ES, 2015, EUR HEART J, V36, P2565, DOI 10.1093/eurheartj/ehv336; Houston BA, 2015, MAYO CLIN PROC, V90, P1247, DOI 10.1016/j.mayocp.2015.05.002; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Ibrahim Nasrien E, 2018, Curr Heart Fail Rep, V15, P37, DOI 10.1007/s11897-018-0381-0; Kirchhof P, 2016, EUR HEART J, V37, P2893, DOI 10.1093/eurheartj/ehw210; Kitzman DW, 2016, J AM COLL CARDIOL, V68, P200, DOI 10.1016/j.jacc.2016.05.019; Kitzman DW, 2016, JAMA-J AM MED ASSOC, V315, P36, DOI 10.1001/jama.2015.17346; Komajda M, 2017, EUR J HEART FAIL, V19, P1495, DOI 10.1002/ejhf.876; Komajda M, 2014, EUR HEART J, V35, P1022, DOI 10.1093/eurheartj/ehu067; Kristensen SL, 2015, EUR J HEART FAIL, V17, P169, DOI 10.1002/ejhf.211; Laborde-Casterot H, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004399; Maggioni AP, 2013, EUR J HEART FAIL, V15, P808, DOI 10.1093/eurjhf/hft050; Massie BM, 2008, NEW ENGL J MED, V359, P2456, DOI 10.1056/NEJMoa0805450; McAlister FA, 2004, J AM COLL CARDIOL, V44, P810, DOI 10.1016/j.jacc.2004.05.055; Mebazaa A, 2018, JACC-HEART FAIL, V6, P76, DOI 10.1016/j.jchf.2017.09.012; Mebazaa A, 2015, EUR J HEART FAIL, V17, P544, DOI 10.1002/ejhf.289; Nilsson E, 2018, EUR HEART J-QUAL CAR, V4, P267, DOI 10.1093/ehjqcco/qcy019; Nishimura RA, 2016, LANCET, V387, P1324, DOI 10.1016/S0140-6736(16)00558-4; Omersa D, 2016, EUR J HEART FAIL, V18, P1321, DOI 10.1002/ejhf.617; Ouwerkerk W, 2017, EUR HEART J, V38, P1883, DOI 10.1093/eurheartj/ehx026; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Packer M, 2018, JACC-HEART FAIL, V6, P73, DOI 10.1016/j.jchf.2017.05.008; Pfeffer MA, 2015, CIRCULATION, V131, P34, DOI 10.1161/CIRCULATIONAHA.114.013255; Pieske B, 2017, EUR HEART J, V38, P1119, DOI 10.1093/eurheartj/ehw593; Pitt B, 2014, NEW ENGL J MED, V370, P1383, DOI 10.1056/NEJMoa1313731; Pitt B, 2011, EUR HEART J, V32, P820, DOI 10.1093/eurheartj/ehq502; Ponikowski P, 2016, EUR J HEART FAIL, V18, P891, DOI 10.1002/ejhf.592; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Ponikowski P, 2015, EUR HEART J, V36, P657, DOI 10.1093/eurheartj/ehu385; Preiss D, 2015, EUR HEART J, V36, P1536, DOI 10.1093/eurheartj/ehv072; Radholm K, 2018, CIRCULATION, V138, P458, DOI 10.1161/CIRCULATIONAHA.118.034222; Reddy YNV, 2018, CIRCULATION, V138, P861, DOI 10.1161/CIRCULATIONAHA.118.034646; Redfield MM, 2016, NEW ENGL J MED, V375, P1868, DOI 10.1056/NEJMcp1511175; Redfield MM, 2015, NEW ENGL J MED, V373, P2314, DOI 10.1056/NEJMoa1510774; Redfield MM, 2013, JAMA-J AM MED ASSOC, V309, P1268, DOI 10.1001/jama.2013.2024; Rodes-Cabau J, 2016, LANCET, V388, P2431, DOI 10.1016/S0140-6736(16)00740-6; Rogers JK, 2014, EUR J HEART FAIL, V16, P33, DOI 10.1002/ejhf.29; Rossignol P, 2011, J AM COLL CARDIOL, V58, P1958, DOI 10.1016/j.jacc.2011.04.049; Sarwar CMS, 2016, J AM COLL CARDIOL, V68, P1575, DOI 10.1016/j.jacc.2016.06.060; Senni M, 2014, INT J CARDIOL, V173, P163, DOI 10.1016/j.ijcard.2014.02.018; Shah KS, 2017, J AM COLL CARDIOL, V70, P2476, DOI 10.1016/j.jacc.2017.08.074; Shen L, 2017, NEW ENGL J MED, V377, P41, DOI 10.1056/NEJMoa1609758; Solomon SD, 2007, CIRCULATION, V116, P1482, DOI 10.1161/CIRCULATIONAHA.107.696906; Solomon SD, 2017, JACC-HEART FAIL, V5, P471, DOI 10.1016/j.jchf.2017.04.013; Solomon SD, 2012, LANCET, V380, P1387, DOI 10.1016/S0140-6736(12)61227-6; Solomon SD, 2005, CIRCULATION, V112, P3738, DOI 10.1161/CIRCULATIONAHA.105.561423; Thomopoulos C, 2016, J HYPERTENS, V34, P373, DOI 10.1097/HJH.0000000000000848; Tromp J, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002541; Turnbull F, 2003, LANCET, V362, P1527; Van Aelst LNL, 2018, EUR J HEART FAIL, V20, P738, DOI 10.1002/ejhf.1050; Wolsk E, 2018, EUR J HEART FAIL, V20, P504, DOI 10.1002/ejhf.1073; Yancy CW, 2017, J CARD FAIL, V23, P628, DOI [10.1016/j.jacc.2017.04.025, 10.1161/CIR.0000000000000509]; Yancy CW, 2013, CIRCULATION, V128, P1810, DOI 10.1161/CIR.0b013e31829e8807; Yun JE, 2018, J CARD FAIL, V24, P19, DOI 10.1016/j.cardfail.2017.09.006; Yusuf S, 2003, LANCET, V362, P777, DOI 10.1016/S0140-6736(03)14285-7; Zannad F, 2018, CIRCULATION, V138, P929, DOI 10.1161/CIRCULATIONAHA.117.028814; Zannad F, 2018, NEW ENGL J MED, V379, P1332, DOI 10.1056/NEJMoa1808848; Zannad F, 2018, LANCET, V391, P518, DOI 10.1016/S0140-6736(17)32873-8; Ziaeian B, 2016, PROG CARDIOVASC DIS, V58, P379, DOI 10.1016/j.pcad.2015.09.004; Zinman B, 2015, NEW ENGL J MED, V373, P2117, DOI 10.1056/NEJMoa1504720	103	160	168	32	134	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 9	2019	393	10175					1034	1044		10.1016/S0140-6736(18)31808-7	http://dx.doi.org/10.1016/S0140-6736(18)31808-7			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HO0OW	30860029	Green Published			2022-12-28	WOS:000460604200037
J	Fuchs, Y				Fuchs, Yaron			The therapeutic promise of apoptosis	SCIENCE			English	Editorial Material							PROGRAMMED CELL-DEATH		[Fuchs, Yaron] Technion Israel Inst Technol, Lorry Lokey Interdisciplinary Ctr Life Sci & Engn, Dept Biol, Haifa, Israel	Technion Israel Institute of Technology	Fuchs, Y (corresponding author), Technion Israel Inst Technol, Lorry Lokey Interdisciplinary Ctr Life Sci & Engn, Dept Biol, Haifa, Israel.	yfuchs@technion.ac.il						Fuchs Y, 2015, NAT REV MOL CELL BIO, V16, P329, DOI 10.1038/nrm3999; Fuchs Y, 2013, SCIENCE, V341, P286, DOI 10.1126/science.1233029; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Koren E, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06941-4; Perez-Garijo A, 2013, ELIFE, V2, DOI 10.7554/eLife.01004; Soteriou D, 2018, NAT REV CANCER, V18, P186, DOI 10.1038/nrc.2017.122; Yosefzon Y, 2018, MOL CELL, V70, P573, DOI 10.1016/j.molcel.2018.04.019	7	5	5	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 8	2019	363	6431					1050	1051		10.1126/science.aaw3607	http://dx.doi.org/10.1126/science.aaw3607			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HO2MV	30846591				2022-12-28	WOS:000460750100030
J	Rajan, V; Berman, JN				Rajan, Vinothkumar; Berman, Jason N.			Fats enhance stem cell emergence	SCIENCE			English	Editorial Material							ACCUMULATION		[Rajan, Vinothkumar; Berman, Jason N.] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada; [Berman, Jason N.] IWK Hlth Ctr, Dept Pediat, Halifax, NS, Canada	Dalhousie University; Dalhousie University	Berman, JN (corresponding author), Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada.; Berman, JN (corresponding author), IWK Hlth Ctr, Dept Pediat, Halifax, NS, Canada.	jason.berman@iwk.nshealth.ca	Rajan, Vinothkumar/U-9687-2019	Rajan, Vinothkumar/0000-0003-3323-181X				Asano L, 2017, CELL CHEM BIOL, V24, P207, DOI 10.1016/j.chembiol.2016.12.017; Cortes M, 2015, STEM CELL REP, V5, P471, DOI 10.1016/j.stemcr.2015.08.010; Fang LH, 2013, NATURE, V498, P118, DOI 10.1038/nature12166; Gu Q., 2019, SCIENCE, V363; Henninger J, 2017, NAT CELL BIOL, V19, P17, DOI 10.1038/ncb3444; Heubi, 2016, ENDOTEXT; Lusis MJ, 2004, ANNU REV GENOM HUM G, V5, P189, DOI [10.1146/annurev.genom.5.061903.175930, 10.1016/j.tig.2012.03.001]; Mitsche MA, 2015, ELIFE, V4, DOI 10.7554/eLife.07999; Murphy AJ, 2011, J CLIN INVEST, V121, P4138, DOI 10.1172/JCI57559; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; Yavuz B, 2009, CARDIOVASC DRUG THER, V23, P295, DOI 10.1007/s10557-009-6181-8	11	0	0	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 8	2019	363	6431					1041	1042		10.1126/science.aaw7059	http://dx.doi.org/10.1126/science.aaw7059			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HO2MV	30846586				2022-12-28	WOS:000460750100023
J	Wise, J				Wise, Jacqui			NHS and Vertex remain deadlocked over price of cystic fibrosis drug	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 8	2019	364								l1094	10.1136/bmj.l1094	http://dx.doi.org/10.1136/bmj.l1094			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HO6TC	30850360				2022-12-28	WOS:000461063500006
J	Achar, YJ; Foiani, M				Achar, Yathish Jagadheesh; Foiani, Marco			An Error-Prone Polymerase in the Fight against Cancer	CELL			English	Editorial Material							DNA-DAMAGE; XERODERMA-PIGMENTOSUM; REPLICATION	Error-prone polymerases are alleged to induce mutations while replicating damaged DNA and to increase the risk of cancer. Using in vitro studies and mice models, Yoon et al. (2019) provide evidence that the error-prone Pol theta polymerase protects against ultraviolet light-induced skin cancer despite its mutagenic potential.	[Achar, Yathish Jagadheesh; Foiani, Marco] Fdn Ist FIRC Oncol Mol IFOM, Via Adamello 16, I-20139 Milan Mi, Italy; [Foiani, Marco] Univ Milan, I-20122 Milan Mi, Italy	IFOM - FIRC Institute of Molecular Oncology; IRCCS Istituti Fisioterapici Ospitalieri (IFO); University of Milan	Foiani, M (corresponding author), Fdn Ist FIRC Oncol Mol IFOM, Via Adamello 16, I-20139 Milan Mi, Italy.; Foiani, M (corresponding author), Univ Milan, I-20122 Milan Mi, Italy.	marco.foiani@ifom.eu	Foiani, Marco/M-8234-2014	Foiani, Marco/0000-0003-4795-834X	Italian Association for Cancer Research (AIRC)	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro)	Work in M.F.'s laboratory is supported by the Italian Association for Cancer Research (AIRC).	Branzei D, 2016, CURR OPIN CELL BIOL, V40, P137, DOI 10.1016/j.ceb.2016.03.015; Friedberg EC, 2002, SCIENCE, V296, P1627, DOI 10.1126/science.1070236; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Kawamura K, 2004, INT J CANCER, V109, P9, DOI 10.1002/ijc.11666; Lange SS, 2011, NAT REV CANCER, V11, P96, DOI 10.1038/nrc2998; Lopes M, 2006, MOL CELL, V21, P15, DOI 10.1016/j.molcel.2005.11.015; Marini F, 1997, EMBO J, V16, P639, DOI 10.1093/emboj/16.3.639; Masutani C, 1999, EMBO J, V18, P3491, DOI 10.1093/emboj/18.12.3491; van Steeg H, 1999, MOL MED TODAY, V5, P86, DOI 10.1016/S1357-4310(98)01394-X; Yoon JH, 2019, CELL, V176, P1295, DOI 10.1016/j.cell.2019.01.023	10	2	2	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 7	2019	176	6					1241	1243		10.1016/j.cell.2019.02.011	http://dx.doi.org/10.1016/j.cell.2019.02.011			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	HN9HD	30849368	Bronze			2022-12-28	WOS:000460509600001
J	Reeping, PM; Cerda, M; Kalesan, B; Wiebe, DJ; Galea, S; Branas, CC				Reeping, Paul M.; Cerda, Magdalena; Kalesan, Bindu; Wiebe, Douglas J.; Galea, Sandro; Branas, Charles C.			State gun laws, gun ownership, and mass shootings in the US: cross sectional time series	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HOUSEHOLD FIREARM OWNERSHIP; UNITED-STATES; HOMICIDE RATES; SUICIDE; AVAILABILITY; VIOLENCE; CRIME; ASSOCIATION; IMPACT	OBJECTIVE To determine whether restrictiveness-permissiveness of state gun laws or gun ownership are associated with mass shootings in the US. DESIGN Cross sectional time series. SETTING AND POPULATION US gun owners from 1998-2015. EXPOSURE An annual rating between 0 (completely restrictive) and 100 (completely permissive) for the gun laws of all 50 states taken from a reference guide for gun owners traveling between states from 1998 to 2015. Gun ownership was estimated annually as the percentage of suicides committed with firearms in each state. MAIN OUTCOME MEASURE Mass shootings were defined as independent events in which four or more people were killed by a firearm. Data from the Federal Bureau of Investigation's Uniform Crime Reporting System from 1998-2015 were used to calculate annual rates of mass shootings in each state. Mass shooting events and rates were further separated into those where the victims were immediate family members or partners (domestic) and those where the victims had other relationships with the perpetrator (non-domestic). RESULTS Fully adjusted regression analyses showed that a 10 unit increase in state gun law permissiveness was associated with a significant 11.5% (95% confidence interval 4.2% to 19.3%, P= 0.002) higher rate of mass shootings. A 10% increase in state gun ownership was associated with a significant 35.1% (12.7% to 62.7%, P= 0.001) higher rate of mass shootings. Partially adjusted regression analyses produced similar results, as did analyses restricted to domestic and non-domestic mass shootings. CONCLUSIONS States with more permissive gun laws and greater gun ownership had higher rates of mass shootings, and a growing divide appears to be emerging between restrictive and permissive states.	[Reeping, Paul M.; Branas, Charles C.] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, 722 West 168th St, New York, NY 10032 USA; [Cerda, Magdalena] NYU, Langone Sch Med, Dept Populat Hlth, New York, NY USA; [Kalesan, Bindu] Boston Univ, Sch Publ Hlth, Dept Community Hlth Sci, Boston, MA USA; [Wiebe, Douglas J.] Univ Penn, Perelman Sch Med, Dept Biostat Epidemiol & Informat, Philadelphia, PA 19104 USA; [Galea, Sandro] Boston Univ, Sch Publ Hlth, Boston, MA USA	Columbia University; New York University; NYU Langone Medical Center; Boston University; University of Pennsylvania; Pennsylvania Medicine; Boston University	Reeping, PM (corresponding author), Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, 722 West 168th St, New York, NY 10032 USA.	pmr2149@cumc.columbia.edu	Galea, Sandro/GLR-6066-2022	Cerda, Magdalena/0000-0001-8441-7046				Alcorn T, 2017, JAMA INTERN MED, V177, P124, DOI 10.1001/jamainternmed.2016.7076; Anestis MD, 2015, AM J PUBLIC HEALTH, V105, P2059, DOI 10.2105/AJPH.2014.302465; Bozzette SA, 2003, NEW ENGL J MED, V348, P416, DOI 10.1056/NEJMsa025075; Branas CC, 2018, P NATL ACAD SCI USA, V115, P2946, DOI 10.1073/pnas.1718503115; Carson AE, PRIS 1998 2016; Centers for Disease Control and Prevention, UND CAUS DEATH 1999; Conner KR, 2003, AM J PREV MED, V25, P320, DOI 10.1016/S0749-3797(03)00212-5; Cook PJ, 2006, J PUBLIC ECON, V90, P379, DOI 10.1016/j.jpubeco.2005.02.003; Cozens P, 2015, J PLAN LIT, V30, P393, DOI 10.1177/0885412215595440; DUWE G, 2002, HOMICIDE STUDIES, V0006; Fleegler EW, 2013, JAMA INTERN MED, V173, DOI [10.1001/jamainternmed.2013.9957, 10.1001/jamainternmed.2013.1286]; Fox JA, 2014, HOMICIDE STUD, V18, P125, DOI 10.1177/1088767913510297; Gius M, 2015, APPL ECON LETT, V22, P281, DOI 10.1080/13504851.2014.939367; Hemenway D, 2000, J TRAUMA, V49, P985, DOI 10.1097/00005373-200012000-00001; Hemenway D, 2006, PRIVATE GUNS PUBLIC; Hepburn LM, 2004, AGGRESS VIOLENT BEH, V9, P417, DOI 10.1016/S1359-1789(03)00044-2; Hoyer M., DOMESTIC SHOOTING HO; Kaplan EH, 2002, P NATL ACAD SCI USA, V99, P10935, DOI 10.1073/pnas.162282799; Kappas JS, 2018, TRAVELERS GUIDE FIRE; Kaufman EJ, 2018, JAMA INTERN MED, V178, P692, DOI 10.1001/jamainternmed.2018.0190; KILLIAS M, 1993, CAN MED ASSOC J, V148, P1721; Kleck G, 2004, J RES CRIME DELINQ, V41, P3, DOI 10.1177/0022427803256229; Kleck G., 2017, TARGETING GUNS FIREA; Knudson M Margaret, 2016, Trauma Surg Acute Care Open, V1, pe000023, DOI 10.1136/tsaco-2016-000023; Krouse WJ, 1999, MASS MURDER FIREARMS; Lemieux F., 2014, INT J CRIMINAL JUSTI, V9; LESTER D, 1988, SUICIDE LIFE-THREAT, V18, P176; LESTER D, 1982, SUICIDE LIFE-THREAT, V12, P131; LESTER D, 1990, PSYCHOL REP, V67, P490, DOI 10.2466/PR0.67.6.490-490; Luca M, 2016, 16126 NOM HARV BUS S, DOI [10.2139/ssrn.2776657, DOI 10.2139/SSRN.2776657]; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; McCarty JC, 2018, INJURY; MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125, DOI 10.1093/oxfordjournals.aje.a115101; Miller M, 2006, INJURY PREV, V12, P178, DOI 10.1136/ip.2005.010850; Miller M, 2002, AM J PUBLIC HEALTH, V92, P1988, DOI 10.2105/AJPH.92.12.1988; Miller M, 2002, J TRAUMA, V52, P267, DOI 10.1097/00005373-200202000-00011; Monuteaux MC, 2015, AM J PREV MED, V49, P207, DOI 10.1016/j.amepre.2015.02.008; Morrall Andrew, 2018, Rand Health Q, V8, P5; Morton RJ, SERIAL MURDER MULTID; Phillips CD, 2013, AM J PUBLIC HEALTH, V103, P86, DOI 10.2105/AJPH.2012.300807; Powell KE, 1998, AM J PUBLIC HEALTH, V88, P969, DOI 10.2105/AJPH.88.6.969; Rajan S, 2018, AM J PUBLIC HEALTH, V108, P860, DOI 10.2105/AJPH.2018.304464; Siegel M, 2013, AM J PUBLIC HEALTH, V103, P2098, DOI 10.2105/AJPH.2013.301409; Swanson J.W., 2017, LAW CONT PROB, V80, P179, DOI 10.1097/AOG.0000000000004391; US Census Bureau, AM FACTFINDER; Wintemute GJ, 2015, ANNU REV PUBL HEALTH, V36, P5, DOI 10.1146/annurev-publhealth-031914-122535; Zeoli AM, 2017, AM J EPIDEMIOL	47	43	43	0	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 6	2019	364								l542	10.1136/bmj.l542	http://dx.doi.org/10.1136/bmj.l542			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HO6SU	30842105	Green Published, hybrid			2022-12-28	WOS:000461062400002
J	Voelker, R				Voelker, Rebecca			New Diagnostic Test for Sexually Transmitted Infection	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 5	2019	321	9					827	827		10.1001/jama.2019.1169	http://dx.doi.org/10.1001/jama.2019.1169			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HN7EL	30835296				2022-12-28	WOS:000460351600005
J	Hawkes, N				Hawkes, Nigel			Daily and high potency cannabis are linked to higher rates of psychosis, study finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Di Forti M, 2019, LANCET PSYCHIAT, V6, P427, DOI 10.1016/S2215-0366(19)30048-3	1	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 20	2019	364								l1290	10.1136/bmj.l1290	http://dx.doi.org/10.1136/bmj.l1290			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HQ8AJ	30894354				2022-12-28	WOS:000462645500015
J	Christopher, PP; Stein, MD				Christopher, Paul P.; Stein, Michael D.			Should a Prison Salt Trial Be Federally Funded?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Christopher, Paul P.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA; [Stein, Michael D.] Boston Univ, Sch Publ Hlth, Boston, MA 02215 USA	Brown University; Boston University	Christopher, PP (corresponding author), Brown Univ, Box G-BH, Providence, RI 02912 USA.	paul_christopher@brown.edu			Greenwall Foundation	Greenwall Foundation	Dr. Christopher is supported by the Greenwall Foundation.	Binswanger IA, 2009, J EPIDEMIOL COMMUN H, V63, P912, DOI 10.1136/jech.2009.090662; Christopher PP, 2017, HASTINGS CENT REP, V47, P21, DOI 10.1002/hast.686; Collins SA, 2012, J CORRECT HEALTH CAR, V18, P210, DOI 10.1177/1078345812444875; Gostin LO, 2007, ETHICAL CONSIDERATIO, DOI [10.17226/11692, DOI 10.17226/11692]; Hornblum AM, 1997, BRIT MED J, V315, P1437, DOI 10.1136/bmj.315.7120.1437; Jones DW, 2018, HYPERTENSION, V72, P10, DOI 10.1161/HYPERTENSIONAHA.118.11103; Oria M., 2013, SOD INT POP ASEV, DOI [10.17226/18311, DOI 10.17226/18311]	7	2	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 19	2019	170	6					409	+		10.7326/M18-3382	http://dx.doi.org/10.7326/M18-3382			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP1ZR	30831598				2022-12-28	WOS:000461468300019
J	Friedrich, MJ				Friedrich, M. J.			Venezuela's Infant Death Rate Rises Amid Worsening Humanitarian Crisis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 19	2019	321	11					1041	1041		10.1001/jama.2019.1933	http://dx.doi.org/10.1001/jama.2019.1933			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JJ1JG	30874764				2022-12-28	WOS:000493916400004
J	Hunter, BR; Kirschner, JM				Hunter, Benton R.; Kirschner, Jonathan M.			Review: In adults with chest pain, a HEART score >= 4 has 96% sensitivity and 45% specificity for predicting MACE	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Hunter, Benton R.; Kirschner, Jonathan M.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington	Hunter, BR (corresponding author), Indiana Univ Sch Med, Indianapolis, IN 46202 USA.							Foy AJ, 2015, JAMA INTERN MED, V175, P428, DOI 10.1001/jamainternmed.2014.7657; Niven WGP, 2018, EMERG MED J, V35, P732, DOI 10.1136/emermed-2018-207540	2	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 19	2019	170	6					JC35	JC35		10.7326/ACPJ201903190-035	http://dx.doi.org/10.7326/ACPJ201903190-035			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP1ZR	30884505				2022-12-28	WOS:000461468300012
J	Kumbhare, D				Kumbhare, Dinesh			Review: Extra physical therapy improves some outcomes by a small amount in acute or subacute health conditions	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Kumbhare, Dinesh] Univ Toronto, Toronto, ON, Canada	University of Toronto	Kumbhare, D (corresponding author), Univ Toronto, Toronto, ON, Canada.			Kumbhare, Dinesh/0000-0003-3889-7557				Brusco NK, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0822-3; McMillan LB, 2018, OSTEOPOROSIS INT, V29, P1379, DOI 10.1007/s00198-018-4446-4; SELIKSON S, 1988, J AM GERIATR SOC, V36, P707, DOI 10.1111/j.1532-5415.1988.tb07172.x; Surkan MJ, 2018, CAN J CARDIOL, V34, P881, DOI 10.1016/j.cjca.2018.04.033	4	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 19	2019	170	6					JC32	JC34		10.7326/ACPJ201903190-032	http://dx.doi.org/10.7326/ACPJ201903190-032			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP1ZR	30884502				2022-12-28	WOS:000461468300009
J	Oliver, D				Oliver, David			ACUTE PERSPECTIVE David Oliver: The health secretary and upstanding nurses	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Field P., 2019, MED NEWS TODAY; Hancock M, 2019, NURSES ARE MISSION C; Hancock Matt, 2019, TELEGRAPH; King's Fund, 2018, HLTH CAR WORKF ENGL; Matthews-King A., 2017, INDEPENDENT; Matthews-King A., 2019, INDEPENDENT; Mitchell G., 2019, NURS TIMES; OLIVER D, 2017, BMJ-BRIT MED J, V359, DOI DOI 10.1136/BMJ.J5552; Syal R., 2018, GUARDIAN	9	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 19	2019	364								l1230	10.1136/bmj.l1230	http://dx.doi.org/10.1136/bmj.l1230			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HQ7ZZ	30890527	Bronze			2022-12-28	WOS:000462644400007
J	Cook, R; Thomas, V; Martin, R				Cook, Rob; Thomas, Vaughan; Martin, Rosie		NIHR Dissemination Ctr	NIHR SIGNALS Can treating vitamin D deficiency reduce exacerbations of chronic obstructive pulmonary disease?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material								The study Jolliffe D, Greenberg L, Hooper R, Mathyssen C, Rafiq R, de Jongh R, Camargo C, Griffiths C, Janssens W, Martineau A. Vitamin D to prevent exacerbations of COPD: systematic review and meta-analysis of individual participant data from randomised controlled trials. Thorax 2019. doi:10.1136/thoraxjnl-2018-212092. This project was funded by the National Institute for Health Research Health Technology Appraisal programme (project number 13/03/25). To read the full NIHR Signal, go to: https://discover.dc.nihr.ac.uk/content/signal-000737/treating-vitamin-d-deficiency-may-reduce-exacerbations-of-copd	[Cook, Rob] Bazian, Economist Intelligence Unit Healthcare, London, England; Univ Southampton, Wessex Inst, Southampton, Hants, England	University of Southampton	Cook, R (corresponding author), Bazian, Economist Intelligence Unit Healthcare, London, England.	rob.cook@bazian.com		Cook, Robert/0000-0002-2210-3989				British Lung Foundation, 2017, EST EC BURD RESP ILL; Martineau AR, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.i6583; Martineau AR, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011511.pub2; National Institute for Health and Care Excellence, 2018, CHRON OBSTR PULM DIS; National Institute for Health and Care Excellence, 2014, VIT D SUPPL US SPEC; NHS website, 2016, CHRON OBSTR PULM DIS; NHS website, 2017, VITAMIN D; Scientific Advisory Committee on Nutrition, 2016, VIT D HLTH SCI ADV C	8	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 18	2019	364								l1025	10.1136/bmj.l1025	http://dx.doi.org/10.1136/bmj.l1025			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HQ7ZV	30885906				2022-12-28	WOS:000462643800001
J	Castel, P; Cheng, A; Cuevas-Navarro, A; Everman, DB; Papageorge, AG; Simanshu, DK; Tankka, A; Galeas, J; Urisman, A; McCormick, F				Castel, Pau; Cheng, Alice; Cuevas-Navarro, Antonio; Everman, David B.; Papageorge, Alex G.; Simanshu, Dhirendra K.; Tankka, Alexandra; Galeas, Jacqueline; Urisman, Anatoly; McCormick, Frank			RIT1 oncoproteins escape LZTR1-mediated proteolysis	SCIENCE			English	Article							NOONAN-SYNDROME; MUTATIONS; RAS; PHENOTYPE; REGULATORS; SPECTRUM; PROTEIN; KLHL7	RIT1 oncoproteins have emerged as an etiologic factor in Noonan syndrome and cancer. Despite the resemblance of RIT1 to other members of the Ras small guanosine triphosphatases (GTPases), mutations affecting RIT1 are not found in the classic hotspots but rather in a region near the switch II domain of the protein. We used an isogenic germline knock-in mouse model to study the effects of RIT1 mutation at the organismal level, which resulted in a phenotype resembling Noonan syndrome. By mass spectrometry, we detected a RIT1 interactor, leucine zipper-like transcription regulator 1 (LZTR1), that acts as an adaptor for protein degradation. Pathogenic mutations affecting either RIT1 or LZTR1 resulted in incomplete degradation of RIT1. This led to RIT1 accumulation and dysregulated growth factor signaling responses. Our results highlight a mechanism of pathogenesis that relies on impaired protein degradation of the Ras GTPase RIT1.	[Castel, Pau; Cheng, Alice; Cuevas-Navarro, Antonio; Galeas, Jacqueline; McCormick, Frank] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Everman, David B.] Greenwood Genet Ctr, Greenwood, SC 29646 USA; [Papageorge, Alex G.] NCI, NIH, Bethesda, MD 20892 USA; [Simanshu, Dhirendra K.] Leidos Biomed Res, NCI RAS Initiat, Canc Res Technol Program, Frederick Natl Lab Canc Res, Frederick, MD USA; [Tankka, Alexandra; Urisman, Anatoly] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Greenwood Genetic Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of California System; University of California San Francisco	McCormick, F (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA.	frank.mccormick@ucsf.edu	Castel, Pau/AAL-5791-2020	Castel, Pau/0000-0002-4972-4347; Cuevas-Navarro, Antonio/0000-0001-6208-6944; Urisman, Anatoly/0000-0001-8364-5303; Simanshu, Dhirendra/0000-0002-9717-4618; Tankka, Alexandra/0000-0003-3337-5725	NCI [1R35CA197709-01]; NIH [P41GM103481, S10OD016229]; NATIONAL CANCER INSTITUTE [R35CA197709] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant from the NCI (1R35CA197709-01 to F.M.). P.C. is a fellow of the Jane Coffin Childs Memorial Fund for Medical Research. A.C.-N. is a fellow of the NSF Graduate Research Fellowship Program. We thank the UCSF Mass Spectrometry Facility and A. L. Burlingame for providing MS instrumentation support for this project (funded by the NIH grants P41GM103481 and S10OD016229).	Angius A, 2016, AM J HUM GENET, V99, P236, DOI 10.1016/j.ajhg.2016.05.026; Aoki Y, 2013, AM J HUM GENET, V93, P173, DOI 10.1016/j.ajhg.2013.05.021; Araki T, 2004, NAT MED, V10, P849, DOI 10.1038/nm1084; Berger AH, 2014, ONCOGENE, V33, P4418, DOI 10.1038/onc.2013.581; Bigenzahn JW, 2018, SCIENCE, V362, P1171, DOI 10.1126/science.aap8210; Bomont P, 2000, NAT GENET, V26, P370, DOI 10.1038/81701; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Chen X, 2009, P NATL ACAD SCI USA, V106, P7979, DOI 10.1073/pnas.0900343106; Cirstea IC, 2010, NAT GENET, V42, P27, DOI 10.1038/ng.497; Dickinson ME, 2016, NATURE, V537, P508, DOI 10.1038/nature19356; Flex E, 2014, HUM MOL GENET, V23, P4315, DOI 10.1093/hmg/ddu148; Frattini V, 2013, NAT GENET, V45, P1141, DOI 10.1038/ng.2734; Friedman JS, 2009, AM J HUM GENET, V84, P792, DOI 10.1016/j.ajhg.2009.05.007; Gomez-Segui I, 2013, LEUKEMIA, V27, P1943, DOI 10.1038/leu.2013.179; Hernandez-Porras I, 2014, P NATL ACAD SCI USA, V111, P16395, DOI 10.1073/pnas.1418126111; Higgins EM, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.91225; Jin JP, 2005, METHOD ENZYMOL, V399, P287, DOI 10.1016/S0076-6879(05)99020-4; Johnston JJ, 2018, GENET MED, V20, P1175, DOI 10.1038/gim.2017.249; Lin ZM, 2016, NAT GENET, V48, P1508, DOI 10.1038/ng.3701; Louis-Dit-Picard H, 2012, NAT GENET, V44, P456, DOI 10.1038/ng.2218; Motta M, 2019, HUM MOL GENET, V28, P1007, DOI 10.1093/hmg/ddy412; Piotrowski A, 2014, NAT GENET, V46, P182, DOI 10.1038/ng.2855; Quilliam LA, 1996, J BIOL CHEM, V271, P11076, DOI 10.1074/jbc.271.19.11076; Ravenscroft G, 2013, AM J HUM GENET, V93, P6, DOI 10.1016/j.ajhg.2013.05.004; Roberts AE, 2013, LANCET, V381, P333, DOI 10.1016/S0140-6736(12)61023-X; Schubbert S, 2006, NAT GENET, V38, P331, DOI 10.1038/ng1748; Shi GX, 2013, CELL SIGNAL, V25, P2060, DOI 10.1016/j.cellsig.2013.06.002; Simanshu DK, 2017, CELL, V170, P17, DOI 10.1016/j.cell.2017.06.009; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Steklov M, 2018, SCIENCE, V362, P1177, DOI 10.1126/science.aap7607; Stogios PJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r82; Tidyman WE, 2016, HUM MOL GENET, V25, pR123, DOI 10.1093/hmg/ddw191; TRAHEY M, 1987, SCIENCE, V238, P542, DOI 10.1126/science.2821624; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Umeki I, 2019, HUM GENET, V138, P21, DOI 10.1007/s00439-018-1951-7; Wu X, 2011, J CLIN INVEST, V121, P1009, DOI 10.1172/JCI44929; Yamamoto GL, 2015, J MED GENET, V52, P413, DOI 10.1136/jmedgenet-2015-103018; Yaoita M, 2016, HUM GENET, V135, P209, DOI 10.1007/s00439-015-1627-5; Yoshida Y, 2015, P NATL ACAD SCI USA, V112, P4630, DOI 10.1073/pnas.1422313112	39	42	42	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 15	2019	363	6432			SI		1226	1229		10.1126/science.aav1444	http://dx.doi.org/10.1126/science.aav1444			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP0BC	30872527	Green Accepted			2022-12-28	WOS:000461329000051
J	Berger, F; Plutschack, MB; Riegger, J; Yu, WW; Speicher, S; Ho, M; Frank, N; Ritter, T				Berger, Florian; Plutschack, Matthew B.; Riegger, Julian; Yu, Wanwan; Speicher, Samira; Ho, Matthew; Frank, Nils; Ritter, Tobias			Site-selective and versatile aromatic C-H functionalization by thianthrenation	NATURE			English	Article							CATION-RADICAL PERCHLORATE; ION RADICALS; SUBSTITUTION; HALOGENATION; ARENES; CHLORINATION; HETEROCYCLES; DERIVATIVES; BORYLATION; ACTIVATION	Direct C-H functionalization can quickly increase useful structural and functional molecular complexity(1-3). Site selectivity can sometimes be achieved through appropriate directing groups or substitution patterns(1-4)-in the absence of such functionality, most aromatic C-H functionalization reactions provide more than one product isomer for most substrates(1,4,5). Development of a C-H functionalization reaction that proceeds with high positional selectivity and installs a functional group that can serve as a synthetic linchpin for further functionalization would provide access to a large variety of well-defined arene derivatives. Here we report a highly selective aromatic C-H functionalization reaction that does not require a particular directing group or substitution pattern to achieve selectivity, and provides functionalized arenes that can participate in various transformations. We introduce a persistent sulfur-based radical to functionalize complex arenes with high selectivity and obtain thianthrenium salts that are ready to engage in different transformations, via both transition-metal and photoredox catalysis. This transformation differs fundamentally from all previous aromatic C-H functionalization reactions in that it provides direct access to a large number of derivatives of complex small molecules, quickly generating functional diversity with selectivity that is not achievable by other methods.	[Berger, Florian; Plutschack, Matthew B.; Riegger, Julian; Yu, Wanwan; Speicher, Samira; Ho, Matthew; Frank, Nils; Ritter, Tobias] Max Planck Inst Kohlenforsch, Mulheim, Germany	Max Planck Society	Ritter, T (corresponding author), Max Planck Inst Kohlenforsch, Mulheim, Germany.	ritter@kofo.mpg.de	Ritter, Tobias/AAJ-8703-2021	Frank, Nils/0000-0002-8512-6598; Plutschack, Matthew Brian/0000-0002-5665-7445	UCB Biopharma; Max-Planck-Institut fur Kohlenforschung	UCB Biopharma; Max-Planck-Institut fur Kohlenforschung	We thank M. van Gastel (Max Planck Institute for Chemical Energy Conversion) for the acquisition of electron paramagnetic resonance spectra, as well as S. Marcus and D. Kampen (Max-Planck-Institut fur Kohlenforschung) for mass spectrometry analysis. We thank G. Berger for assistance with the construction of a photoreactor. We thank UCB Biopharma and the Max-Planck-Institut fur Kohlenforschung for funding.	Boursalian GB, 2016, NAT CHEM, V8, P810, DOI [10.1038/NCHEM.2529, 10.1038/nchem.2529]; Brennfuhrer A, 2009, ANGEW CHEM INT EDIT, V48, P4114, DOI 10.1002/anie.200900013; BROWN HC, 1958, J AM CHEM SOC, V80, P4979, DOI 10.1021/ja01551a055; Cheng C, 2014, SCIENCE, V343, P853, DOI 10.1126/science.1248042; Ham WS, 2019, ANGEW CHEM INT EDIT, V58, P532, DOI 10.1002/anie.201810262; HECK RF, 1979, ACCOUNTS CHEM RES, V12, P146, DOI 10.1021/ar50136a006; Hirano M, 1998, J CHEM RES, P662, DOI 10.1039/a804043e; KIM K, 1974, J ORG CHEM, V39, P2534, DOI 10.1021/jo00931a016; KIM K, 1974, J ORG CHEM, V39, P2537, DOI 10.1021/jo00931a017; Kim KS, 1999, J ORG CHEM, V64, P6483, DOI 10.1021/jo990322p; Leow D, 2012, NATURE, V486, P518, DOI 10.1038/nature11158; Lyons TW, 2010, CHEM REV, V110, P1147, DOI 10.1021/cr900184e; Maddox SM, 2015, ORG LETT, V17, P1042, DOI 10.1021/acs.orglett.5b00186; Minami H, 2018, ACS CATAL, V8, P579, DOI 10.1021/acscatal.7b03841; Mkhalid IAI, 2010, CHEM REV, V110, P890, DOI 10.1021/cr900206p; Mo FY, 2010, ANGEW CHEM INT EDIT, V49, P2028, DOI 10.1002/anie.200906699; NEGISHI EI, 1982, ACCOUNTS CHEM RES, V15, P340, DOI 10.1021/ar00083a001; OLAH GA, 1971, ACCOUNTS CHEM RES, V4, P240, DOI 10.1021/ar50043a002; Prier CK, 2013, CHEM REV, V113, P5322, DOI 10.1021/cr300503r; Saito Y, 2015, J AM CHEM SOC, V137, P5193, DOI 10.1021/jacs.5b02052; Samanta RC, 2015, CHEM-EUR J, V21, P11976, DOI 10.1002/chem.201502234; SHIN SR, 1992, J ORG CHEM, V57, P2706, DOI 10.1021/jo00035a031; SHINE HJ, 1972, J ORG CHEM, V37, P2691, DOI 10.1021/jo00982a014; SHINE HJ, 1992, TETRAHEDRON LETT, V33, P6583, DOI 10.1016/S0040-4039(00)60991-7; SILBER JJ, 1971, J ORG CHEM, V36, P2923; Sonogashira K, 2002, J ORGANOMET CHEM, V653, P46, DOI 10.1016/S0022-328X(02)01158-0; Srogl J, 1997, J AM CHEM SOC, V119, P12376, DOI 10.1021/ja9726926; Suzuki A, 1999, J ORGANOMET CHEM, V576, P147, DOI 10.1016/S0022-328X(98)01055-9; Tang RJ, 2018, J ORG CHEM, V83, P930, DOI 10.1021/acs.joc.7b02920; WINDSCHEIF PM, 1994, SYNTHESIS-STUTTGART, P87; Xiong XD, 2017, ORG LETT, V19, P4243, DOI 10.1021/acs.orglett.7b01899; Yoon K, 2005, J ORG CHEM, V70, P5741, DOI 10.1021/jo050420c	32	213	209	22	226	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 14	2019	567	7747					223	228		10.1038/s41586-019-0982-0	http://dx.doi.org/10.1038/s41586-019-0982-0			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7LD	30867606				2022-12-28	WOS:000461126600039
J	Kuehn, B				Kuehn, Bridget			School-Associated Youth Homicides	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 12	2019	321	10					931	931		10.1001/jama.2019.1318	http://dx.doi.org/10.1001/jama.2019.1318			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HO5JE	30860566				2022-12-28	WOS:000460961000005
J	Watson, DS; Krutzinna, J; Bruce, IN; Griffiths, CEM; McInnes, IB; Barnes, MR; Floridi, L				Watson, David S.; Krutzinna, Jenny; Bruce, Ian N.; Griffiths, Christopher E. M.; McInnes, Iain B.; Barnes, Michael R.; Floridi, Luciano			Clinical applications of machine learning algorithms: beyond the black box	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CANCER; CARE		[Watson, David S.; Krutzinna, Jenny] Univ Oxford, Oxford Internet Inst, 1 St Giles, Oxford OX1 3JS, England; [Floridi, Luciano] Univ Oxford, Oxford Internet Inst, Philosophy & Eth Informat, 1 St Giles, Oxford OX1 3JS, England; [Floridi, Luciano] Univ Oxford, Oxford Internet Inst, Digital Eth Lab, 1 St Giles, Oxford OX1 3JS, England; [Watson, David S.] Queen Mary Univ London, William Harvey Res Inst, Ctr Translat Bioinformat, London, England; [Barnes, Michael R.] Queen Mary Univ London, William Harvey Res Inst, Ctr Translat Bioinformat, Bioinformat, London, England; [Watson, David S.] Alan Turing Inst, London, England; [Barnes, Michael R.] Alan Turing Inst, Bioinformat, London, England; [Floridi, Luciano] Alan Turing Inst, Philosophy & Eth Informat, London, England; [Floridi, Luciano] Alan Turing Inst, Digital Eth Lab, London, England; [Bruce, Ian N.] Univ Manchester, Fac Biol Med & Hlth, Arthrit Res UK Ctr Epidemiol, Ctr Musculoskeletal Res,Rheumatol, Manchester, Lancs, England; [Bruce, Ian N.] Univ Manchester, Fac Biol Med & Hlth, Arthrit Res UK Ctr Epidemiol, Ctr Musculoskeletal Res, Manchester, Lancs, England; [Bruce, Ian N.] Manchester Univ Hosp NHS Fdn Trust, NIHR Manchester Biomed Res Ctr, Rheumatol, Manchester M13 9WL, Lancs, England; [Bruce, Ian N.] Manchester Univ Hosp NHS Fdn Trust, NIHR Manchester Biomed Res Ctr, Manchester M13 9WL, Lancs, England; [Griffiths, Christopher E. M.] Univ Manchester, Salford Royal NHS Fdn Trust, Dermatol Ctr, Dermatol, Salford, Lancs, England; [McInnes, Iain B.] Univ Glasgow, Inst Infect Immun & Inflammat, Med, Glasgow, Lanark, Scotland	University of Oxford; University of Oxford; University of Oxford; University of London; Queen Mary University London; University of London; Queen Mary University London; University of Manchester; University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital NHS Foundation Trust; Salford Royal NHS Foundation Trust; University of Manchester; University of Glasgow	Watson, DS (corresponding author), Univ Oxford, Oxford Internet Inst, 1 St Giles, Oxford OX1 3JS, England.; Watson, DS (corresponding author), Queen Mary Univ London, William Harvey Res Inst, Ctr Translat Bioinformat, London, England.; Watson, DS (corresponding author), Alan Turing Inst, London, England.	david.watson@oii.ox.ac.uk	Krutzinna, Jenny/G-4787-2019; Floridi, Luciano/G-7699-2014	Krutzinna, Jenny/0000-0002-7949-5020; Floridi, Luciano/0000-0002-5444-2280; Watson, David/0000-0001-9632-2159; Bruce, Ian/0000-0003-3047-500X				[Anonymous], 2018, THE GUARDIAN; Caruana R, 2015, KDD'15: PROCEEDINGS OF THE 21ST ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1721, DOI 10.1145/2783258.2788613; Doshi-Velez F, 2017, 170208608V2 ARXIV; Edwards Lilian, 2017, SLAVE ALGORITHM WHY, P18, DOI DOI 10.2139/SSRN.2972855; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Gigerenzer G., 2007, PSYCHOL SCI PUBL INT, V8, P53, DOI [10.1111/j.1539-6053.2008.00033.x, DOI 10.1111/J.1539-6053.2008.00033.X]; Gulshan V, 2016, JAMA-J AM MED ASSOC, V316, P2402, DOI 10.1001/jama.2016.17216; Hallowell N, 2019, GENET MED, V21, P272, DOI 10.1038/s41436-018-0067-8; Hogan H, 2012, BMJ QUAL SAF, V21, P737, DOI 10.1136/bmjqs-2011-001159; Johnson DG, 2019, AI SOC, V34, P639, DOI 10.1007/s00146-017-0781-9; Kibbe WA, 2015, NUCLEIC ACIDS RES, V43, pD1071, DOI 10.1093/nar/gku1011; Kourou K, 2015, COMPUT STRUCT BIOTEC, V13, P8, DOI 10.1016/j.csbj.2014.11.005; Lakkaraju H, 2017, 170701154 ARXIV; Lipton Z, 2015, 171108037V2 ARXIV; Lundberg S, 2017, 170507874V2 ARXIV; Mukherjee S, 2017, NEW YORKER; Obermeyer Z, 2016, NEW ENGL J MED, V375, P1216, DOI 10.1056/NEJMp1606181; Rajpurkar P, 2017, 171105225 ARXIV; Ribeiro MT, 2016, 160204938V3 ARXIV; SCHMIDT C, 2017, JNCI J NATL CANCER I, V109, DOI DOI 10.1093/jnci/djx113; Singh H, 2014, BMJ QUAL SAF, V23, P727, DOI 10.1136/bmjqs-2013-002627; Somashekhar SP, 2018, ANN ONCOL, V29, P418, DOI 10.1093/annonc/mdx781; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Wachter S, 2017, INT DATA PRIV LAW, V7, P76, DOI 10.1093/idpl/ipx005; Wiens J, 2018, CLIN INFECT DIS, V66, P149, DOI 10.1093/cid/cix731; Wolpert D. H., 1997, IEEE Transactions on Evolutionary Computation, V1, P67, DOI 10.1109/4235.585893	27	128	130	6	30	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 12	2019	364								l886	10.1136/bmj.l886	http://dx.doi.org/10.1136/bmj.l886			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP5VS	30862612	Green Submitted, Green Accepted			2022-12-28	WOS:000461751000002
J	Pike, H				Pike, Harriet			enFlow fluid warming device: warning over risk of aluminium toxicity	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Perl T, 2019, ANAESTHESIA, V21, DOI [10.1111/anae.14601.30793280, DOI 10.1111/ANAE.14601.30793280]; The Medicines and Healthcare Products Regulatory Agency, 2019, ENFLOW 4 FLUID BLOOD	2	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 11	2019	364								l1126	10.1136/bmj.l1126	http://dx.doi.org/10.1136/bmj.l1126			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP5VO	30858168				2022-12-28	WOS:000461750400007
J	Gely, MF; Kounalakis, M; Dickel, C; Dalle, J; Vatre, R; Baker, B; Jenkins, MD; Steele, GA				Gely, Mario F.; Kounalakis, Marios; Dickel, Christian; Dalle, Jacob; Vatre, Remy; Baker, Brian; Jenkins, Mark D.; Steele, Gary A.			Observation and stabilization of photonic Fock states in a hot radio-frequency resonator	SCIENCE			English	Article							QUANTUM; ENTANGLEMENT	Detecting weak radio-frequency electromagnetic fields plays a crucial role in a wide range of fields, from radio astronomy to nuclear magnetic resonance imaging. In quantum optics, the ultimate limit of a weak field is a single photon. Detecting and manipulating single photons at megahertz frequencies presents a challenge because, even at cryogenic temperatures, thermal fluctuations are appreciable. Using a gigahertz superconducting qubit, we observed the quantization of a megahertz radio-frequency resonator, cooled it to the ground state, and stabilized Fock states. Releasing the resonator from our control, we observed its rethermalization with nanosecond resolution. Extending circuit quantum electrodynamics to the megahertz regime, we have enabled the exploration of thermodynamics at the quantum scale and allowed interfacing quantum circuits with megahertz systems such as spin systems or macroscopic mechanical oscillators.	[Gely, Mario F.; Kounalakis, Marios; Dickel, Christian; Dalle, Jacob; Vatre, Remy; Jenkins, Mark D.; Steele, Gary A.] Delft Univ Technol, Kavli Inst NanoSci, POB 5046, NL-2600 GA Delft, Netherlands; [Baker, Brian] Northwestern Univ, Dept Phys & Astron, Evanston, IL 60208 USA	Delft University of Technology; Northwestern University	Gely, MF (corresponding author), Delft Univ Technol, Kavli Inst NanoSci, POB 5046, NL-2600 GA Delft, Netherlands.	mario.f.gely@gmail.com	Kounalakis, Marios/U-5517-2019; Dickel, Christian/AAD-8164-2019; Gely, Mario/AAQ-1329-2021	Kounalakis, Marios/0000-0002-9145-7131; Dickel, Christian/0000-0001-9242-2638; Gely, Mario/0000-0002-2861-2709; Baker, Brian/0000-0002-0334-906X	European Research Council under the European Union [681476-QOM3D, 785219-GrapheneCore2]; Dutch Foundation for Scientific Research (NWO) through the Casimir Research School; Army Research Office [W911NF-15-1-0421]	European Research Council under the European Union(European Research Council (ERC)); Dutch Foundation for Scientific Research (NWO) through the Casimir Research School; Army Research Office	This work was supported by the European Research Council under the European Union's H2020 program under grant agreements 681476-QOM3D and 785219-GrapheneCore2, by the Dutch Foundation for Scientific Research (NWO) through the Casimir Research School, and by the Army Research Office through grant W911NF-15-1-0421.	Ares N, 2016, PHYS REV APPL, V5, DOI 10.1103/PhysRevApplied.5.034011; Baker B, 2018, PHYS REV A, V98, DOI 10.1103/PhysRevA.98.052111; Bishop LS, 2009, NAT PHYS, V5, P105, DOI 10.1038/NPHYS1154; Bosman SJ, 2017, NPJ QUANTUM INFORM, V3, DOI 10.1038/s41534-017-0046-y; Bosman SJ, 2017, PHYS REV B, V95, DOI 10.1103/PhysRevB.95.224515; Clerk AA, 2010, REV MOD PHYS, V82, P1155, DOI 10.1103/RevModPhys.82.1155; DIEDRICH F, 1989, PHYS REV LETT, V62, P403, DOI 10.1103/PhysRevLett.62.403; Eichler C, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.227702; Gely MF, 2018, PHYS REV A, V98, DOI 10.1103/PhysRevA.98.053808; Johansson JR, 2012, COMPUT PHYS COMMUN, V183, P1760, DOI 10.1016/j.cpc.2012.02.021; Koch J, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.042319; Leghtas Z, 2015, SCIENCE, V347, P853, DOI 10.1126/science.aaa2085; Murch KW, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.183602; Nigg SE, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.240502; O'Connell AD, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2898887; Ockeloen-Korppi CF, 2018, NATURE, V556, P478, DOI 10.1038/s41586-018-0038-x; Ofek N, 2016, NATURE, V536, P441, DOI 10.1038/nature18949; Rigol M, 2008, NATURE, V452, P854, DOI 10.1038/nature06838; Rips S, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/2/023042; Schuster DI, 2007, NATURE, V445, P515, DOI 10.1038/nature05461; Shankar S, 2013, NATURE, V504, P419, DOI 10.1038/nature12802; Teufel JD, 2011, NATURE, V475, P359, DOI 10.1038/nature10261; Valenzuela SO, 2006, SCIENCE, V314, P1589, DOI 10.1126/science.1134008; Viennot JJ, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.183601; Vool U, 2018, PHYS REV APPL, V9, DOI 10.1103/PhysRevApplied.9.054046; Vool U, 2017, INT J CIRC THEOR APP, V45, P897, DOI 10.1002/cta.2359	29	26	26	3	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 8	2019	363	6431					1072	+		10.1126/science.aaw3101	http://dx.doi.org/10.1126/science.aaw3101			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO2MV	30846596	Green Submitted			2022-12-28	WOS:000460750100041
J	Savolainen-Peltonen, H; Rahkola-Soisalo, P; Hoti, F; Vattulainen, P; Gissler, M; Ylikorkala, O; Mikkola, TS				Savolainen-Peltonen, Hanna; Rahkola-Soisalo, Paivi; Hoti, Fabian; Vattulainen, Pia; Gissler, Mika; Ylikorkala, Olavi; Mikkola, Tomi S.			Use of postmenopausal hormone therapy and risk of Alzheimer's disease in Finland: nationwide case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MILD COGNITIVE IMPAIRMENT; ALL-CAUSE; REPLACEMENT THERAPY; VASCULAR DEMENTIA; APOLIPOPROTEIN-E; ESTROGEN; WOMEN; MENOPAUSAL; MORTALITY; DECLINE	OBJECTIVES To compare the use of hormone therapy between Finnish postmenopausal women with and without a diagnosis for Alzheimer's disease. DESIGN Nationwide case-control study. SETTING Finnish national population and drug register, between 1999 and 2013. PARTICIPANTS All postmenopausal women (n= 84 739) in Finland who, between 1999 and 2013, received a diagnosis of Alzheimer's disease from a neurologist or geriatrician, and who were identified from a national drug register. Control women without a diagnosis (n= 84 739), matched by age and hospital district, were traced from the Finnish national population register. INTERVENTIONS Data on hormone therapy use were obtained from the Finnish national drug reimbursement register. MAIN OUTCOME MEASURES Odds ratios and 95% confidence intervals for Alzheimer's disease, calculated with conditional logistic regression analysis. RESULTS In 83 688 (98.8%) women, a diagnosis for Alzheimer's disease was made at the age of 60 years or older, and 47 239 (55.7%) women had been over 80 years of age at diagnosis. Use of systemic hormone therapy was associated with a 9-17% increased risk of Alzheimer's disease. The risk of the disease did not differ significantly between users of estradiol only (odds ratio 1.09, 95% confidence interval 1.05 to 1.14) and those of oestrogen-progestogen (1.17, 1.13 to 1.21). The risk increases in users of oestrogen-progestogen therapy were not related to different progestogens (noreth isterone acetate, medroxyprogesterone acetate, or other progestogens); but in women younger than 60 at hormone therapy initiation, these risk increases were associated with hormone therapy exposure over 10 years. Furthermore, the age at initiation of systemic hormone therapy was not a decisive determinant for the increase in risk of Alzheimer's disease. The exclusive use of vaginal estradiol did not affect the risk of the disease (0.99, 0.96 to 1.01). CONCLUSIONS Long term use of systemic hormone therapy might be accompanied with an overall increased risk of Alzheimer's disease, which is not related to the type of progestogen or the age at initiation of systemic hormone therapy. By contrast, use of vaginal estradiol shows no such risk. Even though the absolute risk increase for Alzheimer's disease is small, our data should be implemented into information for present and future users of hormone therapy.	[Savolainen-Peltonen, Hanna; Rahkola-Soisalo, Paivi; Ylikorkala, Olavi; Mikkola, Tomi S.] Univ Helsinki, HUS, Haartmaninkatu 2,POB 140, FIN-00029 Helsinki, Finland; [Savolainen-Peltonen, Hanna; Rahkola-Soisalo, Paivi; Ylikorkala, Olavi; Mikkola, Tomi S.] Helsinki Univ Hosp, Obstet & Gynecol, HUS, Haartmaninkatu 2,POB 140, FIN-00029 Helsinki, Finland; [Savolainen-Peltonen, Hanna; Mikkola, Tomi S.] Folkhalsan Res Ctr, Biomedicum, Helsinki, Finland; [Hoti, Fabian; Vattulainen, Pia] EPID Res Oy, Espoo, Finland; [Gissler, Mika] Natl Inst Hlth & Welf, Helsinki, Finland; [Gissler, Mika] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Family Med, Huddinge, Sweden; [Gissler, Mika] Univ Turku, Res Ctr Child Psychiat, Turku, Finland	Hyvinkaan Sairaala; University of Helsinki; Hyvinkaan Sairaala; University of Helsinki; Helsinki University Central Hospital; Folkhalsan Research Center; University of Helsinki; Finland National Institute for Health & Welfare; Karolinska Institutet; University of Turku	Mikkola, TS (corresponding author), Univ Helsinki, HUS, Haartmaninkatu 2,POB 140, FIN-00029 Helsinki, Finland.; Mikkola, TS (corresponding author), Helsinki Univ Hosp, Obstet & Gynecol, HUS, Haartmaninkatu 2,POB 140, FIN-00029 Helsinki, Finland.; Mikkola, TS (corresponding author), Folkhalsan Res Ctr, Biomedicum, Helsinki, Finland.	tomi.mikkola@hus.fi		Rahkola-Soisalo, Paivi/0000-0001-7512-4823; Vattulainen, Pia/0000-0003-0136-3172; Mikkola, Tomi/0000-0003-2049-088X; Savolainen-Peltonen, Hanna/0000-0003-4139-669X; Gissler, Mika/0000-0001-8254-7525	Helsinki University Hospital research grant; Jane and Aatos Erkko Foundation	Helsinki University Hospital research grant; Jane and Aatos Erkko Foundation	This study was supported by a Helsinki University Hospital research grant and the Jane and Aatos Erkko Foundation. The funders had no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. We confirm that the researchers were independent from funders and that all authors had full access to all of the data (including statistical reports and tables) in the study and can take responsibility for the integrity of the data and the accuracy of the data analysis.	Andersen K, 1999, NEUROLOGY, V53, P1992, DOI 10.1212/WNL.53.9.1992; Bove R, 2014, NEUROLOGY, V82, P222, DOI 10.1212/WNL.0000000000000033; Corbo RM, 1999, ANN HUM GENET, V63, P301, DOI 10.1046/j.1469-1809.1999.6340301.x; Depypere H, 2016, MATURITAS, V94, P98, DOI 10.1016/j.maturitas.2016.09.009; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Ewbank DC, 2004, J GERONTOL A-BIOL, V59, P16; Harman SM, 2011, AM J MED, V124, P199, DOI 10.1016/j.amjmed.2010.09.021; Imtiaz B, 2017, NEUROLOGY, V88, P1062, DOI 10.1212/WNL.0000000000003696; Irntiaz B, 2017, MATURITAS, V98, P7, DOI 10.1016/j.maturitas.2017.01.002; Jang H, 2018, NEUROLOGY, V91, pE643, DOI 10.1212/WNL.0000000000006000; Kantarci K, 2016, J ALZHEIMERS DIS, V53, P547, DOI 10.3233/JAD-160258; Lobo A, 2000, NEUROLOGY, V54, pS4; Lyytinen H, 2009, OBSTET GYNECOL, V113, P65, DOI 10.1097/AOG.0b013e31818e8cd6; Maki PM, 2013, MENOPAUSE, V20, P695, DOI [10.1097/gme.0b013e3182960cf8, 10.1097/GME.0b013e3182960cf8]; Manson JE, 2017, JAMA-J AM MED ASSOC, V318, P927, DOI 10.1001/jama.2017.11217; Mikkola TS, 2017, J CLIN ENDOCR METAB, V102, P870, DOI 10.1210/jc.2016-3590; Mikkola TS, 2015, MENOPAUSE, V22, P976, DOI 10.1097/GME.0000000000000450; Morinaga A, 2007, BIOCHEM BIOPH RES CO, V359, P697, DOI 10.1016/j.bbrc.2007.05.158; Mucke L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006338; O'Brien J, 2014, EPIDEMIOL REV, V36, P83, DOI 10.1093/epirev/mxt008; Pike CJ, 2017, J NEUROSCI RES, V95, P671, DOI 10.1002/jnr.23827; Pike CJ, 2009, FRONT NEUROENDOCRIN, V30, P239, DOI 10.1016/j.yfrne.2009.04.015; Pinto-Almazan R, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/8630764; Savolainen-Peltonen H, 2016, J CLIN ENDOCR METAB, V101, P2794, DOI 10.1210/jc.2015-4149; Shao HB, 2012, NEUROLOGY, V79, P1846, DOI 10.1212/WNL.0b013e318271f823; Shumaker SA, 2004, JAMA-J AM MED ASSOC, V291, P2947, DOI 10.1001/jama.291.24.2947; Shumaker SA, 2003, JAMA-J AM MED ASSOC, V289, P2651, DOI 10.1001/jama.289.20.2651; Stanczyk FZ, 2013, ENDOCR REV, V34, P171, DOI 10.1210/er.2012-1008; Taipale H, 2014, INT CLIN PSYCHOPHARM, V29, P216, DOI 10.1097/YIC.0000000000000032; Tang MX, 1996, LANCET, V348, P429, DOI 10.1016/S0140-6736(96)03356-9; Topo P, 1999, MATURITAS, V32, P141, DOI 10.1016/S0378-5122(99)00027-4; Tuomikoski P, 2016, MATURITAS, V94, P106, DOI 10.1016/j.maturitas.2016.09.015; Waring SC, 1999, NEUROLOGY, V52, P965, DOI 10.1212/WNL.52.5.965; Wilson RS, 2012, PSYCHOL AGING, V27, P1008, DOI 10.1037/a0029857; Yue X, 2005, P NATL ACAD SCI USA, V102, P19198, DOI 10.1073/pnas.0505203102; Zandi PP, 2002, JAMA-J AM MED ASSOC, V288, P2123, DOI 10.1001/jama.288.17.2123; Zempell H, 2014, TRENDS NEUROSCI, V37, P721, DOI 10.1016/j.tins.2014.08.004	37	62	63	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 6	2019	364								l665	10.1136/bmj.l665	http://dx.doi.org/10.1136/bmj.l665			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HO6SU	30842086	Green Published, hybrid			2022-12-28	WOS:000461062400003
J	Gerada, C				Gerada, Clare			WOUNDED HEALER Clare Gerada: Doctors and their defences	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SUPPORT		[Gerada, Clare] Hurley Grp, London, England		Gerada, C (corresponding author), Hurley Grp, London, England.	clare.gerada@nhs.net	Gerada, Clare/O-8264-2019					Grohol JM., 2017, PSYCH CENTRAL; Jovanovic A, 2013, PSYCHOL HEALTH MED, V18, P543, DOI 10.1080/13548506.2013.765018; Lee F Joseph, 2008, Can Fam Physician, V54, P234; Leming MR, 1998, UNDERSTANDING DYING; Littlewood S, 2003, PSYCHIAT B, V27, P61; Neighbour R., 1987, INNER CONSULTATION; Thoits PA, 2011, J HEALTH SOC BEHAV, V52, P145, DOI 10.1177/0022146510395592	7	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 4	2019	364								l871	10.1136/bmj.l871	http://dx.doi.org/10.1136/bmj.l871			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HO6SQ	30833278	Bronze			2022-12-28	WOS:000461061900001
J	Yuan, X				Yuan, Xun			Plasma suspected to be contaminated causes fear in China	LANCET			English	Editorial Material								Officials now say that there is no detectable HIV antibody in the suspect plasma batch, but no explanation has been offered to explain original test results. Xun Yuan reports.											0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 23	2019	393	10173					732	732		10.1016/S0140-6736(19)30408-8	http://dx.doi.org/10.1016/S0140-6736(19)30408-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HN1KI	30846240				2022-12-28	WOS:000459945500014
J	Colaianni, CA				Colaianni, C. Alessandra			Informed	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CONSENT; SURGERY		[Colaianni, C. Alessandra] Massachusetts Eye & Ear, Dept Otolaryngol, Boston, MA 02114 USA	Harvard University; Massachusetts Eye & Ear Infirmary	Colaianni, CA (corresponding author), Massachusetts Eye & Ear, Dept Otolaryngol, Boston, MA 02114 USA.							Anandaiah A, 2018, MED TEACH; Hekkenberg RJ, 1997, J OTOLARYNGOL, V26, P155; Lloyd A, 2001, MED DECIS MAKING, V21, P141, DOI 10.1177/0272989X0102100207; Tait AR, 2018, JAMA PEDIATR, V172, P211, DOI 10.1001/jamapediatrics.2017.4088; Thompson BM, 2015, AM J SURG, V210, P578, DOI 10.1016/j.amjsurg.2014.12.044	5	3	3	1	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 21	2019	380	12					1099	1101		10.1056/NEJMp1812229	http://dx.doi.org/10.1056/NEJMp1812229			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HP7VK	30893532				2022-12-28	WOS:000461898400005
J	Marchand, JA; Neugebauer, ME; Ing, MC; Lin, CI; Pelton, JG; Chang, MCY				Marchand, J. A.; Neugebauer, M. E.; Ing, M. C.; Lin, C. -I.; Pelton, J. G.; Chang, M. C. Y.			Discovery of a pathway for terminal-alkyne amino acid biosynthesis	NATURE			English	Article							ENZYME; INTERMEDIATE; CHEMISTRY	Living systems can generate an enormous range of cellular functions, from mechanical infrastructure and signalling networks to enzymatic catalysis and information storage, using a notably limited set of chemical functional groups. This observation is especially notable when compared to the breadth of functional groups used as the basis for similar functions in synthetically derived small molecules and materials. The relatively small cross-section between biological and synthetic reactivity space forms the foundation for the development of bioorthogonal chemistry, in which the absence of a pair of reactive functional groups within the cell allows for a selective in situ reaction(1-4). However, biologically 'rare' functional groups, such as the fluoro(5), chloro(6,7), bromo(7,8), phosphonate(9), enediyne(10,11), cyano(12,) diazo(13), alkene(14) and alkyne(15-17) groups, continue to be discovered in natural products made by plants, fungi and microorganisms, which offers a potential route to genetically encode the endogenous biosynthesis of bioorthogonal reagents within living organisms. In particular, the terminal alkyne has found broad utility via the Cu(i)-catalysed azide-alkyne cycloaddition 'click' reaction(18). Here we report the discovery and characterization of a unique pathway to produce a terminal alkyne-containing amino acid in the bacterium Streptomyces cattleya. We found that l-lysine undergoes an unexpected reaction sequence that includes halogenation, oxidative C-C bond cleavage and triple bond formation through a putative allene intermediate. This pathway offers the potential for de novo cellular production of halo-, alkene-and alkyne-labelled proteins and natural products from glucose for a variety of downstream applications.	[Marchand, J. A.; Neugebauer, M. E.] Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA; [Ing, M. C.; Chang, M. C. Y.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Lin, C. -I.; Chang, M. C. Y.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Pelton, J. G.] Univ Calif Berkeley, QB3 Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Chang, MCY (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.; Chang, MCY (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	mcchang@berkeley.edu		Marchand, Jorge/0000-0002-7765-610X	UC Berkeley Chancellor's Fellowship; Howard Hughes Medical Institute Gilliam Fellowship; National Institutes of Health NRSA Training Grant [1 T32 GMO66698]; National Science Foundation Graduate Research Fellowship; National Science Foundation [CHE-1710588]; National Institutes of Health [1S10RR023679-01, S10 RR16634-01]	UC Berkeley Chancellor's Fellowship; Howard Hughes Medical Institute Gilliam Fellowship(Howard Hughes Medical Institute); National Institutes of Health NRSA Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank W. Zhang, D. Nomura and D. Berkowitz for discussions and advice. J.A.M. acknowledges the support of a UC Berkeley Chancellor's Fellowship, Howard Hughes Medical Institute Gilliam Fellowship, and National Institutes of Health NRSA Training Grant (1 T32 GMO66698). M.E.N. acknowledges the support of a National Science Foundation Graduate Research Fellowship. This work was funded by generous support from the National Science Foundation (CHE-1710588). The College of Chemistry NMR Facility at U.C. Berkeley is supported in part by the National Institutes of Health (1S10RR023679-01 and S10 RR16634-01).	ABELES RH, 1973, J AM CHEM SOC, V95, P6124, DOI 10.1021/ja00799a053; Agarwal V, 2017, CHEM REV, V117, P5619, DOI 10.1021/acs.chemrev.6b00571; Agarwal V, 2014, NAT CHEM BIOL, V10, P640, DOI 10.1038/nchembio.1564; Ahlert J, 2002, SCIENCE, V297, P1173, DOI 10.1126/science.1072105; BRZOVIC P, 1990, BIOCHEMISTRY-US, V29, P442, DOI 10.1021/bi00454a020; Chin JW, 2003, SCIENCE, V301, P964, DOI 10.1126/science.1084772; Cicchillo RM, 2009, NATURE, V459, P871, DOI 10.1038/nature07972; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Guy JE, 2011, P NATL ACAD SCI USA, V108, P16594, DOI 10.1073/pnas.1110221108; Haritos VS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2147; Jensen NB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1271; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.3.CO;2-X; Lang K, 2014, CHEM REV, V114, P4764, DOI 10.1021/cr400355w; Li J, 2016, NAT CHEM BIOL, V12, P129, DOI [10.1038/NCHEMBIO.2024, 10.1038/nchembio.2024]; Liu W, 2002, SCIENCE, V297, P1170, DOI 10.1126/science.1072110; MARCOTTE P, 1976, BIOCHEMISTRY-US, V15, P3070, DOI 10.1021/bi00659a021; McCune CD, 2017, J AM CHEM SOC, V139, P14077, DOI 10.1021/jacs.7b04690; Merkx R, 2013, CHEM SCI, V4, P4494, DOI 10.1039/c3sc51599k; Minto RE, 2008, PROG LIPID RES, V47, P233, DOI 10.1016/j.plipres.2008.02.002; O'Hagan D, 2002, NATURE, V416, P279, DOI 10.1038/416279a; POTGIETER HC, 1977, PHYTOCHEMISTRY, V16, P1757, DOI 10.1016/0031-9422(71)85083-5; Prescher JA, 2005, NAT CHEM BIOL, V1, P13, DOI 10.1038/nchembio0605-13; Rui Z, 2014, P NATL ACAD SCI USA, V111, P18237, DOI 10.1073/pnas.1419701112; SANADA M, 1986, J ANTIBIOT, V39, P304, DOI 10.7164/antibiotics.39.304; SCANNELL JP, 1971, J ANTIBIOT, V24, P239, DOI 10.7164/antibiotics.24.239; Schwarzenbacher R, 2004, J BIOL CHEM, V279, P29320, DOI 10.1074/jbc.M401268200; Scrimgeour C. M, 1979, AL REL NAT CHEM-SPR, V2, P1; Shin-Ichi H, 1992, PROG CHEM ORG NAT PR, V59, P117; Sugai Y, 2016, NAT CHEM BIOL, V12, P73, DOI [10.1038/NCHEMBIO.1991, 10.1038/nchembio.1991]; Sun QX, 2009, J BIOL CHEM, V284, P3076, DOI 10.1074/jbc.M805459200; Tautenhahn R, 2012, ANAL CHEM, V84, P5035, DOI 10.1021/ac300698c; Truong F, 2012, J AM CHEM SOC, V134, P8551, DOI 10.1021/ja3004667; Vaillancourt FH, 2005, NATURE, V436, P1191, DOI 10.1038/nature03797; Wong SD, 2013, NATURE, V499, P320, DOI 10.1038/nature12304; Wright TH, 2016, SCIENCE, V354, DOI 10.1126/science.aag1465; Zhu XJ, 2015, ACS CHEM BIOL, V10, P2785, DOI 10.1021/acschembio.5b00641; Zhu XJ, 2015, NAT CHEM BIOL, V11, P115, DOI [10.1038/NCHEMBIO.1718, 10.1038/nchembio.1718]	39	71	81	11	223	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 21	2019	567	7748					420	+		10.1038/s41586-019-1020-y	http://dx.doi.org/10.1038/s41586-019-1020-y			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP9JT	30867596				2022-12-28	WOS:000462010000061
J	Friedrich, MJ				Friedrich, M. J.			Higher HIV Rates in Adolescent Girls Related to Drought in Lesotho	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 19	2019	321	11					1041	1041		10.1001/jama.2019.1377	http://dx.doi.org/10.1001/jama.2019.1377			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP4YY	30874763				2022-12-28	WOS:000461683500004
J	Kumbhare, D				Kumbhare, Dinesh			Review: Exercise rehabilitation improves outcomes by a small amount in chronic heart failure	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Kumbhare, Dinesh] Univ Toronto, Toronto, ON, Canada	University of Toronto	Kumbhare, D (corresponding author), Univ Toronto, Toronto, ON, Canada.			Kumbhare, Dinesh/0000-0003-3889-7557					0	0	0	1	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 19	2019	170	6					JC34	JC34		10.7326/ACPJ201903190-034	http://dx.doi.org/10.7326/ACPJ201903190-034			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP1ZR	30884504				2022-12-28	WOS:000461468300011
J	Liu, L; Patton, G				Liu, Li; Patton, George			Shedding light on a million annual deaths in mid-childhood	LANCET			English	Editorial Material							ADOLESCENT HEALTH; MORTALITY; CHILDREN		[Liu, Li] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD 21205 USA; [Liu, Li] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Inst Int Programs, Baltimore, MD 21205 USA; [Patton, George] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Patton, George] Murdoch Childrens Res Inst, Populat Hlth Studies, Melbourne, Vic, Australia	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Melbourne; Murdoch Children's Research Institute	Liu, L (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD 21205 USA.; Liu, L (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Inst Int Programs, Baltimore, MD 21205 USA.	lliu26@jhu.edu	liu, li/HGC-0900-2022; Ribeiro, Ana Cristina/HHN-7466-2022; Patton, George C/B-5246-2013	Ribeiro, Ana Cristina/0000-0002-0493-8376; Patton, George C/0000-0001-5039-8326				Boerma T, 2018, LANCET, V392, P607, DOI 10.1016/S0140-6736(18)30586-5; Bundy DAP, 2018, LANCET, V391, P687, DOI 10.1016/S0140-6736(17)32417-0; CHAMPS Network, 2016, MORT SURV PROT VERS; Every Woman Every Child, 2015, GLOBAL STRATEGY WOME; Fadel SA, 2019, LANCET, V393, P1119, DOI 10.1016/S0140-6736(19)30220-X; He CH, 2017, LANCET GLOB HEALTH, V5, pE186, DOI [10.1016/S2214-109X(16)30334-5, 10.1016/s2214-109x(16)30334-5]; Hill K, 2015, LANCET GLOB HEALTH, V3, pE609, DOI 10.1016/S2214-109X(15)00044-3; Institute for International Programs, COUNTR MORT SURV ACT; Kassebaum N, 2017, JAMA PEDIATR, V171, P573, DOI 10.1001/jamapediatrics.2017.0250; Liu L, 2016, LANCET, V388, P3027, DOI 10.1016/S0140-6736(16)31593-8; Masquelier B, 2018, LANCET GLOB HEALTH, V6, pE1087, DOI [10.1016/S2214-109X(18)30353-X, 10.1016/s2214-109x(18)30353-x]; Patton GC, 2018, LANCET GLOB HEALTH, V6, pE1048, DOI 10.1016/S2214-109X(18)30417-0; United Nations Children's fund, 2018, LEV TRENDS CHILD MOR	13	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 16	2019	393	10176					1075	1076		10.1016/S0140-6736(19)30422-2	http://dx.doi.org/10.1016/S0140-6736(19)30422-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HP1HF	30876705	hybrid			2022-12-28	WOS:000461416600005
J	Pighills, A; Drummond, A; Crossland, S; Torgerson, DJ				Pighills, Alison; Drummond, Avril; Crossland, Shelley; Torgerson, David J.			What type of environmental assessment and modification prevents falls in community dwelling older people?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CONTROLLED-TRIAL; RISK-FACTORS; INTERVENTIONS; ADULTS; METAANALYSIS		[Pighills, Alison] Mackay Base Hosp, Queensland Hlth, Mackay Inst Res & Innovat, West Mackay, Qld 4740, Australia; [Pighills, Alison] James Cook Univ, Coll Healthcare Sci, Townsville, Qld, Australia; [Drummond, Avril] Univ Nottingham, Sch Hlth Sci, Nottingham, England; [Crossland, Shelley] Leicestershire Partnership NHS Trust, Mental Hlth Serv Older People, Leicester, Leics, England; [Torgerson, David J.] Univ York, Dept Hlth Sci, York Trials Unit, York, N Yorkshire, England	Queensland Health; James Cook University; University of Nottingham; Leicestershire Partnership NHS Trust; University of York - UK	Pighills, A (corresponding author), Mackay Base Hosp, Queensland Hlth, Mackay Inst Res & Innovat, West Mackay, Qld 4740, Australia.; Pighills, A (corresponding author), James Cook Univ, Coll Healthcare Sci, Townsville, Qld, Australia.	alison.pighills@health.qld.gov.au						[Anonymous], 2010, AGS BGS CLIN PRACTIC; Campbell AJ, 2005, BMJ-BRIT MED J, V331, P817, DOI 10.1136/bmj.38601.447731.55; Chang JT, 2004, BRIT MED J, V328, P680, DOI 10.1136/bmj.328.7441.680; Chu MML, 2017, J AM GERIATR SOC, V65, P364, DOI 10.1111/jgs.14527; Clemson L, 2008, J AGING HEALTH, V20, P954, DOI 10.1177/0898264308324672; Clemson L, 2014, AUST OCCUP THER J, V61, P325, DOI 10.1111/1440-1630.12132; Cockayne S, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-022488; College of Occupational Therapists, 2015, FALLS ROL OCC THER P; Cumming RG, 1999, J AM GERIATR SOC, V47, P1397, DOI 10.1111/j.1532-5415.1999.tb01556.x; Day L, 2002, BRIT MED J, V325, P128, DOI 10.1136/bmj.325.7356.128; GILLESPIE LD, 2009, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD007146.PUB2; Jorstad EC, 2005, J AM GERIATR SOC, V53, P501; Lawton MP, 1982, AGEING ENV THEORETIC; Lin MR, 2007, J AM GERIATR SOC, V55, P499, DOI 10.1111/j.1532-5415.2007.01146.x; Lusardi MM, 2017, J GERIATR PHYS THER, V40, P1, DOI 10.1519/JPT.0000000000000099; National Institute for Health and Care Excellence, FALLS OLD PEOPL QUAL; Nikolaus T, 2003, J AM GERIATR SOC, V51, P300, DOI 10.1046/j.1532-5415.2003.51102.x; Pighills A, 2019, AUST OCCUP THER J, V66, P347, DOI 10.1111/1440-1630.12560; Pighills AC, 2011, J AM GERIATR SOC, V59, P26, DOI 10.1111/j.1532-5415.2010.03221.x; Rubenstein LZ, 2006, AGE AGEING, V35, P37, DOI 10.1093/ageing/afl084; Scuffham P, 2003, J EPIDEMIOL COMMUN H, V57, P740, DOI 10.1136/jech.57.9.740; Stevens M, 2001, J AM GERIATR SOC, V49, P1448, DOI 10.1046/j.1532-5415.2001.4911236.x; The Australian Commission on Safety and Quality in Health Care, 2009, PREV FALLS HARM FALL; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; Tricco AC, 2017, JAMA-J AM MED ASSOC, V318, P1687, DOI 10.1001/jama.2017.15006	25	8	8	1	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 14	2019	364								l880	10.1136/bmj.l880	http://dx.doi.org/10.1136/bmj.l880			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HP5WD	30872322	Green Accepted			2022-12-28	WOS:000461752500003
J	Sanner, C; Huntemann, N; Lange, R; Tamm, C; Peik, E; Safronova, MS; Porsev, SG				Sanner, Christian; Huntemann, Nils; Lange, Richard; Tamm, Christian; Peik, Ekkehard; Safronova, Marianna S.; Porsev, Sergey G.			Optical clock comparison for Lorentz symmetry testing	NATURE			English	Article							INERTIAL MASS; ANISOTROPY	Questioning basic assumptions about the structure of space and time has greatly enhanced our understanding of nature. State-of-the-art atomic clocks(1-3) make it possible to precisely test fundamental symmetry properties of spacetime and search for physics beyond the standard model at low energies of just a few electronvolts(4). Modern tests of Einstein's theory of relativity try to measure so-far-undetected violations of Lorentz symmetry(5); accurately comparing the frequencies of optical clocks is a promising route to further improving such tests(6). Here we experimentally demonstrate agreement between two single-ion optical clocks at the 10(-18) level, directly validating their uncertainty budgets, over a six-month comparison period. The ytterbium ions of the two clocks are confined in separate ion traps with quantization axes aligned along non-parallel directions. Hypothetical Lorentz symmetry violations(5-7) would lead to periodic modulations of the frequency offset as the Earth rotates and orbits the Sun. From the absence of such modulations at the 10(-19) level we deduce stringent limits of the order of 10(-21) on Lorentz symmetry violation parameters for electrons, improving previous limits(8-10) by two orders of magnitude. Such levels of precision will be essential for low-energy tests of future quantum gravity theories describing dynamics at the Planck scale(4), which are expected to predict the magnitude of residual symmetry violations.	[Sanner, Christian; Huntemann, Nils; Lange, Richard; Tamm, Christian; Peik, Ekkehard] Phys Tech Bundesanstalt, Braunschweig, Germany; [Safronova, Marianna S.; Porsev, Sergey G.] Univ Delaware, Dept Phys & Astron, Newark, DE 19716 USA; [Safronova, Marianna S.] NIST, Joint Quantum Inst, College Pk, MD USA; [Safronova, Marianna S.] Univ Maryland, College Pk, MD 20742 USA; [Porsev, Sergey G.] Kurchatov Inst, Petersburg Nucl Phys Inst NRC, Gatchina, Russia; [Sanner, Christian] JILA, Boulder, CO 80309 USA	Physikalisch-Technische Bundesanstalt (PTB); University of Delaware; National Institute of Standards & Technology (NIST) - USA; University System of Maryland; University of Maryland College Park; National Research Centre - Kurchatov Institute	Sanner, C (corresponding author), Phys Tech Bundesanstalt, Braunschweig, Germany.; Sanner, C (corresponding author), JILA, Boulder, CO 80309 USA.	christian.sanner@jila.colorado.edu	Huntemann, Nils/ABA-3086-2021		European Metrology Programme for Innovation and Research (EMPIR project) [OC18]; European Union; DFG [CRC 1227]; Office of Naval Research, USA [N00014-17-1-2252]; NSF (USA) [PHY-1620687]; Russian Foundation for Basic Research [17-02-00216]; Humboldt Foundation	European Metrology Programme for Innovation and Research (EMPIR project); European Union(European Commission); DFG(German Research Foundation (DFG)); Office of Naval Research, USA(Office of Naval Research); NSF (USA)(National Science Foundation (NSF)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Humboldt Foundation(Alexander von Humboldt Foundation)	We thank B. Altschul, A. Goban, R. Hutson, A. Kostelecky, T. Mehlstaubler, M. Mewes, A. Vargas-Silva and J. Zhang for discussions and B. Lipphardt for experimental assistance. This research received funding from the European Metrology Programme for Innovation and Research (EMPIR project OC18), co-financed by the Participating States and the European Union's Horizon 2020 research and innovation programme, and from DFG through CRC 1227 (DQ-mat). This work was also supported in part by the Office of Naval Research, USA, under award number N00014-17-1-2252, by NSF through grant PHY-1620687 (USA) and by the Russian Foundation for Basic Research under grant number 17-02-00216. C.S. thanks the Humboldt Foundation for support.	Altschul B, 2006, PHYS REV D, V74, DOI 10.1103/PhysRevD.74.083003; Bluhm R, 2003, PHYS REV D, V68, DOI 10.1103/PhysRevD.68.125008; Campbell SL, 2017, SCIENCE, V358, P90, DOI 10.1126/science.aam5538; Colladay D, 1998, PHYS REV D, V58, DOI 10.1103/PhysRevD.58.116002; Delva P, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.221102; Dolezal M, 2015, METROLOGIA, V52, P842, DOI 10.1088/0026-1394/52/6/842; DREVER RWP, 1961, PHILOS MAG, V6, P683, DOI 10.1080/14786436108244418; Dube P, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.023806; Dzuba VA, 2016, NAT PHYS, V12, P465, DOI [10.1038/NPHYS3610, 10.1038/nphys3610]; Godun RM, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.210801; Hohensee MA, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.050401; HUGHES VW, 1960, PHYS REV LETT, V4, P342, DOI 10.1103/PhysRevLett.4.342; Huntemann N, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.063001; Keller J, 2015, J APPL PHYS, V118, DOI 10.1063/1.4930037; Kennedy RJ, 1932, PHYS REV, V42, P0400, DOI 10.1103/PhysRev.42.400; Kostelecky VA, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.11; Kostelecky VA, 2018, PHYS REV D, V98, DOI 10.1103/PhysRevD.98.036003; Kostelecky VA, 2011, PHYS REV D, V83, DOI 10.1103/PhysRevD.83.016013; Kostelecky VA, 2002, PHYS REV D, V66, DOI 10.1103/PhysRevD.66.056005; Kostelecky VA, 1999, PHYS REV D, V60, DOI 10.1103/PhysRevD.60.116010; Ludlow AD, 2015, REV MOD PHYS, V87, P637, DOI 10.1103/RevModPhys.87.637; Matei DG, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.263202; Mattingly D, 2005, LIVING REV RELATIV, V8, DOI 10.12942/lrr-2005-5; McGrew WF, 2018, NATURE, V564, P87, DOI 10.1038/s41586-018-0738-2; Megidish E., 2018, PREPRINT; Muller H, 2005, PHYS REV D, V71, DOI 10.1103/PhysRevD.71.045004; Muller H, 2003, PHYS REV D, V68, DOI 10.1103/PhysRevD.68.116006; Nicholson TL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7896; Pruttivarasin T, 2015, NATURE, V517, P592, DOI 10.1038/nature14091; Roos CF, 2006, NATURE, V443, P316, DOI 10.1038/nature05101; Rosenband T, 2008, SCIENCE, V319, P1808, DOI 10.1126/science.1154622; Safronova MS, 2018, REV MOD PHYS, V90, DOI 10.1103/RevModPhys.90.025008; Shaniv R, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.103202; Tamm C, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.023820; Yudin VI, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.011804	37	92	92	5	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 14	2019	567	7747					204	+		10.1038/s41586-019-0972-2	http://dx.doi.org/10.1038/s41586-019-0972-2			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO7LD	30867608	Green Submitted			2022-12-28	WOS:000461126600036
J	Pike, H				Pike, Harriet			Life expectancy in England and Wales has fallen by six months	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		HAWKES N, 2018, BMJ-BRIT MED J, V363, P1454, DOI DOI 10.1136/BMJ.K5291; Hiam L, 2018, J EPIDEMIOL COMMUN H, V72, P404, DOI 10.1136/jech-2017-210401; Institute and Faculty of Actuaries, 2019, 119 CMI I FAC ACT	3	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 11	2019	364								l1123	10.1136/bmj.l1123	http://dx.doi.org/10.1136/bmj.l1123			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP5VO	30858167				2022-12-28	WOS:000461750400006
J	Feldman, BE				Feldman, Benjamin E.			Squeezing strong correlations from graphene	SCIENCE			English	Editorial Material									[Feldman, Benjamin E.] Stanford Univ, Dept Phys, Stanford, CA 94305 USA; [Feldman, Benjamin E.] Stanford Univ, Geballe Lab Adv Mat, Stanford, CA 94305 USA	Stanford University; Stanford University	Feldman, BE (corresponding author), Stanford Univ, Dept Phys, Stanford, CA 94305 USA.; Feldman, BE (corresponding author), Stanford Univ, Geballe Lab Adv Mat, Stanford, CA 94305 USA.	bef@stanford.edu		Feldman, Benjamin/0000-0002-4962-0548				Bistritzer R, 2011, P NATL ACAD SCI USA, V108, P12233, DOI 10.1073/pnas.1108174108; Cao Y, 2019, ARXIV190103710CONDMA; Cao Y, 2018, NATURE, V556, P80, DOI 10.1038/nature26154; Cao Y, 2018, NATURE, V556, P43, DOI 10.1038/nature26160; Chen G., ARXIV190104621CONDMA; Chen G., 2018, ARXIV180301985CONDMA; Choi Y., 2019, ARXIV190102997CONDMA; Kerelsky A., 2018, ARXIV181208776CONDMA; Novoselov KS, 2016, SCIENCE, V353, DOI 10.1126/science.aac9439; Sharpe A. L., 2019, ARXIV190103520CONDMA; Morell ES, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.121407; Yankowitz M, 2019, SCIENCE, V363, P1059, DOI 10.1126/science.aav1910; Yankowitz M, 2018, NATURE, V557, P404, DOI 10.1038/s41586-018-0107-1	13	3	3	2	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 8	2019	363	6431					1035	1036		10.1126/science.aaw4642	http://dx.doi.org/10.1126/science.aaw4642			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HO2MV	30846582				2022-12-28	WOS:000460750100019
J	Li, JY; Stanger, B				Li, Jinyang; Stanger, Ben Z.			The tumor as organizer model	SCIENCE			English	Editorial Material							EVASION		[Li, Jinyang; Stanger, Ben Z.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Li, Jinyang; Stanger, Ben Z.] Univ Penn, Abramson Family Canc Res Inst, Perelman Sch Med, Philadelphia, PA 19104 USA; [Stanger, Ben Z.] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Stanger, B (corresponding author), Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA.; Stanger, B (corresponding author), Univ Penn, Abramson Family Canc Res Inst, Perelman Sch Med, Philadelphia, PA 19104 USA.; Stanger, B (corresponding author), Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA.	bstanger@upenn.edu		Li, Jinyang/0000-0001-8125-6603	NIH [CA169123, DK104196, DK083355]; NATIONAL CANCER INSTITUTE [R01CA169123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083355, UC4DK104196] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank P. Klein and Y. Dor for comments. B.Z.S. is supported by NIH grants CA169123, DK104196, and DK083355.	Arias AM, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.159525; Colak S, 2017, TRENDS CANCER, V3, P56, DOI 10.1016/j.trecan.2016.11.008; Davidson SM, 2017, NAT MED, V23, P235, DOI 10.1038/nm.4256; FOLKMAN J, 1971, NEW ENGL J MED, V285, P404, DOI 10.1056/NEJM197108122850711; Jerby-Arnon L, 2018, CELL, V175, P984, DOI 10.1016/j.cell.2018.09.006; Li JY, 2018, IMMUNITY, V49, P178, DOI 10.1016/j.immuni.2018.06.006; Lyssiotis CA, 2017, TRENDS CELL BIOL, V27, P873, DOI 10.1016/j.tcb.2017.06.003; Malladi S, 2016, CELL, V165, P45, DOI 10.1016/j.cell.2016.02.025; Oudin M. J., 2017, COLD SPRING HARB SYM, V81, P189; Paget S, 1989, LANCET, V8, P98, DOI [DOI 10.1016/S0140-6736(00)49915-0, 10.1016/S0140-6736(00)49915-0]; Peinado H, 2017, NAT REV CANCER, V17, P302, DOI 10.1038/nrc.2017.6; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Spemann H., 1924, ARCH MIKROSKOPISCHE, V101, P458; Spranger S, 2018, NAT REV CANCER, V18, P139, DOI 10.1038/nrc.2017.117; Wellenstein MD, 2018, IMMUNITY, V48, P399, DOI 10.1016/j.immuni.2018.03.004	15	17	17	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 8	2019	363	6431					1038	1039		10.1126/science.aau9861	http://dx.doi.org/10.1126/science.aau9861			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HO2MV	30846584				2022-12-28	WOS:000460750100021
J	Dyer, C				Dyer, Clare			Retired paediatrician can remove his name from medical register against GMC's wishes	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		ARIEFF AI, 1992, BRIT MED J, V304, P1218, DOI 10.1136/bmj.304.6836.1218; O'Hara J, 2018, INQUIRY HYPONATRAEMI	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 5	2019	364								l1012	10.1136/bmj.l1012	http://dx.doi.org/10.1136/bmj.l1012			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HO6SS	30837229				2022-12-28	WOS:000461062200013
J	Voelker, R				Voelker, Rebecca			Generic Seizure Drug Wins Approval	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 5	2019	321	9					827	827		10.1001/jama.2019.1172	http://dx.doi.org/10.1001/jama.2019.1172			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HN7EL	30835297				2022-12-28	WOS:000460351600006
J	Horton, R				Horton, Richard			Offline: UK citizens are losing the right to health-who cares?	LANCET			English	Editorial Material												richard.horton@lancet.com							0	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 2	2019	393	10174					860	860		10.1016/S0140-6736(19)30477-5	http://dx.doi.org/10.1016/S0140-6736(19)30477-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HN4AP	30837132	Bronze			2022-12-28	WOS:000460126900010
J	Marchalik, D				Marchalik, Daniel			The art of medicine Physician burnout in the modern era	LANCET			English	Editorial Material									[Marchalik, Daniel] Georgetown Univ, Sch Med, MedStar Hlth, Off Phys Well Being & Literature & Med Track, Washington, DC 20007 USA	Georgetown University	Marchalik, D (corresponding author), Georgetown Univ, Sch Med, MedStar Hlth, Off Phys Well Being & Literature & Med Track, Washington, DC 20007 USA.	dan.marchalik@gmail.com						Brazeau CMLR, 2014, ACAD MED, V89, P1520, DOI 10.1097/ACM.0000000000000482; GABBARD GO, 1985, JAMA-J AM MED ASSOC, V254, P2926, DOI 10.1001/jama.254.20.2926; Hubbard SD, 1922, AM J PUBLIC HEALTH, V12, P857, DOI 10.2105/AJPH.12.10.857-a; Shanafelt TD, 2015, MAYO CLIN PROC, V90, P1600, DOI 10.1016/j.mayocp.2015.08.023; SHORTT SED, 1979, CAN MED ASSOC J, V121, P283; Thomas K, 2010, INT J EPIDEMIOL, V39, P1464, DOI 10.1093/ije/dyq094; Thornton J L, 1957, Ann R Coll Surg Engl, V21, P199; WEST CP, 2018, INTERNAL MED, V283, P516, DOI DOI 10.1111/JOIM.12752	8	8	8	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 2	2019	393	10174					868	869		10.1016/S0140-6736(19)30399-X	http://dx.doi.org/10.1016/S0140-6736(19)30399-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HN4AP	30837137				2022-12-28	WOS:000460126900015
J	Olmedo-Reneaum, A; Garcia-Juarez, I; Toapanta-Yanchapaxi, L; De La Pena-Lopez, R; Rodriguez-Covarrubias, F; Contreras, AG; Cuellar-Rodriguez, JM				Olmedo-Reneaum, Alejandro; Garcia-Juarez, Ignacio; Toapanta-Yanchapaxi, Liz; De La Pena-Lopez, Roberto; Rodriguez-Covarrubias, Francisco; Contreras, Alan G.; Cuellar-Rodriguez, Jennifer M.			Rogue "stem cell clinic" leads to Mycobacterium abscessus infection	LANCET			English	Editorial Material									[Olmedo-Reneaum, Alejandro] Fdn Clin Med Sur, Dept Internal Med, Mexico City, DF, Mexico; [Garcia-Juarez, Ignacio; Toapanta-Yanchapaxi, Liz] Fdn Clin Med Sur, Dept Gastroenterol, Mexico City, DF, Mexico; [De La Pena-Lopez, Roberto] Fdn Clin Med Sur, Dept Haematol, Mexico City, DF, Mexico; [Rodriguez-Covarrubias, Francisco] Fdn Clin Med Sur, Urol Dept, Mexico City, DF, Mexico; [Contreras, Alan G.] Fdn Clin Med Sur, Surg Dept, Mexico City, DF, Mexico; [Cuellar-Rodriguez, Jennifer M.] Fdn Clin Med Sur, Dept Infect Dis, Mexico City 14080, DF, Mexico; [Cuellar-Rodriguez, Jennifer M.] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City 14080, DF, Mexico	Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico	Cuellar-Rodriguez, JM (corresponding author), Fdn Clin Med Sur, Dept Infect Dis, Mexico City 14080, DF, Mexico.; Cuellar-Rodriguez, JM (corresponding author), Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City 14080, DF, Mexico.	jenncuellar@yahoo.com	García-Juárez, Ignacio/F-5908-2019	Rodriguez-Covarrubias, Francisco Tomas/0000-0003-0056-7886; CONTRERAS, AlAN/0000-0003-4960-2240					0	2	2	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 2	2019	393	10174					918	918		10.1016/S0140-6736(19)30299-5	http://dx.doi.org/10.1016/S0140-6736(19)30299-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HN4AP	30837150				2022-12-28	WOS:000460126900030
J	Ojji, DB; Mayosi, B; Francis, V; Badri, M; Cornelius, V; Smythe, W; Kramer, N; Barasa, F; Damasceno, A; Dzudie, A; Jones, E; Mondo, C; Ogah, O; Ogola, E; Sani, MU; Shedul, GL; Shedul, G; Rayner, B; Okpechi, IG; Sliwa, K; Poulter, N				Ojji, Dike B.; Mayosi, Bongani; Francis, Veronica; Badri, Motasim; Cornelius, Victoria; Smythe, Wynand; Kramer, Nicky; Barasa, Felix; Damasceno, Albertino; Dzudie, Anastase; Jones, Erika; Mondo, Charles; Ogah, Okechukwu; Ogola, Elijah; Sani, Mahmoud U.; Shedul, Gabriel L.; Shedul, Grace; Rayner, Brian; Okpechi, Ikechi G.; Sliwa, Karen; Poulter, Neil		CREOLE Study Investigators	Comparison of Dual Therapies for Lowering Blood Pressure in Black Africans	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ARTERIAL-HYPERTENSION; CARDIOVASCULAR EVENTS; EUROPEAN-SOCIETY; TASK-FORCE; MANAGEMENT; TRIALS; HYDROCHLOROTHIAZIDE; AMLODIPINE; PREVENTION; RATIONALE	Background The prevalence of hypertension among black African patients is high, and these patients usually need two or more medications for blood-pressure control. However, the most effective two-drug combination that is currently available for blood-pressure control in these patients has not been established. Methods In this randomized, single-blind, three-group trial conducted in six countries in sub-Saharan Africa, we randomly assigned 728 black patients with uncontrolled hypertension (>= 140/90 mm Hg while the patient was not being treated or was taking only one antihypertensive drug) to receive a daily regimen of 5 mg of amlodipine plus 12.5 mg of hydrochlorothiazide, 5 mg of amlodipine plus 4 mg of perindopril, or 4 mg of perindopril plus 12.5 mg of hydrochlorothiazide for 2 months. Doses were then doubled (10 and 25 mg, 10 and 8 mg, and 8 and 25 mg, respectively) for an additional 4 months. The primary end point was the change in the 24-hour ambulatory systolic blood pressure between baseline and 6 months. Results The mean age of the patients was 51 years, and 63% were women. Among the 621 patients who underwent 24-hour blood-pressure monitoring at baseline and at 6 months, those receiving amlodipine plus hydrochlorothiazide and those receiving amlodipine plus perindopril had a lower 24-hour ambulatory systolic blood pressure than those receiving perindopril plus hydrochlorothiazide (between-group difference in the change from baseline, -3.14 mm Hg; 95% confidence interval [CI], -5.90 to -0.38; P=0.03; and -3.00 mm Hg; 95% CI, -5.8 to -0.20; P=0.04, respectively). The difference between the group receiving amlodipine plus hydrochlorothiazide and the group receiving amlodipine plus perindopril was -0.14 mm Hg (95% CI, -2.90 to 2.61; P=0.92). Similar differential effects on office and ambulatory diastolic blood pressures, along with blood-pressure control and response rates, were apparent among the three groups. Conclusions These findings suggest that in black patients in sub-Saharan Africa, amlodipine plus either hydrochlorothiazide or perindopril was more effective than perindopril plus hydrochlorothiazide at lowering blood pressure at 6 months. (Funded by GlaxoSmithKline Africa Noncommunicable Disease Open Lab; CREOLE ClinicalTrials.gov number, .) The relative effectiveness of two-drug combinations for blood-pressure control in black African patients is unknown. In this three-group randomized trial, amlodipine plus either hydrochlorothiazide or perindopril was more effective than perindopril plus hydrochlorothiazide in lowering blood pressure.	[Ojji, Dike B.] Univ Abuja, Dept Med, Fac Clin Sci, Gwagwalada, Abuja, Nigeria; [Ojji, Dike B.] Univ Abuja, Teaching Hosp, Gwagwalada, Abuja, Nigeria; [Shedul, Gabriel L.] Univ Abuja, Teaching Hosp, Dept Family Med, Gwagwalada, Abuja, Nigeria; [Shedul, Grace] Univ Abuja, Teaching Hosp, Dept Pharm, Gwagwalada, Abuja, Nigeria; [Ogah, Okechukwu] Univ Coll Hosp, Cardiol Unit, Dept Med, Ibadan, Nigeria; [Sani, Mahmoud U.] Bayero Univ, Dept Med, Kano, Nigeria; [Sani, Mahmoud U.] Aminu Kano Teaching Hosp, Kano, Nigeria; [Mayosi, Bongani] Univ Cape Town, Dept Med, Fac Hlth Sci, Cape Town, South Africa; [Jones, Erika; Rayner, Brian; Okpechi, Ikechi G.] Univ Cape Town, Div Nephrol & Hypertens, Fac Hlth Sci, Cape Town, South Africa; [Francis, Veronica; Smythe, Wynand; Kramer, Nicky] Univ Cape Town, Clin Res Ctr, Fac Hlth Sci, Cape Town, South Africa; [Sliwa, Karen] Hatter Inst Cardiovasc Res Africa, Cape Town, South Africa; [Badri, Motasim] King Saud Bin Abdulaziz Univ Hlth Sci, Dept Epidemiol & Biostat, Coll Publ Hlth & Hlth Informat, Riyadh, Saudi Arabia; [Cornelius, Victoria; Poulter, Neil] Imperial Coll London, Imperial Clin Trials Unit, Sch Publ Hlth, London, England; [Barasa, Felix] Moi Teaching & Referral Hosp, Dept Cardiol, Eldoret, Kenya; [Ogola, Elijah] Univ Nairobi, Dept Clin Med & Therapeut, Nairobi, Kenya; [Damasceno, Albertino] Eduardo Mondlane Univ Hosp, Maputo, Mozambique; [Dzudie, Anastase] Douala Gen Hosp, Douala, Cameroon; [Mondo, Charles] St Francis Hosp, Kampala, Uganda	University of Ibadan; University College Hospital, Ibadan; Bayero University; University of Cape Town; University of Cape Town; University of Cape Town; King Saud Bin Abdulaziz University for Health Sciences; Imperial College London; University of Nairobi	Ojji, DB (corresponding author), Univ Abuja, Dept Med, Fac Clin Sci, Gwagwalada, Abuja, Nigeria.	dike.ojji@uniabuja.edu.ng	Rayner, Brian/AAA-3174-2021; Badri, Motasim/E-1141-2013	DZUDIE, Anastase/0000-0003-4038-4128; Cornelius, Victoria/0000-0002-0080-1065; Shedul, Lamkur/0000-0003-2295-908X; Smythe, Wynand/0000-0003-2495-8814; Suleiman, Abdullahi Kabir/0000-0002-0815-1183; Badri, Motasim/0000-0002-5268-6492	GlaxoSmithKline Africa Noncommunicable Disease Open Lab	GlaxoSmithKline Africa Noncommunicable Disease Open Lab	Funded by GlaxoSmithKline Africa Noncommunicable Disease Open Lab; CREOLE ClinicalTrials.gov number, NCT02742467.	ABERNETHY DR, 1989, AM HEART J, V118, P1100, DOI 10.1016/0002-8703(89)90834-X; Adigun AQ, 2003, J HUM HYPERTENS, V17, P277, DOI 10.1038/sj.jhh.1001538; [Anonymous], 2014, LATEST VOLUME KURT W, VXXXII, P3; Barna I, 1998, Blood Press Monit, V3, P363; Belghazi J, 2007, VASC HEALTH RISK MAN, V3, P389; Cardillo C, 1998, HYPERTENSION, V31, P1235, DOI 10.1161/01.HYP.31.6.1235; COLLINS R, 1990, LANCET, V335, P827, DOI 10.1016/0140-6736(90)90944-Z; Dahlof B, 2005, LANCET, V366, P895, DOI 10.1016/S0140-6736(05)67185-1; Elliott WJ, 2007, LANCET, V369, P201, DOI 10.1016/S0140-6736(07)60108-1; Engberink RHGO, 2015, HYPERTENSION, V65, P1033, DOI 10.1161/HYPERTENSIONAHA.114.05122; Falaschetti E, 2014, LANCET, V383, P1912, DOI 10.1016/S0140-6736(14)60688-7; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981; GILLUM RF, 1979, HYPERTENSION, V1, P468, DOI 10.1161/01.HYP.1.5.468; Jamerson K, 2008, NEW ENGL J MED, V359, P2417, DOI 10.1056/NEJMoa0806182; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Kayima J, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-54; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; LUSCHER TF, 1995, CARDIOVASC DRUG THER, V9, P509, DOI 10.1007/BF00877863; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; Mason RP, 2005, AM J MED, V118, p54S, DOI 10.1016/j.amjmed.2005.09.021; MATERSON BJ, 1995, AM J HYPERTENS, V8, P189, DOI 10.1016/0895-7061(94)00196-I; Msambichaka B, 2018, NUTRIENTS, V10, DOI 10.3390/nu10020222; Ojji DB, 2018, AM HEART J, V202, P5, DOI 10.1016/j.ahj.2018.03.023; Park IU, 2007, ANN FAM MED, V5, P444, DOI 10.1370/afm.708; Poulter NR, 2015, LANCET, V386, P801, DOI 10.1016/S0140-6736(14)61468-9; Roush GC, 2015, HYPERTENSION, V65, P1041, DOI 10.1161/HYPERTENSIONAHA.114.05021; Sareli P, 2001, ARCH INTERN MED, V161, P965, DOI 10.1001/archinte.161.7.965; Schulman Ivonne Hernandez, 2005, Aging Clin Exp Res, V17, P40; Sharma AM, 2007, CARDIOVASC DIABETOL, V6, DOI 10.1186/1475-2840-6-28; Stanaway JD, 2018, LANCET, V392, P1923, DOI [10.1016/S0140-6736(18)32225-6, 10.1016/s0140-6736(18)32225-6]; Twagirumukiza M, 2011, J HYPERTENS, V29, P1243, DOI 10.1097/HJH.0b013e328346995d; Whelton Paul K, 2018, Hypertension, V71, pe13, DOI [10.1016/j.jash.2018.06.010, 10.1161/HYP.0000000000000065]; Williams B, 2018, EUR HEART J, V39, P3021, DOI 10.1093/eurheartj/ehy339	33	56	56	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 20	2019	380	25					2429	2439		10.1056/NEJMoa1901113	http://dx.doi.org/10.1056/NEJMoa1901113			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IE2LF	30883050	Green Published, Bronze			2022-12-28	WOS:000472215000008
J	Foy, BD; Alout, H; Seaman, JA; Rao, S; Magalhaes, T; Wade, M; Parikh, S; Soma, DD; Sagna, AB; Fournet, F; Slater, HC; Bougma, R; Drabo, F; Diabate, A; Coulidiaty, AGV; Rouamba, N; Dabire, RK				Foy, Brian D.; Alout, Haoues; Seaman, Jonathan A.; Rao, Sangeeta; Magalhaes, Tereza; Wade, Martina; Parikh, Sunil; Soma, Dieudonne D.; Sagna, Andre B.; Fournet, Florence; Slater, Hannah C.; Bougma, Roland; Drabo, Francois; Diabate, Abdoulaye; Coulidiaty, A. Gafar V.; Rouamba, Noel; Dabire, Roch K.			Efficacy and risk of harms of repeat ivermectin mass drug administrations for control of malaria (RIMDAMAL): a cluster-randomised trial	LANCET			English	Article							PLASMODIUM-FALCIPARUM; TRANSMISSION; RESISTANCE	Background Ivermectin is widely used in mass drug administrations for controlling neglected parasitic diseases, and can be lethal to malaria vectors that bite treated humans. Therefore, it could be a new tool to reduce plasmodium transmission. We tested the hypothesis that frequently repeated mass administrations of ivermectin to village residents would reduce clinical malaria episodes in children and would be well tolerated with minimal harms. Methods We invited villages (clusters) in Burkina Faso to participate in a single-blind (outcomes assessor), parallel-assignment, two-arm, cluster-randomised trial over the 2015 rainy season. Villages were assigned (1: 1) by random draw to either the intervention group or the control group. In both groups, all eligible participants who consented to the treatment and were at least 90 cm in height received single oral doses of ivermectin (150-200 mu g/kg) and albendazole (400 mg), and those in the intervention group received five further doses of ivermectin alone at 3-week intervals thereafter over the 18-week treatment phase. The primary outcome was cumulative incidence of uncomplicated malaria episodes over 18 weeks (analysed on a cluster intention-to-treat basis) in an active case detection cohort of children aged 5 years or younger living in the study villages. This trial is registered with ClinicalTrials.gov, number NCT02509481. Findings Eight villages agreed to participate, and four were randomly assigned to each group. 2712 participants (1333 [49%] males and 1379 [51%] females; median age 15 years [IQR 6-34]), including 590 children aged 5 years or younger, provided consent and were enrolled between May 22 and July 20, 2015 (except for 77 participants enrolled after these dates because of unavailability before the first mass drug administration, travel into the village during the trial, or birth), with 1447 enrolled into the intervention group and 1265 into the control group. 330 (23%) participants in the intervention group and 233 (18%) in the control group met the exclusion criteria for mass drug administration. Most children in the active case detection cohort were not treated because of height restrictions. 14 (4%) children in the intervention group and 10 (4%) in the control group were lost to follow-up. Cumulative malaria incidence was reduced in the intervention group (648 episodes among 327 children; estimated mean 2.00 episodes per child) compared with the control group (647 episodes among 263 children; 2.49 episodes per child; risk difference -0.49 [95% CI -0.79 to -0.21], p=0.0009, adjusted for sex and clustering). The risk of adverse events among all participants did not differ between groups (45 events [3%] among 1447 participants in the intervention group vs 24 events [2%] among 1265 in the control group; risk ratio 1.63 [1.01 to 2.67]; risk difference 1.21 [0.04 to 2.38], p=0.060), and no adverse reactions were reported. Interpretation Frequently repeated mass administrations of ivermectin during the malaria transmission season can reduce malaria episodes among children without significantly increasing harms in the populace. Copyright (C) 2019 The Author(s). Published by Elsevier Ltd.	[Foy, Brian D.; Alout, Haoues; Seaman, Jonathan A.; Magalhaes, Tereza] Colorado State Univ, Arthropod Borne & Infect Dis Lab, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Rao, Sangeeta] Colorado State Univ, Dept Clin Sci, Ft Collins, CO 80523 USA; [Wade, Martina; Parikh, Sunil] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA; [Soma, Dieudonne D.; Diabate, Abdoulaye; Rouamba, Noel; Dabire, Roch K.] Natl Ctr Sci & Technol Res, Inst Res Hlth Sci, Western Reg Direct, Bobo Dioulasso, Burkina Faso; [Soma, Dieudonne D.; Sagna, Andre B.; Fournet, Florence; Diabate, Abdoulaye; Dabire, Roch K.] Int Mixed Lab Vector Dis, Bobo Dioulasso, Burkina Faso; [Sagna, Andre B.; Fournet, Florence] Univ Montpellier, Inst Dev Infect Dis & Vectors Ecol Genet Evolut &, Natl Ctr Sci Res, Montpellier, France; [Slater, Hannah C.] Imperial Coll London, MRC Ctr Global Infect Dis Anal, Dept Infect Dis Epidemiol, London, England; [Bougma, Roland; Drabo, Francois] Minist Hlth, Natl Program Fight Neglected Trop Dis, Dept Dis Control, Ouagadougou, Burkina Faso; [Coulidiaty, A. Gafar V.] Ctr MURAZ, Dept Clin Res, Bobo Dioulasso, Burkina Faso	Colorado State University; Colorado State University; Yale University; Universite de Montpellier; Imperial College London; Centre Muraz	Foy, BD (corresponding author), Colorado State Univ, Arthropod Borne & Infect Dis Lab, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	brian.foy@colostate.edu	Magalhaes, Tereza/V-6632-2019; Sagna, André/AAY-6478-2021; Rao, Sangeeta/ABH-7983-2020; Dabire, Roch Kounbobr/ABF-3525-2020; ALOUT, HAOUES/N-9556-2016	Rao, Sangeeta/0000-0002-9234-0082; SAGNA, Andre/0000-0001-8586-792X; COULIDIATY, Abdul Gafar Victoir/0000-0002-6050-8573; DIABATE, Abdoulaye/0000-0002-9666-9395; ALOUT, HAOUES/0000-0001-7917-2697	Bill & Melinda Gates Foundation; Bill & Melinda Gates Foundation [OPP1116536]; Laboratoire Mixte International sur les Maladies a Vecteurs micro-projets 2017; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Laboratoire Mixte International sur les Maladies a Vecteurs micro-projets 2017; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Bill & Melinda Gates Foundation.; This study was funded by a Grand Challenges Explorations programme grant (number OPP1116536) from the Bill & Melinda Gates Foundation. Additional funding for testing human antibody responses to the Anopheles salivary gland antigen was provided by the Laboratoire Mixte International sur les Maladies a Vecteurs micro-projets 2017. We acknowledge the Burkina Faso Ministry of Health for donating drugs for use in this study. We thank the many people at the Institut de Recherche en Sciences de la Sante for study support, especially the clinical, parasitology, and entomology team members; and the administrative and institutional review board staff from Colorado State University. Finally, we sincerely thank the participants of the study and others in the Diebougou region for their kind support and hospitality.	Alout H, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-417; [Anonymous], CLIN GOV; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Chaccour CJ, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0691-6; Chaccour CJ, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-153; da Cruz FP, 2012, J INFECT DIS, V205, P1278, DOI 10.1093/infdis/jis184; Dembele B, 2010, CLIN INFECT DIS, V51, P1229, DOI 10.1086/657063; Dondorp AM, 2010, NAT REV MICROBIOL, V8, P272, DOI 10.1038/nrmicro2331; Drakeley C, 2003, TROP MED INT HEALTH, V8, P767, DOI 10.1046/j.1365-3156.2003.01100.x; DUKE BOL, 1991, B WORLD HEALTH ORGAN, V69, P163; Foy BD, 2011, TRENDS PARASITOL, V27, P423, DOI 10.1016/j.pt.2011.05.007; Golding N, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0491-4; Govella NJ, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00199; Ismail MM, 1996, T ROY SOC TROP MED H, V90, P684, DOI 10.1016/S0035-9203(96)90437-X; Killeen GF, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-330; Kobylinski KC, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-381; Kobylinski KC, 2011, AM J TROP MED HYG, V85, P3, DOI 10.4269/ajtmh.2011.11-0160; LARIVIERE M, 1989, B SOC PATHOL EXOT, V82, P35; Mendes AM, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.02005-16; Mueller I, 2012, P NATL ACAD SCI USA, V109, P10030, DOI 10.1073/pnas.1200841109; Nasveld Peter, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P552; Panchal M, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.521; Rumisha SF, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.22682; Russell TL, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-56; Slater HC, 2014, J INFECT DIS, V210, P1972, DOI 10.1093/infdis/jiu351; Smit MR, 2018, LANCET INFECT DIS, V18, P615, DOI 10.1016/S1473-3099(18)30163-4; Sylla M, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-365; Tiono AB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086936; Toe KH, 2014, EMERG INFECT DIS, V20, P1691, DOI 10.3201/eid2010.140619; World Health Organization, 2011, ASS SAF PREV CHEM IN; World Health Organization, 2017, WORLD MALARIA REPORT, P160	31	61	62	4	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 13	2019	393	10180					1517	1526		10.1016/S0140-6736(18)32321-3	http://dx.doi.org/10.1016/S0140-6736(18)32321-3			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU0DA	30878222	Green Published, hybrid			2022-12-28	WOS:000464940400027
J	Kuehl, HS; Boesch, C; Kulik, L; Haas, F; Arandjelovic, M; Dieguez, P; Bocksberger, G; McElreath, MB; Agbor, A; Angedakin, S; Ayimisin, EA; Bailey, E; Barubiyo, D; Bessone, M; Brazzola, G; Chancellor, R; Cohen, H; Coupland, C; Danquah, E; Deschner, T; Dowd, D; Dunn, A; Egbe, VE; Eshuis, H; Goedmakers, A; Granjon, AC; Head, J; Hedwig, D; Hermans, V; Imong, I; Jeffery, KJ; Jones, S; Junker, J; Kadam, P; Kambere, M; Kambi, M; Kienast, I; Kujirakwinja, D; Langergraber, KE; Lapuente, J; Larson, B; Lee, K; Leinert, V; Llana, M; Maretti, G; Marrocoli, S; Martin, R; Mbi, TJ; Meier, AC; Morgan, B; Morgan, D; Mulindahabi, F; Murai, M; Neil, E; Niyigaba, P; Ormsby, LJ; Orume, R; Pacheco, L; Piel, A; Preece, J; Regnaut, S; Rundus, A; Sanz, C; van Schijndel, J; Sommer, V; Stewart, F; Tagg, N; Vendras, E; Vergnes, V; Welsh, A; Wessling, EG; Willie, J; Wittig, RM; Yuh, YG; Yurkiw, K; Zuberbuhler, K; Kalan, AK				Kuehl, Hjalmar S.; Boesch, Christophe; Kulik, Lars; Haas, Fabian; Arandjelovic, Mimi; Dieguez, Paula; Bocksberger, Gaelle; McElreath, Mary Brooke; Agbor, Anthony; Angedakin, Samuel; Ayimisin, Emmanuel Ayuk; Bailey, Emma; Barubiyo, Donatienne; Bessone, Mattia; Brazzola, Gregory; Chancellor, Rebecca; Cohen, Heather; Coupland, Charlotte; Danquah, Emmanuel; Deschner, Tobias; Dowd, Dervla; Dunn, Andrew; Egbe, Villard Ebot; Eshuis, Henk; Goedmakers, Annemarie; Granjon, Anne-Celine; Head, Josephine; Hedwig, Daniela; Hermans, Veerle; Imong, Inaoyom; Jeffery, Kathryn J.; Jones, Sorrel; Junker, Jessica; Kadam, Parag; Kambere, Mbangi; Kambi, Mohamed; Kienast, Ivonne; Kujirakwinja, Deo; Langergraber, Kevin E.; Lapuente, Juan; Larson, Bradley; Lee, Kevin; Leinert, Vera; Llana, Manuel; Maretti, Giovanna; Marrocoli, Sergio; Martin, Rumen; Mbi, Tanyi Julius; Meier, Amelia C.; Morgan, Bethan; Morgan, David; Mulindahabi, Felix; Murai, Mizuki; Neil, Emily; Niyigaba, Protais; Ormsby, Lucy Jayne; Orume, Robinson; Pacheco, Liliana; Piel, Alex; Preece, Jodie; Regnaut, Sebastien; Rundus, Aaron; Sanz, Crickette; van Schijndel, Joost; Sommer, Volker; Stewart, Fiona; Tagg, Nikki; Vendras, Elleni; Vergnes, Virginie; Welsh, Adam; Wessling, Erin G.; Willie, Jacob; Wittig, Roman M.; Yuh, Yisa Ginath; Yurkiw, Kyle; Zuberbuhler, Klaus; Kalan, Ammie K.			Human impact erodes chimpanzee behavioral diversity	SCIENCE			English	Article							CULTURAL-DIFFERENCES; CONSERVATION; HYPOTHESIS	Chimpanzees possess a large number of behavioral and cultural traits among nonhuman species. The "disturbance hypothesis" predicts that human impact depletes resources and disrupts social learning processes necessary for behavioral and cultural transmission. We used a dataset of 144 chimpanzee communities, with information on 31 behaviors, to show that chimpanzees inhabiting areas with high human impact have a mean probability of occurrence reduced by 88%, across all behaviors, compared to low-impact areas. This behavioral diversity loss was evident irrespective of the grouping or categorization of behaviors. Therefore, human impact may not only be associated with the loss of populations and genetic diversity, but also affects how animals behave. Our results support the view that "culturally significant units" should be integrated into wildlife conservation.	[Kuehl, Hjalmar S.; Boesch, Christophe; Kulik, Lars; Haas, Fabian; Arandjelovic, Mimi; Dieguez, Paula; Bocksberger, Gaelle; McElreath, Mary Brooke; Agbor, Anthony; Angedakin, Samuel; Ayimisin, Emmanuel Ayuk; Bailey, Emma; Barubiyo, Donatienne; Bessone, Mattia; Brazzola, Gregory; Cohen, Heather; Coupland, Charlotte; Deschner, Tobias; Egbe, Villard Ebot; Eshuis, Henk; Granjon, Anne-Celine; Head, Josephine; Jones, Sorrel; Junker, Jessica; Kambere, Mbangi; Kambi, Mohamed; Kienast, Ivonne; Lapuente, Juan; Larson, Bradley; Lee, Kevin; Maretti, Giovanna; Marrocoli, Sergio; Martin, Rumen; Mbi, Tanyi Julius; Meier, Amelia C.; Murai, Mizuki; Neil, Emily; Ormsby, Lucy Jayne; Preece, Jodie; van Schijndel, Joost; Vendras, Elleni; Welsh, Adam; Wessling, Erin G.; Wittig, Roman M.; Yuh, Yisa Ginath; Yurkiw, Kyle; Kalan, Ammie K.] Max Planck Inst Evolutionary Anthropol, Deutsch Pl 6, D-04103 Leipzig, Germany; [Wessling, Erin G.] German Ctr Integrat Biodivers Res iDiv, Halle Leipzig Jena, D-04103 Leipzig, Germany; [Boesch, Christophe; Dowd, Dervla; Leinert, Vera; Regnaut, Sebastien; Vergnes, Virginie] Wild Chimpanzee Fdn, Deutsch Pl 6, D-04103 Leipzig, Germany; [Chancellor, Rebecca] West Chester Univ, Dept Anthropol & Sociol, W Chester, PA 19382 USA; [Chancellor, Rebecca; Rundus, Aaron] West Chester Univ, Dept Psychol, W Chester, PA 19382 USA; [Danquah, Emmanuel] Kwame Nkrumah Univ Sci & Technol, Fac Renewable Nat Resources, Dept Wildlife & Range Management, Kumasi, Ghana; [Orume, Robinson] Korup Natl Pk, Korup Rainforest Conservat Soc, POB 36, Mundemba, Sw Region, Cameroon; [Dunn, Andrew; Imong, Inaoyom; Kujirakwinja, Deo; Mulindahabi, Felix; Niyigaba, Protais] Wildlife Conservat Soc, 2300 Southern Blvd, Bronx, NY 10460 USA; [Goedmakers, Annemarie; van Schijndel, Joost] Chimbo Fdn, Amstel 49, NL-1011 PW Amsterdam, Netherlands; [Hedwig, Daniela] Aspinall Fdn, Port Lympne Wild Anim Pk, Hythe, Kent, England; [Hedwig, Daniela] Cornell Univ, Elephant Listening Project, Bioacoust Res Program, Cornell Lab Ornithol, 159 Sapsucker Woods Rd, Ithaca, NY 14850 USA; [Hermans, Veerle; Tagg, Nikki; Willie, Jacob] Royal Zool Soc Antwerp, Ctr Res & Conservat, B-2018 Antwerp, Belgium; [Jeffery, Kathryn J.] Univ Stirling, Sch Nat Sci, Stirling FK9 4LA, Scotland; [Jeffery, Kathryn J.] Agence Natl Parcs Nationaux, Batterie 4,BP20379, Libreville, Gabon; [Jeffery, Kathryn J.] Inst Rech Ecol Trop, Libreville, Gabon; [Jones, Sorrel] Royal Holloway Univ London, Egham Hill, Egham TW20 0EX, Surrey, England; [Jones, Sorrel] Royal Soc Protect Birds, Potton Rd, Sandy SG19 2DL, Beds, England; [Kadam, Parag] Univ Cambridge, Pembroke St, Cambridge CB2 3QG, England; [Langergraber, Kevin E.; Lee, Kevin] Arizona State Univ, Sch Human Evolut & Social Change, 900 Cady Mall, Tempe, AZ 85281 USA; [Langergraber, Kevin E.; Lee, Kevin] Arizona State Univ, Inst Human Origins, 900 Cady Mall, Tempe, AZ 85281 USA; [Llana, Manuel; Pacheco, Liliana] Inst Jane Goodall Espana, Stn Biol Fouta Djallon, Dindefelo, Region De Kedou, Senegal; [Morgan, Bethan] Ebo Forest Res Project, BP3055, Yaounde, Cameroon; [Morgan, Bethan] San Diego Zoo Global, Inst Conservat Res, Escondido, CA 92025 USA; [Morgan, David] Lincoln Pk Zoo, Lester E Fisher Ctr Study & Conservat Apes, Chicago, IL 60614 USA; [Piel, Alex; Stewart, Fiona] Liverpool John Moores Univ, Sch Nat Sci & Psychol, Liverpool L3 3AF, Merseyside, England; [Sanz, Crickette] Washington Univ St Louis, Dept Anthropol, One Brookings Dr, St Louis, MO 63130 USA; [Sommer, Volker] UCL, Dept Anthropol, London WC1H 0BW, England; [Vendras, Elleni] Frankfurt Zool Soc, Bernhard Grzimek Allee 1, D-60316 Frankfurt, Germany; [Willie, Jacob] Univ Ghent, Terr Ecol Unit, KL Ledeganckstr 35, B-9000 Ghent, Belgium; [Wittig, Roman M.] Ctr Suisse Rech Sci, Tai Chimpanzee Project, BP 1301, Abidjan 01, Cote Ivoire; [Zuberbuhler, Klaus] Univ Neuchatel, Inst Biol, CH-2000 Neuchatel, Switzerland; [Zuberbuhler, Klaus] Univ St Andrews, Sch Psychol & Neurosci, St Andrews KY16 9JP, Fife, Scotland	Max Planck Society; Pennsylvania State System of Higher Education (PASSHE); West Chester University of Pennsylvania; Pennsylvania State System of Higher Education (PASSHE); West Chester University of Pennsylvania; Kwame Nkrumah University Science & Technology; Wildlife Conservation Society; Cornell University; University of Stirling; University of London; Royal Holloway University London; Royal Society for Protection of Birds; University of Cambridge; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Liverpool John Moores University; Washington University (WUSTL); University of London; University College London; Ghent University; University of Neuchatel; University of St Andrews	Kuehl, HS; Kalan, AK (corresponding author), Max Planck Inst Evolutionary Anthropol, Deutsch Pl 6, D-04103 Leipzig, Germany.; Kuehl, HS (corresponding author), German Ctr Integrat Biodivers Res iDiv, Halle Leipzig Jena, D-04103 Leipzig, Germany.	kuehl@eva.mpg.de; ammie_kalan@eva.mpg.de	Lapuente, Juan/ABG-3912-2021; Hedwig, Daniela/ABH-7241-2020; Bessone, Mattia/AAL-6716-2021; Kalan, Ammie/M-8027-2019; Zuberbuhler, Klaus/A-9053-2011	Lapuente, Juan/0000-0002-6783-5585; Bessone, Mattia/0000-0002-8066-6413; Kalan, Ammie/0000-0003-1542-7077; Stewart, Fiona/0000-0002-4929-4711; Haas, Fabian/0000-0002-5918-2262; christophe, boesch/0000-0001-9538-7858; McElreath, Mary Brooke/0000-0003-3206-5485; Piel, Alexander/0000-0002-4674-537X; Zuberbuhler, Klaus/0000-0001-8378-088X; Hermans, Veerle/0000-0002-5232-992X; Dieguez, Paula/0000-0002-6951-2771; Bocksberger, Gaelle/0000-0002-3399-0405	Max Planck Society; Max Planck Society Innovation Fund; Krekeler Foundation; Robert Bosch Foundation; Chimbo Foundation; UCSD-SALK Institute Center for Academic Research and Training in Anthropogeny (CARTA)	Max Planck Society(Max Planck SocietyFoundation CELLEX); Max Planck Society Innovation Fund; Krekeler Foundation; Robert Bosch Foundation; Chimbo Foundation; UCSD-SALK Institute Center for Academic Research and Training in Anthropogeny (CARTA)	Generous funding for the Pan African Programme was provided by the Max Planck Society, Max Planck Society Innovation Fund, Krekeler Foundation, Robert Bosch Foundation, Chimbo Foundation and UCSD-SALK Institute Center for Academic Research and Training in Anthropogeny (CARTA).	Aoki K, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0061; Baayen H., 2008, ANAL LINGUISTIC DATA, DOI [10.1017/CBO9780511801686, DOI 10.1017/CBO9780511801686]; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bates D., 2014, LME4 LINEAR MIXED EF; BOESCH C, 1995, INT J PRIMATOL, V16, P1, DOI 10.1007/BF02700150; Boesch C, 2012, WILD CULTURES: A COMPARISON BETWEEN CHIMPANZEE AND HUMAN CULTURES, P1, DOI 10.1017/CBO9781139178532; Boesch C, 2000, CHIMPANZEES TAI FORE; Boesch C, 2017, AM J PRIMATOL, V79, DOI 10.1002/ajp.22613; Boesch Christophe, 2002, BEHAV DIVERSITY CHIM; Bonnie KE, 2007, P ROY SOC B-BIOL SCI, V274, P367, DOI 10.1098/rspb.2006.3733; Burkner PC, 2017, J STAT SOFTW, V80, P1, DOI 10.18637/jss.v080.i01; Campbell G, 2011, BIOL LETTERS, V7, P723, DOI 10.1098/rsbl.2011.0155; Dirzo R, 2014, SCIENCE, V345, P401, DOI 10.1126/science.1251817; Dobson AJ., 2008, INTRO GEN LINEAR MOD, DOI 10.1201/9780367807849; Estienne V, 2017, AM J PRIMATOL, V79, DOI 10.1002/ajp.22672; Field A., 2013, DISCOVERING STAT USI; Fox J., 2019, R COMPANION APPL REG; Gelman A, 2014, BAYESIAN DATA ANAL; Goodall J., 1986, CHIMPANZEES GOMBE PA; Henrich J., 2018, CULTURAL EVOLUTION C, P645, DOI [10.4159/9780674982642-018, DOI 10.4159/9780674982642-018]; Hicks T. C., 2010, THESIS; Hobaiter C, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001960; Hockings KJ, 2015, TRENDS ECOL EVOL, V30, P215, DOI 10.1016/j.tree.2015.02.002; Kuhl HS, 2017, AM J PRIMATOL, V79, DOI 10.1002/ajp.22681; Kuhl HS, 2016, SCI REP-UK, V6, DOI 10.1038/srep22219; Kuhl HS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035610; Lapuente J, 2017, AM J PRIMATOL, V79, DOI 10.1002/ajp.22628; Leblan V., 2008, THESIS; Lefcheck JS, 2016, METHODS ECOL EVOL, V7, P573, DOI 10.1111/2041-210X.12512; Lind J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009241; Luncz LV, 2012, CURR BIOL, V22, P922, DOI 10.1016/j.cub.2012.03.031; Matsuzawa T, 2011, PRIMATOL MONOGR, P1, DOI 10.1007/978-4-431-53921-6; McElreath R, 2016, TEXT STAT SCI, pXI; Mobius Y, 2008, ANIM BEHAV, V76, P37, DOI 10.1016/j.anbehav.2008.01.008; Nishida T., 2010, CHIMPANZEE BEHAV WIL; Nishida Toshisada, 2011, P1; PICKETT S T A, 1989, P110; Powell A, 2009, SCIENCE, V324, P1298, DOI 10.1126/science.1170165; Pruetz JD, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.140507; Pruetz Jill D., 2009, Paleoanthropology, V2009, P252; R Development Core Team, 2009, R LANG ENV STAT COMP; Ryan SJ, 2006, CONSERV BIOL, V20, P1321, DOI 10.1111/j.1523-1739.2006.00347.x; Sanz CM, 2014, J HUM EVOL, V71, P28, DOI 10.1016/j.jhevol.2013.07.017; Sanz CM, 2009, INT J PRIMATOL, V30, P411, DOI 10.1007/s10764-009-9350-5; Schielzeth H, 2009, BEHAV ECOL, V20, P416, DOI 10.1093/beheco/arn145; Sommer V, 2011, DEV PRIMATOL-PROG PR, P1, DOI 10.1007/978-1-4419-7403-7; Strindberg S, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar2964; UNEP/CMS Scientific Council, 2018, CMS WORKSH CONS IMPL, P40; UNEP/CMS Scientific Council, 2018, REP CMS WORKSH CONS, P40; van Schaik CP, 2003, SCIENCE, V299, P102, DOI 10.1126/science.1078004; van Schaik CP, 2002, INT J PRIMATOL, V23, P527, DOI 10.1023/A:1014965516127; WCS, 2005, LAST WILD PROJ VERS; Whitehead H, 2004, BIOL CONSERV, V120, P427, DOI 10.1016/j.biocon.2004.03.017; Whiten A, 2001, BEHAVIOUR, V138, P1481, DOI 10.1163/156853901317367717; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; Whiten A, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0359; Wrangham R. W., 1996, CHIMPANZEE CULTURES; Xue YL, 2015, SCIENCE, V348, P242, DOI 10.1126/science.aaa3952	58	63	63	3	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 29	2019	363	6434					1453	+		10.1126/science.aau4532	http://dx.doi.org/10.1126/science.aau4532			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HQ9HP	30846610	Green Accepted, Green Submitted			2022-12-28	WOS:000462738000036
J	Day, CS; Wu, WK; Smith, CC				Day, Charles S.; Wu, Wei Kang; Smith, C. Christopher			Examination of the Hand and Wrist	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CORTICOSTEROID INJECTIONS; CARPAL; MANAGEMENT		[Day, Charles S.] St Elizabeths Med Ctr, Brighton, MA 02135 USA; [Day, Charles S.] Tufts Univ, Sch Med, Medford, MA 02155 USA; [Smith, C. Christopher] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Smith, C. Christopher] Harvard Med Sch, Boston, MA 02115 USA; [Wu, Wei Kang] St Marys Hosp, San Francisco, CA USA	St. Elizabeth's Medical Center; Tufts University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Day, CS (corresponding author), St Elizabeths Med Ctr, Brighton, MA 02135 USA.; Day, CS (corresponding author), Tufts Univ, Sch Med, Medford, MA 02155 USA.							Agir Ismail, 2014, Open Orthop J, V8, P74, DOI 10.2174/1874325001408010074; Ball C, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-131; Castellanos J, 2015, J HAND SURG-AM, V40, P121, DOI 10.1016/j.jhsa.2014.09.006; Coombes BK, 2010, LANCET, V376, P1751, DOI 10.1016/S0140-6736(10)61160-9; Day CS, 2012, J HAND SURG-AM, V37A, P2619, DOI 10.1016/j.jhsa.2012.07.038; Duckworth AD, 2014, J HAND SURG-AM, V39, P1403, DOI 10.1016/j.jhsa.2014.03.039; Fowler JR, 2015, CLIN SPORT MED, V34, P37, DOI 10.1016/j.csm.2014.09.011; LA Jones, 2006, HUMAN HAND FUNCTION, P3; LeBlanc KE, 2011, AM FAM PHYSICIAN, V83, P952; LESLIE IJ, 1981, J BONE JOINT SURG BR, V63, P225, DOI 10.1302/0301-620X.63B2.7217146; McDermott JD, 2012, CLIN ORTHOP RELAT R, V470, P1925, DOI 10.1007/s11999-012-2369-5; Meenagh GK, 2004, ANN RHEUM DIS, V63, P1260, DOI 10.1136/ard.2003.015438; Meyer Carissa, 2014, Instr Course Lect, V63, P113; Rajan PV, 2015, J HAND SURG-AM, V40, P583, DOI 10.1016/j.jhsa.2014.10.028; Verdugo RJ, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001552.pub2; Welling RD, 2008, AM J ROENTGENOL, V190, P10, DOI 10.2214/AJR.07.2699; Werner RA, 2002, CLIN NEUROPHYSIOL, V113, P1373, DOI 10.1016/S1388-2457(02)00169-4	17	2	2	2	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 21	2019	380	12							e15	10.1056/NEJMvcm1407111	http://dx.doi.org/10.1056/NEJMvcm1407111			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HP7VK	30893537				2022-12-28	WOS:000461898400001
J	Iliff, AR; Jha, AK				Iliff, Andrew R.; Jha, Ashish K.			Public-Private Partnerships in Global Health - Driving Health Improvements without Compromising Values	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Iliff, Andrew R.; Jha, Ashish K.] Harvard Global Hlth Inst, Cambridge, MA 02138 USA; [Jha, Ashish K.] Harvard TH Chan Sch Publ Hlth, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health	Iliff, AR (corresponding author), Harvard Global Hlth Inst, Cambridge, MA 02138 USA.							Buse K, 2000, B WORLD HEALTH ORGAN, V78, P699; Flynn A, 2016, LANCET, V387, P25, DOI 10.1016/S0140-6736(15)01290-8; Griswold MG, 2018, LANCET, V392, P1015, DOI [10.1016/S0140-6736(18)31310-2, 10.1016/s0140-6736(18)31310-2, 10.1136/bmj.l94]; Marten R, 2018, LANCET, V391, P735, DOI 10.1016/S0140-6736(18)30253-8; The Global Fund to Fight AIDS tuberculosis and malaria, 2018, GLOB FUND SUSP PARTN	5	7	7	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 21	2019	380	12					1097	1099		10.1056/NEJMp1812630	http://dx.doi.org/10.1056/NEJMp1812630			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HP7VK	30893531				2022-12-28	WOS:000461898400004
J	Ramachandran, V				Ramachandran, Vijaya			The World Bank must clean up its act	NATURE			English	Editorial Material									[Ramachandran, Vijaya] Ctr Global Dev, Washington, DC 20036 USA		Ramachandran, V (corresponding author), Ctr Global Dev, Washington, DC 20036 USA.	vramachandran@cgdev.org							0	2	2	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 21	2019	567	7748					285	285		10.1038/d41586-019-00876-6	http://dx.doi.org/10.1038/d41586-019-00876-6			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HP9JT	30890809	Bronze			2022-12-28	WOS:000462010000025
J	Sampson, C				Sampson, Christopher			In adults in the emergency department with nausea, neither droperidol nor ondansetron improved symptoms	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Sampson, Christopher] Univ Missouri, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia	Sampson, C (corresponding author), Univ Missouri, Columbia, MO 65211 USA.							[Anonymous], 2014, EMERGENCY PHYS MONTH; Furyk JS, 2015, COCHRANE DB SYST REV, V9; Meek R, 2018, EMERG MED AUSTRALAS, V30, P36, DOI 10.1111/1742-6723.12861; Singer AJ, 2017, AM J EMERG MED, V35, P922, DOI 10.1016/j.ajem.2017.03.011; Singer AJ, 2017, AM J EMERG MED, V35, P790, DOI 10.1016/j.ajem.2016.12.044	5	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 19	2019	170	6					JC30	JC30		10.7326/ACPJ201903190-030	http://dx.doi.org/10.7326/ACPJ201903190-030			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP1ZR	30884500				2022-12-28	WOS:000461468300007
J	Van Spall, HGC				Van Spall, Harriette G. C.			In patients with previous dilated cardiomyopathy, withdrawal of HF drugs increased relapse at 6 months	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Van Spall, Harriette G. C.] McMaster Univ, Hamilton, ON, Canada	McMaster University	Van Spall, HGC (corresponding author), McMaster Univ, Hamilton, ON, Canada.			Van Spall, Harriette Gillian Christine/0000-0002-8370-4569				Merlo M, 2015, J AM HEART ASSOC, V4, DOI [10.1161/JAHA.114.001504, 10.1161/JAHA.114.000570]; Moon J, 2009, CAN J CARDIOL, V25, pE147, DOI 10.1016/S0828-282X(09)70497-0	2	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 19	2019	170	6					JC28	JC28		10.7326/ACPJ201903190-028	http://dx.doi.org/10.7326/ACPJ201903190-028			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP1ZR	30884498				2022-12-28	WOS:000461468300005
J	Zhong, VW; Van Horn, L; Cornelis, MC; Wilkins, JT; Ning, HY; Carnethon, MR; Greenland, P; Mentz, RJ; Tucker, KL; Zhao, LH; Norwood, AF; Lloyd-Jones, DM; Allen, NB				Zhong, Victor W.; Van Horn, Linda; Cornelis, Marilyn C.; Wilkins, John T.; Ning, Hongyan; Carnethon, Mercedes R.; Greenland, Philip; Mentz, Robert J.; Tucker, Katherine L.; Zhao, Lihui; Norwood, Arnita F.; Lloyd-Jones, Donald M.; Allen, Norrina B.			Associations of Dietary Cholesterol or Egg Consumption With Incident Cardiovascular Disease and Mortality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	Scientific Sessions and Meeting of the American-Heart-Association (AHA)	NOV 10-12, 2018	Chicago, IL	Amer Heart Assoc			CORONARY-HEART-DISEASE; LIFETIME RISK; DESIGN; METAANALYSIS; CLASSIFICATION; PROFILE; STROKE; ADULTS	IMPORTANCE Cholesterol is a common nutrient in the human diet and eggs are a major source of dietary cholesterol. Whether dietary cholesterol or egg consumption is associated with cardiovascular disease (CVD) and mortality remains controversial. OBJECTIVE To determine the associations of dietary cholesterol or egg consumption with incident CVD and all-cause mortality. DESIGN, SETTING, AND PARTICIPANTS Individual participant datawere pooled from 6 prospective US cohorts using data collected between March 25, 1985, and August 31, 2016. Self-reported diet data were harmonized using a standardized protocol. EXPOSURES Dietary cholesterol (mg/day) or egg consumption (number/day). MAIN OUTCOMES AND MEASURES Hazard ratio (HR) and absolute risk difference (ARD) over the entire follow-up for incident CVD (composite of fatal and nonfatal coronary heart disease, stroke, heart failure, and other CVD deaths) and all-cause mortality, adjusting for demographic, socioeconomic, and behavioral factors. RESULTS This analysis included 29 615 participants (mean [SD] age, 51.6 [13.5] years at baseline) of whom 13 299 (44.9%) were men and 9204 (31.1%) were black. During a median follow-up of 17.5 years (interquartile range, 13.0-21.7; maximum, 31.3), there were 5400 incident CVD events and 6132 all-cause deaths. The associations of dietary cholesterol or egg consumption with incident CVD and all-cause mortality were monotonic (all P values for nonlinear terms,.19-. 83). Each additional 300mg of dietary cholesterol consumed per day was significantly associated with higher risk of incident CVD (adjusted HR, 1.17 [95% CI, 1.09-1.26]; adjusted ARD, 3.24%[95% CI, 1.39%-5.08%]) and all-cause mortality (adjusted HR, 1.18 [95% CI, 1.10-1.26]; adjusted ARD, 4.43%[95% CI, 2.51%-6.36%]). Each additional half an egg consumed per day was significantly associated with higher risk of incident CVD (adjusted HR, 1.06 [95% CI, 1.03-1.10]; adjusted ARD, 1.11% [95% CI, 0.32%-1.89%]) and all-cause mortality (adjusted HR, 1.08 [95% CI, 1.04-1.11]; adjusted ARD, 1.93%[95% CI, 1.10%-2.76%]). The associations between egg consumption and incident CVD (adjusted HR, 0.99 [95% CI, 0.93-1.05]; adjusted ARD, -0.47%[95% CI, -1.83% to 0.88%]) and all-cause mortality (adjusted HR, 1.03 [95% CI, 0.97-1.09]; adjusted ARD, 0.71% [95% CI, -0.85% to 2.28%]) were no longer significant after adjusting for dietary cholesterol consumption. CONCLUSIONS AND RELEVANCE Among US adults, higher consumption of dietary cholesterol or eggs was significantly associated with higher risk of incident CVD and all-cause mortality in a dose-response manner. These results should be considered in the development of dietary guidelines and updates.	[Zhong, Victor W.; Van Horn, Linda; Cornelis, Marilyn C.; Wilkins, John T.; Ning, Hongyan; Carnethon, Mercedes R.; Greenland, Philip; Zhao, Lihui; Lloyd-Jones, Donald M.; Allen, Norrina B.] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, 680 N Lake Shore Dr,Ste 1400, Chicago, IL 60611 USA; [Mentz, Robert J.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Mentz, Robert J.] Duke Clin Res Inst, Durham, NC USA; [Tucker, Katherine L.] Univ Massachusetts Lowell, Dept Biomed & Nutr Sci, Lowell, MA USA; [Norwood, Arnita F.] Univ Mississippi, Med Ctr, Dept Med, Jackson, MS 39216 USA	Northwestern University; Feinberg School of Medicine; Duke University; Duke University; University of Massachusetts System; University of Massachusetts Lowell; University of Mississippi; University of Mississippi Medical Center	Zhong, VW; Allen, NB (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, 680 N Lake Shore Dr,Ste 1400, Chicago, IL 60611 USA.	wenze.zhong@northwestern.edu; norrina-allen@northwestern.edu	Mentz, Robert/AAV-4758-2021; Greenland, Philip/ABD-5528-2021	Lloyd-Jones, Donald/0000-0003-0847-6110; Mentz, Robert/0000-0002-3222-1719; Allen, Norrina/0000-0002-6993-4384; Carnethon, Mercedes/0000-0001-7035-0848	American Heart Association Strategically Focused Research Networks [14SFRN20480260]; National Institutes of Health/National Heart, Lung, and Blood Institute [R21 HL085375]; Northwestern University Feinberg School of Medicine; Jackson State University from the National Heart, Lung, and Blood Institute [HHSN268201300049C, HHSN268201300050C]; Tougaloo College from the National Heart, Lung, and Blood Institute [HHSN268201300048C]; University of Mississippi Medical Center from the National Heart, Lung, and Blood Institute [HHSN268201300046C, HHSN268201300047C]; National Institute for Minority Health and Health Disparities; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL133601, R01HL136942] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK092949] Funding Source: NIH RePORTER	American Heart Association Strategically Focused Research Networks; National Institutes of Health/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Northwestern University Feinberg School of Medicine; Jackson State University from the National Heart, Lung, and Blood Institute; Tougaloo College from the National Heart, Lung, and Blood Institute; University of Mississippi Medical Center from the National Heart, Lung, and Blood Institute; National Institute for Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by a postdoctoral fellowship to Dr Zhong from the American Heart Association Strategically Focused Research Networks (14SFRN20480260; principal investigator, Greenland). The Lifetime Risk Pooling Project was supported by the National Institutes of Health/National Heart, Lung, and Blood Institute (R21 HL085375) and by the Northwestern University Feinberg School of Medicine. The Jackson Heart Study is supported and conducted in collaboration with Jackson State University (HHSN268201300049C and HHSN268201300050C), Tougaloo College (HHSN268201300048C), and the University of Mississippi Medical Center (HHSN268201300046C and HHSN268201300047C), contracts from the National Heart, Lung, and Blood Institute, and the National Institute for Minority Health and Health Disparities.	Alexander DD, 2016, J AM COLL NUTR, V35, P704, DOI 10.1080/07315724.2016.1152928; Austin PC, 2016, CIRCULATION, V133, P601, DOI 10.1161/CIRCULATIONAHA.115.017719; Berger S, 2015, AM J CLIN NUTR, V102, P276, DOI 10.3945/ajcn.114.100305; Berry JD, 2012, NEW ENGL J MED, V366, P321, DOI 10.1056/NEJMoa1012848; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Chiuve SE, 2012, J NUTR, V142, P1009, DOI 10.3945/jn.111.157222; Clarke R, 1997, BRIT MED J, V314, P112, DOI 10.1136/bmj.314.7074.112; Conrad Z, 2017, NUTRIENTS, V9, DOI 10.3390/nu9040333; Dietary Guidelines Advisory Committee, 2015, RAPP ACT 2015 REP PE; Djousse L, 2016, AM J CLIN NUTR, V103, P474, DOI 10.3945/ajcn.115.119933; FEINLEIB M, 1975, PREV MED, V4, P518, DOI 10.1016/0091-7435(75)90037-7; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; Fung TT, 2008, ARCH INTERN MED, V168, P713, DOI 10.1001/archinte.168.7.713; Fung TT, 2009, CIRCULATION, V119, P1093, DOI 10.1161/CIRCULATIONAHA.108.816736; Hu FB, 1999, JAMA-J AM MED ASSOC, V281, P1387, DOI 10.1001/jama.281.15.1387; Huffman MD, 2013, J AM COLL CARDIOL, V61, P1510, DOI 10.1016/j.jacc.2013.01.022; Institute of Medicine Food and Nutrition Board, 2002, DIET REF INT EN CARB; Keku E, 2005, ETHNIC DIS, V15, pS62; Khawaja O, 2017, FRONT NUTR, V4, DOI 10.3389/fnut.2017.00010; Lau B, 2009, AM J EPIDEMIOL, V170, P244, DOI 10.1093/aje/kwp107; Li YH, 2013, ATHEROSCLEROSIS, V229, P524, DOI 10.1016/j.atherosclerosis.2013.04.003; LIN DY, 1993, BIOMETRIKA, V80, P557, DOI 10.2307/2337177; Micha R, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2272; Rong Y, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e8539; SAS Institute, PHREG PROC TYP 3 TES; Shin JY, 2013, AM J CLIN NUTR, V98, P146, DOI 10.3945/ajcn.112.051318; Taylor HA, 2005, ETHNIC DIS, V15, pS4; Tsao CW, 2015, INT J EPIDEMIOL, V44, P1800, DOI 10.1093/ije/dyv337; US Department of Agriculture Agricultural Research Service, 2019, USDA NATL NUTR DATAB; US Department of Health and Human Services and US Department of Agriculture, 2015, 2015 2020 DIET GUID; Wang DD, 2014, JAMA INTERN MED, V174, P1587, DOI 10.1001/jamainternmed.2014.3422; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Wilkins JT, 2015, INT J EPIDEMIOL, V44, P1557, DOI 10.1093/ije/dyv150; Wilkins JT, 2012, JAMA-J AM MED ASSOC, V308, P1795, DOI 10.1001/jama.2012.14312; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Wong ND, 2013, GLOB HEART, V8, P3, DOI 10.1016/j.gheart.2012.12.001; Xu LD, 2019, ENTERP INF SYST-UK, V13, P148, DOI 10.1080/17517575.2018.1442934; Xu Z, 2018, NUTRIENTS, V10, DOI 10.3390/nu10060771; Yano Y, 2018, JAMA-J AM MED ASSOC, V320, P1774, DOI 10.1001/jama.2018.13551	39	166	181	4	74	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 19	2019	321	11					1081	1095		10.1001/jama.2019.1572	http://dx.doi.org/10.1001/jama.2019.1572			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	HP4YY	30874756	Bronze, Green Published			2022-12-28	WOS:000461683500016
J	Lam, CG; Howard, SC; Bouffet, E; Pritchard-Jones, K				Lam, Catherine G.; Howard, Scott C.; Bouffet, Eric; Pritchard-Jones, Kathy			Science and health for all children with cancer	SCIENCE			English	Review							ACUTE LYMPHOBLASTIC-LEUKEMIA; MIDDLE-INCOME COUNTRIES; MISMATCH REPAIR DEFICIENCY; EARLY WARNING SYSTEM; B-CELL MALIGNANCIES; PEDIATRIC-ONCOLOGY; CHILDHOOD-CANCER; BURKITT-LYMPHOMA; RESOURCE-POOR; ABANDONMENT	Each year similar to 429,000 children and adolescents aged 0 to 19 years are expected to develop cancer. Five-year survival rates exceed 80% for the 45,000 children with cancer in high-income countries (HICs) but are less than 30% for the 384,000 children in lower-middle-income countries (LMICs). Improved survival rates in HICs have been achieved through multidisciplinary care and research, with treatment regimens using mostly generic medicines and optimized risk stratification. Children's outcomes in LMICs can be improved through global collaborative partnerships that help local leaders adapt effective treatments to local resources and clinical needs, as well as address common problems such as delayed diagnosis and treatment abandonment. Together, these approaches may bring within reach the global survival target recently set by the World Health Organization: 60% survival for all children with cancer by 2030.	[Lam, Catherine G.] St Jude Childrens Res Hosp, Dept Global Pediat Med, 332 N Lauderdale St, Memphis, TN 38105 USA; [Lam, Catherine G.] St Jude Childrens Res Hosp, Dept Oncol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Lam, Catherine G.; Howard, Scott C.] Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA; [Howard, Scott C.] Guardian Res Network, Spartanburg, SC USA; [Howard, Scott C.; Bouffet, Eric; Pritchard-Jones, Kathy] Int Soc Paediat Oncol SIOP, Zug, Switzerland; [Bouffet, Eric] Univ Toronto, Hosp Sick Children, Div Haematol Oncol, Toronto, ON, Canada; [Pritchard-Jones, Kathy] UCL, UCL Great Ormond St Inst Child Hlth, London, England	St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of London; University College London	Lam, CG (corresponding author), St Jude Childrens Res Hosp, Dept Global Pediat Med, 332 N Lauderdale St, Memphis, TN 38105 USA.; Lam, CG (corresponding author), St Jude Childrens Res Hosp, Dept Oncol, 332 N Lauderdale St, Memphis, TN 38105 USA.; Lam, CG (corresponding author), Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA.	catherine.lam@stjude.org	Bouffet, Eric/AAB-8999-2020; Pritchard-Jones, Kathryn/F-4286-2014; Howard, Scott/K-3401-2013; Lam, Catherine/K-6328-2014	Pritchard-Jones, Kathryn/0000-0002-2384-9475; Howard, Scott/0000-0003-2244-1686; Lam, Catherine/0000-0003-1363-5331	American Lebanese Syrian Associated Charities; Bristol Myers Squibb [NCT02992964]; Roche [NCT02840409]; National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital	American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); Bristol Myers Squibb(Bristol-Myers Squibb); Roche(Roche Holding); National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital	C.G.L. is funded at St. Jude by the American Lebanese Syrian Associated Charities. E.B. is receiving funding from Bristol Myers Squibb for an investigator-initiated study of immunotherapy (NCT02992964). E.B. also received funding from Roche for an investigator-initiated study (NCT02840409). K.P.-J. is funded in part by the National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital.	Acquatella G, 2004, PEDIATR BLOOD CANCER, V43, P580, DOI 10.1002/pbc.20116; Agulnik A, 2017, CANCER-AM CANCER SOC, V123, P4903, DOI 10.1002/cncr.30951; Agulnik A, 2017, CANCER-AM CANCER SOC, V123, P2965, DOI 10.1002/cncr.30664; Ahmad N, 2010, ASIA-PAC J CLIN ONCO, V6, P49, DOI 10.1111/j.1743-7563.2009.01264.x; AlHarbi M, 2018, ONCOLOGIST, V23, P1401, DOI 10.1634/theoncologist.2018-0163; Allemani C, 2018, LANCET, V391, P1023, DOI 10.1016/S0140-6736(17)33326-3; Alvarez E, 2017, PEDIATR BLOOD CANCER, V64, DOI 10.1002/pbc.26560; Amayiri N., 2018, J GLOBAL ONCOL, V2018, P1; Amayiri N, 2016, INT J CANCER, V138, P380, DOI 10.1002/ijc.29724; [Anonymous], 2012, PHARM TECHNOLOGY; Arora RS, 2016, PEDIATR BLOOD CANCER, V63, P387, DOI 10.1002/pbc.25810; Bhakta N, 2019, LANCET ONCOL, V20, pE42, DOI 10.1016/S1470-2045(18)30761-7; Bloom DE, 2018, SCIENCE, V361, DOI 10.1126/science.aat9644; Bouffet E, 2016, J CLIN ONCOL, V34, P2206, DOI 10.1200/JCO.2016.66.6552; Cairo MS, 2010, BRIT J HAEMATOL, V149, P578, DOI 10.1111/j.1365-2141.2010.08143.x; Casan J. M. L., 2018, HUM VACC IMMUNOTHER, V14, P1; Cecconello DK, 2018, LANCET ONCOL, V19, P1149, DOI 10.1016/S1470-2045(18)30584-9; Ceppi F, 2016, PEDIATR BLOOD CANCER, V63, P78, DOI 10.1002/pbc.25698; Ceppi F, 2015, EXPERT REV HEMATOL, V8, P613, DOI 10.1586/17474086.2015.1049594; Cervio C, 2012, J PEDIAT HEMATOL ONC, V34, pE266, DOI 10.1097/MPH.0b013e31826226b1; Chantada G., 2019, BR J HAEMATOL; Cohen P., 2018, J GLOBAL ONCOL, V2018, P1; Davidson A, 2018, PEDIATR BLOOD CANCER, V65, DOI 10.1002/pbc.27347; De Boer J D, 2009, Afr J Paediatr Surg, V6, P3, DOI 10.4103/0189-6725.48566; DeSantis CE, 2017, CA-CANCER J CLIN, V67, P261, DOI 10.3322/caac.21400; Freeman CL, 2018, CURR ONCOL REP, V20, DOI 10.1007/s11912-018-0748-0; Friedrich P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135230; Gaspar N, 2018, ANN ONCOL, V29, P766, DOI 10.1093/annonc/mdy002; Gaytan-Morales F, 2019, HEMATOLOGY, V24, P79, DOI 10.1080/10245332.2018.1510087; Global Cancer Observatory, CANC TOD; Gupta S, 2013, EUR J CANCER, V49, P2555, DOI 10.1016/j.ejca.2013.03.024; Harif M, 2008, PEDIATR BLOOD CANCER, V50, P1138, DOI 10.1002/pbc.21452; Howard SC, 2005, EUR J CANCER, V41, P1584, DOI 10.1016/j.ejca.2005.04.020; Howard SC, 2004, JAMA-J AM MED ASSOC, V291, P2471, DOI 10.1001/jama.291.20.2471; Howard Scott C, 2007, Pediatr Blood Cancer, V48, P364, DOI 10.1002/pbc.21003; Howard SC, 2008, CANCER, V112, P461, DOI 10.1002/cncr.23205; Howard SC, 2007, PEDIATR BLOOD CANCER, V48, P486, DOI 10.1002/pbc.20989; Howard SC, 2018, LANCET ONCOL, V19, pE252, DOI 10.1016/S1470-2045(18)30123-2; Howard SC, 2017, PEDIATR BLOOD CANCER, V64, DOI 10.1002/pbc.26879; Hsu SC, 2007, PEDIATR BLOOD CANCER, V49, P139, DOI 10.1002/pbc.20883; Israels T, 2019, NAT REV CLIN ONCOL, V16, P211, DOI 10.1038/s41571-018-0121-0; Israels T, 2018, PEDIATR HEMAT ONCOL, V35, P196, DOI 10.1080/08880018.2018.1498564; Israels T, 2018, PEDIATR BLOOD CANCER, V65, DOI 10.1002/pbc.26945; Israels T, 2009, PEDIATR BLOOD CANCER, V53, P47, DOI 10.1002/pbc.22032; Jankovic M, 2018, J CANCER SURVIV, V12, P647, DOI 10.1007/s11764-018-0701-0; Klumb CE, 2004, J PEDIAT HEMATOL ONC, V26, P462, DOI 10.1097/00043426-200407000-00014; La Rosa CGS, 2016, BLOOD, V128; Ladas EJ, 2016, PEDIATR BLOOD CANCER, V63, P1339, DOI 10.1002/pbc.26016; Leander C, 2007, PEDIATR BLOOD CANCER, V49, P817, DOI 10.1002/pbc.21052; Lyerly H. K., 2018, J GLOBAL ONCOL, V2018, P1; Magrath I, 2013, LANCET ONCOL, V14, pE104, DOI 10.1016/S1470-2045(13)70008-1; Martijn HA, 2017, BMJ PAEDIATR OPEN, V1, DOI 10.1136/bmjpo-2017-000149; Metzger ML, 2003, LANCET, V362, P706, DOI 10.1016/S0140-6736(03)14228-6; Ministry of Health, 2017, NAT CANC CONTR STRAT; Ministry of Social Affairs and Public Health Belgium, 2008, NAT CANC PLAN 2008 2; Moleti ML, 2011, PEDIATR BLOOD CANCER, V56, P560, DOI 10.1002/pbc.22905; Mostert S, 2014, PSYCHO-ONCOLOGY, V23, P700, DOI 10.1002/pon.3571; Mostert S, 2015, LANCET, V386, P649, DOI 10.1016/S0140-6736(15)61495-7; Mostert S, 2011, LANCET ONCOL, V12, P719, DOI 10.1016/S1470-2045(11)70128-0; Naresh KN, 2011, BRIT J HAEMATOL, V154, P770, DOI 10.1111/j.1365-2141.2011.08771.x; National Health Service (NHS) National Cancer Survivorship Initiative, 2010, BUILD EV DEV WINN PR; Ogwang MD, 2011, ARCH PATHOL LAB MED, V135, P445, DOI 10.1043/2009-0443-EP.1; Orem Jackson, 2012, Clin Epidemiol, V4, P339, DOI 10.2147/CLEP.S35671; Paintsil V, 2015, EUR J CANCER, V51, P84, DOI 10.1016/j.ejca.2014.10.030; Pan American Health Organization (PAHO), 2014, EARL DIAGN CHILDH CA; Parikh NS, 2015, PEDIATR BLOOD CANCER, V62, P1305, DOI 10.1002/pbc.25501; Parkes J, 2017, PEDIATR BLOOD CANCER, V64, DOI 10.1002/pbc.26903; Patte C, 2015, ARCH PEDIATRIE, V22, P65, DOI 10.1016/S0929-693X(15)30034-8; Pena-Hernandez A., 2019, PEDIAT BLOOD CANC; Perehudoff S. K., 2018, GLOB PUBLIC HEALTH, V2018, P1; Pollack IF, 2010, PEDIATR BLOOD CANCER, V55, P1066, DOI 10.1002/pbc.22634; Poyiadjis S, 2011, PEDIATR BLOOD CANCER, V56, P314, DOI 10.1002/pbc.22853; Pribnow AK, 2017, PEDIATR BLOOD CANCER, V64, DOI 10.1002/pbc.26590; Pritchard-Jones K, 2014, CANCER-AM CANCER SOC, V120, P2388, DOI 10.1002/cncr.28745; Pritchard-Jones K, 2013, LANCET ONCOL, V14, pE95, DOI 10.1016/S1470-2045(13)70010-X; Qaddoumi I, 2008, INT J CANCER, V122, P1203, DOI 10.1002/ijc.23160; Qaddoumi I, 2007, PEDIATR BLOOD CANCER, V48, P39, DOI 10.1002/pbc.21085; Qaddoumi I, 2009, TELEMED J E-HEALTH, V15, P975, DOI 10.1089/tmj.2009.0043; Qaddoumi I, 2009, J CHILD NEUROL, V24, P460, DOI 10.1177/0883073808325650; Ribeiro RC, 2016, J CLIN ONCOL, V34, P53, DOI 10.1200/JCO.2015.61.9148; Robertson J, 2016, B WORLD HEALTH ORGAN, V94, P735, DOI 10.2471/BLT.15.163998; Rodriguez-Galindo C, 2015, J CLIN ONCOL, V33, P3065, DOI 10.1200/JCO.2014.60.6376; Roth L, 2018, GLOBALIZATION HEALTH, V14, DOI 10.1186/s12992-018-0421-2; Salaverria C, 2015, PEDIATR BLOOD CANCER, V62, P1609, DOI 10.1002/pbc.25557; Samudio A, 2015, J PEDIAT HEMATOL ONC, V37, P383, DOI 10.1097/MPH.0000000000000338; San Roman M, 2013, T ROY SOC TROP MED H, V107, P653, DOI 10.1093/trstmh/trt069; Santiago Teresa, 2018, J Glob Oncol, V4, P1, DOI 10.1200/JGO.17.00187; Santiago TC, 2012, PEDIATR BLOOD CANCER, V59, P221, DOI 10.1002/pbc.24071; Schob S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160680; Singh P. Khetrapal, 2018, WHO S E ASIA J PUBLI, V7, P59, DOI DOI 10.1177/2277975217733875; Steliarova-Foucher E, 2017, LANCET ONCOL, V18, P719, DOI 10.1016/S1470-2045(17)30186-9; Sun XF, 2006, EUR J HAEMATOL, V77, P365, DOI 10.1111/j.1600-0609.2006.00735.x; Traore F, 2011, PEDIATR BLOOD CANCER, V56, P70, DOI 10.1002/pbc.22746; Union for International Cancer Control (UICC), 2017, CHILDH CANC SIGNS SY; Vaishnavi K, 2018, PEDIATR BLOOD CANCER, V65, DOI 10.1002/pbc.27241; Walker D, 2016, NEURO-ONCOLOGY, V18, P445, DOI 10.1093/neuonc/nov187; Weaver MS, 2015, BRIT J CANCER, V112, P1845, DOI 10.1038/bjc.2015.158; Weaver MS, 2015, PEDIATR BLOOD CANCER, V62, P565, DOI 10.1002/pbc.25403; WHO Europe, 1978, DECL ALM AT; Woessmann W, 2005, BLOOD, V105, P948, DOI 10.1182/blood-2004-03-0973; World Health Organization, WHO MOD LISTS ESS ME; World Health Organization, GLOB IN CHILDH CANC; Yao JJA, 2013, SAMJ S AFR MED J, V103, P113, DOI [10.7196/samj.6365, 10.7196/SAMJ.6365]; Yeoh AEJ, 2018, J CLIN ONCOL, V36, P2726, DOI 10.1200/JCO.2018.78.3050; Zenatti PP, 2018, EBIOMEDICINE, V30, P158, DOI 10.1016/j.ebiom.2018.03.005	105	94	98	6	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 15	2019	363	6432			SI		1182	1186		10.1126/science.aaw4892	http://dx.doi.org/10.1126/science.aaw4892			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP0BC	30872518	Green Submitted			2022-12-28	WOS:000461329000039
J	Zhu, WJ; Chernew, ME; Sherry, TB; Maestas, N				Zhu, Wenjia; Chernew, Michael E.; Sherry, Tisamarie B.; Maestas, Nicole			Initial Opioid Prescriptions among US Commercially Insured Patients, 2012-2017	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PRESCRIBING PATTERNS; UNITED-STATES; NAIVE PATIENTS; CHRONIC PAIN; OVERDOSE; TRENDS; RISK	BACKGROUND The United States is undergoing a crippling opioid epidemic, spurred in part by overuse of prescription opioids by adults 25 to 64 years of age. Of concern are long-duration and high-dose initial prescriptions, which place the patients and their friends and relatives at heightened risk for long-term opioid use, misuse, overdose, and death. METHODS We estimated the incidence of initial opioid prescriptions in each month between July 2012 and December 2017 using administrative-claims data from across the United States (accessed through Blue Cross-Blue Shield [BCBS] Axis); monthly incidence was estimated as the percentage of enrollees who received an initial opioid prescription among those who had not used opioids (i.e., no opioid prescription or a diagnosis of opioid use disorder in the 6 months before a given month). We then estimated the percentage of enrollees initiating opioid therapy who received a long-duration or high-dose initial opioid prescription in each month during this period. We also calculated the number of providers who initiated opioid therapy in any patient who had not used opioids in each month and examined monthly trends in the duration and dose of initial opioid prescriptions in prescriber and patient subgroups. Our study sample included 63,817,512 enrollees who had not used opioids (mean, 15,897,673 per month). RESULTS The monthly incidence of initial opioid prescriptions among enrollees who had not used opioids declined by 54%, from 1.63% in July 2012 to 0.75% in December 2017. This decline was accompanied by a decreasing number of providers (from 114,043 in July 2012 to 80,462 in December 2017) who initiated opioid therapy in any patient who had not used opioids. Nonetheless, among the shrinking subgroup of physicians who initiated opioid therapy in such patients, high-risk prescribing (i.e., prescriptions for more than a 3-day supply or for a dose of 50 morphine milligram equivalents per day or higher) persisted at a monthly rate of 115,378 prescriptions per 15,897,673 enrollees who had not used opioids. CONCLUSIONS As the opioid crisis progressed between July 2012 and December 2017, many providers stopped initiating opioid therapy. Although the number of initial opioid prescriptions declined, a subgroup of providers continued to write high-risk initial opioid prescriptions. (Funded by the National Institute on Aging and a gift from Owen and Linda Robinson.)	[Zhu, Wenjia; Chernew, Michael E.; Maestas, Nicole] Harvard Med Sch, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA; [Sherry, Tisamarie B.] RAND, Boston, MA USA; [Sherry, Tisamarie B.] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA	Harvard University; Harvard Medical School; RAND Corporation; Harvard University; Brigham & Women's Hospital	Maestas, N (corresponding author), Harvard Med Sch, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.	maestas@hcp.med.harvard.edu			National Institute on Aging; NATIONAL INSTITUTE ON AGING [P01AG005842] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funded by the National Institute on Aging and a gift from Owen and Linda Robinson.	[Anonymous], 2018, WHAT IS US OP EP; [Anonymous], 2016, CDC COMP BENZ DIAZ M; Axeen S, 2018, ANN EMERG MED, V71, P659, DOI 10.1016/j.annemergmed.2017.12.007; Barnett ML, 2017, NEW ENGL J MED, V376, P663, DOI 10.1056/NEJMsa1610524; Boudreau D, 2009, PHARMACOEPIDEM DR S, V18, P1166, DOI 10.1002/pds.1833; Brat GA, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.j5790; Cao S, 2018, JAMA DERMATOL, V154, P317, DOI 10.1001/jamadermatol.2017.5835; Centers for Disease Control and Prevention, 2019, CALC TOT DAIL DOS OP; Centers for Medicaid and Medicare Services, OP OR MORPH MILL EQ; Cicero TJ, 2014, JAMA PSYCHIAT, V71, P821, DOI 10.1001/jamapsychiatry.2014.366; Compton WM, 2016, NEW ENGL J MED, V374, P154, DOI 10.1056/NEJMra1508490; Deyo RA, 2017, J GEN INTERN MED, V32, P21, DOI 10.1007/s11606-016-3810-3; Dowell D, 2016, MMWR RECOMM REP, V65, P1, DOI [10.15585/mmwr.rr7103a1, 10.1001/jama.2016.1464]; Dunn KM, 2010, ANN INTERN MED, V152, P85, DOI 10.7326/0003-4819-152-2-201001190-00006; Food and Drug Administration, NAT DRUG COD DAT FIL; Guy GP, 2017, MMWR-MORBID MORTAL W, V66, P697, DOI 10.15585/mmwr.mm6626a4; Han B, 2017, ANN INTERN MED, V167, P293, DOI 10.7326/M17-0865; Hedegaard Holly, 2017, NCHS Data Brief, P1; Jeffery MM, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k2833; Jena AB, 2016, JAMA INTERN MED, V176, P1294, DOI 10.1001/jamainternmed.2016.3284; Jena AB, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1393; Kuo YF, 2016, AM J MED, V129, DOI 10.1016/j.amjmed.2015.10.002; Levy B, 2015, AM J PREV MED, V49, P409, DOI 10.1016/j.amepre.2015.02.020; Miller M, 2015, JAMA INTERN MED, V175, P608, DOI 10.1001/jamainternmed.2014.8071; Morden NE, 2014, MED CARE, V52, P852, DOI 10.1097/MLR.0000000000000183; Office of the Inspector General, 2017, OP MED D; Pezalla EJ, 2017, J PAIN RES, V10, DOI 10.2147/JPR.S129553; Seth P, 2018, MMWR-MORBID MORTAL W, V67, P349, DOI 10.15585/mmwr.mm6712a1; Shah A, 2017, J PAIN, V18, P1374, DOI 10.1016/j.jpain.2017.06.010; Shah A, 2017, MMWR-MORBID MORTAL W, V66, P265, DOI 10.15585/mmwr.mm6610a1; Sherry TB, 2018, ANN INTERN MED, V169, P892, DOI 10.7326/M18-0644; Tehrani AB, 2018, ADDICT BEHAV, V76, P218, DOI 10.1016/j.addbeh.2017.08.005; Von Korff M, 2008, CLIN J PAIN, V24, P521, DOI 10.1097/AJP.0b013e318169d03b	33	99	99	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 14	2019	380	11					1043	1052		10.1056/NEJMsa1807069	http://dx.doi.org/10.1056/NEJMsa1807069			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HO8NL	30865798	Green Accepted, Bronze			2022-12-28	WOS:000461210000008
J	Mariathas, M; Allan, R; Ramamoorthy, S; Olechowski, B; Hinton, J; Azor, M; Nicholas, Z; Calver, A; Corbett, S; Mahmoudi, M; Rawlins, J; Simpson, I; Wilkinson, J; Kwok, CS; Cook, P; Mamas, MA; Curzen, N				Mariathas, Mark; Allan, Rick; Ramamoorthy, Sanjay; Olechowski, Bartosz; Hinton, Jonathan; Azor, Martin; Nicholas, Zoe; Calver, Alison; Corbett, Simon; Mahmoudi, Michael; Rawlins, John; Simpson, Iain; Wilkinson, James; Kwok, Chun Shing; Cook, Paul; Mamas, Mamas A.; Curzen, Nick			True 99th centile of high sensitivity cardiac troponin for hospital patients: prospective, observational cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACUTE MYOCARDIAL-INFARCTION; CORONARY-HEART-DISEASE; EARLY-DIAGNOSIS; I ASSAY; CARDIOVASCULAR OUTCOMES; POPULATION SELECTION; UNIVERSAL DEFINITION; ATHEROSCLEROSIS RISK; PERCENTILE VALUES; MORTALITY	OBJECTIVE To determine the distribution, and specifically the true 99th centile, of high sensitivity cardiac troponin I (hs-cTnI) for a whole hospital population by applying the hs-cTnI assay currently used routinely at a large teaching hospital. DESIGN Prospective, observational cohort study. SETTING University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom, between 29 June 2017 and 24 August 2017. PARTICIPANTS 20 000 consecutive inpatients and outpatients undergoing blood tests for any clinical reason. Hs-cTnI concentrations were measured in all study participants and nested for analysis except when the supervising doctor had requested hs-cTnI for clinical reasons. MAIN OUTCOME MEASURES Distribution of hs-cTnI concentrations of all study participants and specifically the 99th centile. RESULTS The 99th centile of hs-cTnI for the whole population was 296 ng/L compared with the manufacturer's quoted level of 40 ng/L (currently used clinically as the upper limit of normal; ULN). Hs-cTnI concentrations were greater than 40 ng/L in one in 20 (5.4%, n=1080) of the total population. After excluding participants diagnosed as having acute myocardial infarction (n=122) and those in whom hs-cTnI was requested for clinical reasons (n=1707), the 99th centile was 189 ng/L for the remainder (n=18 171). The 99th centile was 563 ng/L for inpatients (n=4759) and 65 ng/L for outpatients (n=9280). Patients from the emergency department (n=3706) had a 99th centile of 215 ng/L, with 6.07% (n=225) greater than the recommended ULN. 39.02% (n=48) of all patients from the critical care units (n=123) and 14.16% (n=67) of all medical inpatients had an hs-cTnI concentration greater than the recommended ULN. CONCLUSIONS Of 20 000 consecutive patients undergoing a blood test for any clinical reason at our hospital, one in 20 had an hs-cTnI greater than the recommended ULN. These data highlight the need for clinical staff to interpret hs-cTnI concentrations carefully, particularly when applying the recommended ULN to diagnose acute myocardial infarction, in order to avoid misdiagnosis in the absence of an appropriate clinical presentation.	[Mariathas, Mark; Olechowski, Bartosz; Hinton, Jonathan; Nicholas, Zoe; Mahmoudi, Michael; Curzen, Nick] Univ Hosp Southampton NHS Fdn Trust, Coronary Res Grp, Southampton, Hants, England; [Allan, Rick; Cook, Paul] Univ Hosp Southampton NHS Fdn Trust, Biochem Dept, Southampton, Hants, England; [Ramamoorthy, Sanjay] Univ Hosp Southampton NHS Fdn Trust, Emergency Med Dept, Southampton, Hants, England; [Azor, Martin] Univ Hosp Southampton NHS Fdn Trust, Coding Dept, Southampton, Hants, England; [Calver, Alison; Corbett, Simon; Mahmoudi, Michael; Rawlins, John; Simpson, Iain; Wilkinson, James; Curzen, Nick] Univ Hosp Southampton NHS Fdn Trust, Wessex Cardiothorac Unit, Southampton, Hants, England; [Kwok, Chun Shing; Mamas, Mamas A.] Keele Univ, Inst Primary Care & Hlth Sci, Ctr Prognosis Res, Keele Cardiovasc Res Grp, Stoke On Trent, Staffs, England; [Curzen, Nick] Univ Southampton, Fac Med, Southampton, Hants, England	University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Southampton; University Hospital Southampton NHS Foundation Trust; Keele University; University of Southampton	Curzen, N (corresponding author), Univ Hosp Southampton NHS Trust, E Level North Wing, Southampton SO16 6YD, Hants, England.	nick.curzen@uhs.nhs.uk	Mamas, Mamas Andreas/A-2549-2019; curzen, nick/AAD-8161-2020	Mamas, Mamas Andreas/0000-0001-9241-8890; Mahmoudi, Michael/0000-0003-1293-8461; Curzen, Nick/0000-0001-9651-7829	Beckman Beckman Coulter (Brea, CA, USA)	Beckman Beckman Coulter (Brea, CA, USA)	Beckman Beckman Coulter (Brea, CA, USA) provided an unrestricted research grant for the study. The company had no involvement in the data collection, analysis or interpretation; trial design; or patient recruitment. The company had no role in the writing of the manuscript or decision to submit it for publication.	Apple FS, 2012, CLIN CHEM, V58, P1574, DOI 10.1373/clinchem.2012.192716; Apple FS, 2012, CLIN CHEM, V58, P54, DOI 10.1373/clinchem.2011.165795; Apple FS, 2009, CLIN CHEM, V55, P1303, DOI 10.1373/clinchem.2009.128363; Avouac J, 2014, J RHEUMATOL, V41, P248, DOI 10.3899/jrheum.130713; Aw TC, 2013, CLIN CHIM ACTA, V422, P26, DOI 10.1016/j.cca.2013.03.034; Babuin L, 2005, CAN MED ASSOC J, V173, P1191, DOI 10.1503/cmaj/051291; Baron T, 2016, AM J MED, V129, P398, DOI 10.1016/j.amjmed.2015.11.035; Boeddinghaus J, 2017, CIRCULATION, V135, P1597, DOI 10.1161/CIRCULATIONAHA.116.025661; Cavender MA, 2017, CIRCULATION, V135, P1911, DOI 10.1161/CIRCULATIONAHA.116.024632; Cediel G, 2017, HEART, V103, P616, DOI 10.1136/heartjnl-2016-310243; Chapman AR, 2018, CIRCULATION, V137, P1236, DOI 10.1161/CIRCULATIONAHA.117.031806; Chapman AR, 2017, HEART, V103, P10, DOI 10.1136/heartjnl-2016-309530; Christ M, 2011, CLIN CHEM LAB MED, V49, P1955, DOI 10.1515/CCLM.2011.695; Collinson PO, 2012, CLIN CHEM, V58, P219, DOI 10.1373/clinchem.2011.171082; Cullen L, 2016, HEART, V102, P120, DOI 10.1136/heartjnl-2015-308506; Eggers KM, 2013, CLIN CHEM, V59, P1068, DOI 10.1373/clinchem.2012.196634; Egstrup M, 2012, AM J CARDIOL, V110, P552, DOI 10.1016/j.amjcard.2012.04.033; Everett BM, 2015, CIRCULATION, V131, P1851, DOI 10.1161/CIRCULATIONAHA.114.014522; Ford I, 2016, J AM COLL CARDIOL, V68, P2719, DOI 10.1016/j.jacc.2016.10.020; Gimenez MR, 2014, JAMA INTERN MED, V174, P241, DOI 10.1001/jamainternmed.2013.12199; Gore MO, 2014, J AM COLL CARDIOL, V63, P1441, DOI 10.1016/j.jacc.2013.12.032; Hammarsten O, 2012, CLIN CHEM, V58, P628, DOI 10.1373/clinchem.2011.171496; Iribarren C, 2016, HEART, V102, P1177, DOI 10.1136/heartjnl-2015-309136; Keller T, 2011, JAMA-J AM MED ASSOC, V306, P2684, DOI 10.1001/jama.2011.1896; Keller T, 2009, NEW ENGL J MED, V361, P868, DOI 10.1056/NEJMoa0903515; Koerbin G, 2013, CLIN BIOCHEM, V46, P1636, DOI 10.1016/j.clinbiochem.2013.08.004; Kumar N, 2011, NEPHROL DIAL TRANSPL, V26, P665, DOI 10.1093/ndt/gfq442; Mariathas M, 2018, LANCET, V391, P2398, DOI 10.1016/S0140-6736(17)32342-5; Melberg T, 2010, INT J CARDIOL, V139, P228, DOI 10.1016/j.ijcard.2008.10.021; Melki D, 2015, J AM COLL CARDIOL, V65, P1655, DOI 10.1016/j.jacc.2015.02.044; Mueller M, 2012, CLIN CHEM, V58, P209, DOI 10.1373/clinchem.2011.171827; Neukamm A, 2016, BMC PULM MED, V16, DOI 10.1186/s12890-016-0319-9; Reichlin T, 2009, NEW ENGL J MED, V361, P858, DOI 10.1056/NEJMoa0900428; Roffi M, 2016, EUR HEART J, V37, P267, DOI 10.1093/eurheartj/ehv320; Saenger AK, 2008, CIRCULATION, V118, P2200, DOI 10.1161/CIRCULATIONAHA.108.773218; Sandoval Y, 2017, AM J MED, V130, P1076, DOI 10.1016/j.amjmed.2017.02.032; Sandoval Y, 2014, CLIN CHEM, V60, P455, DOI 10.1373/clinchem.2013.211706; Saunders JT, 2011, CIRCULATION, V123, P1367, DOI 10.1161/CIRCULATIONAHA.110.005264; Shah ASV, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4222; Shah ASV, 2015, AM J MED, V128, P493, DOI 10.1016/j.amjmed.2014.10.056; Shah ASV, 2015, BMJ-BRIT MED J, V350, DOI [10.1136/bmj.h626, 10.1136/bmj.g7873]; Than MP, 2018, CLIN CHEM, V64, P1044, DOI 10.1373/clinchem.2017.285700; Thorsteinsdottir I, 2016, CLIN CHEM, V62, P623, DOI 10.1373/clinchem.2015.250811; Thygesen K, 2019, EUR HEART J, V40, P237, DOI [10.1093/eurheartj/ehy462, 10.1016/j.rec.2018.11.011, 10.1016/j.jacc.2018.08.1038]; Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001; Twerenbold R, 2016, EUR HEART J, V37, P3324, DOI 10.1093/eurheartj/ehw232; Whelton SP, 2017, DIABETES CARE, V40, P261, DOI 10.2337/dc16-1541; Willeit P, 2017, J AM COLL CARDIOL, V70, P558, DOI 10.1016/j.jacc.2017.05.062; Wrigley P, 2017, STROKE, V48, P1226, DOI 10.1161/STROKEAHA.116.014561; Wu AHB, 2018, CLIN CHEM, V64, P645, DOI 10.1373/clinchem.2017.277186	50	28	28	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 13	2019	364								l729	10.1136/bmj.l729	http://dx.doi.org/10.1136/bmj.l729			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP5VW	30867154	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000461751600002
J	Howard, S				Howard, Sally			Learning from birthing stories on Twitter	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												sal@sallyhoward.net						Luce A, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0827-x; NHS England, 2018, PARTN NEW MUMS MENT	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 12	2019	364								l1090	10.1136/bmj.l1090	http://dx.doi.org/10.1136/bmj.l1090			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP5VS	30862695				2022-12-28	WOS:000461751000010
J	Devi, S				Devi, Sharmila			Health in Israel and the OPT in the lead-up to elections	LANCET			English	Editorial Material																			0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 9	2019	393	10175					973	974		10.1016/S0140-6736(19)30536-7	http://dx.doi.org/10.1016/S0140-6736(19)30536-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HO0OW	30860039				2022-12-28	WOS:000460604200013
J	Huang, WYC; Alvarez, S; Kondo, Y; Lee, YK; Chung, JK; Lam, HYM; Biswas, KH; Kuriyan, J; Groves, JT				Huang, William Y. C.; Alvarez, Steven; Kondo, Yasushi; Lee, Young Kwang; Chung, Jean K.; Lam, Hiu Yue Monatrice; Biswas, Kabir H.; Kuriyan, John; Groves, Jay T.			A molecular assembly phase transition and kinetic proofreading modulate Ras activation by SOS	SCIENCE			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; SINGLE-MOLECULE; SIGNALING COMPLEXES; STRUCTURAL BASIS; PROTEIN; MECHANISM; RECEPTOR; LAT; BINDING; AUTOINHIBITION	The guanine nucleotide exchange factor (GEF) Son of Sevenless (SOS) is a key Ras activator that is autoinhibited in the cytosol and activates upon membrane recruitment. Autoinhibition release involves structural rearrangements of the protein at the membrane and thus introduces a delay between initial recruitment and activation. In this study, we designed a single-molecule assay to resolve the time between initial receptor-mediated membrane recruitment and the initiation of GEF activity of individual SOS molecules on microarrays of Ras-functionalized supported membranes. The rise-and-fall shape of the measured SOS activation time distribution and the long mean time scale to activation (similar to 50 seconds) establish a basis for kinetic proofreading in the receptor-mediated activation of Ras. We further demonstrate that this kinetic proofreading is modulated by the LAT (linker for activation of T cells)-Grb2-SOS phosphotyrosine-driven phase transition at the membrane.	[Huang, William Y. C.; Kondo, Yasushi; Lee, Young Kwang; Chung, Jean K.; Lam, Hiu Yue Monatrice; Kuriyan, John; Groves, Jay T.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Alvarez, Steven] Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA; [Kondo, Yasushi; Kuriyan, John] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Kondo, Yasushi; Kuriyan, John; Groves, Jay T.] Univ Calif Berkeley, California Inst Quantitat Biosci, Berkeley, CA 94720 USA; [Biswas, Kabir H.] Natl Univ Singapore, Mechanobiol Inst, Singapore 117411, Singapore; [Kuriyan, John] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Kuriyan, John; Groves, Jay T.] Lawrence Berkeley Natl Lab, Div Mol Biophys, Berkeley, CA 94720 USA; [Kuriyan, John; Groves, Jay T.] Lawrence Berkeley Natl Lab, Div Integrated Bioimaging, Berkeley, CA 94720 USA; [Huang, William Y. C.] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Biswas, Kabir H.] Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore 639798, Singapore	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; National University of Singapore; Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Stanford University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Groves, JT (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.; Groves, JT (corresponding author), Univ Calif Berkeley, California Inst Quantitat Biosci, Berkeley, CA 94720 USA.; Groves, JT (corresponding author), Lawrence Berkeley Natl Lab, Div Mol Biophys, Berkeley, CA 94720 USA.; Groves, JT (corresponding author), Lawrence Berkeley Natl Lab, Div Integrated Bioimaging, Berkeley, CA 94720 USA.	jtgroves@lbl.gov	Kondo, Yasushi/AAU-1409-2020; Biswas, Kabir H/AAG-9156-2019	Biswas, Kabir H/0000-0001-9194-4127; Chung, Jean/0000-0001-8221-0500; Huang, William Y. C./0000-0002-6061-8887; LEE, YOUNGKWANG/0000-0003-0056-6357; Kondo, Yasushi/0000-0003-2131-575X	National Institutes of Health (NIH) National Cancer Institute (NCI) Physical Sciences in Oncology Network (PS-ON) project [1-U01CA202241]; Novo Nordisk Foundation Challenge Program under the Center for Geometrically Engineered Cellular Systems; NIH [PO1 A1091580]; NATIONAL CANCER INSTITUTE [U01CA202241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI091580] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Cancer Institute (NCI) Physical Sciences in Oncology Network (PS-ON) project; Novo Nordisk Foundation Challenge Program under the Center for Geometrically Engineered Cellular Systems; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) National Cancer Institute (NCI) Physical Sciences in Oncology Network (PS-ON) project 1-U01CA202241 and by the Novo Nordisk Foundation Challenge Program under the Center for Geometrically Engineered Cellular Systems. Additional support was provided by NIH grant PO1 A1091580.	Andreotti A. H., 2010, COLD SPRING HARB PER, V2, DOI [10.1101/cshperspect.a002287, DOI 10.1101/CSHPERSPECT.A002287MEDLINE]; Andreotti AH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002287; Bandaru  P., 2019, COLD SPRING HARB PER, V9, DOI [10.1101/cshperspect.a031534, DOI 10.1101/CSHPERSPECT.A031534MEDLINE]; Banjade S, 2014, ELIFE, V3, DOI 10.7554/eLife.04123; Case LB, 2019, SCIENCE, V363, P1093, DOI 10.1126/science.aau6313; Cho Kwang-Jin, 2013, Small GTPases, V4, P57, DOI 10.4161/sgtp.23145; Christensen SM, 2016, NAT STRUCT MOL BIOL, V23, P838, DOI 10.1038/nsmb.3275; Cordes T, 2009, J AM CHEM SOC, V131, P5018, DOI 10.1021/ja809117z; Cutler RE, 1998, P NATL ACAD SCI USA, V95, P9214, DOI 10.1073/pnas.95.16.9214; DelProposto J, 2009, PROTEIN EXPRES PURIF, V63, P40, DOI 10.1016/j.pep.2008.08.011; Edelstein Arthur D, 2014, J Biol Methods, V1; GALE NW, 1993, NATURE, V363, P88, DOI 10.1038/363088a0; Groves JT, 2010, NAT STRUCT MOL BIOL, V17, P659, DOI 10.1038/nsmb.1844; Groves JT, 1997, SCIENCE, V275, P651, DOI 10.1126/science.275.5300.651; Gureasko J, 2008, NAT STRUCT MOL BIOL, V15, P452, DOI 10.1038/nsmb.1418; Gureasko J, 2010, P NATL ACAD SCI USA, V107, P3430, DOI 10.1073/pnas.0913915107; Gurry T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006148; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; Houtman JCD, 2004, BIOCHEMISTRY-US, V43, P4170, DOI 10.1021/bi0357311; Houtman JCD, 2006, NAT STRUCT MOL BIOL, V13, P798, DOI 10.1038/nsmb1133; Huang WYC, 2017, J AM CHEM SOC, V139, P18009, DOI 10.1021/jacs.7b09387; Huang WYC, 2017, BIOPHYS J, V113, P1807, DOI 10.1016/j.bpj.2017.08.024; Huang WYC, 2016, P NATL ACAD SCI USA, V113, P8218, DOI 10.1073/pnas.1602602113; Iversen L, 2014, SCIENCE, V345, P50, DOI 10.1126/science.1250373; Jaitner BK, 1997, J BIOL CHEM, V272, P29927, DOI 10.1074/jbc.272.47.29927; Kortum RL, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004494; Kou SC, 2005, J PHYS CHEM B, V109, P19068, DOI 10.1021/jp051490q; Lee YK, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15061; Li K., 2008, IMAGE STABILIZER PLU; Lin J, 2001, J BIOL CHEM, V276, P29588, DOI 10.1074/jbc.M102221200; Lin WC, 2014, P NATL ACAD SCI USA, V111, P2996, DOI 10.1073/pnas.1321155111; Margarit SM, 2003, CELL, V112, P685, DOI 10.1016/S0092-8674(03)00149-1; Mayer BJ, 2018, J MOL BIOL, V430, P4547, DOI 10.1016/j.jmb.2018.05.040; McDonald CB, 2012, BIOCHEMISTRY-US, V51, P2122, DOI 10.1021/bi3000534; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; Moffitt JR, 2010, METHOD ENZYMOL, V475, P221, DOI 10.1016/S0076-6879(10)75010-2; Nag A, 2009, BIOPHYS J, V96, P2604, DOI 10.1016/j.bpj.2009.01.019; Nye JA, 2008, LANGMUIR, V24, P4145, DOI 10.1021/la703788h; Samelson LE, 2002, ANNU REV IMMUNOL, V20, P371, DOI 10.1146/annurev.immunol.20.092601.111357; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Shah NH, 2016, ELIFE, V5, DOI 10.7554/eLife.20105; Shah NH, 2013, J AM CHEM SOC, V135, P5839, DOI 10.1021/ja401015p; Shi TJ, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf0891; Sondermann H, 2004, CELL, V119, P393, DOI 10.1016/j.cell.2004.10.005; Stevens AJ, 2016, J AM CHEM SOC, V138, P2162, DOI 10.1021/jacs.5b13528; Su XL, 2016, SCIENCE, V352, P595, DOI 10.1126/science.aad9964; Tartaglia M, 2007, NAT GENET, V39, P75, DOI 10.1038/ng1939; Tormen M, 2015, MICROELECTRON ENG, V141, P21, DOI 10.1016/j.mee.2015.01.002; Turner M, 2002, NAT REV IMMUNOL, V2, P476, DOI 10.1038/nri840; Vadas O, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002165; Williamson DJ, 2011, NAT IMMUNOL, V12, P655, DOI 10.1038/ni.2049; Yadav KK, 2010, P NATL ACAD SCI USA, V107, P3436, DOI 10.1073/pnas.0914315107; Yan QR, 2013, MOL CELL BIOL, V33, P2188, DOI 10.1128/MCB.01637-12; Zhao C, 2007, NAT CELL BIOL, V9, P706, DOI 10.1038/ncb1594; Ziemba BP, 2014, BIOCHEMISTRY-US, V53, P1697, DOI 10.1021/bi4016082	55	148	152	4	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 8	2019	363	6431					1098	+		10.1126/science.aau5721	http://dx.doi.org/10.1126/science.aau5721			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO2MV	30846600	Green Accepted			2022-12-28	WOS:000460750100045
J	Piller, C; Schmitz, S				Piller, Charles; Schmitz, Stephan			DUBIOUS DIAGNOSIS	SCIENCE			English	Editorial Material																			0	22	25	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 8	2019	363	6431					1027	1031		10.1126/science.363.6431.1026	http://dx.doi.org/10.1126/science.363.6431.1026			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HO2MV	30846581				2022-12-28	WOS:000460750100017
J	O'Dowd, A				O'Dowd, Adrian			Health organisations are slow to tackle gender inequality in workforce, report finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2019, EQ WORKS GLOB HLTH 5	1	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 7	2019	364								l1084	10.1136/bmj.l1084	http://dx.doi.org/10.1136/bmj.l1084			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HO6TA	30846442				2022-12-28	WOS:000461063200010
J	Silber, JH; Bellini, LM; Shea, JA; Desai, SV; Dinges, DF; Basner, M; Even-Shoshan, O; Hill, AS; Hochman, LL; Katz, JT; Ross, RN; Shade, DM; Small, DS; Sternberg, AL; Tonascia, J; Volpp, KG; Asch, DA				Silber, Jeffrey H.; Bellini, Lisa M.; Shea, Judy A.; Desai, Sanjay V.; Dinges, David F.; Basner, Mathias; Even-Shoshan, Orit; Hill, Alexander S.; Hochman, Lauren L.; Katz, Joel T.; Ross, Richard N.; Shade, David M.; Small, Dylan S.; Sternberg, Alice L.; Tonascia, James; Volpp, Kevin G.; Asch, David A.		iCOMPARE Res Grp	Patient Safety Outcomes under Flexible and Standard Resident Duty-Hour Rules	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MORTALITY-RATES; HOSPITALS; STAY	BACKGROUND Concern persists that extended shifts in medical residency programs may adversely affect patient safety. METHODS We conducted a cluster-randomized noninferiority trial in 63 internal-medicine residency programs during the 2015-2016 academic year. Programs underwent randomization to a group with standard duty hours, as adopted by the Accreditation Council for Graduate Medical Education (ACGME) in July 2011, or to a group with more flexible duty-hour rules that did not specify limits on shift length or mandatory time off between shifts. The primary outcome for each program was the change in unadjusted 30-day mortality from the pretrial year to the trial year, as ascertained from Medicare claims. We hypothesized that the change in 30-day mortality in the flexible programs would not be worse than the change in the standard programs (difference-in-difference analysis) by more than 1 percentage point (noninferiority margin). Secondary outcomes were changes in five other patient safety measures and risk-adjusted outcomes for all measures. RESULTS The change in 30-day mortality (primary outcome) among the patients in the flexible programs (12.5% in the trial year vs. 12.6% in the pretrial year) was noninferior to that in the standard programs (12.2% in the trial year vs. 12.7% in the pretrial year). The test for noninferiority was significant (P = 0.03), with an estimate of the upper limit of the one-sided 95% confidence interval (0.93%) for a between-group difference in the change in mortality that was less than the prespecified noninferiority margin of 1 percentage point. Differences in changes between the flexible programs and the standard programs in the unadjusted rate of readmission at 7 days, patient safety indicators, and Medicare payments were also below 1 percentage point; the noninferiority criterion was not met for 30-day readmissions or prolonged length of hospital stay. Risk-adjusted measures generally showed similar findings. CONCLUSIONS Allowing program directors flexibility in adjusting duty-hour schedules for trainees did not adversely affect 30-day mortality or several other measured outcomes of patient safety.	[Silber, Jeffrey H.; Even-Shoshan, Orit; Hill, Alexander S.; Hochman, Lauren L.; Ross, Richard N.] Univ Penn, Childrens Hosp Philadelphia, Sch Med, Ctr Outcomes Res, Philadelphia, PA 19104 USA; [Silber, Jeffrey H.] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Silber, Jeffrey H.] Univ Penn, Sch Med, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; [Bellini, Lisa M.; Shea, Judy A.; Volpp, Kevin G.; Asch, David A.] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Silber, Jeffrey H.; Volpp, Kevin G.; Asch, David A.] Univ Penn, Wharton Sch, Dept Hlth Care Management, Philadelphia, PA 19104 USA; [Small, Dylan S.] Univ Penn, Wharton Sch, Dept Stat, Philadelphia, PA 19104 USA; [Silber, Jeffrey H.; Shea, Judy A.; Small, Dylan S.; Volpp, Kevin G.; Asch, David A.] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Dinges, David F.; Basner, Mathias] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA; [Volpp, Kevin G.; Asch, David A.] Corporal Michael J Crescenz Vet Affairs Med Ctr, Philadelphia, PA USA; [Desai, Sanjay V.] Johns Hopkins Univ, Dept Med, Baltimore, MD USA; [Shade, David M.; Sternberg, Alice L.; Tonascia, James] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA; [Tonascia, James] Johns Hopkins Univ, Dept Biostat, Baltimore, MD 21205 USA; [Katz, Joel T.] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Harvard University; Brigham & Women's Hospital	Silber, JH (corresponding author), Childrens Hosp Philadelphia, Roberts Ctr, Ctr Outcomes Res, 2716 South St,Rm 5123, Philadelphia, PA 19146 USA.	silber@email.chop.edu	Vyas, Jatin/Q-1627-2016; Dinges, David/P-7183-2019	Vyas, Jatin/0000-0002-9985-9565; Asch, David/0000-0002-7970-286X; Patton, Jill/0000-0003-2904-4106	National Heart, Lung, and Blood Institute [U01HL125388, U01HL126088]; Accreditation Council for Graduate Medical Education; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL125388, U01HL126088] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Accreditation Council for Graduate Medical Education; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by grants (U01HL125388, to Dr. Asch, and U01HL126088, to Dr. Tonascia) from the National Heart, Lung, and Blood Institute and grants from the Accreditation Council for Graduate Medical Education to Drs. Desai, Shea, and Silber.	ASCH DA, 1988, NEW ENGL J MED, V318, P771, DOI 10.1056/NEJM198803243181209; Basner M, 2019, NEW ENGL J MED, V380, P915, DOI 10.1056/NEJMoa1810641; Centers for Medicare & Medicaid Services, 2015, 2016 ICD 10 CM GEMS; Chronic Conditions Data Warehouse, 2019, COD MAST BEN SUMM A; Desai SV, 2018, NEW ENGL J MED, V378, P1494, DOI 10.1056/NEJMoa1800965; Drye EE, 2012, ANN INTERN MED, V156, P19, DOI 10.7326/0003-4819-156-1-201201030-00004; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Healthcare Cost and Utilization Project (HCUP, 2017, EL COM SOFTW VERS 3 EL COM SOFTW VERS 3; IEZZONI LI, 1994, INQUIRY-J HEALTH CAR, V31, P40; Krumholz HM, 2013, JAMA-J AM MED ASSOC, V309, P587, DOI 10.1001/jama.2013.333; McCarthy EP, 2000, MED CARE, V38, P868, DOI 10.1097/00005650-200008000-00010; Meehan TP, 1997, JAMA-J AM MED ASSOC, V278, P2080, DOI 10.1001/jama.278.23.2080; Navathe AS, 2013, HEALTH SERV RES, V48, P476, DOI 10.1111/j.1475-6773.2012.01453.x; Patel MS, 2014, JAMA-J AM MED ASSOC, V312, P2364, DOI 10.1001/jama.2014.15273; Rosen AK, 2009, MED CARE, V47, P723, DOI 10.1097/MLR.0b013e31819a588f; SAS Institute, 2011, SAS STAT 93 US GUID, P6531; SAS Institute, 2011, SAS STAT 93 US GUID, P4033; Shea JA, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-021711; Silber JH, 2012, ANN SURG, V256, P79, DOI 10.1097/SLA.0b013e31825375ef; Silber JH, 2009, MED CARE, V47, P1191, DOI 10.1097/MLR.0b013e3181adcbff; Silber JH, 2003, HEALTH SERV RES, V38, P867, DOI 10.1111/1475-6773.00150; Silber JH, 1999, HEALTH SERV RES, V34, P349; Volpp KG, 2007, JAMA-J AM MED ASSOC, V298, P984, DOI 10.1001/jama.298.9.984; Volpp KG, 2007, JAMA-J AM MED ASSOC, V298, P975, DOI 10.1001/jama.298.9.975; Volpp KG, 2013, J GEN INTERN MED, V28, P1048, DOI 10.1007/s11606-013-2401-9; Volpp KG, 2009, J GEN INTERN MED, V24, P1149, DOI 10.1007/s11606-009-1011-z	26	49	49	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 7	2019	380	10					905	914		10.1056/NEJMoa1810642	http://dx.doi.org/10.1056/NEJMoa1810642			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HN8QX	30855740	Green Accepted, Bronze			2022-12-28	WOS:000460461500004
J	Iacobucci, G				Iacobucci, Gareth			Consultants urge BMA to withdraw from negotiations with "spineless" pay review body	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		BMA, 2019, BMA DEM DDRB REC VAL; BMA, DDRB CASH UPL VERS R; RIMMER A, 2019, BMJ-BRIT MED J, V364, P51365, DOI DOI 10.1136/BMJ.L314; Rimmer A, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k3236	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 4	2019	364								l1001	10.1136/bmj.l1001	http://dx.doi.org/10.1136/bmj.l1001			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HO6SQ	30833268				2022-12-28	WOS:000461061900008
J	Lopes, RD; Heizer, G; Aronson, R; Vora, AN; Massaro, T; Mehran, R; Goodman, SG; Windecker, S; Darius, H; Li, J; Averkov, O; Bahit, MC; Berwanger, O; Budaj, A; Hijazi, Z; Parkhomenko, A; Sinnaeve, P; Storey, RF; Thiele, H; Vinereanu, D; Granger, CB; Alexander, JH				Lopes, Renato D.; Heizer, Gretchen; Aronson, Ronald; Vora, Amit N.; Massaro, Tyler; Mehran, Roxana; Goodman, Shaun G.; Windecker, Stephan; Darius, Harald; Li, Jia; Averkov, Oleg; Bahit, M. Cecilia; Berwanger, Otavio; Budaj, Andrzej; Hijazi, Ziad; Parkhomenko, Alexander; Sinnaeve, Peter; Storey, Robert F.; Thiele, Holger; Vinereanu, Dragos; Granger, Christopher B.; Alexander, John H.		AUGUSTUS Investigators	Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DUAL ANTIPLATELET THERAPY; MYOCARDIAL-INFARCTION; ORAL ANTICOAGULATION; OPEN-LABEL; ASPIRIN; WARFARIN; TRIAL; CLOPIDOGREL; METAANALYSIS; PREVENTION	Background Appropriate antithrombotic regimens for patients with atrial fibrillation who have an acute coronary syndrome or have undergone percutaneous coronary intervention (PCI) are unclear. Methods In an international trial with a two-by-two factorial design, we randomly assigned patients with atrial fibrillation who had an acute coronary syndrome or had undergone PCI and were planning to take a P2Y(12) inhibitor to receive apixaban or a vitamin K antagonist and to receive aspirin or matching placebo for 6 months. The primary outcome was major or clinically relevant nonmajor bleeding. Secondary outcomes included death or hospitalization and a composite of ischemic events. Results Enrollment included 4614 patients from 33 countries. There were no significant interactions between the two randomization factors on the primary or secondary outcomes. Major or clinically relevant nonmajor bleeding was noted in 10.5% of the patients receiving apixaban, as compared with 14.7% of those receiving a vitamin K antagonist (hazard ratio, 0.69; 95% confidence interval [CI], 0.58 to 0.81; P<0.001 for both noninferiority and superiority), and in 16.1% of the patients receiving aspirin, as compared with 9.0% of those receiving placebo (hazard ratio, 1.89; 95% CI, 1.59 to 2.24; P<0.001). Patients in the apixaban group had a lower incidence of death or hospitalization than those in the vitamin K antagonist group (23.5% vs. 27.4%; hazard ratio, 0.83; 95% CI, 0.74 to 0.93; P=0.002) and a similar incidence of ischemic events. Patients in the aspirin group had an incidence of death or hospitalization and of ischemic events that was similar to that in the placebo group. Conclusions In patients with atrial fibrillation and a recent acute coronary syndrome or PCI treated with a P2Y(12) inhibitor, an antithrombotic regimen that included apixaban, without aspirin, resulted in less bleeding and fewer hospitalizations without significant differences in the incidence of ischemic events than regimens that included a vitamin K antagonist, aspirin, or both. (Funded by Bristol-Myers Squibb and Pfizer; AUGUSTUS ClinicalTrials.gov number, NCT02415400.)	[Lopes, Renato D.; Heizer, Gretchen; Vora, Amit N.; Massaro, Tyler; Granger, Christopher B.; Alexander, John H.] Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC USA; [Aronson, Ronald; Li, Jia] Bristol Myers Squibb, Princeton, NJ USA; [Mehran, Roxana] Icahn Sch Med Mt Sinai, Zena & Michael A Wiener Cardiovasc Inst, New York, NY 10029 USA; [Mehran, Roxana] Cardiovasc Res Fdn, New York, NY USA; [Goodman, Shaun G.] Univ Alberta, Canadian VIGOUR Ctr, Edmonton, AB, Canada; [Goodman, Shaun G.] Univ Toronto, St Michaels Hosp, Terrence Donnelly Heart Ctr, Toronto, ON, Canada; [Windecker, Stephan] Swiss Cardiovasc Ctr, Bern, Switzerland; [Darius, Harald] Vivantes Neukoelln Med Ctr, Berlin, Germany; [Thiele, Holger] Univ Leipzig, Dept Internal Med Cardiol, Heart Ctr Leipzig, Leipzig, Germany; [Averkov, Oleg] Pirogov Russian Natl Res Med Univ, Moscow, Russia; [Bahit, M. Cecilia] Fdn INECO, Inst Neurol Cognit INECO Neurociencias Orono, Rosario, Santa Fe, Argentina; [Berwanger, Otavio] Hosp Israelita Albert Einstein, Sao Paulo, Brazil; [Budaj, Andrzej] Grochowski Hosp, Postgrad Med Sch, Warsaw, Poland; [Hijazi, Ziad] Uppsala Univ, Dept Med Sci, Cardiol, Uppsala, Sweden; [Hijazi, Ziad] Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden; [Parkhomenko, Alexander] Strazhesko Inst Cardiol, Natl Sci Ctr, Kiev, Ukraine; [Sinnaeve, Peter] Univ Leuven, Univ Hosp Leuven, Leuven, Belgium; [Storey, Robert F.] Univ Sheffield, Dept Infect Immun & Cardiovasc Dis, Sheffield, S Yorkshire, England; [Vinereanu, Dragos] Univ Med & Pharm Carol Davila, Univ & Emergency Hosp, Bucharest, Romania	Duke University; Bristol-Myers Squibb; Icahn School of Medicine at Mount Sinai; Cardiovascular Research Foundation (CRF); University of Alberta; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Heart Center Leipzig GMBH; Leipzig University; Pirogov Russian National Research Medical University; Hospital Israelita Albert Einstein; Centre of Postgraduate Medical Education - Poland; Uppsala University; Uppsala University; National Academy of Medical Sciences of Ukraine; National Scientific Center M.D. Strazhesko Institute of Cardiology of the National Academy of Medical Sciences of Ukraine; KU Leuven; University Hospital Leuven; University of Sheffield; Carol Davila University of Medicine & Pharmacy	Lopes, RD (corresponding author), Duke Clin Res Inst, 200 Morris St, Durham, NC 27701 USA.	renato.lopes@duke.edu	Bilonko, Oksana/AAH-3518-2019; Bagur, Rodrigo/I-5298-2015; Nordbeck, Peter/D-4771-2018; Pinto, Fausto/G-9363-2015; Alexander, John/GVS-7271-2022; Maier, Lars/AAQ-8313-2021; Averkov, Oleg V/P-9566-2017; Thiele, Holger/ABE-6792-2020; Boldueva, Svetlana/AAH-3862-2019; Shvarts, Yury Григорьевич/AAB-4929-2022; Nicolau, Jose C/E-1487-2012; Mehran, Roxana/ABF-4160-2021; Marchev, Sotir/AAH-6529-2020; Maslovskyi, Valentyn/V-3896-2019; Maslovskyi, Valentyn/GQO-9125-2022; Storey, Robert/AAA-6853-2019; Scherr, Daniel/D-4098-2019; Tashchuk, Viktor/D-4901-2017; Braile-Sternieri, Maria Christiane Valeria Braga/P-9461-2018; S.L., Grishaev/P-1708-2015	Bilonko, Oksana/0000-0002-9452-3296; Bagur, Rodrigo/0000-0003-1888-9429; Nordbeck, Peter/0000-0002-2560-4068; Pinto, Fausto/0000-0002-8034-4529; Maier, Lars/0000-0001-9915-4429; Thiele, Holger/0000-0002-0169-998X; Boldueva, Svetlana/0000-0002-1898-084X; Shvarts, Yury Григорьевич/0000-0002-5205-7311; Nicolau, Jose C/0000-0002-9680-3689; Marchev, Sotir/0000-0001-9250-510X; Maslovskyi, Valentyn/0000-0001-5184-1799; Maslovskyi, Valentyn/0000-0001-5184-1799; Scherr, Daniel/0000-0001-5868-5493; Fedacko, Jan/0000-0002-4940-0393; Gaspar, Antonio/0000-0002-1138-0614; Hijazi, Ziad/0000-0002-7420-743X; , Dejan/0000-0002-0261-2137; Pella, Daniel/0000-0001-9999-6271; HEDDLE, WILLIAM/0000-0001-8167-2826; Tashchuk, Viktor/0000-0002-7988-5256; Strobel, Joerg/0000-0003-4077-9269; Brieger, David/0000-0001-6115-0326; ELBAZ, Meyer/0000-0002-3520-7883; Storey, Robert/0000-0002-6677-6229; Petrov, Ivo/0000-0002-9989-0730; Averkov, Oleg/0000-0002-3010-755X; Gorog, Diana/0000-0002-9286-1451; Alexander, John/0000-0002-1444-2462; Feusette, Piotr/0000-0002-5436-987X; Braile-Sternieri, Maria Christiane Valeria Braga/0000-0003-2704-2481; Godlevska, Olga/0000-0001-7473-9711; Rha, Seung-Woon/0000-0001-9456-9852; Katz, Amos/0000-0003-0422-934X; Levy, Tamina/0000-0001-9089-536X; Wlodarczak, Adrian/0000-0003-3104-7728; Wranicz, Jerzy/0000-0002-6335-0273; Nunez, Julio/0000-0003-1672-7119; Shalaev, Sergei/0000-0003-2724-4016; S.L., Grishaev/0000-0002-4830-5220; Kosmacheva, Elena/0000-0001-8600-0199; Costa, Francesco/0000-0002-3097-2834; Sinnaeve, Peter/0000-0003-4716-5892; Budaj, Andrzej/0000-0002-6395-2098	Bristol-Myers Squibb; Pfizer	Bristol-Myers Squibb(Bristol-Myers Squibb); Pfizer(Pfizer)	Supported by Bristol-Myers Squibb and Pfizer.	Amsterdam EA, 2014, J AM COLL CARDIOL, V64, P2645, DOI [10.1016/j.jacc.2014.09.016, 10.1016/j.jacc.2014.09.017]; Angiolillo DJ, 2018, CIRCULATION, V138, P527, DOI 10.1161/CIRCULATIONAHA.118.034722; Bertrand ME, 1998, CIRCULATION, V98, P1597, DOI 10.1161/01.CIR.98.16.1597; Cannon CP, 2017, NEW ENGL J MED, V377, P1513, DOI 10.1056/NEJMoa1708454; Capodanno D, 2018, NAT REV CARDIOL, V15, P480, DOI 10.1038/s41569-018-0049-1; CHESEBRO JH, 1987, CIRCULATION, V76, P142, DOI 10.1161/01.CIR.76.1.142; Connolly S, 2006, LANCET, V367, P1903, DOI 10.1016/s0140-6736(06)68845-4; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Dewilde WJM, 2013, LANCET, V381, P1107, DOI 10.1016/S0140-6736(12)62177-1; Gibson CM, 2016, NEW ENGL J MED, V375, P2423, DOI 10.1056/NEJMoa1611594; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Hansen ML, 2010, ARCH INTERN MED, V170, P1433, DOI 10.1001/archinternmed.2010.271; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; January CT, 2019, J AM COLL CARDIOL; Leon MB, 1998, NEW ENGL J MED, V339, P1665, DOI 10.1056/NEJM199812033392303; Levine GN, 2016, J AM COLL CARDIOL, V68, P1082, DOI 10.1016/j.jacc.2016.03.513; Lip GYH, 2018, EUR HEART J, V39, P2847, DOI 10.1093/eurheartj/ehy396; Lopes RD, 2018, AM HEART J, V200, P17, DOI 10.1016/j.ahj.2018.03.001; Lopes RD, 2016, AM J MED, V129, P592, DOI 10.1016/j.amjmed.2015.12.026; Mant J, 2007, LANCET, V370, P493, DOI 10.1016/S0140-6736(07)61233-1; O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI [10.1016/j.jacc.2012.11.019, 10.1161/CIR.0b013e3182742cf6]; Patel MR, 2010, NEW ENGL J MED, V362, P886, DOI 10.1056/NEJMoa0907272; Perez-Gomez F, 2004, J AM COLL CARDIOL, V44, P1557, DOI 10.1016/j.jacc.2004.05.084; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236; Rubboli A, 2005, CARDIOLOGY, V104, P101, DOI 10.1159/000086918; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; Sorensen R, 2009, LANCET, V374, P1967, DOI 10.1016/S0140-6736(09)61751-7; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; Wang TY, 2008, AM HEART J, V155, P361, DOI 10.1016/j.ahj.2007.09.003	31	566	589	5	77	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 18	2019	380	16					1509	1524		10.1056/NEJMoa1817083	http://dx.doi.org/10.1056/NEJMoa1817083			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU3AO	30883055	Green Accepted, Bronze			2022-12-28	WOS:000465144100012
J	Walkty, A; Embil, J				Walkty, Andrew; Embil, John			Lemierre's Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Walkty, Andrew; Embil, John] Univ Manitoba, Winnipeg, MB, Canada	University of Manitoba	Walkty, A (corresponding author), Univ Manitoba, Winnipeg, MB, Canada.	awalkty@sharedhealthmb.ca	Kirsch, David/A-5854-2011						0	6	9	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 21	2019	380	12					E16	E16		10.1056/NEJMicm1808378	http://dx.doi.org/10.1056/NEJMicm1808378			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HP7VK	30893539				2022-12-28	WOS:000461898400002
J	Chouinard, E				Chouinard, Edmond			In patients with cancer who were starting chemotherapy, apixaban reduced VTE and increased major bleeding at 180 d	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							VENOUS THROMBOEMBOLISM		[Chouinard, Edmond] Cambridge Mem Hosp, Cambridge, ON, Canada		Chouinard, E (corresponding author), Cambridge Mem Hosp, Cambridge, ON, Canada.							Lee AYY, 2003, NEW ENGL J MED, V349, P146, DOI 10.1056/NEJMoa025313; Lyman GH, 2015, J CLIN ONCOL, V33, P654, DOI 10.1200/JCO.2014.59.7351; Young Annie M, 2018, J Clin Oncol, V36, P2017, DOI 10.1200/JCO.2018.78.8034	3	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 19	2019	170	6					JC29	JC29		10.7326/ACPJ201903190-029	http://dx.doi.org/10.7326/ACPJ201903190-029			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP1ZR	30884499				2022-12-28	WOS:000461468300006
J	Sancar, F				Sancar, Feyza			Oversight of Supplements	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 19	2019	321	11					1042	1042		10.1001/jama.2019.1937	http://dx.doi.org/10.1001/jama.2019.1937			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JJ1JG	30874741				2022-12-28	WOS:000493916400001
J	Azzopardi, PS; Hearps, SJC; Francis, KL; Kennedy, EC; Mokdad, AH; Kassebaum, NJ; Lim, S; Irvine, CMS; Vos, T; Brown, AD; Dogra, S; Kinner, SA; Kaoma, NS; Naguib, M; Reavley, NJ; Requejo, J; Santelli, JS; Sawyer, SM; Skirbekk, V; Temmerman, M; Tewhaiti-Smith, J; Ward, JL; Viner, RM; Patton, GC				Azzopardi, Peter S.; Hearps, Stephen J. C.; Francis, Kate L.; Kennedy, Elissa C.; Mokdad, Ali H.; Kassebaum, Nicholas J.; Lim, Stephen; Irvine, Caleb M. S.; Vos, Theo; Brown, Alex D.; Dogra, Surabhi; Kinner, Stuart A.; Kaoma, Natasha S.; Naguib, Mariam; Reavley, Nicola J.; Requejo, Jennifer; Santelli, John S.; Sawyer, Susan M.; Skirbekk, Vegard; Temmerman, Marleen; Tewhaiti-Smith, Jordan; Ward, Joseph L.; Viner, Russell M.; Patton, George C.			Progress in adolescent health and wellbeing: tracking 12 headline indicators for 195 countries and territories, 1990-2016	LANCET			English	Article							SYSTEMATIC ANALYSIS; GLOBAL BURDEN; DISEASE; AGE	Background Rapid demographic, epidemiological, and nutritional transitons have brought a pressing need to track progress in adolescent health. Here, we present country-level estimates of 12 headline indicators from the Lancet Commission on adolescent health and wellbeing, from 1990 to 2016. Methods Indicators included those of health outcomes (disability-adjusted life-years [DALYs] due to communicable, maternal, and nutritional diseases; injuries; and non-communicable diseases); health risks (tobacco smoking, binge drinking, overweight, and anaemia); and social determinants of health (adolescent fertility; completion of secondary education; not in education, employment, or training [NEET]; child marriage; and demand for contraception satisfied with modern methods). We drew data from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2016, International Labour Organisation, household surveys, and the Barro-Lee education dataset. Findings From 1990 to 2016, remarkable shifts in adolescent health occurred. A decrease in disease burden in many countries has been offset by population growth in countries with the poorest adolescent health profiles. Compared with 1990, an additional 250 million adolescents were living in multi-burden countries in 2016, where they face a heavy and complex burden of disease. The rapidity of nutritional transition is evident from the 324.1 million (18%) of 1.8 billion adolescents globally who were overweight or obese in 2016, an increase of 176.9 million compared with 1990, and the 430.7 million (24%) who had anaemia in 2016, an increase of 74.2 million compared with 1990. Child marriage remains common, with an estimated 66 million women aged 20-24 years married before age 18 years. Although gender-parity in secondary school completion exists globally, prevalence of NEET remains high for young women in multi-burden countries, suggesting few opportunities to enter the workforce in these settings. Interpretation Although disease burden has fallen in many settings, demographic shifts have heightened global inequalities. Global disease burden has changed little since 1990 and the prevalence of many adolescent health risks have increased. Health, education, and legal systems have not kept pace with shifting adolescent needs and demographic changes. Gender inequity remains a powerful driver of poor adolescent health in many countries. Funding Australian National Health and Medical Research Council, and the Bill & Melinda Gates Foundation. Copyright (c) 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.	[Azzopardi, Peter S.; Hearps, Stephen J. C.; Francis, Kate L.; Kennedy, Elissa C.; Kinner, Stuart A.; Sawyer, Susan M.; Patton, George C.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Azzopardi, Peter S.; Kennedy, Elissa C.] Burnet Inst, Maternal & Child Hlth Program, Melbourne, Vic 3004, Australia; [Azzopardi, Peter S.; Brown, Alex D.] South Australian Hlth & Med Res Inst, Wardliparingga Aboriginal Res Unit, Adelaide, SA, Australia; [Azzopardi, Peter S.; Sawyer, Susan M.; Patton, George C.] Univ Melbourne, Dept Paediat, Parkville, Vic, Australia; [Kinner, Stuart A.; Reavley, Nicola J.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Parkville, Vic, Australia; [Azzopardi, Peter S.; Francis, Kate L.; Sawyer, Susan M.; Patton, George C.] Royal Childrens Hosp, Ctr Adolescent Hlth, Parkville, Vic, Australia; [Kennedy, Elissa C.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia; [Mokdad, Ali H.; Kassebaum, Nicholas J.; Lim, Stephen; Irvine, Caleb M. S.; Vos, Theo] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Kassebaum, Nicholas J.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Brown, Alex D.] Univ Adelaide, Fac Hlth & Med Sci, Adelaide, SA, Australia; [Dogra, Surabhi; Kaoma, Natasha S.; Naguib, Mariam; Tewhaiti-Smith, Jordan] Lancet Standing Commiss Adolescent Hlth & Wellbei, Lusaka, Zambia; [Kaoma, Natasha S.] Copper Rose, Lusaka, Zambia; [Requejo, Jennifer] United Nations Childrens Fund, New York, NY USA; [Requejo, Jennifer] Johns Hopkins Bloomberg Sch Publ Hlth, Inst Int Programs, Baltimore, MD USA; [Santelli, John S.] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; [Skirbekk, Vegard] Columbia Univ, Mailman Sch, Dept Populat & Family Hlth, New York, NY USA; [Skirbekk, Vegard] Norwegian Inst Publ Hlth, Ctr Fertil & Hlth, Oslo, Norway; [Temmerman, Marleen] Aga Khan Univ, Ctr Excellence Women Child & Adolescent Hlth, Nairobi, Kenya; [Temmerman, Marleen] Univ Ghent, Fac Med & Hlth Sci, Ghent, Belgium; [Ward, Joseph L.; Viner, Russell M.] UCL, Inst Child Hlth, London, England	Murdoch Children's Research Institute; Burnet Institute; South Australian Health & Medical Research Institute (SAHMRI); University of Melbourne; University of Melbourne; Royal Children's Hospital Melbourne; Monash University; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Adelaide; UNICEF; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Columbia University; Columbia University; Norwegian Institute of Public Health (NIPH); Aga Khan University; Ghent University; University of London; University College London	Azzopardi, PS (corresponding author), Burnet Inst, Maternal & Child Hlth Program, Melbourne, Vic 3004, Australia.	peter.azzopardi@burnet.edu.au	Patton, George C/B-5246-2013; Hearps, Stephen/L-6853-2016; Santelli, John/AAG-3046-2021; Reavley, Nicola/ABE-6510-2020; Mokdad, Ali H./AAD-1232-2022; Ribeiro, Ana Cristina/HHN-7466-2022; Francis, Kate/K-2679-2015; Viner, Russell/A-1441-2009	Patton, George C/0000-0001-5039-8326; Reavley, Nicola/0000-0001-5513-8291; Mokdad, Ali H./0000-0002-4994-3339; Ribeiro, Ana Cristina/0000-0002-0493-8376; Hearps, Stephen/0000-0003-2984-1172; azzopardi, peter/0000-0002-9280-6997; Francis, Kate/0000-0002-1751-5313; Viner, Russell/0000-0003-3047-2247; Ward, Joseph/0000-0001-7263-8845; Irvine, Caleb/0000-0003-4445-2079; Dogra, Surabhi/0000-0003-4136-2115; Brown, Alex/0000-0003-2112-3918	Australian National Health and Medical Research Council; Bill & Melinda Gates Foundation - Australian National Health and Medical Research Council; Bill & Melinda Gates Foundation; MRC [MR/R00160X/1] Funding Source: UKRI	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Bill & Melinda Gates Foundation - Australian National Health and Medical Research Council; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Australian National Health and Medical Research Council, and the Bill & Melinda Gates Foundation.; We thank David Anthony Ross (WHO, Geneva, Switzerland) who provided comment on the mansucript. This research was funded by the Australian National Health and Medical Research Council and the Bill & Melinda Gates Foundation.	[Anonymous], 2014, TECHN CONS IND AD HL; [Anonymous], 2017, INCLUSION PROTECTION; Azzopardi P, 2017, DATA INDICATORS MEAS; Banati P, 2016, MEASURING ADOLESCENT; Boerma T, 2018, LANCET, V391, P1538, DOI 10.1016/S0140-6736(18)30104-1; Cahill N, 2018, LANCET, V391, P870, DOI 10.1016/S0140-6736(17)33104-5; Erskine HE, 2017, EPIDEMIOL PSYCH SCI, V26, P395, DOI 10.1017/S2045796015001158; Every Woman Every Child, 2015, GLOBAL STRATEGY WOME; Gakidou E, 2017, LANCET, V390, P1345, DOI 10.1016/S0140-6736(17)32366-8; Goodwin Paula, 2009, NCHS Data Brief, P1; Hay SI, 2017, LANCET, V390, P1260, DOI 10.1016/S0140-6736(17)32130-X; Inter-Agency and Expert Group on Sustainable Development Goal Indicators, 2017, ANN 3 REV LIST GLOB; Kassebaum NJ, 2014, BLOOD, V123, P615, DOI 10.1182/blood-2013-06-508325; Li ZH, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.1072; Lim SS, 2016, LANCET, V388, P1813, DOI 10.1016/S0140-6736(16)31467-2; Mokdad AH, 2016, LANCET, V387, P2383, DOI 10.1016/S0140-6736(16)00648-6; Naghavi M, 2017, LANCET, V390, P1151, DOI 10.1016/S0140-6736(17)32152-9; Patton GC, 2018, LANCET GLOB HEALTH, V6, pE1048, DOI 10.1016/S2214-109X(18)30417-0; Patton GC, 2018, NATURE, V554, P458, DOI 10.1038/nature25759; Patton GC, 2016, LANCET, V387, P2423, DOI 10.1016/S0140-6736(16)00579-1; Patton GC, 2012, LANCET, V379, P1665, DOI 10.1016/S0140-6736(12)60203-7; Sawyer SM, 2018, LANCET CHILD ADOLESC, V2, P223, DOI 10.1016/S2352-4642(18)30022-1; Temmerman M, 2015, BMJ-BRIT MED J, V351; United Nations Economic and Social Council, 2016, STAT COMM 47 SESS IN; Vos T, 2017, LANCET, V390, P1211, DOI 10.1016/S0140-6736(17)32154-2; WHO, 2017, GLOB ACC ACT HLTH AD; World Health Organization, WORLD HLTH STAT 2016; World Health Organization (WHO), 2007, ADOLESCENT PREGNANCY	29	125	131	6	47	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 16	2019	393	10176					1101	1118		10.1016/S0140-6736(18)32427-9	http://dx.doi.org/10.1016/S0140-6736(18)32427-9			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP1HF	30876706	Green Published, hybrid			2022-12-28	WOS:000461416600029
J	Sweet-Cordero, EA; Biegel, JA				Sweet-Cordero, E. Alejandro; Biegel, Jaclyn A.			The genomic landscape of pediatric cancers: Implications for diagnosis and treatment	SCIENCE			English	Review							CHILDRENS ONCOLOGY GROUP; GERMLINE MUTATIONS; GENETIC LANDSCAPE; CREBBP MUTATIONS; PREDISPOSITION; SURVEILLANCE; MEDULLOBLASTOMA; FREQUENT; DNA; PHARMACOGENOMICS	The past decade has witnessed a major increase in our understanding of the genetic underpinnings of childhood cancer. Genomic sequencing studies have highlighted key differences between pediatric and adult cancers. Whereas many adult cancers are characterized by a high number of somatic mutations, pediatric cancers typically have few somatic mutations but a higher prevalence of germline alterations in cancer predisposition genes. Also noteworthy is the remarkable heterogeneity in the types of genetic alterations that likely drive the growth of pediatric cancers, including copy number alterations, gene fusions, enhancer hijacking events, and chromoplexy. Because most studies have genetically profiled pediatric cancers only at diagnosis, the mechanisms underlying tumor progression, therapy resistance, and metastasis remain poorly understood. We discuss evidence that points to a need for more integrative approaches aimed at identifying driver events in pediatric cancers at both diagnosis and relapse. We also provide an overview of key aspects of germline predisposition for cancer in this age group.	[Sweet-Cordero, E. Alejandro] Univ Calif San Francisco, Dept Pediat, Div Hematol & Oncol, San Francisco, CA 94158 USA; [Biegel, Jaclyn A.] Childrens Hosp Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90027 USA; [Biegel, Jaclyn A.] Univ Southern Calif, Keck Sch Med, Los Angeles, CA 90027 USA	University of California System; University of California San Francisco; Children's Hospital Los Angeles; University of Southern California	Sweet-Cordero, EA (corresponding author), Univ Calif San Francisco, Dept Pediat, Div Hematol & Oncol, San Francisco, CA 94158 USA.; Biegel, JA (corresponding author), Childrens Hosp Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90027 USA.; Biegel, JA (corresponding author), Univ Southern Calif, Keck Sch Med, Los Angeles, CA 90027 USA.	alejandro.sweet-cordero@ucsf.edu; jbiegel@chla.usc.edu			National Cancer Institute [5R01CA211657]; NATIONAL CANCER INSTITUTE [R01CA211657] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	E.A.S.-C. was funded by National Cancer Institute grant 5R01CA211657.	Amatu A, 2016, ESMO OPEN, V1, DOI 10.1136/esmoopen-2015-000023; Anderson ND, 2018, SCIENCE, V361, DOI 10.1126/science.aam8419; Andre F, 2017, CANCER DISCOV, V7, P818, DOI 10.1158/2159-8290.CD-17-0151; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Bandopadhayay P, 2016, NAT GENET, V48, P273, DOI 10.1038/ng.3500; Bhatt MD, 2019, PEDIATR BLOOD CANCER, V66, DOI 10.1002/pbc.27546; Biegel JA, 2014, AM J MED GENET C, V166, P350, DOI 10.1002/ajmg.c.31410; Bolouri H, 2018, NAT MED, V24, P103, DOI 10.1038/nm.4439; Bouffet E, 2016, J CLIN ONCOL, V34, P2206, DOI 10.1200/JCO.2016.66.6552; Bourdeaut F, 2011, CLIN CANCER RES, V17, P31, DOI 10.1158/1078-0432.CCR-10-1795; Brodeur GM, 2017, CLIN CANCER RES, V23, pE1, DOI 10.1158/1078-0432.CCR-17-0702; Burdach Stefan E G, 2018, Mol Cell Pediatr, V5, P6, DOI 10.1186/s40348-018-0084-3; Campbell BB, 2017, CELL, V171, P1042, DOI 10.1016/j.cell.2017.09.048; Capper D, 2018, NATURE, V555, P469, DOI 10.1038/nature26000; Cavalli FMG, 2018, ACTA NEUROPATHOL, V136, P227, DOI 10.1007/s00401-018-1888-x; Chen X, 2015, ONCOGENE, V34, P5207, DOI 10.1038/onc.2014.474; Cousin S, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.15_suppl.TPS3125; Downing JR, 2012, NAT GENET, V44, P619, DOI 10.1038/ng.2287; DuBois SG, 2019, SCIENCE, V363, P1175, DOI 10.1126/science.aaw4153; Eaton KW, 2011, PEDIATR BLOOD CANCER, V56, P7, DOI 10.1002/pbc.22831; Eleveld TF, 2015, NAT GENET, V47, P864, DOI 10.1038/ng.3333; Evans DGR, 2017, CLIN CANCER RES, V23, pE46, DOI 10.1158/1078-0432.CCR-17-0589; Foulkes WD, 2017, CLIN CANCER RES, V23, pE62, DOI 10.1158/1078-0432.CCR-17-0595; Gadd S, 2017, NAT GENET, V49, P1487, DOI 10.1038/ng.3940; Greer MLC, 2017, CLIN CANCER RES, V23, pE6, DOI 10.1158/1078-0432.CCR-17-0515; Grobner SN, 2018, NATURE, V555, P321, DOI 10.1038/nature25480; Helfferich J, 2016, CRIT REV ONCOL HEMAT, V104, P30, DOI 10.1016/j.critrevonc.2016.05.008; Huang KL, 2018, CELL, V173, P355, DOI 10.1016/j.cell.2018.03.039; Kadoch C, 2013, NAT GENET, V45, P592, DOI 10.1038/ng.2628; Kamihara J, 2017, CLIN CANCER RES, V23, pE98, DOI 10.1158/1078-0432.CCR-17-0652; Karlsson J, 2018, NAT GENET, V50, P944, DOI 10.1038/s41588-018-0131-y; Kumar R, 2018, CANCER-AM CANCER SOC, V124, P4168, DOI 10.1002/cncr.31583; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lee RS, 2012, J CLIN INVEST, V122, P2983, DOI 10.1172/JCI64400; Liu Y, 2017, NAT GENET, V49, P1211, DOI 10.1038/ng.3909; Ma J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05228-y; Ma XT, 2018, NATURE, V555, P371, DOI 10.1038/nature25795; Ma XT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7604; Mack SC, 2018, NATURE, V553, P101, DOI 10.1038/nature25169; Mack SC, 2017, J CLIN ONCOL, V35, P2346, DOI 10.1200/JCO.2017.72.9921; Malinowska-Ozdowy K, 2015, LEUKEMIA, V29, P1656, DOI 10.1038/leu.2015.107; Mar BG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4469; Maraka S, 2018, DISCOV MED, V26, P51; Mertens F, 2015, NAT REV CANCER, V15, P371, DOI 10.1038/nrc3947; Mody RJ, 2017, PEDIATR BLOOD CANCER, V64, DOI 10.1002/pbc.26288; Mody RJ, 2015, JAMA-J AM MED ASSOC, V314, P913, DOI 10.1001/jama.2015.10080; Morrissy AS, 2016, NATURE, V529, P351, DOI 10.1038/nature16478; Mullighan CG, 2008, SCIENCE, V322, P1377, DOI 10.1126/science.1164266; Mullighan CG, 2011, NATURE, V471, P235, DOI 10.1038/nature09727; Nlemeyer CM, 2014, HAEMATOLOGICA, V99, P1653, DOI 10.3324/haematol.2014.114595; Northcott PA, 2017, NATURE, V547, P311, DOI 10.1038/nature22973; Parker M, 2014, NATURE, V506, P451, DOI 10.1038/nature13109; Parsons DW, 2016, JAMA ONCOL, V2, P616, DOI 10.1001/jamaoncol.2015.5699; Pugh TJ, 2013, NAT GENET, V45, P279, DOI 10.1038/ng.2529; Rahimzadeh V, 2018, JAMA PEDIATR, V172, P476, DOI 10.1001/jamapediatrics.2017.5500; Relling MV, 2017, CLIN PHARMACOL THER, V102, P897, DOI 10.1002/cpt.755; Relling MV, 2019, CLIN PHARMACOL THER, V105, P1095, DOI 10.1002/cpt.1304; Roberts KG, 2014, NEW ENGL J MED, V371, P1005, DOI 10.1056/NEJMoa1403088; Robinson GW, 2018, LANCET ONCOL, V19, P768, DOI 10.1016/S1470-2045(18)30204-3; Rusch M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06485-7; Schultz KR, 2009, J CLIN ONCOL, V27, P5175, DOI 10.1200/JCO.2008.21.2514; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Shulman DS, 2018, BRIT J CANCER, V119, P615, DOI 10.1038/s41416-018-0212-9; Steliarova-Foucher E, 2017, LANCET ONCOL, V18, P719, DOI 10.1016/S1470-2045(17)30186-9; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Tabori U, 2010, J CLIN ONCOL, V28, P1995, DOI 10.1200/JCO.2009.26.8169; Taylor MD, 2012, ACTA NEUROPATHOL, V123, P465, DOI 10.1007/s00401-011-0922-z; Tran TH, 2017, CLIN CANCER RES, V23, P5329, DOI 10.1158/1078-0432.CCR-16-0115; Tricoli JV, 2016, CANCER-AM CANCER SOC, V122, P1017, DOI 10.1002/cncr.29871; Tzoneva G, 2018, NATURE, V553, P511, DOI 10.1038/nature25186; Valentijn LJ, 2015, NAT GENET, V47, P1411, DOI 10.1038/ng.3438; Vaske OM, 2019, SCIENCE, V363, P1125, DOI 10.1126/science.aax2739; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; Villani A, 2016, LANCET ONCOL, V17, P1295, DOI 10.1016/S1470-2045(16)30249-2; Vivanco I, 2012, CANCER DISCOV, V2, P458, DOI 10.1158/2159-8290.CD-11-0284; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Volckmar AL, 2018, GENE CHROMOSOME CANC, V57, P123, DOI 10.1002/gcc.22517; Walsh MF, 2017, CLIN CANCER RES, V23, pE23, DOI 10.1158/1078-0432.CCR-17-0465; Wasserman JD, 2015, J CLIN ONCOL, V33, P602, DOI 10.1200/JCO.2013.52.6863; Waszak SM, 2018, LANCET ONCOL, V19, P785, DOI 10.1016/S1470-2045(18)30242-0; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Yang JJ, 2011, NAT GENET, V43, P237, DOI 10.1038/ng.763; Zhang JH, 2015, NEW ENGL J MED, V373, P2336, DOI 10.1056/NEJMoa1508054; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725	84	66	65	4	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 15	2019	363	6432			SI		1170	+		10.1126/science.aaw3535	http://dx.doi.org/10.1126/science.aaw3535			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP0BC	30872516	Green Accepted			2022-12-28	WOS:000461329000037
J	Sevestre, J; Hasseine, L				Sevestre, Jacques; Hasseine, Lilia			Disseminated Histoplasmosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Sevestre, Jacques; Hasseine, Lilia] Ctr Hosp Univ Nice, Nice, France	CHU Nice	Sevestre, J (corresponding author), Ctr Hosp Univ Nice, Nice, France.	sevestre.j@chu-nice.fr	Mahbub, Md. Shahriar/M-7392-2014; Sevestre, Jacques/AAU-8216-2020	Mahbub, Md. Shahriar/0000-0002-1140-0523; Sevestre, Jacques/0000-0001-8020-0050					0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 14	2019	380	11					E13	E13		10.1056/NEJMicm1809792	http://dx.doi.org/10.1056/NEJMicm1809792			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HO8NL	30865801				2022-12-28	WOS:000461210000011
J	Menviel, L				Menviel, Laurie			The southern amplifier	SCIENCE			English	Editorial Material							OCEAN; INTENSIFICATION; TEMPERATURE; EVOLUTION; CARBON		[Menviel, Laurie] Univ New South Wales, PANGEA, Climate Change Res Ctr, Sydney, NSW 2052, Australia	University of New South Wales Sydney	Menviel, L (corresponding author), Univ New South Wales, PANGEA, Climate Change Res Ctr, Sydney, NSW 2052, Australia.	l.menviel@unsw.edu.au	Menviel, Laurie/O-7833-2019; Menviel, Laurie/D-6902-2013	Menviel, Laurie/0000-0002-5068-1591	Australian Research Council [FT180100606, DP180100048]	Australian Research Council(Australian Research Council)	L.M. acknowledges support from the Australian Research Council grants FT180100606 and DP180100048.	Chalk TB, 2017, P NATL ACAD SCI USA, V114, P13114, DOI 10.1073/pnas.1702143114; Clark PU, 2006, QUATERNARY SCI REV, V25, P3150, DOI 10.1016/j.quascirev.2006.07.008; de Lavergne C, 2014, NAT CLIM CHANGE, V4, P278, DOI [10.1038/nclimate2132, 10.1038/NCLIMATE2132]; Elderfield H, 2012, SCIENCE, V337, P704, DOI 10.1126/science.1221294; Hasenfratz AP, 2019, SCIENCE, V363, P1080, DOI 10.1126/science.aat7067; Lisiecki LE, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2005PA001164; Luthi D, 2008, NATURE, V453, P379, DOI 10.1038/nature06949; Martinez-Garcia A, 2011, NATURE, V476, P312, DOI 10.1038/nature10310; McClymont EL, 2013, EARTH-SCI REV, V123, P173, DOI 10.1016/j.earscirev.2013.04.006; Menviel L, 2017, PALEOCEANOGRAPHY, V32, P2, DOI 10.1002/2016PA003024; Pena LD, 2014, SCIENCE, V345, P318, DOI 10.1126/science.1249770; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Toggweiler JR, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001154; Tzedakis PC, 2017, NATURE, V542, P427, DOI 10.1038/nature21364; Yu J, 2016, NAT GEOSCI, V9, P319, DOI 10.1038/NGEO2657	15	2	4	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 8	2019	363	6431					1040	1041		10.1126/science.aaw7196	http://dx.doi.org/10.1126/science.aaw7196			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HO2MV	30846585				2022-12-28	WOS:000460750100022
J	Landsman, KA; Figgatt, C; Schuster, T; Linke, NM; Yoshida, B; Yao, NY; Monroe, C				Landsman, K. A.; Figgatt, C.; Schuster, T.; Linke, N. M.; Yoshida, B.; Yao, N. Y.; Monroe, C.			Verified quantum information scrambling	NATURE			English	Article								Quantum scrambling is the dispersal of local information into many-body quantum entanglements and correlations distributed throughout an entire system. This concept accompanies the dynamics of thermalization in closed quantum systems, and has recently emerged as a powerful tool for characterizing chaos in black holes(1-4). However, the direct experimental measurement of quantum scrambling is difficult, owing to the exponential complexity of ergodic many-body entangled states. One way to characterize quantum scrambling is to measure an out-of-time-ordered correlation function (OTOC); however, because scrambling leads to their decay, OTOCs do not generally discriminate between quantum scrambling and ordinary decoherence. Here we implement a quantum circuit that provides a positive test for the scrambling features of a given unitary process(5,6). This approach conditionally teleports a quantum state through the circuit, providing an unambiguous test for whether scrambling has occurred, while simultaneously measuring an OTOC. We engineer quantum scrambling processes through a tunable three-qubit unitary operation as part of a seven-qubit circuit on an ion trap quantum computer. Measured teleportation fidelities are typically about 80 per cent, and enable us to experimentally bound the scrambling-induced decay of the corresponding OTOC measurement.	[Landsman, K. A.; Figgatt, C.; Linke, N. M.; Monroe, C.] Univ Maryland, Dept Phys, Joint Quantum Inst, College Pk, MD 20742 USA; [Landsman, K. A.; Figgatt, C.; Linke, N. M.; Monroe, C.] Univ Maryland, Joint Ctr Quantum Informat & Comp Sci, College Pk, MD 20742 USA; [Schuster, T.; Yao, N. Y.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Yoshida, B.] Perimeter Inst Theoret Phys, Waterloo, ON, Canada; [Yao, N. Y.] Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA USA; [Monroe, C.] IonQ Inc, College Pk, MD USA; [Figgatt, C.] Honeywell, Broomfield, CO USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University of California System; University of California Berkeley; Perimeter Institute for Theoretical Physics; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Honeywell	Landsman, KA (corresponding author), Univ Maryland, Dept Phys, Joint Quantum Inst, College Pk, MD 20742 USA.; Landsman, KA (corresponding author), Univ Maryland, Joint Ctr Quantum Informat & Comp Sci, College Pk, MD 20742 USA.	kalands@umd.edu	Monroe, Christopher R/G-8105-2011; Yao, Norman/A-3929-2009	Schuster, Thomas/0000-0002-2084-6586; Linke, Norbert/0000-0001-5655-9258; Yao, Norman/0000-0003-0194-7266	ARO through the IARPA LogiQ programme; AFOSR MURI on Quantum Measurement and Verification; ARO MURI on Modular Quantum Circuits; DOE ASCR Program; NSF Physics Frontier Center at JQI; Office of Science, Office of High Energy Physics of the US Department of Energy through the COMPHEP pilot "Probing information scrambling via quantum teleportation" [DE-AC02-05CH11231]; Office of Advanced Scientific Computing Research, Quantum Algorithm Teams Program; Government of Canada through Innovation, Science and Economic Development Canada; province of Ontario through the Ministry of Economic Development, Job Creation and Trade; National Science Foundation [DGE 1752814]	ARO through the IARPA LogiQ programme; AFOSR MURI on Quantum Measurement and Verification; ARO MURI on Modular Quantum Circuits; DOE ASCR Program; NSF Physics Frontier Center at JQI(National Science Foundation (NSF)); Office of Science, Office of High Energy Physics of the US Department of Energy through the COMPHEP pilot "Probing information scrambling via quantum teleportation"; Office of Advanced Scientific Computing Research, Quantum Algorithm Teams Program; Government of Canada through Innovation, Science and Economic Development Canada; province of Ontario through the Ministry of Economic Development, Job Creation and Trade; National Science Foundation(National Science Foundation (NSF))	We gratefully acknowledge discussions with R. Bousso, D. Harlow, F. Machado, I. Siddiqi, L. Susskind and Q. Zhuang. Additionally, we thank E. Edwards for the development of Fig. 1. This work is supported in part by the ARO through the IARPA LogiQ programme, the AFOSR MURI on Quantum Measurement and Verification, the ARO MURI on Modular Quantum Circuits, the DOE ASCR Program, and the NSF Physics Frontier Center at JQI. T.S. and N.Y.Y. acknowledge support from the Office of Science, Office of High Energy Physics of the US Department of Energy under contract number DE-AC02-05CH11231 through the COMPHEP pilot "Probing information scrambling via quantum teleportation" and the Office of Advanced Scientific Computing Research, Quantum Algorithm Teams Program. Research at the Perimeter Institute is supported by the Government of Canada through Innovation, Science and Economic Development Canada and by the province of Ontario through the Ministry of Economic Development, Job Creation and Trade. T.S. acknowledges support from the National Science Foundation Graduate Research Fellowship Program under grant number DGE 1752814.	Banerjee S, 2017, PHYS REV B, V95, DOI 10.1103/PhysRevB.95.134302; BENNETT CH, 1993, PHYS REV LETT, V70, P1895, DOI 10.1103/PhysRevLett.70.1895; Blake M, 2017, PHYS REV D, V96, DOI 10.1103/PhysRevD.96.106008; Choi T, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.190502; Cirac JI, 2012, NAT PHYS, V8, P264, DOI 10.1038/nphys2275; Debnath S, 2016, NATURE, V536, P63, DOI 10.1038/nature18648; Gao P, 2017, J HIGH ENERGY PHYS, DOI 10.1007/JHEP12(2017)151; Garttner M, 2017, NAT PHYS, V13, P781, DOI [10.1038/NPHYS4119, 10.1038/nphys4119]; Grover L. K., 1996, Proceedings of the Twenty-Eighth Annual ACM Symposium on the Theory of Computing, P212, DOI 10.1145/237814.237866; Halpern NY, 2018, PHYS REV A, V97, DOI 10.1103/PhysRevA.97.042105; Hosur P, 2016, J HIGH ENERGY PHYS, DOI 10.1007/JHEP02(2016)004; Kitaev A, 2015, P KITP; Lanyon BP, 2011, SCIENCE, V334, P57, DOI 10.1126/science.1208001; LARKIN AI, 1969, SOV PHYS JETP-USSR, V28, P1200; Li J, 2017, PHYS REV X, V7, DOI 10.1103/PhysRevX.7.031011; Maldacena J, 1999, INT J THEOR PHYS, V38, P1113, DOI 10.1023/A:1026654312961; MALDACENA J, 2003, J HIGH ENERGY PHYS; Maldacena J, 2016, J HIGH ENERGY PHYS, DOI 10.1007/JHEP08(2016)106; Meier E. J., 2017, PREPRINT; Molmer K, 1999, PHYS REV LETT, V82, P1835, DOI 10.1103/PhysRevLett.82.1835; Nandkishore R, 2015, ANNU REV CONDEN MA P, V6, P15, DOI 10.1146/annurev-conmatphys-031214-014726; Olmschenk S, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.052314; PAGE DN, 1993, PHYS REV LETT, V71, P1291, DOI 10.1103/PhysRevLett.71.1291; Roberts DA, 2015, J HIGH ENERGY PHYS, DOI 10.1007/JHEP03(2015)051; Shenker SH, 2014, J HIGH ENERGY PHYS, DOI 10.1007/JHEP03(2014)067; Swingle B, 2018, PHYS REV A, V97, DOI 10.1103/PhysRevA.97.062113; Swingle B, 2016, PHYS REV A, V94, DOI 10.1103/PhysRevA.94.040302; Wei KX, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.070501; Yao N.Y, 2016, PREPRINT; Yoshida B., 2018, PHYS REV X, V9; Yoshida B., 2017, PREPRINT; Zhu SL, 2006, EUROPHYS LETT, V73, P485, DOI 10.1209/epl/i2005-10424-4	37	147	147	5	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 7	2019	567	7746					61	+		10.1038/s41586-019-0952-6	http://dx.doi.org/10.1038/s41586-019-0952-6			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HN8ED	30842638	Green Submitted			2022-12-28	WOS:000460426900041
J	English, V; Johnson, E; Sadler, BL; Sadler, AM				English, Veronica; Johnson, Emma; Sadler, Blair L.; Sadler, Alfred M., Jr.			HEAD TO HEAD Is an opt-out system likely to increase organ donation?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PRESUMED CONSENT; TRANSPLANTATION		[English, Veronica] BMA, London, England; [Sadler, Blair L.] Inst Healthcare Improvement, Boston, MA 02109 USA; [Sadler, Alfred M., Jr.] Calif State Univ Salinas, Salinas, CA USA	Institute for Healthcare Improvement	English, V (corresponding author), BMA, London, England.; Sadler, BL (corresponding author), Inst Healthcare Improvement, Boston, MA 02109 USA.	venglish@bma.org.uk; bsadler@ucsd.edu						Armstrong J, 2018, DAILY MIRROR; Csillag C, 1998, LANCET, V352, P1367, DOI 10.1016/S0140-6736(05)60767-2; Department of Health, 2008, ORGANS TRANSPLANTS R; Fabre J, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4973; Griffiths S., 2018, BUSTING MYTHS OPT OU; HAWKES N, 2017, BMJ-BRIT MED J, V359, DOI DOI 10.1136/BMJ.J5659; Matesanz R, 2017, AM J TRANSPLANT, V17, P1447, DOI 10.1111/ajt.14104; NHS Blood and Transplant, 2019, ORG DON TRANSPL ACT; NHS Blood and Transplant National Organ Donation Committee, 2019, NODC195; Niven J, 2018, OPT OUT ORGAN DONATI; Palmer M., 2012, OPT OUT SYSTEMS ORGA; Rithalia A, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3162; Rudge CJ, 2018, BRIT J GEN PRACT, V68, P62, DOI 10.3399/bjgp18X694445; SADLER AM, 1969, NEW ENGL J MED, V280, P862, DOI 10.1056/NEJM196904172801605; Sadler BL, 2018, HASTINGS CENT REP, V48, P14, DOI 10.1002/hast.834; Sadler Jr AM, 2018, BMJ OPINION; Sharif A, 2018, KIDNEY INT, V94, P249, DOI 10.1016/j.kint.2018.04.020; Tullius SG, 2018, NEW ENGL J MED, V378, P1920, DOI 10.1056/NEJMra1507080; Welsh Government, 2018, UPD SURV PUBL ATT OR; Wright K., 2018, OPTING OUT EVIDENCE; Young V, 2017, EVALUATION HUMAN TRA	21	10	10	1	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 6	2019	364								l967	10.1136/bmj.l967	http://dx.doi.org/10.1136/bmj.l967			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HO6SU	30842088				2022-12-28	WOS:000461062400011
J	Rimmer, A				Rimmer, Abi			NHS chief attacks anti-vax "fake news" for falling uptake	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Dyer O., 2019, BMJ-BRIT MED J, V364, pI981, DOI [10.1136/bmj.l98130824412, DOI 10.1136/BMJ.L98130824412]	1	0	0	0	22	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 4	2019	364								l1000	10.1136/bmj.l1000	http://dx.doi.org/10.1136/bmj.l1000			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HO6SQ	30833281				2022-12-28	WOS:000461061900007
J	Devi, S				Devi, Sharmila			Lebanon's new Health Minister	LANCET			English	Editorial Material								Jamil Jabak was put forward by Hezbollah, which insists its choice of health minister in newly-formed government will serve all Lebanese communities. Sharmila Devi reports.											0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 23	2019	393	10173					733	733		10.1016/S0140-6736(19)30409-X	http://dx.doi.org/10.1016/S0140-6736(19)30409-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HN1KI	30846241				2022-12-28	WOS:000459945500015
J	Ganeshan, K; Nikkanen, J; Man, K; Leong, YA; Sogawa, Y; Maschek, JA; Van Ry, T; Chagwedera, DN; Cox, JE; Chawla, A				Ganeshan, Kirthana; Nikkanen, Joni; Man, Kevin; Leong, Yew Ann; Sogawa, Yoshitaka; Maschek, J. Alan; Van Ry, Tyler; Chagwedera, D. Nyasha; Cox, James E.; Chawla, Ajay			Energetic Trade-Offs and Hypometabolic States Promote Disease Tolerance	CELL			English	Article							IMMUNE-RESPONSE; BACTERIAL; GROWTH; BROWN; INFLAMMASOME; SPECIFICITY; HIBERNATION; PROTECTION; RESISTANCE; HISTORY	Host defenses against pathogens are energetically expensive, leading ecological immunologists to postulate that they might participate in energetic trade-offs with other maintenance programs. However, the metabolic costs of immunity and the nature of physiologic trade-offs it engages are largely unknown. We report here that activation of immunity causes an energetic trade-off with the homeothermy (the stable maintenance of core temperature), resulting in hypometabolism and hypothermia. This immunity-induced physiologic trade-off was independent of sickness behaviors but required hematopoictic sensing of lipopolysaccharide (LPS) via the toll-like receptor 4 (TLR4). Metabolomics and genome-wide expression profiling revealed that distinct metabolic programs supported entry and recovery from the energy-conserving hypometabolic state. During bacterial infections, hypometabolic states, which could be elicited by competition for energy between maintenance programs or energy restriction, promoted disease tolerance. Together, our findings suggest that energy-conserving hypometabolic states, such as dormancy, might have evolved as a mechanism of tissue tolerance.	[Ganeshan, Kirthana; Nikkanen, Joni; Man, Kevin; Leong, Yew Ann; Sogawa, Yoshitaka; Chagwedera, D. Nyasha; Chawla, Ajay] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Leong, Yew Ann] Monash Univ, Sch Clin Sci Monash Hlth, Dept Med, Ctr Inflammatory Dis, Melbourne, Vic, Australia; [Maschek, J. Alan; Van Ry, Tyler; Cox, James E.] Univ Utah, Dept Biochem, Salt Lake City, UT 84112 USA; [Maschek, J. Alan; Van Ry, Tyler; Cox, James E.] Univ Utah, Metabol Core Res Facil, Salt Lake City, UT 84112 USA; [Chawla, Ajay] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Chawla, Ajay] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Monash University; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Chawla, A (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA.; Chawla, A (corresponding author), Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA.; Chawla, A (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	ajay.chawla@ucsf.edu		Man, Kevin/0000-0002-6585-9532; Nikkanen, Joni/0000-0001-7099-4061; Sogawa, Yoshitaka/0000-0003-1621-0929; Leong, Yew Ann/0000-0002-0999-7084	NIH [DK094641, DK101064, 1S10OD018210-01A1, 1S10OD021505-01]; T32 training grant [4 T32 HL 7731-25]; EMBO [ALTF 1185-2017]; NHMRC [GNT1121917, GNT1142229]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007731] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK105175, R01DK094641, R01DK101064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007618] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021505] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); T32 training grant; EMBO(European Molecular Biology Organization (EMBO)); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the Chawla laboratory and A. Loh for comments on the manuscript and X. Cui for assistance with mouse husbandry. The authors' work was supported by grants from NIH (DK094641, DK101064). K.G., J.N., K.M., and Y.A.L. were supported by postdoctoral fellowships from the T32 training grant (4 T32 HL 7731-25), EMBO (ALTF 1185-2017), and NHMRC (GNT1121917 to K.M. and GNT1142229 to Y.A.L.). Mass-spectrometry equipment was obtained through NIH Shared Instrumentation grants (1S10OD018210-01A1 and 1S10OD021505-01 to J.E.C).	Abram CL, 2014, J IMMUNOL METHODS, V408, P89, DOI 10.1016/j.jim.2014.05.009; Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Ayres JS, 2012, ANNU REV IMMUNOL, V30, P271, DOI 10.1146/annurev-immunol-020711-075030; Ayres JS, 2008, PLOS BIOL, V6, P2764, DOI 10.1371/journal.pbio.0060305; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Cannon B, 2011, J EXP BIOL, V214, P242, DOI 10.1242/jeb.050989; DeBenedetti F, 1997, J CLIN INVEST, V99, P643, DOI 10.1172/JCI119207; DiAngelo JR, 2009, P NATL ACAD SCI USA, V106, P20853, DOI 10.1073/pnas.0906749106; Dibner JJ, 2005, POULTRY SCI, V84, P634, DOI 10.1093/ps/84.4.634; Dijk W, 2015, ELIFE, V4, DOI 10.7554/eLife.08428; Ganeshan K, 2017, NAT REV ENDOCRINOL, V13, P458, DOI 10.1038/nrendo.2017.48; Ganeshan K, 2014, ANNU REV IMMUNOL, V32, P609, DOI 10.1146/annurev-immunol-032713-120236; Garaude J, 2016, NAT IMMUNOL, V17, P1037, DOI 10.1038/ni.3509; Geiser F, 2004, ANNU REV PHYSIOL, V66, P239, DOI 10.1146/annurev.physiol.66.032102.115105; Hagar JA, 2013, SCIENCE, V341, P1250, DOI 10.1126/science.1240988; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Hashimshony T, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0938-8; Holzer M, 2002, NEW ENGL J MED, V346, P549; Jamieson AM, 2013, SCIENCE, V340, P1230, DOI 10.1126/science.1233632; Jha Pooja, 2016, Curr Protoc Mouse Biol, V6, P1, DOI 10.1002/9780470942390.mo150182; Kayagaki N, 2013, SCIENCE, V341, P1246, DOI 10.1126/science.1240248; Knottnerus SJG, 2018, REV ENDOCR METAB DIS, V19, P93, DOI 10.1007/s11154-018-9448-1; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; McDade TW, 2005, AM J HUM BIOL, V17, P81, DOI 10.1002/ajhb.20095; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Melvin RG, 2009, TRENDS ENDOCRIN MET, V20, P490, DOI 10.1016/j.tem.2009.09.005; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519; NODA C, 1976, J BIOCHEM, V80, P1159, DOI 10.1093/oxfordjournals.jbchem.a131371; O'Neill LAJ, 2016, J EXP MED, V213, P15, DOI 10.1084/jem.20151570; Odegaard JI, 2013, SCIENCE, V339, P172, DOI 10.1126/science.1230721; Pimentel H, 2017, NAT METHODS, V14, P687, DOI 10.1038/nmeth.4324; Polderman KH, 2004, INTENS CARE MED, V30, P757, DOI 10.1007/s00134-003-2151-y; Quinones QJ, 2014, INTEGR COMP BIOL, V54, P497, DOI 10.1093/icb/icu047; Raberg L, 2009, PHILOS T R SOC B, V364, P37, DOI 10.1098/rstb.2008.0184; Raberg L, 2007, SCIENCE, V318, P812, DOI 10.1126/science.1148526; Rakhshandehroo M, 2010, PPAR RES, V2010, DOI 10.1155/2010/612089; Rauw Wendy M., 2012, Frontiers in Genetics, V3, P267, DOI 10.3389/fgene.2012.00267; Reeds PJ, 2001, CLIN NUTR, V20, P15, DOI 10.1054/clnu.2001.0402; Sadd BM, 2009, EVOL APPL, V2, P113, DOI 10.1111/j.1752-4571.2008.00057.x; Schieber AMP, 2015, SCIENCE, V350, P558, DOI 10.1126/science.aac6468; Simcox J, 2017, CELL METAB, V26, P509, DOI 10.1016/j.cmet.2017.08.006; SIMMS EL, 1994, EVOLUTION, V48, P1973, DOI 10.1111/j.1558-5646.1994.tb02227.x; Soares MP, 2017, NAT REV IMMUNOL, V17, P83, DOI 10.1038/nri.2016.136; Stearns S.C., 1992, pi; Tan YH, 2014, MOL CELL, V54, P212, DOI 10.1016/j.molcel.2014.03.012; Thompson CB, 2011, COLD SH Q B, V76, P23, DOI 10.1101/sqb.2012.76.010496; Torres BY, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002436; Tripathi S, 2015, CELL HOST MICROBE, V18, P723, DOI 10.1016/j.chom.2015.11.002; TUCKER VA, 1962, SCIENCE, V136, P380, DOI 10.1126/science.136.3514.380; Wang A, 2016, CELL, V166, P1512, DOI 10.1016/j.cell.2016.07.026; Wanichthanarak K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171046; Weis S, 2017, CELL, V169, P1263, DOI 10.1016/j.cell.2017.05.031; Zuk M, 2002, AM NAT, V160, pS9, DOI 10.1086/342131	58	98	99	4	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 4	2019	177	2					399	+		10.1016/j.cell.2019.01.050	http://dx.doi.org/10.1016/j.cell.2019.01.050			27	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	HR7PF	30853215	Green Accepted, Bronze			2022-12-28	WOS:000463346200018
J	Tan, YH; Kagan, JC				Tan, Yunhao; Kagan, Jonathan C.			Innate Immune Signaling Organelles Display Natural and Programmable Signaling Flexibility	CELL			English	Article							MECHANISMS; INTERLEUKIN-1-BETA; SPECIFICITY; ACTIVATION; CASPASE-1; REQUIRES; COMPLEX; ADAPTER; TBK1; TRIF	The signaling organelles of the innate immune system consist of oligomeric protein complexes known as supramolecular organizing centers (SMOCs). Examples of SMOCs include myddosomes and inflammasomes, which respectively induce transcription-dependent and -independent inflammatory responses. The common use of oligomeric structures as signaling platforms suggests multifunctionality, but each SMOC has a singular biochemically defined function. Here, we report that the myddosome is a multifunctional organizing center. In addition to promoting inflammatory transcription factor activation, the myddosome drives the rapid induction of glycolysis. We Hen - the kinase TBK1 as a myddosome component that motes glycolysis, but not nuclear factor kappa B (NF-kappa B) activation. Synthetic immunology approaches further diversified SMOC activities, as we created interferon- or necroptosis-inducing myddosomes, inflammasomes that induce interferon responses instead of pyroptosis, and a SMOC-like nanomachine that induces interferon expression in response to a chemical ligand. These discoveries demonstrate the flexibility of immune signaling organelles, which permits the design of user-defined innate immune responses.	[Tan, Yunhao; Kagan, Jonathan C.] Harvard Med Sch, Boston, MA 02115 USA; [Tan, Yunhao; Kagan, Jonathan C.] Boston Childrens Hosp, Div Gastroenterol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Kagan, JC (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Kagan, JC (corresponding author), Boston Childrens Hosp, Div Gastroenterol, Boston, MA 02115 USA.	jonathan.kagan@childrens.harvard.edu			NIH [AI133524, AI093589, AI116550, P30DK34854]; Burroughs Wellcome Fund; Jane Coffin Childs Memorial Fund for Medical Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093589, R01AI116550, U19AI133524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Jane Coffin Childs Memorial Fund for Medical Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank members of the Kagan and Zanoni labs for helpful discussions. We thank R. Vance for sharing flatox. This work was supported by NIH (AI133524, AI093589, AI116550, and P30DK34854 to J.C.K.). J.C.K. holds an Investigators in the Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund. Y.T. is supported by the Jane Coffin Childs Memorial Fund for Medical Research (the Merck Fellow).	Bonham KS, 2014, CELL, V156, P705, DOI 10.1016/j.cell.2014.01.019; Brubaker SW, 2015, ANNU REV IMMUNOL, V33, P257, DOI 10.1146/annurev-immunol-032414-112240; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Clackson T, 1998, P NATL ACAD SCI USA, V95, P10437, DOI 10.1073/pnas.95.18.10437; Clark K, 2011, P NATL ACAD SCI USA, V108, P17093, DOI 10.1073/pnas.1114194108; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Everts B, 2014, NAT IMMUNOL, V15, P323, DOI 10.1038/ni.2833; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Galluzzi L, 2017, ANNU REV PATHOL-MECH, V12, P103, DOI 10.1146/annurev-pathol-052016-100247; Gay NJ, 2014, NAT REV IMMUNOL, V14, P546, DOI 10.1038/nri3713; George J, 2011, J BIOL CHEM, V286, P1341, DOI 10.1074/jbc.M110.159996; Gong XW, 2010, J CELL BIOCHEM, V110, P1420, DOI 10.1002/jcb.22675; Green D, 1998, TRENDS CELL BIOL, V8, P267, DOI 10.1016/S0962-8924(98)01273-2; GROSSBARD L, 1966, J BIOL CHEM, V241, P3546; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Huang SCC, 2016, IMMUNITY, V45, P817, DOI 10.1016/j.immuni.2016.09.016; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Jiang XM, 2012, IMMUNITY, V36, P959, DOI 10.1016/j.immuni.2012.03.022; June CH, 2018, SCIENCE, V359, P1361, DOI 10.1126/science.aar6711; Kagan JC, 2014, NAT REV IMMUNOL, V14, P821, DOI 10.1038/nri3757; Kaiser WJ, 2013, J BIOL CHEM, V288, P31268, DOI 10.1074/jbc.M113.462341; Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Liu JG, 2015, SCIENCE, V347, DOI 10.1126/science.1258832; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Nagpal K, 2011, J BIOL CHEM, V286, P11875, DOI 10.1074/jbc.M110.199653; O'Neill LAJ, 2016, NAT REV IMMUNOL, V16, P553, DOI 10.1038/nri.2016.70; Pandey S, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016246; Pelgrom LR, 2016, METHODS MOL BIOL, V1390, P273, DOI 10.1007/978-1-4939-3335-8_17; Rathinam VAK, 2016, CELL, V165, P792, DOI 10.1016/j.cell.2016.03.046; Tanaka Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002521; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Troutman TD, 2012, P NATL ACAD SCI USA, V109, P273, DOI 10.1073/pnas.1118579109; Vance RE, 2009, CELL HOST MICROBE, V6, P10, DOI 10.1016/j.chom.2009.06.007; Ve T, 2017, NAT STRUCT MOL BIOL, V24, P743, DOI 10.1038/nsmb.3444; von Moltke J, 2012, NATURE, V490, P107, DOI 10.1038/nature11351; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yang W, 2000, J MED CHEM, V43, P1135, DOI 10.1021/jm9904396	43	54	59	3	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 4	2019	177	2					384	+		10.1016/j.cell.2019.01.039	http://dx.doi.org/10.1016/j.cell.2019.01.039			26	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	HR7PF	30853218	Green Accepted, Bronze			2022-12-28	WOS:000463346200017
J	Murphy, WJ; Longo, DL				Murphy, William J.; Longo, Dan L.			The Surprisingly Positive Association Between Obesity and Cancer Immunotherapy Efficacy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INFLAMMATION		[Murphy, William J.] Univ Calif Davis, Sch Med, Dept Dermatol, Sacramento, CA 95817 USA; Univ Calif Davis, Sch Med, Div Hematol Oncol, Dept Internal Med, Sacramento, CA 95817 USA; [Longo, Dan L.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA	University of California System; University of California Davis; University of California System; University of California Davis; Harvard University; Harvard Medical School	Murphy, WJ (corresponding author), Univ Calif Davis, Sch Med, 2921 Stockton Blvd,Ste 1614, Sacramento, CA 95817 USA.	wmjmurphy@ucdavis.edu	Longo, Dan L./F-6022-2011					Deng T, 2016, ANNU REV PATHOL-MECH, V11, P421, DOI 10.1146/annurev-pathol-012615-044359; Franceschi C, 2014, J GERONTOL A-BIOL, V69, pS4, DOI 10.1093/gerona/glu057; Gibney GT, 2016, LANCET ONCOL, V17, pE542, DOI 10.1016/S1470-2045(16)30406-5; Hales CM, 2018, JAMA-J AM MED ASSOC, V319, P1723, DOI 10.1001/jama.2018.3060; McQuade JL, 2018, LANCET ONCOL, V19, P310, DOI 10.1016/S1470-2045(18)30078-0; Mirsoian A, 2014, J EXP MED, V211, P2373, DOI 10.1084/jem.20140116; Sanmamed MF, 2018, CELL, V175, P313, DOI 10.1016/j.cell.2018.09.035; Siegel RL, 2022, CA-CANCER J CLIN, V72, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Wang ZM, 2019, NAT MED, V25, P141, DOI 10.1038/s41591-018-0221-5	9	50	51	2	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 2	2019	321	13					1247	1248		10.1001/jama.2019.0463	http://dx.doi.org/10.1001/jama.2019.0463			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HR3XR	30882850				2022-12-28	WOS:000463076800007
J	Packer, DL; Mark, DB; Robb, RA; Monahan, KH; Bahnson, TD; Poole, JE; Noseworthy, PA; Rosenberg, YD; Jeffries, N; Mitchell, LB; Flaker, GC; Pokushalov, E; Romanov, A; Bunch, TJ; Noelker, G; Ardashev, A; Revishvili, A; Wilber, DJ; Cappato, R; Kuck, KH; Hindricks, G; Davies, DW; Kowey, PR; Naccarelli, GV; Reiffel, JA; Piccini, JP; Silverstein, AP; Al-Khalidi, HR; Lee, KL				Packer, Douglas L.; Mark, Daniel B.; Robb, Richard A.; Monahan, Kristi H.; Bahnson, Tristram D.; Poole, Jeanne E.; Noseworthy, Peter A.; Rosenberg, Yves D.; Jeffries, Neal; Mitchell, L. Brent; Flaker, Greg C.; Pokushalov, Evgeny; Romanov, Alexander; Bunch, T. Jared; Noelker, Georg; Ardashev, Andrey; Revishvili, Amiran; Wilber, David J.; Cappato, Riccardo; Kuck, Karl-Heinz; Hindricks, Gerhard; Davies, D. Wyn; Kowey, Peter R.; Naccarelli, Gerald V.; Reiffel, James A.; Piccini, Jonathan P.; Silverstein, Adam P.; Al-Khalidi, Hussein R.; Lee, Kerry L.		CABANA Investigators	Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation The CABANA Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EXPERT CONSENSUS STATEMENT; HEART RHYTHM ASSOCIATION; RADIOFREQUENCY ABLATION; SURGICAL ABLATION; AMERICAN-COLLEGE; EUROPEAN-SOCIETY; WORLDWIDE SURVEY; TASK-FORCE; RECOMMENDATIONS; COLLABORATION	IMPORTANCE Catheter ablation is effective in restoring sinus rhythm in atrial fibrillation (AF), but its effects on long-term mortality and stroke risk are uncertain. OBJECTIVE To determine whether catheter ablation is more effective than conventional medical therapy for improving outcomes in AF. DESIGN, SETTING, AND PARTICIPANTS The Catheter Ablation vs Antiarrhythmic Drug Therapy for Atrial Fibrillation trial is an investigator-initiated, open-label, multicenter, randomized trial involving 126 centers in 10 countries. A total of 2204 symptomatic patients with AF aged 65 years and older or younger than 65 years with 1 or more risk factors for stroke were enrolled from November 2009 to April 2016, with follow-up through December 31, 2017. INTERVENTIONS The catheter ablation group (n = 1108) underwent pulmonary vein isolation, with additional ablative procedures at the discretion of site investigators. The drug therapy group (n = 1096) received standard rhythm and/or rate control drugs guided by contemporaneous guidelines. MAIN OUTCOMES AND MEASURES The primary end point was a composite of death, disabling stroke, serious bleeding, or cardiac arrest. Among 13 prespecified secondary end points, 3 are included in this report: all-cause mortality; total mortality or cardiovascular hospitalization; and AF recurrence. RESULTS Of the 2204 patients randomized (median age, 68 years; 37.2% female; 42.9% had paroxysmal AF and 57.1% had persistent AF), 89.3% completed the trial. Of the patients assigned to catheter ablation, 1006 (90.8%) underwent the procedure. Of the patients assigned to drug therapy, 301 (27.5%) ultimately received catheter ablation. In the intention-to-treat analysis, over a median follow-up of 48.5 months, the primary end point occurred in 8.0% (n = 89) of patients in the ablation group vs 9.2%(n = 101) of patients in the drug therapy group (hazard ratio [HR], 0.86 [95% CI, 0.65-1.15]; P =.30). Among the secondary end points, outcomes in the ablation group vs the drug therapy group, respectively, were 5.2% vs 6.1% for all-cause mortality (HR, 0.85 [95% CI, 0.60-1.21]; P =.38), 51.7% vs 58.1% for death or cardiovascular hospitalization (HR, 0.83 [95% CI, 0.74-0.93]; P =.001), and 49.9% vs 69.5% for AF recurrence (HR, 0.52 [95% CI, 0.45-0.60]; P <.001). CONCLUSIONS AND RELEVANCE Among patients with AF, the strategy of catheter ablation, compared with medical therapy, did not significantly reduce the primary composite end point of death, disabling stroke, serious bleeding, or cardiac arrest. However, the estimated treatment effect of catheter ablation was affected by lower-than-expected event rates and treatment crossovers, which should be considered in interpreting the results of the trial.	[Packer, Douglas L.; Robb, Richard A.; Monahan, Kristi H.; Noseworthy, Peter A.] Mayo Clin, Rochester, MN USA; [Mark, Daniel B.; Bahnson, Tristram D.; Piccini, Jonathan P.; Silverstein, Adam P.; Al-Khalidi, Hussein R.; Lee, Kerry L.] Duke Univ, Duke Clin Res Inst, Durham, NC USA; [Poole, Jeanne E.] Univ Washington, Med Ctr, Seattle, WA 98195 USA; [Rosenberg, Yves D.; Jeffries, Neal] NHLBI, NIH, Bldg 10, Bethesda, MD 20892 USA; [Mitchell, L. Brent] Libin Cardiovasc Inst Alberta, Calgary, AB, Canada; [Flaker, Greg C.] Univ Missouri, Columbia, MO 65211 USA; [Pokushalov, Evgeny; Romanov, Alexander] Minist Hlth Russian Federat, E Meshalkin Natl Med Res Ctr, Novosibirsk, Russia; [Bunch, T. Jared] Intermt Hlth Care, Salt Lake City, UT USA; [Noelker, Georg] Herz & Diabet Zentru, Bad Oeynhausen, Germany; [Ardashev, Andrey] Moscow MV Lomonosov State Univ, Med Sci Ctr, Moscow, Russia; [Revishvili, Amiran] Bakoulev Ctr Cardiovasc Surg, Moscow, Russia; [Wilber, David J.] Loyola Univ, Med Ctr, 2160 S 1st Ave, Maywood, IL 60153 USA; [Cappato, Riccardo] Humanitas Rozzano Milano, Milan, Italy; [Kuck, Karl-Heinz] Asklepios Klin St Georg, Hamburg, Germany; [Hindricks, Gerhard] Leipzig Heart Ctr, Leipzig, Germany; [Davies, D. Wyn] St Marys Hosp, London, England; [Kowey, Peter R.] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Wynnewood, PA USA; [Naccarelli, Gerald V.] Penn State Univ, Hershey, PA USA; [Reiffel, James A.] Columbia Univ, New York, NY USA	Mayo Clinic; Duke University; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Libin Cardiovascular Institute Of Alberta; University of Missouri System; University of Missouri Columbia; Meshalkin National Medical Research Center; Ministry of Health of the Russian Federation; Intermountain Healthcare; Ruhr University Bochum; Lomonosov Moscow State University; Loyola University Chicago; Asklepios Klinik St. Georg; Heart Center Leipzig GMBH; Imperial College London; Jefferson University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Columbia University	Packer, DL (corresponding author), Mayo Clin St Marys, 1216 Second St SW,Al 2-416, Rochester, MN 55902 USA.	packer@mayo.edu	Romanov, Alexander/AAC-4799-2019; Pokushalov, Evgeny/ABA-6205-2020; Mitchell, L. Brent/AAJ-5076-2020; Pokushalov, Evgeny A/L-7993-2014; Ардашев, Андрей/AAI-9523-2021	Pokushalov, Evgeny A/0000-0002-2560-5167; Ардашев, Андрей/0000-0003-1908-9802; Silverstein, Adam/0000-0003-2013-5087; Gallagher, Mark/0000-0002-6333-6420	National Heart, Lung, and Blood Institute [U01 HL089645, U01 HL089786, U01 HL089907, U01 HL089709] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL089786] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; Bunch TJ, 2011, J CARDIOVASC ELECTR, V22, P839, DOI 10.1111/j.1540-8167.2011.02035.x; Calkins H, 2007, HEART RHYTHM, V4, P816, DOI 10.1016/j.hrthm.2007.04.005; Calkins H, 2017, J ARRYTHM, V33, P369, DOI 10.1016/j.joa.2017.08.001; Calkins H, 2012, J INTERV CARD ELECTR, V33, P171, DOI 10.1007/s10840-012-9672-7; Calkins H, 2009, CIRC-ARRHYTHMIA ELEC, V2, P349, DOI 10.1161/CIRCEP.108.824789; Cappato R, 2005, CIRCULATION, V111, P1100, DOI 10.1161/01.CIR.0000157153.30978.67; Cappato R, 2010, CIRC-ARRHYTHMIA ELEC, V3, P32, DOI 10.1161/CIRCEP.109.859116; COX DR, 1972, J R STAT SOC B, V34, P187; Di Biase L, 2016, CIRCULATION, V133, P1637, DOI 10.1161/CIRCULATIONAHA.115.019406; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Friberg L, 2016, EUR HEART J, V37, P2478, DOI 10.1093/eurheartj/ehw087; Fuster V, 2006, CIRCULATION, V114, pe257, DOI DOI 10.1161/CIRCULATI0NAHA.106.177292; Fuster V, 2011, J AM COLL CARDIOL, V57, pE101, DOI 10.1016/j.jacc.2010.09.013; Hunter RJ, 2014, CIRC-ARRHYTHMIA ELEC, V7, P31, DOI 10.1161/CIRCEP.113.000806; Jais P, 2008, CIRCULATION, V118, P2498, DOI 10.1161/CIRCULATIONAHA.108.772582; Kalbfleisch J.D., 1980, STAT ANAL FAILURE TI, DOI [10.1002/9781118032985, DOI 10.1002/9781118032985]; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Liao JM, 2018, ANN INTERN MED, V169, P485, DOI 10.7326/M18-2003; Mark DB, 2019, JAMA-J AM MED ASSOC, V321, P1275, DOI 10.1001/jama.2019.0692; Marrouche NF, 2018, NEW ENGL J MED, V378, P417, DOI 10.1056/NEJMoa1707855; Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140; Mont L, 2014, EUR HEART J, V35, P501, DOI 10.1093/eurheartj/eht457; Morillo CA, 2014, JAMA-J AM MED ASSOC, V311, P692, DOI 10.1001/jama.2014.467; Nielsen JC, 2012, NEW ENGL J MED, V367, P1587, DOI 10.1056/NEJMoa1113566; Noseworthy PA, 2019, EUR HEART J, V40, P1257, DOI 10.1093/eurheartj/ehz085; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Packer DL, 2018, AM HEART J, V199, P192, DOI 10.1016/j.ahj.2018.02.015; Packer DL, 2013, J AM COLL CARDIOL, V61, P1713, DOI 10.1016/j.jacc.2012.11.064; Pappone C, 2006, J AM COLL CARDIOL, V48, P2340, DOI 10.1016/j.jacc.2006.08.037; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; SHEINER LB, 1995, CLIN PHARMACOL THER, V57, P6, DOI 10.1016/0009-9236(95)90260-0; Wilber DJ, 2010, JAMA-J AM MED ASSOC, V303, P333, DOI 10.1001/jama.2009.2029	34	607	623	3	44	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 2	2019	321	13					1261	1274		10.1001/jama.2019.0693	http://dx.doi.org/10.1001/jama.2019.0693			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HR3XR	30874766	Bronze, Green Published			2022-12-28	WOS:000463076800013
J	Shi, YF; Lim, SK; Liang, QR; Iyer, SV; Wang, HY; Wang, ZL; Xie, XH; Sun, DC; Chen, YJ; Tabar, V; Gutin, P; Williams, N; De Brabander, JK; Parada, LF				Shi, Yufeng; Lim, S. Kyun; Liang, Qiren; Iyer, Swathi V.; Wang, Hua-Yu; Wang, Zilai; Xie, Xuanhua; Sun, Daochun; Chen, Yu-Jung; Tabar, Viviane; Gutin, Philip; Williams, Noelle; De Brabander, Jef K.; Parada, Luis F.			Gboxin is an oxidative phosphorylation inhibitor that targets glioblastoma	NATURE			English	Article							PERMEABILITY TRANSITION PORE; CARCINOMA-CELLS; CANCER; METABOLISM; MITOCHONDRIA; METFORMIN; COMPLEX; GROWTH; RESISTANCE; RISK	Cancer-specific inhibitors that reflect the unique metabolic needs of cancer cells are rare. Here we describe Gboxin, a small molecule that specifically inhibits the growth of primary mouse and human glioblastoma cells but not that of mouse embryonic fibroblasts or neonatal astrocytes. Gboxin rapidly and irreversibly compromises oxygen consumption in glioblastoma cells. Gboxin relies on its positive charge to associate with mitochondrial oxidative phosphorylation complexes in a manner that is dependent on the proton gradient of the inner mitochondrial membrane, and it inhibits the activity of F0F1 ATP synthase. Gboxin-resistant cells require a functional mitochondrial permeability transition pore that regulates pH and thus impedes the accumulation of Gboxin in the mitochondrial matrix. Administration of a metabolically stable Gboxin analogue inhibits glioblastoma allografts and patient-derived xenografts. Gboxin toxicity extends to established human cancer cell lines of diverse organ origin, and shows that the increased proton gradient and pH in cancer cell mitochondria is a mode of action that can be targeted in the development of antitumour reagents.	[Shi, Yufeng; Iyer, Swathi V.; Wang, Zilai; Xie, Xuanhua; Sun, Daochun; Chen, Yu-Jung; Tabar, Viviane; Gutin, Philip; Parada, Luis F.] Mem Sloan Kettering Canc Ctr, Brain Tumor Ctr, 1275 York Ave, New York, NY 10021 USA; [Shi, Yufeng; Iyer, Swathi V.; Wang, Zilai; Xie, Xuanhua; Sun, Daochun; Chen, Yu-Jung; Parada, Luis F.] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA; [Lim, S. Kyun; Liang, Qiren; Wang, Hua-Yu; Williams, Noelle; De Brabander, Jef K.] UT Southwestern Med Ctr, Dept Biochem, Dallas, TX USA; [Lim, S. Kyun] UT Southwestern Med Ctr, Dept Dev Biol, Dallas, TX USA; [Chen, Yu-Jung] Mem Sloan Kettering Canc Ctr, Louis V Gerstner Jr Grad Sch Biomed Sci, 1275 York Ave, New York, NY 10021 USA; [Tabar, Viviane; Gutin, Philip; Parada, Luis F.] Mem Sloan Kettering Canc Ctr, Dept Neurosurg, 1275 York Ave, New York, NY 10021 USA; [Parada, Luis F.] Mem Sloan Kettering Canc Ctr, Dept Neurol, 1275 York Ave, New York, NY 10021 USA; [Lim, S. Kyun] Vivid Biosci, Boston, MA USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Parada, LF (corresponding author), Mem Sloan Kettering Canc Ctr, Brain Tumor Ctr, 1275 York Ave, New York, NY 10021 USA.; Parada, LF (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA.; Parada, LF (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Neurosurg, 1275 York Ave, New York, NY 10021 USA.; Parada, LF (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Neurol, 1275 York Ave, New York, NY 10021 USA.	paradal@mskcc.org	Xie, xuanhua Peter/C-5267-2012	Xie, xuanhua Peter/0000-0001-8032-4715	American Brain Tumor Association; NCI [R35: CA210100, R01: CA131313]; Commonwealth Foundation for Cancer Research; Center for Experimental Therapeutics at the Memorial Sloan Kettering Cancer Center; CPRIT [RP100782, RP120262, RP150242]; Robert A. Welch Foundation [I-1422]; NATIONAL CANCER INSTITUTE [P30CA008748, R35CA210100] Funding Source: NIH RePORTER	American Brain Tumor Association; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Commonwealth Foundation for Cancer Research; Center for Experimental Therapeutics at the Memorial Sloan Kettering Cancer Center; CPRIT; Robert A. Welch Foundation(The Welch Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Y.-J. Li, T. Shipman and S. Bapat for technical assistance; D. Sabatini (Whitehead Institute) for supplying U937, NCI-H82, Cal-62 and NCI-H524 cell lines, N. Rosen (MSKCC) for supplying Mel30, Colo205, NCI-H2030, HCT116, SK-MEL113 and A375 cell lines, A. Messing (University of Wisconsin-Madison) for supplying primary astrocytes, and C. Brennan (MSKCC) for supplying ts603 IDH1 mutant human GBM cells. S.K.L. was a recipient of the Basic Research Fellowship from American Brain Tumor Association (in memory of Theodore Sapper). L.F.P. received funding from NCI (R35: CA210100 and R01: CA131313) and support from 'Mr. William H. and Mrs. Alice Goodwin and the Commonwealth Foundation for Cancer Research' and the Center for Experimental Therapeutics at the Memorial Sloan Kettering Cancer Center. L.F.P. and J.K.D.B. received funding from CPRIT (RP100782, RP120262 and RP150242). J.K.D.B. acknowledges support from the Robert A. Welch Foundation (I-1422).	Baines CP, 2018, CELL CALCIUM, V73, P121, DOI 10.1016/j.ceca.2018.05.003; Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; BERNAL SD, 1982, SCIENCE, V218, P1117, DOI 10.1126/science.7146897; Biasutto L, 2016, BBA-MOL CELL RES, V1863, P2515, DOI 10.1016/j.bbamcr.2016.02.012; Bonora M, 2015, ONCOGENE, V34, P1608, DOI [10.1038/onc.2014.462, 10.1038/onc.2014.96]; Bonora M, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00302; Bosc C, 2017, CELL METAB, V26, P705, DOI 10.1016/j.cmet.2017.10.013; Brenner C, 2006, ONCOGENE, V25, P4744, DOI 10.1038/sj.onc.1209609; Caro P, 2012, CANCER CELL, V22, P547, DOI 10.1016/j.ccr.2012.08.014; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Cole A, 2015, CANCER CELL, V27, P864, DOI 10.1016/j.ccell.2015.05.004; Dasgupta B, 2016, TRENDS PHARMACOL SCI, V37, P192, DOI 10.1016/j.tips.2015.11.007; De Brabander J. K, 2017, International application no. PCT/US2016/065751, Patent No. 2016065751; De Brabander J. K, 2017, Patent No. 2017100525; Deribe YL, 2018, NAT MED, V24, P1047, DOI 10.1038/s41591-018-0019-5; DILMAN VM, 1980, GERONTOLOGY, V26, P241, DOI 10.1159/000212423; Dubinsky L, 2012, BIOORGAN MED CHEM, V20, P554, DOI 10.1016/j.bmc.2011.06.066; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Forrest M.D., 2015, WHY CANC CELLS HAVE; Galluzzi L, 2012, ONCOGENE, V31, P1869, DOI 10.1038/onc.2011.384; Heerdt BG, 2005, CANCER RES, V65, P9861, DOI 10.1158/0008-5472.CAN-05-2444; Heerdt BG, 2006, CANCER RES, V66, P1591, DOI 10.1158/0008-5472.CAN-05-2717; Jekimovs C, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00086; Kwon CH, 2008, CANCER RES, V68, P3286, DOI 10.1158/0008-5472.CAN-07-6867; Li F, 2005, MOL CELL BIOL, V25, P6225, DOI 10.1128/MCB.25.14.6225-6234.2005; Libby G, 2009, DIABETES CARE, V32, P1620, DOI 10.2337/dc08-2175; Liu XJ, 2016, CELL METAB, V24, P728, DOI 10.1016/j.cmet.2016.09.005; Lord SR, 2018, CELL METAB, V28, P679, DOI 10.1016/j.cmet.2018.08.021; Milani M, 2009, CANCER RES, V69, P4415, DOI 10.1158/0008-5472.CAN-08-2839; Mo W, 2013, CELL, V152, P1077, DOI 10.1016/j.cell.2013.01.053; Modica-Napolitano JS, 2001, ADV DRUG DELIVER REV, V49, P63, DOI 10.1016/S0169-409X(01)00125-9; Molina JR, 2018, NAT MED, V24, P1036, DOI 10.1038/s41591-018-0052-4; Naguib A, 2018, CELL REP, V23, P58, DOI 10.1016/j.celrep.2018.03.032; Parada LF, 2017, J CLIN ONCOL, V35, P2428, DOI 10.1200/JCO.2017.73.9540; Parikh H, 2007, PLOS MED, V4, P868, DOI 10.1371/journal.pmed.0040158; Perry SW, 2011, BIOTECHNIQUES, V50, P98, DOI 10.2144/000113610; Quiros PM, 2017, J CELL BIOL, V216, P2027, DOI 10.1083/jcb.201702058; Senese S, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.420; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Vander Heiden MG, 2017, CELL, V168, DOI 10.1016/j.cell.2016.12.039; Viale A, 2016, RECENT RESULTS CANC, V207, P135, DOI 10.1007/978-3-319-42118-6_6; Viale A, 2014, NATURE, V514, P628, DOI 10.1038/nature13611; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Weinberg SE, 2015, NAT CHEM BIOL, V11, P9, DOI 10.1038/nchembio.1712; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wheaton WW, 2014, ELIFE, V3, DOI 10.7554/eLife.02242; Ye JB, 2010, EMBO J, V29, P2082, DOI 10.1038/emboj.2010.81; Yu FX, 2010, J BIOL CHEM, V285, P25822, DOI 10.1074/jbc.M110.108290; Zhou WC, 2017, ELIFE, V6, DOI 10.7554/eLife.23781; Zhu Y, 2005, CANCER CELL, V8, P119, DOI 10.1016/j.ccr.2005.07.004; Zorov DB, 2014, PHYSIOL REV, V94, P909, DOI 10.1152/physrev.00026.2013	51	136	140	6	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 21	2019	567	7748					341	+		10.1038/s41586-019-0993-x	http://dx.doi.org/10.1038/s41586-019-0993-x			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP9JT	30842654	Green Accepted			2022-12-28	WOS:000462010000046
J	Holmes, DR; Mack, MJ				Holmes, David R., Jr.; Mack, Michael J.			Rational Dispersion for the Introduction of Transcatheter Mitral Valve Repair Into Clinical Practice Lessons Learned From TAVR	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Holmes, David R., Jr.] Mayo Clin, 200 First St SW, Rochester, MN 55905 USA; [Mack, Michael J.] Baylor Scott & White Hlth, Plano, TX USA	Mayo Clinic; Baylor Health Care System	Holmes, DR (corresponding author), Mayo Clin, 200 First St SW, Rochester, MN 55905 USA.	holmes.david@mayo.edu						Carroll JD, 2013, J AM COLL CARDIOL, V62, P1026, DOI 10.1016/j.jacc.2013.03.060; Feldman T, 2011, NEW ENGL J MED, V364, P1395, DOI 10.1056/NEJMoa1009355; Mack MJ, 2011, JAMA-J AM MED ASSOC, V306, P2149, DOI 10.1001/jama.2011.1675; Nishimura RA, 2017, J AM COLL CARDIOL, V70, P252, DOI 10.1016/j.jacc.2017.03.011; Obadia JF, 2018, NEW ENGL J MED, V379, P2297, DOI 10.1056/NEJMoa1805374; Sannino A, 2017, JAMA CARDIOL, V2, P1130, DOI 10.1001/jamacardio.2017.2976; Stone GW, 2018, NEW ENGL J MED, V379, P2307, DOI 10.1056/NEJMoa1806640	7	2	2	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 19	2019	321	11					1043	1044		10.1001/jama.2019.1542	http://dx.doi.org/10.1001/jama.2019.1542			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP4YY	30874762				2022-12-28	WOS:000461683500006
J	Fadel, SA; Boschi-Pinto, C; Yu, SC; Reynales-Shigematsu, LM; Menon, GR; Newcombe, L; Strong, KL; Wang, QQ; Jha, P				Fadel, Shaza A.; Boschi-Pinto, Cynthia; Yu, Shicheng; Reynales-Shigematsu, Luz Myriam; Menon, Geetha R.; Newcombe, Leslie; Strong, Kathleen L.; Wang, Qiqi; Jha, Prabhat			Trends in cause-specific mortality among children aged 5-14 years from 2005 to 2016 in India, China, Brazil, and Mexico: an analysis of nationally representative mortality studies	LANCET			English	Article							SEX-SPECIFIC MORTALITY; SYSTEMATIC ANALYSIS; GLOBAL BURDEN; DEATH; SURVEILLANCE; COUNTRIES; DISEASE	Background With global survival increasing for children younger than 5 years of age, attention is required to reduce the approximately 1 million deaths of children aged 5-14 years occurring every year. Causes of death at these ages remain poorly documented. We aimed to explore trends in mortality by causes of death in India, China, Brazil, and Mexico, which are home to about 40% of the world's children aged 5-14 years and experience more than 200 000 deaths annually at these ages. Methods We examined data on 244 401 deaths in children aged 5-14 years from four nationally representative data sources that obtained direct distributions of causes of death: the Indian Million Death Study, the Chinese Disease Surveillance Points, mortality data from the Mexican Instituto Nacional de Estadistica y Geografia, and mortality data from the Brazilian Institute of Geography and Statistics. We present data on 12 main disease groups in all countries, with breakdown by communicable and nutritional diseases, non-communicable diseases, injuries, and ill-defined causes. To calculate age-specific and sex-specific death rates for each cause, we applied the national cause of death distribution to the UN mortality envelopes for 2005-16 for each country. Findings Unlike Brazil, China, and Mexico, communicable diseases still account for nearly half of deaths in India in children aged 5-14 years (73 920 [46.1%] of 160 330 estimated deaths in 2016). In 2016, India had the highest death rates in nearly every category, including from communicable diseases. Fast declines among girls in communicable disease mortality narrowed the gap by 2016 with boys in India (32.6 deaths per 100 000 girls vs 26.2 per 100 000 boys) and China (1.7 vs 1.5). In China, injuries accounted for the greatest proportions of deaths (20 970 [53.2%] of 39 430 estimated deaths, in which drowning was a leading cause). The homicide death rate at ages 10-14 years was higher for boys than for girls in Brazil, increasing annually by an average of 0.7% (0.3-1.1). In India and China, the suicide death rates were higher for girls than for boys at ages 10-14 years. By contrast, in Mexico it was higher for boys than for girls, increasing annually by an average of 2.8% (2.0-3.6). Deaths from transport injuries, drowning, and cancer are common in all four countries, with transport accidents among the top three causes of death for both sexes in all countries, except for Indian girls, and cancer in the top three causes for both sexes in Mexico, Brazil, and China. Interpretation Most of the deaths that occurred between 2005 and 2016 in children aged 5-14 years in India, China, Brazil, and Mexico arose from preventable or treatable conditions. This age group is important for extending some of the global disease-specific targets developed for children younger than 5 years of age. Interventions to control noncommunicable diseases and injuries and to strengthen cause of death reporting systems are also required. Funding WHO and the University of Toronto Connaught Global Challenge. Copyright (c) This is an Open Access article published under the CC BY 3.0 IGO license which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. In any use of this article, there should be no suggestion that WHO endorses any specific organisation, products or services. The use of the WHO logo is not permitted. This notice should be preserved along with the article's original URL.	[Fadel, Shaza A.; Newcombe, Leslie; Jha, Prabhat] Univ Toronto, St Michaels Hosp, Dalla Lana Sch Publ Hlth, Ctr Global Hlth Res, Toronto, ON, Canada; [Boschi-Pinto, Cynthia] Univ Fed Fluminense, Inst Saude Colet, Niteroi, RJ, Brazil; [Yu, Shicheng; Wang, Qiqi] Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China; [Reynales-Shigematsu, Luz Myriam] Inst Nacl Salud Publ, Cuernavaca, Morelos, Mexico; [Menon, Geetha R.] Indian Council Med Res, New Delhi, India; [Strong, Kathleen L.] WHO, Maternal Newborn Child & Adolescent Hlth Dept, Geneva, Switzerland	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Universidade Federal Fluminense; Chinese Center for Disease Control & Prevention; Instituto Nacional de Salud Publica; Indian Council of Medical Research (ICMR); World Health Organization	Jha, P (corresponding author), St Michaels Hosp, Ctr Global Hlth Res, Toronto, ON M5B 1W8, Canada.; Jha, P (corresponding author), Univ Toronto, Toronto, ON M5B 1W8, Canada.	prabhat.jha@utoronto.ca	Menon, Geetha R/AAQ-7062-2020; Pinto, Cynthia Boschi/AAA-6990-2020	Pinto, Cynthia Boschi/0000-0002-0069-7974; Reynales - Shigematsu, Luz Myriam/0000-0002-5350-0928; Strong, Kathleen/0000-0002-8092-1955; Menon, Geetha/0000-0003-2491-0650; Newcombe, Leslie/0000-0003-3153-4008; Fadel, Shaza/0000-0002-2336-6254	WHO [SPHQ14-APW-4755]; University of Toronto Connaught Global Challenge Award	WHO(World Health Organization); University of Toronto Connaught Global Challenge Award	We thank David Lightfoot, information specialist at St Michael's Hospital (Toronto, Canada), for assisting us in designing the literature search strategy; Doris Ma Fat at WHO (Geneva, Switzerland) for providing Chinese statistical reports; and Patrick Gerland at the United Nations Population Division (New York, USA) for feedback. The opinions expressed in this Article are those of the authors and do not necessarily represent those of the institutions with which they are affiliated or the governments of the involved countries. This work was supported by grants by WHO (SPHQ14-APW-4755) and the University of Toronto Connaught Global Challenge Award.	Aleksandrowicz L, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-21; Boerma T, 2018, LANCET, V392, P607, DOI 10.1016/S0140-6736(18)30586-5; Bonell C, 2017, CHILD AD HLTH DEV; Borges GM, 2017, CAD SAUDE PUBLICA, V33, DOI [10.1590/0102-311X00080316, 10.1590/0102-311x00080316]; Cervantes CAD, 2016, SALUD COLECT, V12, P251, DOI 10.18294/sc.2016.743; Department-Related Parliamentary Standing Committee on Health and Family Welfare, 2018, 106 REP DEM GRANTS 2; Dhingra N, 2010, LANCET, V376, P1768, DOI 10.1016/S0140-6736(10)60831-8; Dicker D, 2018, LANCET, V392, P1684, DOI 10.1016/s0140-6736(18)31891-9; Fadel SA, 2017, LANCET, V390, P1972, DOI 10.1016/S0140-6736(17)32162-1; Gomes M, 2017, HEALTH AFFAIR, V36, P1887, DOI 10.1377/hlthaff.2017.0635; Guo K, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0051-3; Gupta S, 2015, CANC DIS CONTROL PRI, V3, DOI [10.1596/978-1-4648-0349-9_ch7, DOI 10.1596/978-1-4648-0349-9_CH7]; Health Quality Ontario, 2018, STAND IMPR QUAL CAR; Hill K, 2015, LANCET GLOB HEALTH, V3, pE609, DOI 10.1016/S2214-109X(15)00044-3; Jamison DT, 2015, DIS CONTROL PRIORITI, VThird; Jha P, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-19; Liu SW, 2016, B WORLD HEALTH ORGAN, V94, P46, DOI 10.2471/BLT.15.153148; Masquelier B, 2018, LANCET GLOB HEALTH, V6, pE1087, DOI [10.1016/S2214-109X(18)30353-X, 10.1016/s2214-109x(18)30353-x]; Morris SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020119; National Centre for the Prevention and Control of Chronic Noncommunicable Diseases, 2012, MON DAT SET CAUS DEA; Patton GC, 2016, LANCET, V387, P2423, DOI 10.1016/S0140-6736(16)00579-1; Peden M., 2008, World report on child injury prevention; Phillips DE, 2014, POPUL HEALTH METR, V12, DOI 10.1186/1478-7954-12-14; Pillay-van Wyk V, 2016, LANCET GLOB HEALTH, V4, pE642, DOI 10.1016/S2214-109X(16)30113-9; Rigby M, 2019, LANCET, V393, P225, DOI 10.1016/S0140-6736(18)32844-7; Roth GA, 2018, LANCET, V392, P1736, DOI 10.1016/s0140-6736(18)32203-7; UNESCO Office in Brazil, 2015, MAP VIOL EX DEATHS F; UNICEF, 2007, TECHN NOT CALC AV AN; United Nations Population Division, 2017, WORLD POP PROSP 2017; Wang LJ, 2019, INJURY PREV, V25, P47, DOI 10.1136/injuryprev-2017-042713; WHO, 2018, PARTN MAT NEWB CHILD; Xu R B, 2018, Zhonghua Yu Fang Yi Xue Za Zhi, V52, P802, DOI 10.3760/cma.j.issn.0253-9624.2018.08.006	32	27	32	0	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 16	2019	393	10176					1119	1127		10.1016/S0140-6736(19)30220-X	http://dx.doi.org/10.1016/S0140-6736(19)30220-X			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP1HF	30876707	hybrid, Green Published			2022-12-28	WOS:000461416600030
J	Schor, J				Schor, Joshua			When Sparks Fly - Or How Birding Beat My Burnout	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Schor, Joshua] Daughters Israel, W Orange, NJ 07052 USA; [Schor, Joshua] OptumHealth, Eden Prairie, MN 55344 USA	Optum	Schor, J (corresponding author), Daughters Israel, W Orange, NJ 07052 USA.; Schor, J (corresponding author), OptumHealth, Eden Prairie, MN 55344 USA.								0	0	0	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 14	2019	380	11					997	999		10.1056/NEJMp1812109	http://dx.doi.org/10.1056/NEJMp1812109			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HO8NL	30865792				2022-12-28	WOS:000461210000003
J	Tian, Y; Kharazmi, E; Sundquist, K; Sundquist, J; Brenner, H; Fallah, M				Tian, Yu; Kharazmi, Elham; Sundquist, Kristina; Sundquist, Jan; Brenner, Hermann; Fallah, Mahdi			Familial colorectal cancer risk in half siblings and siblings: nationwide cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							POPULATION-BASED FAMILY; HISTORY; SURVEILLANCE; HEREDITARY	OBJECTIVE To explore the risk of colorectal cancer in family members of patients with colorectal cancer, with an emphasis on subtypes of second degree relatives, especially half siblings, which were lacking in the literature. DESIGN Ambidirectional cohort study. SETTING Nationwide Swedish Family Cancer Data (record linkage). PARTICIPANTS All people residing in Sweden and born after 1931, with their biological parents, totalling >16 million individuals (follow-up: 1958-2015); of those with clear genealogy, 173 796 developed colorectal cancer. MAIN OUTCOME MEASURES Lifetime (0-79 years) cumulative risk and standardised incidence ratio of colorectal cancer among first degree relatives and second degree relatives. RESULTS The overall lifetime cumulative risk of colorectal cancer in siblings of patients was 7%, which represents a 1.7-fold (95% confidence interval 1.6 to 1.7; n=2089) increase over the risk in those without any family history of colorectal cancer. A similarly increased lifetime cumulative risk (6%) was found among half siblings (standardised incidence ratio 1.5, 95% confidence interval 1.3 to 1.8; n=140). The risk in people with colorectal cancer in both a parent and a half sibling (standardised incidence ratio 3.6, 2.4 to 5.0; n=32) was close to the risk in those with both an affected parent and an affected sibling (2.7, 2.4 to 3.0; n=396). Family history of colorectal cancer in only one second degree relative other than a half sibling (without any affected first degree relatives), such as a grandparent, uncle, or aunt, showed minor association with the risk of colorectal cancer. CONCLUSION Family history of colorectal cancer in half siblings is similarly associated with colorectal cancer risk to that in siblings. The increase in risk of colorectal cancer among people with one affected second degree relative was negligible, except for half siblings, but the risk was substantially increased for a combination of family history in one affected second degree relative and an affected first degree relative (or even another second degree relative). These evidence based findings provide novel information to help to identify people at high risk with a family history of colorectal cancer that can potentially be used for risk adapted screening.	[Tian, Yu; Kharazmi, Elham; Brenner, Hermann; Fallah, Mahdi] German Canc Res Ctr, Div Prevent Oncol, Heidelberg, Germany; [Tian, Yu; Kharazmi, Elham; Brenner, Hermann; Fallah, Mahdi] Natl Ctr Tumor Dis NCT, Heidelberg, Germany; [Tian, Yu] Heidelberg Univ, Med Fac Heidelberg, Heidelberg, Germany; [Kharazmi, Elham; Sundquist, Kristina; Sundquist, Jan; Fallah, Mahdi] Lund Univ, Ctr Primary Hlth Care Res, Malmo, Sweden; [Sundquist, Kristina; Sundquist, Jan] Icahn Sch Med Mt Sinai, Dept Populat Hlth Sci & Policy, Dept Family Med & Community Hlth, New York, NY 10029 USA; [Sundquist, Kristina; Sundquist, Jan] Shimane Univ, Sch Med, Dept Funct Pathol, Ctr Community Based Healthcare Res & Educ CoHRE, Matsue, Shimane, Japan; [Brenner, Hermann] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany; [Brenner, Hermann] German Canc Res Ctr, German Canc Consortium DKTK, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Lund University; Icahn School of Medicine at Mount Sinai; Shimane University; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ)	Fallah, M (corresponding author), German Canc Res Ctr, Div Prevent Oncol, Heidelberg, Germany.; Fallah, M (corresponding author), Natl Ctr Tumor Dis NCT, Heidelberg, Germany.; Fallah, M (corresponding author), Lund Univ, Ctr Primary Hlth Care Res, Malmo, Sweden.	m.fallah@dkfz.de	Brenner, Hermann/B-4627-2017; Tian, Yu/AAP-8207-2021; Brenner, Hermann/ABE-6383-2020; Fallah, Mahdi/A-8745-2008	Brenner, Hermann/0000-0002-6129-1572; Tian, Yu/0000-0001-7218-5954; Brenner, Hermann/0000-0002-6129-1572; Fallah, Mahdi/0000-0002-6639-065X	China Scholarship Council	China Scholarship Council(China Scholarship Council)	YT has been supported by the China Scholarship Council. The funder had no role in the design, implementation, or interpretation of results of this study.	American Cancer Society, 2018, CANC FACTS FIG 2015; Andrieu N, 2004, GUT, V53, P1322, DOI 10.1136/gut.2003.036376; Arnold M, 2017, GUT, V66, P683, DOI 10.1136/gutjnl-2015-310912; Basu P, 2018, INT J CANCER, V142, P44, DOI 10.1002/ijc.31043; Bevier M, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-163; Boyle P, 2000, BRIT MED J, V321, P805, DOI 10.1136/bmj.321.7264.805; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Butterworth AS, 2006, EUR J CANCER, V42, P216, DOI 10.1016/j.ejca.2005.09.023; Cairns SR, 2010, GUT, V59, P666, DOI 10.1136/gut.2009.179804; Ferlay J, 2007, ANN ONCOL, V18, P581, DOI 10.1093/annonc/mdl498; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Frank C, 2015, SCI REP-UK, V5, DOI 10.1038/srep12891; Frank C, 2014, INT J CANCER, V134, P1899, DOI 10.1002/ijc.28510; Hemminki K, 2004, CANCER EPIDEM BIOMAR, V13, P1253; Hemminki K, 2001, BRIT J CANCER, V84, P1466, DOI 10.1054/bjoc.2001.1811; Hemminki K, 2010, INT J CANCER, V126, P2259, DOI 10.1002/ijc.24795; Jasperson KW, 2010, GASTROENTEROLOGY, V138, P2044, DOI 10.1053/j.gastro.2010.01.054; Leddin D, 2018, GASTROENTEROLOGY, V155, P1325, DOI 10.1053/j.gastro.2018.08.017; Levin B, 2008, CA-CANCER J CLIN, V58, P130, DOI 10.3322/CA.2007.0018; Mitchell RJ, 2004, GUT, V53, P291, DOI 10.1136/gut.2003.027896; Patel SS, 2015, CANCER CONTROL, V22, P248, DOI 10.1177/107327481502200219; Safaee A, 2010, INDIAN J CANCER, V47, P27, DOI 10.4103/0019-509X.58855; Samadder NJ, 2014, GASTROENTEROLOGY, V147, P814, DOI 10.1053/j.gastro.2014.07.006; Solomon BL, 2016, BMC FAM PRACT, V17, DOI 10.1186/s12875-016-0521-0; Sundquist K, 2015, EUR J CANCER PREV, V24, P162, DOI 10.1097/CEJ.0000000000000101; Taylor DP, 2010, GASTROENTEROLOGY, V138, P877, DOI 10.1053/j.gastro.2009.11.044; Vasen HFA, 1999, GASTROENTEROLOGY, V116, P1453, DOI 10.1016/S0016-5085(99)70510-X; Weigl K, 2018, CLIN EPIDEMIOL, V10, P143, DOI 10.2147/CLEP.S145636; WHO, 2016, WORLD HLTH STAT 2016; Wolf AMD, 2018, CA-CANCER J CLIN, V68, P250, DOI 10.3322/caac.21457	30	15	16	2	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 14	2019	364								l803	10.1136/bmj.l803	http://dx.doi.org/10.1136/bmj.l803			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP5WD	30872356	Green Published, hybrid			2022-12-28	WOS:000461752500002
J	Salisbury, H				Salisbury, Helen			Helen Salisbury: Disruptive innovation-technology is not the problem	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												helen.salisbury@phc.ox.ac.uk						Advertising Standards Authority, 2018, ASA RUL BAB HEALTHC; Greenhalgh T, 2018, J MED INTERNET RES, V20, DOI 10.2196/jmir.9897; Legraien L, 2019, BABYLON GP HAND GIVE	3	1	1	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 13	2019	364								l1091	10.1136/bmj.l1091	http://dx.doi.org/10.1136/bmj.l1091			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP5VW	30867158	Bronze			2022-12-28	WOS:000461751600008
J	Hedman-Lagerlof, E; Tyrer, P; Hague, J; Tyrer, H				Hedman-Lagerlof, Erik; Tyrer, Peter; Hague, John; Tyrer, Helen			Health anxiety	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							COGNITIVE-BEHAVIOR THERAPY; HYPOCHONDRIASIS		[Hedman-Lagerlof, Erik] Karolinska Inst, Dept Clin Neurosci, Div Psychol, Stockholm, Sweden; [Tyrer, Peter] Imperial Coll, Ctr Psychiat, Community Psychiat, London, England; [Tyrer, Helen] Imperial Coll, Ctr Psychiat, London, England; [Hague, John] Ipswich & East Suffolk Clin Commissioning Grp, Clin Execut, Derby Rd Practice, Ipswich, Suffolk, England	Karolinska Institutet; Imperial College London; Imperial College London	Hedman-Lagerlof, E (corresponding author), Karolinska Inst, Dept Clin Neurosci, Div Psychol, Stockholm, Sweden.	kire.hedman@ki.se		Hedman-Lagerlof, Erik/0000-0002-7939-9848				American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Barsky AJ, 2001, MED CARE, V39, P705, DOI 10.1097/00005650-200107000-00007; CLAHRC East Midlands, COGN BEH THER HLTH A; Cooper K, 2017, BEHAV COGN PSYCHOTH, V45, P110, DOI 10.1017/S1352465816000527; Fallon BA, 2017, AM J PSYCHIAT, V174, P756, DOI 10.1176/appi.ajp.2017.16020189; Greeven A, 2007, AM J PSYCHIAT, V164, P91, DOI 10.1176/appi.ajp.164.1.91; KELLNER R, 1987, J NERV MENT DIS, V175, P20, DOI 10.1097/00005053-198701000-00004; Lucock MP, 1997, BRIT MED J, V315, P572; Muse K, 2012, J ANXIETY DISORD, V26, P189, DOI 10.1016/j.janxdis.2011.11.005; Rask CU, 2016, J ABNORM CHILD PSYCH, V44, P823, DOI 10.1007/s10802-015-0071-2; Rief W, 2006, PLOS MED, V3, P1266, DOI 10.1371/journal.pmed.0030269; Starcevic V, 2015, WORLD PSYCHIATRY, V14, P97, DOI 10.1002/wps.20195; Tyrer P, 2018, CURR PSYCHIAT REP, V20, DOI 10.1007/s11920-018-0912-0; Tyrer P, 2014, LANCET, V383, P219, DOI 10.1016/S0140-6736(13)61905-4; Weck F, 2010, J PERS ASSESS, V92, P260, DOI 10.1080/00223891003670216	15	7	7	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 12	2019	364								l774	10.1136/bmj.l774	http://dx.doi.org/10.1136/bmj.l774			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HP5VS	30862624				2022-12-28	WOS:000461751000001
J	Iacobucci, G				Iacobucci, Gareth			NHS is to test scrapping the four hour A&E target	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		IACOBUCCI G, 2019, BMJ-BRIT MED J, V364, P96634, DOI DOI 10.1136/BMJ.L455; NHS England, 2019, CLIN LED REV NHS ACC	2	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 12	2019	364								l1148	10.1136/bmj.l1148	http://dx.doi.org/10.1136/bmj.l1148			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP5VS	30862627				2022-12-28	WOS:000461751000019
J	Silberner, J				Silberner, Joanne			On the Ebola frontline: five minutes with ... Oliver Johnson	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 11	2019	364								l1106	10.1136/bmj.l1106	http://dx.doi.org/10.1136/bmj.l1106			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HP5VO	30858155				2022-12-28	WOS:000461750400003
J	Normand, C; Kaye, DM; Povsic, TJ; Dickstein, K				Normand, Camilla; Kaye, David M.; Povsic, Thomas J.; Dickstein, Kenneth			Beyond pharmacological treatment: an insight into therapies that target specific aspects of heart failure pathophysiology	LANCET			English	Review							CARDIAC-RESYNCHRONIZATION THERAPY; PRESERVED EJECTION FRACTION; LEFT-VENTRICULAR DYSFUNCTION; ACUTE MYOCARDIAL-INFARCTION; IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; ATRIOVENTRICULAR JUNCTION ABLATION; VAGUS NERVE-STIMULATION; STEM-CELL THERAPY; REDUCE LAP-HF; EXERCISE HEMODYNAMICS	Heart failure is a common syndrome associated with substantial morbidity and mortality. The management of symptoms and the strategies for improving prognosis have largely been based on pharmacological treatments. The pathophysiology of heart failure is complex because of the multiple causes responsible for this syndrome. This Series paper presents some examples of advances in heart failure management, in which the treatment specifically targets the underlying pathophysiological mechanisms responsible for the symptoms. These treatments include treatment of electromechanical dyssynchrony and dysrhythmia by cardiac resynchronisation and implantable cardioverter-defibrillators; neurohumoral modification by baroreflex and vagal stimulation; prevention of adverse cardiac remodelling by interatrial shunts; and finally targeting the myocardium directly by cell therapy in an attempt to regenerate new myocardial cells.	[Normand, Camilla; Dickstein, Kenneth] Stavanger Univ Hosp, Dept Cardiol, N-4011 Stavanger, Norway; [Normand, Camilla; Dickstein, Kenneth] Univ Bergen, Inst Internal Med, Bergen, Norway; [Kaye, David M.] Alfred Hosp, Dept Cardiol, Melbourne, Vic, Australia; [Povsic, Thomas J.] Duke Clin Res Inst, Duke Dept Med, Durham, NC USA	Stavanger University Hospital; University of Bergen; Florey Institute of Neuroscience & Mental Health; Duke University	Dickstein, K (corresponding author), Stavanger Univ Hosp, Dept Cardiol, N-4011 Stavanger, Norway.	kenneth.dickstein@med.uib.no	Kaye, David/AAF-1202-2021	Normand, Camilla/0000-0002-0978-3449; Kaye, David/0000-0003-4058-0372				Abdel-Latif A, 2007, ARCH INTERN MED, V167, P989, DOI 10.1001/archinte.167.10.989; Abraham WT, 2002, NEW ENGL J MED, V346, P1845, DOI 10.1056/NEJMoa013168; Aquilante CL, 2006, J CARD FAIL, V12, P171, DOI 10.1016/j.cardfail.2005.12.002; Arshad A, 2011, J AM COLL CARDIOL, V57, P814, DOI 10.1016/j.jacc.2010.06.061; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Bartunek J, 2017, EUR HEART J, V38, P648, DOI 10.1093/eurheartj/ehw543; Bartunek J, 2013, J AM COLL CARDIOL, V61, P2329, DOI 10.1016/j.jacc.2013.02.071; Bax JJ, 2004, J AM COLL CARDIOL, V44, P1834, DOI 10.1016/j.jacc.2004.08.016; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bhatia RS, 2006, NEW ENGL J MED, V355, P260, DOI 10.1056/NEJMoa051530; Borlaug BA, 2018, JAMA-J AM MED ASSOC, V320, P1764, DOI 10.1001/jama.2018.14852; Borlaug BA, 2015, J AM COLL CARDIOL, V66, P1672, DOI 10.1016/j.jacc.2015.07.067; Borlaug BA, 2010, CIRC-HEART FAIL, V3, P588, DOI 10.1161/CIRCHEARTFAILURE.109.930701; Brignole M, 2013, EUR HEART J, V34, P2281, DOI 10.1093/eurheartj/eht150; Brignole M, 2011, EUR HEART J, V32, P2420, DOI 10.1093/eurheartj/ehr162; Bristow MR, 2004, NEW ENGL J MED, V350, P2140, DOI 10.1056/NEJMoa032423; Buckley O, 2010, INT J CARDIOVAS IMAG, V26, P65, DOI 10.1007/s10554-009-9504-8; Burridge PW, 2012, CELL STEM CELL, V10, P16, DOI 10.1016/j.stem.2011.12.013; Cazeau S, 2001, NEW ENGL J MED, V344, P873, DOI 10.1056/NEJM200103223441202; Chan JYS, 2011, EUR HEART J, V32, P2533, DOI 10.1093/eurheartj/ehr336; Chan MMY, 2013, EUR J HEART FAIL, V15, P604, DOI 10.1093/eurjhf/hft062; Chong JJH, 2014, NATURE, V510, P273, DOI 10.1038/nature13233; Chung ES, 2008, CIRCULATION, V117, P2608, DOI 10.1161/CIRCULATIONAHA.107.743120; Cipriani M, 2015, INT J CARDIOL, V182, P454, DOI 10.1016/j.ijcard.2015.01.028; Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496; Cleland JG, 2013, EUR HEART J, V34, P3547, DOI 10.1093/eurheartj/eht290; Cleland JGF, 2006, EUR HEART J, V27, P2338, DOI 10.1093/eurheartj/ehl250; Cubbon RM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1265; Curtis AB, 2013, NEW ENGL J MED, V368, P1585, DOI 10.1056/NEJMoa1210356; de Jong R, 2014, CIRC-CARDIOVASC INTE, V7, P156, DOI 10.1161/CIRCINTERVENTIONS.113.001009; Del Trigo M, 2016, LANCET, V387, P1290, DOI 10.1016/S0140-6736(16)00585-7; Delewi R, 2013, HEART, V99, P225, DOI 10.1136/heartjnl-2012-302230; Dhesi S, 2017, CAN J CARDIOL, V33, P1060, DOI 10.1016/j.cjca.2017.04.007; Dickstein K, 2018, EUR J HEART FAIL, V20, P1039, DOI 10.1002/ejhf.1142; Dorfs S, 2014, EUR HEART J, V35, P3103, DOI 10.1093/eurheartj/ehu315; Duckers HJ, 2011, EUROINTERVENTION, V6, P805, DOI 10.4244/EIJV6I7A139; Dunham-Snary KJ, 2017, CHEST, V151, P181, DOI 10.1016/j.chest.2016.09.001; Dunlay SM, 2017, NAT REV CARDIOL, V14, DOI 10.1038/nrcardio.2017.65; Eschenhagen T, 2017, CIRCULATION, V136, P680, DOI 10.1161/CIRCULATIONAHA.117.029343; Ezekowitz JA, 2017, CAN J CARDIOL, V33, P1342, DOI 10.1016/j.cjca.2017.08.022; Feldman T, 2018, CIRCULATION, V137, P364, DOI 10.1161/CIRCULATIONAHA.117.032094; Floras JS, 2015, EUR HEART J, V36, P1974, DOI 10.1093/eurheartj/ehv087; Fukuta H, 2017, HEART FAIL REV, V22, P657, DOI 10.1007/s10741-017-9629-0; Gasparini M, 2006, J AM COLL CARDIOL, V48, P734, DOI 10.1016/j.jacc.2006.03.056; Gasparini M, 2018, EUR J HEART FAIL, V20, P1472, DOI 10.1002/ejhf.1117; Gasparini M, 2013, JACC-HEART FAIL, V1, P500, DOI 10.1016/j.jchf.2013.06.003; Gerson MC, 2010, JACC-CARDIOVASC IMAG, V3, P101, DOI 10.1016/j.jcmg.2009.07.013; Gierula J, 2014, EUR J HEART FAIL, V16, P117, DOI 10.1002/ejhf.53; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Gold MR, 2016, J AM COLL CARDIOL, V68, P149, DOI 10.1016/j.jacc.2016.03.525; Gold MR, 2012, CIRCULATION, V126, P822, DOI 10.1161/CIRCULATIONAHA.112.097709; Harris DJ, 2000, NEW ENGL J MED, V343, P475, DOI 10.1056/NEJM200008173430706; Hasenfuss G, 2016, LANCET, V387, P1298, DOI 10.1016/S0140-6736(16)00704-2; Hawkins NM, 2006, EUR HEART J, V27, P1270, DOI 10.1093/eurheartj/ehi826; Heiat A, 2002, ARCH INTERN MED, V162, P1682, DOI 10.1001/archinte.162.15.1682; Ibrahim AGE, 2014, STEM CELL REP, V2, P606, DOI 10.1016/j.stemcr.2014.04.006; Jacobson AF, 2010, J AM COLL CARDIOL, V55, P2212, DOI 10.1016/j.jacc.2010.01.014; Jansson K, 1999, CLIN CARDIOL, V22, P397, DOI 10.1002/clc.4960220606; Jeevanantham V, 2012, CIRCULATION, V126, P551, DOI 10.1161/CIRCULATIONAHA.111.086074; Kaye D, 2014, J CARD FAIL, V20, P212, DOI 10.1016/j.cardfail.2014.01.005; KAYE DM, 1995, J AM COLL CARDIOL, V26, P1257, DOI 10.1016/0735-1097(95)00332-0; Khadjooi K, 2008, HEART, V94, P879, DOI 10.1136/hrt.2007.129429; Khan M, 2015, CIRC RES, V117, P52, DOI 10.1161/CIRCRESAHA.117.305990; Kitzman DW, 2005, PROG CARDIOVASC DIS, V47, P367, DOI 10.1016/j.pcad.2005.02.002; Kober L, 2016, NEW ENGL J MED, V375, P1221, DOI 10.1056/NEJMoa1608029; Kristensen SL, 2016, EUR HEART J, V37, P3167, DOI 10.1093/eurheartj/ehw226; Kutyifa V, 2014, EUR J HEART FAIL, V16, P1323, DOI 10.1002/ejhf.185; Laflamme MA, 2002, CIRC RES, V90, P634, DOI 10.1161/01.RES.0000014822.62629.EB; Leclercq C, 2002, EUR HEART J, V23, P1780, DOI 10.1053/euhj.2002.3232; Lee DS, 2009, CIRCULATION, V119, P3070, DOI 10.1161/CIRCULATIONAHA.108.815944; Lee PY, 2001, JAMA-J AM MED ASSOC, V286, P708, DOI 10.1001/jama.286.6.708; Lewis EF, 2007, EUR J HEART FAIL, V9, P83, DOI 10.1016/j.ejheart.2006.10.012; Linde C, 2017, EUR J HEART FAIL, V19, P1056, DOI 10.1002/ejhf.795; Linde C, 2015, EUROPACE, V17, P424, DOI 10.1093/europace/euu205; Linde C, 2008, J AM COLL CARDIOL, V52, P1834, DOI 10.1016/j.jacc.2008.08.027; Lund LH, 2018, EUR J HEART FAIL, V20, P769, DOI 10.1002/ejhf.929; Lund LH, 2017, EUR J HEART FAIL, V19, P1270, DOI 10.1002/ejhf.781; Maeder MT, 2010, J AM COLL CARDIOL, V56, P855, DOI 10.1016/j.jacc.2010.04.040; Maisel WH, 2003, AM J CARDIOL, V91, p2D, DOI 10.1016/S0002-9149(02)03373-8; Marijon E, 2015, EUR HEART J, V36, P2767, DOI 10.1093/eurheartj/ehv455; Mathur A, 2017, EUR J HEART FAIL, V19, P1545, DOI 10.1002/ejhf.829; Melenovsky V, 2015, CIRC-HEART FAIL, V8, P295, DOI 10.1161/CIRCHEARTFAILURE.114.001667; Melloni C, 2010, CIRC-CARDIOVASC QUAL, V3, P135, DOI 10.1161/CIRCOUTCOMES.110.868307; Menasche P, 2008, CIRCULATION, V117, P1189, DOI 10.1161/CIRCULATIONAHA.107.734103; Mortara A, 1997, CIRCULATION, V96, P3450; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Moss AJ, 2009, NEW ENGL J MED, V361, P1329, DOI 10.1056/NEJMoa0906431; Muller P, 2002, CIRCULATION, V106, P31, DOI 10.1161/01.CIR.0000022405.68464.CA; Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446; National Institute for Health and Care Excellence (NICE), 2014, IMPL CARD DEF CARD R; Normand C, 2018, JACC-HEART FAIL, V6, P309, DOI 10.1016/j.jchf.2018.01.022; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Patel AN, 2016, LANCET, V387, P2412, DOI 10.1016/S0140-6736(16)30137-4; Patel HC, 2016, EUR J HEART FAIL, V18, P703, DOI 10.1002/ejhf.502; Pitt B, 2014, NEW ENGL J MED, V370, P1383, DOI 10.1056/NEJMoa1313731; Ponikowski P, 2016, EUR J HEART FAIL, V18, P891, DOI 10.1002/ejhf.592; Povsic TJ, 2011, AM HEART J, V162, P654, DOI 10.1016/j.ahj.2011.07.020; Premchand RK, 2014, J CARD FAIL, V20, P808, DOI 10.1016/j.cardfail.2014.08.009; Priori SG, 2015, EUROPACE, V17, P1601, DOI 10.1093/europace/euv319; Quaini F, 2002, NEW ENGL J MED, V346, P5, DOI 10.1056/NEJMoa012081; Redfield MM, 2015, NEW ENGL J MED, V373, P2314, DOI 10.1056/NEJMoa1510774; Redfield MM, 2013, JAMA-J AM MED ASSOC, V309, P1268, DOI 10.1001/jama.2013.2024; Ruschitzka F, 2013, NEW ENGL J MED, V369, P1395, DOI 10.1056/NEJMoa1306687; Schwartz PJ, 2015, CIRC-HEART FAIL, V8, P619, DOI 10.1161/CIRCHEARTFAILURE.114.001964; Shah SJ, 2015, CIRCULATION, V131, P269, DOI 10.1161/CIRCULATIONAHA.114.010637; Shiba Y, 2012, NATURE, V489, P322, DOI 10.1038/nature11317; Solomon SD, 2005, NEW ENGL J MED, V352, P2581, DOI 10.1056/NEJMoa043938; Steffel J, 2014, CIRCULATION, V130, P87, DOI 10.1161/CIRCULATIONAHA.113.006124; Stevenson LW, 2006, J CARD FAIL, V12, P407, DOI 10.1016/j.cardfail.2006.06.001; STEVENSON WG, 1993, CIRCULATION, V88, P2953, DOI 10.1161/01.CIR.88.6.2953; Tang ASL, 2010, NEW ENGL J MED, V363, P2385, DOI 10.1056/NEJMoa1009540; Teerlink JR, 2017, EUR J HEART FAIL, V19, P1520, DOI 10.1002/ejhf.898; TOMASELLI GF, 1994, CIRCULATION, V90, P2534, DOI 10.1161/01.CIR.90.5.2534; Tribouilloy C, 2008, EUR HEART J, V29, P339, DOI 10.1093/eurheartj/ehm554; Vaduganathan M, 2017, J AM COLL CARDIOL, V69, P556, DOI 10.1016/j.jacc.2016.10.078; van Empel VPM, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001293; van Veldhuisen DJ, 2009, J AM COLL CARDIOL, V53, P2150, DOI 10.1016/j.jacc.2009.02.046; Verbrugge FH, 2013, EUR J HEART FAIL, V15, P203, DOI 10.1093/eurjhf/hfs151; von Roeder M, 2017, CIRC-CARDIOVASC IMAG, V10, DOI 10.1161/CIRCIMAGING.116.005467; Vrtovec B, 2013, CIRC RES, V112, P165, DOI 10.1161/CIRCRESAHA.112.276519; Wallen WJ, 2010, ANN THORAC CARDIOVAS, V16, P72; Whitbeck MG, 2014, EUROPACE, V16, P803, DOI 10.1093/europace/eut335; Wolsk E, 2018, EUR J HEART FAIL, V20, P715, DOI 10.1002/ejhf.976; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; Yu CM, 2009, NEW ENGL J MED, V361, P2123, DOI 10.1056/NEJMoa0907555; Yusuf S, 2003, LANCET, V362, P777, DOI 10.1016/S0140-6736(03)14285-7; Zabarovskaja S, 2012, EUROPACE, V14, P1148, DOI 10.1093/europace/eus039; Zamani P, 2015, CIRCULATION, V131, P371, DOI 10.1161/CIRCULATIONAHA.114.012957; Zareba W, 2011, CIRCULATION, V123, P1061, DOI 10.1161/CIRCULATIONAHA.110.960898; Zipes DP, 2016, JACC-HEART FAIL, V4, P129, DOI 10.1016/j.jchf.2015.10.006; Zusterzeel R, 2014, J AM COLL CARDIOL, V64, P887, DOI 10.1016/j.jacc.2014.06.1162; Zusterzeel R, 2014, JAMA INTERN MED, V174, P1340, DOI 10.1001/jamainternmed.2014.2717	133	36	38	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 9	2019	393	10175					1045	1055		10.1016/S0140-6736(18)32216-5	http://dx.doi.org/10.1016/S0140-6736(18)32216-5			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HO0OW	30860030				2022-12-28	WOS:000460604200038
J	Turk, AS; Siddiqui, A; Fifi, JT; De Leacy, RA; Fiorella, DJ; Gu, E; Levy, EI; Snyder, KV; Hanel, RA; Aghaebrahim, A; Woodward, BK; Hixson, HR; Chaudry, MI; Spiotta, AM; Rai, AT; Frei, D; Almandoz, JED; Kelly, M; Arthur, A; Baxter, B; English, J; Linfante, I; Fargen, KM; Mocco, J				Turk, Aquilla S., III; Siddiqui, Adnan; Fifi, Johanna T.; De Leacy, Reade A.; Fiorella, David J.; Gu, Eugene; Levy, Elad I.; Snyder, Kenneth V.; Hanel, Ricardo A.; Aghaebrahim, Amin; Woodward, B. Keith; Hixson, Harry R.; Chaudry, Mohammad I.; Spiotta, Alejandro M.; Rai, Ansaar T.; Frei, Donald; Almandoz, Josser E. Delgado; Kelly, Mike; Arthur, Adam; Baxter, Blaise; English, Joey; Linfante, Italo; Fargen, Kyle M.; Mocco, J.			Aspiration thrombectomy versus stent retriever thrombectomy as first-line approach for large vessel occlusion (COMPASS): a multicentre, randomised, open label, blinded outcome, non-inferiority trial	LANCET			English	Article							ACUTE ISCHEMIC-STROKE; 1ST PASS TECHNIQUE; ENDOVASCULAR TREATMENT; INTRAVENOUS ALTEPLASE; GUIDELINES; THERAPY; SOCIETY	Background Stent retriever thrombectomy of large-vessel occlusion results in better outcomes than medical therapy alone. Alternative thrombectomy strategies, particularly a direct aspiration as first pass technique, while promising, have not been rigorously assessed for clinical efficacy in randomised trials. We designed COMPASS to assess whether patients treated with aspiration as first pass have non-inferior functional outcomes to those treated with a stent retriever as first line. Methods We did a multicentre, randomised, open label, blinded outcome, core lab adjudicated non-inferiority trial at 15 sites (ten hospitals and four specialty clinics in the USA and one hospital in Canada). Eligible participants were patients presenting with acute ischaemic stroke from anterior circulation large-vessel occlusion within 6 h of onset and an Alberta Stroke Program Early CT Score of greater than 6. We randomly assigned participants (1: 1) via a central web-based system without stratification to either direct aspiration first pass or stent retriever first line thrombectomy. Those assessing primary outcomes via clinical examinations were masked to group assignment as they were not involved in the procedures. Physicians were allowed to use adjunctive technology as was consistent with their standard of care. The null hypothesis for this study was that patients treated with aspiration as first pass achieve inferior outcomes compared with those treated with a stent retriever first line approach. The primary outcome was non-inferiority of clinical functional outcome at 90 days as measured by the percentage of patients achieving a modified Rankin Scale score of 0-2, analysed by intent to treat; non-inferiority was established with a margin of 0.15. All randomly assigned patients were included in the safety analyses. This trial is registered at ClinicalTrials.gov, number: NCT02466893. Findings Between June 1, 2015, and July 5, 2017, we assigned 270 patients to treatment: 134 to aspiration first pass and 136 to stent retriever first line. A modified Rankin score of 0-2 at 90 days was achieved by 69 patients (52%; 95% CI 43.8-60.3) in the aspiration group and 67 patients (50%; 41.6-57.4) in the stent retriever group, showing that aspiration as first pass was non-inferior to stent retriever first line (p(non-inferiority) = 0.0014). Intracranial haemorrhage occurred in 48 (36%) of 134 in the aspiration first pass group, and 46 (34%) of 135 in the stent retriever first line group. All-cause mortality at 3 months occurred in 30 patients (22%) in both groups. Interpretation A direct aspiration as first pass thrombectomy conferred non-inferior functional outcome at 90 days compared with stent retriever first line thrombectomy. This study supports the use of direct aspiration as an alternative to stent retriever as first-line therapy for stroke thrombectomy. Funding Penumbra. Copyright (C) 2019 Elsevier Ltd. All rights reserved.	[Turk, Aquilla S., III; Chaudry, Mohammad I.] Greenville Hlth Syst, Dept Neurosurg, Greenville, SC 29605 USA; [Spiotta, Alejandro M.] Med Univ South Carolina, Dept Neurosurg, Charleston, SC 29425 USA; [Siddiqui, Adnan; Levy, Elad I.; Snyder, Kenneth V.] SUNY Buffalo, Dept Neurosurg, Buffalo, NY USA; [Fifi, Johanna T.; De Leacy, Reade A.; Mocco, J.] Icahn Sch Med Mt Sinai, Dept Neurosurg, New York, NY 10029 USA; [Fiorella, David J.; Gu, Eugene] SUNY Stony Brook, Cerebrovasc Ctr, Stony Brook, NY 11794 USA; [Hanel, Ricardo A.; Aghaebrahim, Amin] Baptist Med Ctr, Lyerly Neurosurg, Jacksonville, FL USA; [Woodward, B. Keith; Hixson, Harry R.] Ft Sanders Reg Med Ctr, Dept Radiol, Knoxville, TN USA; [Rai, Ansaar T.] West Virginia Univ, Dept Neurointervent Radiol, Morgantown, WV 26506 USA; [Frei, Donald] Swedish Med Ctr, RIA Neurovasc, Radiol Imaging Associates, Englewood, CO 80110 USA; [Almandoz, Josser E. Delgado] Abbott NW Hosp, Dept Radiol, Minneapolis, MN 55407 USA; [Kelly, Mike] Univ Saskatchewan, Dept Surg, Saskatoon, SK, Canada; [Arthur, Adam] Semmes Murphey Clin, Dept Neurosurg, Memphis, TN USA; [Baxter, Blaise] Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA; [Baxter, Blaise] Erlanger Med Ctr, Dept Radiol, Chattanooga, TN USA; [English, Joey] Calif Pacific Med Ctr, Dept Neurointervent Serv, San Francisco, CA USA; [Linfante, Italo] Miami Vasc Specialist, Cardiac & Vasc Inst, Miami, FL USA; [Fargen, Kyle M.] Wake Forest Baptist Med Ctr, Dept Neurosurg, Winston Salem, NC USA	Greenville Health System; Medical University of South Carolina; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Icahn School of Medicine at Mount Sinai; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; West Virginia University; University of Saskatchewan; University of Tennessee System; University of Tennessee Health Science Center; California Pacific Medical Center; Baptist Cardiac & Vascular Institute; Wake Forest University; Wake Forest Baptist Medical Center	Turk, AS (corresponding author), Greenville Hlth Syst, Dept Neurosurg, Greenville, SC 29605 USA.	aturk@ghs.org	Siddiqui, Adnan H./AAG-9781-2019	Fargen, Kyle/0000-0001-8979-1993; Fifi, Johanna/0000-0001-7786-5668; Kelly, Michael/0000-0002-3278-2620	Penumbra	Penumbra	Penumbra.	Albers GW, 2018, NEW ENGL J MED, V378, P708, DOI 10.1056/NEJMoa1713973; Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Blackham KA, 2012, J NEUROINTERV SURG, V4, P87, DOI 10.1136/neurintsurg-2011-010243; Bracard S, 2016, LANCET NEUROL, V15, P1138, DOI 10.1016/S1474-4422(16)30177-6; Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792; Comai A, 2015, RADIOL MED, V120, P655, DOI 10.1007/s11547-015-0501-9; Froehler MT, 2018, J NEUROINTERV SURG, V10, P784, DOI 10.1136/neurintsurg-2018-013769; Goyal M, 2015, NEW ENGL J MED, V372, P1019, DOI 10.1056/NEJMoa1414905; Jovin TG, 2015, NEW ENGL J MED, V372, P2296, DOI 10.1056/NEJMoa1503780; Lapergue B, 2017, JAMA-J AM MED ASSOC, V318, P443, DOI 10.1001/jama.2017.9644; Lavine SD, 2016, INTERV NEUROL, V5, P51, DOI 10.1159/000444945; Long TD, 2019, J NEUROINTERV SURG, V11, P190, DOI 10.1136/neurintsurg-2017-013702; Mocco J, 2016, STROKE, V47, P2331, DOI 10.1161/STROKEAHA.116.013372; Powers WJ, 2018, STROKE, V49, pE46, DOI 10.1161/STR.0000000000000158; Saver JL, 2015, NEW ENGL J MED, V372, P2285, DOI 10.1056/NEJMoa1415061; Saver JL, 2010, STROKE, V41, P992, DOI 10.1161/STROKEAHA.109.571364; Simon SD, 2014, J NEUROINTERV SURG, V6, P205, DOI 10.1136/neurintsurg-2012-010638; Turk AS, 2018, J NEUROINTERV SURG, V10, P953, DOI 10.1136/neurintsurg-2017-013722; Turk AS, 2015, J NEUROINTERV SURG, V7, P666, DOI 10.1136/neurintsurg-2014-011282; Turk AS, 2014, J NEUROINTERV SURG, V6, P260, DOI 10.1136/neurintsurg-2014-011125; Turk AS, 2014, J NEUROINTERV SURG, V6, P231, DOI 10.1136/neurintsurg-2013-010713	21	215	221	7	42	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 9	2019	393	10175					998	1008		10.1016/S0140-6736(19)30297-1	http://dx.doi.org/10.1016/S0140-6736(19)30297-1			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HO0OW	30860055				2022-12-28	WOS:000460604200033
J	Brauer, P; Parker, JL; Gerondopoulos, A; Zimmermann, I; Seeger, MA; Barr, FA; Newstead, S				Brauer, Philipp; Parker, Joanne L.; Gerondopoulos, Andreas; Zimmermann, Iwan; Seeger, Markus A.; Barr, Francis A.; Newstead, Simon			Structural basis for pH-dependent retrieval of ER proteins from the Golgi by the KDEL receptor	SCIENCE			English	Article							MEMBRANE-PROTEINS; BINDING; COMPLEX	Selective export and retrieval of proteins between the endoplasmic reticulum (ER) and Golgi apparatus is indispensable for eukaryotic cell function. An essential step in the retrieval of ER luminal proteins from the Golgi is the pH-dependent recognition of a carboxyl-terminal Lys-Asp-Glu-Leu (KDEL) signal by the KDEL receptor. Here, we present crystal structures of the chicken KDEL receptor in the apo ER state, KDEL-bound Golgi state, and in complex with an antagonistic synthetic nanobody (sybody). These structures show a transporter-like architecture that undergoes conformational changes upon KDEL binding and reveal a pH-dependent interaction network crucial for recognition of the carboxyl terminus of the KDEL signal. Complementary in vitro binding and in vivo cell localization data explain how these features create a pH-dependent retrieval system in the secretory pathway.	[Brauer, Philipp; Parker, Joanne L.; Gerondopoulos, Andreas; Barr, Francis A.; Newstead, Simon] Univ Oxford, Dept Biochem, South Parks Rd, Oxford OX1 3QU, England; [Zimmermann, Iwan; Seeger, Markus A.] Univ Zurich, Inst Med Microbiol, CH-8006 Zurich, Switzerland	University of Oxford; University of Zurich	Barr, FA; Newstead, S (corresponding author), Univ Oxford, Dept Biochem, South Parks Rd, Oxford OX1 3QU, England.	francis.barr@bioch.ox.ac.uk; simon.newstead@bioch.ox.ac.uk		Zimmermann, Iwan/0000-0003-3476-4749; Newstead, Simon/0000-0001-7432-2270; Barr, Francis/0000-0001-7518-253X; Brauer, Philipp/0000-0003-4127-2638; Parker, Joanne/0000-0003-2964-2720; Seeger, Markus/0000-0003-1761-8571	Wellcome awards [102890/Z/13/Z, 109133/Z/15/A, 097769/Z/11/Z]; SNSF Professorship of the Swiss National Science Foundation [PP00P3_144823]; Commission for Technology and Innovation CTI [16003.1 PFLS-LS]	Wellcome awards; SNSF Professorship of the Swiss National Science Foundation; Commission for Technology and Innovation CTI	This work was supported by Wellcome awards (102890/Z/13/Z, 109133/Z/15/A, and 097769/Z/11/Z) to S.N. and F.A.B. and SNSF Professorship of the Swiss National Science Foundation (PP00P3_144823) and Commission for Technology and Innovation CTI (16003.1 PFLS-LS) to M.A.S.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Barlowe C, 2003, TRENDS CELL BIOL, V13, P295, DOI 10.1016/S0962-8924(03)00082-5; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Drew D, 2008, NAT PROTOC, V3, P784, DOI 10.1038/nprot.2008.44; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Feng L, 2016, TRENDS BIOCHEM SCI, V41, P118, DOI 10.1016/j.tibs.2015.11.014; Gomez-Navarro N, 2016, J CELL BIOL, V215, P769, DOI 10.1083/jcb.201610031; GRIFFITHS G, 1994, J CELL BIOL, V127, P1557, DOI 10.1083/jcb.127.6.1557; Jackson LP, 2012, DEV CELL, V23, P1255, DOI 10.1016/j.devcel.2012.10.017; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; LETOURNEUR F, 1994, CELL, V79, P1199, DOI 10.1016/0092-8674(94)90011-6; LEWIS MJ, 1992, CELL, V68, P353, DOI 10.1016/0092-8674(92)90476-S; Majoul I, 2001, DEV CELL, V1, P139, DOI 10.1016/S1534-5807(01)00004-1; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Parker JL, 2017, NATURE, V551, P521, DOI 10.1038/nature24464; Parker JL, 2014, PROTEIN SCI, V23, P1309, DOI 10.1002/pro.2507; PELHAM HRB, 1988, EMBO J, V7, P1757, DOI 10.1002/j.1460-2075.1988.tb03005.x; Pfeffer SR, 2007, ANNU REV BIOCHEM, V76, P629, DOI 10.1146/annurev.biochem.76.061705.130002; Scheel AA, 1998, J BIOL CHEM, V273, P2467, DOI 10.1074/jbc.273.4.2467; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; SEMENZA JC, 1990, CELL, V61, P1349, DOI 10.1016/0092-8674(90)90698-E; Sharpe HJ, 2010, CELL, V142, P158, DOI 10.1016/j.cell.2010.05.037; Tao YY, 2015, NATURE, V527, P259, DOI 10.1038/nature15391; TOWNSLEY FM, 1994, J CELL BIOL, V127, P21, DOI 10.1083/jcb.127.1.21; TOWNSLEY FM, 1993, EMBO J, V12, P2821, DOI 10.1002/j.1460-2075.1993.tb05943.x; WILSON DW, 1993, J BIOL CHEM, V268, P7465; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Winter G, 2018, ACTA CRYSTALLOGR D, V74, P85, DOI 10.1107/S2059798317017235; Wu MM, 2001, J BIOL CHEM, V276, P33027, DOI 10.1074/jbc.M103917200; Wu MM, 2000, CHEM BIOL, V7, P197, DOI 10.1016/S1074-5521(00)00088-0; Zimmermann I, 2018, ELIFE, V7, DOI 10.7554/eLife.34317	35	60	60	3	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 8	2019	363	6431					1103	1107		10.1126/science.aaw2859	http://dx.doi.org/10.1126/science.aaw2859			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HO2MV	30846601	Green Submitted			2022-12-28	WOS:000460750100046
J	Ameratunga, R; Klonin, H; Vaughan, J; Merry, A; Cusack, J				Ameratunga, Rohan; Klonin, Hilary; Vaughan, Jenny; Merry, Alan; Cusack, Jonathan			Criminalisation of unintentional error in healthcare in the UK: a perspective from New Zealand	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ACCOUNTABILITY		[Ameratunga, Rohan; Merry, Alan] Auckland City Hosp, Pk Rd, Auckland 1010, New Zealand; [Ameratunga, Rohan; Merry, Alan] Univ Auckland, Pk Rd, Auckland 1010, New Zealand; [Klonin, Hilary] Hull Royal Infirm, Dept Paediat, Anlaby Rd, Kingston Upon Hull HU3 2JZ, N Humberside, England; [Vaughan, Jenny] North West London Healthcare NHS Trust, Ealing Hosp, Uxbridge Rd, London UB1 3HW, England; [Vaughan, Jenny] Imperial Coll Healthcare NHS Trust, Charing Cross Hosp, Fulham Palace Rd, London W6 8RF, England; [Merry, Alan] Univ Auckland, Auckland 1142, New Zealand; [Cusack, Jonathan] Leicester Med Sch, Infirm Rd, Leicester LE1 5WW, Leics, England	Auckland City Hospital; University of Auckland; University of Hull; Imperial College London; University of Auckland; University of Leicester	Ameratunga, R (corresponding author), Auckland City Hosp, Pk Rd, Auckland 1010, New Zealand.; Ameratunga, R (corresponding author), Univ Auckland, Pk Rd, Auckland 1010, New Zealand.	rohana@adhb.govt.nz						[Anonymous], 2018, BBC DOCT TRIAL BBC; Bismark M, 2006, CAN MED ASSOC J, V175, P889, DOI 10.1503/cmaj.060429; Braithwaite J, 2017, COMPLEXITY SCI HEALT; Brazier M, 2017, J PATIENT SAF RISK M, V22, P88; Cartwright SR, 1988, REPORT COMMITTEE INQ; Cohen D., 2018, BBC; Cusack J, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k212; DYER C, 2018, BMJ-BRIT MED J, V363, DOI DOI 10.1136/BMJ.K4412; DYER C, 2017, BMJ-BRIT MED J, V357, DOI DOI 10.1136/BMJ.J2928; Ferner RE, 2006, J ROY SOC MED, V99, P309, DOI 10.1258/jrsm.99.6.309; GMC, 2018, WILL REV GROSS NEGL; Jansen P, 2017, COLES MED PRACTICE N, P445; Jha S., 2018, ERR IS HOMICIDE BRIT; Kahneman D., 2011, THINKING FAST SLOW; LRI, 2012, INV REP DEATH J ADC; Merry A, 2017, CAMB BIOETH LAW, P1, DOI 10.1017/9781316848050; NPSA, 2013, 7 STEPS PAT SAF; Paterson R., 2013, BIOETHICS MED CRIMIN, P229, DOI [10.1017/CBO9781139109376.017, DOI 10.1017/CBO9781139109376.017]; Perrow C., 1999, NORMAL ACCIDENTS LIV; Quick O., 2013, BIOETHICS MED CRIMIN, DOI [10.1017/CBO9781139109376.009, DOI 10.1017/CBO9781139109376.009]; RCN, 2013, DEF STAFF LEV CHILDR; RCPCH, 2015, FAC FUT STAND AC GEN; Reason J., 1997, MANAGING RISK ORG AC; Skegg P, 1998, MED LAW REV, V6, P220, DOI DOI 10.1093/MEDLAW/6.2.220; The Secret Barrister, 2018, SOM THOUGHTS DR BAWA; Vaughan J., 2018, RCS B, V100, P325; Wachter RM, 2009, NEW ENGL J MED, V361, P1401, DOI 10.1056/NEJMsb0903885; Williams N., 2018, PROFESSOR N WILLIAMS	28	11	11	2	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 7	2019	364								l706	10.1136/bmj.l706	http://dx.doi.org/10.1136/bmj.l706			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HO6TA	30846443				2022-12-28	WOS:000461063200003
J	Salisbury, H				Salisbury, Helen			PRIMARY COLOUR Helen Salisbury: Primary care networks-cause for celebration or concern?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												helen.salisbury@phc.ox.ac.uk						NHS England, PRIM CAR NETW	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 5	2019	364								l973	10.1136/bmj.l973	http://dx.doi.org/10.1136/bmj.l973			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HO6SS	30837220	Bronze			2022-12-28	WOS:000461062200007
J	Wise, J				Wise, Jacqui			The BMJ Awards 2019: Anaesthesia and Perioperative Medicine Team of the Year	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 4	2019	364								l976	10.1136/bmj.l976	http://dx.doi.org/10.1136/bmj.l976			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HO6SQ	30833269				2022-12-28	WOS:000461061900005
